PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bailleul, B; Berne, N; Murik, O; Petroutsos, D; Prihoda, J; Tanaka, A; Villanova, V; Bligny, R; Flori, S; Falconet, D; Krieger-Liszkay, A; Santabarbara, S; Rappaport, F; Joliot, P; Tirichine, L; Falkowski, PG; Cardol, P; Bowler, C; Finazzi, G				Bailleul, Benjamin; Berne, Nicolas; Murik, Omer; Petroutsos, Dimitris; Prihoda, Judit; Tanaka, Atsuko; Villanova, Valeria; Bligny, Richard; Flori, Serena; Falconet, Denis; Krieger-Liszkay, Anja; Santabarbara, Stefano; Rappaport, Fabrice; Joliot, Pierre; Tirichine, Leila; Falkowski, Paul G.; Cardol, Pierre; Bowler, Chris; Finazzi, Giovanni			Energetic coupling between plastids and mitochondria drives CO2 assimilation in diatoms	NATURE			English	Article							CYCLIC ELECTRON FLOW; CHLAMYDOMONAS-REINHARDTII; OXYGEN PHOTOREDUCTION; PHOTOSYNTHESIS; LIGHT; ATP; MEMBRANE; GENE; INACTIVATION; TRANSPORT	Diatoms are one of the most ecologically successful classes of photosynthetic marine eukaryotes in the contemporary oceans. Over the past 30 million years, they have helped to moderate Earth's climate by absorbing carbon dioxide from the atmosphere, sequestering it via the biological carbon pump and ultimately burying organic carbon in the lithosphere(1). The proportion of planetary primary production by diatoms in the modern oceans is roughly equivalent to that of terrestrial rainforests(2). In photosynthesis, the efficient conversion of carbon dioxide into organic matter requires a tight control of the ATP/NADPHratio which, in other photosynthetic organisms, relies principally on a range of plastid-localized ATP generating processes(3-6). Here we show that diatoms regulate ATP/NADPH through extensive energetic exchanges between plastids and mitochondria. This interaction comprises the re-routing of reducing power generated in the plastid towards mitochondria and the import of mitochondrial ATP into the plastid, and is mandatory for optimized carbon fixation and growth. We propose that the process may have contributed to the ecological success of diatoms in the ocean.	[Bailleul, Benjamin; Berne, Nicolas; Cardol, Pierre] Univ Liege, Dept Sci Vie & PhytoSYST, Genet & Physiol Microalgues, B-4000 Liege, Belgium; [Bailleul, Benjamin; Falkowski, Paul G.] Rutgers State Univ, Environm Biophys & Mol Ecol Program, Dept Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Bailleul, Benjamin; Falkowski, Paul G.] Rutgers State Univ, Environm Biophys & Mol Ecol Program, Dept Earth & Planetary Sci, New Brunswick, NJ 08901 USA; [Bailleul, Benjamin; Rappaport, Fabrice; Joliot, Pierre] Univ Paris 06, CNRS, IBPC, UMR 7141, F-75005 Paris, France; [Bailleul, Benjamin; Murik, Omer; Prihoda, Judit; Tanaka, Atsuko; Tirichine, Leila; Bowler, Chris] PSL Res Univ, Ecole Normale Super, IBENS, CNRS,UMR 8197,INSERM,U1024, F-75005 Paris, France; [Petroutsos, Dimitris; Bligny, Richard; Flori, Serena; Falconet, Denis; Finazzi, Giovanni] Univ Grenoble Alpes, Inst Rech Sci & Technol Vivant iRTSV, Lab Physiol Cellulaire & Vegetale, UMR 5168,CNRS,CEA,INRA,CEA Grenoble, F-38054 Grenoble 9, France; [Villanova, Valeria] Fermentalg SA, F-33500 Libourne, France; [Krieger-Liszkay, Anja] Univ Paris Sud, Inst Biol & Technol Saclay, Inst Integrat Biol Cell I2BC, CEA,CNRS, F-91191 Gif Sur Yvette, France; [Santabarbara, Stefano] CNR, Ist Biofis, I-20133 Milan, Italy	University of Liege; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Bailleul, B (corresponding author), Univ Liege, Dept Sci Vie & PhytoSYST, Genet & Physiol Microalgues, B-4000 Liege, Belgium.	bailleul@ibpc.fr; cbowler@biologie.ens.fr; giovanni.finazzi@cea.fr	Villanova, Valeria/Q-6723-2018; Flori, Serena/GPP-7017-2022; Petroutsos, Dimitris/AAB-1976-2021; Cardol, Pierre/AAA-3090-2019; Petroutsos, Dimitris/E-4958-2011; Murik, Omer/O-7894-2019; Bowler, Chris/AAC-6256-2019; Villanova, Valeria/AAI-9561-2021	Flori, Serena/0000-0003-3407-2785; Petroutsos, Dimitris/0000-0002-9656-661X; Cardol, Pierre/0000-0001-9799-0546; Petroutsos, Dimitris/0000-0002-9656-661X; Villanova, Valeria/0000-0001-6619-6315; Bowler, Chris/0000-0003-3835-6187; Tanaka, Atsuko/0000-0002-8277-1188; Krieger-Liszkay, Anja/0000-0001-7141-4129; TIRICHINE DELACOUR, LEILA/0000-0002-9491-4414; Santabarbara, Stefano/0000-0002-7993-2614	Agence Nationale de la Recherche [ANR-12-BIME-0005, ANR-8NT09567009, ANR-11-LABX-0011-01, ANR-11-IDEX-0001-02, ANR-10-LABX-54]; Region Rhone-Alpes; Marie Curie Initial Training Network Accliphot [316427]; ERC; EU; CNRS Defi; CEA Bioenergies program; Belgian Fonds de la Recherche Scientifique F.R.S.-F.N.R.S. [F.R.F.C. 2.4597.11, CDR J.0032.15, F.4520]; Rutgers University; COSI ITN project	Agence Nationale de la Recherche(French National Research Agency (ANR)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Marie Curie Initial Training Network Accliphot; ERC(European Research Council (ERC)European Commission); EU(European Commission); CNRS Defi; CEA Bioenergies program; Belgian Fonds de la Recherche Scientifique F.R.S.-F.N.R.S.(Fonds de la Recherche Scientifique - FNRS); Rutgers University; COSI ITN project	This work was supported by grants from Agence Nationale de la Recherche (ANR-12-BIME-0005, DiaDomOil to C.B., D.P. and G.F.; ANR-8NT09567009, Phytadapt to B.B., G.F. and C.B.; ANR-11-LABX-0011-01, Dynamo to F.R. and P.J.; ANR-11-IDEX-0001-02, PSL Research University and ANR-10-LABX-54, MEMOLIFE to C.B.), the Region Rhone-Alpes (Cible project) to G.F., the Marie Curie Initial Training Network Accliphot (FP7-PEPOPLE-2012-ITN; 316427) to G.F., D.P., S.F. and V.V., an ERC Advanced Award (Diatomite) and the EU MicroB3 project to C.B., the CNRS Defi (ENRS 2013) to G.F. and L.T., and the CEA Bioenergies program to G.F and D.P. P.C., N.B. and B.B acknowledge financial support from the Belgian Fonds de la Recherche Scientifique F.R.S.-F.N.R.S. (F.R.F.C. 2.4597.11, CDR J.0032.15 and Incentive Grant for Scientific Research F.4520). B.B. also acknowledges a post-doctoral fellowship from Rutgers University and J.P. was funded from the COSI ITN project to C.B. Thanks are due to J.-L. Putaux and C. Lancelon-Pin for help with electron microscopy, to L. Moyet for technical support for the in vivo NMR analysis, to A. E. Allen for the AOX antibody, and to A. Falciatore and F. Barneche for critical reading the manuscript.	Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; ALLEN JF, 1975, NATURE, V256, P599, DOI 10.1038/256599a0; Asada K, 2000, PHILOS T ROY SOC B, V355, P1419, DOI 10.1098/rstb.2000.0703; ASADA K, 1974, AGR BIOL CHEM TOKYO, V38, P471, DOI 10.1080/00021369.1974.10861178; BADGER MR, 1985, ANNU REV PLANT PHYS, V36, P27, DOI 10.1146/annurev.arplant.36.1.27; Bailleul B, 2010, PHOTOSYNTH RES, V106, P179, DOI 10.1007/s11120-010-9579-z; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Bligny R, 2001, CURR OPIN PLANT BIOL, V4, P191, DOI 10.1016/S1369-5266(00)00160-6; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Cardol P, 2009, P NATL ACAD SCI USA, V106, P15979, DOI 10.1073/pnas.0908111106; Dang KV, 2014, PLANT CELL, V26, P3036, DOI 10.1105/tpc.114.126375; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; DINER B, 1976, BIOCHIM BIOPHYS ACTA, V423, P479, DOI 10.1016/0005-2728(76)90202-4; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Finazzi G, 1998, BIOCHEMISTRY-US, V37, P9999, DOI 10.1021/bi980320j; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Grouneva I, 2011, J PROTEOME RES, V10, P5338, DOI 10.1021/pr200600f; Guillard R.R.L., 1975, CULTURE MARINE INVER, P26, DOI DOI 10.1007/978-1-4615-8714-9_3; Joet T, 2001, PLANT PHYSIOL, V125, P1919, DOI 10.1104/pp.125.4.1919; Johnson X, 2009, PHOTOSYNTH RES, V102, P85, DOI 10.1007/s11120-009-9487-2; JOLIOT P, 1974, BIOCHIM BIOPHYS ACTA, V357, P267, DOI 10.1016/0005-2728(74)90066-8; JOLIOT P, 1989, BIOCHIM BIOPHYS ACTA, V975, P355, DOI 10.1016/S0005-2728(89)80343-3; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Kinoshita H, 2011, PLANT J, V65, P15, DOI 10.1111/j.1365-313X.2010.04397.x; LEMAIRE C, 1988, P NATL ACAD SCI USA, V85, P1344, DOI 10.1073/pnas.85.5.1344; Lucker B, 2013, PHOTOSYNTH RES, V117, P449, DOI 10.1007/s11120-013-9932-0; MELIS A, 1982, ARCH BIOCHEM BIOPHYS, V217, P536, DOI 10.1016/0003-9861(82)90535-5; NAKANO Y, 1987, PLANT CELL PHYSIOL, V28, P131; Ort DR, 2002, CURR OPIN PLANT BIOL, V5, P193, DOI 10.1016/S1369-5266(02)00259-5; PELTIER G, 1985, PLANT PHYSIOL, V79, P225, DOI 10.1104/pp.79.1.225; Petersen J, 2012, P NATL ACAD SCI USA, V109, P11150, DOI 10.1073/pnas.1202799109; Prihoda J, 2012, J EXP BOT, V63, P1543, DOI 10.1093/jxb/err441; RADMER RJ, 1976, PLANT PHYSIOL, V58, P336, DOI 10.1104/pp.58.3.336; Rivasseau C, 2009, PLANT CELL ENVIRON, V32, P82, DOI 10.1111/j.1365-3040.2008.01903.x; Santabarbara S, 2009, BIOCHEMISTRY-US, V48, P10457, DOI 10.1021/bi901052c; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Van de Meene AML, 2004, EUR J PHYCOL, V39, P93, DOI 10.1080/09670260310001646522; Vartanian M, 2009, NEW PHYTOL, V182, P429, DOI 10.1111/j.1469-8137.2009.02769.x; Waring J, 2010, J PHYCOL, V46, P1206, DOI 10.1111/j.1529-8817.2010.00919.x; WISHNICK M, 1969, J BIOL CHEM, V244, P55; WITT HT, 1979, BIOCHIM BIOPHYS ACTA, V505, P355, DOI 10.1016/0304-4173(79)90008-9	44	204	207	12	277	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					366	+		10.1038/nature14599	http://dx.doi.org/10.1038/nature14599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26168400	Green Published, Green Submitted			2022-12-28	WOS:000359714000039
J	Wyles, DL; Ruane, PJ; Sulkowski, MS; Dieterich, D; Luetkemeyer, A; Morgan, TR; Sherman, KE; Dretler, R; Fishbein, D; Gathe, JC; Henn, S; Hinestrosa, F; Huynh, C; McDonald, C; Mills, A; Overton, ET; Ramgopal, M; Rashbaum, B; Ray, G; Scarsella, A; Yozviak, J; McPhee, F; Liu, Z; Hughes, E; Yin, PD; Noviello, S; Ackerman, P				Wyles, D. L.; Ruane, P. J.; Sulkowski, M. S.; Dieterich, D.; Luetkemeyer, A.; Morgan, T. R.; Sherman, K. E.; Dretler, R.; Fishbein, D.; Gathe, J. C., Jr.; Henn, S.; Hinestrosa, F.; Huynh, C.; McDonald, C.; Mills, A.; Overton, E. T.; Ramgopal, M.; Rashbaum, B.; Ray, G.; Scarsella, A.; Yozviak, J.; McPhee, F.; Liu, Z.; Hughes, E.; Yin, P. D.; Noviello, S.; Ackerman, P.		ALLY-2 Investigators	Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-C VIRUS; TREATMENT-NAIVE PATIENTS; GENOTYPE 1 INFECTION; ANTIRETROVIRAL THERAPY; FIBROSIS PROGRESSION; GRAZOPREVIR MK-5172; ELBASVIR MK-8742; RIBAVIRIN; INTERFERON; LEDIPASVIR	BACKGROUND The combination of daclatasvir, a hepatitis C virus (HCV) NS5A inhibitor, and the NS5B inhibitor sofosbuvir has shown efficacy in patients with HCV monoinfection. Data are lacking on the efficacy and safety of this combination in patients coinfected with human immunodeficiency virus type 1 (HIV-1). METHODS This was an open-label study involving 151 patients who had not received HCV treatment and 52 previously treated patients, all of whom were coinfected with HIV-1. Previously untreated patients were randomly assigned in a 2: 1 ratio to receive either 12 weeks or 8 weeks of daclatasvir at a standard dose of 60 mg daily (with dose adjustment for concomitant antiretroviral medications) plus 400 mg of sofosbuvir daily. Previously treated patients were assigned to undergo 12 weeks of therapy at the same doses. The primary end point was a sustained virologic response at week 12 after the end of therapy among previously untreated patients with HCV genotype 1 who were treated for 12 weeks. RESULTS Patients had HCV genotypes 1 through 4 (83% with genotype 1), and 14% had compensated cirrhosis; 98% were receiving antiretroviral therapy. Among patients with genotype 1, a sustained virologic response was reported in 96.4% (95% confidence interval [CI], 89.8 to 99.2) who were treated for 12 weeks and in 75.6% (95% CI, 59.7 to 87.6) who were treated for 8 weeks among previously untreated patients and in 97.7% (95% CI, 88.0 to 99.9) who were treated for 12 weeks among previously treated patients. Rates of sustained virologic response across all genotypes were 97.0% (95% CI, 91.6 to 99.4), 76.0% (95% CI, 61.8 to 86.9), and 98.1% (95% CI, 89.7 to 100), respectively. The most common adverse events were fatigue, nausea, and headache. There were no study-drug discontinuations because of adverse events. HIV-1 suppression was not compromised. CONCLUSIONS Among previously untreated HIV-HCV coinfected patients receiving daclatasvir plus sofosbuvir for HCV infection, the rate of sustained virologic response across all genotypes was 97.0% after 12 weeks of treatment and 76.0% after 8 weeks. (Funded by Bristol-Myers Squibb;	[Wyles, D. L.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Ruane, P. J.] Ruane Med & Liver Hlth Inst, Los Angeles, CA USA; [Huynh, C.] Los Angeles LGBT Ctr, Jeffrey Goodman Clin, Los Angeles, CA USA; [Mills, A.] Southern Calif Mens Med Grp, Mens Hlth Fdn, Los Angeles, CA USA; [Luetkemeyer, A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Morgan, T. R.] Vet Affairs Long Beach Healthcare Syst, Long Beach, CA USA; [Scarsella, A.] Pacific Oaks Med Grp, Beverly Hills, CA USA; [Sulkowski, M. S.] Johns Hopkins Univ, Lutherville Timonium, MD USA; [Dieterich, D.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Sherman, K. E.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Dretler, R.] Infect Dis Specialists Atlanta, Decatur, GA USA; [Fishbein, D.] MedStar Washington Hosp Ctr, Washington, DC USA; [Henn, S.] Whitman Walker Hlth, Washington, DC USA; [Rashbaum, B.] Capital Med Associates, Washington, DC USA; [Gathe, J. C., Jr.] Cure C Consortium, Houston, TX USA; [McDonald, C.] Tarrant Cty Infect Dis Associates, Ft Worth, TX USA; [Hinestrosa, F.] Orlando Immunol Ctr, Orlando, FL USA; [Ramgopal, M.] Midway Immunol & Res Ctr, Ft Pierce, FL USA; [Overton, E. T.] Univ Alabama Birmingham, Birmingham, AL USA; [Ray, G.] Univ Colorado, Denver, CO 80202 USA; [Yozviak, J.] Lehigh Valley Hlth Network, Allentown, PA USA; [McPhee, F.; Yin, P. D.; Ackerman, P.] Bristol Myers Squibb Co, Wallingford, CT 06492 USA; [Liu, Z.; Hughes, E.; Noviello, S.] Bristol Myers Squibb Co, Princeton, NJ USA	University of California System; University of California San Diego; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; University System of Ohio; University of Cincinnati; MedStar Washington Hospital Center; Orlando Immunology Center; University of Alabama System; University of Alabama Birmingham; University of Colorado System; University of Colorado Denver; Lehigh Valley Health Network; Bristol-Myers Squibb; Bristol-Myers Squibb	Wyles, DL (corresponding author), Univ Calif San Diego, Stein Clin Res Bldg,9500 Gilman Dr, La Jolla, CA 92093 USA.	dwyles@ucsd.edu		Overton, Edgar/0000-0002-4013-536X	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Funded by Bristol-Myers Squibb; ALLY-2 ClinicalTrials.gov number, NCT02032888.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; [Anonymous], 2013, SOV SOF US PRESCR IN; [Anonymous], 2014, HARV LED SOF US PRES; Bifano M, 2013, ANTIVIR THER, V18, P931, DOI 10.3851/IMP2674; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID LIN US ANT AG H; Eley T, 2014, GLOBAL ANTIVIRAL S1, V10, P54; Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gatti F, 2007, AIDS REV, V9, P16; Grint D, 2013, HIV MED, V14, P614, DOI 10.1111/hiv.12068; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2015, LANCET, V385, P1075, DOI 10.1016/S0140-6736(14)61795-5; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Osinusi A, 2015, JAMA-J AM MED ASSOC, V313, P1232, DOI 10.1001/jama.2015.1373; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Reiberger T, 2010, J VIRAL HEPATITIS, V17, P400, DOI 10.1111/j.1365-2893.2009.01197.x; Reiberger T, 2011, ANTIVIR THER, V16, P815, DOI 10.3851/IMP1831; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski M, 2015, LANCET, V385, P1087, DOI 10.1016/S0140-6736(14)61793-1; Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Svarovskaia ES, 2014, CLIN INFECT DIS, V59, P1666, DOI 10.1093/cid/ciu697; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Wilby KJ, 2012, ANN HEPATOL, V11, P179, DOI 10.1016/S1665-2681(19)31022-1	38	317	328	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8					714	725		10.1056/NEJMoa1503153	http://dx.doi.org/10.1056/NEJMoa1503153			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26196502	Bronze			2022-12-28	WOS:000359709400008
J	Ma, H; Folmes, CDL; Wu, J; Morey, R; Mora-Castilla, S; Ocampo, A; Ma, L; Poulton, J; Wang, XJ; Ahmed, R; Kang, EJ; Lee, Y; Hayama, T; Li, Y; Van Dyken, C; Gutierrez, NM; Tippner-Hedges, R; Koski, A; Mitalipov, N; Amato, P; Wolf, DP; Huang, TS; Terzic, A; Laurent, LC; Belmonte, JCI; Mitalipov, S				Ma, Hong; Folmes, Clifford D. L.; Wu, Jun; Morey, Robert; Mora-Castilla, Sergio; Ocampo, Alejandro; Ma, Li; Poulton, Joanna; Wang, Xinjian; Ahmed, Riffat; Kang, Eunju; Lee, Yeonmi; Hayama, Tomonari; Li, Ying; Van Dyken, Crystal; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Koski, Amy; Mitalipov, Nargiz; Amato, Paula; Wolf, Don P.; Huang, Taosheng; Terzic, Andre; Laurent, Louise C.; Belmonte, Juan Carlos Izpisua; Mitalipov, Shoukhrat			Metabolic rescue in pluripotent cells from patients with mtDNA disease	NATURE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; GENE	Mitochondria have a major role in energy production via oxidative phosphorylation(1), which is dependent on the expression of critical genes encoded by mitochondrial (mt) DNA. Mutations in mtDNA can cause fatal or severely debilitating disorders with limited treatment options(2). Clinical manifestations vary based on mutation type and heteroplasmy (that is, the relative levels of mutant and wild-type mtDNA within each cell)(3,4). Here we generated genetically corrected pluripotent stem cells (PSCs) from patients with mtDNA disease. Multiple induced pluripotent stem (iPS) cell lines were derived from patients with common heteroplasmic mutations including 3243A>G, causing mitochondrial encephalomyopathy and stroke-like episodes (MELAS)(5), and 8993T>G and 13513G>A, implicated in Leigh syndrome. Isogenic MELAS and Leigh syndrome iPS cell lines were generated containing exclusively wildtype or mutant mtDNA through spontaneous segregation of heteroplasmic mtDNA in proliferating fibroblasts. Furthermore, somatic cell nuclear transfer (SCNT) enabled replacement of mutant mtDNA from homoplasmic 8993T>G fibroblasts to generate corrected Leigh-NT1 PSCs. Although Leigh-NT1 PSCs contained donor oocyte wild-type mtDNA (human haplotype D4a) that differed from Leigh syndrome patient haplotype (F1a) at a total of 47 nucleotide sites, Leigh-NT1 cells displayed transcriptomic profiles similar to those in embryo-derived PSCs carrying wild-type mtDNA, indicative of normal nuclear-to-mitochondrial interactions. Moreover, genetically rescued patient PSCs displayed normal metabolic function compared to impaired oxygen consumption and ATP production observed in mutant cells. We conclude that both reprogramming approaches offer complementary strategies for derivation of PSCs containing exclusively wild-type mtDNA, through spontaneous segregation of heteroplasmic mtDNA in individual iPS cell lines or mitochondrial replacement by SCNT in homoplasmic mtDNA-based disease.	[Ma, Hong; Ahmed, Riffat; Kang, Eunju; Lee, Yeonmi; Hayama, Tomonari; Li, Ying; Van Dyken, Crystal; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Koski, Amy; Mitalipov, Nargiz; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, Portland, OR 97239 USA; [Ma, Hong; Ahmed, Riffat; Kang, Eunju; Lee, Yeonmi; Hayama, Tomonari; Li, Ying; Van Dyken, Crystal; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Koski, Amy; Mitalipov, Nargiz; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Folmes, Clifford D. L.; Terzic, Andre] Mayo Clin, Ctr Regenerat Med, Rochester, MN 55905 USA; [Folmes, Clifford D. L.; Terzic, Andre] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Wu, Jun; Ocampo, Alejandro; Ma, Li; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Morey, Robert; Mora-Castilla, Sergio; Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Poulton, Joanna] Univ Oxford, John Radcliffe Hosp, Dept Obstet & Gynaecol, Oxford OX3 9DU, England; [Wang, Xinjian; Huang, Taosheng] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Amato, Paula] Oregon Hlth & Sci Univ, Div Reprod Endocrinol, Dept Obstet & Gynecol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Mayo Clinic; Mayo Clinic; Salk Institute; University of California System; University of California San Diego; University of Oxford; Cincinnati Children's Hospital Medical Center; Oregon Health & Science University	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 SW Bond Ave, Portland, OR 97239 USA.	mitalipo@ohsu.edu	Poulton, Joanna/I-3913-2016; Wu, Jun/AAF-1830-2019; Poulton, Joanna/AAB-4828-2021	Wu, Jun/0000-0001-9863-1668; Folmes, Clifford/0000-0002-3683-9970; Ocampo, Alejandro/0000-0002-3731-3647; Laurent, Louise/0000-0002-2095-7534; Huang, Taosheng/0000-0001-6601-6687; Poulton, Joanna/0000-0002-2460-5587	Leducq Foundation; Mayo Clinic Center for Regenerative Medicine; OHSU; UCSD; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL121079] Funding Source: NIH RePORTER; MRC [MR/J010448/1] Funding Source: UKRI	Leducq Foundation(Leducq Foundation); Mayo Clinic Center for Regenerative Medicine; OHSU; UCSD; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge the OHSU Embryonic Stem Cell Research Oversight Committee and the Institutional Review Board for providing oversight and guidance. We thank skin and oocyte donors and the Women's Health Research Unit staff at the Center for Women's Health, University Fertility Consultants and the Reproductive Endocrinology & Infertility Division in the Department of Obstetrics & Gynecology of Oregon Health & Science University for their support and procurement of gametes. We are grateful to M. Tachibana and A. Polat for help with derivation of PSCs and to M. Sparman for technical support. We are indebted to S. Gokhale for teratoma analysis and M. C. T. Penedo for microsatellite genotyping. We thank the staff at the Institute for Genomic Medicine Genomics Facility at UCSD for sequencing the RNA-seq libraries. Studies were supported by the Leducq Foundation, Mayo Clinic Center for Regenerative Medicine and OHSU and UCSD institutional funds. Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation and the Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002).	Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Borchin B, 2013, STEM CELL REP, V1, P620, DOI 10.1016/j.stemcr.2013.10.007; Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611; Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020; Chinnery PF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004315; Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188; Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Grossman LI, 1996, BIOESSAYS, V18, P983, DOI 10.1002/bies.950181208; Hamalainen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; MORTEN KJ, 1995, HUM MOL GENET, V4, P1689; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398	30	126	132	5	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					234	+		10.1038/nature14546	http://dx.doi.org/10.1038/nature14546			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26176921	Green Published			2022-12-28	WOS:000359386900035
J	Stein, LY				Stein, Lisa Y.			MICROBIOLOGY Cyanate fuels the nitrogen cycle	NATURE			English	Editorial Material								Cyanate, a degradation product of urea and cyanide, has been found to be a sufficient single substrate for the growth and reciprocal feeding of microorganisms that are essential to the global nitrogen cycle. SEE LETTER P.105	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alberta	Stein, LY (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	lisa.stein@ualberta.ca						Bernhard A., 2010, NATURE ED, V3, P25; Galloway JN, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0120; Luque-Almagro VM, 2011, BIOCHEM SOC T, V39, P269, DOI 10.1042/BST0390269; Patel BH, 2015, NAT CHEM, V7, P301, DOI [10.1038/nchem.2202, 10.1038/NCHEM.2202]; Purcarea C, 2003, J BIOL CHEM, V278, P52924, DOI 10.1074/jbc.M309383200; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Ward BB, 2011, NITRIFICATION, P3; Widner B, 2013, ANAL CHEM, V85, P6661, DOI 10.1021/ac400351c; Yu XZ, 2015, INT J ENVIRON SCI TE, V12, P763, DOI 10.1007/s13762-014-0571-6	9	14	14	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					43	44		10.1038/nature14639	http://dx.doi.org/10.1038/nature14639			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26222024				2022-12-28	WOS:000359002300026
J	Scher, HD; Whittaker, JM; Williams, SE; Latimer, JC; Kordesch, WEC; Delaney, ML				Scher, Howie D.; Whittaker, Joanne M.; Williams, Simon E.; Latimer, Jennifer C.; Kordesch, Wendy E. C.; Delaney, Margaret L.			Onset of Antarctic Circumpolar Current 30 million years ago as Tasmanian Gateway aligned with westerlies	NATURE			English	Article							SOUTHERN-OCEAN; ISOTOPIC COMPOSITION; CASCADE SEAMOUNT; ATLANTIC SECTOR; BOTTOM WATER; PACIFIC; DEEP; ND; EOCENE; NEODYMIUM	Earth's mightiest ocean current, the Antarctic Circumpolar Current (ACC), regulates the exchange of heat and carbon between the ocean and the atmosphere(1), and influences vertical ocean structure, deep-water production(2) and the global distribution of nutrients and chemical tracers(3). The eastward-flowing ACC occupies a unique circumglobal pathway in the Southern Ocean that was enabled by the tectonic opening of key oceanic gateways during the break-up of Gondwana (for example, by the opening of the Tasmanian Gateway, which connects the Indian and Pacific oceans). Although the ACC is a key component of Earth's present and past climate system(1), the timing of the appearance of diagnostic features of the ACC (for example, low zonal gradients in water-mass tracer fields(4-7)) is poorly known and represents a fundamental gap in our understanding of Earth history. Here we show, using geophysically determined positions of continent-ocean boundaries(8), that the deep Tasmanian Gateway opened 33.5+/-1.5 million years ago (the errors indicate uncertainty in the boundary positions). Following this opening, sediments from Indian and Pacific cores recorded Pacific-type neodymium isotope ratios, revealing deep westward flow equivalent to the present-day Antarctic Slope Current. We observe onset of the ACC at around 30 million years ago, when Southern Ocean neodymium isotopes record a permanent shift to modern Indian-Atlantic ratios. Our reconstructions of ocean circulation show that massive reorganization and homogenization of Southern Ocean water masses coincided with migration of the northern margin of the Tasmanian Gateway into the mid-latitude westerly wind band, which we reconstruct at 64 degrees S, near to the northern margin. Onset of the ACC about 30 million years ago coincided with major changes in global ocean circulation(9) and probably contributed to the lower atmospheric carbon dioxide levels that appear after this time(10).	[Scher, Howie D.] Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA; [Whittaker, Joanne M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Williams, Simon E.] Univ Sydney, Sch Geosci, EarthByte Grp, Sydney, NSW 2006, Australia; [Latimer, Jennifer C.] Indiana State Univ, Dept Earth & Environm Syst, Terre Haute, IN 47809 USA; [Kordesch, Wendy E. C.] Univ Southampton, Natl Oceanog Ctr, Dept Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Delaney, Margaret L.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Delaney, Margaret L.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Tasmania; University of Sydney; Indiana State University; NERC National Oceanography Centre; University of Southampton; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Scher, HD (corresponding author), Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA.	hscher@geol.sc.edu	Whittaker, Joanne M/B-3695-2010; Scher, Howie/C-4927-2013	Whittaker, Joanne M/0000-0002-3170-3935; Scher, Howie/0000-0002-7778-6772; Williams, Simon/0000-0003-4670-8883	UTAS IMAS Visiting Scholarship; EES travel grant; US National Science Foundation (NSF) [OCE 1155630]; ARC [DE140100376]; NSF [OCE-0647876]; Division Of Ocean Sciences [1155630] Funding Source: National Science Foundation	UTAS IMAS Visiting Scholarship; EES travel grant; US National Science Foundation (NSF)(National Science Foundation (NSF)); ARC(Australian Research Council); NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	H.D.S. received support from an UTAS IMAS Visiting Scholarship and an EES travel grant while this manuscript was prepared, and was supported by the US National Science Foundation (NSF) award OCE 1155630. J.M.W. was supported by ARC grant DE140100376. M.L.D. was supported by NSF award OCE-0647876. This research used data and samples from the Ocean Drilling Program (ODP), which was sponsored by the NSF and participating countries under the management of Joint Oceanographic Institutions. GPlates is free software that is licensed for distribution under the GNU General Public License v2 (http://www.gplates.org). Researchers in the EarthByte group have made GPlates compatible data available, some of which were used in this study. We thank C. Moy, C. Riesselman, R. Rykaczewski and A. Winguth for discussions. M. Seton and W. Sijp provided feedback on an early version of the manuscript. J. Aggarwal, E. Bair, M. Frank and S. Sampson provided analytical support.	Albarede F, 1997, GEOCHIM COSMOCHIM AC, V61, P1277, DOI 10.1016/S0016-7037(96)00404-8; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Basak C, 2015, EARTH PLANET SC LETT, V419, P211, DOI 10.1016/j.epsl.2015.03.011; Bijl PK, 2013, P NATL ACAD SCI USA, V110, P9645, DOI 10.1073/pnas.1220872110; Bindoff NL, 2000, DEEP-SEA RES PT II, V47, P2299, DOI 10.1016/S0967-0645(00)00038-2; Bouma A.H, 1962, SEDIMENTOLOGY SOME F, P168; BOYLE EA, 1981, EARTH PLANET SC LETT, V53, P11, DOI 10.1016/0012-821X(81)90022-4; BOYLE EA, 1985, EARTH PLANET SC LETT, V76, P135, DOI 10.1016/0012-821X(85)90154-2; Cande SC, 2004, GEOPHYS J INT, V157, P399, DOI 10.1111/j.1365-246X.2004.02224.x; CANDE SC, 1982, EARTH PLANET SC LETT, V58, P151, DOI 10.1016/0012-821X(82)90190-X; Chavagnac V, 2007, ANAL CHIM ACTA, V599, P177, DOI 10.1016/j.aca.2007.08.015; COX MD, 1989, J PHYS OCEANOGR, V19, P1730, DOI 10.1175/1520-0485(1989)019<1730:AIMOTW>2.0.CO;2; Dong S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC004051; Fuller M., 2004, CENOZOIC SO OCEAN TE, P63; Gille ST, 2003, J PHYS OCEANOGR, V33, P1167, DOI 10.1175/1520-0485(2003)033<1167:FOOTSO>2.0.CO;2; Goldstein S.L., 2003, TREATISE GEOCHEMISTR, P453, DOI [10.1016/B0-08-043751-6/06179-X, DOI 10.1016/B0-08-043751-6/06179-X]; GOLDSTEIN SJ, 1987, CHEM GEOL, V66, P245, DOI 10.1016/0168-9622(87)90045-5; GOLDSTEIN SJ, 1988, EARTH PLANET SC LETT, V87, P249, DOI 10.1016/0012-821X(88)90013-1; Hill DJ, 2013, GEOPHYS RES LETT, V40, P5199, DOI 10.1002/grl.50941; Hill PJ, 2004, GEOPH MONOG SERIES, V151, P19; Hoernle K, 2010, GEOCHIM COSMOCHIM AC, V74, P7196, DOI 10.1016/j.gca.2010.09.030; Huber M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001014; JEANDEL C, 1993, EARTH PLANET SC LETT, V117, P581, DOI 10.1016/0012-821X(93)90104-H; Joseph LH, 2004, MAR GEOL, V205, P185, DOI 10.1016/S0025-3227(04)00023-4; Katz ME, 2011, SCIENCE, V332, P1076, DOI 10.1126/science.1202122; LANYON R, 1993, GEOLOGY, V21, P555, DOI 10.1130/0091-7613(1993)021<0555:TTBTBP>2.3.CO;2; Ling HF, 2005, EARTH PLANET SC LETT, V232, P345, DOI 10.1016/j.epsl.2004.12.009; Ling HF, 1997, EARTH PLANET SC LETT, V146, P1, DOI 10.1016/S0012-821X(96)00224-5; Martin EE, 2004, EARTH PLANET SC LETT, V220, P25, DOI 10.1016/S0012-821X(04)00030-5; Martin EE, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001302; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Nelson CS, 2001, NEW ZEAL J GEOL GEOP, V44, P535, DOI 10.1080/00288306.2001.9514954; O'Neill C, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000784; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Pagani M, 2011, SCIENCE, V334, P1261, DOI 10.1126/science.1203909; Quilty PG, 2001, AUST J EARTH SCI, V48, P633, DOI 10.1046/j.1440-0952.2001.485886.x; Quilty PG, 1997, AUST J EARTH SCI, V44, P655, DOI 10.1080/08120099708728343; Scher H. D., 2014, RENDICONTI SOC GEOL, V31, P191, DOI [10.3301/rol.2014.115, DOI 10.3301/ROL.2014.115]; Scher HD, 2006, SCIENCE, V312, P428, DOI 10.1126/science.1120044; Scher HD, 2004, EARTH PLANET SC LETT, V228, P391, DOI 10.1016/j.epsl.2004.10.016; Scher HD, 2014, PALEOCEANOGRAPHY, V29, P628, DOI 10.1002/2014PA002648; Scher HD, 2011, GEOLOGY, V39, P383, DOI 10.1130/G31726.1; Scher HD, 2010, CHEM GEOL, V269, P329, DOI 10.1016/j.chemgeo.2009.10.007; Sijp WP, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002143; Stichel T, 2012, GEOCHIM COSMOCHIM AC, V94, P22, DOI 10.1016/j.gca.2012.07.005; Stichel T, 2012, EARTH PLANET SC LETT, V317, P282, DOI 10.1016/j.epsl.2011.11.025; Stickley C. E., 2004, P ODP SCI RES; Stickley CE, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001022; Taylor S.R., 1985, CONTINENTAL CRUST IT; TOGGWEILER JR, 1995, DEEP-SEA RES PT I, V42, P477, DOI 10.1016/0967-0637(95)00012-U; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Torsvik TH, 2012, EARTH-SCI REV, V114, P325, DOI 10.1016/j.earscirev.2012.06.007; Torsvik TH, 2008, EARTH PLANET SC LETT, V276, P273, DOI 10.1016/j.epsl.2008.09.026; van de Flierdt T, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000923; Williams SE, 2011, TECTONICS, V30, DOI 10.1029/2011TC002912	55	99	102	5	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					580	+		10.1038/nature14598	http://dx.doi.org/10.1038/nature14598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26223626				2022-12-28	WOS:000358655200042
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Taking patient safety seriously means minimum staffing levels	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OUTCOMES					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Aiken LH, 2014, LANCET, V383, P1824, DOI 10.1016/S0140-6736(13)62631-8; Bray BD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001705; Carthey J, 2010, PATIENT SAFETY 1 IMP; Dominiczak P, 2013, TELEGRAPH; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; National Institute for Health and Care Excellence, 2015, NHS ENGL ASKS NICE S; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Nichols P, 2008, MED J AUSTRALIA, V188, P276, DOI 10.5694/j.1326-5377.2008.tb01619.x; Rafferty AM, 2007, INT J NURS STUD, V44, P175, DOI 10.1016/j.ijnurstu.2006.08.003; Smith MD, 2013, INT J HEALTH CARE Q, V26, P536, DOI 10.1108/IJHCQA-03-2012-0029; Stephenson J, 2011, NURS TIMES; The National Advisory Group on the Safety of Patients in England, 2013, PROMISE LEARN COMMIT	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2015	351								h3903	10.1136/bmj.h3903	http://dx.doi.org/10.1136/bmj.h3903			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2TV	26215477	Bronze			2022-12-28	WOS:000359010400003
J	Izaurralde, E				Izaurralde, Elisa			Breakers and blockers-miRNAs at work	SCIENCE			English	Editorial Material							MAMMALIAN MICRORNAS; GW182 PROTEINS; REPRESSION; CCR4-NOT; COMPLEX; DEADENYLASE; BINDING; MOTIFS		Max Planck Inst Dev Biol, Dept Biochem, D-72076 Tubingen, Germany	Max Planck Society	Izaurralde, E (corresponding author), Max Planck Inst Dev Biol, Dept Biochem, D-72076 Tubingen, Germany.	elisa.izaurralde@tuebingen.mpg.de						Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; Christie M, 2013, MOL CELL, V51, P360, DOI 10.1016/j.molcel.2013.07.011; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fukao A, 2014, MOL CELL, V56, P79, DOI 10.1016/j.molcel.2014.09.005; Fukaya T, 2014, MOL CELL, V56, P67, DOI 10.1016/j.molcel.2014.09.004; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551	15	46	47	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					380	382		10.1126/science.1260969	http://dx.doi.org/10.1126/science.1260969			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206919				2022-12-28	WOS:000358381400023
J	Bates, ER				Bates, Eric R.			Review: After coronary DES placement, shorter vs longer dual-antiplatelet therapy reduces mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COLLEGE-OF-CARDIOLOGY; CARDIOVASCULAR ANGIOGRAPHY; HEART-ASSOCIATION; AMERICAN-COLLEGE; INTERVENTIONS; SOCIETY; STENTS		Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Baber U, 2011, J AM COLL CARDIOL, V58, P1569, DOI 10.1016/j.jacc.2011.06.049; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2							JC2	10.7326/ACPJC-2015-163-2-002	http://dx.doi.org/10.7326/ACPJC-2015-163-2-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26192582				2022-12-28	WOS:000358407500002
J	Fink, HA; Hemmy, LS; MacDonald, R; Carlyle, MH; Olson, CM; Dysken, MW; McCarten, JR; Kane, RL; Garcia, SA; Rutks, IR; Ouellette, J; Wilt, TJ				Fink, Howard A.; Hemmy, Laura S.; MacDonald, Roderick; Carlyle, Maureen H.; Olson, Carin M.; Dysken, Maurice W.; McCarten, J. Riley; Kane, Robert L.; Garcia, Santiago A.; Rutks, Indulis R.; Ouellette, Jeannine; Wilt, Timothy J.			Intermediate- and Long-Term Cognitive Outcomes After Cardiovascular Procedures in Older Adults A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-ARTERY-BYPASS; AORTIC-VALVE IMPLANTATION; HIGH-RISK PATIENTS; OFF-PUMP; CARDIOPULMONARY BYPASS; CAROTID-ENDARTERECTOMY; CATHETER ABLATION; ATRIAL-FIBRILLATION; MILD HYPOTHERMIA; NEUROCOGNITIVE FUNCTION	Background: Risks for intermediate-and long-term cognitive impairment after cardiovascular procedures in older adults are poorly understood. Purpose: To summarize evidence about cognitive outcomes in adults aged 65 years or older at least 3 months after coronary or carotid revascularization, cardiac valve procedures, or ablation for atrial fibrillation. Data Sources: MEDLINE, Cochrane, and Scopus databases from 1990 to January 2015; ClinicalTrials. gov; and bibliographies of reviews and eligible studies. Study Selection: English-language trials and prospective cohort studies. Data Extraction: One reviewer extracted data, a second checked accuracy, and 2 independently rated quality and strength of evidence (SOE). Data Synthesis: 17 trials and 4 cohort studies were included; 80% of patients were men, and mean age was 68 years. Cognitive function did not differ after the procedure between on-and off-pump coronary artery bypass grafting (CABG) (n = 6; low SOE), hypothermic and normothermic CABG (n = 3; moderate to low SOE), or CABG and medical management (n = 1; insufficient SOE). One trial reported lower risk for incident cognitive impairment with minimal versus conventional extracorporeal CABG (risk ratio, 0.34 [95% CI, 0.16 to 0.73]; low SOE). Two trials found no difference between surgical carotid revascularization and carotid stenting or angioplasty (low and insufficient SOE, respectively). One cohort study reported increased cognitive decline after transcatheter versus surgical aortic valve replacement but had large selection and outcome measurement biases (insufficient SOE). Limitations: Mostly low to insufficient SOE; no pertinent data for ablation; limited generalizability to the most elderly patients, women, and persons with substantial baseline cognitive impairment; and possible selective reporting and publication bias. Conclusion: Intermediate-and long-term cognitive impairment in older adults attributable to the studied cardiovascular procedures may be uncommon. Nevertheless, clinicians counseling patients before these procedures should discuss the uncertainty in their risk for adverse cognitive outcomes.	Univ Minnesota, Minnesota Evidence Based Practice Ctr, Minneapolis, MN 55455 USA; Geriatr Res Educ & Clin Ctr, Minneapolis, MN USA; Vet Affairs Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Fink, HA (corresponding author), Vet Affairs Hlth Care Syst 11 G, Geriatr Res Educ & Clin Ctr, One Vet Dr, Minneapolis, MN 55417 USA.	Howard.fink@va.gov			Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Altinbas A, 2011, NEUROLOGY, V77, P1084, DOI 10.1212/WNL.0b013e31822e55b9; Anastasiadis K, 2015, COMP MINIMAL VERSUS; Anastasiadis K, 2011, ANN THORAC SURG, V92, P1933, DOI 10.1016/j.athoracsur.2011.03.074; Andrew MJ, 2001, J CARDIOTHOR VASC AN, V15, P9, DOI 10.1053/jcan.2001.20210; Baracchini C, 2012, SURGERY, V151, P99, DOI 10.1016/j.surg.2011.06.031; Bonati LH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000515.pub4; Boodhwani M, 2007, J THORAC CARDIOV SUR, V134, P1443, DOI 10.1016/j.jtcvs.2007.08.016; Bunch TJ, 2011, J CARDIOVASC ELECTR, V22, P839, DOI 10.1111/j.1540-8167.2011.02035.x; Cormack F, 2012, NEUROSCI BIOBEHAV R, V36, P2118, DOI 10.1016/j.neubiorev.2012.06.002; Coyle RF, 2014, RELEASE COUNTY FEE F; Crawley F, 2000, STROKE, V31, P1329, DOI 10.1161/01.STR.31.6.1329; De Rango P, 2008, STROKE, V39, P3116, DOI 10.1161/STROKEAHA.108.518357; Dieleman J, 2009, EUR J CARDIO-THORAC, V35, P48, DOI 10.1016/j.ejcts.2008.10.004; Djaiani G, 2012, CAN J ANESTH, V59, P449, DOI 10.1007/s12630-012-9675-y; Ernest CS, 2006, ANN THORAC SURG, V82, P812, DOI 10.1016/j.athoracsur.2006.04.005; Fakin R, 2012, J CARDIOVASC SURG, V53, P107; Flesch M, 2009, CLIN RES CARDIOL, V98, P33, DOI 10.1007/s00392-008-0719-9; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GOLD JP, 1995, J THORAC CARDIOV SUR, V110, P1302, DOI 10.1016/S0022-5223(95)70053-6; Goldberg JB, 2011, ANN VASC SURG, V25, P270, DOI 10.1016/j.avsg.2010.07.013; Healey JS, 2012, CURR OPIN CARDIOL, V27, P36, DOI 10.1097/HCO.0b013e32834d846a; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Ho PM, 2004, ANN THORAC SURG, V77, P597, DOI 10.1016/S0003-4975(03)01358-4; Irvine CD, 1998, EUR J VASC ENDOVASC, V15, P195, DOI 10.1016/S1078-5884(98)80176-7; Jensen BO, 2006, CIRCULATION, V113, P2790, DOI 10.1161/CIRCULATIONAHA.105.587931; Jensen BO, 2008, EUR J CARDIO-THORAC, V34, P1016, DOI 10.1016/j.ejcts.2008.07.053; Kadoi Y, 2003, ANN THORAC SURG, V75, P840, DOI 10.1016/S0003-4975(02)04498-3; Kadoi Y, 2011, J ANESTH, V25, P10, DOI 10.1007/s00540-010-1072-5; Keizer AMA, 2005, ACTA ANAESTH SCAND, V49, P1232, DOI 10.1111/j.1399-6576.2005.00835.x; Kennedy ED, 2013, J CARDIOTHOR VASC AN, V27, P253, DOI 10.1053/j.jvca.2012.11.008; Knipp SC, 2013, INTERACT CARDIOV TH, V16, P116, DOI 10.1093/icvts/ivs461; Lamy A, 2013, NEW ENGL J MED, V368, P1179, DOI 10.1056/NEJMoa1301228; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P695, DOI 10.1093/arclin/acu049; Lee JD, 2003, ANN THORAC SURG, V76, P18, DOI 10.1016/S0003-4975(03)00342-4; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Lewis MS, 2006, ANN THORAC SURG, V81, P2097, DOI 10.1016/j.athoracsur.2006.01.044; Lombard FW, 2010, SEMIN CARDIOTHORAC V, V14, P102, DOI 10.1177/1089253210371519; Lund C, 2005, ANN THORAC SURG, V80, P2126, DOI 10.1016/j.athoracsur.2005.06.012; Lunn S, 1999, CEREBROVASC DIS, V9, P74, DOI 10.1159/000015901; Marasco SF, 2008, EUR J CARDIO-THORAC, V33, P961, DOI 10.1016/j.ejcts.2008.03.022; McKhann GM, 2009, ANN THORAC SURG, V87, P27, DOI 10.1016/j.athoracsur.2008.09.023; Medi C, 2013, J AM COLL CARDIOL, V62, P531, DOI 10.1016/j.jacc.2013.03.073; Medicare Payment Advisory Commission, 2012, REP C MED PAYM POL, P311; Miller DC, 2012, J THORAC CARDIOV SUR, V143, P832, DOI 10.1016/j.jtcvs.2012.01.055; Nathan HJ, 2001, CIRCULATION, V104, pI85; Nathan HJ, 2007, J THORAC CARDIOV SUR, V133, P1206, DOI 10.1016/j.jtcvs.2006.09.112; National Center for Health Statistics, 2013, HLTH US 2012 SPEC FE; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Paraskevas KI, 2014, EUR J VASC ENDOVASC, V47, P221, DOI 10.1016/j.ejvs.2013.11.006; Piccini JP, 2012, CIRCULATION, V126, P2200, DOI 10.1161/CIRCULATIONAHA.112.109330; Plassman BL, 2011, ANN NEUROL, V70, P418, DOI 10.1002/ana.22362; Rerkasem K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001081.pub2; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schwarz N, 2010, HEART RHYTHM, V7, P1761, DOI 10.1016/j.hrthm.2010.07.035; Selnes OA, 2005, ANN THORAC SURG, V79, P1201, DOI 10.1016/j.athoracsur.2004.10.011; Selnes OA, 2007, ANN THORAC SURG, V83, P374, DOI 10.1016/j.athoracsur.2006.07.005; Selnes OA, 2012, NEW ENGL J MED, V366, P250, DOI 10.1056/NEJMra1100109; Silbert BS, 2006, ANESTHESIOLOGY, V104, P1137, DOI 10.1097/00000542-200606000-00007; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Sun JH, 2012, J INT MED RES, V40, P852, DOI 10.1177/147323001204000303; Vedin J, 2006, EUR J CARDIO-THORAC, V30, P305, DOI 10.1016/j.ejcts.2006.03.037; Viswanathan M., 2012, SYSTEMATIC REV HLTH	63	27	28	2	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2					107	+		10.7326/M14-2793	http://dx.doi.org/10.7326/M14-2793			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26192563				2022-12-28	WOS:000358407500018
J	Imamura, F; O'Connor, L; Ye, Z; Mursu, J; Hayashino, Y; Bhupathiraju, SN; Forouhi, NG				Imamura, Fumiaki; O'Connor, Laura; Ye, Zheng; Mursu, Jaakko; Hayashino, Yasuaki; Bhupathiraju, Shilpa N.; Forouhi, Nita G.			Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ARTERY RISK DEVELOPMENT; SOFT DRINK CONSUMPTION; METABOLIC SYNDROME; NONNUTRITIVE SWEETENERS; ATHEROSCLEROSIS RISK; MEASUREMENT ERROR; GLYCEMIC LOAD; HEART-DISEASE; HEALTH; MELLITUS	OBJECTIVES To examine the prospective associations between consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice with type 2 diabetes before and after adjustment for adiposity, and to estimate the population attributable fraction for type 2 diabetes from consumption of sugar sweetened beverages in the United States and United Kingdom. DESIGN Systematic review and meta-analysis. DATA SOURCE AND ELIGIBILITY PubMed, Embase, Ovid, and Web of Knowledge for prospective studies of adults without diabetes, published until February 2014. The population attributable fraction was estimated in national surveys in the USA, 2009-10 (n=4729 representing 189.1 million adults without diabetes) and the UK, 2008-12 (n=1932 representing 44.7 million). SYNTHESIS METHODS Random effects meta-analysis and survey analysis for population attributable fraction associated with consumption of sugar sweetened beverages. RESULTS Prespecified information was extracted from 17 cohorts (38 253 cases/10 126 754 person years). Higher consumption of sugar sweetened beverages was associated with a greater incidence of type 2 diabetes, by 18% per one serving/day (95% confidence interval 9% to 28%, I-2 for heterogeneity=89%) and 13% (6% to 21%, I-2=79%) before and after adjustment for adiposity; for artificially sweetened beverages, 25% (18% to 33%, I-2=70%) and 8% (2% to 15%, I-2=64%); and for fruit juice, 5% (-1% to 11%, I-2=58%) and 7% (1% to 14%, I-2=51%). Potential sources of heterogeneity or bias were not evident for sugar sweetened beverages. For artificially sweetened beverages, publication bias and residual confounding were indicated. For fruit juice the finding was non-significant in studies ascertaining type 2 diabetes objectively (P for heterogeneity=0.008). Under specified assumptions for population attributable fraction, of 20.9 million events of type 2 diabetes predicted to occur over 10 years in the USA (absolute event rate 11.0%), 1.8 million would be attributable to consumption of sugar sweetened beverages (population attributable fraction 8.7%, 95% confidence interval 3.9% to 12.9%); and of 2.6 million events in the UK (absolute event rate 5.8%), 79 000 would be attributable to consumption of sugar sweetened beverages (population attributable fraction 3.6%, 1.7% to 5.6%). CONCLUSIONS Habitual consumption of sugar sweetened beverages was associated with a greater incidence of type 2 diabetes, independently of adiposity. Although artificially sweetened beverages and fruit juice also showd positive associations with incidence of type 2 diabetes, the findings were likely to involve bias. None the less, both artificially sweetened beverages and fruit juice were unlikely to be healthy alternatives to sugar sweetened beverages for the prevention of type 2 diabetes. Under assumption of causality, consumption of sugar sweetened beverages over years may be related to a substantial number of cases of new onset diabetes.	[Imamura, Fumiaki; O'Connor, Laura; Ye, Zheng; Forouhi, Nita G.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, Med Res Council,Epidemiol Unit, Cambridge CB2 0QQ, England; [Mursu, Jaakko] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Hayashino, Yasuaki] Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan; [Hayashino, Yasuaki] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Sakyo Ku, Kyoto, Japan; [Bhupathiraju, Shilpa N.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Eastern Finland; Tenri Hospital; Kyoto University; Harvard University; Harvard T.H. Chan School of Public Health	Imamura, F (corresponding author), Univ Cambridge, Sch Clin Med, Inst Metab Sci, Med Res Council,Epidemiol Unit, Cambridge CB2 0QQ, England.	fumiaki.imamura@mrc-epid.cam.ac.uk	Hayashino, Yasuaki/AAA-8637-2022; O'Connor, Laura/ABD-7999-2021; Imamura, Fumiaki/J-1038-2019	Hayashino, Yasuaki/0000-0002-2932-8478; O'Connor, Laura/0000-0002-6022-2022; Imamura, Fumiaki/0000-0002-6841-8396; Forouhi, Nita/0000-0002-5041-248X	Medical Research Council [MC_UU_12015/5]; American Heart Association [13POST14370012]; MRC [MC_UP_A100_1003, MC_UU_12015/5] Funding Source: UKRI; Medical Research Council [MC_UP_A100_1003] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); American Heart Association(American Heart Association); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Medical Research Council Epidemiology Unit Core Support (MC_UU_12015/5). SNB was supported by an American Heart Association postdoctoral fellowship grant (13POST14370012).	Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974; Bazzano LA, 2008, DIABETES CARE, V31, P1311, DOI 10.2337/dc08-0080; Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603; Bleich SN, 2014, AM J PUBLIC HEALTH, V104, pE72, DOI 10.2105/AJPH.2013.301556; Bray GA, 2013, ADV NUTR, V4, P220, DOI 10.3945/an.112.002816; BRENNER H, 1993, AM J EPIDEMIOL, V138, P1007, DOI 10.1093/oxfordjournals.aje.a116805; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; CARROLL RJ, 1994, STAT MED, V13, P1265, DOI 10.1002/sim.4780131208; COOK JR, 1994, J AM STAT ASSOC, V89, P1314, DOI 10.2307/2290994; Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.85; Crowe KM, 2013, J ACAD NUTR DIET, V113, P1354, DOI 10.1016/j.jand.2013.04.024; de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922; de la Pena C, 2010, ANN NY ACAD SCI, V1190, P159, DOI 10.1111/j.1749-6632.2009.05253.x; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Duffey KJ, 2012, AM J CLIN NUTR, V95, P909, DOI 10.3945/ajcn.111.026682; Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478; Eliopoulos Panos., 2019, UKRAINIAN POLICYMAKE, V4, P4, DOI [10.29202/up/4/1, DOI 10.29202/UP/4/1]; Eshak ES, 2013, CLIN NUTR, V32, P300, DOI 10.1016/j.clnu.2012.08.003; Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997; Fitzpatrick L, 2003, J BONE MINER RES, V18, P1570, DOI 10.1359/jbmr.2003.18.9.1570; Franco M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1515; Gardner C, 2012, CIRCULATION, V126, P509, DOI 10.1161/CIR.0b013e31825c42ee; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Greenland S, 2001, BIOMETRICS, V57, P182, DOI 10.1111/j.0006-341X.2001.00182.x; Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329; Hayashino Y, 2008, DIABETES CARE, V31, P732, DOI 10.2337/dc07-1905; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Hunter DJ, 1996, NEW ENGL J MED, V334, P356, DOI 10.1056/NEJM199602083340603; International Diabetes Federatoin, 2013, IDF DIAB ATL, P29; Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x; Jonathan ESA, 2008, COCHRANE HDB SYSTEMA, P1; Kellow NJ, 2013, EUR J CLIN NUTR, V67, P239, DOI 10.1038/ejcn.2012.220; Lash TL, 2003, EPIDEMIOLOGY, V14, P451, DOI 10.1097/01.EDE.0000071419.41011.cf; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Livesey G, 2013, AM J CLIN NUTR, V97, P584, DOI 10.3945/ajcn.112.041467; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Montonen J, 2007, J NUTR, V137, P1447, DOI 10.1093/jn/137.6.1447; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; Mursu J, 2014, AM J CLIN NUTR, V99, P328, DOI 10.3945/ajcn.113.069641; Nettleton JA, 2009, DIABETES CARE, V32, P688, DOI 10.2337/dc08-1799; Odegaard AO, 2010, AM J EPIDEMIOL, V171, P701, DOI 10.1093/aje/kwp452; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Pan A, 2012, AM J CLIN NUTR, V95, P1454, DOI 10.3945/ajcn.111.032698; Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323; Pepino MY, 2011, CURR OPIN CLIN NUTR, V14, P391, DOI 10.1097/MCO.0b013e3283468e7e; PEREIRA MA, 2005, DIABETES S1, V54, pA258; Piernas C, 2013, AM J CLIN NUTR, V97, P604, DOI 10.3945/ajcn.112.048405; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Sakurai M, 2014, EUR J NUTR, V53, P251, DOI 10.1007/s00394-013-0523-9; Sch_unemann H, 2013, GRADE HDB; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Schunemann H. J., 2008, COCHRANE HDB SYSTEMA, P1; Slavin JL, 2012, ADV NUTR, V3, P506, DOI 10.3945/an.112.002154; Smith GD, 1996, BMJ-BRIT MED J, V312, P1659, DOI 10.1136/bmj.312.7047.1659; Stanhope KL, 2012, ANNU REV MED, V63, P329, DOI 10.1146/annurev-med-042010-113026; Sterne JAC., 2014, COCHRANE RISK BIAS A; Suez Jotham, 2014, Nature, V514, P181, DOI 10.1038/nature13793; Sun Q, 2010, AM J EPIDEMIOL, V172, P1442, DOI 10.1093/aje/kwq306; United States National Center for Health Statistics, 2005, NAT HLTH NUTR EX SUR; Walter WC, 2012, NUTR EPIDEMIOLOGY; Weed DL, 2011, AM J CLIN NUTR, V94, P1340, DOI 10.3945/ajcn.111.015875; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wojcicki JM, 2012, AM J PUBLIC HEALTH, V102, P1630, DOI 10.2105/AJPH.2012.300719; Xi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093471; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	78	553	565	10	146	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2015	351								h3576	10.1136/bmj.h3576	http://dx.doi.org/10.1136/bmj.h3576			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WG	26199070	Green Published, hybrid			2022-12-28	WOS:000358644400003
J	Kirby, T				Kirby, Tony			Wayne Cutfield: putting the spotlight on early life development	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					239	239		10.1016/S0140-6736(15)61270-3	http://dx.doi.org/10.1016/S0140-6736(15)61270-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN1XI	26194516				2022-12-28	WOS:000358213700017
J	Han, S; Soleiman, MT; Soden, ME; Zweifel, LS; Palmiter, RD				Han, Sung; Soleiman, Matthew T.; Soden, Marta E.; Zweifel, Larry S.; Palmiter, Richard D.			Elucidating an Affective Pain Circuit that Creates a Threat Memory	CELL			English	Article							PERIAQUEDUCTAL GRAY-MATTER; CALCITONIN-GENE; PARABRACHIAL NUCLEUS; NEURONS MEDIATE; AMYGDALA; FEAR; CGRP; ACQUISITION; EXPRESSION; PATHWAYS	Animals learn to avoid harmful situations by associating a neutral stimulus with a painful one, resulting in a stable threat memory. In mammals, this form of learning requires the amygdala. Although pain is the main driver of aversive learning, the mechanism that transmits pain signals to the amygdala is not well resolved. Here, we show that neurons expressing calcitonin gene-related peptide (CGRP) in the parabrachial nucleus are critical for relaying pain signals to the central nucleus of amygdala and that this pathway may transduce the affective motivational aspects of pain. Genetic silencing of CGRP neurons blocks pain responses and memory formation, whereas their optogenetic stimulation produces defensive responses and a threat memory. The pain-recipient neurons in the central amygdala expressing CGRP receptors are also critical for establishing a threat memory. The identification of the neural circuit conveying affective pain signals may be pertinent for treating pain conditions with psychiatric comorbidities.	[Han, Sung; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Han, Sung; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Soleiman, Matthew T.; Palmiter, Richard D.] Univ Washington, Grad Program Neurosci, Seattle, WA 98195 USA; [Soden, Marta E.; Zweifel, Larry S.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Soden, Marta E.; Zweifel, Larry S.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	palmiter@uw.edu	Zweifel, Larry/O-3284-2017	Zweifel, Larry/0000-0003-3465-5331; Soden, Marta/0000-0002-0695-8653	NIH [R01MH094536]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024908] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Authors thank Dr. S. Dymecki for a GFP:TetTox construct and Dr. K. Deisseroth for AAV-ChR2:YFP and YFP constructs. M. Chiang assisted with animal husbandry; A. Bowen helped with histology; and K. Kafer and S. Tsang helped generate Calcrl<SUP>Cre</SUP> mice. We appreciate feedback on the manuscript from laboratory members and Drs. M. Carter, J. Kim, A. Dhaka, and D. Anderson. L.S.Z. is supported by a grant from NIH (R01MH094536).	Al-Khater KM, 2009, J COMP NEUROL, V515, P629, DOI 10.1002/cne.22081; Asede D, 2015, NEURON, V86, P541, DOI 10.1016/j.neuron.2015.03.008; Auvray M, 2010, NEUROSCI BIOBEHAV R, V34, P214, DOI 10.1016/j.neubiorev.2008.07.008; BERNARD JF, 1994, J NEUROPHYSIOL, V71, P1646, DOI 10.1152/jn.1994.71.5.1646; Bernard JF, 1996, PROG BRAIN RES, V107, P243; Bester H, 2000, J NEUROPHYSIOL, V83, P2239, DOI 10.1152/jn.2000.83.4.2239; Bienvenu TCM, 2015, J NEUROSCI, V35, P2044, DOI 10.1523/JNEUROSCI.1323-14.2015; Brunzell DH, 2001, BEHAV NEUROSCI, V115, P365, DOI 10.1037//0735-7044.115.2.365; Cai HJ, 2014, NAT NEUROSCI, V17, P1240, DOI 10.1038/nn.3767; Carter ME, 2015, J NEUROSCI, V35, P4582, DOI 10.1523/JNEUROSCI.3729-14.2015; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Ciocchi S., 2009, THESIS U BASEL BASEL; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; D'Hanis W, 2007, J COMP NEUROL, V505, P268, DOI 10.1002/cne.21495; Dobolyi A, 2005, J COMP NEUROL, V489, P92, DOI 10.1002/cne.20618; Duvarci S, 2011, J NEUROSCI, V31, P289, DOI 10.1523/JNEUROSCI.4985-10.2011; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Han JS, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-10; Han JS, 2005, J NEUROSCI, V25, P10717, DOI 10.1523/JNEUROSCI.4112-05.2005; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Herry C, 2014, NAT NEUROSCI, V17, P1644, DOI 10.1038/nn.3869; Hirsch S, 2014, SCHMERZ, V28, P532, DOI 10.1007/s00482-014-1460-0; Hirsch S, 2013, PAIN, V154, P700, DOI 10.1016/j.pain.2013.01.002; Ho TW, 2014, NEUROLOGY, V83, P958, DOI 10.1212/WNL.0000000000000771; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Jhamandas JH, 1996, BRAIN RES BULL, V39, P115, DOI 10.1016/0361-9230(95)02084-5; Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594; Kim EJ, 2013, P NATL ACAD SCI USA, V110, P14795, DOI 10.1073/pnas.1310845110; Kim JC, 2009, NEURON, V63, P305, DOI 10.1016/j.neuron.2009.07.010; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Kocorowski LH, 2001, NEUROBIOL LEARN MEM, V75, P149, DOI 10.1006/nlme.2000.3963; Krout KE, 1998, J COMP NEUROL, V401, P437; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1043; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Lu Y.C., 2014, MOL NEUROBIOL, V51, P105; Malick A, 2001, P NATL ACAD SCI USA, V98, P9930, DOI 10.1073/pnas.171616898; Moreno MJ, 2002, NEUROPHARMACOLOGY, V42, P270, DOI 10.1016/S0028-3908(01)00176-9; Neugebauer V, 2002, J NEUROPHYSIOL, V87, P103, DOI 10.1152/jn.00264.2001; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2012, CURR OPIN NEUROBIOL, V22, P717, DOI 10.1016/j.conb.2012.02.014; Petrovich GD, 2009, J NEUROSCI, V29, P15205, DOI 10.1523/JNEUROSCI.3656-09.2009; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Sarhan M, 2005, J COMP NEUROL, V491, P418, DOI 10.1002/cne.20697; Sato M, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0108-z; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Strobel C, 2014, SCI CHINA LIFE SCI, V57, P384, DOI 10.1007/s11427-014-4638-x; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Veinante Pierre, 2013, J Mol Psychiatry, V1, P9, DOI 10.1186/2049-9256-1-9; Watabe AM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-11; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006	54	223	227	5	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					363	374		10.1016/j.cell.2015.05.057	http://dx.doi.org/10.1016/j.cell.2015.05.057			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186190	Green Accepted, Bronze			2022-12-28	WOS:000358087700016
J	Hunt, DP; Scheske, JA; Dudzinski, DM; Arvikar, SL				Hunt, Daniel P.; Scheske, Jonathan A.; Dudzinski, David M.; Arvikar, Sheila L.			Case 22-2015: A 20-Year-Old Man with Sore Throat, Fever, Myalgias, and a Pericardial Effusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ONSET STILLS-DISEASE; CONSTRICTIVE PERICARDITIS; CARDIAC-TAMPONADE; ADULT; CRITERIA; CLASSIFICATION		[Hunt, Daniel P.; Arvikar, Sheila L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Scheske, Jonathan A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Dudzinski, David M.] Harvard Univ, Sch Med, Dept Cardiol, Boston, MA USA; [Hunt, Daniel P.; Arvikar, Sheila L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hunt, DP (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.		Hunt, Dan/AAL-3807-2021					Buss SJ, 2010, INT J CARDIOL, V144, pE23, DOI 10.1016/j.ijcard.2008.12.079; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; Dudzinski DM, 2012, CURR PROB CARDIOLOGY, V37, P75, DOI 10.1016/j.cpcardiol.2011.10.002; Fautrel B, 2002, MEDICINE, V81, P194, DOI 10.1097/00005792-200205000-00003; Fautrel B, 2008, BEST PRACT RES CL RH, V22, P773, DOI 10.1016/j.berh.2008.08.006; Gerfaud-Valentin M, 2014, MEDICINE, V93, P91, DOI 10.1097/MD.0000000000000021; Maria ATJ, 2014, AUTOIMMUN REV, V13, P1149, DOI 10.1016/j.autrev.2014.08.032; McMinn F J, 1959, Ann Rheum Dis, V18, P293, DOI 10.1136/ard.18.4.293; Najam F, 2001, JCR-J CLIN RHEUMATOL, V7, P97, DOI 10.1097/00124743-200104000-00009; Parvez N, 2009, SOUTH MED J, V102, P832, DOI 10.1097/SMJ.0b013e3181ad4847; Sagrista-Sauleda J, 2004, NEW ENGL J MED, V350, P469, DOI 10.1056/NEJMoa035630; Syed FF, 2013, HEART FAIL REV, V18, P277, DOI 10.1007/s10741-012-9308-0; Troughton RW, 2004, LANCET, V363, P717, DOI 10.1016/S0140-6736(04)15648-1; Uppal SS, 2007, CLIN RHEUMATOL, V26, P1055, DOI 10.1007/s10067-006-0440-x; YAMAGUCHI M, 1992, J RHEUMATOL, V19, P424	15	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3					263	271		10.1056/NEJMcpc1501310	http://dx.doi.org/10.1056/NEJMcpc1501310			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MS	26176384				2022-12-28	WOS:000357956200011
J	Mariani, J; Coppola, G; Zhang, P; Abyzov, A; Provini, L; Tomasini, L; Amenduni, M; Szekely, A; Palejev, D; Wilson, M; Gerstein, M; Grigorenko, EL; Chawarska, K; Pelphrey, KA; Howe, JR; Vaccarino, FM				Mariani, Jessica; Coppola, Gianfilippo; Zhang, Ping; Abyzov, Alexej; Provini, Lauren; Tomasini, Livia; Amenduni, Mariangela; Szekely, Anna; Palejev, Dean; Wilson, Michael; Gerstein, Mark; Grigorenko, Elena L.; Chawarska, Katarzyna; Pelphrey, Kevin A.; Howe, James R.; Vaccarino, Flora M.			FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders	CELL			English	Article							SEVERE MENTAL-RETARDATION; PLURIPOTENT STEM-CELLS; INHIBITORY INTERNEURONS; CONGENITAL VARIANT; HEAD CIRCUMFERENCE; BRAIN-DEVELOPMENT; SYNAPTIC FUNCTION; SODIUM-CHANNELS; RETT-SYNDROME; MOUSE MODEL	Autism spectrum disorder (ASD) is a disorder of brain development. Most cases lack a clear etiology or genetic basis, and the difficulty of re-enacting human brain development has precluded understanding of ASD pathophysiology. Here we use three-dimensional neural cultures (organoids) derived from induced pluripotent stem cells (iPSCs) to investigate neurodevelopmental alterations in individuals with severe idiopathic ASD. While no known underlying genomic mutation could be identified, transcriptome and gene network analyses revealed upregulation of genes involved in cell proliferation, neuronal differentiation, and synaptic assembly. ASD-derived organoids exhibit an accelerated cell cycle and overproduction of GABAergic inhibitory neurons. Using RNA interference, we show that overexpression of the transcription factor FOXG1 is responsible for the overproduction of GABAergic neurons. Altered expression of gene network modules and FOXG1 are positively correlated with symptom severity. Our data suggest that a shift toward GABAergic neuron fate caused by FOXG1 is a developmental precursor of ASD.	[Mariani, Jessica; Coppola, Gianfilippo; Abyzov, Alexej; Provini, Lauren; Tomasini, Livia; Amenduni, Mariangela; Szekely, Anna; Palejev, Dean; Wilson, Michael; Gerstein, Mark; Grigorenko, Elena L.; Chawarska, Katarzyna; Pelphrey, Kevin A.; Vaccarino, Flora M.] Yale Univ, Program Neurodev & Regenerat, New Haven, CT 06520 USA; [Mariani, Jessica; Coppola, Gianfilippo; Provini, Lauren; Tomasini, Livia; Amenduni, Mariangela; Palejev, Dean; Wilson, Michael; Grigorenko, Elena L.; Chawarska, Katarzyna; Pelphrey, Kevin A.; Vaccarino, Flora M.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Zhang, Ping; Howe, James R.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Abyzov, Alexej; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Szekely, Anna] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Vaccarino, Flora M.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Vaccarino, FM (corresponding author), Yale Univ, Program Neurodev & Regenerat, New Haven, CT 06520 USA.	flora.vaccarino@yale.edu	Coppola, Gianfilippo/A-9754-2009; Abyzov, Alexej/M-4284-2013; Grigorenko, Elena/V-2418-2019; Abyzov, Alexej/AAT-4615-2020	Coppola, Gianfilippo/0000-0003-2675-783X; Wilson, Michael/0000-0001-5892-6074; Gerstein, Mark/0000-0002-9746-3719; Provini, Lauren/0000-0001-8061-3269; Vaccarino, Flora/0000-0003-2167-981X; Abyzov, Alexej/0000-0001-5405-6729; Palejev, Dean/0000-0002-0563-6636	NIH; Harris Professorship fund; Foster-Davis Foundation Inc. through the Brain and Behavior Research Foundation; Simons Foundation (SFARI) [137055, 206929 R10981]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH066494, R21MH087879, R33MH087879, R01MH089176] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harris Professorship fund; Foster-Davis Foundation Inc. through the Brain and Behavior Research Foundation; Simons Foundation (SFARI); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge support from the NIH and from the Harris Professorship fund. We thank Dr. Alexander Urban, Stanford University, for help in experimental design. We also acknowledge the support team of the Yale University Biomedical High Performance Computing Center (in particular, Robert Bjornson and Nicholas Carriero). We thank Anita Huttner for culturing fibrobasts, Ying Zhang for preparing the sequencing libraries, and Nathaniel Calixto and Anahita Amiri for help in iPSC maintenance and characterization. We thank Elizabeth Jonas for facilities and help with the preliminary patch clamp experiments on dissociated cultures. We acknowledge the following grant support: NIMH MH089176, MH087879 (F.M.V.), U54 MH066494 (Project 2, K.C.), and the State of Connecticut (F.M.V.) and the Foster-Davis Foundation Inc (G.C.) through the Brain and Behavior Research Foundation. This work was supported in part by grants from the Simons Foundation (SFARI #137055, F.M.V. and SFARI #206929 R10981, K.A.P.). We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, E. Wijsman). We appreciate obtaining access to phenotypic data on SFARI Base (https://base.sfari.org). We acknowledge the Yale Center for Clinical Investigation for clinical support in obtaining the biopsy specimens. We thank Dr. John Overton, the Yale Center for Genome Analysis and the Stanford Genomic Facility for advice in carrying out DNA and RNA sequencing.	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Ariani F, 2008, AM J HUM GENET, V83, P89, DOI 10.1016/j.ajhg.2008.05.015; Bahi-Buisson N, 2010, NEUROGENETICS, V11, P241, DOI 10.1007/s10048-009-0220-2; Casanova MF, 2003, NEUROSCIENTIST, V9, P496, DOI 10.1177/1073858403253552; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chaste P, 2013, BIOL PSYCHIAT, V74, P576, DOI 10.1016/j.biopsych.2013.04.018; Chawarska K, 2011, ARCH GEN PSYCHIAT, V68, P1021, DOI 10.1001/archgenpsychiatry.2011.106; Cheah CS, 2012, P NATL ACAD SCI USA, V109, P14646, DOI 10.1073/pnas.1211591109; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Habegger L, 2011, BIOINFORMATICS, V27, P281, DOI 10.1093/bioinformatics/btq643; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kortum F, 2011, J MED GENET, V48, P396, DOI 10.1136/jmg.2010.087528; Lainhart JE, 2006, AM J MED GENET A, V140A, P2257, DOI 10.1002/ajmg.a.31465; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lawrence YA, 2010, ACTA NEUROL SCAND, V121, P99, DOI 10.1111/j.1600-0404.2009.01234.x; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; Mencarelli MA, 2010, J MED GENET, V47, P49, DOI 10.1136/jmg.2009.067884; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Piven J, 1996, J AM ACAD CHILD PSY, V35, P530, DOI 10.1097/00004583-199604000-00020; Pizzarelli R, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00085; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13; Shoichet SA, 2005, HUM GENET, V117, P536, DOI 10.1007/s00439-005-1310-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vaccarino FM, 2009, J AUTISM DEV DISORD, V39, P511, DOI 10.1007/s10803-008-0653-8; Volkmar FR, 2009, J CHILD PSYCHOL PSYC, V50, P108, DOI 10.1111/j.1469-7610.2008.02010.x; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	51	610	619	11	149	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					375	390		10.1016/j.cell.2015.06.034	http://dx.doi.org/10.1016/j.cell.2015.06.034			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186191	Green Accepted, Bronze			2022-12-28	WOS:000358087700017
J	Daniels, PR				Daniels, Paul R.			Peri-procedural management of patients taking oral anticoagulants	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MOLECULAR-WEIGHT HEPARIN; VITAMIN-K-ANTAGONISTS; FACTOR XA INHIBITOR; PROSTHETIC HEART-VALVES; DIRECT THROMBIN INHIBITOR; PROTHROMBIN COMPLEX CONCENTRATE; INTERNATIONAL NORMALIZED RATIO; ATRIAL-FIBRILLATION; BRIDGING THERAPY; TEMPORARY INTERRUPTION	The use of oral anticoagulants is becoming increasingly common. For many years warfarin was the main oral anticoagulant available, but therapeutic options have expanded with the introduction of oral direct thrombin (dabigatran) and factor Xa inhibitors (apixaban, rivaroxaban, and edoxaban). Management of patients taking any oral anticoagulant in the peri-procedural period poses a challenge to medical and surgical providers because of the competing risks of thrombosis and hemorrhage. Bridging therapy has been used to minimize time without anticoagulation when warfarin is interrupted for invasive procedures, but validated strategies based on high quality data are lacking. Existing data suggest that the use of bridging therapy may increase the risk of bleeding for some patients without reducing the risk of thrombosis. Clinical trials are currently under way to answer these questions. Because the half lives and time to anticoagulant activity of newer oral anticoagulants are shorter than for warfarin, bridging therapy is not thought to be necessary with these agents. Peri-procedural management of patients taking these agents is complicated by the lack of demonstrated reversal agents in emergency situations, although specific antidotes are being developed and tested. Existing guidelines for peri-procedural management of patients on oral anticoagulants highlight the importance of individualized patient decision making and suggest strategies to minimize complications. From a patient's perspective, given the uncertainties surrounding optimal management, explicit discussions regarding risks and benefits of treatment options and demonstration of effective communication among medical and surgical providers are essential.	[Daniels, Paul R.] Mayo Clin, Mayo Clin Thrombophilia Ctr, Rochester, MN 55905 USA; [Daniels, Paul R.] Mayo Clin, Div Gen Internal Med, Dept Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Daniels, PR (corresponding author), Mayo Clin, Mayo Clin Thrombophilia Ctr, Rochester, MN 55905 USA.	daniels.paul@mayo.edu	Daniels, Paul/AAU-5745-2020					Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; [Anonymous], 2014, PRAD PACK INS; [Anonymous], 2015, SAV PACK INS; [Anonymous], 2014, XAR R PACK INS; Ansell JE, 2014, NEW ENGL J MED, V371, P2141, DOI 10.1056/NEJMc1411800; Babilonia K, 2014, THROMB J, V12, DOI 10.1186/1477-9560-12-8; Baglin T, 2013, J THROMB HAEMOST, V11, P122, DOI 10.1111/jth.12227; Bajkin BV, 2009, J ORAL MAXIL SURG, V67, P990, DOI 10.1016/j.joms.2008.12.027; Bathala MS, 2012, DRUG METAB DISPOS, V40, P2250, DOI 10.1124/dmd.112.046888; Bauer KA, 2011, J THROMB HAEMOST, V9, P12, DOI 10.1111/j.1538-7836.2011.04321.x; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Beyer-Westendorf J, 2014, EUR HEART J, V35, P1888, DOI 10.1093/eurheartj/eht557; Birnie DH, 2014, CIRCULATION, V129, P2062, DOI 10.1161/CIRCULATIONAHA.113.006027; Birnie DH, 2013, NEW ENGL J MED, V368, P2084, DOI 10.1056/NEJMoa1302946; Blech S, 2008, DRUG METAB DISPOS, V36, P386, DOI 10.1124/dmd.107.019083; Bombuy E, 2009, CIR ESPAN, V86, P38, DOI 10.1016/j.ciresp.2009.02.016; Boutitie F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3036; BRECKENRIDGE A, 1978, SEMIN HEMATOL, V15, P19; Bristol-Myers Squibb Company, 2014, EL PACK INS; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Bui HT, 2009, AM J CARDIOL, V104, P1429, DOI 10.1016/j.amjcard.2009.06.065; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Camm AJ, 2011, DRUGS, V71, P1503, DOI 10.2165/11595540-000000000-00000; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Canadian Institutes of Health Research (CIHR); Pfizer; Lawson Health Research Institute, PERIOP 2 SAF EFF STU; CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635; Cheng M, 2009, EUROPACE, V11, P1183, DOI 10.1093/europace/eup212; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Constans M, 2007, INT J CLIN PRACT, V61, P212, DOI 10.1111/j.1742-1241.2006.01081.x; Dale BJ, 2014, J THROMB HAEMOST, V12, P1810, DOI 10.1111/jth.12720; Daniels PR, 2009, THROMB RES, V124, P300, DOI 10.1016/j.thromres.2009.01.011; Deitelzweig SB, 2011, AM J HEMATOL, V86, P217, DOI 10.1002/ajh.21917; Dentali F, 2011, THROMB HAEMOSTASIS, V106, P429, DOI 10.1160/TH11-01-0052; Desai NR, 2014, AM J MED, V127, P1075, DOI 10.1016/j.amjmed.2014.05.013; Dotan ZA, 2002, J UROLOGY, V168, P610, DOI 10.1016/S0022-5347(05)64689-7; Douketis JD, 2015, NEW ENGL J MED, V373, P823, DOI 10.1056/NEJMoa1501035; Douketis JD, 2012, CHEST, V141, pE326S, DOI 10.1378/chest.11-2298; Douketis JD, 2005, THROMB HAEMOSTASIS, V94, P528, DOI 10.1160/TH05-01-0064; Douketis JD, 2004, ARCH INTERN MED, V164, P1319, DOI 10.1001/archinte.164.12.1319; Douketis JD, 2000, ARCH INTERN MED, V160, P3431, DOI 10.1001/archinte.160.22.3431; Dunn AS, 2007, J THROMB HAEMOST, V5, P2211, DOI 10.1111/j.1538-7836.2007.02729.x; Ebright J, 2015, CLIN APPL THROMB-HEM, V21, P105, DOI 10.1177/1076029614545211; Eijgenraam P, 2013, CURR PHARM DESIGN, V19, P4014, DOI 10.2174/1381612811319220010; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Ercan M, 2010, LANGENBECK ARCH SURG, V395, P247, DOI 10.1007/s00423-009-0483-y; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; Furugohri T, 2008, J THROMB HAEMOST, V6, P1542, DOI 10.1111/j.1538-7836.2008.03064.x; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Garcia D, 2014, BLOOD, V124, P3692, DOI 10.1182/blood-2014-08-595496; Garcia DA, 2008, ARCH INTERN MED, V168, P63, DOI 10.1001/archinternmed.2007.23; GARVER D, 1995, TEX HEART I J, V22, P86; Genewein U, 1996, BRIT J HAEMATOL, V92, P479, DOI 10.1046/j.1365-2141.1996.d01-1499.x; Ghanbari H, 2010, PACE, V33, P400, DOI 10.1111/j.1540-8159.2010.02703.x; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; GODBILLON J, 1981, BRIT J CLIN PHARMACO, V12, P621, DOI 10.1111/j.1365-2125.1981.tb01280.x; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; GRIP L, 1991, EUR HEART J, V12, P1225, DOI 10.1093/eurheartj/12.11.1225; Grottke O, 2014, CRIT CARE, V18, DOI 10.1186/cc13717; Halbritter KM, 2005, J THROMB HAEMOST, V3, P2823, DOI 10.1111/j.1538-7836.2005.01674.x; Hankey GJ, 2011, CIRCULATION, V123, P1436, DOI 10.1161/CIRCULATIONAHA.110.004424; Haustein KO, 1999, SEMIN THROMB HEMOST, V25, P5, DOI 10.1055/s-2007-996417; Healey JS, 2012, CIRCULATION, V126, P343, DOI 10.1161/CIRCULATIONAHA.111.090464; Heidbuchel H, 2013, EUR HEART J, V34, P2094, DOI 10.1093/eurheartj/eht134; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Hillarp A, 2014, J THROMB HAEMOST, V12, P1545, DOI 10.1111/jth.12649; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70; Jaffer AK, 2005, J THROMB THROMBOLYS, V20, P11, DOI 10.1007/s11239-005-3120-9; Jaffer AK, 2010, AM J MED, V123, P141, DOI 10.1016/j.amjmed.2009.09.017; Jamula E, 2009, THROMB RES, V124, P292, DOI 10.1016/j.thromres.2009.01.007; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Johnston M, 1996, J LAB CLIN MED, V128, P214, DOI 10.1016/S0022-2143(96)90014-1; KATHOLI RE, 1978, AM HEART J, V96, P163, DOI 10.1016/0002-8703(78)90080-7; Keeling D, 2011, BRIT J HAEMATOL, V154, P311, DOI 10.1111/j.1365-2141.2011.08753.x; Khadzhynov D, 2013, THROMB HAEMOSTASIS, V109, P596, DOI 10.1160/TH12-08-0573; KIRKWOOD TBL, 1983, THROMB HAEMOSTASIS, V49, P238; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Kovacs MJ, 2004, CIRCULATION, V110, P1658, DOI 10.1161/01.CIR.0000142859.77578.C9; Lee FMH, 2014, THROMB RES, V133, P705, DOI 10.1016/j.thromres.2014.01.031; Liesenfeld KH, 2006, BRIT J CLIN PHARMACO, V62, P527, DOI 10.1111/j.1365-2125.2006.02667.x; Lindahl TL, 2011, THROMB HAEMOSTASIS, V105, P371, DOI 10.1160/TH10-06-0342; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Malato A, 2010, J THROMB HAEMOST, V8, P107, DOI 10.1111/j.1538-7836.2009.03649.x; Marquie C, 2006, EUROPACE, V8, P283, DOI 10.1093/europace/eul011; McBane RD, 2010, ARTERIOSCL THROM VAS, V30, P442, DOI 10.1161/ATVBAHA.109.199406; Mercadante N, 2000, J THROMB THROMBOLYS, V10, P29, DOI 10.1023/A:1018742620401; Miners JO, 1998, BRIT J CLIN PHARMACO, V45, P525, DOI 10.1046/j.1365-2125.1998.00721.x; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nematullah A, 2009, J CAN DENT ASSOC, V75, P41; Nishimura RA, 2014, CIRCULATION, V129, P2440, DOI 10.1161/CIR.0000000000000029; Nitzki-George D, 2013, ANN PHARMACOTHER, V47, P841, DOI 10.1345/aph.1R724; O'Donnell MJ, 2007, ANN INTERN MED, V146, P184, DOI 10.7326/0003-4819-146-3-200702060-00007; Ogata K, 2010, J CLIN PHARMACOL, V50, P743, DOI 10.1177/0091270009351883; Omran H, 2012, THROMB HAEMOSTASIS, V108, P65, DOI 10.1160/TH11-12-0827; OREILLY RA, 1963, J CLIN INVEST, V42, P1542, DOI 10.1172/JCI104839; OREILLY RA, 1976, ANNU REV MED, V27, P245, DOI 10.1146/annurev.me.27.020176.001333; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pengo V, 2009, CIRCULATION, V119, P2920, DOI 10.1161/CIRCULATIONAHA.108.823211; Perzborn E, 2010, ARTERIOSCL THROM VAS, V30, P376, DOI 10.1161/ATVBAHA.110.202978; Pinto DJP, 2007, J MED CHEM, V50, P5339, DOI 10.1021/jm070245n; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Raghavan N, 2009, DRUG METAB DISPOS, V37, P74, DOI 10.1124/dmd.108.023143; RASKOB GE, 1995, BLOOD, V85, P3034, DOI 10.1182/blood.V85.11.3034.bloodjournal85113034; Robinson M, 2009, PACE, V32, P378, DOI 10.1111/j.1540-8159.2008.02247.x; Roehrig S, 2005, J MED CHEM, V48, P5900, DOI 10.1021/jm050101d; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; RUSTAD H, 1963, ACTA MED SCAND, V173, P115; SAKATA T, 1995, ARTERIOSCL THROM VAS, V15, P241, DOI 10.1161/01.ATV.15.2.241; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Schiele F, 2013, BLOOD, V121, P3554, DOI 10.1182/blood-2012-11-468207; SCHOFIELD KP, 1987, CLIN LAB HAEMATOL, V9, P255, DOI 10.1111/j.1365-2257.1987.tb00089.x; Schulman S, 1998, AM J MED, V104, P332, DOI 10.1016/S0002-9343(98)00060-6; Schulman S, 2015, CIRCULATION, V132, P167, DOI 10.1161/CIRCULATIONAHA.115.015688; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Sherwood MW, 2014, CIRCULATION, V129, P1850, DOI 10.1161/CIRCULATIONAHA.113.005754; Siegal D, 2012, CIRCULATION, V126, P1630, DOI 10.1161/CIRCULATIONAHA.112.105221; Siegal DM, 2014, BLOOD, V123, P1152, DOI 10.1182/blood-2013-09-529784; Spandorfer JM, 1999, AM J CARDIOL, V84, P478, DOI 10.1016/S0002-9149(99)00341-0; Spyropoulos AC, 2006, J THROMB HAEMOST, V4, P1246, DOI 10.1111/j.1538-7836.2006.01908.x; Spyropoulos AC, 2004, CHEST, V125, P1642, DOI 10.1378/chest.125.5.1642; Spyropoulos AC, 2004, PHARMACOTHERAPY, V24, P649, DOI 10.1592/phco.24.6.649.34740; Spyropoulos AC, 2008, AM J CARDIOL, V102, P883, DOI 10.1016/j.amjcard.2008.05.042; Spyropoulos AC, 2012, BLOOD, V120, P2954, DOI 10.1182/blood-2012-06-415943; Stangier J, 2008, CLIN PHARMACOKINET, V47, P285, DOI 10.2165/00003088-200847050-00001; Stangier J, 2010, CLIN PHARMACOKINET, V49, P259, DOI 10.2165/11318170-000000000-00000; Tafur AJ, 2012, ANN ONCOL, V23, P1998, DOI 10.1093/annonc/mds058; Tafur AJ, 2012, J THROMB HAEMOST, V10, P261, DOI 10.1111/j.1538-7836.2011.04572.x; TINKER JH, 1978, JAMA-J AM MED ASSOC, V239, P738, DOI 10.1001/jama.239.8.738; Tinmouth AH, 2001, ANN PHARMACOTHER, V35, P669; Tischenko A, 2009, AM HEART J, V158, P252, DOI 10.1016/j.ahj.2009.06.005; Tompkins C, 2010, J AM COLL CARDIOL, V55, P2376, DOI 10.1016/j.jacc.2009.12.056; Ufer M, 2005, CLIN PHARMACOKINET, V44, P1227, DOI 10.2165/00003088-200544120-00003; van Ryn J, 2014, CLIN LAB MED, V34, P479, DOI 10.1016/j.cll.2014.06.008; Varkarakis IM, 2005, J UROLOGY, V174, P1020, DOI 10.1097/01.ju.0000169461.35421.f6; Varkarakis IM, 2005, J UROLOGY, V174, P23; Wazni OM, 2007, CIRCULATION, V116, P2531, DOI 10.1161/CIRCULATIONAHA.107.727784; Weinz C, 2009, DRUG METAB DISPOS, V37, P1056, DOI 10.1124/dmd.108.025569; WESSLER S, 1984, NEW ENGL J MED, V311, P645; White RH, 2003, CIRCULATION, V107, P14, DOI [DOI 10.1161/01.C1R.0000078468.11849.66, 10.1161/01.CIR.0000078468.11849.66, DOI 10.1161/01.CIR.0000078468.11849.66, 10.1161/01.cir.0000078468.11849.66]; WILSON S, 2001, CAN J HOSP PHARM, V54, P269; Wysokinski WE, 2008, MAYO CLIN PROC, V83, P639, DOI 10.4065/83.6.639; Zhu TN, 2009, ARTERIOSCL THROM VAS, V29, P298, DOI 10.1161/ATVBAHA.108.182428; ZIMMERMA.A, 1974, BIOCHEM PHARMACOL, V23, P1033, DOI 10.1016/0006-2952(74)90002-1	149	31	35	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2015	351								h2391	10.1136/bmj.h2391	http://dx.doi.org/10.1136/bmj.h2391			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CO	26174061				2022-12-28	WOS:000358301600001
J	Lange, P; Celli, B; Agusti, A; Jensen, GB; Divo, M; Faner, R; Guerra, S; Marott, JL; Martinez, FD; Martinez-Camblor, P; Meek, P; Owen, CA; Petersen, H; Pinto-Plata, V; Schnohr, P; Sood, A; Soriano, JB; Tesfaigzi, Y; Vestbo, J				Lange, Peter; Celli, Bartolome; Agusti, Alvar; Jensen, Gorm Boje; Divo, Miguel; Faner, Rosa; Guerra, Stefano; Marott, Jacob Louis; Martinez, Fernando D.; Martinez-Camblor, Pablo; Meek, Paula; Owen, Caroline A.; Petersen, Hans; Pinto-Plata, Victor; Schnohr, Peter; Sood, Akshay; Soriano, Joan B.; Tesfaigzi, Yohannes; Vestbo, Jorgen			Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FORCED EXPIRATORY VOLUME; FUNCTION DECLINE; NATURAL-HISTORY; INHALED BUDESONIDE; CHILDHOOD ASTHMA; PROGRESSION; REGRESSION; MODERATE; SMOKERS; FACTS	BACKGROUND Chronic obstructive pulmonary disease (COPD) is thought to result from an accelerated decline in forced expiratory volume in 1 second (FEV1) over time. Yet it is possible that a normal decline in FEV1 could also lead to COPD in persons whose maximally attained FEV1 is less than population norms. METHODS We stratified participants in three independent cohorts (the Framingham Offspring Cohort, the Copenhagen City Heart Study, and the Lovelace Smokers Cohort) according to lung function (FEV1 >= 80% or <80% of the predicted value) at cohort inception (mean age of patients, approximately 40 years) and the presence or absence of COPD at the last study visit. We then determined the rate of decline in FEV1 over time among the participants according to their FEV1 at cohort inception and COPD status at study end. RESULTS Among 657 persons who had an FEV1 of less than 80% of the predicted value before 40 years of age, 174 (26%) had COPD after 22 years of observation, whereas among 2207 persons who had a baseline FEV1 of at least 80% of the predicted value before 40 years of age, 158 (7%) had COPD after 22 years of observation (P<0.001). Approximately half the 332 persons with COPD at the end of the observation period had had a normal FEV1 before 40 years of age and had a rapid decline in FEV1 thereafter, with a mean (+/- SD) decline of 53 +/- 21 ml per year. The remaining half had had a low FEV1 in early adulthood and a subsequent mean decline in FEV1 of 27 +/- 18 ml per year (P<0.001), despite similar smoking exposure. CONCLUSIONS Our study suggests that low FEV1 in early adulthood is important in the genesis of COPD and that accelerated decline in FEV1 is not an obligate feature of COPD. (Funded by an unrestricted grant from GlaxoSmithKline and others.)	[Lange, Peter] Univ Copenhagen, Inst Publ Hlth, Sect Social Med, DK-1014 Copenhagen K, Denmark; [Lange, Peter] Univ Copenhagen, Resp Sect, Hvidovre Hosp, DK-1014 Copenhagen K, Denmark; [Lange, Peter; Jensen, Gorm Boje; Marott, Jacob Louis; Schnohr, Peter] Univ Copenhagen, Copenhagen City Heart Study, Frederiksberg Hosp, DK-1014 Copenhagen K, Denmark; [Vestbo, Jorgen] Univ Copenhagen, Dept Resp Med, Gentofte Hosp, DK-1014 Copenhagen K, Denmark; [Jensen, Gorm Boje] Univ Southern Denmark, Odense, Denmark; [Celli, Bartolome; Divo, Miguel; Owen, Caroline A.; Pinto-Plata, Victor] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Agusti, Alvar] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Serv Pneumol,Thorax Inst, Barcelona, Spain; [Faner, Rosa] Fundacio Clin Recerca Biomed, Barcelona, Spain; [Agusti, Alvar; Faner, Rosa] Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain; [Soriano, Joan B.] Univ Autonoma Madrid, Catedra UAM Linde, Inst Invest Hosp Univ Princesa, Madrid, Spain; [Guerra, Stefano; Martinez, Fernando D.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Martinez-Camblor, Pablo] Univ Autonoma Chile, Santiago, Chile; [Meek, Paula] Univ Colorado, Denver, CO 80202 USA; [Petersen, Hans; Tesfaigzi, Yohannes] Lovelace Resp Res Inst, Albuquerque, NM USA; [Sood, Akshay] Univ New Mexico, Albuquerque, NM 87131 USA; [Vestbo, Jorgen] Univ Manchester, Manchester Acad Hlth Sci Ctr, Resp & Allergy Res Grp, Manchester, Lancs, England	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Madrid; University of Arizona; Universidad Autonoma de Chile; University of Colorado System; University of Colorado Denver; Lovelace Respiratory Research Institute; University of New Mexico; University of Manchester	Lange, P (corresponding author), Univ Copenhagen, Inst Publ Hlth, Sect Social Med, POB 2099,Oster Farimagsgade 5, DK-1014 Copenhagen K, Denmark.	peter.lange@sund.ku.dk	Meek, Paula M/AAS-3669-2020; Soriano, Joan B/O-1215-2017; Sood, Anoop Kumar/A-7344-2013; Martinez-Camblor, Pablo/Q-1715-2015; Vestbo, Jorgen/Y-2912-2019; Camblor, Pablo Martinez/Z-4834-2019; RG, SMABSS/N-3322-2018	Soriano, Joan B/0000-0001-9740-2994; Sood, Anoop Kumar/0000-0001-5702-4108; Camblor, Pablo Martinez/0000-0001-7845-3905; Vestbo, Jorgen/0000-0001-6355-6362; Faner, Rosa/0000-0002-8159-0115; Research Group, SMIRE+CoDiRE/0000-0002-8871-4942; RG, SMABSS/0000-0001-9944-3861	GlaxoSmithKline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL094531, P50HL107165, R01HL068111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015482] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by an unrestricted grant from GlaxoSmithKline and others.	Altose MD, 2000, NEW ENGL J MED, V343, P1902; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Baughman P, 2012, EUR J EPIDEMIOL, V27, P933, DOI 10.1007/s10654-012-9750-2; Bisgaard H, 2012, AM J RESP CRIT CARE, V185, P1183, DOI 10.1164/rccm.201110-1922OC; BLAND JM, 1994, BRIT MED J, V309, P780, DOI 10.1136/bmj.309.6957.780; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; BURROWS B, 1977, AM REV RESPIR DIS, V115, P751; BURROWS B, 1986, AM REV RESPIR DIS, V133, P974; Casanova C, 2011, AM J RESP CRIT CARE, V184, P1015, DOI 10.1164/rccm.201105-0831OC; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Decramer M, 2005, LANCET, V365, P1552, DOI 10.1016/S0140-6736(05)66456-2; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hnizdo E, 2006, J OCCUP ENVIRON MED, V48, P625, DOI 10.1097/01.jom.0000214351.18905.48; Hoesein FAAM, 2012, CHEST, V142, P1530, DOI 10.1378/chest.11-2837; Kerstjens HAM, 1997, THORAX, V52, P820, DOI 10.1136/thx.52.9.820; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Kohansal R, 2009, CHEST, V135, P1330, DOI 10.1378/chest.08-1750; Lokke A, 2013, CLIN RESPIR J, V7, P153, DOI 10.1111/j.1752-699X.2012.00297.x; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Petersen H, 2014, CHEST, V145, P695, DOI 10.1378/chest.13-0799; Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3; Sanchez-Salcedo P, 2014, EUR RESPIR J, V44, P324, DOI 10.1183/09031936.00208613; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; SHERRILL DL, 1992, EUR RESPIR J, V5, P452; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Stocks J, 2013, LANCET RESP MED, V1, P728, DOI 10.1016/S2213-2600(13)70118-8; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; Tantucci C, 2012, INT J CHRONIC OBSTR, V7, P95, DOI 10.2147/COPD.S27480; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Tashkin DP, 2013, CURR OPIN PULM MED, V19, P116, DOI 10.1097/MCP.0b013e32835d8ea4; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Weiss ST, 1996, AM J RESP CRIT CARE, V154, pS208, DOI 10.1164/ajrccm/154.6_Pt_2.S208	36	653	672	0	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					111	122		10.1056/NEJMoa1411532	http://dx.doi.org/10.1056/NEJMoa1411532			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3QP	26154786	Green Published, Green Submitted			2022-12-28	WOS:000357598600004
J	Theoharides, TC; Valent, P; Akin, C				Theoharides, Theoharis C.; Valent, Peter; Akin, Cem			Mast Cells, Mastocytosis, and Related Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SYSTEMIC MASTOCYTOSIS; BONE-MARROW; DIFFERENTIAL RELEASE; MEDIATOR RELEASE; TRYPTASE LEVELS; ALLELE BURDEN; HORMONE CRH; ACTIVATION; ANAPHYLAXIS; DIAGNOSIS		[Theoharides, Theoharis C.] Tufts Univ, Sch Med, Mol Immunopharmacol & Drug Discovery Lab, Dept Integrat Physiol & Pathobiol,Tufts Med Ctr, Boston, MA 02111 USA; [Theoharides, Theoharis C.] Tufts Univ, Sch Med, Tufts Med Ctr, Dept Internal Med, Boston, MA 02111 USA; [Akin, Cem] Harvard Univ, Brigham & Womens Hosp, Dept Med, Mastocytosis Ctr,Med Sch, Boston, MA 02115 USA; [Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Valent, Peter] Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna	Theoharides, TC (corresponding author), Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, 136 Harrison Ave,Suite J304, Boston, MA 02111 USA.	theoharis.theoharides@tufts.edu	Valent, Peter/B-8533-2016; Gamperl, Susi/V-2715-2019; Test, PV/U-9451-2019; Test, Test/Y-7921-2019	Valent, Peter/0000-0003-0456-5095; Gamperl, Susi/0000-0003-0456-5095; Akin, Cem/0000-0001-6301-4520	Ariad Pharmaceuticals; Celgene; Bristol-Myers Squibb; Pfizer; Novartis; Blueprint Medicines; Patara Pharma	Ariad Pharmaceuticals; Celgene(Bristol-Myers SquibbCelgene Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Novartis(Novartis); Blueprint Medicines; Patara Pharma(Dexcel Pharma)	Dr. Theoharides reports receiving royalties from a patent (US 8,268,365 B2) related to an antiinflammatory composition for treating brain inflammation, licensed to Algonot (a portion of the proceeds is given to Tufts University under an agreement and another portion is given to to AutismFreeBrain, a nonprofit company for autism research). He also reports holding a patent (US 7,906,153 B2) related to mast cells, antiinflammatory agents, multiple sclerosis, central nervous system disorders, and a mixture of flavonoids and olive extracts, a patent (US 7,799,766 B2) related to the treatment of hormonally dependent cancers, and a patent (US 6,689,748 B1) related to a method of treating mast-cell activation-induced diseases with a proteoglycan that is licensed to Algonot. Dr. Valent reports receiving grant support from Ariad Pharmaceuticals, Celgene, Bristol-Myers Squibb, Pfizer, Novartis, and Blueprint Medicines. Dr. Akin reports receiving consulting fees from Novartis, Patara Pharma, and Blueprint Medicines and royalties from a patent (WO2003065986 A2) related to the Laboratory of Allergic Diseases 2 mast-cell line. No other potential conflict of interest relevant to this article was reported.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Akin C, 2004, BLOOD, V103, P3222, DOI 10.1182/blood-2003-11-3816; Akin C, 2007, BLOOD, V110, P2331, DOI 10.1182/blood-2006-06-028100; Akin C, 2010, J ALLERGY CLIN IMMUN, V126, P1099, DOI 10.1016/j.jaci.2010.08.035; Alevizos M, 2013, ANN ALLERG ASTHMA IM, V111, P542, DOI 10.1016/j.anai.2013.08.025; Altman MC, 2013, NEW ENGL J MED, V368, P2528, DOI 10.1056/NEJMc1305687; Alvarez-Twose I, 2012, ALLERGY, V67, P813, DOI 10.1111/j.1398-9995.2012.02812.x; Bodemer C, 2010, J INVEST DERMATOL, V130, P804, DOI 10.1038/jid.2009.281; Brockow K, 2008, ALLERGY, V63, P226, DOI 10.1111/j.1398-9995.2007.01569.x; Bryniarski K, 2013, J ALLERGY CLIN IMMUN, V132, P170, DOI 10.1016/j.jaci.2013.04.048; Butterfield JH, 2010, PROSTAG OTH LIPID M, V92, P73, DOI 10.1016/j.prostaglandins.2010.03.003; Cao J, 2005, J IMMUNOL, V174, P7665, DOI 10.4049/jimmunol.174.12.7665; Carter MC, 2007, J ALLERGY CLIN IMMUN, V119, P1550, DOI 10.1016/j.jaci.2007.03.032; Carter MC, 2015, BRIT J HAEMATOL, V168, P865, DOI 10.1111/bjh.13231; Castells M, 2011, AM J CLIN DERMATOL, V12, P259, DOI 10.2165/11588890-000000000-00000; Clemons A, 2011, J CLIN PSYCHOPHARM, V31, P385, DOI 10.1097/JCP.0b013e3182196e50; Cohen SS, 2014, BRIT J HAEMATOL, V166, P521, DOI 10.1111/bjh.12916; Donelan J, 2006, P NATL ACAD SCI USA, V103, P7759, DOI 10.1073/pnas.0602210103; dos Santos RV, 2010, BRIT J DERMATOL, V162, P674, DOI 10.1111/j.1365-2133.2009.09516.x; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Dudeck A, 2011, EUR J IMMUNOL, V41, P1883, DOI 10.1002/eji.201040994; Enoksson M, 2011, J IMMUNOL, V186, P2523, DOI 10.4049/jimmunol.1003383; Erben P, 2014, ANN HEMATOL, V93, P81, DOI 10.1007/s00277-013-1964-1; Escribano L, 2009, J ALLERGY CLIN IMMUN, V124, P514, DOI 10.1016/j.jaci.2009.05.003; Fux M, 2014, ALLERGY, V69, P216, DOI 10.1111/all.12309; Gagari E, 1997, BLOOD, V89, P2654, DOI 10.1182/blood.V89.8.2654; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Godt O, 1997, DERMATOLOGY, V195, P35, DOI 10.1159/000245681; Harvima IT, 2014, J ALLERGY CLIN IMMUN, V134, P530, DOI 10.1016/j.jaci.2014.03.007; Hoermann G, 2014, ALLERGY, V69, P810, DOI 10.1111/all.12409; HORAN RF, 1990, J ALLERGY CLIN IMMUN, V85, P852, DOI 10.1016/0091-6749(90)90067-E; Jennings S, 2014, J ALLER CL IMM-PRACT, V2, P70, DOI 10.1016/j.jaip.2013.09.004; Kandere-Grzybowska K, 2003, J IMMUNOL, V171, P4830, DOI 10.4049/jimmunol.171.9.4830; Kenna TJ, 2013, NAT REV RHEUMATOL, V9, P375, DOI 10.1038/nrrheum.2012.205; Kluin-Nelemans HC, 2003, BLOOD, V102, P4270, DOI 10.1182/blood-2003-05-1699; Krauth MT, 2009, CLIN EXP ALLERGY, V39, P1711, DOI 10.1111/j.1365-2222.2009.03353.x; Kristensen T, 2011, J MOL DIAGN, V13, P180, DOI 10.1016/j.jmoldx.2010.10.004; Libby P, 2013, NEW ENGL J MED, V369, P883, DOI 10.1056/NEJMc1307806; Lieberman P, 2010, J ALLERGY CLIN IMMUN, V126; Lim KH, 2009, BLOOD, V113, P5727, DOI 10.1182/blood-2009-02-205237; Migalovich-Sheikhet H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00238; Moura DS, 2014, IMMUNOL ALLERGY CLIN, V34, P407, DOI 10.1016/j.iac.2014.02.001; Moura DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039468; Nakae S, 2005, P NATL ACAD SCI USA, V102, P6467, DOI 10.1073/pnas.0501912102; Oka T, 2012, LAB INVEST, V92, P1472, DOI 10.1038/labinvest.2012.116; Olszewski MB, 2007, J IMMUNOL, V178, P5701, DOI 10.4049/jimmunol.178.9.5701; Pardanani A, 2004, LEUKEMIA RES, V28, P127, DOI 10.1016/S0145-2126(03)00185-1; Ravi A, 2014, J ALLER CL IMM-PRACT, V2, P775, DOI 10.1016/j.jaip.2014.06.011; Ribatti D, 2015, EUR J PHARM; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Rottem M, 2005, AUTOIMMUN REV, V4, P21, DOI 10.1016/j.autrev.2004.05.001; Schoch C, 2003, J OCUL PHARMACOL TH, V19, P75, DOI 10.1089/108076803762718132; Schwartz LB, 2006, IMMUNOL ALLERGY CLIN, V26, P451, DOI 10.1016/j.iac.2006.05.010; SCHWARTZ LB, 1987, NEW ENGL J MED, V316, P1622, DOI 10.1056/NEJM198706253162603; Shah NP, 2006, BLOOD, V108, P286, DOI 10.1182/blood-2005-10-3969; Skokos D, 2003, J IMMUNOL, V170, P3037, DOI 10.4049/jimmunol.170.6.3037; Smith JH, 2011, CLIN NEUROL NEUROSUR, V113, P570, DOI 10.1016/j.clineuro.2011.05.002; Sokol H, 2013, J ALLERGY CLIN IMMUN, V132, P866, DOI 10.1016/j.jaci.2013.05.026; Sonneck K, 2007, INT ARCH ALLERGY IMM, V142, P158, DOI 10.1159/000096442; Teodosio C, 2015, J LEUKOCYTE BIOL, V97, P49, DOI 10.1189/jlb.5RU0614-296R; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Theoharides TC, 2014, J ALLERGY CLIN IMMUN, V134, P1197, DOI 10.1016/j.jaci.2014.05.023; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Ustun C, 2014, J CLIN ONCOL, V32, P3264, DOI 10.1200/JCO.2014.55.2018; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Valent P, 2012, INT ARCH ALLERGY IMM, V157, P215, DOI 10.1159/000328760; van Anrooij B, 2013, J ALLERGY CLIN IMMUN, V132, P125, DOI 10.1016/j.jaci.2012.12.1578; Weng Z, 2015, J ALLERGY CLIN IMMUN, V135, P1044, DOI 10.1016/j.jaci.2014.10.032; Wheatley LM, 2015, NEW ENGL J MED, V372, P456, DOI 10.1056/NEJMcp1412282; Yavuz AS, 2002, BLOOD, V100, P661, DOI 10.1182/blood-2002-01-0203; Zanotti R, 2015, J ALLERGY CLIN IMMUN; Zhang BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049767	74	279	288	6	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					163	172		10.1056/NEJMra1409760	http://dx.doi.org/10.1056/NEJMra1409760			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3QP	26154789				2022-12-28	WOS:000357598600009
J	Whitmee, S; Haines, A; Beyrer, C; Boltz, F; Capon, AG; Dias, BFDS; Ezeh, A; Frumkin, H; Gong, P; Head, P; Horton, R; Mace, GM; Marten, R; Myers, SS; Nishtar, S; Osofsky, SA; Pattanayak, SK; Pongsiri, MJ; Romanelli, C; Soucat, A; Vega, J; Yach, D				Whitmee, Sarah; Haines, Andy; Beyrer, Chris; Boltz, Frederick; Capon, Anthony G.; Dias, Braulio Ferreira de Souza; Ezeh, Alex; Frumkin, Howard; Gong, Peng; Head, Peter; Horton, Richard; Mace, Georgina M.; Marten, Robert; Myers, Samuel S.; Nishtar, Sania; Osofsky, Steven A.; Pattanayak, Subhrendu K.; Pongsiri, Montira J.; Romanelli, Cristina; Soucat, Agnes; Vega, Jeanette; Yach, Derek			Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on planetary health	LANCET			English	Review							GREENHOUSE-GAS EMISSIONS; CLIMATE-CHANGE; FOOD SECURITY; HURRICANE-KATRINA; PUBLIC-HEALTH; CO-BENEFITS; RETROSPECTIVE ANALYSIS; MISSISSIPPI DELTA; BIODIVERSITY LOSS; IRRIGATION WATER		[Whitmee, Sarah; Mace, Georgina M.] UCL, Ctr Biodivers & Environm Res, London WC1E 6BT, England; [Haines, Andy; Marten, Robert] London Sch Hyg & Trop Med, London WC1, England; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Boltz, Frederick; Marten, Robert] Rockefeller Fdn, New York, NY USA; [Capon, Anthony G.] United Nations Univ, Int Inst Global Hlth, Kuala Lumpur, Malaysia; [Dias, Braulio Ferreira de Souza; Romanelli, Cristina] Convent Biol Divers, Montreal, PQ, Canada; [Ezeh, Alex] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Frumkin, Howard] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Gong, Peng] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [Head, Peter] Ecol Sequestrat Trust, London, England; [Horton, Richard] Lancet, London, England; [Myers, Samuel S.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Myers, Samuel S.] Harvard Univ, TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Osofsky, Steven A.] Wildlife Conservat Soc, Oakton, VA USA; [Pattanayak, Subhrendu K.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Pattanayak, Subhrendu K.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Pongsiri, Montira J.] US EPA, Washington, DC 20460 USA; [Soucat, Agnes] World Bank, Washington, DC 20433 USA; [Vega, Jeanette] Natl Chilean Publ Hlth Insurance Agcy, Santiago, Chile; [Yach, Derek] Vital Grp, New York, NY USA	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; African Population & Health Research Centre; University of Washington; University of Washington Seattle; Tsinghua University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Wildlife Conservation Society; Duke University; Duke University; United States Environmental Protection Agency; The World Bank	Whitmee, S (corresponding author), UCL, Dept Genet Evolut & Environm, Ctr Biodivers & Environm Res, London WC1E 6BT, England.	s.whitmee@ucl.ac.uk	Ezeh, Alex/AAN-8646-2020; Romanelli, Cristina/D-6243-2016; Gong, Peng/AAM-1516-2021; Mace, Georgina M/I-3072-2016	Ezeh, Alex/0000-0002-1309-4697; Romanelli, Cristina/0000-0002-0642-4563; Gong, Peng/0000-0003-1513-3765; Mace, Georgina M/0000-0001-8965-5211; Frumkin, Howard/0000-0001-7079-3534; Haines, Andy/0000-0002-8053-4605; Whitmee, Sarah/0000-0001-9161-868X; Boltz, Frederick/0000-0002-4225-248X; Capon, Anthony/0000-0003-0354-6810	Rockefeller Foundation; Medical Research Council; Wellcome Trust; NERC; Department for Environment, Food Rural Affairs; Leverhulme Trust; Bill AMP; Melinda Gates Foundation; Winslow Foundation	Rockefeller Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Department for Environment, Food Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Leverhulme Trust(Leverhulme Trust); Bill AMP; Melinda Gates Foundation(CGIAR); Winslow Foundation	All authors declare that the work of the Commission on Planetary Health was supported by The Rockefeller Foundation. SW, AH, and GMM were compensated for their time working on the Commission. AH, GMM, and PG are also members of the Lancet Commission on Health and Climate Change. AH has received funds from the Medical Research Council and from the Wellcome Trust for research on global environmental change and health. RH is the editor of The Lancet. GMM chaired the Royal Society science-policy report on Resilience to Extreme Weather, is a trustee of the World Wide Fund for Nature UK, a member of the UK Government Natural Capital Committee (England), and a member of Council of the Natural Environment Research Council (NERC) and the Royal Society; she has received funding from the NERC, the Department for Environment, Food & Rural Affairs, and the Leverhulme Trust. FB and RM are employees of The Rockefeller Foundation. SM has received funding from The Rockefeller Foundation, the Bill & Melinda Gates Foundation, the Winslow Foundation, and the Wellcome Trust for research into the human health impacts of global environmental change. DY is senior vice president of the Vitality Group, part of Discovery Ltd, where he leads the Vitality Institute. Previously, he was senior vice president of Global Health and Agriculture Policy at PepsiCo and head of global health at The Rockefeller Foundation. SN is also a member of the Lancet Commission on Pain and Palliative Care and is (as president and founder of Heartfile) a recipient of a grant from The Rockefeller Foundation. JV is a former employee of The Rockefeller Foundation. HF was a resident at The Rockefeller Foundation, Bellagio Center during March, 2015, and has previously received funding from The Rockefeller Foundation. HF is a board member of the Bullitt Foundation and the Washington Global Health Alliance. SAO (through WCS and HEAL) has received funding from The Rockefeller Foundation. The other authors declare no competing interests.	Agyeman J, 2009, ENVIRON PLANN A, V41, P509, DOI 10.1068/a41301; Ahern M, 2005, EPIDEMIOL REV, V27, P36, DOI 10.1093/epirev/mxi004; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Albrecht G, 2007, AUSTRALAS PSYCHIATRY, V15, pS95, DOI 10.1080/10398560701701288; Alcott B, 2005, ECOL ECON, V54, P9, DOI 10.1016/j.ecolecon.2005.03.020; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; American Society of Civil Engineers Hurricane Katrina External Review Panel, 2007, NEW ORLEANS HURRICAN; [Anonymous], 1995, COD COND RESP FISH; [Anonymous], 2015, ADV REP SECR HLTH HU; [Anonymous], 2015, LANCET, V386, P1861, DOI DOI 10.1016/S0140-6736(15)60854-6; [Anonymous], 2012, GLOB ENV OUTL SUMM P; [Anonymous], 2011, PAK FLOODS ON YEAR; [Anonymous], 2014, WHO WE AR; Arriagada RA, 2010, AGR ECON-BLACKWELL, V41, P567, DOI 10.1111/j.1574-0862.2010.00472.x; Arrow K, 2004, J ECON PERSPECT, V18, P147, DOI 10.1257/0895330042162377; Atehnkeng J, 2008, FOOD ADDIT CONTAM A, V25, P1264, DOI 10.1080/02652030802112635; Atta-ur-Rahman, 2013, NAT HAZARDS, V66, P887, DOI 10.1007/s11069-012-0528-3; Avnery S, 2011, ATMOS ENVIRON, V45, P2284, DOI 10.1016/j.atmosenv.2010.11.045; Bai ZG, 2008, SOIL USE MANAGE, V24, P223, DOI 10.1111/j.1475-2743.2008.00169.x; Bailis R, 2005, SCIENCE, V308, P98, DOI 10.1126/science.1106881; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Barnosky AD, 2013, INFORM POLICY MAKERS; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Bauch SC, P NATL ACAD IN PRESS; Bauch SC, 2014, WORLD DEV, V64, pS135, DOI 10.1016/j.worlddev.2014.03.009; Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056; Beguin A, 2011, GLOBAL ENVIRON CHANG, V21, P1209, DOI 10.1016/j.gloenvcha.2011.06.001; Bene C, 2015, FOOD SECUR, V7, P261, DOI 10.1007/s12571-015-0427-z; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Bereuter D, 2015, HLTH FOOD HLTH WORLD; Bergman A, 2013, ENVIRON HEALTH PERSP, V121, pA104, DOI 10.1289/ehp.1205448; Berry H, 2009, AUSTRALAS PSYCHIATRY, V17, P453, DOI 10.1080/10398560903045328; Biermann F, 2012, SCIENCE, V335, P1306, DOI 10.1126/science.1217255; Biran A, 2014, LANCET GLOB HEALTH, V2, pE145, DOI 10.1016/S2214-109X(13)70160-8; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bond T.N., 2014, 19950 NAT BUR EC RES; Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987; Bouwman L, 2013, P NATL ACAD SCI USA, V110, P20882, DOI 10.1073/pnas.1012878108; Bowler D, 2010, ENV EVIDENCE; Bradshaw CJA, 2014, P NATL ACAD SCI USA, V111, P16610, DOI 10.1073/pnas.1410465111; Bradshaw CJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010440; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brown L, 2014, PUBLIC HEALTH, V128, P29, DOI 10.1016/j.puhe.2013.09.006; Brubaker M, 2011, GLOB HLTH ACTION, V4, P10; Brundtland Commission, 1987, OUR COMMON FUTURE, DOI DOI 10.1080/07488008808408783; Brunkard J, 2008, DISASTER MED PUBLIC, V2, P215, DOI 10.1097/DMP.0b013e31818aaf55; Bryant L, 2009, B WORLD HEALTH ORGAN, V87, P852, DOI 10.2471/BLT.08.062562; BUCHANAN JM, 1962, ECONOMICA, V29, P371, DOI 10.2307/2551386; Bush GW., 2005, STATEMENT FEDERAL EM; Bustinduy A, 2014, LANCET INFECT DIS, V14, P640, DOI 10.1016/S1473-3099(14)70001-5; Butler CD., 2014, CAB REV, V9; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3628, DOI 10.1073/pnas.1114772109; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3632, DOI 10.1073/pnas.1114845109; Campbell-Lendrum D, 2007, J URBAN HEALTH, V84, pI109, DOI 10.1007/s11524-007-9170-x; Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653; Capon AG, 2007, MED J AUSTRALIA, V187, P658, DOI 10.5694/j.1326-5377.2007.tb01465.x; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carpenter SR, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014009; Cassidy ES, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034015; CBD-WHO, 2015, CONN GLOB PRIOR BIOD; Chakraborty S, 2011, PLANT PATHOL, V60, P2, DOI 10.1111/j.1365-3059.2010.02411.x; Chen LD, 2007, PROG PHYS GEOG, V31, P389, DOI 10.1177/0309133307081290; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Cheng JJ, 2013, INT J PUBLIC HEALTH, V58, P305, DOI 10.1007/s00038-012-0422-5; Chichilnisky G, 2000, RESOUR ENERGY ECON, V22, P221, DOI 10.1016/S0928-7655(00)00032-4; Cinner JE, 2012, GLOBAL ENVIRON CHANG, V22, P12, DOI 10.1016/j.gloenvcha.2011.09.018; Clements B, 2013, ENERGY SUBSIDY REFOR; Climate and Clean Air Coalition (CCAC), 2014, SCI ADV PAN BRIEF KE; CNA Military Advisory Board, 2014, NAT SEC ACC RISKS CL; Coady D., 2015, WP15105 IMF; Colding Johan, 2013, P313; Conway E. M., 2010, MERCHANTS DOUBT HAND; Conway G, 2012, ONE BILLION HUNGRY C; Cook RA, 2004, ONE WORLD ONE HLTH; Cookson J, 2013, NATL GEOGRAPHIC; Corvalan C, 2005, MILLENNIUM ECOSYSTEM; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Costanza R, 2006, FRONT ECOL ENVIRON, V4, P465, DOI 10.1890/1540-9295(2006)4[465:ANVFNO]2.0.CO;2; Costanza R, 2014, NATURE, V505, P283, DOI 10.1038/505283a; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Coyle D., 2014, GDP BRIEF AFFECTIONA; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Cumming-Bruce N., 2014, NY TIMES; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; Dasgupta P., 2001, HUMAN WELL BEING NAT; Dasgupta P, 2010, PHILOS T R SOC B, V365, P5, DOI 10.1098/rstb.2009.0231; Daszak P, 2013, P NATL ACAD SCI USA, V110, P3681, DOI 10.1073/pnas.1201243109; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Davidson NC, 2014, MAR FRESHWATER RES, V65, P934, DOI 10.1071/MF14173; Daviglus M., 2002, COMMENTS TOXICOL, V8, P345, DOI DOI 10.1080/08865140215064; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; de Sherbinin A, 2007, ANNU REV ENV RESOUR, V32, P345, DOI 10.1146/annurev.energy.32.041306.100243; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; De Steur H, 2015, NAT BIOTECHNOL, V33, P25, DOI 10.1038/nbt.3110; Dean R. G., 2006, BRIDGE, V36, P35; Dearing JA, 2014, GLOBAL ENVIRON CHANG, V28, P227, DOI 10.1016/j.gloenvcha.2014.06.012; Deaton A., 2013, GREAT ESCAPE HLTH WE; DeFries RS, 2004, FRONT ECOL ENVIRON, V2, P249, DOI 10.1890/1540-9295(2004)002[0249:LCBHNA]2.0.CO;2; Diallo Y, 2010, GLOBAL CHILD LABOUR; Diamond ML, 2015, ENVIRON INT, V78, P8, DOI 10.1016/j.envint.2015.02.001; Diboulo E, 2012, GLOBAL HEALTH ACTION, V5, P6, DOI 10.3402/gha.v5i0.19078; Dora C, 2015, LANCET, V385, P380, DOI 10.1016/S0140-6736(14)60605-X; Dunne JP, 2013, NAT CLIM CHANGE, V3, P563, DOI 10.1038/NCLIMATE1827; Ekstrom JA, 2015, NAT CLIM CHANGE, V5, P207, DOI 10.1038/NCLIMATE2508; El-Zein A, 2014, LANCET, V383, P458, DOI 10.1016/S0140-6736(13)62338-7; Elliott J, 2014, P NATL ACAD SCI USA, V111, P3239, DOI 10.1073/pnas.1222474110; Ellis AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114805; Englberger L, 2003, J FOOD COMPOS ANAL, V16, P3, DOI 10.1016/S0889-1575(02)00133-3; Epule TE, 2015, GEOJOURNAL, V80, P79, DOI 10.1007/s10708-014-9528-z; Eshel G, 2014, P NATL ACAD SCI USA, V111, P11996, DOI 10.1073/pnas.1402183111; European Commission, 2014, CIRCULAR EC ZERO WAS; Evans MR, 2012, PHILOS T R SOC B, V367, P181, DOI 10.1098/rstb.2011.0172; FAO, 2008, CLIM CHANG FOOD SEC; FAO, 2011, STAT WORLD FISH AQ O; FAO, 2012, STAT WORLDS FOR 2012; FAO, 2013, FOOD WASTAGE FOOTPRI; Federal Emergency Management Agency, 2013, NAT RESP FRAM NRF; Ferraro PJ, 2012, REV ENV ECON POLICY, V6, P20, DOI 10.1093/reep/rer019; Fischer J, 2009, TRENDS ECOL EVOL, V24, P549, DOI 10.1016/j.tree.2009.03.020; Fisher BS, 2007, MITIGATION CONTRIBUT; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2007, P NATL ACAD SCI USA, V104, P12585, DOI 10.1073/pnas.0705190104; Food and Agriculture Organization (FAO), 2012, STAT WORLD FISH AQ 2; Food and Agriculture Organization of the United Nations-FAO, 2003, REV WORLD WAT RES CO; Fowler C., 1990, THREATENED GENE FOOD; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Frenken K, 2011, FAO WATER REPORTS, V37; Friel S, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-46; Galaz V, 2014, GLOBAL ENV GOVERNANC, DOI 10.4337/9781781955550; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gerbens-Leenes W, 2009, P NATL ACAD SCI USA, V106, P10219, DOI 10.1073/pnas.0812619106; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gilles HM, 1999, EPIDEMIOLOGY; Global Commission on the Economy and Climate, 2014, BETT GROWTH BETT CLI; Global Ocean Commission, 2014, DECL REC RESC PACK G; Global Reporting Initiative, SUST REP FRAM; Godfray H Charles J, 2014, Philos Trans R Soc Lond B Biol Sci, V369, P20120273, DOI 10.1098/rstb.2012.0273; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Gomez-Baggethun Erik, 2013, P175; Gomez-Olive FX, 2013, AIDS CARE, V25, P1122, DOI 10.1080/09540121.2012.750710; Goodman A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-52; Green R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3703; Guynup S., 2010, INDIA CHINA SHARE GR; Haase Dagmar, 2013, P253; HAINES A, 1993, LANCET, V342, P1464, DOI 10.1016/0140-6736(93)92937-O; Haines A, 2014, LANCET, V384, P479, DOI 10.1016/S0140-6736(14)61289-7; Hallstrom E, 2015, J CLEAN PROD, V91, P1, DOI 10.1016/j.jclepro.2014.12.008; Hamoudi A, 2012, AM J TROP MED HYG, V87, P18, DOI 10.4269/ajtmh.2012.12-0051; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Higginbotham N, 2006, ECOHEALTH, V3, P245, DOI 10.1007/s10393-006-0069-x; Hijioka Y, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1327; HLPE, 2013, BIOF FOOD SEC; Hoberg EP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0553; Horton R, 2014, LANCET, V383, P847, DOI 10.1016/S0140-6736(14)60409-8; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Hunter LM, 2007, SCAND J PUBLIC HEALT, V35, P165, DOI 10.1080/14034950701356385; Hunter LM, 2011, SOC NATUR RESOUR, V24, P256, DOI 10.1080/08941920903443327; Huybers P, 2014, J CLIMATE, V27, P7368, DOI 10.1175/JCLI-D-14-00216.1; IEA, 2011, WORLD EN OUTL; IFRC, 2002, MANGR PLANT SAV LIV; IGBP IOC SCOR, 2013, 3 S OC HIGH CO2 WORL; Ikeme J, 2003, GLOBAL ENVIRON CHANG, V13, P195, DOI 10.1016/S0959-3780(03)00047-5; Imran Z., 2013, CLIMATE CHANGE ITS I; Institution of Mechanical Engineers, 2013, GLOB FOOD WAST NOT W; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; International Commission on Stratigraphy, 2013, INT STRAT CHART; International Federation of Red Cross and Red Crescent Societies, 1998, WORLD DIS REP 1997; International Health Conference, 2002, Bull World Health Organ, V80, P983; IOM (Int. Organ. Migr.), 2009, MIGRATION ENV CLIMAT; IPCC, 2018, SUMMARY POLICYMAKERS; IPCC, 2013, CLIMATE CHANGE 2022; ISSC, 2015, REV SUST DEV GOALS S; Jacob B, 2008, PUBLIC HEALTH REP, V123, P555, DOI 10.1177/003335490812300505; Jacobson MZ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD002044; Jagger P, 2009, REALIZING REDD NATL, P283; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Jelmayer R, 2015, WALL STREET J; Jepson PC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0491; Jeuland MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030338; Johansson TB, 2012, GLOBAL ENERGY ASSESS; Johnston FH, 2012, ENVIRON HEALTH PERSP, V120, P695, DOI 10.1289/ehp.1104422; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Kamins AO, 2015, ECOHEALTH, V12, P104, DOI 10.1007/s10393-014-0977-0; Kang L, 2009, J SOIL WATER CONSERV, V16, P76; Kar NP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-265; Kawaguchi S, 2013, NAT CLIM CHANGE, V3, DOI 10.1038/NCLIMATE1937; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kelley CP, 2015, P NATL ACAD SCI USA, V112, P3241, DOI 10.1073/pnas.1421533112; Kennedy G, 2003, FOOD CHEM, V80, P589, DOI 10.1016/S0308-8146(02)00507-1; Khandekar ML, 2010, CMOS B SCMO, V38, P165; Kim PS, 2015, ATMOS ENVIRON, V102, P11, DOI 10.1016/j.atmosenv.2014.09.045; Kimball AM, 2014, LANCET, V384, P2023, DOI 10.1016/S0140-6736(14)62330-8; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Kirsch Thomas D, 2012, PLoS Curr, V4, pe4fdfb212d2432, DOI 10.1371/4fdfb212d2432; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klinger Chaamala, 2014, PLoS Curr, V6, DOI 10.1371/currents.dis.04eb1dc5e73dd1377e05a10e9edde673; Klunder H, 2013, EDIBLE INSECTS FUTUR; Knabb R.D., 2006, TROPICAL CYCLONE REP; Knox JH, 2012, REP INDEPENDENT EXPE; Koch A, 2013, GLOB POLICY, V4, P434, DOI 10.1111/1758-5899.12096; Koppelaar R, 2013, REV CURRENT ADV INTE; Krey V, 2012, ENERG ECON, V34, pS272, DOI 10.1016/j.eneco.2012.04.013; Kruk ME, 2015, LANCET, V385, P1910, DOI 10.1016/S0140-6736(15)60755-3; Kummu M, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034006; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2010, BIOSCIENCE, V60, P708, DOI 10.1525/bio.2010.60.9.8; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Landrigan P.J., 2013, TXB CHILDRENS ENV HL, DOI [10.1093/med/9780199929573.001.0001/med-9780199929573, DOI 10.1093/MED/9780199929573.001.0001/MED-9780199929573]; Lane K, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/913064; Lang T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5466; LEBEL J., 2003, HLTH ECOSYSTEM APPRO; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu S, 2012, CHINESE SCI BULL, V57, P2835, DOI 10.1007/s11434-012-5267-z; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Lloyd SJ, 2011, ENVIRON HEALTH PERSP, V119, P1817, DOI 10.1289/ehp.1003311; Loughry M., 2010, CLIMATE CHANGE DISPL; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Ma L., 2001, ECON GEOGR, V21, P23; Mace G.M., 2005, ECOSYSTEMS HUMAN WEL, P77; Mace GM, 2015, J APPL ECOL, V52, P641, DOI 10.1111/1365-2664.12431; Mace GM, 2014, GLOBAL ENVIRON CHANG, V28, P289, DOI 10.1016/j.gloenvcha.2014.07.009; Mace GM, 2013, ENVIRON RESOUR ECON, V55, P555, DOI 10.1007/s10640-013-9678-3; Macpherson CC, 2015, PUBLIC HEALTH ETH-UK, V8, P196, DOI 10.1093/phe/phv008; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; May-Tobin C., 2011, ROOT PROBLEM WHATS D; Mazhar N., 2014, PAKISTAN EC SURVEY 2, P179; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; McDonald RI, 2014, URBAN WATER BLUEPRIN; McDonald Robert I, 2011, Proc Natl Acad Sci U S A, V108, P6312, DOI 10.1073/pnas.1011615108; McLellan R, 2014, LIV PLAN REP 2014 SP; McMichael A J, 1993, PLANETARY OVERLOAD G; McMichael AJ, 2014, ANTHROPOCENE REV, V1, P44, DOI 10.1177/2053019613514035; Medina A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00348; Medlock Jolyon M., 2011, European Mosquito Bulletin, V29, P38; Memon AA, 2004, CRITICAL TRANSITIONS, P1; Millennium Ecosystem Assessment, 2005, LIV OUR MEANS NAT AS; Milner J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007364; Miteva D, PLOS ONE IN PRESS; Molyneux DH, 1998, INT J PARASITOL, V28, P927, DOI 10.1016/S0020-7519(98)00067-8; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Montgomery MR, 2008, SCIENCE, V319, P761, DOI 10.1126/science.1153012; Moors E, 2013, SCI TOTAL ENVIRON, V468, pS139, DOI 10.1016/j.scitotenv.2013.07.021; Mueller V, 2014, NAT CLIM CHANGE, V4, P182, DOI [10.1038/NCLIMATE2103, 10.1038/nclimate2103]; Mullan D, 2013, CATENA, V109, P234, DOI 10.1016/j.catena.2013.03.007; Munich RE NatCatSERVICE, 2014, LOSS EVENTS WORLDWID; Myers SS, 2014, NATURE, V510, P139, DOI 10.1038/nature13179; Myers SS, 2013, P NATL ACAD SCI USA, V110, P18753, DOI 10.1073/pnas.1218656110; Myers SS, 2009, ANNU REV ENV RESOUR, V34, P223, DOI 10.1146/annurev.environ.033108.102650; Myers SS, LANCET GLOB IN PRESS; Natural Capital Initiative, 2011, POL MAK BAS WORKSH H; [Nature http://www.nature.com/subjects/climate-and-earth-system-modelling], CLIM EARTH SYST MOD; Nelson DR, 2007, ANNU REV ENV RESOUR, V32, P395, DOI 10.1146/annurev.energy.32.051807.090348; New Economics Foundation, 2012, HAPP PLAN IND 2012 R; Nicolia A, 2014, CRIT REV BIOTECHNOL, V34, P77, DOI 10.3109/07388551.2013.823595; O'Neill BC, 2012, LANCET, V380, P157, DOI 10.1016/S0140-6736(12)60958-1; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P17521, DOI 10.1073/pnas.1004581107; Odeman LR, 1998, ASSESSMENT STATUS HU; OECD, 2012, WAT OECD ENV OUTL 20; Olson Sarah H, 2012, Emerg Health Threats J, V5, DOI 10.3402/ehtj.v5i0.9134; Organisation for Economic Co-operation and Development, 2011, ENV TAX GUID POL MAK; Ostrom E, 2010, AM ECON REV, V100, P641, DOI 10.1257/aer.100.3.641; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Pachauri S, 2014, NAT CLIM CHANGE, V4, P1073, DOI 10.1038/NCLIMATE2414; Parry I, 2014, MUCH CARBON PRICING; Passmore S, 2015, JANUARY 2015 STATUS; Pattanayak SK, 2007, BIODIVERS CONSERV, V16, P2801, DOI 10.1007/s10531-007-9215-1; Pattanayak SK, 2009, ANNU REV RESOUR ECON, V1, P183, DOI 10.1146/annurev.resource.050708.144053; Pattanayak SK, 2009, B WORLD HEALTH ORGAN, V87, P580, DOI 10.2471/BLT.08.057422; Patterson ST., 2008, HUMAN HLTH FORESTS G, P197; Patz JA, 2005, ECOSYSTEMS HUMAN WEL; Patz JA, 2014, JAMA-J AM MED ASSOC, V312, P1565, DOI 10.1001/jama.2014.13186; Pauly D, 2013, NATURE, V494, P303, DOI 10.1038/494303a; Penafiel D, 2011, ECOHEALTH, V8, P381, DOI 10.1007/s10393-011-0700-3; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Polasky S, 2011, TRENDS ECOL EVOL, V26, P398, DOI 10.1016/j.tree.2011.04.007; Pongsiri MJ, 2009, BIOSCIENCE, V59, P945, DOI 10.1525/bio.2009.59.11.6; Population Division of the Department of Economic and Social Affairs of the United Nations, 2013, WORLD POP PROSP 2012; Porter ME, 2014, SOCIAL PROGR INDEX 2; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Pruss-Ustun A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-9; Pruss-Ustun A., 2006, Preventing disease through healthy environments: towards an estimate of the environmental burden of disease; Pruss-Ustun A, 2011, WORLD EC REV, V10, P9, DOI 10.1186/1476-069X-10-9; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Qin TFD, 2013, IPCC 2013 SUMMARY PO; Rah JH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005180; Raskin Paul D., 2010, Sustainability, V2, P2626, DOI 10.3390/su2082626; Raudsepp-Hearne C, 2010, BIOSCIENCE, V60, P576, DOI 10.1525/bio.2010.60.8.4; Raworth K, 2012, SAFE JUST SPACE HUMA, DOI DOI 10.5822/978-1-61091-458-1; Redwood-Campbell L, 2011, PREHOSP DISASTER MED, V26, P184, DOI 10.1017/S1049023X11006388; Rickson RJ, 2015, FOOD SECUR, V7, P351, DOI 10.1007/s12571-015-0437-x; Robeco SAM, D JONES SUSTAINABILI; Roberts CM, 2013, OCEANS OF LIFE; Rocha J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0273; Rocha JC, 2014, REGIME SHIFTS WHAT A; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rodin Judith, 2014, RESILIENCE DIVIDEND, P6; Rosegrant MW, 2009, ANNU REV ENV RESOUR, V34, P205, DOI 10.1146/annurev.environ.030308.090351; Roser M., 2015, WORLD POVERTY; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Royal Society, 2014, RES EXTR WEATH; Russi D., 2013, EC ECOSYSTEMS BIODIV; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Sanchez-Rodriguez R, 2005, SCI PLAN URBANIZATIO; Sanford T, 2014, NAT CLIM CHANGE, V4, P164, DOI 10.1038/nclimate2148; Savilaakso S, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-4; Searchinger T, 2013, MENU SOLUTIONS SUSTA; Secor WE, 2012, CURR OPIN HIV AIDS, V7, P254, DOI 10.1097/COH.0b013e328351b9e3; Secretariat of the Convention on Biological Diversity, 2014, GLOB BIOD OUTL 4; Secretariat of the Convention on Biological Diversity, 2014, UPD SYNTH IMP OC AC; Secretariat of the Convention on Biological Diversity, 2010, GLOB BIOD OUTL 3; Shabir Omar, 2013, PLoS Curr, V5, DOI 10.1371/currents.dis.cc7bd532ce252c1b740c39a2a827993f; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sheeshka J, 2010, COMMENTS TOXICOL, V8, P375; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Siegel KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104059; Singer AW, 2015, AIDS BEHAV, V19, P1510, DOI 10.1007/s10461-014-0873-1; Singh S, 2012, ADDING IT COSTS BENE; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Smith MR, LANCET IN PRESS; Smith VK, 2006, ECOL ECON, V60, P361, DOI 10.1016/j.ecolecon.2006.04.002; Snider AG, 2003, J FOREST, V101, P18; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Stanke Carla, 2013, PLoS Curr, V5, DOI 10.1371/currents.dis.7a2cee9e980f91ad7697b570bcc4b004; Starmer C, 2000, J ECON LIT, V38, P332, DOI 10.1257/jel.38.2.332; Steffen W, 2015, ANTHROPOCENE REV, V2, P81, DOI 10.1177/2053019614564785; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Stiglitz J. E., 2010, FREEFALL AM FREE MAR; Stockholm Resilience Centre, RES DICT 2015; Stone B, 2010, ENVIRON HEALTH PERSP, V118, P1425, DOI 10.1289/ehp.0901879; Strosnider H, 2006, ENVIRON HEALTH PERSP, V114, P1898, DOI 10.1289/ehp.9302; Sturm R, 2013, AM J PREV MED, V44, P567, DOI 10.1016/j.amepre.2013.02.011; Sukhdev P., 2010, MAINSTREAMING EC NAT; Sukhdev P., 2014, NATURE BALANCE EC BI; Sunstein CR, 2007, HARVARD ENVIRON LAW, V31, P1; Suweis S, 2013, P NATL ACAD SCI USA, V110, P4230, DOI 10.1073/pnas.1222452110; Tai APK, 2014, NAT CLIM CHANGE, V4, P817, DOI [10.1038/nclimate2317, 10.1038/NCLIMATE2317]; Talberth Dr John, 2006, GENUINE PROGR INDICA, P33; Tang BH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-623; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; The Government Office for Science, 2011, FOR FUT FOOD FARM; The McKinsey Global Institute McKinsey & Company's Sustainability & Resource Productivity Practice, 2011, RES REV MEET WORLDS; The President's Council of Advisors on Science and Technology, 2011, SUST ENV CAP PROT SO; The Rockefeller Foundation, 2015, 100 RES CIT 100RC; The Royal Society, 2012, PEOPL PLAN; The Secretary-General's Independent Expert Advisory Group on a Data Revolution for Sustainable Development, WORLD COUNTS MOB DAT; Thomas SL, 2004, BRIT MED BULL, V69, P115, DOI 10.1093/bmb/ldh009; Thompson TM, 2014, NAT CLIM CHANGE, V4, P917, DOI [10.1038/nclimate2342, 10.1038/NCLIMATE2342]; Thurstan RH, 2014, MAR POLLUT BULL, V89, P5, DOI 10.1016/j.marpolbul.2014.09.016; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Timko J. A., 2010, BIODIVERSITY-OTTAWA, V11, P45, DOI 10.1080/14888386.2010.9712646; Toloo Ghasem Sam, 2013, Environ Health, V12, P27, DOI 10.1186/1476-069X-12-27; Traore M., 2012, SUSTAINABLE NUTR SEC; Troell M, 2014, P NATL ACAD SCI USA, V111, P13257, DOI 10.1073/pnas.1404067111; Twine W, 2010, AIDS RURAL LIVELIHOO, P153; Twine W, 2011, DEV SO AFR, V28, P431, DOI 10.1080/0376835X.2011.605559; Uematsu H, 2013, STATE POOR ARE POOR; UKNEA, 2011, TECHNICAL REPORT; UN Conference on Environment and Development, 1992, EARTH SUMM 92; UN Department of Economic and Social Affairs Population Division, 2014, WORLD URB PROSP 2014; UN Environment Programme, 2006, STRAT APPR INT CHEM; UN Environment Programme, 2013, REP COSTS IN SOUND M; UN General Assembly, 2013, HAPP HOL APPR TC DEV; UN-Department of Economic and Social Affairs Population Division, 2010, WORLD URB PROSP 2009; *UNAIDS, 2000, REP GLOB HIV AIDS EP; UNDP, 2012, SHIN SOIL CONS PROGR; UNEP, 2007, GLOB ENV OUTL; UNEP, 2010, ISLAMIC REPUBLIC IRA; UNEP U.N., 2013, GLOB CHEM OUTL SOUND; UNHCR (United Nations High Commissioner for Refugees), 2013, DISPL NEW 21 CENT CH; UNICEF, ETH FAR REACH HLTH W; UNISDR. Hyogo, 2005, FRAM ACT 2005 2015 B, DOI DOI 10.1017/CBO9781107415324.004; United Nations, 2014, A68970 UN; United Nations, 2014, MILL DEV GOALS REP 2; United Nations Human Settlements Programme (UN Habitat), 2014, STAT AFR CIT 2014 RE; United Nations Population Fund (UNFPA), 2007, UNL POT URB GROWTH; United States Coral Reef Task Force, 2000, NAT ACT PLAN CONS CO; United States Environmental Protection Agency, TOX REL INV TRI PROG; United States Environmental Protection Agency, 2013, HIGH PROD VOL HPV CH; urkova P., 2012, CLIMATE REFUGEES 21; US Government, 2006, FED RESP HURR KATR L; van der Spiegel M, 2013, COMPR REV FOOD SCI F, V12, P662, DOI 10.1111/1541-4337.12032; Van Houtven G, 2007, RESOUR ENERGY ECON, V29, P206, DOI 10.1016/j.reseneeco.2007.01.002; Vieux F, 2013, AM J CLIN NUTR, V97, P569, DOI 10.3945/ajcn.112.035105; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Waage J, 2015, LANCET GLOB HEALTH, V3, pE251, DOI 10.1016/S2214-109X(15)70112-9; Waite R., 2014, IMPROVING PRODUCTIVI; Wallace RG, 2014, ENVIRON PLANN A, V46, P2533, DOI 10.1068/a4712com; Weber JG, 2011, LAND ECON, V87, P661, DOI 10.3368/le.87.4.661; West JJ, 2013, NAT CLIM CHANGE, V3, P885, DOI [10.1038/NCLIMATE2009, 10.1038/nclimate2009]; Whitehead JC, 2008, J ECON SURV, V22, P872, DOI 10.1111/j.1467-6419.2008.00552.x; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Withana S, 2012, STUDY SUPPORTING PHA; Wohlson B., 2006, BRIDGE, V36, P27; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Bank, 2003, IDA26160 WORLD BANK; World Bank, 2005, PAK COUNTR WAT RES A; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO; World Food Program, 2014, VAM FOOD SEC AN SPEC, P12; World Health Organisation, 2003, NUTR REQ PEOPL LIV H; World Health Organization, 2013, STATE SCI ENDOCRINE; World Health Organization, 2014, 7 MILL PREM DEATHS A; World Health Organization, 2009, SUMM POL IMPL VIS 20; World Meteorological Organization, 2014, ATL MORT EC LOSS WEA; World Water Assessment Programme, 2012, 4 UNESCO WORLD WAT A; World We Want, 2011, AN IMP FLOODS MDGS P; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2012, TRENDS ECOL EVOL, V27, P594, DOI 10.1016/j.tree.2012.07.005; Yardley J., 2007, NY TIMES; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450; Yates R, 2014, B WORLD HEALTH ORGAN, V92, P547, DOI 10.2471/BLT.14.143495; You D, 2014, LEVELS TRENDS CHILD; Zahid M, 2012, CLIMATIC CHANGE, V113, P883, DOI 10.1007/s10584-011-0390-4	425	983	997	23	359	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					1973	2028		10.1016/S0140-6736(15)60901-1	http://dx.doi.org/10.1016/S0140-6736(15)60901-1			56	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PI	26188744				2022-12-28	WOS:000364763200032
J	Tomkins, A; Duff, J; Fitzgibbon, A; Karam, A; Mills, EJ; Munnings, K; Smith, S; Seshadri, SR; Steinberg, A; Vitillo, R; Yugi, P				Tomkins, Andrew; Duff, Jean; Fitzgibbon, Atallah; Karam, Azza; Mills, Edward J.; Munnings, Keith; Smith, Sally; Seshadri, Shreelata Rao; Steinberg, Avraham; Vitillo, Robert; Yugi, Philemon			Controversies in faith and health care	LANCET			English	Article							BIOETHICS; ABORTION; RELIGION; VIOLENCE	Differences in religious faith-based viewpoints (controversies) on the sanctity of human life, acceptable behaviour, health-care technologies and health-care services contribute to the widespread variations in health care worldwide. Faith-linked controversies include family planning, child protection (especially child marriage, female genital mutilation, and immunisation), stigma and harm reduction, violence against women, sexual and reproductive health and HIV, gender, end-of-life issues, and faith activities including prayer. Buddhism, Christianity, Hinduism, Islam, Judaism, and traditional beliefs have similarities and differences in their viewpoints. Improved understanding by health-care providers of the heterogeneity of viewpoints, both within and between faiths, and their effect on health care is important for clinical medicine, public-health programmes, and health-care policy. Increased appreciation in faith leaders of the effect of their teachings on health care is also crucial. This Series paper outlines some faith-related controversies, describes how they influence health-care provision and uptake, and identifies opportunities for research and increased interaction between faith leaders and health-care providers to improve health care.	[Tomkins, Andrew] UCL, Inst Child Hlth, Inst Global Hlth, London WC1N 1EH, England; [Fitzgibbon, Atallah] Islamic Relief Worldwide, Birmingham, W Midlands, England; [Karam, Azza] UNFPA, New York, NY USA; [Mills, Edward J.] Univ Ottawa, Ottawa, ON, Canada; [Munnings, Keith] Buddhist Healthcare Chaplaincy Grp, London, England; [Smith, Sally] UNAIDS, Geneva, Switzerland; [Seshadri, Shreelata Rao] Azim Premji Univ, Bangalore, Karnataka, India; [Steinberg, Avraham] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel; [Vitillo, Robert] Caritas Int, Geneva, Switzerland; [Yugi, Philemon] Daystar Univ, Nairobi, Kenya	University of London; University College London; United Nations Population Fund; University of Ottawa; UNAIDS; Hebrew University of Jerusalem; Daystar University	Tomkins, A (corresponding author), UCL, Inst Child Hlth, Inst Global Hlth, London WC1N 1EH, England.	a.tomkins@ucl.ac.uk			Capital for Good	Capital for Good	The writing of this Series paper, and the review process by the Lancet Working Group on Faith and Global Health was supported by Capital for Good.	Ahmad Imad-ad-Dean, FEMALE GENITAL MUTIL; Ahmed QA, 2013, LANCET, V381, P1521, DOI 10.1016/S0140-6736(13)60764-3; [Anonymous], 2013, GLOB REP UNAIDS; Antai D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-181; Beer D, 2006, CHRISTIAN MED FOLLOW; Berkley Center for Religion, RES FAITH ETH PUBL L; Berkley Center for Religion Peace and World Aff airs, WOM FAITH DEV ALL; Best M, 2012, FEARFULLY WONDERFULL, P1; Burton E, 1996, MEMBERS ATTITUDES AB; Care not Killing, WHAT WE DO; Catholic News Service, WHO AM I JUDG HOM PE; Chalke S, BIBLE HOMOSEXUALIT 1; Chitando Ezra, 2012, REDEMPTIVE MASCULINI; Clark F, 2014, LANCET, V383, P500, DOI 10.1016/S0140-6736(14)60169-0; Coward H, 2000, CAN MED ASSOC J, V163, P1167; Dignity in dying, ASS DYING; Downes G, BIBLE HOMOSEXUALIT 2; Elafros MA, 2013, INT HEALTH, V5, P288, DOI 10.1093/inthealth/iht028; Fadel HE, 2012, BIOETHICS, V26, P128, DOI 10.1111/j.1467-8519.2010.01840.x; Gatrad R, 2000, PALLIATIVE CARE S AS; General Medical Council, 2013, PERS BEL MED PRACT; George Washington Institute for Spirituality and Health, AB GWISH; Grabenstein JD, 2013, VACCINE, V31, P2011, DOI 10.1016/j.vaccine.2013.02.026; Habibzadeh F, 2013, LANCET, V382, P310, DOI 10.1016/S0140-6736(13)61636-0; Hartwig KN, 2010, J PALLIAT CARE, V26, P194, DOI 10.1177/082585971002600308; Harvey P., 2000, BUDDHIST EC; Hayford SR, 2011, J SCI STUD RELIG, V50, P252, DOI 10.1111/j.1468-5906.2011.01566.x; Hollins S., 2009, RELIG CULTURE HEALTH; Hughes D, COMMUNICATION; Inerela, AIDS 2014 FAITH BAS; Inerela, 2015, IN SAV TOOLK; Inerela, IN COR BUS IS ER ALL; Integrated Regional Information Networks (IRIN), LAOS REG BUDDH HIV O; International Religious Health Assets Programme University of Cape Town South Africa, AB IRHAP; Islamic Relief Worldwide, EFF PEER ED VIOL WOM; Islamopedia, GRANS A FADL RESP QU; Islamopedia, GRAND MUFT EG AL GOM; Joint Learning Initiative on Faith and Local Communities, RES HUB; Justin Welby the Archbishop of Canterbury, ARCHB JUST VIS PROJ; Kamarulzaman A, 2013, LANCET, V381, P2058, DOI 10.1016/S0140-6736(13)61033-8; Kaoma K, GLOBALIZING CULTURE; Karpf, 2014, CJGH, V1, P16; Keown D., 1995, BUDDHISM BIOETHICS, P1; Koenig HG, 2001, ANN PHARMACOTHER, V35, P352, DOI 10.1345/aph.10215; Koenig HG, 2001, HDB RELIG HLTH, P1; Mahawar KK, 2005, LANCET, V366, P1848, DOI 10.1016/S0140-6736(05)67753-7; Mahomed, 2011, J GENDER RELIG AFRIC, V17, P41; Marshall K, POLICY BRIEF; Moad EO, HINDU ETICS MORAL QU; Monash University Medicine Nursing and Health Services, WHAT IS DIFF SEX GEN; Nuffield Council on Bioethics, PUBL HLTH ETH ISS; Olivier, 2014, LOCAL FAITH COMMUNIT; Olivier J, 2015, LANCET; PEPFAR, FIRM FDN; Pew Research Center, 2010, GLOB REL LANDSC; Plan International, 2014, ENG REL LEAD END CHI; Rambachan A, HINDU PERSPECTIVE WO; Ruijs WLM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-102; Schenker JG, 2013, GYNECOL ENDOCRINOL, V29, P945, DOI 10.3109/09513590.2013.825715; Serour GI, 2013, GYNECOL ENDOCRINOL, V29, P949, DOI 10.3109/09513590.2013.825714; Serour GI, 2001, INT J GYNECOL OBSTET, V74, P187, DOI 10.1016/S0020-7292(01)00425-8; Smith S, 2014, GLOBAL MEMBER CARE C, V2, P37; Smith SD, 2007, U TORONTO MED J, V88, P16; STEINBERG A, 1989, ISRAEL J MED SCI, V25, P404; Steinberg A, 2003, CHILD NERV SYST, V19, P592, DOI 10.1007/s00381-003-0783-4; Steinberg A., 2003, ENCY JEWISH MED ETHI, V2; Stephens M, 2010, J RELIG HEALTH, V49, P513, DOI 10.1007/s10943-009-9273-7; Tearfund, GUARD OUR CHILDR HLT; Tearfund International Learning Zone, PREV PAR CHILD TRANS; The House of Bishops, 2013, WORK GROUP HUM SEX R; The Sphere Project, THE SPHER HDB; Thielman NM, 2014, JAIDS-J ACQ IMM DEF, V65, pE104, DOI 10.1097/01.qai.0000437619.23031.83; Tolerance Religious, DEB FGM EG 2007; Tomkins AM, LOSING TRUST WHY IMM; Tostan, DIGN ALL NEWS RES; UNAIDS, 2013, UNAIDS GUID CRIM HIV; UNAIDS, ROADM FAITH BAS ORG; UNAIDS, PARTN FAITH BAS ORG; UNAIDS, 2013, UNAIDS GLOB REP AIDS; UNAIDS, 2012, UNAIDS GLOB REP AIDS; UNAIDS, UN VIOL HIV; UNFPA, EL FEM GEN MUT STRAT; UNFPA and UNICEF, NEW EX PARTN REL TRA; UNFPA and UNICEF, 2013, UNFPA UNICEF JOINT P; United National International Children's Emergency Fund (UNICEF), 2015, STAT WORLDS CHILDR; United States Conference of Catholic Bishops, WHEN I CALL HELP PAS; USAID. Yemen Basic Health Services Project, 2006, YEM BAS HLTH SERV PR; Vatican Insider, CARD TURKS DEF GAYS; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; WHO, PALL CAR IS CRUC PAR; WHO, FEM GEN MUTL; WHO, WHAT IS GEND; Widmer M, 2011, INT J GYNECOL OBSTET, V114, P218, DOI 10.1016/j.ijgo.2011.03.015; Witchcraft Evans-Pritchard E., 1976, ORACLES MAGIC AZANDE, P1; World Vision International, CHANN HO IGN MOV TRA; Wyatt J, 2009, MATTERS LIFE DEATH, P1; Yeatman SE, 2008, DEMOGR RES, V19, P1851, DOI 10.4054/DemRes.2008.19.55; Young KK, 1994, WOMEN HINDUISM TODAY; Young MT, 2012, END CHILD MARRIAGE; Yount KM, 2011, SOC SCI MED, V72, P1534, DOI 10.1016/j.socscimed.2011.02.042; Yount KM, 2004, SOC FORCES, V82, P1063, DOI 10.1353/sof.2004.0062	101	62	62	2	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1776	1785		10.1016/S0140-6736(15)60252-5	http://dx.doi.org/10.1016/S0140-6736(15)60252-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	CV0WK	26159392				2022-12-28	WOS:000363974200037
J	Coleman, R; Powles, T; Paterson, A; Gnant, M; Anderson, S; Diel, I; Gralow, J; von Minckwitz, G; Moebus, V; Bergh, J; Pritchard, KI; Bliss, J; Cameron, D; Evans, V; Pan, H; Peto, R; Bradley, R; Gray, R; Bartsch, R; Dubsky, P; Fesl, C; Fohler, H; Greil, R; Jakesz, R; Lang, A; Luschin-Ebengreuth, G; Marth, C; Mlineritsch, B; Samonigg, H; Singer, CF; Steger, GG; Stoger, H; Olivotto, I; Ragaz, J; Christiansen, P; Ejlertsen, B; Ewertz, M; Jensen, MB; Moller, S; Mouridsen, HT; Eiermann, W; Hilfrich, J; Jonat, W; Kaufmann, M; Kreienberg, R; Schumacher, M; Blohmer, JU; Costa, SD; Eidtmann, H; Gerber, B; Jackisch, C; Loibl, S; von Minckwitz, G; Dafni, U; Markopoulos, C; Blomqvist, C; Saarto, T; Ahn, JH; Jung, KH; Perrone, F; Anderson, S; Bass, G; Brown, A; Bryant, J; Costantino, J; Dignam, J; Fisher, B; Geyer, C; Mamounas, EP; Paik, S; Redmond, C; Swain, S; Wickerham, L; Wolmark, N; Perez, E; Ingle, JN; Suman, VJ; Hadji, P; A'Hern, R; Dowsett, M; Makris, A; Parton, M; Pennert, K; Powles, TJ; Smith, IE; Yarnold, JR; Clack, G; Van Poznak, C; Safra, T; Bell, R; Cameron, D; Coleman, RE; Dodwell, D; Hinsley, S; Marshall, HC; Solomayer, E; Fehm, T; Coleman, RE; Lester, J; Winter, MC; Horsman, JM; Aft, R; Brufsky, AM; Coleman, R; Llombart, HA				Coleman, R.; Powles, T.; Paterson, A.; Gnant, M.; Anderson, S.; Diel, I.; Gralow, J.; von Minckwitz, G.; Moebus, V.; Bergh, J.; Pritchard, K. I.; Bliss, J.; Cameron, D.; Evans, V.; Pan, H.; Peto, R.; Bradley, R.; Gray, R.; Bartsch, R.; Dubsky, P.; Fesl, C.; Fohler, H.; Greil, R.; Jakesz, R.; Lang, A.; Luschin-Ebengreuth, G.; Marth, C.; Mlineritsch, B.; Samonigg, H.; Singer, C. F.; Steger, G. G.; Stoeger, H.; Olivotto, I.; Ragaz, J.; Christiansen, P.; Ejlertsen, B.; Ewertz, M.; Jensen, M-B; Moller, S.; Mouridsen, H. T.; Eiermann, W.; Hilfrich, J.; Jonat, W.; Kaufmann, M.; Kreienberg, R.; Schumacher, M.; Blohmer, J. U.; Costa, S. D.; Eidtmann, H.; Gerber, B.; Jackisch, C.; Loibl, S.; von Minckwitz, G.; Dafni, U.; Markopoulos, C.; Blomqvist, C.; Saarto, T.; Ahn, J-H; Jung, K. H.; Perrone, F.; Anderson, S.; Bass, G.; Brown, A.; Bryant, J.; Costantino, J.; Dignam, J.; Fisher, B.; Geyer, C.; Mamounas, E. P.; Paik, S.; Redmond, C.; Swain, S.; Wickerham, L.; Wolmark, N.; Perez, E.; Ingle, J. N.; Suman, V. J.; Hadji, P.; A'Hern, R.; Dowsett, M.; Makris, A.; Parton, M.; Pennert, K.; Powles, T. J.; Smith, I. E.; Yarnold, J. R.; Clack, G.; Van Poznak, C.; Safra, T.; Bell, R.; Cameron, D.; Coleman, R. E.; Dodwell, D.; Hinsley, S.; Marshall, H. C.; Solomayer, E.; Fehm, T.; Coleman, R. E.; Lester, J.; Winter, M. C.; Horsman, J. M.; Aft, R.; Brufsky, A. M.; Coleman, R.; Llombart, H. A.		Early Breast Canc Trialists'; Novartis Pharmaceuticals	Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials	LANCET			English	Article							ZOLEDRONIC ACID; ORAL CLODRONATE; BONE; CELLS; RISK; PAMIDRONATE; MENOPAUSE; SURVIVAL; THERAPY; DISEASE	Background Bisphosphonates have profound effects on bone physiology, and could modify the process of metastasis. We undertook collaborative meta-analyses to clarify the risks and benefits of adjuvant bisphosphonate treatment in breast cancer. Methods We sought individual patient data from all unconfounded trials in early breast cancer that randomised between bisphosphonate and control. Primary outcomes were recurrence, distant recurrence, and breast cancer mortality. Primary subgroup investigations were site of first distant recurrence (bone or other), menopausal status (postmenopausal [combining natural and artificial] or not), and bisphosphonate class (aminobisphosphonate [eg, zoledronic acid, ibandronate, pamidronate] or other [ie, clodronate]). Intention-to-treat log-rank methods yielded bisphosphonate versus control first-event rate ratios (RRs). Findings We received data on 18 766 women (18 206 [97%] in trials of 2-5 years of bisphosphonate) with median follow-up 5.6 woman-years, 3453 first recurrences, and 2106 subsequent deaths. Overall, the reductions in recurrence (RR 0.94, 95% CI 0.87-1.01; 2p=0.08), distant recurrence (0.92, 0.85-0.99; 2p=0.03), and breast cancer mortality (0.91, 0.83-0.99; 2p=0.04) were of only borderline significance, but the reduction in bone recurrence was more definite (0.83, 0.73-0.94; 2p=0.004). Among premenopausal women, treatment had no apparent effect on any outcome, but among 11 767 postmenopausal women it produced highly significant reductions in recurrence (RR 0.86, 95% CI 0.78-0.94; 2p=0.002), distant recurrence (0.82, 0.74-0.92; 2p=0.0003), bone recurrence (0.72, 0.60-0.86; 2p=0.0002), and breast cancer mortality (0.82, 0.73-0.93; 2p=0.002). Even for bone recurrence, however, the heterogeneity of benefit was barely significant by menopausal status (2p=0.06 for trend with menopausal status) or age (2p=0.03), and it was non-significant by bisphosphonate class, treatment schedule, oestrogen receptor status, nodes, tumour grade, or concomitant chemotherapy. No differences were seen in non-breast cancer mortality. Bone fractures were reduced (RR 0.85, 95% CI 0.75-0.97; 2p=0.02). Interpretation Adjuvant bisphosphonates reduce the rate of breast cancer recurrence in the bone and improve breast cancer survival, but there is definite benefit only in women who were postmenopausal when treatment began. Copyright (C) Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Open Access article distributed under the terms of CC BY.	[Coleman, R.] Univ Sheffield, Weston Pk Hosp, Sheffield Canc Res Ctr, Sheffield S10 2TN, S Yorkshire, England; [Powles, T.] Royal Marsden Hosp, Sutton, Surrey, England; [Paterson, A.] Tom Baker Canc Clin, Calgary, AB, Canada; [Paterson, A.] Univ Calgary, Calgary, AB, Canada; [Gnant, M.] Med Univ Vienna, Dept Surg, Austrian Breast & Colorectal Canc Study Grp, Vienna, Austria; [Gnant, M.] Med Univ Vienna, Ctr Comprehens Canc, Austrian Breast & Colorectal Canc Study Grp, Vienna, Austria; [Anderson, S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Diel, I.] Ctr Gynecol Oncol, Mannheim, Germany; [Gralow, J.] Univ Washington, Sch Med, Seattle, WA USA; [von Minckwitz, G.] German Breast Grp, Neu Isenburg, Germany; [Moebus, V.] Klinikum Frankfurt Hochst, Frankfurt, Germany; [Bergh, J.] Karolinska Inst, Stockholm, Sweden; [Bergh, J.] St Gorans Univ Hosp, S-11281 Stockholm, Sweden; [Pritchard, K. I.] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [Pritchard, K. I.] Univ Toronto, Toronto, ON, Canada; [Bliss, J.] Inst Canc Res, Div Clin Studies, ICR CTSU, London SW3 6JB, England; [Cameron, D.] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Evans, V.; Pan, H.; Peto, R.; Bradley, R.; Gray, R.] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Bartsch, R.; Dubsky, P.; Fesl, C.; Fohler, H.; Greil, R.; Jakesz, R.; Lang, A.; Luschin-Ebengreuth, G.; Marth, C.; Mlineritsch, B.; Samonigg, H.; Singer, C. F.; Steger, G. G.; Stoeger, H.] Austrian Breast Canc Study Grp, Vienna, Austria; [Olivotto, I.; Ragaz, J.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Christiansen, P.; Ejlertsen, B.; Ewertz, M.; Jensen, M-B; Moller, S.; Mouridsen, H. T.] Danish Breast Canc Cooperat Grp, Copenhagen, Denmark; [Eiermann, W.; Hilfrich, J.; Jonat, W.; Kaufmann, M.; Kreienberg, R.; Schumacher, M.] German Adjuvant Breast Grp, Frankfurt, Germany; [Blohmer, J. U.; Costa, S. D.; Eidtmann, H.; Gerber, B.; Jackisch, C.; Loibl, S.; von Minckwitz, G.] German Breast Grp, Neu Isenburg, Germany; [Dafni, U.; Markopoulos, C.] Hellen Breast Surg Soc, Athens, Greece; [Blomqvist, C.; Saarto, T.] Univ Helsinki, FIN-00014 Helsinki, Finland; [Ahn, J-H; Jung, K. H.] Korean Canc Study Grp, Seoul, South Korea; [Perrone, F.] Ist Nazl Tumori IRCCS Fdn Pascale, Naples, Italy; [Anderson, S.; Bass, G.; Brown, A.; Bryant, J.; Costantino, J.; Dignam, J.; Fisher, B.; Geyer, C.; Mamounas, E. P.; Paik, S.; Redmond, C.; Swain, S.; Wickerham, L.; Wolmark, N.] Natl Surg Adjuvant Breast & Bowel Project, Pittsburgh, PA USA; [Perez, E.; Ingle, J. N.; Suman, V. J.] Mayo Clin, North Cent Canc Treatment Grp, Rochester, MN USA; [Hadji, P.] ProBONE Study Grp, Marburg, Germany; [A'Hern, R.; Dowsett, M.; Makris, A.; Parton, M.; Pennert, K.; Powles, T. J.; Smith, I. E.; Yarnold, J. R.] Royal Marsden Hosp, London SW3 6JJ, England; [A'Hern, R.; Dowsett, M.; Makris, A.; Parton, M.; Pennert, K.; Powles, T. J.; Smith, I. E.; Yarnold, J. R.] Royal Marsden Hosp, Sutton, Surrey, England; [Safra, T.] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Bell, R.; Cameron, D.; Coleman, R. E.; Dodwell, D.; Hinsley, S.; Marshall, H. C.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England; [Solomayer, E.; Fehm, T.] Univ Saarland, D-66123 Saarbrucken, Germany; [Coleman, R. E.; Lester, J.; Winter, M. C.; Horsman, J. M.] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; [Aft, R.] Washington Univ, St Louis, MO USA	University of Sheffield; Weston Park Hospital; Royal Marsden NHS Foundation Trust; Tom Baker Cancer Clinic; University of Calgary; University of Calgary; Medical University of Vienna; Medical University of Vienna; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; German Breast Group; Karolinska Institutet; Saint Goran's Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Edinburgh; University of Oxford; British Columbia Cancer Agency; Danish Breast Cancer Cooperative Group (DBCG); German Breast Group; University of Helsinki; IRCCS Fondazione Pascale; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Mayo Clinic; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Leeds; Saarland University; University of Sheffield; Washington University (WUSTL)	Coleman, R (corresponding author), Univ Sheffield, Weston Pk Hosp, Sheffield Canc Res Ctr, Sheffield S10 2TN, S Yorkshire, England.		Roché, Henri/O-9211-2014; Dafni, Ourania/AAH-4453-2019; Markopoulos, Christos/AAD-8501-2019; Brufsky, Adam/AAE-7470-2020; Greil, Richard F/C-7673-2017; Gnant, Michael/AAN-7054-2020; Boccardo, Francesco Mario/AAF-2654-2019	Roché, Henri/0000-0001-7463-205X; Dafni, Ourania/0000-0003-4367-4497; Markopoulos, Christos/0000-0002-5072-6390; Greil, Richard F/0000-0002-4462-3694; Gnant, Michael/0000-0003-1002-2118; Foroglou, Pericles/0000-0002-2285-0968; Brufsky, Adam/0000-0001-8080-7960; Bliss, Judith/0000-0001-7957-7424; Boccardo, Francesco Mario/0000-0002-5392-4077; Lang, Alois Hermann/0000-0002-8773-735X; Jung, Keun-Hwa/0000-0003-1433-8005; Wang, Xiang/0000-0002-1522-9532; Buyse, Marc/0000-0002-4559-0994; malmstrom, per-uno/0000-0001-8572-9957; Sparano, Joseph/0000-0002-9031-2010; de Vries, Elisabeth/0000-0002-8949-7425; Gray, Richard/0000-0003-4440-574X; Ewertz, Marianne/0000-0002-5965-969X; Bowden, Sarah/0000-0001-7506-1340; Blomqvist, Carl/0000-0003-3041-1938; Warnberg, Fredrik/0000-0002-0130-7296; Swain, Sandra/0000-0002-1320-3830; GIANNI, LUCA/0000-0002-2372-9625; Hinsley, Samantha/0000-0001-6903-4688; Cardoso, Fatima/0000-0002-6692-2249; Evans, Vaughan/0000-0002-2366-2301; Duane, Frances/0000-0001-7838-5957; Yarnold, John/0000-0002-9010-1854; Bergh, Jonas/0000-0001-5526-1847; Anderson, Stewart/0000-0001-8948-0650	Cancer Research UK; Medical Research Council; UK Medical Research Council; Cancer Research UK [15958, 15955] Funding Source: researchfish; Medical Research Council [MC_U137686850] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10026] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Cancer Research UK, Medical Research Council.r We thank the tens of thousands of women who took part in the trials, the many staff in trial centres and participating clinics who helped conduct the trials, and the trialists who shared their data. Funding for individual trials was chiefly from manufacturers (see trial publications) but no commercial funding was sought or used by the secretariat. Funding for the EBCTCG secretariat is through the direct support from Cancer Research UK and the UK Medical Research Council, to the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, UK.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Brincker H, 1998, BRIT J HAEMATOL, V101, P280, DOI 10.1046/j.1365-2141.1998.00695.x; Chlebowski RT, 2010, J CLIN ONCOL, V28, P3582, DOI 10.1200/JCO.2010.28.2095; Coleman R, 2013, ANN ONCOL, V24, P398, DOI 10.1093/annonc/mds277; Coleman R, 2014, LANCET ONCOL, V15, P997, DOI 10.1016/S1470-2045(14)70302-X; Coleman R, 2012, JNCI-J NATL CANCER I, V104, P1059, DOI 10.1093/jnci/djs263; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Diel IJ, 2008, ANN ONCOL, V19, P2007, DOI 10.1093/annonc/mdn429; Early Breast Cancer Trialists' Collaborative Group, 1990, TREATM EARL BREAST C; Gnant M, 2014, ANN ONCOL, V25, P339, DOI 10.1093/annonc/mdt494; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Guo WJ, 2014, STEM CELL TRANSL MED, V3, P942, DOI 10.5966/sctm.2014-0020; Hadji P, 2012, ANN ONCOL, V23, P2782, DOI 10.1093/annonc/mds169; Hue TF, 2014, JAMA INTERN MED, V174, P1550, DOI 10.1001/jamainternmed.2014.3634; Kanis JA, 1996, BONE, V19, P663, DOI 10.1016/S8756-3282(96)00285-2; Kristensen B, 2008, ACTA ONCOL, V47, P740, DOI 10.1080/02841860801964988; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nicks KM, 2010, ANN NY ACAD SCI, V1192, P153, DOI 10.1111/j.1749-6632.2009.05349.x; Ottewell PD, 2014, ENDOCR-RELAT CANCER, V21, P769, DOI 10.1530/ERC-14-0199; Ottewell PD, 2014, CLIN CANCER RES, V20, P2922, DOI 10.1158/1078-0432.CCR-13-1246; Paterson AHG, 2012, LANCET ONCOL, V13, P734, DOI 10.1016/S1470-2045(12)70226-7; Powles T, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1384; Rathbone EJ, 2013, J CLIN ONCOL, V31, P2685, DOI 10.1200/JCO.2012.46.4792; Rennert G, 2010, J CLIN ONCOL, V28, P3577, DOI 10.1200/JCO.2010.28.1113; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Thompson K, 2010, ADV EXP MED BIOL, V658, P11, DOI 10.1007/978-1-4419-1050-9_2; von Minckwitz G, 2013, J CLIN ONCOL, V31, P3531, DOI 10.1200/JCO.2012.47.2167; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055	30	327	329	3	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1353	1361		10.1016/S0140-6736(15)60908-4	http://dx.doi.org/10.1016/S0140-6736(15)60908-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8DP	26211824	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000362316200028
J	Hadinegoro, SR; Arredondo-Garcia, JL; Capeding, MR; Deseda, C; Chotpitayasunondh, T; Dietze, R; Ismail, HIHM; Reynales, H; Limkittikul, K; Rivera-Medina, DM; Tran, HN; Bouckenooghe, A; Chansinghakul, D; Cortes, M; Fanouillere, K; Forrat, R; Frago, C; Gailhardou, S; Jackson, N; Noriega, F; Plennevaux, E; Wartel, TA; Zambrano, B; Saville, M				Hadinegoro, S. R.; Arredondo-Garcia, J. L.; Capeding, M. R.; Deseda, C.; Chotpitayasunondh, T.; Dietze, R.; Ismail, H. I. Hj Muhammad; Reynales, H.; Limkittikul, K.; Rivera-Medina, D. M.; Tran, H. N.; Bouckenooghe, A.; Chansinghakul, D.; Cortes, M.; Fanouillere, K.; Forrat, R.; Frago, C.; Gailhardou, S.; Jackson, N.; Noriega, F.; Plennevaux, E.; Wartel, T. A.; Zambrano, B.; Saville, M.		CYD-TDV Dengue Vaccine Working Grp	Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDREN; AMERICA	BACKGROUND A candidate tetravalent dengue vaccine is being assessed in three clinical trials involving more than 35,000 children between the ages of 2 and 16 years in Asian-Pacific and Latin American countries. We report the results of long-term follow-up interim analyses and integrated efficacy analyses. METHODS We are assessing the incidence of hospitalization for virologically confirmed dengue as a surrogate safety end point during follow-up in years 3 to 6 of two phase 3 trials, CYD14 and CYD15, and a phase 2b trial, CYD23/57. We estimated vaccine efficacy using pooled data from the first 25 months of CYD14 and CYD15. RESULTS Follow-up data were available for 10,165 of 10,275 participants (99%) in CYD14 and 19,898 of 20,869 participants (95%) in CYD15. Data were available for 3203 of the 4002 participants (80%) in the CYD23 trial included in CYD57. During year 3 in the CYD14, CYD15, and CYD57 trials combined, hospitalization for virologically confirmed dengue occurred in 65 of 22,177 participants in the vaccine group and 39 of 11,089 participants in the control group. Pooled relative risks of hospitalization for dengue were 0.84 (95% confidence interval [CI], 0.56 to 1.24) among all participants, 1.58 (95% CI, 0.83 to 3.02) among those under the age of 9 years, and 0.50 (95% CI, 0.29 to 0.86) among those 9 years of age or older. During year 3, hospitalization for severe dengue, as defined by the independent data monitoring committee criteria, occurred in 18 of 22,177 participants in the vaccine group and 6 of 11,089 participants in the control group. Pooled rates of efficacy for symptomatic dengue during the first 25 months were 60.3% (95% CI, 55.7 to 64.5) for all participants, 65.6% (95% CI, 60.7 to 69.9) for those 9 years of age or older, and 44.6% (95% CI, 31.6 to 55.0) for those younger than 9 years of age. CONCLUSIONS Although the unexplained higher incidence of hospitalization for dengue in year 3 among children younger than 9 years of age needs to be carefully monitored during long-term follow-up, the risk among children 2 to 16 years of age was lower in the vaccine group than in the control group. (Funded by Sanofi Pasteur; ClinicalTrials.gov numbers, NCT00842530, NCT01983553, NCT01373281, and NCT01374516.)	[Hadinegoro, S. R.] Univ Indonesia, Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Arredondo-Garcia, J. L.] Inst Nacl Pediat, Mexico City, DF, Mexico; [Capeding, M. R.] Res Inst Trop Med, Muntinlupa, Philippines; [Deseda, C.] Caribbean Travel Med Clin, San Juan, PR USA; [Chotpitayasunondh, T.] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Limkittikul, K.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Chansinghakul, D.] Sanofi Pasteur, Bangkok, Thailand; [Dietze, R.] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Spain; [Ismail, H. I. Hj Muhammad] Hosp Kuala Lumpur, Kuala Lumpur, Malaysia; [Reynales, H.] Ctr Atenc & Invest Med SAS CAIMED, Bogota, Colombia; [Cortes, M.] Sanofi Pasteur, Bogota, Colombia; [Rivera-Medina, D. M.] Org Desarrollo & Invest Salud Honduras ODIS, Tegucigalpa, Honduras; [Tran, H. N.] Pasteur Inst Ho Chi Minh City, Ho Chi Minh City, Vietnam; [Bouckenooghe, A.; Frago, C.; Wartel, T. A.] Sanofi Pasteur, Singapore, Singapore; [Fanouillere, K.] Sanofi R&D, Chilly Mazarin, France; [Forrat, R.; Plennevaux, E.] Sanofi R&D, Marcy Letoile, France; [Gailhardou, S.; Jackson, N.; Saville, M.] Sanofi R&D, Lyon, France; [Noriega, F.] Sanofi Pasteur, Swiftwater, PA USA; [Zambrano, B.] Sanofi Pasteur, Montevideo, Uruguay	University of Indonesia; Research Institute for Tropical Medicine - Philippines; Mahidol University; Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis	Saville, M (corresponding author), Sanofi Pasteur, 2 Ave Pont Pasteur, F-69367 Lyon 07, France.	melanie.saville@sanofipasteur.com		Arredondo-Garcia, Jose Luis/0000-0001-6560-046X; Dietze, Reynaldo/0000-0002-6995-8001; Vigne, Claire/0000-0003-3417-9814	Sanofi Pasteur	Sanofi Pasteur	Funded by Sanofi Pasteur	Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Committee for Proprietary Medicinal Products (CPMP), 2001, POINTS CONS APPL 1 M; Gamble J, 2000, CLIN SCI, V98, P211, DOI 10.1042/CS19990296; Hanna-Wakim R, 2009, J INFECT DIS, V200, P1921, DOI 10.1086/648375; Initiative for Vaccine Research Department of Immunization Vaccines and Biologicals, 2008, GUID CLIN EV DENG VA; L'Azou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003235; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Mizumoto K, 2014, J VECTOR DIS, V51, P153; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; World Health Organization, 2011, GUID QUAL SAF EFF DE	12	681	698	0	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1195	1206		10.1056/NEJMoa1506223	http://dx.doi.org/10.1056/NEJMoa1506223			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR8WP	26214039				2022-12-28	WOS:000361635200005
J	Xu, SY; Belopolski, I; Alidoust, N; Neupane, M; Bian, G; Zhang, CL; Sankar, R; Chang, GQ; Yuan, ZJ; Lee, CC; Huang, SM; Zheng, H; Ma, J; Sanchez, DS; Wang, BK; Bansil, A; Chou, FC; Shibayev, PP; Lin, H; Jia, S; Hasan, MZ				Xu, Su-Yang; Belopolski, Ilya; Alidoust, Nasser; Neupane, Madhab; Bian, Guang; Zhang, Chenglong; Sankar, Raman; Chang, Guoqing; Yuan, Zhujun; Lee, Chi-Cheng; Huang, Shin-Ming; Zheng, Hao; Ma, Jie; Sanchez, Daniel S.; Wang, BaoKai; Bansil, Arun; Chou, Fangcheng; Shibayev, Pavel P.; Lin, Hsin; Jia, Shuang; Hasan, M. Zahid			Discovery of a Weyl fermion semimetal and topological Fermi arcs	SCIENCE			English	Article							DIRAC SEMIMETALS; PHASE-TRANSITION; METAL; INSULATORS; ARSENIDES; TANTALUM	A Weyl semimetal is a new state of matter that hosts Weyl fermions as emergent quasiparticles and admits a topological classification that protects Fermi arc surface states on the boundary of a bulk sample. This unusual electronic structure has deep analogies with particle physics and leads to unique topological properties. We report the experimental discovery of a Weyl semimetal, tantalum arsenide (TaAs). Using photoemission spectroscopy, we directly observe Fermi arcs on the surface, as well as the Weyl fermion cones and Weyl nodes in the bulk of TaAs single crystals. We find that Fermi arcs terminate on the Weyl fermion nodes, consistent with their topological character. Our work opens the field for the experimental study of Weyl fermions in physics and materials science.	[Xu, Su-Yang; Belopolski, Ilya; Alidoust, Nasser; Neupane, Madhab; Bian, Guang; Zheng, Hao; Sanchez, Daniel S.; Shibayev, Pavel P.; Hasan, M. Zahid] Princeton Univ, Dept Phys, Lab Topol Quantum Matter & Spect B7, Princeton, NJ 08544 USA; [Xu, Su-Yang; Alidoust, Nasser; Hasan, M. Zahid] Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton Ctr Complex Mat, Princeton, NJ 08544 USA; [Neupane, Madhab] Los Alamos Natl Lab, Condensed Matter & Magnet Sci Grp, Los Alamos, NM 87545 USA; [Zhang, Chenglong; Yuan, Zhujun; Jia, Shuang] Peking Univ, Sch Phys, Int Ctr Quantum Mat, Beijing, Peoples R China; [Sankar, Raman; Chou, Fangcheng] Natl Taiwan Univ, Ctr Condensed Matter Sci, Taipei 10617, Taiwan; [Chang, Guoqing; Lee, Chi-Cheng; Huang, Shin-Ming; Wang, BaoKai; Lin, Hsin] Natl Univ Singapore, Ctr Adv Mat 2D, Singapore 117546, Singapore; [Chang, Guoqing; Lee, Chi-Cheng; Huang, Shin-Ming; Wang, BaoKai; Lin, Hsin] Natl Univ Singapore, Graphene Res Ctr, Singapore 117546, Singapore; [Chang, Guoqing; Lee, Chi-Cheng; Huang, Shin-Ming; Wang, BaoKai; Lin, Hsin] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Ma, Jie] Oak Ridge Natl Lab, Quantum Condensed Matter Div, Oak Ridge, TN 37831 USA; [Wang, BaoKai; Bansil, Arun] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Shibayev, Pavel P.] Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton, NJ 08544 USA; [Jia, Shuang] Collaborat Innovat Ctr Quantum Matter, Beijing 100871, Peoples R China	Princeton University; Princeton University; United States Department of Energy (DOE); Los Alamos National Laboratory; Peking University; National Taiwan University; National University of Singapore; National University of Singapore; National University of Singapore; United States Department of Energy (DOE); Oak Ridge National Laboratory; Northeastern University; Princeton University	Hasan, MZ (corresponding author), Princeton Univ, Dept Phys, Lab Topol Quantum Matter & Spect B7, Princeton, NJ 08544 USA.	mzhasan@princeton.edu	chang, guoqing/Z-1900-2019; Jia, Shuang/AFH-9416-2022; Zhang, Cheng-Long/O-8000-2017; zheng, hao/HHM-6949-2022; Neupane, Madhab/ABE-8747-2020; Huang, Shin-Ming/AAE-7825-2019; Raman, Sankar/AAQ-1043-2021; Bian, Guang/C-5182-2016; Ma, Jie/C-1637-2013; HASAN, M. Zahid/D-8237-2012; Lin, Hsin/F-9568-2012; Lee, Chi-Cheng/F-5057-2015; Zheng, Hao/H-8636-2015	chang, guoqing/0000-0003-1180-3127; Zhang, Cheng-Long/0000-0001-9859-0114; Huang, Shin-Ming/0000-0003-4273-9682; Raman, Sankar/0000-0003-2817-0952; Bian, Guang/0000-0001-7055-2319; Ma, Jie/0000-0002-7060-1325; Lin, Hsin/0000-0002-4688-2315; Lee, Chi-Cheng/0000-0002-3895-9802; Zheng, Hao/0000-0002-6495-874X; Chou, Fang-Cheng/0000-0002-9255-7986; Shibayev, Pavel/0000-0002-7214-5706	Gordon and Betty Moore Foundations EPiQS Initiative [GBMF4547]; National Research Foundation, Prime Minister's Office, Singapore [NRF-NRFF2013-03]; National Basic Research Program of China [2013CB921901, 2014CB239302]; U.S. Department of Energy [DE-FG-02-05ER46200]; MOST-Taiwan [102-2119-M-002-004]	Gordon and Betty Moore Foundations EPiQS Initiative; National Research Foundation, Prime Minister's Office, Singapore(National Research Foundation, Singapore); National Basic Research Program of China(National Basic Research Program of China); U.S. Department of Energy(United States Department of Energy (DOE)); MOST-Taiwan(Ministry of Science and Technology, Taiwan)	Work at Princeton University and Princeton-led synchrotron-based ARPES measurements were supported by the Gordon and Betty Moore Foundations EPiQS Initiative through grant GBMF4547 (Hasan). First-principles band structure calculations at National University of Singapore were supported by the National Research Foundation, Prime Minister's Office, Singapore, under its NRF fellowship (NRF Award no. NRF-NRFF2013-03). Single-crystal growth was supported by National Basic Research Program of China (grant nos. 2013CB921901 and 2014CB239302) and characterization by U.S. Department of Energy DE-FG-02-05ER46200. F.C. acknowledges the support provided by MOST-Taiwan under project no. 102-2119-M-002-004. We gratefully acknowledge J. D. Denlinger, S. K. Mo, A. V. Fedorov, M. Hashimoto, M. Hoesch, T. Kim, and V. N. Strocov for their beamline assistance at the Advanced Light Source, the Stanford Synchrotron Radiation Lightsource, the Diamond Light Source, and the Swiss Light Source under their external user programs. Part of the work was carried out at the Swiss Light Source through the external/international facility user program. We thank T.-R. Chang for help on theoretical band structure calculations. We also thank L. Balents, D. Huse, I. Klebanov, T. Neupert, A. Polyakov, P. Steinhardt, H. Verlinde, and A. Vishwanath for discussions. R. S. and H. L. acknowledge visiting scientist support from Princeton University. M. Z. H. acknowledges hospitality of the Lawrence Berkeley National Laboratory and Aspen Center for Physics as a visiting scientist. A patent application is being prepared on behalf of the authors on the discovery of a Weyl semimetal.	Ashby PEC, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245131; Balents L., 2011, PHYSICS, V4, P36, DOI [DOI 10.1103/PHYSICS.4.36, 10.1103/Physics.4.36, DOI 10.1103/Physics.4.36]; FURUSETH S, 1965, ACTA CHEM SCAND, V19, P95, DOI 10.3891/acta.chem.scand.19-0095; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hasan M. Z., 2014, 2014 NOB S NEW FORMS; Hosur P, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195102; Huang SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8373; Liu CX, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.235306; Liu JP, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155316; Murakami S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/9/356; MURRAY JJ, 1976, J LESS-COMMON MET, V46, P311, DOI 10.1016/0022-5088(76)90220-4; NIELSEN HB, 1983, PHYS LETT B, V130, P389, DOI 10.1016/0370-2693(83)91529-0; Ojanen T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245112; Potter AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6161; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Singh B, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115208; Son DT, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.104412; Strocov VN, 2014, J SYNCHROTRON RADIAT, V21, P32, DOI 10.1107/S1600577513019085; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wei HZ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.196403; Weng HM, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.011029; Weyl H, 1929, Z PHYS, V56, P330, DOI 10.1007/BF01339504; Wilczek F, 1998, PHYS TODAY, V51, P11, DOI 10.1063/1.882086; Xu SY, 2011, SCIENCE, V332, P560, DOI 10.1126/science.1201607; Yang BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5898; Zhang C.-L., 2015, OBSERVATION ADLER BE; Zyuzin AA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115133	29	2335	2361	38	967	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					613	617		10.1126/science.aaa9297	http://dx.doi.org/10.1126/science.aaa9297			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26184916	Green Submitted			2022-12-28	WOS:000359092900034
J	Benovic, JL				Benovic, Jeffrey L.			STRUCTURAL BIOLOGY Arresting developments in receptor signalling	NATURE			English	Editorial Material							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; RHODOPSIN	The first crystal structure of a G-protein-coupled receptor in complex with an arrestin protein provides insight into how the signalling pathways activated by these receptors are switched off through desensitization. See Article p.561	Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	jeffrey.benovic@jefferson.edu						Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801	10	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					538	539		10.1038/nature14637	http://dx.doi.org/10.1038/nature14637			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ZL	26200346				2022-12-28	WOS:000358655200030
J	Lodge, DM				Lodge, David M.			Faith and science can find common ground	NATURE			English	Editorial Material									Univ Notre Dame, Environm Change Initiat, Notre Dame, IN 46556 USA	University of Notre Dame	Lodge, DM (corresponding author), Univ Notre Dame, Environm Change Initiat, Notre Dame, IN 46556 USA.	dlodge@nd.edu	Lodge, David Michael/AAX-1781-2021						0	0	0	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					503	503		10.1038/523503a	http://dx.doi.org/10.1038/523503a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ZL	26223590	Bronze			2022-12-28	WOS:000358655200004
J	Su, J; Hu, C; Yan, X; Jin, Y; Chen, Z; Guan, Q; Wang, Y; Zhong, D; Jansson, C; Wang, F; Schnurer, A; Sun, C				Su, J.; Hu, C.; Yan, X.; Jin, Y.; Chen, Z.; Guan, Q.; Wang, Y.; Zhong, D.; Jansson, C.; Wang, F.; Schnurer, A.; Sun, C.			Expression of barley SUSIBA2 transcription factor yields high-starch low-methane rice	NATURE			English	Article							GENE-EXPRESSION; COMMUNITIES; EMISSIONS; FLUXES; FIELD	Atmospheric methane is the second most important greenhouse gas after carbon dioxide, and is responsible for about 20% of the global warming effect since pre-industrial times(1,2). Rice paddies are the largest anthropogenic methane source and produce 7-17% of atmospheric methane(2,3). Warm waterlogged soil and exuded nutrients from rice roots provide ideal conditions for methanogenesis in paddies with annual methane emissions of 25-100-million tonnes(3,4). This scenario will be exacerbated by an expansion in rice cultivation needed to meet the escalating demand for food in the coming decades(4). There is an urgent need to establish sustainable technologies for increasing rice production while reducing methane fluxes from rice paddies. However, ongoing efforts for methane mitigation in rice paddies are mainly based on farming practices and measures that are difficult to implement(5). Despite proposed strategies to increase rice productivity and reduce methane emissions(4,6), no high-starch low-methane-emission rice has been developed. Here we show that the addition of a single transcription factor gene, barley SUSIBA2 (refs 7, 8), conferred a shift of carbon flux to SUSIBA2 rice, favouring the allocation of photo-synthates to aboveground biomass over allocation to roots. The altered allocation resulted in an increased biomass and starch content in the seeds and stems, and suppressed methanogenesis, possibly through a reduction in root exudates. Three-year field trials in China demonstrated that the cultivation of SUSIBA2 rice was associated with a significant reduction in methane emissions and a decrease in rhizospheric methanogen levels. SUSIBA2 rice offers a sustainable means of providing increased starch content for food production while reducing greenhouse gas emissions from rice cultivation. Approaches to increase rice productivity and reduce methane emissions as seen in SUSIBA2 rice may be particularly beneficial in a future climate with rising temperatures resulting in increased methane emissions from paddies(9,10).	[Su, J.; Hu, C.; Chen, Z.; Guan, Q.; Wang, Y.; Zhong, D.; Wang, F.] Fujian Acad Agr Sci, Inst Biotechnol, Fuzhou 350003, Peoples R China; [Su, J.; Hu, C.; Yan, X.; Jin, Y.; Sun, C.] Swedish Univ Agr Sci, Linnean Ctr Plant Biol, Uppsala BioCtr, Dept Plant Biol, SE-75007 Uppsala, Sweden; [Jin, Y.] Hunan Agr Univ, Hunan Prov Key Lab Crop Germplasm Innovat & Utili, Changsha 410128, Hunan, Peoples R China; [Jansson, C.] Pacific NW Natl Lab, Environm Mol Sci Lab EMSL, Richland, WA 99352 USA; [Schnurer, A.] Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, SE-75007 Uppsala, Sweden	Fujian Academy of Agricultural Sciences; Swedish University of Agricultural Sciences; Hunan Agricultural University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Swedish University of Agricultural Sciences	Sun, C (corresponding author), Swedish Univ Agr Sci, Linnean Ctr Plant Biol, Uppsala BioCtr, Dept Plant Biol, POB 7080, SE-75007 Uppsala, Sweden.	wf@fjage.org; Chuanxin.Sun@slu.se		Schnurer, Anna/0000-0003-0038-553X; SU, JUN/0000-0001-5486-542X	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) [219-2014-1172]; Formas/Sida [220-2009-2069]; SLU Larosatesansokan Programme (TC4F) for Team 4 - Vinnova; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) under the Strategic Research Area for the TCBB Programme; National Natural Science Foundation of China [30771298, 31370389]; SLU programme BarleyFunFood; Carl Trygger Foundation [CTS 11: 450]; US Department of Energy [DE-AC05-76RL01830]; Pacific Northwest National Laboratory	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Formas/Sida; SLU Larosatesansokan Programme (TC4F) for Team 4 - Vinnova; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) under the Strategic Research Area for the TCBB Programme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SLU programme BarleyFunFood; Carl Trygger Foundation; US Department of Energy(United States Department of Energy (DOE)); Pacific Northwest National Laboratory(United States Department of Energy (DOE))	Special thanks to S. Stymne. We would also like to thank B. Muller, X. Feng, M. Erikson, L. Sun, S. Isaksson, J. Ascue and S. Mayer for their help in determining concentrations of methane and methanogens, and B. Ingemarsson for discussions concerning the work layout. This work was funded by the following organisations and foundations: The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) for Project No 219-2014-1172; the joint Formas/Sida-funded programme (Project No 220-2009-2069) on sustainable development in developing countries; the SLU Larosatesansokan Programme (TC4F) for Team 4 supported by Vinnova; the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) under the Strategic Research Area for the TCBB Programme; National Natural Science Foundation of China (projects no 30771298 and no 31370389); the SLU programme BarleyFunFood; the Carl Trygger Foundation for Project No CTS 11: 450; funding in part by the US Department of Energy Contract DE-AC05-76RL01830 with the Pacific Northwest National Laboratory.	Angel R, 2012, ISME J, V6, P847, DOI 10.1038/ismej.2011.141; Ashby KD, 2001, J AGR FOOD CHEM, V49, P1123, DOI 10.1021/jf000689r; Bridgham SD, 2013, GLOBAL CHANGE BIOL, V19, P1325, DOI 10.1111/gcb.12131; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Conrad R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00004; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Harrison RM, 1995, J GEOPHYS RES-ATMOS, V100, P25923, DOI 10.1029/95JD02461; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hoehler TM, 2014, NATURE, V507, P436, DOI 10.1038/nature13215; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/NGEO1955, 10.1038/ngeo1955]; Liu PF, 2014, APPL ENVIRON MICROB, V80, P4668, DOI 10.1128/AEM.01259-14; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Nalawade S, 2012, APPL ENERG, V91, P405, DOI 10.1016/j.apenergy.2011.09.042; Narihiro T, 2011, MICROB BIOTECHNOL, V4, P585, DOI 10.1111/j.1751-7915.2010.00239.x; Peng JJ, 2008, APPL ENVIRON MICROB, V74, P2894, DOI 10.1128/AEM.00070-08; Qiu J., 2009, NATURE; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sass RL, 2002, P NATL ACAD SCI USA, V99, P11993, DOI 10.1073/pnas.202483599; Sun CX, 2005, PLANT J, V44, P128, DOI 10.1111/j.1365-313X.2005.02515.x; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Sun CX, 1998, PLANT PHYSIOL, V118, P37, DOI 10.1104/pp.118.1.37; van der Gon HACD, 2002, P NATL ACAD SCI USA, V99, P12021, DOI 10.1073/pnas.192276599; Westerholm M, 2012, BIORESOURCE TECHNOL, V114, P314, DOI 10.1016/j.biortech.2012.03.005; Westerholm M, 2011, ENV MICROBIOL REP, V3, P500, DOI 10.1111/j.1758-2229.2011.00249.x; Yang SH, 2012, PHYS CHEM EARTH, V53-54, P30, DOI 10.1016/j.pce.2011.08.020; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Yvon-Durocher G, 2014, NATURE, V507, P488, DOI 10.1038/nature13164; Zhang MZ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-230	29	103	118	19	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					602	+		10.1038/nature14673	http://dx.doi.org/10.1038/nature14673			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26200336				2022-12-28	WOS:000358655200047
J	Henao-Restrepo, AM				Henao-Restrepo, Ana Maria			The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola	BMJ-BRITISH MEDICAL JOURNAL			English	Article								A World Health Organization expert meeting on Ebola vaccines proposed urgent safety and efficacy studies in response to the outbreak in West Africa. One approach to communicable disease control is ring vaccination of individuals at high risk of infection due to their social or geographical connection to a known case. This paper describes the protocol for a novel cluster randomised controlled trial design which uses ring vaccination. In the Ebola ca suffit ring vaccination trial, rings are randomised 1:1 to (a) immediate vaccination of eligible adults with single dose vaccination or (b) vaccination delayed by 21 days. Vaccine efficacy against disease is assessed in participants over equivalent periods from the day of randomisation. Secondary objectives include vaccine effectiveness at the level of the ring, and incidence of serious adverse events. Ring vaccination trials are adaptive, can be run until disease elimination, allow interim analysis, and can go dormant during inter-epidemic periods.	WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva 27, Switzerland	World Health Organization	Henao-Restrepo, AM (corresponding author), WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva 27, Switzerland.	henaorestrepoa@who.int		Trelle, Sven/0000-0002-8162-8910; Watson, Conall/0000-0002-2469-791X; Hall, Yper/0000-0002-8537-8920; Hossmann, Stefanie/0000-0003-1600-5925	Research Council of Norway through the Norwegian Institute of Public Health; Canadian government through the Public Health Agency of Canada; Canadian Institutes of Health Research; International Development Research Centre; Department of Foreign Affairs, Trade and Development; WHO; Wellcome Trust, United Kingdom; Research for Health in Humanitarian Crises (R2HC) Programme [13165]; UK Medical Research Council [MR/J003999/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM111274] Funding Source: NIH RePORTER; Medical Research Council [1263989] Funding Source: researchfish	Research Council of Norway through the Norwegian Institute of Public Health; Canadian government through the Public Health Agency of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); International Development Research Centre; Department of Foreign Affairs, Trade and Development; WHO(World Health Organization); Wellcome Trust, United Kingdom(Wellcome Trust); Research for Health in Humanitarian Crises (R2HC) Programme; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The trial is funded by the Research Council of Norway through the Norwegian Institute of Public Health; the Canadian government through the Public Health Agency of Canada, Canadian Institutes of Health Research, International Development Research Centre and Department of Foreign Affairs, Trade and Development; and WHO, with support from the Wellcome Trust, United Kingdom. AC was funded by the Research for Health in Humanitarian Crises (R2HC) Programme, managed by Research for Humanitarian Assistance (Grant 13165). CHW is supported by the UK Medical Research Council grant MR/J003999/1. Role of the sponsor: the role of the sponsor is described in the accompanying protocol.	Aalen OO, 2008, STAT BIOL HEALTH, P1; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Camacho A, 2014, EPIDEMICS-NETH, V9, P70, DOI 10.1016/j.epidem.2014.09.003; Campbell Marion K, 2012, BMJ, V345, pe5661, DOI 10.1136/bmj.e5661; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chow SC, 2007, ADAPTIVE DESIGN METH; DeMets D L, 1995, Cancer Treat Res, V75, P1; Donner A, 2000, DESIGN ANAL CLUSTER; Eichner M, 2003, AM J EPIDEMIOL, V158, P118, DOI 10.1093/aje/kwg104; Eldridge SM, 2006, INT J EPIDEMIOL, V35, P1292, DOI 10.1093/ije/dyl129; Fenner F., 1988, SMALLPOX ITS ERADICA; Halloran ME, 1997, AM J EPIDEMIOL, V146, P789; Hayes RJ, 2009, INTERD STAT, P3; Heymann DL, 2015, LANCET, V6736, P10; Kretzschmar M, 2004, EMERG INFECT DIS, V10, P832, DOI 10.3201/eid1005.030419; Mohammadi D, 2015, LANCET, V385, P214, DOI 10.1016/S0140-6736(15)60035-6; Munda M, 2014, PHARM STAT, V13, P145, DOI 10.1002/pst.1612; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; WHO Ethics Working Group, 2014, ETH ISS REL STUD DES; World Health Organization Regional Office for Africa, 2014, CONT TRAC OUTBR EB V	20	100	100	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2015	351								h3740	10.1136/bmj.h3740	http://dx.doi.org/10.1136/bmj.h3740			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2TV	26215666	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000359010400001
J	Kondo, A; Shahpasand, K; Mannix, R; Qiu, JH; Moncaster, J; Chen, CH; Yao, YD; Lin, YM; Driver, JA; Sun, Y; Wei, S; Luo, ML; Albayram, O; Huang, PY; Rotenberg, A; Ryo, A; Goldstein, LE; Pascual-Leone, A; McKee, AC; Meehan, W; Zhou, XZ; Lu, KP				Kondo, Asami; Shahpasand, Koorosh; Mannix, Rebekah; Qiu, Jianhua; Moncaster, Juliet; Chen, Chun-Hau; Yao, Yandan; Lin, Yu-Min; Driver, Jane A.; Sun, Yan; Wei, Shuo; Luo, Man-Li; Albayram, Onder; Huang, Pengyu; Rotenberg, Alexander; Ryo, Akihide; Goldstein, Lee E.; Pascual-Leone, Alvaro; McKee, Ann C.; Meehan, William; Zhou, Xiao Zhen; Lu, Kun Ping			Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy	NATURE			English	Article							PROLYL ISOMERASE PIN1; CHRONIC TRAUMATIC ENCEPHALOPATHY; ALZHEIMERS-DISEASE; HEAD-INJURY; PATHOLOGY; PROTEIN; IMMUNOTHERAPY; MODEL; ONSET; TRANSMISSION	Traumatic brain injury (TBI), characterized by acute neurological dysfunction, is one of the best known environmental risk factors for chronic traumatic encephalopathy and Alzheimer's disease, the defining pathologic features of which include tauopathy made of phosphorylated tau protein (P-tau). However, tauopathy has not been detected in the early stages after TBI, and how TBI leads to tauopathy is unknown. Here we find robust cis P-tau pathology after TBI in humans and mice. After TBI in mice and stress in vitro, neurons acutely produce cis P-tau, which disrupts axonal microtubule networks and mitochondrial transport, spreads to other neurons, and leads to apoptosis. This process, which we term 'cistauosis', appears long before other tauopathy. Treating TBI mice with cis antibody blocks cistauosis, prevents tauopathy development and spread, and restores many TBI-related structural and functional sequelae. Thus, cis P-tau is a major early driver of disease after TBI and leads to tauopathy in chronic traumatic encephalopathy and Alzheimer's disease. The cis antibody may be further developed to detect and treat TBI, and prevent progressive neurodegeneration after injury.	[Kondo, Asami; Shahpasand, Koorosh; Chen, Chun-Hau; Yao, Yandan; Lin, Yu-Min; Driver, Jane A.; Wei, Shuo; Luo, Man-Li; Albayram, Onder; Huang, Pengyu; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Translat Therapeut, Dept Med,Med Sch, Boston, MA 02215 USA; [Kondo, Asami; Shahpasand, Koorosh; Chen, Chun-Hau; Yao, Yandan; Lin, Yu-Min; Wei, Shuo; Luo, Man-Li; Albayram, Onder; Huang, Pengyu; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Beth Israel Deaconess Med Ctr, Canc Res Inst, Sch Med, Boston, MA 02215 USA; [Mannix, Rebekah; Qiu, Jianhua] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Emergency Med, Boston, MA 02115 USA; [Moncaster, Juliet; Goldstein, Lee E.; McKee, Ann C.] Boston Univ, Sch Med, Alzheimers Dis Ctr, CTE Program, Boston, MA 02118 USA; [Driver, Jane A.] Harvard Univ, Sch Med, Geriatr Res Educ & Clin Ctr, VA Boston Healthcare Syst, Boston, MA 02130 USA; [Sun, Yan; Rotenberg, Alexander] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Neurol, Boston, MA 02115 USA; [Ryo, Akihide] Yokohama City Univ, Dept Microbiol, Sch Med, Yokohama, Kanagawa 2360004, Japan; [Pascual-Leone, Alvaro] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Meehan, William] Harvard Univ, Sch Med, Childrens Hosp Boston, Micheli Ctr Sports Injury Prevent, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Boston University; Geriatric Research Education & Clinical Center; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Boston Children's Hospital; Harvard Medical School; Yokohama City University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Lu, KP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Translat Therapeut, Dept Med,Med Sch, Boston, MA 02215 USA.	xzhou@bidmc.harvard.edu; klu@bidmc.harvard.edu	Mannix, Rebekah/AAD-8702-2020; luo, man/HGC-7868-2022; Pascual-Leone, Alvaro/AAC-5101-2019; Luo, Man/GWQ-4789-2022	Pascual-Leone, Alvaro/0000-0001-8975-0382; Albayram, Onder/0000-0002-2028-1458; Moncaster, Juliet/0000-0002-7849-4325; Mannix, Rebekah/0000-0003-3608-2792	NIH [S10RR017927, T32HD040128, UO1NS086659-01, P30AG13846, R01AG029385, R01CA167677, R01HL111430, R01AG046319]; NIA; VA Career Development Award; Susan G. Komen postdoctoral fellowship; Boston Children's Hospital Pilot Grant Award; NFLPA; VA; Sports Legacy Institute; Andlinger Foundation; NFL; WWE; Alzheimer's Association [DVT-14-322623]; BIDMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040128] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA167677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017927] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029385, R01AG046319, P30AG013846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); VA Career Development Award; Susan G. Komen postdoctoral fellowship(Susan G. Komen Breast Cancer Foundation); Boston Children's Hospital Pilot Grant Award; NFLPA; VA(US Department of Veterans Affairs); Sports Legacy Institute; Andlinger Foundation; NFL; WWE; Alzheimer's Association(Alzheimer's Association); BIDMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. Hunter and M. Zeidel for advice; S. Hagen for Microscopy Facility (NIH grantS10RR017927) and P. Davies for tauopathy antibodies. C.-H.C., Y.-M.L., J.A.D. and S.W. are recipients of NIA-funded T32 Translational Research in Aging Training Grant, National Science Council Postdoctoral Fellowship from Taiwan, a VA Career Development Award, and Susan G. Komen postdoctoral fellowship, respectively. R.M. is supported by Boston Children's Hospital Pilot Grant Award and NIH training grant T32HD040128, and A.P.-L. and W.M. by NFLPA. The CTE and blast samples used are supported by grants from NIH (UO1NS086659-01, P30AG13846), VA, Sports Legacy Institute, Andlinger Foundation, NFL and WWE. The work is supported by NIH grants R01AG029385, R01CA167677, R01HL111430 and R01AG046319, and Alzheimer's Association grant DVT-14-322623 to K.P.L. and BIDMC and NFLPA pilot grants to K.P.L. and X.Z.Z.	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Chen CH, 2015, NEUROBIOL DIS, V76, P13, DOI 10.1016/j.nbd.2014.12.027; Clavaguera F, 2015, NEUROPATH APPL NEURO, V41, P47, DOI 10.1111/nan.12197; Clavaguera F, 2014, ACTA NEUROPATHOL, V127, P299, DOI 10.1007/s00401-013-1231-5; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Congdon EE, 2013, J BIOL CHEM, V288, P35452, DOI 10.1074/jbc.M113.491001; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Driver J.A., 2015, BIOCH BIOPHYS ACTA; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kim BM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.216; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lee TH, 2011, MOL CELL, V42, P147, DOI 10.1016/j.molcel.2011.03.005; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 1999, NATURE, V399, P784; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Ma SL, 2012, NEUROBIOL AGING, V33, P804, DOI 10.1016/j.neurobiolaging.2010.05.018; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Rosenmann H, 2013, CURR ALZHEIMER RES, V10, P217, DOI 10.2174/1567205011310030001; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Sigurdsson EM, 2014, NEURODEGENER DIS, V13, P103, DOI 10.1159/000354491; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	50	279	289	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					431	U118		10.1038/nature14658	http://dx.doi.org/10.1038/nature14658			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26176913	Green Submitted, Green Accepted			2022-12-28	WOS:000358378900030
J	Yang, SH; Wang, L; Huang, J; Zhang, XH; Yuan, Y; Chen, JQ; Hurst, LD; Tian, DC				Yang, Sihai; Wang, Long; Huang, Ju; Zhang, Xiaohui; Yuan, Yang; Chen, Jian-Qun; Hurst, Laurence D.; Tian, Dacheng			Parent-progeny sequencing indicates higher mutation rates in heterozygotes	NATURE			English	Article							ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; RECOMBINATION; DNA; BREAKS; CHROMOSOMES; COEVOLUTION; EVOLUTION; FRAMEWORK; GENOMICS	Mutation rates vary within genomes, but the causes of this remain unclear(1). As many prior inferences rely on methods that assume an absence of selection, potentially leading to artefactual results(2), we call mutation events directly using a parent-offspring sequencing strategy focusing on Arabidopsis and using rice and honey bee for replication. Here we show that mutation rates are higher in heterozygotes and in proximity to crossover events. A correlation between recombination rate and intraspecific diversity is in part owing to a higher mutation rate in domains of high recombination/ diversity. Implicating diversity per se as a cause, we find an similar to 3.5-fold higher mutation rate in heterozygotes than in homozygotes, with mutations occurring in closer proximity to heterozygous sites than expected by chance. In a genome that is a patchwork of heterozygous and homozygous domains, mutations occur disproportionately more often in the heterozygous domains. If segregating mutations predispose to a higher local mutation rate, clusters of genes dominantly under purifying selection (more commonly homozygous) and under balancing selection (more commonly heterozygous), might have low and high mutation rates, respectively. Our results are consistent with this, there being a ten times higher mutation rate in pathogen resistance genes, expected to be under positive or balancing selection. Consequently, we do not necessarily need to evoke extremely weak(1,2) selection on the mutation rate to explain why mutational hot and cold spots might correspond to regions under positive/balancing and purifying selection, respectively(3,4).	[Yang, Sihai; Wang, Long; Huang, Ju; Zhang, Xiaohui; Yuan, Yang; Chen, Jian-Qun; Tian, Dacheng] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Peoples R China; [Hurst, Laurence D.] Univ Bath, Dept Biol & Biochem, Milner Ctr Evolut, Bath BA2 7AY, Avon, England	Nanjing University; University of Bath	Tian, DC (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Peoples R China.	bssldh@bath.ac.uk; dtian@nju.edu.cn	; Hurst, Laurence/F-9215-2010	Yang, Sihai/0000-0002-7862-6412; Hurst, Laurence/0000-0002-1002-1054; Wang, Long/0000-0002-7067-0558; Chen, Jian-Qun/0000-0003-4376-5655	National Natural Science Foundation of China [91331205, 91231102, 31170210]; Program for Changjiang Scholars and Innovative Research Team [IRT_14R27]; Jiangsu Collaborative Innovation Center for Modern Crop Production	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Jiangsu Collaborative Innovation Center for Modern Crop Production	This work was supported by the National Natural Science Foundation of China (91331205, 91231102 and 31170210), Program for Changjiang Scholars and Innovative Research Team (IRT_14R27) and Jiangsu Collaborative Innovation Center for Modern Crop Production to D.T., S.H. and J.-Q.C., respectively.	Amos W, 2010, P ROY SOC B-BIOL SCI, V277, P1443, DOI 10.1098/rspb.2009.1757; Amos W, 2010, BIOESSAYS, V32, P82, DOI 10.1002/bies.200900108; Arbeithuber B, 2015, P NATL ACAD SCI USA, V112, P2109, DOI 10.1073/pnas.1416622112; Boateng KA, 2013, DEV CELL, V24, P196, DOI 10.1016/j.devcel.2012.12.002; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen XZ, 2013, MOL BIOL EVOL, V30, P1559, DOI 10.1093/molbev/mst060; Chuang JH, 2004, PLOS BIOL, V2, P253, DOI 10.1371/journal.pbio.0020029; COX ED, 1972, NATURE-NEW BIOL, V239, P133, DOI 10.1038/newbio239133a0; Cutter AD, 2013, NAT REV GENET, V14, P262, DOI 10.1038/nrg3425; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gao ZY, 2013, P NATL ACAD SCI USA, V110, P14492, DOI 10.1073/pnas.1306579110; Ghoneim Dalia H, 2014, BMC Res Notes, V7, P864, DOI 10.1186/1756-0500-7-864; Gladyshev E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4509; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Hollister JD, 2010, MOL BIOL EVOL, V27, P409, DOI 10.1093/molbev/msp249; Ichijima Y, 2011, GENE DEV, V25, P959, DOI 10.1101/gad.2030811; Jiang CF, 2014, GENOME RES, V24, P1821, DOI 10.1101/gr.177659.114; Keightley PD, 2014, GENETICS, V196, P313, DOI 10.1534/genetics.113.158758; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Li H., 2013, ARXIV13033997 Q BIO; Li MK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r34; Liu HX, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0566-0; MAGNI GE, 1962, GENETICS, V47, P1097; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Martincorena I, 2012, NATURE, V485, P95, DOI 10.1038/nature10995; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; North BV, 2003, AM J HUM GENET, V72, P498, DOI 10.1086/346173; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Pal C, 2003, NAT GENET, V33, P392, DOI 10.1038/ng1111; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Perry J, 1999, CURR BIOL, V9, P987, DOI 10.1016/S0960-9822(99)80430-8; Pratto F, 2014, SCIENCE, V346, P826, DOI 10.1126/science.1256442; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rattray A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004910; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Shee C, 2012, CELL REP, V2, P714, DOI 10.1016/j.celrep.2012.08.033; Sung W, 2012, P NATL ACAD SCI USA, V109, P18488, DOI 10.1073/pnas.1216223109; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	43	99	104	4	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					463	U187		10.1038/nature14649	http://dx.doi.org/10.1038/nature14649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26176923	Green Accepted			2022-12-28	WOS:000358378900037
J	Jones, BE; Sauer, B; Jones, MM; Campo, J; Damal, K; He, T; Ying, J; Greene, T; Goetz, MB; Neuhauser, MM; Hicks, LA; Samore, MH				Jones, Barbara Ellen; Sauer, Brian; Jones, Makoto M.; Campo, Jose; Damal, Kavitha; He, Tao; Ying, Jian; Greene, Tom; Goetz, Matthew Bidwell; Neuhauser, Melinda M.; Hicks, Lauri A.; Samore, Matthew H.			Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Infections in the Veteran Population A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; TRACT INFECTIONS; DISEASES SOCIETY; ACUTE BRONCHITIS; AMBULATORY-CARE; ADULTS; AMERICA; TRENDS; RATES	Background: Despite efforts to reduce antibiotic prescribing for acute respiratory infections (ARIs), information on factors that drive prescribing is limited. Objective: To examine trends in antibiotic prescribing in the Veterans Affairs population over an 8-year period and to identify patient, provider, and setting sources of variation. Design: Retrospective, cross-sectional study. Setting: All emergency departments and primary and urgent care clinics in the Veterans Affairs health system. Participants: All patient visits between 2005 and 2012 with primary diagnoses of ARIs that typically had low proportions of bacterial infection. Patients with infections or comorbid conditions that indicated antibiotic use were excluded. Measurements: Overall antibiotic prescription; macrolide prescription; and patient, provider, and setting characteristics extracted from the electronic health record. Results: The proportion of 1 million visits with ARI diagnoses that resulted in antibiotic prescriptions increased from 67.5% in 2005 to 69.2% in 2012 (P < 0.001). The proportion of macrolide antibiotics prescribed increased from 36.8% to 47.0% (P < 0.001). Antibiotic prescribing was highest for sinusitis (adjusted proportion, 86%) and bronchitis (85%) and varied little according to fever, age, setting, or comorbid conditions. Substantial variation was identified in prescribing at the provider level: The 10% of providers who prescribed the most antibiotics did so during at least 95% of their ARI visits, and the 10% who prescribed the least did so during 40% or fewer of their ARI visits. Limitation: Some clinical data that may have influenced the prescribing decision were missing. Conclusion: Veterans with ARIs commonly receive antibiotics, regardless of patient, provider, or setting characteristics. Macrolide use has increased, and substantial variation was identified in antibiotic prescribing at the provider level.	Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; Univ Utah, Salt Lake City, UT 84112 USA; Vet Affairs Kansas City Hlth Care Syst, Kansas City, MO USA; Univ Calif Los Angeles, Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; US Dept Vet Affairs, Hines, IL USA; Ctr Dis Control & Prevent, Atlanta, GA USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Centers for Disease Control & Prevention - USA	Jones, BE (corresponding author), George E Wahlen Dept Vet Affairs Med Ctr, Decision Enhancement & Analyt Sci Ctr, 500 Foothill Blvd,Mail Code 182, Salt Lake City, UT 84148 USA.	barbara.jones@hsc.utah.edu	Goetz, Matthew Bidwell/GPX-4090-2022; Sauer, Brian C./AAC-4416-2020; Sauer, Brian C/C-2548-2014	Sauer, Brian C./0000-0002-3546-3051; Sauer, Brian C/0000-0002-3546-3051; Goetz, Matthew/0000-0003-4542-992X; Greene, Tom/0000-0002-3706-7570	U.S. Department of Veterans Affairs, Centers for Disease Control and Prevention	U.S. Department of Veterans Affairs, Centers for Disease Control and Prevention	U.S. Department of Veterans Affairs, Centers for Disease Control and Prevention.	Ackerman S, 2012, ANN INTERN MED, V157, P211, DOI 10.7326/0003-4819-157-3-201208070-00013; Agency for Healthcare Research and Quality, 2012, CLIN CLASS SOFTW CCS; Aspinall SL, 2005, CLIN THER, V27, P258, DOI 10.1016/j.clinthera.2005.02.002; Barnett ML, 2014, JAMA-J AM MED ASSOC, V311, P2020, DOI 10.1001/jama.2013.286141; Barnett ML, 2014, JAMA INTERN MED, V174, P138, DOI 10.1001/jamainternmed.2013.11673; Boyko EJ, 2000, AM J EPIDEMIOL, V151, P307, DOI 10.1093/oxfordjournals.aje.a010207; Centers for Disease Control and Prevention, 2015, GET SMART KNOW ANT W; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Bui DDA, 2014, J AM MED INFORM ASSN, V21, P850, DOI 10.1136/amiajnl-2013-002411; Fairlie T, 2012, ARCH INTERN MED, V172, P1513, DOI 10.1001/archinternmed.2012.4089; Franck AJ, 2010, J AM PHARM ASSOC, V50, P726, DOI 10.1331/JAPhA.2010.09103; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Gonzales R, 1998, J GEN INTERN MED, V13, P541, DOI 10.1046/j.1525-1497.1998.00165.x; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Hicks LA, 2013, NEW ENGL J MED, V368, P1461, DOI 10.1056/NEJMc1212055; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Jenkins SG, 2009, EMERG INFECT DIS, V15, P1260, DOI 10.3201/eid1508.081187; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Lee GC, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-96; McCaig Linda E., 2011, Morbidity and Mortality Weekly Report, V60, P1153; McCarthy M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5649; MCCULLOCH CE, 2005, ENCY BIOSTATISTICS, P2085; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Office of Quality Safety and Value, 2012, 2012 VHA FAC QUAL SA; Roumie CL, 2005, J GEN INTERN MED, V20, P697, DOI 10.1111/j.1525-1497.2005.0148.x; Shapiro DJ, 2014, J ANTIMICROB CHEMOTH, V69, P234, DOI 10.1093/jac/dkt301; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; Steinman MA, 2009, AM J MANAG CARE, V15, P861; US Department of Veterans Affairs, 2015, VA INF COMP INFR VIN; Zhang YT, 2012, ARCH INTERN MED, V172, P1465, DOI 10.1001/archinternmed.2012.3717	32	73	75	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2					73	+		10.7326/M14-1933	http://dx.doi.org/10.7326/M14-1933			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26192562				2022-12-28	WOS:000358407500014
J	Jordan, MI; Mitchell, TM				Jordan, M. I.; Mitchell, T. M.			Machine learning: Trends, perspectives, and prospects	SCIENCE			English	Review							NEURAL-NETWORKS	Machine learning addresses the question of how to build computers that improve automatically through experience. It is one of today's most rapidly growing technical fields, lying at the intersection of computer science and statistics, and at the core of artificial intelligence and data science. Recent progress in machine learning has been driven both by the development of new learning algorithms and theory and by the ongoing explosion in the availability of online data and low-cost computation. The adoption of data-intensive machine-learning methods can be found throughout science, technology and commerce, leading to more evidence-based decision-making across many walks of life, including health care, manufacturing, education, financial modeling, policing, and marketing.	[Jordan, M. I.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Dept Stat, Berkeley, CA 94720 USA; [Mitchell, T. M.] Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA	University of California System; University of California Berkeley; Carnegie Mellon University	Jordan, MI (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Dept Stat, Berkeley, CA 94720 USA.	jordan@cs.berkeley.edu; tom.mitchell@cs.cmu.edu	Jordan, Michael I/C-5253-2013	Jordan, Michael/0000-0001-8935-817X				Balcan M. -F., 2012, P 29 C COMP LEARN TH; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Berthet Q, 2013, ANN STAT, V41, P1780, DOI 10.1214/13-AOS1127; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blum A., 2013, J ACM, V20; Boyd S., 2010, FDN TRENDS MACH LEAR, V3, P1, DOI [10.1561/2200000016, DOI 10.1561/2200000016]; Chandrasekaran V, 2013, P NATL ACAD SCI USA, V110, pE1181, DOI 10.1073/pnas.1302293110; Decatur SE, 2000, SIAM J COMPUT, V29, P854, DOI 10.1137/S0097539797325648; Duchi JC, 2014, J ACM, V61, DOI 10.1145/2666468; Dwork C, 2006, LECT NOTES COMPUT SC, V3876, P265, DOI 10.1007/11681878_14; Hastie T., 2009, UNSUPERVISED LEARNIN; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Kleiner A, 2014, J R STAT SOC B, V76, P795, DOI 10.1111/rssb.12050; Mahoney MW, 2011, FOUND TRENDS MACH LE, V3, P123, DOI 10.1561/2200000035; Mitchell T., 2015, P 25 C ART INT AAAI; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Romero A., 2015, INT C LEARNING REPRE, P1097; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shalev-Shwartz S., 2012, P 15 C ART INT STAT; Sra S, 2012, OPTIMIZATION FOR MACHINE LEARNING, P1; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Taylor ME, 2009, J MACH LEARN RES, V10, P1633; Thrun S., 1998, LEARNING TO LEARN; VALIANT LG, 1984, COMMUN ACM, V27, P1134, DOI 10.1145/1968.1972; Wehbe L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112575; Xu K, 2015, PR MACH LEARN RES, V37, P2048; Yaylali E., 2011, ENCY OPERATIONS RES; Zhang YG, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-17	31	2459	2549	325	3090	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		255	260		10.1126/science.aaa8415	http://dx.doi.org/10.1126/science.aaa8415			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185243				2022-12-28	WOS:000358218600040
J	Parkes, DC; Wellman, MP				Parkes, David C.; Wellman, Michael P.			Economic reasoning and artificial intelligence	SCIENCE			English	Review							CHALLENGE; AUCTIONS; GAMES	The field of artificial intelligence (AI) strives to build rational agents capable of perceiving the world around them and taking actions to advance specified goals. Put another way, AI researchers aim to construct a synthetic homo economicus, the mythical perfectly rational agent of neoclassical economics. We review progress toward creating this new species of machine, machina economicus, and discuss some challenges in designing AIs that can reason effectively in economic contexts. Supposing that AI succeeds in this quest, or at least comes close enough that it is useful to think about AIs in rationalistic terms, we ask how to design the rules of interaction in multi-agent systems that come to represent an economy of AIs. Theories of normative design from economics may prove more relevant for artificial agents than human agents, with AIs that better respect idealized assumptions of rationality than people, interacting through novel rules and incentive systems quite distinct from those tailored for people.	[Parkes, David C.] Harvard Univ, Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Wellman, Michael P.] Univ Michigan, Comp Sci & Engn, Ann Arbor, MI 48109 USA	Harvard University; University of Michigan System; University of Michigan	Parkes, DC (corresponding author), Harvard Univ, Harvard John A Paulson Sch Engn & Appl Sci, 33 Oxford St, Cambridge, MA 02138 USA.	parkes@eecs.harvard.edu; wellman@umich.edu	Wellman, Michael/AAQ-7063-2020	Wellman, Michael/0000-0002-1691-6844				Abernethy J., 2013, ACM T EC COMPUTATION, V1, P12; Abernethy J.D., 2011, ADV NEURAL INFORM PR, P2600; Abraham D. J., 2007, 8 ACM C EL COMM, P295; Alaei S., 2012, 13 ACM C EL COMM, P17; Alon N., 2011, 13 C THEOR ASP RAT K, P101; Altman A, 2008, J ARTIF INTELL RES, V31, P473, DOI 10.1613/jair.2306; [Anonymous], 1998, THEORY LEARNING GAME; Billings D, 2002, ARTIF INTELL, V134, P201, DOI 10.1016/S0004-3702(01)00130-8; Billings D., 2003, 18 INT JOINT C ART I, P661; Bolton G, 2013, MANAGE SCI, V59, P265, DOI 10.1287/mnsc.1120.1609; Borgs C, 2007, P 16 INT C WORLD WID, P531, DOI DOI 10.1145/1242572.1242644; Brafman RI, 2004, ARTIF INTELL, V159, P27, DOI 10.1016/j.artint.2004.04.013; Broder A. Z., 2011, 4 INT C WEB SEARCH W, P515; Brown N, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS (AAMAS'15), P7; Budish E., 2015, 1403 U CHIC BOOTH SC; Cai Y, 2013, ANN IEEE SYMP FOUND, P618, DOI 10.1109/FOCS.2013.72; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cavallo R., 2006, 22 C UNC ART INT CAM, P55; Chen Y, 2006, J ECON THEORY, V127, P202, DOI 10.1016/j.jet.2004.10.006; Cheng A, 2005, P 2005 ACM SIGCOMM W, P128, DOI DOI 10.1145/1080192.1080202; Clarke E., 1971, PUBLIC CHOICE, V11, P17, DOI [10.1007/BF01726210, DOI 10.1007/BF01726210]; Conitzer Vincent, 2002, P 18 ANN C UNC ART I, P103; Dekel O, 2010, J COMPUT SYST SCI, V76, P759, DOI 10.1016/j.jcss.2010.03.003; Dellarocas C, 2003, MANAGE SCI, V49, P1407, DOI 10.1287/mnsc.49.10.1407.17308; DOYLE J, 1992, COMPUTATIONAL INTELL, V8, P376, DOI DOI 10.1111/J.1467-8640.1992.TB00371.X; Dudik M., 2013, 14 ACM C EL COMM, P341; Duetting P., 2015, ACM T EC COMPUTATION, V3, P5; Echenique F., 2013, WORKSING PAPERS U PI; Edelman B, 2007, AM ECON REV, V97, P242, DOI 10.1257/aer.97.1.242; Edelman B, 2007, DECIS SUPPORT SYST, V43, P192, DOI 10.1016/j.dss.2006.08.008; Feldman J., 2007, 8 ACM C EL COMM, P40; Forsythe R., 1991, CONT LAB EXPT POLITI, P69; Frechette A., 2015, 24 INT JOINT C ART I; Friedman EJ, 2001, J ECON MANAGE STRAT, V10, P173, DOI 10.1162/105864001300122476; Gal Y, 2008, J ARTIF INTELL RES, V33, P109, DOI 10.1613/jair.2503; Getoor Lise, 2007, INTRO STAT RELATIONA; GIBBARD A, 1973, ECONOMETRICA, V41, P587, DOI 10.2307/1914083; Gibson R. G., 2014, THESIS U ALBERTA; Gilpin A., 2007, 3 INT WORKSH INT NET, P57; Gilpin A., 2006, 7 ACM C EL COMM, P160; GROVES T, 1973, ECONOMETRICA, V41, P617, DOI 10.2307/1914085; Halpern J., 2004, P 36 ANN ACM S THEOR, P623, DOI DOI 10.1145/1007352.1007447; Hanson R, 2003, INFORM SYST FRONT, V5, P107, DOI 10.1023/A:1022058209073; Hendershott T, 2011, J FINANC, V66, P1, DOI 10.1111/j.1540-6261.2010.01624.x; Hirschberg J, 2015, SCIENCE, V349, P261, DOI 10.1126/science.aaa8685; Hoda S, 2010, MATH OPER RES, V35, P494, DOI 10.1287/moor.1100.0452; Horvitz E. J., 1990, THESIS STANFORD U; Hu J., 2014, 31 INT C MACH LEARN, P1773; Hurwicz L., 1972, DECISION ORG VOLUME, P297; Hurwicz L., 1960, MATH SOC SCI, P27; Jiang AX, 2014, ADV NEUR IN, V27; Jordan MI, 2015, SCIENCE, V349, P255, DOI 10.1126/science.aaa8415; Kearns Michael, 2013, HIGH FREQUENCY TRADI, p[122, 91]; Koller D, 1997, ARTIF INTELL, V94, P167, DOI 10.1016/S0004-3702(97)00023-4; McCue M., 2014, CANT SECURE RESERVAT; Milgrom P., 2004, PUTTING AUCTION THEO; Monderer D, 2009, ARTIF INTELL, V173, P180, DOI 10.1016/j.artint.2008.10.005; MYERSON RB, 1979, ECONOMETRICA, V47, P61, DOI 10.2307/1912346; Ng AY, 1999, MACHINE LEARNING, PROCEEDINGS, P278; Nisan N., 2006, COMBINATORIAL AUCTIO; Parkes DC, 2007, ALGORITHMIC GAME THEORY, P411; Parkes DC, 2004, ADV NEUR IN, V16, P791; Ramchurn SD, 2012, COMMUN ACM, V55, P86, DOI 10.1145/2133806.2133825; Resnick P, 2000, COMMUN ACM, V43, P45, DOI 10.1145/355112.355122; Rosenschein J. S., 1994, RULES ENCOUNTER DESI; Russell S., 2015, FUNDAMENTAL ISUES AR; Russell S, 2009, ARTIFICIAL INTELLIGE; Sandholm T, 2002, ARTIF INTELL, V135, P1, DOI 10.1016/S0004-3702(01)00159-X; SANDHOLM T, 2006, COMBINATORIAL AUCTIO; Sandholm T, 2010, AI MAG, V31, P13, DOI 10.1609/aimag.v31i4.2311; Seuken S, 2010, AAAI CONF ARTIF INTE, P860; Shoham Y, 2005, THEOR COMPUT SCI, V343, P97, DOI 10.1016/j.tcs.2005.05.009; Shoham Y., 2009, MULTIAGENT SYSTEMS A; Shoham Y, 2008, COMMUN ACM, V51, P74, DOI 10.1145/1378704.1378721; Singh S, 2010, IEEE T AUTON MENT DE, V2, P70, DOI 10.1109/TAMD.2010.2051031; Sonmez T., 2011, HDB SOCIAL EC, V1A, P781; Sorg J., 2010, 27 INT C MACH LEARN, P1007; Sutter J. D., 2011, CNN             0425; Tambe M., 2011, SECURITY GAME THEORY; Varian HR, 2014, AM ECON REV, V104, P442, DOI 10.1257/aer.104.5.442; Varian HR, 1995, PROCEEDINGS OF THE FIRST USENIX WORKSHOP OF ELECTRONIC COMMERCE, P13; VICKREY W, 1961, J FINANC, V16, P8, DOI 10.2307/2977633; Way E., 2013, P 14 ACM C EL COMM, P855, DOI DOI 10.1145/2482540.2482577; Wellman MP, 2004, J ARTIF INTELL RES, V21, P19, DOI 10.1613/jair.1333; Witkowski J., 2012, 13 ACM C EL COMM, P964; Wright J. R., 2013, CORR; Yang R, 2013, ARTIF INTELL, V195, P440, DOI 10.1016/j.artint.2012.11.004; Yokoo M, 2004, GAME ECON BEHAV, V46, P174, DOI 10.1016/S0899-8256(03)00045-9; Zinkevich Martin, 2007, ADV NEURAL INFORM PR, V20, P905	90	94	96	9	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		267	272		10.1126/science.aaa8403	http://dx.doi.org/10.1126/science.aaa8403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1ZB	26185245	Green Submitted			2022-12-28	WOS:000358218600042
J	[Anonymous]				[Anonymous]			THE SCIENTIST OF THE FUTURE	NATURE			English	News Item																			0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					271	271		10.1038/523271a	http://dx.doi.org/10.1038/523271a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26178947	Bronze			2022-12-28	WOS:000357950900013
J	Reiling, J				Reiling, Jennifer			Reinforcements in the Pure Food Crusade	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1905, JAMA-J AM MED ASSOC, V45, P198	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					190	190		10.1001/jama.2014.11860	http://dx.doi.org/10.1001/jama.2014.11860			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26172908				2022-12-28	WOS:000357867500028
J	Smith, JM				Smith, Jeanette M.			The Tree Philip Sutton	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					108	109		10.1001/jama.2014.11853	http://dx.doi.org/10.1001/jama.2014.11853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26172881				2022-12-28	WOS:000357867500001
J	Babu, S; Al-Obaidi, B; Abdul-Jabar, HB; Al-Hadithy, N; Gupte, C				Babu, Satish; Al-Obaidi, Bilal; Abdul-Jabar, Hani B.; Al-Hadithy, Nawfal; Gupte, Chinmay			CASE REVIEW Knee injury in a 12 year old girl	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTERIOR CRUCIATE LIGAMENT; SKELETALLY IMMATURE PATIENTS; DIAGNOSIS; CHILDREN; TEARS; RECONSTRUCTION; MANAGEMENT; RUPTURE; DELAY		[Babu, Satish; Al-Obaidi, Bilal; Abdul-Jabar, Hani B.; Al-Hadithy, Nawfal; Gupte, Chinmay] Imperial Coll Healthcare NHS Trust, London W2 1NY, England	Imperial College London	Babu, S (corresponding author), Imperial Coll Healthcare NHS Trust, London W2 1NY, England.	sbabu@doctors.org.uk						Al-Hadithy N, 2013, BONE JOINT J, V95B, P1562, DOI 10.1302/0301-620X.95B11.31778; Benjammse A, 2006, J ORTHOP SPORT PHYS, V36, P267, DOI 10.2519/jospt.2006.2011; Dorizas JA, 2003, ORTHOP CLIN N AM, V34, P355, DOI 10.1016/S0030-5898(02)00072-X; Flynn JM, 2000, J PEDIATR ORTHOPED, V20, P259, DOI 10.1097/00004694-200003000-00025; Fritz Russell C, 2003, Magn Reson Imaging Clin N Am, V11, P283; Frosch KH, 2010, ARTHROSCOPY, V26, P1539, DOI 10.1016/j.arthro.2010.04.077; GRAF BK, 1992, ARTHROSCOPY, V8, P229, DOI 10.1016/0749-8063(92)90041-9; Herring JA, 2002, TACHDJIANS PEDIAT OR; JOHNSON DL, 1993, CLIN SPORT MED, V12, P671; Klass D, 2007, KNEE, V14, P339, DOI 10.1016/j.knee.2007.04.008; Kocher MS, 2002, J PEDIATR ORTHOPED, V22, P452, DOI 10.1097/00004694-200207000-00008; Kocher MS, 2001, AM J SPORT MED, V29, P292, DOI 10.1177/03635465010290030601; Lawrence JTR, 2011, AM J SPORT MED, V39, P2582, DOI 10.1177/0363546511420818; Lee K, 1999, RADIOLOGY, V213, P697, DOI 10.1148/radiology.213.3.r99dc26697; Liu-Ambrose T, 2003, BCMJ, V45, P495; Luhmann SJ, 2003, J PEDIATR ORTHOPED, V23, P199, DOI 10.1097/00004694-200303000-00013; Magnussen RA, 2012, ARTHROSCOPY, V28, P526, DOI 10.1016/j.arthro.2011.11.024; Millett PJ, 2002, ARTHROSCOPY, V18, P955, DOI 10.1053/jars.2002.36114; MIZUTA H, 1995, J BONE JOINT SURG BR, V77B, P890, DOI 10.1302/0301-620X.77B6.7593101; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; PARKER AW, 1994, AM J SPORT MED, V22, P44, DOI 10.1177/036354659402200108; Preiss A, 2012, UNFALLCHIRURG, V115, P848, DOI 10.1007/s00113-012-2215-y; Spindler KR, 2004, AM J SPORT MED, V32, P1986, DOI 10.1177/0363546504271211; Stanitski, 1995, J Am Acad Orthop Surg, V3, P146; STANITSKI CL, 1993, J PEDIATR ORTHOPED, V13, P506, DOI 10.1097/01241398-199307000-00016	25	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2015	351								h3420	10.1136/bmj.h3420	http://dx.doi.org/10.1136/bmj.h3420			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MU	26160649				2022-12-28	WOS:000357956500002
J	Stein, LD; Knoppers, BM; Campbell, P; Getz, G; Korbel, JO				Stein, Lincoln D.; Knoppers, Bartha M.; Campbell, Peter; Getz, Gad; Korbel, Jan O.			Data analysis: Create a cloud commons	NATURE			English	Editorial Material									[Stein, Lincoln D.] Ontario Inst Canc Res, Informat & Biocomp, Toronto, ON, Canada; [Knoppers, Bartha M.] McGill Univ, Ctr Genom & Policy, Montreal, PQ, Canada; [Campbell, Peter] Wellcome Trust Sanger Inst, Canc Genom, Hinxton, Cambs, England; [Getz, Gad] Broad Inst MIT & Harvard, Canc Genome Computat Anal Grp, Cambridge, MA USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Bioinformat, Boston, MA USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Korbel, Jan O.] European Mol Biol Lab, Genome Biol, D-69012 Heidelberg, Germany	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; McGill University; Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; European Molecular Biology Laboratory (EMBL)	Stein, LD (corresponding author), Ontario Inst Canc Res, Informat & Biocomp, Toronto, ON, Canada.	lincoln.stein@gmail.com						Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; European Commission, 2008, 11 ANN REP ART 29 WO; Gutmann A, 2013, HASTINGS CENT REP, V43, P15, DOI 10.1002/hast.162; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Tryka KA, 2014, NUCLEIC ACIDS RES, V42, pD975, DOI 10.1093/nar/gkt1211	6	65	67	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					149	151		10.1038/523149a	http://dx.doi.org/10.1038/523149a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4ZO	26156357	Bronze			2022-12-28	WOS:000357695900011
J	Reefhuis, J; Devine, O; Friedman, JM; Louik, C; Honein, MA				Reefhuis, Jennita; Devine, Owen; Friedman, Jan M.; Louik, Carol; Honein, Margaret A.			Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN-REUPTAKE INHIBITORS; UNITED-STATES; 1ST-TRIMESTER USE; EARLY-PREGNANCY; MEDICATION USE; HEART-DEFECTS; RISK; PREVALENCE; METAANALYSIS; PAROXETINE	Objective To follow up on previously reported associations between periconceptional use of selective serotonin reuptake inhibitors (SSRIs) and specific birth defects using an expanded dataset from the National Birth Defects Prevention Study. Design Bayesian analysis combining results from independent published analyses with data from a multicenter population based case-control study of birth defects. Setting 10 centers in the United States. Participants 17 952 mothers of infants with birth defects and 9857 mothers of infants without birth defects, identified through birth certificates or birth hospitals, with estimated dates of delivery between 1997 and 2009. Exposures Citalopram, escitalopram, fluoxetine, paroxetine, or sertraline use in the month before through the third month of pregnancy. Posterior odds ratio estimates were adjusted to account for maternal race/ethnicity, education, smoking, and prepregnancy obesity. Main outcome measure 14 birth defects categories that had associations with SSRIs reported in the literature. Results Sertraline was the most commonly reported SSRI, but none of the five previously reported birth defects associations with sertraline was confirmed. For nine previously reported associations between maternal SSRI use and birth defect in infants, findings were consistent with no association. High posterior odds ratios excluding the null value were observed for five birth defects with paroxetine (anencephaly 3.2, 95% credible interval 1.6 to 6.2; atrial septal defects 1.8, 1.1 to 3.0; right ventricular outflow tract obstruction defects 2.4, 1.4 to 3.9; gastroschisis 2.5, 1.2 to 4.8; and omphalocele 3.5, 1.3 to 8.0) and for two defects with fluoxetine (right ventricular outflow tract obstruction defects 2.0, 1.4 to 3.1 and craniosynostosis 1.9, 1.1 to 3.0). Conclusions These data provide reassuring evidence for some SSRIs but suggest that some birth defects occur 2-3.5 times more frequently among the infants of women treated with paroxetine or fluoxetine early in pregnancy.	[Reefhuis, Jennita; Devine, Owen; Honein, Margaret A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30329 USA; [Friedman, Jan M.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Louik, Carol] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA	Centers for Disease Control & Prevention - USA; University of British Columbia; Boston University	Reefhuis, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30329 USA.	JReefhuisNZR5@cdc.gov		Friedman, Jan/0000-0002-7482-9570	US Centers for Disease Control and Prevention	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Data collection was funded by the US Centers for Disease Control and Prevention.	Abuhamad Alfred Z, 2008, Obstet Gynecol, V112, P951, DOI 10.1097/AOG.0b013e31818b1fba; ACOG Committee on Obstetric Practice, 2006, Obstet Gynecol, V108, P1601; Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Alwan S, 2011, J CLIN PHARMACOL, V51, P264, DOI 10.1177/0091270010373928; Bakker MK, 2010, BIRTH DEFECTS RES A, V88, P94, DOI 10.1002/bdra.20641; Bedard T, 2013, BIRTH DEFECTS RES A, V97, P564, DOI 10.1002/bdra.23162; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Edwards JG, 1999, DRUGS, V57, P507, DOI 10.2165/00003495-199957040-00005; FDA, 2005, FDA ADV RISK BIRTH D; Furu K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1798; Gelman Andrew, 2013, Br J Math Stat Psychol, V66, P8, DOI 10.1111/j.2044-8317.2011.02037.x; Gentile S, 2011, ACTA PSYCHIAT SCAND, V123, P266, DOI 10.1111/j.1600-0447.2011.01673.x; Goodman JH, 2009, BIRTH-ISS PERINAT C, V36, P60, DOI 10.1111/j.1523-536X.2008.00296.x; Huybrechts KF, 2013, GEN HOSP PSYCHIAT, V35, P265, DOI 10.1016/j.genhosppsych.2012.12.010; Kornum Jette B, 2010, Clin Epidemiol, V2, P29; Kwon A, 2003, MED CARE, V41, P368, DOI 10.1097/00005650-200303000-00005; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Lunn D., 2012, BUGS BOOK PRACTICAL, DOI DOI 10.1201/B13613; Malm H, 2011, OBSTET GYNECOL, V118, P111, DOI 10.1097/AOG.0b013e318220edcc; MITCHELL AA, 1986, AM J EPIDEMIOL, V123, P670, DOI 10.1093/oxfordjournals.aje.a114286; Obican S, 2011, AM J MED GENET C, V157C, P150, DOI 10.1002/ajmg.c.30310; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Rasmussen SA, 2003, BIRTH DEFECTS RES A, V67, P193, DOI 10.1002/bdra.10012; Reefhuis J, 2006, NEW ENGL J MED, V354, P2188; Reefhuis J, 2015, BIRTH DEFECT RES A; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sadler TW, 2011, REPROD TOXICOL, V32, P484, DOI 10.1016/j.reprotox.2011.09.004; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Tinker SC, 2015, MATERN CHILD HLTH J, V19, P1097, DOI 10.1007/s10995-014-1611-z; Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627; Yoon PW, 2001, PUBLIC HEALTH REP, V116, P32, DOI 10.1093/phr/116.S1.32	32	96	101	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2015	351								h3190	10.1136/bmj.h3190	http://dx.doi.org/10.1136/bmj.h3190			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MP	26156519	Green Published, hybrid			2022-12-28	WOS:000357955800002
J	Spencer, DR				Spencer, Danielle R.			The art of medicine All creatures great and small	LANCET			English	Editorial Material									Columbia Univ Coll Phys & Surg, Program Narrat Med, New York, NY 10032 USA	Columbia University	Spencer, DR (corresponding author), Columbia Univ Coll Phys & Surg, Program Narrat Med, 630 W 168th St, New York, NY 10032 USA.	spencer@aya.yale.edu		Spencer, Danielle/0000-0002-7997-1613					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					22	23		10.1016/S0140-6736(15)61192-8	http://dx.doi.org/10.1016/S0140-6736(15)61192-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM2OA	26169854	Bronze			2022-12-28	WOS:000357519400015
J	Li, R; Qu, SL; Zhang, P; Chattopadhyay, S; Gregg, EW; Albright, A; Hopkins, D; Pronk, NP				Li, Rui; Qu, Shuli; Zhang, Ping; Chattopadhyay, Sajal; Gregg, Edward W.; Albright, Ann; Hopkins, David; Pronk, Nicolaas P.			Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; COST-EFFECTIVENESS; CARDIOVASCULAR-DISEASE; STRATEGIES; METFORMIN; MELLITUS; PEOPLE; TRANSLATION; OUTCOMES	Background: Diabetes is a highly prevalent and costly disease. Studies indicate that combined diet and physical activity promotion programs can prevent type 2 diabetes among persons at increased risk. Purpose: To systematically evaluate the evidence on cost, cost-effectiveness, and cost-benefit estimates of diet and physical activity promotion programs. Data Sources: Cochrane Library, EMBASE, MEDLINE, PsycINFO, Sociological Abstracts, Web of Science, EconLit, and CINAHL through 7 April 2015. Study Selection: English-language studies from high-income countries that provided data on cost, cost-effectiveness, or cost-benefit ratios of diet and physical activity promotion programs with at least 2 sessions over at least 3 months delivered to persons at increased risk for type 2 diabetes. Data Extraction: Dual abstraction and assessment of relevant study details. Data Synthesis: Twenty-eight studies were included. Costs were expressed in 2013 U.S. dollars. The median program cost per participant was $653. Costs were lower for group-based pro-grams (median, $417) and programs implemented in community or primary care settings (median, $424) than for the U.S. DPP (Diabetes Prevention Program) trial and the DPP Outcomes Study ($5881). Twenty-two studies assessed the incremental cost-effectiveness ratios (ICERs) of the programs. From a health system perspective, 16 studies reported a median ICER of $13 761 per quality-adjusted life-year (QALY) saved. Group-based programs were more cost-effective (median, $1819 per QALY) than those that used individual sessions (median, $15 846 per QALY). No cost-benefit studies were identified. Limitation: Information on recruitment costs and cost-effectiveness of translational programs implemented in community and primary care settings was limited. Conclusion: Diet and physical activity promotion programs to prevent type 2 diabetes are cost-effective among persons at increased risk. Costs are lower when programs are delivered to groups in community or primary care settings.	[Li, Rui; Qu, Shuli; Zhang, Ping; Chattopadhyay, Sajal; Gregg, Edward W.; Albright, Ann; Hopkins, David] Ctr Dis Control & Prevent, Atlanta, GA 30341 USA; [Pronk, Nicolaas P.] HealthPartners Res Fdn, Minneapolis, MN 55425 USA	Centers for Disease Control & Prevention - USA; HealthPartners Institute for Education & Research	Li, R (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, 4770 Buford Highway Northeast,MS F-75, Atlanta, GA 30341 USA.	eok8@cdc.gov	Chattopadhyay, Sajal/GWU-8667-2022	Chattopadhyay, Sajal/0000-0002-7245-1631; Gregg, Edward/0000-0003-2381-6822	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Ackermann RT, 2006, DIABETES CARE, V29, P1237, DOI 10.2337/dc05-1709; Albright AL, 2013, AM J PREV MED, V44, pS346, DOI 10.1016/j.amepre.2012.12.009; Alderson P, 2004, COHRANE REV HDB 4 2; Ali MK, 2012, HEALTH AFFAIR, V31, P67, DOI 10.1377/hlthaff.2011.1009; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2014, DIAB PREV CONTR COMB; Balk EM, 2015, ANN INTERN MED, V163, P437, DOI 10.7326/M15-0452; Bertram MY, 2010, DIABETOLOGIA, V53, P875, DOI 10.1007/s00125-010-1661-8; Board of Governors of the Federal Reserve System, 2015, FOR EXCH RAT; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Bureau of Labor Statistics, 2014, CONS PRIC IND ALL UR; Caro JJ, 2004, DIABETIC MED, V21, P1229, DOI 10.1111/j.1464-5491.2004.01330.x; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP; Centers for Medicare and Medicaid Services, 2014, PHYS FEE SCHEDULE; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; Colagiuri S, 2008, HEALTH AFFAIR, V27, P256, DOI 10.1377/hlthaff.27.1.256; Diabet Prevention Program Res Grp, 2003, DIABETES CARE, V26, P2518, DOI 10.2337/diacare.26.9.2518; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006; Feldman Inna, 2013, Cost Eff Resour Alloc, V11, P19, DOI 10.1186/1478-7547-11-19; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Herman WH, 2005, ANN INTERN MED, V142, P323, DOI 10.7326/0003-4819-142-5-200503010-00007; Herman WH, 2012, DIABETES CARE, V35, P723, DOI 10.2337/dc11-1468; Hoerger TJ, 2007, DIABETES CARE, V30, P2874, DOI 10.2337/dc07-0885; Irvine L, 2011, INT J TECHNOL ASSESS, V27, P275, DOI 10.1017/S0266462311000365; Jacobs-van der Bruggen MAM, 2007, DIABETES CARE, V30, P128, DOI 10.2337/dc06-0690; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kramer MK, 2011, DIABETES EDUCATOR, V37, P659, DOI 10.1177/0145721711411930; Kramer MK, 2009, AM J PREV MED, V37, P505, DOI 10.1016/j.amepre.2009.07.020; Krukowski RA, 2013, PREV MED, V57, P400, DOI 10.1016/j.ypmed.2013.06.027; Lawlor MS, 2013, AM J PREV MED, V44, pS381, DOI 10.1016/j.amepre.2012.12.016; Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843; Li YF, 2013, MMWR-MORBID MORTAL W, V62, P209; Lin J.S., 2014, AHRQ PUBLICATION; Lindgren P, 2007, INT J TECHNOL ASSESS, V23, P177, DOI 10.1017/S0266462307070286; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Neumann Anne, 2011, Cost Eff Resour Alloc, V9, P17, DOI 10.1186/1478-7547-9-17; Ockene IS, 2012, AM J PUBLIC HEALTH, V102, P336, DOI 10.2105/AJPH.2011.300357; Palmer AJ, 2012, PRIM CARE DIABETES, V6, P109, DOI 10.1016/j.pcd.2011.10.006; Palmer AJ, 2004, CLIN THER, V26, P304, DOI 10.1016/S0149-2918(04)90029-X; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Png ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107225; Radl K, 2013, EPIDEMOLOGY BIOSTATI, V10, P8; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Sagarra R, 2014, REV CLIN ESP, V214, P59, DOI 10.1016/j.rce.2013.10.005; Segal L, 1998, HEALTH PROMOT INT, V13, P197, DOI 10.1093/heapro/13.3.197; Smith KJ, 2010, PREV CHRONIC DIS, V7; Vadheim LM, 2010, J RURAL HEALTH, V26, P266, DOI 10.1111/j.1748-0361.2010.00288.x; Vijgen SMC, 2006, PHARMACOECONOMICS, V24, P425, DOI 10.2165/00019053-200624050-00002; World bank, 2021, GDP PER CAP CURR US; World Health Organization, 2001, MACR HLTH INV HLTH E; Wylie-Rosett J, 2006, CURR OPIN LIPIDOL, V17, P37, DOI 10.1097/01.mol.0000203890.27267.eb; Zhuo XH, 2012, HEALTH AFFAIR, V31, P50, DOI 10.1377/hlthaff.2011.1115	54	85	87	2	42	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6					452	+		10.7326/M15-0469	http://dx.doi.org/10.7326/M15-0469			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR5FL	26167962	Green Accepted			2022-12-28	WOS:000361365900019
J	Gara, SK; Jia, L; Merino, MJ; Agarwal, SK; Zhang, LS; Cam, M; Patel, D; Kebebew, E				Gara, Sudheer Kumar; Jia, Li; Merino, Maria J.; Agarwal, Sunita K.; Zhang, Lisa; Cam, Maggie; Patel, Dhaval; Kebebew, Electron			Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VII-ACTIVATING PROTEASE; MARBURG-I POLYMORPHISM; HYALURONAN-BINDING PROTEIN; WILD-TYPE P53; VENOUS THROMBOEMBOLISM; BREAST-CANCER; CARCINOMA; THROMBOSIS; RISK; IDENTIFICATION	Familial nonmedullary thyroid cancer accounts for 3 to 9% of all cases of thyroid cancer, but the susceptibility genes are not known. Here, we report a germline variant of HABP2 in seven affected members of a kindred with familial nonmedullary thyroid cancer and in 4.7% of 423 patients with thyroid cancer. This variant was associated with increased HABP2 protein expression in tumor samples from affected family members, as compared with normal adjacent thyroid tissue and samples from sporadic cancers. Functional studies showed that HABP2 has a tumor-suppressive effect, whereas the G534E variant results in loss of function.	[Gara, Sudheer Kumar; Jia, Li; Patel, Dhaval; Kebebew, Electron] NCI, Endocrine Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Jia, Li] NCI, Bioinformat Core, Ctr Canc Res, Bethesda, MD 20892 USA; [Merino, Maria J.] NCI, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Cam, Maggie] NCI, Off Sci & Technol Resources, Bethesda, MD 20892 USA; [Agarwal, Sunita K.] NIDDK, Metab Dis Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kebebew, E (corresponding author), NCI, Endocrine Oncol Branch, NIH, CRC, Bldg 10,Rm 4W-5952,10 Ctr Dr,MSC 1201, Bethesda, MD 20892 USA.	kebebewe@mail.nih.gov	Agarwal, Sunita K/D-1428-2016; Gara, Sudheer Kumar/E-8084-2016; Pinheiro, Maísa/E-7424-2012	Agarwal, Sunita K/0000-0002-7557-3191; Patel, Dhaval/0000-0002-5744-568X	Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC011532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075035] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health.	Ahmad-Nejad P, 2012, THROMB RES, V130, P441, DOI 10.1016/j.thromres.2012.02.009; Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205; Choi-Miura NH, 2001, BIOL PHARM BULL, V24, P140, DOI 10.1248/bpb.24.140; ChoiMiura NH, 1996, J BIOCHEM, V119, P1157; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Franchi F, 2006, BLOOD, V107, P1731, DOI 10.1182/blood-2005-09-3603; He HL, 2013, J CLIN ENDOCR METAB, V98, pE973, DOI 10.1210/jc.2012-3823; Hoppe B, 2005, BLOOD, V105, P1549, DOI 10.1182/blood-2004-08-3328; Iacobone M, 2014, LANGENBECK ARCH SURG, V399, P141, DOI 10.1007/s00423-013-1145-7; Karbownik MS, 2013, PHARMACOL REP, V65, P1056, DOI 10.1016/S1734-1140(13)71465-8; Martinez-Palacian A, 2014, PROTEOM CLIN APPL, V8, P438, DOI 10.1002/prca.201300078; Moses W, 2011, THYROID, V21, P367, DOI 10.1089/thy.2010.0256; Ngan ESW, 2009, JNCI-J NATL CANCER I, V101, P162, DOI 10.1093/jnci/djn471; Parr C, 2004, CLIN CANCER RES, V10, P202, DOI 10.1158/1078-0432.CCR-0553-3; Pereira JS, 2015, ENDOCRINE, V49, P204, DOI 10.1007/s12020-014-0470-0; Romisch J, 1999, HAEMOSTASIS, V29, P292; SCHMEIDLERSAPIRO KT, 1991, P NATL ACAD SCI USA, V88, P4382, DOI 10.1073/pnas.88.10.4382; Sidelmann JJ, 2008, THROMB RES, V122, P848, DOI 10.1016/j.thromres.2008.02.002; Slade I, 2011, J MED GENET, V48, P273, DOI 10.1136/jmg.2010.083790; Uchino S, 2002, WORLD J SURG, V26, P897, DOI 10.1007/s00268-002-6615-y; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Minkelen R, 2005, BLOOD, V105, P4898, DOI 10.1182/blood-2005-02-0576; Vriens MR, 2009, THYROID, V19, P1343, DOI 10.1089/thy.2009.1607; Weisbach V, 2007, THROMB HAEMOSTASIS, V97, P870, DOI 10.1160/TH06-12-0739; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396	25	94	96	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2015	373	5					448	455		10.1056/NEJMoa1502449	http://dx.doi.org/10.1056/NEJMoa1502449			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8BO	26222560	Green Accepted			2022-12-28	WOS:000358662200008
J	Liu, ZF; Fang, S; Moura, FA; Ding, JN; Jiang, N; Di, J; Zhang, M; Lepro, X; Galvao, DS; Haines, CS; Yuan, NY; Yin, SG; Lee, DW; Wang, R; Wang, HY; Lv, W; Dong, C; Zhang, RC; Chen, MJ; Yin, Q; Chong, YT; Zhang, R; Wang, X; Lima, MD; Ovalle-Robles, R; Qian, D; Lu, H; Baughman, RH				Liu, Z. F.; Fang, S.; Moura, F. A.; Ding, J. N.; Jiang, N.; Di, J.; Zhang, M.; Lepro, X.; Galvao, D. S.; Haines, C. S.; Yuan, N. Y.; Yin, S. G.; Lee, D. W.; Wang, R.; Wang, H. Y.; Lv, W.; Dong, C.; Zhang, R. C.; Chen, M. J.; Yin, Q.; Chong, Y. T.; Zhang, R.; Wang, X.; Lima, M. D.; Ovalle-Robles, R.; Qian, D.; Lu, H.; Baughman, R. H.			Hierarchically buckled sheath-core fibers for superelastic electronics, sensors, and muscles	SCIENCE			English	Article							CARBON NANOTUBE FORESTS; HUMAN-MOTION DETECTION; DIELECTRIC ELASTOMERS; ARTIFICIAL MUSCLES; STRETCHABLE CONDUCTORS; STRAIN; TRANSPARENT; PERFORMANCE; GRAPHENE; ACTUATORS	Superelastic conducting fibers with improved properties and functionalities are needed for diverse applications. Here we report the fabrication of highly stretchable (up to 1320%) sheath-core conducting fibers created by wrapping carbon nanotube sheets oriented in the fiber direction on stretched rubber fiber cores. The resulting structure exhibited distinct short-and long-period sheath buckling that occurred reversibly out of phase in the axial and belt directions, enabling a resistance change of less than 5% for a 1000% stretch. By including other rubber and carbon nanotube sheath layers, we demonstrated strain sensors generating an 860% capacitance change and electrically powered torsional muscles operating reversibly by a coupled tension-to-torsion actuation mechanism. Using theory, we quantitatively explain the complementary effects of an increase in muscle length and a large positive Poisson's ratio on torsional actuation and electronic properties.	[Liu, Z. F.; Fang, S.; Moura, F. A.; Jiang, N.; Di, J.; Lepro, X.; Haines, C. S.; Lima, M. D.; Baughman, R. H.] Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75080 USA; [Liu, Z. F.; Ding, J. N.; Yuan, N. Y.; Wang, R.; Lv, W.; Dong, C.; Chen, M. J.; Yin, Q.] Changzhou Univ, Jiangsu Collaborat Innovat Ctr Photovolta Sci & E, Changzhou 213164, Peoples R China; [Fang, S.; Jiang, N.; Yuan, N. Y.; Yin, S. G.; Lee, D. W.; Wang, R.; Wang, H. Y.; Lv, W.; Dong, C.; Zhang, R. C.; Chen, M. J.; Yin, Q.; Chong, Y. T.; Baughman, R. H.] Jiangnan Graphene Res Inst, Changzhou 213149, Peoples R China; [Moura, F. A.; Galvao, D. S.] Univ Estadual Campinas, Dept Appl Phys, BR-13081970 Campinas, SP, Brazil; [Zhang, M.] Florida State Univ, High Performance Mat Inst, Tallahassee, FL 32310 USA; [Yin, S. G.; Wang, H. Y.; Zhang, R. C.] Tianjin Univ Technol, Inst Mat Phys, Tianjin 300384, Peoples R China; [Zhang, R.] Northwestern Polytech Univ, Sch Astronaut, Xian 710072, Peoples R China; [Zhang, R.; Wang, X.; Qian, D.; Lu, H.] Univ Texas Dallas, Dept Mech Engn, Richardson, TX 75080 USA; [Ovalle-Robles, R.] Lintec Amer, Nanosci & Technol Ctr, Richardson, TX 75081 USA; [Ding, J. N.] Jiangsu Univ, Micronano Sci & Technol Ctr, Zhenjiang 212013, Peoples R China	University of Texas System; University of Texas Dallas; Changzhou University; Universidade Estadual de Campinas; State University System of Florida; Florida State University; Tianjin University of Technology; Northwestern Polytechnical University; University of Texas System; University of Texas Dallas; LINTEC Corporation; Jiangsu University	Fang, S (corresponding author), Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75080 USA.	sfang@utdallas.edu; ray.baughman@utdallas.edu	Yuan, Ningyi/HDO-3272-2022; UNICAMP, CCES -/J-7787-2015; Zhang, Rui/AAV-4453-2020; Qian, Dong/B-2326-2008; Di, Jiangtao/C-3241-2017; Galvao, Douglas/J-6017-2013; Baughman, Ray Henry/A-8628-2018; Lepro, Xavier/G-1021-2012	Qian, Dong/0000-0001-9367-0924; Di, Jiangtao/0000-0002-5152-0765; Lu, Hongbing/0000-0003-4268-7245; Galvao, Douglas/0000-0003-0145-8358; Zhang, Rui/0000-0002-2948-7276; Baughman, Ray Henry/0000-0001-5845-5137; Lepro, Xavier/0000-0002-0166-3127	Air Force Office of Scientific Research [FA9550-12-1-0211, FA9550-15-1-0089, FA9550-14-1-0227]; Robert A. Welch Foundation [AT-0029]; U.S. Army [W91CRB-14-C-0019, W91CRB-13-C-0037]; Department of Defense [W81XWH-14-1-0228]; NIH [1R01DC011585-01]; NSF [CMMI-1031829, CMMI-1120382, CMMI-1335204, ECCS-1307997]; Office of Naval Research Multidisciplinary University Research Initiative [NOOD14-11-1-0691]; Louis A. Beecherl Jr. Chair; Priority Academic Program Development of Jiangsu Higher Education Institutions on Renewable Energy Materials Science and Engineering; Jiangsu Key Laboratory for Photovoltaic Engineering Science; Jiangsu Specially-Appointed Professor Program [Sujiaoshi-2012-34]; National Natural Science Foundation of China [31200637]; Jiangsu Basic Research Program [BK2012148]; Science and Technology Support Program of Changzhou [CC20140016, CZ20140013]; Chinese Ministry of Science and Technology [2013AA014201]; State Scholarship Fund [201406290125]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Scholarship [12264/13-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-Centros de Pesquisa, Inovacao e Difusao [2013/08293-7]; Div Of Civil, Mechanical, & Manufact Inn [1335204] Funding Source: National Science Foundation; Div Of Electrical, Commun & Cyber Sys [1307997] Funding Source: National Science Foundation	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Robert A. Welch Foundation(The Welch Foundation); U.S. Army; Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Office of Naval Research Multidisciplinary University Research Initiative(MURIOffice of Naval Research); Louis A. Beecherl Jr. Chair; Priority Academic Program Development of Jiangsu Higher Education Institutions on Renewable Energy Materials Science and Engineering; Jiangsu Key Laboratory for Photovoltaic Engineering Science; Jiangsu Specially-Appointed Professor Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Basic Research Program; Science and Technology Support Program of Changzhou; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); State Scholarship Fund; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Scholarship; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-Centros de Pesquisa, Inovacao e Difusao; Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank A. Ruhparwar, S. F. Cogan, and X. Li for discussions of pacemaker applications; X. Zhang, B. Lin, X. Zhou, Y. Hou, and F. Jia for sample preparations; H. Luo for mechanical properties characterizations; A. Needleman for discussions on periodic necking and buckling; T. Xu, L. Tong, H. Zhang, and Y. Du for discussions on modeling and measurement techniques; and D. Wang for drawings. Support in the United States was from Air Force Office of Scientific Research grants FA9550-12-1-0211, FA9550-15-1-0089, and FA9550-14-1-0227; Robert A. Welch Foundation grant AT-0029; U.S. Army grants W91CRB-14-C-0019 and W91CRB-13-C-0037; Department of Defense grant W81XWH-14-1-0228; NIH grant 1R01DC011585-01; NSF grants CMMI-1031829, CMMI-1120382, CMMI-1335204, and ECCS-1307997; Office of Naval Research Multidisciplinary University Research Initiative grant NOOD14-11-1-0691; and the Louis A. Beecherl Jr. Chair. Support in China was from the Priority Academic Program Development of Jiangsu Higher Education Institutions on Renewable Energy Materials Science and Engineering, Jiangsu Key Laboratory for Photovoltaic Engineering Science, Jiangsu Specially-Appointed Professor Program Sujiaoshi-2012-34, National Natural Science Foundation of China grant 31200637, Jiangsu Basic Research Program grant BK2012148, Science and Technology Support Program of Changzhou grants CC20140016 and CZ20140013, Chinese Ministry of Science and Technology grant 2013AA014201, and State Scholarship Fund grant 201406290125. Brazilian support was from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Scholarship 12264/13-0 and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-Centros de Pesquisa, Inovacao e Difusao grant 2013/08293-7. A provisional patent application has been filed.	Boland CS, 2014, ACS NANO, V8, P8819, DOI 10.1021/nn503454h; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Brochu P, 2010, MACROMOL RAPID COMM, V31, P10, DOI 10.1002/marc.200900425; Cai L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03048; Carpi F, 2010, SCIENCE, V330, P1759, DOI 10.1126/science.1194773; Chen T, 2015, ANGEW CHEM INT EDIT, V54, P618, DOI 10.1002/anie.201409385; Chen T, 2014, ACS NANO, V8, P1039, DOI 10.1021/nn405939w; Cheng HH, 2014, ADV MATER, V26, P2909, DOI 10.1002/adma.201305708; Chun KY, 2010, NAT NANOTECHNOL, V5, P853, DOI 10.1038/NNANO.2010.232; Foroughi J, 2011, SCIENCE, V334, P494, DOI 10.1126/science.1211220; Haines CS, 2014, SCIENCE, V343, P868, DOI 10.1126/science.1246906; HANKER JS, 1988, SCIENCE, V242, P885, DOI 10.1126/science.3055300; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Kim J, 2001, SMART MATER STRUCT, V10, P750, DOI 10.1088/0964-1726/10/4/320; Kim Y, 2013, NATURE, V500, P59, DOI 10.1038/nature12401; Kofod G, 2011, APPL PHYS A-MATER, V102, P577, DOI 10.1007/s00339-010-6066-5; Lee P, 2014, ADV FUNCT MATER, V24, P5671, DOI 10.1002/adfm.201400972; Liang JJ, 2013, NAT PHOTONICS, V7, P817, DOI [10.1038/NPHOTON.2013.242, 10.1038/nphoton.2013.242]; Lima MD, 2012, SCIENCE, V338, P928, DOI 10.1126/science.1226762; Pan CL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2830009; Park M, 2012, NAT NANOTECHNOL, V7, P803, DOI [10.1038/nnano.2012.206, 10.1038/NNANO.2012.206]; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/NMAT2459, 10.1038/nmat2459]; Shankar R, 2007, SOFT MATTER, V3, P1116, DOI 10.1039/b705737g; Shin MK, 2010, ADV MATER, V22, P2663, DOI 10.1002/adma.200904270; Shin UH, 2014, CARBON, V80, P396, DOI 10.1016/j.carbon.2014.08.079; Wang CY, 2011, ADV MATER, V23, P3580, DOI 10.1002/adma.201101067; White MS, 2013, NAT PHOTONICS, V7, P811, DOI [10.1038/NPHOTON.2013.188, 10.1038/nphoton.2013.188]; Yamada T, 2011, NAT NANOTECHNOL, V6, P296, DOI [10.1038/nnano.2011.36, 10.1038/NNANO.2011.36]; Zang JF, 2013, NAT MATER, V12, P321, DOI [10.1038/NMAT3542, 10.1038/nmat3542]; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101; Zhang ZT, 2015, ADV MATER, V27, P356, DOI 10.1002/adma.201404573; Zhu S, 2013, ADV FUNCT MATER, V23, P2308, DOI 10.1002/adfm.201202405; Zhu Y, 2012, ADV MATER, V24, P1073, DOI 10.1002/adma.201103382	36	354	368	61	1071	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					400	404		10.1126/science.aaa7952	http://dx.doi.org/10.1126/science.aaa7952			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206929				2022-12-28	WOS:000358381400036
J	Viennot, JJ; Dartiailh, MC; Cottet, A; Kontos, T				Viennot, J. J.; Dartiailh, M. C.; Cottet, A.; Kontos, T.			Coherent coupling of a single spin to microwave cavity photons	SCIENCE			English	Article							QUANTUM-DOT; ENTANGLEMENT; QUBIT	Electron spins and photons are complementary quantum-mechanical objects that can be used to carry, manipulate, and transform quantum information. To combine these resources, it is desirable to achieve the coherent coupling of a single spin to photons stored in a superconducting resonator. Using a circuit design based on a nanoscale spin valve, we coherently hybridize the individual spin and charge states of a double quantum dot while preserving spin coherence. This scheme allows us to achieve spin-photon coupling up to the megahertz range at the single-spin level. The cooperativity is found to reach 2.3, and the spin coherence time is about 60 nanoseconds. We thereby demonstrate a mesoscopic device suitable for nondestructive spin readout and distant spin coupling.	[Viennot, J. J.; Dartiailh, M. C.; Cottet, A.; Kontos, T.] Univ Paris 06, Univ Paris Diderot, Sorbonne Univ,Sorbonne Paris Cite,CNRS, Ecole Normale Super PSL Res Univ,Lab Pierre Aigra, 24 Rue Lhomond, F-75231 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Viennot, JJ (corresponding author), Univ Paris 06, Univ Paris Diderot, Sorbonne Univ,Sorbonne Paris Cite,CNRS, Ecole Normale Super PSL Res Univ,Lab Pierre Aigra, 24 Rue Lhomond, F-75231 Paris 05, France.	viennot@jila.colorado.edu; kontos@lpa.ens.fr	Viennot, Jeremie J/A-2910-2019; Cottet, Audrey/F-7769-2011	Viennot, Jeremie J/0000-0003-3565-9844; Cottet, Audrey/0000-0003-2044-7718; Dartiailh, Matthieu Claude Jean/0000-0001-6451-0577	European Union project SE2ND; European Research Council Starting Grant CirQys	European Union project SE2ND; European Research Council Starting Grant CirQys(European Research Council (ERC))	We acknowledge fruitful discussions with the Quantronics group, J. M. Raimond, B. Huard, A. Thiaville, L. Bretheau, E. Flurin, L. E. Bruhat, and M. P. Desjardins and acknowledge the technical support of M. Rosticher and J. Palomo. We gratefully acknowledge P. Senellart and L. Lanco for discussions and for communicating results to us prior to publication. The work was financed by the European Union project SE2ND and the European Research Council Starting Grant CirQys. The data described in the paper are presented in this report and supplementary materials.	Arnold C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7236; Awschalom DD, 2013, SCIENCE, V339, P1174, DOI 10.1126/science.1231364; Buckley BB, 2010, SCIENCE, V330, P1212, DOI 10.1126/science.1196436; Buluta I, 2009, SCIENCE, V326, P108, DOI 10.1126/science.1177838; Burkard G, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041307; Chauleau JY, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.094416; Cottet A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.160502; Deng G. - W., 2013, CIRCUIT QED GRAPHENE; Faraon A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.033604; Feuillet-Palma C, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115414; Frey T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.046807; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hauptmann JR, 2008, NAT PHYS, V4, P373, DOI 10.1038/nphys931; Hu XD, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035314; Huebl H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.127003; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Jin PQ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.190506; Kubo Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.220501; Kubo Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.140502; Laird EA, 2013, NAT NANOTECHNOL, V8, P565, DOI [10.1038/NNANO.2013.140, 10.1038/nnano.2013.140]; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Ono K, 2002, SCIENCE, V297, P1313, DOI 10.1126/science.1070958; Petersson KD, 2012, NATURE, V490, P380, DOI 10.1038/nature11559; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Sahoo S, 2005, NAT PHYS, V1, P99, DOI 10.1038/nphys149; Schuster DI, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.140501; Tabuchi Y, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.083603; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Toida H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.066802; Tosi G, 2014, AIP ADV, V4, DOI 10.1063/1.4893242; Trif M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.045434; Viennot JJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.165404; Viennot JJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868868; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wallraff A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.249701; Zhu XB, 2011, NATURE, V478, P221, DOI 10.1038/nature10462	37	145	148	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					408	411		10.1126/science.aaa3786	http://dx.doi.org/10.1126/science.aaa3786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206930	Green Submitted			2022-12-28	WOS:000358381400038
J	Doshi, P				Doshi, Peter			21st century cures: is US medicines bill a colossal mistake?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												pdoshi@bmj.com						[Anonymous], 2014, NY TIMES; Gonsalves G, 2015, NY TIMES; Johnson JA, 2013, BRIEF HIST NIH FUNDI	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2015	351								h4013	10.1136/bmj.h4013	http://dx.doi.org/10.1136/bmj.h4013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WL	26205953				2022-12-28	WOS:000358645000015
J	McCartney, M				McCartney, Margaret			Partnerships: pharma is closer than you think	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				ABPI, 2009, GUID NOT JOINT WORK; Arie S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6093; Bayer, 2014, JOINT WORK EX SUMM; Bury Clinical Commissioning Group, 2013, JOINT WORK IND COLL; Department of Health, 2010, MOV SPONS INT TOOLK; Gorog DA, 2014, BR J CARDIOL S1, V20, pS1; Health and Social Care Information Centre, 2014, PRESCR DISP COMM ENG; House of Commons Health Committee, 4 HOUS COMM HLTH COM; Interface Clinical Services, IMPR OUTC OST; Ministerial Industry Strategy Group, ROL OF GROUP; National Institute for Health and Care Excellence, 2012, FIN APPR DET RIV PRE; NHS England, 2013, WORKSH REP MAK MED T; Pfizer, JOINT WORK IMPR SAF; Teva UK, TRANSP 2013 INF	14	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2015	351								h3688	10.1136/bmj.h3688	http://dx.doi.org/10.1136/bmj.h3688			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WL	26206956				2022-12-28	WOS:000358645000001
J	Cole, TB				Cole, Thomas B.			Untitled, Bronx Storefront, "La Rumba Supermarket" Emilio Sanchez	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					210	211		10.1001/jama.2014.11867	http://dx.doi.org/10.1001/jama.2014.11867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197168				2022-12-28	WOS:000358228000032
J	Hansen, CM; Kragholm, K; Pearson, DA; Tyson, C; Monk, L; Myers, B; Nelson, D; Dupre, ME; Fosbol, EL; Jollis, JG; Strauss, B; Anderson, ML; McNally, B; Granger, CB				Hansen, Carolina Malta; Kragholm, Kristian; Pearson, David A.; Tyson, Clark; Monk, Lisa; Myers, Brent; Nelson, Darrell; Dupre, Matthew E.; Fosbol, Emil L.; Jollis, James G.; Strauss, Benjamin; Anderson, Monique L.; McNally, Bryan; Granger, Christopher B.			Association of Bystander and First-Responder Intervention With Survival After Out-of-Hospital Cardiac Arrest in North Carolina, 2010-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSISTED CARDIOPULMONARY-RESUSCITATION; AUTOMATED EXTERNAL DEFIBRILLATORS; PUBLIC-ACCESS DEFIBRILLATION; MULTIPLE IMPUTATION; UNITED-STATES; LAY RESCUERS; COMMUNITY; HEART; IMPLEMENTATION; PROGRAM	IMPORTANCE Out-of-hospital cardiac arrest is associated with low survival, but early cardiopulmonary resuscitation (CPR) and defibrillation can improve outcomes if more widely adopted. OBJECTIVE To examine temporal changes in bystander and first-responder resuscitation efforts before arrival of the emergency medical services (EMS) following statewide initiatives to improve bystander and first-responder efforts in North Carolina from 2010-2013 and to examine the association between bystander and first-responder resuscitation efforts and survival and neurological outcome. DESIGN, SETTINGS, AND PARTICIPANTS We studied 4961 patients with out-of-hospital cardiac arrest for whom resuscitation was attempted and who were identified through the Cardiac Arrest Registry to Enhance Survival (2010-2013). First responders were dispatched police officers, firefighters, rescue squad, or life-saving crew trained to perform basic life support until arrival of the EMS. EXPOSURES Statewide initiatives to improve bystander and first-responder interventions included training members of the general population in CPR and in use of automated external defibrillators (AEDs), training first responders in team-based CPR including AED use and high-performance CPR, and training dispatch centers in recognition of cardiac arrest. MAIN OUTCOMES AND MEASURES The proportion of bystander and first-responder resuscitation efforts, including the combination of efforts between bystanders and first responders, from 2010 through 2013 and the association between these resuscitation efforts and survival and neurological outcome. RESULTS The combination of bystander CPR and first-responder defibrillation increased from 14.1% (51 of 362; 95% CI, 10.9%-18.1%) in 2010 to 23.1%(104 of 451; 95% CI, 19.4%-27.2%) in 2013 (P < .01). Survival with favorable neurological outcome increased from 7.1%(82 of 1149; 95% CI, 5.8%-8.8%) in 2010 to 9.7%(129 of 1334; 95% CI, 8.2%-11.4%) in 2013(P = .02) and was associated with by stander-initiated CPR. Adjusting for age and sex, bystander and first-responder interventions were associated with higher survival to hospital discharge. Survival following EMS-initiated CPR and defibrillation was 15.2%(30 of 198; 95% CI, 10.8%-20.9%) compared with 33.6%(38 of 113; 95% CI, 25.5%-42.9%) following bystander-initiated CPR and defibrillation (odds ratio [OR], 3.12; 95% CI, 1.78-5.46); 24.2%(83 of 343; 95% CI, 20.0%-29.0%) following bystander CPR and first-responder defibrillation (OR, 1.70; 95% CI, 1.06-2.71); and 25.2%(109 of 432; 95% CI, 21.4%-29.6%) following first-responder CPR and defibrillation (OR, 1.77; 95% CI, 1.13-2.77). CONCLUSIONS AND RELEVANCE Following a statewide educational intervention on rescusitation training, the proportion of patients receiving bystander-initiated CPR and defibrillation by first responders increased and was associated with greater likelihood of survival. Bystander-initiated CPR was associated with greater likelihood of survival with favorable neurological outcome.	[Hansen, Carolina Malta; Kragholm, Kristian; Tyson, Clark; Monk, Lisa; Dupre, Matthew E.; Fosbol, Emil L.; Jollis, James G.; Anderson, Monique L.; Granger, Christopher B.] Duke Clin Res Inst, Durham, NC 27705 USA; [Pearson, David A.] Carolinas Med Ctr, Charlotte, NC 28203 USA; [Tyson, Clark] Ctr Educ Excellence, Durham, NC USA; [Myers, Brent] Wake Cty EMS, Raleigh, NC USA; [Nelson, Darrell] WFU Hlth Sci, Winston Salem, NC USA; [Dupre, Matthew E.] Duke Univ, Dept Community & Family Med, Durham, NC USA; [Fosbol, Emil L.] Rigshosp, Univ Copenhagen Hosp, Ctr Heart, Copenhagen, Denmark; [Strauss, Benjamin] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [McNally, Bryan] Emory Univ, Sch Med, Atlanta, GA USA; [McNally, Bryan] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Duke University; Carolinas Medical Center; Duke University; Rigshospitalet; University of Copenhagen; Duke University; Emory University; Emory University; Rollins School Public Health	Hansen, CM (corresponding author), Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	carolina.hansen@duke.edu	McNally, Bryan/AAE-9332-2020; Dupre, Matthew/ABG-6728-2021	Dupre, Matthew/0000-0002-0976-4715; Fosbol, Emil/0000-0002-2048-4167; Kragholm, Kristian/0000-0001-9629-8670				Anderson ML, 2014, JAMA INTERN MED, V174, P194, DOI 10.1001/jamainternmed.2013.11320; Blom MT, 2014, CIRCULATION, V130, P1868, DOI 10.1161/CIRCULATIONAHA.114.010905; Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Chan PS, 2014, CIRCULATION, V130, P1876, DOI 10.1161/CIRCULATIONAHA.114.009711; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Hansen CM, 2014, CIRCULATION, V130, P1859, DOI 10.1161/CIRCULATIONAHA.114.008850; He YL, 2010, CIRC-CARDIOVASC QUAL, V3, P98, DOI 10.1161/CIRCOUTCOMES.109.875658; Hollenberg J, 2008, CIRCULATION, V118, P389, DOI 10.1161/CIRCULATIONAHA.107.734137; Iwami T, 2009, CIRCULATION, V119, P728, DOI 10.1161/CIRCULATIONAHA.108.802058; JENNETT B, 1975, LANCET, V1, P480; Kitamura T, 2012, CIRCULATION, V126, P2834, DOI 10.1161/CIRCULATIONAHA.112.109496; Lee KJ, 2010, AM J EPIDEMIOL, V171, P624, DOI 10.1093/aje/kwp425; Lewis M, 2013, CIRCULATION, V128, P1522, DOI 10.1161/CIRCULATIONAHA.113.002627; Lindner TW, 2011, RESUSCITATION, V82, P1508, DOI 10.1016/j.resuscitation.2011.06.016; McNally B, CARDIAC ARREST REGIS; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; McNally B, 2009, ANN EMERG MED, V54, P674, DOI 10.1016/j.annemergmed.2009.03.018; Merchant RM, 2013, CIRC-CARDIOVASC QUAL, V6, P229, DOI 10.1161/CIRCOUTCOMES.113.000140; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Myerburg RJ, 2002, CIRCULATION, V106, P1058, DOI 10.1161/01.CIR.0000028147.92190.A7; Neumar RW, 2011, CIRCULATION, V123, P2898, DOI 10.1161/CIR.0b013e31821d79f3; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nichol G, 2010, CIRCULATION, V121, P709, DOI 10.1161/CIR.0b013e3181cdb7db; Nielsen AM, 2013, RESUSCITATION, V84, P430, DOI 10.1016/j.resuscitation.2012.11.008; Nielsen AM, 2012, RESUSCITATION, V83, P1067, DOI 10.1016/j.resuscitation.2012.04.012; Perkins GD, 2014, CIRCULATION; RACE Heart Rescue Project, OPT CARD ARR SYST SP; Rea TD, 2001, CIRCULATION, V104, P2513, DOI 10.1161/hc4601.099468; Rea TD, 2006, CIRCULATION, V114, P2760, DOI 10.1161/CIRCULATIONAHA.106.654715; Rea TD, 2010, CIRCULATION, V121, P1134, DOI 10.1161/CIRCULATIONAHA.109.899799; Sasson C, 2012, NEW ENGL J MED, V367, P1607, DOI 10.1056/NEJMoa1110700; Stiell IG, 1999, JAMA-J AM MED ASSOC, V281, P1175, DOI 10.1001/jama.281.13.1175; Stromsoe A, 2010, RESUSCITATION, V81, P211, DOI 10.1016/j.resuscitation.2009.10.014; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; van Diepen S, 2013, AM HEART J, V166, P647, DOI 10.1016/j.ahj.2013.05.022; Weisfeldt ML, 2010, J AM COLL CARDIOL, V55, P1712, DOI 10.1016/j.jacc.2009.11.077; White RD, 2005, RESUSCITATION, V65, P279, DOI 10.1016/j.resuscitation.2004.10.018; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483; Zijlstra JA, 2014, RESUSCITATION, V85, P1444, DOI 10.1016/j.resuscitation.2014.07.020	39	262	262	2	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					255	264		10.1001/jama.2015.7938	http://dx.doi.org/10.1001/jama.2015.7938			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197186	Bronze			2022-12-28	WOS:000358228000020
J	Levin, E				Levin, Elizabeth			Learning to Breathe	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Hennepin Cty Med Ctr, Dept Internal Med, Minneapolis, MN 55415 USA	Hennepin County Medical Center	Levin, E (corresponding author), Hennepin Cty Med Ctr, Dept Internal Med, Minneapolis, MN 55415 USA.	elizabeth.levin@hcmed.org							0	0	0	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					229	230		10.1001/jama.2015.3448	http://dx.doi.org/10.1001/jama.2015.3448			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197180				2022-12-28	WOS:000358228000014
J	Warnatsch, A; Ioannou, M; Wang, Q; Papayannopoulos, V				Warnatsch, Annika; Ioannou, Marianna; Wang, Qian; Papayannopoulos, Venizelos			Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis	SCIENCE			English	Article							NLRP3 INFLAMMASOME ACTIVATION; MYELOPEROXIDASE; RECRUITMENT; ELASTASE; ATHEROGENESIS; INFILTRATION; MECHANISMS; INFECTION; RELEASE; LESIONS	Secretion of the cytokine interleukin-1b (IL-1b) by macrophages, a major driver of pathogenesis in atherosclerosis, requires two steps: Priming signals promote transcription of immature IL-1b, and then endogenous "danger" signals activate innate immune signaling complexes called inflammasomes to process IL-1b for secretion. Although cholesterol crystals are known to act as danger signals in atherosclerosis, what primes IL-1b transcription remains elusive. Using a murine model of atherosclerosis, we found that cholesterol crystals acted both as priming and danger signals for IL-1b production. Cholesterol crystals triggered neutrophils to release neutrophil extracellular traps (NETs). NETs primed macrophages for cytokine release, activating T helper 17 (TH17) cells that amplify immune cell recruitment in atherosclerotic plaques. Therefore, danger signals may drive sterile inflammation, such as that seen in atherosclerosis, through their interactions with neutrophils.	[Warnatsch, Annika; Ioannou, Marianna; Wang, Qian; Papayannopoulos, Venizelos] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England	Francis Crick Institute	Papayannopoulos, V (corresponding author), Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England.	veni.p@crick.ac.uk		Warnatsch, Annika/0000-0003-2013-1625; Papayannopoulos, Venizelos/0000-0002-3741-8190	UK Medical Research Council [MC_UP_1202/13]; UK Medical Research Council; Cancer Research UK; Wellcome Trust; MRC [MC_UP_1202/13] Funding Source: UKRI; Medical Research Council [MC_UP_1202/13] Funding Source: researchfish; The Francis Crick Institute [10129] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	We thank Q. Xu for providing the ApoE<SUP>-/-</SUP> mice and A. Zychlinsky for the PR3/NE<SUP>-/-</SUP> mice; Z. Zhang for training; L. Mrowietz for help with NET preparations; and B. Stockinger, A. Zychlinsky, A. Schaefer, and M. Wilson for comments on the manuscript. This work was supported by the UK Medical Research Council (grant MC_UP_1202/13) and was principally conducted at the MRC National Institute for Medical Research and completed at the Francis Crick Institute, which receives its core funding from the UK Medical Research Council, Cancer Research UK, and the Wellcome Trust. The data are contained in the manuscript and the supplementary materials.	Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Branzk N, 2013, SEMIN IMMUNOPATHOL, V35, P513, DOI 10.1007/s00281-013-0384-6; Bretscher P, 2015, EMBO MOL MED, V7, P593, DOI 10.15252/emmm.201404702; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Doring Y, 2012, CIRC RES, V110, P1052, DOI 10.1161/CIRCRESAHA.112.265868; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Grebe A, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0313-z; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Horibata S, 2012, J REPROD DEVELOP, V58, P274, DOI 10.1262/jrd.2011-040; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Knight JS, 2014, CIRC RES, V114, P947, DOI 10.1161/CIRCRESAHA.114.303312; Koulis C, 2014, ARTERIOSCL THROM VAS, V34, P516, DOI 10.1161/ATVBAHA.113.302407; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7; Megens RTA, 2012, THROMB HAEMOSTASIS, V107, P597, DOI 10.1160/TH11-09-0650; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Miyake Y, 2012, ADV EXP MED BIOL, V738, P144, DOI 10.1007/978-1-4614-1680-7_9; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Papayannopoulos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028526; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Walter A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2566; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072	38	670	691	17	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		316	320		10.1126/science.aaa8064	http://dx.doi.org/10.1126/science.aaa8064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185250	Green Accepted, Green Submitted			2022-12-28	WOS:000358218600054
J	Whiteman, JP; Harlow, HJ; Durner, GM; Anderson-Sprecher, R; Albeke, SE; Regehr, EV; Amstrup, SC; Ben-David, M				Whiteman, J. P.; Harlow, H. J.; Durner, G. M.; Anderson-Sprecher, R.; Albeke, S. E.; Regehr, E. V.; Amstrup, S. C.; Ben-David, M.			Summer declines in activity and body temperature offer polar bears limited energy savings	SCIENCE			English	Article							SOUTHERN BEAUFORT SEA; URSUS-MARITIMUS; RINGED SEALS; ACTIVITY PATTERNS; CLIMATE-CHANGE; HIBERNATION; METABOLISM; SURVIVAL; WATER	Polar bears (Ursus maritimus) summer on the sea ice or, where it melts, on shore. Although the physiology of "ice" bears in summer is unknown, "shore" bears purportedly minimize energy losses by entering a hibernation-like state when deprived of food. Such a strategy could partially compensate for the loss of on-ice foraging opportunities caused by climate change. However, here we report gradual, moderate declines in activity and body temperature of both shore and ice bears in summer, resembling energy expenditures typical of fasting, nonhibernating mammals. Also, we found that to avoid unsustainable heat loss while swimming, bears employed unusual heterothermy of the body core. Thus, although well adapted to seasonal ice melt, polar bears appear susceptible to deleterious declines in body condition during the lengthening period of summer food deprivation.	[Whiteman, J. P.; Ben-David, M.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Whiteman, J. P.; Harlow, H. J.; Ben-David, M.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Durner, G. M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Anderson-Sprecher, R.] Univ Wyoming, Dept Stat, Laramie, WY 82071 USA; [Albeke, S. E.] Univ Wyoming, Wyoming Geog Informat Sci Ctr, Laramie, WY 82071 USA; [Regehr, E. V.] US Fish & Wildlife Serv, Marine Mammals Management, Anchorage, AK 99503 USA; [Amstrup, S. C.] Polar Bears Int, Bozeman, MT 59772 USA	University of Wyoming; University of Wyoming; United States Department of the Interior; United States Geological Survey; University of Wyoming; University of Wyoming; United States Department of the Interior; US Fish & Wildlife Service	Whiteman, JP (corresponding author), Univ Wyoming, Program Ecol, Laramie, WY 82071 USA.	jwhitema@uwyo.edu	Albeke, Shannon/J-1668-2012	Albeke, Shannon/0000-0001-7297-8049	NSF [OPP 0732713]; U.S. Geological Survey (USGS) Climate and Land Use Change Research and Development Program; U.S. Fish and Wildlife Service Marine Mammals Management; Wyoming NASA Space Grant [NNG05G165H]; University of Wyoming; Environmental Protection Agency (EPA) Science To Achieve Results program [F91737301]	NSF(National Science Foundation (NSF)); U.S. Geological Survey (USGS) Climate and Land Use Change Research and Development Program; U.S. Fish and Wildlife Service Marine Mammals Management(US Fish & Wildlife Service); Wyoming NASA Space Grant; University of Wyoming; Environmental Protection Agency (EPA) Science To Achieve Results program(United States Environmental Protection Agency)	This study was funded by NSF (OPP 0732713), the U.S. Geological Survey (USGS) Climate and Land Use Change Research and Development Program, U.S. Fish and Wildlife Service Marine Mammals Management, Wyoming NASA Space Grant (NNG05G165H), the University of Wyoming, and the Environmental Protection Agency (EPA) Science To Achieve Results program (F91737301). This report was approved under USGS Fundamental Science Practices but not by the EPA. Views are solely those of the authors. Data are archived by the National Center for Atmospheric Research (http://www.eol.ucar.edu/projects/arcss/).	Amstrup SC., 2003, WILD MAMMALS N AM BI, P587; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; BEST RC, 1982, J COMP PHYSIOL, V146, P63, DOI 10.1007/BF00688718; Boyd IL, 2000, J EXP BIOL, V203, P1907; Bromaghin JF, 2015, ECOL APPL, V25, P634, DOI 10.1890/14-1129.1; Durner GM, 2011, POLAR BIOL, V34, P975, DOI 10.1007/s00300-010-0953-2; Dyck MG, 2007, ECOL COMPLEX, V4, P73, DOI 10.1016/j.ecocom.2007.03.002; Friebe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101410; Galley RJ, 2013, ARCTIC, V66, P105; Handrich Y, 1997, NATURE, V388, P64, DOI 10.1038/40392; HARWOOD LA, 1992, CAN J ZOOL, V70, P891, DOI 10.1139/z92-127; Harwood LA, 2012, ARCTIC, V65, P35; Kelly BP, 2010, POLAR BIOL, V33, P1095, DOI 10.1007/s00300-010-0796-x; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; Meier WN, 2014, REV GEOPHYS, V52, P185, DOI 10.1002/2013RG000431; MESSIER F, 1992, J ZOOL, V226, P219, DOI 10.1111/j.1469-7998.1992.tb03835.x; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Nelson R., 1983, URSUS, V5, P284; Owen O E, 1979, Adv Exp Med Biol, V111, P169; Pagano AM, 2012, CAN J ZOOL, V90, P663, DOI 10.1139/Z2012-033; Paisley S, 2006, J ZOOL, V268, P25, DOI 10.1111/j.1469-7998.2005.00019.x; PFEIFFER EW, 1979, COMP BIOCHEM PHYS A, V63, P19, DOI 10.1016/0300-9629(79)90621-2; POND CM, 1992, CAN J ZOOL, V70, P326, DOI 10.1139/z92-049; Robbins CT, 2012, J MAMMAL, V93, P1493, DOI 10.1644/11-MAMM-A-406.1; Rode KD, 2015, FRONT ECOL ENVIRON, V13, P138, DOI 10.1890/140202; SCHOLANDER PF, 1950, BIOL BULL, V99, P225, DOI 10.2307/1538740; Stirling I, 2012, GLOBAL CHANGE BIOL, V18, P2694, DOI 10.1111/j.1365-2486.2012.02753.x; Toien O, 2011, SCIENCE, V331, P906, DOI 10.1126/science.1199435; Whiteman J., 2014, THESIS U WYOMING LAR; Williams TM, 2014, SCIENCE, V346, P81, DOI 10.1126/science.1254885	31	51	51	3	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		295	298		10.1126/science.aaa8623	http://dx.doi.org/10.1126/science.aaa8623			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185248				2022-12-28	WOS:000358218600048
J	Mascola, JR				Mascola, John R.			The modern era of HIV-1 vaccine development	SCIENCE			English	Editorial Material							NEUTRALIZING ANTIBODIES; ENV		NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jmascola@mail.nih.gov	Mascola, John/AAI-7193-2021					Chen J, 2015, SCIENCE, V349, P191, DOI 10.1126/science.aaa9804; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007	14	24	25	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					139	140		10.1126/science.aac7800	http://dx.doi.org/10.1126/science.aac7800			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4OM	26160931				2022-12-28	WOS:000357664300022
J	Sharfstein, JM				Sharfstein, Joshua M.			A Spotlight on Sunscreen Regulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.							[Anonymous], 2015, WALL STREET J; National Cancer Institute, SNAPSH MEL; Public Access to SunScreens Coalition (PASS), 2015, FDAS ANN EC ENZ APPL; Tucker ME, 2014, MEDSCAPE MED NEWS	4	6	6	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					101	103		10.1056/NEJMp1504912	http://dx.doi.org/10.1056/NEJMp1504912			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM3QP	26154783				2022-12-28	WOS:000357598600001
J	Israelsson, LA				Israelsson, Leif A.			Abdominal incision closure: small but important bites	LANCET			English	Editorial Material							MIDLINE LAPAROTOMY; LENGTH; HERNIA; TRIAL		Umea Univ, Dept Surg & Perioperat Sci, S-90234 Umea, Sweden	Umea University	Israelsson, LA (corresponding author), Umea Univ, Dept Surg & Perioperat Sci, S-90234 Umea, Sweden.	leif.israelsson@lvn.se						CAMPBELL JA, 1989, SURGERY, V106, P888; Cengiz Y, 2001, EUR J SURG, V167, P60; Deerenberg EB, 2015, LANCET; Harlaar JJ, 2009, AM J SURG, V198, P392, DOI 10.1016/j.amjsurg.2008.10.018; Israelsson L A, 2006, Hernia, V10, P258, DOI 10.1007/s10029-006-0084-4; Israelsson LA, 1996, EUR J SURG, V162, P125; Israelsson LA, 2000, EUR J SURG, V166, P642; ISRAELSSON LA, 1993, BRIT J SURG, V80, P1284, DOI 10.1002/bjs.1800801020; LEAPER DJ, 1977, BRIT J SURG, V64, P603, DOI 10.1002/bjs.1800640822; Millbourn D, 2014, HERNIA, V18, P775, DOI 10.1007/s10029-013-1135-2; Millbourn D, 2009, ARCH SURG-CHICAGO, V144, P1056, DOI 10.1001/archsurg.2009.189; Muysoms FE, 2015, HERNIA, V19, P1, DOI 10.1007/s10029-014-1342-5; POLLOCK AV, 1989, BRIT J SURG, V76, P953, DOI 10.1002/bjs.1800760926	13	7	7	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1216	1218		10.1016/S0140-6736(15)60687-0	http://dx.doi.org/10.1016/S0140-6736(15)60687-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26188747				2022-12-28	WOS:000361700100006
J	Vanorio, T; Kanitpanyacharoen, W				Vanorio, Tiziana; Kanitpanyacharoen, Waruntorn			Rock physics of fibrous rocks akin to Roman concrete explains uplifts at Campi Flegrei Caldera	SCIENCE			English	Article							LONG VALLEY CALDERA; DEFORMATION; SEISMICITY; GRAPHITE	Uplifts in the Campi Flegrei caldera reach values unsurpassed anywhere in the world (similar to 2 meters). Despite the marked deformation, the release of strain appears delayed. The rock physics analysis of well cores highlights the presence of two horizons, above and below the seismogenic area, underlying a coupled process. The basement is a calc-silicate rock housing hydrothermal decarbonation reactions, which provide lime-rich fluids. The caprock above the seismogenic area has a pozzolanic composition and a fibril-rich matrix that results from lime-pozzolanic reactions. These findings provide evidence for a natural process reflecting that characterizing the cementitious pastes in modern and Roman concrete. The formation of fibrous minerals by intertwining filaments confers shear and tensile strength to the caprock, contributing to its ductility and increased resistance to fracture.	[Vanorio, Tiziana; Kanitpanyacharoen, Waruntorn] Stanford Univ, Dept Geophys, Stanford Rock Phys Lab, Stanford, CA 94305 USA	Stanford University	Vanorio, T (corresponding author), Stanford Univ, Dept Geophys, Stanford Rock Phys Lab, Stanford, CA 94305 USA.	tvanorio@stanford.edu			NSF CAREER Award [EAR-1451345]; Division Of Earth Sciences [1451345] Funding Source: National Science Foundation	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We are grateful to A. Nur and H.-R. Wenk for discussions and valuable feedback. We also thank the anonymous reviewers for their comments and contributions that improved the manuscript. We greatly appreciated the access to beamlime 11-ID-C of the Advanced Photon Source, Argonne National Laboratory, and thank Y. Ren for technical help. We thank L.-M. Joubert for assistance with SEM imaging at the Cell Sciences Imaging Facility, Stanford University. Part of this work was supported by the NSF CAREER Award (EAR-1451345 to T.V.) and by the startup fund to T.V. of the School of Earth, Energy, and Environmental Sciences at Stanford University. Data are available in the supplementary materials.	AGIP, 1987, MOD GEOT SIST SINT; ALLARD P, 1991, J VOLCANOL GEOTH RES, V48, P139, DOI 10.1016/0377-0273(91)90039-3; [Anonymous], 2013, J GEOPHYS RES SOLID, V118, P1; ASTER RC, 1988, TECTONOPHYSICS, V149, P195, DOI 10.1016/0040-1951(88)90173-4; BARBERI F, 1984, B VOLCANOL, V47, P173, DOI DOI 10.1007/BF01961546; Battaglia M, 1999, SCIENCE, V285, P2119, DOI 10.1126/science.285.5436.2119; Berrino G., 1984, B VOLCANOL, V47, P187, DOI [10.1007/BF01961548, DOI 10.1007/BF01961548]; BIANCHI R, 1987, J GEOPHYS RES-SOLID, V92, P14139, DOI 10.1029/JB092iB13p14139; Brandon C., 2014, BUILDING ETERNITY; Camodeca G., 1980, PUTEOLI, V4-5, P59; Carella R., 1983, P 9 WORKSH GEOTH RES; CASERTANO L, 1976, NATURE, V264, P161, DOI 10.1038/264161a0; Chiodini G, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036347; D'Auria L, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007837; Farrell J, 2014, GEOPHYS RES LETT, V41, P3068, DOI 10.1002/2014GL059588; GIARDINI AA, 1968, SCIENCE, V159, P317, DOI 10.1126/science.159.3812.317; Heap MJ, 2014, SOLID EARTH, V5, P25, DOI 10.5194/se-5-25-2014; Hill DP, 2003, J VOLCANOL GEOTH RES, V127, P175, DOI 10.1016/S0377-0273(03)00169-0; Hobbs L. W., 2011, BUILDING ROMA AETERN, P35; Jackson MD, 2013, AM MINERAL, V98, P1669, DOI 10.2138/am.2013.4484; Jones D., 2006, BANKERS PUTEOLI FINA; Lechtman H., 1986, HIGH TECHNOLOGY CERA; Mehta P.K., 2014, MICROSTRUCTURE PROPE, V4th; Parascandola A., 1983, FEN BRAD SER POZZ; Pliny, NATURAL HIST, P35; Rosi M., 1987, CNR QUAD RIC SCI ROM, V114; SILVA KKMW, 1987, ECON GEOL, V82, P1710, DOI 10.2113/gsecongeo.82.7.1710; Vanorio T, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003102; Vanorio T, 2002, GEOPHYS J INT, V149, P22, DOI 10.1046/j.0956-540x.2001.01580.x; Zollo A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018173	30	34	34	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					617	621		10.1126/science.aab1292	http://dx.doi.org/10.1126/science.aab1292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26160377				2022-12-28	WOS:000359092900035
J	Bodelier, PLE				Bodelier, Paul L. E.			SUSTAINABILITY Bypassing the methane cycle	NATURE			English	Editorial Material							ROOTS	A genetically modified rice with more starch in its grains also provides fewer nutrients for methane-producing soil microbes. This dual benefit might help to meet the urgent need for globally sustainable food production. See Letter p.602	Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, NL-6708 PB Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Bodelier, PLE (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, NL-6708 PB Wageningen, Netherlands.	p.bodelier@nioo.knaw.nl	Bodelier, Paul L/A-9591-2011; Bodelier, Paul/AAF-8353-2020; KNAW, NIOO-KNAW/A-4320-2012	Bodelier, Paul L/0000-0002-5757-5572; Bodelier, Paul/0000-0002-5757-5572; KNAW, NIOO-KNAW/0000-0002-3835-159X				Bodelier PLE, 2014, CURR OPIN ENV SUST, V9-10, P26, DOI 10.1016/j.cosust.2014.07.004; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Hernandez M, 2015, APPL ENVIRON MICROB, V81, P2244, DOI 10.1128/AEM.03209-14; Hussain S, 2015, ENVIRON SCI POLLUT R, V22, P3342, DOI 10.1007/s11356-014-3760-4; Montzka SA, 2011, NATURE, V476, P43, DOI 10.1038/nature10322; Myhre G., 2013, CONTRIBUTION WORKING; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Su J, 2015, NATURE, V523, P602, DOI 10.1038/nature14673; van der Gon HACD, 2002, P NATL ACAD SCI USA, V99, P12021, DOI 10.1073/pnas.192276599	9	17	17	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					534	535		10.1038/nature14633	http://dx.doi.org/10.1038/nature14633			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26200334				2022-12-28	WOS:000358655200027
J	Sarlio-Laehteenkorva, S; Winkler, J				Sarlio-Laehteenkorva, Sirpa; Winkler, Jack			Could a sugar tax help combat obesity?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDREN; ADULTS		[Sarlio-Laehteenkorva, Sirpa] Minist Social Affairs & Hlth, Helsinki, Finland; [Winkler, Jack] London Metropolitan Univ, Nutr Policy, London, England	London Metropolitan University	Sarlio-Laehteenkorva, S (corresponding author), Minist Social Affairs & Hlth, Helsinki, Finland.	sirpa.sarlio-lahteenkorva@stm.fi; jtw@blueyonder.co.uk						Alianza por La Salud, 2015, MEX NAT I PUBL HLTH; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Campa J, 2006, PASS EXCHANGE RATES; Chaloupka FJ, TOBACCO CONTROL, V21, P172; Ciaian P, 2014, EU SUGAR POLICY SWEE; Department for Food and Rural Affairs, 2013, IMPL CAP REF ENGL; ECSIP Consortium for European Commission DG Enterprise and Industry, 2014, FOOD TAX THEIR IMP C; European Commission, 2012, 342012 EUR COMM EU D; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Gill JMR, 2014, LANCET DIABETES ENDO, V2, P444, DOI 10.1016/S2213-8587(14)70013-0; Jensen JD, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-10; Jensen JD, 2013, FOOD POLICY, V42, P18, DOI 10.1016/j.foodpol.2013.06.004; Kamerow D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3719; Kantar Worldpanel, 2015, EF IMP AL BEB SAB; Kotakorpi K, 2011, WELFARE EFFECTS HLTH; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Ministry of Finance, 2013, SUG TAX WORK GROUP R; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; New Zealand Tax Payers' Union, 2015, FIZZ OUT WHY SUG TAX; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Rita lse Santa, 2015, CNN EXPANSION   0707; Sweanor D, 2013, GROCER          1220; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; WHO, 2015, US PRIC POL PROM HEA; Winkler JT, 2012, BRIT J NUTR, V108, P395, DOI 10.1017/S0007114511006477	27	11	11	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2015	351								h4047	10.1136/bmj.h4047	http://dx.doi.org/10.1136/bmj.h4047			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2UA	26223432				2022-12-28	WOS:000359010900010
J	Altman, D; Frist, WH				Altman, Drew; Frist, William H.			Medicare and Medicaid at 50 Years Perspectives of Beneficiaries, Health Care Professionals and Institutions, and Policy Makers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE Medicare and Medicaid are the nation's 2 largest public health insurance programs, serving the elderly, those with disabilities, and mostly lower-income populations. The 2 programs are the focus of often deep partisan disagreement. Medicare and Medicaid payment policies influence the health care system and Medicare and Medicaid spending influences federal and state budgets. Debate about Medicare and Medicaid policy sometimes influences elections. OBJECTIVE To review the roles of Medicare and Medicaid in the health system and the challenges the 2 programs face from the perspectives of the general public and beneficiaries, health care professionals and health care institutions, and policy makers. EVIDENCE Analysis of publicly available data and private surveys of the public and beneficiaries. FINDINGS Together, Medicare and Medicaid serve 111 million beneficiaries and account for $1 trillion in total spending, generating 43% of hospital revenue and representing 39% of national health spending. The median income for Medicare beneficiaries is $23 500 and the median income for Medicaid beneficiaries is $15 000. Future issues confronting both programs include whether they will remain open-ended entitlements, the degree to which the programs may be privatized, the scope of their cost-sharing structures for beneficiaries, and the roles the programs will play in payment and delivery reform. CONCLUSIONS AND RELEVANCE As the number of beneficiaries and the amount of spending for both Medicare and Medicaid increase, these programs will remain a focus of national attention and policy debate. Beneficiaries, health care professionals, health care organizations, and policy makers often have different interests in Medicare and Medicaid, complicating efforts to make changes to these large programs.	[Altman, Drew; Frist, William H.] Kaiser Family Fdn, Menlo Pk, CA USA; [Frist, William H.] US Senate, Washington, DC USA		Altman, D (corresponding author), 2400 Sand Hill Rd, Menlo Pk, CA 94025 USA.	daltman@kff.org						Bell F.C., 2005, NUMBER 11 11536 SOCI, P26; Blendon RJ, 2013, NEW ENGL J MED, V369, P1066, DOI 10.1056/NEJMsr1307622; Caswell KJ, 2015, INQUIRY-J HEALTH CAR, V52, P1, DOI 10.1177/0046958015575524; Centers for Medicare and Medicaid Services, NAT HLTH EXP DAT NHE; Centers for Medicare and Medicaid Services, SEN MED MED ENR; Centers for Medicare & Medicaid Services, CMS CTR MED MED INN; Centers for Medicare & Medicaid Services, 2014, 2014 ANN REP BOARDS; Centers of Medicare and Medicaid Services, 2015, BETT CAR SMART SPEND; COHEN RA, 2009, HLTH INSURANCE COVER; Congressional Budget Office, 2015, MARCH 20015 MED BAS; Congressional Budget Office, 2005, MARCH 2005 MED BAS; Congressional Budget Office, 2015, UPD BUDG PROJ 2015 2; *CTR MED MED SERV, MED MAN CAR ENR REP; Cubanski J, 2014, HLTH CARE BUDGET FIN; Cubanski J, 2015, PRIM MED KEY FACTS M; Decker SL, 2013, HEALTH AFFAIR, V32, P1183, DOI 10.1377/hlthaff.2013.0361; Department of Health and Human Services, 2015, MED SPEND GROWTH 200; Department of Health and Human Services, 2014, FED REG, V79, P3385; Department of Health and Human Services, FISC YEAR 2016 BUDG; Eichner J, 2005, HEALTH AFFAIR, V24, P365, DOI 10.1377/hlthaff.24.2.365; File, 2014, YOUNG ADULT VOTING A; Garfield R., 2015, TRENDS MED SPENDING; Griffin Susan O, 2014, MMWR Suppl, V63, P54; House of Representatives Committee on the Budget, 2013, PATH PROSP RESP BAL; Jacobson G, 2014, INC ASS MED BEN 2013; Kaiser Commission on Medicaid and the Uninsured, 2014, MED ENR JUN 2013 DAT; Kaiser Family Foundation, 2015, NUMB POOR UN NON AD; Kaiser Family Foundation, 2012, ROL MED PEOPL BEH HL; Kaiser Family Foundation, 2010, MED FIN EL PRIM PATH; Kaiser Family Foundation, 2019, MED MAN CAR MARK TRA; Kaiser Family Foundation, STAT STAT ACT MED EX; Kaiser Family Foundation, 2012, INCR MED PAYM CERT P; Kaiser Family Foundation, 2011, IMPL FED BLOCK GRANT; Kaiser Family Foundation, 2015, WHER AR STAT TOD MED; Kaiser Family Foundation, 2011, KAIS HLTH TRACK POLL; Kaiser Family Foundation, 2012, KAIS HLTH TRACK POLL; Kaiser Family Foundation, TOT MED MCO ENR; Kaiser Family Foundation; Robert Wood Johnson Foundation; Harvard School of Public Health, 2013, PUBL HLTH CAR AG 113; Mann C, 2003, HIST OVERVIEW CHILDR; Mark TL, 2014, HEALTH AFFAIR, V33, P1407, DOI 10.1377/hlthaff.2014.0163; Medicaid and CHIP Payment and Access Commission, 2014, C MED CHIP; Medicare Payment Advisory Commission, 2015, MED ADV PROGR STAT R; Medicare Payment Advisory Commission and Medicaid and CHIP Payment and Access Commission, 2015, DAT BOOK BEN DUALL E; Musumeci, 2014, KEY THEMES CAPITATED; National Bureau of Economic Research, OR HLTH INS EXP; National Governors Association, 2013, 2012 MAT CHILD HLTH; Neuman T, 2014, MYSTERY MISSING 1200; Paradise J., 2013, WHAT IS MED IMPACT A; Paradise J., 2015, MEDICAID MOVING FORW; Paradise J., 2015, MED AT 50; Reaves EL, 2015, MEDICAID LONG TERM S; Rosenbaum S, 2002, NEW ENGL J MED, V346, P635, DOI 10.1056/NEJM200202213460825; Rosenbaum S, 2012, HEALTH AFFAIR, V31, P1663, DOI 10.1377/hlthaff.2012.0766; ROWLAND D, 1995, JAMA-J AM MED ASSOC, V274, P271, DOI 10.1001/jama.274.3.271; Rudowitz Robin, 2015, ACA MED EXPANSION WA; Shartzer Adele., 2013, ACCESS PHYS SERVICES; Shin Peter, 2015, COMMUNITY HLTH CTR 2; Smith Vernon K, 2014, MED ERA HLTH DELIVER; Snyder L, 2014, ACA PRIMARY CARE INC; Snyder L, 2015, MED FIN DOES WORK WH; US Census Bureau, TAB 12 PROJ POP AG S; US Census Bureau, TAB 1 ANN EST RES PO; Weil A, 2003, HEALTH AFFAIR, V22, P13, DOI 10.1377/hlthaff.22.1.13; Young K, 2013, MEDICAIDS ROLE DUAL; Zaman O, 2012, AM SAFETY NET HOSP H; Zuckerman S., 2012, MUCH WILL MEDICAID P	66	57	60	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					384	395		10.1001/jama.2015.7811	http://dx.doi.org/10.1001/jama.2015.7811			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219056				2022-12-28	WOS:000358581700020
J	Mandell, LA; Waterer, GW				Mandell, Lionel A.; Waterer, Grant W.			Empirical Therapy of Community-Acquired Pneumonia Advancing Evidence or Just More Doubt?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NONINFERIORITY TRIAL; GUIDELINES; OUTCOMES	IMPORTANCE The clinical benefit of adding a macrolide to a beta-lactam for empirical treatment of moderately severe community-acquired pneumonia remains controversial. OBJECTIVE To test noninferiority of a beta-lactam alone compared with a beta-lactam and macrolide combination in moderately severe community-acquired pneumonia. DESIGN, SETTING, AND PARTICIPANTS Open-label, multicenter, noninferiority, randomized trial conducted from January 13, 2009, through January 31, 2013, in 580 immunocompetent adult patients hospitalized in 6 acute care hospitals in Switzerland for moderately severe community-acquired pneumonia. Follow-up extended to 90 days. Outcome assessors were masked to treatment allocation. INTERVENTIONS Patients were treated with a beta-lactam and a macrolide (combination arm) or with a beta-lactam alone (monotherapy arm). Legionella pneumophila infection was systematically searched and treated by addition of a macrolide to the monotherapy arm. MAIN OUTCOMES AND MEASURES Proportion of patients not reaching clinical stability (heart rate <100/min, systolic blood pressure >90 mm Hg, temperature <38.0 degrees C, respiratory rate <24/min, and oxygen saturation >90% on room air) at day 7. RESULTS After 7 days of treatment, 120 of 291 patients (41.2%) in the monotherapy arm vs 97 of 289 (33.6%) in the combination arm had not reached clinical stability (7.6% difference, P = .07). The upper limit of the 1-sided 90% CI was 13.0%, exceeding the predefined noninferiority boundary of 8%. Patients infected with atypical pathogens (hazard ratio [HR], 0.33; 95% CI, 0.13-0.85) or with Pneumonia Severity Index (PSI) category IV pneumonia (HR, 0.81; 95% CI, 0.59-1.10) were less likely to reach clinical stability with monotherapy, whereas patients not infected with atypical pathogens (HR, 0.99; 95% CI, 0.80-1.22) or with PSI category I to III pneumonia (HR, 1.06; 95% CI, 0.82-1.36) had equivalent outcomes in the 2 arms. There were more 30-day readmissions in the monotherapy arm (7.9% vs 3.1%, P = .01). Mortality, intensive care unit admission, complications, length of stay, and recurrence of pneumonia within 90 days did not differ between the 2 arms. CONCLUSIONS AND RELEVANCE We did not find noninferiority of beta-lactam monotherapy in patients hospitalized for moderately severe community-acquired pneumonia. Patients infected with atypical pathogens or with PSI category IV pneumonia had delayed clinical stability with monotherapy.	[Mandell, Lionel A.] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Waterer, Grant W.] Univ Western Australia, Perth, WA 6009, Australia; [Waterer, Grant W.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA	McMaster University; University of Western Australia; Northwestern University	Mandell, LA (corresponding author), McMaster Univ, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada.	lmandell@mcmaster.ca	Waterer, Grant/AAG-2385-2021					Arnold FW, 2009, ARCH INTERN MED, V169, P1515, DOI 10.1001/archinternmed.2009.265; Asadi L, 2012, CLIN INFECT DIS, V55, P371, DOI 10.1093/cid/cis414; Frei CR, 2010, CLIN THER, V32, P293, DOI 10.1016/j.clinthera.2010.02.006; Garin N, 2014, JAMA INTERN MED, V174, P1894, DOI 10.1001/jamainternmed.2014.4887; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Meterky ML, 2007, CHEST, V131, P466, DOI 10.1378/chest.06-1426; Mulla SM, 2012, JAMA-J AM MED ASSOC, V308, P2605, DOI 10.1001/2012.jama.11235; Ramirez JA, 2011, J ANTIMICROB CHEMOTH, V66, pIII3, DOI 10.1093/jac/dkr094; [No title captured]	9	6	6	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					396	+		10.1001/jama.2015.3858	http://dx.doi.org/10.1001/jama.2015.3858			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219057				2022-12-28	WOS:000358581700021
J	Lipchik, RJ				Lipchik, Randolph J.			In ICUs, 24-, 16-, and 12-hour overnight resident duty schedules did not differ for patient adverse events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTERNAL-MEDICINE RESIDENCY; WORK HOURS; FAILURES; CARE		Med Coll Wisconsin, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Lipchik, RJ (corresponding author), Med Coll Wisconsin, Milwaukee, WI 53226 USA.							Arora V, 2005, QUAL SAF HEALTH CARE, V14, P401, DOI 10.1136/qshc.2005.015107; Goitein L, 2005, ARCH INTERN MED, V165, P2601, DOI 10.1001/archinte.165.22.2601; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lockley SW, 2007, JT COMM J QUAL PATIE, V33, P7, DOI 10.1016/S1553-7250(07)33109-7; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; McMahon GT, 2010, NEW ENGL J MED, V362, P1304, DOI 10.1056/NEJMsa0908136	6	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2							JC12	10.7326/ACPJC-2015-163-2-012	http://dx.doi.org/10.7326/ACPJC-2015-163-2-012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26192580				2022-12-28	WOS:000358407500012
J	Chen, CY; Stevenson, LW; Stewart, GC; Bhatt, DL; Desai, M; Seeger, JD; Williams, L; Jalbert, JJ; Setoguchi, S				Chen, Chih-Ying; Stevenson, Lynne Warner; Stewart, Garrick C.; Bhatt, Deepak L.; Desai, Manisha; Seeger, John D.; Williams, Lauren; Jalbert, Jessica J.; Setoguchi, Soko			Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASSOCIATION TASK-FORCE; CARDIAC-RESYNCHRONIZATION THERAPY; ACUTE MYOCARDIAL-INFARCTION; PEDIATRIC ICD PROCEDURES; DEVICE-BASED THERAPY; BUNDLE-BRANCH BLOCK; QUALITY-OF-CARE; AMERICAN-COLLEGE; CLINICAL EFFECTIVENESS; RHYTHM ABNORMALITIES	OBJECTIVES To examine the effectiveness of primary implantable cardioverter defibrillators (ICDs) in elderly patients receiving the device during a hospital admission for exacerbation of heart failure or other acute co-morbidities, with an emphasis on adjustment for early mortality and other factors reflecting healthy candidate bias rather than the effect of the ICD. DESIGN Retrospective cohort study. SETTING Linked data from the Centers for Medicare and Medicaid Services and American College of Cardiology-National Cardiovascular Data Registry ICD registry, nationwide heart failure registry, and Medicare claims data 2004-09. POPULATION 23 111 patients aged >= 66 who were admitted to hospital for exacerbation of heart failure or other acute co-morbidities and eligible for primary ICDs. MAIN OUTCOME MEASURES All cause mortality and sudden cardiac death. Latency analyses with Cox regression were used to derive crude hazard ratios and hazard ratios adjusted for high dimension propensity score for outcomes after 180 days from index implantation or discharge. RESULTS Patients who received an ICD during a hospital admission had lower crude mortality risk than patients who did not receive an ICD (40% v 60% at three years); however, with conditioning on 180 day survival and with adjustment for high dimension propensity score, the apparent benefit with ICD was no longer evident for sudden cardiac death (adjusted hazard ratio 0.95, 95% confidence interval 0.78 to 1.17) and had a diminished impact on total mortality (0.91, 0.82 to 1.00). There were trends towards a benefit with ICD in reducing mortality or sudden cardiac death in patients who had had a myocardial infarction more than 40 days previously, left bundle branch block, or low serum B type natriuretic peptide; however, these trends did not reach significance. CONCLUSION After adjustment for healthy candidate bias and confounding, the benefits of primary ICD therapy seen in pivotal trials were not apparent in patients aged 66 or over who received ICDs during a hospital admission for exacerbation of heart failure or other acute co-morbidities. Future research is warranted to further identify subgroups of elderly patients who are more likely to benefit from ICDs. Recognition of those patients whose dominant risk factors are from decompensated heart failure and non-cardiac co-morbidities will allow better focus on ICDs in those patients for whom the device offers the most benefit and provides meaningful prolonging of life.	[Chen, Chih-Ying; Seeger, John D.; Williams, Lauren; Jalbert, Jessica J.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Chen, Chih-Ying; Seeger, John D.; Williams, Lauren; Jalbert, Jessica J.] Harvard Univ, Sch Med, Boston, MA 02120 USA; [Stevenson, Lynne Warner; Stewart, Garrick C.; Bhatt, Deepak L.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Stevenson, Lynne Warner; Stewart, Garrick C.; Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Desai, Manisha] Stanford Univ, Sch Med, Quantitat Sci Unit, Palo Alto, CA 94305 USA; [Setoguchi, Soko] Duke Clin Res Inst, Durham, NC 27705 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stanford University; Duke University	Setoguchi, S (corresponding author), Duke Clin Res Inst, Durham, NC 27705 USA.	soko.setoguchi@duke.edu			Agency for Healthcare Research and Quality (AHRQ) [HHSA290-2005-0016-I-TO3]; US Department of Health and Human Services (DHHS) as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program; IAA from the Center for Medicare and Medicaid Services (CMS), US DHHS [500-2010-00001I TO6]; CEA from the Center for Medicare and Medicaid Services (CMS), US DHHS [500-2010-00001I TO2]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017731] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); US Department of Health and Human Services (DHHS) as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program; IAA from the Center for Medicare and Medicaid Services (CMS), US DHHS; CEA from the Center for Medicare and Medicaid Services (CMS), US DHHS; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project is funded by contract No HHSA290-2005-0016-I-TO3 from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services (DHHS) as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program, IAA Contract 500-2010-00001I TO6 and CEA Contract 500-2010-00001I TO2 from the Centers for Medicare and Medicaid Services (CMS), US DHHS. The funding agency had no role in the design and conduct of the study and in the collection, analysis, and interpretation of the data. The manuscript was based on a report done under contract to AHRQ; AHRQ had the draft report reviewed by independent peer reviewers before acceptance of the final report.	Abdel-Qadir HM, 2011, INT J CARDIOL, V146, P213, DOI 10.1016/j.ijcard.2010.01.012; Al-Khatib SM, 2014, JAMA-J AM MED ASSOC, V311, P2209, DOI 10.1001/jama.2014.5310; Albert NM, 2009, JAMA-J AM MED ASSOC, V302, P1658, DOI 10.1001/jama.2009.1493; ARRIGHI HM, 1994, EPIDEMIOLOGY, V5, P189, DOI 10.1097/00001648-199403000-00009; Arrighi HM, 1996, OCCUP ENVIRON MED, V53, P455, DOI 10.1136/oem.53.7.455; Baldasseroni S, 2002, AM HEART J, V143, P398, DOI 10.1067/mhj.2002.121264; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Chan PS, 2006, ARCH INTERN MED, V166, P2228, DOI 10.1001/archinte.166.20.2228; Chan PS, 2009, CIRC-CARDIOVASC QUAL, V2, P16, DOI 10.1161/CIRCOUTCOMES.108.807123; Chen CY, 2013, J AM COLL CARDIOL, V61, P2142, DOI 10.1016/j.jacc.2013.02.043; Chung CP, 2010, PHARMACOEPIDEM DR S, V19, P563, DOI 10.1002/pds.1888; Cleland JGF, 2001, EUR HEART J, V22, P1601, DOI 10.1053/euhj.2000.2570; Dorian P, 2010, CIRCULATION, V122, P2645, DOI 10.1161/CIRCULATIONAHA.109.924225; Epstein AE, 2008, CIRCULATION, V117, P2820, DOI 10.1161/CIRCUALTIONAHA.108.189741; Fonarow GC, 2007, J AM COLL CARDIOL, V49, P1943, DOI 10.1016/j.jacc.2007.02.037; Hammill SC, 2008, HEART RHYTHM, V5, P1359, DOI 10.1016/j.hrthm.2008.07.015; Hammill SC, 2007, HEART RHYTHM, V4, P1260, DOI 10.1016/j.hrthm.2007.07.021; Hammill SC, 2010, HEART RHYTHM, V7, P1340, DOI 10.1016/j.hrthm.2010.07.015; Hammill SC, 2009, HEART RHYTHM, V6, P1397, DOI 10.1016/j.hrthm.2009.07.015; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Hernandez AF, 2010, CIRC-HEART FAIL, V3, P7, DOI 10.1161/CIRCHEARTFAILURE.109.884395; Hjalmarson A, 1999, LANCET, V353, P2001; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Huang DT, 2007, J CARDIOVASC ELECTR, V18, P833, DOI 10.1111/j.1540-8167.2007.00857.x; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Little R. J. A., 2002, STAT ANAL MISSING DA; MacFadden DR, 2012, ANN INTERN MED, V156, P195, DOI 10.7326/0003-4819-156-3-201202070-00007; Mehta PA, 2008, EUR J HEART FAIL, V10, P1108, DOI 10.1016/j.ejheart.2008.09.004; Messenger JC, 2012, J AM COLL CARDIOL, V60, P1484, DOI 10.1016/j.jacc.2012.07.020; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Mozaffarian D, 2007, CIRCULATION, V116, P392, DOI 10.1161/CIRCULATIONAHA.106.687103; Nunez J, 2008, REV ESP CARDIOL, V61, P1332, DOI 10.1016/S0300-8932(08)75743-9; Patel UD, 2008, AM HEART J, V156, P674, DOI 10.1016/j.ahj.2008.05.028; Peterson PN, 2009, CIRCULATION, V119, P1078, DOI 10.1161/CIRCULATIONAHA.108.793463; Proclemer A, 2009, EUROPACE, V11, P465, DOI 10.1093/europace/eun370; Rassen JA, 2014, PHARMACOEPIDEMIOLOGY; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P697, DOI 10.1002/pds.2256; Rho RW, 2012, CIRCULATION, V126, P2402, DOI 10.1161/CIRCULATIONAHA.111.069245; Santaguida PL, 2014, HEART FAIL REV, V19, P453, DOI 10.1007/s10741-014-9442-y; Setoguchi S, 2014, CIRC-CARDIOVASC QUAL, V7, P475, DOI 10.1161/CIRCOUTCOMES.113.000294; Setoguchi S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2866; Setoguchi S, 2009, CAN MED ASSOC J, V180, P611, DOI 10.1503/cmaj.080769; Solomon SD, 2007, CIRCULATION, V116, P1482, DOI 10.1161/CIRCULATIONAHA.107.696906; Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stewart G, 2013, CIRCULATION, V128; Stewart S, 2003, HEART, V89, P49, DOI 10.1136/heart.89.1.49; Strickberger SA, 2005, CIRCULATION, V111, P2146, DOI 10.1161/01.CIR.0000161276.09685.4A; Thygesen LC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-571; Tracy CM, 2012, CIRCULATION, V126, P1784, DOI 10.1161/CIR.0b013e3182618569; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807	54	18	18	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2015	351								h3529	10.1136/bmj.h3529	http://dx.doi.org/10.1136/bmj.h3529			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CO	26174233	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000358301600007
J	Chang, HY; Lee, HC; Huang, FY; Lin, CY				Chang, Hung-Yang; Lee, Hung-Chang; Huang, Fu-Yuan; Lin, Chien-Yu			Plain radiograph in a neonate with abdominal distension	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chang, Hung-Yang; Huang, Fu-Yuan] Hsinchu Mackay Mem Hosp, Dept Paediat & Neonatol, Hsinchu 30071, Taiwan; [Lee, Hung-Chang] Hsinchu Mackay Mem Hosp, Dept Paediat & Gastroenterol, Hsinchu 30071, Taiwan; [Lin, Chien-Yu] Hsinchu Mackay Mem Hosp, Dept Paediat & Infect Dis, Hsinchu 30071, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital	Lin, CY (corresponding author), Hsinchu Mackay Mem Hosp, Dept Paediat & Infect Dis, Hsinchu 30071, Taiwan.	mmhped.lin@gmail.com						Shah J, 2015, J PERINATOL, V35, P595, DOI 10.1038/jp.2015.41	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2015	351								h3551	10.1136/bmj.h3551	http://dx.doi.org/10.1136/bmj.h3551			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MY	26163017				2022-12-28	WOS:000357956900001
J	Spitzer, MH; Gherardini, PF; Fragiadakis, GK; Bhattacharya, N; Yuan, RT; Hotson, AN; Finck, R; Carmi, Y; Zunder, ER; Fantl, WJ; Bendall, SC; Engleman, EG; Nolan, GP				Spitzer, Matthew H.; Gherardini, Pier Federico; Fragiadakis, Gabriela K.; Bhattacharya, Nupur; Yuan, Robert T.; Hotson, Andrew N.; Finck, Rachel; Carmi, Yaron; Zunder, Eli R.; Fantl, Wendy J.; Bendall, Sean C.; Engleman, Edgar G.; Nolan, Garry P.			An interactive reference framework for modeling a dynamic immune system	SCIENCE			English	Article							MASS CYTOMETRY; GENE-EXPRESSION; T-CELLS; MOUSE; NETWORK; IDENTIFICATION; PROGRESSION; VISUALIZATION; BIOLOGY; GAMMA	Immune cells function in an interacting hierarchy that coordinates the activities of various cell types according to genetic and environmental contexts. We developed graphical approaches to construct an extensible immune reference map from mass cytometry data of cells from different organs, incorporating landmark cell populations as flags on the map to compare cells from distinct samples. The maps recapitulated canonical cellular phenotypes and revealed reproducible, tissue-specific deviations. The approach revealed influences of genetic variation and circadian rhythms on immune system structure, enabled direct comparisons of murine and human blood cell phenotypes, and even enabled archival fluorescence-based flow cytometry data to be mapped onto the reference framework. This foundational reference map provides a working definition of systemic immune organization to which new data can be integrated to reveal deviations driven by genetics, environment, or pathology.	[Spitzer, Matthew H.; Gherardini, Pier Federico; Fragiadakis, Gabriela K.; Hotson, Andrew N.; Finck, Rachel; Zunder, Eli R.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Spitzer, Matthew H.; Bhattacharya, Nupur; Yuan, Robert T.; Carmi, Yaron; Bendall, Sean C.; Engleman, Edgar G.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Spitzer, Matthew H.; Yuan, Robert T.; Bendall, Sean C.; Engleman, Edgar G.; Nolan, Garry P.] Stanford Univ, Program Immunol, Stanford, CA 94305 USA; [Fantl, Wendy J.] Stanford Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Spitzer, MH (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	matthew.spitzer@stanford.edu; gnolan@stanford.edu	Bendall, Sean/AGG-0126-2022; Nolan, Garry/AAE-7903-2019	Spitzer, Matthew/0000-0002-5291-3819; Bendall, Sean/0000-0003-1341-2453; Zunder, Eli/0000-0002-0356-1685; Nolan, Garry/0000-0002-8862-9043	Fluidigm Sciences; George D. Smith Stanford graduate fellowship; NIH [F31CA189331, T32GM007276, NRSA F32 GM093508-01, K99GM104148-01, 1U19AI100627, 1R01GM109836, 7500108142]; Stanford Bio-X graduate fellowship; CIRM Basic Biology II [RB2-01592]; Damon Runyon Cancer Research Foundation [DRG-2017-09]; NIAID [HHSN272201200028C, PN2EY018228 0158 G KB065, 1R01CA130826]; DOD [OC110674, 11491122]; Bill and Melinda Gates Foundation [OPP1113682]; CIRM [RB2-01592, DR1-01477]; FDA [HHSF223201210194C BAA-12-00118]; European Commission [HEALTH.2010.1.2-1]; Rachford and Carlota A. Harris endowed professorship; The NIAID [5U54CA143907NIH, HHSN272200700038C, N01-HV-00242, 41000411217, 5-24927, P01 CA034233-22A1, RFA CA 09-009, RFA CA 09-011, U19 AI057229, U54CA149145, 5R01AI073724, R01CA184968, R33 CA183654, R33 CA183692, 1R01NS089533, 201303028]; NATIONAL CANCER INSTITUTE [F31CA189331, R01CA130826, P01CA034233, U54CA149145, F32CA009011, U01CA141468, R01CA184968, U54CA143907, F32CA009009, R01CA163441, R33CA183654, R33CA183692] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027582] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, U19AI100627, R01AI073724, T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096038, R01DK082537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109836, R00GM104148, F32GM093508, K99GM104148, T32GM007276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089533] Funding Source: NIH RePORTER	Fluidigm Sciences; George D. Smith Stanford graduate fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Bio-X graduate fellowship; CIRM Basic Biology II; Damon Runyon Cancer Research Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DOD(United States Department of Defense); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); CIRM(California Institute for Regenerative Medicine); FDA(United States Department of Health & Human Services); European Commission(European CommissionEuropean Commission Joint Research Centre); Rachford and Carlota A. Harris endowed professorship; The NIAID; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All mass cytometry data are accessible at www.cytobank.org/nolanlab/reports and the. R package is available at https://github.com/nolanlab. R. Finck, S. Bendall, and G.P.N. have served as paid consultants of Fluidigm Sciences, the maker of the mass cytometry instrumentation and reagents used for the data collection in this study. We thank J. Kenkel, B. Burt, D.-H. Wang, and M. Ch'ng for their assistance in tissue processing; A. Trejo and A. Jager for mass cytometry quality control and maintenance; B. Gaudilliere and M. Angst for access to human whole blood data; and M. Angelo, C. Loh, N. Reticker-Flynn, and L. Sanman for constructive feedback. Supported by a George D. Smith Stanford graduate fellowship and NIH grant F31CA189331 (M.H.S.); a Stanford Bio-X graduate fellowship and NIH grant T32GM007276 (G.K.F.); CIRM Basic Biology II RB2-01592 and NIH grant NRSA F32 GM093508-01 (E.R.Z.); Damon Runyon Cancer Research Foundation fellowship DRG-2017-09 and NIH grant K99GM104148-01 (S. C. B.); NIH grants 1U19AI100627, 1R01GM109836, and 7500108142, NIAID Bioinformatics Support Contract HHSN272201200028C, PN2EY018228 0158 G KB065, 1R01CA130826, 5U54CA143907NIH, HHSN272200700038C, N01-HV-00242, 41000411217, 5-24927, P01 CA034233-22A1, RFA CA 09-009, RFA CA 09-011, U19 AI057229, U54CA149145, 5R01AI073724, R01CA184968, R33 CA183654, R33 CA183692, 1R01NS089533, 201303028; DOD grants OC110674 and 11491122; Bill and Melinda Gates Foundation grant OPP1113682; CIRM grants DR1-01477 and RB2-01592; FDA grant HHSF223201210194C BAA-12-00118; European Commission grant HEALTH.2010.1.2-1; and the Rachford and Carlota A. Harris endowed professorship (G.P.N.).. P.F.G. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation.	Aderem A, 2001, NAT IMMUNOL, V2, P373, DOI 10.1038/87665; Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Beutler B, 2011, MAMM GENOME, V22, P1, DOI 10.1007/s00335-010-9312-4; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Carter H, 2013, CURR OPIN GENET DEV, V23, P611, DOI 10.1016/j.gde.2013.10.003; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dutkowski J, 2014, NUCLEIC ACIDS RES, V42, pD1269, DOI 10.1093/nar/gkt1192; Dutkowski J, 2013, NAT BIOTECHNOL, V31, P38, DOI 10.1038/nbt.2463; Eades P., 1984, C NUMERANTIUM, V42, P149; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gavin AL, 2000, IMMUNOGENETICS, V51, P206, DOI 10.1007/s002510050033; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Hadeiba H, 2013, EUR J IMMUNOL, V43, P1425, DOI 10.1002/eji.201243192; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; HULETT HR, 1969, SCIENCE, V166, P747, DOI 10.1126/science.166.3906.747; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17302, DOI 10.1073/pnas.0508649102; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ideker T, 2011, CELL, V144, P860, DOI 10.1016/j.cell.2011.03.007; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; KAUFMAN L, 1990, FINDING GROUPS IN DA; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kirby AC, 2009, J IMMUNOL, V183, P1983, DOI 10.4049/jimmunol.0901089; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Lou XD, 2007, ANGEW CHEM INT EDIT, V46, P6111, DOI 10.1002/anie.200700796; Mahnke Y, 2010, CYTOM PART A, V77A, P814, DOI 10.1002/cyto.a.20916; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Movita D, 2012, J LEUKOCYTE BIOL, V92, P723, DOI 10.1189/jlb.1111566; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; Panzer SE, 2003, J ALLERGY CLIN IMMUN, V111, P308, DOI 10.1067/mai.2003.65; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Shimomura Y, 2008, J EXP MED, V205, P1343, DOI 10.1084/jem.20071572; Sirota M, 2011, NAT REV RHEUMATOL, V7, P489, DOI 10.1038/nrrheum.2011.87; SMOLENSKY MH, 1995, J ALLERGY CLIN IMMUN, V95, P1084, DOI 10.1016/S0091-6749(95)70212-1; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Usary J, 2013, CLIN CANCER RES, V19, P4889, DOI 10.1158/1078-0432.CCR-13-0522; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zak DE, 2014, ANNU REV IMMUNOL, V32, P547, DOI 10.1146/annurev-immunol-032713-120254; Zunder ER, 2015, CELL STEM CELL, V16, P323, DOI 10.1016/j.stem.2015.01.015	63	159	163	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244							1259425	10.1126/science.1259425	http://dx.doi.org/10.1126/science.1259425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26160952	Green Accepted			2022-12-28	WOS:000357664300034
J	Pulla, P				Pulla, Priyanka			CORRUPTION IN MEDICINE Gurinder Singh Grewal: can the new medical council president clean up medicine in Punjab?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												emailpriyanka@gmail.com						Bharti V., 2015, HINDUSTAN TIMES 0319; Bharti V., 2015, HINDUSTAN TIMES 0428; Gyanesh A., 2014, TIMES OF INDIA  0809; Kanwa S, 2015, ET INDIA TIMES  0317	4	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2015	351								h3694	10.1136/bmj.h3694	http://dx.doi.org/10.1136/bmj.h3694			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MU	26160774				2022-12-28	WOS:000357956500004
J	Yeo, A; James, K; Ramachandran, M				Yeo, Andrea; James, Kyle; Ramachandran, Manoj			Normal lower limb variants in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MUSCULOSKELETAL COMPLAINTS; METATARSUS ADDUCTUS; ROTATIONAL PROBLEMS; OBESITY; FOOT; PREVALENCE; OVERWEIGHT; CHILDHOOD; BOWLEGS; TORSION		[Yeo, Andrea] Barts Hlth NHS Trust, Royal London Hosp, London E1 1BB, England; Barts Hlth NHS Trust, Barts & London Childrens Hosp, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital; Barts Health NHS Trust	Yeo, A (corresponding author), Barts Hlth NHS Trust, Royal London Hosp, London E1 1BB, England.	andreayeo@doctors.org.uk		James, Kyle/0000-0003-2314-0156				Al-Nammari SS, 2009, J BONE JOINT SURG BR, V91B, P1413, DOI 10.1302/0301-620X.91B11.22445; [Anonymous], 2015, LANCET LONDON ENGLAN, DOI [DOI 10.1016/S0140-6736(14)61746-3, 10.1016/S0140-6736(14)61746-3]; Beck-Nielsen SS, 2009, EUR J PEDIATR, V168, P941, DOI 10.1007/s00431-008-0864-1; Bell LM, 2011, J PAEDIATR CHILD H, V47, P911, DOI 10.1111/j.1440-1754.2011.02102.x; Blackmur James P, 2010, J Pediatr Orthop B, V19, P415, DOI 10.1097/BPB.0b013e3283339067; BLECK EE, 1983, J PEDIATR ORTHOPED, V3, P2, DOI 10.1097/01241398-198302000-00002; Bordin D, 2001, Minerva Pediatr, V53, P7; Carli A, 2012, PAED CHILD HEALT-CAN, V17, pE93, DOI 10.1093/pch/17.9.e93; CHANTRAINE A, 1985, MED SCI SPORT EXER, V17, P434, DOI 10.1249/00005768-198508000-00005; Department of Health, 2011, PHYS ACT HLTH IMPR P; Department of Health UK, 2012, VIT D ADV SUPPL RISK; Department of Health UK, 2011, HLTH LIV HLTH PEOPL; DIETZ WH, 1982, J PEDIATR-US, V101, P735, DOI 10.1016/S0022-3476(82)80305-3; ECKHOFF DG, 1994, J PEDIATR ORTHOPED, V14, P608, DOI 10.1097/01241398-199409000-00010; Evans AM, 2008, J AM PODIAT MED ASSN, V98, P386, DOI 10.7547/0980386; FABRY G, 1973, J BONE JOINT SURG AM, VA 55, P1726, DOI 10.2106/00004623-197355080-00017; Fabry G, 2010, EUR J PEDIATR, V169, P529, DOI 10.1007/s00431-009-1122-x; Foster HE, 2006, ARTHRIT RHEUM-ARTHR, V55, P709, DOI 10.1002/art.22230; Foster H, 2011, ARTHRIT CARE RES, V63, P1503, DOI 10.1002/acr.20569; Fuchs R, 1996, J PEDIATR ORTHOPED, V16, P489, DOI 10.1097/01241398-199607000-00013; Gettys FK, 2011, ORTHOP CLIN N AM, V42, P95, DOI 10.1016/j.ocl.2010.08.005; Grimshaw JM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005471; Gunz AC, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-98; HEATH CH, 1993, J PEDIATR ORTHOPED, V13, P259; Hendry G, 2008, MUSCULOSKELET CARE, V6, P221, DOI 10.1002/msc.134; HUBBARD DD, 1988, J PEDIATR ORTHOPED, V8, P540, DOI 10.1097/01241398-198809000-00008; HUTTER CG, 1949, J BONE JOINT SURG AM, V31-A, P511, DOI 10.2106/00004623-194931030-00006; Jackson AM, 2001, J BONE JOINT SURG BR, V83B, P937, DOI 10.1302/0301-620X.83B7.12756; Jandial S, 2009, J PEDIATR-US, V154, P267, DOI 10.1016/j.jpeds.2008.08.013; Karol Lori A., 1997, Current Opinion in Pediatrics, V9, P77, DOI 10.1097/00008480-199702000-00016; Mauch M, 2008, INT J OBESITY, V32, P1068, DOI 10.1038/ijo.2008.52; Molony D, 2006, Ir Med J, V99, P13; Murray AW, 2008, J BONE JOINT SURG BR, V90B, P92, DOI 10.1302/0301-620X.90B1.19502; National Institute for Health and Care Excellence, 2014, VIT D INCR SUPPL US; O'Malley G, 2012, PEDIATR PHYS THER, V24, P292, DOI 10.1097/PEP.0b013e31825c14f8; Paulis WD, 2014, OBES REV, V15, P52, DOI 10.1111/obr.12067; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Pfeiffer M, 2006, PEDIATRICS, V118, P634, DOI 10.1542/peds.2005-2126; PONSETI IV, 1966, J BONE JOINT SURG AM, VA 48, P702, DOI 10.2106/00004623-196648040-00004; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Riddiford-Harland DL, 2000, INT J OBESITY, V24, P541, DOI 10.1038/sj.ijo.0801192; Rome K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006311.pub2; Sabharwal S, 2008, J PEDIATR ORTHOPED, V28, P740, DOI 10.1097/BPO.0b013e318186eb79; SALENIUS P, 1975, J BONE JOINT SURG AM, VA 57, P259, DOI 10.2106/00004623-197557020-00021; Sass P, 2003, AM FAM PHYSICIAN, V68, P461; Shultz SP, 2009, OBES REV, V10, P576, DOI 10.1111/j.1467-789X.2009.00587.x; STAHELI LT, 1985, J BONE JOINT SURG AM, V67A, P39, DOI 10.2106/00004623-198567010-00006; STAHELI LT, 1993, J BONE JOINT SURG AM, V75A, P939, DOI 10.2106/00004623-199306000-00017; STAHELI LT, 1980, CLIN ORTHOP RELAT R, P222; Talley W, 2011, AM FAM PHYSICIAN, V84, P937; Taylor ED, 2006, PEDIATRICS, V117, P2167, DOI 10.1542/peds.2005-1832; Thijs Y, 2012, MED SCI SPORT EXER, V44, P993, DOI 10.1249/MSS.0b013e3182407ca0; Voloc A, 2010, EUR J ENDOCRINOL, V163, P811, DOI 10.1530/EJE-10-0434; VOLPON JB, 1994, J PEDIATR ORTHOPED, V14, P83, DOI 10.1097/01241398-199401000-00017; WILKINS KE, 1986, PEDIATR CLIN N AM, V33, P1429; Witvrouw E, 2009, KNEE SURG SPORT TR A, V17, P422, DOI 10.1007/s00167-008-0710-z; Yaniv M, 2006, CLIN J SPORT MED, V16, P392, DOI 10.1097/01.jsm.0000244602.74460.e4	57	13	15	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2015	351								h3394	10.1136/bmj.h3394	http://dx.doi.org/10.1136/bmj.h3394			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MI	26152216				2022-12-28	WOS:000357955100001
J	Olivier, J; Tsimpo, C; Gemignani, R; Shojo, M; Coulombe, H; Dimmock, F; Nguyen, MC; Hines, H; Mills, EJ; Dieleman, JL; Haakenstad, A; Wodon, Q				Olivier, Jill; Tsimpo, Clarence; Gemignani, Regina; Shojo, Mari; Coulombe, Harold; Dimmock, Frank; Minh Cong Nguyen; Hines, Harrison; Mills, Edward J.; Dieleman, Joseph L.; Haakenstad, Annie; Wodon, Quentin			Understanding the roles of faith-based health-care providers in Africa: review of the evidence with a focus on magnitude, reach, cost, and satisfaction	LANCET			English	Review							MARKET SHARE; ORGANIZATIONS; POOR	At a time when many countries might not achieve the health targets of the Millennium Development Goals and the post-2015 agenda for sustainable development is being negotiated, the contribution of faith-based health-care providers is potentially crucial. For better partnership to be achieved and for health systems to be strengthened by the alignment of faith-based health-providers with national systems and priorities, improved information is needed at all levels. Comparisons of basic factors (such as magnitude, reach to poor people, cost to patients, modes of financing, and satisfaction of patients with the services received) within faith-based health-providers and national systems show some differences. As the first report in the Series on faith-based health care, we review a broad body of published work and introduce some empirical evidence on the role of faith-based health-care providers, with a focus on Christian faith-based health providers in sub-Saharan Africa (on which the most detailed documentation has been gathered). The restricted and diverse evidence reported supports the idea that faith-based health providers continue to play a part in health provision, especially in fragile health systems, and the subsequent reports in this Series review controversies in faith-based health care and recommendations for how public and faith sectors might collaborate more effectively.	[Olivier, Jill] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Tsimpo, Clarence; Gemignani, Regina; Shojo, Mari; Coulombe, Harold; Minh Cong Nguyen; Wodon, Quentin] World Bank, Washington, DC 20433 USA; [Dimmock, Frank] World Mission, Presbyterian Church USA, Louisville, KY USA; [Hines, Harrison] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Mills, Edward J.] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Dieleman, Joseph L.; Haakenstad, Annie] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	University of Cape Town; The World Bank; Stanford University; Stanford University; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Olivier, J (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Policy & Syst Div, ZA-7925 Observatory, South Africa.	jill.olivier@uct.ac.za	Olivier, Jill/M-9735-2015	Olivier, Jill/0000-0001-9155-6896	Capital for Good	Capital for Good	The authors would like to acknowledge Rakesh Nangia, Elizabeth King, Harry Patrinos, and Nicole Klingmen who reviewed and supported the initial World Bank study. The writing of this Series paper, and the review process by the Lancet Working Group on Faith and Global Health was supported by Capital for Good. In particular, the authors would like to thank Jean Duff, Katherine Marshall, and Liz Grant for their useful review comments during the writing process.	Annan I., 2005, RESULTS GHANA BASELI; [Anonymous], 1981, QUEST HLTH WHOLENESS; ARHAP, 2006, APPR ASS CONTR REL U; BANDA EEN, 1994, HEALTH POLICY PLANN, V9, P63, DOI 10.1093/heapol/9.1.63; Bandy G., 2008, BUILDING COMMON FDN; Barragan JL, 2006, UN GEN ASS SPEC SESS; Benn C., 2003, AFR REL HLTH ASS PRO, P3; Bennett S, 1997, PUBLIC PRIVATE ROLES; Birdsall K., 2005, FAITH BASED RESPONSE; Blevins J, 2012, HNP DISCUSSION PAPER, P76; Bohnett T, 2010, EXPERIENCES ISSUES I; Boulenger D, 2012, DIFFICULT RELATIONSH; CAFOD, 2006, REV YEAR 2005 2006; Chand S, 2007, FAITH BASED MODELS I; Christian Connections for International Health, GRHAM MAPP RWAND BUR; Christian Health Association of Ghana, 2006, CHRIST HLTH ASS GHAN; Christian Social Services Commission. Christian Health Association at crossroad towards achieving health Millenium Development Goals, 2007, CHRIST HLTH ASS C JA, P28; Coulombe H, 2013, ECON BULL, V33, P1615; Dackpa S., 2010, ACHAP, V11, P3; De Jong J., 1991, NONGOVERNMENTAL ORG; Dimmock F., 2005, CHRISTIAN HLTH ASS A; Dimmock F, 2012, HNP DISCUSSION PAPER, P71; Dimmock F., 2007, CHRIST CONN INT HLTH; Foley EE, 2012, HNP DISCUSSION PAPER, P41; Foster G., 2004, STUDY RESPONSE FAITH; Gemignani R, 2014, REV FAITH INT AFF, V12, P30, DOI 10.1080/15570274.2013.876732; General Conference of Seventh-day Adventists, 2012, 7 DAY ADV YB 2012; GFTAM, 2008, REP INV FAITH BAS OR; GILSON L, 1994, HEALTH POLICY PLANN, V9, P14, DOI 10.1093/heapol/9.1.14; Gilson L, 1997, PRIVATE HLTH PROVIDE; Green A, 2002, INT J HEALTH PLAN M, V17, P333, DOI 10.1002/hpm.685; Green A., 2005, DEV PRACT, V5, P313; Grills N, 2009, GLOBAL GOV, V15, P505, DOI 10.1163/19426720-01504009; Haakenstad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128389; Hackett Conrad, 2012, GLOBAL RELIG LANDSCA; Haddad B., 2008, POTENTIAL PERILS PAR; Hanson K., 1994, NONGOVERNMENT FINANC; Hecht RM, 1993, ROLE NONGOVERNMENTAL; HERA, PUBL PRIV PARN EQ PR; Kawasaki E., 2002, DRUG SUPPLY SYSTEMS; Kelly K., 2007, PIONEERS PARTNERS PR; Kintaudi L, 2006, FBOS MIN HLTH DR CON; Kitchen, 2002, WORLD MUST COORDINAT; Knowles J. C., 1994, PRIVATE SECTOR DELIV; Leonard KL, 2008, FAITH EC, V52, P1; Marshall K, 2003, MILLENNIUM CHALLENGE; Mhango D., 2006, INNOVATIVE RECRUITME; Ministry of Health Zambia, 2002, ZAMB NAT HLTH ACC 19; Mogedal S, 1995, J INT DEV, V7, P349, DOI DOI 10.1002/jid.3380070304; Muriithi P., 2007, SITUATIONAL ANAL STU; MWABU GM, 1986, SOC SCI MED, V22, P315, DOI 10.1016/0277-9536(86)90129-2; Mwenda S., 2007, CHURCH HLTH ASS C DA; Nussbaum S., 2005, CONTRIBUTION CHRISTI; Olivier, 2014, LOCAL FAITH COMMUNIT; Olivier J, 2012, HNP DISCUSSION PAPER, P25; Olivier J., 2014, CARTOGRAPHY HIV AIDS; Olivier J., 2014, SEMIBOUNDED FIELD RE; Olivier J, 2012, STRENGTHENING EVIDEN, V1, P11; Olivier J., 2011, RELIG HLTH ALIGN MOB; Olivier J., 2011, RELIG HIV AIDS CHART, P25; Olivier J., 2012, HNP DISCUSSION PAPER; Olivier J, 2012, HNP DISCUSSION PAPER, P1; Olivier J, 2012, HNP DISCUSSION PAPER; Olivier J, 2012, HNP DISCUSSION PAPER; Olivier J, 2012, DEV PRACT, V22, P819, DOI 10.1080/09614524.2012.685870; Olivier J, 2014, REV FAITH INT AFF, V12, P84, DOI 10.1080/15570274.2013.876735; Olivier J, 2014, REV FAITH INT AFF, V12, P53, DOI 10.1080/15570274.2013.876736; Pallant D., 2012, HNP DISCUSSION PAPER, P89; Parry S, 2003, RESPONSES FAITH BASE; PEPFAR, 2005, PRES EM PLAN AIDS RE; Reinikka R, 2003, WORKING GOD EVALUATI; Republic of Uganda, 2001, FAC BAS PRIV NOT FOR; Rookes P, 2012, COMMITMENT CONSCIENC; Schmid B, 2008, CONTRIBUTION RELIG E; See Holy, 2010, STAT YB CHURCH 2010; Smith A., 2013, HIV MATERNAL HLTH FA; Tearfund,, 2006, FAITH UNT WHY CHURCH; Todd S, 2009, HUMAN RESOURCES GEOG; Tsimpo C, 2012, HNP DISCUSSION PAPER, P91; Turshen M., 1999, PRIVATIZING HLTH SER; UNAIDS, 2009, PARTN FAITH BAS ORG; UNFPA, 2009, GUID ENG FAITH BAS O; Vitillo RJ, 2010, INT PREC INT AIDS C; Vitillo RJ, 2005, ROLE FAITH GLOBAL RE; Ward N., 2010, FAITH SYSTEM IMPACT; WFDD (World Faiths Development Dialogue), 2012, GLOB HLTH AFR ASS FA; Wheeler G., 2009, FAITH DEV LEAD M FAI; White Gordon, 1997, ROLE CIVIC ORG PROVI; Widmer M, 2011, INT J GYNECOL OBSTET, V114, P218, DOI 10.1016/j.ijgo.2011.03.015; Wodon Q., 2012, FAITH HUMAN DEV SERV; Wodon Q, 2014, REV FAITH INT AFF, V12, P8, DOI 10.1080/15570274.2013.876739; World Bank, 1983, COUNTR POP HLTH SECT; World Bank, 2009, REP BEN HLTH NUTR PO; World Health Organization, 2004, WORLD HLTH REP 2004; Wuthnow Robert, 2010, BOUNDLESS FAITH GLOB	95	95	96	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1765	1775		10.1016/S0140-6736(15)60251-3	http://dx.doi.org/10.1016/S0140-6736(15)60251-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV0WK	26159398				2022-12-28	WOS:000363974200036
J	Pincus, HA; England, MJ				Pincus, Harold Alan; England, Mary Jane			Improving the Quality of Psychosocial Interventions for Mental and Substance Use Disorders A Report From the IOM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BURDEN; HEALTH		[Pincus, Harold Alan] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY 10032 USA; [Pincus, Harold Alan] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Pincus, Harold Alan] New York Presbyterian Hosp, New York, NY USA; [England, Mary Jane] Boston Univ, Sch Publ Hlth, Boston, MA USA	Columbia University; New York State Psychiatry Institute; NewYork-Presbyterian Hospital; Boston University	Pincus, HA (corresponding author), Columbia Univ, Med Ctr, New York State Psychiat Inst, 1051 Riverside Dr, New York, NY 10032 USA.	pincush@nyspi.columbia.edu						[Anonymous], [No title captured]; Cuijpers P, 2010, CLIN PSYCHOL REV, V30, P51, DOI 10.1016/j.cpr.2009.09.003; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Institute of Medicine, 2006, IMPR QUAL CAR MENT S; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Institute of Medicine (IOM), 2015, PSYCH INT MENT SUBST; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	9	15	15	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1227	1228		10.1001/jama.2015.9212	http://dx.doi.org/10.1001/jama.2015.9212			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS5IE	26181890				2022-12-28	WOS:000362110700006
J	Raghavan, M; Steinrucken, M; Harris, K; Schiffels, S; Rasmussen, S; DeGiorgio, M; Albrechtsen, A; Valdiosera, C; Avila-Arcos, MC; Malaspinas, AS; Eriksson, A; Moltke, I; Metspalu, M; Homburger, JR; Wall, J; Cornejo, OE; Moreno-Mayar, JV; Korneliussen, TS; Pierre, T; Rasmussen, M; Campos, PF; Damgaard, PD; Allentoft, ME; Lindo, J; Metspalu, E; Rodriguez-Varela, R; Mansilla, J; Henrickson, C; Seguin-Orlando, A; Malmstrom, H; Stafford, T; Shringarpure, SS; Moreno-Estrada, A; Karmin, M; Tambets, K; Bergstrom, A; Xue, Y; Warmuth, V; Friend, AD; Singarayer, J; Valdes, P; Balloux, F; Leboreiro, I; Vera, JL; Rangel-Villalobos, H; Pettener, D; Luiselli, D; Davis, LG; Heyer, E; Zollikofer, CPE; de Leon, MSP; Smith, CI; Grimes, V; Pike, KA; Deal, M; Fuller, BT; Arriaza, B; Standen, V; Luz, MF; Ricaut, F; Guidon, N; Osipova, L; Voevoda, MI; Posukh, OL; Balanovsky, O; Lavryashina, M; Bogunov, Y; Khusnutdinova, E; Gubina, M; Balanovska, E; Fedorova, S; Litvinov, S; Malyarchuk, B; Derenko, M; Mosher, MJ; Archer, D; Cybulski, J; Petzelt, B; Mitchell, J; Worl, R; Norman, PJ; Parham, P; Kemp, BM; Kivisild, T; Tyler-Smith, C; Sandhu, MS; Crawford, M; Villems, R; Smith, DG; Waters, MR; Goebel, T; Johnson, JR; Malhi, RS; Jakobsson, M; Meltzer, DJ; Manica, A; Durbin, R; Bustamante, CD; Song, YS; Nielsen, R; Willerslev, E				Raghavan, Maanasa; Steinruecken, Matthias; Harris, Kelley; Schiffels, Stephan; Rasmussen, Simon; DeGiorgio, Michael; Albrechtsen, Anders; Valdiosera, Cristina; Avila-Arcos, Maria C.; Malaspinas, Anna-Sapfo; Eriksson, Anders; Moltke, Ida; Metspalu, Mait; Homburger, Julian R.; Wall, Jeff; Cornejo, Omar E.; Moreno-Mayar, J. Victor; Korneliussen, Thorfinn S.; Pierre, Tracey; Rasmussen, Morten; Campos, Paula F.; Damgaard, Peter De Barros; Allentoft, Morten E.; Lindo, John; Metspalu, Ene; Rodriguez-Varela, Ricardo; Mansilla, Josefina; Henrickson, Celeste; Seguin-Orlando, Andaine; Malmstrom, Helena; Stafford, Thomas, Jr.; Shringarpure, Suyash S.; Moreno-Estrada, Andres; Karmin, Monika; Tambets, Kristiina; Bergstrom, Anders; Xue, Yali; Warmuth, Vera; Friend, Andrew D.; Singarayer, Joy; Valdes, Paul; Balloux, Francois; Leboreiro, Ilan; Vera, Jose Luis; Rangel-Villalobos, Hector; Pettener, Davide; Luiselli, Donata; Davis, Loren G.; Heyer, Evelyne; Zollikofer, Christoph P. E.; de Leon, Marcia S. Ponce; Smith, Colin I.; Grimes, Vaughan; Pike, Kelly-Anne; Deal, Michael; Fuller, Benjamin T.; Arriaza, Bernardo; Standen, Vivien; Luz, Maria F.; Ricaut, Francois; Guidon, Niede; Osipova, Ludmila; Voevoda, Mikhail I.; Posukh, Olga L.; Balanovsky, Oleg; Lavryashina, Maria; Bogunov, Yuri; Khusnutdinova, Elza; Gubina, Marina; Balanovska, Elena; Fedorova, Sardana; Litvinov, Sergey; Malyarchuk, Boris; Derenko, Miroslava; Mosher, M. J.; Archer, David; Cybulski, Jerome; Petzelt, Barbara; Mitchell, Joycelynn; Worl, Rosita; Norman, Paul J.; Parham, Peter; Kemp, Brian M.; Kivisild, Toomas; Tyler-Smith, Chris; Sandhu, Manjinder S.; Crawford, Michael; Villems, Richard; Smith, David Glenn; Waters, Michael R.; Goebel, Ted; Johnson, John R.; Malhi, Ripan S.; Jakobsson, Mattias; Meltzer, David J.; Manica, Andrea; Durbin, Richard; Bustamante, Carlos D.; Song, Yun S.; Nielsen, Rasmus; Willerslev, Eske			Genomic evidence for the Pleistocene and recent population history of Native Americans	SCIENCE			English	Article							CONDITIONAL SAMPLING DISTRIBUTION; CRANIAL MORPHOLOGY; SEQUENCE; MIGRATION; CLOVIS; MODEL; COLONIZATION; SETTLEMENT; ANCESTRY; PATTERNS	Howand when the Americas were populated remains contentious. Using ancient and modern genome-wide data, we found that the ancestors of all present-day Native Americans, including Athabascans and Amerindians, entered the Americas as a single migration wave from Siberia no earlier than 23 thousand years ago (ka) and after no more than an 8000-year isolation period in Beringia. After their arrival to the Americas, ancestral Native Americans diversified into two basal genetic branches around 13 ka, one that is now dispersed across North and South America and the other restricted to North America. Subsequent gene flow resulted in some Native Americans sharing ancestry with present-day East Asians (including Siberians) and, more distantly, Australo-Melanesians. Putative "Paleoamerican" relict populations, including the historical Mexican Pericues and South American Fuego-Patagonians, are not directly related to modern Australo-Melanesians as suggested by the Paleoamerican Model.	[Raghavan, Maanasa; Valdiosera, Cristina; Avila-Arcos, Maria C.; Malaspinas, Anna-Sapfo; Moreno-Mayar, J. Victor; Korneliussen, Thorfinn S.; Pierre, Tracey; Rasmussen, Morten; Campos, Paula F.; Damgaard, Peter De Barros; Allentoft, Morten E.; Seguin-Orlando, Andaine; Stafford, Thomas, Jr.; Meltzer, David J.; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Steinruecken, Matthias; Song, Yun S.] Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA; [Steinruecken, Matthias; Song, Yun S.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Steinruecken, Matthias] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Harris, Kelley] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Schiffels, Stephan; Bergstrom, Anders; Xue, Yali; Tyler-Smith, Chris; Sandhu, Manjinder S.; Durbin, Richard] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Rasmussen, Simon] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [DeGiorgio, Michael] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [DeGiorgio, Michael] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Albrechtsen, Anders; Moltke, Ida] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Valdiosera, Cristina; Smith, Colin I.] La Trobe Univ, Dept Archaeol & Hist, Melbourne, Vic 3086, Australia; [Avila-Arcos, Maria C.; Homburger, Julian R.; Rasmussen, Morten; Shringarpure, Suyash S.; Moreno-Estrada, Andres; Bustamante, Carlos D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Eriksson, Anders; Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Eriksson, Anders] KAUST, Integrat Syst Biol Lab, Thuwal 239556900, Saudi Arabia; [Metspalu, Mait; Metspalu, Ene; Karmin, Monika; Tambets, Kristiina; Litvinov, Sergey; Kivisild, Toomas; Villems, Richard] Evolutionary Biol Grp, Estonian Bioctr, Tartu 51010, Estonia; [Metspalu, Mait; Metspalu, Ene; Karmin, Monika; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, Tartu 51010, Estonia; [Wall, Jeff] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Cornejo, Omar E.; Kemp, Brian M.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Campos, Paula F.] Univ Porto, Ctr Invest Ciencias Mar & Limnol, P-4050123 Oporto, Portugal; [Campos, Paula F.] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, P-4050123 Oporto, Portugal; [Lindo, John; Malhi, Ripan S.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Rodriguez-Varela, Ricardo] Univ Complutense Madrid, Inst Salud Carlos Evoluc & Comportamiento Humano, Ctr Mixto, Madrid, Spain; [Mansilla, Josefina; Leboreiro, Ilan] Inst Nacl Antropol & Hist, Mexico City 06060, DF, Mexico; [Henrickson, Celeste] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [Malmstrom, Helena; Jakobsson, Mattias] Uppsala Univ, Dept Evolutionary Biol & Sci Life Lab, SE-75236 Uppsala, Sweden; [Stafford, Thomas, Jr.] Aarhus Univ, Dept Phys & Astron, Accelerat Mass Spectrometry Dating Ctr 14C, DK-8000 Aarhus, Denmark; [Moreno-Estrada, Andres] Ctr Invest & Estudios Avanzados, LANGEBIO, Guanajuato 36821, Mexico; [Warmuth, Vera; Balloux, Francois] UCL, Genet Inst, London WC1E 6BT, England; [Warmuth, Vera] Evolut Biol Ctr, Uppsala, Sweden; [Friend, Andrew D.] Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England; [Singarayer, Joy] Univ Reading, Ctr Climate Change, Reading, Berks, England; [Singarayer, Joy] Univ Reading, Dept Meteorol, Reading, Berks, England; [Valdes, Paul] Sch Geol Sci, Bristol BS8 1SS, Avon, England; [Vera, Jose Luis] Escuela Nacl Antropol & Hist, Mexico City 14030, DF, Mexico; [Rangel-Villalobos, Hector] Univ Guadalajara, Inst Invest Genet Mol, Ocotlan, Mexico; [Pettener, Davide; Luiselli, Donata] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali BiGeA, I-40126 Bologna, Italy; [Davis, Loren G.] Oregon State Univ, Dept Anthropol, Corvallis, OR 97331 USA; [Heyer, Evelyne] Univ Paris 07, Univ Paris 04, Museum Natl Hist Nat, CNRS,Unite Ecoanthropol & Ethnobiol UMR7206, Paris, France; [Zollikofer, Christoph P. E.; de Leon, Marcia S. Ponce] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Grimes, Vaughan; Pike, Kelly-Anne; Deal, Michael] Mem Univ Newfoundland, Queens Coll, Dept Archaeol, St John, NF A1C 5S7, Canada; [Grimes, Vaughan] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Fuller, Benjamin T.] Univ Calif Irvine, Dept Earth Syst Sci, Keck Carbon Cycle Accelerator Mass Spectrometry G, Irvine, CA 92697 USA; [Arriaza, Bernardo] Univ Tarapaca, Inst Alta Invest, Carsilla, Chile; [Standen, Vivien] Univ Tarapaca, Dept Antropol, Carsilla, Chile; [Luz, Maria F.; Guidon, Niede] Fundacao Museu Homem Amer, Ctr Cultural Sergio Motta, BR-64770000 Campestre, Sao Raimundo No, Brazil; [Ricaut, Francois] Univ Toulouse, CNRS, UMR 5288, Lab Anthropol Mol & Imageie Synthese, F-31073 Toulouse, France; [Osipova, Ludmila; Voevoda, Mikhail I.; Posukh, Olga L.; Gubina, Marina] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Osipova, Ludmila; Posukh, Olga L.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Voevoda, Mikhail I.] RAS, Siberian Branch, Inst Internal Med, Novosibirsk 630089, Russia; [Voevoda, Mikhail I.] Novosibirsk State Univ, Lab Mol Epidemiol & Bioinformat, Novosibirsk 630090, Russia; [Balanovsky, Oleg; Bogunov, Yuri] Vavilov Inst Gen Genet, Moscow 119333, Russia; [Balanovsky, Oleg; Balanovska, Elena] Res Ctr Med Genet, Moscow 115478, Russia; [Lavryashina, Maria] Kemerovo State Univ, Kemerovo 650000, Russia; [Khusnutdinova, Elza; Litvinov, Sergey] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Ufa 450054, Russia; [Khusnutdinova, Elza] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa 450076, Russia; [Fedorova, Sardana] Yakut Sci Ctr Complex Med Problems, Dept Mol Genet, Yakutsk 677010, Russia; [Fedorova, Sardana] MK Ammosov North Eastern Fed Univ, Inst Nat Sci, Lab Mol Biol, Yakutsk 677000, Russia; [Malyarchuk, Boris; Derenko, Miroslava] Russian Acad Sci, Inst Biol Problems North, Magadan 685000, Russia; [Mosher, M. J.] Western Washington Univ, Dept Anthropol, Bellingham, WA 98225 USA; [Archer, David] Northwest Community Coll, Dept Anthropol, Prince Rupert, BC V8J 3L6, Canada; [Cybulski, Jerome] Canadian Museum Hist, Quebec City, PQ K1A 0M8, Canada; [Cybulski, Jerome] Univ Western Ontario, London, ON N6A 3K7, Canada; [Cybulski, Jerome] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Petzelt, Barbara; Mitchell, Joycelynn] Metlakatla Treaty Off, Prince Rupert, BC V8J 3P6, Canada; [Worl, Rosita] Sealaska Heritage Inst, Juneau, AK 99801 USA; [Norman, Paul J.; Parham, Peter] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Kemp, Brian M.] Washington State Univ, Dept Anthropol, Pullman, WA 99163 USA; [Kivisild, Toomas] Univ Cambridge, Div Biol Anthropol, Cambridge CB2 1QH, England; [Sandhu, Manjinder S.] Univ Cambridge, Med Res Council, Mol Biol Lab, Dept Med, Cambridge CB2 0QH, England; [Crawford, Michael] Univ Kansas, Lab Biol Anthropol, Lawrence, KS 66045 USA; [Smith, David Glenn] Univ Calif Davis, Dept Anthropol, Mol Anthropol Lab, Davis, CA 95616 USA; [Waters, Michael R.; Goebel, Ted] Texas A&M Univ, Ctr Study First Amer, College Stn, TX 77843 USA; [Waters, Michael R.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Waters, Michael R.] Texas A&M Univ, Dept Geog, College Stn, TX 77843 USA; [Johnson, John R.] Santa Barbara Museum Nat Hist, Santa Barbara, CA 93105 USA; [Malhi, Ripan S.] Univ Illinois, Carle R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Meltzer, David J.] So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Song, Yun S.; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Copenhagen; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Berkeley; Wellcome Trust Sanger Institute; Technical University of Denmark; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Copenhagen; La Trobe University; Stanford University; University of Cambridge; King Abdullah University of Science & Technology; Estonian Biocentre; University of Tartu; University of California System; University of California San Francisco; Washington State University; Universidade do Porto; Universidade do Porto; University of Illinois System; University of Illinois Urbana-Champaign; Complutense University of Madrid; Utah System of Higher Education; University of Utah; Uppsala University; Aarhus University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of London; University College London; University of Cambridge; University of Reading; University of Reading; University of Bristol; Universidad de Guadalajara; University of Bologna; Oregon State University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Zurich; Memorial University Newfoundland; Max Planck Society; University of California System; University of California Irvine; Universidad de Tarapaca; Universidad de Tarapaca; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; Russian Academy of Sciences; Novosibirsk State University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Research Centre for Medical Genetics; Kemerovo State University; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; Yakut Science Centre of Complex Medical Problems; North-Eastern Federal University in Yakutsk; Institute of Biological Problems of the North; Russian Academy of Sciences; Western Washington University; Western University (University of Western Ontario); Simon Fraser University; Stanford University; Washington State University; University of Cambridge; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Kansas; University of California System; University of California Davis; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Urbana-Champaign; Southern Methodist University; University of California System; University of California Berkeley	Song, YS (corresponding author), Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA.	yss@berkeley.edu; rasmus_nielsen@berkeley.edu; ewillierslev@snm.ku.dk	Albrechtsen, Anders/K-4281-2013; Schiffels, Stephan/D-5675-2018; Kivisild, Toomas/P-5889-2017; Lindo, John/R-5833-2019; Manica, Andrea/B-5497-2008; Campos, Paula/ABF-9898-2021; Willerslev, Eske/AAA-5686-2019; Heyer, Evelyne/K-9184-2013; Fedorova, Sardana/K-5445-2017; Gubina, Marina/AAD-9163-2019; Osipova, Ludmila P/O-6480-2014; Litvinov, Sergey/L-1738-2013; Smith, David/GQQ-8257-2022; Malyarchuk, Boris/D-5783-2018; Moreno-Mayar, J. Víctor/AAB-3732-2022; Valdes, Paul/T-2004-2019; Moreno-Estrada, Andres/R-3950-2017; Khusnutdinova, Elza Kamilevna/A-4810-2013; Voevoda, Mikhail/N-6713-2015; Moltke, Ida/C-6158-2011; Waters, Michael R/A-9430-2009; Eriksson, Anders/C-9767-2010; Pettener, Davide/E-1576-2017; Ricaut, Francois Xavier/G-1206-2010; Nielsen, Rasmus/D-4405-2009; Metspalu, Mait/G-8671-2015; Rodríguez_varela, Ricardo/N-1508-2017; Tambets, Kristiina/M-2568-2019; Durbin, Richard/AAE-7178-2019; Manica, Andrea/N-9013-2019; Rasmussen, Simon/AAA-2308-2020; Posukh, Olga L/Q-6065-2016; Malmström, Helena/C-2476-2017; Valdes, Paul/C-4129-2013; Korneliussen, Thorfinn Sand/ABB-7656-2021; Derenko, Miroslava/J-1495-2018; Rodríguez-Varela, Ricardo/L-1104-2017; Moreno-Estrada, Andres/AAP-4657-2021; Willerslev, Eske/A-9619-2011; Rasmussen, Simon/G-6258-2016; Jakobsson, Mattias/A-6116-2011; Balloux, Francois/D-4783-2009; Balloux, Francois/X-7856-2019; Grimes, Vaughan/AAG-5174-2021; Campos, Paula F/B-1634-2010; Waters, Michael/ABI-2377-2020; Ávila-Arcos, Maria C./AGZ-3897-2022	Albrechtsen, Anders/0000-0001-7306-031X; Schiffels, Stephan/0000-0002-1017-9150; Kivisild, Toomas/0000-0002-6297-7808; Manica, Andrea/0000-0003-1895-450X; Osipova, Ludmila P/0000-0001-7602-1156; Malyarchuk, Boris/0000-0002-0304-0652; Moreno-Mayar, J. Víctor/0000-0002-7712-4496; Valdes, Paul/0000-0002-1902-3283; Moreno-Estrada, Andres/0000-0001-8329-8292; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Voevoda, Mikhail/0000-0001-9425-413X; Moltke, Ida/0000-0001-7052-8554; Eriksson, Anders/0000-0003-3436-3726; Nielsen, Rasmus/0000-0003-0513-6591; Metspalu, Mait/0000-0003-3099-9161; Rodríguez_varela, Ricardo/0000-0002-4173-8648; Tambets, Kristiina/0000-0002-8173-6380; Durbin, Richard/0000-0002-9130-1006; Manica, Andrea/0000-0003-1895-450X; Rasmussen, Simon/0000-0001-6323-9041; Posukh, Olga L/0000-0003-1352-3591; Malmström, Helena/0000-0002-6456-8055; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Derenko, Miroslava/0000-0002-1849-784X; Rodríguez-Varela, Ricardo/0000-0002-4173-8648; Moreno-Estrada, Andres/0000-0001-8329-8292; Willerslev, Eske/0000-0002-7081-6748; Rasmussen, Simon/0000-0001-6323-9041; Jakobsson, Mattias/0000-0001-7840-7853; Balloux, Francois/0000-0003-1978-7715; Balloux, Francois/0000-0003-1978-7715; Grimes, Vaughan/0000-0002-2177-3147; Campos, Paula F/0000-0003-1285-4671; Waters, Michael/0000-0003-2660-3355; Ávila-Arcos, Maria C./0000-0003-1691-1696; Homburger, Julian/0000-0001-7412-3503; Mansilla, Josefina/0000-0002-1581-6462; Heyer, Evelyne/0000-0002-0266-3196; Raghavan, Maanasa/0000-0003-1997-0739; RICAUT, Francois-Xavier/0000-0001-7609-7898; Malaspinas, Anna-Sapfo/0000-0003-1001-7511; Leboreiro, Ilan/0000-0001-7144-4790; Karmin, Monika/0000-0001-9827-5579; Meltzer, David/0000-0001-8084-9802; Bustamante, Carlos D./0000-0002-4187-7920	Lundbeck Foundation; Danish National Research Foundation (Centre for GeoGenetics); Wellcome Trust [098051]; Marie Curie Intra-European Fellowship [PIEF-GA-2009-255503]; Transforming Human Societies Research Focus Areas Fellowship from La Trobe University; National Science Foundation [DMS-1201234, BCS-1025139]; Swiss National Science Foundation [PBSKP3_143529]; Ministerio de Ciencia e Innovacion (MICINN) [CGL2009-12703-C03-03]; MICINN [BES-2010-030127]; Consejo Nacional de Ciencia y Tecnologia (Mexico); Biotechnology and Biological Sciences Research Council [BB/H005854/1]; European Research Council; Marie Curie Actions Grant [300554]; Wenner Foundation; Gren Foundation; Australian Research Council Future Fellowship [FT0992258]; European Research Council [ERC-2011-AdG 295733, 261213]; Bernice Peltier Huber Charitable Trust; Russian Foundation for Basic Research [13-06-00670, 14-0400725, 14-06-00384]; European Union European Regional Development Fund through the Centre of Excellence in Genomics [IUT24-1]; Estonian Science Foundation [8973]; Stanford Graduate Fellowship; Washington State University; French National Research Agency [ANR-14-CE31-0013-01]; Social Science Research Council of Canada; National Institutes of Health [R01-GM094402, R01-AI17892, 2R01HG003229-09]; Packard Fellowship for Science and Engineering; Russian Science Fund [14-04-00827]; Presidium of Russian Academy of Sciences Molecular and Cell Biology Programme; Biotechnology and Biological Sciences Research Council [BB/H008802/1, BB/H008802/2] Funding Source: researchfish; Lundbeck Foundation [R38-2008-3048, R109-2012-9995, R70-2010-6286, R155-2013-16338, R24-2008-2527] Funding Source: researchfish; Villum Fonden [00010120, 00007171] Funding Source: researchfish; BBSRC [BB/H008802/1, BB/H008802/2, BB/H005854/1] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094402, R01GM090087] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation (Centre for GeoGenetics); Wellcome Trust(Wellcome Trust); Marie Curie Intra-European Fellowship(European Commission); Transforming Human Societies Research Focus Areas Fellowship from La Trobe University; National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Marie Curie Actions Grant; Wenner Foundation; Gren Foundation; Australian Research Council Future Fellowship(Australian Research Council); European Research Council(European Research Council (ERC)European Commission); Bernice Peltier Huber Charitable Trust; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); European Union European Regional Development Fund through the Centre of Excellence in Genomics; Estonian Science Foundation; Stanford Graduate Fellowship(Stanford University); Washington State University; French National Research Agency(French National Research Agency (ANR)); Social Science Research Council of Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship for Science and Engineering; Russian Science Fund(Russian Science Foundation (RSF)); Presidium of Russian Academy of Sciences Molecular and Cell Biology Programme; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lundbeck Foundation(Lundbeckfonden); Villum Fonden(Villum Fonden); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Valdes for providing craniometric measurements of the Pericues at the National Museum of Anthropology in Mexico; A. Monteverde from Centro Instituto Nacional de Antropologia e Historia, Baja California Sur and V. Laborde at the Musee de l'Homme in Paris for providing documentation on Pericu and Fuego-Patagonian samples, respectively; T. Gilbert, M. McCoy, C. Sarkissian, M. Sikora, and L. Orlando for helpful discussions and input; D. Yao and C. Barbieri for helping with the collection of the Aymara population sample; B. Henn and J. Kidd for providing early access to the Mayan sequencing data; Canadian Museum of History; Metlakatla and Lax Kw'alaams First Nations; Listuguj Mi'gmaq Band Council; A. Pye of TERRA Facility, Core Research Equipment & Instrument Training (CREAIT) Network at Memorial University; the Danish National High-throughput DNA Sequencing Centre (Copenhagen) for help with sequencing; and Fondation Jean Dausset-Centre d'Etude du Polymorphism Humain (CEPH) for providing DNA for the Human Genome Diversity Project (HGDP) samples that were genome-sequenced in this study. This study was supported by several funding bodies: Lundbeck Foundation and the Danish National Research Foundation (Centre for GeoGenetics members); Wellcome Trust grant 098051 (S.S., A. B., Y.X., C.T.-S., M.S.S., and R.D.); Marie Curie Intra-European Fellowship-FP7-People-PIEF-GA-2009-255503 and the Transforming Human Societies Research Focus Areas Fellowship from La Trobe University (C.V.); George Rosenkranz Prize for Health Care Research in Developing Countries and National Science Foundation award DMS-1201234 (M. C. A. A); Swiss National Science Foundation (PBSKP3_143529) (A.-S.M.); Ministerio de Ciencia e Innovacion (MICINN) Project CGL2009-12703-C03-03 and MICINN (BES-2010-030127) (R.R.-V.); Consejo Nacional de Ciencia y Tecnologia (Mexico) (J.V.M.M.); Biotechnology and Biological Sciences Research Council BB/H005854/1 (V.W., F.B., and A. M.); European Research Council and Marie Curie Actions Grant 300554 (M.E.A.); Wenner-Gren Foundations and the Australian Research Council Future Fellowship FT0992258 (C. I.S.); European Research Council ERC-2011-AdG 295733 grant (Langelin) (D.P. and D. L.); Bernice Peltier Huber Charitable Trust (C.H. and L.G.D.); Russian Foundation for Basic Research grant 13-06-00670 (E.B.); Russian Foundation for Basic Research grant 14-0400725 (E.K.); European Union European Regional Development Fund through the Centre of Excellence in Genomics to Estonian Biocentre and Estonian Institutional Research grant IUT24-1 (E.M., K.T., M. M., M.K., and R.V.); Estonian Science Foundation grant 8973 (M. M.); Stanford Graduate Fellowship (J.R.H.); Washington State University (B.M.K.); French National Research Agency grant ANR-14-CE31-0013-01 (F-X.R); European Research Council grant 261213 (T.K.); National Science Foundation BCS-1025139 (R.S.M.); Social Science Research Council of Canada (K.-A.P. and V.G.); National Institutes of Health grants R01-GM094402 (M.S. and Y.S.S.), R01-AI17892 (P.J.N. and P.P.), and 2R01HG003229-09 (R.N. and C.D.B.); Packard Fellowship for Science and Engineering (Y.S.S.); Russian Science Fund grant 14-04-00827 and Presidium of Russian Academy of Sciences Molecular and Cell Biology Programme (O.B.); and Russian Foundation for Basic Research grant 14-06-00384 (Y.B.). Informed consent was obtained for the sequencing of the modern individuals, with ethical approval from the National Committee on Health Research Ethics, Denmark (H-3-2012-FSP21).; SNP chip genotype data and whole-genome data for select present-day individuals are available only for demographic research under data access agreement with E.W. (a list of these samples is provided in tables S1 and S4). Raw reads from the ancient and the remainder of the present-day genomes are available for download through European Nucleotide Archive (ENA) accession no. PRJEB9733, and the corresponding alignment files are available at www.cbs.dtu.dk/suppl/NativeAmerican. The remainder of the SNP chip genotype data can be accessed through Gene Expression Omnibus (GEO) series accession no. GSE70987 and at www.ebc.ee/free_data. The authors declare no competing financial interests. C.D.B. is on the advisory board of Personalis, Identify Genomics, Etalon DX, and Ancestry.com.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Achilli A, 2013, P NATL ACAD SCI USA, V110, P14308, DOI 10.1073/pnas.1306290110; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Battaglia V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071390; Boeda E, 2014, ANTIQUITY, V88, P927, DOI 10.1017/S0003598X00050845; Brace CL, 2001, P NATL ACAD SCI USA, V98, P10017, DOI 10.1073/pnas.171305898; Cardona A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098076; Chatters JC, 2014, SCIENCE, V344, P750, DOI 10.1126/science.1252619; Crawford MH, 2010, HUM BIOL, V82, P695, DOI 10.3378/027.082.0511; Davis RS, 2010, HUM BIOL, V82, P507, DOI 10.3378/027.082.0503; Dillehay T. D., 1997, LATE PLEISTOCENE SET; Dillehay TD, 1999, EVOL ANTHROPOL, V7, P206, DOI 10.1002/(SICI)1520-6505(1999)7:6<206::AID-EVAN5>3.0.CO;2-G; Dixon EJ, 2013, QUATERN INT, V285, P57, DOI 10.1016/j.quaint.2011.02.027; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P16089, DOI 10.1073/pnas.1209494109; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; Garcia-Bour J, 2004, AM J PHYS ANTHROPOL, V123, P361, DOI 10.1002/ajpa.10337; Gonzalez-Jose R, 2001, AM J PHYS ANTHROPOL, V116, P154, DOI 10.1002/ajpa.1108; Gonzalez-Jose RG, 2003, NATURE, V425, P62, DOI 10.1038/nature01816; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Harris K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003521; Hernandez M, 1997, AM J PHYS ANTHROPOL, V103, P103, DOI 10.1002/(SICI)1096-8644(199705)103:1<103::AID-AJPA7>3.0.CO;2-X; Hoffecker J. F., 2007, HUMAN ECOLOGY BERING; Holen S. R., 2014, PALEOAMERICAN ODYSSE, P429; Hubbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011105; Perez SI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005746; Jenkins DL, 2012, SCIENCE, V337, P223, DOI 10.1126/science.1218443; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Lahr MM, 1995, YEARB PHYS ANTHROPOL, V38, P163; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; Meltzer D. J., 2009, 1 PEOPLES NEW WORLD; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Neves W. A., 2014, PALEOAMERICAN ODYSSE, P397; Neves WA, 2005, P NATL ACAD SCI USA, V102, P18309, DOI 10.1073/pnas.0507185102; Oppenheimer S, 2014, WORLD ARCHAEOL, V46, P752, DOI 10.1080/00438243.2014.966273; Owsley D.W., 2014, KENNEWICK MAN SCI IN; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Santos GM, 2003, QUATERNARY SCI REV, V22, P2303, DOI 10.1016/S0277-3791(03)00205-1; Sarkissian CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087612; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Schroeder KB, 2007, BIOL LETTERS, V3, P218, DOI 10.1098/rsbl.2006.0609; Sheehan S, 2013, GENETICS, V194, P647, DOI 10.1534/genetics.112.149096; Steinrucken M, 2013, THEOR POPUL BIOL, V87, P51, DOI 10.1016/j.tpb.2012.08.004; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Verdu P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004530; Waters MR, 2011, SCIENCE, V331, P1599, DOI 10.1126/science.1201855; Yunusbayev B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005068; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	63	295	296	5	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250							aab3884	10.1126/science.aab3884	http://dx.doi.org/10.1126/science.aab3884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26198033	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000359832700041
J	George, J; Lim, JS; Jang, SJ; Cun, YP; Ozretic, L; Kong, G; Leenders, F; Lu, X; Fernandez-Cuesta, L; Bosco, G; Muller, C; Dahmen, I; Jahchan, NS; Park, KS; Yang, D; Karnezis, AN; Vaka, D; Torres, A; Wang, MS; Korbel, JO; Menon, R; Chun, SM; Kim, D; Wilkerson, M; Hayes, N; Engelmann, D; Putzer, B; Bos, M; Michels, S; Vlasic, I; Seidel, D; Pinther, B; Schaub, P; Becker, C; Altmuller, J; Yokota, J; Kohno, T; Iwakawa, R; Tsuta, K; Noguchi, M; Muley, T; Hoffmann, H; Schnabel, PA; Petersen, I; Chen, Y; Soltermann, A; Tischler, V; Choi, CM; Kim, YH; Massion, PP; Zou, Y; Jovanovic, D; Kontic, M; Wright, GM; Russell, PA; Solomon, B; Koch, I; Lindner, M; Muscarella, LA; la Torre, A; Field, JK; Jakopovic, M; Knezevic, J; Castanos-Velez, E; Roz, L; Pastorino, U; Brustugun, OT; Lund-Iversen, M; Thunnissen, E; Kohler, J; Schuler, M; Botling, J; Sandelin, M; Sanchez-Cespedes, M; Salvesen, HB; Achter, V; Lang, U; Bogus, M; Schneider, PM; Zander, T; Ansen, S; Hallek, M; Wolf, J; Vingron, M; Yatabe, Y; Travis, WD; Nurnberg, P; Reinhardt, C; Perner, S; Heukamp, L; Buttner, R; Haas, SA; Brambilla, E; Peifer, M; Sage, J; Thomas, RK				George, Julie; Lim, Jing Shan; Jang, Se Jin; Cun, Yupeng; Ozretic, Luka; Kong, Gu; Leenders, Frauke; Lu, Xin; Fernandez-Cuesta, Lynnette; Bosco, Graziella; Mueller, Christian; Dahmen, Ilona; Jahchan, Nadine S.; Park, Kwon-Sik; Yang, Dian; Karnezis, Anthony N.; Vaka, Dedeepya; Torres, Angela; Wang, Maia Segura; Korbel, Jan O.; Menon, Roopika; Chun, Sung-Min; Kim, Deokhoon; Wilkerson, Matt; Hayes, Neil; Engelmann, David; Puetzer, Brigitte; Bos, Marc; Michels, Sebastian; Vlasic, Ignacija; Seidel, Danila; Pinther, Berit; Schaub, Philipp; Becker, Christian; Altmueller, Janine; Yokota, Jun; Kohno, Takashi; Iwakawa, Reika; Tsuta, Koji; Noguchi, Masayuki; Muley, Thomas; Hoffmann, Hans; Schnabel, Philipp A.; Petersen, Iver; Chen, Yuan; Soltermann, Alex; Tischler, Verena; Choi, Chang-min; Kim, Yong-Hee; Massion, Pierre P.; Zou, Yong; Jovanovic, Dragana; Kontic, Milica; Wright, Gavin M.; Russell, Prudence A.; Solomon, Benjamin; Koch, Ina; Lindner, Michael; Muscarella, Lucia A.; la Torre, Annamaria; Field, John K.; Jakopovic, Marko; Knezevic, Jelena; Castanos-Velez, Esmeralda; Roz, Luca; Pastorino, Ugo; Brustugun, Odd-Terje; Lund-Iversen, Marius; Thunnissen, Erik; Koehler, Jens; Schuler, Martin; Botling, Johan; Sandelin, Martin; Sanchez-Cespedes, Montserrat; Salvesen, Helga B.; Achter, Viktor; Lang, Ulrich; Bogus, Magdalena; Schneider, Peter M.; Zander, Thomas; Ansen, Sascha; Hallek, Michael; Wolf, Juergen; Vingron, Martin; Yatabe, Yasushi; Travis, William D.; Nuernberg, Peter; Reinhardt, Christian; Perner, Sven; Heukamp, Lukas; Buettner, Reinhard; Haas, Stefan A.; Brambilla, Elisabeth; Peifer, Martin; Sage, Julien; Thomas, Roman K.			Comprehensive genomic profiles of small cell lung cancer	NATURE			English	Article							CYCLE ARREST; C-KIT; NEUROENDOCRINE; MUTATIONS; NOTCH; CARCINOMA; PATHWAY; GROWTH; GENES; HETEROGENEITY	We have sequenced the genomes of 110 small cell lung cancers (SCLC), one of the deadliest human cancers. In nearly all the tumours analysed we found bi-allelic inactivation of TP53 and RB1, sometimes by complex genomic rearrangements. Two tumours with wild-type RB1 had evidence of chromothripsis leading to overexpression of cyclin D1 (encoded by the CCND1 gene), revealing an alternative mechanism of Rb1 deregulation. Thus, loss of the tumour suppressors TP53 and RB1 is obligatory in SCLC. We discovered somatic genomic rearrangements of TP73 that create an oncogenic version of this gene, TP73Dex2/3. In rare cases, SCLC tumours exhibited kinase gene mutations, providing a possible therapeutic opportunity for individual patients. Finally, we observed inactivating mutations in NOTCH family genes in 25% of human SCLC. Accordingly, activation of Notch signalling in a pre-clinical SCLC mouse model strikingly reduced the number of tumours and extended the survival of the mutant mice. Furthermore, neuroendocrine gene expression was abrogated by Notch activity in SCLC cells. This first comprehensive study of somatic genome alterations in SCLC uncovers several key biological processes and identifies candidate therapeutic targets in this highly lethal form of cancer.	[George, Julie; Cun, Yupeng; Leenders, Frauke; Lu, Xin; Fernandez-Cuesta, Lynnette; Bosco, Graziella; Mueller, Christian; Dahmen, Ilona; Bos, Marc; Seidel, Danila; Pinther, Berit; Schaub, Philipp; Peifer, Martin; Thomas, Roman K.] Univ Cologne, Fac Med, Dept Translat Genom, Ctr Integrated Oncol Cologne Bonn, D-50931 Cologne, Germany; [Lim, Jing Shan; Jahchan, Nadine S.; Park, Kwon-Sik; Yang, Dian; Vaka, Dedeepya; Torres, Angela; Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Lim, Jing Shan; Jahchan, Nadine S.; Park, Kwon-Sik; Yang, Dian; Vaka, Dedeepya; Torres, Angela; Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Jang, Se Jin; Chun, Sung-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul 138736, South Korea; [Jang, Se Jin; Chun, Sung-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Ctr Canc Genome Discovery, Seoul 138736, South Korea; [Ozretic, Luka; Heukamp, Lukas; Buettner, Reinhard; Thomas, Roman K.] Univ Hosp Cologne, Dept Pathol, D-50937 Cologne, Germany; [Kong, Gu] Hanyang Univ, Dept Pathol, Coll Med, Seoul 133791, South Korea; [Karnezis, Anthony N.] Vancouver Gen Hosp, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Wang, Maia Segura; Korbel, Jan O.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Menon, Roopika] Univ Hosp Bonn, Inst Pathol, Ctr Integrated Oncol Cologne Bonn, D-53127 Bonn, Germany; [Kim, Deokhoon; Perner, Sven] Univ Ulsan, Coll Med, Asan Med Ctr, Ctr Canc Genome Discovery, Seoul 138736, South Korea; [Wilkerson, Matt] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; [Hayes, Neil] Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Engelmann, David; Puetzer, Brigitte] Univ Rostock, Med Ctr, Inst Expt Gene Therapy & Canc Res, D-18057 Rostock, Germany; [Michels, Sebastian; Ansen, Sascha; Hallek, Michael; Wolf, Juergen] Univ Hosp Cologne, Ctr Integrated Oncol Cologne Bonn, Dept Internal Med 1, D-50937 Cologne, Germany; [Vlasic, Ignacija; Reinhardt, Christian] Univ Hosp Cologne, Dept Internal Med, D-50931 Cologne, Germany; [Becker, Christian; Altmueller, Janine; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Altmueller, Janine] Univ Hosp Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Yokota, Jun; Kohno, Takashi; Iwakawa, Reika] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 1040045, Japan; [Yokota, Jun] Inst Predict & Personalized Med Canc IMPPC, Genom & Epigen Canc Predict Program, Barcelona 08916, Spain; [Tsuta, Koji] Natl Canc Ctr, Dept Pathol & Clin Labs, Chuo Ku, Tokyo 1040045, Japan; [Noguchi, Masayuki] Univ Tsukuba, Fac Med, Dept Pathol, Tsukuba, Ibaraki 3058575, Japan; [Muley, Thomas; Hoffmann, Hans] Univ Heidelberg Hosp, Thoraxklin, D-69126 Heidelberg, Germany; [Muley, Thomas; Schnabel, Philipp A.] TLRC H, D-69126 Heidelberg, Germany; [Schnabel, Philipp A.] Heidelberg Univ, Inst Pathol, D-69120 Heidelberg, Germany; [Petersen, Iver; Chen, Yuan] Univ Jena, Jena Univ Hosp, Inst Pathol, D-07743 Jena, Germany; [Soltermann, Alex; Tischler, Verena] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Choi, Chang-min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul 138736, South Korea; [Kim, Yong-Hee] Univ Ulsan, Coll Med, Dept Thorac & Cardiovasc Surg, Asan Med Ctr, Seoul 138736, South Korea; [Massion, Pierre P.; Zou, Yong] Vanderbilt Ingram Canc Ctr, Thorac Program, Nashville, TN 37232 USA; [Jovanovic, Dragana; Kontic, Milica] Univ Belgrade, Sch Med, Univ Hosp Pulmonol, Clin Ctr Serbia, Belgrade 11000, Serbia; [Wright, Gavin M.] St Vincents Hosp, Peter MacCallum Canc Ctr, Dept Surg, Melbourne, Vic 3065, Australia; [Russell, Prudence A.] St Vincents Hosp, Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic 3065, Australia; Peter MacCallum Canc Ctr, Dept Haematol & Med Oncol, Melbourne, Vic 3065, Australia; [Koch, Ina; Lindner, Michael] Asklepios Fachkliniken, Comprehens Pneumol Ctr Munich, Asklepios Biobank Lungenerkrankungen, D-82131 Munich, Germany; [Muscarella, Lucia A.; la Torre, Annamaria] IRCCS Casa Sollievo Sofferenza, Lab Oncol, I-71013 San Giovanni, Rotondo, Italy; [Field, John K.] Univ Liverpool, Canc Res Ctr, Roy Castle Lung Canc Res Programme, Dept Mol & Clin Canc Med,Inst Translat Med, Liverpool L69 3GA, Merseyside, England; [Jakopovic, Marko] Univ Zagreb, Sch Med, Dept Resp Dis Jordanovac, Univ Hosp Ctr Zagreb, Zagreb 10000, Croatia; [Knezevic, Jelena] Rudjer Boskovic Inst, Lab Translat Med, Zagreb 10000, Croatia; [Castanos-Velez, Esmeralda] Charite Campus Mitte, Charite Comprehens Canc Ctr, D-10115 Berlin, Germany; [Roz, Luca] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Tumor Genom Unit, I-20133 Milan, Italy; [Pastorino, Ugo] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Thorac Surg Unit, I-20133 Milan, Italy; [Brustugun, Odd-Terje] Univ Oslo, Fac Med, Inst Clin Med, N-0424 Oslo, Norway; [Brustugun, Odd-Terje] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, N-0310 Oslo, Norway; [Lund-Iversen, Marius] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway; [Thunnissen, Erik] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands; [Koehler, Jens; Schuler, Martin] Univ Hosp Essen, Dept Med Oncol, West German Canc Ctr, D-45147 Essen, Germany; [Koehler, Jens; Schuler, Martin] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Botling, Johan; Sandelin, Martin] Uppsala Univ, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden; [Botling, Johan; Sandelin, Martin] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, S-75185 Uppsala, Sweden; [Sanchez-Cespedes, Montserrat] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Genes & Canc Grp, Barcelona 08908, Spain; [Salvesen, Helga B.] Univ Bergen, Ctr Canc Biomarkers, Dept Clin Sci, N-5058 Bergen, Norway; [Salvesen, Helga B.] Haukeland Hosp, Dept Gynecol & Obstet, N-5058 Bergen, Norway; [Achter, Viktor; Lang, Ulrich] Univ Cologne, Ctr Comp, D-50931 Cologne, Germany; [Lang, Ulrich; Bogus, Magdalena] Univ Cologne, Dept Informat, D-50931 Cologne, Germany; [Schneider, Peter M.] Univ Cologne, Inst Legal Med, D-50823 Cologne, Germany; [Zander, Thomas] Univ Hosp Cologne, Dept Internal Med 1, Ctr Integrated Oncol Cologne Bonn, Gastrointestinal Canc Grp Cologne, D-50937 Cologne, Germany; [Hallek, Michael; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Vingron, Martin; Haas, Stefan A.] Max Planck Inst Mol Genet, Computat Mol Biol Grp, D-14195 Berlin, Germany; [Yatabe, Yasushi] Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Nagoya, Aichi 4648681, Japan; [Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Nuernberg, Peter; Peifer, Martin] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Brambilla, Elisabeth] Univ Grenoble 1, Inst Albert Bonniot 38043, Dept Pathol, CHU Grenoble,INSERM,U823, F-38043 Grenoble, France	University of Cologne; Stanford University; Stanford University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Cologne; Hanyang University; University of British Columbia; European Molecular Biology Laboratory (EMBL); University of Bonn; University of Ulsan; Asan Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Rostock; University of Cologne; University of Cologne; University of Cologne; University of Cologne; National Cancer Center - Japan; National Cancer Center - Japan; University of Tsukuba; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Friedrich Schiller University of Jena; University of Zurich; University Zurich Hospital; University of Ulsan; Asan Medical Center; University of Ulsan; Vanderbilt University; Clinical Centre of Serbia; University of Belgrade; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; Peter Maccallum Cancer Center; IRCCS Casa Sollievo Della Sofferenza; University of Liverpool; University of Zagreb; Rudjer Boskovic Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Oslo; University of Oslo; University of Oslo; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Uppsala University; Uppsala University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Bergen; University of Bergen; Haukeland University Hospital; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; Aichi Cancer Center; Memorial Sloan Kettering Cancer Center; University of Cologne; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Thomas, RK (corresponding author), Univ Cologne, Fac Med, Dept Translat Genom, Ctr Integrated Oncol Cologne Bonn, D-50931 Cologne, Germany.	mpeifer@uni-koeln.de; julsage@stanford.edu; roman.thomas@uni-koeln.de	Cun, Yupeng/B-5864-2011; Field, John K./AAD-5674-2020; Soltermann, Alex/AAE-3012-2020; Hallek, Michael/Y-3191-2019; Pastorino, Ugo/C-2712-2017; Fernandez-Cuesta, Lynnette/O-2415-2017; YATABE, Yasushi/J-6461-2014; Vlašić, Ignacija/AAW-3007-2021; lindner, michael/AAO-8653-2020; Muley, Thomas/AAY-9200-2020; Lang, Ulrich/O-1487-2013; Botling, Johan/ABA-2586-2020; salvesen, Helga B/C-1187-2017; la Torre, Annamaria/B-2717-2017; Fernandez-Cuesta, Lynnette/Z-1875-2019; Roz, Luca/AAB-3889-2019; Soltermann, Alex/GRR-3265-2022; Vaka, Dedeepya/L-9041-2016; Sanchez-Cespedes, Montse/H-8485-2012; Muscarella, Lucia Anna/K-5979-2016; Tischler, Verena/Q-7263-2017; Köhler, Jens/AAK-1541-2021; Seidel, Danila/Y-6795-2018; Heukamp, Lukas/G-9967-2012	Cun, Yupeng/0000-0002-4241-8099; Field, John K./0000-0003-3951-6365; Hallek, Michael/0000-0002-7425-4455; Pastorino, Ugo/0000-0001-9974-7902; Fernandez-Cuesta, Lynnette/0000-0002-0724-6703; YATABE, Yasushi/0000-0003-1788-559X; lindner, michael/0000-0002-2106-0286; Lang, Ulrich/0000-0001-7166-0805; Botling, Johan/0000-0003-2226-3517; salvesen, Helga B/0000-0002-4438-8831; la Torre, Annamaria/0000-0003-4199-1077; Fernandez-Cuesta, Lynnette/0000-0002-0724-6703; Roz, Luca/0000-0001-5817-7149; Sanchez-Cespedes, Montse/0000-0002-6045-5627; Muscarella, Lucia Anna/0000-0002-1866-8151; Tischler, Verena/0000-0002-6673-8329; Seidel, Danila/0000-0003-4388-3117; la Torre, Annamaria/0000-0002-7017-0879; Schneider, Peter M./0000-0003-0744-2349; Haas, Stefan/0000-0003-3418-3688; Vaka, Dedeepya/0000-0001-7951-5514; Solomon, Benjamin/0000-0003-3059-5730; Peifer, Martin/0000-0002-5243-5503; Park, Kwon-Sik/0000-0003-3346-9086; Kontic Jovanovic, Milica/0000-0003-1285-3812; Sandelin, Martin/0000-0002-0370-8819; Bosco, Graziella/0000-0001-6601-4518; Soltermann, Alex/0000-0001-9509-6938; Segura-Wang, Maia/0000-0003-2424-618X; Kohler (MD), Jens/0000-0002-9922-6469; Knezevic, Jelena/0000-0002-3152-3563; Chun, Sung-Min/0000-0002-3357-1382; Castanos-Velez, Esmeralda/0000-0002-2670-1118; Heukamp, Lukas/0000-0002-3388-3482; Altmuller, Janine/0000-0003-4372-1521	DFG; German Cancer Aid (Deutsche Krebshilfe) as part of the small cell lung cancer genome sequencing consortium [109679]; Korea Research Foundation [KRF 2011-0030105]; NIH [5R01CA114102-08]; German Ministry of Science and Education (BMBF) [01GS08101, 01ZX1303A, 01ZX1406]; Deutsche Forschungsgemeinschaft (DFG) [TH1386/3-1, KFO-286]; German federal state North Rhine Westphalia (NRW); European Union as part of the PerMed NRW initiative [005-1111-0025]; Deutsche Krebshilfe as part of the Oncology Centers of Excellence; EU [HEALTH-F2-2010-258677]; Stand Up To Cancer-American Association of Cancer Research Innovative Research Grant [SU2C-AACR-IR60109]; German Consortium for Translational Cancer Research (DKTK); National Cancer Center Research and Development Fund [NCC Biobank: 23A-1]; Italian Ministry of Health [RC1303LO57, 2010-2316264]; Roy Castle Lung Cancer Foundation UK; AIRC/MGAF [12983]; A*STAR in Singapore;  [SFB832];  [TP6];  [TP5]; NATIONAL CANCER INSTITUTE [R01CA114102] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); German Cancer Aid (Deutsche Krebshilfe) as part of the small cell lung cancer genome sequencing consortium; Korea Research Foundation(National Research Foundation of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German federal state North Rhine Westphalia (NRW); European Union as part of the PerMed NRW initiative; Deutsche Krebshilfe as part of the Oncology Centers of Excellence(Deutsche Krebshilfe); EU(European Commission); Stand Up To Cancer-American Association of Cancer Research Innovative Research Grant; German Consortium for Translational Cancer Research (DKTK); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Italian Ministry of Health(Ministry of Health, Italy); Roy Castle Lung Cancer Foundation UK; AIRC/MGAF(Fondazione AIRC per la ricerca sul cancro); A*STAR in Singapore(Agency for Science Technology & Research (A*STAR)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to all the patients who contributed their tumour specimens. We thank the computing center of the University of Cologne (RRZK) for providing the CPU time on the DFG-funded supercomputer 'CHEOPS', as well as for the support. We thank S. Artavanis-Tsakonas and S. Fre for the gift of the mice with inducible NICD expression. We thank C. Nguyen, J. Berg, J. Heuckmann, F. Malchers, C. Lovely and A. Bernschein for scientific discussions and advice. We thank Genentech/gRED for providing raw sequencing data from a previously published study<SUP>3</SUP>. Some tumors in these studies were provided by the LungBiobank Heidelberg, member of the NCT-Tissue bank, the biomaterial bank Heidelberg and the biobank platform of the German Center for Lung Research, Heidelberg, Germany. This work was supported by the German Cancer Aid (Deutsche Krebshilfe) as part of the small cell lung cancer genome sequencing consortium (grant ID: 109679 to R.K.T., M.P., R.B., P.N., M.V. and S.A.H.). Further support was provided by the Korea Research Foundation (KRF 2011-0030105; grant to S. J. J.). Additional funding was provided by the NIH (5R01CA114102-08 to J. S.), the German Ministry of Science and Education (BMBF) as part of the NGFNplus program(grant 01GS08101 to R.K.T., J.W. and P.N.) and as part of the e:Med program (grant no. 01ZX1303A to R.K.T., J.W., C.R., R.B. and M.P. and grant no. 01ZX1406 to M.P.), by the Deutsche Forschungsgemeinschaft (DFG; through TH1386/3-1 to R.K.T and KFO-286 to P.N.), by the German federal state North Rhine Westphalia (NRW), by the European Union (European Regional Development Fund: Investing In Your Future) as part of the PerMed NRW initiative (grant 005-1111-0025 to R.K.T., J.W. and R.B.), by SFB832 (TP6 to R.K.T., TP5 to L.C.H.), by the Deutsche Krebshilfe as part of the Oncology Centers of Excellence funding program (to R.B., R.K.T. and M.S.), by the EU-Framework program CURELUNG (HEALTH-F2-2010-258677 to R.K.T., J.W., J.K.F., L.R., M.S.C. and E.B.), by Stand Up To Cancer-American Association of Cancer Research Innovative Research Grant (SU2C-AACR-IR60109 to R.K.T.), by the German Consortium for Translational Cancer Research (DKTK) Joint Funding program, by the National Cancer Center Research and Development Fund (NCC Biobank: 23A-1, to T.K., J.Y. and R. I.), by the Italian Ministry of Health (Ricerca Corrente RC1303LO57 and GR program 2010-2316264 to L.A.M.), by the Roy Castle Lung Cancer Foundation UK (to J.K.F.), by the AIRC/MGAF grant 12983 (to L.A.M.) and by A*STAR in Singapore (scholarship to J.S.L.). J. S. is the Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases.	Angeloni D, 2006, GENE CHROMOSOME CANC, V45, P676, DOI 10.1002/gcc.20332; Augustyn A, 2014, P NATL ACAD SCI USA, V111, P14788, DOI 10.1073/pnas.1410419111; Ball DW, 2004, CANCER LETT, V204, P159, DOI 10.1016/S0304-3835(03)00452-X; Beasley MB, 2003, HUM PATHOL, V34, P136, DOI 10.1053/hupa.2003.8; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Falix FA, 2012, BBA-MOL BASIS DIS, V1822, P988, DOI 10.1016/j.bbadis.2012.02.003; Fernandez-Cuesta L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4518; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Helman E, 2014, GENOME RES, V24, P1053, DOI 10.1101/gr.163659.113; HIBI K, 1991, ONCOGENE, V6, P2291; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Iwakawa R, 2013, GENE CHROMOSOME CANC, V52, P802, DOI 10.1002/gcc.22076; Jahchan NS, 2013, CANCER DISCOV, V3, P1364, DOI 10.1158/2159-8290.CD-13-0183; Jancalek R, 2014, BRIT J NEUROSURG, V28, P598, DOI 10.3109/02688697.2014.908162; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Kovatich A, 1998, CANCER-AM CANCER SOC, V83, P1109, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1109::AID-CNCR9>3.0.CO;2-2; Lafkas D, 2013, J CELL BIOL, V203, P47, DOI 10.1083/jcb.201307046; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu X, 2014, BIOINFORMATICS, V30, P1295, DOI 10.1093/bioinformatics/btu011; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; MORI N, 1990, ONCOGENE, V5, P1713; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pitkanen E, 2014, ONCOTARGET, V5, P853, DOI 10.18632/oncotarget.1781; Qi RZ, 2003, CANCER RES, V63, P8323; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Seidel D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006802; Shibata T, 2009, CANCER LETT, V283, P203, DOI 10.1016/j.canlet.2009.03.038; Sriuranpong V, 2001, CANCER RES, V61, P3200; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Tannapfel A, 2008, CARCINOGENESIS, V29, P211, DOI 10.1093/carcin/bgm236; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Venkatanarayan A, 2015, NATURE, V517, P626, DOI 10.1038/nature13910; Wael H, 2014, LUNG CANCER, V85, P131, DOI 10.1016/j.lungcan.2014.05.001; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Yokomizo A, 1998, ONCOGENE, V17, P475, DOI 10.1038/sj.onc.1201956; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	50	1105	1137	8	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					47	53		10.1038/nature14664	http://dx.doi.org/10.1038/nature14664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26168399	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000359002300029
J	Jeong, JW; McCall, JG; Shin, G; Zhang, YH; Al-Hasani, R; Kim, M; Li, S; Sim, JY; Jang, KI; Shi, Y; Hong, DY; Liu, YH; Schmitz, GP; Xia, L; He, ZB; Gamble, P; Ray, WZ; Huang, YG; Bruchas, MR; Rogers, JA				Jeong, Jae-Woong; McCall, Jordan G.; Shin, Gunchul; Zhang, Yihui; Al-Hasani, Ream; Kim, Minku; Li, Shuo; Sim, Joo Yong; Jang, Kyung-In; Shi, Yan; Hong, Daniel Y.; Liu, Yuhao; Schmitz, Gavin P.; Xia, Li; He, Zhubin; Gamble, Paul; Ray, Wilson Z.; Huang, Yonggang; Bruchas, Michael R.; Rogers, John A.			Wireless Optofluidic Systems for Programmable In Vivo Pharmacology and Optogenetics	CELL			English	Article							VENTRAL TEGMENTAL AREA; NEURAL INTERFACES; LATERAL HABENULA; DOPAMINE NEURONS; DENDRITIC SPINES; OPTICAL CONTROL; DRUG-DELIVERY; BLIND MICE; ACTIVATION; MORPHINE	In vivo pharmacology and optogenetics hold tremendous promise for dissection of neural circuits, cellular signaling, and manipulating neurophysiological systems in awake, behaving animals. Existing neural interface technologies, such as metal cannulas connected to external drug supplies for pharmacological infusions and tethered fiber optics for optogenetics, are not ideal for minimally invasive, un-tethered studies on freely behaving animals. Here, we introduce wireless optofluidic neural probes that combine ultrathin, soft microfluidic drug delivery with cellular-scale inorganic light-emitting diode (m-ILED) arrays. These probes are orders of magnitude smaller than cannulas and allow wireless, programmed spatiotemporal control of fluid delivery and photostimulation. We demonstrate these devices in freely moving animals to modify gene expression, deliver peptide ligands, and provide concurrent photostimulation with antagonist drug delivery to manipulate mesoaccumbens reward-related behavior. The minimally invasive operation of these probes forecasts utility in other organ systems and species, with potential for broad application in biomedical science, engineering, and medicine.	[Jeong, Jae-Woong] Univ Colorado, Dept Elect Comp & Energy Engn, Boulder, CO 80309 USA; [Jeong, Jae-Woong; Shin, Gunchul; Kim, Minku; Li, Shuo; Jang, Kyung-In; Liu, Yuhao; Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Jeong, Jae-Woong; Shin, Gunchul; Kim, Minku; Li, Shuo; Jang, Kyung-In; Liu, Yuhao; Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [McCall, Jordan G.; Al-Hasani, Ream; Hong, Daniel Y.; Schmitz, Gavin P.; Bruchas, Michael R.] Washington Univ, Sch Med, Dept Anesthesiol, Basic Res Div, St Louis, MO 63110 USA; [McCall, Jordan G.; Al-Hasani, Ream; Bruchas, Michael R.] Washington Univ, Sch Med, Anat & Neurobiol, St Louis, MO 63110 USA; [McCall, Jordan G.; Bruchas, Michael R.] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Zhang, Yihui; Shi, Yan; He, Zhubin; Huang, Yonggang] Northwestern Univ, Skin Dis Res Ctr, Ctr Engn & Hlth, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Zhang, Yihui; Shi, Yan; He, Zhubin; Huang, Yonggang] Northwestern Univ, Skin Dis Res Ctr, Ctr Engn & Hlth, Dept Mech Engn, Evanston, IL 60208 USA; [Zhang, Yihui] Tsinghua Univ, Ctr Mech & Mat, Beijing 100084, Peoples R China; [Sim, Joo Yong] Elect & Telecommun Res Inst, Biomed IT Convergence Res Dept, Taejon 305700, South Korea; [Shi, Yan] Nanjing Univ Aeronaut & Astronaut, State Key Lab Mech & Control Mech Struct, Nanjing 210016, Peoples R China; [Xia, Li; Bruchas, Michael R.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [He, Zhubin] Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China; [Gamble, Paul; Ray, Wilson Z.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA; [Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61802 USA; [Rogers, John A.] Univ Illinois, Dept Engn Sci & Mech, Urbana, IL 61802 USA; [Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61802 USA	University of Colorado System; University of Colorado Boulder; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Northwestern University; Northwestern University; Tsinghua University; Electronics & Telecommunications Research Institute - Korea (ETRI); Nanjing University of Aeronautics & Astronautics; Washington University (WUSTL); Harbin Institute of Technology; Washington University (WUSTL); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bruchas, MR (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Basic Res Div, St Louis, MO 63110 USA.	bruchasm@wustl.edu; jrogers@uiuc.edu	Huang, Yonggang/B-6998-2009; Zhang, Yihui/G-9876-2011; Bruchas, Michael/G-7616-2012; Jeong, Jae-Woong/A-7903-2018; Shi, Yan/K-3115-2012; Al-Hasani, Ream/GPX-3398-2022; Rogers, John/L-2798-2016; huang, yonggang/O-6236-2019; Sim, Joo Yong/AAC-8087-2019; Li, Shuo/Y-4581-2018	Zhang, Yihui/0000-0003-0885-2067; Jeong, Jae-Woong/0000-0001-7607-5453; Shi, Yan/0000-0001-7421-3306; Li, Shuo/0000-0003-4913-730X; Sim, Joo Yong/0000-0003-3779-7589	EUREKA NIDA [R01DA037152]; NIMH [F31 MH101956]; NIDA [K99DA038725]; National Security Science and Engineering Faculty Fellowship of Energy; US Department of Energy, Division of Materials Sciences [DE-FG02-07ER46471]; NIH Common Fund NINDS [R01NS081707]; Materials Research Laboratory and Center for Microanalysis of Materials [DE-FG02-07ER46453]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH101956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037152, K99DA038725] Funding Source: NIH RePORTER	EUREKA NIDA; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Security Science and Engineering Faculty Fellowship of Energy; US Department of Energy, Division of Materials Sciences(United States Department of Energy (DOE)); NIH Common Fund NINDS; Materials Research Laboratory and Center for Microanalysis of Materials; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This material is based on work supported by the EUREKA NIDA R01DA037152 (M.R.B.), NIMH F31 MH101956 (J.G.M.), and NIDA K99DA038725 (to R.A.). We thank the Bruchas laboratory and the laboratory of Dr. Robert W. Gereau IV, in particular Tayler Sheahan and Dr. Judith Golden (Washington University) for helpful discussion. We thank Dr. Karl Deisseroth (Stanford University) for the channelrhodopsin-2 (H134), Dr. Garret Stuber (UNC) for the TH-IRES-Cre mice, the WUSTL Hope Center Viral Vector Core for viral packaging, and the WUSTL Pain Center for use of the rotarod and running wheels. All biomedical aspects of the device work were supported by a National Security Science and Engineering Faculty Fellowship of Energy (J.A.R.). The LED development was enabled by funding from the US Department of Energy, Division of Materials Sciences under award number DE-FG02-07ER46471 (J.A.R.), the NIH Common Fund NINDS R01NS081707 (J.A.R. and M.R.B.), and through the Materials Research Laboratory and Center for Microanalysis of Materials (DE-FG02-07ER46453) (J.A.R.).	Banghart MR, 2012, NEURON, V73, P249, DOI 10.1016/j.neuron.2011.11.016; BILLARD W, 1984, LIFE SCI, V35, P1885, DOI 10.1016/0024-3205(84)90540-X; CALENCOCHOUKROUN G, 1991, PSYCHOPHARMACOLOGY, V103, P493, DOI 10.1007/BF02244249; Callahan WJ, 2001, PHARM RES-DORDR, V18, P261, DOI 10.1023/A:1011034425896; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Canales A, 2015, NAT BIOTECHNOL, V33, P277, DOI 10.1038/nbt.3093; Capadona JR, 2012, MRS BULL, V37, P581, DOI 10.1557/mrs.2012.97; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; DEVINE DP, 1994, J NEUROSCI, V14, P1978; Fan Wu, 2013, 2013 Transducers & Eurosensors XXVII: 17th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS & EUROSENSORS XXVII), P888, DOI 10.1109/Transducers.2013.6626910; Gilletti A, 2006, J NEURAL ENG, V3, P189, DOI 10.1088/1741-2560/3/3/001; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hoare T, 2011, NANO LETT, V11, P1395, DOI 10.1021/nl200494t; Hoare T, 2009, NANO LETT, V9, P3651, DOI 10.1021/nl9018935; HYTTEL J, 1983, EUR J PHARMACOL, V91, P153, DOI 10.1016/0014-2999(83)90381-3; JENCK F, 1988, BRAIN RES, V450, P382, DOI 10.1016/0006-8993(88)91580-6; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Jeong JW, 2015, NEURON, V86, P175, DOI 10.1016/j.neuron.2014.12.035; JOYCE JR, 1984, BIOMED MASS SPECTROM, V11, P284, DOI 10.1002/bms.1200110607; Kim KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033612; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]; Kozai TDY, 2009, J NEUROSCI METH, V184, P199, DOI 10.1016/j.jneumeth.2009.08.002; Kramer RH, 2013, NAT NEUROSCI, V16, P816, DOI 10.1038/nn.3424; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; LATIMER LG, 1987, J PHARMACOL EXP THER, V241, P328; Lee H, 2005, J NEURAL ENG, V2, P81, DOI 10.1088/1741-2560/2/4/003; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; McCall JG, 2013, NAT PROTOC, V8, P2413, DOI 10.1038/nprot.2013.158; Minev IR, 2015, SCIENCE, V347, P159, DOI 10.1126/science.1260318; Mourot A, 2012, NAT METHODS, V9, P396, DOI [10.1038/NMETH.1897, 10.1038/nmeth.1897]; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Polosukhina A, 2012, NEURON, V75, P271, DOI 10.1016/j.neuron.2012.05.022; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Spieth S, 2012, BIOMED MICRODEVICES, V14, P799, DOI 10.1007/s10544-012-9659-2; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Steger PJK, 1996, J CLIN PHARM THER, V21, P73, DOI 10.1111/j.1365-2710.1996.tb00003.x; Stuber GD, 2015, NEURON, V85, P439, DOI 10.1016/j.neuron.2014.12.034; Subbaroyan J, 2005, J NEURAL ENG, V2, P103, DOI 10.1088/1741-2560/2/4/006; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Timko BP, 2014, P NATL ACAD SCI USA, V111, P1349, DOI 10.1073/pnas.1322651111; Tochitsky I, 2014, NEURON, V81, P800, DOI 10.1016/j.neuron.2014.01.003; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Walsh JJ, 2014, NAT NEUROSCI, V17, P27, DOI 10.1038/nn.3591; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zhang K, 2015, TRENDS BIOTECHNOL, V33, P92, DOI 10.1016/j.tibtech.2014.11.007	55	320	329	11	181	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					662	674		10.1016/j.cell.2015.06.058	http://dx.doi.org/10.1016/j.cell.2015.06.058			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26189679	Bronze, Green Accepted			2022-12-28	WOS:000358801800023
J	Sommers, BD; Gunja, MZ; Finegold, K; Musco, T				Sommers, Benjamin D.; Gunja, Munira Z.; Finegold, Kenneth; Musco, Thomas			Changes in Self-reported Insurance Coverage, Access to Care, and Health Under the Affordable Care Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAID EXPANSION STATES; YOUNG-ADULTS; REFORM; MORTALITY	IMPORTANCE The Affordable Care Act (ACA) completed its second open enrollment period in February 2015. Assessing the law's effects has major policy implications. OBJECTIVES To estimate national changes in self-reported coverage, access to care, and health during the ACA's first 2 open enrollment periods and to assess differences between low-income adults in states that expanded Medicaid and in states that did not expand Medicaid. DESIGN, SETTING, AND PARTICIPANTS Analysis of the 2012-2015 Gallup-Healthways Well-Being Index, a daily national telephone survey. Using multivariable regression to adjust for pre-ACA trends and sociodemographics, we examined changes in outcomes for the nonelderly US adult population aged 18 through 64 years (n = 507 055) since the first open enrollment period began in October 2013. Linear regressions were used to model each outcome as a function of a linear monthly time trend and quarterly indicators. Then, pre-ACA (January 2012-September 2013) and post-ACA (January 2014-March 2015) changes for adults with incomes below 138% of the poverty level in Medicaid expansion states (n = 48 905 among 28 states and Washington, DC) vs nonexpansion states (n = 37 283 among 22 states) were compared using a differences-in-differences approach. EXPOSURES Beginning of the ACA's first open enrollment period (October 2013). MAIN OUTCOMES AND MEASURES Self-reported rates of being uninsured, lacking a personal physician, lacking easy access to medicine, inability to afford needed care, overall health status, and health-related activity limitations. RESULTS Among the 507 055 adults in this survey, pre-ACA trends were significantly worsening for all outcomes. Compared with the pre-ACA trends, by the first quarter of 2015, the adjusted proportions who were uninsured decreased by 7.9 percentage points (95% CI, -9.1 to -6.7); who lacked a personal physician, -3.5 percentage points (95% CI, -4.8 to -2.2); who lacked easy access to medicine, -2.4 percentage points (95% CI, -3.3 to -1.5); who were unable to afford care, -5.5 percentage points (95% CI, -6.7 to -4.2); who reported fair/poor health, -3.4 percentage points (95% CI, -4.6 to -2.2); and the percentage of days with activities limited by health, -1.7 percentage points (95% CI, -2.4 to -0.9). Coverage changes were largest among minorities; for example, the decrease in the uninsured rate was larger among Latino adults (-11.9 percentage points [95% CI, -15.3 to -8.5]) than white adults (-6.1 percentage points [95% CI, -7.3 to -4.8]). Medicaid expansion was associated with significant reductions among low-income adults in the uninsured rate (differences-indifferences estimate, -5.2 percentage points [95% CI, -7.9 to -2.6]), lacking a personal physician (-1.8 percentage points [95% CI, -3.4 to -0.3]), and difficulty accessing medicine (-2.2 percentage points [95% CI, -3.8 to -0.7]). CONCLUSIONS AND RELEVANCE The ACA's first 2 open enrollment periods were associated with significantly improved trends in self-reported coverage, access to primary care and medications, affordability, and health. Low-income adults in states that expanded Medicaid reported significant gains in insurance coverage and access compared with adults in states that did not expand Medicaid.	[Sommers, Benjamin D.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Sommers, Benjamin D.; Gunja, Munira Z.; Finegold, Kenneth; Musco, Thomas] US Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA; [Gunja, Munira Z.] Commonwealth Fund, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Commonwealth Fund	Sommers, BD (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Kresge Room 406, Boston, MA 02115 USA.	bsommers@hsph.harvard.edu			AHRQ; National Institute for Health Care Management; Commonwealth Fund; University of Michigan; MedPAC; Johns Hopkins University; University of Pennsylvania	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute for Health Care Management; Commonwealth Fund; University of Michigan(University of Michigan System); MedPAC; Johns Hopkins University(Johns Hopkins University); University of Pennsylvania	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Sommers reports receiving grants from AHRQ, National Institute for Health Care Management, and Commonwealth Fund; travel expenses from Georgia Budget and Policy Institute, America's Health Insurance Plan, and Healthcare Channel; and personal fees and travel expenses from University of Michigan, MedPAC, Johns Hopkins University, and University of Pennsylvania. No other disclosures were reported.	Allen H, 2014, HEALTH AFFAIR, V33, P292, DOI 10.1377/hlthaff.2013.1002; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Bureau of Labor Statistics, 2015, LOC AR UN STAT; Carman KG, 2013, HLTH AFF MILLWOOD, V34; Centers for Medicare & Medicaid Services, MED CHIP MARCH 2015; Chua KP, 2014, JAMA-J AM MED ASSOC, V311, P2437, DOI 10.1001/jama.2014.2202; Collins SR, 2015, RISE HLTH CARE COVER; Davern M, 2013, HEALTH SERV RES, V48, P905, DOI 10.1111/1475-6773.12070; Finegold K, SURVEY DATA HLTH INS; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; IMS Institute for Healthcare Informatics, 2015, MED US SPEND SHIFTS; Kaiser Family Foundation, EXPL PUBL VIEWS AFF; Kaiser Family Foundation, STAT STAT ACT MED EX; Kaufman HW, 2015, DIABETES CARE, V38, P833, DOI 10.2337/dc14-2334; Kenney GM, 2012, HEALTH AFFAIR, V31, P899, DOI 10.1377/hlthaff.2012.0159; Levy J, US UNINSURED RATE DI; Long SK, 2014, HEALTH AFFAIR, V33, P161, DOI 10.1377/hlthaff.2013.0934; Martinez ME, 2014, HLTH INSURANCE COVER; Martinez ME, 2011, HLTH INSURANCE COVER; McMorrow S, 2015, HEALTH AFFAIR, V34, P616, DOI 10.1377/hlthaff.2015.0044; McWilliams JM, 2007, JAMA-J AM MED ASSOC, V298, P2886, DOI 10.1001/jama.298.24.2886; Mendes E., US SIGNIFICANTLY FEW; Meyer PA, 2013, MMWR-MORBID MORTAL W, V62, P3; Office of the Assistant Secretary for Planning and Evaluation, HLTH INS MARK 2015 O; Pew Research Center, ASS REPR PUBL OP SUR; Shartzer A., 2014, WHO ARE REMAINING UN; Shartzer A., 2015, QUICKTAKE INSURANCE; Skopec L, 2014, HEALTHCARE, V2, P113, DOI 10.1016/j.hjdsi.2014.03.001; Sommers BD, 2014, NEW ENGL J MED, V371, P867, DOI 10.1056/NEJMsr1406753; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275; Sommers BD, 2013, HEALTH AFFAIR, V32, P165, DOI 10.1377/hlthaff.2012.0552; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; The Council of Economic Advisors, MISS OPP CONS STAT D; US Department of Health and Human Services, PRIOR HHS POV GUID F; Van der Wees PJ, 2013, MILBANK Q, V91, P663, DOI 10.1111/1468-0009.12029; Wallace J, 2015, JAMA PEDIATR, V169, P495, DOI 10.1001/jamapediatrics.2014.3574	37	419	420	2	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					366	374		10.1001/jama.2015.8421	http://dx.doi.org/10.1001/jama.2015.8421			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN6YY	26219054	Bronze, Green Submitted			2022-12-28	WOS:000358581700018
J	Wilensky, GR				Wilensky, Gail R.			Improving and Refining the Affordable Care Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Project Hope, Bethesda, MD 20814 USA		Wilensky, GR (corresponding author), Project Hope, 7500 Old Georgetown Rd,Ste 600, Bethesda, MD 20814 USA.	gwilensky@projecthope.org						Capretta J, 2014, HLTH AFFAIRS BLOG; Pickert K., 2014, TIME; Wilensky G, 2015, JAMA	3	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					339	340		10.1001/jama.2015.5468	http://dx.doi.org/10.1001/jama.2015.5468			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219045				2022-12-28	WOS:000358581700009
J	Charo, RA				Charo, R. Alta			Yellow lights for emerging technologies	SCIENCE			English	Editorial Material							CONDITIONAL APPROVAL; EUROPE		[Charo, R. Alta] Univ Wisconsin Madison, Sch Law, Madison, WI 53706 USA; Univ Wisconsin Madison, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin Madison, Sch Law, Madison, WI 53706 USA.	alta.charo@wisc.edu		Charo, Robin Alta/0000-0003-3710-1043				Akst Jef., 2012, SCIENTIST; [Anonymous], 1999, ENH REG DEC MAK APPR; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Boon WPC, 2010, CLIN PHARMACOL THER, V88, P848, DOI 10.1038/clpt.2010.207; Charo RA, 2013, JAMA INTERN MED, V173, P1165, DOI 10.1001/jamainternmed.2013.7161; Food Insight, 2015, RIG ROAD FOOD INGR A; Government Accountability Office, 2013, 13145 GAO; Konomi K, 2015, CELL STEM CELL, V16, P350, DOI 10.1016/j.stem.2015.03.012; Lexchin J., 2015, BRIT J PHARMACOL, V79, P8; Marchant G.E, 2011, GROWING GAP EMERGING; Noah L., 1999, ENHANCING REGULATORY; Office of Science and Technology Policy, PRINC REG OV EM TECH; RANCHORDAS S., 2015, JURIMETRICS, V55, P201; Sanchez M., 2014, FOOD LAW REGULATION; Sipp D, 2015, CELL STEM CELL, V16, P353, DOI 10.1016/j.stem.2015.03.013; USDA, DET REG STAT FOOD IN; Vogel D, 2003, BRIT J POLIT SCI, V33, P557, DOI 10.1017/S0007123403000255	17	14	14	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					384	385		10.1126/science.aab3885	http://dx.doi.org/10.1126/science.aab3885			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN4DX	26206921				2022-12-28	WOS:000358381400025
J	Liedl, T				Liedl, Tim			NANOTECHNOLOGY Pathfinder for DNA constructs	NATURE			English	Editorial Material							NANOSTRUCTURES; SHAPES		Univ Munich, Dept Phys, D-80539 Munich, Germany	University of Munich	Liedl, T (corresponding author), Univ Munich, Dept Phys, D-80539 Munich, Germany.	tim.liedl@physik.lmu.de	Liedl, Tim/O-7539-2014	Liedl, Tim/0000-0002-0040-0173				Benson E, 2015, NATURE, V523, P441, DOI 10.1038/nature14586; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Euler L., 1736, COMMENTARII ACAD SCI, V8, P128; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Perrault SD, 2014, ACS NANO, V8, P5132, DOI 10.1021/nn5011914; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Simmel SS, 2014, ACCOUNTS CHEM RES, V47, P1691, DOI 10.1021/ar400319n; TURK G, 1994, P SIGGRAPH 94, V94, P311	13	3	3	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					412	413		10.1038/523412a	http://dx.doi.org/10.1038/523412a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26201592				2022-12-28	WOS:000358378900023
J	Ragni, MV				Ragni, Margaret V.			Targeting Antithrombin to Treat Hemophilia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEMOSTASIS		[Ragni, Margaret V.] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15213 USA; [Ragni, Margaret V.] Hemophilia Ctr Western Penn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ragni, MV (corresponding author), Univ Pittsburgh, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15213 USA.							Bolliger D, 2010, THROMB HAEMOSTASIS, V103, P1233, DOI 10.1160/TH09-10-0732; Gouw SC, 2013, BLOOD, V121, P4046, DOI 10.1182/blood-2012-09-457036; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Sehgal A, 2015, NAT MED, V21, P492, DOI 10.1038/nm.3847	5	22	23	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					389	391		10.1056/NEJMcibr1505657	http://dx.doi.org/10.1056/NEJMcibr1505657			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3NL	26200986				2022-12-28	WOS:000358333500015
J	Mervis, J				Mervis, Jeffrey			BEHIND THE NUMBERS Salaries pump up biomedical inflation	SCIENCE			English	News Item																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		225	225		10.1126/science.349.6245.225	http://dx.doi.org/10.1126/science.349.6245.225			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185225				2022-12-28	WOS:000358218600016
J	Mauss, AS; Pankova, K; Arenz, A; Nern, A; Rubin, GM; Borst, A				Mauss, Alex S.; Pankova, Katarina; Arenz, Alexander; Nern, Aljoscha; Rubin, Gerald M.; Borst, Alexander			Neural Circuit to Integrate Opposing Motions in the Visual Field	CELL			English	Article							LATERAL GENICULATE-NUCLEUS; OPTIC FLOW; DROSOPHILA-MELANOGASTER; DIRECTION SELECTIVITY; SENSITIVE NEURONS; LOBULA PLATE; COMPUTATIONAL STRUCTURE; RESPONSE PROPERTIES; GAIN-CONTROL; FLY	When navigating in their environment, animals use visual motion cues as feedback signals that are elicited by their own motion. Such signals are provided by wide-field neurons sampling motion directions at multiple image points as the animal maneuvers. Each one of these neurons responds selectively to a specific optic flow-field representing the spatial distribution of motion vectors on the retina. Here, we describe the discovery of a group of local, inhibitory interneurons in the fruit fly Drosophila key for filtering these cues. Using anatomy, molecular characterization, activity manipulation, and physiological recordings, we demonstrate that these interneurons convey direction-selective inhibition to wide-field neurons with opposite preferred direction and provide evidence for how their connectivity enables the computation required for integrating opposing motions. Our results indicate that, rather than sharpening directional selectivity per se, these circuit elements reduce noise by eliminating non-specific responses to complex visual information.	[Mauss, Alex S.; Pankova, Katarina; Arenz, Alexander; Borst, Alexander] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Nern, Aljoscha; Rubin, Gerald M.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Max Planck Society; Howard Hughes Medical Institute	Mauss, AS (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	amauss@neuro.mpg.de		Rubin, Gerald/0000-0001-8762-8703; Pankova, Katarina/0000-0002-7182-5486; Mauss, Alex/0000-0002-8061-8024	EMBO Long-Term Fellowship; Max-Planck-Society; Deutsche Forschungsgemeinschaft [CRC 870]; HHMI	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Max-Planck-Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HHMI(Howard Hughes Medical Institute)	We would like to thank Barry Dickson (Janelia) for sharing unpublished fly lines; Matthias Meier, Etienne Serbe, and Jurgen Haag for help with two-photon calcium imaging; Christoph Kapfer for advice on fixation procedures; Georg Ammer and Wolfgang Essbauer for tetanus toxin staining; Aljoscha Leonhardt, Armin Bahl, and Tabea Schilling for experimental help; Wolfgang Essbauer, Christian Theile, Michael Sauter, and Renate Gleich for technical assistance; and Jurgen Haag for critically reading the manuscript. We thank the Janelia Fly-Light Project Team (especially Jennifer Jeter) for assistance with MCFO sample preparation and imaging. We would also like to acknowledge Karin Nordstrom (Uppsala University) for sharing unpublished results. We acknowledge the Developmental Studies Hybridoma Bank for antibodies and the Bloomington Drosophila Stock Center for flies. A.A. was funded by an EMBO Long-Term Fellowship. This work was supported by the Max-Planck-Society, the Deutsche Forschungsgemeinschaft (CRC 870), and HHMI.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Bahl A, 2013, NAT NEUROSCI, V16, P730, DOI 10.1038/nn.3386; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; BORST A, 1995, J COMPUT NEUROSCI, V2, P5, DOI 10.1007/BF00962705; BORST A, 1990, P NATL ACAD SCI USA, V87, P9363, DOI 10.1073/pnas.87.23.9363; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Brotz TM, 1996, J NEUROPHYSIOL, V76, P1786, DOI 10.1152/jn.1996.76.3.1786; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; COLLETT TS, 1966, NATURE, V212, P1330, DOI 10.1038/2121330a0; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; EGELHAAF M, 1990, BRAIN RES, V509, P156, DOI 10.1016/0006-8993(90)90325-6; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Freifeld L, 2013, NEURON, V78, P1075, DOI 10.1016/j.neuron.2013.04.024; HAUSEN K, 1980, CELL TISSUE RES, V208, P371; HAUSEN K, 1976, Z NATURFORSCH C, V31, P629; Hausen K., 1984, PHOTORECEPTION VISIO, V74, P523; Hopp E, 2014, J COMP PHYSIOL A, V200, P359, DOI 10.1007/s00359-014-0893-3; IBBOTSON MR, 1991, J COMP PHYSIOL A, V168, P91, DOI 10.1007/BF00217107; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2013, J NEUROSCI, V33, P902, DOI 10.1523/JNEUROSCI.3374-12.2013; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; LEVICK WR, 1969, SCIENCE, V165, P712, DOI 10.1126/science.165.3894.712; Liu WW, 2013, P NATL ACAD SCI USA, V110, P10294, DOI 10.1073/pnas.1220560110; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; MARDER E, 1978, J PHYSIOL-LONDON, V280, P213, DOI 10.1113/jphysiol.1978.sp012381; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; Mauss AS, 2014, J NEUROSCI, V34, P2254, DOI 10.1523/JNEUROSCI.3938-13.2014; Nern A, 2015, P NATL ACAD SCI USA, V112, pE2967, DOI 10.1073/pnas.1506763112; OYSTER CW, 1971, DOC OPHTHALMOL, V30, P161, DOI 10.1007/BF00142519; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; REICHARDT W, 1987, J COMP PHYSIOL A, V161, P533, DOI 10.1007/BF00603660; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; SATO H, 1991, BRAIN RES, V544, P156, DOI 10.1016/0006-8993(91)90899-7; Schnell B, 2012, J COMP PHYSIOL A, V198, P389, DOI 10.1007/s00359-012-0716-3; Scott EK, 2002, J COMP NEUROL, V454, P470, DOI 10.1002/cne.10467; Shinomiya K, 2014, CURR BIOL, V24, P1062, DOI 10.1016/j.cub.2014.03.051; Silies M, 2013, NEURON, V79, P111, DOI 10.1016/j.neuron.2013.04.029; SINGER W, 1977, PHYSIOL REV, V57, P386, DOI 10.1152/physrev.1977.57.3.386; Single S, 1997, J NEUROSCI, V17, P6023; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Takemura SY, 2011, CURR BIOL, V21, P2077, DOI 10.1016/j.cub.2011.10.053; Tuthill JC, 2013, NEURON, V79, P128, DOI 10.1016/j.neuron.2013.05.024; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; Wang X, 2011, NAT NEUROSCI, V14, P224, DOI 10.1038/nn.2707; Wasserman SM, 2015, CURR BIOL, V25, P467, DOI 10.1016/j.cub.2014.12.012; Wertz A, 2008, J NEUROSCI, V28, P3131, DOI 10.1523/JNEUROSCI.5460-07.2008; Wylie DRW, 1998, NATURE, V392, P278, DOI 10.1038/32648	60	66	66	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					351	362		10.1016/j.cell.2015.06.035	http://dx.doi.org/10.1016/j.cell.2015.06.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186189	Bronze			2022-12-28	WOS:000358087700015
J	Ning, ZJ; Gong, XW; Comin, R; Walters, G; Fan, FJ; Voznyy, O; Yassitepe, E; Buin, A; Hoogland, S; Sargent, EH				Ning, Zhijun; Gong, Xiwen; Comin, Riccardo; Walters, Grant; Fan, Fengjia; Voznyy, Oleksandr; Yassitepe, Emre; Buin, Andrei; Hoogland, Sjoerd; Sargent, Edward H.			Quantum-dot-in-perovskite solids	NATURE			English	Article							PBS NANOCRYSTALS; DIFFUSION	Heteroepitaxy-atomically aligned growth of a crystalline film atop a different crystalline substrate-is the basis of electrically driven lasers, multijunction solar cells, and blue-light-emitting diodes(1-5). Crystalline coherence is preserved even when atomic identity is modulated, a fact that is the critical enabler of quantum wells, wires, and dots(6-10). The interfacial quality achieved as a result of hetero-epitaxial growth allows new combinations of materials with complementary properties, which enables the design and realization of functionalities that are not available in the single-phase constituents. Here we show that organohalide perovskites and preformed colloidal quantum dots, combined in the solution phase, produce epitaxially aligned 'dots-in-a-matrix' crystals. Using transmission electron microscopy and electron diffraction, we reveal heterocrystals as large as about 60 nanometres and containing at least 20 mutually aligned dots that inherit the crystalline orientation of the perovskite matrix. The heterocrystals exhibit remarkable optoelectronic properties that are traceable to their atom-scale crystalline coherence: photoelectrons and holes generated in the larger-bandgap perovskites are transferred with 80% efficiency to become excitons in the quantum dot nanocrystals, which exploit the excellent photocarrier diffusion of perovskites to produce bright-light emission from infrared-bandgap quantum-tuned materials. By combining the electrical transport properties of the perovskite matrix with the high radiative efficiency of the quantum dots, we engineer a new platform to advance solution-processed infrared optoelectronics.	[Ning, Zhijun; Gong, Xiwen; Comin, Riccardo; Walters, Grant; Fan, Fengjia; Voznyy, Oleksandr; Yassitepe, Emre; Buin, Andrei; Hoogland, Sjoerd; Sargent, Edward H.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 1A4, Canada	University of Toronto	Sargent, EH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, 35 St George St, Toronto, ON M5S 1A4, Canada.	ted.sargent@utoronto.ca	Fan, Fengjia/A-7173-2018; Walters, Grant/ABD-9428-2021; Comin, Riccardo/H-7731-2016; Ning, Zhijun/C-8871-2019; Sargent, Edward H./O-9520-2014; Yassitepe, Emre/C-9035-2011; Ning, Zhijun/A-3601-2013	Fan, Fengjia/0000-0002-5447-6296; Walters, Grant/0000-0002-9005-2335; Comin, Riccardo/0000-0002-1069-9973; Sargent, Edward H./0000-0003-0396-6495; Yassitepe, Emre/0000-0002-4487-2631; Gong, Xiwen/0000-0003-4004-1299	King Abdullah University of Science and Technology (KAUST) [KUS-11-009-21]; Ontario Research Fund Research Excellence Program; Natural Sciences and Engineering Research Council (NSERC) of Canada; FAPESP-BEPE [14/18327-9]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); Ontario Research Fund Research Excellence Program; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); FAPESP-BEPE	This publication is based, in part, on work supported by an award (KUS-11-009-21) from the King Abdullah University of Science and Technology (KAUST), by the Ontario Research Fund Research Excellence Program and by the Natural Sciences and Engineering Research Council (NSERC) of Canada. Computations were performed using the BlueGene/Q supercomputer at the SciNet HPC Consortium provided through the Southern Ontario Smart Computing Innovation Platform (SOSCIP). E.Y. acknowledges support from an FAPESP-BEPE (14/18327-9) fellowship. The authors thank L. Levina for assistance in CQD synthesis, E. Beauregard for assistance in PHC synthesis, Z. Yang and M. Adachi for discussions, and E. Palmiano, R. Wolowiec and D. Kopilovic for their help during the course of study.	Adhikari H, 2006, NANO LETT, V6, P318, DOI 10.1021/nl052231f; Bian KF, 2014, J PHYS CHEM LETT, V5, P3688, DOI 10.1021/jz501797y; Bork N, 2013, J PHYS CHEM A, V117, P3143, DOI 10.1021/jp311103z; Buin A, 2014, NANO LETT, V14, P6281, DOI 10.1021/nl502612m; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Choi JJ, 2010, NANO LETT, V10, P1805, DOI 10.1021/nl100498e; Choi K, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826931; deMello JC, 1997, ADV MATER, V9, P230, DOI 10.1002/adma.19970090308; Diao Y, 2013, NAT MATER, V12, P665, DOI [10.1038/NMAT3650, 10.1038/nmat3650]; Dirin DN, 2014, J AM CHEM SOC, V136, P6550, DOI 10.1021/ja5006288; Feng J, 2014, APL MATER, V2, DOI 10.1063/1.4885256; Gao YN, 2011, NANO LETT, V11, P5471, DOI 10.1021/nl203235u; Graetzel M, 2012, NATURE, V488, P304, DOI 10.1038/nature11476; Hartwigsen C, 1998, PHYS REV B, V58, P3641, DOI 10.1103/PhysRevB.58.3641; Haruyama J, 2014, J PHYS CHEM LETT, V5, P2903, DOI 10.1021/jz501510v; Hines MA, 2003, ADV MATER, V15, P1844, DOI 10.1002/adma.200305395; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Kagan CR, 1996, PHYS REV LETT, V76, P1517, DOI 10.1103/PhysRevLett.76.1517; Koch C. T., 2002, THESIS ARIZ STATE; Leitsmann R, 2010, SURF SCI, V604, P1808, DOI 10.1016/j.susc.2010.07.011; Liu W, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205421; Ma W, 2009, NANO LETT, V9, P1699, DOI 10.1021/nl900388a; Manser JS, 2014, NAT PHOTONICS, V8, P737, DOI [10.1038/nphoton.2014.171, 10.1038/NPHOTON.2014.171]; McCray WP, 2007, NAT NANOTECHNOL, V2, P259, DOI 10.1038/nnano.2007.121; Mitzi DB, 2001, IBM J RES DEV, V45, P29, DOI 10.1147/rd.451.0029; Moroz P, 2013, ACS NANO, V7, P6964, DOI 10.1021/nn402844m; Ning ZJ, 2014, ACS NANO, V8, P10321, DOI 10.1021/nn503569p; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pohl U. W, 2013, EPITAXY SEMICONDUCTO; Ponseca CS, 2014, J AM CHEM SOC, V136, P5189, DOI 10.1021/ja412583t; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI 10.1038/nphoton.2012.328; Smecca E, 2013, J PHYS CHEM C, V117, P5364, DOI 10.1021/jp308983p; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Takaluoma TT, 2013, INORG CHEM, V52, P4648, DOI 10.1021/ic400273p; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Tan ZK, 2014, NAT NANOTECHNOL, V9, P687, DOI [10.1038/nnano.2014.149, 10.1038/NNANO.2014.149]; Tikhomirov G, 2011, NAT NANOTECHNOL, V6, P485, DOI [10.1038/nnano.2011.100, 10.1038/NNANO.2011.100]; VandeVondele J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770708; Wise FW, 2000, ACCOUNTS CHEM RES, V33, P773, DOI 10.1021/ar970220q; Xu F, 2011, ACS NANO, V5, P9950, DOI 10.1021/nn203728t; Zherebetskyy D, 2014, SCIENCE, V344, P1380, DOI 10.1126/science.1252727	42	386	394	39	1268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					324	+		10.1038/nature14563	http://dx.doi.org/10.1038/nature14563			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26178963	Green Submitted			2022-12-28	WOS:000357950900037
J	Sendinc, E; Jambhekar, A; Shi, Y				Sendinc, Erdem; Jambhekar, Ashwini; Shi, Yang			Remodeling Your Way out of Cell Cycle	CELL			English	Editorial Material							COMPLEXES	Throughout development, proliferative progenitors lose their mitotic potential, exit the cell cycle, and differentiate. In this issue, Ruijtenberg and van den Heuvel identify an important lineage-specific role for a SWI/SNF chromatin-remodeling complex that collaborates with core cell-cycle regulators to promote cell-cycle exit and terminal muscle cell differentiation.	[Sendinc, Erdem; Jambhekar, Ashwini; Shi, Yang] Childrens Hosp Boston, Div Newborn Med, Boston, MA 02115 USA; [Sendinc, Erdem; Jambhekar, Ashwini; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Shi, Y (corresponding author), Childrens Hosp Boston, Div Newborn Med, 300 Longwood Ave, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu		Jambhekar, Ashwini/0000-0003-1078-6601	NCI NIH HHS [R01 CA118487, CA118487] Funding Source: Medline; NIMH NIH HHS [R01 MH096066, MH096066] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA118487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096066] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Joliot V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108858; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Ruijtenberg S, 2015, CELL, V162, P300, DOI 10.1016/j.cell.2015.06.013; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X	8	4	5	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					235	236		10.1016/j.cell.2015.06.050	http://dx.doi.org/10.1016/j.cell.2015.06.050			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186182	Bronze			2022-12-28	WOS:000358087700003
J	Shafei, R; Goalby, R; Hutchinson, J				Shafei, Rachelle; Goalby, Rowena; Hutchinson, John			CASE REVIEW A case of breathlessness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERSTITIAL LUNG-DISEASE; RHEUMATOID-ARTHRITIS; METHOTREXATE; PNEUMONITIS; PROGNOSIS; SOCIETY		[Shafei, Rachelle] N Middlesex Hosp, Dept Med, London N18 1QX, England; [Hutchinson, John] Nottingham Univ Hosp Trust, Dept Resp Med, Nottingham, England	Nottingham University Hospital NHS Trust; University of Nottingham	Shafei, R (corresponding author), N Middlesex Hosp, Dept Med, London N18 1QX, England.	r.shafei@doctors.org.uk						BNF Online, METH; Bongartz T, 2010, ARTHRITIS RHEUM-US, V62, P1583, DOI 10.1002/art.27405; Cavagna L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/759760; Chan E, 2013, INTERSTITITAL LUNG D; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; de Lauretis A, 2011, CHRON RESP DIS, V8, P53, DOI 10.1177/1479972310393758; du Bois R, 2007, THORAX, V62, P1008, DOI 10.1136/thx.2004.031039; Gaffo AL, 2008, ARCH INTERN MED, V168, P1927, DOI 10.1001/archinte.168.17.1927; Gochuico BR, 2008, ARCH INTERN MED, V168, P159, DOI 10.1001/archinternmed.2007.59; Hamblin MJ, 2011, PULM MED, V2011, DOI 10.1155/2011/872120; HARGREAVES MR, 1992, THORAX, V47, P628, DOI 10.1136/thx.47.8.628; Hozumi H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003132; Imokawa S, 2000, EUR RESPIR J, V15, P373, DOI 10.1034/j.1399-3003.2000.15b25.x; Kim EJ, 2009, CHEST, V136, P1397, DOI 10.1378/chest.09-0444; Kinder AJ, 2005, RHEUMATOLOGY, V44, P61, DOI 10.1093/rheumatology/keh512; Koduri G, 2010, RHEUMATOLOGY, V49, P1483, DOI 10.1093/rheumatology/keq035; McLean-Tooke A, 2009, RHEUMATOLOGY, V48, P867, DOI 10.1093/rheumatology/kep101; O'Dwyer DN, 2013, EUR J INTERN MED, V24, P597, DOI 10.1016/j.ejim.2013.07.004; Saravanan V, 2006, RHEUMATOLOGY, V45, P787, DOI 10.1093/rheumatology/kel075; Sathi N, 2011, RHEUMATOLOGY, V50, P620, DOI 10.1093/rheumatology/keq426; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Wells AU, 2008, THORAX, V63, DOI 10.1136/thx.2008.101691	22	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2015	351								h3515	10.1136/bmj.h3515	http://dx.doi.org/10.1136/bmj.h3515			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CV	26185147				2022-12-28	WOS:000358302400002
J	Taylor, MRG; Spirek, M; Chaurasiya, KR; Ward, JD; Carzaniga, R; Yu, X; Egelman, EH; Collinson, LM; Rueda, D; Krejci, L; Boulton, SJ				Taylor, Martin R. G.; Spirek, Mario; Chaurasiya, Kathy R.; Ward, Jordan D.; Carzaniga, Raffaella; Yu, Xiong; Egelman, Edward H.; Collinson, Lucy M.; Rueda, David; Krejci, Lumir; Boulton, Simon J.			Rad51 Paralogs Remodel Pre-synaptic Rad51 Filaments to Stimulate Homologous Recombination	CELL			English	Article							STRAND BREAK REPAIR; RECA PROTEIN; FANCONI-ANEMIA; GERMLINE MUTATIONS; DNA-MOLECULES; BRCA2; PROMOTES; COMPLEX; GENE; SUSCEPTIBILITY	Repair of DNA double strand breaks by homologous recombination (HR) is initiated by Rad51 filament nucleation on single-stranded DNA (ssDNA), which catalyzes strand exchange with homologous duplex DNA. BRCA2 and the Rad51 paralogs are tumor suppressors and critical mediators of Rad51. To gain insight into Rad51 paralog function, we investigated a heterodimeric Rad51 paralog complex, RFS-1/RIP-1, and uncovered the molecular basis by which Rad51 paralogs promote HR. Unlike BRCA2, which nucleates RAD-51-ssDNA filaments, RFS-1/RIP-1 binds and remodels pre-synaptic filaments to a stabilized, "open,'' and flexible conformation, in which the ssDNA is more accessible to nuclease digestion and RAD-51 dissociation rate is reduced. Walker box mutations in RFS-1, which abolish filament remodeling, fail to stimulate RAD-51 strand exchange activity, demonstrating that remodeling is essential for RFS-1/RIP-1 function. We propose that Rad51 paralogs stimulate HR by remodeling the Rad51 filament, priming it for strand exchange with the template duplex.	[Taylor, Martin R. G.; Ward, Jordan D.; Boulton, Simon J.] Francis Crick Inst, Clare Hall Lab, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Spirek, Mario; Krejci, Lumir] Masaryk Univ, Dept Biol, Brno 62500, Czech Republic; [Spirek, Mario; Krejci, Lumir] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno 62500, Czech Republic; [Krejci, Lumir] Masaryk Univ, Natl Ctr Biomol Res, Brno 62500, Czech Republic; [Chaurasiya, Kathy R.; Rueda, David] Univ London Imperial Coll Sci Technol & Med, Single Mol Imaging Grp, Sect Virol, London W12 0NN, England; [Chaurasiya, Kathy R.; Rueda, David] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Dept Med, London W12 0NN, England; [Ward, Jordan D.] UCSF Miss Bay, San Francisco, CA 94158 USA; [Carzaniga, Raffaella; Collinson, Lucy M.] Francis Crick Inst, Lincolns Inn Fields Lab, Electron Microscopy Sci Technol Platform, London WC2A 3LY, England; [Yu, Xiong; Egelman, Edward H.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Imperial College London; Imperial College London; Francis Crick Institute; University of Virginia	Krejci, L (corresponding author), Masaryk Univ, Dept Biol, Brno 62500, Czech Republic.	lkrejci@chemi.muni.cz; simon.boulton@crick.ac.uk	Krejci, Lumir/B-7842-2009; Spirek, Mario/D-2329-2013; Ward, Jordan/H-3444-2019	Krejci, Lumir/0000-0002-4732-1405; Ward, Jordan/0000-0001-9870-8936; Collinson, Lucy/0000-0003-0260-613X; Egelman, Edward/0000-0003-4844-5212; Spirek, Mario/0000-0002-7213-7693	Cancer Research UK; European Research Council; Czech Science Foundation [GA13-26629S, GAP207/12/2323]; European Regional Development Fund - Project FNUSA-ICRC [CZ.1.05/1.1.00/02.012]; project ICRC-ERA-HumanBridge [316345]; European Commission; Clinical Sciences Center of the Medical Research Council [RCUK MC-A658-5TY10]; Imperial College London; MRC [MC_UP_1102/5] Funding Source: UKRI; Cancer Research UK [11581] Funding Source: researchfish; Medical Research Council [MC_UP_1102/5] Funding Source: researchfish; The Francis Crick Institute [10048, 10004] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund - Project FNUSA-ICRC; project ICRC-ERA-HumanBridge; European Commission(European CommissionEuropean Commission Joint Research Centre); Clinical Sciences Center of the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	We thank A. Alidoust and N. Patel for yeast fermentation and J. Frigola for assistance with protein expression in yeast. We are grateful to members of the S.J.B. and L.K. laboratories and M. Petalcorin, M. McIlwraith, S. West, S. Kowalczykowski, W. Dietrich-Heyer, and J. Svejstrup for comments and discussion throughout the project. This work was supported by a Cancer Research UK PhD studentship (to M.R.G.T.). The S.J.B. laboratory is funded by Cancer Research UK and an European Research Council advanced investigator grant (RecMitMei). S.J.B. is a Royal Society Wolfson Research Merit Award holder. The L.K. laboratory is supported by the Czech Science Foundation (GA13-26629S and GAP207/12/2323), the European Regional Development Fund - Project FNUSA-ICRC (no. CZ.1.05/1.1.00/02.0123), and project ICRC-ERA-HumanBridge (no. 316345), which is funded by the European Commission. The D.R. laboratory is funded by the Clinical Sciences Center of the Medical Research Council (RCUK MC-A658-5TY10) and a startup grant from the Imperial College London.	Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Burgess RC, 2009, J CELL BIOL, V185, P969, DOI 10.1083/jcb.200810055; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chun J, 2013, MOL CELL BIOL, V33, P387, DOI 10.1128/MCB.00465-12; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; Fortin GS, 2002, EMBO J, V21, P3160, DOI 10.1093/emboj/cdf293; French CA, 2003, J BIOL CHEM, V278, P45445, DOI 10.1074/jbc.M308621200; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Godthelp BC, 2002, NUCLEIC ACIDS RES, V30, P2172, DOI 10.1093/nar/30.10.2172; Golmard L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-484; GONDA DK, 1986, J BIOL CHEM, V261, P3087; GONDA DK, 1983, CELL, V34, P647, DOI 10.1016/0092-8674(83)90397-5; Gruver AM, 2005, MUTAGENESIS, V20, P433, DOI 10.1093/mutage/gei059; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; HONIGBERG SM, 1986, P NATL ACAD SCI USA, V83, P9586, DOI 10.1073/pnas.83.24.9586; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Jensen RB, 2013, DNA REPAIR, V12, P306, DOI 10.1016/j.dnarep.2012.12.007; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Jeyasekharan AD, 2013, NAT STRUCT MOL BIOL, V20, P1191, DOI 10.1038/nsmb.2666; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Liu J, 2011, NATURE, V479, P245, DOI 10.1038/nature10522; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Liu T, 2011, J BIOL CHEM, V286, P41758, DOI 10.1074/jbc.M111.271080; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; Martin V, 2006, EMBO J, V25, P2564, DOI 10.1038/sj.emboj.7601141; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Petalcorin MIR, 2007, P NATL ACAD SCI USA, V104, P8299, DOI [10.1073/pnas.0702805104, 10.1073/pnas.0702808104]; Petalcorin MIR, 2006, J MOL BIOL, V361, P231, DOI 10.1016/j.jmb.2006.06.020; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; RATTRAY AJ, 1995, GENETICS, V139, P45; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Sasanuma H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2678; Shor E, 2005, GENETICS, V169, P1275, DOI 10.1534/genetics.104.036764; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tao YY, 2012, J BIOL CHEM, V287, P20231, DOI 10.1074/jbc.M111.334698; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; TSANG SS, 1985, BIOCHEMISTRY-US, V24, P3226, DOI 10.1021/bi00334a023; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Ward JD, 2007, EMBO J, V26, P3384, DOI 10.1038/sj.emboj.7601766; Ward JD, 2010, MOL CELL, V37, P259, DOI 10.1016/j.molcel.2009.12.026; Wiese C, 2006, NUCLEIC ACIDS RES, V34, P2833, DOI 10.1093/nar/gkl366; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Yamada NA, 2004, J BIOL CHEM, V279, P23250, DOI 10.1074/jbc.M402247200; Yonetani Y, 2005, NUCLEIC ACIDS RES, V33, P4544, DOI 10.1093/nar/gki766; Zaitsev EN, 1999, J MOL BIOL, V287, P21, DOI 10.1006/jmbi.1998.2580	59	93	93	0	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					271	286		10.1016/j.cell.2015.06.015	http://dx.doi.org/10.1016/j.cell.2015.06.015			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186187	hybrid, Green Published			2022-12-28	WOS:000358087700009
J	Hogan, H; Zipfel, R; Neuburger, J; Hutchings, A; Darzi, A; Black, N				Hogan, Helen; Zipfel, Rebecca; Neuburger, Jenny; Hutchings, Andrew; Darzi, Ara; Black, Nick			Avoidability of hospital deaths and association with hospital-wide mortality ratios: retrospective case record review and regression analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADVERSE EVENTS; PREVENTABLE DEATHS; DUTCH HOSPITALS; QUALITY; CARE; PERFORMANCE; SAFETY	OBJECTIVES To determine the proportion of avoidable deaths (due to acts of omission and commission) in acute hospital trusts in England and to determine the association with the trust's hospital-wide standardised mortality ratio assessed using the two commonly used methods the hospital standardised mortality ratio (HSMR) and the summary hospital level mortality indicator (SHMI). DESIGN Retrospective case record review of deaths. SETTING 34 English acute hospital trusts (10 in 2009 and 24 in 2012/13) randomly selected from across the spectrum of HSMR. MAIN OUTCOME MEASURES Avoidable death, defined as those with at least a 50% probability of avoidability in view of trained medical reviewers. Association of avoidable death proportion with the HSMR and the SHMI assessed using regression coefficients, to estimate the increase in avoidable death proportion for a one standard deviation increase in standardised mortality ratio. PARTICIPANTS 100 randomly selected hospital deaths from each trust. RESULTS The proportion of avoidable deaths was 3.6% (95% confidence interval 3.0% to 4.3%). It was lower in 2012/13 (3.0%, 2.4% to 3.7%) than in 2009 (5.2%, 3.8% to 6.6%). This difference is subject to several factors, including reviewers' greater awareness in 2012/13 of orders not to resuscitate, patients being perceived as sicker on admission, minor differences in review form questions, and cultural changes that might have discouraged reviewers from criticising other clinicians. There was a small but statistically non-significant association between HSMR and the proportion of avoidable deaths (regression coefficient 0.3, 95% confidence interval -0.2 to 0.7). The regression coefficient was similar for both time periods (0.1 and 0.3). This implies that a difference in HSMR of between 105 and 115 would be associated with an increase of only 0.3% (95% confidence interval -0.2% to 0.7%) in the proportion of avoidable deaths. A similar weak non-significant association was observed for SHMI (regression coefficient 0.3, 95% confidence interval -0.3 to 1.0). CONCLUSIONS The small proportion of deaths judged to be avoidable means that any metric based on mortality is unlikely to reflect the quality of a hospital. The lack of association between the proportion of avoidable deaths and hospital-wide SMRs partly reflects methodological shortcomings in both metrics. Instead, reviews of individual deaths should focus on identifying ways of improving the quality of care, whereas the use of standardised mortality ratios should be restricted to assessing the quality of care for conditions with high case fatality for which good quality clinical data exist.	[Hogan, Helen; Zipfel, Rebecca; Neuburger, Jenny; Hutchings, Andrew; Black, Nick] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England; [Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Hogan, H (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England.	Helen.Hogan@lshtm.ac.uk		Hutchings, Andrew/0000-0003-0215-9923; Hogan, Helen/0000-0002-0920-2093	National Institute of Health Research [PB-PG-1207-15215]; Department of Health; National Institute for Health Research [NF-SI-0510-10186] Funding Source: researchfish	National Institute of Health Research(National Institute for Health Research (NIHR)); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))	The 2009 phase of this study was funded by the National Institute of Health Research, research for patient benefit programme (PB-PG-1207-15215) and the 2012/13 phase by the Department of Health policy research programme. The views expressed in this paper are those of the authors and not necessarily those of the funding bodies. The funders of the study, DH PRP and NIHR had no role in the study design; data collection, analysis, and interpretation; or composition of the report. The views expressed in this publication are those of the authors and not necessarily those of the NHS or the Department of Health.	Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Brooke BS, 2008, J VASC SURG, V47, P1155, DOI 10.1016/j.jvs.2008.01.021; Campbell MJ, 2011, EVALUATION SUMMARY H; Davis P, 2001, NEW ZEAL MED J, V114, P200; Francis R, 2015, FREEDOM SPEAK INDEPE; Francis R., 2013, REP MIDST NHS FDN TR; Girling AJ, 2012, BMJ QUAL SAF, V21, P1052, DOI 10.1136/bmjqs-2012-001202; Hogan H, 2014, INT J QUAL HEALTH C, V26, P298, DOI 10.1093/intqhc/mzu049; Hogan H, 2012, BMJ QUAL SAF, V21, P737, DOI 10.1136/bmjqs-2011-001159; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Hutchinson A, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14100; Jarman B, 2010, QUAL SAF HEALTH CARE, V19, P9, DOI 10.1136/qshc.2009.032953; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Keogh B, 2013, REV QUALITY CARE TRE; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Lilford Richard, 2007, J Health Serv Res Policy, V12, P173, DOI 10.1258/135581907781543012; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; NHS Choices, KEOGH MORT REV; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Richardson F M, 1972, Med Care, V10, P29, DOI 10.1097/00005650-197201000-00004; Rubenstein L, 1991, STRUCTURED IMPLICIT; Scott IA, 2011, MED J AUSTRALIA, V194, P645, DOI 10.5694/j.1326-5377.2011.tb03150.x; Shahian DM, 2012, BMJ QUAL SAF, V21, P325, DOI 10.1136/bmjqs-2011-000615; Shojania KG, 2008, CAN MED ASSOC J, V179, P153, DOI 10.1503/cmaj.080010; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; van Gestel YRBM, 2012, MED CARE, V50, P662, DOI 10.1097/MLR.0b013e31824ebd9f; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Zegers M, 2009, QUAL SAF HEALTH CARE, V18, P297, DOI 10.1136/qshc.2007.025924	28	77	77	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2015	351								h3239	10.1136/bmj.h3239	http://dx.doi.org/10.1136/bmj.h3239			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CO	26174149	Green Published, Green Accepted			2022-12-28	WOS:000358301600002
J	Ladha, K; Melo, MFV; McLean, DJ; Wanderer, JP; Grabitz, SD; Kurth, T; Eikermann, M				Ladha, Karim; Melo, Marcos F. Vidal; McLean, Duncan J.; Wanderer, Jonathan P.; Grabitz, Stephanie D.; Kurth, Tobias; Eikermann, Matthias			Intraoperative protective mechanical ventilation and risk of postoperative respiratory complications: hospital based registry study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TIDAL-VOLUME VENTILATION; ACUTE LUNG INJURY; GENERAL-ANESTHESIA; FRACTIONAL POLYNOMIALS; ABDOMINAL-SURGERY; PATIENT SAFETY; FAILURE; PREDICTORS; REGRESSION; OUTCOMES	OBJECTIVE To evaluate the effects of intraoperative protective ventilation on major postoperative respiratory complications and to define safe intraoperative mechanical ventilator settings that do not translate into an increased risk of postoperative respiratory complications. DESIGN Hospital based registry study. SETTING Academic tertiary care hospital and two affiliated community hospitals in Massachusetts, United States. PARTICIPANTS 69 265 consecutively enrolled patients over the age of 18 who underwent a non-cardiac surgical procedure between January 2007 and August 2014 and required general anesthesia with endotracheal intubation. INTERVENTIONS Protective ventilation, defined as a median positive end expiratory pressure (PEEP) of 5 cmH(2)O or more, a median tidal volume of less than 10 mL/kg of predicted body weight, and a median plateau pressure of less than 30 cmH(2)O. MAIN OUTCOME MEASURE Composite outcome of major respiratory complications, including pulmonary edema, respiratory failure, pneumonia, and re-intubation. RESULTS Of the 69 265 enrolled patients 34 800 (50.2%) received protective ventilation and 34 465 (49.8%) received non-protective ventilation intraoperatively. Protective ventilation was associated with a decreased risk of postoperative respiratory complications in multivariable regression (adjusted odds ratio 0.90, 95% confidence interval 0.82 to 0.98, P = 0.013). The results were similar in the propensity score matched cohort (odds ratio 0.89, 95% confidence interval 0.83 to 0.97, P = 0.004). A PEEP of 5 cmH(2)O and median plateau pressures of 16 cmH(2)O or less were associated with the lowest risk of postoperative respiratory complications. CONCLUSIONS Intraoperative protective ventilation was associated with a decreased risk of postoperative respiratory complications. A PEEP of 5 cmH(2)O and a plateau pressure of 16 cmH(2)O or less were identified as protective mechanical ventilator settings. These findings suggest that protective thresholds differ for intraoperative ventilation in patients with normal lungs compared with those used for patients with acute lung injury.	[Ladha, Karim; Melo, Marcos F. Vidal; McLean, Duncan J.; Grabitz, Stephanie D.; Eikermann, Matthias] Massachusetts Gen Hosp, Dept Anesthesia Crit Care, Pain Med, Boston, MA 02114 USA; [Wanderer, Jonathan P.] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN 37235 USA; [Kurth, Tobias] INSERM, Res Ctr Epidemiol & Biostat U897, Team Neuroepidemiol, Bordeaux, France; [Kurth, Tobias] Univ Bordeaux, Coll Hlth Sci, Bordeaux, France; [Kurth, Tobias] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Eikermann, Matthias] Essen Duisburg Univ, Essen, Germany	Harvard University; Massachusetts General Hospital; Vanderbilt University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Brigham & Women's Hospital	Eikermann, M (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care, Pain Med, Boston, MA 02114 USA.	meikermann@partners.org	Melo, Marcos Vidal/AAN-7219-2020; Kurth, Tobias/A-9243-2012; Ladha, Karim/K-7170-2015	Kurth, Tobias/0000-0001-7169-2620; Ladha, Karim/0000-0001-7303-2458; Grabitz, Stephanie D./0000-0002-3071-873X; Wanderer, Jonathan/0000-0002-3119-6873	Buzen's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121228] Funding Source: NIH RePORTER	Buzen's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by a grant from the Buzen's Foundation.	Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; BENDIXEN HH, 1963, NEW ENGL J MED, V269, P991, DOI 10.1056/NEJM196311072691901; Bensley RP, 2013, J AM COLL SURGEONS, V216, P1159, DOI 10.1016/j.jamcollsurg.2013.01.060; Borzecki AM, 2011, J AM COLL SURGEONS, V212, P935, DOI 10.1016/j.jamcollsurg.2010.09.034; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brueckmann B, 2013, ANESTHESIOLOGY, V118, P1276, DOI 10.1097/ALN.0b013e318293065c; Canver CC, 2003, ANN THORAC SURG, V75, P853, DOI 10.1016/S0003-4975(02)04493-4; Davenport DL, 2005, ANN SURG, V242, P463, DOI 10.1097/01.sla.0000183348.15117.ab; Dimick JB, 2004, J AM COLL SURGEONS, V199, P531, DOI 10.1016/j.jamcollsurg.2004.05.276; Eikermann M, 2015, ANESTHESIOLOGY; Fernandez-Perez ER, 2009, THORAX, V64, P121, DOI 10.1136/thx.2008.102228; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Glance LG, 2010, ANESTHESIOLOGY, V113, P859, DOI 10.1097/ALN.0b013e3181eff32e; Grosse-Sundrup M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6329; Heisler CA, 2009, J AM COLL SURGEONS, V209, P119, DOI 10.1016/j.jamcollsurg.2009.03.017; Hemmes SNT, 2014, LANCET, V384, P495, DOI 10.1016/S0140-6736(14)60416-5; Hess DR, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.014; Jaber S, 2012, ANAESTHESIA, V67, P999, DOI 10.1111/j.1365-2044.2012.07218.x; Johnson RG, 2007, J AM COLL SURGEONS, V204, P1188, DOI 10.1016/j.jamcollsurg.2007.02.070; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Lellouche F, 2012, ANESTHESIOLOGY, V116, P1072, DOI 10.1097/ALN.0b013e3182522df5; Nafiu OO, 2011, EUR J ANAESTH, V28, P220, DOI 10.1097/EJA.0b013e328342659c; NUNN JF, 1962, LANCET, V2, P631, DOI 10.1016/S0140-6736(62)92541-2; Parsons LS., 2001, P 26 ANN SAS US GROU, P214; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ramachandran SK, 2011, ANESTHESIOLOGY, V115, P44, DOI 10.1097/ALN.0b013e31821cf6de; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015; Schultz MJ, 2007, ANESTHESIOLOGY, V106, P1226, DOI 10.1097/01.anes.0000267607.25011.e8; Serpa Neto A, 2015, ANESTHESIOLOGY; Severgnini P, 2013, ANESTHESIOLOGY, V118, P1307, DOI 10.1097/ALN.0b013e31829102de; Shah Bhumika, 2006, Nutr Clin Pract, V21, P312, DOI 10.1177/0115426506021003312; Smetana Gerald W, 2009, Cleve Clin J Med, V76 Suppl 4, pS60, DOI 10.3949/ccjm.76.s4.10; Treschan TA, 2012, BRIT J ANAESTH, V109, P263, DOI 10.1093/bja/aes140; Utter GH, 2010, J AM COLL SURGEONS, V211, P347, DOI 10.1016/j.jamcollsurg.2010.04.022; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Wellman TJ, 2014, CRIT CARE MED, V42, pE491, DOI 10.1097/CCM.0000000000000346; Yilmaz M, 2007, CRIT CARE MED, V35, P1660, DOI 10.1097/01.CCM.0000269037.66955.F0	42	170	182	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2015	351								h3646	10.1136/bmj.h3646	http://dx.doi.org/10.1136/bmj.h3646			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CO	26174419	Green Published, hybrid			2022-12-28	WOS:000358301600008
J	Tobias, JA				Tobias, Joseph A.			BIODIVERSITY Hidden impacts of logging	NATURE			English	Editorial Material							ECOSYSTEM FUNCTION; FOREST	A meta-analysis of changes in the abundance of tropical-forest birds reveals that the effect of selective timber harvesting varies with logging practices and species traits. The results offer a framework for managing impacts on biodiversity.	Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England	Imperial College London	Tobias, JA (corresponding author), Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England.	j.tobias@imperial.ac.uk		Tobias, Joseph/0000-0003-2429-6179				Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Bicknell JE, 2014, CURR BIOL, V24, pR1119, DOI 10.1016/j.cub.2014.10.067; Bregman TP, 2014, BIOL CONSERV, V169, P372, DOI 10.1016/j.biocon.2013.11.024; Burivalova Z, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0164; Burivalova Z, 2014, CURR BIOL, V24, P1893, DOI 10.1016/j.cub.2014.06.065; Cleary DFR, 2007, ECOL APPL, V17, P1184, DOI 10.1890/05-0878; Edwards DP, 2014, TRENDS ECOL EVOL, V29, P511, DOI 10.1016/j.tree.2014.07.003; Ewers RM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7836; Hamer KC, 2015, BIOL CONSERV, V188, P82, DOI 10.1016/j.biocon.2014.09.026; Newbold T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2131; Wilman H, 2014, ECOLOGY, V95, P2027, DOI DOI 10.1890/13-1917.1	11	6	6	3	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					163	164		10.1038/523163a	http://dx.doi.org/10.1038/523163a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4ZO	26156368				2022-12-28	WOS:000357695900022
J	Dashti, SG; Chau, R; Ouakrim, DA; Buchanan, DD; Clendenning, M; Young, JP; Winship, IM; Arnold, J; Ahnen, DJ; Haile, RW; Casey, G; Gallinger, S; Thibodeau, SN; Lindor, NM; Le Marchand, L; Newcomb, PA; Potter, JD; Baron, JA; Hopper, JL; Jenkins, MA; Win, AK				Dashti, Seyedeh Ghazaleh; Chau, Rowena; Ouakrim, Driss Ait; Buchanan, Daniel D.; Clendenning, Mark; Young, Joanne P.; Winship, Ingrid M.; Arnold, Julie; Ahnen, Dennis J.; Haile, Robert W.; Casey, Graham; Gallinger, Steven; Thibodeau, Stephen N.; Lindor, Noralane M.; Le Marchand, Loic; Newcomb, Polly A.; Potter, John D.; Baron, John A.; Hopper, John L.; Jenkins, Mark A.; Win, Aung Ko			Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; MUTATION CARRIERS; COLORECTAL-CANCER; REPRODUCTIVE FACTORS; BREAST-CANCER; WOMEN; AGE; EPIDEMIOLOGY; METAANALYSIS; CARCINOMAS	IMPORTANCE Apart from hysterectomy, there is no consensus recommendation for reducing endometrial cancer risk for women with a mismatch repair gene mutation ( Lynch syndrome). OBJECTIVE To investigate the association between hormonal factors and endometrial cancer risk in Lynch syndrome. DESIGN, SETTING, AND PARTICIPANTS A retrospective cohort study included 1128 women with a mismatch repair gene mutation identified from the Colon Cancer Family Registry. Data were analyzed with a weighted cohort approach. Participants were recruited between 1997 and 2012 from centers across the United States, Australia, Canada, and New Zealand. EXPOSURES Age at menarche, first and last live birth, and menopause; number of live births; hormonal contraceptive use; and postmenopausal hormone use. MAIN OUTCOMES AND MEASURES Self-reported diagnosis of endometrial cancer. RESULTS Endometrial cancer was diagnosed in 133 women ( incidence rate per 100 person-years, 0.29; 95% CI, 0.24 to 0.34). Later age at menarche, parity (>= 1 live births), and hormonal contraceptive use (>= 1 year) were associated with a lower risk of endometrial cancer. [GRAPHICS] There was no statistically significant association between endometrial cancer and age at first and last live birth, age at menopause, and postmenopausal hormone use. CONCLUSIONS AND RELEVANCE For women with a mismatch repair gene mutation, some endogenous and exogenous hormonal factors were associated with a lower risk of endometrial cancer. These directions and strengths of associations were similar to those for the general population. If replicated, these findings suggest that women with a mismatch repair gene mutation may be counseled like the general population in regard to hormonal influences on endometrial cancer risk.	[Dashti, Seyedeh Ghazaleh; Chau, Rowena; Ouakrim, Driss Ait; Buchanan, Daniel D.; Hopper, John L.; Jenkins, Mark A.; Win, Aung Ko] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Parkville, Vic 3010, Australia; [Buchanan, Daniel D.; Clendenning, Mark] Univ Melbourne, Dept Pathol, Oncogenom Grp, Genet Epidemiol Lab, Parkville, Vic 3010, Australia; [Young, Joanne P.] Queen Elizabeth Hosp, Dept Haematol, Woodville, SA 5011, Australia; [Young, Joanne P.] Queen Elizabeth Hosp, Dept Oncol, Woodville, SA 5011, Australia; [Young, Joanne P.] Basil Hetzel Inst Translat Res, SAHMRI Colorectal Node, Woodville, SA, Australia; [Young, Joanne P.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia; [Winship, Ingrid M.] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia; [Winship, Ingrid M.] Royal Melbourne Hosp, Genet Med, Parkville, Vic 3050, Australia; [Arnold, Julie] New Zealand Familial Gastrointestinal Canc Serv, Auckland, New Zealand; [Ahnen, Dennis J.] Univ Colorado, Sch Med, Dept Med, Denver, CO USA; [Haile, Robert W.] Stanford Univ, Dept Med, Inst Canc, Div Oncol, Stanford, CA 94305 USA; [Casey, Graham] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Casey, Graham] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Gallinger, Steven] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Mol Genet Lab, Rochester, MN USA; [Lindor, Noralane M.] Mayo Clin Arizona, Dept Hlth Sci Res, Scottsdale, AZ USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Newcomb, Polly A.; Potter, John D.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Newcomb, Polly A.; Potter, John D.] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Baron, John A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Hopper, John L.] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea; [Hopper, John L.] Seoul Natl Univ, Sch Publ Hlth, Inst Hlth & Environm, Seoul, South Korea	University of Melbourne; University of Melbourne; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; University of Melbourne; Royal Melbourne Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Stanford University; University of Southern California; University of Southern California; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Cancer Research Center of Hawaii; University of Hawaii System; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Massey University; University of North Carolina; University of North Carolina Chapel Hill; Seoul National University (SNU); Seoul National University (SNU)	Win, AK (corresponding author), Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Level 3,207 Bouverie St, Parkville, Vic 3010, Australia.	awin@unimelb.edu.au	Gallinger, Steven/E-4575-2013; Dashti, Seyedeh Ghazaleh/ABG-4363-2020; Win, Aung K./J-6204-2015; Winship, Ingrid M/D-7204-2016; Jenkins, Mark/P-7803-2015	Dashti, Seyedeh Ghazaleh/0000-0002-1399-7220; Win, Aung K./0000-0002-2794-5261; Jenkins, Mark/0000-0002-8964-6160; Young, Joanne/0000-0002-1514-1522; Buchanan, Daniel/0000-0003-2225-6675; Winship, Ingrid/0000-0001-8535-6003; Ait Ouakrim, Driss/0000-0001-7715-2561; Potter, John/0000-0001-5439-1500	National Cancer Institute, National Institutes of Health [UM1 CA167551]; National Health and Medical Research Council (NHMRC), Australia [APP1042021, APP1074383]; NATIONAL CANCER INSTITUTE [U24CA074806, U24CA074794, U01CA074800, P30CA015704, U01CA074806, U24CA097735, U24CA074800, U01CA097735, U01CA074794, U24CA074799, U01CA074783, U01CA074799, UM1CA167551, U24CA074783] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant UM1 CA167551 from the National Cancer Institute, National Institutes of Health, and through cooperative agreements with members of the Colon Cancer Family Registry and principal investigators. Collaborating centers include the Australasian Colorectal Cancer Family Registry (U01/U24 CA097735), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01/U24 CA074800), Ontario Familial Colorectal Cancer Registry (U01/U24 CA074783), Seattle Colorectal Cancer Family Registry (U01/U24 CA074794), Stanford Consortium Colorectal Cancer Family Registry (U01/U24 CA074799), and University of Hawaii Colorectal Cancer Family Registry (U01/U24 CA074806). This work was also supported by Centre for Research Excellence grant APP1042021 and program grant APP1074383 from the National Health and Medical Research Council (NHMRC), Australia. Dr Win is an NHMRC Early Career Fellow. Dr Jenkins is an NHMRC Senior Research Fellow. Dr Hopper is an NHMRC Senior Principal Research Fellow. Dr Buchanan is a University of Melbourne Research at Melbourne Accelerator Program Senior Research Fellow.	Ali AT, 2014, INT J GYNECOL CANCER, V24, P384, DOI 10.1097/IGC.0000000000000075; Amankwah EK, 2013, CANCER EPIDEM BIOMAR, V22, P1325, DOI 10.1158/1055-9965.EPI-13-0105; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Andrieu N, 2006, J CLIN ONCOL, V24, P3361, DOI 10.1200/JCO.2005.03.3126; Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Antoniou AC, 2008, AM J HUM GENET, V82, P937, DOI 10.1016/j.ajhg.2008.02.008; Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Blokhuis MM, 2010, FAM CANCER, V9, P357, DOI 10.1007/s10689-010-9334-9; Cleves M., 2008, INTRO SURVIVAL ANAL; Crosbie EJ, 2010, CANCER EPIDEM BIOMAR, V19, P3119, DOI 10.1158/1055-9965.EPI-10-0832; Curado MP, 2007, IARC SCI PUBL, VIX; Dossus L, 2010, INT J CANCER, V127, P442, DOI 10.1002/ijc.25050; Dowty JG, 2013, HUM MUTAT, V34, P490, DOI 10.1002/humu.22262; Fujita M, 2008, TOHOKU J EXP MED, V216, P297, DOI 10.1620/tjem.216.297; Gierisch JM, 2013, CANCER EPIDEM BIOMAR, V22, P1931, DOI 10.1158/1055-9965.EPI-13-0298; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grzankowski KS, 2012, GYNECOL ONCOL, V126, P408, DOI 10.1016/j.ygyno.2012.05.019; Haidopoulos D, 2010, ACTA OBSTET GYN SCAN, V89, P1326, DOI 10.3109/00016349.2010.515666; Hampel H, 2011, CANCER PREV RES, V4, P1, DOI 10.1158/1940-6207.CAPR-10-0345; Huang M, 2013, CANCER-AM CANCER SOC, V119, P3027, DOI 10.1002/cncr.28152; Joehlin-Price AS, 2014, GYNECOL ONCOL, V133, P43, DOI 10.1016/j.ygyno.2014.01.017; Lu KH, 2007, J CLIN ONCOL, V25, P5158, DOI 10.1200/JCO.2007.10.8597; Lu KH, 2013, CANCER PREV RES, V6, P774, DOI 10.1158/1940-6207.CAPR-13-0020; Lynch HT, 2014, CURR TREAT OPTION ON, V15, P429, DOI 10.1007/s11864-014-0293-5; MacDonald ND, 2000, CANCER RES, V60, P1750; Meyer LA, 2009, CANCER CONTROL, V16, P14, DOI 10.1177/107327480901600103; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Pocobelli G, 2011, EPIDEMIOLOGY, V22, P638, DOI 10.1097/EDE.0b013e3182263018; Rogers WH, 1993, STATA TECHN B, V13, P19; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Rumilla K, 2011, J MOL DIAGN, V13, P93, DOI 10.1016/j.jmoldx.2010.11.011; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Schonfeld SJ, 2013, CANCER-AM CANCER SOC, V119, P1393, DOI 10.1002/cncr.27909; Senter L, 2008, GASTROENTEROLOGY, V135, P419, DOI 10.1053/j.gastro.2008.04.026; Setiawan VW, 2012, AM J EPIDEMIOL, V176, P269, DOI 10.1093/aje/kws129; Southey MC, 2005, J CLIN ONCOL, V23, P6524, DOI 10.1200/JCO.2005.04.671; StataCorp LP, 2013, LP GAS SAFETY REFERE; Uharcek P, 2008, INT J GYNECOL CANCER, V18, P324, DOI 10.1111/j.1525-1438.2007.00997.x; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Win AK, 2013, J MED GENET, V50, P785, DOI 10.1136/jmedgenet-2013-101803; Win AK, 2012, JNCI-J NATL CANCER I, V104, P1363, DOI 10.1093/jnci/djs351; Win AK, 2011, OBSTET GYNECOL, V117, P899, DOI 10.1097/AOG.0b013e3182110ea3; Xu WH, 2004, INT J CANCER, V108, P613, DOI 10.1002/ijc.11598; Zhang YY, 2014, INT J BIOL MARKER, V29, pE21, DOI 10.5301/jbm.5000047; Zucchetto A, 2009, EUR J CANCER PREV, V18, P316, DOI 10.1097/CEJ.0b013e328329d830	46	44	50	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					61	71		10.1001/jama.2015.6789	http://dx.doi.org/10.1001/jama.2015.6789			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151267	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000357455900015
J	Middeldorp, S; Hutten, BA				Middeldorp, Saskia; Hutten, Barbara A.			Long-term vs Short-term Therapy With Vitamin K Antagonists for Symptomatic Venous Thromboembolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							THROMBOSIS; GUIDELINES	CLINICAL QUESTION Is long-term (>= 3 months) vs short-term therapy with vitamin K antagonists (VKAs) associated with differences in the incidence of recurrent venous thromboembolism (VTE), major bleeding, and mortality in patients with symptomatic VTE? BOTTOM LINE Long-term treatment with VKAs is associated with a reduced risk for recurrent VTE and an increased risk for major bleeding compared with short-term treatment in patients with VTE, but is not associated with differences in mortality.	[Middeldorp, Saskia] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands; [Hutten, Barbara A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1100 DD Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Hutten, BA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, POB 22660, NL-1100 DD Amsterdam, Netherlands.	b.a.hutten@amc.uva.nl	Middeldorp, Saskia/ABI-8197-2020	Middeldorp, Saskia/0000-0002-1006-6420	Bayer; Bristol-Myers Squibb/Pfizer; Boehringer Ingelheim; Daiichi Sankyo; Aspen; GlaxoSmithKline; Sanquin	Bayer(Bayer AG); Bristol-Myers Squibb/Pfizer(Bristol-Myers SquibbPfizer); Boehringer Ingelheim(Boehringer Ingelheim); Daiichi Sankyo(Daiichi Sankyo Company Limited); Aspen; GlaxoSmithKline(GlaxoSmithKline); Sanquin	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Middeldorp reports receiving consulting fees to her institution from Bayer, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, and Daiichi Sankyo; grant funding from Aspen, Bayer, GlaxoSmithKline, Bristol-Myers Squibb/Pfizer, and Sanquin; and receiving personal fees from GlaxoSmithKline, Bayer, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, and Daiichi Sankyo. No other disclosures were reported.	Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI DOI 10.1093/EURHEARTJ/EHU283; Middeldorp S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001367.pub3; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; van Dongen CJJ, 2003, ARCH INTERN MED, V163, P1285, DOI 10.1001/archinte.163.11.1285	6	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					72	73		10.1001/jama.2015.2693	http://dx.doi.org/10.1001/jama.2015.2693			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151268				2022-12-28	WOS:000357455900016
J	Mayer, EL; Burstein, HJ				Mayer, Erica L.; Burstein, Harold J.			Postmenopausal breast cancer: a best endocrine strategy?	LANCET			English	Editorial Material							TAMOXIFEN; THERAPY; ANASTROZOLE; TRIAL; WOMEN		[Mayer, Erica L.; Burstein, Harold J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Susan F Smith Ctr Womens Canc, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Burstein, HJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Susan F Smith Ctr Womens Canc, Boston, MA 02215 USA.	hburstein@partners.org						Bowles EJA, 2012, J ONCOL PRACT, V8, pE149, DOI 10.1200/JOP.2012.000543; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Early Breast Cancer Trialists' Collaborative G, 2015, LANCET; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Goss PE, 2005, JNCI-J NATL CANCER I, V16, P707; Hadji P, 2014, ANN ONCOL, V25, P372, DOI 10.1093/annonc/mdt513; National Comprehensive Cancer Network, 2015, BREAST CANC GUID; Regan MM, 2011, LANCET ONCOL, V12, P1101, DOI 10.1016/S1470-2045(11)70270-4; Sestak I, 2013, JNCI-J NATL CANCER I, V105, P1504, DOI 10.1093/jnci/djt244; van de Velde CJH, 2011, LANCET, V377, P321, DOI 10.1016/S0140-6736(10)62312-4; Viale G, 2011, ANN ONCOL, V22, P2201, DOI 10.1093/annonc/mdq738	15	7	7	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1317	1319		10.1016/S0140-6736(15)61206-5	http://dx.doi.org/10.1016/S0140-6736(15)61206-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8DP	26211823	hybrid			2022-12-28	WOS:000362316200008
J	Podolsky, SH; Powers, JH				Podolsky, Scott H.; Powers, John H., III			Regulating Antibiotics in an Era of Resistance: The Historical Basis and Continued Need for Adequate and Well-Controlled Investigations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DRUG DEVELOPMENT; SUCCESS RATES; RISKS		Harvard Univ, Sch Med, Boston, MA 02115 USA; George Washington Univ, Sch Med, Washington, DC USA	Harvard University; Harvard Medical School; George Washington University	Podolsky, SH (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, 641 Huntington Ave, Boston, MA 02115 USA.			Powers III, John H/0000-0002-5150-5119				[Anonymous], 2013, FDA DRUG SAF COMM FD; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; Doshi P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1453; Evans R, 2009, NAT REV DRUG DISCOV, V8, P189, DOI 10.1038/nrd2744; FINLAND M, 1957, Antibiotic Med Clin Ther (New York), V4, P17; Lear J, 1959, SATURDAY REV, V3, P35; Podolsky SH, 2015, ANTIBIOTIC ERA: REFORM, RESISTANCE, AND THE PURSUIT OF A RATIONAL THERAPEUTICS, P1; U.S. Food and Drug Administration, 2014, DOR DOR DRUG SAF COM; U.S. Food and Drug Administration, 2014, LAB DAPT CUB	10	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2015	163	5					386	U142		10.7326/M15-0802	http://dx.doi.org/10.7326/M15-0802			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0OM	26167660				2022-12-28	WOS:000360296000011
J	Hie, L; Nathel, NFF; Shah, TK; Baker, EL; Hong, X; Yang, YF; Liu, P; Houk, KN; Garg, NK				Hie, Liana; Nathel, Noah F. Fine; Shah, Tejas K.; Baker, Emma L.; Hong, Xin; Yang, Yun-Fang; Liu, Peng; Houk, K. N.; Garg, Neil K.			Conversion of amides to esters by the nickel-catalysed activation of amide C-N bonds	NATURE			English	Article							CROSS-COUPLING REACTIONS; ARYL CARBOXYLATES; METHYL-ESTERS; AZOLES; CHEMOSELECTIVITY; TRANSAMIDATION; CLEAVAGE; AMINES; SCOPE; MILD	Amides are common functional groups that have been studied for more than a century(1). They are the key building blocks of proteins and are present in a broad range of other natural and synthetic compounds. Amides are known to be poor electrophiles, which is typically attributed to the resonance stability of the amide bond(1,2). Although amides can readily be cleaved by enzymes such as proteases(3), it is difficult to selectively break the carbon-nitrogen bond of an amide using synthetic chemistry. Here we demonstrate that amide carbon-nitrogen bonds can be activated and cleaved using nickel catalysts. We use this methodology to convert amides to esters, which is a challenging and underdeveloped transformation. The reaction methodology proceeds under exceptionally mild reaction conditions, and avoids the use of a large excess of an alcohol nucleophile. Density functional theory calculations provide insight into the thermodynamics and catalytic cycle of the amide-to-ester transformation. Our results provide a way to harness amide functional groups as synthetic building blocks and are expected to lead to the further use of amides in the construction of carbon-heteroatom or carbon-carbon bonds using non-precious-metal catalysis.	[Hie, Liana; Nathel, Noah F. Fine; Shah, Tejas K.; Baker, Emma L.; Hong, Xin; Yang, Yun-Fang; Liu, Peng; Houk, K. N.; Garg, Neil K.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Houk, KN (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	houk@chem.ucla.edu; neilgarg@chem.ucla.edu	Hong, Xin/Q-4176-2019; Hong, Xin/M-3916-2017; Liu, Peng/A-9043-2008	Hong, Xin/0000-0003-4717-2814; Hong, Xin/0000-0003-4717-2814; Liu, Peng/0000-0002-8188-632X; Shah, Tejas/0000-0002-2345-4764	Boehringer Ingelheim; DuPont; Bristol-Myers Squibb; Camille and Henry Dreyfus Foundation; A. P. Sloan Foundation; S. T. Li Foundation; University of California, Los Angeles (UCLA); NIH-NIGMS [GM036700]; NIH [F31 GM101951-02]; NSF [DGE-1144087, OCI-1053575, CHE-1048804]; Foote Family; ACS Division of Organic Chemistry; National Center for Research Resources [S10RR025631]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036700, F31GM101951, R37GM036700] Funding Source: NIH RePORTER	Boehringer Ingelheim(Boehringer Ingelheim); DuPont; Bristol-Myers Squibb(Bristol-Myers Squibb); Camille and Henry Dreyfus Foundation; A. P. Sloan Foundation(Alfred P. Sloan Foundation); S. T. Li Foundation; University of California, Los Angeles (UCLA)(University of California System); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Foote Family; ACS Division of Organic Chemistry; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Boehringer Ingelheim, DuPont, Bristol-Myers Squibb, the Camille and Henry Dreyfus Foundation, the A. P. Sloan Foundation, the S. T. Li Foundation, the University of California, Los Angeles (UCLA), and the NIH-NIGMS (grant number GM036700 to K.N.H.) for financial support. We are grateful to the NIH (grant number F31 GM101951-02 to N.F.F.N.), the NSF (grant number DGE-1144087 to E.L.B.), the Foote Family (L.H., T.K.S. and X.H.), and the ACS Division of Organic Chemistry (L.H.) for fellowship support. Computations were performed with resources made available by the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by the NSF (grant number OCI-1053575), as well as the UCLA Institute of Digital Research and Education (IDRE). This work was also supported by shared instrumentation grants from the NSF (grant number CHE-1048804) and the National Center for Research Resources (grant number S10RR025631).	Amaike K, 2012, J AM CHEM SOC, V134, P13573, DOI 10.1021/ja306062c; Blakey SB, 2003, J AM CHEM SOC, V125, P6046, DOI 10.1021/ja034908b; Blangetti M, 2013, MOLECULES, V18, P1188, DOI 10.3390/molecules18011188; Brix K., 2013, PROTEASES STRUCTUE F; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; Dineen TA, 2006, J AM CHEM SOC, V128, P16406, DOI 10.1021/ja066728i; Greenberg A., 2003, AMIDE LINKAGE STRUCT; GUTHRIE JP, 1992, CAN J CHEM, V70, P1671, DOI 10.1139/v92-210; Hong X, 2014, J AM CHEM SOC, V136, P2017, DOI 10.1021/ja4118413; Keck GE, 2000, TETRAHEDRON, V56, P9875, DOI 10.1016/S0040-4020(00)00969-8; Lu QQ, 2014, J AM CHEM SOC, V136, P8252, DOI 10.1021/ja4127455; Mesganaw T, 2013, ORG PROCESS RES DEV, V17, P29, DOI 10.1021/op300236f; Mesganaw T, 2011, CHEM SCI, V2, P1766, DOI 10.1039/c1sc00230a; NAHM S, 1981, TETRAHEDRON LETT, V22, P3815, DOI 10.1016/S0040-4039(01)91316-4; NISHIMOTO S, 1982, B CHEM SOC JPN, V55, P1484, DOI 10.1246/bcsj.55.1484; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Quasdorf KW, 2011, J AM CHEM SOC, V133, P6352, DOI 10.1021/ja200398c; Reed J. W, 2007, WAY SYNTHESIS EVOLUT; Rosen BM, 2011, CHEM REV, V111, P1346, DOI 10.1021/cr100259t; Shiba T, 2013, J AM CHEM SOC, V135, P13636, DOI 10.1021/ja4068172; Spletstoser JT, 2007, J AM CHEM SOC, V129, P3408, DOI 10.1021/ja066362+; Stephenson NA, 2009, J AM CHEM SOC, V131, P10003, DOI 10.1021/ja8094262; Tasker SZ, 2014, NATURE, V509, P299, DOI 10.1038/nature13274; Tatamidani H, 2004, ORG LETT, V6, P3597, DOI 10.1021/ol048513o; Tobisu M, 2014, J AM CHEM SOC, V136, P5587, DOI 10.1021/ja501649a; Van Vranken D., 2013, INTRO BIOORGANIC CHE; WHITE EH, 1955, J AM CHEM SOC, V77, P6011, DOI 10.1021/ja01627a064; Xu HY, 2014, J AM CHEM SOC, V136, P14834, DOI [10.1021/ja5071174, 10.1021/ja50711741]; YAMAMOTO T, 1980, J AM CHEM SOC, V102, P3758, DOI 10.1021/ja00531a016; Zhang XQ, 2014, ORG BIOMOL CHEM, V12, P1448, DOI 10.1039/c3ob41989d	30	380	381	15	357	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					79	83		10.1038/nature14615	http://dx.doi.org/10.1038/nature14615			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26200342	Green Accepted, Green Submitted			2022-12-28	WOS:000359002300035
J	Orelle, C; Carlson, ED; Szal, T; Florin, T; Jewett, MC; Mankin, AS				Orelle, Cedric; Carlson, Erik D.; Szal, Teresa; Florin, Tanja; Jewett, Michael C.; Mankin, Alexander S.			Protein synthesis by ribosomes with tethered subunits	NATURE			English	Article							PEPTIDYL TRANSFERASE CENTER; RNA; TRANSLATION; MUTATIONS; SITE; TRANSCRIPTION; SYSTEM	The ribosome is a ribonucleoprotein machine responsible for protein synthesis. In all kingdoms of life it is composed of two subunits, each built on its own ribosomal RNA (rRNA) scaffold. The independent but coordinated functions of the subunits, including their ability to associate at initiation, rotate during elongation, and dissociate after protein release, are an established model of protein synthesis. Furthermore, the bipartite nature of the ribosome is presumed to be essential for biogenesis, since dedicated assembly factors keep immature ribosomal subunits apart and prevent them from translation initiation(1). Free exchange of the subunits limits the development of specialized orthogonal genetic systems that could be evolved for novel functions without interfering with native translation. Here we show that ribosomes with tethered and thus inseparable subunits (termed Ribo-T) are capable of successfully carrying out protein synthesis. By engineering a hybrid rRNA composed of both small and large subunit rRNA sequences, we produced a functional ribosome in which the subunits are covalently linked into a single entity by short RNA linkers. Notably, Ribo-T was not only functional in vitro, but was also able to support the growth of Escherichia coli cells even in the absence of wild-type ribosomes. We used Ribo-T to create the first fully orthogonal ribosome-messenger RNA system, and demonstrate its evolvability by selecting otherwise dominantly lethal rRNA mutations in the peptidyl transferase centre that facilitate the translation of a problematic protein sequence. Ribo-T can be used for exploring poorly understood functions of the ribosome, enabling orthogonal genetic systems, and engineering ribosomes with new functions.	[Orelle, Cedric; Szal, Teresa; Florin, Tanja; Mankin, Alexander S.] Univ Illinois, Ctr Pharmaceut Biotechnol MC 870, Chicago, IL 60607 USA; [Carlson, Erik D.; Jewett, Michael C.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Carlson, Erik D.; Jewett, Michael C.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Northwestern University	Mankin, AS (corresponding author), Univ Illinois, Ctr Pharmaceut Biotechnol MC 870, 900 South Ashland Ave, Chicago, IL 60607 USA.	m-jewett@northwestern.edu; shura@uic.edu	Orelle, Cédric/AAI-1495-2020; Jewett, Michael C/E-3506-2010	Orelle, Cédric/0000-0003-3418-3290; Jewett, Michael/0000-0003-2948-6211; Florin, Tanja/0000-0002-0176-6898	Defense Advanced Research Projects Agency [N66001-12-C-4211]; National Science Foundation [MCB-0943393, MCB-1244455]; David and Lucille Packard Foundation [2011-37152]; Div Of Molecular and Cellular Bioscience [1244455] Funding Source: National Science Foundation	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank I. Ntai for mass spectrometry analysis, K. N. Swonger, C. Burghard, E. M. Fulk, V. Raghavan and N. Aleksashin for help with some experiments, K. Ito for providing the sequence of the pNH122 secM-lacZa reporter, Y. Polikanov for help in preparing ribosome images, J. Lee for assistance in genome sequence analysis, S. Sothiselvam and J. Marks for discussions and suggestions, and N. Vazquez-Laslop for advice on the project and critical reading of the manuscript. This work was supported by the Defense Advanced Research Projects Agency (N66001-12-C-4211), the National Science Foundation grants MCB-0943393 (to M. C. J.) and MCB-1244455 (to A.S.M.) and the David and Lucille Packard Foundation Fellowship (2011-37152) (to M.C.J.).	An WL, 2009, P NATL ACAD SCI USA, V106, P8477, DOI 10.1073/pnas.0900267106; Arenz S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4501; Asai T, 1999, P NATL ACAD SCI USA, V96, P1971, DOI 10.1073/pnas.96.5.1971; Bhushan S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000581; Bundy BC, 2010, BIOCONJUGATE CHEM, V21, P255, DOI 10.1021/bc9002844; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Dorywalska M, 2005, NUCLEIC ACIDS RES, V33, P182, DOI 10.1093/nar/gki151; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Erlacher MD, 2005, NUCLEIC ACIDS RES, V33, P1618, DOI 10.1093/nar/gki308; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fredrick K, 2000, J MOL BIOL, V298, P379, DOI 10.1006/jmbi.2000.3563; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HUI A, 1987, P NATL ACAD SCI USA, V84, P4762, DOI 10.1073/pnas.84.14.4762; INOUYE S, 1985, NUCLEIC ACIDS RES, V13, P3101, DOI 10.1093/nar/13.9.3101; Kannan K, 2012, CELL, V151, P508, DOI 10.1016/j.cell.2012.09.018; Karamyshev AL, 2004, BIOCHIMIE, V86, P933, DOI 10.1016/j.biochi.2004.08.006; Karbstein K, 2013, TRENDS CELL BIOL, V23, P242, DOI 10.1016/j.tcb.2013.01.004; Kitahara K, 2009, MOL CELL, V34, P760, DOI 10.1016/j.molcel.2009.05.014; Mankin AS, 1997, J MOL BIOL, V274, P8, DOI 10.1006/jmbi.1997.1387; Merryman C, 1998, PRACT APPROACH SER, V192, P237; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; Orelle C, 2013, ANTIMICROB AGENTS CH, V57, P5994, DOI 10.1128/AAC.01673-13; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Sato NS, 2006, P NATL ACAD SCI USA, V103, P15386, DOI 10.1073/pnas.0605970103; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Thompson J, 2001, P NATL ACAD SCI USA, V98, P9002, DOI 10.1073/pnas.151257098; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	38	141	146	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					119	U289		10.1038/nature14862	http://dx.doi.org/10.1038/nature14862			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26222032	Green Published			2022-12-28	WOS:000359002300044
J	Nieves, V; Willis, JK; Patzert, WC				Nieves, Veronica; Willis, Josh K.; Patzert, William C.			Recent hiatus caused by decadal shift in Indo-Pacific heating	SCIENCE			English	Article							INDONESIAN THROUGHFLOW; OCEAN; REANALYSIS	Recent modeling studies have proposed different scenarios to explain the slowdown in surface temperature warming in the most recent decade. Some of these studies seem to support the idea of internal variability and/or rearrangement of heat between the surface and the ocean interior. Others suggest that radiative forcing might also play a role. Our examination of observational data over the past two decades shows some significant differences when compared to model results from reanalyses and provides the most definitive explanation of how the heat was redistributed. We find that cooling in the top 100-meter layer of the Pacific Ocean was mainly compensated for by warming in the 100-to 300-meter layer of the Indian and Pacific Oceans in the past decade since 2003.	[Nieves, Veronica] Univ Calif Los Angeles, Joint Inst Reg Earth Syst Sci & Engn, Los Angeles, CA 90095 USA; [Nieves, Veronica; Willis, Josh K.; Patzert, William C.] CALTECH, Jet Prop Lab, Pasadena, CA USA	University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Nieves, V (corresponding author), Univ Calif Los Angeles, Joint Inst Reg Earth Syst Sci & Engn, Los Angeles, CA 90095 USA.	veronica.nieves@jpl.nasa.gov	Willis, Josh/AGY-7817-2022; NIEVES, VERONICA/A-7859-2018	NIEVES, VERONICA/0000-0003-0024-8383	NASA;  [NNN13D772T-10-OSST10-0015]	NASA(National Aeronautics & Space Administration (NASA)); 	The research described in this paper was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. This work was supported by grant NNN13D772T-10-OSST10-0015.	Balmaseda MA, 2013, GEOPHYS RES LETT, V40, P1754, DOI 10.1002/grl.50382; Balmaseda MA, 2013, Q J ROY METEOR SOC, V139, P1132, DOI 10.1002/qj.2063; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Chen XY, 2014, SCIENCE, V345, P897, DOI 10.1126/science.1254937; Cheng LJ, 2014, J ATMOS OCEAN TECH, V31, P1793, DOI 10.1175/JTECH-D-13-00197.1; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Drijfhout SS, 2014, GEOPHYS RES LETT, V41, P7868, DOI 10.1002/2014GL061456; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Huber M, 2014, NAT GEOSCI, V7, P651, DOI [10.1038/NGEO2228, 10.1038/ngeo2228]; IPCC, 2013, CLIMATE CHANGE 2022; Ishii M, 2005, INT J CLIMATOL, V25, P865, DOI 10.1002/joc.1169; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Lee SK, 2015, NAT GEOSCI, V8, P445, DOI 10.1038/NGEO2438; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Lyman JM, 2008, J CLIMATE, V21, P5629, DOI 10.1175/2008JCLI2259.1; Nishida T., 2011, VALIDATION GLOBAL OC; Purkey SG, 2014, J GEOPHYS RES-OCEANS, V119, P7509, DOI 10.1002/2014JC010180; Roemmich D, 2015, NAT CLIM CHANGE, V5, P240, DOI [10.1038/NCLIMATE2513, 10.1038/nclimate2513]; Roemmich D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047992; Schwarzkopf FU, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047651; Sprintall J, 2014, J GEOPHYS RES-OCEANS, V119, P1161, DOI 10.1002/2013JC009533; Trenberth KE, 2013, EARTHS FUTURE, V1, P19, DOI 10.1002/2013EF000165; van Sebille E, 2014, J GEOPHYS RES-OCEANS, V119, P1365, DOI 10.1002/2013JC009525	23	137	140	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247					532	535		10.1126/science.aaa4521	http://dx.doi.org/10.1126/science.aaa4521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	26160379				2022-12-28	WOS:000358713300055
J	Dickert, NW; Miller, FG				Dickert, Neal W.; Miller, Franklin G.			Involving patients in enrolment decisions for acute myocardial infarction trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFORMED-CONSENT; PATIENTS PERCEPTIONS		[Dickert, Neal W.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [Dickert, Neal W.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Miller, Franklin G.] NIH, Dept Bioeth, Bethesda, MD 20892 USA	Emory University; Emory University; Rollins School Public Health; National Institutes of Health (NIH) - USA	Dickert, NW (corresponding author), Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA.	njr@emory.edu						[Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; [Anonymous], 1986, Lancet, V1, P397; Dickert NW, 2009, J MED ETHICS, V35, P419, DOI 10.1136/jme.2008.027235; Dickert Neal W, 2015, Acute Card Care, V17, P1, DOI 10.3109/17482941.2014.994642; Dickert NW, 2012, PROG CARDIOVASC DIS, V55, P251, DOI 10.1016/j.pcad.2012.10.001; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Gammelgaard A, 2004, J MED PHILOS, V29, P417, DOI 10.1080/03605310490503533; Gammelgaard A, 2004, HEART, V90, P1124, DOI 10.1136/hrt.2003.021931; Gammelgaard A, 2004, SOC SCI MED, V58, P2313, DOI 10.1016/j.socscimed.2003.08.023; Kass N, 2012, JAMA-J AM MED ASSOC, V307, P1589, DOI 10.1001/jama.2012.491; Kim SYH, 2014, NEW ENGL J MED, V370, P769, DOI 10.1056/NEJMhle1312508; LEVINE RJ, 1991, CONTROL CLIN TRIALS, V12, P546, DOI 10.1016/0197-2456(91)90012-B; Selker HP, 2012, JAMA-J AM MED ASSOC, V307, P1925, DOI 10.1001/jama.2012.426; Shahzad A, 2014, LANCET, V384, P1849, DOI 10.1016/S0140-6736(14)60924-7; Shaw D, 2014, LANCET, V384, P1826, DOI 10.1016/S0140-6736(14)61040-0; SMITH HL, 1974, SOC SCI MED, V8, P399, DOI 10.1016/0037-7856(74)90125-5; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Tognoni G, 1997, CONTROL CLIN TRIALS, V18, P621, DOI 10.1016/S0197-2456(97)00057-3; van Belle G, 2015, RESUSCITATION, V91, P76, DOI 10.1016/j.resuscitation.2014.11.029; Williams BF, 2003, LANCET, V361, P918, DOI 10.1016/S0140-6736(03)12773-0; Wood S., 2014, HEARTWIRE       0401	21	11	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2015	351								h3791	10.1136/bmj.h3791	http://dx.doi.org/10.1136/bmj.h3791			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO2UA	26223782	Green Published			2022-12-28	WOS:000359010900004
J	Mann, C; Osius, E				Mann, Cindy; Osius, Elizabeth			Medicaid's New Role in the Health Care System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mann, Cindy; Osius, Elizabeth] Manatt, Phelps & Phillips, Washington, DC 20036 USA		Mann, C (corresponding author), Manatt, Phelps & Phillips, 1050 Connecticut Ave NW, Washington, DC 20036 USA.	cmann@manatt.com						[Anonymous], MED CHIP APPL EL DET; [Anonymous], INS EXP HOSP UNC CAR; [Anonymous], UPD BUDG PROJ 2015 2; [Anonymous], FLOR SEEM WANT MED C; [Anonymous], DUAL EL PERC TOT MED; [Anonymous], STAT DEM PROP INT CA; Bachrach D, STATES EXPANDING MED; Sommers BD, 2014, HEALTH AFFAIR, V33, P700, DOI 10.1377/hlthaff.2013.1023; The Council of Economic Advisors, MISS OPP CONS STAT D	9	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					343	344		10.1001/jama.2015.8433	http://dx.doi.org/10.1001/jama.2015.8433			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219047				2022-12-28	WOS:000358581700011
J	Baron, TH; Grimm, IS; Swanstrom, LL				Baron, Todd H.; Grimm, Ian S.; Swanstrom, Lee L.			Interventional Approaches to Gallbladder Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RANDOMIZED CLINICAL-TRIAL; INCISION LAPAROSCOPIC CHOLECYSTECTOMY; RISK SURGICAL-PATIENTS; BILE-DUCT INJURY; QUALITY-OF-LIFE; ACUTE CHOLECYSTITIS; PERCUTANEOUS CHOLECYSTOSTOMY; DELAYED-CHOLECYSTECTOMY; ENDOSCOPIC SURGERY; DRAINAGE		[Baron, Todd H.; Grimm, Ian S.] Univ N Carolina, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA; [Swanstrom, Lee L.] Oregon Clin, Div Gastrointestinal & Minimally Invas Surg, Portland, OR USA; [Swanstrom, Lee L.] Inst Hosp Univ Strasbourg, Strasbourg, France	University of North Carolina; University of North Carolina Chapel Hill; CHU Strasbourg	Baron, TH (corresponding author), Univ N Carolina, Div Gastroenterol & Hepatol, 130 Mason Farm Rd,CB 7080, Chapel Hill, NC 27599 USA.	todd_baron@med.unc.edu		Grimm, Ian/0000-0001-9083-5930; Swanstrom, Lee/0000-0002-1740-463X				Abu Dayyeh BK, 2012, CLIN GASTROENTEROL H, V10, P947, DOI 10.1016/j.cgh.2012.03.006; Atar E, 2014, CLIN RADIOL, V69, pE247, DOI 10.1016/j.crad.2014.01.012; Auyang ED, 2011, SURG ENDOSC, V25, P3135, DOI 10.1007/s00464-011-1718-x; Baron TH, 2007, GASTROINTEST ENDOSC, V65, P735, DOI 10.1016/j.gie.2006.07.041; Baron TH, 2015, CLIN GASTROENTEROL H, V13, pE13, DOI 10.1016/j.cgh.2014.09.001; Booij KAC, 2015, ENDOSCOPY, V47, P40, DOI 10.1055/s-0034-1390908; Bulian DR, 2015, ANN SURG, V261, P451, DOI 10.1097/SLA.0000000000000218; Cha Byung Hyo, 2014, Korean J Gastroenterol, V63, P32; Choi JH, 2014, ENDOSCOPY, V46, P656, DOI 10.1055/s-0034-1365720; Duszak R, 2012, J AM COLL RADIOL, V9, P474, DOI 10.1016/j.jacr.2012.02.019; Elmunzer BJ, 2011, CLIN GASTROENTEROL H, V9, P18, DOI 10.1016/j.cgh.2010.09.023; Elshaer M, 2015, JAMA SURG, V150, P159, DOI 10.1001/jamasurg.2014.1219; FERETIS CB, 1990, GASTROINTEST ENDOSC, V36, P523, DOI 10.1016/S0016-5107(90)71134-0; Gutt CN, 2013, ANN SURG, V258, P385, DOI 10.1097/SLA.0b013e3182a1599b; Horn T, 2015, HPB, V17, P326, DOI 10.1111/hpb.12360; Ingraham AM, 2010, J AM COLL SURGEONS, V211, P176, DOI 10.1016/j.jamcollsurg.2010.04.003; Itoi T, 2008, GASTROINTEST ENDOSC, V68, P455, DOI 10.1016/j.gie.2008.02.052; Itoi T, 2010, GASTROINTEST ENDOSC, V71, P1038, DOI 10.1016/j.gie.2010.01.026; Jang JW, 2012, GASTROENTEROLOGY, V142, P805, DOI 10.1053/j.gastro.2011.12.051; Jorgensen LN, 2014, BRIT J SURG, V101, P347, DOI 10.1002/bjs.9393; Kamata K, 2010, ENDOSCOPY, V42, pE331, DOI 10.1055/s-0030-1255941; Karakayali FY, 2014, HEPATOB PANCREAT DIS, V13, P316, DOI 10.1016/S1499-3872(14)60045-X; Kim YH, 2011, KOREAN J RADIOL, V12, P210, DOI 10.3348/kjr.2011.12.2.210; Kortram K, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-7; Landman MP, 2013, HPB, V15, P252, DOI 10.1111/j.1477-2574.2012.00586.x; Lee PC, 2010, BRIT J SURG, V97, P1007, DOI 10.1002/bjs.7087; Lee TH, 2011, ENDOSCOPY, V43, P702, DOI 10.1055/s-0030-1256226; Marks JM, 2013, J AM COLL SURGEONS, V216, P1037, DOI 10.1016/j.jamcollsurg.2013.02.024; McCarthy ST, 2014, DIG DIS SCI; McKay A, 2012, SURG ENDOSC, V26, P1343, DOI 10.1007/s00464-011-2035-0; Pannala R, 2008, Minerva Gastroenterol Dietol, V54, P107; Penas-Herrero I, 2015, J HEPATO-BIL-PAN SCI, V22, P35, DOI 10.1002/jhbp.182; RADDER RW, 1980, DIAGN IMAGING, V49, P330; Rattner DW, 2011, SURG ENDOSC, V25, P2441, DOI 10.1007/s00464-011-1605-5; Rosemurgy A, 2014, SURG ENDOSC; Rosenmuller MH, 2013, BRIT J SURG, V100, P886, DOI 10.1002/bjs.9133; Saad S, 2013, BRIT J SURG, V100, P339, DOI 10.1002/bjs.9003; Simorov A, 2013, AM J SURG, V206, P935, DOI 10.1016/j.amjsurg.2013.08.019; Sodergren MH, 2014, SURG ENDOSC; Soper NJ, 2011, WORLD J SURG, V35, P1422, DOI 10.1007/s00268-011-1063-1; Strasberg SM, 2013, J AM COLL SURGEONS, V217, P751, DOI 10.1016/j.jamcollsurg.2013.05.001; Strasberg SM, 2012, ANN SURG, V256, P7, DOI 10.1097/SLA.0b013e31825b381a; Takada T, 2013, J HEPATO-BIL-PAN SCI, V20, P1, DOI 10.1007/s00534-012-0566-y; Talseth A, 2014, SCAND J GASTROENTERO, V49, P92, DOI 10.3109/00365521.2013.853828; Tucker JJ, 2014, AM SURGEON, V80, P652; Tujios SR, 2014, J CLIN GASTROENTEROL; Venara A, 2014, J VISC SURG, V151, P435, DOI 10.1016/j.jviscsurg.2014.06.003; Walter D, 2015, GUT; Wood SG, 2013, JAMA SURG, V148, P435, DOI 10.1001/jamasurg.2013.108; Yokoe M, 2013, J HEPATO-BIL-PAN SCI, V20, P35, DOI 10.1007/s00534-012-0568-9; Zafar SN, 2015, JAMA SURG, V150, P129, DOI 10.1001/jamasurg.2014.2339	51	66	68	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					357	365		10.1056/NEJMra1411372	http://dx.doi.org/10.1056/NEJMra1411372			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3NL	26200981				2022-12-28	WOS:000358333500009
J	Prystowsky, EN; Padanilam, BJ; Fogel, RI				Prystowsky, Eric N.; Padanilam, Benzy J.; Fogel, Richard I.			Treatment of Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TACHYCARDIA-INDUCED CARDIOMYOPATHY; LEFT-VENTRICULAR DYSFUNCTION; DIRECT-CURRENT CARDIOVERSION; RHYTHM-CONTROL; CATHETER ABLATION; RADIOFREQUENCY ABLATION; ANTIARRHYTHMIC-DRUGS; HEART-FAILURE; FOLLOW-UP; TRANSTHORACIC CARDIOVERSION	IMPORTANCE Atrial fibrillation is a common arrhythmia that affects more than 2.5 million people in the United States and causes substantial morbidity and mortality, especially regarding the increased risk of stroke. OBJECTIVE To summarize atrial fibrillation treatment exclusive of stroke prevention. EVIDENCE REVIEW An Ovid MEDLINE comprehensive literature search was performed on atrial fibrillation therapy excluding anticoagulation and emphasizing studies published within the last 5 years through April 2015 (N = 5044 references). The 2014 atrial fibrillation guideline from the American Heart Association, the American College of Cardiology, and the Heart Rhythm Society also was reviewed. FINDINGS Reversible causes of atrial fibrillation should be identified. Risk factor modification, including weight loss and treatment of hypertension, diabetes, and obstructive sleep apnea can reduce atrial fibrillation episodes. Appropriate anticoagulation is necessary for patients at substantial stroke risk regardless of rate or rhythm treatment strategy. Sinus rhythm is often needed to control symptoms; however, an alternative strategy for atrial fibrillation is appropriate rate control. Rate control is safe in older patients (those who are about age >= 65 years) followed up for a few years, but no such safety data exist for patients younger than 60 years or for those followed up for longer periods. Thus, selection of therapy is individualized, taking into account present and future medical problems for the patient. Choice of an antiarrhythmic drug is based on safety first vs efficacy. Catheter ablation is an effective nonpharmacological alternative that is often, but not always, the second-line treatment. Reduction of the frequency and duration of atrial fibrillation episodes that result in a significant improvement in quality of life is a good marker of drug treatment success and complete elimination of atrial fibrillation is not required in many patients. Rate control is usually achieved with a beta-blocker or non-dihydropyridine calcium channel blockers. It is important to assess adequate rate control during both rest and activity. If the ventricular rate goes uncontrolled for a prolonged period, tachycardia-mediated cardiomyopathy can occur. CONCLUSIONS AND RELEVANCE Therapy for atrial fibrillation includes prevention and modification of inciting causes and appropriate anticoagulation. Rate control is necessary for all patients. Maintenance of sinus rhythm with drugs or catheter ablation should be considered based on the individual needs of each patient.	[Prystowsky, Eric N.; Padanilam, Benzy J.; Fogel, Richard I.] St Vincent Hosp, St Vincent Med Grp, Indianapolis, IN USA		Prystowsky, EN (corresponding author), St Vincent Med Grp, 8333 Naab Rd, Indianapolis, IN 46260 USA.	enprysto@stvincent.org			Abbott; EP/Topera; CardioNet; Stereotaxis; Medtronic; Boston Scientific; St Jude	Abbott(Abbott Laboratories); EP/Topera; CardioNet; Stereotaxis; Medtronic(Medtronic); Boston Scientific(Boston Scientific); St Jude(St. Jude Medical)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Prystowsky reported receiving personal fees for serving on the board of directors for Stereotaxis; previously serving on the board of directors for CardioNet; owning stock in Stereotaxis; previously owning stock in CardioNet and Topera; receiving personal fees for serving as a consultant to Abbott, EP/Topera, CardioNet, Stereotaxis, and Medtronic; receiving institutional grant support from Boston Scientific, Medtronic, and St Jude; and holding a patent with CardioNet but not receiving royalties. Dr Padanilam reported owning stock in Topera. No other disclosures were reported.	Abed HS, 2013, JAMA-J AM MED ASSOC, V310, P2050, DOI 10.1001/jama.2013.280521; Al-Khatib SM, 2014, ANN INTERN MED, V160, P760, DOI 10.7326/M13-1467; Alboni P, 2004, NEW ENGL J MED, V351, P2384, DOI 10.1056/NEJMoa041233; Botto GL, 1999, HEART, V82, P726, DOI 10.1136/hrt.82.6.726; Brignole M, 2011, EUR HEART J, V32, P2420, DOI 10.1093/eurheartj/ehr162; Bunch TJ, 2010, HEART RHYTHM, V7, P433, DOI 10.1016/j.hrthm.2009.12.004; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Chatterjee S, 2013, PACE, V36, P122, DOI 10.1111/j.1540-8159.2012.03513.x; CHEUNG DW, 1981, J PHYSIOL-LONDON, V314, P445, DOI 10.1113/jphysiol.1981.sp013718; COUMEL P, 1978, ARCH MAL COEUR VAISS, V71, P645; Curtis AB, 2013, NEW ENGL J MED, V368, P1585, DOI 10.1056/NEJMoa1210356; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Gallagher MM, 2001, J AM COLL CARDIOL, V38, P1498, DOI 10.1016/S0735-1097(01)01540-6; Gallagher MM, 2002, J AM COLL CARDIOL, V40, P926, DOI 10.1016/S0735-1097(02)02052-1; Gentlesk PJ, 2007, J CARDIOVASC ELECTR, V18, P9, DOI 10.1111/j.1540-8167.2006.00653.x; Gillis AM, 2011, CAN J CARDIOL, V27, P27, DOI 10.1016/j.cjca.2010.11.003; GROGAN M, 1992, AM J CARDIOL, V69, P1570, DOI 10.1016/0002-9149(92)90705-4; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Haissaguerre M, 2014, CIRCULATION, V130, P530, DOI 10.1161/CIRCULATIONAHA.113.005421; Hsu LF, 2004, NEW ENGL J MED, V351, P2373, DOI 10.1056/NEJMoa041018; Ionescu-Ittu R, 2012, ARCH INTERN MED, V172, P997, DOI 10.1001/archinternmed.2012.2266; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Jalife J, 2002, CARDIOVASC RES, V54, P204, DOI 10.1016/S0008-6363(02)00223-7; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Katritsis DG, 2013, J AM COLL CARDIOL, V62, P2318, DOI 10.1016/j.jacc.2013.06.053; Khand AU, 2003, J AM COLL CARDIOL, V42, P1944, DOI 10.1016/j.jacc.2003.07.020; Kotecha D, 2014, LANCET, V384, P2235, DOI 10.1016/S0140-6736(14)61373-8; Lin WS, 2003, CIRCULATION, V107, P3176, DOI 10.1161/01.CIR.0000074206.52056.2D; Lip GYH, 2015, JAMA-J AM MED ASSOC, V313, P1950, DOI 10.1001/jama.2015.4369; Mittal S, 2000, CIRCULATION, V101, P1282, DOI 10.1161/01.CIR.101.11.1282; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; Mont L, 2014, EUR HEART J, V35, P501, DOI 10.1093/eurheartj/eht457; Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Narayan SM, 2014, J AM COLL CARDIOL, V63, P1761, DOI 10.1016/j.jacc.2014.02.543; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Narayan SM, 2012, J CARDIOVASC ELECTR, V23, P447, DOI 10.1111/j.1540-8167.2012.02332.x; Nattel S, 2014, J AM COLL CARDIOL, V63, P2335, DOI 10.1016/j.jacc.2014.02.555; Nerheim P, 2004, CIRCULATION, V110, P247, DOI 10.1161/01.CIR.0000135472.28234.CC; Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566; Nishida K, 2014, J AM COLL CARDIOL, V64, P823, DOI 10.1016/j.jacc.2014.06.1172; Olshansky B, 2004, J AM COLL CARDIOL, V43, P1201, DOI 10.1016/j.jacc.2003.11.032; Oral H, 1999, NEW ENGL J MED, V340, P1849, DOI 10.1056/NEJM199906173402401; Ozcan C, 2002, J AM COLL CARDIOL, V40, P105, DOI 10.1016/S0735-1097(02)01927-7; PACKER DL, 1986, AM J CARDIOL, V57, P563, DOI 10.1016/0002-9149(86)90836-2; Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064; Padanilam Benzy J, 2012, Card Electrophysiol Clin, V4, P299, DOI 10.1016/j.ccep.2012.06.003; Page RL, 2002, J AM COLL CARDIOL, V39, P1956, DOI 10.1016/S0735-1097(02)01898-3; Pathak RK, 2015, J AM COLL CARDIOL, V65, P2159, DOI 10.1016/j.jacc.2015.03.002; Pathak RK, 2014, J AM COLL CARDIOL, V64, P2222, DOI 10.1016/j.jacc.2014.09.028; Prystowsky E N, 1996, Am J Cardiol, V78, P35, DOI 10.1016/S0002-9149(96)00564-4; Prystowsky EN, 2011, HURSTS THE HEART, P963; Prystowsky EN, 2008, J CARDIOVASC ELECTR, V19, P575, DOI 10.1111/j.1540-8167.2008.01184.x; Prystowsky EN, 2013, J AM COLL CARDIOL, V62, P540, DOI 10.1016/j.jacc.2013.04.038; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; SCHERF D, 1948, AM HEART J, V36, P241, DOI 10.1016/0002-8703(48)90403-7; Shen MJ, 2012, NAT REV CARDIOL, V9, P30, DOI 10.1038/nrcardio.2011.139; Soliman EZ, 2014, JAMA INTERN MED, V174, pE107, DOI 10.1001/jamainternmed.2013.11912; Trulock KM, 2014, J AM COLL CARDIOL, V64, P710, DOI 10.1016/j.jacc.2014.06.1169; Turakhia MP, 2014, J AM COLL CARDIOL, V64, P660, DOI 10.1016/j.jacc.2014.03.060; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Van Gelder IC, 2006, EUROPACE, V8, P935, DOI 10.1093/europace/eul106; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; Verma A, 2014, CAN J CARDIOL, V30, P1114, DOI 10.1016/j.cjca.2014.08.001; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Wood MA, 2000, CIRCULATION, V101, P1138, DOI 10.1161/01.CIR.101.10.1138; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	69	54	59	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					278	288		10.1001/jama.2015.7505	http://dx.doi.org/10.1001/jama.2015.7505			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197188				2022-12-28	WOS:000358228000022
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Hunt's plan will shame patients who need costly drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Department of Health, 2015, COMMUNICATION	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2015	351								h3929	10.1136/bmj.h3929	http://dx.doi.org/10.1136/bmj.h3929			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WE	26195212	Bronze			2022-12-28	WOS:000358644200005
J	Borowiak, M; Nahaboo, W; Reynders, M; Nekolla, K; Jalinot, P; Hasserodt, J; Rehberg, M; Delattre, M; Zahler, S; Vollmar, A; Trauner, D; Thorn-Seshold, O				Borowiak, Malgorzata; Nahaboo, Wallis; Reynders, Martin; Nekolla, Katharina; Jalinot, Pierre; Hasserodt, Jens; Rehberg, Markus; Delattre, Marie; Zahler, Stefan; Vollmar, Angelika; Trauner, Dirk; Thorn-Seshold, Oliver			Photoswitchable Inhibitors of Microtubule Dynamics Optically Control Mitosis and Cell Death	CELL			English	Article							SOLID TUMORS; TUBULIN; AGENTS; COMBRETASTATIN; ANALOGS; COLCHICINE; PRODRUG; EMBRYOS; DRUGS	Small molecules that interfere with microtubule dynamics, such as Taxol and the Vinca alkaloids, are widely used in cell biology research and as clinical anticancer drugs. However, their activity cannot be restricted to specific target cells, which also causes severe side effects in chemotherapy. Here, we introduce the photostatins, inhibitors that can be switched on and off in vivo by visible light, to optically control microtubule dynamics. Photostatins modulate microtubule dynamics with a subsecond response time and control mitosis in living organisms with single-cell spatial precision. In longer-term applications in cell culture, photostatins are up to 250 times more cytotoxic when switched on with blue light than when kept in the dark. Therefore, photostatins are both valuable tools for cell biology, and are promising as a new class of precision chemotherapeutics whose toxicity may be spatiotemporally constrained using light.	[Borowiak, Malgorzata; Reynders, Martin; Zahler, Stefan; Vollmar, Angelika; Trauner, Dirk; Thorn-Seshold, Oliver] Univ Munich, Dept Chem & Pharm, D-81377 Munich, Germany; [Borowiak, Malgorzata; Reynders, Martin; Zahler, Stefan; Vollmar, Angelika; Trauner, Dirk; Thorn-Seshold, Oliver] Univ Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Borowiak, Malgorzata; Nahaboo, Wallis; Jalinot, Pierre; Delattre, Marie] CNRS, Ecole Normale Super Lyon, Lab Biol Mol Cellule, F-69364 Lyon, France; [Hasserodt, Jens; Thorn-Seshold, Oliver] CNRS, Ecole Normale Super Lyon, Chim Lab, F-69364 Lyon, France; [Nekolla, Katharina; Rehberg, Markus] Univ Munich, Walter Brendel Ctr Expt Med, D-81377 Munich, Germany	University of Munich; University of Munich; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Munich	Trauner, D (corresponding author), Univ Munich, Dept Chem & Pharm, 5-13 Butenandtstr, D-81377 Munich, Germany.	dirk.trauner@cup.uni-muenchen.de; oliver.thorn-seshold@cup.uni-muenchen.de	Delattre, Marie/AAJ-1491-2020; Delattre, Marie/CAG-5526-2022; Thorn-Seshold, Oliver/AAA-3382-2021	Delattre, Marie/0000-0003-1640-0300; Delattre, Marie/0000-0003-1640-0300; Thorn-Seshold, Oliver/0000-0003-3981-651X; Nahaboo, Wallis/0000-0001-8283-097X; Rehberg, Markus/0000-0001-7314-6332; Zahler, Stefan/0000-0002-5140-7287; Hasserodt, Jens/0000-0002-9437-4032	European Research Council (ERC Advanced Grant) [268795]; Deutsche Forschungsgemeinschaft [SFB 1032]; Comite de la Recherche Academique, Rhone-Alpes Region, France (ARC1-Sante project "PHOTO-CAN''); ENS-Lyon (Fonds Recherche); Canceropole Lyon Auvergne Rhone-Alpes (CLARA Mobilite Jeunes); French Government PhD fellowship; NIH NCRR	European Research Council (ERC Advanced Grant)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Comite de la Recherche Academique, Rhone-Alpes Region, France (ARC1-Sante project "PHOTO-CAN'')(Region Auvergne-Rhone-Alpes); ENS-Lyon (Fonds Recherche); Canceropole Lyon Auvergne Rhone-Alpes (CLARA Mobilite Jeunes); French Government PhD fellowship; NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This paper is dedicated to Dr Michael Bishop, who was an outstanding mentor, and is a lasting inspiration. This project was supported by funds from the European Research Council (ERC Advanced Grant No. 268795 "CARV'' to D.T.), the Deutsche Forschungsgemeinschaft (SFB 1032 to D.T., M. Rehberg, and S.Z.), and the Comite de la Recherche Academique, Rhone-Alpes Region, France (ARC1-Sante 2013 project "PHOTO-CAN'' to O.T.-S., M.B., J.H., and P.J.). O.T.-S. and M.B. were additionally supported by fellowships from the ENS-Lyon (Fonds Recherche 2013) and the Canceropole Lyon Auvergne Rhone-Alpes (CLARA Mobilite Jeunes 2013). W.N. was supported by a French Government PhD fellowship. We thank G. Hofner, L. de la Osa de la Rosa, P. Mayer, and the CALM platform (LMU), the PLATIM facility (UMS Biosciences, Lyon), H. Bachmeier and A. Gersdorf (LMU Elektrotechnik), and J.-C. Mulatier (ENS-Lyon) for help with equipment and assays. We thank V. Small (IMBA, Vienna) for EB3-mCherry plasmid, Caenorhabditis Genetics Center for nematode strains (supported by NIH NCRR), and A. Wainman, R. Zimmermann and A. Haines for electronics advice. O.T.-S. intends to found a startup in 2016/2017 to make photostatins commercially available.	Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Bhattacharyya B, 2008, MED RES REV, V28, P155, DOI 10.1002/med.20097; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bisby R. H., 2013, UK Patent Application, Patent No. [WO 2013021208 (A2), 2013021208]; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024656; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; CUSHMAN M, 1991, J MED CHEM, V34, P2579, DOI 10.1021/jm00112a036; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Fehrentz T, 2011, ANGEW CHEM INT EDIT, V50, P12156, DOI 10.1002/anie.201103236; Ghinet A, 2013, BIOORGAN MED CHEM, V21, P2932, DOI 10.1016/j.bmc.2013.03.064; Gill JH, 2014, MOL PHARMACEUT, V11, P1294, DOI 10.1021/mp400760b; Hadfield J., 2002, Substituted Stilbenes, Their Reactions and Anticancer Activity, Patent No. [WO200250007, 200250007]; HAMAGUCHI MS, 1986, DEV GROWTH DIFFER, V28, P143, DOI 10.1111/j.1440-169x.1986.00143.x; Hooper A.T., 2013, NATURAL PRODUCTS CAN, P17, DOI DOI 10.1007/978-1-4614-4654-5_2; Ibsen S, 2013, PHOTOCHEM PHOTOBIOL, V89, P698, DOI 10.1111/php.12045; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Lenci, 2003, CRC HDB ORGANIC PHOT; LIN CM, 1988, MOL PHARMACOL, V34, P200; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Ohsumi K, 1998, J MED CHEM, V41, P3022, DOI 10.1021/jm980101w; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; PETTIT GR, 1989, EXPERIENTIA, V45, P209, DOI 10.1007/BF01954881; Pettit GR, 2009, Tempe, AZ, US, Patent No. [7557096, US007557096B2, 007557096]; Rehberg M, 2010, NANO LETT, V10, P3656, DOI 10.1021/nl102100m; SAOTOME K, 1989, TOXICOL IN VITRO, V3, P317, DOI 10.1016/0887-2333(89)90039-8; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Tahir SK, 2000, BIOTECHNIQUES, V29, P156, DOI 10.2144/00291rr02; Thorn-Seshold O., 2014, THORNSESHOLD O; Thorn-Seshold O, 2012, CHEM COMMUN, V48, P6253, DOI 10.1039/c2cc32227g; Tozer GM, 2002, INT J EXP PATHOL, V83, P21, DOI 10.1046/j.1365-2613.2002.00211.x; Tron GC, 2006, J MED CHEM, V49, P3033, DOI 10.1021/jm0512903; Velema WA, 2014, J AM CHEM SOC, V136, P2178, DOI 10.1021/ja413063e; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024	36	231	232	9	133	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					403	411		10.1016/j.cell.2015.06.049	http://dx.doi.org/10.1016/j.cell.2015.06.049			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26165941	Bronze			2022-12-28	WOS:000358087700019
J	Campbell, EK; Holz, M; Gerlich, D; Maier, JP				Campbell, E. K.; Holz, M.; Gerlich, D.; Maier, J. P.			Laboratory confirmation of C-60(+) as the carrier of two diffuse interstellar bands	NATURE			English	Article							ELECTRONIC-SPECTRA; ARGON MATRICES; CLOUDS; SPECTROSCOPY; FEATURES	The diffuse interstellar bands are absorption lines seen towards reddened stars(1). None of the molecules responsible for these bands have been conclusively identified(2). Two bands at 9,632 (a) over circle ngstroms and 9,577 (a) over circle ngstroms were reported in 1994, and were suggested to arise from C-60(+) molecules (ref. 3), on the basis of the proximity of these wavelengths to the absorption bands of C-60(+) measured in a neon matrix(4). Confirmation of this assignment requires the gas-phase spectrum of C-60(+). Here we report laboratory spectroscopy of C-60(+) in the gas phase, cooled to 5.8 kelvin. The absorption spectrum hasmaxima at 9,632.7 +/- 0.1 (a) over circle ngstroms and 9,577.5 +/- 0.1 (a) over circle ngstroms, and the full widths at half-maximum of these bands are 2.2 +/- 0.2 (a) over circle ngstroms and 2.5 +/- 0.2 (a) over circle ngstroms, respectively. We conclude that we have positively identified the diffuse interstellar bands at 9,632 (a) over circle ngstroms and 9,577 (a) over circle ngstroms as arising from C-60(+) in the interstellarmedium.	[Campbell, E. K.; Holz, M.; Maier, J. P.] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland; [Gerlich, D.] Tech Univ Chemnitz, Dept Phys, D-09107 Chemnitz, Germany	University of Basel; Technische Universitat Chemnitz	Maier, JP (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.	j.p.maier@unibas.ch			European Research Council [ERC-AdG-ElecSpecIons: 246998]	European Research Council(European Research Council (ERC)European Commission)	This work was financially supported by the European Research Council (ERC-AdG-ElecSpecIons: 246998)	BIESKE EJ, 1992, J CHEM PHYS, V96, P28, DOI 10.1063/1.462517; Cami J, 2010, SCIENCE, V329, P1180, DOI 10.1126/science.1192035; Chakrabarty S, 2013, J PHYS CHEM A, V117, P9574, DOI 10.1021/jp312294f; Chakrabarty S, 2013, J PHYS CHEM LETT, V4, P4051, DOI 10.1021/jz402264n; Duncan MA, 2012, J PHYS CHEM A, V116, P11477, DOI 10.1021/jp309037d; EDWARDS SA, 1993, ASTRON ASTROPHYS, V272, P533; FOING BH, 1994, NATURE, V369, P296, DOI 10.1038/369296a0; Foing BH, 1997, ASTRON ASTROPHYS, V317, pL59; FULARA J, 1993, CHEM PHYS LETT, V211, P227, DOI 10.1016/0009-2614(93)85190-Y; Galazutdinov GA, 2000, MON NOT R ASTRON SOC, V317, P750, DOI 10.1046/j.1365-8711.2000.03566.x; GASYNA Z, 1992, J PHYS CHEM-US, V96, P1525, DOI 10.1021/j100183a005; GERLICH D, 1995, PHYS SCRIPTA, VT59, P256, DOI 10.1088/0031-8949/1995/T59/035; HERBIG GH, 1995, ANNU REV ASTRON ASTR, V33, P19, DOI 10.1146/annurev.aa.33.090195.000315; Herbig GH, 2000, ASTROPHYS J, V542, P334, DOI 10.1086/309523; Indriolo N, 2007, ASTROPHYS J, V671, P1736, DOI 10.1086/523036; Jasik J, 2013, INT J MASS SPECTROM, V354, P204, DOI 10.1016/j.ijms.2013.06.007; Jenniskens P, 1997, ASTRON ASTROPHYS, V327, P337; KROTO H, 1988, SCIENCE, V242, P1139, DOI 10.1126/science.242.4882.1139; KROTO HW, 1992, ASTRON ASTROPHYS, V263, P275; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Langford VS, 1999, J PHYS CHEM A, V103, P6533, DOI 10.1021/jp991393v; Maier JP, 2001, ASTROPHYS J, V553, P267, DOI 10.1086/320668; Sellgren K, 2010, ASTROPHYS J LETT, V722, pL54, DOI 10.1088/2041-8205/722/1/L54; Snow TP, 2006, ANNU REV ASTRON ASTR, V44, P367, DOI 10.1146/annurev.astro.43.072103.150624	24	373	374	12	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					322	+		10.1038/nature14566	http://dx.doi.org/10.1038/nature14566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26178962				2022-12-28	WOS:000357950900036
J	Merad, M; Salmon, H				Merad, Miriam; Salmon, Helene			A dendritic-cell brake on antitumour immunity	NATURE			English	Editorial Material							CANCER		[Merad, Miriam; Salmon, Helene] Icahn Sch Med Mt Sinai, Oncol Sci Dept, Tisch Canc & Immunol Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Oncol Sci Dept, Tisch Canc & Immunol Inst, New York, NY 10029 USA.	miriam.merad@mssm.edu			NATIONAL CANCER INSTITUTE [R01CA173861, R01CA190400] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA173861, R01 CA190400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chaput N, 2008, ONCOGENE, V27, P5920, DOI 10.1038/onc.2008.270; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; Spranger S, 2015, NATURE	11	10	11	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					294	295		10.1038/523294a	http://dx.doi.org/10.1038/523294a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26178959	Green Accepted			2022-12-28	WOS:000357950900028
J	Sniderman, AD; D'Agostino, RB; Pencina, MJ				Sniderman, Allan D.; D'Agostino, Ralph B.; Pencina, Michael J.			The Role of Physicians in the Era of Predictive Analytics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK		[Sniderman, Allan D.] McGill Univ, Royal Victoria Hosp, Montreal, PQ H4A 3J1, Canada; [D'Agostino, Ralph B.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Pencina, Michael J.] Duke Univ, Duke Clin Res Inst, Dept Biostat & Bioinformat, Durham, NC 27705 USA	McGill University; Royal Victoria Hospital; Boston University; Duke University	Pencina, MJ (corresponding author), Duke Univ, Duke Clin Res Inst, Dept Biostat & Bioinformat, 2400 Pratt St, Durham, NC 27705 USA.	allan.sniderman@mcgill.ca; michael.pencina@duke.edu						Cohen MF., 2011, INTRO LOGIC SCI METH; D'Agostino RB, 2013, GLOB HEART, V8, P11, DOI 10.1016/j.gheart.2013.01.001; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Sniderman AD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3047; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Sussman J, 2013, CIRCULATION, V128, P2309, DOI 10.1161/CIRCULATIONAHA.113.002290; Tjur T, 2009, AM STAT, V63, P366, DOI 10.1198/tast.2009.08210	8	46	46	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					25	26		10.1001/jama.2015.6177	http://dx.doi.org/10.1001/jama.2015.6177			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151261				2022-12-28	WOS:000357455900009
J	Demaio, AR; Rockstroem, J				Demaio, Alessandro R.; Rockstroem, Johan			Human and planetary health: towards a common language	LANCET			English	Editorial Material									[Demaio, Alessandro R.] Harvard Univ, Sch Med, Harvard Global Equ Initiat, Boston, MA 02115 USA; [Demaio, Alessandro R.] Univ Copenhagen, Dept Publ Hlth, Sch Global Hlth, Copenhagen, Denmark; [Rockstroem, Johan] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden	Harvard University; Harvard Medical School; University of Copenhagen; Stockholm University	Demaio, AR (corresponding author), Harvard Univ, Sch Med, Harvard Global Equ Initiat, Boston, MA 02115 USA.	demaio@sund.ku.dk		Demaio, Alessandro/0000-0002-1767-4576; Rockstrom, Johan/0000-0001-8988-2983				Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bellarby J., 2008, COOL FARMING CLIMATE; Folke C, 2011, AMBIO, V40, P719, DOI 10.1007/s13280-011-0184-y; Food and Agriculture Organization of the United Nations, 2010, TACKL CLIM CHANG LIV; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Rockstrom J, 2010, AMBIO, V39, P257, DOI 10.1007/s13280-010-0033-4; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Whitmee S., 2015, LANCET; World Health Organisation, 2013, GLOB ACT PLAN PREV N	10	16	18	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					E36	E37		10.1016/S0140-6736(15)61044-3	http://dx.doi.org/10.1016/S0140-6736(15)61044-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PI	26188745				2022-12-28	WOS:000364763200001
J	Carolan, J; Harrold, C; Sparrow, C; Martin-Lopez, E; Russell, NJ; Silverstone, JW; Shadbolt, PJ; Matsuda, N; Oguma, M; Itoh, M; Marshall, GD; Thompson, MG; Matthews, JCF; Hashimoto, T; O'Brien, JL; Laing, A				Carolan, Jacques; Harrold, Christopher; Sparrow, Chris; Martin-Lopez, Enrique; Russell, Nicholas J.; Silverstone, Joshua W.; Shadbolt, Peter J.; Matsuda, Nobuyuki; Oguma, Manabu; Itoh, Mikitaka; Marshall, Graham D.; Thompson, Mark G.; Matthews, Jonathan C. F.; Hashimoto, Toshikazu; O'Brien, Jeremy L.; Laing, Anthony			Universal linear optics	SCIENCE			English	Article							QUANTUM INTERFERENCE; GUIDE; ENTANGLEMENT; REALIZATION; PHOTONS; VERIFICATION	Linear optics underpins fundamental tests of quantum mechanics and quantum technologies. We demonstrate a single reprogrammable optical circuit that is sufficient to implement all possible linear optical protocols up to the size of that circuit. Our six-mode universal system consists of a cascade of 15 Mach-Zehnder interferometers with 30 thermo-optic phase shifters integrated into a single photonic chip that is electrically and optically interfaced for arbitrary setting of all phase shifters, input of up to six photons, and their measurement with a 12-single-photon detector system. We programmed this system to implement heralded quantum logic and entangling gates, boson sampling with verification tests, and six-dimensional complex Hadamards. We implemented 100 Haar random unitaries with an average fidelity of 0.999 +/- 0.001. Our system can be rapidly reprogrammed to implement these and any other linear optical protocol, pointing the way to applications across fundamental science and quantum technologies.	[Carolan, Jacques; Harrold, Christopher; Sparrow, Chris; Russell, Nicholas J.; Silverstone, Joshua W.; Marshall, Graham D.; Thompson, Mark G.; Matthews, Jonathan C. F.; O'Brien, Jeremy L.; Laing, Anthony] Univ Bristol, HH Wills Phys Lab, Ctr Quantum Photon, Bristol BS8 1UB, Avon, England; [Carolan, Jacques; Harrold, Christopher; Sparrow, Chris; Russell, Nicholas J.; Silverstone, Joshua W.; Marshall, Graham D.; Thompson, Mark G.; Matthews, Jonathan C. F.; O'Brien, Jeremy L.; Laing, Anthony] Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1UB, Avon, England; [Sparrow, Chris; Shadbolt, Peter J.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England; [Martin-Lopez, Enrique] Nokia Technol, Cambridge CB3 0FA, England; [Matsuda, Nobuyuki] Nippon Telegraph & Tel NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; [Oguma, Manabu; Itoh, Mikitaka; Hashimoto, Toshikazu] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan	University of Bristol; University of Bristol; Imperial College London; Nokia Corporation; Nippon Telegraph & Telephone Corporation; Nippon Telegraph & Telephone Corporation	Laing, A (corresponding author), Univ Bristol, HH Wills Phys Lab, Ctr Quantum Photon, Merchant Venturers Bldg,Woodland Rd, Bristol BS8 1UB, Avon, England.	anthony.laing@bristol.ac.uk	Marshall, Graham D/H-7820-2013; Matsuda, Nobuyuki/T-2724-2019; Hashimoto, Toshikazu/W-3455-2019; Matthews, Jonathan/D-7129-2011	Matthews, Jonathan/0000-0001-6184-1813; O'Brien, Jeremy/0000-0002-3576-8285; Matsuda, Nobuyuki/0000-0001-6014-3570; Silverstone, Joshua/0000-0002-3429-4890; Laing, Anthony/0000-0002-1066-3110; Thompson, Mark/0000-0002-2865-9558; Martin-Lopez, Enrique/0000-0002-3595-458X; Carolan, Jacques/0000-0002-5736-2753	Engineering and Physical Sciences Research Council (EPSRC); European Research Council (ERC); BBOI, QUCHIP [H2020-FETPROACT-3-2014]; PIQUE [FP7-PEOPLE-2013-ITN]; Centre for Nanoscience and Quantum Information (NSQI); U.S. Army Research Office (ARO) [W911NF-14-1-0133]; U.S. Air Force Office of Scientific Research (AFOSR); Leverhulme Trust Early Career Fellowship; Royal Society Wolfson Merit Award; Royal Academy of Engineering Chair in Emerging Technologies; EPSRC [EP/K021931/1, EP/M013472/1, EP/L024020/1, EP/K033085/1, EP/K023063/1, EP/J017175/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M013472/1, EP/K023063/1, EP/J017175/1, EP/K021931/1, EP/K033085/1, 1230322, EP/L024020/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council (ERC)(European Research Council (ERC)European Commission); BBOI, QUCHIP; PIQUE; Centre for Nanoscience and Quantum Information (NSQI); U.S. Army Research Office (ARO); U.S. Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Leverhulme Trust Early Career Fellowship(Leverhulme Trust); Royal Society Wolfson Merit Award(Royal Society of London); Royal Academy of Engineering Chair in Emerging Technologies(Royal Academy of Engineering - UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors acknowledge support from the Engineering and Physical Sciences Research Council (EPSRC), the European Research Council (ERC), including BBOI, QUCHIP (H2020-FETPROACT-3-2014: Quantum simulation), PIQUE (FP7-PEOPLE-2013-ITN), the Centre for Nanoscience and Quantum Information (NSQI), the U.S. Army Research Office (ARO) grant W911NF-14-1-0133, and the U.S. Air Force Office of Scientific Research (AFOSR). J.C.F.M. was supported by a Leverhulme Trust Early Career Fellowship. J.L.O'B. acknowledges a Royal Society Wolfson Merit Award and a Royal Academy of Engineering Chair in Emerging Technologies.	Aaronson S, 2014, QUANTUM INF COMPUT, V14, P1383; Aaronson S, 2011, ACM S THEORY COMPUT, P333; Bengtsson I, 2007, J MATH PHYS, V48, DOI 10.1063/1.2716990; Broome MA, 2013, SCIENCE, V339, P794, DOI 10.1126/science.1231440; Browne DE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010501; Crespi A, 2013, NAT PHOTONICS, V7, P545, DOI [10.1038/nphoton.2013.112, 10.1038/NPHOTON.2013.112]; Crespi A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1570; Gasparoni S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.020504; Halmos PR., 1950, SUMMA BRASIL MATH, V2, P125; Himeno A, 1998, IEEE J SEL TOP QUANT, V4, P913, DOI 10.1109/2944.736076; Hofmann HF, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.024308; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Hurwitz A., 1897, NACHR GES WISS GOTT, P71; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kok P, 2007, REV MOD PHYS, V79, P135, DOI 10.1103/RevModPhys.79.135; KWIAT PG, 1995, PHYS REV LETT, V75, P4337, DOI 10.1103/PhysRevLett.75.4337; Laing A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.260505; Laing A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3497087; Langford N. K., 2007, THESIS U QUEENSLAND; Li HW, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063017; Marshall GD, 2009, OPT EXPRESS, V17, P12546, DOI 10.1364/OE.17.012546; Matthews JCF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01539; Matthews JCF, 2009, NAT PHOTONICS, V3, P346, DOI 10.1038/NPHOTON.2009.93; Mattle K., 2004, APPL PHYS B, V60, pS111; Miller DAB, 2013, PHOTONICS RES, V1, P1, DOI 10.1364/PRJ.1.000001; Muscalu C, 2003, MATH RES LETT, V10, P237; Nielsen, 2010, QUANTUM COMPUTATION; Nielsen MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040503; O'Brien JL, 2009, NAT PHOTONICS, V3, P687, DOI 10.1038/nphoton.2009.229; O'Brien JL, 2003, NATURE, V426, P264, DOI 10.1038/nature02054; Okamoto R, 2011, P NATL ACAD SCI USA, V108, P10067, DOI 10.1073/pnas.1018839108; OU ZY, 1992, PHYS REV LETT, V68, P3663, DOI 10.1103/PhysRevLett.68.3663; Pan JW, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.777; Peruzzo A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1228; Peruzzo A, 2010, SCIENCE, V329, P1500, DOI 10.1126/science.1193515; Politi A, 2008, SCIENCE, V320, P646, DOI 10.1126/science.1155441; Ralph TC, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.062324; Ralph TC, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.012314; RECK M, 1994, PHYS REV LETT, V73, P58, DOI 10.1103/PhysRevLett.73.58; Sansoni L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.010502; Shadbolt PJ, 2012, NAT PHOTONICS, V6, P45, DOI [10.1038/nphoton.2011.283, 10.1038/NPHOTON.2011.283]; Shi YY, 2003, QUANTUM INF COMPUT, V3, P84; SHOR PW, 1994, AN S FDN CO, P124; Silverstone JW, 2014, NAT PHOTONICS, V8, P104, DOI [10.1038/NPHOTON.2013.339, 10.1038/nphoton.2013.339]; Smith BJ, 2009, OPT EXPRESS, V17, P13516, DOI 10.1364/OE.17.013516; Sohma S., 2006, PROC EUR C OPT COMMU, P1, DOI DOI 10.1109/ECOC.2006.4801113; Spagnolo N, 2014, NAT PHOTONICS, V8, P615, DOI [10.1038/NPHOTON.2014.135, 10.1038/nphoton.2014.135]; Spagnolo N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2616; Sprengers JP, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3657518; Spring JB, 2013, SCIENCE, V339, P798, DOI 10.1126/science.1231692; Szollosi F, 2012, J LOND MATH SOC, V85, P616, DOI 10.1112/jlms/jdr052; Takahashi H, 2011, OPT EXPRESS, V19, P173; Tanida M, 2012, OPT EXPRESS, V20, P15275, DOI 10.1364/OE.20.015275; Thomson DJ, 2012, IEEE PHOTONIC TECH L, V24, DOI 10.1109/LPT.2011.2177081; Tichy MC, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.020502; Tichy MC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.220405; Tillmann M, 2013, NAT PHOTONICS, V7, P540, DOI [10.1038/nphoton.2013.102, 10.1038/NPHOTON.2013.102]; Werner RF, 2001, J PHYS A-MATH GEN, V34, P7081, DOI 10.1088/0305-4470/34/35/332; Wunderlich H, 2009, J MOD OPTIC, V56, P2100, DOI 10.1080/09500340903184303	65	586	611	21	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2015	349	6249					711	716		10.1126/science.aab3642	http://dx.doi.org/10.1126/science.aab3642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8JO	26160375	Green Submitted			2022-12-28	WOS:000359415100030
J	Blees, MK; Barnard, AW; Rose, PA; Roberts, SP; McGill, KL; Huang, PY; Ruyack, AR; Kevek, JW; Kobrin, B; Muller, DA; McEuen, PL				Blees, Melina K.; Barnard, Arthur W.; Rose, Peter A.; Roberts, Samantha P.; McGill, Kathryn L.; Huang, Pinshane Y.; Ruyack, Alexander R.; Kevek, Joshua W.; Kobrin, Bryce; Muller, David A.; McEuen, Paul L.			Graphene kirigami	NATURE			English	Article							MEMBRANES; FLUCTUATIONS; RIPPLES; SHEETS	For centuries, practitioners of origami ('ori', fold; 'kami', paper) and kirigami ('kiru', cut) have fashioned sheets of paper into beautiful and complex three-dimensional structures. Both techniques are scalable, and scientists and engineers are adapting them to different two-dimensional starting materials to create structures from the macro-to the microscale(1,2). Here we show that graphene(3-6) is well suited for kirigami, allowing us to build robust microscale structures with tunable mechanical properties. The material parameter crucial for kirigami is the Foppl-von Karman number(7,8) gamma: an indication of the ratio between in-plane stiffness and out-of-plane bending stiffness, with high numbers corresponding to membranes that more easily bend and crumple than they stretch and shear. To determine gamma, we measure the bending stiffness of graphene monolayers that are 10-100 micrometres in size and obtain a value that is thousands of times higher than the predicted atomic-scale bending stiffness. Interferometric imaging attributes this finding to ripples in the membrane(9-13) that stiffen the graphene sheets considerably, to the extent that gamma is comparable to that of a standard piece of paper. We may therefore apply ideas from kirigami to graphene sheets to build mechanical metamaterials such as stretchable electrodes, springs, and hinges. These results establish graphene kirigami as a simple yet powerful and customizable approach for fashioning one-atom-thick graphene sheets into resilient and movable parts with microscale dimensions.	[Blees, Melina K.; Rose, Peter A.; Roberts, Samantha P.; McGill, Kathryn L.; Kevek, Joshua W.; Kobrin, Bryce; McEuen, Paul L.] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Barnard, Arthur W.; Huang, Pinshane Y.; Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Ruyack, Alexander R.] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA; [Muller, David A.; McEuen, Paul L.] Cornell Univ, Kavli Inst, Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	McEuen, PL (corresponding author), Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA.	plm23@cornell.edu	McGill, Kathryn/N-4438-2013; Ruyack, Alexander/T-6349-2019; Muller, David/A-7745-2010	McGill, Kathryn/0000-0002-8841-6910; Muller, David/0000-0003-4129-0473; Huang, Pinshane/0000-0002-1095-1833	Cornell Center for Materials Research (National Science Foundation, NSF) [DMR-1120296]; Office of Naval Research [N00014-13-1-0749]; Kavli Institute at Cornell for Nanoscale Science; NSF [ECCS-0335765]; NSF Graduate Research Fellowship Program [DGE-1144153, DGE-0707428]; SBIR [DE-SC0011385]	Cornell Center for Materials Research (National Science Foundation, NSF)(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Kavli Institute at Cornell for Nanoscale Science; NSF(National Science Foundation (NSF)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); SBIR	We thank D. Nelson, M. Bowick, A. Kosmrlj, J. Alden, A. van der Zande, and R. Martin-Wells for discussions. We thank E. Minot for assistance with electrolyte gating. We thank R. Hovden for discussions on three-dimensional reconstruction theory and techniques, and R. Hovden, M. Hanwell, and U. Ayachit for developing and supporting the TomViz three-dimensional visualization software. We thank J. Wardini, P. Ong, A. Zaretski, and S. P. Wang for additional graphene samples, and F. Parish with Cornell's College of Architecture, Art, and Planning for assistance with the paper models. We also acknowledge the Origami Resource Center (http://www.origami-resource-center.com/) for kirigami design ideas. This work was supported by the Cornell Center for Materials Research (National Science Foundation, NSF, grant DMR-1120296), the Office of Naval Research (N00014-13-1-0749), and the Kavli Institute at Cornell for Nanoscale Science. Devices were fabricated at the Cornell Nanoscale Science and Technology Facility, a member of the National Nanotechnology Infrastructure Network, which is supported by the NSF (ECCS-0335765). K.L.M. and P.Y.H. acknowledge support from the NSF Graduate Research Fellowship Program (DGE-1144153 and DGE-0707428). Tomography visualization software development was supported by a SBIR grant (DE-SC0011385).	ARONOVITZ JA, 1988, PHYS REV LETT, V60, P2634, DOI 10.1103/PhysRevLett.60.2634; Booth TJ, 2008, NANO LETT, V8, P2442, DOI 10.1021/nl801412y; Braghin FL, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.035407; Bunch JS, 2007, SCIENCE, V315, P490, DOI 10.1126/science.1136836; Chen D, 2010, CHEM SOC REV, V39, P3157, DOI 10.1039/b923596e; Fasolino A, 2007, NAT MATER, V6, P858, DOI 10.1038/nmat2011; Foppl A., 1905, VORLESUNGEN TECHNISC; Georgiou T, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3631632; Hawkes E, 2010, P NATL ACAD SCI USA, V107, P12441, DOI 10.1073/pnas.0914069107; Kosmrlj A, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022126; Kosmrlj A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012136; LEDOUSSAL P, 1992, PHYS REV LETT, V69, P1209, DOI 10.1103/PhysRevLett.69.1209; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Los JH, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.121405; Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545; NELSON DR, 1987, J PHYS-PARIS, V48, P1085, DOI 10.1051/jphys:019870048070108500; NICKLOW R, 1972, PHYS REV B, V5, P4951, DOI 10.1103/PhysRevB.5.4951; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Roldan R, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.174104; Velasco S., 1985, European Journal of Physics, V6, P259, DOI 10.1088/0143-0807/6/4/009; Velthuis AJWT, 2010, BIOPHYS J, V99, P1292, DOI 10.1016/j.bpj.2010.06.008; von Karman T., 1910, FESTIGKEITSPROBLEM M, V4; Wang WL, 2012, NANO LETT, V12, P2278, DOI 10.1021/nl300071y; Wang-Iverson P., 2011, OR 5 5 INT M OR SCI; Yuk JM, 2011, NANO LETT, V11, P3290, DOI 10.1021/nl201647p; Zhu SE, 2011, NANO LETT, V11, P977, DOI 10.1021/nl103618e	27	558	570	35	765	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					204	+		10.1038/nature14588	http://dx.doi.org/10.1038/nature14588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26222025				2022-12-28	WOS:000359386900028
J	Puglisi, JD				Puglisi, Joseph D.			SYNTHETIC BIOLOGY Ribosomal ties that bind	NATURE			English	Editorial Material							PROTEIN-SYNTHESIS; TRANSLATION	The ribosome is the cellular complex of proteins and RNA molecules that synthesizes proteins. An artificial ribosome in which the two main subunits are tethered together creates opportunities for engineering this process. SEE LETTER P.119	Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA	Stanford University	Puglisi, JD (corresponding author), Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA.	puglisi@stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051266] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051266] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bock LV, 2013, NAT STRUCT MOL BIOL, V20, P1390, DOI 10.1038/nsmb.2690; Dorywalska M, 2005, NUCLEIC ACIDS RES, V33, P182, DOI 10.1093/nar/gki151; HUI A, 1987, P NATL ACAD SCI USA, V84, P4762, DOI 10.1073/pnas.84.14.4762; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; O'Donoghue P, 2013, NAT CHEM BIOL, V9, P594, DOI 10.1038/nchembio.1339; Orelle C, 2015, NATURE, V524, P119, DOI 10.1038/nature14862; Petrov A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011551; Ramakrishnan V, 2014, CELL, V159, P979, DOI 10.1016/j.cell.2014.10.052	8	1	1	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					45	46		10.1038/nature14642	http://dx.doi.org/10.1038/nature14642			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26222027				2022-12-28	WOS:000359002300028
J	Madarampalli, B; Yuan, YS; Liu, D; Lengel, K; Xu, YD; Li, GF; Yang, JM; Liu, XY; Lu, ZM; Liu, DX				Madarampalli, Bhanupriya; Yuan, Yunsheng; Liu, Dan; Lengel, Kathleen; Xu, Yidi; Li, Guangfu; Yang, Jinming; Liu, Xinyuan; Lu, Zhimin; Liu, David X.			ATF5 Connects the Pericentriolar Materials to the Proximal End of the Mother Centriole	CELL			English	Article							TRANSCRIPTION FACTOR ATF5; GAMMA-TUBULIN; CENTROSOME MATURATION; SPINDLE ORGANIZATION; CYTOPLASMIC DYNEIN; VERTEBRATE CELLS; PROTEIN; MITOSIS; INTERACTS; REVEALS	Although it is known that the centrioles play instructive roles in pericentriolar material (PCM) assembly and that the PCM is essential for proper centriole formation, the mechanism that governs centriole-PCM interaction is poorly understood. Here, we show that ATF5 forms a characteristic 9-fold symmetrical ring structure in the inner layer of the PCM outfitting the proximal end of the mother centriole. ATF5 controls the centriole-PCM interaction in a cell-cycle-and centriole-age-dependent manner. Interaction of ATF5 with polyglutamylated tubulin (PGT) on the mother centriole and with PCNT in the PCM renders ATF5 as a required molecule in mother centriole-directed PCM accumulation and in PCM-dependent centriole formation. ATF5 depletion blocks PCM accumulation at the centrosome and causes fragmentation of centrioles, leading to the formation of multi-polar mitotic spindles and genomic instability. These data show that ATF5 is an essential structural protein that is required for the interaction between the mother centriole and the PCM.	[Madarampalli, Bhanupriya; Yuan, Yunsheng; Liu, Dan; Lengel, Kathleen; Xu, Yidi; Li, Guangfu; Liu, David X.] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Spokane, WA 99202 USA; [Yang, Jinming] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Liu, Xinyuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Liu, Xinyuan] Zhejiang Sci Tech Univ, Coll Life Sci, Xinyuan Inst Med & Biotechnol, Hangzhou 310018, Peoples R China; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neuro Oncol, Houston, TX 77030 USA	Washington State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang Sci-Tech University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Liu, DX (corresponding author), Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Spokane, WA 99202 USA.	d.liu@wsu.edu	Liu, Xinyuan/HDM-5505-2022	Li, Guangfu/0000-0002-9817-568X	American Cancer Society; U.S. Department of Defense; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); U.S. Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Stanley, A. Stanley, and J. Dai for help with mass spectrometry analysis and R. Myers for help with electron microscopy. We thank J. Angelastro, P. Baas, S. Doxsey, M. Green, L. Greene, L. Mourey, J. Rattner, O. Semmes, and R. Vallee for providing valuable reagents. We thank T. Denton and Z. Xia for expert consultation on synthesis of EDC-activated polyglutamate- and polylysinate-conjugated tubulin. We also thank Edward Liu for helping draw the Graphical Abstract for this manuscript. This work was supported in part by grants from the American Cancer Society and the U.S. Department of Defense (to D.X.L.).	Al Sarraj J, 2005, BIOL CHEM, V386, P873, DOI 10.1515/BC.2005.102; Angelastro JM, 2003, J NEUROSCI, V23, P4590; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Dalton RP, 2013, CELL, V155, P321, DOI 10.1016/j.cell.2013.09.033; Dluzen D, 2011, J BIOL CHEM, V286, P7705, DOI 10.1074/jbc.M110.207639; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Firat-Karalar EN, 2014, CURR BIOL, V24, P664, DOI 10.1016/j.cub.2014.01.067; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; Greene LA, 2009, J NEUROCHEM, V108, P11, DOI 10.1111/j.1471-4159.2008.05749.x; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Kakiuchi C, 2007, NEUROSCI LETT, V417, P316, DOI 10.1016/j.neulet.2007.02.054; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Kong D, 2014, J CELL BIOL, V206, P855, DOI 10.1083/jcb.201407087; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Li GF, 2009, MOL CANCER RES, V7, P933, DOI 10.1158/1541-7786.MCR-08-0365; Liu DX, 2011, MOL CELL BIOL, V31, P3906, DOI 10.1128/MCB.05887-11; Liu XJ, 2012, J BIOL CHEM, V287, P19599, DOI 10.1074/jbc.M112.363622; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Lukinaviclus G, 2013, CURR BIOL, V23, P265, DOI 10.1016/j.cub.2012.12.030; Mardin BR, 2011, CURR BIOL, V21, P1145, DOI 10.1016/j.cub.2011.05.047; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Nam HJ, 2015, TRENDS CELL BIOL, V25, P65, DOI 10.1016/j.tcb.2014.10.002; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449; Peters CS, 2001, J BIOL CHEM, V276, P13718, DOI 10.1074/jbc.M011562200; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Yamazaki T, 2010, LIFE SCI, V87, P294, DOI 10.1016/j.lfs.2010.07.006; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	45	25	29	1	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					580	592		10.1016/j.cell.2015.06.055	http://dx.doi.org/10.1016/j.cell.2015.06.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26213385	Bronze			2022-12-28	WOS:000358801800017
J	Walton, KS				Walton, Krista S.			INORGANIC CHEMISTRY Movies of a growth mechanism	NATURE			English	Editorial Material								A microscopy technique has been used to study the formation and growth of crystals of porous solids known as metal-organic frameworks in real time. The findings will aid the design of methods for making these useful compounds.	Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Walton, KS (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	krista.walton@chbe.gatech.edu						Ahnfeldt T, 2011, CHEM-EUR J, V17, P6462, DOI 10.1002/chem.201003708; de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; Liao HG, 2013, CHEM COMMUN, V49, P11720, DOI 10.1039/c3cc47473a; Patterson JP, 2015, J AM CHEM SOC, V137, P7322, DOI 10.1021/jacs.5b00817; Ragon F, 2015, CHEM-EUR J, V21, P7135, DOI 10.1002/chem.201406119; Venna SR, 2010, J AM CHEM SOC, V132, P18030, DOI 10.1021/ja109268m; Zheng CM, 2014, CRYSTENGCOMM, V16, P1064, DOI 10.1039/c3ce41291a	7	3	3	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					535	536		10.1038/523535a	http://dx.doi.org/10.1038/523535a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ZL	26223619				2022-12-28	WOS:000358655200028
J	Zhao, L; Chen, XJ; Zhu, J; Xi, YB; Yang, X; Hu, LD; Ouyang, H; Patel, SH; Jin, X; Lin, DN; Wu, F; Flagg, K; Cai, HM; Li, G; Cao, GQ; Lin, Y; Chen, D; Wen, C; Chung, C; Wang, YD; Qiu, A; Yeh, E; Wang, WQ; Hu, X; Grob, S; Abagyan, R; Su, ZG; Tjondro, HC; Zhao, XJ; Luo, HR; Hou, R; Perry, JJP; Gao, WW; Kozak, I; Granet, D; Li, YR; Sun, XD; Wang, J; Zhang, LF; Liu, YZ; Yan, YB; Zhang, K				Zhao, Ling; Chen, Xiang-Jun; Zhu, Jie; Xi, Yi-Bo; Yang, Xu; Hu, Li-Dan; Ouyang, Hong; Patel, Sherrina H.; Jin, Xin; Lin, Danni; Wu, Frances; Flagg, Ken; Cai, Huimin; Li, Gen; Cao, Guiqun; Lin, Ying; Chen, Daniel; Wen, Cindy; Chung, Christopher; Wang, Yandong; Qiu, Austin; Yeh, Emily; Wang, Wenqiu; Hu, Xun; Grob, Seanna; Abagyan, Ruben; Su, Zhiguang; Tjondro, Harry Christianto; Zhao, Xi-Juan; Luo, Hongrong; Hou, Rui; Perry, J. Jefferson P.; Gao, Weiwei; Kozak, Igor; Granet, David; Li, Yingrui; Sun, Xiaodong; Wang, Jun; Zhang, Liangfang; Liu, Yizhi; Yan, Yong-Bin; Zhang, Kang			Lanosterol reverses protein aggregation in cataracts	NATURE			English	Article							SELENITE-INDUCED CATARACTOGENESIS; DOMINANT CONGENITAL CATARACT; HUMAN OXIDOSQUALENE CYCLASE; ALPHA-B-CRYSTALLIN; SEQUENCING DATA; CHINESE FAMILY; LENS; MUTATION; EXPRESSION; PREVENTION	The human lens is comprised largely of crystallin proteins assembled into a highly ordered, interactive macro-structure essential for lens transparency and refractive index. Any disruption of intra-or inter-protein interactions will alter this delicate structure, exposing hydrophobic surfaces, with consequent protein aggregation and cataract formation. Cataracts are the most common cause of blindness worldwide, affecting tens of millions of people(1), and currently the only treatment is surgical removal of cataractous lenses. The precise mechanisms by which lens proteins both prevent aggregation and maintain lens transparency are largely unknown. Lanosterol is an amphipathic molecule enriched in the lens. It is synthesized by lanosterol synthase (LSS) in a key cyclization reaction of a cholesterol synthesis pathway. Here we identify two distinct homozygous LSS missense mutations (W581R and G588S) in two families with extensive congenital cataracts. Both of these mutations affect highly conserved amino acid residues and impair key catalytic functions of LSS. Engineered expression of wild-type, but not mutant, LSS prevents intracellular protein aggregation of various cataract-causing mutant crystallins. Treatment by lanosterol, but not cholesterol, significantly decreased preformed protein aggregates both in vitro and in cell-transfection experiments. We further show that lanosterol treatment could reduce cataract severity and increase transparency in dissected rabbit cataractous lenses in vitro and cataract severity in vivo in dogs. Our study identifies lanosterol as a key molecule in the prevention of lens protein aggregation and points to a novel strategy for cataract prevention and treatment.	[Zhao, Ling; Cai, Huimin; Li, Gen; Cao, Guiqun; Hu, Xun; Su, Zhiguang; Zhang, Kang] Sichuan Univ, Mol Med Res Ctr, State Key Lab Biotherapy, West China Hosp, Chengdu 610041, Peoples R China; [Zhao, Ling; Ouyang, Hong; Lin, Ying; Wang, Yandong; Liu, Yizhi; Zhang, Kang] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Zhao, Ling; Zhu, Jie; Ouyang, Hong; Patel, Sherrina H.; Lin, Danni; Wu, Frances; Flagg, Ken; Lin, Ying; Chen, Daniel; Wen, Cindy; Chung, Christopher; Qiu, Austin; Yeh, Emily; Wang, Wenqiu; Grob, Seanna; Luo, Hongrong; Gao, Weiwei; Granet, David; Zhang, Liangfang; Zhang, Kang] Univ Calif San Diego, Inst Engn Med, Dept Ophthalmol, La Jolla, CA 92093 USA; [Zhao, Ling; Zhu, Jie; Ouyang, Hong; Patel, Sherrina H.; Lin, Danni; Wu, Frances; Flagg, Ken; Lin, Ying; Chen, Daniel; Wen, Cindy; Chung, Christopher; Qiu, Austin; Yeh, Emily; Wang, Wenqiu; Grob, Seanna; Luo, Hongrong; Gao, Weiwei; Granet, David; Zhang, Liangfang; Zhang, Kang] Univ Calif San Diego, Inst Engn Med, Biomat & Tissue Engn Ctr, La Jolla, CA 92093 USA; [Chen, Xiang-Jun; Xi, Yi-Bo; Hu, Li-Dan; Tjondro, Harry Christianto; Zhao, Xi-Juan] Tsinghua Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Zhu, Jie; Yan, Yong-Bin] Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian 710032, Peoples R China; [Yang, Xu; Jin, Xin; Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Cai, Huimin; Hou, Rui] Guangzhou KangRui Biol Pharmaceut Technol Co, Guangzhou 510005, Guangdong, Peoples R China; [Qiu, Austin] CapitalBio Genom Co Ltd, Dongguan 523808, Peoples R China; [Wang, Wenqiu; Sun, Xiaodong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 20080, Peoples R China; [Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Perry, J. Jefferson P.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Gao, Weiwei; Zhang, Liangfang; Zhang, Kang] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Kozak, Igor] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia; [Zhang, Kang] Vet Adm Healthcare Syst, San Diego, CA 92093 USA	Sichuan University; Sun Yat Sen University; University of California System; University of California San Diego; University of California System; University of California San Diego; Tsinghua University; Air Force Military Medical University; Beijing Genomics Institute (BGI); Shanghai Jiao Tong University; University of California System; University of California San Diego; University of California System; University of California Riverside; University of California System; University of California San Diego; King Khaled Eye Specialist Hospital	Zhang, K (corresponding author), Sichuan Univ, Mol Med Res Ctr, State Key Lab Biotherapy, West China Hosp, Chengdu 610041, Peoples R China.	zhang@ucsd.edu; yzliu62@yahoo.com; ybyan@tsinghua.edu.cn; kang.zhang@gmail.com	Su, Zhiguang/AFS-0022-2022; Li, Yingrui/K-1064-2015; Zhu, Jie/AAD-1330-2022; Kozak, Igor/AAC-4645-2019; hu, li/ABB-5154-2021; Jin, Xin/ABF-1329-2020; Zhang, Kang/Y-2740-2019; liu, yi/GXE-9662-2022; Chen, Xiangjun/A-6174-2019; Yan, Yong-Bin/A-4282-2008; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Zhu, Jie/0000-0001-6862-9022; hu, li/0000-0002-1145-2745; Jin, Xin/0000-0001-7554-4975; Zhang, Kang/0000-0002-4549-1697; Chen, Xiangjun/0000-0003-0766-3416; Yan, Yong-Bin/0000-0002-8565-3558; Wang, Jun/0000-0002-8540-8931; Su, Zhiguang/0000-0001-8635-9310; Tjondro, Harry/0000-0001-5037-0091; Ouyang, Hong/0000-0002-7622-7733; Wang, Jun/0000-0002-2113-5874; Zhao, Ling/0000-0002-6644-2886; xi, yibo/0000-0002-9709-2698	973 Project [2015CB94600, 2012CB917304]; 863 Program [2014AA021604]; NSFC [31327901]; State Key Laboratory of Ophthalmology; State Key Laboratory of Membrane Biology	973 Project(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Ophthalmology; State Key Laboratory of Membrane Biology	We thank the study participants for their support. We thank G. Hannum, M. Kruppa, J. H. Shin, J. Mei, H. Zheng, F. Xu, J. Zhang, M. Kircher, J. Shendure, S. J. Fliesler, J. Gleeson, X.-T. Zuo, Y. Li and Y. Ding for their helpful advice during the course of the experiments and data analysis. This work is supported in part by grants from 973 Project (2015CB94600, 2012CB917304), 863 Program (2014AA021604), NSFC (31327901), State Key Laboratory of Ophthalmology, and State Key Laboratory of Membrane Biology.	ABAGYAN R, 1992, J MOL BIOL, V225, P519, DOI 10.1016/0022-2836(92)90936-E; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Cenedella RJ, 2004, J LIPID RES, V45, P1232, DOI 10.1194/jlr.M300469-JLR200; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diehn JJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r74; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Geraldine P, 2006, EXP EYE RES, V83, P1340, DOI 10.1016/j.exer.2006.07.009; Gu F, 2008, HUM MUTAT, V29, P769, DOI 10.1002/humu.20724; Huff MW, 2005, TRENDS PHARMACOL SCI, V26, P335, DOI 10.1016/j.tips.2005.05.004; La Croix N, 2008, TOP COMPANION ANIM M, V23, P46, DOI 10.1053/j.ctsap.2007.12.006; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li XQ, 2012, HUM MUTAT, V33, P391, DOI 10.1002/humu.21648; Makri OE, 2013, MOL VIS, V19, P1188; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Mori M, 2006, J CLIN INVEST, V116, P395, DOI 10.1172/JCI20797; NAGINENI CN, 1989, CURR EYE RES, V8, P285, DOI 10.3109/02713688908997570; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ruf A, 2004, BIOCHEM BIOPH RES CO, V315, P247, DOI 10.1016/j.bbrc.2004.01.052; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Sun TX, 1997, J BIOL CHEM, V272, P6220, DOI 10.1074/jbc.272.10.6220; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang S, 2011, BIOCHEMISTRY-US, V50, P10451, DOI 10.1021/bi201375p; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051200; Zhang LF, 2008, ACS NANO, V2, P1696, DOI 10.1021/nn800275r	35	251	266	29	352	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					607	+		10.1038/nature14650	http://dx.doi.org/10.1038/nature14650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26200341				2022-12-28	WOS:000358655200048
J	Appleby, J				Appleby, John			Day case surgery: a good news story for the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Appleby J., 2011, VARIATIONS HLTH CARE; Audit Commission, 2001, REV NAT FIND DAY SUR; Audit Commission, 1990, SHORT CUT BETT SERV; Department of Health, 2014, NAT REF COSTS 2013 2; Department of Health and Social Services, 1974, NHS HOSP ACT STAT; Health and Social Care Information Centre, 2015, HOSP EP STAT	6	11	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2015	351								h4060	10.1136/bmj.h4060	http://dx.doi.org/10.1136/bmj.h4060			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2UA	26223680				2022-12-28	WOS:000359010900014
J	Fauci, AS; Marston, HD				Fauci, Anthony S.; Marston, Hilary D.			Toward an HIV vaccine: A scientific journey	SCIENCE			English	Editorial Material							BROADLY NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; EFFICACY; INFECTION; POTENT		[Fauci, Anthony S.] NIAID, NIH, Bethesda, MD 20892 USA; [Marston, Hilary D.] NIAID, Global Hlth, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chun TW, 2014, P NATL ACAD SCI USA, V111, P13151, DOI 10.1073/pnas.1414148111; Collins H., 1994, PHILADELPHIA INQUIRE, pA1; DOLIN R, 1991, ANN INTERN MED, V114, P119, DOI 10.7326/0003-4819-114-2-119; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; DOWDLE W, 1986, PUBLIC HEALTH REP, V101, P232; Fauci AS, 2014, SCIENCE, V344, P49, DOI 10.1126/science.1250672; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kolata Gina, 1988, NEW YORK TIMES; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; PRINCE AM, 1988, P NATL ACAD SCI USA, V85, P6944, DOI 10.1073/pnas.85.18.6944; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; U.S. Military Health Research Program, 2013, POX PROT PUBL PRIV P	25	21	22	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					386	387		10.1126/science.aac6300	http://dx.doi.org/10.1126/science.aac6300			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206922				2022-12-28	WOS:000358381400026
J	Zhang, L; Roling, LT; Wang, X; Vara, M; Chi, MF; Liu, JY; Choi, SI; Park, J; Herron, JA; Xie, ZX; Mavrikakis, M; Xia, YN				Zhang, Lei; Roling, Luke T.; Wang, Xue; Vara, Madeline; Chi, Miaofang; Liu, Jingyue; Choi, Sang-Il; Park, Jinho; Herron, Jeffrey A.; Xie, Zhaoxiong; Mavrikakis, Manos; Xia, Younan			Platinum-based nanocages with subnanometer-thick walls and well-defined, controllable facets	SCIENCE			English	Article							FUEL-CELL ELECTROCATALYSTS; SHAPE-CONTROLLED SYNTHESIS; OXYGEN REDUCTION ACTIVITY; BY-LAYER DEPOSITION; NANOCRYSTALS; NANOFRAMES; DURABILITY; MONOLAYER; NANOCUBES; CATALYSTS	A cost-effective catalyst should have a high dispersion of the active atoms, together with a controllable surface structure for the optimization of activity, selectivity, or both. We fabricated nanocages by depositing a few atomic layers of platinum (Pt) as conformal shells on palladium (Pd) nanocrystals with well-defined facets and then etching away the Pd templates. Density functional theory calculations suggest that the etching is initiated via a mechanism that involves the formation of vacancies through the removal of Pd atoms incorporated into the outermost layer during the deposition of Pt. With the use of Pd nanoscale cubes and octahedra as templates, we obtained Pt cubic and octahedral nanocages enclosed by {100} and {111} facets, respectively, which exhibited distinctive catalytic activities toward oxygen reduction.	[Zhang, Lei; Wang, Xue; Choi, Sang-Il; Xia, Younan] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Zhang, Lei; Wang, Xue; Choi, Sang-Il; Xia, Younan] Emory Univ, Atlanta, GA 30332 USA; [Zhang, Lei; Wang, Xue; Xie, Zhaoxiong] Xiamen Univ, State Key Lab Phys Chem Solid Surfaces, Collaborat Innovat Ctr Chem Energy Mat, Xiamen 361005, Fujian, Peoples R China; [Zhang, Lei; Wang, Xue; Xie, Zhaoxiong] Xiamen Univ, Dept Chem, Xiamen 361005, Fujian, Peoples R China; [Roling, Luke T.; Herron, Jeffrey A.; Mavrikakis, Manos] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Vara, Madeline; Park, Jinho; Xia, Younan] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Chi, Miaofang] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Liu, Jingyue] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Xia, Younan] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Xiamen University; Xiamen University; University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; Georgia Institute of Technology; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; Arizona State University; Arizona State University-Tempe; University System of Georgia; Georgia Institute of Technology	Xia, YN (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	younan.xia@bme.gatech.edu	Wang, Xue/D-4488-2012; Roling, Luke T/B-8793-2015; Wang, Zhong Lin/E-2176-2011; wang, jie/GRS-0942-2022; Xie, Zhaoxiong/G-3416-2010; Zhang, Lei/N-7527-2015; Choi, Sangil/N-7571-2013; Park, Jinho/AAR-9508-2021; Choi, Sang-Il/AGR-1133-2022; Chi, Miaofang/Y-3603-2019; Wang, Xue/AAE-1236-2019; Mavrikakis, Manos/D-5702-2012; Xia, Younan/E-8499-2011; Chi, Miaofang/Q-2489-2015	Wang, Xue/0000-0002-6298-1858; Roling, Luke T/0000-0001-9742-2573; Wang, Zhong Lin/0000-0002-5530-0380; Zhang, Lei/0000-0001-7146-0184; Choi, Sangil/0000-0002-8280-3100; Chi, Miaofang/0000-0003-0764-1567; Wang, Xue/0000-0002-6298-1858; Mavrikakis, Manos/0000-0002-5293-5356; Chi, Miaofang/0000-0003-0764-1567; Zhang, Lei/0000-0002-9637-4845; Park, Jinho/0000-0001-8223-3390; Xia, Younan/0000-0003-2431-7048	Georgia Institute of Technology; China Scholarship Council; U.S. Department of Energy (DOE)-Basic Energy Sciences (BES), Office of Chemical Sciences [DE-FG02-05ER15731]; DOE Office of Biological and Environmental Research at the Pacific Northwest National Laboratory; DOE [DE-AC02-06CH11357, DE-AC02-05CH11231]; Oak Ridge National Laboratory's Center for Nanophase Materials Sciences, which is a DOE Office of Science User Facility	Georgia Institute of Technology; China Scholarship Council(China Scholarship Council); U.S. Department of Energy (DOE)-Basic Energy Sciences (BES), Office of Chemical Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research at the Pacific Northwest National Laboratory; DOE(United States Department of Energy (DOE)); Oak Ridge National Laboratory's Center for Nanophase Materials Sciences, which is a DOE Office of Science User Facility	The syntheses were supported by start-up funds from the Georgia Institute of Technology (to Y.X.). As jointly supervised PhD students from Xiamen University, L.Z. and X.W. were also partially supported by fellowships from the China Scholarship Council. The theoretical modeling work at University of Wisconsin-Madison was supported by the U.S. Department of Energy (DOE)-Basic Energy Sciences (BES), Office of Chemical Sciences, grant DE-FG02-05ER15731. Calculations were performed at supercomputing centers located at the Environmental Molecular Sciences Laboratory, which is sponsored by the DOE Office of Biological and Environmental Research at the Pacific Northwest National Laboratory; Center for Nanoscale Materials at Argonne National Laboratory, supported by DOE contract DE-AC02-06CH11357; and National Energy Research Scientific Computing Center, supported by DOE contract DE-AC02-05CH11231. Part of the electron microscopy work was performed through a user project supported by the Oak Ridge National Laboratory's Center for Nanophase Materials Sciences, which is a DOE Office of Science User Facility. J.L. gratefully acknowledges the support by Arizona State University and the use of facilities in the John M. Cowley Center for High Resolution Electron Microscopy at Arizona State University. Data described can be found in the main figures and supplementary materials. The authors declare no conflict of interests.	Adzic RR, 2007, TOP CATAL, V46, P249, DOI 10.1007/s11244-007-9003-x; Baheti VA, 2013, J MATER SCI-MATER EL, V24, P2833, DOI 10.1007/s10854-013-1179-1; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Chen JY, 2009, NANO TODAY, V4, P81, DOI 10.1016/j.nantod.2008.09.002; Choi SI, 2013, NANO LETT, V13, P3420, DOI 10.1021/nl401881z; Cui CH, 2013, NAT MATER, V12, P765, DOI [10.1038/NMAT3668, 10.1038/nmat3668]; de Bruijn FA, 2008, FUEL CELLS, V8, P3, DOI 10.1002/fuce.200700053; Duan HH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4093; Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529; Funatsu A, 2014, CHEM COMMUN, V50, P8503, DOI 10.1039/c4cc02527j; Gan L, 2014, SCIENCE, V346, P1502, DOI 10.1126/science.1261212; Han BH, 2015, ENERG ENVIRON SCI, V8, P258, DOI 10.1039/c4ee02144d; Heggen M, 2012, J PHYS CHEM C, V116, P19073, DOI 10.1021/jp306426a; Jin MS, 2011, NANO RES, V4, P83, DOI 10.1007/s12274-010-0051-3; Li H, 2013, ANGEW CHEM INT EDIT, V52, P8368, DOI 10.1002/anie.201303772; Lu XM, 2007, NANO LETT, V7, P1764, DOI 10.1021/nl070838l; Markovic NM, 2002, SURF SCI REP, V45, P121, DOI 10.1016/S0167-5729(01)00022-X; Park J, 2015, ACS NANO, V9, P2635, DOI 10.1021/nn506387w; Sasaki K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2124; Shao MH, 2013, CHEM COMMUN, V49, P9030, DOI 10.1039/c3cc43276a; Wang X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8594; Wu JB, 2011, NANO LETT, V11, P798, DOI 10.1021/nl104094p; Xia XH, 2013, P NATL ACAD SCI USA, V110, P6669, DOI 10.1073/pnas.1222109110; Xie SF, 2014, NANO LETT, V14, P3570, DOI 10.1021/nl501205j; Xie SF, 2012, ANGEW CHEM INT EDIT, V51, P10266, DOI 10.1002/anie.201206044; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566; Zhang J, 2010, NANO LETT, V10, P638, DOI 10.1021/nl903717z	27	725	738	43	1207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					412	416		10.1126/science.aab0801	http://dx.doi.org/10.1126/science.aab0801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206931				2022-12-28	WOS:000358381400039
J	Iglehart, JK				Iglehart, John K.			The Expansion of Retail Clinics - Corporate Titans vs. Organized Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Bachrach D., 2015, BUILDING CULTURE HLT; Chang JE., 2015, CONVENIENT CARE RETA; Hwang J, 2013, HARVARD BUSINESS REV; Pollack CE, 2009, ARCH INTERN MED, V169, P945, DOI 10.1001/archinternmed.2009.69; Tavernise S, 2015, NY TIMES, pD1	5	9	9	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					301	303		10.1056/NEJMp1506864	http://dx.doi.org/10.1056/NEJMp1506864			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN3NL	26200975				2022-12-28	WOS:000358333500002
J	Maron, M				Maron, Martine			Conservation: Stop misuse of biodiversity offsets	NATURE			English	Editorial Material							PROTECTED AREAS		[Maron, Martine] Univ Queensland, Environm Management, Brisbane, Qld, Australia; [Maron, Martine] Univ Queensland, Sch Geog Planning & Environm Management, Australian Res Council, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Maron, M (corresponding author), Univ Queensland, Environm Management, Brisbane, Qld, Australia.	m.maron@uq.edu.au	Watson, James Edward Maxwell/D-8779-2013; Maron, Martine/D-9699-2011; Gordon, Ascelin/I-9184-2012; Possingham, Hugh/B-1337-2008	Watson, James Edward Maxwell/0000-0003-4942-1984; Maron, Martine/0000-0002-5563-5789; Gordon, Ascelin/0000-0002-0648-0346; Mackey, Brendan/0000-0003-1996-4064; Possingham, Hugh/0000-0001-7755-996X				Aiama D., 2015, NO NET LOSS NET POSI; Bos M, 2014, ENVIRON SCI POLICY, V42, P1, DOI 10.1016/j.envsci.2014.05.002; Bull JW, 2013, ORYX, V47, P369, DOI 10.1017/S003060531200172X; International Union for Conservation of Nature, 2014, BIOD OFFS TECHN STUD; Kormos R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111671; Maron M., 2015, BIOL CONSERV; Pilgrim JD, 2014, CONSERV LETT, V7, P423, DOI 10.1111/conl.12145; Temple HJ, 2012, FORECASTING PATH NET; The Biodiversity Consultancy, 2012, IND REP BIOD OFFS; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947	10	83	84	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					401	403		10.1038/523401a	http://dx.doi.org/10.1038/523401a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN4DD	26201581	Bronze			2022-12-28	WOS:000358378900013
J	Schermerhorn, ML; Buck, DB; O'Malley, AJ; Curran, T; McCallum, JC; Darling, J; Landon, BE				Schermerhorn, Marc L.; Buck, Dominique B.; O'Malley, A. James; Curran, Thomas; McCallum, John C.; Darling, Jeremy; Landon, Bruce E.			Long-Term Outcomes of Abdominal Aortic Aneurysm in the Medicare Population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOVASCULAR REPAIR; SURVIVAL	BACKGROUND Randomized trials and observational studies have shown that perioperative morbidity and mortality are lower with endovascular repair of abdominal aortic aneurysm than with open repair, but the survival benefit is not sustained. In addition, concerns have been raised about the long-term risk of aneurysm rupture or the need for reintervention after endovascular repair. METHODS We assessed perioperative and long-term survival, reinterventions, and complications after endovascular repair as compared with open repair of abdominal aortic aneurysm in propensity-score-matched cohorts of Medicare beneficiaries who underwent repair during the period from 2001 through 2008 and were followed through 2009. RESULTS We identified 39,966 matched pairs of patients who had undergone either open repair or endovascular repair. The overall perioperative mortality was 1.6% with endovascular repair versus 5.2% with open repair (P<0.001). From 2001 through 2008, perioperative mortality decreased by 0.8 percentage points among patients who underwent endovascular repair (P = 0.001) and by 0.6 percentage points among patients who underwent open repair (P = 0.01). The rate of conversion from endovascular to open repair decreased from 2.2% in 2001 to 0.3% in 2008 (P< 0.001). The rate of survival was significantly higher after endovascular repair than after open repair through the first 3 years of follow-up, after which time the rates of survival were similar. Through 8 years of follow-up, interventions related to the management of the aneurysm or its complications were more common after endovascular repair, whereas interventions for complications related to laparotomy were more common after open repair. Aneurysm rupture occurred in 5.4% of patients after endovascular repair versus 1.4% of patients after open repair through 8 years of follow-up (P<0.001). The rate of total reinterventions at 2 years after endovascular repair decreased over time (from 10.4% among patients who underwent procedures in 2001 to 9.1% among patients who underwent procedures in 2007). CONCLUSIONS Endovascular repair, as compared with open repair, of abdominal aortic aneurysm was associated with a substantial early survival advantage that gradually decreased over time. The rate of late rupture was significantly higher after endovascular repair than after open repair. The outcomes of endovascular repair have been improving over time.	[Schermerhorn, Marc L.; Buck, Dominique B.; Curran, Thomas; McCallum, John C.; Darling, Jeremy] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Landon, Bruce E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [O'Malley, A. James] Geisel Sch Med Dartmouth, Inst Hlth Policy & Clin Practice, Lebanon, NH USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Dartmouth College	Schermerhorn, ML (corresponding author), Beth Israel Deaconess Med Ctr, Div Vasc Surg, 110 Francis St, Boston, MA 02215 USA.	mscherm@bidmc.harvard.edu			National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105453, T32HL007734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC4MH092717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by the National Institutes of Health.	Andersen PK, 2004, LIFETIME DATA ANAL, V10, P335, DOI 10.1007/s10985-004-4771-0; Baldwin LM, 2006, MED CARE, V44, P745, DOI 10.1097/01.mlr.0000223475.70440.07; Bensley RP, 2013, J AM COLL SURGEONS, V216; Buck DB, 2014, J VASC SURG, V60, P830, DOI 10.1016/j.jvs.2014.06.072; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; De Bruin JL, 2010, NEW ENGL J MED, V362, P1881, DOI 10.1056/NEJMoa0909499; Dua A, 2014, J VASC SURG, V59, P1512, DOI 10.1016/j.jvs.2014.01.007; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Jackson RS, 2012, JAMA-J AM MED ASSOC, V307, P1621, DOI 10.1001/jama.2012.453; Lederle FA, 2012, NEW ENGL J MED, V367, P1988, DOI 10.1056/NEJMoa1207481; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348; Schermerhorn ML, 2012, ANN SURG, V256, P651, DOI 10.1097/SLA.0b013e31826b4f91; Schermerhorn ML, 2011, J AM COLL SURGEONS, V212, P349, DOI 10.1016/j.jamcollsurg.2010.12.003; Therneau TM, 2000, MODELING SURVIVAL DA; Zhang JX, 1999, MED CARE, V37, P1128, DOI 10.1097/00005650-199911000-00005	20	300	310	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					328	338		10.1056/NEJMoa1405778	http://dx.doi.org/10.1056/NEJMoa1405778			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3NL	26200979	Green Accepted, Bronze			2022-12-28	WOS:000358333500006
J	Shamji, MF; Ibrahim, A				Shamji, Mohammed F.; Ibrahim, Ahmed			Cervical Meningocele	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shamji, Mohammed F.; Ibrahim, Ahmed] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Shamji, MF (corresponding author), Toronto Western Hosp, Toronto, ON M5T 2S8, Canada.	mohammed.shamji@uhn.ca							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4							e4	10.1056/NEJMicm1408098	http://dx.doi.org/10.1056/NEJMicm1408098			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3NL	26200992				2022-12-28	WOS:000358333500011
J	Sperling, EA; Wolock, CJ; Morgan, AS; Gill, BC; Kunzmann, M; Halverson, GP; Macdonald, FA; Knoll, AH; Johnston, DT				Sperling, Erik A.; Wolock, Charles J.; Morgan, Alex S.; Gill, Benjamin C.; Kunzmann, Marcus; Halverson, Galen P.; Macdonald, Francis A.; Knoll, Andrew H.; Johnston, David T.			Statistical analysis of iron geochemical data suggests limited late Proterozoic oxygenation	NATURE			English	Article							FERRUGINOUS CONDITIONS; OCEAN OXYGENATION; NEW-MODEL; RISE; REDOX; EUKARYOTES; SULFIDE; SULFATE; ANOXIA	Sedimentary rocks deposited across the Proterozoic-Phanerozoic transition record extreme climate fluctuations, a potential rise in atmospheric oxygen or re-organization of the seafloor redox landscape, and the initial diversification of animals(1,2). It is widely assumed that the inferred redox change facilitated the observed trends in biodiversity. Establishing this palaeoenvironmental context, however, requires that changes in marine redox structure be tracked by means of geochemical proxies and translated into estimates of atmospheric oxygen. Iron-based proxies are among the most effective tools for tracking the redox chemistry of ancient oceans(3,4). These proxies are inherently local, but have global implications when analysed collectively and statistically. Here we analyse about 4,700 iron-speciation measurements from shales 2,300 to 360 million years old. Our statistical analyses suggest that subsurface water masses in mid-Proterozoic oceans were predominantly anoxic and ferruginous (depleted in dissolved oxygen and iron-bearing), but with a tendency towards euxinia (sulfide-bearing) that is not observed in the Neoproterozoic era. Analyses further indicate that early animals did not experience appreciable benthic sulfide stress. Finally, unlike proxies based on redox-sensitive trace-metal abundances(1,5,6), iron geochemical data do not show a statistically significant change in oxygen content through the Ediacaran and Cambrian periods, sharply constraining the magnitude of the end-Proterozoic oxygen increase. Indeed, this re-analysis of trace-metal data is consistent with oxygenation continuing well into the Palaeozoic era. Therefore, if changing redox conditions facilitated animal diversification, it did so through a limited rise in oxygen past critical functional and ecological thresholds, as is seen in modern oxygen minimum zone benthic animal communities(7-9).	[Sperling, Erik A.; Morgan, Alex S.; Macdonald, Francis A.; Knoll, Andrew H.; Johnston, David T.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Sperling, Erik A.] Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 90089 USA; [Wolock, Charles J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Gill, Benjamin C.] Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA; [Kunzmann, Marcus; Halverson, Galen P.] McGill Univ, Dept Earth & Planetary Sci, GEOTOP, Montreal, PQ H3A 0E8, Canada	Harvard University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Harvard University; Virginia Polytechnic Institute & State University; McGill University	Sperling, EA (corresponding author), Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA.	esper@stanford.edu; johnston@eps.harvard.edu	Gill, Benjamin C/B-8047-2012	Gill, Benjamin C/0000-0001-7402-0811; Halverson, Galen/0000-0003-3061-7928	Agouron Geobiology Fellowship; NAI Postdoctoral Fellowship; NSF-EAR [1324095]; NASA Astrobiology Institute; Division Of Earth Sciences [1324095] Funding Source: National Science Foundation	Agouron Geobiology Fellowship; NAI Postdoctoral Fellowship; NSF-EAR(National Science Foundation (NSF)); NASA Astrobiology Institute; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank D. Cole, A. Masterson, E. Beirne, G. Resendiz, A. Miller and W. Mai for laboratory assistance, E. Smith, T. Petach, M. Laflamme, S. Darroch, P. Myrow, J. Strauss, C. Carbone and G. Narbonne for field assistance, L. Levin, P. Girguis, C. Frieder, L. Duncan, C. Partin, S. Darroch and U. Farrell for discussions, and E. Hammarlund, C. Scott, R. Raiswell, G. Gilleaudeau, S. Sahoo, Y. Shen, J. Creveling, T. Dahl, C. Partin and D. Stolper for providing raw data from published studies. E. A. S. is funded by Agouron Geobiology and NAI Postdoctoral Fellowships and by the NSF-EAR 1324095 grant to L. Levin. This work is supported by the NSF-EAR 1324095 grant to D.T.J. and by the NASA Astrobiology Institute (A.H.K. and F.A.M.).	Algeo TJ, 2012, CHEM GEOL, V324, P6, DOI 10.1016/j.chemgeo.2011.09.002; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Belcher CM, 2008, SCIENCE, V321, P1197, DOI 10.1126/science.1160978; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; BERRY WBN, 1978, AM J SCI, V278, P257, DOI 10.2475/ajs.278.3.257; CANFIELD DE, 1989, GEOCHIM COSMOCHIM AC, V53, P619, DOI 10.1016/0016-7037(89)90005-7; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Dahl TW, 2010, P NATL ACAD SCI USA, V107, P17911, DOI 10.1073/pnas.1011287107; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Johnston DT, 2013, CHEM GEOL, V362, P273, DOI 10.1016/j.chemgeo.2013.08.046; Leavitt WD, 2013, P NATL ACAD SCI USA, V110, P11244, DOI 10.1073/pnas.1218874110; Lenton TM, 2014, NAT GEOSCI, V7, P257, DOI 10.1038/ngeo2108; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Lyons TW, 2006, GEOCHIM COSMOCHIM AC, V70, P5698, DOI 10.1016/j.gca.2006.08.021; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Martin W, 2003, IUBMB LIFE, V55, P193, DOI 10.1080/1521654031000141231; Mills DB, 2014, P NATL ACAD SCI USA, V111, P4168, DOI 10.1073/pnas.1400547111; Partin CA, 2013, EARTH PLANET SC LETT, V369, P284, DOI 10.1016/j.epsl.2013.03.031; Planavsky NJ, 2014, SCIENCE, V346, P635, DOI 10.1126/science.1258410; Planavsky NJ, 2011, NATURE, V477, P448, DOI 10.1038/nature10327; Poulton SW, 2011, ELEMENTS, V7, P107, DOI 10.2113/gselements.7.2.107; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; Reinhard CT, 2013, P NATL ACAD SCI USA, V110, P5357, DOI 10.1073/pnas.1208622110; RHOADS DC, 1971, LETHAIA, V4, P413, DOI 10.1111/j.1502-3931.1971.tb01864.x; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P43, DOI 10.1017/S0094837300012306; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Sperling EA, 2014, GEOBIOLOGY, V12, P373, DOI 10.1111/gbi.12091; Sperling EA, 2013, P NATL ACAD SCI USA, V110, P13446, DOI 10.1073/pnas.1312778110; Sperling EA, 2013, EARTH PLANET SC LETT, V371, P143, DOI 10.1016/j.epsl.2013.04.003; Vaquer-Sunyer R, 2010, LIMNOL OCEANOGR, V55, P1075, DOI 10.4319/lo.2010.55.3.1075; Woulds C, 2007, LIMNOL OCEANOGR, V52, P1698, DOI 10.4319/lo.2007.52.4.1698	33	385	397	6	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					451	454		10.1038/nature14589	http://dx.doi.org/10.1038/nature14589			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26201598	Green Submitted			2022-12-28	WOS:000358378900034
J	Bohannon, J				Bohannon, John			The synthetic therapist	SCIENCE			English	Editorial Material																			0	13	15	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		250	251		10.1126/science.349.6245.250	http://dx.doi.org/10.1126/science.349.6245.250			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1ZB	26185240				2022-12-28	WOS:000358218600037
J	Mukhopadhyay, RD; Ajayaghosh, A				Mukhopadhyay, Rahul Dev; Ajayaghosh, Ayyappanpillai			SUPRAMOLECULAR CHEMISTRY Living supramolecular polymerization	SCIENCE			English	Editorial Material									[Mukhopadhyay, Rahul Dev; Ajayaghosh, Ayyappanpillai] CSIR NIIST, Chem Sci & Technol Div, Trivandrum 695019, Kerala, India; [Mukhopadhyay, Rahul Dev; Ajayaghosh, Ayyappanpillai] CSIR NIIST, Acad Sci & Innovat Res AcSIR, Trivandrum 695019, Kerala, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Mukhopadhyay, RD (corresponding author), CSIR NIIST, Chem Sci & Technol Div, Trivandrum 695019, Kerala, India.	ajayaghosh@niist.res.in	Mukhopadhyay, Rahul Dev/J-5032-2015; Ajayaghosh, Ayyappanpillai/B-3025-2009; Mukhopadhyay, Rahul Dev/AAI-2886-2020	Mukhopadhyay, Rahul Dev/0000-0003-0802-5344; Ajayaghosh, Ayyappanpillai/0000-0001-8574-5391; 				de Greef TFA, 2008, NATURE, V453, P171, DOI 10.1038/453171a; Faramarzi V, 2012, NAT CHEM, V4, P485, DOI [10.1038/nchem.1332, 10.1038/NCHEM.1332]; Hudson ZM, 2014, NAT CHEM, V6, P893, DOI [10.1038/NCHEM.2038, 10.1038/nchem.2038]; Kang J, 2015, SCIENCE, V347, P646, DOI 10.1126/science.aaa4249; Kang J, 2014, J AM CHEM SOC, V136, P10640, DOI 10.1021/ja505941b; Ogi S, 2015, J AM CHEM SOC, V137, P3300, DOI 10.1021/ja511952c; Ogi S, 2014, NAT CHEM, V6, P188, DOI [10.1038/NCHEM.1849, 10.1038/nchem.1849]; Qiu HB, 2015, SCIENCE, V347, P1329, DOI 10.1126/science.1261816; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; WEBSTER OW, 1991, SCIENCE, V251, P887, DOI 10.1126/science.251.4996.887	11	116	116	2	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		241	242		10.1126/science.aac7422	http://dx.doi.org/10.1126/science.aac7422			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185233				2022-12-28	WOS:000358218600024
J	Pokrovsky, V				Pokrovsky, Vladimir			SCIENCE POLICY Russia targets Western ties	SCIENCE			English	News Item													Pokrovskii, Vladimir/H-6251-2017						0	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		224	225		10.1126/science.349.6245.224	http://dx.doi.org/10.1126/science.349.6245.224			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185224				2022-12-28	WOS:000358218600015
J	Gupta, R; Geiter, LJ; Wells, CD				Gupta, Rajesh; Geiter, Lawrence J.; Wells, Charles D.			Delamanid for Extensively Drug-Resistant Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Gupta, Rajesh; Geiter, Lawrence J.; Wells, Charles D.] Otsuka Pharmaceut Dev & Commercializat, Rockville, MD 20850 USA	Otsuka Pharmaceutical	Gupta, R (corresponding author), Otsuka Pharmaceut Dev & Commercializat, Rockville, MD 20850 USA.	rajesh.gupta@otsuka-us.com		Gupta, Rajesh/0000-0002-3307-6541				[Anonymous], 2008, GUID PROGR MAN DRUG; Food and Drug Administration, 2013, GUID IND PULM TUB DE; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Maurice E, 2006, JAMA-J AM MED ASSOC, V296, P2792; Wells CD, 2015, EUR RESPIR J, V45, P1	5	40	42	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3					291	292		10.1056/NEJMc1415332	http://dx.doi.org/10.1056/NEJMc1415332			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MS	26176402				2022-12-28	WOS:000357956200030
J	Narula, J; Kuchina, A; Lee, DYD; Fujita, M; Suel, GM; Igoshin, OA				Narula, Jatin; Kuchina, Anna; Lee, Dong-yeon D.; Fujita, Masaya; Sueel, Guerol M.; Igoshin, Oleg A.			Chromosomal Arrangement of Phosphorelay Genes Couples Sporulation and DNA Replication	CELL			English	Article							BACILLUS-SUBTILIS; CELL-CYCLE; SIGNAL-TRANSDUCTION; MASTER REGULATOR; EXPRESSION; INITIATION; BACTERIA; LEVEL; FATE; COMPETENCE	Genes encoding proteins in a common regulatory network are frequently located close to one another on the chromosome to facilitate co-regulation or couple gene expression to growth rate. Contrasting with these observations, here, we demonstrate a functional role for the arrangement of Bacillus subtilis sporulation network genes on opposite sides of the chromosome. We show that the arrangement of two sporulation network genes, one located close to the origin and the other close to the terminus, leads to a transient gene dosage imbalance during chromosome replication. This imbalance is detected by the sporulation network to produce cell-cycle coordinated pulses of the sporulation master regulator Spo0A similar to P. This pulsed response allows cells to decide between sporulation and continued vegetative growth during each cell cycle spent in starvation. The simplicity of this coordination mechanism suggests that it may be widely applicable in a variety of gene regulatory and stress-response settings.	[Narula, Jatin; Igoshin, Oleg A.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Narula, Jatin; Igoshin, Oleg A.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA; [Kuchina, Anna; Lee, Dong-yeon D.; Sueel, Guerol M.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Fujita, Masaya] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	Rice University; Rice University; University of California System; University of California San Diego; University of Houston System; University of Houston	Suel, GM (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	gsuel@ucsd.edu; igoshin@rice.edu	Narula, Jatin/AAB-5082-2022; Igoshin, Oleg/P-3937-2014	Narula, Jatin/0000-0002-2458-2055; Igoshin, Oleg/0000-0002-1449-4772; Fujita, Masaya/0000-0003-0060-5328	National Science Foundation (NSF) grants [MCB-1244135, EAGER-1450867, MCB-1244423]; NIH NIGMS grant [R01 GM088428]; HHMI International Student Fellowship; Direct For Biological Sciences [1244135] Funding Source: National Science Foundation; Division Of Physics [1427654] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1244423] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088428] Funding Source: NIH RePORTER	National Science Foundation (NSF) grants(National Science Foundation (NSF)); NIH NIGMS grant; HHMI International Student Fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Authors thank Carla Vidal for her help with strain construction. This work is supported by National Science Foundation (NSF) grants MCB-1244135 (to O.A.I.), EAGER-1450867 (to G.S.), MCB-1244423 (to M.F.), NIH NIGMS grant R01 GM088428 (to G.S.), and HHMI International Student Fellowship to J.N.	Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0; Blanc-Potard AB, 1999, J BACTERIOL, V181, P2938, DOI 10.1128/JB.181.9.2938-2941.1999; Block DHS, 2012, NUCLEIC ACIDS RES, V40, P8979, DOI 10.1093/nar/gks694; Chastanet A, 2010, P NATL ACAD SCI USA, V107, P8486, DOI 10.1073/pnas.1002499107; Doncic A, 2011, MOL CELL, V43, P528, DOI 10.1016/j.molcel.2011.06.025; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Eswaramoorthy P, 2010, J BACTERIOL, V192, P3870, DOI 10.1128/JB.00466-10; Fujita M, 2005, GENE DEV, V19, P2236, DOI 10.1101/gad.1335705; Grimshaw CE, 1998, BIOCHEMISTRY-US, V37, P1365, DOI 10.1021/bi971917m; HAUSER PM, 1995, J BACTERIOL, V177, P3923, DOI 10.1128/jb.177.14.3923-3931.1995; HOCH JA, 1993, ANNU REV MICROBIOL, V47, P441, DOI 10.1146/annurev.micro.47.1.441; Igoshin OA, 2008, MOL MICROBIOL, V68, P1196, DOI 10.1111/j.1365-2958.2008.06221.x; Igoshin OA, 2006, MOL MICROBIOL, V61, P165, DOI 10.1111/j.1365-2958.2006.05212.x; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kuchina A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002273; Kuchina A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.88; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; LEDEAUX JR, 1995, J BACTERIOL, V177, P861, DOI 10.1128/jb.177.3.861-863.1995; Levine JH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001252; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Narula J, 2012, P NATL ACAD SCI USA, V109, pE3513, DOI 10.1073/pnas.1213974109; PEREGO M, 1989, J BACTERIOL, V171, P6187, DOI 10.1128/jb.171.11.6187-6196.1989; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Schultz D, 2009, P NATL ACAD SCI USA, V106, P21027, DOI 10.1073/pnas.0912185106; Sen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025102; Slager J, 2014, CELL, V157, P395, DOI 10.1016/j.cell.2014.01.068; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Su'etsugu M, 2011, MOL CELL, V41, P720, DOI 10.1016/j.molcel.2011.02.024; Toettcher JE, 2009, P NATL ACAD SCI USA, V106, P785, DOI 10.1073/pnas.0806196106; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Veening JW, 2009, GENE DEV, V23, P1959, DOI 10.1101/gad.528209; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; Young JW, 2012, NAT PROTOC, V7, P80, DOI 10.1038/nprot.2011.432; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1	35	49	49	3	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					328	337		10.1016/j.cell.2015.06.012	http://dx.doi.org/10.1016/j.cell.2015.06.012			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26165942	Green Accepted, Bronze			2022-12-28	WOS:000358087700013
J	Rochmyaningsih, D				Rochmyaningsih, Dyna			Don't distort policy in the name of national pride	NATURE			English	Editorial Material												drochmya87@gmail.com							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					257	257		10.1038/523257a	http://dx.doi.org/10.1038/523257a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM8KY	26178928	Bronze			2022-12-28	WOS:000357950900004
J	Engheta, N				Engheta, Nader			150 years of Maxwell's equations	SCIENCE			English	Editorial Material							SPONTANEOUS EMISSION; GRAPHENE PLASMONS; LIGHT; METAMATERIALS		Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA	University of Pennsylvania	Engheta, N (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.	engheta@ee.upenn.edu						Agio M., 2013, OPTICAL ANTENNAS, DOI DOI 10.1017/CBO9781139013475; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Jun YC, 2010, J PHYS CHEM C, V114, P7269, DOI 10.1021/jp9083376; Mahmoud AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6638; Maxwell J.C., 1865, PHILOS T R SOC LONDO, V155, P499; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Silva A, 2014, SCIENCE, V343, P160, DOI [10.1126/science.1242818, 10.1126/science.124405]; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	12	8	9	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					136	137		10.1126/science.aaa7224	http://dx.doi.org/10.1126/science.aaa7224			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4OM	26160929				2022-12-28	WOS:000357664300020
J	Rho, JM				Rho, Jong M.			Inhibition of Lactate Dehydrogenase to Treat Epilepsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rho, Jong M.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp Res Inst, Cumming Sch Med, Calgary, AB T2N 1N4, Canada; [Rho, Jong M.] Univ Calgary, Dept Clin Neurosci, Alberta Childrens Hosp Res Inst, Cumming Sch Med, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Rho, JM (corresponding author), Univ Calgary, Dept Pediat, Alberta Childrens Hosp Res Inst, Cumming Sch Med, Calgary, AB T2N 1N4, Canada.							Boison D, 2008, PROG NEUROBIOL, V84, P249, DOI 10.1016/j.pneurobio.2007.12.002; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Sada N, 2015, SCIENCE, V347, P1362, DOI 10.1126/science.aaa1299	5	18	20	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					187	189		10.1056/NEJMcibr1503558	http://dx.doi.org/10.1056/NEJMcibr1503558			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3QP	26154793				2022-12-28	WOS:000357598600014
J	[Anonymous]				[Anonymous]			Modern English Usage (Reprinted from JAMA, vol 193, pg 64, 1965)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Fowler H. W., 1965, DICT MODERN ENGLISH, V2nd; 1965, JAMA, V193, P64	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					88	88		10.1001/jama.2014.11846	http://dx.doi.org/10.1001/jama.2014.11846			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151284				2022-12-28	WOS:000357455900031
J	Hommelhoff, P; Higuchi, T				Hommelhoff, Peter; Higuchi, Takuya			STRONG-FIELD PHYSICS Harmonic radiation from crystals	NATURE			English	Editorial Material							SOLIDS	Electrons in a crystal can tunnel between energy bands when a strong electric field is switched on. It emerges that electron pathways interfere almost instantaneously, giving rise to ultra-short, pulsed emission of light. See Letter p.572	[Hommelhoff, Peter; Higuchi, Takuya] Univ Erlangen Nurnberg, Dept Phys, D-91058 Erlangen, Germany	University of Erlangen Nuremberg	Hommelhoff, P (corresponding author), Univ Erlangen Nurnberg, Dept Phys, D-91058 Erlangen, Germany.	peter.hommelhoff@fau.de	Higuchi, Takuya/A-5312-2011; Hommelhoff, Peter/C-5121-2013	Hommelhoff, Peter/0000-0003-4757-5410				Durach M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.086602; Ghimire S, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/20/204030; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Hohenleutner M, 2015, NATURE, V523, P572, DOI 10.1038/nature14652; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Luu TT, 2015, NATURE, V521, P498, DOI 10.1038/nature14456; Schiffrin A, 2013, NATURE, V493, P70, DOI 10.1038/nature11567; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/NPHOTON.2013.349, 10.1038/nphoton.2013.349]; Schultze M, 2014, SCIENCE, V346, P1348, DOI 10.1126/science.1260311; Vampa G, 2015, NATURE, V522, P462, DOI 10.1038/nature14517; ZENER C, 1934, P ROYAL SOC, V145, P523, DOI DOI 10.1098/RSPA.1934.0116	11	1	1	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					541	542		10.1038/523541a	http://dx.doi.org/10.1038/523541a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ZL	26223621				2022-12-28	WOS:000358655200033
J	Kinder, JM; Jiang, TT; Ertelt, JM; Xin, LJ; Strong, BS; Shaaban, AF; Way, SS				Kinder, Jeremy M.; Jiang, Tony T.; Ertelt, James M.; Xin, Lijun; Strong, Beverly S.; Shaaban, Aimen F.; Way, Sing Sing			Cross-Generational Reproductive Fitness Enforced by Microchimeric Maternal Cells	CELL			English	Article							REGULATORY T-CELLS; BONE-MARROW-TRANSPLANTATION; LEISHMANIA-MAJOR; FETAL TOLERANCE; IMMUNE-SYSTEM; HLA ANTIGENS; PREGNANCY; DISEASE; MHC; PREECLAMPSIA	Exposure to maternal tissue during in utero development imprints tolerance to immunologically foreign non-inherited maternal antigens (NIMA) that persists into adulthood. The biological advantage of this tolerance, conserved across mammalian species, remains unclear. Here, we show maternal cells that establish microchimerism in female offspring during development promote systemic accumulation of immune suppressive regulatory T cells (Tregs) with NIMA specificity. NIMA-specific Tregs expand during pregnancies sired by males expressing alloantigens with overlapping NIMA specificity, thereby averting fetal wastage triggered by prenatal infection and non-infectious disruptions of fetal tolerance. Therefore, exposure to NIMA selectively enhances reproductive success in second-generation females carrying embryos with overlapping paternally inherited antigens. These findings demonstrate that genetic fitness, canonically thought to be restricted to Mendelian inheritance, is enhanced in female placental mammals through vertically transferred maternal cells that promote conservation of NIMA and enforce cross-generational reproductive benefits.	[Kinder, Jeremy M.; Jiang, Tony T.; Ertelt, James M.; Xin, Lijun; Way, Sing Sing] Cincinnati Childrens Hospital, Div Infect Dis, Cincinnati, OH 45229 USA; [Kinder, Jeremy M.; Jiang, Tony T.; Ertelt, James M.; Xin, Lijun; Way, Sing Sing] Cincinnati Childrens Hospital, Perinatal Inst, Cincinnati, OH 45229 USA; [Strong, Beverly S.; Shaaban, Aimen F.] Cincinnati Childrens Hospital, Ctr Fetal Cellular & Mol Therapy, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Way, SS (corresponding author), Cincinnati Childrens Hospital, Div Infect Dis, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	singsing.way@cchmc.org		Way, Sing Sing/0000-0001-8948-1952; Kinder, Jeremy/0000-0001-5145-1344; Shaaban, Aimen/0000-0002-9459-107X	NIH-NIAID [R01-AI100934, R21-AI112186]; NIH-NHLBI [R01-HL103745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI112186, R01AI100934] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Marc Jenkins for providing 2W1S-OVA transgenic mice and Drs. James Moon, Louis Muglia, Joseph Qualls, Anne Stevens, Kevin Urdahl for helpful discussions. This work as supported by the NIH-NIAID through awards R01-AI100934 and R21-AI112186 (to S.S.W.) and the NIH-NHLBI through award R01-HL103745 (to A.F.S.). S.S.W. holds an Investigator in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund.	Akiyama Y, 2011, J IMMUNOL, V186, P1442, DOI 10.4049/jimmunol.1003023; Andrassy J, 2003, J IMMUNOL, V171, P5554, DOI 10.4049/jimmunol.171.10.5554; Araki M, 2010, J IMMUNOL, V185, P7739, DOI 10.4049/jimmunol.1001226; Bakkour Sonia, 2014, Chimerism, V5, P6, DOI 10.4161/chim.27778; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; BOOTH PB, 1953, BRIT MED J, V2, P41, DOI 10.1136/bmj.2.4826.41-b; Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; CAMPBELL DA, 1984, TRANSPLANTATION, V37, P340, DOI 10.1097/00007890-198404000-00004; CAMPBELL DM, 1985, BRIT J OBSTET GYNAEC, V92, P131, DOI 10.1111/j.1471-0528.1985.tb01064.x; Chaix R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000184; Chaturvedi V, 2015, J CLIN INVEST, V125, P1713, DOI 10.1172/JCI78578; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Dutta P, 2011, CURR OPIN ORGAN TRAN, V16, P359, DOI 10.1097/MOT.0b013e3283484b57; Dutta P, 2009, BLOOD, V114, P3578, DOI 10.1182/blood-2009-03-213561; Eikmans Michael, 2014, Chimerism, V5, P24; Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gammill H.S., 2015, CHIMERISM, V16, P1; Hirayama M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00135; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ichinohe T, 2004, BLOOD, V104, P3821, DOI 10.1182/blood-2004-03-1212; Israeli M, 2014, AM J REPROD IMMUNOL, V71, P467, DOI 10.1111/aji.12213; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Jiang TT, 2014, J IMMUNOL, V192, P4949, DOI 10.4049/jimmunol.1400498; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Loubiere LS, 2006, LAB INVEST, V86, P1185, DOI 10.1038/labinvest.3700471; Maloney S, 1999, J CLIN INVEST, V104, P41, DOI 10.1172/JCI6611; Matsuoka K, 2006, BLOOD, V107, P404, DOI 10.1182/blood-2005-07-3045; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mold JE, 2012, ADV IMMUNOL, V115, P73, DOI 10.1016/B978-0-12-394299-9.00003-5; Molitor ML, 2004, HUM IMMUNOL, V65, P231, DOI 10.1016/j.humimm.2003.12.006; Molitor-Dart ML, 2007, J IMMUNOL, V179, P6749, DOI 10.4049/jimmunol.179.10.6749; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Mylonakis E, 2002, MEDICINE, V81, P260, DOI 10.1097/00005792-200207000-00002; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; Nelson RW, 2013, J IMMUNOL, V190, P2828, DOI 10.4049/jimmunol.1202183; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; OWEN RD, 1954, P NATL ACAD SCI USA, V40, P420, DOI 10.1073/pnas.40.6.420; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; PICUS J, 1985, TRANSPLANTATION, V39, P297, DOI 10.1097/00007890-198503000-00018; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Rowe JH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002873; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Santner-Nanan B, 2009, J IMMUNOL, V183, P7023, DOI 10.4049/jimmunol.0901154; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Trupin LS, 1996, EPIDEMIOLOGY, V7, P240, DOI 10.1097/00001648-199605000-00004; Uzonna JE, 2001, J IMMUNOL, V167, P6967, DOI 10.4049/jimmunol.167.12.6967; van Rood JJ, 2002, BLOOD, V99, P1572, DOI 10.1182/blood.V99.5.1572; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Zhou L, 2000, IMMUNOLOGY, V101, P570, DOI 10.1046/j.1365-2567.2000.00144.x; Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X	61	76	79	2	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					505	515		10.1016/j.cell.2015.07.006	http://dx.doi.org/10.1016/j.cell.2015.07.006			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26213383	Green Accepted, Bronze			2022-12-28	WOS:000358801800011
J	Luangasanatip, N; Hongsuwan, M; Limmathurotsakul, D; Lubell, Y; Lee, AS; Harbarth, S; Day, NPJ; Graves, N; Cooper, BS				Luangasanatip, Nantasit; Hongsuwan, Maliwan; Limmathurotsakul, Direk; Lubell, Yoel; Lee, Andie S.; Harbarth, Stephan; Day, Nicholas P. J.; Graves, Nicholas; Cooper, Ben S.			Comparative efficacy of interventions to promote hand hygiene in hospital: systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEALTH-CARE WORKERS; INTERRUPTED TIME-SERIES; RESISTANT STAPHYLOCOCCUS-AUREUS; LEADERS-DIRECTED STRATEGY; IMPROVE NURSES ADHERENCE; SUSTAINED IMPROVEMENT; NOSOCOMIAL INFECTION; SEGMENTED REGRESSION; POSITIVE DEVIANCE; PROGRAM	OBJECTIVE To evaluate the relative efficacy of the World Health Organization 2005 campaign (WHO-5) and other interventions to promote hand hygiene among healthcare workers in hospital settings and to summarize associated information on use of resources. DESIGN Systematic review and network meta-analysis. DATA SOURCES Medline, Embase, CINAHL, NHS Economic Evaluation Database, NHS Centre for Reviews and Dissemination, Cochrane Library, and the EPOC register (December 2009 to February 2014); studies selected by the same search terms in previous systematic reviews (1980-2009). REVIEW METHODS Included studies were randomised controlled trials, non-randomised trials, controlled before-after trials, and interrupted time series studies implementing an intervention to improve compliance with hand hygiene among healthcare workers in hospital settings and measuring compliance or appropriate proxies that met predefined quality inclusion criteria. When studies had not used appropriate analytical methods, primary data were re-analysed. Random effects and network meta-analyses were performed on studies reporting directly observed compliance with hand hygiene when they were considered sufficiently homogeneous with regard to interventions and participants. Information on resources required for interventions was extracted and graded into three levels. RESULTS Of 3639 studies retrieved, 41 met the inclusion criteria (six randomised controlled trials, 32 interrupted time series, one non-randomised trial, and two controlled before-after studies). Meta-analysis of two randomised controlled trials showed the addition of goal setting to WHO-5 was associated with improved compliance (pooled odds ratio 1.35, 95% confidence interval 1.04 to 1.76; I-2= 81%). Of 22 pairwise comparisons from interrupted time series, 18 showed stepwise increases in compliance with hand hygiene, and all but four showed a trend for increasing compliance after the intervention. Network meta-analysis indicated considerable uncertainty in the relative effectiveness of interventions, but nonetheless provided evidence that WHO-5 is effective and that compliance can be further improved by adding interventions including goal setting, reward incentives, and accountability. Nineteen studies reported clinical outcomes; data from these were consistent with clinically important reductions in rates of infection resulting from improved hand hygiene for some but not all important hospital pathogens. Reported costs of interventions ranged from $225 to $4669 (146- pound 3035;(sic)204-(sic)4229) pound per 1000 bed days. CONCLUSION Promotion of hand hygiene with WHO-5 is effective at increasing compliance in healthcare workers. Addition of goal setting, reward incentives, and accountability strategies can lead to further improvements. Reporting of resources required for such interventions remains inadequate.	[Luangasanatip, Nantasit; Hongsuwan, Maliwan; Limmathurotsakul, Direk; Lubell, Yoel; Day, Nicholas P. J.; Cooper, Ben S.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Luangasanatip, Nantasit; Graves, Nicholas] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Lubell, Yoel; Day, Nicholas P. J.; Cooper, Ben S.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Lee, Andie S.; Harbarth, Stephan] Univ Hosp Geneva, Infect Control Program, CH-1211 Geneva, Switzerland; [Lee, Andie S.; Harbarth, Stephan] Fac Med, CH-1211 Geneva, Switzerland; [Lee, Andie S.] Royal Prince Alfred Hosp, Dept Infect Dis, Sydney, NSW 2050, Australia; [Lee, Andie S.] Royal Prince Alfred Hosp, Dept Microbiol, Sydney, NSW 2050, Australia; [Graves, Nicholas] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Queensland University of Technology (QUT); Mahidol University; University of Oxford; University of Geneva; University of Geneva; University of Sydney; University of Sydney; Queensland University of Technology (QUT)	Luangasanatip, N (corresponding author), Mahidol Oxford Trop Med Res Unit, 420-6 60th Anniversary Chalermprakiat Bldg, Bangkok 10400, Thailand.	nantasit@tropmedres.ac	Cooper, Ben/HGC-7082-2022	Lubell, Yoel/0000-0002-0237-1070; Graves, Nicholas/0000-0002-5559-3267; Cooper, Ben/0000-0002-9445-7217	Wellcome Trust of Great Britain [089275/Z/09/Z]; Oak Foundation; Medical Research Council; Department for International Development [MR/K006924/1]; Medical Research Council [MR/K006924/1] Funding Source: researchfish; MRC [MR/K006924/1] Funding Source: UKRI	Wellcome Trust of Great Britain(Wellcome Trust); Oak Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was part of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme supported by the Wellcome Trust of Great Britain (089275/Z/09/Z). BSC was supported by the Oak Foundation and the Medical Research Council and Department for International Development (grant No MR/K006924/1).	Aboelela SW, 2007, J HOSP INFECT, V66, P101, DOI 10.1016/j.jhin.2006.10.019; Al-Tawfiq JA, 2013, AM J INFECT CONTROL, V41, P482, DOI 10.1016/j.ajic.2012.08.009; Ansari F, 2003, J ANTIMICROB CHEMOTH, V52, P842, DOI 10.1093/jac/dkg459; Armellino D, 2013, AM J INFECT CONTROL, V41, P925, DOI 10.1016/j.ajic.2012.12.011; Armellino D, 2012, CLIN INFECT DIS, V54, P1, DOI 10.1093/cid/cir773; BAUER TM, 1990, J HOSP INFECT, V15, P301, DOI 10.1016/0195-6701(90)90087-5; Benning A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d199; Bolker B, 2008, ECOLOGICAL MODELS DA; Borenstein M., 2009, INTRO METAANALYSIS; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Chan BP, 2013, INFECT CONT HOSP EP, V34, P987, DOI 10.1086/671729; Chou T, 2010, AM J INFECT CONTROL, V38, P575, DOI 10.1016/j.ajic.2010.01.016; Cochrane Effective Practice and Organisation of Care Review Group, 2013, DAT COLL CHECKL  POC; Crews JD, 2013, INFECT CONT HOSP EP, V34, P751, DOI 10.1086/671002; Dancer SJ, 1999, J HOSP INFECT, V43, P85, DOI 10.1053/jhin.1999.0616; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Derde LPG, 2014, LANCET INFECT DIS, V14, P31, DOI 10.1016/S1473-3099(13)70295-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dijkstra R, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-53; Doron SI, 2011, JT COMM J QUAL PATIE, V37, P3, DOI 10.1016/S1553-7250(11)37001-8; Drummond MF, 2015, METHODS EC EVALUATIO; DUBBERT PM, 1990, INFECT CONT HOSP EP, V11, P191; Effective Practice and Organisation of Care (EPOC), 2013, WHAT STUD DES SHOULD; Eldridge NE, 2006, J GEN INTERN MED, V21, pS35, DOI 10.1111/j.1525-1497.2006.00361.x; Fisher DA, 2013, INFECT CONT HOSP EP, V34, P919, DOI 10.1086/671738; Fuller C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041617; Gould D, 1997, J CLIN NURS, V6, P55, DOI 10.1111/j.1365-2702.1997.tb00284.x; Gould DJ, 2011, COCHRANE DB SYST REV, V9; Graves N, 2007, INFECT CONT HOSP EP, V28, P178, DOI 10.1086/510787; Graves N, 2013, INFECT CONT HOSP EP, V34, P424, DOI 10.1086/669862; Grayson ML, 2008, MED J AUSTRALIA, V188, P633, DOI 10.5694/j.1326-5377.2008.tb01820.x; Hagel S, 2015, INFECT CONT HOSP EP, P1; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Helder OK, 2012, AM J INFECT CONTROL, V40, P951, DOI 10.1016/j.ajic.2011.12.003; Helms B, 2010, AM J INFECT CONTROL, V38, P572, DOI 10.1016/j.ajic.2009.08.020; Higgins A, 2013, J HOSP INFECT, V84, P32, DOI 10.1016/j.jhin.2013.02.004; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Huang Jin, 2002, J Contin Educ Nurs, V33, P217; Hugonnet S, 2000, CLIN MICROBIOL INFEC, V6, P350; Huis A, 2013, INT J NURS STUD, V50, P464, DOI 10.1016/j.ijnurstu.2012.08.004; Huis A, 2013, INT J NURS STUD, V50, P518, DOI 10.1016/j.ijnurstu.2012.11.016; Huis A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-92; Jaggi N, 2012, J CLIN DIAGN RES, V6, P1372, DOI 10.7860/JCDR/2012/4229.2362; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552; Johnson PDR, 2005, MED J AUSTRALIA, V183, P509, DOI 10.5694/j.1326-5377.2005.tb07151.x; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Khatib M, 1999, CHEST, V116, P172, DOI 10.1378/chest.116.1.172; Kirkland KB, 2012, BMJ QUAL SAF, V21, P1019, DOI 10.1136/bmjqs-2012-000800; Koff MD, 2011, J CRIT CARE, V26, P489, DOI 10.1016/j.jcrc.2010.12.013; Lee AS, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003126; Lee YT, 2012, J ANTIBIOT, V65, P311, DOI 10.1038/ja.2012.20; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Marra AR, 2013, AM J INFECT CONTROL, V41, P984, DOI 10.1016/j.ajic.2013.05.013; Marra AR, 2011, AM J INFECT CONTROL, V39, P1, DOI 10.1016/j.ajic.2010.05.024; Marra AR, 2010, INFECT CONT HOSP EP, V31, P12, DOI 10.1086/649224; Marwick CA, 2014, BMJ QUAL SAF, V23, DOI 10.1136/bmjqs-2013-002176; Mayer J, 2011, INFECT CONT HOSP EP, V32, P59, DOI 10.1086/657666; Mertz D, 2010, INFECT CONT HOSP EP, V31, P1170, DOI 10.1086/656592; Mestre G, 2013, ANN MED, V96, P1; Mestre G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047200; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Morgan DJ, 2012, AM J INFECT CONTROL, V40, P955, DOI 10.1016/j.ajic.2012.01.026; Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086; Naikoba S, 2001, J HOSP INFECT, V47, P173, DOI 10.1053/jhin.2000.0882; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; Page K, 2013, J HOSP INFECT, V84, P200, DOI 10.1016/j.jhin.2013.03.006; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Rosenthal VD, 2010, AM J INFECT CONTROL, V38, P95, DOI 10.1016/j.ajic.2009.12.004; Salamati P, 2013, INT J PREVENTIVE MED, V4, P441; Salmon S, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-16; Schweizer ML, 2014, CLIN INFECT DIS, V58, P248, DOI 10.1093/cid/cit670; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Srigley JA, 2014, BMJ QUAL SAF, V23, P974, DOI 10.1136/bmjqs-2014-003080; Stone Sheldon Paul, 2012, BMJ, V344, pe3005, DOI 10.1136/bmj.e3005; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; Talbot TR, 2013, INFECT CONT HOSP EP, V34, P1129, DOI 10.1086/673445; Taljaard M, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-77; Tibballs J, 1996, MED J AUSTRALIA, V164, P395, DOI 10.5694/j.1326-5377.1996.tb122084.x; Turner RM, 2009, J R STAT SOC A STAT, V172, P21, DOI 10.1111/j.1467-985X.2008.00547.x; Vernaz N, 2008, J ANTIMICROB CHEMOTH, V62, P601, DOI 10.1093/jac/dkn199; Vidanapathirana J, 2005, COCHRANE DB SYST REV, V3; Weinstein RA, 1998, EMERG INFECT DIS, V4, P416, DOI 10.3201/eid0403.980320; Whitby M, 2008, AM J INFECT CONTROL, V36, P349, DOI 10.1016/j.ajic.2007.07.016; World Health Organization, 2009, WHO GUID HAND HYG HL; Yngstrom D, 2011, BMJ QUAL SAF, V20, P631, DOI 10.1136/bmjqs.2007.023846	89	182	191	8	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2015	351								h3728	10.1136/bmj.h3728	http://dx.doi.org/10.1136/bmj.h3728			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO2TX	26220070	hybrid, Green Published			2022-12-28	WOS:000359010600002
J	Grey, A; Bolland, M				Grey, Andrew; Bolland, Mark			Web of industry, advocacy, and academia in the management of osteoporosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VITAMIN-D SUPPLEMENTATION; CALCIUM INTAKE; FRACTURE RISK; D DEFICIENCY; BONE; HEALTH; WOMEN; MEN; REQUIREMENTS; SKELETAL		[Grey, Andrew; Bolland, Mark] Univ Auckland, Dept Med, Auckland 1142, New Zealand	University of Auckland	Grey, A (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland 1142, New Zealand.	a.grey@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674				Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Avenell A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub3; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; Bailey RL, 2010, J NUTR, V140, P817, DOI 10.3945/jn.109.118539; BERNSTEIN MJ, 1984, JAMA-J AM MED ASSOC, V252, P799; Berry SD, 2010, OSTEOPOROSIS INT, V21, P53, DOI 10.1007/s00198-009-1127-3; Bilinski K, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4743; Bischoff-Ferrari HA, 2010, OSTEOPOROSIS INT, V21, P1121, DOI 10.1007/s00198-009-1119-3; Bischoff-Ferrari HA, 2007, AM J CLIN NUTR, V86, P1780; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Body JJ, 2012, OSTEOPOROSIS INT, V23, pS1, DOI 10.1007/s00198-011-1891-8; Body JJ, 2011, OSTEOPOROSIS INT, V22, P2769, DOI 10.1007/s00198-011-1545-x; Bolland M, 2013, AUST PRESCR, V36, P5; Bolland MJ, 2014, LANCET DIABETES ENDO, V2, P307, DOI 10.1016/S2213-8587(13)70212-2; Bolland MJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f942; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bonjour JP, 2013, J AM COLL NUTR, V32, P251, DOI 10.1080/07315724.2013.816604; Brouwer-Brolsma EM, 2013, OSTEOPOROSIS INT, V24, P1567, DOI 10.1007/s00198-012-2231-3; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Cumming RG, 1997, AM J EPIDEMIOL, V145, P926, DOI 10.1093/oxfordjournals.aje.a009052; Dawson-Hughes B, 2013, CALCIFIED TISSUE INT, V92, P184, DOI 10.1007/s00223-012-9606-5; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Grey A, 2012, JAMA-J AM MED ASSOC, V308, P1428, DOI 10.1001/jama.2012.12814; Heaney RP, 2012, ADV NUTR, V3, P763, DOI 10.3945/an.112.002899; HEANEY RP, 1977, AM J CLIN NUTR, V30, P1603, DOI 10.1093/ajcn/30.10.1603; Holick MF, 2012, J CLIN ENDOCR METAB, V97, P1153, DOI 10.1210/jc.2011-2601; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Jarvinen TLN, 2014, CAN MED ASSOC J, V186, P165, DOI 10.1503/cmaj.121874; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Lips P, 2001, J CLIN ENDOCR METAB, V86, P1212, DOI 10.1210/jc.86.3.1212; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; Moyer VA, 2013, ANN INTERN MED, V158, P691, DOI 10.7326/0003-4819-158-9-201305070-00603; PECK WA, 1993, AM J MED, V94, P646; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Prasad Vinay, 2011, Yale Journal of Biology and Medicine, V84, P471; Prentice RL, 2013, OSTEOPOROSIS INT, V24, P567, DOI 10.1007/s00198-012-2224-2; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Rizzoli R, 2013, CURR MED RES OPIN, V29, P305, DOI 10.1185/03007995.2013.766162; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Sattar N, 2012, LANCET, V379, P95, DOI 10.1016/S0140-6736(11)61816-3; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Siris E, 2014, OSTEOPOROSIS INT, V25, P1439, DOI 10.1007/s00198-014-2655-z; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Tosteson ANA, 2008, OSTEOPOROSIS INT, V19, P437, DOI 10.1007/s00198-007-0550-6; Vieth R, 2007, J BONE MINER RES, V22, pV64, DOI 10.1359/JBMR.07S221; Vieth R, 2012, SCAND J CLIN LAB INV, V72, P144, DOI 10.3109/00365513.2012.682893; Wang MTM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101533; Warensjo E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1473	50	21	21	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2015	351								h3170	10.1136/bmj.h3170	http://dx.doi.org/10.1136/bmj.h3170			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WG	26198274				2022-12-28	WOS:000358644400002
J	Bradforth, SE; Miller, ER; Dichtel, WR; Leibovich, AK; Feig, AL; Martin, JD; Bjorkman, KS; Schultz, ZD; Smith, TL				Bradforth, Stephen E.; Miller, Emily R.; Dichtel, William R.; Leibovich, Adam K.; Feig, Andrew L.; Martin, James D.; Bjorkman, Karen S.; Schultz, Zachary D.; Smith, Tobin L.			University learning: Improve undergraduate science education	NATURE			English	Editorial Material									[Bradforth, Stephen E.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Miller, Emily R.] Assoc Amer Univ, AAU Undergrad STEM Educ Initiat, Washington, DC USA; [Dichtel, William R.] Cornell Univ, Chem & Chem Biol, Ithaca, NY USA; [Leibovich, Adam K.] Univ Pittsburgh, Phys & Astron, Pittsburgh, PA 15260 USA; [Feig, Andrew L.] Wayne State Univ, Chem, Detroit, MI USA; [Martin, James D.] N Carolina State Univ, Chem, Raleigh, NC 27695 USA; [Bjorkman, Karen S.] Univ Toledo, Dept Phys & Astron, Toledo, OH USA; [Schultz, Zachary D.] Univ Notre Dame, Chem & Biochem, Notre Dame, IN 46556 USA; [Smith, Tobin L.] Assoc Amer Univ, Washington, DC USA	University of Southern California; American University; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wayne State University; University of North Carolina; North Carolina State University; University System of Ohio; University of Toledo; University of Notre Dame; American University	Bradforth, SE (corresponding author), Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA.	emily.miller@aau.edu	Bradforth, Stephen E/B-5186-2008; Schultz, Zachary D/L-5724-2013; Bradforth, Stephen/GSM-7470-2022; Dichtel, William R/A-5503-2009	Bradforth, Stephen E/0000-0002-6164-3347; Schultz, Zachary D/0000-0003-1741-8801; Dichtel, William R/0000-0002-3635-6119; Feig, Andrew/0000-0002-5783-1097; Bjorkman, Karen S./0000-0003-1975-4710; Martin, James/0000-0001-7414-2683	Direct For Education and Human Resources [1347576] Funding Source: National Science Foundation; Direct For Mathematical & Physical Scien [1056657] Funding Source: National Science Foundation	Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Benton SL, 2013, ASSESS EVAL HIGH EDU, V38, P377, DOI 10.1080/02602938.2011.636799; Corbo J. C., 2015, PREPRINT; Eddy SL, 2014, CBE-LIFE SCI EDUC, V13, P453, DOI 10.1187/cbe.14-03-0050; Fairweather J, 2009, ISSUES HIGH EDUC-PAL, P171; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Hanauer DI, 2014, CBE-LIFE SCI EDUC, V13, P149, DOI 10.1187/cbe.13-06-0123; Kober N., 2015, REACHING STUDENTS WH; National Research Council, 2012, DISCIPLINE BASED ED, DOI 10.17226/13362; Seymour E., 1997, TALKING LEAVING WHY; Stark P., 2014, SCIENCEOPEN RES, DOI 10.14293/S2199-1006.1.SQR-EDU.AOFRQA.v1Stark	10	78	78	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					282	284		10.1038/523282a	http://dx.doi.org/10.1038/523282a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM8KY	26178951	Bronze			2022-12-28	WOS:000357950900017
J	Shin, JY; Park, MJ; Lee, SH; Choi, SH; Kim, MH; Choi, NK; Lee, J; Park, BJ				Shin, Ju-Young; Park, Mi-Ju; Lee, Shin Haeng; Choi, So-Hyun; Kim, Mi-Hee; Choi, Nam-Kyong; Lee, Joongyub; Park, Byung-Joo			Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; STROKE DIAGNOSIS; HEALTH; DEPRESSION; REGISTER; VALIDITY	OBJECTIVE To define the risk of intracranial haemorrhage among patients treated with antidepressants and non-steroid anti-inflammatory drugs (NSAIDs), compared with the risk among those treated with antidepressants without NSAIDs. DESIGN Retrospective nationwide propensity score matched cohort study. SETTING Korean nationwide health insurance database between 1 January 2009 and 31 December 2013. PARTICIPANTS Patients who began receiving antidepressants for the first time (index date) without a history of having received a prescription for antidepressants during the preceding year. Patients who had been diagnosed as having cerebrovascular diseases within a year before the index date were excluded. MAIN OUTCOME MEASURE Time to first hospital admission with intracranial haemorrhage within 30 days after drug use. Matched Cox regression models were used to compare the risk of intracranial haemorrhage among patients who were treated with antidepressants with and without NSAIDs, after propensity score matching with a 1: 1 ratio. RESULTS After propensity score estimation and matching in a 1: 1 ratio, the cohort used in the analysis included 4 145 226 people. The 30 day risk of intracranial haemorrhage during the entire study period was higher for combined use of antidepressants and NSAIDs than for use of antidepressants without NSAIDs (hazard ratio 1.6, 95% confidence interval 1.32 to 1.85). No statistically meaningful differences were found in risk of intracranial haemorrhage between the antidepressant drug classes. CONCLUSIONS Combined use of antidepressants and NSAIDs was associated with an increased risk of intracranial haemorrhage within 30 days of initial combination.	[Shin, Ju-Young; Park, Mi-Ju; Lee, Shin Haeng; Choi, So-Hyun; Kim, Mi-Hee] Korea Inst Drug Safety & Risk Management, Seoul 110750, South Korea; [Choi, Nam-Kyong; Lee, Joongyub] Seoul Natl Univ, Med Res Collaborating Ctr, Coll Med, Seoul 110799, South Korea; [Choi, Nam-Kyong; Lee, Joongyub] Seoul Natl Univ Hosp, Seoul 110799, South Korea; [Park, Byung-Joo] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Park, BJ (corresponding author), Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul 110799, South Korea.	bjpark@snu.ac.kr		Lee, Shin Haeng/0000-0002-4062-7903; Shin, Ju-Young/0000-0003-1010-7525; Choi, Nam-Kyong/0000-0003-1153-9928				Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Anglin R, 2014, AM J GASTROENTEROL, V109, P810, DOI 10.1038/ajg.2014.82; [Anonymous], 2001, P 26 ANN SAS US GROU; [Anonymous], 2012, UN APPR MEAS EFF SIZ; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bak S, 2002, STROKE, V33, P1465, DOI 10.1161/01.STR.0000018589.56991.BA; de Abajo FJ, 2000, BRIT J CLIN PHARMACO, V50, P43, DOI 10.1046/j.1365-2125.2000.00216.x; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; de Abajo FJ, 2013, EUR J CLIN PHARMACOL, V69, P691, DOI 10.1007/s00228-012-1386-3; Huang ES, 2011, GASTROENTEROLOGY, V140, pS137; Johnsen SP, 2003, STROKE, V34, P387, DOI 10.1161/01.STR.0000054057.11892.5B; Jung SY, 2011, NEUROLOGY, V77, P1229, DOI 10.1212/WNL.0b013e318230201a; Katzung B.G., 2012, PHARMACOL TOXICOL; Kharofa J, 2007, STROKE, V38, P3049, DOI 10.1161/STROKEAHA.107.491472; Korean Ministry of Health and Welfare, 2000, PIL TEST NAT CARD DI; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Kwon S, 2003, HEALTH POLICY PLANN, V18, P84, DOI 10.1093/heapol/18.1.84; Leppala JM, 1999, EUR J EPIDEMIOL, V15, P155, DOI 10.1023/A:1007504310431; Liu LY, 1999, CEREBROVASC DIS, V9, P224, DOI 10.1159/000015960; Loke YK, 2008, ALIMENT PHARM THERAP, V27, P31, DOI 10.1111/j.1365-2036.2007.03541.x; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Osborn DPJ, 2003, INT J GERIATR PSYCH, V18, P623, DOI 10.1002/gps.896; Park B., 2003, REPORT EVALUATION VA, P19; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Schafer AI, 1999, AM J MED, V106, P25, DOI DOI 10.1016/S0002-9343(99)00114-X; Shin JY, 2011, J KOREAN MED SCI, V26, P1461, DOI 10.3346/jkms.2011.26.11.1461; Skop BP, 1996, PSYCHOSOMATICS, V37, P12, DOI 10.1016/S0033-3182(96)71592-X; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Warner-Schmidt JL, 2011, P NATL ACAD SCI USA, V108, P9262, DOI 10.1073/pnas.1104836108	30	58	62	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2015	351								h3517	10.1136/bmj.h3517	http://dx.doi.org/10.1136/bmj.h3517			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CO	26173947	hybrid, Green Published			2022-12-28	WOS:000358301600006
J	Brewer, T; Pringle, Y				Brewer, Tim; Pringle, Yolana			The art of medicine Beyond Bazalgette: 150 years of sanitation	LANCET			English	Editorial Material									[Brewer, Tim] WaterAid, London SE11 5JD, England; [Pringle, Yolana] Univ Cambridge, Ctr Res Arts Social Sci & Humanities, Cambridge, England	University of Cambridge	Brewer, T (corresponding author), WaterAid, London SE11 5JD, England.	timbrewer@wateraid.org		Pringle, Yolana/0000-0001-6471-5839				[Anonymous], 1831, LANCET, V1, P241; [Anonymous], 1871, LANCET, V2, P828; Hamlin C., 1998, PUBLIC HLTH SOCIAL J; Hardy Anne, 1993, OUT CLOSET STREETS; Penner B, 2014, J ARCHITECTURE, V19, P249, DOI 10.1080/13602365.2014.908589; WaterAid, 2015, ACH TOT SAN HYG COV; World Health Organization and United Nations Children's Fund (WHO and UNICEF), 2015, 25 YEARS PROGR SAN D; World Health Organization WHO/UNICEF, WHO UNICEF JOINT MON	8	3	3	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					128	129		10.1016/S0140-6736(15)61231-4	http://dx.doi.org/10.1016/S0140-6736(15)61231-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	CM5QC	26194385	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000357742200017
J	Trakhtenbrot, B; Urry, CM; Civano, F; Rosario, DJ; Elvis, M; Schawinski, K; Suh, H; Bongiorno, A; Simmons, BD				Trakhtenbrot, Benny; Urry, C. Megan; Civano, Francesca; Rosario, David J.; Elvis, Martin; Schawinski, Kevin; Suh, Hyewon; Bongiorno, Angela; Simmons, Brooke D.			An over-massive black hole in a typical star-forming galaxy, 2 billion years after the Big Bang	SCIENCE			English	Article							ACTIVE GALACTIC NUCLEI; HOST GALAXIES; HIGH-REDSHIFT; COSMIC EVOLUTION; STELLAR MASS; GROWTH-RATE; NGC 1277; COEVOLUTION; FIELD; M87	Supermassive black holes (SMBHs) and their host galaxies are generally thought to coevolve, so that the SMBH achieves up to about 0.2 to 0.5% of the host galaxy mass in the present day. The radiation emitted from the growing SMBH is expected to affect star formation throughout the host galaxy. The relevance of this scenario at early cosmic epochs is not yet established. We present spectroscopic observations of a galaxy at redshift z = 3.328, which hosts an actively accreting, extremely massive BH, in its final stages of growth. The SMBH mass is roughly one-tenth the mass of the entire host galaxy, suggesting that it has grown much more efficiently than the host, contrary to models of synchronized coevolution. The host galaxy is forming stars at an intense rate, despite the presence of a SMBH-driven gas outflow.	[Trakhtenbrot, Benny; Schawinski, Kevin] ETH, Inst Astron, Dept Phys, CH-8093 Zurich, Switzerland; [Urry, C. Megan] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Urry, C. Megan; Civano, Francesca] Yale Ctr Astron & Astrophys, New Haven, CT 06520 USA; [Urry, C. Megan] Yale Univ, Dept Astron, New Haven, CT 06520 USA; [Civano, Francesca; Elvis, Martin; Suh, Hyewon] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Rosario, David J.] Max Planck Inst Extraterr Phys MPE, D-85741 Garching, Germany; [Suh, Hyewon] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Bongiorno, Angela] INAF Osservatorio Astron Roma, I-00040 Rome, Italy; [Simmons, Brooke D.] Oxford Astrophys, Oxford OX1 3RH, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; Yale University; Yale University; Yale University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Max Planck Society; University of Hawaii System; Istituto Nazionale Astrofisica (INAF); University of Oxford	Trakhtenbrot, B (corresponding author), ETH, Inst Astron, Dept Phys, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland.	benny.trakhtenbrot@phys.ethz.ch	Rosario, David/HCH-4013-2022; Suh, Hyewon/O-9966-2017; Schawinski, Kevin/N-7057-2016; Urry, Meg/G-7381-2011	Suh, Hyewon/0000-0002-2536-1633; Schawinski, Kevin/0000-0001-5464-0888; Bongiorno, Angela/0000-0002-0101-6624; Rosario, David/0000-0002-0001-3587; Urry, Meg/0000-0002-0745-9792; Trakhtenbrot, Benny/0000-0002-3683-7297; Simmons, Brooke/0000-0001-5882-3323	W. M. Keck Foundation; European Southern Observatory (ESO) Telescopes at the La Silla Paranal Observatory under ESO program [179.A-2005]; Swiss National Science Foundation [PP00P2 138979/1]; NASA [GO3-14150C]; NASA Chandra [GO2-13127X]	W. M. Keck Foundation(W.M. Keck Foundation); European Southern Observatory (ESO) Telescopes at the La Silla Paranal Observatory under ESO program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NASA(National Aeronautics & Space Administration (NASA)); NASA Chandra(National Aeronautics & Space Administration (NASA))	The new MOSFIRE data presented herein were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and the National Aeronautics and Space Administration. The Observatory was made possible by the generous financial support of the W. M. Keck Foundation. We thank M. Kassis and the rest of the staff at the W. M. Keck observatories at Waimea, HI, for their support during the observing run. We recognize and acknowledge the very significant cultural role and reverence that the summit of Mauna Kea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain. Some of the analysis presented here is based on data products from observations made with European Southern Observatory (ESO) Telescopes at the La Silla Paranal Observatory under ESO program ID 179.A-2005 and on data products produced by TERAPIX and the Cambridge Astronomy Survey Unit on behalf of the UltraVISTA consortium. We are grateful to A. Faisst and M. Onodera for their assistance with the acquisition and reduction of the MOSFIRE data. We thank S. Tacchella, J. Woo, and W. Hartley for their assistance with some of the evolutionary calculations. K.S. gratefully acknowledges support from Swiss National Science Foundation Professorship grant PP00P2 138979/1. F.C. acknowledges financial support by the NASA grant GO3-14150C. M.E. acknowledges financial support by the NASA Chandra grant GO2-13127X. B.T. is a Zwicky Fellow at the ETH Zurich.	Baldry IK, 2012, MON NOT R ASTRON SOC, V421, P621, DOI 10.1111/j.1365-2966.2012.20340.x; Bennert VN, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/107; Bongiorno A, 2012, MON NOT R ASTRON SOC, V427, P3103, DOI 10.1111/j.1365-2966.2012.22089.x; Civano F, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/91; De Rosa G, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/56; Decarli R, 2010, MON NOT R ASTRON SOC, V402, P2453, DOI 10.1111/j.1365-2966.2009.16049.x; Emsellem E, 2013, MON NOT R ASTRON SOC, V433, P1862, DOI 10.1093/mnras/stt840; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Gebhardt K, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/119; Haring N, 2004, ASTROPHYS J, V604, pL89, DOI 10.1086/383567; Ilbert O, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321100; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Masters D, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/169; McConnell NJ, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/179; McLure RJ, 2006, MON NOT R ASTRON SOC, V368, P1395, DOI 10.1111/j.1365-2966.2006.10228.x; Merloni A, 2010, ASTROPHYS J, V708, P137, DOI 10.1088/0004-637X/708/1/137; Netzer H, 2007, ASTROPHYS J, V671, P1256, DOI 10.1086/523035; Peng CY, 2006, ASTROPHYS J, V649, P616, DOI 10.1086/506266; Scoville N, 2007, ASTROPHYS J SUPPL S, V172, P1, DOI 10.1086/516585; Shen Y, 2013, B ASTRON SOC INDIA, V41, P61; Speagle JS, 2014, ASTROPHYS J SUPPL S, V214, DOI 10.1088/0067-0049/214/2/15; Trakhtenbrot B, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/7; van den Bosch RCE, 2012, NATURE, V491, P729, DOI 10.1038/nature11592; Volonteri M, 2010, ASTRON ASTROPHYS REV, V18, P279, DOI 10.1007/s00159-010-0029-x; Walsh JL, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/86; Zheng XZ, 2009, ASTROPHYS J, V707, P1566, DOI 10.1088/0004-637X/707/2/1566	29	44	45	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					168	171		10.1126/science.aaa4506	http://dx.doi.org/10.1126/science.aaa4506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26160942	Green Submitted			2022-12-28	WOS:000357664300038
J	Gornall, J				Gornall, Jonathan			New Pacific trade deal-good for pharma, bad for public health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						[Anonymous], 2013, TRANSPACIFIC PARTNER; [Anonymous], 2014, ANN TRANSP PROC FAIR; Fergusson I, 2015, TRANSPACIFIC PARTNER; Foundation for AIDS Research, 2015, TRANSP PARTN CURB AC; Groser T, 2015, COMMUNICATION; Hilary J, 2015, TRANSATLANTIC TRADE; Marchbein D, 2015, TRANSPACIFIC PARTNER; Office of the United States Trade Representative, TRANS TRAD INV; Office of the United States Trade Representative, TRANSP PARTN; Palermo J, 2015, HUFFINGTON POST; Petri P, 2012, POLICY BRIEF	11	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2015	351								h3649	10.1136/bmj.h3649	http://dx.doi.org/10.1136/bmj.h3649			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MP	26155990				2022-12-28	WOS:000357955800010
J	Semigran, HL; Linder, JA; Gidengil, C; Mehrotra, A				Semigran, Hannah L.; Linder, Jeffrey A.; Gidengil, Courtney; Mehrotra, Ateev			Evaluation of symptom checkers for self diagnosis and triage: audit study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TELEPHONE TRIAGE; GENERAL-PRACTICE; UNITED-STATES; CARE; ACCURACY; INTERNET; CONSULTATION; INFORMATION; PHYSICIAN; RESOURCE	OBJECTIVE To determine the diagnostic and triage accuracy of online symptom checkers (tools that use computer algorithms to help patients with self diagnosis or self triage). DESIGN Audit study. SETTING Publicly available, free symptom checkers. PARTICIPANTS 23 symptom checkers that were in English and provided advice across a range of conditions. 45 standardized patient vignettes were compiled and equally divided into three categories of triage urgency: emergent care required (for example, pulmonary embolism), non-emergent care reasonable (for example, otitis media), and self care reasonable (for example, viral upper respiratory tract infection). MAIN OUTCOME MEASURES For symptom checkers that provided a diagnosis, our main outcomes were whether the symptom checker listed the correct diagnosis first or within the first 20 potential diagnoses (n= 770 standardized patient evaluations). For symptom checkers that provided a triage recommendation, our main outcomes were whether the symptom checker correctly recommended emergent care, non-emergent care, or self care (n= 532 standardized patient evaluations). RESULTS The 23 symptom checkers provided the correct diagnosis first in 34% (95% confidence interval 31% to 37%) of standardized patient evaluations, listed the correct diagnosis within the top 20 diagnoses given in 58% (55% to 62%) of standardized patient evaluations, and provided the appropriate triage advice in 57% (52% to 61%) of standardized patient evaluations. Triage performance varied by urgency of condition, with appropriate triage advice provided in 80% (95% confidence interval 75% to 86%) of emergent cases, 55% (47% to 63%) of non-emergent cases, and 33% (26% to 40%) of self care cases (P<0.001). Performance on appropriate triage advice across the 23 individual symptom checkers ranged from 33% (95% confidence interval 19% to 48%) to 78% (64% to 91%) of standardized patient evaluations. CONCLUSIONS Symptom checkers had deficits in both triage and diagnosis. Triage advice from symptom checkers is generally risk averse, encouraging users to seek care for conditions where self care is reasonable.	[Semigran, Hannah L.; Mehrotra, Ateev] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Linder, Jeffrey A.] Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02115 USA; [Linder, Jeffrey A.] Harvard Univ, Sch Med, Boston, MA USA; [Gidengil, Courtney] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Gidengil, Courtney] RAND Corp, Boston, MA USA; [Mehrotra, Ateev] Beth Israel Deaconess Med Ctr, Div Gen Internal Med & Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; RAND Corporation; Harvard University; Beth Israel Deaconess Medical Center	Mehrotra, A (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	mehrotra@hcp.med.harvard.edu	Linder, Jeffrey/AAF-3424-2021; Mehrotra, Ateev/AAO-8454-2021	Linder, Jeffrey/0000-0003-2217-184X; Mehrotra, Ateev/0000-0003-2223-1582	US National Institute of Health (National Institute of Allergy and Infectious Disease) [R21 AI097759-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097759] Funding Source: NIH RePORTER	US National Institute of Health (National Institute of Allergy and Infectious Disease); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the US National Institute of Health (National Institute of Allergy and Infectious Disease grant No R21 AI097759-01).	[Anonymous], 2014, ENG MED BIOL SOC EMB; Barnett ML, 2014, JAMA-J AM MED ASSOC, V311, P2020, DOI 10.1001/jama.2013.286141; Barnett ML, 2014, JAMA INTERN MED, V174, P138, DOI 10.1001/jamainternmed.2013.11673; Bierbrier R, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3062; Bisson LJ, 2014, AM J SPORT MED, V42, P2371, DOI 10.1177/0363546514541654; Black Peter, 2009, Br J Nurs, V18, P1157; Brigo F, 2014, EPILEPSY BEHAV, V31, P67, DOI 10.1016/j.yebeh.2013.11.020; Bunn F, 2005, BRIT J GEN PRACT, V55, P956; Campbell JL, 2014, LANCET, V384, P1859, DOI 10.1016/S0140-6736(14)61058-8; CDC NAMCS NHAMCS, 2010, ANN NUMB PERC DISTR; Cook DA, 2014, INTERACT J MED RES, V3, P15, DOI 10.2196/ijmr.2811; DeJong C, 2014, JAMA-J AM MED ASSOC, V311, P1287, DOI 10.1001/jama.2014.1026; Donnelly L., 2015, TELEGRAPH; Edney A, 2013, BUSINESSWEEK; Elliot AJ, 2015, EPIDEMIOL INFECT, P1, DOI DOI 10.1109/ECOC.2015.7341993; Eminovic N, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.2.e17; Eysenbach G, 1999, ARCH DERMATOL, V135, P151, DOI 10.1001/archderm.135.2.151; Farmer SEJ, 2011, CLIN OTOLARYNGOL, V36, P517, DOI 10.1111/j.1749-4486.2011.02375.x; Fine AM, 2013, ANN INTERN MED, V159, P577, DOI 10.7326/0003-4819-159-9-201311050-00003; Fox S, 2013, HLTH ONLINE 2013 INT, P4; Gann B, 2012, Yearb Med Inform, V7, P70; Giesen P, 2007, QUAL SAF HEALTH CARE, V16, P181, DOI 10.1136/qshc.2006.018846; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Graber ML, 2013, BMJ QUAL SAF, V22, pii21, DOI 10.1136/bmjqs-2012-001615; Hartzband P, 2010, NEW ENGL J MED, V362, P1063, DOI 10.1056/NEJMp0911938; Husain I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1887; Lattimer V, 1998, BMJ-BRIT MED J, V317, P1054; Lewis TL, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3133; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Luger TM, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2924; Lupton D, 2015, SOC SCI MED, V133, P128, DOI 10.1016/j.socscimed.2015.04.004; Mehrotra A, 2013, JAMA INTERN MED, V173, P72, DOI 10.1001/2013.jamainternmed.305; Meyer AND, 2013, JAMA INTERN MED, V173, P1952, DOI 10.1001/jamainternmed.2013.10081; North F, 2012, TELEMED E-HEALTH, V18, P213, DOI 10.1089/tmj.2011.0127; North F, 2011, TELEMED E-HEALTH, V17, P19, DOI 10.1089/tmj.2010.0120; Orizio G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1795; Poote AE, 2014, J TELEMED TELECARE, V20, P123, DOI 10.1177/1357633X14529246; Reuters, 2013, REUTERS; Richards DA, 2002, BRIT MED J, V325, P1214, DOI 10.1136/bmj.325.7374.1214; Saczynski JS, 2008, AM J CARDIOL, V102, P1589, DOI 10.1016/j.amjcard.2008.07.056; Sadeghi S, 2006, INT J MED INFORM, V75, P403, DOI 10.1016/j.ijmedinf.2005.07.028; Schmitt BD, 2012, PEDIAT TELEPHONE PRO; Stacey D, 2005, WORLDV EVID-BASED NU, V2, P184, DOI 10.1111/j.1741-6787.2005.00035.x; Staub GM, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-110; Thompson DA, 2013, ADULT TELEPHONE PROT; Usborne S, 2009, INDEPENDENT; White Ryen W, 2009, AMIA Annu Symp Proc, V2009, P696; Zhongbo C, 2010, AMYOTROPH LATERAL SC, V11, P566	48	202	206	1	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2015	351								h3480	10.1136/bmj.h3480	http://dx.doi.org/10.1136/bmj.h3480			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MP	26157077	hybrid, Green Published			2022-12-28	WOS:000357955800007
J	Cooperberg, MR; Carroll, PR				Cooperberg, Matthew R.; Carroll, Peter R.			Trends in Management for Patients With Localized Prostate Cancer, 1990-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							DIAGNOSIS; TIME		[Cooperberg, Matthew R.; Carroll, Peter R.] Univ Calif San Francisco, Dept Urol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Cooperberg, MR (corresponding author), Univ Calif San Francisco, Dept Urol, Helen Diller Family Comprehens Canc Ctr, 550 16th St, San Francisco, CA 94143 USA.	mcooperberg@urology.ucsf.edu	Cooperberg, Matthew R/G-6249-2017	Cooperberg, Matthew R/0000-0003-4339-6685				Bechis SK, 2011, J CLIN ONCOL, V29, P235, DOI 10.1200/JCO.2010.30.2075; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Cooperberg MR, 2009, JNCI-J NATL CANCER I, V101, P878, DOI 10.1093/jnci/djp122; Ganz Patricia A, 2011, NIH Consens State Sci Statements, V28, P1; Lubeck DP, 1996, UROLOGY, V48, P773, DOI 10.1016/S0090-4295(96)00226-9; Womble PR, 2015, EUR UROL, V67, P44, DOI 10.1016/j.eururo.2014.08.024	6	431	434	2	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					80	82		10.1001/jama.2015.6036	http://dx.doi.org/10.1001/jama.2015.6036			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151271	Green Published, Bronze			2022-12-28	WOS:000357455900019
J	Cavalli, R; Milani, GP; Chelleri, C; Donelli, S; Fossali, EF				Cavalli, Riccardo; Milani, Gregorio P.; Chelleri, Cristina; Donelli, Stefano; Fossali, Emilio F.			Plaque-type glomuvenous malformations in a child	LANCET			English	Editorial Material									[Cavalli, Riccardo; Chelleri, Cristina] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Paediat Dermatol Dept, I-20122 Milan, Italy; [Milani, Gregorio P.; Fossali, Emilio F.] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Paediat Emergency Dept, I-20122 Milan, Italy; [Donelli, Stefano] Osped Civile, Dept Dermatol, Piacenza, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico	Milani, GP (corresponding author), Osped Maggiore Policlin, Fdn IRCCS Ca Granda, I-20122 Milan, Italy.	milani.gregoriop@gmail.com	Fossali, Emilio/K-2200-2015; Milani, Gregorio/I-7777-2015	Fossali, Emilio/0000-0002-3197-062X; Milani, Gregorio/0000-0003-3829-4254; Chelleri, Cristina/0000-0003-2473-5282					0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					E61	E61		10.1016/S0140-6736(15)60660-2	http://dx.doi.org/10.1016/S0140-6736(15)60660-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ1LD	26211830				2022-12-28	WOS:000366866400001
J	Bannuru, RR; McAlindon, TE; Sullivan, MC; Wong, JB; Kent, DM; Schmid, CH				Bannuru, Raveendhara R.; McAlindon, Timothy E.; Sullivan, Matthew C.; Wong, John B.; Kent, David M.; Schmid, Christopher H.			Effectiveness and Implications of Alternative Placebo Treatments A Systematic Review and Network Meta-analysis of Osteoarthritis Trials	ANNALS OF INTERNAL MEDICINE			English	Review							INTRAARTICULAR HYALURONIC-ACID; TOPICAL DICLOFENAC SOLUTION; RANDOMIZED CONTROLLED-TRIAL; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CONTROLLED CLINICAL-TRIAL; HYLAN G-F-20 SYNVISC(R); ETORICOXIB 30 MG; CELECOXIB 200 MG; QUALITY-OF-LIFE; VEHICLE TDT 064	Background: Placebo controls are essential in evaluating the effectiveness of medical treatments. Although it is unclear whether different placebo interventions for osteoarthritis vary in efficacy, systematic differences would substantially affect interpretation of the results of placebo-controlled trials. Objective: To evaluate the effects of alternative placebo types on pain outcomes in knee osteoarthritis. Data Sources: MEDLINE, EMBASE, Web of Science, Google Scholar, and Cochrane Database from inception through 1 June 2015 and unpublished data. Study Selection: 149 randomized trials of adults with knee osteoarthritis that reported pain outcomes and compared widely used pharmaceuticals against oral, intra-articular, topical, and oral plus topical placebos. Data Extraction: Study data were independently double-extracted; study quality was assessed by using the Cochrane risk of bias tool. Data Synthesis: Placebo effects that were evaluated by using a network meta-analysis with 4 separate placebo nodes (differential model) showed that intra-articular placebo (effect size, 0.29 [95% credible interval, 0.09 to 0.49]) and topical placebo (effect size, 0.20 [credible interval, 0.02 to 0.38]) had significantly greater effect sizes than did oral placebo. This differential model showed marked differences in the relative efficacies and hierarchy of the active treatments compared with a network model that considered all placebos equivalent. In the model accounting for differential effects, intra-articular and topical therapies were superior to oral treatments in reducing pain. When these differential effects were ignored, oral nonsteroidal anti-inflammatory drugs were superior. Limitations: Few studies compared different placebos directly. The study could not decisively conclude whether disease severity and co-interventions systematically differed between trials evaluating different placebos. Conclusion: All placebos are not equal, and some can trigger clinically relevant responses. Differential placebo effects can substantially alter estimates of the relative efficacies of active treatments, an important consideration for the design of clinical trials and interpretation of their results.	Tufts Univ, Sackler Sch Grad Biomed Sci, Tufts Med Ctr, Boston, MA 02111 USA; Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA	Tufts Medical Center; Tufts University; Brown University	Bannuru, RR (corresponding author), Tufts Med Ctr, CTCIA, 800 Washington St,Box 406, Boston, MA 02111 USA.	rbannuru@tuftsmedicalcenter.org	Schmid, Christopher H./J-2398-2014; Bannuru, Raveendhara/G-2601-2011	Schmid, Christopher H./0000-0002-0855-5313; Bannuru, Raveendhara/0000-0002-8069-5783; Sullivan, Matthew/0000-0002-2528-7787; Wong, John/0000-0003-4203-9010	Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS021396] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Adams ME, 1995, OSTEOARTHR CARTILAGE, V3, P213, DOI 10.1016/S1063-4584(05)80013-5; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, P454, DOI 10.1016/j.joca.2006.10.008; Altman RD, 2004, OSTEOARTHR CARTILAGE, V12, P642, DOI 10.1016/j.joca.2004.04.010; Altman RD, 1998, J RHEUMATOL, V25, P2203; Altman RD, 2009, SEMIN ARTHRITIS RHEU, V39, P1, DOI 10.1016/j.semarthrit.2009.04.001; [Anonymous], 2001, SODIUM HYALURONATE S; Arden NK, 2014, CURR MED RES OPIN, V30, P279, DOI 10.1185/03007995.2013.855631; Asmus MJ, 2013, OSTEOARTHR CARTILAGE, V21, pS253, DOI 10.1016/j.joca.2013.02.523; Baer PA, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-44; Baltzer AWA, 2009, OSTEOARTHR CARTILAGE, V17, P152, DOI 10.1016/j.joca.2008.06.014; Bannuru RR, 2011, OSTEOARTHR CARTILAGE, V19, P611, DOI 10.1016/j.joca.2010.09.014; Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Baraf HSB, 2011, DRUG AGING, V28, P27, DOI 10.2165/11584880-000000000-00000; Baraf HSB, 2010, PHYSICIAN SPORTSMED, V38, P19, DOI 10.3810/psm.2010.06.1779; Barthel HR, 2009, SEMIN ARTHRITIS RHEU, V39, P203, DOI 10.1016/j.semarthrit.2009.09.002; Bensen WG, 1999, MAYO CLIN PROC, V74, P1095, DOI 10.4065/74.11.1095; Bijlsma JWJ, 2008, ANN RHEUM DIS, V67, P1653, DOI 10.1136/ard.2008.097006; Bingham CO, 2007, RHEUMATOLOGY, V46, P496, DOI 10.1093/rheumatology/kel296; Birbara C, 2006, CURR MED RES OPIN, V22, P199, DOI 10.1185/030079906X80242; BLANCO FJ, 2008, OPEN ARTHRITIS J, V1, P1; Bookman AAM, 2004, CAN MED ASSOC J, V171, P333, DOI 10.1503/cmaj.1031793; Boswell Diane J, 2008, Medscape J Med, V10, P259; BRADLEY JD, 1991, NEW ENGL J MED, V325, P87, DOI 10.1056/NEJM199107113250203; BRAGANTINI A, 1987, CLIN TRIALS J, V24, P333; Brandt KD, 2001, CLIN ORTHOP RELAT R, P130; Bunyaratavej Narong, 2001, Journal of the Medical Association of Thailand, V84, pS576; Caborn D, 2004, J RHEUMATOL, V31, P333; Carrabba M., 1995, European Journal of Rheumatology and Inflammation, V15, P25; Case JP, 2003, ARCH INTERN MED, V163, P169, DOI 10.1001/archinte.163.2.169; Chao J, 2010, J RHEUMATOL, V37, P650, DOI 10.3899/jrheum.090575; Chevalier X, 2010, ANN RHEUM DIS, V69, P113, DOI 10.1136/ard.2008.094623; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; COHEN MA, 1994, ARTHRITIS RHEUM, V37, pR31; Conaghan PG, 2013, RHEUMATOLOGY, V52, P1303, DOI 10.1093/rheumatology/ket133; Corrado E. M., 1995, European Journal of Rheumatology and Inflammation, V15, P47; Creamer P, 1994, Osteoarthritis Cartilage, V2, P133, DOI 10.1016/S1063-4584(05)80063-9; Cubukcu D, 2005, CLIN RHEUMATOL, V24, P336, DOI 10.1007/s10067-004-1043-z; DAHLBERG L, 1994, ARTHRITIS RHEUM, V37, P521, DOI 10.1002/art.1780370412; Davies GM, 1999, ARTHRIT CARE RES, V12, P172, DOI 10.1002/1529-0131(199906)12:3<172::AID-ART4>3.0.CO;2-Y; Day R, 2000, ARCH INTERN MED, V160, P1781, DOI 10.1001/archinte.160.12.1781; Day R, 2004, J RHEUMATOL, V31, P775; DeCaria JE, 2012, ARCH GERONTOL GERIAT, V55, P310, DOI 10.1016/j.archger.2011.11.007; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P618, DOI 10.1177/0272989X13485157; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Dickson DJ, 2001, J CLIN RES, V4, P41; Diracoglu D, 2009, J BACK MUSCULOSKELET, V22, P1, DOI 10.3233/BMR-2009-0207; DIXON ASJ, 1988, CURR MED RES OPIN, V11, P205, DOI 10.1185/03007998809114237; Doherty M, 2011, ANN RHEUM DIS, V70, P1534, DOI 10.1136/ard.2011.154047; DORE R, 1995, CLIN THER, V17, P656, DOI 10.1016/0149-2918(95)80042-5; Dougados M, 1993, Osteoarthritis Cartilage, V1, P97, DOI 10.1016/S1063-4584(05)80024-X; Essex MN, 2013, OSTEOARTHR CARTILAGE, V21, pS252; Essex MN, 2012, J INT MED RES, V40, P2251, DOI 10.1177/030006051204000623; Essex MN, 2012, J INT MED RES, V40, P1357, DOI 10.1177/147323001204000414; Essex MN, 2014, INT J GEN MED, V7, P227, DOI 10.2147/IJGM.S61297; Ferring Pharmaceuticals, 26 WEEK DOUBL BLIND; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Fleischmann R, 2006, CLIN RHEUMATOL, V25, P42, DOI 10.1007/s10067-005-1126-5; Fleischmann RM, 1997, CLIN THER, V19, P642, DOI 10.1016/S0149-2918(97)80090-2; Formiguera Sala S, 1995, EUR J RHEUMATOL INFL, V15, P33; FRIEDMAN DM, 1980, J RHEUMATOL, V7, P850; Frizziero L, 2002, J ORTHOP TRAUMATOL, V3, P89; GAFFNEY K, 1995, ANN RHEUM DIS, V54, P379, DOI 10.1136/ard.54.5.379; Geba GP, 2002, JAMA-J AM MED ASSOC, V287, P64, DOI 10.1001/jama.287.1.64; Ghosh S, 2007, J Indian Med Assoc, V105, P260; Gibofsky A, 2003, ARTHRITIS RHEUM-US, V48, P3102, DOI 10.1002/art.11330; GRECOMORO G, 1987, PHARMATHERAPEUTICA, V5, P137; GRENFELL RF, 1961, JAMA-J AM MED ASSOC, V176, P124, DOI 10.1001/jama.1961.03040150040010; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; HENDERSON EB, 1994, ANN RHEUM DIS, V53, P529, DOI 10.1136/ard.53.8.529; Herrero-Beaumont G, 2007, ARTHRITIS RHEUM-US, V56, P555, DOI 10.1002/art.22371; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hochberg MC, 2011, CURR MED RES OPIN, V27, P1243, DOI 10.1185/03007995.2011.580340; Housman L, 2014, KNEE SURG SPORT TR A, V22, P1684, DOI 10.1007/s00167-013-2438-7; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Huang TL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-221; Huskisson EC, 1999, RHEUMATOLOGY, V38, P602, DOI 10.1093/rheumatology/38.7.602; Ishijima M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4446; Jonas WB, 2011, PHILOS T R SOC B, V366, P1896, DOI 10.1098/rstb.2010.0405; Jones A, 1996, ANN RHEUM DIS, V55, P829, DOI 10.1136/ard.55.11.829; Jones AC, 1995, OSTEOARTHR CARTILAGE, V3, P269, DOI 10.1016/S1063-4584(05)80018-4; Jorgensen A, 2010, ANN RHEUM DIS, V69, P1097, DOI 10.1136/ard.2009.118042; Jubb RW, 2003, INT J CLIN PRACT, V57, P467; Juhl C, 2012, ARTHRITIS, DOI 10.1155/2012/136245; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Karlsson J, 2002, RHEUMATOLOGY, V41, P1240, DOI 10.1093/rheumatology/41.11.1240; Kivitz A, 2002, J FAM PRACTICE, V51, P530; Kneer W, 2013, J PAIN RES, V6, P743, DOI 10.2147/JPR.S51054; Koshi Edvin B, 2007, Pain Pract, V7, P4, DOI 10.1111/j.1533-2500.2007.00104.x; Kosuwon W, 2012, CLIN EXP PHARM, V2; Kotevoglu N, 2006, RHEUMATOL INT, V26, P325, DOI 10.1007/s00296-005-0611-0; Kul-Panza E, 2010, MINERVA MED, V101, P63; LEARDINI G, 1991, CLIN EXP RHEUMATOL, V9, P375; LEARDINI G, 1987, CLIN TRIALS J, V24, P341; Lehmann R, 2005, CURR MED RES OPIN, V21, P517, DOI 10.1185/030079905X38196; Leighton R, 2014, OSTEOARTHR CARTILAGE, V22, P17, DOI 10.1016/j.joca.2013.10.009; Leung AT, 2002, CURR MED RES OPIN, V18, P49, DOI 10.1185/030079902125000282; Lohmander LS, 2005, ANN RHEUM DIS, V64, P449, DOI 10.1136/ard.2004.023572; Lohmander LS, 1996, ANN RHEUM DIS, V55, P424, DOI 10.1136/ard.55.7.424; Lundsgaard C, 2008, SCAND J RHEUMATOL, V37, P142, DOI 10.1080/03009740701813103; Manyanga T, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-312; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; McKenna F, 2001, SCAND J RHEUMATOL, V30, P11; McKenna F, 2001, JCR-J CLIN RHEUMATOL, V7, P151, DOI 10.1097/00124743-200106000-00004; Meissner K, 2013, JAMA INTERN MED, V173, P1941, DOI 10.1001/jamainternmed.2013.10391; Miceli-Richard C, 2004, ANN RHEUM DIS, V63, P923, DOI 10.1136/ard.2003.017236; Miller FG, 2006, J CLIN EPIDEMIOL, V59, P331, DOI 10.1016/j.jclinepi.2005.12.001; MORELAND LW, 1993, ARTHRITIS RHEUM, V36, pS165; MORISON RA, 1961, ANN RHEUM DIS, V20, P179, DOI 10.1136/ard.20.2.179; National Clinical Guideline Centre (UK), 2014, OST CAR MAN AD, V1st ed.; Naudet F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-230; Navarro-Sarabia F, 2011, ANN RHEUM DIS, V70, P1957, DOI 10.1136/ard.2011.152017; Neustadt D, 2005, J RHEUMATOL, V32, P1928; Novartis N, 2012, NOVARTIS CLIN TRIAL; Orwin R.G., 1994, HDB RES SYNTHESIS; Ottillinger B, 2001, OSTEOARTHR CARTILAGE, V9, P273, DOI 10.1053/joca.2000.0385; Petrella RJ, 2006, J RHEUMATOL, V33, P951; Petrella RJ, 2002, ARCH INTERN MED, V162, P292, DOI 10.1001/archinte.162.3.292; Petrella RJ, 2008, CLIN RHEUMATOL, V27, P975, DOI 10.1007/s10067-007-0834-4; Pham T, 2004, ANN RHEUM DIS, V63, P1611, DOI 10.1136/ard.2003.019703; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; PIETROGRANDE V, 1991, CURR THER RES CLIN E, V50, P691; Pincus T, 2004, ANN RHEUM DIS, V63, P931, DOI 10.1136/ard.2003.020313; Pincus T, 2001, ARTHRITIS RHEUM-US, V44, P1587, DOI 10.1002/1529-0131(200107)44:7<1587::AID-ART282>3.0.CO;2-X; Puhl W, 1993, Osteoarthritis Cartilage, V1, P233, DOI 10.1016/S1063-4584(05)80329-2; Puopolo A, 2007, OSTEOARTHR CARTILAGE, V15, P1348, DOI 10.1016/j.joca.2007.05.022; Ravaud P, 1999, ARTHRITIS RHEUM-US, V42, P475, DOI 10.1002/1529-0131(199904)42:3<475::AID-ANR12>3.0.CO;2-S; Raynauld JP, 2003, ARTHRITIS RHEUM, V48, P370, DOI 10.1002/art.10777; Reginster Y, 2007, ANN RHEUM DIS, V66, P945, DOI 10.1136/ard.2006.059162; ROLF CG, 2005, J DRUG ASSESS, V8, P183; Roth SH, 2004, ARCH INTERN MED, V164, P2017, DOI 10.1001/archinte.164.18.2017; Rother M, 2007, ANN RHEUM DIS, V66, P1178, DOI 10.1136/ard.2006.065128; Rother M, 2013, J RHEUMATOL, V40, P1742, DOI 10.3899/jrheum.130192; RUSSELL IJ, 1992, ARTHRITIS RHEUM, V35, pS132; Saag K, 2000, ARCH FAM MED, V9, P1124, DOI 10.1001/archfami.9.10.1124; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Sandelin J, 1997, SCAND J RHEUMATOL, V26, P287, DOI 10.3109/03009749709105318; Sanofi-Aventis, 2008, DOUBL BLIND RAND TRI; Saravanan V, 2002, RHEUMATOLOGY, V41, P121; SCALE D, 1994, CURR THER RES CLIN E, V55, P220, DOI 10.1016/S0011-393X(05)80166-3; Schnitzer TJ, 2010, OSTEOARTHR CARTILAGE, V18, P629, DOI 10.1016/j.joca.2009.12.013; Schnitzer TJ, 2011, SEMIN ARTHRITIS RHEU, V40, P285, DOI 10.1016/j.semarthrit.2010.06.002; Schnitzer TJ, 2005, J RHEUMATOL, V32, P1093; Schnitzer TJ, 2005, ARTHRIT RHEUM-ARTHR, V53, P827, DOI 10.1002/art.21586; Sezgin M, 2005, RHEUMATOL INT, V25, P264, DOI 10.1007/s00296-003-0428-7; Sheldon E, 2005, CLIN THER, V27, P64, DOI 10.1016/j.clinthera.2005.01.002; Shichikawa K, 1983, Ryumachi, V23, P280; Shichikawa K, 1983, JPN J CLIN PHARM THE, V14, P545; Shimizu M, 2010, J ORTHOP SCI, V15, P51, DOI 10.1007/s00776-009-1421-0; Simon LS, 2009, PAIN, V143, P238, DOI 10.1016/j.pain.2009.03.008; Skwara A, 2009, EUR J MED RES, V14, P157; Skwara A, 2009, KNEE, V16, P466, DOI 10.1016/j.knee.2009.03.003; Strand V, 2012, OSTEOARTHR CARTILAGE, V20, P350, DOI 10.1016/j.joca.2012.01.013; Svensson O, 2006, ANN RHEUM DIS, V65, P781, DOI 10.1136/ard.2005.040519; Tamir E, 2001, CLIN EXP RHEUMATOL, V19, P265; Tannenbaum H, 2004, ANN RHEUM DIS, V63, P1419, DOI 10.1136/ard.2003.015974; Tascioglu F, 2003, CLIN RHEUMATOL, V22, P112, DOI 10.1007/s10067-002-0690-1; Tekeoglu I, 1998, J RHEUM MED REHAB, V9, P220; THOMAS KB, 1987, BRIT MED J, V294, P1200, DOI 10.1136/bmj.294.6581.1200; Thorlund K, 2011, RES SYNTH METHODS, V2, P188, DOI 10.1002/jrsm.46; TRAUT EF, 1957, ANN RHEUM DIS, V16, P18, DOI 10.1136/ard.16.1.18; Tsai CL, 2003, OSTEOARTHR CARTILAGE, V11, P119; Tugwell PS, 2004, J RHEUMATOL, V31, P2002; van der Weegen W, 2015, J ARTHROPLASTY, V30, P754, DOI 10.1016/j.arth.2014.12.012; Wampold BE, 2005, J CLIN PSYCHOL, V61, P835, DOI 10.1002/jclp.20129; Wiesenhutter CW, 2005, MAYO CLIN PROC, V80, P470, DOI 10.4065/80.4.470; Williams GW, 2001, CLIN THER, V23, P213, DOI 10.1016/S0149-2918(01)80004-7; Williams GW, 2000, JCR-J CLIN RHEUMATOL, V6, P65, DOI 10.1097/00124743-200004000-00002; WILLIAMS HJ, 1993, ARTHRITIS RHEUM-US, V36, P1196, DOI 10.1002/art.1780360904; Wobig M, 1998, CLIN THER, V20, P410, DOI 10.1016/S0149-2918(98)80052-0; Wu J J, 1997, Zhonghua Yi Xue Za Zhi (Taipei), V59, P99; Yavuz U, 2012, RHEUMATOL INT, V32, P3391, DOI 10.1007/s00296-011-2188-0; Yocum D, 2000, ARCH INTERN MED, V160, P2947, DOI 10.1001/archinte.160.19.2947; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; Zhao SZ, 1999, PHARMACOTHERAPY, V19, P1269, DOI 10.1592/phco.19.16.1269.30879	177	115	115	0	43	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2015	163	5					365	U109		10.7326/M15-0623	http://dx.doi.org/10.7326/M15-0623			28	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0OM	26215539				2022-12-28	WOS:000360296000008
J	Mello, MM; Studdert, DM; Parmet, WE				Mello, Michelle M.; Studdert, David M.; Parmet, Wendy E.			Shifting Vaccination Politics - The End of Personal-Belief Exemptions in California	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Studdert, David M.] Stanford Law Sch, Stanford, CA 94305 USA; [Mello, Michelle M.; Studdert, David M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Parmet, Wendy E.] Northeastern Univ, Sch Law, Boston, MA 02115 USA	Stanford University; Stanford University; Northeastern University	Mello, MM (corresponding author), Stanford Law Sch, Stanford, CA 94305 USA.		Studdert, David/AAF-3116-2021; Duro, Eduardo Alfredo/E-7721-2017	Studdert, David/0000-0003-0585-5537; Duro, Eduardo Alfredo/0000-0001-5069-853X; Mello, Michelle/0000-0003-2877-4270				Bloch M., 2015, NY TIMES; Majumder MS, 2015, JAMA PEDIATR, V169, P494, DOI 10.1001/jamapediatrics.2015.0384; Wang E, 2014, AM J PUBLIC HEALTH, V104, pE62, DOI 10.2105/AJPH.2014.302190	3	61	61	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					785	787		10.1056/NEJMp1508701	http://dx.doi.org/10.1056/NEJMp1508701			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP8VC	26200843				2022-12-28	WOS:000360171700002
J	Wang, XW; Chen, XJ				Wang, Xiaowen; Chen, Xin Jie			A cytosolic network suppressing mitochondria-mediated proteostatic stress and cell death	NATURE			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; CAP-INDEPENDENT TRANSLATION; SACCHAROMYCES-CEREVISIAE; PROTEOMIC ANALYSIS; ISOBARIC TAGS; LIFE-SPAN; YEAST; DISEASES; COMPLEX; DNA	Mitochondria are multifunctional organelles whose dysfunction leads to neuromuscular degeneration and ageing. The multifunctionality poses a great challenge for understanding the mechanisms by which mitochondrial dysfunction causes specific pathologies. Among the leading mitochondrial mediators of cell death are energy depletion, free radical production, defects in iron-sulfur cluster biosynthesis, the release of pro-apoptotic and non-cell-autonomous signalling molecules, and altered stress signalling(1-5). Here we identify a new pathway of mitochondria-mediated cell death in yeast. This pathway was named mitochondrial precursor over-accumulation stress (mPOS), and is characterized by aberrant accumulation of mitochondrial precursors in the cytosol. mPOS can be triggered by clinically relevant mitochondrial damage that is not limited to the core machineries of protein import. We also discover a large network of genes that suppress mPOS, by modulating ribosomal biogenesis, messenger RNA decapping, transcript-specific translation, protein chaperoning and turnover. In response to mPOS, several ribosome-associated proteins were upregulated, including Gis2 and Nog2, which promote cap-independent translation and inhibit the nuclear export of the 60S ribosomal subunit, respectively(6,7). Gis2 and Nog2 upregulation promotes cell survival, which may be part of a feedback loop that attenuates mPOS. Our data indicate that mitochondrial dysfunction contributes directly to cytosolic proteostatic stress, and provide an explanation for the association between these two hallmarks of degenerative diseases and ageing. The results are relevant to understanding diseases (for example, spinocerebellar ataxia, amyotrophic lateral sclerosis and myotonic dystrophy) that involve mutations within the anti-degenerative network.	[Wang, Xiaowen; Chen, Xin Jie] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Chen, XJ (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	chenx@upstate.edu			National Institutes of Health (NIH) [R01AG023731, R21AG047400]; NATIONAL INSTITUTE ON AGING [R21AG047400, R01AG023731] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Mollapour, W. Decatur and the Kane laboratory for help in the ubiquitination and ribosomal analysis experiments, S. Hanes for critical reading of the manuscript, and S. Zhang for processing the iTRAQ data. This work was supported by the National Institutes of Health (NIH) grants R01AG023731 and R21AG047400.	Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chiabudini M, 2012, MOL CELL BIOL, V32, P4769, DOI 10.1128/MCB.00809-12; Diekert K., 2001, MITOCHONDRION, P41; Dunn CD, 2003, GENETICS, V165, P35; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Gerbasi VR, 2007, MOL CELL PROTEOMICS, V6, P1049, DOI 10.1074/mcp.M600384-MCP200; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kryndushkin DS, 2002, J BIOL CHEM, V277, P23702, DOI 10.1074/jbc.M111547200; Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109; Liu YX, 2015, MOL BIOL CELL, V26, P1985, DOI 10.1091/mbc.E15-01-0030; Matsuo Y, 2014, NATURE, V505, P112, DOI 10.1038/nature12731; Merkwirth C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003021; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Redding Alyssa M., 2006, Briefings in Functional Genomics & Proteomics, V5, P133, DOI 10.1093/bfgp/ell025; Rikhvanov EG, 2005, CURR GENET, V48, P44, DOI 10.1007/s00294-005-0587-z; Segref A, 2014, CELL METAB, V19, P642, DOI 10.1016/j.cmet.2014.01.016; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; THORSNESS PE, 1993, MOL CELL BIOL, V13, P5418, DOI 10.1128/MCB.13.9.5418; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang XD, 2001, GENE DEV, V15, P2922; Wang XW, 2008, NAT CELL BIOL, V10, P1090, DOI 10.1038/ncb1769; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Xue SF, 2015, NATURE, V517, P33, DOI 10.1038/nature14010; Yang QS, 2012, MOL CELL PROTEOMICS, V11, P1853, DOI 10.1074/mcp.M112.022079; Yang Y, 2011, J PROTEOME RES, V10, P4647, DOI 10.1021/pr200455s	34	199	202	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					481	+		10.1038/nature14859	http://dx.doi.org/10.1038/nature14859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26192197	Green Accepted			2022-12-28	WOS:000360069300041
J	Gitlin, AD; Mayer, CT; Oliveira, TY; Shulman, Z; Jones, MJK; Koren, A; Nussenzweig, MC				Gitlin, Alexander D.; Mayer, Christian T.; Oliveira, Thiago Y.; Shulman, Ziv; Jones, Mathew J. K.; Koren, Amnon; Nussenzweig, Michel C.			T cell help controls the speed of the cell cycle in germinal center B cells	SCIENCE			English	Article							DNA-REPLICATION; DENDRITIC CELLS; CLONAL SELECTION; MATURATION; AFFINITY; DYNAMICS; MYC; ACTIVATION; REVEALS; CANCER	The germinal center (GC) is a microanatomical compartment wherein high-affinity antibody-producing B cells are selectively expanded. B cells proliferate and mutate their antibody genes in the dark zone (DZ) of the GC and are then selected by T cells in the light zone (LZ) on the basis of affinity. Here, we show that T cell help regulates the speed of cell cycle phase transitions and DNA replication of GC B cells. Genome sequencing and single-molecule analyses revealed that T cell help shortens S phase by regulating replication fork progression, while preserving the relative order of replication origin activation. Thus, high-affinity GC B cells are selected by a mechanism that involves prolonged dwell time in the DZ where selected cells undergo accelerated cell cycles.	[Gitlin, Alexander D.; Mayer, Christian T.; Oliveira, Thiago Y.; Shulman, Ziv; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Jones, Mathew J. K.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, HHMI, New York, NY 10065 USA; [Koren, Amnon] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard Medical School	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Oliveira, Thiago Y/ABF-5186-2020; Nussenzweig, Michel/AAE-7292-2019; Oliveira, Thiago Y/HGA-3848-2022	Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Jones, Mathew/0000-0003-2714-8411; Gitlin, Alexander/0000-0002-9229-0919	NIH Medical Scientist Training Program [T32GM07739]; National Institute of Allergy and Infectious Diseases, NIH [1F30AI109903-01]; NIH [AI037526-19, AI072529-06]; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1 AI100663-01]; European Commission FP7 (Marie Curie Actions) [EMBOCOFUND2012, GA-2012-600394]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI037526, R01AI072529, R01AI037526, UM1AI100663, F30AI109903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); European Commission FP7 (Marie Curie Actions); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Miyawaki and T. Kurosaki for mice, T. Eisenreich for help with mouse colony management, K. Yao for technical help, J. Hurwitz and A. Farina for advice, B. Zhang and C. Zhao and the Rockefeller University Genomics Resource Center for assistance with high-throughput sequencing, K. Velinzon for assistance with cell sorting, and all members of the Nussenzweig laboratory for discussion. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Supported by NIH Medical Scientist Training Program grant T32GM07739 and National Institute of Allergy and Infectious Diseases, NIH, grant 1F30AI109903-01 (A.D.G.); NIH grants AI037526-19 and AI072529-06 (M.C.N.); and the NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) 1UM1 AI100663-01 (M.C.N). Z.S. is a Human Frontiers of Science Program Fellow (reference LT000340/2011-L). C.T.M is an EMBO fellow (ALTF 456-2014) and is supported by the European Commission FP7 (Marie Curie Actions, EMBOCOFUND2012, GA-2012-600394). M.C.N. is an HHMI investigator. RNA sequencing data was deposited in the National Center for Biotechnology Information (NCBI), NIH, Gene Expression Omnibus (GEO) and is accessible through accession number GSE71295. Replication timing data was deposited in NCBI's Sequence Read Archive (SRA) and is accessible through accession number SRP061569.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Blumenthal AB, 1974, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/sqb.1974.038.01.024; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Collart C, 2013, SCIENCE, V341, P893, DOI 10.1126/science.1241530; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dominguez-Sola D, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014423; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Farrell JA, 2012, GENE DEV, V26, P714, DOI 10.1101/gad.186429.111; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; HYRIEN O, 1995, SCIENCE, V270, P994, DOI 10.1126/science.270.5238.994; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Malinsky J, 2001, J CELL SCI, V114, P747; MCKNIGHT SL, 1977, CELL, V12, P795, DOI 10.1016/0092-8674(77)90278-1; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nordman J, 2012, DEVELOPMENT, V139, P455, DOI 10.1242/dev.061838; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032	39	132	133	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					643	646		10.1126/science.aac4919	http://dx.doi.org/10.1126/science.aac4919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26184917	Green Accepted			2022-12-28	WOS:000359092900042
J	Anderson, GR; Aoto, J; Tabuchi, K; Foldy, C; Covy, J; Yee, AX; Wu, D; Lee, SJ; Chen, L; Malenka, RC; Sudhof, TC				Anderson, Garret R.; Aoto, Jason; Tabuchi, Katsuhiko; Foeldy, Csaba; Covy, Jason; Yee, Ada Xin; Wu, Dick; Lee, Sung-Jin; Chen, Lu; Malenka, Robert C.; Suedhof, Thomas C.			beta-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling	CELL			English	Article							CB1 CANNABINOID RECEPTOR; CELL-SURFACE PROTEINS; ENDOGENOUS CANNABINOIDS; GLUTAMATERGIC SYNAPSES; PRESYNAPTIC NEUREXIN-3; EXCITATORY SYNAPSES; PYRAMIDAL NEURONS; CALCIUM-CHANNELS; ALPHA-NEUREXINS; CA2+ CHANNELS	alpha- and beta-neurexins are presynaptic cell-adhesion molecules implicated in autism and schizophrenia. We find that, although beta-neurexins are expressed at much lower levels than alpha-neurexins, conditional knockout of beta-neurexins with continued expression of alpha-neurexins dramatically decreased neurotransmitter release at excitatory synapses in cultured cortical neurons. The beta-neurexin knockout phenotype was attenuated by CB1-receptor inhibition, which blocks presynaptic endocannabinoid signaling, or by 2-arachidonoylglycerol synthesis inhibition, which impairs postsynaptic endocannabinoid release. In synapses formed by CA1-region pyramidal neurons onto burst-firing subiculum neurons, presynaptic in vivo knockout of beta-neurexins aggravated endocannabinoid-mediated inhibition of synaptic transmission and blocked LTP; presynaptic CB1-receptor antagonists or postsynaptic 2-arachidonoylglycerol synthesis inhibition again reversed this block. Moreover, conditional knockout of beta-neurexins in CA1-region neurons impaired contextual fear memories. Thus, our data suggest that presynaptic beta-neurexins control synaptic strength in excitatory synapses by regulating postsynaptic 2-arachidonoylglycerol synthesis, revealing an unexpected role for beta-neurexins in the endocannabinoid-dependent regulation of neural circuits.	[Anderson, Garret R.; Aoto, Jason; Tabuchi, Katsuhiko; Foeldy, Csaba; Covy, Jason; Wu, Dick; Lee, Sung-Jin; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Anderson, Garret R.; Foeldy, Csaba; Wu, Dick; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Yee, Ada Xin; Chen, Lu] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Aoto, Jason] Shinshu Univ, Sch Med, Dept Neurophysiol, Matsumoto, Nagano 3908621, Japan	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Shinshu University	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 265 Campus Dr, Stanford, CA 94305 USA.	tcs1@stanford.edu	Yee, Ada/GRX-9171-2022; Aoto, Jason/AAR-3604-2021; Anderson, Garret/AAX-7011-2021	Foldy, Csaba/0000-0001-8709-8490; Chen, Lu/0000-0002-8097-2699; Aoto, Jason/0000-0003-0568-634X	NIH [R37 MH052804, K99 MH103531, P50 MH086403]; Autism Speaks [7953]; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH103531, R37MH052804, P50MH086403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA034029] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Dr. Wei Xu and Dr. Theodoros Tsetsenis for advice on fear conditioning experiments and Dr. Ken Mackie (Indiana University) for his generous contribution of CB1R antibodies, which were used in this study. This paper was supported by grants from the NIH (R37 MH052804 to T.C.S.; K99 MH103531 to J.A.; K99 DA034029 to C.F.; P50 MH086403 to R.C.M., T.C.S., and L.C.) and from Autism Speaks (7953) (to G.R.A.).	Aoto J, 2015, NAT NEUROSCI, V18, P997, DOI 10.1038/nn.4037; Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Bang ML, 2013, NEUROCHEM RES, V38, P1174, DOI 10.1007/s11064-013-1029-9; Behr J, 2009, PROG NEUROBIOL, V89, P334, DOI 10.1016/j.pneurobio.2009.09.002; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Clarke RA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00052; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Graves AR, 2012, NEURON, V76, P776, DOI 10.1016/j.neuron.2012.09.036; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Melis M, 2014, EUR J NEUROSCI, V39, P1189, DOI 10.1111/ejn.12501; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Murataeva N, 2014, BRIT J PHARMACOL, V171, P1379, DOI 10.1111/bph.12411; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Peterfi Z, 2012, J NEUROSCI, V32, P14448, DOI 10.1523/JNEUROSCI.1676-12.2012; Petrenko AG, 1996, J NEUROSCI, V16, P4360; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szabo Gergely G, 2014, J Neurosci, V34, P7958, DOI 10.1523/JNEUROSCI.0247-14.2014; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; Twitchell W, 1997, J NEUROPHYSIOL, V78, P43, DOI 10.1152/jn.1997.78.1.43; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; van Welie I, 2006, J PHYSIOL-LONDON, V576, P203, DOI 10.1113/jphysiol.2006.113944; Wozny C, 2008, J NEUROSCI, V28, P14358, DOI 10.1523/JNEUROSCI.4973-08.2008; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320	52	82	83	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					593	606		10.1016/j.cell.2015.06.056	http://dx.doi.org/10.1016/j.cell.2015.06.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26213384	Green Accepted, Bronze			2022-12-28	WOS:000358801800018
J	McCay, L				McCay, Layla			Emotional motivators might improve hand hygiene among healthcare workers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BEHAVIOR		Global Publ Private Partnership Handwashing, Washington, DC 20008 USA		McCay, L (corresponding author), Global Publ Private Partnership Handwashing, 1825 Connecticut Ave NW, Washington, DC 20008 USA.	laylamccay@hotmail.com	McCay, Layla/H-4030-2017	McCay, Layla/0000-0003-1759-5218				Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Bhalla A, 2004, INFECT CONT HOSP EP, V25, P164, DOI 10.1086/502369; Biran A, 2014, LANCET GLOB HEALTH, V2, pE145, DOI 10.1016/S2214-109X(13)70160-8; Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906; CASEWELL M, 1977, BRIT MED J, V2, P1315, DOI 10.1136/bmj.2.6098.1315; Contzen N, 2015, SOC SCI MED, V124, P103, DOI 10.1016/j.socscimed.2014.11.006; Curtis VA, 2009, HEALTH EDUC RES, V24, P655, DOI 10.1093/her/cyp002; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Pittet D, 1999, ARCH INTERN MED, V159, P821, DOI 10.1001/archinte.159.8.821	12	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2015	351								h3968	10.1136/bmj.h3968	http://dx.doi.org/10.1136/bmj.h3968			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO2TX	26220073				2022-12-28	WOS:000359010600005
J	Inagaki, F; Hinrichs, KU; Kubo, Y; Bowles, MW; Heuer, VB; Hong, WL; Hoshino, T; Ijiri, A; Imachi, H; Ito, M; Kaneko, M; Lever, MA; Lin, YS; Methe, BA; Morita, S; Morono, Y; Tanikawa, W; Bihan, M; Bowden, SA; Elvert, M; Glombitza, C; Gross, D; Harrington, GJ; Hori, T; Li, K; Limmer, D; Liu, CH; Murayama, M; Ohkouchi, N; Ono, S; Park, YS; Phillips, SC; Prieto-Mollar, X; Purkey, M; Riedinger, N; Sanada, Y; Sauvage, J; Snyder, G; Susilawati, R; Takano, Y; Tasumi, E; Terada, T; Tomaru, H; Trembath-Reichert, E; Wang, DT; Yamada, Y				Inagaki, F.; Hinrichs, K. -U.; Kubo, Y.; Bowles, M. W.; Heuer, V. B.; Hong, W. -L.; Hoshino, T.; Ijiri, A.; Imachi, H.; Ito, M.; Kaneko, M.; Lever, M. A.; Lin, Y. -S.; Methe, B. A.; Morita, S.; Morono, Y.; Tanikawa, W.; Bihan, M.; Bowden, S. A.; Elvert, M.; Glombitza, C.; Gross, D.; Harrington, G. J.; Hori, T.; Li, K.; Limmer, D.; Liu, C. -H.; Murayama, M.; Ohkouchi, N.; Ono, S.; Park, Y. -S.; Phillips, S. C.; Prieto-Mollar, X.; Purkey, M.; Riedinger, N.; Sanada, Y.; Sauvage, J.; Snyder, G.; Susilawati, R.; Takano, Y.; Tasumi, E.; Terada, T.; Tomaru, H.; Trembath-Reichert, E.; Wang, D. T.; Yamada, Y.			Exploring deep microbial life in coal-bearing sediment down to similar to 2.5 km below the ocean floor	SCIENCE			English	Article							MARINE SUBSURFACE SEDIMENTS; BIOGENIC METHANE; COENZYME F430; SEA SEDIMENTS; METHANOGENESIS; SUBSEAFLOOR; OIL; COMMUNITIES; BIOSPHERE; OXIDATION	Microbial life inhabits deeply buried marine sediments, but the extent of this vast ecosystem remains poorly constrained. Here we provide evidence for the existence of microbial communities in similar to 40 degrees to 60 degrees C sediment associated with lignite coal beds at similar to 1.5 to 2.5 km below the seafloor in the Pacific Ocean off Japan. Microbial methanogenesis was indicated by the isotopic compositions of methane and carbon dioxide, biomarkers, cultivation data, and gas compositions. Concentrations of indigenous microbial cells below 1.5 km ranged from <10 to similar to 10(4) cells cm(-3). Peak concentrations occurred in lignite layers, where communities differed markedly from shallower subseafloor communities and instead resembled organotrophic communities in forest soils. This suggests that terrigenous sediments retain indigenous community members tens of millions of years after burial in the seabed.	[Inagaki, F.; Hoshino, T.; Ijiri, A.; Ito, M.; Morono, Y.; Tanikawa, W.] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kochi Inst Core Sample Res, Nankoku, Kochi 7838502, Japan; [Inagaki, F.; Hoshino, T.; Ijiri, A.; Imachi, H.; Ito, M.; Kaneko, M.; Morono, Y.; Tanikawa, W.; Ohkouchi, N.; Takano, Y.] JAMSTEC, Res & Dev Ctr Marine Resources, Yokosuka, Kanagawa 2370061, Japan; [Hinrichs, K. -U.; Bowles, M. W.; Heuer, V. B.; Lin, Y. -S.; Elvert, M.; Prieto-Mollar, X.] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Kubo, Y.; Sanada, Y.] JAMSTEC, Ctr Deep Earth Explorat, Yokohama, Kanagawa 2360061, Japan; [Kubo, Y.; Sanada, Y.] JAMSTEC, Res & Dev Ctr Ocean Drilling Sci, Yokohama, Kanagawa 2360001, Japan; [Hong, W. -L.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Imachi, H.; Tasumi, E.] JAMSTEC, Dept Subsurface Geobiol Anal & Res, Yokosuka, Kanagawa 2370061, Japan; [Kaneko, M.; Takano, Y.] JAMSTEC, Dept Biogeochem, Yokosuka, Kanagawa 2370061, Japan; [Lever, M. A.; Glombitza, C.] Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark; [Methe, B. A.; Bihan, M.; Li, K.] J Craig Venter Inst, Dept Environm Genom, Rockville, MD 20850 USA; [Morita, S.] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Bowden, S. A.; Limmer, D.] Univ Aberdeen, Sch Geosci, Dept Geol & Petr Geol, Aberdeen AB2A 3UE, Scotland; [Gross, D.] Montanuniv, Dept Appl Geosci & Geophys, A-8700 Leoben, Austria; [Harrington, G. J.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; [Hori, T.] AIST, Environm Management Res Inst, Tsukuba, Ibaraki 3058569, Japan; [Liu, C. -H.] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Murayama, M.] Kochi Univ, Ctr Adv Marine Core Res, Nankoku, Kochi 7838502, Japan; [Ono, S.; Wang, D. T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Park, Y. -S.] Korea Inst Geosci & Mineral Resources, Petr & Marine Resources Res Div, Taejon 305350, South Korea; [Phillips, S. C.] Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA; [Purkey, M.] Univ Nebraska, Dept Earth & Atmospher Sci, Lincoln, NE 68588 USA; [Riedinger, N.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Sauvage, J.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Snyder, G.] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Susilawati, R.] Univ Queensland, Sch Earth Sci, Brisbane, Qld 4072, Australia; [Terada, T.] Marine Works Japan, Yokosuka, Kanagawa 2370063, Japan; [Tomaru, H.] Chiba Univ, Grad Sch Sci, Dept Earth Sci, Chiba 2638522, Japan; [Trembath-Reichert, E.] CALTECH, Geol & Planetary Sci, Pasadena, CA 91125 USA; [Yamada, Y.] Kyoto Univ, Grad Sch Engn, Dept Urban Management, Kyoto 6158540, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Bremen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Oregon State University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Aarhus University; J. Craig Venter Institute; National Institute of Advanced Industrial Science & Technology (AIST); University of Aberdeen; University of Birmingham; National Institute of Advanced Industrial Science & Technology (AIST); Nanjing University; Kochi University; Massachusetts Institute of Technology (MIT); Korea Institute of Geoscience & Mineral Resources (KIGAM); University System Of New Hampshire; University of New Hampshire; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Riverside; University of Rhode Island; Rice University; University of Queensland; Chiba University; California Institute of Technology; Kyoto University	Inagaki, F (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kochi Inst Core Sample Res, Nankoku, Kochi 7838502, Japan.	inagaki@jamstec.go.jp; khinrichs@uni-bremen.de	Hori, Tomoyuki/L-9289-2018; Snyder, Glen/ABG-7762-2021; Lever, Mark A/C-2134-2011; Hinrichs, Kai-Uwe/C-7675-2009; Phillips, Stephen/F-7239-2016; Snyder, Glen T/E-7873-2017; Inagaki, Fumio/AAI-1156-2019; Glombitza, Clemens/C-3129-2014; Glombitza, Clemens/T-1633-2019; Imachi, Hiroyuki/D-3298-2009; Hong, Wei-Li/E-9816-2013; Morita, Sumito/L-7483-2018; Yamada, Yasuhiro/D-7890-2011; Kaneko, Masanori/I-1157-2013	Hori, Tomoyuki/0000-0003-4459-7999; Lever, Mark A/0000-0002-2046-8028; Hinrichs, Kai-Uwe/0000-0002-0739-9291; Phillips, Stephen/0000-0003-0858-4701; Snyder, Glen T/0000-0001-5289-7903; Inagaki, Fumio/0000-0003-2887-6525; Glombitza, Clemens/0000-0002-0938-2952; Imachi, Hiroyuki/0000-0001-6588-5055; Hong, Wei-Li/0000-0002-7247-1827; Morita, Sumito/0000-0003-0926-4259; Yamada, Yasuhiro/0000-0002-5330-234X; Morono, Yuki/0000-0001-8928-4254; Kaneko, Masanori/0000-0003-0787-4731; Ohkouchi, Naohiko/0000-0002-6355-7469; Wang, David/0000-0002-2656-8951; Trembath-Reichert, Elizabeth/0000-0002-3979-8676; Purkey Phillips, Marcella/0000-0003-1342-4358; Tanikawa, Wataru/0000-0002-3083-0959; Kubo, Yusuke/0000-0002-6796-4950; Gross, Doris/0000-0001-7442-5093; Elvert, Marcus/0000-0003-3863-0975; Heuer, Verena/0000-0002-1856-116X; Glombitza, Clemens/0000-0002-7182-9532	Japan Society for the Promotion of Science (JSPS) Strategic Fund for Strengthening Leading-Edge Research and Development; Japan Society for the Promotion of Science (JSPS) Strategic Fund for Strengthening Leading-Edge Research and Development (JAMSTEC); JSPS Funding Program for Next Generation World-Leading Researchers [GR102]; JSPS [26251041, 24770033, 24687011, 26287142, 25610166, 24651018, 24687004]; European Research Council [247153]; Deutsche Forschungsgemeinschaft through MARUM-Cluster of Excellence [HI 616/16, 309]; NSF [EAR-1250394]; Grants-in-Aid for Scientific Research [26650169, 26251041] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) Strategic Fund for Strengthening Leading-Edge Research and Development(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS) Strategic Fund for Strengthening Leading-Edge Research and Development (JAMSTEC); JSPS Funding Program for Next Generation World-Leading Researchers; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft through MARUM-Cluster of Excellence(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful to IODP and the Ministry of Education, Culture, Sports, Science and Technology of Japan for providing an opportunity to explore the deep coal-bed biosphere off Shimokita during Expedition 337. We thank all crews, drilling team members, lab technicians, and scientists on the drilling vessel Chikyu for supporting core sampling and onboard measurements during Chikyu shakedown cruise CK06-06 and IODP Expedition 337. The authors thank J. A. McKenzie and K. H. Nealson for useful discussions during project design; S. Fukunaga, S. Hashimoto, A. Imajo, Y. Saito, S. Tanaka, K. Uematsu, and N. Xiao for assistance in microbiological analyses; and D. Gruen for technical assistance during clumped isotope analysis. This work was supported in part by the Japan Society for the Promotion of Science (JSPS) Strategic Fund for Strengthening Leading-Edge Research and Development (to F.I. and JAMSTEC), the JSPS Funding Program for Next Generation World-Leading Researchers (grant no. GR102 to F.I.), the JSPS Grants-in-Aid for Science Research (no. 26251041 to F.I., no. 24770033 to T.H., no. 24687011 to H.I., no. 26287142 to M.I., no. 25610166 to M.K., and nos. 24651018 and 24687004 to Y.M.), the European Research Council (Advanced Grant no. 247153 to K.-U.H.), the Deutsche Forschungsgemeinschaft trough project HI 616/16 (to K.-U.H.) through MARUM-Cluster of Excellence 309, and NSF (no. EAR-1250394 to S.O). All shipboard and shore-based data presented in this manuscript are archived and publicly available online in the IODP Expedition 337 Proceedings (6) through the J-CORES database (http://sio7.jamstec.go.jp/j-cores.data/337/C0020A/) and the PANGAEA database (http://doi.pangaea.de/10.1594/PANGAEA.845984). This is a contribution to the Deep Carbon Observatory.	Ciobanu MC, 2014, ISME J, V8, P1370, DOI 10.1038/ismej.2013.250; Colwell FS, 2008, APPL ENVIRON MICROB, V74, P3444, DOI 10.1128/AEM.02114-07; D'Hondt S, 2015, NAT GEOSCI, V8, P299, DOI 10.1038/NGEO2387; Dodsworth JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2884; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; Hoehler TM, 1998, GEOCHIM COSMOCHIM AC, V62, P1745, DOI 10.1016/S0016-7037(98)00106-9; Horsfield B, 2006, EARTH PLANET SC LETT, V246, P55, DOI 10.1016/j.epsl.2006.03.040; Hoshino T, 2012, SYST APPL MICROBIOL, V35, P390, DOI 10.1016/j.syapm.2012.06.006; Imachi H, 2011, ISME J, V5, P1913, DOI 10.1038/ismej.2011.64; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Inagaki F., 2013, P INTEGRATED OCENA D, V337; Jones DM, 2008, NATURE, V451, P176, DOI 10.1038/nature06484; Kaneko M, 2014, ANAL CHEM, V86, P3633, DOI 10.1021/ac500305j; Konyukhov AI, 2010, LITHOL MINER RESOUR+, V45, P465, DOI 10.1134/S0024490210050056; Lever MA, 2015, FEMS MICROBIOL REV, V39, P688, DOI 10.1093/femsre/fuv020; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; Morono Y, 2011, P NATL ACAD SCI USA, V108, P18295, DOI 10.1073/pnas.1107763108; Morono Y, 2009, ISME J, V3, P503, DOI 10.1038/ismej.2009.1; Osawa M., 2002, J JAPANESE ASS PETRO, V67, P38, DOI [10.3720/japt.67.1_38, DOI 10.3720/JAPT.67.1_]; Parkes RJ, 2007, ORG GEOCHEM, V38, P845, DOI 10.1016/j.orggeochem.2006.12.011; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Stolper DA, 2014, SCIENCE, V344, P1500, DOI 10.1126/science.1254509; Strapoc D, 2011, ANNU REV EARTH PL SC, V39, P617, DOI 10.1146/annurev-earth-040610-133343; Takano Y, 2013, ORG GEOCHEM, V58, P137, DOI 10.1016/j.orggeochem.2013.01.012; Teske AP, 2006, GEOMICROBIOL J, V23, P357, DOI 10.1080/01490450600875613; Webster G, 2004, APPL ENVIRON MICROB, V70, P5708, DOI 10.1128/AEM.70.9.5708-5713.2004; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3	30	245	255	13	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					420	424		10.1126/science.aaa6882	http://dx.doi.org/10.1126/science.aaa6882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206933	Green Submitted			2022-12-28	WOS:000358381400041
J	Sansom, DM				Sansom, David M.			Moving CTLA-4 from the trash to recycling	SCIENCE			English	Editorial Material							IMMUNE DYSREGULATION; T-CELLS; MUTATIONS; POLYENDOCRINOPATHY; ENTEROPATHY; ENDOCYTOSIS; PROTEINS		UCL, Inst Immun & Transplantat, Royal Free Hosp, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Sansom, DM (corresponding author), UCL, Inst Immun & Transplantat, Royal Free Hosp, London, England.	d.sansom@ucl.ac.uk		Sansom, David/0000-0001-6506-3115	BBSRC [BB/H013598/1, BB/H013598/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H013598/1, BB/H013598/2] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Charbonnier LM, 2015, J ALLERGY CLIN IMMUN, V135, P217, DOI 10.1016/j.jaci.2014.10.019; Cullinane AR, 2013, TRAFFIC, V14, P749, DOI 10.1111/tra.12069; d'Hennezel E, 2012, J MED GENET, V49, P291, DOI 10.1136/jmedgenet-2012-100759; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Lo B, 2015, SCIENCE, V349, P436, DOI 10.1126/science.aaa1663; Qureshi OS, 2012, J BIOL CHEM, V287, P9429, DOI 10.1074/jbc.M111.304329; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wang JW, 2001, J IMMUNOL, V166, P4586, DOI 10.4049/jimmunol.166.7.4586; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	15	19	20	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					377	378		10.1126/science.aac7888	http://dx.doi.org/10.1126/science.aac7888			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206917				2022-12-28	WOS:000358381400021
J	Nahrendorf, M; Swirski, FK				Nahrendorf, Matthias; Swirski, Filip K.			IMMUNOLOGY Neutrophil-macrophage communication in inflammation and atherosclerosis	SCIENCE			English	Editorial Material									[Nahrendorf, Matthias; Swirski, Filip K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Nahrendorf, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02114 USA.	mnahrendorf@mgh.harvard.edu; fswirski@mgh.harvard.edu	Swirski, Filip/AAF-1340-2019	Swirski, Filip/0000-0002-3163-9152				Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Quillard T, 2015, EUR HEART J, V36, P1394, DOI 10.1093/eurheartj/ehv044; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Wong S. L., 2015, NAT MED, DOI [10.1038/nm3887, DOI 10.1038/NM3887]	12	69	75	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		237	238		10.1126/science.aac7801	http://dx.doi.org/10.1126/science.aac7801			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185231				2022-12-28	WOS:000358218600022
J	Das, K; Arnold, E				Das, Kalyan; Arnold, Eddy			Negative-Strand RNA Virus L Proteins: One Machine, Many Activities	CELL			English	Editorial Material							CRYO-EM; POLYMERASE	Structures of L proteins from La Crosse orthobunyavirus and vesicular stomatitis virus reveal insights into RNA synthesis and distinctive mRNA capping mechanisms of segmented and non-segmented negative-sense single-strand RNA viruses.	[Das, Kalyan; Arnold, Eddy] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Das, K (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Lane, Piscataway, NJ 08854 USA.	kalyan@cabm.rutgers.edu; arnold@cabm.rutgers.edu	Das, Kalyan/O-9224-2019; Das, Kalyan/B-2967-2018	Das, Kalyan/0000-0002-8897-324X; Das, Kalyan/0000-0002-8897-324X				Chang SH, 2015, MOL CELL, V57, P925, DOI 10.1016/j.molcel.2014.12.031; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Das K, 2013, CURR OPIN VIROL, V3, P111, DOI 10.1016/j.coviro.2013.03.012; Gerlach P, 2015, CELL, V161, P1267, DOI 10.1016/j.cell.2015.05.006; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Liang B, 2015, CELL, V162, P314, DOI 10.1016/j.cell.2015.06.018; Ogino T, 2007, MOL CELL, V25, P85, DOI 10.1016/j.molcel.2006.11.013; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009	10	14	16	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					237	239		10.1016/j.cell.2015.06.063	http://dx.doi.org/10.1016/j.cell.2015.06.063			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186183	Bronze			2022-12-28	WOS:000358087700004
J	Leiserson, CE; McVinney, C				Leiserson, Charles E.; McVinney, Chuck			Lifelong learning: Science professors need leadership training	NATURE			English	Editorial Material									[Leiserson, Charles E.] MIT, MIT Comp Sci & Artificial Intelligence Lab, Comp Sci & Engn, Cambridge, MA 02139 USA; [McVinney, Chuck] McVinney & Co, Brookline, MA USA	Massachusetts Institute of Technology (MIT)	Leiserson, CE (corresponding author), MIT, MIT Comp Sci & Artificial Intelligence Lab, Comp Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chuckmcvinney@gmail.com						Bennett LM., 2013, COLLABORATION TEAM S; Bruns JW, 2007, J LEADERSH STUD, V1, P53, DOI 10.1002/jls.20015; DeRidder C. G., 2006, IMPROVE PRODUCTIVITY; Gazzaniga M. S., 2015, TALES BOTH SIDES BRA; Goleman D, 2020, EMOTIONAL INTELLIGEN, V25th; Herrmann N, 2015, WHOLE BRAIN BUSINESS, V2nd; Kahneman D., 2011, THINKING FAST SLOW; Stephan P., 2007, SCI U	8	11	12	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					279	281		10.1038/523279a	http://dx.doi.org/10.1038/523279a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM8KY	26178950	Bronze, Green Submitted			2022-12-28	WOS:000357950900016
J	New, AM; Lehner, B				New, Aaron M.; Lehner, Ben			Network evolution hinges on history	NATURE			English	Editorial Material							CIRCUITS; DYNAMICS		[New, Aaron M.; Lehner, Ben] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain; [New, Aaron M.; Lehner, Ben] Univ Pompeu Fabra, Barcelona, Spain; [Lehner, Ben] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	New, AM (corresponding author), Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain.	ben.lehner@crg.eu	Lehner, Ben/L-3413-2014; new, aaron m/K-8958-2017; Lehner, Ben/ABH-6562-2020	Lehner, Ben/0000-0002-8817-1124; new, aaron m/0000-0002-4097-1835; Lehner, Ben/0000-0002-8817-1124	ICREA Funding Source: Custom	ICREA(ICREA)		Baker CR, 2012, CELL, V151, P80, DOI 10.1016/j.cell.2012.08.018; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Harms MJ, 2013, NAT REV GENET, V14, P559, DOI 10.1038/nrg3540; Jimenez A, 2015, P NATL ACAD SCI USA, V112, P2103, DOI 10.1073/pnas.1411065112; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Sorrells TR, 2015, NATURE, V523, P361, DOI 10.1038/nature14613; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	10	4	4	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					297	298		10.1038/nature14537	http://dx.doi.org/10.1038/nature14537			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM8KY	26153857				2022-12-28	WOS:000357950900030
J	Sorrells, TR; Booth, LN; Tuch, BB; Johnson, AD				Sorrells, Trevor R.; Booth, Lauren N.; Tuch, Brian B.; Johnson, Alexander D.			Intersecting transcription networks constrain gene regulatory evolution	NATURE			English	Article							HISTORICAL CONTINGENCY; CELL-TYPE; YEAST; BINDING; PROTEIN; DIVERGENCE; ALIGNMENT; CIRCUIT	Epistasis-the non-additive interactions between different genetic loci-constrains evolutionary pathways, blocking some and permitting others(1-8). For biological networks such as transcription circuits, the nature of these constraints and their consequences are largely unknown. Here we describe the evolutionary pathways of a transcription network that controls the response to mating pheromone in yeast(9). A component of this network, the transcription regulator Ste12, has evolved two different modes of binding to a set of its target genes. In one group of species, Ste12 binds to specific DNA binding sites, while in another lineage it occupies DNA indirectly, relying on a second transcription regulator to recognize DNA. We show, through the construction of various possible evolutionary intermediates, that evolution of the direct mode of DNA binding was not directly accessible to the ancestor. Instead, it was contingent on a lineage-specific change to an overlapping transcription network with a different function, the specification of cell type. These results show that analysing and predicting the evolution of cis-regulatory regions requires an understanding of their positions in overlapping networks, as this placement constrains the available evolutionary pathways.	[Sorrells, Trevor R.; Booth, Lauren N.; Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Sorrells, Trevor R.; Booth, Lauren N.; Johnson, Alexander D.] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA; [Tuch, Brian B.] Univ Calif San Francisco, Biol & Med Informat Grad Program, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	ajohnson@cgl.ucsf.edu		Sorrells, Trevor/0000-0002-3527-8622	National Institutes of Health [R01 GM037049]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Coyle, I. Nocedal, C. Dalal, C. Britton, C. Baker, and V. Hanson-Smith for valuable comments on the manuscript. We also thank K. Pollard, E. Mancera, C. Nobile, and Q. Mitrovich for advice and assistance with experiments and analysis. We thank K. Boundy-Mills of the Phaff Yeast Culture Collection, University of California, Davis for the K. lactis isolates. The work was supported by grant R01 GM037049 from the National Institutes of Health. T.R.S. was supported by a Graduate Research Fellowship from the National Science Foundation.	Baker CR, 2012, CELL, V151, P80, DOI 10.1016/j.cell.2012.08.018; Bennett RJ, 2003, MOL CELL BIOL, V23, P8189, DOI 10.1128/MCB.23.22.8189-8201.2003; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Booth LN, 2010, NATURE, V468, P959, DOI 10.1038/nature09560; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Coria R, 2006, FEMS YEAST RES, V6, P336, DOI 10.1111/j.1567-1364.2005.00022.x; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P423, DOI 10.1038/nbt0406-423; DOLAN JW, 1989, P NATL ACAD SCI USA, V86, P5703, DOI 10.1073/pnas.86.15.5703; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Gojkovic Z, 2000, J MOL BIOL, V295, P1073, DOI 10.1006/jmbi.1999.3393; Gordon JL, 2011, P NATL ACAD SCI USA, V108, P20024, DOI 10.1073/pnas.1112808108; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; Harms MJ, 2014, NATURE, V512, P203, DOI 10.1038/nature13410; Harms MJ, 2013, NAT REV GENET, V14, P559, DOI 10.1038/nrg3540; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Kensche PR, 2008, TRENDS GENET, V24, P207, DOI 10.1016/j.tig.2008.02.003; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lusk RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053778; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; MOHRIG JR, 1995, SCIENCE, V269, P527; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Otto W, 2009, GENOME BIOL EVOL, V1, P85, DOI 10.1093/gbe/evp010; Payne JL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003071; Posada D, 2001, MOL BIOL EVOL, V18, P897, DOI 10.1093/oxfordjournals.molbev.a003890; Ramos AI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0018; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; Swanson CI, 2011, CURR BIOL, V21, P1186, DOI 10.1016/j.cub.2011.05.056; Tagwerker C, 2006, YEAST, V23, P623, DOI 10.1002/yea.1380; Tirosh I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100198; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	49	45	45	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					361	+		10.1038/nature14613	http://dx.doi.org/10.1038/nature14613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26153861	Green Accepted, Green Submitted			2022-12-28	WOS:000357950900045
J	Knox, K				Knox, Kyle			PERSONAL VIEW Women should be able to get antibiotics for urinary tract infection without a prescription	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EPIDEMIOLOGY; MANAGEMENT		Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6NW, England	University of Oxford	Knox, K (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6NW, England.	kyle.knox@phc.ox.ac.uk						[Anonymous], 2013, RUSSIA TODAY    0124; Etienne M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-137; Fenwick EAL, 2000, BRIT J GEN PRACT, V50, P635; Fleming DM, 2005, BRIT J GEN PRACT, V55, P589; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Kassakian SZ, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-9; Leydon GM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c279; Little P, 2010, BRIT J GEN PRACT, V60, P495, DOI 10.3399/bjgp10X514747; Milo G, 2005, COCHRANE DB SYST REV, V2; Public Health England, 2015, MAN INF GUID PRIM CA; Public Health England British Infection Association Health Protection Agency, 2014, DIAGN UTI QUICK REF; STAMM WE, 1982, NEW ENGL J MED, V307, P463, DOI 10.1056/NEJM198208193070802	12	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2015	351								h3441	10.1136/bmj.h3441	http://dx.doi.org/10.1136/bmj.h3441			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CU	26173946				2022-12-28	WOS:000358302300001
J	Rubin, GA				Rubin, Geoffrey A.			BECOMING A PHYSICIAN Breaking Up Is Hard to Do	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Med Ctr, New York, NY 10027 USA	Columbia University	Rubin, GA (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					107	109		10.1056/NEJMp1504477	http://dx.doi.org/10.1056/NEJMp1504477			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM3QP	26154785				2022-12-28	WOS:000357598600003
J	Marshall, K; Smith, S				Marshall, Katherine; Smith, Sally			Religion and Ebola: learning from experience	LANCET			English	Editorial Material									[Marshall, Katherine] Georgetown Univ, Berkley Ctr Relig Peace & World Affairs, Washington, DC 20007 USA; [Smith, Sally] Joint United Nations Programme HIV & AIDS, Geneva, Switzerland	Georgetown University	Marshall, K (corresponding author), Georgetown Univ, Berkley Ctr Relig Peace & World Affairs, Washington, DC 20007 USA.	km398@georgetown.edu	Marshall, Katherine/AHC-5415-2022					Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, pS293, DOI 10.1080/17441692.2011.594451; Centers for Disease Control and Prevention, 2014, 2014 EB OUTBR W AFR; Conteh P.S., 2011, J STUDY RELIG, VXXIV, P55; Corman C, RESPONSE EBOLA MAPPI; Ekwensi J, 2014, MEDCRAVE ONLINE J PU, V1, P1; Haynes J, 2009, COMMONW COMP POLIT, V47, P52, DOI 10.1080/14662040802659033; Marshall K., 2015, COMMUNICATION; Nielsen C. F., 2015, IMPROVING BURIAL PRA; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Vitillo R., 2014, THE TABLET      1018; WHO, 2015, EB SIT REP; World Bank Group, POP TOT; World Health Organization, 2014, NEW WHO SAF DIGN BUR; World Health Organization (WHO), 2014, COND SAF DIGN BUR PA	14	29	29	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					E24	E25		10.1016/S0140-6736(15)61082-0	http://dx.doi.org/10.1016/S0140-6736(15)61082-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	CV0WK	26159395				2022-12-28	WOS:000363974200002
J	Deerenberg, EB; Harlaar, JJ; Steyerberg, EW; Lont, HE; van Doorn, HC; Heisterkamp, J; Wijnhoven, BPL; Schouten, WR; Cense, HA; Stockmann, HBAC; Berends, FJ; Dijkhuizen, FPHLJ; Dwarkasing, RS; Jairam, AP; van Ramshorst, GH; Kleinrensink, GJ; Jeekel, J; Lange, JF				Deerenberg, Eva B.; Harlaar, Joris J.; Steyerberg, Ewout W.; Lont, Harold E.; van Doorn, Helena C.; Heisterkamp, Joos; Wijnhoven, Bas P. L.; Schouten, Willem R.; Cense, Huib A.; Stockmann, Hein B. A. C.; Berends, Frits J.; Dijkhuizen, F. Paul H. L. J.; Dwarkasing, Roy S.; Jairam, An P.; van Ramshorst, Gabrielle H.; Kleinrensink, Gert-Jan; Jeekel, Johannes; Lange, Johan F.			Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; HERNIA	Background Incisional hernia is a frequent complication of midline laparotomy and is as sociated with high morbidity, decreased quality of life, and high costs. We aimed to compare the large bites suture technique with the small bites technique for fascial closure of midline laparotomy incisions. Methods We did this prospective, multicentre, double-blind, randomised controlled trial at surgical and gynaecological departments in ten hospitals in the Netherlands. Patients aged 18 years or older who were scheduled to undergo elective abdominal surgery with midline laparotomy were randomly assigned (1: 1), via a computer-generated randomisation sequence, to receive small tissue bites of 5 mm every 5 mm or large bites of 1 cm every 1 cm. Randomisation was stratified by centre and between surgeons and residents with a minimisation procedure to ensure balanced allocation. Patients and study investigators were masked to group allocation. The primary outcome was the occurrence of incisional hernia; we postulated a reduced incidence in the small bites group. We analysed patients by intention to treat. This trial is registered at Clinicaltrials.gov, number NCT01132209 and with the Nederlands Trial Register, number NTR2052. Findings Between Oct 20, 2009, and March 12, 2012, we randomly assigned 560 patients to the large bites group (n= 284) or the small bites group (n= 276). Follow-up ended on Aug 30, 2013; 545 (97%) patients completed follow-up and were included in the primary outcome analysis. Patients in the small bites group had fascial closures sutured with more stitches than those in the large bites group (mean number of stitches 45 [SD 12] vs 25 [10]; p< 0.0001), a higher ratio of suture length to wound length (5.0 [1.5] vs 4.3 [1.4]; p< 0.0001) and a longer closure time (14 [6] vs 10 [4] min; p< 0.0001). At 1 year follow-up, 57 (21%) of 277 patients in the large bites group and 35 (13%) of 268 patients in the small bites group had incisional hernia (p= 0.0220, covariate adjusted odds ratio 0.52, 95% CI 0.31-0.87; p= 0.0131). Rates of adverse events did not differ significantly between groups. Interpretation Our findings show that the small bites suture technique is more effective than the traditional large bites technique for prevention of incisional hernia in midline incisions and is not associated with a higher rate of adverse events. The small bites technique should become the standard closure technique for midline incisions.	[Deerenberg, Eva B.; Harlaar, Joris J.; Wijnhoven, Bas P. L.; Schouten, Willem R.; Jairam, An P.; Lange, Johan F.] Erasmus Univ, Med Ctr, Dept Surg, NL-3000 CA Rotterdam, Netherlands; [Steyerberg, Ewout W.] Erasmus Univ, Med Ctr, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Dwarkasing, Roy S.] Erasmus Univ, Med Ctr, Dept Radiol, NL-3000 CA Rotterdam, Netherlands; [Kleinrensink, Gert-Jan; Jeekel, Johannes] Erasmus Univ, Med Ctr, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Lont, Harold E.] Vlietland Ziekenhuis, Dept Surg, Schiedam, Netherlands; [van Doorn, Helena C.] Erasmus MC Canc Inst, Dept Gynecol, Rotterdam, Netherlands; [Heisterkamp, Joos] St Elizabeth Hosp, Dept Surg, Tilburg, Netherlands; [Schouten, Willem R.] Havenziekenhuis, Dept Surg, Rotterdam, Netherlands; [Stockmann, Hein B. A. C.] Kennemer Gasthuis, Dept Surg, Haarlem, Netherlands; [Berends, Frits J.] Rijnstate Ziekenhuis, Dept Surg, Arnhem, Netherlands; [Dijkhuizen, F. Paul H. L. J.] Rijnstate Ziekenhuis, Dept Gynecol, Arnhem, Netherlands; [Cense, Huib A.; van Ramshorst, Gabrielle H.] Rode Kruis Ziekenhuis, Dept Surg, Beverwijk, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Elisabeth-TweeSteden Ziekenhuis (ETZ); Spaarne Hospital; Rijnstate Hospital; Rijnstate Hospital	Harlaar, JJ (corresponding author), Erasmus Univ, Med Ctr, Dept Surg, NL-3000 CA Rotterdam, Netherlands.	j.harlaar@erasmusmc.nl	Dwarkasing, Roy/AAR-6825-2021; van Ramshorst, Gabrielle H./H-9140-2019; Berends, Frits/AAG-9519-2020; Wijnhoven, Bas/AAF-4838-2020	van Ramshorst, Gabrielle H./0000-0002-5368-582X; Berends, Frits/0000-0002-5853-8781; Deerenberg, Eva/0000-0002-1421-8567	Erasmus University Medical Center; Ethicon; Ethicon [09-107]; Erasmus University Medical Center [2008-8106]	Erasmus University Medical Center; Ethicon; Ethicon; Erasmus University Medical Center	Erasmus University Medical Center and Ethicon.; This trial was funded by Ethicon (Investigator Initiated Clinical Research Funding Grant 09-107) and the Erasmus University Medical Center (Efficiency Research Grant 2008-8106). We thank the patients and their families for their participation in this study; members of the data and safety monitoring board (Wim CJ Hop, Harry van Goor, and Dick van Geldere) for their contributions; and to Anneke van Duuren for the data management of this trial.	Arndt V, 2004, J CLIN ONCOL, V22, P4829, DOI 10.1200/JCO.2004.02.018; Bevis PM, 2010, BRIT J SURG, V97, P1497, DOI 10.1002/bjs.7137; Bloemen A, 2012, HERNIA, V16, P53, DOI 10.1007/s10029-011-0865-2; Bloemen A, 2011, BRIT J SURG, V98, P633, DOI 10.1002/bjs.7398; Cengiz Y, 2001, EUR J SURG, V167, P60; DesCoteaux J G, 1993, J Invest Surg, V6, P201; Diener MK, 2010, ANN SURG, V251, P843, DOI 10.1097/SLA.0b013e3181d973e4; Fink C, 2014, BRIT J SURG, V101, P51, DOI 10.1002/bjs.9364; Harlaar JJ, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-20; Harlaar JJ, 2009, AM J SURG, V198, P392, DOI 10.1016/j.amjsurg.2008.10.018; Hernandez AV, 2004, J CLIN EPIDEMIOL, V57, P454, DOI 10.1016/j.jclinepi.2003.09.014; Hoer J J, 2002, Hernia, V6, P93; Israelsson LA, 2013, SURG CLIN N AM, V93, P1027, DOI 10.1016/j.suc.2013.06.009; JENKINS TPN, 1976, BRIT J SURG, V63, P873, DOI 10.1002/bjs.1800631110; Klink CD, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-36; Lee JA, 2014, JPN J CLIN ONCOL, V44, P141, DOI 10.1093/jjco/hyt184; Millbourn D, 2009, ARCH SURG-CHICAGO, V144, P1056, DOI 10.1001/archsurg.2009.189; Muysoms FE, 2015, HERNIA, V19, P1, DOI 10.1007/s10029-014-1342-5; Muysoms FE, 2009, HERNIA, V13, P407, DOI 10.1007/s10029-009-0518-x; Nieuwenhuizen J, 2011, HERNIA, V15, P297, DOI 10.1007/s10029-010-0779-4; Poulose BK, 2012, HERNIA, V16, P179, DOI 10.1007/s10029-011-0879-9; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Schreinemacher MHF, 2011, ARCH SURG-CHICAGO, V146, P94, DOI 10.1001/archsurg.2010.281; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; van Ramshorst Gabrielle H, 2013, Surg Technol Int, V23, P34; van Ramshorst GH, 2013, SURG INFECT, V14, P181, DOI 10.1089/sur.2012.045; van Ramshorst GH, 2012, AM J SURG, V204, P144, DOI 10.1016/j.amjsurg.2012.01.012; van't Riet M, 2002, BRIT J SURG, V89, P1350, DOI 10.1046/j.1365-2168.2002.02258.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	29	244	244	5	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1254	1260		10.1016/S0140-6736(15)60459-7	http://dx.doi.org/10.1016/S0140-6736(15)60459-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26188742				2022-12-28	WOS:000361700100034
J	Guo, P; Shin, J; Greenaway, AG; Min, JG; Su, J; Choi, HJ; Liu, LF; Cox, PA; Hong, SB; Wright, PA; Zou, XD				Guo, Peng; Shin, Jiho; Greenaway, Alex G.; Min, Jung Gi; Su, Jie; Choi, Hyun June; Liu, Leifeng; Cox, Paul A.; Hong, Suk Bong; Wright, Paul A.; Zou, Xiaodong			A zeolite family with expanding structural complexity and embedded isoreticular structures	NATURE			English	Article							DIFFRACTION; DESIGN; FRAMEWORKS; CO2	The prediction and synthesis of new crystal structures enable the targeted preparation of materials with desired properties. Among porous solids, this has been achieved for metal-organic frameworks(1-3), but not for the more widely applicable zeolites(4,5), where new materials are usually discovered using exploratory synthesis. Although millions of hypothetical zeolite structures have been proposed(6,7), not enough is known about their synthesis mechanism to allow any given structure to be prepared. Here we present an approach that combines structure solution with structure prediction, and inspires the targeted synthesis of new super-complex zeolites. We used electron diffraction to identify a family of related structures and to discover the structural 'coding' within them. This allowed us to determine the complex, and previously unknown, structure of zeolite ZSM-25 (ref. 8), which has the largest unit-cell volume of all known zeolites (91,554 cubic angstroms) and demonstrates selective CO2 adsorption. By extending our method, we were able to predict other members of a family of increasingly complex, but structurally related, zeolites and to synthesize two more-complex zeolites in the family, PST-20 and PST-25, with much larger cell volumes (166,988 and 275,178 cubic angstroms, respectively) and similar selective adsorption properties. Members of this family have the same symmetry, but an expanding unit cell, and are related by hitherto unrecognized structural principles; we call these family members embedded isoreticular zeolite structures.	[Guo, Peng; Su, Jie; Liu, Leifeng; Zou, Xiaodong] Stockholm Univ, Inorgan & Struct Chem, Dept Mat & Environm Chem, SE-10691 Stockholm, Sweden; [Guo, Peng; Su, Jie; Liu, Leifeng; Zou, Xiaodong] Stockholm Univ, Berzelii Ctr EXSELENT Porous Mat, SE-10691 Stockholm, Sweden; [Shin, Jiho; Min, Jung Gi; Choi, Hyun June; Hong, Suk Bong] POSTECH, Ctr Ordered Nanoporous Mat Synth, Sch Environm Sci & Engn, Pohang 790784, South Korea; [Greenaway, Alex G.; Wright, Paul A.] Univ St Andrews, EaStCHEM Sch Chem, St Andrews KY16 9ST, Fife, Scotland; [Cox, Paul A.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England	Stockholm University; Stockholm University; Pohang University of Science & Technology (POSTECH); University of St Andrews; University of Portsmouth	Hong, SB (corresponding author), POSTECH, Ctr Ordered Nanoporous Mat Synth, Sch Environm Sci & Engn, Pohang 790784, South Korea.	sbhong@postech.ac.kr; paw2@st-andrews.ac.uk; xzou@mmk.su.se	Su, Jie/V-5224-2017; Liu, Leifeng/N-4246-2018; Su, Jie/T-3271-2019	Su, Jie/0000-0001-9800-3370; Liu, Leifeng/0000-0002-6159-7475; Cox, Paul/0000-0002-6618-8427; MIN, JUNG GI/0000-0002-4084-1192; Greenaway, Alex/0000-0002-8573-9124; Choi, Hyun June/0000-0001-5341-4176; Hong, Suk Bong/0000-0002-2855-1600	Swedish Research Council (VR); Swedish Governmental Agency for Innovation Systems (VINNOVA); Rontgen-Angstrom Cluster through the project grant MATsynCELL; Knut and Alice Wallenberg Foundation through the project grant 3DEM-NATUR; NCRI [2012R1A3A-2048833]; BK 21-plus programmes through the National Research Foundation of Korea; UK EPSRC [EP/J02077X/1]; Knut and Alice Wallenberg Foundation; EPSRC [EP/J02077X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J02077X/1] Funding Source: researchfish	Swedish Research Council (VR)(Swedish Research Council); Swedish Governmental Agency for Innovation Systems (VINNOVA)(Vinnova); Rontgen-Angstrom Cluster through the project grant MATsynCELL; Knut and Alice Wallenberg Foundation through the project grant 3DEM-NATUR; NCRI; BK 21-plus programmes through the National Research Foundation of Korea; UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge financial support from the Swedish Research Council (VR), the Swedish Governmental Agency for Innovation Systems (VINNOVA), the Rontgen-Angstrom Cluster through the project grant MATsynCELL, the Knut and Alice Wallenberg Foundation through the project grant 3DEM-NATUR, the NCRI (2012R1A3A-2048833) and BK 21-plus programmes through the National Research Foundation of Korea, and the UK EPSRC (EP/J02077X/1). We acknowledge the ESRF, Grenoble (ID31, A. N. Fitch; ID22, C. Drathen) and the PAL, Pohang (9B, D. Ahn) for synchrotron X-ray beam time. We thank L. B. McCusker and C. Baerlocher for suggestions about the Rietveld refinement. The TEM was financed by the Knut and Alice Wallenberg Foundation.	Baerlocher C. H, 2007, DATABASE ZEOLITE STR; Baerlocher C, 2008, NAT MATER, V7, P631, DOI 10.1038/nmat2228; Baerlocher C, 2007, SCIENCE, V315, P1113, DOI 10.1126/science.1137920; Blatov VA, 2010, GLASS PHYS CHEM+, V36, P663, DOI 10.1134/S1087659610060040; CHATELAIN T, 1995, MICROPOROUS MATER, V4, P231, DOI 10.1016/0927-6513(95)00009-X; Coe C. G., 1990, U.S. Patent, Patent No. [4,925,460, 4925460]; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Deem M. W., 2011, DEEM DATABASE; Deng HX, 2012, SCIENCE, V336, P1018, DOI 10.1126/science.1220131; Doherty H. G., 1981, U. S. Patent, Patent No. [4247416, 4,247 416]; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Ferey G, 2000, J SOLID STATE CHEM, V152, P37, DOI 10.1006/jssc.2000.8667; Foster M. D., 2010, ATLAS PROSPECTIVE ZE; GORDON EK, 1966, SCIENCE, V154, P1004, DOI 10.1126/science.154.3752.1004; Gramm F, 2006, NATURE, V444, P79, DOI 10.1038/nature05200; HENSON NJ, 1994, CHEM MATER, V6, P1647, DOI 10.1021/cm00046a015; Hong S. B., 2001, STUD SURF SCI CATAL, V135, P186; Hua W, 2014, ANGEW CHEM INT EDIT, V53, P5868, DOI 10.1002/anie.201309766; KARLE J, 1966, ACTA CRYSTALLOGR, V21, P849, DOI 10.1107/S0365110X66004079; Larson A. C., 2004, 86748 LAUR LOS ALM N; LE BAIL A, 1988, MATER RES BULL, V23, P447, DOI 10.1016/0025-5408(88)90019-0; Lin HY, 2013, SCIENCE, V339, P811, DOI 10.1126/science.1232097; Lozinska MM, 2014, CHEM MATER, V26, P2052, DOI 10.1021/cm404028f; Martinez-Franco R, 2013, P NATL ACAD SCI USA, V110, P3749, DOI 10.1073/pnas.1220733110; Palatinus L, 2007, J APPL CRYSTALLOGR, V40, P786, DOI 10.1107/S0021889807029238; Palatinus L, 2012, J APPL CRYSTALLOGR, V45, P575, DOI 10.1107/S0021889812016068; Rochelle GT, 2009, SCIENCE, V325, P1652, DOI 10.1126/science.1176731; Shang J, 2012, J AM CHEM SOC, V134, P19246, DOI 10.1021/ja309274y; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Totktarev A., 1999, P 12 INT ZEOL C, V1; Vaughan DEW, 1999, MICROPOR MESOPOR MAT, V28, P233, DOI 10.1016/S1387-1811(98)00240-6; Wan W, 2013, J APPL CRYSTALLOGR, V46, P1863, DOI 10.1107/S0021889813027714; Wang ZP, 2012, CHEM SOC REV, V41, P1729, DOI 10.1039/c1cs15150a; Willhammar T, 2014, ADV FUNCT MATER, V24, P182, DOI 10.1002/adfm.201301949; Willhammar T, 2012, NAT CHEM, V4, P188, DOI [10.1038/nchem.1253, 10.1038/NCHEM.1253]; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Young R.A., 1995, RIETVELD METHOD; Zhang DL, 2010, Z KRIST-CRYST MATER, V225, P94, DOI 10.1524/zkri.2010.1202; Zhang H, 2006, PHILOS MAG, V86, P543, DOI 10.1080/14786430500279658; Zou X. D., 2011, ELECTRON CRYSTALLOGR; Zou XD, 2005, NATURE, V437, P716, DOI 10.1038/nature04097	41	122	123	26	399	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					74	U143		10.1038/nature14575	http://dx.doi.org/10.1038/nature14575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26176918	Green Submitted, Green Accepted			2022-12-28	WOS:000359002300034
J	Hu, LT; Tsibris, AM; Branda, JA				Hu, Linden T.; Tsibris, Athe M.; Branda, John A.			Case 24-2015: A 28-Year-Old Pregnant Woman with Fever, Chills, Headache, and Fatigue	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS; BORRELIA-MIYAMOTOI INFECTION; NORTHEASTERN UNITED-STATES; CONFIRMED ERYTHEMA MIGRANS; LYME BORRELIOSIS; RELAPSING FEVER; SENSU-LATO; DISEASE; PCR; BURGDORFERI		[Hu, Linden T.] Tufts Med Ctr, Dept Geog Med & Infect Dis, Boston, MA 02111 USA; [Tsibris, Athe M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Tsibris, Athe M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Tufts Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Hu, LT (corresponding author), Tufts Med Ctr, Dept Geog Med & Infect Dis, Boston, MA 02111 USA.		Branda, John/ABD-5620-2020; Hu, Linden/L-6314-2016	Hu, Linden/0000-0003-1659-5558	Abzyme; FoodSource Lure; DynaMed/EBSCO; AdvanDx; bioMerieux; Immunetics; Alere; DiaSorin	Abzyme; FoodSource Lure; DynaMed/EBSCO; AdvanDx; bioMerieux; Immunetics; Alere; DiaSorin	Dr. Hu reports receiving consulting fees from Abzyme and grant support to his institution from FoodSource Lure; Dr. Tsibris, consulting and editing fees from DynaMed/EBSCO; and Dr. Branda, consulting fees from AdvanDx and grant support to his institution from bioMerieux, Immunetics, Alere, and DiaSorin. No other potential conflict of interest relevant to this article was reported.	Bakken JS, 2008, INFECT DIS CLIN N AM, V22, P433, DOI 10.1016/j.idc.2008.03.011; Chowdri HR, 2013, ANN INTERN MED, V159, P21, DOI 10.7326/0003-4819-159-1-201307020-00005; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Krause PJ, 2014, EMERG INFECT DIS, V20, P1183, DOI 10.3201/eid2007.131587; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Krause PJ, 1996, J CLIN MICROBIOL, V34, P2791, DOI 10.1128/JCM.34.11.2791-2794.1996; Masters EJ, 2008, INFECT DIS CLIN N AM, V22, P361, DOI 10.1016/j.idc.2007.12.010; Molloy PJ, 2015, ANN INTERN MED, V163, P91, DOI 10.7326/M15-0333; Nadelman RB, 1996, AM J MED, V100, P502, DOI 10.1016/S0002-9343(95)99915-9; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Sato K, 2014, EMERG INFECT DIS, V20, P1391, DOI 10.3201/eid2008.131761; Schutzer SE, 2013, EMERG INFECT DIS, V19, P815, DOI 10.3201/eid1905.120796; Schwan TG, 1996, J CLIN MICROBIOL, V34, P2483, DOI 10.1128/JCM.34.10.2483-2492.1996; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Ullmann AJ, 2005, J MED ENTOMOL, V42, P1057, DOI 10.1603/0022-2585(2005)042[1057:TMAFDO]2.0.CO;2; Wormser GP, 2005, CLIN INFECT DIS, V41, P958, DOI 10.1086/432935	18	4	4	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2015	373	5					468	475		10.1056/NEJMcpc1501763	http://dx.doi.org/10.1056/NEJMcpc1501763			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8BO	26222563				2022-12-28	WOS:000358662200012
J	Kole, A; Chandakole, D				Kole, Alakes; Chandakole, Dalia			Strawberry Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kole, Alakes] ID & BG Hosp, Kolkata, India; [Chandakole, Dalia] BP Poddar Hosp & Res Inst, Kolkata, India		Kole, A (corresponding author), ID & BG Hosp, Kolkata, India.	dralakeskole72@gmail.com							0	1	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2015	373	5					467	467		10.1056/NEJMicm1411222	http://dx.doi.org/10.1056/NEJMicm1411222			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8BO	26222562				2022-12-28	WOS:000358662200010
J	Li, Q; Chen, L; Gadinski, MR; Zhang, SH; Zhang, GZ; Li, HY; Haque, A; Chen, LQ; Jackson, TN; Wang, Q				Li, Qi; Chen, Lei; Gadinski, Matthew R.; Zhang, Shihai; Zhang, Guangzu; Li, Haoyu; Haque, Aman; Chen, Long-Qing; Jackson, Thomas N.; Wang, Qing			Flexible high-temperature dielectric materials from polymer nanocomposites	NATURE			English	Article							ENERGY-STORAGE; ELECTRONICS; CAPACITORS; CERAMICS; DENSITY; FILMS	Dielectric materials, which store energy electrostatically, are ubiquitous in advanced electronics and electric power systems(1-8). Compared to their ceramic counterparts, polymer dielectrics have higher breakdown strengths and greater reliability(1-3,9), are scalable, lightweight and can be shaped into intricate configurations, and are therefore an ideal choice for many power electronics, power conditioning, and pulsed power applications(1,9,10). However, polymer dielectrics are limited to relatively low working temperatures, and thus fail to meet the rising demand for electricity under the extreme conditions present in applications such as hybrid and electric vehicles, aerospace power electronics, and underground oil and gas exploration(11-13). Here we describe crosslinked polymer nanocomposites that contain boron nitride nanosheets, the dielectric properties of which are stable over a broad temperature and frequency range. The nanocomposites have outstanding high-voltage capacitive energy storage capabilities at record temperatures (a Weibull breakdown strength of 403 megavolts per metre and a discharged energy density of 1.8 joules per cubic centimetre at 250 degrees Celsius). Their electrical conduction is several orders of magnitude lower than that of existing polymers and their high operating temperatures are attributed to greatly improved thermal conductivity, owing to the presence of the boron nitride nanosheets, which improve heat dissipation compared to pristine polymers (which are inherently susceptible to thermal runaway). Moreover, the polymer nanocomposites are lightweight, photopatternable and mechanically flexible, and have been demonstrated to preserve excellent dielectric and capacitive performance after intensive bending cycles. These findings enable broader applications of organic materials in high-temperature electronics and energy storage devices.	[Li, Qi; Chen, Lei; Gadinski, Matthew R.; Zhang, Guangzu; Chen, Long-Qing; Wang, Qing] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Zhang, Shihai] PolyK Technol, State Coll, PA 16802 USA; [Li, Haoyu; Jackson, Thomas N.] Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA; [Haque, Aman] Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wang, Q (corresponding author), Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.	wang@matse.psu.edu	LI, QI/ABA-7025-2020; Chen, LongQing/I-7536-2012	Chen, LongQing/0000-0003-3359-3781; Wang, Qing/0000-0002-5968-3235; Li, Qi/0000-0002-8282-4884	US Office of Naval Research [N00014-11-1-0342]; Air Force Office of Scientific Research [FA9550-14-1-0264]; Dow Chemical Corporation	US Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Dow Chemical Corporation	Q.W. acknowledges financial support from the US Office of Naval Research under grant number N00014-11-1-0342. L.-Q.C. is supported by the Air Force Office of Scientific Research under grant number FA9550-14-1-0264. H.L. and T.J. acknowledge support from the Dow Chemical Corporation.	Bell AJ, 2008, J EUR CERAM SOC, V28, P1307, DOI 10.1016/j.jeurceramsoc.2007.12.014; Chu BJ, 2006, SCIENCE, V313, P334, DOI 10.1126/science.1127798; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Dang ZM, 2013, ADV MATER, V25, P6334, DOI 10.1002/adma.201301752; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Ho J., 2012, POW MOD HIGH VOLT C; Ho J, 2010, IEEE ELECTR INSUL M, V26, P20, DOI 10.1109/MEI.2010.5383924; IEDA M, 1980, IEEE T ELECTR INSUL, V15, P206, DOI 10.1109/TEI.1980.298314; Irvine J. T. S., 1990, Advanced Materials, V2, P132, DOI 10.1002/adma.19900020304; Johnson RW, 2004, IEEE T ELECTRON PACK, V27, P164, DOI 10.1109/TEPM.2004.843109; Li Q, 2015, ENERG ENVIRON SCI, V8, P922, DOI 10.1039/c4ee02962c; Mark J. E., 1996, PHYS PROPERTIES POLY; Montanari D., 2009, P CARTS US, P23; O'Dwyer J. J., 1973, THEORY ELECT CONDUCT; Ogihara H, 2009, J AM CERAM SOC, V92, P1719, DOI 10.1111/j.1551-2916.2009.03104.x; Pan JL, 2010, ACS APPL MATER INTER, V2, P1286, DOI 10.1021/am100146u; Qin S, 2011, IEEE ELECTR INSUL M, V27, P7, DOI 10.1109/MEI.2011.5699442; Rabuffi M, 2002, IEEE T PLASMA SCI, V30, P1939, DOI 10.1109/TPS.2002.805318; Reaney IM, 2006, J AM CERAM SOC, V89, P2063, DOI 10.1111/j.1551-2916.2006.01025.x; Sarjeant WJ, 1998, IEEE T PLASMA SCI, V26, P1368, DOI 10.1109/27.736020; Sarjeant WJ, 2001, P IEEE, V89, P846, DOI 10.1109/5.931475; Sevik C, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085409; Tan D, 2014, J ELECTRON MATER, V43, P4569, DOI 10.1007/s11664-014-3440-7; Tan Q., 2006, IEEJ T FM, V126, P1152; Venkat N, 2010, MATER SCI ENG B-ADV, V168, P16, DOI 10.1016/j.mseb.2009.12.038; Wang DH, 2015, J POLYM SCI POL CHEM, V53, P422, DOI 10.1002/pola.27445; Watson J., 2012, ANALOG DIALOG, V46-4, P1; Weimer J. A., 1993, P AIAA IEEE DIG AV S; Xiong B, 2011, J AM CERAM SOC, V94, P3412, DOI 10.1111/j.1551-2916.2011.04519.x; Zebouchi N, 1996, J APPL PHYS, V79, P2497, DOI 10.1063/1.361178	30	1094	1124	103	1581	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					576	+		10.1038/nature14647	http://dx.doi.org/10.1038/nature14647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26223625				2022-12-28	WOS:000358655200041
J	Gostin, LO; DeBartolo, MC; Hougendobler, DA				Gostin, Lawrence O.; DeBartolo, Mary C.; Hougendobler, Daniel A.			King v Burwell Subsidizing US Health Insurance for Low- and Middle-Income Individuals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [DeBartolo, Mary C.; Hougendobler, Daniel A.] ONeill Inst Natl & Global Hlth Law, Washington, DC USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Cohen RA, 2014, HLTH INSURANCE COVER; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Garfield, COVERAGE GAP UNINSUR; Karlamangla S, 35 CALIFORNIA COUNTI; US Department of Health and Human Services, EC IMP MED EXP; Wallace SP, UNDOCUMENTED UNINSUR; Zuckerman S, 2011, HEALTH AFFAIR, V30, P1997, DOI 10.1377/hlthaff.2011.0604	7	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					333	334		10.1001/jama.2015.8673	http://dx.doi.org/10.1001/jama.2015.8673			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN6YY	26158803				2022-12-28	WOS:000358581700006
J	Green, A				Green, Andrew			McLeod Ernest Chitiyo Obituary	LANCET			English	Biographical-Item												theandrewgreen@gmail.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					242	242		10.1016/S0140-6736(15)61272-7	http://dx.doi.org/10.1016/S0140-6736(15)61272-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN1XI	26194518				2022-12-28	WOS:000358213700019
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			CLINICAL TRIALS Researchers seek clear reasons when clinical trials end early	SCIENCE			English	News Item																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		222	222		10.1126/science.349.6245.222	http://dx.doi.org/10.1126/science.349.6245.222			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185222				2022-12-28	WOS:000358218600013
J	Park, J; Elmlund, H; Ercius, P; Yuk, JM; Limmer, DT; Chen, Q; Kim, K; Han, SH; Weitz, DA; Zettl, A; Alivisatos, AP				Park, Jungwon; Elmlund, Hans; Ercius, Peter; Yuk, Jong Min; Limmer, David T.; Chen, Qian; Kim, Kwanpyo; Han, Sang Hoon; Weitz, David A.; Zettl, A.; Alivisatos, A. Paul			3D structure of individual nanocrystals in solution by electron microscopy	SCIENCE			English	Article							GOLD NANOPARTICLES; ATOMIC-RESOLUTION; GROWTH; TOMOGRAPHY; CELL; CONTRAST	Knowledge about the synthesis, growth mechanisms, and physical properties of colloidal nanoparticles has been limited by technical impediments. We introduce a method for determining three-dimensional (3D) structures of individual nanoparticles in solution. We combine a graphene liquid cell, high-resolution transmission electron microscopy, a direct electron detector, and an algorithm for single-particle 3D reconstruction originally developed for analysis of biological molecules. This method yielded two 3D structures of individual platinum nanocrystals at near-atomic resolution. Because our method derives the 3D structure from images of individual nanoparticles rotating freely in solution, it enables the analysis of heterogeneous populations of potentially unordered nanoparticles that are synthesized in solution, thereby providing a means to understand the structure and stability of defects at the nanoscale.	[Park, Jungwon; Chen, Qian; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Park, Jungwon; Weitz, David A.] Harvard Univ, Dept Appl Phys, Cambridge, MA 02138 USA; [Park, Jungwon; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Elmlund, Hans] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Elmlund, Hans] ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Ercius, Peter] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Yuk, Jong Min; Zettl, A.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Yuk, Jong Min; Chen, Qian; Zettl, A.; Alivisatos, A. Paul] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Yuk, Jong Min; Zettl, A.; Alivisatos, A. Paul] Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Limmer, David T.] Princeton Univ, Princeton Ctr Theoret Sci, Princeton, NJ 08540 USA; [Chen, Qian] Univ Calif Berkeley, Miller Inst Basic Res Sci, Berkeley, CA 93720 USA; [Kim, Kwanpyo] Ulsan Natl Inst Sci & Technol, Dept Phys, Ulsan 689798, South Korea; [Han, Sang Hoon] Amore Pacific Co, R&D Ctr, Yongin 446829, South Korea	University of California System; University of California Berkeley; Harvard University; Harvard University; Monash University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Princeton University; University of California System; University of California Berkeley; Ulsan National Institute of Science & Technology (UNIST); Samsung	Alivisatos, AP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	alivis@berkeley.edu	Zettl, Alex K/O-4925-2016; Kim, Kwanpyo/D-9121-2011; Park, Jungwon/O-1153-2016; Ercius, Peter/AAN-2870-2020; Yuk, Jong Min/I-8770-2016; Alivisatos, Paul/N-8863-2015; ELMLUND, HANS/AAA-6625-2021	Zettl, Alex K/0000-0001-6330-136X; Kim, Kwanpyo/0000-0001-8497-2330; Park, Jungwon/0000-0003-2927-4331; Ercius, Peter/0000-0002-6762-9976; Yuk, Jong Min/0000-0002-4677-7363; Alivisatos, Paul/0000-0001-6895-9048; Chen, Qian/0000-0002-1968-441X; Elmlund, Hans/0000-0002-6992-0601	Physical Chemistry of Inorganic Nanostructures Program [KC3103]; Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; NSF [DMR-1310266, DMR-1206512]; Harvard Materials Research Science and Engineering Center [DMR-1420570]; Amore Pacific; Multimodal Australian Sciences Imaging and Visualization Environment; Monash University; DOE Office of Energy Research, Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-05CH11231]; Molecular Foundry; Office of Naval Research [N00014-12-1]; Defense Threat Reduction Agency [HDTRA1-13-1-0035]; Princeton Center for Theoretical Science; Miller Institute for Basic Research in Science at UC Berkeley; National Research Foundation of Korea - Ministry of Education [NRF-2014R1A1A2058178]; DOE [DE-AC02-05CH11231]; Direct For Mathematical & Physical Scien [1310266] Funding Source: National Science Foundation	Physical Chemistry of Inorganic Nanostructures Program; Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Harvard Materials Research Science and Engineering Center(National Science Foundation (NSF)); Amore Pacific; Multimodal Australian Sciences Imaging and Visualization Environment; Monash University(Monash University); DOE Office of Energy Research, Basic Energy Sciences, Materials Sciences and Engineering Division; Molecular Foundry; Office of Naval Research(Office of Naval Research); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Princeton Center for Theoretical Science; Miller Institute for Basic Research in Science at UC Berkeley; National Research Foundation of Korea - Ministry of Education; DOE(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by the Physical Chemistry of Inorganic Nanostructures Program (KC3103), Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy (DOE) under contract DE-AC02-05CH11231 (J.P. and A.P.A.); NSF grant DMR-1310266, Harvard Materials Research Science and Engineering Center grant DMR-1420570, and Amore Pacific (J.P., S.H.H., and D.A.W.); the Multimodal Australian Sciences Imaging and Visualization Environment (www.massive.org.au) and funds from Monash University (H.E.); the DOE Office of Energy Research, Basic Energy Sciences, Materials Sciences and Engineering Division under contract DE-AC02-05CH11231 within the SP2-Bonded Materials Program and the Molecular Foundry (construction of GLC and TEM characterization), Office of Naval Research grant N00014-12-1 (graphene growth), NSF grant DMR-1206512 (graphene transfer methods development), and postdoctoral support from Defense Threat Reduction Agency grant HDTRA1-13-1-0035 (J.M.Y., K.K., and A.Z.); the Princeton Center for Theoretical Science (D.T.L.); a Miller fellowship from Miller Institute for Basic Research in Science at UC Berkeley (Q.C.); and the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education grant NRF-2014R1A1A2058178 (K.K.). Electron microscopy was performed at the Molecular Foundry supported by DOE contract DE-AC02-05CH11231.	Azubel M, 2014, SCIENCE, V345, P909, DOI 10.1126/science.1251959; Battaglia M, 2009, NUCL INSTRUM METH A, V598, P642, DOI 10.1016/j.nima.2008.09.029; BRACEWELL R. N., 1956, AUST J PHYS, V9, P198, DOI 10.1071/PH560198; Chen CC, 2013, NATURE, V496, P74, DOI 10.1038/nature12009; Chen Q, 2013, NANO LETT, V13, P4556, DOI 10.1021/nl402694n; Cheng YF, 2009, ANNU REV BIOCHEM, V78, P723, DOI 10.1146/annurev.biochem.78.070507.140543; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; FRENKEL D, 1984, J CHEM PHYS, V81, P3188, DOI 10.1063/1.448024; Goris B, 2012, NAT MATER, V11, P930, DOI [10.1038/NMAT3462, 10.1038/nmat3462]; Leis A, 2009, TRENDS BIOCHEM SCI, V34, P60, DOI 10.1016/j.tibs.2008.10.011; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406; Mocatta D, 2011, SCIENCE, V332, P77, DOI 10.1126/science.1196321; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; Polte J, 2012, ACS NANO, V6, P5791, DOI 10.1021/nn301724z; Polte J, 2010, ACS NANO, V4, P1076, DOI 10.1021/nn901499c; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Sheng HW, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134118; Takesue M, 2011, J AM CHEM SOC, V133, P14164, DOI 10.1021/ja202815y; Van Aert S, 2011, NATURE, V470, P374, DOI 10.1038/nature09741; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Zhang HJ, 2012, NAT MATER, V11, P49, DOI [10.1038/NMAT3143, 10.1038/nmat3143]; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104; Zhu C, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.100201	28	184	187	2	327	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		290	295		10.1126/science.aab1343	http://dx.doi.org/10.1126/science.aab1343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185247	Green Published, Green Submitted			2022-12-28	WOS:000358218600047
J	Machado, TA; Pnevmatikakis, E; Paninski, L; Jessell, TM; Miri, A				Machado, Timothy A.; Pnevmatikakis, Eftychios; Paninski, Liam; Jessell, Thomas M.; Miri, Andrew			Primacy of Flexor Locomotor Pattern Revealed by Ancestral Reversion of Motor Neuron Identity	CELL			English	Article							FICTIVE LOCOMOTION; HINDLIMB MUSCLES; HB9 INTERNEURONS; SPINAL-CORD; MOUSE; ORGANIZATION; NETWORKS; ACTIVATION; RHYTHM; IDENTIFICATION	Spinal circuits can generate locomotor output in the absence of sensory or descending input, but the principles of locomotor circuit organization remain unclear. We sought insight into these principles by considering the elaboration of locomotor circuits across evolution. The identity of limb-innervating motor neurons was reverted to a state resembling that of motor neurons that direct undulatory swimming in primitive aquatic vertebrates, permitting assessment of the role of motor neuron identity in determining locomotor pattern. Two-photon imaging was coupled with spike inference to measure locomotor firing in hundreds of motor neurons in isolated mouse spinal cords. In wild-type preparations, we observed sequential recruitment of motor neurons innervating flexor muscles controlling progressively more distal joints. Strikingly, after reversion of motor neuron identity, virtually all firing patterns became distinctly flexor like. Our findings show that motor neuron identity directs locomotor circuit wiring and indicate the evolutionary primacy of flexor pattern generation.	[Machado, Timothy A.; Jessell, Thomas M.; Miri, Andrew] Columbia Univ, Kavli Inst Brain Sci, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA; [Machado, Timothy A.; Jessell, Thomas M.; Miri, Andrew] Columbia Univ, Kavli Inst Brain Sci, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Machado, Timothy A.; Pnevmatikakis, Eftychios; Paninski, Liam] Columbia Univ, Ctr Theoret Neurosci, Dept Stat, New York, NY 10027 USA; [Machado, Timothy A.; Pnevmatikakis, Eftychios; Paninski, Liam] Columbia Univ, Grossman Ctr Stat Mind, New York, NY 10027 USA; [Pnevmatikakis, Eftychios] Simons Fdn, Simons Ctr Data Anal, New York, NY 10010 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Machado, TA (corresponding author), Columbia Univ, Kavli Inst Brain Sci, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA.	tam2138@columbia.edu; tmj1@columbia.edu		Machado, Tim/0000-0003-3762-1460; Pnevmatikakis, Eftychios/0000-0003-1509-6394	NSF Graduate Research Fellowship Program; DARPA [W91NF-14-1-0269]; ARO [MURI W911NF-12-1-0594]; NSF [IOS-0641912]; Simons Foundation Global Brain Research Award [325398]; NIH grant [NS033245]; Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080932, R37NS033245, R01NS033245] Funding Source: NIH RePORTER	NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ARO; NSF(National Science Foundation (NSF)); Simons Foundation Global Brain Research Award; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to D. Wu for assistance with mouse genotyping; M. Mendelsohn and N. Zabello for animal care; H. Tucker for the conditional FoxP1 strain; Y. Ivanenko for advice about analysis; and B. Han, K. MacArthur, S. Morton, and I. Schieren for technical assistance. We thank G.Z. Mentis for the custom-built recording stage used in the electrophysiology experiments and for advice about experimental approaches. We are grateful to R. Axel, E. Azim, J. Bikoff, R. Brownstone, S. Druckmann, A. Fink, A. Karpova, A. Murray, and J. de Nooij for helpful comments on the work and manuscript. T.A.M. was supported by the NSF Graduate Research Fellowship Program. L.P. was supported by DARPA W91NF-14-1-0269, ARO MURI W911NF-12-1-0594, NSF CAREER award IOS-0641912, and Simons Foundation Global Brain Research Award 325398. T.M.J. was supported by NIH grant NS033245, the Harold and Leila Y. Mathers Foundation, and Project A.L.S. and is an investigator of the Howard Hughes Medical Institute. A. M. is a Howard Hughes Medical Institute Fellow of the Helen Hay Whitney Foundation.	Akay T, 2014, P NATL ACAD SCI USA, V111, P16877, DOI 10.1073/pnas.1419045111; Alvarez FJ, 2007, J PHYSIOL-LONDON, V584, P31, DOI 10.1113/jphysiol.2007.136200; Beliez L, 2015, J NEUROSCI, V35, P6117, DOI 10.1523/JNEUROSCI.4145-14.2015; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bonnot AS, 2005, J NEUROPHYSIOL, V93, P1793, DOI 10.1152/jn.00923.2004; Bonnot AS, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0001.2002; Brown TG, 1914, J PHYSIOL-LONDON, V48, P18; Brownstone RM, 2008, BRAIN RES REV, V57, P64, DOI 10.1016/j.brainresrev.2007.06.025; Burke RE, 2001, J NEUROPHYSIOL, V86, P447, DOI 10.1152/jn.2001.86.1.447; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; Duysens J, 2006, J NEUROPHYSIOL, V95, P562, DOI 10.1152/jn.00888.2005; DUYSENS J, 1977, J NEUROPHYSIOL, V40, P737, DOI 10.1152/jn.1977.40.4.737; Falgairolle M, 2007, J PHYSIOL-LONDON, V580, P87, DOI 10.1113/jphysiol.2006.115709; Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Grillner S, 2002, BRAIN RES REV, V40, P92, DOI 10.1016/S0165-0173(02)00193-5; GRILLNER S, 1975, BRAIN RES, V88, P367, DOI 10.1016/0006-8993(75)90401-1; HELMCHEN F, 2005, IMAGING NEUROSCIENCE, P265; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Krouchev N, 2006, J NEUROPHYSIOL, V96, P1991, DOI 10.1152/jn.00241.2006; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; Kusakabe R, 2005, DEV DYNAM, V234, P824, DOI 10.1002/dvdy.20587; Kwan AC, 2009, J NEUROSCI, V29, P11601, DOI 10.1523/JNEUROSCI.1612-09.2009; Lam T, 2001, J NEUROPHYSIOL, V86, P1321, DOI 10.1152/jn.2001.86.3.1321; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; LOEB GE, 1985, J EXP BIOL, V115, P137; Lowell B. B., 2006, DEV PHENOTYPE CHAT I; Machacek DW, 2006, J NEUROSCI, V26, P5920, DOI 10.1523/JNEUROSCI.4623-05.2006; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; O'Donovan MJ, 2008, DEV NEUROBIOL, V68, P788, DOI 10.1002/dneu.20620; O'Donovan MJ, 2010, ANN NY ACAD SCI, V1198, P63, DOI 10.1111/j.1749-6632.2010.05535.x; Pearson KG, 1976, NEURAL CONTROL LOCOM, P519, DOI DOI 10.1007/978-1-4757-0964-3_21; PERRET C, 1980, BRAIN RES, V187, P333, DOI 10.1016/0006-8993(80)90207-3; Platzer W, 2004, COLOR ATLAS HUMAN AN, V1; Pnevmatikakis EA, 2014, ARXIV14092903; Rossignol S, 2011, EXERCISE REGULATION, P173, DOI [10.1002/cphy.cp120105, DOI 10.1002/CPHY.CP120105]; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Talpalar AE, 2011, NEURON, V71, P1071, DOI 10.1016/j.neuron.2011.07.011; Vanderhorst VGJM, 1997, J COMP NEUROL, V382, P46; Yakovenko S, 2002, J NEUROPHYSIOL, V87, P1542, DOI 10.1152/jn.00479.2001; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhang JM, 2014, NEURON, V82, P138, DOI 10.1016/j.neuron.2014.02.013; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhong GS, 2012, J PHYSIOL-LONDON, V590, P4735, DOI 10.1113/jphysiol.2012.240895	51	42	44	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					338	350		10.1016/j.cell.2015.06.036	http://dx.doi.org/10.1016/j.cell.2015.06.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186188	Green Accepted, Bronze			2022-12-28	WOS:000358087700014
J	Snow, R				Snow, Rosamund			Psychiatric assessments: how much is too much?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rsnow@bmj.com							0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2015	351								h3503	10.1136/bmj.h3503	http://dx.doi.org/10.1136/bmj.h3503			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN3CV	26186009	Bronze			2022-12-28	WOS:000358302400001
J	Steinhorn, BS; Loscalzo, J; Michel, T				Steinhorn, Benjamin S.; Loscalzo, Joseph; Michel, Thomas			Nitroglycerin and Nitric Oxide - A Rondo of Themes in Cardiovascular Therapeutics	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIOACTIVATION		[Steinhorn, Benjamin S.; Loscalzo, Joseph; Michel, Thomas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	thomas_michel@hms.harvard.edu	Loscalzo, Joseph/ABD-8980-2021		NCRR NIH HHS [P41 RR010888] Funding Source: Medline; NHLBI NIH HHS [P01 HL048743] Funding Source: Medline; NIGMS NIH HHS [T32 GM008313, T32 GM007753] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM008313] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALLIGAND JL, 1995, J BIOL CHEM, V270, P14582, DOI 10.1074/jbc.270.24.14582; Chen ZQ, 2006, TRENDS CARDIOVAS MED, V16, P259, DOI 10.1016/j.tcm.2006.05.001; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Ichinose F, 2004, CIRCULATION, V109, P3106, DOI 10.1161/01.CIR.0000134595.80170.62; Kim-Shapiro DB, 2014, NITRIC OXIDE-BIOL CH, V38, P58, DOI 10.1016/j.niox.2013.11.002; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Murrell W, 1879, LANCET, P151; Murrell W., 1879, LANCET, V80, P225; Murrell W, 1879, LANCET, V1, P113; Murrell W, 1879, LANCET, V113, P80, DOI [10.1016/S0140-6736(02)46032-1, DOI 10.1016/S0140-6736(02)46032-1]; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928	14	22	25	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3					277	280		10.1056/NEJMsr1503311	http://dx.doi.org/10.1056/NEJMsr1503311			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MS	26176386	Green Accepted			2022-12-28	WOS:000357956200014
J	Wedding, LM; Reiter, SM; Smith, CR; Gjerde, KM; Kittinger, JN; Friedlander, AM; Gaines, SD; Clark, MR; Thurnherr, AM; Hardy, SM; Crowder, LB				Wedding, L. M.; Reiter, S. M.; Smith, C. R.; Gjerde, K. M.; Kittinger, J. N.; Friedlander, A. M.; Gaines, S. D.; Clark, M. R.; Thurnherr, A. M.; Hardy, S. M.; Crowder, L. B.			Managing mining of the deep seabed	SCIENCE			English	Editorial Material							MANAGEMENT; ECOSYSTEM		[Wedding, L. M.; Reiter, S. M.; Kittinger, J. N.; Crowder, L. B.] Stanford Univ, Ctr Ocean Solut, Palo Alto, CA 94304 USA; [Reiter, S. M.] Monterey Bay Aquarium, Monterey, CA USA; [Smith, C. R.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Gjerde, K. M.] Middlebury Inst Int Studies, Monterey, CA USA; [Gjerde, K. M.] Wycliffe Management, Warsaw, Poland; [Kittinger, J. N.] Conservat Int, Honolulu, HI USA; [Friedlander, A. M.] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Friedlander, A. M.] Univ Hawaii Manoa, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Gaines, S. D.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Clark, M. R.] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Thurnherr, A. M.] Columbia Univ, Lamont Doherty Earth Observ, New York, NY USA; [Hardy, S. M.] Univ Alaska, Sch Fisheries & Ocean Sci, Fairbanks, AK 99701 USA	Stanford University; Monterey Bay Aquarium Research Institute; University of Hawaii System; University of Hawaii Manoa; Conservation International; National Geographic Society; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California Santa Barbara; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Columbia University; University of Alaska System; University of Alaska Fairbanks	Smith, CR (corresponding author), Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA.	craigsmi@hawaii.edu	Wedding, Lisa/GRY-3972-2022; Gaines, Steven/Y-3234-2019	Wedding, Lisa/0000-0002-3782-915X; Mincks, Sarah/0000-0002-3328-712X; Thurnherr, Andreas/0000-0002-1977-7122				[Anonymous], 2012, 18C22 ISBA; Beaudoin Y, 2014, ENVIRON DEV, V12, P50, DOI 10.1016/j.envdev.2014.07.001; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Grorud-Colvert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102298; Halfar J, 2002, MAR POLICY, V26, P103, DOI 10.1016/S0308-597X(01)00041-0; Levy j. P., 2014, INT SEABED AUTHORITY; Lodge M, 2014, MAR POLICY, V49, P66, DOI 10.1016/j.marpol.2014.04.006; Mengerink KJ, 2014, SCIENCE, V344, P696, DOI 10.1126/science.1251458; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Smith C. R., 2008, AQUATIC ECOSYSTEMS T; Thurber AR, 2014, BIOGEOSCIENCES, V11, P3941, DOI 10.5194/bg-11-3941-2014; Wedding LM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1684; WOLFRUM R, 2009, M PLANCK ENCY PUBLIC	13	141	143	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					144	145		10.1126/science.aac6647	http://dx.doi.org/10.1126/science.aac6647			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4OM	26160934	Green Submitted			2022-12-28	WOS:000357664300025
J	Watts, G				Watts, Geoff			Judith Rodin: on the path to resilience in planetary health	LANCET			English	Biographical-Item																			0	0	0	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					1936	1936		10.1016/S0140-6736(15)61214-4	http://dx.doi.org/10.1016/S0140-6736(15)61214-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PI	26188751				2022-12-28	WOS:000364763200016
J	Yang, YT; Barraza, L; Weidenaar, K				Yang, Y. Tony; Barraza, Leila; Weidenaar, Kim			Measles Outbreak as a Catalyst for Stricter Vaccine Exemption Legislation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Yang, Y. Tony] George Mason Univ, Dept Hlth Adm & Policy, Fairfax, VA 22030 USA; [Barraza, Leila] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Div Community Environm & Policy, Tucson, AZ USA; [Weidenaar, Kim] Arizona State Univ, Sandra Day OConnor Coll Law, Tempe, AZ USA	George Mason University; University of Arizona; Arizona State University; Arizona State University-Tempe	Yang, YT (corresponding author), George Mason Univ, Dept Hlth Adm & Policy, Mail Stop 1J3,4400 Univ Dr, Fairfax, VA 22030 USA.	ytyang@gmu.edu		Barraza, Leila/0000-0001-5336-6901				California Department of Public Health IB, IMM LEV CHILD CAR SC; Gostin LO, 2015, JAMA-J AM MED ASSOC, V313, P1099, DOI 10.1001/jama.2015.1518; Omer SB, 2014, JAMA-J AM MED ASSOC, V311, P620, DOI 10.1001/jama.2013.282869; Pew Research Center, 2015, 83 SAY MEASL VACC IS; Seither R, 2014, MMWR-MORBID MORTAL W, V63, P913; Zipprich J, 2015, MMWR-MORBID MORTAL W, V64, P153	6	18	18	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2015	314	12					1229	1230		10.1001/jama.2015.9579	http://dx.doi.org/10.1001/jama.2015.9579			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS5IE	26214397				2022-12-28	WOS:000362110700007
J	Perera, R; Stoykova, S; Nicolay, BN; Ross, KN; Fitamant, J; Boukhali, M; Lengrand, J; Deshpande, V; Selig, MK; Ferrone, CR; Settleman, J; Stephanopoulos, G; Dyson, NJ; Zoncu, R; Ramaswamy, S; Haas, W; Bardeesy, N				Perera, RushikaM.; Stoykova, Svetlana; Nicolay, Brandon N.; Ross, Kenneth N.; Fitamant, Julien; Boukhali, Myriam; Lengrand, Justine; Deshpande, Vikram; Selig, Martin K.; Ferrone, Cristina R.; Settleman, Jeff; Stephanopoulos, Gregory; Dyson, Nicholas J.; Zoncu, Roberto; Ramaswamy, Sridhar; Haas, Wilhelm; Bardeesy, Nabeel			Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism	NATURE			English	Article							NUCLEAR IMPORT; GENOMIC ANALYSES; TUMOR-GROWTH; PROTEIN; BIOGENESIS; CELLS; MTOR; TFEB; P53; CLEARANCE	Activation of cellular stress response pathways to maintain metabolic homeostasis is emerging as a critical growth and survival mechanism in many cancers(1). The pathogenesis of pancreatic ductal adenocarcinoma (PDA) requires high levels of autophagy(2-4), a conserved self-degradative process(5). However, the regulatory circuits that activate autophagy and reprogram PDA cell metabolism are unknown. Here we show that autophagy induction in PDA occurs as part of a broader transcriptional program that coordinates activation of lysosome biogenesis and function, and nutrient scavenging, mediated by the MiT/TFE family of transcription factors. In human PDA cells, the MiT/TFE proteins(6)-MITF, TFE3 and TFEB-are decoupled from regulatory mechanisms that control their cytoplasmic retention. Increased nuclear import in turn drives the expression of a coherent network of genes that induce high levels of lysosomal catabolic function essential for PDA growth. Unbiased global metabolite profiling reveals that MiT/TFE-dependent autophagy-lysosome activation is specifically required to maintain intracellular amino acid pools. These results identify the MiT/TFE proteins as master regulators of metabolic reprogramming in pancreatic cancer and demonstrate that transcriptional activation of clearance pathways converging on the lysosome is a novel hallmark of aggressive malignancy.	[Perera, RushikaM.; Stoykova, Svetlana; Nicolay, Brandon N.; Ross, Kenneth N.; Fitamant, Julien; Boukhali, Myriam; Lengrand, Justine; Ferrone, Cristina R.; Settleman, Jeff; Dyson, Nicholas J.; Ramaswamy, Sridhar; Haas, Wilhelm; Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Perera, RushikaM.; Stoykova, Svetlana; Ross, Kenneth N.; Fitamant, Julien; Lengrand, Justine; Ramaswamy, Sridhar; Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Perera, RushikaM.; Nicolay, Brandon N.; Ross, Kenneth N.; Fitamant, Julien; Deshpande, Vikram; Ferrone, Cristina R.; Dyson, Nicholas J.; Ramaswamy, Sridhar; Haas, Wilhelm; Bardeesy, Nabeel] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Deshpande, Vikram; Selig, Martin K.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ferrone, Cristina R.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Zoncu, Roberto] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley	Bardeesy, N (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.	Bardeesy.Nabeel@MGH.Harvard.edu			National Institutes of Health [P50CA1270003, P01 CA117969-07, R01 CA133557-05]; Linda J. Verville Cancer Research Foundation; Hirshberg Foundation for Pancreatic Cancer; NATIONAL CANCER INSTITUTE [R01CA133557, DP2CA195761, P50CA127003, P01CA117969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Linda J. Verville Cancer Research Foundation; Hirshberg Foundation for Pancreatic Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank A. Kimmelman, L. Ellisen, W. Kim and R. Mostoslavsky for advice and helpful comments on the manuscript, S. Gygi for access to proteomics data analysis software, F. Kottakis, Y. Mizukami and M. Leisa for technical support, and C. Ivan for bioinformatics support. This work was supported by grants from the National Institutes of Health (P50CA1270003, P01 CA117969-07, R01 CA133557-05) and the Linda J. Verville Cancer Research Foundation to N.B. N.B. holds the Gallagher Endowed Chair in Gastrointestinal Cancer Research. R.M.P. holds a Hirshberg Foundation for Pancreatic Cancer seed grant. N.B. and R.M.P. are members of the Andrew Warshaw Institute for Pancreatic Cancer Research.	Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Golomb L, 2012, MOL CELL, V45, P222, DOI 10.1016/j.molcel.2011.11.022; Haq R, 2011, J CLIN ONCOL, V29, P3474, DOI 10.1200/JCO.2010.32.6223; Hershey CL, 2005, GENE, V347, P73, DOI 10.1016/j.gene.2004.12.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Petersen NHT, 2013, CANCER CELL, V24, P379, DOI 10.1016/j.ccr.2013.08.003; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Raices M., NATURE REV MOL CELL; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Saftig P, 2013, NATURE, V502, P312, DOI 10.1038/nature12692; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Tzatsos A, 2013, J CLIN INVEST, V123, P727, DOI 10.1172/JCI64535; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028; White E, 2013, GENE DEV, V27, P2065, DOI 10.1101/gad.228122.113; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yao XH, 2008, J BIOL CHEM, V283, P22867, DOI 10.1074/jbc.M801320200; Zehorai E, 2014, MOL CELL BIOL, V34, P259, DOI 10.1128/MCB.00799-13; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	46	494	514	9	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					361	U251		10.1038/nature14587	http://dx.doi.org/10.1038/nature14587			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26168401	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000359714000038
J	Wauer, T; Simicek, M; Schubert, A; Komander, D				Wauer, Tobias; Simicek, Michal; Schubert, Alexander; Komander, David			Mechanism of phospho-ubiquitin-induced PARKIN activation	NATURE			English	Article							MITOCHONDRIAL TRANSLOCATION; PHOSPHORYLATION; DISEASE; PINK1; REVEALS; DOMAIN; RING; CHAIN; E3; MITOPHAGY	The E3 ubiquitin ligase PARKIN (encoded by PARK2) and the protein kinase PINK1 (encoded by PARK6) are mutated in autosomal-recessive juvenile Parkinsonism (AR-JP) and work together in the disposal of damaged mitochondria by mitophagy(1-3). PINK1 is stabilized on the outside of depolarized mitochondria and phosphorylates polyubiquitin(4-8) as well as the PARKIN ubiquitin-like (Ubl) domain(9,10). These phosphorylation events lead to PARKIN recruitment to mitochondria, and activation by an unknown allosteric mechanism(4-12). Here we present the crystal structure of Pediculus humanus PARKIN in complex with Ser65-phosphorylated ubiquitin (phosphoUb), revealing the molecular basis for PARKIN recruitment and activation. The phosphoUb binding site on PARKIN comprises a conserved phosphate pocket and harbours residues mutated in patients with AR-JP. PhosphoUb binding leads to straightening of a helix in the RING1 domain, and the resulting conformational changes release the Ubl domain from the PARKIN core; this activates PARKIN. Moreover, phosphoUb-mediated Ubl release enhances Ubl phosphorylation by PINK1, leading to conformational changes within the Ubl domain and stabilization of an open, active conformation of PARKIN. We redefine the role of the Ubl domain not only as an inhibitory(13) but also as an activating element that is restrained in inactive PARKIN and released by phosphoUb. Our work opens up new avenues to identify small-molecule PARKIN activators.	[Wauer, Tobias; Simicek, Michal; Schubert, Alexander; Komander, David] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Komander, D (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	dk@mrc-lmb.cam.ac.uk	Simicek, Michal/C-2514-2019	Simicek, Michal/0000-0003-2388-2723	Medical Research Council [U105192732]; European Research Council [309756]; Lister Institute for Preventive Medicine; EMBO; MRC [MC_U105192732] Funding Source: UKRI; Medical Research Council [1571029, MC_U105192732] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Lister Institute for Preventive Medicine; EMBO(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank M. Yu and beamline staff at Diamond Light Source, beamline I-04 and I-04-1, S. Freund and J. Wagstaff for NMR data, C. Johnson and S. McLaughlin for help with biophysics, BostonBiochem for providing UbVs and UbVME, C. Gladkova for help with cloning, and N. Birsa and J. Kittler (UCL London) for providing YFP-HsPARKIN plasmids. We thank members of the D.K. laboratory for reagents and discussions, and D. Barford, J. Pruneda and P. Elliott for comments on the manuscript. This work was supported by the Medical Research Council (U105192732), the European Research Council (309756), the Lister Institute for Preventive Medicine, the EMBO Young Investigator Program(to D.K.), and an EMBO Long-term Fellowship (to M.S.).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Corti O, 2013, CURR OPIN NEUROBIOL, V23, P100, DOI 10.1016/j.conb.2012.11.002; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; Kazlauskaite A, 2015, FEBS J, V282, P215, DOI 10.1111/febs.13127; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F., 2015, BIOCH BIOPHYS ACTA; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Macedo MG, 2009, MOVEMENT DISORD, V24, P196, DOI 10.1002/mds.22287; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Okatsu K, 2015, J CELL BIOL, V209, P111, DOI 10.1083/jcb.201410050; Ordureau A, 2015, P NATL ACAD SCI USA, V112, P6637, DOI 10.1073/pnas.1506593112; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shiba-Fukushima K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004861; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66	37	276	284	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					370	+		10.1038/nature14879	http://dx.doi.org/10.1038/nature14879			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26161729	Green Accepted			2022-12-28	WOS:000359714000040
J	Wilkinson, K; Hershko, A				Wilkinson, Keith; Hershko, Avram			Irwin Allan Rose (1926-2015) OBITUARY	NATURE			English	Biographical-Item									[Wilkinson, Keith] Emory Univ, Biochem, Atlanta, GA 30322 USA; [Hershko, Avram] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel	Emory University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Wilkinson, K (corresponding author), Emory Univ, Biochem, Atlanta, GA 30322 USA.	genekdw@emory.edu; hershko@tx.technion.ac.il						ROSE I, PUBLICATION LIST	1	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					532	532		10.1038/523532a	http://dx.doi.org/10.1038/523532a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26223618	Bronze			2022-12-28	WOS:000358655200026
J	Swenson, SM; Chamberlain, LJ; Sanders, LM; Sundaram, V; Wise, PH				Swenson, Sonja M.; Chamberlain, Lisa J.; Sanders, Lee M.; Sundaram, Vandana; Wise, Paul H.			Outpatient Pharmacy Expenditures for Children With Serious Chronic Illness in California, 2010-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							UNITED-STATES; HEALTH		[Swenson, Sonja M.; Sanders, Lee M.; Sundaram, Vandana] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Chamberlain, Lisa J.; Wise, Paul H.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Swenson, SM (corresponding author), Stanford Univ, Ctr Hlth Policy, Ctr Primary Care & Outcomes Res, 117 Encina Commons, Stanford, CA 94305 USA.	sonjas1@stanford.edu						American Hospital Formulary System, AHFS PHARM THER CLAS; Guh S, 2012, HAEMOPHILIA, V18, P276, DOI 10.1111/j.1365-2516.2011.02713.x; Kuo DZ, 2015, MATERN CHILD HLTH J, V19, P40, DOI 10.1007/s10995-014-1493-0; Nocera Joe, 2014, NY TIMES, pA19; North Carolina Department of Health and Human Services, PRESCR DRUGS N CAR P; Wise PH, 2004, HEALTH AFFAIR, V23, P9, DOI 10.1377/hlthaff.23.5.9	6	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					405	407		10.1001/jama.2015.7169	http://dx.doi.org/10.1001/jama.2015.7169			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219060	Bronze			2022-12-28	WOS:000358581700024
J	Fernandes, E				Fernandes, Edmond			PERSONAL VIEW Doctors and medical students in India should stop wearing white coats	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTAMINATION		Yenepoya Univ, Yenepoya Med Coll, Dept Community Med, Mangalore, Karnataka, India	Yenepoya (Deemed to be University)	Fernandes, E (corresponding author), Yenepoya Univ, Yenepoya Med Coll, Dept Community Med, Mangalore, Karnataka, India.	edmondvirgo@gmail.com						Arnold P Gold Foundation, WHIT COAT CER; Banu A, 2012, J CLIN DIAGN RES, V6, P1381, DOI 10.7860/JCDR/2012/4286.2364; Department of Health, 2007, JOHNS OUTL NEW MEAS; Jones VA, 1999, JAMA-J AM MED ASSOC, V281, P478, DOI 10.1001/jama.281.5.478; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Muhadi SA, 2007, MALAYS J MICROBIOL, V3, P35, DOI 10.21161/mjm.00607; Neely AN, 2000, J BURN CARE REHABIL, V21, P523, DOI 10.1097/00004630-200021060-00009; Sharma R, 2012, J HOSP ADM, V1, P27, DOI DOI 10.5430/JHA.V1N2P27; Treakle AM, 2009, AM J INFECT CONTROL, V37, P101, DOI 10.1016/j.ajic.2008.03.009; Uneke C J, 2010, World Health Popul, V11, P44; Varghese D, 1999, BRIT MED J, V319, P519; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	12	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2015	351								h3855	10.1136/bmj.h3855	http://dx.doi.org/10.1136/bmj.h3855			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WG	26198987				2022-12-28	WOS:000358644400005
J	Nakahara, S; Tomio, J; Ichikawa, M; Nakamura, F; Nishida, M; Takahashi, H; Morimura, N; Sakamoto, T				Nakahara, Shinji; Tomio, Jun; Ichikawa, Masao; Nakamura, Fumiaki; Nishida, Masamichi; Takahashi, Hideto; Morimura, Naoto; Sakamoto, Tetsuya			Association of Bystander Interventions With Neurologically Intact Survival Among Patients With Bystander-Witnessed Out-of-Hospital Cardiac Arrest in Japan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; PUBLIC-ACCESS DEFIBRILLATION; AMERICAN-HEART-ASSOCIATION; EMERGENCY CARDIOVASCULAR CARE; CARDIOPULMONARY-RESUSCITATION; COST-EFFECTIVENESS; LIFE-SUPPORT; GUIDELINES; LOCATION; PROFESSIONALS	IMPORTANCE Neurologically intact survival after out-of-hospital cardiac arrest (OHCA) has been increasing in Japan. However, associations between increased prehospital care, including bystander interventions and increases in survival, have not been well estimated. OBJECTIVE To estimate the associations between bystander interventions and changes in neurologically intact survival among patients with OHCA in Japan. DESIGN, SETTING, AND PARTICIPANTS Retrospective descriptive study using data from Japan's nationwide OHCA registry, which started in January 2005. The registry includes all patients with OHCA transported to the hospital by emergency medical services (EMS) and recorded patients' characteristics, prehospital interventions, and outcomes. Participants were 167 912 patients with bystander-witnessed OHCA of presumed cardiac origin in the registry between January 2005 and December 2012. EXPOSURES Prehospital interventions by bystander, including defibrillation using public-access automated external defibrillators and chest compression. MAIN OUTCOMES AND MEASURES Neurologically intact survival was defined as Glasgow-Pittsburgh cerebral performance category score 1 or 2 and overall performance category scores 1 or 2 at 1 month or at discharge. The association between the interventions and neurologically intact survival was evaluated. RESULTS From 2005 to 2012, the number of bystander-witnessed OHCAs of presumed cardiac origin increased from 17 882 (14.0 per 100 000 persons [95% CI, 13.8-14.2]) to 23 797 (18.7 per 100 000 persons [95% CI, 18.4-18.9]), and neurologically intact survival increased from 587 cases (age-adjusted proportion, 3.3%[95% CI, 3.0%-3.5%]) to 1710 cases (8.2%[95% CI, 7.8%-8.6%]). The rates of bystander chest compression increased from 38.6% to 50.9%, bystander-only defibrillation increased from 0.1% to 2.3%, bystander defibrillation combined with EMS defibrillation increased from 0.1% to 1.4%, and EMS-only defibrillation decreased from 26.6% to 23.5%. Performance of bystander chest compression, compared with no bystander chest compression, was associated with increased neurologically intact survival (8.4%[6594 survivors/78 592 cases] vs 4.1% [3595 survivors/88 720 cases]; odds ratio [OR], 1.52 [95% CI, 1.45-1.60]). Compared with EMS-only defibrillation (15.0%[6445 survivors/42 916 cases]), bystander-only defibrillation (40.7% [931 survivors/2287 cases]) was associated with increased neurologically intact survival (OR, 2.24 [95% CI, 1.93-2.61]), as was combined bystander and EMS defibrillation (30.5%[444 survivors/1456 cases]; OR, 1.50 [95% CI, 1.31-1.71]), whereas no defibrillation (2.0% [2369 survivors/120 653 cases]) was associated with reduced survival (OR, 0.43 [95% CI, 0.39-0.48]). CONCLUSIONS AND RELEVANCE In Japan, between 2005 and 2012, the rates of bystander chest compression and bystander defibrillation increased and were associated with increased odds of neurologically intact survival.	[Nakahara, Shinji] Kanagawa Univ Human Serv, Dept Liberal Arts & Human Dev, Yokosuka, Kanagawa, Japan; [Tomio, Jun; Nakamura, Fumiaki] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Ichikawa, Masao] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Nishida, Masamichi] Toranomon Gen Hosp, Dept Emergency Med, Tokyo, Japan; [Takahashi, Hideto] Fukushima Med Univ, Sch Med, Fukushima, Japan; [Morimura, Naoto] Yokohama City Univ, Sch Med, Dept Emergency Med, Yokohama, Kanagawa 232, Japan; [Sakamoto, Tetsuya] Teikyo Univ, Sch Med, Dept Emergency Med, Tokyo 173, Japan	University of Tokyo; University of Tsukuba; Toranomon Hospital; Fukushima Medical University; Yokohama City University; Teikyo University	Nakahara, S (corresponding author), Teikyo Univ, Sch Med, Dept Emergency Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738606, Japan.	snakahara-tky@umin.net		Nakahara, Shinji/0000-0001-7243-4797				Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Brooks SC, 2013, ANN EMERG MED, V61, P530, DOI 10.1016/j.annemergmed.2012.10.037; Culley LL, 2004, CIRCULATION, V109, P1859, DOI 10.1161/01.CIR.0000124721.83385.B2; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Davies CS, 2005, HEART, V91, P1299, DOI 10.1136/hrt.2003.032631; Fire and Disaster Management Agency, 2014, KYUK NO GENK 2013; Folke F, 2009, CIRCULATION, V120, P510, DOI 10.1161/CIRCULATIONAHA.108.843755; Gold LS, 2007, CURR OPIN CARDIOL, V22, P1, DOI 10.1097/HCO.0b013e32801173c1; Greenland S., 2008, MODERN EPIDEMIOLOGY, P283; Greenland S., 2008, MEASURES EFFECT MEAS, P51; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Hansen CM, 2014, CIRCULATION, V130, P1859, DOI 10.1161/CIRCULATIONAHA.114.008850; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kitamura T, 2012, CIRCULATION, V126, P2834, DOI 10.1161/CIRCULATIONAHA.112.109496; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Link MS, 2010, CIRCULATION, V122, pS706, DOI 10.1161/CIRCULATIONAHA.110.970954; Marukawa S, 2014, JUNKANKISIKKANTOUNO, P146; Murakami Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000533; Muraoka H, 2006, CIRC J, V70, P827, DOI 10.1253/circj.70.827; Nakahara S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6829; Nakamura F, 2013, RESUSCITATION, V84, P747, DOI 10.1016/j.resuscitation.2012.11.012; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Pell JP, 2007, CURR OPIN CARDIOL, V22, P5, DOI 10.1097/HCO.0b013e3280118fec; Pell JP, 2002, BMJ-BRIT MED J, V325, P515; Sasaki M, 2011, CIRC J, V75, P2821, DOI 10.1253/circj.CJ-11-0316; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Travers AH, 2010, CIRCULATION, V122, pS676, DOI 10.1161/CIRCULATIONAHA.110.970913; Weisfeldt ML, 2010, J AM COLL CARDIOL, V55, P1712, DOI 10.1016/j.jacc.2009.11.077; Winkle RA, 2010, CLIN CARDIOL, V33, P396, DOI 10.1002/clc.20790; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483	33	112	114	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					247	254		10.1001/jama.2015.8068	http://dx.doi.org/10.1001/jama.2015.8068			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197185	Bronze			2022-12-28	WOS:000358228000019
J	Venkatraman, V				Venkatraman, Vijaysree			The space roboticist	SCIENCE			English	Editorial Material								The first motorized vehicle that Vandi Verma ever operated was a tractor. "I must've been 11 years old at the time," she told Science. During school vacations, she visited her grandparents, who lived in a village in central India. At their farm, her uncle let her take a few turns behind the tractor wheel. Later, when she was a teenager, her father, who was a pilot with the Indian Air Force, taught her how to drive a car. That was unusual in India at that time, where those who could afford a car hired a driver.				SciCareerEditor@aaas.org							0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		338	338		10.1126/science.349.6245.338	http://dx.doi.org/10.1126/science.349.6245.338			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1ZB	26185251				2022-12-28	WOS:000358218600058
J	Gewin, V				Gewin, Virginia			COLLABORATIONS Recipe for a team	NATURE			English	Editorial Material																			0	11	11	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					245	247		10.1038/nj7559-245a	http://dx.doi.org/10.1038/nj7559-245a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB6CN	26161446	Bronze			2022-12-28	WOS:000416366400008
J	Shepherd, K; Hubbard, D; Fenton, N; Claxton, K; Luedeling, E; de Leeuw, J				Shepherd, Keith; Hubbard, Douglas; Fenton, Norman; Claxton, Karl; Luedeling, Eike; de Leeuw, Jan			Policy: Development goals should enable decision-making	NATURE			English	Editorial Material									[Shepherd, Keith] World Agroforestry Ctr, Sci Domain Land Hlth Decis, Nairobi, Kenya; [Shepherd, Keith] Consultat Grp Int Agr Res, Res Programme Water Land & Ecosyst, Decis Anal & Informat, Montpellier, France; [Hubbard, Douglas] Hubbard Decis Res, Chicago, IL USA; [Fenton, Norman] Univ London, Queen Mary, Risk Management, London WC1E 7HU, England; [Claxton, Karl] Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England; [Claxton, Karl] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Luedeling, Eike; de Leeuw, Jan] World Agroforestry Ctr, Nairobi, Kenya	CGIAR; World Agroforestry (ICRAF); University of London; Queen Mary University London; University of York - UK; University of York - UK; CGIAR; World Agroforestry (ICRAF)	Shepherd, K (corresponding author), World Agroforestry Ctr, Sci Domain Land Hlth Decis, Nairobi, Kenya.	k.shepherd@cgiar.org	Luedeling, Eike/I-3269-2019; Fenton, Norman/L-5861-2019	Luedeling, Eike/0000-0002-7316-3631; Fenton, Norman/0000-0003-2924-0510; de Leeuw, Jan/0000-0001-7020-2503				Clapp A., 2013, SURVEY ANAL DATA REQ; Claxton K, 2006, DECISION MODELLING H; Erisman JW, 2015, NATURE, V519, P151, DOI 10.1038/519151a; Fenton N, 2012, RISK ASSESSMENT DECI, DOI 10.1201/b13102; Howard Ronald A., 2015, FDN DECISION ANAL; Hubbard D., 2010, MEASURE ANYTHING FIN, V2nd ed.; Seddon J., 2008, SYSTEM THINKING PUBL, P162; Sustainable Development Solutions Network, 2015, IND MON FRAM SUST DE; Sustainable Development Solutions Network, 2015, DAT DEV NEEDS ASS SD; Unterhalter E, 2014, J HUM DEV CAPABIL, V15, P176, DOI 10.1080/19452829.2014.880673	10	38	40	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					152	154		10.1038/523152a	http://dx.doi.org/10.1038/523152a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4ZO	26156358	Bronze			2022-12-28	WOS:000357695900012
J	Kiernan, M; Bhogal, M; Wong, K; Sivaprakasam, R; Ashman, N; Ali, N				Kiernan, Miles; Bhogal, Maninder; Wong, Ken; Sivaprakasam, Rajesh; Ashman, Neil; Ali, Nadeem			Sight-threatening intraocular pressure due to an upper arm dialysis fistula	LANCET			English	Editorial Material									[Kiernan, Miles; Wong, Ken; Sivaprakasam, Rajesh; Ashman, Neil; Ali, Nadeem] Royal London Hosp, London E1 1BB, England; [Bhogal, Maninder] Moorfields Eye Hosp, London, England	Barts Health NHS Trust; Royal London Hospital; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Kiernan, M (corresponding author), Royal London Hosp, Dept Ophthalmol, Whitechapel Rd, London E1 1BB, England.	miles.kiernan@doctors.org.uk	Kiernan, Matthew C/E-4460-2011					BARROW DL, 1985, J NEUROSURG, V62, P248, DOI 10.3171/jns.1985.62.2.0248; Gonsalves CF, 2003, CARDIOVASC INTER RAD, V26, P123, DOI 10.1007/s00270-002-2628-z; HUMMER MG, 1981, STROKE, V12, P689, DOI 10.1161/01.STR.12.5.689; Otten TR, 2003, CHEST, V123, P809, DOI 10.1378/chest.123.3.809; Watson RR, 2007, AM J NEURORADIOL, V28, P1155, DOI 10.3174/ajnr.A0504	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					101	102		10.1016/S0140-6736(15)61003-0	http://dx.doi.org/10.1016/S0140-6736(15)61003-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM2OA	26169868				2022-12-28	WOS:000357519400033
J	Puente, XS; Bea, S; Valdes-Mas, R; Villamor, N; Gutierrez-Abril, J; Martin-Subero, JI; Munar, M; Rubio-Perez, C; Jares, P; Aymerich, M; Baumann, T; Beekman, R; Belver, L; Carrio, A; Castellano, G; Clot, G; Colado, E; Colomer, D; Costa, D; Delgado, J; Enjuanes, A; Estivill, X; Ferrando, AA; Gelpi, JL; Gonzalez, B; Gonzalez, S; Gonzalez, M; Gut, M; Hernandez-Rivas, JM; Lopez-Guerra, M; Martin-Garcia, D; Navarro, A; Nicolas, P; Orozco, M; Payer, AR; Pinyol, M; Pisano, DG; Puente, DA; Queiros, AC; Quesada, V; Romeo-Casabona, CM; Royo, C; Royo, R; Rozman, M; Russinol, N; Salaverria, I; Stamatopoulos, K; Stunnenberg, HG; Tamborero, D; Terol, MJ; Valencia, A; Lopez-Bigas, N; Torrents, D; Gut, I; Lopez-Guillermo, A; Lopez-Otin, C; Campo, E				Puente, Xose S.; Bea, Silvia; Valdes-Mas, Rafael; Villamor, Neus; Gutierrez-Abril, Jesus; Martin-Subero, Jose I.; Munar, Marta; Rubio-Perez, Carlota; Jares, Pedro; Aymerich, Marta; Baumann, Tycho; Beekman, Renee; Belver, Laura; Carrio, Anna; Castellano, Giancarlo; Clot, Guillem; Colado, Enrique; Colomer, Dolors; Costa, Dolors; Delgado, Julio; Enjuanes, Anna; Estivill, Xavier; Ferrando, Adolfo A.; Gelpi, Josep L.; Gonzalez, Blanca; Gonzalez, Santiago; Gonzalez, Marcos; Gut, Marta; Hernandez-Rivas, Jesus M.; Lopez-Guerra, Monica; Martin-Garcia, David; Navarro, Alba; Nicolas, Pilar; Orozco, Modesto; Payer, Angel R.; Pinyol, Magda; Pisano, David G.; Puente, Diana A.; Queiros, Ana C.; Quesada, Victor; Romeo-Casabona, Carlos M.; Royo, Cristina; Royo, Romina; Rozman, Maria; Russinol, Nuria; Salaverria, Itziar; Stamatopoulos, Kostas; Stunnenberg, Hendrik G.; Tamborero, David; Terol, Maria J.; Valencia, Alfonso; Lopez-Bigas, Nuria; Torrents, David; Gut, Ivo; Lopez-Guillermo, Armando; Lopez-Otin, Carlos; Campo, Elias			Non-coding recurrent mutations in chronic lymphocytic leukaemia	NATURE			English	Article							DNA METHYLATION; NOTCH1 MUTATIONS; GENE-MUTATIONS; CANCER; ABERRATIONS; EVOLUTION; HYPERMUTATION; EXPRESSION; SIGNATURES; SURVIVAL	Chronic lymphocytic leukaemia (CLL) is a frequent disease in which the genetic alterations determining the clinicobiological behaviour are not fully understood. Here we describe a comprehensive evaluation of the genomic landscape of 452 CLL cases and 54 patients with monoclonal B-lymphocytosis, a precursor disorder. We extend the number of CLL driver alterations, including changes in ZNF292, ZMYM3, ARID1A and PTPN11. We also identify novel recurrent mutations in non-coding regions, including the 39 region of NOTCH1, which cause aberrant splicing events, increase NOTCH1 activity and result in a more aggressive disease. In addition, mutations in an enhancer located on chromosome 9p13 result in reduced expression of the B-cell-specific transcription factor PAX5. The accumulative number of driver alterations (0 to >= 4) discriminated between patients with differences in clinical behaviour. This study provides an integrated portrait of the CLL genomic landscape, identifies new recurrent driver mutations of the disease, and suggests clinical interventions that may improve the management of this neoplasia.	[Puente, Xose S.; Valdes-Mas, Rafael; Gutierrez-Abril, Jesus; Puente, Diana A.; Quesada, Victor; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Bea, Silvia; Beekman, Renee; Castellano, Giancarlo; Clot, Guillem; Martin-Garcia, David; Navarro, Alba; Royo, Cristina; Russinol, Nuria; Salaverria, Itziar] IDIBAPS, Barcelona 08036, Spain; [Villamor, Neus; Aymerich, Marta; Carrio, Anna; Colomer, Dolors; Costa, Dolors; Gonzalez, Blanca; Lopez-Guerra, Monica; Rozman, Maria; Campo, Elias] Univ Barcelona, IDIBAPS, Hosp Clin, Unitat Hematol, E-08036 Barcelona, Spain; [Martin-Subero, Jose I.; Queiros, Ana C.] Univ Barcelona, Dept Anat Patol Microbiol & Farmacol, E-08036 Barcelona, Spain; [Munar, Marta; Gelpi, Josep L.; Gonzalez, Santiago; Orozco, Modesto; Royo, Romina; Torrents, David] Univ Barcelona, Spanish Natl Bioinformat Inst, Programa Conjunto Biol Computac, BSC,IRB, E-08028 Barcelona, Spain; [Rubio-Perez, Carlota; Tamborero, David; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona 08003, Spain; [Jares, Pedro; Enjuanes, Anna; Pinyol, Magda] IDIBAPS, Unidad Genom, Barcelona 08036, Spain; [Baumann, Tycho; Delgado, Julio; Lopez-Guillermo, Armando] IDIBAPS, Hosp Clin, Serv Hematol, Barcelona 08036, Spain; [Belver, Laura; Ferrando, Adolfo A.] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Colado, Enrique; Payer, Angel R.] Hosp Univ Cent Asturias, Serv Hematol, Oviedo 33011, Spain; [Estivill, Xavier] Pompeu Fabra Univ, Hosp Mar Res Inst IMIM, CRG, Barcelona 08003, Spain; [Gonzalez, Marcos; Hernandez-Rivas, Jesus M.] Univ Salamanca, Hosp Univ Salamanca, Ctr Invest Canc, Serv Hematol,IBSAL,CSIC, Salamanca 37007, Spain; [Gut, Marta; Gut, Ivo] Ctr Nacl Anal Genom, Barcelona 08028, Spain; [Nicolas, Pilar; Romeo-Casabona, Carlos M.] Univ Basque Country, Univ Deusto, Catedra Interuniv Derecho & Genoma Humano, Bilbao 48007, Spain; [Pisano, David G.; Valencia, Alfonso] Spanish Natl Bioinformat Inst, Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Madrid 28029, Spain; [Stamatopoulos, Kostas] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki 57001, Greece; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6500 HB Nijmegen, Netherlands; [Terol, Maria J.] Hosp Clin Valencia, Serv Hematol, Valencia 46010, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Pompeu Fabra University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Columbia University; Central University Hospital Asturias; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; University of Basque Country; University of Deusto; Centro Nacional de Investigaciones Oncologicas (CNIO); Centre for Research & Technology Hellas; Radboud University Nijmegen	Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	clo@uniovi.es; ecampo@clinic.ub.es	Clot, Guillem/AAD-9087-2020; Valencia, Alfonso/AAN-9230-2020; Belver, Laura/AAH-2177-2019; bea, silvia/K-7699-2014; Lopez-Guillermo, Armando/Z-5684-2019; Campo, elias/O-7192-2016; Campo, Elias/AAC-5593-2019; Gut, Ivo/ABF-3188-2020; SALAVERRIA, ITZIAR/AAW-9019-2021; Jares, Pedro/T-3778-2019; Estivill, Xavier/A-3125-2013; ENJUANES, Anna/H-3245-2015; Colado, Enrique/Z-6326-2019; Gasull, Martina/J-4076-2019; Belver, Laura/AAC-1621-2021; Beekman, Renée/AAF-2088-2020; Hernández, Jesus M/B-5459-2017; COLOMER, DOLORS/ABG-6894-2020; Colado, Enrique/GXF-7705-2022; Lopez-Bigas, Nuria/F-6193-2011; Valencia, Alfonso/I-3127-2015; Quesada, Víctor/B-6557-2014; Delgado, Julio/D-4891-2013; Martín, David/AAC-9334-2020; Stunnenberg, Hendrik G./D-6875-2012; Valdés-Mas, Rafael/AAC-2879-2021; Pisano, David G/H-4764-2019; Puente, Xosé S./ADB-0672-2022; López-Otín, Carlos/AAB-2106-2020; tamborero, david/M-5283-2015; Gelpi, Josep Lluis/M-6401-2013; Navarro, Alba/H-2611-2015; Salaverria, Itziar/L-2246-2015; Torrents, David/G-5785-2015	Clot, Guillem/0000-0003-2588-7413; Valencia, Alfonso/0000-0002-8937-6789; bea, silvia/0000-0001-7192-2385; Campo, elias/0000-0001-9850-9793; Campo, Elias/0000-0001-9850-9793; Gut, Ivo/0000-0001-7219-632X; Estivill, Xavier/0000-0002-0723-2256; ENJUANES, Anna/0000-0002-4679-6687; Colado, Enrique/0000-0001-8675-8207; Belver, Laura/0000-0001-7493-7072; Beekman, Renée/0000-0001-7081-7874; Hernández, Jesus M/0000-0002-9661-9371; Lopez-Bigas, Nuria/0000-0003-4925-8988; Valencia, Alfonso/0000-0002-8937-6789; Quesada, Víctor/0000-0002-8398-3457; Delgado, Julio/0000-0002-5157-4376; Martín, David/0000-0002-0289-5915; Stunnenberg, Hendrik G./0000-0002-0066-1576; Valdés-Mas, Rafael/0000-0002-0737-5425; Pisano, David G/0000-0002-4895-4124; Puente, Xosé S./0000-0001-9525-1483; López-Otín, Carlos/0000-0001-6964-1904; tamborero, david/0000-0002-7218-2806; Rubio-Perez, Carlota/0000-0002-1921-168X; Terol, Maria J/0000-0002-9467-932X; JARES, PEDRO/0000-0002-8401-579X; COLOMER, DOLORS/0000-0001-7486-8484; Gonzalez-Farre, Blanca/0000-0002-1796-7248; Gelpi, Josep Lluis/0000-0002-0566-7723; Rozman, Maria/0000-0002-2641-1110; Castellano, Giancarlo/0000-0002-5715-7733; NICOLAS JIMENEZ, MARIA PILAR/0000-0003-4166-5941; Royo, Romina/0000-0003-3493-0874; Navarro, Alba/0000-0002-4041-0974; Salaverria, Itziar/0000-0002-2427-9822; Orozco Lopez, Modesto/0000-0002-8608-3278; Gonzalez Rosado, Santiago/0000-0001-5685-4580; Gonzalez Diaz, Marcos/0000-0001-6637-1072; Torrents, David/0000-0002-6086-9037; Stamatopoulos, Kostas/0000-0001-8529-640X; Carrio, Ana/0000-0002-8394-2321; Queiros, Ana/0000-0001-8585-4803; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Baumann, Tycho Stephan/0000-0003-4421-0088	Spanish Ministry of Economy and Competitiveness through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC); Banco Santander through its Santander Universities Global Division	Spanish Ministry of Economy and Competitiveness through the Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC); Banco Santander through its Santander Universities Global Division	This work was funded by Spanish Ministry of Economy and Competitiveness through the Instituto de Salud Carlos III (ISCIII) and Red Tematica de Investigacion del Cancer (RTICC). We are grateful to E. Santos for his continued support to this project, and N. Villahoz and M. C. Muro for their excellent work in the coordination of the CLL Spanish Consortium. C.L.-O. is an Investigator of the Botin Foundation supported by Banco Santander through its Santander Universities Global Division, and E.Ca. and D.T. are Institucio Catalana de Recerca i Estudis Avancats-Academia investigators. We acknowledge Partnership for Advanced Computing in Europe (PRACE) for awarding us access to resource Marenostrum based in Spain at the BSC, the Pershing Square Sohn Cancer Research Alliance and European Union's FP7 through the Blueprint Consortium. We are also very grateful to all patients with CLL who have participated in this study.	Agathangelidis A, 2012, BLOOD, V119, P4467, DOI 10.1182/blood-2011-11-393694; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Balatti V, 2012, BLOOD, V119, P329, DOI 10.1182/blood-2011-10-386144; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Damm F, 2014, CANCER DISCOV, V4, P1088, DOI 10.1158/2159-8290.CD-14-0104; Delgado J, 2014, HAEMATOLOGICA, V99, DOI 10.3324/haematol.2014.108365; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Edelmann J, 2012, BLOOD, V120, P4783, DOI 10.1182/blood-2012-04-423517; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Ferreira PG, 2014, GENOME RES, V24, P212, DOI 10.1101/gr.152132.112; Gaidano G, 2012, J CLIN INVEST, V122, P3432, DOI 10.1172/JCI64101; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Khodabakhshi AH, 2012, ONCOTARGET, V3, P1308; Kluk MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067306; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Malek SN, 2013, ONCOGENE, V32, P2805, DOI 10.1038/onc.2012.411; Moncunill V, 2014, NAT BIOTECHNOL, V32, P1106, DOI 10.1038/nbt.3027; O'Brien P, 2011, CANCER RES, V71, P7345, DOI 10.1158/0008-5472.CAN-11-1874; Oakes CC, 2014, CANCER DISCOV, V4, P348, DOI 10.1158/2159-8290.CD-13-0349; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pekarsky Y, 2010, SEMIN CANCER BIOL, V20, P370, DOI 10.1016/j.semcancer.2010.09.003; PETO R, 1973, BIOMETRICS, V29, P579, DOI 10.2307/2529177; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Queiros AC, 2015, LEUKEMIA, V29, P598, DOI 10.1038/leu.2014.252; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Rossi D, 2012, BLOOD, V119, P2854, DOI 10.1182/blood-2011-12-395673; Rubio-Perez C, 2015, CANCER CELL, V27, P382, DOI 10.1016/j.ccell.2015.02.007; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Strefford JC, 2013, LEUKEMIA, V27, P2196, DOI 10.1038/leu.2013.98; Valdes-Mas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051422; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Villamor N, 2013, LEUKEMIA, V27, P1100, DOI 10.1038/leu.2012.357; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	55	555	566	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2015	526	7574					519	U115		10.1038/nature14666	http://dx.doi.org/10.1038/nature14666			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1NX	26200345				2022-12-28	WOS:000364026100039
J	O'Leary, M; Mulholland, K				O'Leary, Maureen; Mulholland, Kim			Oral cholera vaccines in endemic countries	LANCET			English	Editorial Material							KOLKATA		[O'Leary, Maureen; Mulholland, Kim] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Mulholland, Kim] Royal Childrens Hosp, Murdoch Childrens Res Inst, Infect & Immun Theme, Melbourne, Vic, Australia	University of London; London School of Hygiene & Tropical Medicine; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	O'Leary, M (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	maureen.oleary@lshtm.ac.uk						Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Ali M, 2013, CLIN INFECT DIS, V56, P1123, DOI 10.1093/cid/cit009; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P321; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Dimitrov DT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003343; ECDC, 2013, REV SCI LIT DRIV BAR; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Qadri F, 2015, LANCET; Sinclair D, 2011, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD008603.PUB2	12	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1321	1322		10.1016/S0140-6736(15)60246-X	http://dx.doi.org/10.1016/S0140-6736(15)60246-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CS8DP	26164098				2022-12-28	WOS:000362316200010
J	Morris, AM				Morris, Arden M.			Laparoscopic peritoneal lavage for perforated diverticulitis: in search of evidence	LANCET			English	Editorial Material							SIGMOID DIVERTICULITIS; SURGERY		Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Morris, AM (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	ammsurg@med.umich.edu		Morris, Arden/0000-0001-5795-2940				Morris AM, 2014, JAMA-J AM MED ASSOC, V311, P287, DOI 10.1001/jama.2013.282025; Regenbogen SE, 2014, JAMA SURG, V149, P292, DOI 10.1001/jamasurg.2013.5477; Toorenvliet BR, 2010, COLORECTAL DIS, V12, P862, DOI 10.1111/j.1463-1318.2009.02052.x; Vennix S, 2015, LANCET; Vermeulen J, 2009, COLORECTAL DIS, V11, P619, DOI 10.1111/j.1463-1318.2008.01667.x; Wong WD, 2000, DIS COLON RECTUM, V43, P290	6	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1219	1221		10.1016/S0140-6736(15)61284-3	http://dx.doi.org/10.1016/S0140-6736(15)61284-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26209029				2022-12-28	WOS:000361700100008
J	Ackermann, RT				Ackermann, Ronald T.			Diabetes Prevention at the Tipping Point: Aligning Clinical and Public Health Recommendations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK-FACTORS; ADULTS		[Ackermann, Ronald T.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Ackermann, RT (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, 750 North Lake Shore Dr,10th Floor, Chicago, IL 60611 USA.	r.ackermann@northwestern.edu						Balk EM, 2015, ANN INTERN MED, V163, P437, DOI 10.7326/M15-0452; Centers for Disease Control and Prevention, 2012, NAT DIAB PREV PROGR; Gakhar M., 2015, MEASURABLE PROGR UNL; Geiss LS, 2010, AM J PREV MED, V38, P403, DOI 10.1016/j.amepre.2009.12.029; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; Li R, 2015, ANN INTERN MED, V163, P452, DOI 10.7326/M15-0469; Pronk NP, 2015, ANN INTERN MED, V163, P465, DOI 10.7326/M15-1029; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337/dc10-1235; U.S. Preventive Services Task Force, 2014, DRAFT REC STAT ABN G	10	9	9	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6					475	476		10.7326/M15-1563	http://dx.doi.org/10.7326/M15-1563			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26168323				2022-12-28	WOS:000361365900025
J	SteelFisher, GK; Blendon, RJ; Lasala-Blanco, N				SteelFisher, Gillian K.; Blendon, Robert J.; Lasala-Blanco, Narayani			Ebola in the United States - Public Reactions and Implications	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[SteelFisher, Gillian K.; Blendon, Robert J.; Lasala-Blanco, Narayani] Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	SteelFisher, GK (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Lasala-Blanco, Narayani/0000-0002-3211-8551				[Anonymous], 2014, NY TIMES, pA30; [Anonymous], 2014, REP EB COV TV NEWS P; GRABER D, 1988, PROCESSING NEWS PEOP; Gross K, 2008, POLIT PSYCHOL, V29, P169, DOI 10.1111/j.1467-9221.2008.00622.x; Kraft PW, 2015, ANN AM ACAD POLIT SS, V658, P121, DOI 10.1177/0002716214554758	5	33	33	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					789	791		10.1056/NEJMp1506290	http://dx.doi.org/10.1056/NEJMp1506290			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP8VC	26222381				2022-12-28	WOS:000360171700004
J	Schumacher, MA; Balani, P; Min, JK; Chinnam, NB; Hansen, S; Vulic, M; Lewis, K; Brennan, RG				Schumacher, Maria A.; Balani, Pooja; Min, Jungki; Chinnam, Naga Babu; Hansen, Sonja; Vulic, Marin; Lewis, Kim; Brennan, Richard G.			HipBA-promoter structures reveal the basis of heritable multidrug tolerance	NATURE			English	Article							ESCHERICHIA-COLI K-12; PERSISTER CELLS; AFFECTS LETHALITY; AFFECTS FREQUENCY; PROTEIN-DNA; INHIBITION; MECHANISMS; PEPTIDOGLYCAN; STRAINS; OPERON	Multidrug tolerance is largely responsible for chronic infections and caused by a small population of dormant cells called persisters. Selection for survival in the presence of antibiotics produced the first genetic link to multidrug tolerance: a mutant in the Escherichia coli hipA locus. HipA encodes a serine-protein kinase, the multidrug tolerance activity of which is neutralized by binding to the transcriptional regulator HipB and hipBA promoter. The physiological role of HipA in multidrug tolerance, however, has been unclear. Here we show that wild-type HipA contributes to persister formation and that high-persister hipA mutants cause multidrug tolerance in urinary tract infections. Perplexingly, high-persister mutations map to the N-subdomain-1 of HipA far from its active site. Structures of higher-order HipA-HipB-promoter complexes reveal HipA forms dimers in these assemblies via N-subdomain-1 interactions that occlude their active sites. High-persistence mutations, therefore, diminish HipA-HipA dimerization, thereby unleashing HipA to effect multidrug tolerance. Thus, our studies reveal the mechanistic basis of heritable, clinically relevant antibiotic tolerance.	[Schumacher, Maria A.; Min, Jungki; Chinnam, Naga Babu; Brennan, Richard G.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Balani, Pooja; Hansen, Sonja; Vulic, Marin; Lewis, Kim] Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA	Duke University; Northeastern University	Schumacher, MA (corresponding author), Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA.	maria.schumacher@duke.edu; k.lewis@neu.edu; Richard.brennan@duke.edu	Chinnam, Nagababu/ABF-5512-2021; chinnam, Nagababu/AFS-2420-2022; Balani, Pooja/D-8374-2017	Chinnam, Nagababu/0000-0001-8925-5365; chinnam, Nagababu/0000-0001-8925-5365; Balani, Pooja/0000-0002-6544-8696; Brennan, Richard/0000-0001-7647-485X; Min, Jungki/0000-0003-1860-3064	NIAID-GSCID; MD Anderson Trust; Welch Foundation [G-0040]; Duke University School of Medicine; National Institutes of Health [T-R01 AI085585, R01GM061162]; Army Research Office [W911NF-09-1-0278]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061162] Funding Source: NIH RePORTER	NIAID-GSCID; MD Anderson Trust; Welch Foundation(The Welch Foundation); Duke University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Advanced Light Source and their support staff. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division, of the US Department of Energy at the Lawrence Berkeley National Laboratory. We also thank the Broad Institute and funding from the NIAID-GSCID for whole-genome sequencing, and A. E. Stapleton and J. R. Johnson for the UTI E. coli strains. This work was supported by an MD Anderson Trust Fellowship (to M.A.S.), the Welch Foundation (G-0040) and Duke University School of Medicine (to R.G.B.), and by National Institutes of Health grants T-R01 AI085585 and R01GM061162 and by an Army Research Office instrumentation grant W911NF-09-1-0278 (to K.L.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell EA, 2008, CURR OPIN MICROBIOL, V11, P121, DOI 10.1016/j.mib.2008.02.016; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Kaspy I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4001; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2005, BIOFILMS, INFECTION, AND ANTIMICROBIAL THERAPY, P241; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Miller J. H., 1992, SHORT COURSE BACTERI, P357; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Ni L, 2013, NUCLEIC ACIDS RES, V41, P1998, DOI 10.1093/nar/gks1207; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Schilling JD, 2002, INT J ANTIMICROB AG, V19, P457, DOI 10.1016/S0924-8579(02)00098-5; Schumacher MA, 2012, CELL REP, V2, P518, DOI 10.1016/j.celrep.2012.08.013; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	44	137	144	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					59	U108		10.1038/nature14662	http://dx.doi.org/10.1038/nature14662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26222023	Green Accepted			2022-12-28	WOS:000359002300031
J	Durand, E; Nguyen, VS; Zoued, A; Logger, L; Pehau-Arnaudet, G; Aschtgen, MS; Spinelli, S; Desmyter, A; Bardiaux, B; Dujeancourt, A; Roussel, A; Cambillau, C; Cascales, E; Fronzes, R				Durand, Eric; Van Son Nguyen; Zoued, Abdelrahim; Logger, Laureen; Pehau-Arnaudet, Gerard; Aschtgen, Marie-Stephanie; Spinelli, Silvia; Desmyter, Aline; Bardiaux, Benjamin; Dujeancourt, Annick; Roussel, Alain; Cambillau, Christian; Cascales, Eric; Fronzes, Remi			Biogenesis and structure of a type VI secretion membrane core complex	NATURE			English	Article							BACTERIAL TYPE VI; ICMF FAMILY PROTEIN; HIGH-RESOLUTION; SYSTEM; LIPOPROTEIN; REFINEMENT; EFFECTORS; REQUIRES; TSSL; REPLACEMENT	Bacteria share their ecological niches with other microbes. The bacterial type VI secretion system is one of the key players in microbial competition, as well as being an important virulence determinant during bacterial infections. It assembles a nano-crossbow-like structure in the cytoplasm of the attacker cell that propels an arrow made of a haemolysin co-regulated protein (Hcp) tube and a valine-glycine repeat protein G (VgrG) spike and punctures the prey's cell wall. The nano-crossbow is stably anchored to the cell envelope of the attacker by a membrane core complex. Here we show that this complex is assembled by the sequential addition of three type VI subunits (Tss) - TssJ, TssM and TssL-and present a structure of the fully assembled complex at 11.6 angstrom resolution, determined by negative-stain electron microscopy. With overall C-5 symmetry, this 1.7-megadalton complex comprises a large base in the cytoplasm. It extends in the periplasm via ten arches to form a double-ring structure containing the carboxy-terminal domain of TssM (TssM(ct)) and TssJ that is anchored in the outer membrane. The crystal structure of the TssM(ct)-TssJ complex coupled to whole-cell accessibility studies suggest that large conformational changes induce transient pore formation in the outer membrane, allowing passage of the attacking Hcp tube/VgrG spike.	[Durand, Eric; Zoued, Abdelrahim; Logger, Laureen; Aschtgen, Marie-Stephanie] Aix Marseille Univ, CNRS, UMR 7255, Lab Ingn Syst Macromol, F-13402 Marseille 20, France; [Durand, Eric; Van Son Nguyen; Spinelli, Silvia; Desmyter, Aline; Roussel, Alain; Cambillau, Christian] CNRS, UMR 7257, Architecture & Fonct Macromol Biol, F-13288 Marseille 09, France; [Durand, Eric; Dujeancourt, Annick; Fronzes, Remi] Inst Pasteur, Biol Struct Secret Bacterienne G5, F-75015 Paris, France; [Durand, Eric] CNRS, UMR3528, Inst Pasteur, F-75015 Paris, France; [Durand, Eric; Van Son Nguyen; Spinelli, Silvia; Desmyter, Aline; Roussel, Alain; Cambillau, Christian] Aix Marseille Univ, AFMB, IHU Mediterrane Infect, F-13288 Marseille 09, France; [Bardiaux, Benjamin] Inst Pasteur, Unite Bioinformat Struct, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cambillau, C (corresponding author), CNRS, UMR 7257, Architecture & Fonct Macromol Biol, Campus Luminy,Case 932, F-13288 Marseille 09, France.	cambillau@afmb.univ-mrs.fr; cascales@imm.cnrs.fr; remi.fronzes@pasteur.fr	Fronzes, Remi/T-2578-2019; Fronzes, Rémi/GLS-0406-2022; Durand, Eric/E-6739-2017; CASCALES, ERIC/G-7420-2011; Bardiaux, Benjamin/AAN-2741-2021	Durand, Eric/0000-0002-0577-8220; CASCALES, ERIC/0000-0003-0611-9179; Bardiaux, Benjamin/0000-0003-4014-9195; nguyen, van-son/0000-0002-3079-2016; aschtgen, marie-stephanie/0000-0003-2413-8226; Zoued, Abdelrahim/0000-0002-6973-1755; Fronzes, Remi/0000-0003-3031-9824; pehau-arnaudet, gerard/0000-0001-6479-9470	Agence Nationale de la Recherche (ANR) [ANR-10-JCJC-1303-03, ANR-14-CE14-0006-02]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Fondation pour la Recherche Medicale [SPF20101221116]; ANR [ANR-10-JCJC-1303-03, Bip:Bip]; French Embassy in Vietnam [792803C]; French Ministere de la Recherche; Fondation pour la Recherche Medicale fellowship [FDT20140931060]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); French Embassy in Vietnam; French Ministere de la Recherche(Ministry of Research, France); Fondation pour la Recherche Medicale fellowship(Fondation pour la Recherche Medicale)	This work was funded by Agence Nationale de la Recherche (ANR) grants ANR-10-JCJC-1303-03 to E.C., Bip:Bip to R.F., ANR-14-CE14-0006-02 to C.C. and E.C., and supported by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01. E.D. was supported by a post-doctoral fellowship from the Fondation pour la Recherche Medicale (SPF20101221116) and ANR grants Bip:Bip and ANR-10-JCJC-1303-03. V.S.N. was supported by a PhD grant from the French Embassy in Vietnam (792803C). A.Z., L.L. and M.S.A. were recipients of doctoral fellowships from the French Ministere de la Recherche. A.Z. received a Fondation pour la Recherche Medicale fellowship (FDT20140931060). We thank O. Francetic for providing anti-DglA and anti-OmpF antibodies. We thank E. Marza, P. Violinova Krasteva and H. Remaut for comments on the manuscript, and T. Mignot, M. Guzzo and L. Espinosa for advice about the fluorescence microscopy experiments and the statistical analyses. We also thank the members of the R.F. and E.C. research groups for discussions and suggestions, and R. Lloubes, J. Sturgis and A. Galinier for encouragement. We thank the ERSF and Soleil Synchrotron radiation facilities for beamline allocation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2014, PYMOL MOL GRAPH SYST; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Blango MG, 2009, CURR OPIN MICROBIOL, V12, P177, DOI 10.1016/j.mib.2009.01.011; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Borgeaud S, 2015, SCIENCE, V347, P63, DOI 10.1126/science.1260064; Brunet YR, 2014, EMBO REP, V15, P315, DOI 10.1002/embr.201337936; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chang JH, 2015, J MICROBIOL, V53, P32, DOI 10.1007/s12275-015-4539-0; Chapman MS, 2013, J STRUCT BIOL, V182, P10, DOI 10.1016/j.jsb.2013.01.003; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Crago AM, 1998, MOL MICROBIOL, V30, P47, DOI 10.1046/j.1365-2958.1998.01036.x; Daefler S, 1998, MOL MICROBIOL, V28, P1367, DOI 10.1046/j.1365-2958.1998.00908.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Drake SL, 1997, MOL MICROBIOL, V23, P657, DOI 10.1046/j.1365-2958.1997.2511618.x; Du DJ, 2014, NATURE, V509, P512, DOI 10.1038/nature13205; Durand E, 2014, TRENDS MICROBIOL, V22, P498, DOI 10.1016/j.tim.2014.06.004; Durand E, 2012, J BIOL CHEM, V287, P14157, DOI 10.1074/jbc.M111.338731; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Goemaere EL, 2007, J BIOL CHEM, V282, P17749, DOI 10.1074/jbc.M701002200; Gueguen E, 2013, APPL ENVIRON MICROB, V79, P32, DOI 10.1128/AEM.02504-12; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Judd PK, 2005, P NATL ACAD SCI USA, V102, P11498, DOI 10.1073/pnas.0505290102; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kudryashev M, 2015, CELL, V160, P952, DOI 10.1016/j.cell.2015.01.037; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; Ma LS, 2014, CELL HOST MICROBE, V16, P94, DOI 10.1016/j.chom.2014.06.002; Ma LS, 2012, J BIOL CHEM, V287, P15610, DOI 10.1074/jbc.M111.301630; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Nguyen VS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122187; Nguyen VS, 2015, ACTA CRYSTALLOGR F, V71, P266, DOI 10.1107/S2053230X15000709; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zoued A, 2014, BBA-MOL CELL RES, V1843, P1664, DOI 10.1016/j.bbamcr.2014.03.018; Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772	74	174	178	4	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					555	+		10.1038/nature14667	http://dx.doi.org/10.1038/nature14667			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26200339	Green Submitted			2022-12-28	WOS:000358655200037
J	Wu, YW; Hu, L; Li, Z; Deng, L				Wu, Yongwei; Hu, Lin; Li, Zhe; Deng, Li			Catalytic asymmetric umpolung reactions of imines	NATURE			English	Article							ENANTIOSELECTIVE SYNTHESIS; ANION EQUIVALENTS; ALKYLATIONS; GENERATION; REACTIVITY; AMINES	The carbon-nitrogen double bonds in imines are fundamentally important functional groups in organic chemistry. This is largely due to the fact that imines act as electrophiles towards carbon nucleophiles in reactions that form carbon-carbon bonds, thereby serving as one of the most widely used precursors for the formation of amines in both synthetic and biosynthetic settings(1-5). If the carbon atom of the imine could be rendered electron-rich, the imine could react as a nucleophile instead of as an electrophile. Such a reversal in the electronic characteristics of the imine functionality would facilitate the development of new chemical transformations that convert imines into amines via carbon-carbon bond-forming reactions with carbon electrophiles, thereby creating new opportunities for the efficient synthesis of amines. The development of asymmetric umpolung reactions of imines (in which the imines act as nucleophiles) remains uncharted territory, in spite of the far-reaching impact such reactions would have in organic synthesis. Here we report the discovery and development of new chiral phase-transfer catalysts that promote the highly efficient asymmetric umpolung reactions of imines with the carbon electrophile enals. These catalysts mediate the deprotonation of imines and direct the 2-azaallyl anions thus formed to react with enals in a highly chemoselective, regioselective, diastereoselective and enantioselective fashion. The reaction tolerates a broad range of imines and enals, and can be carried out in high yield with as little as 0.01 mole per cent catalyst with a moisture-and air-tolerant operational protocol. These umpolung reactions provide a conceptually new and practical approach to chiral amino compounds.	[Wu, Yongwei; Hu, Lin; Li, Zhe; Deng, Li] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA	Brandeis University	Deng, L (corresponding author), Brandeis Univ, Dept Chem, 415 South St, Waltham, MA 02454 USA.	deng@brandeis.edu		Hu, Lin/0000-0002-8600-965X	National Institute of General Medical Science (NIH) [GM-61591]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061591] Funding Source: NIH RePORTER	National Institute of General Medical Science (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for financial support from the National Institute of General Medical Science (NIH, GM-61591). We thank M. Bezpalko and B. Foxman for X-ray crystallographic characterizations of structures. C. Fei and B. Hu are acknowledged for the help in substrate preparation.	Bandini M, 2010, CHEM-EUR J, V16, P12462, DOI 10.1002/chem.201000560; BORDWELL FG, 1977, J ORG CHEM, V42, P1817, DOI 10.1021/jo00430a039; Brehme R, 2007, EUR J ORG CHEM, V2007, P5629, DOI 10.1002/ejoc.200700746; Dewick P.M., 2009, MED NATURAL PRODUCTS; DOLLING UH, 1984, J AM CHEM SOC, V106, P446, DOI 10.1021/ja00314a045; Fu P, 2008, J AM CHEM SOC, V130, P5530, DOI 10.1021/ja8001343; Giacalone F, 2012, CHEM SOC REV, V41, P2406, DOI 10.1039/c1cs15206h; Hartwig JF, 2010, ACCOUNTS CHEM RES, V43, P1461, DOI 10.1021/ar100047x; Jakubowska A, 2013, CURR ORG SYNTH, V10, P547; JAUN B, 1980, J AM CHEM SOC, V102, P5741, DOI 10.1021/ja00538a008; Jesse B, 2004, J ORG CHEM, V69, P1357, DOI 10.1021/jo035245j; Knowles RR, 2010, J AM CHEM SOC, V132, P5030, DOI 10.1021/ja101256v; Kobayashi S, 2011, CHEM REV, V111, P2626, DOI 10.1021/cr100204f; Liu M, 2013, CHEM COMMUN, V49, P1404, DOI 10.1039/c2cc37423d; Liu XL, 2014, ORG LETT, V16, P2118, DOI 10.1021/ol500522d; Matsumoto M, 2014, CHEM COMMUN, V50, P13041, DOI 10.1039/c4cc06156j; Nie J, 2011, CHEM REV, V111, P455, DOI 10.1021/cr100166a; Ogle JW, 2008, ORG LETT, V10, P3677, DOI 10.1021/ol8012765; Ooi T, 2004, J AM CHEM SOC, V126, P6844, DOI 10.1021/ja048600b; Qian XY, 2014, ORG LETT, V16, P5228, DOI 10.1021/ol502693r; Robak MT, 2010, CHEM REV, V110, P3600, DOI 10.1021/cr900382t; Royer J., 2010, CHIRAL AMINE SYNTHES, DOI 10.1002/anie.201005721; SEEBACH D, 1975, J ORG CHEM, V40, P231, DOI 10.1021/jo00890a018; SEEBACH D, 1979, ANGEW CHEM INT EDIT, V18, P239, DOI 10.1002/anie.197902393; Shirakawa S, 2013, ANGEW CHEM INT EDIT, V52, P4312, DOI 10.1002/anie.201206835; Silverio DL, 2013, NATURE, V494, P216, DOI 10.1038/nature11844; Smith AB, 2004, ACCOUNTS CHEM RES, V37, P365, DOI 10.1021/ar030245r; Vora HU, 2011, ALDRICHIM ACTA, V44, P3; Wu YW, 2012, J AM CHEM SOC, V134, P14334, DOI 10.1021/ja306771n; Zhu Y, 2014, J AM CHEM SOC, V136, P4500, DOI 10.1021/ja501560x	30	170	171	7	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					445	450		10.1038/nature14617	http://dx.doi.org/10.1038/nature14617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26201597	Green Accepted			2022-12-28	WOS:000358378900033
J	Jackson, LA; Campbell, JD; Frey, SE; Edwards, KM; Keitel, WA; Kotloff, KL; Berry, AA; Graham, I; Atmar, RL; Creech, CB; Thomsen, IP; Patel, SM; Gutierrez, AF; Anderson, EL; El Sahly, HM; Hill, H; Noah, DL; Bellamy, AR				Jackson, Lisa A.; Campbell, James D.; Frey, Sharon E.; Edwards, Kathryn M.; Keitel, Wendy A.; Kotloff, Karen L.; Berry, Andrea A.; Graham, Irene; Atmar, Robert L.; Creech, C. Buddy; Thomsen, Isaac P.; Patel, Shital M.; Gutierrez, Andres F.; Anderson, Edwin L.; El Sahly, Hana M.; Hill, Heather; Noah, Diana L.; Bellamy, Abbie R.			Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							A H1N1 VACCINE; A(H1N1)PMD09 VACCINE; SEASONAL INFLUENZA; ANTIBODY-RESPONSE; IMMUNOGENICITY; VIRUS; SAFETY; ADULTS; TRANSMISSION; CHILDREN	IMPORTANCE Human infections with the avian influenza A(H7N9) virus were first reported in China in 2013 and continue to occur. Hemagglutinin H7 administered alone is a poor immunogen necessitating evaluation of adjuvanted H7N9 vaccines. OBJECTIVE To evaluate the immunogenicity and safety of an inactivated H7N9 vaccine with and without AS03 adjuvant, as well as mixed vaccine schedules that included sequential administration of AS03- and MF59-containing formulations and of adjuvanted and unadjuvanted formulations. DESIGN, SETTING, AND PARTICIPANTS Double-blind, phase 2 trial at 5 US sites enrolled 980 adults aged 19 through 64 years from September 2013 through November 2013; safety follow-up was completed in January 2015. INTERVENTIONS The H7N9 vaccine was given on days 0 and 21 at nominal doses of 3.75 mu g, 7.5 mu g, 15 mu g, and 45 mu g of hemagglutinin with or without AS03 or MF59 adjuvant mixed on site. MAIN OUTCOMES AND MEASURES Proportions achieving a hemagglutination inhibition antibody (HIA) titer of 40 or higher at 21 days after the second vaccination; vaccine-related serious adverse events through 12 months after the first vaccination; and solicited signs and symptoms after vaccination through day 7. RESULTS Two doses of vaccine were required to induce detectable antibody titers in most participants. After 2 doses of an H7N9 formulation containing 15 mu g of hemagglutinin given without adjuvant, with AS03 adjuvant, or with MF59 adjuvant, the proportion achieving an HIA titer of 40 or higher was 2%(95% CI, 0%-7%) without adjuvant (n = 94), 84%(95% CI, 76%-91%) with AS03 adjuvant (n = 96), and 57%(95% CI, 47%-68%) with MF59 adjuvant (n = 92) (P < .001 for comparison of the AS03 and MF59 schedules). The 2 schedules alternating AS03- and MF59-adjuvanted formulations led to lower geometric mean titers (GMTs) of (41.5 [95% CI, 31.7-54.4]; n = 92) and (58.6 [95% CI, 44.3-77.6]; n = 96) than the group induced by 2 AS03-adjuvanted formulations (n = 96) (103.4 [95% CI, 78.7-135.9]; P <.001) but higher GMTs than 2 doses of MF59-adjuvanted formulation (n = 94) (29.0 [95% CI, 22.4-37.6]; P < .001). CONCLUSIONS AND RELEVANCE The AS03 and MF59 adjuvants augmented the immune responses to 2 doses of an inactivated H7N9 influenza vaccine, with AS03-adjuvanted formulations inducing the highest titers. This study of 2 adjuvants used in influenza vaccine formulations with adjuvant mixed on site provides immunogenicity information that may be informative to influenza pandemic preparedness programs.	[Jackson, Lisa A.] Grp Hlth Res Inst, Seattle, WA 98101 USA; [Campbell, James D.; Kotloff, Karen L.; Berry, Andrea A.] Univ Maryland, Sch Med, Div Infect Dis & Trop Pediat, Dept Pediat,Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Frey, Sharon E.; Graham, Irene; Anderson, Edwin L.] St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, St Louis, MO USA; [Edwards, Kathryn M.; Creech, C. Buddy; Thomsen, Isaac P.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Res Program, Nashville, TN USA; [Keitel, Wendy A.; Atmar, Robert L.; Patel, Shital M.; Gutierrez, Andres F.; El Sahly, Hana M.] Baylor Coll Med, Dept Mol Virol & Microbiol & Med, Houston, TX 77030 USA; [Hill, Heather; Bellamy, Abbie R.] EMMES Corp, Rockville, MD USA; [Noah, Diana L.] So Res Inst, Birmingham, AL 35255 USA	University System of Maryland; University of Maryland Baltimore; Saint Louis University; Vanderbilt University; Baylor College of Medicine; Emmes Corporation	Jackson, LA (corresponding author), Grp Hlth Res Inst, 1730 Minor Ave,Ste 1600, Seattle, WA 98101 USA.	jackson.l@ghc.org	kotloff, karen l/E-7768-2012; Campbell, James D/AFN-5982-2022; Atmar, Robert/AFQ-5392-2022	kotloff, karen l/0000-0003-1808-6431; Atmar, Robert/0000-0001-9989-6772; Berry, Andrea/0000-0003-3140-3868	National Institute of Allergy and Infectious Diseases; National Institutes of Health; US Department of Health and Human Services [HHSN272200800004C, HHSN27220080000C, HHSN272200800001C, HHSN272200800002C, HHSN272200800003C, HHSN2722012000031, HHSN27200003, HHSN272200800013C]; University of Maryland General Clinical Research Center [M01-RR-016500]; National Center for Research Resources [K12-RR-023250]; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250, M01RR016500] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; University of Maryland General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by federal funds from the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, and the US Department of Health and Human Services (contracts HHSN272200800004C [Group Health], HHSN27220080000C [Vanderbilt University], HHSN272200800001C [University of Maryland], HHSN272200800002C [Baylor College of Medicine], HHSN272200800003C [Saint Louis University], HHSN2722012000031 and HHSN27200003 [Battelle and subcontractor Southern Research], and HHSN272200800013C [EMMES Corporation]). At the University of Maryland, partial support was also provided by additional funding sources, including grant M01-RR-016500 from the University of Maryland General Clinical Research Center and grant K12-RR-023250 from the National Center for Research Resources. The vaccine and adjuvants were provided by the US Department of Health and Human Services Biomedical Advanced Research and Development Authority from the national prepandemic influenza vaccine stockpile and were manufactured by Sanofi Pasteur (H7N9 vaccine), Novartis Vaccines (MF59 adjuvant), and GlaxoSmithKline (AS03 adjuvant).	Andrews NJ, 2011, VACCINE, V29, P7913, DOI 10.1016/j.vaccine.2011.08.076; Bart SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008761; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Jackson LA, 2012, J INFECT DIS, V206, P811, DOI 10.1093/infdis/jis427; Keitel WA, 2009, VACCINE, V27, P6642, DOI 10.1016/j.vaccine.2009.03.015; Langley JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-279; McElhaney JE, 2013, LANCET INFECT DIS, V13, P485, DOI 10.1016/S1473-3099(13)70046-X; Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854; Noah DL, 2009, CLIN VACCINE IMMUNOL, V16, P558, DOI 10.1128/CVI.00368-08; Nolan T, 2014, J INFECT DIS, V210, P545, DOI 10.1093/infdis/jiu173; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; Peeters M, 2012, VACCINE, V30, P6483, DOI 10.1016/j.vaccine.2012.07.081; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Roman F, 2010, VACCINE, V28, P1740, DOI 10.1016/j.vaccine.2009.12.014; Roy-Ghanta S, 2014, J INFECT DIS, V210, P1419, DOI 10.1093/infdis/jiu284; Tetsutani K, 2012, VACCINE, V30, P7658, DOI 10.1016/j.vaccine.2012.10.007; Uno S, 2011, MICROBIOL IMMUNOL, V55, P783, DOI 10.1111/j.1348-0421.2011.00381.x; Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331; World Health Organization, WHO RISK ASS HUM INF; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532	25	97	109	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					237	246		10.1001/jama.2015.7916	http://dx.doi.org/10.1001/jama.2015.7916			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197184	Bronze			2022-12-28	WOS:000358228000018
J	Hirschberg, J; Manning, CD				Hirschberg, Julia; Manning, Christopher D.			Advances in natural language processing	SCIENCE			English	Review								Natural language processing employs computational techniques for the purpose of learning, understanding, and producing human language content. Early computational approaches to language research focused on automating the analysis of the linguistic structure of language and developing basic technologies such as machine translation, speech recognition, and speech synthesis. Today's researchers refine and make use of such tools in real-world applications, creating spoken dialogue systems and speech-to-speech translation engines, mining social media for information about health or finance, and identifying sentiment and emotion toward products and services. We describe successes and challenges in this rapidly advancing area.	[Hirschberg, Julia] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Manning, Christopher D.] Stanford Univ, Dept Linguist, Stanford, CA 94305 USA; [Manning, Christopher D.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Columbia University; Stanford University; Stanford University	Hirschberg, J (corresponding author), Columbia Univ, Dept Comp Sci, New York, NY 10027 USA.	julia@cs.columbia.edu	Manning, Christopher/AAM-9535-2020	Manning, Christopher/0000-0001-6155-649X				Angeli Gabor, 2014, P 2014 C EMP METH NA, P534; [Anonymous], 2014, P COLING 2014 25 INT; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahdanau D., 2015, 3 INT C LEARN REPR I; Banko M, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2670; Berant J., 2014, EMNLP, P1499; Bjorne J, 2011, COMPUT INTELL-US, V27, P541, DOI 10.1111/j.1467-8640.2011.00399.x; Bollen J., 2011, ICWSM, P450; Brown P. F., 1993, Computational Linguistics, V19, P263; Chiang David, 2005, P 43 ANN M ASS COMPU, P263, DOI DOI 10.3115/1219840.1219873; Core M., 2014, DESIGN RECOMMENDATIO, V2, P249; Coulet A, 2012, J BIOMED INFORM, V45, P825, DOI 10.1016/j.jbi.2012.08.001; Culotta A, 2004, P 42 ANN M ASS COMP, P423, DOI [10.3115/1218955.1219009, DOI 10.3115/1218955.1219009]; DeVault David, 2014, P 13 INT C AUT AG MU; Elhadad N., 2014, KDD BLOOMB WORKSH DA; Etzioni O., 2006, AAAI, V6, P1517; Etzioni Oren, 2011, IJCAI, P3, DOI DOI 10.5591/978-1-57735-516-8/IJCAI11-012; Fader A, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1156, DOI 10.1145/2623330.2623677; Fasola J, 2013, J HUM-ROBOT INTERACT, V2, P3, DOI 10.5898/JHRI.2.2.Fasola; Fundel K, 2007, BIOINFORMATICS, V23, P365, DOI 10.1093/bioinformatics/btl616; Galley M., 2004, P HUM LANG TECHN C N; Giles H., 1987, ANN INT COMMUNICATIO, V10, P13, DOI [DOI 10.1080/23808985.1987.11678638, 10.1080/23808985.1987.11678638]; Gonzalez-Ibanez R., 2011, P 49 ANN M ASS COMP, P581; Goodman N. D., 2015, HDB CONT SEMANTICS; Green Spence, 2014, P 27 ANN ACM S US IN, P177; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hunter L, 2006, MOL CELL, V21, P589, DOI 10.1016/j.molcel.2006.02.012; Jean S., 2015, USING VERY LARGE TAR; Jones B. K., 2012, COLING, P1359; Koehn P, 2003, P 2003 C N AM CHAPT, V1, P48, DOI DOI 10.3115/1073445.1073462; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; LISCOMBE J, 2007, THESIS COLUMBIA U; Londe Zsuzsa Cziraky, 2006, PHONOLOGY, V23, P59, DOI [DOI 10.1017/S0952675706000765, 10.1017/S0952675706000765]; Luong MT, 2015, ADDRESSING RARE WORD; Manning CD, 2014, PROCEEDINGS OF 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: SYSTEM DEMONSTRATIONS, P55, DOI 10.3115/v1/p14-5010; Min B., 2013, P 2013 C N AM CHAPT, P777, DOI [DOI 10.1186/S40537-016-0043-6, 10.1609/aaai.v33i01.33016407]; Mintz M., 2009, P JOINT C 47 ANN M A, V2, P1003, DOI DOI 10.3115/1690219.1690287; NASS C, 1995, INT J HUM-COMPUT ST, V43, P223, DOI 10.1006/ijhc.1995.1042; Nonaka Yuko, 2012, Intelligent Virtual Agents. Proceedings 12th International Conference, IVA 2012, P496, DOI 10.1007/978-3-642-33197-8_57; Ott M., 2012, P 21 INT C WORLD WID, V21, P201, DOI DOI 10.1145/2187836.2187864; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Percha B, 2012, BIOCOMPUT-PAC SYM, P410; Peters SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113523; Rambow O., 2012, P 2 WORKSH LANG SOC, P37; Riedel S., 2013, P 2013 C N AM CHAPT, DOI DOI 10.4218/ETRIJ.2018-0553; Rosenthal S, 2010, P 9 INT C AUTONOMOUS, P915; Russell M. A., 2013, MINING SOCIAL WEB DA; Stymne S, 2013, P WORKSH DIS MACH TR, P60; Surdeanu M, 2012, P 2012 JOINT C EMP M, V2012, P455; Sutskever I., 2014, NEURAL INFORM PROCES, P3104; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Thomas M., 2006, P 2006 C EMP METH NA, P327, DOI DOI 10.3115/1610075.1610122; Turk O, 2010, IEEE T AUDIO SPEECH, V18, P965, DOI 10.1109/TASL.2010.2041113; Van Landeghem S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055814; Wang Hao, 2014, C EMP METH NAT LANG, P1192; WEIZENBAUM J, 1966, COMMUN ACM, V9, P36, DOI 10.1145/357980.357991; Whissell C., 1989, EMOTION THEORY RES E; Wiebe J, 2005, LANG RESOUR EVAL, V39, P165, DOI 10.1007/s10579-005-7880-9	59	450	467	60	423	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		261	266		10.1126/science.aaa8685	http://dx.doi.org/10.1126/science.aaa8685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185244				2022-12-28	WOS:000358218600041
J	Castle, BT; Odde, DJ				Castle, Brian T.; Odde, David J.			Optical Control of Microtubule Dynamics in Time and Space	CELL			English	Editorial Material							MITOSIS; AGENTS	Small molecule inhibitors of microtubule dynamics are widely used as cell biology research tools and clinically as cancer chemotherapeutics. By slight modification to the chemical structure of a known microtubule inhibitor, combretastatin A-4, Borowiak et al. develop a photoswitchable derivative that can be turned "on'' and "off'' with low-intensity light to spatially and temporally control microtubule dynamics.	[Castle, Brian T.; Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Odde, DJ (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	oddex002@umn.edu	Odde, David/AAY-1720-2020	Odde, David/0000-0001-7731-2799; Castle, Brian/0000-0003-3765-7711				Borowiak M, 2015, CELL, V162, P403, DOI 10.1016/j.cell.2015.06.049; Carlson K, 2011, CLIN BREAST CANCER, V11, P73, DOI 10.1016/j.clbc.2011.03.006; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965	8	13	13	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					243	245		10.1016/j.cell.2015.06.064	http://dx.doi.org/10.1016/j.cell.2015.06.064			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186185	Bronze			2022-12-28	WOS:000358087700006
J	Lee, JD; Kim, HS				Lee, Jeong Deuk; Kim, Hei Sung			Cerebriform Nevus Sebaceous	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Jeong Deuk] Incheon St Marys Hosp, Inchon, South Korea; [Kim, Hei Sung] Catholic Univ Korea, Seoul, South Korea	Catholic University of Korea	Lee, JD (corresponding author), Incheon St Marys Hosp, Inchon, South Korea.	hazelkimhoho@gmail.com							0	2	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3					262	262		10.1056/NEJMicm1412178	http://dx.doi.org/10.1056/NEJMicm1412178			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MS	26176383				2022-12-28	WOS:000357956200009
J	Pandya, A; Sy, S; Cho, S; Weinstein, MC; Gaziano, TA				Pandya, Ankur; Sy, Stephen; Cho, Sylvia; Weinstein, Milton C.; Gaziano, Thomas A.			Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; CHOLESTEROL; GUIDELINES; MEDICATIONS; VALIDATION; ASPIRIN; UTILITY; EVENTS; MODELS; STROKE	IMPORTANCE The American College of Cardiology and the American Heart Association (ACC/AHA) cholesterol treatment guidelines have wide-scale implications for treating adults without history of atherosclerotic cardiovascular disease (ASCVD) with statins. OBJECTIVE To estimate the cost-effectiveness of various 10-year ASCVD risk thresholds that could be used in the ACC/AHA cholesterol treatment guidelines. DESIGN, SETTING, AND PARTICIPANTS Microsimulation model, including lifetime time horizon, US societal perspective, 3% discount rate for costs, and health outcomes. In the model, hypothetical individuals from a representative US population aged 40 to 75 years received statin treatment, experienced ASCVD events, and died from ASCVD-related or non-ASCVD-related causes based on ASCVD natural history and statin treatment parameters. Data sources for model parameters included National Health and Nutrition Examination Surveys, large clinical trials and meta-analyses for statin benefits and treatment, and other published sources. MAIN OUTCOMES AND MEASURES Estimated ASCVD events prevented and incremental costs per quality-adjusted life-year (QALY) gained. RESULTS In the base-case scenario, the current ASCVD threshold of 7.5% or higher, which was estimated to be associated with 48% of adults treated with statins, had an incremental cost-effectiveness ratio (ICER) of $37 000/QALY compared with a 10% or higher threshold. More lenient ASCVD thresholds of 4.0% or higher (61% of adults treated) and 3.0% or higher (67% of adults treated) had ICERs of $81 000/QALY and $140 000/QALY, respectively. Shifting from a 7.5% or higher ASCVD risk threshold to a 3.0% or higher ASCVD risk threshold was estimated to be associated with an additional 161 560 cardiovascular disease events averted. Cost-effectiveness results were sensitive to changes in the disutility associated with taking a pill daily, statin price, and the risk of statin-induced diabetes. In probabilistic sensitivity analysis, there was a higher than 93% chance that the optimal ASCVD threshold was 5.0% or lower using a cost-effectiveness threshold of $100 000/QALY. CONCLUSIONS AND RELEVANCE In this microsimulation model of US adults aged 45 to 70 years, the current 10-year ASCVD risk threshold (>= 7.5% risk threshold) used in the ACC/AHA cholesterol treatment guidelines has an acceptable cost-effectiveness profile (ICER, $37 000/QALY), but more lenient ASCVD thresholds would be optimal using cost-effectiveness thresholds of $100 000/QALY (>= 4.0% risk threshold) or $ 150 000/QALY (>= 3.0% risk threshold). The optimal ASCVD threshold was sensitive to patient preferences for taking a pill daily, changes to statin price, and the risk of statin-induced diabetes.	[Pandya, Ankur; Sy, Stephen; Cho, Sylvia; Weinstein, Milton C.; Gaziano, Thomas A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Gaziano, Thomas A.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Pandya, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 718 Huntington Ave,Second Floor, Boston, MA 02115 USA.	anpandya@hsphharvard.edu		Cho, Sylvia/0000-0002-0263-0343	National Heart, Lung, and Blood Institute [5R01HL104284-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104284] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by grant 5R01HL104284-03 to the Harvard School of Public Health from the National Heart, Lung, and Blood Institute (Dr Gaziano).	Abramson JD, DONT GIVE MORE PATIE; AHRQ, MED EXP PAN SURV; Alsheikh-Ali AA, 2005, CIRCULATION, V111, P3051, DOI 10.1161/CIRCULATIONAHA.105.555482; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Centers for Disease Control and Prevention (CDC), 2014, NAT HLTH NUTR EX SUR; Coles AH, 2012, AM J CARDIOL, V110, P1073, DOI 10.1016/j.amjcard.2012.05.046; Deano RC, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0438-9; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Ford ES, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001097; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Greving JP, 2011, BMJ-BRIT MED J, V342, pd1672; Guallar E, 2014, ANN INTERN MED, V160, P361, DOI 10.7326/M14-0112; Heron M, 2010, DEATHS LEADING CAUSE, V58; Hunink MGM, 2014, DECISION MAKING IN HEALTH AND MEDICINE: INTEGRATING EVIDENCE AND VALUES, 2ND EDITION, P1, DOI 10.1017/CBO9781139506779; Hutchins R, 2015, CIRC-CARDIOVASC QUAL, V8, P155, DOI 10.1161/CIRCOUTCOMES.114.001240; Jackevicius CA, 2012, NEW ENGL J MED, V366, P201, DOI 10.1056/NEJMp1113112; Krumholz HM, 2014, JAMA-J AM MED ASSOC, V311, P1403, DOI 10.1001/jama.2014.2634; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Lee KK, 2010, CIRCULATION, V122, P1478, DOI 10.1161/CIRCULATIONAHA.110.947960; Muntner P, 2014, JAMA-J AM MED ASSOC, V311, P1406, DOI 10.1001/jama.2014.2630; National Center for Health Statistics, 2018, NAT HLTH NUTR EX SUR; National Heart Lung and Blood Institute (NHLBI), INC PREV 2006 CHART; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; O'Sullivan AK, 2011, PHARMACOECONOMICS, V29, P693, DOI 10.2165/11584620-000000000-00000; Optum, 2014, DRG EXP COMPR GUID D; Pandya A, 2014, CIRC-CARDIOVASC QUAL, V7, P25, DOI 10.1161/CIRCOUTCOMES.113.000397; Pandya A, 2013, HEALTH AFFAIR, V32, P1706, DOI 10.1377/hlthaff.2013.0449; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Pignone M, 2006, ANN INTERN MED, V144, P326, DOI 10.7326/0003-4819-144-5-200603070-00007; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; Psaty BM, 2014, JAMA-J AM MED ASSOC, V311, P461, DOI 10.1001/jama.2013.284203; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Ridker PM, 2009, CIRC-CARDIOVASC QUAL, V2, P279, DOI 10.1161/CIRCOUTCOMES.109.868299; Robinson JG, 2013, JAMA-J AM MED ASSOC, V310, P2405, DOI 10.1001/jama.2013.281355; Rosenbaum L, 2015, NEW ENGL J MED, V372, P183, DOI 10.1056/NEJMms1409015; Russell LB, 2008, PATIENT, V1, P211, DOI 10.2165/1312067-200801030-00008; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Smith SL, 2011, MEDICARE RBRVS PHYS; Smolina K, 2012, CIRC-CARDIOVASC QUAL, V5, P532, DOI 10.1161/CIRCOUTCOMES.111.964700; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Thomson Healthcare, 2014, RED BOOK; Unal B, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-213; US Bureau of Labor Statistics, HIGHL WOM EARN 2013; van Kempen BJH, 2012, MED DECIS MAKING, V32, P507, DOI 10.1177/0272989X12439754; Vanni T, 2011, PHARMACOECONOMICS, V29, P35, DOI 10.2165/11584600-000000000-00000; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	57	172	173	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					142	150		10.1001/jama.2015.6822	http://dx.doi.org/10.1001/jama.2015.6822			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26172894	Green Accepted, Bronze			2022-12-28	WOS:000357867500014
J	Pfeiffer, BE; Foster, DJ				Pfeiffer, Brad E.; Foster, David J.			Autoassociative dynamics in the generation of sequences of hippocampal place cells	SCIENCE			English	Article							GAMMA-OSCILLATIONS; CA3; MEMORY; REPLAY; RECALL; PATHS; MODEL; SLOW	Neuronal circuits produce self-sustaining sequences of activity patterns, but the precise mechanisms remain unknown. Here we provide evidence for autoassociative dynamics in sequence generation. During sharp-wave ripple (SWR) events, hippocampal neurons express sequenced reactivations, which we show are composed of discrete attractors. Each attractor corresponds to a single location, the representation of which sharpens over the course of several milliseconds, as the reactivation focuses at that location. Subsequently, the reactivation transitions rapidly to a spatially discontiguous location. This alternation between sharpening and transition occurs repeatedly within individual SWRs and is locked to the slow-gamma (25 to 50 hertz) rhythm. These findings support theoretical notions of neural network function and reveal a fundamental discretization in the retrieval of memory in the hippocampus, together with a function for gamma oscillations in the control of attractor dynamics.	[Pfeiffer, Brad E.; Foster, David J.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University	Foster, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	david.foster@jhu.edu			National Institute for Mental Health	National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank K. Zhang for discussion. This work was supported by the National Institute for Mental Health (D.J.F.). The data described in this manuscript are stored in the laboratory of D.J.F. in the Department of Neuroscience, Johns Hopkins University.	Bieri KW, 2014, NEURON, V82, P670, DOI 10.1016/j.neuron.2014.03.013; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 2015, NAT NEUROSCI, V18, P484, DOI 10.1038/nn.3952; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Carr MF, 2012, NEURON, V75, P700, DOI 10.1016/j.neuron.2012.06.014; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gold AE, 2005, HIPPOCAMPUS, V15, P808, DOI 10.1002/hipo.20103; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Igarashi KM, 2014, NATURE, V510, P143, DOI 10.1038/nature13162; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; KLEINFELD D, 1986, P NATL ACAD SCI USA, V83, P9469, DOI 10.1073/pnas.83.24.9469; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; Lisman JE, 2005, NEURAL NETWORKS, V18, P1191, DOI 10.1016/j.neunet.2005.08.008; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Shirvalkar PR, 2010, P NATL ACAD SCI USA, V107, P7054, DOI 10.1073/pnas.0911184107; SOMPOLINSKY H, 1986, PHYS REV LETT, V57, P2861, DOI 10.1103/PhysRevLett.57.2861; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020	30	104	104	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					180	183		10.1126/science.aaa9633	http://dx.doi.org/10.1126/science.aaa9633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26160946				2022-12-28	WOS:000357664300042
J	Stroes, ES; van der Valk, FM				Stroes, Erik S.; van der Valk, Fleur M.			sense of excitement for a specific Lp(a)-lowering therapy	LANCET			English	Editorial Material							LIPOPROTEIN(A)		[Stroes, Erik S.; van der Valk, Fleur M.] Acad Med Ctr, NL-1100 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Stroes, ES (corresponding author), Acad Med Ctr, NL-1100 AZ Amsterdam, Netherlands.	e.s.stroes@amc.uva.nl						Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Boffa MB, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0417-8; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Davidson MH, 2011, J CLIN LIPIDOL, V5, P338, DOI 10.1016/j.jacl.2011.07.005; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Taleb A, 2011, BIOMARK MED, V5, P673, DOI [10.2217/BMM.11.60, 10.2217/bmm.11.60]; Thomas GS, 2013, J AM COLL CARDIOL, V62, P2178, DOI 10.1016/j.jacc.2013.07.081; Tsimikas S, 2015, LANCET, V386, P1472, DOI 10.1016/S0140-6736(15)61252-1; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631	11	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1427	1429		10.1016/S0140-6736(15)60638-9	http://dx.doi.org/10.1016/S0140-6736(15)60638-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5UU	26210643				2022-12-28	WOS:000362877300009
J	Tsimikas, S; Viney, NJ; Hughes, SG; Singleton, W; Graham, MJ; Baker, BF; Burkey, JL; Yang, QQ; Marcovina, SM; Geary, RS; Crooke, RM; Witztum, JL				Tsimikas, Sotirios; Viney, Nicholas J.; Hughes, Steven G.; Singleton, Walter; Graham, Mark J.; Baker, Brenda F.; Burkey, Jennifer L.; Yang, Qingqing; Marcovina, Santica M.; Geary, Richard S.; Crooke, Rosanne M.; Witztum, Joseph L.			Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study	LANCET			English	Article							CORONARY-ARTERY-DISEASE; OXIDIZED PHOSPHOLIPIDS; CARDIOVASCULAR EVENTS; LIPOPROTEIN(A) LEVELS; HEART-DISEASE; ELEVATED LIPOPROTEIN(A); MYOCARDIAL-INFARCTION; NET RECLASSIFICATION; LP(A) LIPOPROTEIN; LIPID APHERESIS	Background Lipoprotein(a) (Lp[a]) is a risk factor for cardiovascular disease and calcific aortic valve stenosis. No effective therapies to lower plasma Lp(a) concentrations exist. We have assessed the safety, pharmacokinetics, and pharmacodynamics of ISIS-APO(a)(Rx), a second-generation antisense drug designed to reduce the synthesis of apolipoprotein(a) (apo[a]) in the liver. Methods In this randomised, double-blind, placebo-controlled, phase 1 study at the PAREXEL Clinical Pharmacology Research Unit (Harrow, Middlesex, UK), we screened for healthy adults aged 18-65 years, with a body-mass index less than 32.0 kg/m(2), and Lp(a) concentration of 25 nmol/L (100 mg/L) or more. Via a randomisation technique, we randomly assigned participants to receive a single subcutaneous injection of ISIS-APO(a)(Rx) (50 mg, 100 mg, 200 mg, or 400 mg) or placebo (3: 1) in the single-dose part of the study or to receive six subcutaneous injections of ISIS-APO(a)(Rx) (100 mg, 200 mg, or 300 mg, for a total dose exposure of 600 mg, 1200 mg, or 1800 mg) or placebo (4: 1) during a 4 week period in the multi-dose part of the study. Participants, investigators, and study staff were masked to the treatment assignment, except for the pharmacist who prepared the ISIS-APO(a)(Rx) or placebo. The primary efficacy endpoint was the percentage change from baseline in Lp(a) concentration at 30 days in the single-dose cohorts and at 36 days for the multi-dose cohorts. Safety and tolerability was assessed 1 week after last dose and included determination of the incidence, severity, and dose relation of adverse events and changes in laboratory variables, including lipid panel, routine haematology, blood chemistry, urinalysis, coagulation, and complement variables. Other assessments included vital signs, a physical examination, and 12-lead electrocardiograph. This trial is registered with European Clinical Trials Database, number 2012-004909-27. Findings Between Feb 27, 2013, and July 15, 2013, 47 (23%) of 206 screened volunteers were randomly assigned to receive ISIS-APO(a)(Rx) as a single-dose or multi-dose of ascending concentrations or placebo. In the single-dose study, we assigned three participants to receive 50 mg ISIS-APO(a)(Rx), three participants to receive 100 mg ISIS-APO(a)(Rx), three participants to receive 200 mg ISIS-APO(a)(Rx), three participants to receive 400 mg ISIS-APO(a)(Rx), and four participants to receive placebo. All 16 participants completed treatment and follow-up and were included in the pharmacodynamics, pharmacokinetics, and safety analyses. For the multi-dose study, we assigned eight participants to receive six doses of 100 mg ISIS-APO(a)(Rx), nine participants to receive six doses of 200 mg ISIS-APO(a)(Rx), eight participants to receive six doses of 300 mg ISIS-APO(a)(Rx), and six participants to receive six doses of placebo. Whereas single doses of ISIS-APO(a)(Rx) (50-400 mg) did not decrease Lp(a) concentrations at day 30, six doses of ISIS-APO(a)(Rx) (100-300 mg) resulted in dose-dependent, mean percentage decreases in plasma Lp(a) concentration of 39.6% from baseline in the 100 mg group (p=0.005), 59.0% in the 200 mg group (p=0.001), and 77.8% in the 300 mg group (p=0.001). Similar reductions were observed in the amount of oxidized phospholipids associated with apolipoprotein B-100 and apolipoprotein(a). Mild injection site reactions were the most common adverse events. Interpretation ISIS-APO(a)(Rx) results in potent, dose-dependent, selective reductions of plasma Lp(a). The safety and tolerability support continued clinical development of ISIS-APO(a)(Rx) as a potential therapeutic drug to reduce the risk of cardiovascular disease and calcific aortic valve stenosis in patients with elevated Lp(a) concentration.	[Tsimikas, Sotirios; Witztum, Joseph L.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Tsimikas, Sotirios; Viney, Nicholas J.; Hughes, Steven G.; Singleton, Walter; Graham, Mark J.; Baker, Brenda F.; Burkey, Jennifer L.; Yang, Qingqing; Geary, Richard S.; Crooke, Rosanne M.] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Marcovina, Santica M.] Univ Washington, Seattle, WA 98195 USA	University of California System; University of California San Diego; Isis Pharmaceuticals Inc; University of Washington; University of Washington Seattle	Tsimikas, S (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	stsimikas@ucsd.edu	Yang, Heroine/GRY-2630-2022	Baker, Brenda/0000-0001-8586-768X	Isis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093] Funding Source: NIH RePORTER	Isis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Isis Pharmaceuticals.	Albers JJ, 2007, KIDNEY INT, V71, P961, DOI 10.1038/sj.ki.5002240; Albers JJ, 2013, J AM COLL CARDIOL, V62, P1575, DOI 10.1016/j.jacc.2013.06.051; Arai K, 2012, J LIPID RES, V53, P1670, DOI 10.1194/jlr.P027235; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Crooke ST, 2013, BRIT J CLIN PHARMACO, V76, P269, DOI 10.1111/j.1365-2125.2012.04469.x; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Guyton JR, 2007, CURR OPIN LIPIDOL, V18, P415, DOI 10.1097/MOL.0b013e3282364add; Jaeger BR, 2009, NAT CLIN PRACT CARD, V6, P229, DOI 10.1038/ncpcardio1456; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Khera AV, 2014, CIRCULATION, V129, P635, DOI 10.1161/CIRCULATIONAHA.113.004406; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; Lamon-Fava S, 2011, J LIPID RES, V52, P1181, DOI 10.1194/jlr.M012526; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Leebmann J, 2013, CIRCULATION, V128, P2567, DOI 10.1161/CIRCULATIONAHA.113.002432; Leibundgut G, 2013, J LIPID RES, V54, P2815, DOI 10.1194/jlr.M040733; Leibundgut G, 2012, J AM COLL CARDIOL, V59, P1426, DOI 10.1016/j.jacc.2011.12.033; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, P2030, DOI 10.1161/ATVBAHA.107.141291; Marcovina SM, 1996, CLIN CHEM, V42, P436; MARCOVINA SM, 1995, CLIN CHEM, V41, P246; Merki E, 2011, J AM COLL CARDIOL, V57, P1611, DOI 10.1016/j.jacc.2010.10.052; Nestel PJ, 2013, ARTERIOSCL THROM VAS, V33, P2902, DOI 10.1161/ATVBAHA.113.302479; O'Donoghue ML, 2014, J AM COLL CARDIOL, V63, P520, DOI 10.1016/j.jacc.2013.09.042; Prakash TP, 2014, NUCLEIC ACIDS RES, V42, P8796, DOI 10.1093/nar/gku531; Rosada A, 2014, ARTIF ORGANS, V38, P135, DOI 10.1111/aor.12135; Santos RD, 2015, ARTERIOSCL THROM VAS, V35, P689, DOI 10.1161/ATVBAHA.114.304549; SEMAN LJ, 1986, BIOCHEM CELL BIOL, V64, P999, DOI 10.1139/o86-133; Spence JD, 2012, ARTERIOSCL THROM VAS, V32, P1550, DOI 10.1161/ATVBAHA.112.251306; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175; Tsimikas S, 2014, J AM COLL CARDIOL, V63, P1724, DOI 10.1016/j.jacc.2013.12.030; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P2218, DOI 10.1016/j.jacc.2012.08.979; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; Tsimikas S, 2009, CIRCULATION, V119, P1711, DOI 10.1161/CIRCULATIONAHA.108.836940; Willeit P, 2014, J AM COLL CARDIOL, V64, P851, DOI 10.1016/j.jacc.2014.03.061	35	313	335	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2015	386	10002					1472	1483		10.1016/S0140-6736(15)61252-1	http://dx.doi.org/10.1016/S0140-6736(15)61252-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5UU	26210642				2022-12-28	WOS:000362877300030
J	Bochman, ML; Schwacha, A				Bochman, Matthew L.; Schwacha, Anthony			DNA REPLICATION Strand separation unravelled	NATURE			English	Editorial Material							MCM COMPLEX; HELICASE; ORIGIN; HEXAMER		[Bochman, Matthew L.] Indiana Univ, Mol & Cellular Biochem Dept, Bloomington, IN 47405 USA; [Schwacha, Anthony] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bochman, ML (corresponding author), Indiana Univ, Mol & Cellular Biochem Dept, Bloomington, IN 47405 USA.	bochman@indiana.edu; schwacha@pitt.edu	Bochman, Matthew L./I-2033-2019	Bochman, Matthew L./0000-0002-2807-0452				Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gai DH, 2010, CURR OPIN STRUC BIOL, V20, P756, DOI 10.1016/j.sbi.2010.08.009; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Kuhlbrandt W, 2014, ELIFE, V3, DOI 10.7554/eLife.03678; Li NN, 2015, NATURE, V524, P186, DOI 10.1038/nature14685; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Schuck S, 2011, MOL CELL, V43, P776, DOI 10.1016/j.molcel.2011.06.026; Shin J, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4916379; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Ticau S, 2015, CELL, V161, P513, DOI 10.1016/j.cell.2015.03.012; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992	16	5	5	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					166	167		10.1038/nature14643	http://dx.doi.org/10.1038/nature14643			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26222029				2022-12-28	WOS:000359386900018
J	Clement, ME; Okeke, L; Hicks, CB				Clement, Meredith E.; Okeke, Lance; Hicks, Charles B.			Fever and Rash in a Patient With Hepatitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYPHILITIC HEPATITIS; AUTOIMMUNE HEPATITIS; LIVER-INJURY		[Clement, Meredith E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Okeke, Lance] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA; [Hicks, Charles B.] Univ Calif San Diego, Div Gen Internal Med, San Diego, CA 92103 USA; [Hicks, Charles B.] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA	Duke University; Duke University; University of California System; University of California San Diego; University of California System; University of California San Diego	Hicks, CB (corresponding author), Univ Calif San Diego, 200W Arbor Dr,Mail Stop 8681, San Diego, CA 92103 USA.	cbhicks@ucsd.edu			NIAID NIH HHS [T32 AI007392] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2014, JAMA, V312, P122; Bjornsson E, 2012, J HEPATOL, V56, P374, DOI [10.1016/j.jhep.2011.08.016, 10.1016/j.jhep.2011.07.023]; Buffet M, 2007, J INVEST DERMATOL, V127, P2345, DOI 10.1038/sj.jid.5700888; Clement ME, 2014, JAMA-J AM MED ASSOC, V312, P1905, DOI 10.1001/jama.2014.13259; FEHER J, 1975, LANCET, V2, P896; Hagel S, 2012, INT J STD AIDS, V23, P448, DOI 10.1258/ijsa.2009.009337; MacSween RNM, 2011, MACSWEENS PATHOLOGY, V6th; Mullick CJ, 2004, CLIN INFECT DIS, V39, pE100, DOI 10.1086/425501; Suzuki A, 2011, HEPATOLOGY, V54, P931, DOI 10.1002/hep.24481; Vernazza P, 2008, HIV POSITIVE INDIVID	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					400	401		10.1001/jama.2015.3401	http://dx.doi.org/10.1001/jama.2015.3401			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219059	Green Published, Green Accepted			2022-12-28	WOS:000358581700023
J	Rajaram, R; Chung, JW; Kinnier, CV; Barnard, C; Mohanty, S; Pavey, ES; McHugh, MC; Bilimoria, KY				Rajaram, Ravi; Chung, Jeanette W.; Kinnier, Christine V.; Barnard, Cynthia; Mohanty, Sanjay; Pavey, Emily S.; McHugh, Megan C.; Bilimoria, Karl Y.			Hospital Characteristics Associated With Penalties in the Centers for Medicare & Medicaid Services Hospital-Acquired Condition Reduction Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURVEILLANCE BIAS; UNITED-STATES; CARE; QUALITY; OUTCOMES; HEALTH; PERFORMANCE; ADJUSTMENT; SURGERY; VOLUME	IMPORTANCE In fiscal year (FY) 2015, the Centers for Medicare & Medicaid Services (CMS) instituted the Hospital-Acquired Condition (HAC) Reduction Program, which reduces payments to the lowest-performing hospitals. However, it is uncertain whether this program accurately measures quality and fairly penalizes hospitals. OBJECTIVE To examine the characteristics of hospitals penalized by the HAC Reduction Program and to evaluate the association of a summary score of hospital characteristics related to quality with penalization in the HAC program. DESIGN, SETTING, AND PARTICIPANTS Data for hospitals participating in the FY2015 HAC Reduction Program were obtained from CMS' Hospital Compare and merged with the 2014 American Hospital Association Annual Survey and FY2015 Medicare Impact File. Logistic regression models were developed to examine the association between hospital characteristics and HAC program penalization. An 8-point hospital quality summary score was created using hospital characteristics related to volume, accreditations, and offering of advanced care services. The relationship between the hospital quality summary score and HAC program penalization was examined. Publicly reported process-of-care and outcome measures were examined from 4 clinical areas (surgery, acute myocardial infarction, heart failure, pneumonia), and their association with the hospital quality summary score was evaluated. EXPOSURES Penalization in the HAC Reduction Program. MAIN OUTCOMES AND MEASURES Hospital characteristics associated with penalization. RESULTS Of the 3284 hospitals participating in the HAC program, 721 (22.0%) were penalized. Hospitals were more likely to be penalized if they were accredited by the Joint Commission (24.0% accredited, 14.4% not accredited; odds ratio [OR], 1.33; 95% CI, 1.04-1.70); they were major teaching hospitals (42.3%; OR, 1.58; 95% CI, 1.09-2.29) or very major teaching hospitals (62.2%; OR, 2.61; 95% CI, 1.55-4.39; vs nonteaching hospitals, 17.0%); they cared for more complex patient populations based on case mix index (quartile 4 vs quartile 1: 32.8% vs 12.1%; OR, 1.98; 95% CI, 1.44-2.71); or they were safety-net hospitals vs non-safety-net hospitals (28.3% vs 19.9%; OR, 1.36; 95% CI, 1.11-1.68). Hospitals with higher hospital quality summary scores had significantly better performance on 9 of 10 publicly reported process and outcomes measures compared with hospitals that had lower quality scores (all P <= .01 for trend). However, hospitals with the highest quality score of 8 were penalized significantly more frequently than hospitals with the lowest quality score of 0 (67.3%[37/55] vs 12.6%[53/422]; P < .001 for trend). CONCLUSIONS AND RELEVANCE Among hospitals participating in the HAC Reduction Program, hospitals that were penalized more frequently had more quality accreditations, offered advanced services, were major teaching institutions, and had better performance on other process and outcome measures. These paradoxical findings suggest that the approach for assessing hospital penalties in the HAC Reduction Program merits reconsideration to ensure it is achieving the intended goals.	[Rajaram, Ravi; Chung, Jeanette W.; Kinnier, Christine V.; Pavey, Emily S.; Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, SOQIC, Dept Surg, Chicago, IL 60611 USA; [Rajaram, Ravi; Barnard, Cynthia; McHugh, Megan C.; Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, Inst Publ Hlth & Med, Chicago, IL 60611 USA; [Kinnier, Christine V.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Barnard, Cynthia; Bilimoria, Karl Y.] Northwestern Mem HealthCare, Div Qual, Chicago, IL USA; [Mohanty, Sanjay] Henry Ford Hosp, Dept Surg, Detroit, MI 48202 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Harvard University; Massachusetts General Hospital; Henry Ford Health System; Henry Ford Hospital	Bilimoria, KY (corresponding author), Northwestern Univ, Feinberg Sch Med, SOQIC, Dept Surg, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu	Callahan, Charles D/L-1641-2013		Agency for Healthcare Research and Quality [T32HS000078]; American College of Surgeons Clinical Scholars in Residence Program; Merck; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000078] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American College of Surgeons Clinical Scholars in Residence Program; Merck(Merck & Company); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr Rajaramis supported by the Agency for Healthcare Research and Quality (T32HS000078), the American College of Surgeons Clinical Scholars in Residence Program, and an unrestricted educational grant from Merck.	[Anonymous], HOSP ACQ COND RED PR; [Anonymous], IS SIR ADJ RISK; [Anonymous], CAS MIX IND; [Anonymous], FED REG; [Anonymous], NAT HEALTHC SAF NET; Ayanian JZ, 2002, MILBANK Q, V80, P569, DOI 10.1111/1468-0009.00023; Bilimoria KY, 2013, JAMA-J AM MED ASSOC, V310, P1482, DOI 10.1001/jama.2013.280048; Bilimoria KY, 2009, J CLIN ONCOL, V27, P4177, DOI 10.1200/JCO.2008.21.7018; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Centers for Medicare and Medicaid Services, READM RED PROGR; Centers for Medicare & Medicaid Services, HOSP ACQ COND HAC RE; Chung JW, 2014, BMJ QUAL SAF, V23, P947, DOI 10.1136/bmjqs-2014-003150; Cohen ME, 2016, ANN SURG, V263, P267, DOI 10.1097/SLA.0000000000001192; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Dimick JB, 2012, ANN SURG, V255, P703, DOI 10.1097/SLA.0b013e31824b46ff; Dixon-Woods M, 2012, MILBANK Q, V90, P548, DOI 10.1111/j.1468-0009.2012.00674.x; Gilman M, 2015, HEALTH AFFAIR, V34, P398, DOI 10.1377/hlthaff.2014.1059; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Hospital participation, SURG CAR OUTC ASS PR; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Ju MH, 2015, JAMA SURG, V150, P51, DOI 10.1001/jamasurg.2014.2891; KEELER EB, 1992, JAMA-J AM MED ASSOC, V268, P1709, DOI 10.1001/jama.268.13.1709; McBryde ES, 2009, INFECT CONT HOSP EP, V30, P1045, DOI 10.1086/606168; McGregor JC, 2014, INFECT CONT HOSP EP, V35, P8, DOI 10.1086/674412; Member hospitals, MEM HOSP; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; QualityNet, SCOR METH HOSP ACQ C; Rajaram R, 2015, JAMA-J AM MED ASSOC, V313, P897, DOI 10.1001/jama.2015.52; Rajaram R, 2014, JAMA-J AM MED ASSOC, V312, P2374, DOI 10.1001/jama.2014.15277; Rau J, KAISER HLTH NEWS; Sarrazin MS, 2012, JAMA-J AM MED ASSOC, V307, P1433; Schmaltz SP, 2011, J HOSP MED, V6, P454, DOI 10.1002/jhm.905; Stone PW, 2014, AM J INFECT CONTROL, V42, P94, DOI 10.1016/j.ajic.2013.10.003; Trick WE, 2013, CLIN INFECT DIS, V57, P434, DOI 10.1093/cid/cit249	34	115	115	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					375	383		10.1001/jama.2015.8609	http://dx.doi.org/10.1001/jama.2015.8609			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219055	Bronze			2022-12-28	WOS:000358581700019
J	Sokol, DK				Sokol, Daniel K.			Let's raise a glass to the ordinary sensible patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UK LAW				Sokol, DK (corresponding author), 12 Kings Bench Walk, London, England.	Sokol@12kbw.co.uk						Edozien LC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2877; Sokol DK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1481	2	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2015	351								h3956	10.1136/bmj.h3956	http://dx.doi.org/10.1136/bmj.h3956			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2TX	26220072				2022-12-28	WOS:000359010600004
J	Poortmans, PM; Collette, S; Kirkove, C; Van Limbergen, E; Budach, V; Struikmans, H; Collette, L; Fourquet, A; Maingon, P; Valli, M; De Winter, K; Marnitz, S; Barillot, I; Scandolaro, L; Vonk, E; Rodenhuis, C; Marsiglia, H; Weidner, N; van Tienhoven, G; Glanzmann, C; Kuten, A; Arriagada, R; Bartelink, H; van den Bogaert, W				Poortmans, P. M.; Collette, S.; Kirkove, C.; Van Limbergen, E.; Budach, V.; Struikmans, H.; Collette, L.; Fourquet, A.; Maingon, P.; Valli, M.; De Winter, K.; Marnitz, S.; Barillot, I.; Scandolaro, L.; Vonk, E.; Rodenhuis, C.; Marsiglia, H.; Weidner, N.; van Tienhoven, G.; Glanzmann, C.; Kuten, A.; Arriagada, R.; Bartelink, H.; van den Bogaert, W.		EORTC Radiation Oncology Grp; EORTC Breast Canc Grp	Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LYMPH-NODE CHAIN; QUALITY-ASSURANCE; CARDIAC TOXICITY; HIGH-RISK; POSTOPERATIVE RADIOTHERAPY; PREMENOPAUSAL WOMEN; RADIATION-THERAPY; RANDOMIZED-TRIAL; STAGE-I; MORTALITY	BACKGROUND The effect of internal mammary and medial supraclavicular lymph-node irradiation (regional nodal irradiation) added to whole-breast or thoracic-wall irradiation after surgery on survival among women with early-stage breast cancer is unknown. METHODS We randomly assigned women who had a centrally or medially located primary tumor, irrespective of axillary involvement, or an externally located tumor with axillary involvement to undergo either whole-breast or thoracic-wall irradiation in addition to regional nodal irradiation (nodal-irradiation group) or whole-breast or thoracic-wall irradiation alone (control group). The primary end point was overall survival. Secondary end points were the rates of disease-free survival, survival free from distant disease, and death from breast cancer. RESULTS Between 1996 and 2004, a total of 4004 patients underwent randomization. The majority of patients (76.1%) underwent breast-conserving surgery. After mastectomy, 73.4% of the patients in both groups underwent chest-wall irradiation. Nearly all patients with node-positive disease (99.0%) and 66.3% of patients with node-negative disease received adjuvant systemic treatment. At a median follow-up of 10.9 years, 811 patients had died. At 10 years, overall survival was 82.3% in the nodal-irradiation group and 80.7% in the control group (hazard ratio for death with nodal irradiation, 0.87; 95% confidence interval [CI], 0.76 to 1.00; P = 0.06). The rate of disease-free survival was 72.1% in the nodal-irradiation group and 69.1% in the control group (hazard ratio for disease progression or death, 0.89; 95% CI, 0.80 to 1.00; P = 0.04), the rate of distant disease-free survival was 78.0% versus 75.0% (hazard ratio, 0.86; 95% CI, 0.76 to 0.98; P = 0.02), and breast-cancer mortality was 12.5% versus 14.4% (hazard ratio, 0.82; 95% CI, 0.70 to 0.97; P = 0.02). Acute side effects of regional nodal irradiation were modest. CONCLUSIONS In patients with early-stage breast cancer, irradiation of the regional nodes had a marginal effect on overall survival. Disease-free survival and distant disease-free survival were improved, and breast-cancer mortality was reduced.	[Poortmans, P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6500 HB Nijmegen, Netherlands; [Poortmans, P. M.; De Winter, K.] Inst Verbeeten, Dept Radiat Oncol, Tilburg, Netherlands; [Struikmans, H.] Med Ctr Haaglanden, Dept Radiat Oncol, The Hague, Netherlands; [Struikmans, H.; Rodenhuis, C.] Univ Med Ctr Utrecht, Dept Radiat Oncol, Utrecht, Netherlands; [Vonk, E.] Inst Stedendriehoek & Omstreken, Inst Radiat Oncol Radiotherapeut, Dept Radiat Oncol, Deventer, Netherlands; [van Tienhoven, G.] Univ Amsterdam, Acad Med Ctr, Dept Radiat Oncol, NL-1105 AZ Amsterdam, Netherlands; [Bartelink, H.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands; [Collette, S.; Collette, L.] Catholic Univ Louvain, European Org Res & Treatment Canc EORTC Headquart, B-1200 Brussels, Belgium; [Kirkove, C.] Catholic Univ Louvain, St Luc Univ Hosp, Dept Radiat Oncol, B-1200 Brussels, Belgium; [Van Limbergen, E.; van den Bogaert, W.] Univ Hosp Gasthuisberg, Dept Radiat Oncol, Leuven, Belgium; [Budach, V.; Marnitz, S.] Charite, Dept Radiat Oncol, D-13353 Berlin, Germany; [Weidner, N.] Univ Hosp, Dept Radiat Oncol, Tubingen, Germany; [Fourquet, A.] Inst Curie, Dept Radiat Oncol, Paris, France; [Maingon, P.; Barillot, I.] Ctr Georges Francois Leclerc, Dept Radiat Oncol, Dijon, France; [Barillot, I.] Univ Tours, Dept Radiat Oncol, Tours, France; [Marsiglia, H.] Gustave Roussy Canc Ctr, Dept Radiat Oncol, Villejuif, France; [Valli, M.] Osped Reg Bellinzona & Valli, Dept Radiat Oncol, Bellinzona, Switzerland; [Glanzmann, C.] Univ Zurich Hosp, Dept Radiat Oncol, Zurich, Switzerland; [Valli, M.; Scandolaro, L.] St Anna Hosp, Dept Radiat Oncol, Como, Italy; [Kuten, A.] Rambam Med Ctr, Dept Radiat Oncol, Haifa, Israel; [Arriagada, R.] Grp Oncol Cooperat Chileno Invest, Santiago, Chile	Radboud University Nijmegen; Instituut Verbeeten; Haaglanden Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; KU Leuven; University Hospital Leuven; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Georges-Francois Leclerc; Universite de Tours; UNICANCER; Gustave Roussy; Regional Hospital of Bellinzona & Valleys, San Giovanni; University of Zurich; University Zurich Hospital; University of Ferrara; Arcispedale Sant'Anna; Rambam Health Care Campus; Technion Israel Institute of Technology	Poortmans, PM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	philip.poortmans@radboudumc.nl	Poortmans, P.M.P./L-4581-2015	SCANDOLARO, LUCIANO/0000-0001-9186-3730; Collette, Laurence/0000-0003-2518-7281; van Tienhoven, Geertjan/0000-0002-2516-2263; Arriagada, Rodrigo/0000-0002-3134-1735; Budach, Volker/0000-0002-2191-9871; Matzinger, Oscar/0000-0002-5054-1564	Fonds Cancer	Fonds Cancer	Funded by Fonds Cancer; ClinicalTrials.gov number, NCT00002851.	ABE O, 1995, NEW ENGL J MED, V333, P1444; ARRIAGADA R, 1988, RADIOTHER ONCOL, V11, P213, DOI 10.1016/0167-8140(88)90003-5; ARRIAGADA R, 1995, J CLIN ONCOL, V13, P2869, DOI 10.1200/JCO.1995.13.12.2869; Bird BRJH, 2008, CLIN CANCER RES, V14, P14, DOI 10.1158/1078-0432.CCR-07-1033; Chen RC, 2008, J CLIN ONCOL, V26, P4981, DOI 10.1200/JCO.2008.17.4862; Correa CR, 2007, J CLIN ONCOL, V25, P3031, DOI 10.1200/JCO.2006.08.6595; Cuzick J, 1988, Recent Results Cancer Res, V111, P108; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Doyle JJ, 2007, INT J RADIAT ONCOL, V68, P82, DOI 10.1016/j.ijrobp.2006.12.019; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Estourgie SH, 2004, ANN SURG, V239, P232, DOI 10.1097/01.sla.0000109156.26378.90; Harris EER, 2006, J CLIN ONCOL, V24, P4100, DOI 10.1200/JCO.2005.05.1037; Hennequin C, 2013, INT J RADIAT ONCOL, V86, P860, DOI 10.1016/j.ijrobp.2013.03.021; Heuts EM, 2009, EJSO-EUR J SURG ONC, V35, P252, DOI 10.1016/j.ejso.2008.06.1493; Hooning MJ, 2007, JNCI-J NATL CANCER I, V99, P365, DOI 10.1093/jnci/djk064; Huang O, 2008, BREAST CANCER RES TR, V107, P379, DOI 10.1007/s10549-007-9561-4; Krengli M, 2008, INT J RADIAT ONCOL, V70, P1460, DOI 10.1016/j.ijrobp.2007.08.050; Lievens Y, 2001, RADIOTHER ONCOL, V60, P257, DOI 10.1016/S0167-8140(01)00351-6; Lind P, 2006, ACTA ONCOL, V45, P13, DOI 10.1080/02841860500466632; Matzinger O, 2010, ACTA ONCOL, V49, P24, DOI 10.3109/02841860903352959; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Muren LP, 2002, RADIOTHER ONCOL, V62, P173, DOI 10.1016/S0167-8140(01)00468-6; Musat E, 2007, EUR J CANCER, V43, P718, DOI 10.1016/j.ejca.2006.11.015; Offersen BV, 2015, RADIOTHER ONCOL, V114, P3, DOI 10.1016/j.radonc.2014.11.030; Osman SOS, 2014, RADIOTHER ONCOL, V112, P17, DOI 10.1016/j.radonc.2014.04.004; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Poortmans P, 2006, STRAHLENTHER ONKOL, V182, P576, DOI 10.1007/s00066-006-1629-2; Poortmans P, 2014, LANCET, V383, P2104, DOI 10.1016/S0140-6736(14)60192-6; Poortmans PMP, 2001, INT J RADIAT ONCOL, V49, P1399, DOI 10.1016/S0360-3016(00)01549-2; Prosnitz RG, 2007, CANCER-AM CANCER SOC, V110, P1840, DOI 10.1002/cncr.22965; Ragaz J, 1997, NEW ENGL J MED, V337, P956, DOI 10.1056/NEJM199710023371402; Roychoudhuri R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-9; Senkus-Konefka E, 2007, CANCER TREAT REV, V33, P578, DOI 10.1016/j.ctrv.2007.07.011; Taylor CW, 2009, INT J RADIAT ONCOL, V73, P1061, DOI 10.1016/j.ijrobp.2008.05.066; Thorsen LBJ, 2014, ACTA ONCOL, V53, P1027, DOI 10.3109/0284186X.2014.925579; Veronesi U, 2008, ANN ONCOL, V19, P1553, DOI 10.1093/annonc/mdn183; Veronesi U, 1999, EUR J CANCER, V35, P1320, DOI 10.1016/S0959-8049(99)00133-1; Whelan TJ, 2015, NEW ENGL J MED, V373, P307, DOI 10.1056/NEJMoa1415340	39	674	711	3	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					317	327		10.1056/NEJMoa1415369	http://dx.doi.org/10.1056/NEJMoa1415369			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3NL	26200978	Green Accepted, Green Published			2022-12-28	WOS:000358333500005
J	Reese, PP; Abt, PL; Blumberg, EA; Goldberg, DS				Reese, Peter P.; Abt, Peter L.; Blumberg, Emily A.; Goldberg, David S.			Transplanting Hepatitis C-Positive Kidneys	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HCV		[Reese, Peter P.] Univ Penn, Perelman Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Reese, Peter P.; Goldberg, David S.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Abt, Peter L.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Blumberg, Emily A.] Univ Penn, Div Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA; [Goldberg, David S.] Univ Penn, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Reese, PP (corresponding author), Univ Penn, Perelman Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.		Abt, Peter/AAD-6856-2019					Abbott KC, 2003, J AM SOC NEPHROL, V14, P2908, DOI 10.1097/01.ASN.0000090743.43034.72; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Kucirka LM, 2010, AM J TRANSPLANT, V10, P1238, DOI 10.1111/j.1600-6143.2010.03091.x; Reddy KR, 2014, HEPATOLOGY, V60, p200A; Schnitzler MA, 2005, TRANSPLANTATION, V80, P1636, DOI 10.1097/01.tp.0000179637.37276.5a	5	123	124	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					303	305		10.1056/NEJMp1505074	http://dx.doi.org/10.1056/NEJMp1505074			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3NL	26200976				2022-12-28	WOS:000358333500003
J	Diamandis, EP				Diamandis, Eleftherios P.			Getting noticed is half the battle	SCIENCE			English	Editorial Material									[Diamandis, Eleftherios P.] Univ Toronto, Clin Biochem, Toronto, ON, Canada; [Diamandis, Eleftherios P.] Univ Hlth Network, Toronto, ON, Canada; [Diamandis, Eleftherios P.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Diamandis, EP (corresponding author), Univ Toronto, Clin Biochem, Toronto, ON, Canada.			Diamandis, Eleftherios/0000-0002-1589-820X					0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					206	206		10.1126/science.349.6244.206	http://dx.doi.org/10.1126/science.349.6244.206			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4OM	26160950				2022-12-28	WOS:000357664300047
J	Katz, SJ; Kurian, AW; Morrow, M				Katz, Steven J.; Kurian, Allison W.; Morrow, Monica			Treatment Decision Making and Genetic Testing for Breast Cancer Mainstreaming Mutations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Katz, Steven J.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Katz, Steven J.] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Kurian, Allison W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Kurian, Allison W.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Morrow, Monica] Mem Sloan Kettering Canc Ctr, Breast Serv, New York, NY 10021 USA; [Morrow, Monica] Cornell Univ, Dept Surg, Weill Med Coll, New York, NY 10021 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; Stanford University; Memorial Sloan Kettering Cancer Center; Cornell University	Katz, SJ (corresponding author), Univ Michigan, Dept Med, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	skatz@umich.edu	KATZ, STEVEN/ABH-8886-2020; Kurian, Allison/A-4560-2019	Kurian, Allison/0000-0002-6175-9470	NATIONAL CANCER INSTITUTE [P01CA163233] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA163233] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Hooker GW, 2014, AM COLL MED GEN ANN; Jagsi R, 2015, AM SOC CLIN ONC ANN; Kurian AW, 2015, JAMA ONCOL, V1, P277, DOI 10.1001/jamaoncol.2015.28; Maxwell KN, 2015, GENET MED, V17, P630, DOI 10.1038/gim.2014.176; Morrow M, 2011, LANCET, V378, P1804, DOI 10.1016/S0140-6736(11)61350-0; Nichols HB, 2011, J CLIN ONCOL, V29, P1564, DOI 10.1200/JCO.2010.32.7395; Tuttle TM, 2007, J CLIN ONCOL, V25, P5203, DOI 10.1200/JCO.2007.12.3141	8	24	24	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2015	314	10					997	998		10.1001/jama.2015.8088	http://dx.doi.org/10.1001/jama.2015.8088			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ8FA	26203642				2022-12-28	WOS:000360840700007
J	Danel, C; Moh, R; Gabillard, D; Badje, A; Le Carrou, J; Ouassa, T; Ouattara, E; Anzian, A; Ntakpe, JB; Minga, A; Kouame, GM; Bouhoussou, F; Emieme, A; Kouame, A; Inwoley, A; Toni, TD; Ahiboh, H; Kabran, M; Rabe, C; Sidibe, B; Nzunetu, G; Konan, R; Gnokoro, J; Gouesse, P; Messou, E; Dohoun, L; Kamagate, S; Yao, A; Amon, S; Kouame, AB; Koua, A; Kouame, E; Ndri, Y; Ba-Gomis, O; Daligou, M; Ackoundze, S; Hawerlander, D; Ani, A; Dembele, F; Guehi, C; Kanga, C; Seri, J; Oyebi, M; Mbakop, N; Makaila, O; Babatunde, C; Babatounde, N; Bleoue, G; Tchoutedjem, M; Kouadio, AC; Sena, G; Yededji, SY; Assi, R; Bakayoko, A; Mahassadi, A; Attia, A; Oussou, A; Mobio, M; Bamba, D; Koman, M; Horo, A; Deschamps, N; Chenal, H; Sassan-Morokro, M; Konate, S; Aka, K; Aoussi, E; Journot, V; Nchot, C; Karcher, S; Chaix, ML; Rouzioux, C; Sow, PS; Perronne, C; Girard, PM; Menan, H; Bissagnene, E; Kadio, A; Ettiegne-Traore, V; Moh-Semde, C; Kouame, A; Massumbuko, JM; Chene, G; Dosso, M; Domoua, SK; N'Dri-Yoman, T; Salamon, R; Eholiee, SP; Anglaret, X				Danel, Christine; Moh, Raoul; Gabillard, Delphine; Badje, Anani; Le Carrou, Jerome; Ouassa, Timothee; Ouattara, Eric; Anzian, Amani; Ntakpe, Jean-Baptiste; Minga, Albert; Kouame, Gerard M.; Bouhoussou, Franck; Emieme, Arlette; Kouame, Antoine; Inwoley, Andre; Toni, Thomas-d'Aquin; Ahiboh, Hugues; Kabran, Mathieu; Rabe, Cyprien; Sidibe, Baba; Nzunetu, Gustave; Konan, Romuald; Gnokoro, Joachim; Gouesse, Patrice; Messou, Eugene; Dohoun, Lambert; Kamagate, Synali; Yao, Abo; Amon, Solange; Kouame, Amadou-Barenson; Koua, Aboli; Kouame, Emmanuel; Ndri, Yao; Ba-Gomis, Olivier; Daligou, Marcelle; Ackoundze, Simplice; Hawerlander, Denise; Ani, Alex; Dembele, Fassery; Guehi, Calixte; Kanga, Constance; Seri, Jonas; Oyebi, Mykayila; Mbakop, Nathalie; Makaila, Olewole; Babatunde, Carole; Babatounde, Nathanael; Bleoue, Gisele; Tchoutedjem, Mireille; Kouadio, Alain-Claude; Sena, Ghislaine; Yededji, Sahinou-Yediga; Assi, Rodrigue; Bakayoko, Alima; Mahassadi, Alassane; Attia, Alain; Oussou, Armel; Mobio, Max; Bamba, Dofere; Koman, Mesmin; Horo, Apollinaire; Deschamps, Nina; Chenal, Henri; Sassan-Morokro, Madeleine; Konate, Seidou; Aka, Kakou; Aoussi, Eba; Journot, Valerie; Nchot, Celestin; Karcher, Sophie; Chaix, Marie-Laure; Rouzioux, Christine; Sow, Papa-Salif; Perronne, Christian; Girard, Pierre-Marie; Menan, Herve; Bissagnene, Emmanuel; Kadio, Auguste; Ettiegne-Traore, Virginie; Moh-Semde, Corinne; Kouame, Abo; Massumbuko, Jean-Marie; Chene, Genevieve; Dosso, Mireille; Domoua, Serge K.; N'Dri-Yoman, Theresse; Salamon, Roger; Eholie, Serge P.; Anglaret, Xavier			A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED ADULTS; PLACEBO-CONTROLLED TRIAL; CLINICAL-OUTCOMES; SOUTH-AFRICA; DOUBLE-BLIND; TUBERCULOSIS; MORTALITY; DEATH; IMPLEMENTATION	BACKGROUND In sub-Saharan Africa, the burden of human immunodeficiency virus (HIV)-associated tuberculosis is high. We conducted a trial with a 2-by-2 factorial design to assess the benefits of early antiretroviral therapy (ART), 6-month isoniazid preventive therapy (IPT), or both among HIV-infected adults with high CD4+ cell counts in Ivory Coast. METHODS We included participants who had HIV type 1 infection and a CD4+ count of less than 800 cells per cubic millimeter and who met no criteria for starting ART according to World Health Organization (WHO) guidelines. Participants were randomly assigned to one of four treatment groups: deferred ART (ART initiation according to WHO criteria), deferred ART plus IPT, early ART (immediate ART initiation), or early ART plus IPT. The primary end point was a composite of diseases included in the case definition of the acquired immunodeficiency syndrome (AIDS), non-AIDS-defining cancer, non-AIDS-defining invasive bacterial disease, or death from any cause at 30 months. We used Cox proportional models to compare outcomes between the deferred-ART and early-ART strategies and between the IPT and no-IPT strategies. RESULTS A total of 2056 patients (41% with a baseline CD4+ count of >= 500 cells per cubic millimeter) were followed for 4757 patient-years. A total of 204 primary end-point events were observed (3.8 events per 100 person-years; 95% confidence interval [CI], 3.3 to 4.4), including 68 in patients with a baseline CD4+ count of at least 500 cells per cubic millimeter (3.2 events per 100 person-years; 95% CI, 2.4 to 4.0). Tuberculosis and invasive bacterial diseases accounted for 42% and 27% of primary end-point events, respectively. The risk of death or severe HIV-related illness was lower with early ART than with deferred ART (adjusted hazard ratio, 0.56; 95% CI, 0.41 to 0.76; adjusted hazard ratio among patients with a baseline CD4+ count of >= 500 cells per cubic millimeter, 0.56; 95% CI, 0.33 to 0.94) and lower with IPT than with no IPT (adjusted hazard ratio, 0.65; 95% CI, 0.48 to 0.88; adjusted hazard ratio among patients with a baseline CD4+ count of >= 500 cells per cubic millimeter, 0.61; 95% CI, 0.36 to 1.01). The 30-month probability of grade 3 or 4 adverse events did not differ significantly among the strategies. CONCLUSIONS In this African country, immediate ART and 6 months of IPT independently led to lower rates of severe illness than did deferred ART and no IPT, both overall and among patients with CD4+ counts of at least 500 cells per cubic millimeter.	[Danel, Christine; Moh, Raoul; Gabillard, Delphine; Badje, Anani; Le Carrou, Jerome; Ouattara, Eric; Ntakpe, Jean-Baptiste; Minga, Albert; Kouame, Gerard M.; Messou, Eugene; Guehi, Calixte; Journot, Valerie; Karcher, Sophie; Chene, Genevieve; Salamon, Roger; Eholie, Serge P.; Anglaret, Xavier] Univ Bordeaux, INSERM, U897, Talence, France; [Chaix, Marie-Laure] Ctr Hosp Univ CHU St Louis, Lab Virol, Paris, France; [Rouzioux, Christine] CHU Necker, Lab Virol, Paris, France; [Girard, Pierre-Marie] CHU St Antoine, Serv Malad Infect & Trop, Paris, France; [Perronne, Christian] CHU Raymond Poincare, Garches, France; [Danel, Christine; Moh, Raoul; Gabillard, Delphine; Badje, Anani; Le Carrou, Jerome; Ouassa, Timothee; Ouattara, Eric; Anzian, Amani; Minga, Albert; Bouhoussou, Franck; Emieme, Arlette; Kouame, Antoine; Inwoley, Andre; Toni, Thomas-d'Aquin; Ahiboh, Hugues; Kabran, Mathieu; Konan, Romuald; Dohoun, Lambert; Yao, Abo; Deschamps, Nina; Nchot, Celestin; Karcher, Sophie; Menan, Herve; N'Dri-Yoman, Theresse; Salamon, Roger; Eholie, Serge P.; Anglaret, Xavier] Agence Natl Rech SIDA Res Site, Programme PAC CI, Abidjan, Cote Ivoire; [Rabe, Cyprien; Sidibe, Baba; Nzunetu, Gustave; Aka, Kakou; Aoussi, Eba; Bissagnene, Emmanuel; Kadio, Auguste; Eholie, Serge P.] CHU Treichville, Serv Malad Infect & Trop, Abidjan, Cote Ivoire; [Assi, Rodrigue; Bakayoko, Alima; Domoua, Serge K.] CHU Treichville, Serv Pneumol, Abidjan, Cote Ivoire; [Mobio, Max] CHU Treichville, Serv Otorhinolaryngol, Abidjan, Cote Ivoire; [Bamba, Dofere] CHU Treichville, Serv Ophtalmol, Abidjan, Cote Ivoire; [Koman, Mesmin] CHU Treichville, Serv Gynecol, Abidjan, Cote Ivoire; [Dohoun, Lambert; Kamagate, Synali; Yao, Abo; Amon, Solange] Ctr Med Suivi Donneurs Sang, Abidjan, Cote Ivoire; [Ba-Gomis, Olivier; Daligou, Marcelle; Ackoundze, Simplice; Hawerlander, Denise; Chenal, Henri] Ctr Integre Rech Bioclin Abidjan, Abidjan, Cote Ivoire; [Ani, Alex; Dembele, Fassery; Guehi, Calixte; Kanga, Constance; Seri, Jonas; Konate, Seidou] Unite Soins Ambulatoire & Conseil, Abidjan, Cote Ivoire; [Kouadio, Alain-Claude; Sena, Ghislaine; Yededji, Sahinou-Yediga; Sassan-Morokro, Madeleine] Ctr La Pierre Angulaire, Abidjan, Cote Ivoire; [Anzian, Amani; Gnokoro, Joachim; Gouesse, Patrice; Messou, Eugene; Moh-Semde, Corinne] Ctr Prise Charge & Format, Abidjan, Cote Ivoire; [Mahassadi, Alassane; Attia, Alain; N'Dri-Yoman, Theresse] Serv Gastroentorohepatol, Abidjan, Cote Ivoire; [Horo, Apollinaire] Serv Gastroentorohepatol, Abidjan, Cote Ivoire; [Horo, Apollinaire] CHU Yopougon, Serv Gynecol Obstet, Abidjan, Cote Ivoire; [Amon, Solange; Kouame, Amadou-Barenson; Koua, Aboli; Kouame, Emmanuel; Ndri, Yao] Hop Gen Abobo Nord, Abidjan, Cote Ivoire; [Oyebi, Mykayila; Mbakop, Nathalie; Makaila, Olewole] Format Sanit Urbaine Communautaire Anonkoua Koute, Abidjan, Cote Ivoire; [Babatunde, Carole; Babatounde, Nathanael; Bleoue, Gisele; Tchoutedjem, Mireille] Hop El Rapha, Abidjan, Cote Ivoire; [Ettiegne-Traore, Virginie; Kouame, Abo] Minist Sante & Lutte VIH SIDA, Programme Natl Lutte SIDA, Abidjan, Cote Ivoire; [Massumbuko, Jean-Marie] Ensemble Solidarie Therapeut Hosp Reseau, Abidjan, Cote Ivoire; [Dosso, Mireille] Inst Pasteur Cote Ivoire, Abidjan, Cote Ivoire; [Oussou, Armel] CHU Bouake, Serv Dermatol, Bouake, Cote Ivoire; [Sow, Papa-Salif] CHU Fann, Serv Malad Infect & Trop, Dakar, Senegal	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Anglaret, X (corresponding author), Univ Bordeaux, INSERM, U897, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	xavier.anglaret@isped.ubordeaux2.fr	Anglaret, Xavier/T-2757-2019; Ouattara, Eric/T-2833-2019; Anglaret, Xavier/F-7333-2013; Jean, Kevin/ABA-6355-2020; chene, genevieve/H-8665-2014	Jean, Kevin/0000-0001-6462-7185; chene, genevieve/0000-0002-8368-6460; Badje, Anani Dodzi/0000-0001-8917-4266; Dray-Spira, Rosemary/0000-0001-7646-3667; Anglaret, Xavier/0000-0003-3319-8423; Ouassa, Timothee Dieudonne/0000-0002-5456-3103; Desgrees du Lou, annabel/0000-0002-2223-5316	French National Agency for Research on AIDS and Viral Hepatitis	French National Agency for Research on AIDS and Viral Hepatitis(ANRS)	Funded by the French National Agency for Research on AIDS and Viral Hepatitis; TEMPRANO ANRS 12136 ClinicalTrials.gov number, NCT00495651.	Anglaret X, 2012, CLIN INFECT DIS, V54, P714, DOI 10.1093/cid/cir898; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Briggs MA, 2015, JAIDS-J ACQ IMM DEF, V68, pS297, DOI 10.1097/QAI.0000000000000497; Charalambous S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000391010.02774.6f; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Cox JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033685; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Getahun H, 2010, AIDS, V24, pS57, DOI 10.1097/01.aids.0000391023.03037.1f; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Gupta S, 2014, INT J TUBERC LUNG D, V18, P1149, DOI 10.5588/ijtld.13.0889; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Kufa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111209; Kufa T, 2012, JAIDS-J ACQ IMM DEF, V60, pE22, DOI 10.1097/QAI.0b013e318251ae0b; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lester R, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000391021.18284.12; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; Mwinga A, 1998, AIDS, V12, P2447, DOI 10.1097/00002030-199818000-00014; Ouattara E, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18059; PAPE JW, 1993, LANCET, V342, P268, DOI 10.1016/0140-6736(93)91817-6; PERRIENS JH, 1995, NEW ENGL J MED, V332, P779, DOI 10.1056/NEJM199503233321204; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; WHO, 2010, ANT THER HIV INF AD; Williams BG, 2010, AIDS, V24, P1790, DOI 10.1097/QAD.0b013e32833ac860; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, GUID INT TUB CAS FIN; World Health Organization, CONS GUID US ANT DRU; Yirdaw KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104557	42	815	838	2	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					808	822		10.1056/NEJMoa1507198	http://dx.doi.org/10.1056/NEJMoa1507198			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP8VC	26193126	Green Published			2022-12-28	WOS:000360171700007
J	Rossi, A; Kontarakis, Z; Gerri, C; Nolte, H; Holper, S; Kruger, M; Stainier, DYR				Rossi, Andrea; Kontarakis, Zacharias; Gerri, Claudia; Nolte, Hendrik; Hoelper, Soraya; Krueger, Marcus; Stainier, Didier Y. R.			Genetic compensation induced by deleterious mutations but not gene knockdowns	NATURE			English	Article							EGFL7; IDENTIFICATION; ELASTOGENESIS; EXPRESSION; PHENOTYPES; KNOCKOUT; TALEN	Cells sense their environment and adapt to it by fine-tuning their transcriptome. Wired into this network of gene expression control are mechanisms to compensate for gene dosage. The increasing use of reverse genetics in zebrafish, and other model systems, has revealed profound differences between the phenotypes caused by genetic mutations and those caused by gene knockdowns at many loci(1-3), an observation previously reported in mouse and Arabidopsis(4-7). To identify the reasons underlying the phenotypic differences between mutants and knockdowns, we generated mutations in zebrafish egfl7, an endothelial extracellular matrix gene of therapeutic interest, as well as in vegfaa. Here we show that egfl7 mutants do not show any obvious phenotypes while animals injected with egfl7 morpholino (morphants) exhibit severe vascular defects. We further observe that egfl7 mutants are less sensitive than their wild-type siblings to Egfl7 knockdown, arguing against residual protein function in the mutants or significant off-target effects of the morpholinos when used at a moderate dose. Comparing egfl7 mutant and morphant proteomes and transcriptomes, we identify a set of proteins and genes that are upregulated in mutants but not in morphants. Among them are extracellular matrix genes that can rescue egfl7 morphants, indicating that they could be compensating for the loss of Egfl7 function in the phenotypically wild-type egfl7 mutants. Moreover, egfl7 CRISPR interference, which obstructs transcript elongation and causes severe vascular defects, does not cause the upregulation of these genes. Similarly, vegfaa mutants but not morphants show an upregulation of vegfab. Taken together, these data reveal the activation of a compensatory network to buffer against deleterious mutations, which was not observed after translational or transcriptional knockdown.	[Rossi, Andrea; Kontarakis, Zacharias; Gerri, Claudia; Nolte, Hendrik; Hoelper, Soraya; Krueger, Marcus; Stainier, Didier Y. R.] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	Max Planck Society	Stainier, DYR (corresponding author), Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany.	didier.stainier@mpi-bn.mpg.de	Gerri, Claudia/AAN-4277-2020	Gerri, Claudia/0000-0002-9046-3820; Rossi, Andrea/0000-0001-5863-6448; Kontarakis, Zacharias/0000-0001-8825-8513; Stainier, Didier/0000-0002-0382-0026	Max Planck Society; Packard foundation; EMBO	Max Planck Society(Max Planck SocietyFoundation CELLEX); Packard foundation(The David & Lucile Packard Foundation); EMBO(European Molecular Biology Organization (EMBO))	We thank H.-B. Kwon and other members of the laboratory, past and present, as well as K. Sampath, D. Wainstock, C. Moens and M. Grether, for discussions, comments on the manuscript and/or reagents, and the Max Planck Society, Packard foundation, and EMBO for funding.	[Anonymous], 2006, NAT METHODS, V3, P659; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Charpentier MS, 2013, DEV CELL, V25, P132, DOI 10.1016/j.devcel.2013.03.003; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daude N, 2012, P NATL ACAD SCI USA, V109, P9035, DOI 10.1073/pnas.1202130109; De Souza AT, 2006, NUCLEIC ACIDS RES, V34, P4486, DOI 10.1093/nar/gkl609; Doyle EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082120; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Huang CH, 2014, INT J CLIN EXP PATHO, V7, P1077; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Law SHW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100268; Lelievre E, 2008, EMBO J, V27, P1658, DOI 10.1038/emboj.2008.103; Nichol D, 2012, BLOOD, V119, P1345, DOI 10.1182/blood-2011-10-322446; Nolte H, 2014, J PROTEOME RES, V13, P2162, DOI 10.1021/pr5000335; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Smart N, 2013, CIRC RES, V112, pE29, DOI 10.1161/CIRCRESAHA.112.300555; Stainier DYR, 2015, DEV CELL, V32, P7, DOI 10.1016/j.devcel.2014.12.012; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004	29	752	765	8	152	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					230	+		10.1038/nature14580	http://dx.doi.org/10.1038/nature14580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26168398				2022-12-28	WOS:000359386900034
J	Okada, S; Markle, JG; Deenick, EK; Mele, F; Averbuch, D; Lagos, M; Alzahrani, M; Al-Muhsen, S; Halwani, R; Ma, CS; Wong, N; Soudais, C; Henderson, LA; Marzouqa, H; Shamma, J; Gonzalez, M; Martinez-Barricarte, R; Okada, C; Avery, DT; Latorre, D; Deswarte, C; Jabot-Hanin, F; Torrado, E; Fountain, J; Belkadi, A; Itan, Y; Boisson, B; Migaud, M; Arlehamn, CSL; Sette, A; Breton, S; McCluskey, J; Rossjohn, J; de Villartay, JP; Moshous, D; Hambleton, S; Latour, S; Arkwright, PD; Picard, C; Lantz, O; Engelhard, D; Kobayashi, M; Abel, L; Cooper, AM; Notarangelo, LD; Boisson-Dupuis, S; Puel, A; Sallusto, F; Bustamante, J; Tangye, SG; Casanova, JL				Okada, Satoshi; Markle, Janet G.; Deenick, Elissa K.; Mele, Federico; Averbuch, Dina; Lagos, Macarena; Alzahrani, Mohammed; Al-Muhsen, Saleh; Halwani, Rabih; Ma, Cindy S.; Wong, Natalie; Soudais, Claire; Henderson, Lauren A.; Marzouqa, Hiyam; Shamma, Jamal; Gonzalez, Marcela; Martinez-Barricarte, Ruben; Okada, Chizuru; Avery, Danielle T.; Latorre, Daniela; Deswarte, Caroline; Jabot-Hanin, Fabienne; Torrado, Egidio; Fountain, Jeffrey; Belkadi, Aziz; Itan, Yuval; Boisson, Bertrand; Migaud, Melanie; Arlehamn, Cecilia S. Lindestam; Sette, Alessandro; Breton, Sylvain; McCluskey, James; Rossjohn, Jamie; de Villartay, Jean-Pierre; Moshous, Despina; Hambleton, Sophie; Latour, Sylvain; Arkwright, Peter D.; Picard, Capucine; Lantz, Olivier; Engelhard, Dan; Kobayashi, Masao; Abel, Laurent; Cooper, Andrea M.; Notarangelo, Luigi D.; Boisson-Dupuis, Stephanie; Puel, Anne; Sallusto, Federica; Bustamante, Jacinta; Tangye, Stuart G.; Casanova, Jean-Laurent			Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations	SCIENCE			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; IFN-GAMMA IMMUNITY; T-CELLS; ORPHAN RECEPTOR; INBORN-ERRORS; DEFICIENCY; DIFFERENTIATION; ALPHA; IL-17; GENE	Human inborn errors of immunity mediated by the cytokines interleukin-17A and interleukin-17F (IL-17A/F) underlie mucocutaneous candidiasis, whereas inborn errors of interferon-gamma (IFN-gamma) immunity underlie mycobacterial disease. We report the discovery of bi-allelic RORC loss-of-function mutations in seven individuals from three kindreds of different ethnic origins with both candidiasis and mycobacteriosis. The lack of functional ROR gamma and ROR gamma T isoforms resulted in the absence of IL-17A/F-producing T cells in these individuals, probably accounting for their chronic candidiasis. Unexpectedly, leukocytes from ROR gamma- and ROR gamma T-deficient individuals also displayed an impaired IFN-gamma response to Mycobacterium. This principally reflected profoundly defective IFN-gamma production by circulating gamma delta T cells and CD4+CCR6+CXCR3+ alpha beta T cells. In humans, both mucocutaneous immunity to Candida and systemic immunity to Mycobacterium require ROR gamma, ROR gamma T, or both.	[Okada, Satoshi; Markle, Janet G.; Martinez-Barricarte, Ruben; Okada, Chizuru; Itan, Yuval; Boisson, Bertrand; Picard, Capucine; Abel, Laurent; Boisson-Dupuis, Stephanie; Puel, Anne; Bustamante, Jacinta; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Okada, Satoshi; Kobayashi, Masao] Hiroshima Univ, Grad Sch Biomed Hlth Sci, Dept Pediat, Hiroshima, Japan; [Deenick, Elissa K.; Wong, Natalie; Avery, Danielle T.; Tangye, Stuart G.] Garvan Inst Med Res, Div Immunol, Darlinghurst, NSW, Australia; [Deenick, Elissa K.; Ma, Cindy S.; Tangye, Stuart G.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Mele, Federico; Latorre, Daniela] Univ Italian Switzerland, Inst Res Biomed, Bellinzona, Switzerland; [Averbuch, Dina; Engelhard, Dan] Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel; [Lagos, Macarena; Gonzalez, Marcela] Univ Valparaiso, Sch Med, Dept Immunol, Santiago, Chile; [Lagos, Macarena] Padre Hurtado Hosp & Clin Alemana, Dept Pediat, Santiago, Chile; [Alzahrani, Mohammed; Al-Muhsen, Saleh] King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; [Al-Muhsen, Saleh; Halwani, Rabih] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Dept Pediat, Riyadh 11461, Saudi Arabia; [Soudais, Claire; Lantz, Olivier] Inst Curie, INSERM, U932, Paris, France; [Henderson, Lauren A.; Notarangelo, Luigi D.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Marzouqa, Hiyam; Shamma, Jamal] Caritas Baby Hosp, Jerusalem, Israel; [Deswarte, Caroline; Jabot-Hanin, Fabienne; Belkadi, Aziz; Migaud, Melanie; Picard, Capucine; Abel, Laurent; Boisson-Dupuis, Stephanie; Puel, Anne; Bustamante, Jacinta; Casanova, Jean-Laurent] INSERM, Lab Human Genet Infect Dis, Necker Branch, UMR 1163, Paris, France; [Deswarte, Caroline; Jabot-Hanin, Fabienne; Belkadi, Aziz; Migaud, Melanie; Picard, Capucine; Abel, Laurent; Boisson-Dupuis, Stephanie; Puel, Anne; Bustamante, Jacinta; Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, Paris, France; [Torrado, Egidio; Fountain, Jeffrey; Cooper, Andrea M.] Trudeau Inst, Saranac Lake, NY 12983 USA; [Arlehamn, Cecilia S. Lindestam; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Breton, Sylvain] Necker Hosp Sick Children, AP HP, Dept Radiol, Paris, France; [McCluskey, James] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Rossjohn, Jamie] Monash Univ, Ctr Excellence Adv Mol Imaging, Australian Res Council, Clayton, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [de Villartay, Jean-Pierre; Moshous, Despina] Univ Paris 05, Sorbonne Paris Cite, INSERM, UMR 1163,Lab Dynam Genome & Syst Immunitaire,Imag, Paris, France; [Moshous, Despina; Picard, Capucine; Casanova, Jean-Laurent] Necker Hosp Sick Children, AP HP, Pediat Hematol Immunol Unit, Paris, France; [Hambleton, Sophie] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Hambleton, Sophie] Great North Childrens Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Latour, Sylvain] Univ Paris 05, Sorbonne Paris Cite, INSERM, UMR 1163,Imagine Inst,Lab Lymphocyte Activat & Su, Paris, France; [Arkwright, Peter D.] Univ Manchester, Royal Manchester Childrens Hosp, Dept Paediat Allergy Immunol, Manchester, Lancs, England; [Picard, Capucine; Bustamante, Jacinta] Necker Hosp Sick Children, AP HP, Ctr Study Primary Immunodeficiencies, Paris, France; [Notarangelo, Luigi D.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Sallusto, Federica] Univ Italian Switzerland, Inst Res Biomed, Ctr Med Immunol, Bellinzona, Switzerland; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Hiroshima University; Garvan Institute of Medical Research; University of New South Wales Sydney; Universita della Svizzera Italiana; Hebrew University of Jerusalem; Universidad de Valparaiso; Clinica Alemana; King Faisal Specialist Hospital & Research Center; King Saud University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Harvard University; Boston Children's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Trudeau Institute; La Jolla Institute for Immunology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Melbourne; Monash University; Monash University; Cardiff University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Newcastle University - UK; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Royal Manchester Children's Hospital; University of Manchester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Boston Children's Hospital; Universita della Svizzera Italiana; Howard Hughes Medical Institute	Markle, JG (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA.	jmarkle@rockefeller.edu; jean-laurent.casanova@rockefeller.edu	Torrado, Egídio/T-5156-2018; Migaud, Mélanie/H-8044-2017; Boisson-Dupuis, Stephanie/AAF-5066-2021; Sette, Alessandro/AFO-8916-2022; Abel, Laurent/H-8888-2017; Barricarte, Ruben Martinez/W-8695-2019; Deswarte, Caroline/H-8018-2017; Casanova, Jean-Laurent/I-3418-2017; Deenick, Elissa/AAY-8998-2020; S, Cindy/B-2340-2012; McCluskey, James/A-1291-2007; Rossjohn, Jamie/F-9032-2013; Halwani, Rabih/AAN-1568-2021; Latorre, Daniela/HHZ-9540-2022; Notarangelo, Luigi D/F-9718-2016; Averbuch, Dina/ABA-6433-2020; Tangye, Stuart G/H-4023-2014; Boisson-Dupuis, Stéphanie/I-2040-2017; Boisson, Bertrand/AAC-6058-2019; Boisson, Bertrand/I-2485-2017; soudais, claire/F-9756-2016; Puel, Anne/H-7305-2017; Okada, Satoshi/B-8901-2011; Bustamante, Jacinta/H-7877-2017; de Villartay, jean pierre/H-9353-2017; Moshous, Despina/B-7507-2017; Al-muhsen, saleh/E-9315-2014; Markle, Janet/X-1975-2019; Latour, Sylvain/H-3652-2017	Torrado, Egídio/0000-0002-7462-8234; Migaud, Mélanie/0000-0003-3062-1214; Abel, Laurent/0000-0001-7016-6493; Barricarte, Ruben Martinez/0000-0001-7925-449X; Deswarte, Caroline/0000-0002-8775-3368; Deenick, Elissa/0000-0002-9271-0004; S, Cindy/0000-0001-5387-8413; McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Halwani, Rabih/0000-0002-6516-7771; Latorre, Daniela/0000-0003-1031-1534; Notarangelo, Luigi D/0000-0002-8335-0262; Tangye, Stuart G/0000-0002-5360-5180; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Boisson, Bertrand/0000-0001-5240-3555; Boisson, Bertrand/0000-0001-5240-3555; soudais, claire/0000-0002-4387-6649; Puel, Anne/0000-0003-2603-0323; Okada, Satoshi/0000-0002-4622-5657; Bustamante, Jacinta/0000-0002-3439-2482; de Villartay, jean pierre/0000-0001-5987-0463; Moshous, Despina/0000-0001-6719-3693; Al-muhsen, saleh/0000-0003-3698-9968; Markle, Janet/0000-0003-2189-4368; Lindestam Arlehamn, Cecilia/0000-0001-7302-8002; Hambleton, Sophie/0000-0001-7954-3267; Lantz, olivier/0000-0003-3161-7719; Cooper, Andrea/0000-0001-6050-3863; Latour, Sylvain/0000-0001-8238-4391; Fountain, Jeffrey/0000-0001-9473-7705; JABOT-HANIN, Fabienne/0000-0001-9294-7135; Casanova, Jean-Laurent/0000-0002-7782-4169; Arkwright, Peter/0000-0002-7411-5375	Laboratory of Human Genetics of Infectious Diseases; National Center for Research Resources, NIH; National Center for Advancing Sciences, NIH [8UL1TR000043]; French National Research Agency (ANR) [ANR-10-IAHU-01, 13-ISV3-0001-01, 11-BSV3-005-01]; Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]; National Health and Medical Research Council (NHMRC); Rockefeller University; INSERM; Universite Paris Descartes; St. Giles Foundation; National Institute of Allergy and Infectious Diseases [R37AI095983]; NIH [HHSN272200900044C]; Japan Society for the Promotion of Science [25713039, 25670477]; Canadian Institutes of Health Research; European Molecular Biology Organization; AXA Research Fund; Rheumatology Research Foundation's Scientist Development Award; European Research Council [323183 PREDICT]; Swiss National Science Foundation [149475]; Helmut Horten Foundation; The Sir Jules Thorn Charitable Trust [12JTA] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI095983, T32AI007512] Funding Source: NIH RePORTER	Laboratory of Human Genetics of Infectious Diseases; National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Sciences, NIH; French National Research Agency (ANR)(French National Research Agency (ANR)); Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Rockefeller University; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Descartes; St. Giles Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); AXA Research Fund(AXA Research Fund); Rheumatology Research Foundation's Scientist Development Award; European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Helmut Horten Foundation; The Sir Jules Thorn Charitable Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the patients and their families for their collaboration; both branches of the Laboratory of Human Genetics of Infectious Diseases for helpful discussions and support; M. Hindiyeh for expert clinical care of the patients from Kindred A; G. C. Tsokos for providing the IL17A reporter luciferase plasmid; E. Van de Vosse for providing the pLZRS-IRES-DNGFR vector; D. Littman for helpful discussions; B. Fleckenstein and M. Schmidt for the generation of patient-derived T cell lines; and Y. Nemirovskaya, L. Amar, E. Anderson, M. Courat, and T. Nivare for administrative support. The data presented in the manuscript are tabulated in the main paper and in the supplementary materials. The sequence data are available in the Sequence Read Archive (www.ncbi.nlm.nih.gov/sra) with accession numbers SRS964935, SRS965039, SRS965040, and SRS965042. J.Mc. and The University of Melbourne filed Australian provisional patent application numbers 2014901185 and 2014901 that relate to ligands that bind MR1 and stimulate MAIT cells. The Laboratory of Human Genetics of Infectious Diseases is supported by grants from the National Center for Research Resources and the National Center for Advancing Sciences, NIH (8UL1TR000043); the French National Research Agency (ANR) under the "Investments for the Future" program (grant ANR-10-IAHU-01), grant IFNGPHOX (13-ISV3-0001-01 to J.B.), and grant GENCMCD (11-BSV3-005-01 to A.P); Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID); the National Health and Medical Research Council (NHMRC) (to E.K.D., C.S.M., S.G.T, and J.Mc.); the Rockefeller University; INSERM; Universite Paris Descartes; the St. Giles Foundation; the National Institute of Allergy and Infectious Diseases (R37AI095983 to J.-L.C.); and the NIH (contract HHSN272200900044C to A.S.). S.O. was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (25713039 and 25670477), J.G.M. by the Canadian Institutes of Health Research, R.M.-B. by the European Molecular Biology Organization, Y.I. by the AXA Research Fund, L.A.H. by the Rheumatology Research Foundation's Scientist Development Award, and F.S. by grants from the European Research Council (323183 PREDICT) and the Swiss National Science Foundation (149475). The Institute for Research in Biomedicine and the Center of Medical Immunology are supported by the Helmut Horten Foundation. S.A.-M. is the bronchial asthma research chair of the Prince Naif Center for Immunology Research.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; de la Calle-Martin O, 2001, J CLIN INVEST, V108, P117, DOI 10.1172/JCI10993; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Feinberg J, 2004, EUR J IMMUNOL, V34, P3276, DOI 10.1002/eji.200425221; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; Hoft DF, 1998, J IMMUNOL, V161, P1045; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Ling Y, 2015, J EXP MED, V212, P619, DOI 10.1084/jem.20141065; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Martin E, 2014, NATURE, V510, P288, DOI 10.1038/nature13386; Medvedev A, 1997, GENOMICS, V46, P93, DOI 10.1006/geno.1997.4980; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Morgan NV, 2011, J CLIN INVEST, V121, P695, DOI 10.1172/JCI41931; Notarangelo LD, 2013, ANNU REV IMMUNOL, V31, P195, DOI 10.1146/annurev-immunol-032712-095927; Ouederni M, 2011, BLOOD, V118, P5108, DOI 10.1182/blood-2011-05-352716; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Van Rhijn I, 2013, NAT IMMUNOL, V14, P706, DOI 10.1038/ni.2630; Villey I, 1999, EUR J IMMUNOL, V29, P4072, DOI 10.1002/(SICI)1521-4141(199912)29:12<4072::AID-IMMU4072>3.0.CO;2-E; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	36	262	268	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					606	613		10.1126/science.aaa4282	http://dx.doi.org/10.1126/science.aaa4282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26160376	Green Accepted			2022-12-28	WOS:000359092900033
J	Parikh, RB; Montgomery, A; Lynn, J				Parikh, Ravi B.; Montgomery, Anne; Lynn, Joanne			The Older Americans Act at 50-Community-Based Care in a Value-Driven Era	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH		[Parikh, Ravi B.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Montgomery, Anne; Lynn, Joanne] Ctr Elder Care & Adv Illness, Altarum Inst, Washington, DC USA	Harvard University; Brigham & Women's Hospital	Parikh, RB (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049339] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2013, SEQ SUMM SURV; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Sandberg SF, 2014, HEALTH AFFAIR, V33, P1975, DOI 10.1377/hlthaff.2014.0648; Thomas KS., 2015, RESULTS PILOT RANDOM	4	9	9	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2015	373	5					399	401		10.1056/NEJMp1503493	http://dx.doi.org/10.1056/NEJMp1503493			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN8BO	26222555				2022-12-28	WOS:000358662200002
J	Parnas, O; Jovanovic, M; Eisenhaure, TM; Herbst, RH; Dixit, A; Ye, CJ; Przybylski, D; Platt, RJ; Tirosh, I; Sanjana, NE; Shalem, O; Satija, R; Raychowdhury, R; Mertins, P; Carr, SA; Zhang, F; Hacohen, N; Regev, A				Parnas, Oren; Jovanovic, Marko; Eisenhaure, Thomas M.; Herbst, Rebecca H.; Dixit, Atray; Ye, Chun Jimmie; Przybylski, Dariusz; Platt, Randall J.; Tirosh, Itay; Sanjana, Neville E.; Shalem, Ophir; Satija, Rahul; Raychowdhury, Raktima; Mertins, Philipp; Carr, Steven A.; Zhang, Feng; Hacohen, Nir; Regev, Aviv			A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks	CELL			English	Article							GENE-EXPRESSION; PROTEIN; DIFFERENTIATION; CANCER; ACTIVATION; RESPONSES; ALPHA	Finding the components of cellular circuits and determining their functions systematically remains a major challenge in mammalian cells. Here, we introduced genome-wide pooled CRISPR-Cas9 libraries into dendritic cells (DCs) to identify genes that control the induction of tumor necrosis factor (Tnf) by bacterial lipopolysaccharide (LPS), a key process in the host response to pathogens, mediated by the Tlr4 pathway. We found many of the known regulators of Tlr4 signaling, as well as dozens of previously unknown candidates that we validated. By measuring protein markers and mRNA profiles in DCs that are deficient in known or candidate genes, we classified the genes into three functional modules with distinct effects on the canonical responses to LPS and highlighted functions for the PAF complex and oligosaccharyltransferase (OST) complex. Our findings uncover new facets of innate immune circuits in primary cells and provide a genetic approach for dissection of mammalian cell circuits.	[Parnas, Oren; Jovanovic, Marko; Eisenhaure, Thomas M.; Herbst, Rebecca H.; Dixit, Atray; Przybylski, Dariusz; Platt, Randall J.; Tirosh, Itay; Sanjana, Neville E.; Shalem, Ophir; Raychowdhury, Raktima; Mertins, Philipp; Carr, Steven A.; Zhang, Feng; Hacohen, Nir; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Eisenhaure, Thomas M.; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Herbst, Rebecca H.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Dixit, Atray] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Ye, Chun Jimmie] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Dept Epidemiol & Biostat, Inst Human Genet, San Francisco, CA 94143 USA; [Platt, Randall J.; Sanjana, Neville E.; Shalem, Ophir; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Platt, Randall J.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Platt, Randall J.; Sanjana, Neville E.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Sanjana, Neville E.; Zhang, Feng] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Satija, Rahul] New York Genome Ctr, New York, NY 10013 USA; [Satija, Rahul] NYU, Ctr Genom & Syst Biol, New York, NY 10012 USA; [Hacohen, Nir] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02140 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; New York University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Hacohen, N (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	nhacohen@broadinstitute.org; aregev@broadinstitute.org	Satija, Rahul/AAF-9564-2019; Carr, Steven A./AAH-8366-2019; Ye, Chun/AAK-4868-2021; Macrae, Rhiannon/AAX-1536-2020	Ye, Chun/0000-0001-6560-3783; Shalem, Ophir/0000-0002-2267-0801; Platt, Randall/0000-0002-2914-7052; Dixit, Atray/0000-0002-5065-6492; Herbst, Rebecca/0000-0002-1004-8919; /0000-0003-2193-9001; Sanjana, Neville/0000-0002-1504-0027	NHGRI CEGS [P50 HG006193]; Broad Institute Funds; Klarman Cell Obervatory; HHMI; MGH Research Scholars Program; Swiss National Science Foundation (SNF); Marie Sklodowska-Curie IOF; National Institutes of Health through NIMH [5DP1-MH100706]; National Institutes of Health through NIDDK [5R01-DK097768]; National Science Foundation; Keck Foundation; New York Stem Cell Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Foundation; Vallee Foundation; Simons Center for the Social Brain Postdoctoral Fellowship; NIH NHGRI [K99-HG008171]; National Science Foundation [1122374]; Human Frontier Science Program fellowship; National Space Biomedical Research Institute through NASA [NCC 9-58]; National Defense Science and Engineering Fellowship; Herchel Smith Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193, K99HG008171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049, DP1MH100706] Funding Source: NIH RePORTER	NHGRI CEGS; Broad Institute Funds; Klarman Cell Obervatory; HHMI(Howard Hughes Medical Institute); MGH Research Scholars Program; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Marie Sklodowska-Curie IOF; National Institutes of Health through NIMH; National Institutes of Health through NIDDK; National Science Foundation(National Science Foundation (NSF)); Keck Foundation(W.M. Keck Foundation); New York Stem Cell Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Foundation; Vallee Foundation; Simons Center for the Social Brain Postdoctoral Fellowship; NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program fellowship(Human Frontier Science Program); National Space Biomedical Research Institute through NASA; National Defense Science and Engineering Fellowship(United States Department of Defense); Herchel Smith Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Max Artyomov and Laurie Glimcher for help and data related to Xbp1 targets and Jonathan Weissman for very helpful discussions on ER stress. We thank the Broad's Genomic Perturbation Platform for help in design of the secondary library and Broad Technology labs (Tarjei Mikkelssen) for help with synthesis of the secondary library. We thank Dave Gennert, Carl De Boer, Alex Shalek, John Trombetta, Schraga Schwartz, Maxwell Mumbach, Dawn Thompson, Timothy Tickle, Brian Haas, Chloe Villani, and all members of the Regev, Hacohen, Carr, and Zhang groups for input and discussions. We thank Terry Means for discussions and advice. We thank Leslie Gaffney for help with figure preparation and the Broad Genomics Platform for all sequencing. FACS sorting was performed at the Bauer Core Laboratory, Harvard FAS Center for Systems Biology, with great help from Patricia Rogers. This work was supported by NHGRI CEGS P50 HG006193 (A.R., N.H., and S.A.C.) and Broad Institute Funds. A.R. was supported by the Klarman Cell Obervatory and HHMI. N.H. was supported by the MGH Research Scholars Program. M.J. was supported by fellowships of the Swiss National Science Foundation for advanced researchers (SNF) and the Marie Sklodowska-Curie IOF. F.Z. is supported by the National Institutes of Health through NIMH (5DP1-MH100706) and NIDDK (5R01-DK097768), a Waterman Award from the National Science Foundation, the Keck, New York Stem Cell, Damon Runyon, Searle Scholars, Merkin, and Vallee Foundations, and Bob Metcalfe. F.Z. is a New York Stem Cell Foundation Robertson Investigator. N.E.S. is supported by a Simons Center for the Social Brain Postdoctoral Fellowship and NIH NHGRI award K99-HG008171. O.S. is a fellow of the Klarman Cell Observatory. R.J.P. is supported by a National Science Foundation Graduate Research Fellowship under grant number 1122374. I.T. was supported by a Human Frontier Science Program fellowship. A.D. is supported by the National Space Biomedical Research Institute through NASA NCC 9-58 and the National Defense Science and Engineering Fellowship. R.H.H. receives support from the Herchel Smith Fellowship. A.R. is on the scientific advisory board for Thermo Fisher Scientific. F.Z. is a founder and scientific advisor of Editas Medicine and a scientific advisor for Horizon Discovery.	Amit I, 2011, NAT REV IMMUNOL, V11, P873, DOI 10.1038/nri3109; Beck T, 2014, EUR J HUM GENET, V22, P949, DOI 10.1038/ejhg.2013.274; Bochenek G, 2013, HUM MOL GENET, V22, P4516, DOI 10.1093/hmg/ddt299; Boehringer N, 1999, EUR CYTOKINE NETW, V10, P211; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Koesters C, 2007, IMMUNOL LETT, V109, P165, DOI 10.1016/j.imlet.2007.02.006; Komura T, 2013, CELL IMMUNOL, V282, P44, DOI 10.1016/j.cellimm.2013.04.006; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kurimoto K, 2009, PROTEINS, V75, P360, DOI 10.1002/prot.22246; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehtonen A, 2005, J IMMUNOL, V175, P6570, DOI 10.4049/jimmunol.175.10.6570; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; NAKAGAWA J, 1995, P NATL ACAD SCI USA, V92, P2051, DOI 10.1073/pnas.92.6.2051; Nikolic T, 2014, CELL MOL IMMUNOL, V11, P58, DOI 10.1038/cmi.2013.41; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Ramirez-Ortiz ZG, 2015, NAT IMMUNOL, V16, P495, DOI 10.1038/ni.3143; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sebastian C, 2008, J IMMUNOL, V180, P5898, DOI 10.4049/jimmunol.180.9.5898; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yamashita N, 2001, GENES CELLS, V6, P641, DOI 10.1046/j.1365-2443.2001.00449.x; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	48	270	324	5	125	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					675	686		10.1016/j.cell.2015.06.059	http://dx.doi.org/10.1016/j.cell.2015.06.059			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26189680	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000358801800024
J	Macbeth, F; Newton-Bishop, J; O'Connell, S; Hawkins, JE				Macbeth, Fergus; Newton-Bishop, Julia; O'Connell, Susan; Hawkins, James E.		Guideline Dev Grp	Melanoma: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Macbeth, Fergus] Wales Canc Trials Unit, Cardiff CF14 4YS, S Glam, Wales; [Newton-Bishop, Julia] Univ Leeds, Leeds, W Yorkshire, England; [O'Connell, Susan; Hawkins, James E.] Natl Collaborating Ctr Canc, Cardiff, S Glam, Wales	University of Leeds	Macbeth, F (corresponding author), Wales Canc Trials Unit, Cardiff CF14 4YS, S Glam, Wales.	fergus.macbeth@btinternet.com	O'Connell, Susan/V-8945-2019	Newton-Bishop, Julia/0000-0001-9147-6802	Cancer Research UK [15954, 19167] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		American Joint Committee on Cancer, 2009, MEL SKIN STAG; National Cancer Intelligence Network, MORT INC GEND MAL ME; National Institute for Health and Care Excellence, 2014, DABR TREAT UNR MET B; National Institute for Health and Care Excellence, 2015, MEL ASS MAN MEL NG14; National Institute for Health and Care Excellence, 2010, IMPR OUTC PEOPL SKIN; National Institute for Health and Care Excellence, 2012, IP PREV TREAT ADV UN; National Institute for Health and Care Excellence, 2014, IP PREV UNTR ADV UNR; National Institute for Health and Care Excellence, 2014, VIT D INCR SUPPL US; National Institute for Health and Care Excellence, 2012, VEM TREAT LOC ADV ME	9	19	19	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2015	351								h3708	10.1136/bmj.h3708	http://dx.doi.org/10.1136/bmj.h3708			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2UA	26223435	Green Published			2022-12-28	WOS:000359010900002
J	Hirsch, C				Hirsch, Calvin			Review: Multicomponent nonpharmacologic interventions reduce incident delirium in inpatients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Davis, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Sacramento, CA 95817 USA.							Rothberg MB, 2013, J AM GERIATR SOC, V61, P923, DOI 10.1111/jgs.12253; Yue JR, 2014, J AM GERIATR SOC, V62, P754, DOI 10.1111/jgs.12768; Zhang H, 2013, CRIT CARE, V17, DOI 10.1186/cc12566	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2							JC4	10.7326/ACPJC-2015-163-2-004	http://dx.doi.org/10.7326/ACPJC-2015-163-2-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN4NS	26192584				2022-12-28	WOS:000358407500004
J	Lancaster, T; Cahill, K				Lancaster, Tim; Cahill, Kate			Review: Varenicline does not differ from placebo for adverse neuropsychiatric events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lancaster, Tim; Cahill, Kate] Univ Oxford, Oxford, England	University of Oxford	Lancaster, T (corresponding author), Univ Oxford, Oxford, England.			Lancaster, Timothy Ross/0000-0002-0580-1099				Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Pfizer, STUD EV SAF EFF VAR	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2							JC6	10.7326/ACPJC-2015-163-2-006	http://dx.doi.org/10.7326/ACPJC-2015-163-2-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26192586				2022-12-28	WOS:000358407500006
J	Richardson, DS; Lichtman, JW				Richardson, Douglas S.; Lichtman, Jeff W.			Clarifying Tissue Clearing	CELL			English	Review							SINGLE-CELL RESOLUTION; BACKGROUND AUTOFLUORESCENCE; FLUORESCENCE MICROSCOPY; BRAIN; PLANAR; REDUCTION; PROTEINS; AGENT	Biological specimens are intrinsically three dimensional; however, because of the obscuring effects of light scatter, imaging deep into a tissue volume is problematic. Although efforts to eliminate the scatter by "clearing'' the tissue have been ongoing for over a century, there have been a large number of recent innovations. This Review introduces the physical basis for light scatter in tissue, describes the mechanisms underlying various clearing techniques, and discusses several of the major advances in light microscopy for imaging cleared tissue.	[Richardson, Douglas S.; Lichtman, Jeff W.] Harvard Univ, Harvard Ctr Biol Imaging, Cambridge, MA 02138 USA; [Richardson, Douglas S.; Lichtman, Jeff W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lichtman, Jeff W.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Richardson, DS (corresponding author), Harvard Univ, Harvard Ctr Biol Imaging, Cambridge, MA 02138 USA.	drichardson@fas.harvard.edu; jeff@mcb.harvard.edu	Richardson, Douglas/K-9922-2016	Richardson, Douglas/0000-0002-3189-2190	NIMH Silvio Conte Center [1P50MH094271-010]; NIH [1R01NS076467-01, 1U01NS090449-01]; DOD [GG008784]; NSF NIH Johns Hopkins University [2001668272]; HFSP [RGP0051/2014]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076467, U01NS090449] Funding Source: NIH RePORTER	NIMH Silvio Conte Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NSF NIH Johns Hopkins University; HFSP(Human Frontier Science Program); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the Harvard Center for Biological Imaging for infrastructure and imaging support. J.W.L. is supported by NIMH Silvio Conte Center 1P50MH094271-010, NIH 1R01NS076467-01, DOD GG008784, NIH 1U01NS090449-01, NSF NIH Johns Hopkins University 2001668272, and HFSP RGP0051/2014.	Alnuami AA, 2008, INT J BIOL MACROMOL, V43, P182, DOI 10.1016/j.ijbiomac.2008.05.002; Aoyagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116280; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Booth MJ, 2007, PHILOS T R SOC A, V365, P2829, DOI 10.1098/rsta.2007.0013; Bouchard MB, 2015, NAT PHOTONICS, V9, P113, DOI [10.1038/NPHOTON.2014.323, 10.1038/nphoton.2014.323]; BOYDE A, 1985, SCIENCE, V230, P1270, DOI 10.1126/science.4071051; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chiang AS, 2002, P NATL ACAD SCI USA, V99, P37, DOI 10.1073/pnas.012318899; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Clancy B, 1998, J NEUROSCI METH, V83, P97, DOI 10.1016/S0165-0270(98)00066-1; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; Costantini I, 2015, SCI REP-UK, V5, DOI 10.1038/srep09808; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Duong H, 2013, J NEUROSCI METH, V220, P46, DOI 10.1016/j.jneumeth.2013.08.018; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hecht E., 2001, OPTICS, P532; HELL S, 1993, J MICROSC-OXFORD, V169, P391, DOI 10.1111/j.1365-2818.1993.tb03315.x; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hong GS, 2014, NAT PHOTONICS, V8, P723, DOI [10.1038/NPHOTON.2014.166, 10.1038/nphoton.2014.166]; Hou B, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00019; Hua L, 2008, P NATL ACAD SCI USA, V105, P16928, DOI 10.1073/pnas.0808427105; Ichimura K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08993; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Meglinski IV, 2003, LASER PHYS, V13, P65; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; MINSKY M, 1988, SCANNING, V10, P128, DOI 10.1002/sca.4950100403; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Paez-Segala MG, 2015, NAT METHODS, V12, P215, DOI [10.1038/NMETH.3225, 10.1038/nmeth.3225]; Peters W., 1961, Zoologischer Anzeiger Leipzig, V167, P233; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Reynaud EG, 2008, HFSP J, V2, P266, DOI 10.2976/1.2974980; Rost FW., 1992, FLUORESCENCE MICROSC; Siedentopf H, 1902, ANN PHYS, V315, P1, DOI [10.1002/andp.19023150102, DOI 10.1002/ANDP.19023150102]; Spalteholz W., 1898, HAND ATLAS HUMAN ANA; Spalteholz W., 1914, DURCHSICHTIGMACHEN M; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Steinke H, 2001, ANN ANAT, V183, P91, DOI 10.1016/S0940-9602(01)80020-0; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; TOGA AW, 1994, NEUROIMAGE, V1, P334, DOI 10.1006/nimg.1994.1018; Toga AW, 1997, COMPUT MED IMAG GRAP, V21, P131, DOI 10.1016/S0895-6111(96)00072-9; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Verveer PJ, 2007, NAT METHODS, V4, P311, DOI 10.1038/NMETH1017; Wang K, 2014, NAT METHODS, V11, P625, DOI [10.1038/NMETH.2925, 10.1038/nmeth.2925]; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wu YC, 2013, NAT BIOTECHNOL, V31, P1032, DOI 10.1038/nbt.2713; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Zimmermann T, 2005, ADV BIOCHEM ENG BIOT, V95, P245, DOI 10.1007/b102216	63	673	697	11	192	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					246	257		10.1016/j.cell.2015.06.067	http://dx.doi.org/10.1016/j.cell.2015.06.067			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186186	Green Accepted, Bronze			2022-12-28	WOS:000358087700007
J	Salay, LD; Huberman, AD				Salay, Lindsey D.; Huberman, Andrew D.			When Visual Circuits Collide: Motion Processing in the Brain	CELL			English	Editorial Material							INFORMATION	How is sensory information transformed by each station of a synaptic circuit as it flows progressively deeper into the brain? In this issue of Cell, Mauss et al. describe a set of connections in the fly brain that combines opposing directional signals, and they hypothesize that this motif limits global motion noise as the fly moves through space.	[Huberman, Andrew D.] Univ Calif San Diego, Sch Med, Dept Neurosci, San Diego, CA 92093 USA; [Salay, Lindsey D.; Huberman, Andrew D.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, San Diego, CA 92093 USA; [Huberman, Andrew D.] Univ Calif San Diego, Sch Med, Dept Ophthalmol, San Diego, CA 92093 USA; [Huberman, Andrew D.] Salk Inst Biol Studies, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Huberman, AD (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, San Diego, CA 92093 USA.	ahuberman@ucsd.edu						Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; LEVICK WR, 1969, SCIENCE, V165, P712, DOI 10.1126/science.165.3894.712; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Mauss AS, 2015, CELL, V162, P351, DOI 10.1016/j.cell.2015.06.035; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450	10	1	1	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					239	243		10.1016/j.cell.2015.06.051	http://dx.doi.org/10.1016/j.cell.2015.06.051			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186184	Bronze			2022-12-28	WOS:000358087700005
J	Aronson, L				Aronson, Louise			Story as Evidence, Evidence as Story	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Aronson, L (corresponding author), Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA.	louise.aronson@ucsf.edu							0	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					125	126		10.1001/jama.2015.3930	http://dx.doi.org/10.1001/jama.2015.3930			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26172890				2022-12-28	WOS:000357867500009
J	Andersson, N; Nava-Aguilera, E; Arostegui, J; Morales-Perez, A; Suazo-Laguna, H; Legorreta-Soberanis, J; Hernandez-Alvarez, C; Fernandez-Salas, I; Paredes-Solis, S; Balmaseda, A; Cortes-Guzman, AJ; de los Santos, RS; Coloma, J; Ledogar, RJ; Harris, E				Andersson, Neil; Nava-Aguilera, Elizabeth; Arostegui, Jorge; Morales-Perez, Arcadio; Suazo-Laguna, Harold; Legorreta-Soberanis, Jose; Hernandez-Alvarez, Carlos; Fernandez-Salas, Ildefonso; Paredes-Solis, Sergio; Balmaseda, Angel; Juan Cortes-Guzman, Antonio; Serrano de los Santos, Rene; Coloma, Josefina; Ledogar, Robert J.; Harris, Eva			Evidence based community mobilization for dengue prevention in Nicaragua and Mexico (Camino Verde, the Green Way): cluster randomized controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AEGYPTI CONTROL PROGRAM; RIO-DE-JANEIRO; AEDES-AEGYPTI; RESISTANCE; MUNICIPALITIES; TRANSMISSION; INSECTICIDE; VECTORS	OBJECTIVE To test whether community mobilization adds effectiveness to conventional dengue control. DESIGN Pragmatic open label parallel group cluster randomized controlled trial. Those assessing the outcomes and analyzing the data were blinded to group assignment. Centralized computerized randomization after the baseline study allocated half the sites to intervention, stratified by country, evidence of recent dengue virus infection in children aged 3-9, and vector indices. SETTINGS Random sample of communities in Managua, capital of Nicaragua, and three coastal regions in Guerrero State in the south of Mexico. PARTICIPANTS Residents in a random sample of census enumeration areas across both countries: 75 intervention and 75 control clusters (about 140 households each) were randomized and analyzed (60 clusters in Nicaragua and 90 in Mexico), including 85 182 residents in 18 838 households. INTERVENTIONS A community mobilization protocol began with community discussion of baseline results. Each intervention cluster adapted the basic intervention-chemical- free prevention of mosquito reproduction-to its own circumstances. All clusters continued the government run dengue control program. MAIN OUTCOME MEASURES Primary outcomes per protocol were self reported cases of dengue, serological evidence of recent dengue virus infection, and conventional entomological indices (house index: households with larvae or pupae/households examined; container index: containers with larvae or pupae/containers examined; Breteau index: containers with larvae or pupae/households examined; and pupae per person: pupae found/number of residents). Per protocol secondary analysis examined the effect of Camino Verde in the context of temephos use. RESULTS With cluster as the unit of analysis, serological evidence from intervention sites showed a lower risk of infection with dengue virus in children (relative risk reduction 29.5%, 95% confidence interval 3.8% to 55.3%), fewer reports of dengue illness (24.7%, 1.8% to 51.2%), fewer houses with larvae or pupae among houses visited (house index) (44.1%, 13.6% to 74.7%), fewer containers with larvae or pupae among containers examined (container index) (36.7%, 24.5% to 44.8%), fewer containers with larvae or pupae among houses visited (Breteau index) (35.1%, 16.7% to 55.5%), and fewer pupae per person (51.7%, 36.2% to 76.1%). The numbers needed to treat were 30 (95% confidence interval 20 to 59) for a lower risk of infection in children, 71 (48 to 143) for fewer reports of dengue illness, 17 (14 to 20) for the house index, 37 (35 to 67) for the container index, 10 (6 to 29) for the Breteau index, and 12 (7 to 31) for fewer pupae per person. Secondary per protocol analysis showed no serological evidence of a protective effect of temephos. CONCLUSIONS Evidence based community mobilization can add effectiveness to dengue vector control. Each site implementing the intervention in its own way has the advantage of local customization and strong community engagement.	[Andersson, Neil; Nava-Aguilera, Elizabeth; Morales-Perez, Arcadio; Legorreta-Soberanis, Jose; Paredes-Solis, Sergio; Serrano de los Santos, Rene] Univ Autonoma Guerrero, CIET, Acapulco, Mexico; [Andersson, Neil] McGill Univ, Dept Family Med, Montreal, PQ H3A 2T5, Canada; [Arostegui, Jorge; Suazo-Laguna, Harold; Hernandez-Alvarez, Carlos] CIET, Managua, Nicaragua; [Fernandez-Salas, Ildefonso] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Monterrey, Mexico; [Balmaseda, Angel] Minist Salud, Ctr Nacl Diagnost Referencia, Lab Nacl Virol, Managua, Nicaragua; [Juan Cortes-Guzman, Antonio] Serv Estat Salud Guerrero, Dept Prevenc & Control Enfermedades Transmisibles, Colonia Burocratas, Chilpancingo, Mexico; [Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Ledogar, Robert J.] CIET Int, New York, NY USA	McGill University; Universidad Autonoma de Nuevo Leon; University of California System; University of California Berkeley	Andersson, N (corresponding author), Univ Autonoma Guerrero, CIET, Acapulco, Mexico.	andersson@ciet.org	Andersson, Neil/G-2248-2011	Suazo Laguna, Harold/0000-0002-0383-6896				Al-Muhandis N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001278; Andersson Neil, 2006, Int J Health Geogr, V5, P1, DOI 10.1186/1476-072X-5-1; Arostegui J, 2008, AM J TROP MED HYG, V79, P216; Arunachalam N, 2012, PATHOG GLOB HEALTH, V106, P488, DOI 10.1179/2047773212Y.0000000056; Balmaseda A, 2008, J CLIN VIROL, V43, P287, DOI 10.1016/j.jcv.2008.07.016; Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015; Califf RM, 1997, EUR HEART J, V18, P367; Campbell MK, 2000, FAM PRACT, V17, P192, DOI 10.1093/fampra/17.2.192; Castro M, 2012, T ROY SOC TROP MED H, V106, P315, DOI 10.1016/j.trstmh.2012.01.013; Daniel J, 2012, SAMPLING ESSENTIALS, P140; DONNER A, 1993, J CLIN EPIDEMIOL, V46, P123, DOI 10.1016/0895-4356(93)90050-B; Espinoza-Gomez F, 2002, J EPIDEMIOL COMMUN H, V56, P148, DOI 10.1136/jech.56.2.148; Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Honaker J, AMELIA; Imai Kosuke, 2007, ZELIG EVERYONES STAT; Jirakanjanakit N, 2007, ENVIRON ENTOMOL, V36, P506, DOI 10.1603/0046-225X(2007)36[506:TOTRIA]2.0.CO;2; Kittayapong P, 2012, PATHOG GLOB HEALTH, V106, P446, DOI 10.1179/2047773212Y.0000000059; Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092; LEONTSINI E, 1993, T ROY SOC TROP MED H, V87, P267, DOI 10.1016/0035-9203(93)90120-F; Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329; LLOYD LS, 1992, AM J TROP MED HYG, V46, P635, DOI 10.4269/ajtmh.1992.46.635; Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1; Rubin DB, 1987, MULTIPLE IMPUTATION; TAYLOR DW, 1990, STAT MED, V9, P787, DOI 10.1002/sim.4780090708; Vanlerberghe V, 2009, BMJ-BRIT MED J, V338, P1959; WHO, 2009, WHO TECH REP SER, V958, P1	32	123	126	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2015	351								h3267	10.1136/bmj.h3267	http://dx.doi.org/10.1136/bmj.h3267			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MP	26156323	Green Published, hybrid			2022-12-28	WOS:000357955800004
J	Priest, N; Esmail, A; Kline, R; Rao, M; Coghill, Y; Williams, DR				Priest, Naomi; Esmail, Aneez; Kline, Roger; Rao, Mala; Coghill, Yvonne; Williams, David R.			Promoting equality for ethnic minority NHS staff-what works?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AFFIRMATIVE-ACTION; DIVERSITY; DISCRIMINATION; HEALTH; BIAS; RACE		[Priest, Naomi] Deakin Univ, Alfred Deakin Inst Citizenship & Globalisat, Melbourne, Vic, Australia; [Priest, Naomi] Univ Melbourne, Fac Med Dent & Hlth Serv, Melbourne Sch Populat & Global Hlth, Ctr Hlth Equ, Melbourne, Vic 3010, Australia; [Esmail, Aneez] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Kline, Roger] Middlesex Univ, Sch Business, London N17 8HR, England; [Rao, Mala] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Coghill, Yvonne] NHS England, Workforce Race Equal Standard Implementat, London, England; [Williams, David R.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Publ Hlth, Cambridge, MA 02138 USA; [Williams, David R.] Harvard Univ, Dept African & African Amer Studies & Soci, Publ Hlth, Cambridge, MA 02138 USA; [Williams, David R.] Univ Cape Town, Dept Psychiat & Mental Hlth, Publ Hlth, ZA-7700 Rondebosch, South Africa	Deakin University; University of Melbourne; University of Manchester; Middlesex University; Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Cape Town	Williams, DR (corresponding author), Deakin Univ, Alfred Deakin Inst Citizenship & Globalisat, Melbourne, Vic, Australia.	dwilliam@hsph.harvard.edu	Esmail, Aneez/I-6903-2013	Esmail, Aneez/0000-0001-7061-7434; kline, roger/0000-0002-5896-8802	Alfred Deakin Research Fellowship, Deakin University; Victorian Health Promotion Foundation (VicHealth); National Cancer Institute [P50 CA 148596]; NATIONAL CANCER INSTITUTE [P50CA148596] Funding Source: NIH RePORTER	Alfred Deakin Research Fellowship, Deakin University; Victorian Health Promotion Foundation (VicHealth); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We have read and understood BMJ policy on declaration of interests and declare AE and RK have both been involved in the development of the WRES since its announcement. NP was supported by an Alfred Deakin Research Fellowship, Deakin University, and by the Victorian Health Promotion Foundation (VicHealth). DW was supported by grant P50 CA 148596 from the National Cancer Institute. Provenance and peer review: Not commissioned; externally peer reviewed.	Ahern KR, 2012, Q J ECON, V127, P137, DOI 10.1093/qje/qjr049; Archibong U, 2010, INVOLVEMENT BLACK MI; Balafoutas L, 2012, SCIENCE, V335, P579, DOI 10.1126/science.1211180; Bansal N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003415; Beaman L, 2012, SCIENCE, V335, P582, DOI 10.1126/science.1212382; Becares L, 2008, 14 BETT HLTH; Bhopal RS, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003485; Blandford E, 2011, EQUALITY HIGHER ED S; Castillo-Page L, 2012, DIVERSITY MED ED FAC; Childs P, 2014, COMPARE; Cohen JJ, 2002, HEALTH AFFAIR, V21, P90, DOI 10.1377/hlthaff.21.5.90; Collins BW, 2007, NEW YORK U LAW REV, V82, P870; Daly A, 2013, AUSTR J LABOUR EC, V16, P277; Dawson J, 2009, DOES EXPERIENCE STAF; Devine PG, 2012, J EXP SOC PSYCHOL, V48, P1267, DOI 10.1016/j.jesp.2012.06.003; Duderstadt JJ, 1990, MICHIGAN MANDATE STR; ESMAIL A, 1993, BRIT MED J, V306, P691, DOI 10.1136/bmj.306.6879.691; Harris R, 2013, INT J NURS STUD, V50, P303, DOI 10.1016/j.ijnurstu.2012.10.008; Herring C, 2012, CRIT SOCIOL, V38, P629, DOI 10.1177/0896920511402701; Herring C, 2009, AM SOCIOL REV, V74, P208, DOI 10.1177/000312240907400203; Hollowell J, 2011, SEMIN PERINATOL, V35, P240, DOI 10.1053/j.semperi.2011.02.021; Holzer HJ, 2006, J POLICY ANAL MANAG, V25, P463, DOI 10.1002/pam.20181; Hunt V., 2015, WHY DIVERSITY MATTER; Jaques H, 2013, BMJ CAREERS; Kalev A, 2006, AM SOCIOL REV, V71, P589, DOI 10.1177/000312240607100404; Kalra V S, 2009, J Health Organ Manag, V23, P103; KANTER RM, 1977, AM J SOCIOL, V82, P965, DOI 10.1086/226425; Kelly Y, 2009, J PUBLIC HEALTH-UK, V31, P131, DOI 10.1093/pubmed/fdn057; Kline R., 2014, SNOWY WHITE PEAKS NH; Kline R, 2013, DISCRIMINATION APPOI; Kowal E., 2013, ETHNICITIES, V13, P316, DOI [10.1177/1468796812472885, DOI 10.1177/1468796812472885]; Lewis T, 2014, ANN REV CLIN PSYCH, V11, P101; Lewis Tene T, 2014, Curr Cardiovasc Risk Rep, V8, P365; Limb M, 2014, BMJ CAREERS     0731; Lovrich N, 1983, REV PUBLIC PERS ADM, V41, P55; Moses MS, 2010, EDUC RESEARCHER, V39, P211, DOI 10.3102/0013189X10365086; NHS, 2007, RAC EQ ACT PLAN 2007; NHS England /Equality & Health Inequalities Team, 2015, NHS WORKF RAC EQ STA; NHS Leadership Academy, 2013, GOOD GOV; Nickens HW, 1996, JAMA-J AM MED ASSOC, V275, P572, DOI 10.1001/jama.275.7.572; Noon M, 2010, WORK EMPLOY SOC, V24, P728, DOI 10.1177/0950017010380648; Paradies Y., 2009, BUILDING OUR STRENGT; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Passman R, 2015, TECHNICAL GUIDANCE N; Phillips KW, 2014, SCI AM, V311, P42, DOI 10.1038/scientificamerican1014-42; Phillips KW, 2012, RES MANAG GROUP TEAM, V15, P185, DOI 10.1108/S1534-0856(2012)0000015011; Risteska M, 2013, INT J PUBLIC ADMIN, V36, P26, DOI 10.1080/01900692.2012.691239; Roach R, 2005, DIVERSE ED; Rowley LL, 2002, 83 ANN M AM ED RES A; Singh B, 2013, J OCCUP ORGAN PSYCH, V86, P242, DOI 10.1111/joop.12015; Soljak Michael A, 2007, Int J Equity Health, V6, P8, DOI 10.1186/1475-9276-6-8; Stevenson J, 2014, EXPLAINING LEVELS WE; Syal R., 2014, GUARDIAN; Torchia M, 2011, J BUS ETHICS, V102, P299, DOI 10.1007/s10551-011-0815-z; Turner CSV, 2008, J DIVERS HIGH EDUC, V1, P139, DOI 10.1037/a0012837; West M, 2012, NHS STAFF MANAGEMENT; Williams DR, 2013, AM BEHAV SCI, V57, P1152, DOI 10.1177/0002764213487340; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0	58	14	14	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2015	351								h3297	10.1136/bmj.h3297	http://dx.doi.org/10.1136/bmj.h3297			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM8MP	26157106	Green Published			2022-12-28	WOS:000357955800005
J	Lane, R				Lane, Richard			Avraham Steinberg: leading light in faith-based medical ethics	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1723	1723		10.1016/S0140-6736(15)61218-1	http://dx.doi.org/10.1016/S0140-6736(15)61218-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0WK	26159397				2022-12-28	WOS:000363974200017
J	Deng, D; Sun, PC; Yan, CY; Ke, M; Jiang, X; Xiong, L; Ren, WL; Hirata, K; Yamamoto, M; Fan, SL; Yan, N				Deng, Dong; Sun, Pengcheng; Yan, Chuangye; Ke, Meng; Jiang, Xin; Xiong, Lei; Ren, Wenlin; Hirata, Kunio; Yamamoto, Masaki; Fan, Shilong; Yan, Nieng			Molecular basis of ligand recognition and transport by glucose transporters	NATURE			English	Article							ALPHA-D-GLUCOSE; BETA-D-GLUCOSE; SUGAR-TRANSPORT; SWISS-MODEL; CRYSTAL-STRUCTURE; XENOPUS OOCYTES; MEMBRANE; GLUT3; BINDING; PROTEINS	The major facilitator superfamily glucose transporters, exemplified by human GLUT1-4, have been central to the study of solute transport. Using lipidic cubic phase crystallization and microfocus X-ray diffraction, we determined the structure of human GLUT3 in complex with D-glucose at 1.5 angstrom resolution in an outward-occluded conformation. The high-resolution structure allows discrimination of both alpha- and beta-anomers of D-glucose. Two additional structures of GLUT3 bound to the exofacial inhibitor maltose were obtained at 2.6 angstrom in the outward-open and 2.4 angstrom in the outward-occluded states. In all three structures, the ligands are predominantly coordinated by polar residues from the carboxy terminal domain. Conformational transition from outward-open to outward-occluded entails a prominent local rearrangement of the extracellular part of transmembrane segment TM7. Comparison of the outward-facing GLUT3 structures with the inward-open GLUT1 provides insights into the alternating access cycle for GLUTs, whereby the C-terminal domain provides the primary substrate-binding site and the amino-terminal domain undergoes rigid-body rotation with respect to the C-terminal domain. Our studies provide an important framework for the mechanistic and kinetic understanding of GLUTs and shed light on structure-guided ligand design.	[Deng, Dong; Sun, Pengcheng; Yan, Chuangye; Ke, Meng; Jiang, Xin; Ren, Wenlin; Yan, Nieng] Tsinghua Univ, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Deng, Dong; Sun, Pengcheng; Yan, Chuangye; Ke, Meng; Jiang, Xin; Ren, Wenlin; Fan, Shilong; Yan, Nieng] Tsinghua Univ, Struct Biol Ctr, Beijing 100084, Peoples R China; [Deng, Dong; Sun, Pengcheng; Yan, Chuangye; Ke, Meng; Xiong, Lei; Yan, Nieng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Deng, Dong; Sun, Pengcheng; Yan, Chuangye; Ke, Meng; Xiong, Lei; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Hirata, Kunio; Yamamoto, Masaki] RIKEN SPring 8 Ctr, Adv Photon Technol Div, Res Infrastruct Grp, SR Life Sci Instrumentat Unit, Mikazuki, Hyogo 6795148, Japan; [Hirata, Kunio] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; RIKEN; Japan Science & Technology Agency (JST)	Yan, N (corresponding author), Tsinghua Univ, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Yamamoto, Masaki/B-7844-2015; Xiong, Lei/ADK-2392-2022; Yan, Chuangye/AAJ-5832-2021	Yamamoto, Masaki/0000-0002-1311-1768; Xiong, Lei/0000-0002-2392-114X; Deng, Dong/0000-0002-8590-9525; Yan, Chuangye/0000-0001-9338-8048; jiang, xin/0000-0002-7288-8278; Ke, Meng/0000-0002-9213-7439; Fan, Shilong/0000-0001-9272-2438; Sun, Pengcheng/0000-0002-7549-1161	Ministry of Science and Technology of China [2015CB910101, 2011CB910501, 2014ZX09507003006]; National Natural Science Foundation of China [31130002, 31125009]; Howard Hughes Medical Institute	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for providing the facility support. The computation was completed on the "Explorer 100" cluster system of Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from the Ministry of Science and Technology of China (2015CB910101, 2011CB910501, 2014ZX09507003006) and National Natural Science Foundation of China (projects 31130002 and 31125009). The research of N. Y. was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute and an endowed professorship from Bayer Healthcare.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Airley RE, 2007, CHEMOTHERAPY, V53, P233, DOI 10.1159/000104457; Amann T, 2009, EXPERT OPIN THER TAR, V13, P1411, DOI 10.1517/14728220903307509; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARNETT JEG, 1973, BIOCHEM J, V135, P539, DOI 10.1042/bj1350539; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Calvaresi EC, 2013, CHEM SCI, V4, P2319, DOI 10.1039/c3sc22205e; CARRUTHERS A, 1985, BIOCHEMISTRY-US, V24, P4244, DOI 10.1021/bi00336a065; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3907, DOI 10.1021/bi00230a015; CHEN CC, 1986, P NATL ACAD SCI USA, V83, P2652, DOI 10.1073/pnas.83.8.2652; COLVILLE CA, 1993, BIOCHEM J, V290, P701, DOI 10.1042/bj2900701; DeLano W.L, PYMOL MOL GRAPHICS S; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; DICK APK, 1984, P NATL ACAD SCI-BIOL, V81, P7233, DOI 10.1073/pnas.81.22.7233; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5434, DOI 10.1073/pnas.85.15.5434; Gallamini A, 2014, CANCERS, V6, P1821, DOI 10.3390/cancers6041821; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JANOSHAZI A, 1993, J MEMBRANE BIOL, V132, P167; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaira K, 2014, LUNG CANCER, V83, P197, DOI 10.1016/j.lungcan.2013.11.025; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; LACKO L, 1973, J CELL PHYSIOL, V82, P213, DOI 10.1002/jcp.1040820209; LEFEVRE PG, 1948, J GEN PHYSIOL, V31, P505, DOI 10.1085/jgp.31.6.505; Leitch JM, 2009, AM J PHYSIOL-CELL PH, V296, pC151, DOI 10.1152/ajpcell.00359.2008; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; Maher F, 1996, BIOCHEM J, V315, P827, DOI 10.1042/bj3150827; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nelson D.L., 2004, PRINCIPLES BIOCH, V4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascual JM, 2004, EUR J ENDOCRINOL, V150, P627, DOI 10.1530/eje.0.1500627; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Ramani P, 2013, VIRCHOWS ARCH, V462, P203, DOI 10.1007/s00428-012-1370-4; Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982; Rumsey SC, 2000, J BIOL CHEM, V275, P28246; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Shim BY, 2013, INT J COLORECTAL DIS, V28, P375, DOI 10.1007/s00384-012-1542-3; SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Uldry M, 2002, FEBS LETT, V524, P199, DOI 10.1016/S0014-5793(02)03058-2; Wisedchaisri G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5521; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003	65	227	235	17	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2015	526	7573					391	+		10.1038/nature14655	http://dx.doi.org/10.1038/nature14655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT3TQ	26176916				2022-12-28	WOS:000362730200043
J	Cook, D; Swinton, M; Toledo, F; Clarke, F; Rose, T; Hand-Breckenridge, T; Boyle, A; Woods, A; Zytaruk, N; Heels-Ansdell, D; Sheppard, R				Cook, Deborah; Swinton, Marilyn; Toledo, Feli; Clarke, France; Rose, Trudy; Hand-Breckenridge, Tracey; Boyle, Anne; Woods, Anne; Zytaruk, Nicole; Heels-Ansdell, Diane; Sheppard, Robert			Personalizing Death in the Intensive Care Unit: The 3 Wishes Project A Mixed-Methods Study	ANNALS OF INTERNAL MEDICINE			English	Article							OF-LIFE CARE; PALLIATIVE CARE; HEALTH-CARE; QUALITATIVE RESEARCH; COMMUNICATION; MEDICINE; DIGNITY	Background: Dying in the complex, efficiency-driven environment of the intensive care unit can be dehumanizing for the patient and have profound, long-lasting consequences for all persons attendant to that death. Objective: To bring peace to the final days of a patient's life and to ease the grieving process. Design: Mixed-methods study. Setting: 21-bed medical-surgical intensive care unit. Participants: Dying patients and their families and clinicians. Intervention: To honor each patient, a set of wishes was generated by patients, family members, or clinicians. The wishes were implemented before or after death by patients, families, clinicians (6 of whom were project team members), or the project team. Measurements: Quantitative data included demographic characteristics, processes of care, and scores on the Quality of End-of-Life Care-10 instrument. Semistructured interviews of family members and clinicians were transcribed verbatim, and qualitative description was used to analyze them. Results: Participants included 40 decedents, at least 1 family member per patient, and 3 clinicians per patient. The 159 wishes were implemented and classified into 5 categories: humanizing the environment, tributes, family reconnections, observances, and "paying it forward."Scores on the Quality of End-of-Life Care-10 instrument were high. The central theme from 160 interviews of 170 persons was how the 3 Wishes Project personalized the dying process. For patients, eliciting and customizing the wishes honored them by celebrating their lives and dignifying their deaths. For families, it created positive memories and individualized end-of-life care for their loved ones. For clinicians, it promoted interprofessional care and humanism in practice. Limitation: Impaired consciousness limited understanding of patients' viewpoints. Conclusion: The 3 Wishes Project facilitated personalization of the dying process through explicit integration of palliative and spiritual care into critical care practice. Primary Funding Source: Hamilton Academy of Health Science Research Organization, Canadian Intensive Care Foundation.	[Cook, Deborah] McMaster Univ, Hlth Sci Ctr, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Cook, Deborah] McMaster Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Swinton, Marilyn] McMaster Univ, Hamilton, ON L8N 3Z5, Canada; [Toledo, Feli; Rose, Trudy; Hand-Breckenridge, Tracey] St Josephs Healthcare, Spiritual Care Dept, Hamilton, ON L8N 4A6, Canada; [Clarke, France] St Josephs Healthcare, Hamilton, ON L8N 4A6, Canada; [Boyle, Anne; Woods, Anne] St Josephs Healthcare Hamilton, Palliat Care Serv, Hamilton, ON L8N 4A6, Canada; [Zytaruk, Nicole] St Josephs Healthcare Hamilton, Hamilton, ON L8N 4A6, Canada; [Heels-Ansdell, Diane] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4K1, Canada; [Sheppard, Robert] North Cypress Med Ctr, Cypress, TX 77429 USA	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; McMaster University; McMaster University; McMaster University; McMaster University	Cook, D (corresponding author), McMaster Univ, Hlth Sci Ctr, Dept Med, Room 2C11,1200 Main St West, Hamilton, ON L8N 3Z5, Canada.	debcook@mcmaster.ca			Hamilton Academy of Health Science Research Organization; Canadian Intensive Care Foundation	Hamilton Academy of Health Science Research Organization; Canadian Intensive Care Foundation	Hamilton Academy of Health Science Research Organization, Canadian Intensive Care Foundation.	Adamson Keith, 2012, Healthc Q, V15, P63; Aslakson RA, 2014, CRIT CARE MED, V42, P2418, DOI 10.1097/CCM.0000000000000573; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Back AL, 2014, J PALLIAT MED, V17, P1019, DOI 10.1089/jpm.2013.0651; Chochinov H, 2007, BRIT MED J, V335, P184, DOI 10.1136/bmj.39244.650926.47; Chochinov HM, 2013, CANCER-AM CANCER SOC, V119, P1706, DOI 10.1002/cncr.27949; Clarke EB, 2003, CRIT CARE MED, V31, P2255, DOI 10.1097/01.CCM.0000084849.96385.85; Cook D, 2014, NEW ENGL J MED, V370, P2506, DOI 10.1056/NEJMra1208795; Cook DJ, 1999, CAN MED ASSOC J, V161, P1109; Curtis JR, 2001, J GEN INTERN MED, V16, P41; End-of-Life Care Research Program University of Washington School of Medicine, INSTR; Ho LA, 2011, CRIT CARE MED, V39, P975, DOI 10.1097/CCM.0b013e31820a91db; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Johnson N, 2000, CULT MED PSYCHIAT, V24, P275, DOI 10.1023/A:1005690501494; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Patton MQ., 2015, QUALITATIVE RES EVAL, V3; Puchalski C, 2009, J PALLIAT MED, V12, P885, DOI 10.1089/jpm.2009.0142; RODGERS BL, 1993, RES NURS HEALTH, V16, P219, DOI 10.1002/nur.4770160309; Sabo Brenda, 2011, Online J Issues Nurs, V16, P1, DOI 10.3912/OJIN.Vol16No01Man01; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Scheunemann LP, 2011, CHEST, V139, P543, DOI 10.1378/chest.10-0595; Stajduhar KI, 2008, SOC SCI MED, V67, P1789, DOI 10.1016/j.socscimed.2008.09.012; Strauss Anslem, 1990, BASICS QUALITATIVE R, P23; Sulmasy DP, 2009, CHEST, V135, P1634, DOI 10.1378/chest.08-2241; Thurmond VA, 2001, J NURS SCHOLARSHIP, V33, P253, DOI 10.1111/j.1547-5069.2001.00253.x; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461; Wolpaw DR, 2014, NEW ENGL J MED, V370, P1283, DOI 10.1056/NEJMp1315661; World Health Organization, WHO DEF PALL CAR; [No title captured]	30	55	57	2	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					271	+		10.7326/M15-0502	http://dx.doi.org/10.7326/M15-0502			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LC	26167721				2022-12-28	WOS:000360286400005
J	Palatinszky, M; Herbold, C; Jehmlich, N; Pogoda, M; Han, P; von Bergen, M; Lagkouvardos, I; Karst, SM; Galushko, A; Koch, H; Berry, D; Daims, H; Wagner, M				Palatinszky, Marton; Herbold, Craig; Jehmlich, Nico; Pogoda, Mario; Han, Ping; von Bergen, Martin; Lagkouvardos, Ilias; Karst, Soren M.; Galushko, Alexander; Koch, Hanna; Berry, David; Daims, Holger; Wagner, Michael			Cyanate as an energy source for nitrifiers	NATURE			English	Article							NITRITE-OXIDIZING BACTERIA; SP-NOV; ALIGNMENT; GROWTH; POPULATIONS; HYDROGEN; AMMONIUM; CYANIDE; NITRATE; VERSION	Ammonia- and nitrite-oxidizing microorganisms are collectively responsible for the aerobic oxidation of ammonia via nitrite to nitrate and have essential roles in the global biogeochemical nitrogen cycle. The physiology of nitrifiers has been intensively studied, and urea and ammonia are the only recognized energy sources that promote the aerobic growth of ammonia-oxidizing bacteria and archaea. Here we report the aerobic growth of a pure culture of the ammonia-oxidizing thaumarchaeote Nitrososphaera gargensis(1) using cyanate as the sole source of energy and reductant; to our knowledge, the first organism known to do so. Cyanate, a potentially important source of reduced nitrogen in aquatic and terrestrial ecosystems(2), is converted to ammonium and carbon dioxide in Nitrososphaera gargensis by a cyanase enzyme that is induced upon addition of this compound. Within the cyanase gene family, this cyanase is a member of a distinct clade also containing cyanases of nitrite-oxidizing bacteria of the genus Nitrospira. We demonstrate by co-culture experiments that these nitrite oxidizers supply cyanase-lacking ammonia oxidizers with ammonium from cyanate, which is fully nitrified by this microbial consortium through reciprocal feeding. By screening a comprehensive set of more than 3,000 publically available metagenomes from environmental samples, we reveal that cyanase-encoding genes clustering with the cyanases of these nitrifiers are widespread in the environment. Our results demonstrate an unexpected metabolic versatility of nitri-fying microorganisms, and suggest a previously unrecognized importance of cyanate in cycling of nitrogen compounds in the environment.	[Palatinszky, Marton; Herbold, Craig; Pogoda, Mario; Han, Ping; Lagkouvardos, Ilias; Galushko, Alexander; Koch, Hanna; Berry, David; Daims, Holger; Wagner, Michael] Univ Vienna, Dept Microbiol & Ecosyst Sci, Div Microbial Ecol, A-1090 Vienna, Austria; [Jehmlich, Nico; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Prote, D-04318 Leipzig, Germany; [von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Metabol, D-04318 Leipzig, Germany; [von Bergen, Martin; Karst, Soren M.] Aalborg Univ, Dept Chem & Biosci, Fac Engn & Sci, DK-9220 Aalborg, Denmark; [Lagkouvardos, Ilias] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany; [Galushko, Alexander] Agrophys Res Inst, 14 Grazhdanskiy Pr, St Petersburg 195220, Russia	University of Vienna; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Aalborg University; Technical University of Munich; Agrophysics Research Institute	Wagner, M (corresponding author), Univ Vienna, Dept Microbiol & Ecosyst Sci, Div Microbial Ecol, Althanstr 14, A-1090 Vienna, Austria.	wagner@microbial-ecology.net	von Bergen, Martin/D-7960-2011; Palatinszky, Marton/HGB-7938-2022; Galushko, Alexander/I-4980-2015; Berry, David/C-8455-2011; Herbold, Craig W./S-4397-2018; Wagner, Michael/A-7801-2011; Han, Ping/P-5401-2019; Daims, Holger/I-8410-2012; Lagkouvardos, Ilias/AAV-1857-2020; Palatinszky, Márton/ABB-2723-2020; Han, Ping/F-2360-2017; Jehmlich, Nico/B-5403-2009; Jehmlich, Nico/D-9041-2015; Palatinszky, Marton/D-9876-2011; Koch, Hanna/ABD-5584-2021	von Bergen, Martin/0000-0003-2732-2977; Palatinszky, Marton/0000-0002-3627-085X; Galushko, Alexander/0000-0002-0387-7997; Berry, David/0000-0002-8997-608X; Herbold, Craig W./0000-0003-3479-0197; Wagner, Michael/0000-0002-9778-7684; Han, Ping/0000-0001-6025-1651; Daims, Holger/0000-0002-4195-0913; Lagkouvardos, Ilias/0000-0001-9337-4033; Han, Ping/0000-0001-6025-1651; Jehmlich, Nico/0000-0002-5638-6868; Jehmlich, Nico/0000-0002-5638-6868; Palatinszky, Marton/0000-0002-3627-085X; Karst, Soren Michael/0000-0002-0233-160X; Koch, Hanna/0000-0002-8550-9871; Valeeva, Aygul V./0000-0002-9968-9586	European Research Council [294343]; Austrian Science Fund (FWF) [P25231-B21, P26127-B20]; European Regional Development Funds (EFRE-Europe funds Saxony); Helmholtz Association; Collaborative Research Centre AquaDiva of the German Research Foundation	European Research Council(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Regional Development Funds (EFRE-Europe funds Saxony); Helmholtz Association(Helmholtz Association); Collaborative Research Centre AquaDiva of the German Research Foundation	We thank E. Lebedeva for efforts in purifying N. gargensis, M. Mooshammer for help with cyanate analytics, K. Eismann and B. Scheer for help with the proteomic analysis, and M. Schmid for performing the FISH experiment. A. Pommerening-Roser is acknowledged for providing the Nitrosomonas nitrosa Nm90 strain. M.Pa., M.Po., A.G., P.H., and M.W. were supported by the European Research Council Advanced Grant project NITRICARE 294343 (to M.W). H.D., H.K., and D.B. were supported by the Austrian Science Fund (FWF, grants P25231-B21 and P26127-B20). We are grateful for use of the analytical facilities of the Centre for Chemical Microscopy (ProVIS) at the Helmholtz Centre for Environmental Research, which is supported by European Regional Development Funds (EFRE-Europe funds Saxony) and the Helmholtz Association. M.vB. was partially funded by the Collaborative Research Centre AquaDiva of the German Research Foundation.	Alonso-Saez L, 2012, P NATL ACAD SCI USA, V109, P17989, DOI 10.1073/pnas.1201914109; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; BOCK E, 1995, ARCH MICROBIOL, V163, P16, DOI 10.1007/BF00262198; BOCK E, 1976, ARCH MICROBIOL, V108, P305, DOI 10.1007/BF00454857; Daims H, 2001, APPL ENVIRON MICROB, V67, P5273, DOI 10.1128/AEM.67.11.5273-5284.2001; DeMartini N, 2004, IND ENG CHEM RES, V43, P4815, DOI 10.1021/ie034189+; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EHRICH S, 1995, ARCH MICROBIOL, V164, P16; Gallant R. H., 1987, NONLINEAR EQUATION E, P610; GUILLOTON M, 1985, ANAL BIOCHEM, V149, P291, DOI 10.1016/0003-2697(85)90572-X; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Henningsen A, 2007, J STAT SOFTW, V23; Hommes NG, 2003, J BACTERIOL, V185, P6809, DOI 10.1128/JB.185.23.6809-6814.2003; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kamennaya NA, 2013, LIMNOL OCEANOGR, V58, P1959, DOI 10.4319/lo.2013.58.6.1959; Kamennaya NA, 2008, LIMNOL OCEANOGR, V53, P2485, DOI 10.4319/lo.2008.53.6.2485; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koch H, 2014, SCIENCE, V345, P1052, DOI 10.1126/science.1256985; KOOPS HP, 1991, J GEN MICROBIOL, V137, P1689, DOI 10.1099/00221287-137-7-1689; Lebedeva EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080835; Luque-Almagro VM, 2008, APPL ENVIRON MICROB, V74, P6280, DOI 10.1128/AEM.00916-08; Maeda S, 2009, J BACTERIOL, V191, P3265, DOI 10.1128/JB.00013-09; Maixner F, 2006, ENVIRON MICROBIOL, V8, P1487, DOI 10.1111/j.1462-2920.2006.01033.x; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Mobarry BK, 1996, APPL ENVIRON MICROB, V62, P2156, DOI 10.1128/AEM.62.6.2156-2162.1996; MunozCenteno MC, 1996, FEMS MICROBIOL LETT, V137, P91, DOI 10.1016/0378-1097(96)00039-0; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; Purcarea C, 2003, J BIOL CHEM, V278, P52924, DOI 10.1074/jbc.M309383200; Qian MW, 1997, BIOCHEM J, V326, P159, DOI 10.1042/bj3260159; Qin W, 2014, P NATL ACAD SCI USA, V111, P12504, DOI 10.1073/pnas.1324115111; Rees AP, 2006, DEEP-SEA RES PT II, V53, P1649, DOI 10.1016/j.dsr2.2006.05.008; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Schiffmann CL, 2014, J PROTEOMICS, V98, P59, DOI 10.1016/j.jprot.2013.12.009; Schramm A, 1999, APPL ENVIRON MICROB, V65, P3690; Spang A, 2012, ENVIRON MICROBIOL, V14, P3122, DOI 10.1111/j.1462-2920.2012.02893.x; Stieglmeier M, 2014, INT J SYST EVOL MICR, V64, P2738, DOI 10.1099/ijs.0.063172-0; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; Taillades J, 2001, J CHEM SOC PERK T 2, P1247, DOI 10.1039/b005856o; Team R. D. C. R., 2011, P NATL ACAD SCI US; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Ubalua AO, 2010, AUST J CROP SCI, V4, P223; Widdel F., 1980, ANAEROBER ABBAU FETT; Widner B, 2013, ANAL CHEM, V85, P6661, DOI 10.1021/ac400351c	47	144	153	11	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					105	+		10.1038/nature14856	http://dx.doi.org/10.1038/nature14856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26222031	Green Accepted			2022-12-28	WOS:000359002300041
J	Chabner, B; Richon, V				Chabner, Bruce; Richon, Victoria			Focus on Research Structural Approaches to Cancer Drug Development	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chabner, Bruce] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Richon, Victoria] Sanofi Aventis, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Sanofi-Aventis	Chabner, B (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Izar Benjamin, 2013, Pharmacol Rev, V65, P1351, DOI 10.1124/pr.113.007807; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Verspoor FGM, 2013, FUTURE ONCOL, V9, P1515, DOI 10.2217/fon.13.124; Wang XL, 2012, J MED CHEM, V55, P7332, DOI 10.1021/jm300613w	4	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2015	373	5					402	403		10.1056/NEJMp1503567	http://dx.doi.org/10.1056/NEJMp1503567			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8BO	26222556				2022-12-28	WOS:000358662200003
J	Liu, JT; Prindle, A; Humphries, J; Gabalda-Sagarra, M; Asally, M; Lee, DYD; Ly, S; Garcia-Ojalvo, J; Suel, GM				Liu, Jintao; Prindle, Arthur; Humphries, Jacqueline; Gabalda-Sagarra, Marcal; Asally, Munehiro; Lee, Dong-Yeon D.; Ly, San; Garcia-Ojalvo, Jordi; Sueel, Guerol M.			Metabolic co-dependence gives rise to collective oscillations within biofilms	NATURE			English	Article							BACILLUS-SUBTILIS; BACTERIAL BIOFILMS; TRANSPORT; ASSIMILATION; COOPERATION; OPERON	Cells that reside within a community can cooperate and also compete with each other for resources. It remains unclear how these opposing interactions are resolved at the population level. Here we investigate such an internal conflict within a microbial (Bacillus subtilis) biofilm community: cells in the biofilm periphery not only protect interior cells from external attack but also starve them through nutrient consumption. We discover that this conflict between protection and starvation is resolved through emergence of long-range metabolic co-dependence between peripheral and interior cells. As a result, biofilm growth halts periodically, increasing nutrient availability for the sheltered interior cells. We show that this collective oscillation in biofilm growth benefits the community in the event of a chemical attack. These findings indicate that oscillations support population-level conflict resolution by coordinating competing metabolic demands in space and time, suggesting new strategies to control biofilm growth.	[Liu, Jintao; Prindle, Arthur; Humphries, Jacqueline; Lee, Dong-Yeon D.; Ly, San; Sueel, Guerol M.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Gabalda-Sagarra, Marcal; Garcia-Ojalvo, Jordi] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08003, Spain; [Asally, Munehiro] Univ Warwick, Sch Life Sci, Warwick Integrat Synthet Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Asally, Munehiro] Univ Warwick, Sch Life Sci, Warwick Integrat Synthet Biol Ctr, Coventry CV4 7AL, W Midlands, England	University of California System; University of California San Diego; Pompeu Fabra University; University of Warwick; University of Warwick	Suel, GM (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	gsuel@ucsd.edu	Garcia-Ojalvo, Jordi/A-4574-2009; Liu, Jintao/P-9232-2018; Asally, Munehiro/AAZ-3693-2020	Garcia-Ojalvo, Jordi/0000-0002-3716-7520; Liu, Jintao/0000-0002-6710-2605; Asally, Munehiro/0000-0002-8273-7617; Gabalda-Sagarra, Marcal/0000-0002-3933-2577	UCSD Cell and Molecular Genetics Training Grant; Ministerio de Economia y Competitividad (Spain) [FIS2012-37655-C02-01]; FEDER [FIS2012-37655-C02-01]; ICREA Academia Programme; National Institutes of Health, National Institute of General Medical Sciences [R01 GM088428]; National Science Foundation [MCB-1450867]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088428, T32GM007240] Funding Source: NIH RePORTER	UCSD Cell and Molecular Genetics Training Grant; Ministerio de Economia y Competitividad (Spain); FEDER(European Commission); ICREA Academia Programme(ICREA); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank K. Suel, T. Cagatay, R. Wollman, T. Hwa and M. Elowitz for comments during the writing of the manuscript. A.P. is a Simons Foundation Fellow of the Helen Hay Whitney Foundation. J.H. is supported by the UCSD Cell and Molecular Genetics Training Grant. J.G.-O. is supported by the Ministerio de Economia y Competitividad (Spain) and FEDER, under project FIS2012-37655-C02-01, and by the ICREA Academia Programme. This research was funded by the National Institutes of Health, National Institute of General Medical Sciences Grant R01 GM088428 and the National Science Foundation Grant MCB-1450867 (both to G.M.S.).	Anyan ME, 2014, P NATL ACAD SCI USA, V111, P18013, DOI 10.1073/pnas.1414661111; Asally M, 2012, P NATL ACAD SCI USA, V109, P18891, DOI 10.1073/pnas.1212429109; Belitsky BR, 1998, J BACTERIOL, V180, P6298; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981; Boogerd FC, 2011, FEBS LETT, V585, P23, DOI 10.1016/j.febslet.2010.11.055; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; CASTORPH H, 1984, ARCH MICROBIOL, V139, P245, DOI 10.1007/BF00402008; Commichau FM, 2008, J BACTERIOL, V190, P3557, DOI 10.1128/JB.00099-08; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Detsch C, 2003, MICROBIOL-SGM, V149, P3289, DOI 10.1099/mic.0.26512-0; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Eldar A, 2011, P NATL ACAD SCI USA, V108, P13635, DOI 10.1073/pnas.1102923108; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; Gunka K, 2012, MOL MICROBIOL, V85, P213, DOI 10.1111/j.1365-2958.2012.08105.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; JAYAKUMAR A, 1986, J BACTERIOL, V166, P281, DOI 10.1128/jb.166.1.281-284.1986; Kim M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.46; KLEINER D, 1985, FEMS MICROBIOL LETT, V32, P87, DOI 10.1016/0378-1097(85)90059-X; NAKANO MM, 1995, J BACTERIOL, V177, P573, DOI 10.1128/jb.177.3.573-579.1995; Oliveira NM, 2014, P NATL ACAD SCI USA, V111, P17941, DOI 10.1073/pnas.1412673111; Stannek L., 2015, ENV MICROBIOL; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Wilking JN, 2013, P NATL ACAD SCI USA, V110, P848, DOI 10.1073/pnas.1216376110; Wingreen NS, 2006, PLOS BIOL, V4, P1486, DOI 10.1371/journal.pbio.0040299; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08	29	244	253	18	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					550	+		10.1038/nature14660	http://dx.doi.org/10.1038/nature14660			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26200335	Green Submitted, Green Accepted			2022-12-28	WOS:000358655200036
J	Ploehn, HJ				Ploehn, Harry J.			MATERIALS SCIENCE Composite for energy storage takes the heat	NATURE			English	Editorial Material							COVALENT; SYSTEMS	A polymer-based material has been discovered that breaks the rules - it has the right combination of properties for use in energy-storage devices called dielectric capacitors, and can function at high temperatures. See Letter p.576	Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ploehn, HJ (corresponding author), Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA.	ploehn@mailbox.sc.edu						Barshaw EJ, 2007, IEEE T MAGN, V43, P223, DOI 10.1109/TMAG.2006.887682; Emadi A, 2006, IEEE T POWER ELECTR, V21, P567, DOI 10.1109/TPEL.2006.872378; Li Q, 2015, NATURE, V523, P576, DOI 10.1038/nature14647; Li Q, 2015, ENERG ENVIRON SCI, V8, P922, DOI 10.1039/c4ee02962c; Carrasco JM, 2006, IEEE T IND ELECTRON, V53, P1002, DOI 10.1109/TIE.2006.878356; Nelson JK, 2010, DIELECTRIC POLYMER NANOCOMPOSITES, P1, DOI 10.1007/978-1-4419-1591-7; Raju G.G., 2003, DIELECTRICS ELECT FI; VANVECHTEN JA, 1969, PHYS REV, V182, P891, DOI 10.1103/PhysRev.182.891; WEMPLE SH, 1971, PHYS REV B, V3, P1338, DOI 10.1103/PhysRevB.3.1338; Ziman J. M., 1972, PRINCIPLES THEORY SO	10	11	11	5	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					536	537		10.1038/523536a	http://dx.doi.org/10.1038/523536a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26223620				2022-12-28	WOS:000358655200029
J	Greenhill, SD; Juczewski, K; de Haan, AM; Seaton, G; Fox, K; Hardingham, NR				Greenhill, Stuart D.; Juczewski, Konrad; de Haan, Annelies M.; Seaton, Gillian; Fox, Kevin; Hardingham, Neil R.			Adult cortical plasticity depends on an early postnatal critical period	SCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; BARREL CORTEX; SOMATOSENSORY CORTEX; EXCITATORY SYNAPSES; DISC1; SCHIZOPHRENIA; PROTEIN; RISK; NEURODEVELOPMENT; SYNAPTOGENESIS	Development of the cerebral cortex is influenced by sensory experience during distinct phases of postnatal development known as critical periods. Disruption of experience during a critical period produces neurons that lack specificity for particular stimulus features, such as location in the somatosensory system. Synaptic plasticity is the agent by which sensory experience affects cortical development. Here, we describe, in mice, a developmental critical period that affects plasticity itself. Transient neonatal disruption of signaling via the C-terminal domain of "disrupted in schizophrenia 1" (DISC1)-a molecule implicated in psychiatric disorders-resulted in a lack of long-term potentiation (LTP) (persistent strengthening of synapses) and experience-dependent potentiation in adulthood. Long-term depression (LTD) (selective weakening of specific sets of synapses) and reversal of LTD were present, although impaired, in adolescence and absent in adulthood. These changes may form the basis for the cognitive deficits associated with mutations in DISC1 and the delayed onset of a range of psychiatric symptoms in late adolescence.	[Greenhill, Stuart D.; de Haan, Annelies M.; Seaton, Gillian; Fox, Kevin; Hardingham, Neil R.] Cardiff Univ, Sch Biosci, Cardiff CF23 3AX, S Glam, Wales; [Juczewski, Konrad] Natl Inst Alcohol Abuse & Alcoholism, NIH, Rockville, MD 20852 USA	Cardiff University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Hardingham, NR (corresponding author), Cardiff Univ, Sch Biosci, Cardiff CF23 3AX, S Glam, Wales.	sbinrh@cardiff.ac.uk	Greenhill, Stuart D./N-9412-2019; Juczewski, Konrad/P-9920-2019	Seaton, Gillian/0000-0002-2768-7514; Fox, Kevin/0000-0002-2563-112X; Hardingham, Neil/0000-0002-0703-6175; Greenhill, Stuart/0000-0002-5038-5258	UK Medical Research Council; U.S. National Institute of Mental Health, NIH; MRC [MR/N003896/1, MR/K004603/1] Funding Source: UKRI; Medical Research Council [MR/N003896/1, MR/K004603/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.S. National Institute of Mental Health, NIH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge the support of the UK Medical Research Council and U.S. National Institute of Mental Health, NIH, to K.F. for this work. We also thank T. Gould for histology, A. Siva for discussions on DISC1cc, and S. Butt for suggestions on methods of tamoxifen delivery. Supplement contains additional data.	Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Burdick KE, 2008, HUM MOL GENET, V17, P2462, DOI 10.1093/hmg/ddn146; Carlisle HJ, 2011, J NEUROSCI, V31, P16194, DOI 10.1523/JNEUROSCI.5877-10.2011; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Cheetham CEJ, 2010, J NEUROSCI, V30, P12566, DOI 10.1523/JNEUROSCI.2544-10.2010; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Hardingham N, 2003, J NEUROSCI, V23, P4428; Hardingham N, 2006, J NEUROSCI, V26, P7395, DOI 10.1523/JNEUROSCI.0652-06.2006; Hardingham N, 2008, NEURON, V60, P861, DOI 10.1016/j.neuron.2008.10.018; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Kang EC, 2011, NEURON, V72, P559, DOI 10.1016/j.neuron.2011.09.032; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lipina TV, 2012, NEUROPHARMACOLOGY, V62, P1252, DOI 10.1016/j.neuropharm.2011.02.020; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Ranson A, 2012, P NATL ACAD SCI USA, V109, P1311, DOI 10.1073/pnas.1112204109; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Soares DC, 2012, J BIOL CHEM, V287, P32381, DOI 10.1074/jbc.M112.393439; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Sudarov A, 2013, EMBO MOL MED, V5, P591, DOI 10.1002/emmm.201202106; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Wang Q, 2011, MOL PSYCHIATR, V16, P1006, DOI 10.1038/mp.2010.87; Wen JA, 2011, J NEUROSCI, V31, P4456, DOI 10.1523/JNEUROSCI.6042-10.2011; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716	35	57	60	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					424	427		10.1126/science.aaa8481	http://dx.doi.org/10.1126/science.aaa8481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206934	Green Accepted			2022-12-28	WOS:000358381400042
J	Benson, E; Mohammed, A; Gardell, J; Masich, S; Czeizler, E; Orponen, P; Hogberg, B				Benson, Erik; Mohammed, Abdulmelik; Gardell, Johan; Masich, Sergej; Czeizler, Eugen; Orponen, Pekka; Hogberg, Bjorn			DNA rendering of polyhedral meshes at the nanoscale	NATURE			English	Article							SINGLE-STRANDED-DNA; FOLDING DNA; ORIGAMI; SHAPES; NANOSTRUCTURES; JUNCTIONS	It was suggested(1) more than thirty years ago that Watson-Crick base pairing might be used for the rational design of nanometre-scale structures from nucleic acids. Since then, and especially since the introduction of the origami technique(2), DNA nanotechnology has enabled increasingly more complex structures(3-18). But although general approaches for creating DNA origami polygonal meshes and design software are available(14,16,17,19-21), there are still important constraints arising from DNA geometry and sense/antisense pairing, necessitating some manual adjustment during the design process. Here we present a general method of folding arbitrary polygonal digital meshes in DNA that readily produces structures that would be very difficult to realize using previous approaches. The design process is highly automated, using a routeing algorithm based on graph theory and a relaxation simulation that traces scaffold strands through the target structures. Moreover, unlike conventional origami designs built from close-packed helices, our structures have a more open conformation with one helix per edge and are therefore stable under the ionic conditions usually used in biological assays.	[Benson, Erik; Gardell, Johan; Hogberg, Bjorn] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Benson, Erik; Gardell, Johan; Hogberg, Bjorn] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; [Mohammed, Abdulmelik; Czeizler, Eugen; Orponen, Pekka] Aalto Univ, Dept Comp Sci, FI-00076 Aalto, Finland; [Masich, Sergej] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Aalto University; Karolinska Institutet	Hogberg, B (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.	bjorn.hogberg@ki.se	benson, erik/AAM-5254-2021; Benson, Erik/AHA-6673-2022; Orponen, Pekka/E-7332-2012; Czeizler, Eugen/AAA-6628-2019	Benson, Erik/0000-0003-3374-501X; Orponen, Pekka/0000-0002-0417-2104; Czeizler, Eugen/0000-0002-1607-1554; Hogberg, Bjorn/0000-0003-2715-7887	Swedish Research Council [2010-5060, 2013-5883]; Swedish Foundation for Strategic Research [FFL12-0219]; Knut and Alice Wallenberg foundation [KAW2014.0241]; Wallenberg Scholars grant; Helsinki Doctoral Education Network on Information and Communications Technology	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Wallenberg Scholars grant; Helsinki Doctoral Education Network on Information and Communications Technology	This work was funded through grants from the Swedish Research Council (grants 2010-5060 and 2013-5883 to B.H.), the Swedish Foundation for Strategic Research (grant FFL12-0219 to B.H.) and the Knut and Alice Wallenberg foundation (Academy Fellow grant KAW2014.0241 to B.H.). E.B. was also funded by a Wallenberg Scholars grant to O. Inganas. The work of A.M. was supported by the Helsinki Doctoral Education Network on Information and Communications Technology. We acknowledge the computational resources provided by the Aalto Science-IT project and the use of the Facility for EM Tomography at the Karolinska Institutet. A.M., E.C. and P.O. thank G. Garcia Perez for help in implementing early variants of the scaffold routing software. We thank P. Kumar Areddy (Karolinska Institutet) and A.-L. Bank Kodal and K. Gothelf (Aarhus University) for help with early experimental testing.	Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/nnano.2014.58, 10.1038/NNANO.2014.58]; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Bhatia D, 2009, ANGEW CHEM INT EDIT, V48, P4134, DOI 10.1002/anie.200806000; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Dovling Andersen L., 1995, DISCRETE APPL MATH, V59, P203; Ducani C, 2013, NAT METHODS, V10, P647, DOI [10.1038/NMETH.2503, 10.1038/nmeth.2503]; Edmonds J., 1973, Mathematical Programming, V5, P88, DOI 10.1007/BF01580113; Ellis-Monaghan J. A., 2014, NATURAL COMPUT; Geary C, 2014, SCIENCE, V345, P799, DOI 10.1126/science.1253920; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; Gradisar H, 2013, NAT CHEM BIOL, V9, P362, DOI 10.1038/nchembio.1248; Hahn J, 2014, ACS NANO, V8, P8765, DOI 10.1021/nn503513p; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; He Y, 2006, J AM CHEM SOC, V128, P15978, DOI 10.1021/ja0665141; Iinuma R, 2014, SCIENCE, V344, P65, DOI 10.1126/science.1250944; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Liedl T, 2010, NAT NANOTECHNOL, V5, P520, DOI [10.1038/nnano.2010.107, 10.1038/NNANO.2010.107]; List J, 2014, ANGEW CHEM INT EDIT, V53, P4236, DOI 10.1002/anie.201310259; Marchi AN, 2014, NANO LETT, V14, P5740, DOI 10.1021/nl502626s; Martin TG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2095; Rothemund PWK, 2006, NAT COMP SER, P3, DOI 10.1007/3-540-30296-4_1; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Shaw A, 2014, NAT METHODS, V11, P841, DOI [10.1038/NMETH.3025, 10.1038/nmeth.3025]; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307	30	414	424	13	270	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					441	U139		10.1038/nature14586	http://dx.doi.org/10.1038/nature14586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26201596	Green Accepted			2022-12-28	WOS:000358378900032
J	Kondrashov, F				Kondrashov, Fyodor			Russia's crackdowns are jeopardizing its science	NATURE			English	Editorial Material									Ctr Genom Regulat, Catalan Inst Res & Adv Studies ICREA Res, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Kondrashov, F (corresponding author), Ctr Genom Regulat, Catalan Inst Res & Adv Studies ICREA Res, Barcelona, Spain.				ICREA Funding Source: Custom	ICREA(ICREA)			0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					383	383		10.1038/523383a	http://dx.doi.org/10.1038/523383a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN4DD	26201562	Bronze			2022-12-28	WOS:000358378900004
J	Armstrong, S				Armstrong, Stephen			TECHNOLOGY Finally, the NHS goes digital. Or does it?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stephen.armstrong@me.com						HM Government, 2014, PERS HLTH CAR 2020; King's Fund, 2015, DIG HLTH CAR C 2015	2	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2015	351								h3726	10.1136/bmj.h3726	http://dx.doi.org/10.1136/bmj.h3726			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CD	26169657				2022-12-28	WOS:000358300400002
J	Erb, DK				Erb, Dawn K.			Feedback in low-mass galaxies in the early Universe	NATURE			English	Review							STAR-FORMING GALAXIES; ALPHA-EMITTING GALAXIES; SIMILAR-TO 2-3; GRAVITATIONALLY LENSED GALAXY; UV LUMINOSITY FUNCTION; METAL-LINE ABSORPTION; LYMAN BREAK GALAXIES; 10 BILLION YEARS; LY-ALPHA; METALLICITY RELATION	The formation, evolution and death of massive stars release large quantities of energy and momentum into the gas surrounding the sites of star formation. This process, generically termed 'feedback', inhibits further star formation either by removing gas from the galaxy, or by heating it to temperatures that are too high to form new stars. Observations reveal feedback in the form of galactic-scale outflows of gas in galaxies with high rates of star formation, especially in the early Universe. Feedback in faint, low-mass galaxies probably facilitated the escape of ionizing radiation from galaxies when the Universe was about 500 million years old, so that the hydrogen between galaxies changed from neutral to ionized-the last major phase transition in the Universe.	Univ Wisconsin, Dept Phys, Ctr Gravitat Cosmol & Astrophys, Milwaukee, WI 53211 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Erb, DK (corresponding author), Univ Wisconsin, Dept Phys, Ctr Gravitat Cosmol & Astrophys, 3135 North Maryland Ave, Milwaukee, WI 53211 USA.	erbd@uwm.edu						Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Adelberger KL, 2003, ASTROPHYS J, V584, P45, DOI 10.1086/345660; Alavi A, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/143; Atek H, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/18; Behroozi PS, 2010, ASTROPHYS J, V717, P379, DOI 10.1088/0004-637X/717/1/379; Booth CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01738; Borthakur S, 2014, SCIENCE, V346, P216, DOI 10.1126/science.1254214; Bouwens RJ, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/1/34; BURKE JA, 1968, MON NOT R ASTRON SOC, V140, P241, DOI 10.1093/mnras/140.2.241; Chonis TS, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/99; COWIE LL, 1995, ASTRON J, V109, P1522, DOI 10.1086/117381; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; Dalcanton JJ, 2007, ASTROPHYS J, V658, P941, DOI 10.1086/508913; Dave R, 2012, MON NOT R ASTRON SOC, V421, P98, DOI 10.1111/j.1365-2966.2011.20148.x; Dave R, 2010, MON NOT R ASTRON SOC, V408, P2051, DOI 10.1111/j.1365-2966.2010.17279.x; Dessauges-Zavadsky M, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913337; Erb DK, 2008, ASTROPHYS J, V674, P151, DOI 10.1086/524727; Erb DK, 2006, ASTROPHYS J, V644, P813, DOI 10.1086/503623; Erb DK, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/1/33; Erb DK, 2010, ASTROPHYS J, V719, P1168, DOI 10.1088/0004-637X/719/2/1168; Fan XH, 2006, ANNU REV ASTRON ASTR, V44, P415, DOI 10.1146/annurev.astro.44.051905.092514; Finlator K, 2008, MON NOT R ASTRON SOC, V385, P2181, DOI 10.1111/j.1365-2966.2008.12991.x; Gawiser E, 2006, ASTROPHYS J, V642, pL13, DOI 10.1086/504467; Geach JE, 2014, NATURE, V516, P68, DOI 10.1038/nature14012; George RD, 2014, MON NOT R ASTRON SOC, V442, P1877, DOI 10.1093/mnras/stu967; Guaita L, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220013; Guaita L, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/114; Haas MR, 2013, MON NOT R ASTRON SOC, V435, P2931, DOI 10.1093/mnras/stt1487; Hashimoto T, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/70; Heckman TM, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/5; Heckman TM, 2000, ASTROPHYS J SUPPL S, V129, P493, DOI 10.1086/313421; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P1, DOI 10.1086/499298; Hopkins PF, 2014, MON NOT R ASTRON SOC, V445, P581, DOI 10.1093/mnras/stu1738; Hopkins PF, 2012, MON NOT R ASTRON SOC, V421, P3522, DOI 10.1111/j.1365-2966.2012.20593.x; Hu EM, 1996, NATURE, V382, P231, DOI 10.1038/382231a0; Jones T, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/51; Kim JH, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/1/14; Kuhlen M, 2012, MON NOT R ASTRON SOC, V423, P862, DOI 10.1111/j.1365-2966.2012.20924.x; Kulas KR, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/33; Laursen P, 2009, ASTROPHYS J, V704, P1640, DOI 10.1088/0004-637X/704/2/1640; Law DR, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/29; Madau P, 2014, ANNU REV ASTRON ASTR, V52, P415, DOI 10.1146/annurev-astro-081811-125615; Maiolino R, 2008, ASTRON ASTROPHYS, V488, P463, DOI 10.1051/0004-6361:200809678; Martin CL, 2005, ASTROPHYS J, V621, P227, DOI 10.1086/427277; Martin CL, 2002, ASTROPHYS J, V574, P663, DOI 10.1086/341092; McLinden EM, 2014, MON NOT R ASTRON SOC, V439, P446, DOI 10.1093/mnras/stu023; McLure RJ, 2013, MON NOT R ASTRON SOC, V432, P2696, DOI 10.1093/mnras/stt627; Mostardi RE, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/65; Moster BP, 2010, ASTROPHYS J, V710, P903, DOI 10.1088/0004-637X/710/2/903; Murray N, 2005, ASTROPHYS J, V618, P569, DOI 10.1086/426067; Murray N, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/66; Nestor DB, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/47; Nestor DB, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/18; Oesch PA, 2010, ASTROPHYS J LETT, V725, pL150, DOI 10.1088/2041-8205/725/2/L150; Oppenheimer BD, 2006, MON NOT R ASTRON SOC, V373, P1265, DOI 10.1111/j.1365-2966.2006.10989.x; Oppenheimer BD, 2012, MON NOT R ASTRON SOC, V420, P829, DOI 10.1111/j.1365-2966.2011.20096.x; Pettini M, 2002, ASTROPHYS J, V569, P742, DOI 10.1086/339355; Quider AM, 2010, MON NOT R ASTRON SOC, V402, P1467, DOI 10.1111/j.1365-2966.2009.16005.x; Quider AM, 2009, MON NOT R ASTRON SOC, V398, P1263, DOI 10.1111/j.1365-2966.2009.15234.x; Reddy NA, 2009, ASTROPHYS J, V692, P778, DOI 10.1088/0004-637X/692/1/778; Rhoads JE, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/20; Robertson BE, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/71; Rudie GC, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/67; Rupke DS, 2005, ASTROPHYS J SUPPL S, V160, P115, DOI 10.1086/432889; Sanders RL, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/138; Sell PH, 2014, MON NOT R ASTRON SOC, V441, P3417, DOI 10.1093/mnras/stu636; Shibuya T, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/74; Simcoe RA, 2006, ASTROPHYS J, V637, P648, DOI 10.1086/498441; Simcoe RA, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/159; Song MM, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/3; Stark DP, 2014, MON NOT R ASTRON SOC, V445, P3200, DOI 10.1093/mnras/stu1618; STEIDEL CC, 1994, ASTROPHYS J, V437, pL75, DOI 10.1086/187686; Steidel CC, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/165; Strickland DK, 2004, ASTROPHYS J, V606, P829, DOI 10.1086/383136; TELESCO CM, 1991, ASTROPHYS J, V369, P135, DOI 10.1086/169744; Tremonti CA, 2004, ASTROPHYS J, V613, P898, DOI 10.1086/423264; Turner ML, 2014, MON NOT R ASTRON SOC, V445, P794, DOI 10.1093/mnras/stu1801; Vargas CJ, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/26; Veilleux S, 2005, ANNU REV ASTRON ASTR, V43, P769, DOI 10.1146/annurev.astro.43.072103.150610; Verhamme A, 2008, ASTRON ASTROPHYS, V491, P89, DOI 10.1051/0004-6361:200809648; Verhamme A, 2006, ASTRON ASTROPHYS, V460, P397, DOI 10.1051/0004-6361:20065554; Verhamme A, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201218783; Werk JK, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/8; Wisnioski E, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/209; Wyithe JSB, 2007, ASTROPHYS J, V659, P890, DOI 10.1086/511948; YUN MS, 1993, ASTROPHYS J, V411, pL17, DOI 10.1086/186901	100	46	46	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					169	176		10.1038/nature14454	http://dx.doi.org/10.1038/nature14454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26156371	Green Submitted			2022-12-28	WOS:000357695900026
J	Wilsdon, J				Wilsdon, James			We need a measured approach to metrics	NATURE			English	Editorial Material									Univ Sussex, Sci & Democracy, Brighton BN1 9RH, E Sussex, England	University of Sussex	Wilsdon, J (corresponding author), Univ Sussex, Sci & Democracy, Brighton BN1 9RH, E Sussex, England.	j.wilsdon@sussex.ac.uk	Wilsdon, James/AAF-6379-2019	Wilsdon, James/0000-0002-5395-5949	ESRC [ES/I021620/1] Funding Source: UKRI; Economic and Social Research Council [ES/I021620/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))			0	30	30	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					129	129		10.1038/523129a	http://dx.doi.org/10.1038/523129a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4ZO	26156338	Bronze			2022-12-28	WOS:000357695900004
J	Watts, G				Watts, Geoff			Ralph Lainson Obituary	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					24	24		10.1016/S0140-6736(15)61193-X	http://dx.doi.org/10.1016/S0140-6736(15)61193-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM2OA	26169855	Bronze			2022-12-28	WOS:000357519400016
J	Dowsett, M; Forbes, JF; Bradley, R; Ingle, J; Aihara, T; Bliss, J; Boccardo, F; Coates, A; Coombes, RC; Cuzick, J; Dubsky, P; Gnant, M; Kaufmann, M; Kilburn, L; Perrone, F; Rea, D; Thurlimann, B; van de Velde, C; Pan, H; Peto, R; Davies, C; Gray, R; Baum, M; Buzdar, A; Sestak, I; Markopoulos, C; Fesl, C; Jakesz, R; Colleoni, M; Gelber, R; Regan, M; von Minckwitz, G; Snowdon, C; Goss, P; Pritchard, K; Anderson, S; Costantino, J; Mamounas, E; Ohashi, Y; Watanabe, T; Bastiaannet, E				Dowsett, M.; Forbes, J. F.; Bradley, R.; Ingle, J.; Aihara, T.; Bliss, J.; Boccardo, F.; Coates, A.; Coombes, R. C.; Cuzick, J.; Dubsky, P.; Gnant, M.; Kaufmann, M.; Kilburn, L.; Perrone, F.; Rea, D.; Thuerlimann, B.; van de Velde, C.; Pan, H.; Peto, R.; Davies, C.; Gray, R.; Baum, M.; Buzdar, A.; Sestak, I.; Markopoulos, C.; Fesl, C.; Jakesz, R.; Colleoni, M.; Gelber, R.; Regan, M.; von Minckwitz, G.; Snowdon, C.; Goss, P.; Pritchard, K.; Anderson, S.; Costantino, J.; Mamounas, E.; Ohashi, Y.; Watanabe, T.; Bastiaannet, E.		Early Breast Canc Trialists	Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials	LANCET			English	Article							ADJUVANT ENDOCRINE THERAPY; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; CONTINUED TAMOXIFEN; AUSTRIAN BREAST; BIG 1-98; ANASTROZOLE; EXEMESTANE; LETROZOLE; LONG	Background The optimal ways of using aromatase inhibitors or tamoxifen as endocrine treatment for early breast cancer remains uncertain. Methods We undertook meta-analyses of individual data on 31 920 postmenopausal women with oestrogen-receptor-positive early breast cancer in the randomised trials of 5 years of aromatase inhibitor versus 5 years of tamoxifen; of 5 years of aromatase inhibitor versus 2-3 years of tamoxifen then aromatase inhibitor to year 5; and of 2-3 years of tamoxifen then aromatase inhibitor to year 5 versus 5 years of tamoxifen. Primary outcomes were any recurrence of breast cancer, breast cancer mortality, death without recurrence, and all-cause mortality. Intention-to-treat log-rank analyses, stratified by age, nodal status, and trial, yielded aromatase inhibitor versus tamoxifen first-event rate ratios (RRs). Findings In the comparison of 5 years of aromatase inhibitor versus 5 years of tamoxifen, recurrence RRs favoured aromatase inhibitors significantly during years 0-1 (RR 0.64, 95% CI 0.52-0.78) and 2-4 (RR 0.80, 0.68-0.93), and non-significantly thereafter. 10-year breast cancer mortality was lower with aromatase inhibitors than tamoxifen (12.1% vs 14.2%; RR 0.85, 0.75-0.96; 2p=0.009). In the comparison of 5 years of aromatase inhibitor versus 2-3 years of tamoxifen then aromatase inhibitor to year 5, recurrence RRs favoured aromatase inhibitors significantly during years 0-1 (RR 0.74, 0.62-0.89) but not while both groups received aromatase inhibitors during years 2-4, or thereafter; overall in these trials, there were fewer recurrences with 5 years of aromatase inhibitors than with tamoxifen then aromatase inhibitors (RR 0.90, 0.81-0.99; 2p=0.045), though the breast cancer mortality reduction was not significant (RR 0.89, 0.78-1.03; 2p=0.11). In the comparison of 2-3 years of tamoxifen then aromatase inhibitor to year 5 versus 5 years of tamoxifen, recurrence RRs favoured aromatase inhibitors significantly during years 2-4 (RR 0.56, 0.46-0.67) but not subsequently, and 10-year breast cancer mortality was lower with switching to aromatase inhibitors than with remaining on tamoxifen (8.7% vs 10.1%; 2p=0.015). Aggregating all three types of comparison, recurrence RRs favoured aromatase inhibitors during periods when treatments differed (RR 0.70, 0.64-0.77), but not significantly thereafter (RR 0.93, 0.86-1.01; 2p=0.08). Breast cancer mortality was reduced both while treatments differed (RR 0.79, 0.67-0.92), and subsequently (RR 0.89, 0.81-0.99), and for all periods combined (RR 0.86, 0.80-0.94; 2p=0.0005). All-cause mortality was also reduced (RR 0.88, 0.82-0.94; 2p=0.0003). RRs differed little by age, body-mass index, stage, grade, progesterone receptor status, or HER2 status. There were fewer endometrial cancers with aromatase inhibitors than tamoxifen (10-year incidence 0.4% vs 1.2%; RR 0.33, 0.21-0.51) but more bone fractures (5-year risk 8.2% vs 5.5%; RR 1.42, 1.28-1.57); non-breast-cancer mortality was similar. Interpretation Aromatase inhibitors reduce recurrence rates by about 30% (proportionately) compared with tamoxifen while treatments diff er, but not thereafter. 5 years of an aromatase inhibitor reduces 10-year breast cancer mortality rates by about 15% compared with 5 years of tamoxifen, hence by about 40% (proportionately) compared with no endocrine treatment. Copyright (C) Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Open Access article distributed under the terms of CC BY.	[Dowsett, M.; Bliss, J.; Kilburn, L.] Inst Canc Res, Sutton, Surrey, England; [Forbes, J. F.] Univ Newcastle, Callaghan, NSW 2308, Australia; [Bradley, R.; Pan, H.; Davies, C.; Gray, R.] Nuffield Dept Populat Hlth, Oxford, England; [Ingle, J.] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA; [Aihara, T.] Aihara Hosp, Breast Ctr, Osaka, Japan; [Boccardo, F.] Univ Genoa, Natl Inst Canc Res, Genoa, Italy; [Coates, A.] Univ Sydney, Sydney, NSW 2006, Australia; [Coombes, R. C.] Univ London Imperial Coll Sci Technol & Med, London, England; [Cuzick, J.] Queen Mary Univ London, Wolfson Inst Prevent Med, London, England; [Dubsky, P.; Gnant, M.] Med Univ Vienna, Vienna, Austria; [Kaufmann, M.] Univ Frauenklin, Frankfurt, Germany; [Perrone, F.] Ist Nazl Tumori IRCCS Fdn Pascale, Naples, Italy; [Rea, D.] Univ Birmingham, Birmingham, W Midlands, England; [Thuerlimann, B.] Cantonal Hosp, St Gallen, Switzerland; [van de Velde, C.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Peto, R.] Nuffield Dept Populat Hlth, CTSU, Oxford, England; [Markopoulos, C.] Adjuvant Posttamoxifen Exemestane Versus Nothing, Athens, Greece; [Dubsky, P.; Gnant, M.; Fesl, C.; Jakesz, R.] Austrian Breast & Colorectal Canc Study Grp ABCSG, Vienna, Austria; [Perrone, F.] Ist Nazl Tumori Napoli HOBOE IRCCS Fdn Pascale, Naples, Italy; [Ingle, J.; Goss, P.; Pritchard, K.] Natl Canc Inst Canada Trial Grp, Kingston, ON, Canada; [Anderson, S.; Costantino, J.; Mamounas, E.] Natl Surg Adjuvant Breast & Bowel Project NSABP, Pittsburgh, PA USA; [Aihara, T.; Ohashi, Y.; Watanabe, T.] Natl Surg Adjuvant Study Breast Canc N SAS BC Jap, Hamamatsu, Shizuoka, Japan	University of London; Institute of Cancer Research - UK; University of Newcastle; Mayo Clinic; University of Genoa; IRCCS AOU San Martino IST; University of Sydney; Imperial College London; University of London; Queen Mary University London; Medical University of Vienna; IRCCS Fondazione Pascale; University of Birmingham; Kantonsspital St. Gallen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford; IRCCS Fondazione Pascale; Queens University - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project	Dowsett, M (corresponding author), Inst Canc Res, Sutton, Surrey, England.		Sestak, Ivana/H-7305-2014; Boccardo, Francesco Mario/AAF-2654-2019; Colleoni, Marco/AAN-8647-2020; Greil, Richard F/C-7673-2017; Whelan, Timothy/D-3185-2017; Markopoulos, Christos/AAD-8501-2019; Roché, Henri/O-9211-2014; Gnant, Michael/AAN-7054-2020	Sestak, Ivana/0000-0001-6999-2851; Boccardo, Francesco Mario/0000-0002-5392-4077; Colleoni, Marco/0000-0002-5743-3013; Greil, Richard F/0000-0002-4462-3694; Whelan, Timothy/0000-0001-9844-2023; Markopoulos, Christos/0000-0002-5072-6390; Roché, Henri/0000-0001-7463-205X; Gnant, Michael/0000-0003-1002-2118; Warnberg, Fredrik/0000-0002-0130-7296; Coombes, Raoul Charles/0000-0002-4811-1100; Hans, Trampisch/0000-0001-9136-1079; Wang, Xiang/0000-0002-0913-0501; de Vries, Elisabeth/0000-0002-8949-7425; Bliss, Judith/0000-0001-7957-7424; Anderson, Stewart/0000-0001-8948-0650; GIANNI, LUCA/0000-0002-2372-9625; Foroglou, Pericles/0000-0002-2285-0968; Gray, Richard/0000-0003-4440-574X; Bowden, Sarah/0000-0001-7506-1340; Duane, Frances/0000-0001-7838-5957; Swain, Sandra/0000-0002-1320-3830; Kilburn, Lucy/0000-0002-1987-7545; Sparano, Joseph/0000-0002-9031-2010; Wang, Xiang/0000-0002-1522-9532; Ewertz, Marianne/0000-0002-5965-969X; Cardoso, Fatima/0000-0002-6692-2249	Cancer Research UK; Medical Research Council; Cancer Research UK [16891, 16896, 5032, 12011, 15958, 15955] Funding Source: researchfish; Medical Research Council [MC_U137686850] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10122] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Cancer Research UK, Medical Research Council.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; *ATAC TRIAL GROUP, 2003, CANCER, V98, P1802, DOI DOI 10.1002/CNCR.11745; Boccardo F, 2005, J CLIN ONCOL, V23, P5138, DOI 10.1200/JCO.2005.04.120; Burstein HJ, 2012, J CLIN ONCOL, V30, P684, DOI 10.1200/JCO.2011.40.1455; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Dowsett M, 2005, J CLIN ONCOL, V23, P7512, DOI 10.1200/JCO.2005.01.4829; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Dubsky PC, 2012, J CLIN ONCOL, V30, P722, DOI 10.1200/JCO.2011.36.8993; Early Breast Cancer Trialists' Collaborative Group, 1990, TREATM EARL BREAST C; Freidlin B, 2013, J CLIN ONCOL, V31, P3158, DOI 10.1200/JCO.2012.48.3826; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Goss PE, 2014, LANCET ONCOL, V15, P474, DOI 10.1016/S1470-2045(14)70035-X; Goss PE, 2013, J CLIN ONCOL, V31, P1398, DOI 10.1200/JCO.2012.44.7805; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Jakesz R, 2007, JNCI-J NATL CANCER I, V99, P1845, DOI 10.1093/jnci/djm246; Kaufmann M, 2007, J CLIN ONCOL, V25, P2664, DOI 10.1200/JCO.2006.08.8054; LOVE RR, 1992, NEW ENGL J MED, V326, P852, DOI 10.1056/NEJM199203263261302; Mamounas EP, 2008, J CLIN ONCOL, V26, P1965, DOI 10.1200/JCO.2007.14.0228; Pagani O, 2014, NEW ENGL J MED, V371, P107, DOI 10.1056/NEJMoa1404037; Peto R, 2011, BRIT J CANCER, V104, P1057, DOI 10.1038/bjc.2011.79; Regan MM, 2011, LANCET ONCOL, V12, P1101, DOI 10.1016/S1470-2045(11)70270-4; Regan MM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2837; van de Velde CJH, 2011, LANCET, V377, P321, DOI 10.1016/S0140-6736(10)62312-4	26	754	761	3	88	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1341	1352		10.1016/S0140-6736(15)61074-1	http://dx.doi.org/10.1016/S0140-6736(15)61074-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8DP	26211827	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000362316200027
J	Vennix, S; Musters, GD; Mulder, IM; Swank, HA; Consten, EC; Belgers, EH; van Geloven, AA; Gerhards, MF; Govaert, MJ; van Grevenstein, WM; Hoofwijk, AG; Kruyt, PM; Nienhuijs, SW; Boermeester, MA; Vermeulen, J; van Dieren, S; Lange, JF; Bemelman, WA				Vennix, Sandra; Musters, Gijsbert D.; Mulder, Irene M.; Swank, Hilko A.; Consten, Esther C.; Belgers, Eric H.; van Geloven, Anna A.; Gerhards, Michael F.; Govaert, Marc J.; van Grevenstein, Wilhelmina M.; Hoofwijk, Anton G.; Kruyt, Philip M.; Nienhuijs, Simon W.; Boermeester, Marja A.; Vermeulen, Jefrey; van Dieren, Susan; Lange, Johan F.; Bemelman, Willem A.		Ladies Trial Collaborators	Laparoscopic peritoneal lavage or sigmoidectomy for perforated diverticulitis with purulent peritonitis: a multicentre, parallel-group, randomised, open-label trial	LANCET			English	Article							PRIMARY ANASTOMOSIS; HARTMANNS PROCEDURE; GENERALIZED PERITONITIS; COLONIC DIVERTICULITIS; CLINICAL-TRIAL; RESECTION; MANAGEMENT; QUALITY; DISEASE; HEALTH	Background Case series suggest that laparoscopic peritoneal lavage might be a promising alternative to sigmoidectomy in patients with perforated diverticulitis. We aimed to assess the superiority of laparoscopic lavage compared with sigmoidectomy in patients with purulent perforated diverticulitis, with respect to overall long-term morbidity and mortality. Methods We did a multicentre, parallel-group, randomised, open-label trial in 34 teaching hospitals and eight academic hospitals in Belgium, Italy, and the Netherlands (the Ladies trial). The Ladies trial is split into two groups: the LOLA group comparing laparoscopic lavage with sigmoidectomy and the DIVA group comparing Hartmann's procedure with sigmoidectomy plus primary anastomosis. The DIVA section of this trial is still underway but here we report the results of the LOLA section. Patients with purulent perforated diverticulitis were enrolled for LOLA, excluding patients with faecal peritonitis, aged older than 85 years, with high-dose steroid use (>= 20 mg daily), and haemodynamic instability. Patients were randomly assigned (2: 1: 1; stratified by age [>= 60 years vs >= 60 years]) using secure online computer randomisation to laparoscopic lavage, Hartmann's procedure, or primary anastomosis in a parallel design after diagnostic laparoscopy. Patients were analysed according to a modified intention-to-treat principle and were followed up after the index operation at least once in the outpatient setting and after sigmoidoscopy and stoma reversal, according to local protocols. The primary endpoint was a composite endpoint of major morbidity and mortality within 12 months. This trial is registered with ClinicalTrials.gov, number NCT01317485. Findings Between July 1, 2010, and Feb 22, 2013, 90 patients were randomly assigned in the LOLA section of the Ladies trial when the study was terminated by the data and safety monitoring board because of an increased event rate in the lavage group. Two patients were excluded for protocol violations. The primary endpoint occurred in 30 (67%) of 45 patients in the lavage group and 25 (60%) of 42 patients in the sigmoidectomy group (odds ratio 1.28, 95% CI 0.54-3.03, p= 0.58). By 12 months, four patients had died after lavage and six patients had died after sigmoidectomy (p= 0.43). Interpretation Laparoscopic lavage is not superior to sigmoidectomy for the treatment of purulent perforated diverticulitis.	[Vennix, Sandra; Musters, Gijsbert D.; Swank, Hilko A.; Boermeester, Marja A.; van Dieren, Susan; Bemelman, Willem A.] Univ Amsterdam, Acad Med Ctr, Dept Surg, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands; [Vennix, Sandra; Mulder, Irene M.; Lange, Johan F.] Erasmus Univ, Dept Surg, Med Ctr, Rotterdam, Netherlands; [Consten, Esther C.] Meander Med Ctr, Dept Surg, Amersfoort, Netherlands; [Belgers, Eric H.] Atrium Med Ctr, Dept Surg, Heerlen, Netherlands; [van Geloven, Anna A.] Tergooi Hosp, Dept Surg, Hilversum, Netherlands; [Gerhards, Michael F.] OLVG Hosp, Dept Surg, Amsterdam, Netherlands; [Govaert, Marc J.] Westfriesgasthuis, Dept Surg, Hoorn, Netherlands; [van Grevenstein, Wilhelmina M.] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [Hoofwijk, Anton G.] Orbis Med Ctr, Dept Surg, Sittard, Netherlands; [Kruyt, Philip M.] Gelderse Vallei Hosp, Dept Surg, Ede, Netherlands; [Nienhuijs, Simon W.] Catharina Hosp, Dept Surg, Eindhoven, Netherlands; [Vermeulen, Jefrey] Kennemer Hosp, Dept Surg, Haarlem, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Meander Medisch Centrum; Atrium Medical Center; Utrecht University; Utrecht University Medical Center; Orbis Medical Center; Gelderse Vallei Hospital; Catharina Hospital; Spaarne Hospital	Bemelman, WA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.a.bemelman@amc.nl	Tanis, Pieter/U-2827-2019; Bemelman, Wilhelmus Adrianus/AAA-1635-2021; Besselink, Marc G/R-4268-2019; Schijven, Marlies/B-9767-2016; Nienhuijs, Simon/H-7505-2019	Tanis, Pieter/0000-0002-3146-3310; Bemelman, Wilhelmus Adrianus/0000-0002-1037-9945; Besselink, Marc G/0000-0003-2650-9350; Schijven, Marlies/0000-0001-7013-0116; van Wagensveld, Bart/0000-0002-7112-8947; Boermeester, Marja/0000-0003-3890-8105; Vennix, Sandra/0000-0002-4889-6710; Koffeman, Geert/0000-0003-2826-9717; Hoofwijk, Anton G.M./0000-0002-4672-6398; Stoot, Jan/0000-0003-3178-0049; Reitsma, Johannes/0000-0003-4026-4345; de Vos, Robert-Jan/0000-0003-0372-0188; De Hingh, Ignace/0000-0003-3491-4268; Toorenvliet, Boudewijn/0000-0002-3615-6889	Netherlands Organisation for Health Research and Development	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	Netherlands Organisation for Health Research and Development.	Abbas S, 2007, INT J COLORECTAL DIS, V22, P351, DOI 10.1007/s00384-005-0059-4; Agresta F, 2012, SURG ENDOSC, V26, P2134, DOI 10.1007/s00464-012-2331-3; Andersen JC, 2012, DAN MED J, V59; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Binda GA, 2012, COLORECTAL DIS, V14, P1403, DOI 10.1111/j.1463-1318.2012.03117.x; Binda GA, 2015, ANN SURG, V261, pE116, DOI 10.1097/SLA.0000000000000536; Breitenstein S, 2007, WORLD J SURG, V31, P2117, DOI 10.1007/s00268-007-9199-8; Broder JS, 2013, J EMERG MED, V44, P423, DOI 10.1016/j.jemermed.2012.08.027; Delvaux M, 2003, ALIMENT PHARM THERAP, V18, P71, DOI 10.1046/j.0953-0673.2003.01720.x; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; EYPASCH E, 1995, BRIT J SURG, V82, P216, DOI 10.1002/bjs.1800820229; Hinchey E J, 1978, Adv Surg, V12, P85; Li D, 2014, DIS COLON RECTUM, V57, P1397, DOI 10.1097/DCR.0000000000000224; Loffeld R. J. L. F, 2002, Colorectal Dis, V4, P189, DOI 10.1046/j.1463-1318.2002.00328.x; Myers E, 2008, BRIT J SURG, V95, P97, DOI 10.1002/bjs.6024; O'Leary DP, 2012, ACTA CHIR BELG, V112, P436, DOI 10.1080/00015458.2012.11680869; Oberkofler CE, 2012, ANN SURG, V256, P819, DOI 10.1097/SLA.0b013e31827324ba; Oresland T, 2010, SCANDIV SCANDINAVIAN; OSullivan GC, 1996, AM J SURG, V171, P432, DOI 10.1016/S0002-9610(97)89625-0; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Rafferty J, 2006, DIS COLON RECTUM, V49, P939, DOI 10.1007/s10350-006-0578-2; Rizk N, 1996, ANN CHIR, V50, P283; Swank HA, 2013, BRIT J SURG, V100, P704, DOI 10.1002/bjs.9063; Swank HA, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-29; Thornell A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-186; Toorenvliet BR, 2010, COLORECTAL DIS, V12, P862, DOI 10.1111/j.1463-1318.2009.02052.x; Vermeulen J, 2007, DIGEST SURG, V24, P361, DOI 10.1159/000107719; White SI, 2010, DIS COLON RECTUM, V53, P1537, DOI 10.1007/DCR.0b013e3181f2ee2a; Winter DC HA, 2009, LAPLAND LAPAROSCOPIC; Zeitoun G, 2000, BRIT J SURG, V87, P1366, DOI 10.1046/j.1365-2168.2000.01552.x	30	168	171	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 26	2015	386	10000					1269	1277		10.1016/S0140-6736(15)61168-0	http://dx.doi.org/10.1016/S0140-6736(15)61168-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR9TQ	26209030				2022-12-28	WOS:000361700100036
J	Balk, EM; Earley, A; Raman, G; Avendano, EA; Pittas, AG; Remington, PL				Balk, Ethan M.; Earley, Amy; Raman, Gowri; Avendano, Esther A.; Pittas, Anastassios G.; Remington, Patrick L.			Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; HEALTHY-LIVING PARTNERSHIPS; FOLLOW-UP; WEIGHT-LOSS; METABOLIC SYNDROME; PRIMARY-CARE; REAL-WORLD; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC-STATUS	Background: Trials have shown efficacy of rigorous diet and physical activity promotion programs to reduce diabetes incidence and improve glycemic measures in adults at increased risk for type 2 diabetes. Purpose: To evaluate diet and physical activity promotion programs for persons at increased risk for type 2 diabetes, primarily to reduce diabetes risk and decrease body weight and glycemia. Data Sources: MEDLINE, the Cochrane Central Register of Controlled Trials, CAB Abstracts, Global Health, and Ovid HealthSTAR from 1991 through 27 February 2015, with no language restriction. Study Selection: 8 researchers screened articles for singlegroup or comparative studies of combined diet and physical activity promotion programs with at least 2 sessions over at least 3 months in participants at increased risk for type 2 diabetes. Data Extraction: 7 researchers extracted data on study design; participant, intervention, and outcome descriptions; and results and assessed study quality. Data Synthesis: 53 studies (30 of diet and physical activity promotion programs vs. usual care, 13 of more intensive vs. less intensive programs, and 13 of single programs) evaluated 66 programs. Compared with usual care, diet and physical activity promotion programs reduced type 2 diabetes incidence (risk ratio [RR], 0.59 [95% CI, 0.52 to 0.66]) (16 studies), decreased body weight (net change, -2.2% [CI, -2.9% to -1.4%]) (24 studies) and fasting blood glucose level (net change, -0.12 mmol/L [-2.2 mg/dL] [CI, -0.20 to -0.05 mmol/L {-3.6 to -0.9 mg/dL}]) (17 studies), and improved other cardiometabolic risk factors. Evidence for clinical events was limited. More intensive programs were more effective. Limitations: Wide variation in diet and physical activity promotion programs limited identification of features most relevant to effectiveness. Evidence on clinical outcomes and in children was sparse. Conclusion: Combined diet and physical activity promotion programs are effective at decreasing diabetes incidence and improving cardiometabolic risk factors in persons at increased risk. More intensive programs are more effective.	[Balk, Ethan M.] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA; [Raman, Gowri; Avendano, Esther A.] Tufts Med Ctr, Ctr Clin Evidence Synth, Boston, MA 02111 USA; [Pittas, Anastassios G.] Tufts Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02111 USA; Mapi Grp, Boston, MA USA; Univ Wisconsin, Madison, WI USA	Brown University; Tufts Medical Center; Tufts Medical Center; University of Wisconsin System; University of Wisconsin Madison	Balk, EM (corresponding author), Brown Univ, Sch Publ Hlth, Box G-S121-8, Providence, RI 02912 USA.	ethan_balk@brown.edu	Balk, Ethan/AAJ-2547-2020		Centers for Disease Control and Prevention Community Preventive Services Task Force; CDC [200-2012-53787]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK098245] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention Community Preventive Services Task Force; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Centers for Disease Control and Prevention Community Preventive Services Task Force.; By contract 200-2012-53787 from the CDC.	Absetz P, 2007, DIABETES CARE, V30, P2465, DOI 10.2337/dc07-0171; Absetz P, 2009, DIABETES CARE, V32, P1418, DOI 10.2337/dc09-0039; Ackermann RT, 2014, OBESITY, V22, P1601, DOI 10.1002/oby.20762; Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Admiraal WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068605; Agency for Healthcare Research and Quality, 2012, AHRQ PUBLICATION; Aguiar EJ, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-2; Albright AL, 2013, AM J PREV MED, V44, pS346, DOI 10.1016/j.amepre.2012.12.009; Alibasic Esad, 2013, Mater Sociomed, V25, P80, DOI 10.5455/msm.2013.25.80-82; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Azar KMJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/191209; Bhopal RS, 2014, LANCET DIABETES ENDO, V2, P218, DOI 10.1016/S2213-8587(13)70204-3; Bouchard DR, 2012, DIABETES RES CLIN PR, V96, P129, DOI 10.1016/j.diabres.2011.12.019; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bray GA, 1999, DIABETES CARE, V22, P623; Briss PA, 2000, AM J PREV MED, V18, P35, DOI 10.1016/S0749-3797(99)00119-1; Carr DB, 2005, DIABETES, V54, P340, DOI 10.2337/diabetes.54.2.340; Centers for Disease Control, 2020, NATL DIABETES STAT R; Cezaretto A, 2012, QUAL LIFE RES, V21, P105, DOI 10.1007/s11136-011-9919-2; Cole RE, 2013, DIABETES EDUCATOR, V39, P344, DOI 10.1177/0145721713484812; Costa B, 2012, DIABETOLOGIA, V55, P1319, DOI 10.1007/s00125-012-2492-6; Crandall J, 2006, J GERONTOL A-BIOL, V61, P1075; Critchley CR, 2012, DIABETES CARE, V35, P699, DOI 10.2337/dc11-1183; De la Rosa A, 2008, ETHNIC DIS, V18, pS16; Delahanty LM, 2013, DIABETES CARE, V36, P34, DOI 10.2337/dc12-0733; den Boer AT, 2013, NUTR METAB CARDIOVAS, V23, P1147, DOI 10.1016/j.numecd.2012.12.005; Diabet Prevention Program Res Grp, 2005, DIABETES, V54, P1566; Dunbar JA, 2010, INT J DIABETES MELLI, V2, P95, DOI DOI 10.1016/j.ijdm.2010.05.002; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; Eriksson KF, 1998, DIABETOLOGIA, V41, P1010, DOI 10.1007/s001250051024; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Gagnon C, 2011, DIABETES METAB, V37, P410, DOI 10.1016/j.diabet.2011.01.003; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Gilis-Januszewska A., 2011, BR J DIABETES VASC D, V11, P198, DOI DOI 10.1177/1474651411412429; GILLETT M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI DOI 10.3310/hta16330; Gillison F, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-014-0160-6; Gong Q, 2011, DIABETOLOGIA, V54, P300, DOI 10.1007/s00125-010-1948-9; Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Hosper K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-406; Huang ES, 2009, DIABETES CARE, V32, P2225, DOI 10.2337/dc09-0459; Hydrie MZI, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/867604; Ilanne-Parikka P, 2008, DIABETES CARE, V31, P805, DOI 10.2337/dc07-1117; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; International Diabetes Federation, 2014, IDF DIABETES ATLAS, V6th; Islam NS, 2014, INT J ENV RES PUB HE, V11, P5462, DOI 10.3390/ijerph110505462; JANUS ED, 2012, TRIALS, V13, pNIL_0001, DOI DOI 10.1186/1745-6215-13-152; Jiang LH, 2013, DIABETES CARE, V36, P2027, DOI 10.2337/dc12-1250; Kanaya AM, 2012, AM J PUBLIC HEALTH, V102, P1551, DOI 10.2105/AJPH.2011.300456; Katula JA, 2013, AM J PREV MED, V44, pS324, DOI 10.1016/j.amepre.2012.12.015; Katula JA, 2011, DIABETES CARE, V34, P1451, DOI 10.2337/dc10-2115; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Knowler WC, 2015, DIABETES CARE, V38, P51, DOI 10.2337/dc14-0886; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Kulzer B, 2009, DIABETES CARE, V32, P1143, DOI 10.2337/dc08-2141; Kyrios M, 2009, MED J AUSTRALIA, V190, pS81; Laatikainen T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-249; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Liao D, 2002, DIABETES CARE, V25, P1504, DOI 10.2337/diacare.25.9.1504; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Lindstrom J, 2003, J AM SOC NEPHROL, V14, pS108, DOI 10.1097/01.ASN.0000070157.96264.13; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Lindstrom J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; Makrilakis K, 2010, DIABETIC MED, V27, P459, DOI 10.1111/j.1464-5491.2010.02918.x; Makrilakis K, 2012, HORM-INT J ENDOCRINO, V11, P316, DOI 10.14310/horm.2002.1360; Merriam PA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-20; Moore SM, 2011, PSYCHOL HEALTH, V26, P485, DOI 10.1080/08870440903548749; Nilsen V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-893; Ockene IS, 2012, AM J PUBLIC HEALTH, V102, P336, DOI 10.2105/AJPH.2011.300357; Oldroyd JC, 2006, DIABETES RES CLIN PR, V72, P117, DOI 10.1016/j.diabres.2005.09.018; Oldroyd JC, 2001, DIABETES RES CLIN PR, V52, P29, DOI 10.1016/S0168-8227(00)00244-8; Orchard TJ, 2013, DIABETIC MED, V30, P46, DOI 10.1111/j.1464-5491.2012.03750.x; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Patrick Kevin, 2013, J Diabetes Sci Technol, V7, P759; Penn L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003585; Penn L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057143; Penn L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-342; Perreault L, 2008, DIABETES CARE, V31, P1416, DOI 10.2337/dc07-2390; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Perreault L, 2009, DIABETES CARE, V32, P1583, DOI 10.2337/dc09-0523; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2009, DIABETOLOGIA, V52, P1019, DOI 10.1007/s00125-009-1315-x; Ramachandran A, 2013, LANCET DIABETES ENDO, V1, P191, DOI 10.1016/S2213-8587(13)70067-6; Ramachandran A, 2010, DIABETES CARE, V33, P2164, DOI 10.2337/dc09-1150; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Rautio N, 2012, DIABETIC MED, V29, P207, DOI 10.1111/j.1464-5491.2011.03388.x; Rautio N, 2014, PRIM CARE DIABETES, V8, P43, DOI 10.1016/j.pcd.2013.10.005; Rautio N, 2013, J PRIM CARE COMMUNIT, V4, P59, DOI 10.1177/2150131912444130; Rautio N, 2012, PRIM CARE DIABETES, V6, P277, DOI 10.1016/j.pcd.2012.07.002; Rautio N, 2011, SCAND J PUBLIC HEALT, V39, P561, DOI 10.1177/1403494811408482; Roumen C, 2008, DIABETIC MED, V25, P597, DOI 10.1111/j.1464-5491.2008.02417.x; Roumen C, 2011, EUR J CLIN NUTR, V65, P1141, DOI 10.1038/ejcn.2011.74; Saaristo T, 2010, DIABETES CARE, V33, P2146, DOI 10.2337/dc10-0410; Saito T, 2011, ARCH INTERN MED, V171, P1352, DOI 10.1001/archinternmed.2011.275; Sakane N, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000003; Sakane N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-40; Savoye M, 2014, DIABETES CARE, V37, P317, DOI 10.2337/dc13-1571; Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007; Sepah SC, 2014, DIABETES EDUCATOR, V40, P435, DOI 10.1177/0145721714531339; Snehalatha C, 2009, DIABETES CARE, V32, P1796, DOI 10.2337/dc09-0676; Swanson CM, 2012, ENDOCR PRACT, V18, P200, DOI 10.4158/EP11226.OR; Tate DF, 2003, JAMA-J AM MED ASSOC, V289, P1833, DOI 10.1001/jama.289.14.1833; The Community Guide, DAT ABSTR FORM; Trief PM, 2014, OBESITY, V22, P2532, DOI 10.1002/oby.20916; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; Uusitupa MI, 2011, DIABETES CARE, V34, P418, DOI 10.2337/dc10-1013; Vanderwood KK, 2010, DIABETES CARE, V33, P2543, DOI 10.2337/dc10-0862; Vermunt PWA, 2012, DIABETIC MED, V29, pE223, DOI 10.1111/j.1464-5491.2012.03648.x; Vermunt PWA, 2011, DIABETES CARE, V34, P1919, DOI 10.2337/dc10-2293; Vlaar EMA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-371; Vojta D, 2013, AM J PREV MED, V44, pS301, DOI 10.1016/j.amepre.2012.12.018; Wallace B.C., 2012, P ACM INT HLTH INF S, P819, DOI DOI 10.1145/2110363.2110464; Weinstock RS, 2013, J GEN INTERN MED, V28, P1620, DOI 10.1007/s11606-013-2529-7; West DS, 2008, OBESITY, V16, P1413, DOI 10.1038/oby.2008.224; Wikstrom Katja, 2009, Diabetes Res Clin Pract, V86, pe1, DOI 10.1016/j.diabres.2009.06.014; Wing RR, 2004, OBES RES, V12, P1426; Xiao L, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.17; Zaza S, 2000, AM J PREV MED, V18, P44, DOI 10.1016/S0749-3797(99)00122-1	123	206	208	3	66	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6					437	+		10.7326/M15-0452	http://dx.doi.org/10.7326/M15-0452			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR5FL	26167912	Green Accepted			2022-12-28	WOS:000361365900018
J	Pronk, NP; Remington, PL				Pronk, Nicolaas P.; Remington, Patrick L.		Community Preventive Serv	Combined Diet and Physical Activity Promotion Programs for Prevention of Diabetes: Community Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							LIFE-STYLE INTERVENTION; INCREASED RISK; TYPE-2	Description: Community Preventive Services Task Force recommendation on the use of combined diet and physical activity promotion programs to reduce progression to type 2 diabetes in persons at increased risk. Methods: The Task Force commissioned an evidence review that assessed the benefits and harms of programs to promote and support individual improvements in diet, exercise, and weight and supervised a review on the economic efficiency of these programs in clinical trial, primary care, and primary care-referable settings. Population: Adolescents and adults at increased risk for progression to type 2 diabetes. Recommendation: The Task Force recommends the use of combined diet and physical activity promotion programs by health care systems, communities, and other implementers to provide counseling and support to clients identified as being at increased risk for type 2 diabetes. Economic evidence indicates that these programs are cost-effective.	[Pronk, Nicolaas P.; Remington, Patrick L.; Community Preventive Serv] Community Prevent Serv Task Force, Atlanta, GA 30329 USA		Pronk, NP (corresponding author), Community Prevent Serv Task Force, Atlanta, GA 30329 USA.			, Ron/0000-0003-4989-4108; Omenn, Gilbert S./0000-0002-8976-6074	Merck Foundation	Merck Foundation(Merck & Company)	Dr. Chin reports a grant from the Merck Foundation outside the submitted work. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOf InterestForms.do?msNum=M15-1029.	Ackermann RT, 2007, DIABETES EDUCATOR, V33, P69, DOI 10.1177/0145721706297743; Albright AL, 2013, AM J PREV MED, V44, pS346, DOI 10.1016/j.amepre.2012.12.009; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Balk EM, 2015, ANN INTERN MED, V163, P437, DOI 10.7326/M15-0452; Barber SR, 2014, DIABETES RES CLIN PR, V105, P1, DOI 10.1016/j.diabres.2014.03.007; Jiang LH, 2013, DIABETES CARE, V36, P2027, DOI 10.2337/dc12-1250; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li R, 2015, ANN INTERN MED, V163, P452, DOI 10.7326/M15-0469; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Vanderwood KK, 2010, DIABETES CARE, V33, P2543, DOI 10.2337/dc10-0862; Vojta D, 2013, AM J PREV MED, V44, pS301, DOI 10.1016/j.amepre.2012.12.018	12	45	45	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6					465	+		10.7326/M15-1029	http://dx.doi.org/10.7326/M15-1029			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26168073				2022-12-28	WOS:000361365900021
J	Rodrigues, NTL; Lekomtsev, S; Jananji, S; Kriston-Vizi, J; Hickson, GRX; Baum, B				Rodrigues, Nelio T. L.; Lekomtsev, Sergey; Jananji, Silvana; Kriston-Vizi, Janos; Hickson, Gilles R. X.; Baum, Buzz			Kinetochore-localized PP1-Sds22 couples chromosome segregation to polar relaxation	NATURE			English	Article							CELL-SHAPE CHANGES; AURORA B; CYTOKINESIS; SPINDLE; DROSOPHILA; POLARIZATION; ANAPHASE; CONTRACTILITY; MEMBRANE; POSITION	Cell division requires the precise coordination of chromosome segregation and cytokinesis. This coordination is achieved by the recruitment of an actomyosin regulator, Ect2, to overlapping microtubules at the centre of the elongating anaphase spindle(1). Ect2 then signals to the overlying cortex to promote the assembly and constriction of an actomyosin ring between segregating chromosomes(1). Here, by studying division in proliferating Drosophila and human cells, we demonstrate the existence of a second, parallel signalling pathway, which triggers the relaxation of the polar cell cortex at mid anaphase. This is independent of furrow formation, centrosomes and microtubules and, instead, depends on PP1 phosphatase and its regulatory subunit Sds22 (refs 2, 3). As separating chromosomes move towards the polar cortex at mid anaphase, kinetochore-localized PP1-Sds22 helps to break cortical symmetry by inducing the dephosphorylation and inactivation of ezrin/radixin/moesin proteins at cell poles. This promotes local softening of the cortex(2,3), facilitating anaphase elongation and orderly cell division. In summary, this identifies a conserved kinetochore-based phosphatase signal and substrate, which function together to link anaphase chromosome movements to cortical polarization, thereby coupling chromosome segregation to cell division.	[Rodrigues, Nelio T. L.; Lekomtsev, Sergey; Kriston-Vizi, Janos; Baum, Buzz] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England; [Jananji, Silvana; Hickson, Gilles R. X.] St Justine Hosp Res Ctr, Montreal, PQ H3T 1C5, Canada; [Hickson, Gilles R. X.] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada; [Baum, Buzz] UCL, Inst Phys Living Syst, London WC1E 6BT, England; [Baum, Buzz] Inst Curie, CelTisPhyBio Labex, F-75248 Paris 05, France	MRC Laboratory Molecular Biology; University of London; University College London; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; University of London; University College London; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Baum, B (corresponding author), UCL, MRC Lab Mol Cell Biol, Gower St, London WC1E 6BT, England.	b.baum@ucl.ac.uk	Kriston-Vizi, Janos/L-6021-2013	Kriston-Vizi, Janos/0000-0002-0149-145X; Baum, Buzz/0000-0002-9201-6186; Hickson, Gilles/0000-0001-7670-9815; Rodrigues, Nelio TL/0000-0002-7066-9135	Cancer Research UK; Medical Research Council; Canadian Institutes of Health Research; Canada Foundation for Innovation; Fonds de Recherche du Quebec-Sante; Cole Foundation; INCa; BBSRC [BB/K009001/1]; Biotechnology and Biological Sciences Research Council [BB/K009001/1] Funding Source: researchfish; Cancer Research UK [17343, 9786] Funding Source: researchfish; Medical Research Council [MC_CF12266] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Cole Foundation; INCa(Institut National du Cancer (INCA) France); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	N.T.L.R., S.L. and B.B. thank Cancer Research UK, and J.K.-V. the Medical Research Council for funding. S.J. and G.R.X.H. were funded by the Canadian Institutes of Health Research, the Canada Foundation for Innovation and a salary award from the Fonds de Recherche du Quebec-Sante, and G.R.X.H. thanks the Cole Foundation for a Transition award. This study benefited from support from INCa and the BBSRC (BB/K009001/1). We thank M. Lam, E. Paluch, M. Petronczki, G. Salbreux and members of the Baum laboratory for input and critical reading of the manuscript.	Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Dehapiot B, 2013, CELL CYCLE, V12, P1672, DOI 10.4161/cc.24901; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Georgiou M, 2010, J CELL SCI, V123, P1089, DOI 10.1242/jcs.060772; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Hickson GRX, 2008, J CELL BIOL, V180, P285, DOI 10.1083/jcb.200709005; Hickson GRX, 2006, CURR BIOL, V16, P359, DOI 10.1016/j.cub.2005.12.043; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Kunda P, 2012, CURR BIOL, V22, P231, DOI 10.1016/j.cub.2011.12.016; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Lekomtsev S, 2012, NATURE, V492, P276, DOI 10.1038/nature11773; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lesage B, 2011, CURR BIOL, V21, pR898, DOI 10.1016/j.cub.2011.08.063; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r26; MATSUMOTO K, 1978, J BACTERIOL, V134, P446, DOI 10.1128/JB.134.2.446-457.1978; Matthews HK, 2012, DEV CELL, V23, P371, DOI 10.1016/j.devcel.2012.06.003; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Murthy K, 2008, J CELL SCI, V121, P2350, DOI 10.1242/jcs.027052; Posch M, 2010, J CELL BIOL, V191, P61, DOI 10.1083/jcb.200912046; Qian JB, 2011, CURR BIOL, V21, P766, DOI 10.1016/j.cub.2011.03.047; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Roubinet C, 2011, J CELL BIOL, V195, P99, DOI 10.1083/jcb.201106048; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Tse YC, 2011, MOL BIOL CELL, V22, P3165, DOI 10.1091/mbc.E11-05-0399; Turlier H, 2014, BIOPHYS J, V106, P114, DOI 10.1016/j.bpj.2013.11.014; Werner M, 2007, CURR BIOL, V17, P1286, DOI 10.1016/j.cub.2007.06.070; Wurzenberger C, 2012, J CELL BIOL, V198, P173, DOI 10.1083/jcb.201112112; Zhang DH, 1996, NATURE, V382, P466, DOI 10.1038/382466a0	35	66	69	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2015	524	7566					489	+		10.1038/nature14496	http://dx.doi.org/10.1038/nature14496			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP7LN	26168397	Green Submitted			2022-12-28	WOS:000360069300043
J	Sivanand, S; Wellen, KE				Sivanand, Sharanya; Wellen, Kathryn E.			MOLECULAR BIOLOGY Salvaging the genome	NATURE			English	Editorial Material							THERAPEUTIC WINDOW; CANCER; DNA; METABOLISM; MTH1	Overexpression of the enzyme cytidine deaminase allows the incorporation of abnormally modified nucleotides into DNA, leading to cell death. This discovery might point the way to treating some cancers. SEE LETTER P.114	[Sivanand, Sharanya; Wellen, Kathryn E.] Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Sivanand, S (corresponding author), Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.	wellenk@exchange.upenn.edu						ABBRUZZESE JL, 1991, J CLIN ONCOL, V9, P491, DOI 10.1200/JCO.1991.9.3.491; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Brooks SC, 2013, BBA-PROTEINS PROTEOM, V1834, P247, DOI 10.1016/j.bbapap.2012.10.005; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; JEKUNEN A, 1983, BIOCHEM PHARMACOL, V32, P1165, DOI 10.1016/0006-2952(83)90265-4; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Shin G, 2011, CANCER INFORM, V10, P149, DOI 10.4137/CIN.S7226; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; VILPO JA, 1993, MUTAT RES, V286, P217, DOI 10.1016/0027-5107(93)90186-J; Zauri M, 2015, NATURE, V524, P114, DOI 10.1038/nature14948	13	3	3	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					40	41		10.1038/nature14638	http://dx.doi.org/10.1038/nature14638			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26200344				2022-12-28	WOS:000359002300024
J	Cai, N; Bigdeli, TB; Kretzschmar, W; Li, YH; Liang, JQ; Song, L; Hu, JC; Li, QB; Jin, W; Hu, ZF; Wang, GB; Wang, LM; Qian, PY; Liu, Y; Jiang, T; Lu, Y; Zhang, XQ; Yin, Y; Li, YR; Xu, X; Gao, JF; Reimers, M; Webb, T; Riley, B; Bacanu, S; Peterson, RE; Chen, YP; Zhong, H; Liu, ZR; Wang, G; Sun, J; Sang, H; Jiang, GQ; Zhou, XY; Li, Y; Li, Y; Zhang, W; Wang, XY; Fang, X; Pan, RD; Miao, GD; Zhang, QW; Hu, J; Yu, FY; Du, B; Sang, WH; Li, KQ; Chen, GB; Cai, M; Yang, LJ; Yang, DL; Ha, BW; Hong, XH; Deng, H; Li, GY; Li, K; Song, Y; Gao, SG; Zhang, JB; Gan, ZY; Meng, HQ; Pan, JY; Gao, CG; Zhang, KR; Sun, N; Li, YH; Niu, QH; Zhang, YT; Liu, TQ; Hu, CM; Zhang, Z; Lv, LX; Dong, JC; Wang, XP; Tao, M; Wang, XM; Xia, J; Rong, H; He, Q; Liu, TB; Huang, GP; Mei, QY; Shen, ZM; Liu, Y; Shen, JH; Tian, T; Liu, XJ; Wu, WY; Gu, DH; Fu, GY; Shi, JG; Chen, YC; Gan, XC; Liu, LF; Wang, LN; Yang, FZ; Cong, EZ; Marchini, J; Yang, HM; Wang, J; Shi, SX; Mott, R; Xu, Q; Wang, J; Kendler, KS; Flint, J				Cai, Na; Bigdeli, Tim B.; Kretzschmar, Warren; Li, Yihan; Liang, Jieqin; Song, Li; Hu, Jingchu; Li, Qibin; Jin, Wei; Hu, Zhenfei; Wang, Guangbiao; Wang, Linmao; Qian, Puyi; Liu, Yuan; Jiang, Tao; Lu, Yao; Zhang, Xiuqing; Yin, Ye; Li, Yingrui; Xu, Xun; Gao, Jingfang; Reimers, Mark; Webb, Todd; Riley, Brien; Bacanu, Silviu; Peterson, Roseann E.; Chen, Yiping; Zhong, Hui; Liu, Zhengrong; Wang, Gang; Sun, Jing; Sang, Hong; Jiang, Guoqing; Zhou, Xiaoyan; Li, Yi; Li, Yi; Zhang, Wei; Wang, Xueyi; Fang, Xiang; Pan, Runde; Miao, Guodong; Zhang, Qiwen; Hu, Jian; Yu, Fengyu; Du, Bo; Sang, Wenhua; Li, Keqing; Chen, Guibing; Cai, Min; Yang, Lijun; Yang, Donglin; Ha, Baowei; Hong, Xiaohong; Deng, Hong; Li, Gongying; Li, Kan; Song, Yan; Gao, Shugui; Zhang, Jinbei; Gan, Zhaoyu; Meng, Huaqing; Pan, Jiyang; Gao, Chengge; Zhang, Kerang; Sun, Ning; Li, Youhui; Niu, Qihui; Zhang, Yutang; Liu, Tieqiao; Hu, Chunmei; Zhang, Zhen; Lv, Luxian; Dong, Jicheng; Wang, Xiaoping; Tao, Ming; Wang, Xumei; Xia, Jing; Rong, Han; He, Qiang; Liu, Tiebang; Huang, Guoping; Mei, Qiyi; Shen, Zhenming; Liu, Ying; Shen, Jianhua; Tian, Tian; Liu, Xiaojuan; Wu, Wenyuan; Gu, Danhua; Fu, Guangyi; Shi, Jianguo; Chen, Yunchun; Gan, Xiangchao; Liu, Lanfen; Wang, Lina; Yang, Fuzhong; Cong, Enzhao; Marchini, Jonathan; Yang, Huanming; Wang, Jian; Shi, Shenxun; Mott, Richard; Xu, Qi; Wang, Jun; Kendler, Kenneth S.; Flint, Jonathan		CONVERGE Consortium	Sparse whole-genome sequencing identifies two loci for major depressive disorder	NATURE			English	Article							LINEAR MIXED MODELS; EPIDEMIOLOGY; ASSOCIATION; COMORBIDITY; INFERENCE	Major depressive disorder (MDD), one of the most frequently encountered forms ofmental illness and a leading cause of disability worldwide(1), poses a major challenge to genetic analysis. To date, no robustly replicated genetic loci have been identified(2), despite analysis of more than 9,000 cases(3). Here, using low-coverage whole-genome sequencing of 5,303 Chinese women with recurrent MDD selected to reduce phenotypic heterogeneity, and 5,337 controls screened to exclude MDD, we identified, and subsequently replicated in an independent sample, two loci contributing to risk of MDD on chromosome 10: one near the SIRT1 gene (P = 2.53 x 10(-10)), the other in an intron of the LHPP gene (P = 6.45 x10(-12)). Analysis of 4,509 cases with a severe subtype of MDD, melancholia, yielded an increased genetic signal at the SIRT1 locus. We attribute our success to the recruitment of relatively homogeneous cases with severe illness.	[Cai, Na; Kretzschmar, Warren; Li, Yihan; Fu, Guangyi; Marchini, Jonathan; Mott, Richard; Flint, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England; [Bigdeli, Tim B.; Reimers, Mark; Webb, Todd; Riley, Brien; Bacanu, Silviu; Peterson, Roseann E.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [Liang, Jieqin; Song, Li; Hu, Jingchu; Li, Qibin; Jin, Wei; Hu, Zhenfei; Wang, Guangbiao; Wang, Linmao; Qian, Puyi; Liu, Yuan; Jiang, Tao; Lu, Yao; Zhang, Xiuqing; Yin, Ye; Li, Yingrui; Xu, Xun; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China; [Gao, Jingfang] Zhejiang Tradit Chinese Med Hosp, Hangzhou 310000, Zhejiang, Peoples R China; [Chen, Yiping] Univ Oxford, CTSU, Oxford OX3 7LF, England; [Zhong, Hui] Anhui Mental Hlth Ctr, Hefei 230000, Anhui, Peoples R China; [Liu, Zhengrong] Anshan Psychiat Rehabil Hosp, Anshan 114000, Liaoning, Peoples R China; [Wang, Gang] Capital Univ Med Sci, Beijing Anding Hosp, Beijing 100000, Peoples R China; [Sun, Jing] Nanjing Med Univ, Brain Hosp, Nanjing 210000, Jiangsu, Peoples R China; [Sang, Hong] Changchun Mental Hosp, Changchun 130000, Jilin, Peoples R China; [Jiang, Guoqing; Zhou, Xiaoyan] Chongqing Mental Hlth Ctr, Chongqing 404100, Peoples R China; [Li, Yi] Dalian 7 Hosp, Dalian 116000, Liaoning, Peoples R China; [Li, Yi] Wuhan Mental Hlth Ctr, Wuhan 430000, Hubei, Peoples R China; [Zhang, Wei] Daqing 3 Hosp Heilongjiang, Daqing 163000, Heilongjiang, Peoples R China; [Wang, Xueyi] Hebei Med Univ, Hosp 1, Shijiazhuang 50000, Hebei, Peoples R China; [Fang, Xiang] Fuzhou Psychiat Hosp, Fuzhou 350000, Fujian, Peoples R China; [Pan, Runde] Guangxi Longquanshan Hosp, Guangxi 545000, Zhuangzu, Peoples R China; [Miao, Guodong] Guangzhou Psychiat Hosp, Guangzhou Brain Hosp, Guangzhou 510000, Guangdong, Peoples R China; [Zhang, Qiwen] Hainan Anning Hosp, Haikou 570100, Hainan, Peoples R China; [Hu, Jian] Harbin Med Univ, Haerbin 150000, Heilongjiang, Peoples R China; [Yu, Fengyu] Harbin 1 Special Hosp, Haerbin 150000, Heilongjiang, Peoples R China; [Du, Bo; Sang, Wenhua; Li, Keqing] Hebei Mental Hlth Ctr, Baoding 71000, Hebei, Peoples R China; [Chen, Guibing] Huaian 3 Hosp, Huaian 223001, Jiangsu, Peoples R China; [Cai, Min] Huzhou 3 Hosp, Huzhou 313000, Zhejiang, Peoples R China; [Yang, Lijun] Jilin Brain Hosp, Siping 136000, Jilin, Peoples R China; [Yang, Donglin] Jining Psychiat Hosp, Jining 272000, Shandong, Peoples R China; [Ha, Baowei] Liaocheng 4 Hosp, Liaocheng 252000, Shandong, Peoples R China; [Hong, Xiaohong] Shantou Univ, Mental Hlth Ctr, Shantou 515000, Guangdong, Peoples R China; [Deng, Hong] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu 610000, Sichuan, Peoples R China; [Li, Gongying] Jining Med Coll, Mental Hlth Inst, Jining 272000, Shandong, Peoples R China; [Li, Kan] Mental Hosp Jiangxi Prov, Nanchang 330000, Jiangxi, Peoples R China; [Song, Yan] Mudanjiang Psychiat Hosp Heilongjiang Prov, Mudanjiang 157000, Heilongjiang, Peoples R China; [Gao, Shugui] Ningbo Kang Ning Hosp, Ningbo 315000, Zhejiang, Peoples R China; [Zhang, Jinbei; Gan, Zhaoyu] Sun Yat Sen Univ, Hosp 3, Guangzhou 510630, Guangdong, Peoples R China; [Meng, Huaqing] ChongqingMed Univ, Hosp 1, Chongqing 400016, Peoples R China; [Pan, Jiyang] Jinan Univ, Hosp 1, Guangzhou 510000, Guangdong, Peoples R China; [Gao, Chengge] Xi An Jiao Tong Univ, Coll Med, Hosp 1, Xian, Shaan Xi, Peoples R China; [Zhang, Kerang; Sun, Ning] Shanxi Med Univ, Hosp 1, Taiyuan 30000, Shanxi, Peoples R China; [Li, Youhui; Niu, Qihui] Zhengzhou Univ, Hosp 1, Zhengzhou 450000, Henan, Peoples R China; [Zhang, Yutang] Lanzhou Univ, Hosp 2, Lanzhou 730000, Gansu, Peoples R China; [Liu, Tieqiao] Zhongnan Univ, Xiangya Hosp 2, Changsha 410000, Hunan, Peoples R China; [Hu, Chunmei] 3 Hosp Heilongjiang Prov, Beian 164000, Heilongjiang, Peoples R China; [Zhang, Zhen] Jiangsu Univ, Hosp 4, Zhenjiang 212000, Jiangsu, Peoples R China; [Lv, Luxian] Psychiat Hosp Henan Prov, Xinxiang 453000, Henan, Peoples R China; [Dong, Jicheng] Qingdao Mental Hlth Ctr, Qingdao 266000, Shandong, Peoples R China; [Wang, Xiaoping] Wuhan Univ, Renmin Hosp, Wuhan 430000, Hubei, Peoples R China; [Tao, Ming] Zhejiang Chinese Med Univ, Affiliated Hosp 2, Hangzhou 310000, Zhejiang, Peoples R China; [Wang, Xumei; Xia, Jing] China Med Univ, ShengJing Hosp, Shenyang 110001, Liaoning, Peoples R China; [Rong, Han] Kangning Hosp, Shenzhen Key Lab Psychol Healthcare, Shenzhen 518000, Guangdong, Peoples R China; [He, Qiang] Kanazawa Med Univ, Dept Gen Internal Med, Kahoku, Ishikawa 9200293, Japan; [Liu, Tiebang] Shenzhen Key Lab Psychol Healthcare, Shenzhen 518000, Guangdong, Peoples R China; [Liu, Tiebang] Shenzhen Kangning Hosp, Shenzhen 518000, Guangdong, Peoples R China; [Huang, Guoping] Sichuan Mental Hlth Ctr, Mianyang 621000, Sichuan, Peoples R China; [Mei, Qiyi] Suzhou Guangji Hosp, Suzhou 215000, Jiangsu, Peoples R China; [Shen, Zhenming] Tangshan 5 Hosp, Tangshan 63000, Hebei, Peoples R China; [Liu, Ying] ChinaMed Univ, Hosp 1, Shenyang 110001, Liaoning, Peoples R China; [Shen, Jianhua; Tian, Tian] Tianjin Anding Hosp, Tianjin 300000, Peoples R China; [Liu, Xiaojuan] Tianjin First Ctr Hosp, Tianjin 300000, Peoples R China; [Wu, Wenyuan] Tongji Univ Hosp, Shanghai 200000, Peoples R China; [Gu, Danhua] Weihai Mental Hlth Ctr, Weihai 264200, Shandong, Peoples R China; [Gu, Danhua] Weihai Mental Hlth Ctr, Weihai 264200, Shandong, Peoples R China; [Shi, Jianguo] Xian Mental Hlth Ctr, Xian 710000, Shaanxi, Peoples R China; [Chen, Yunchun] 4 Mil Med Univ, Xijing Hosp, Xian 710000, Shaanxi, Peoples R China; [Gan, Xiangchao] Max Planck Inst Plant Breeding Res, Dept Comparat Dev Genet, D-50829 Cologne, Germany; [Liu, Lanfen; Wang, Lina] Shandong Mental Hlth Ctr, Jinan 250000, Shandong, Peoples R China; [Yang, Fuzhong; Cong, Enzhao; Shi, Shenxun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Shi, Shenxun] Fudan Univ, Huashan Hosp, Shanghai 200040, Peoples R China; [Xu, Qi] Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 10005, Peoples R China; [Xu, Qi] Chinese Acad Med Sci, Neurosci Ctr, Beijing 10005, Peoples R China; [Xu, Qi] Peking Union Med Coll, Beijing 10005, Peoples R China; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China; [Wang, Jun] King Abdulaziz Univ, Princess Jawhara Ctr Excellence Res Hereditary Di, Jeddah 21589, Saudi Arabia; [Flint, Jonathan] East China Normal Univ, Shanghai 200062, Peoples R China	University of Oxford; Wellcome Centre for Human Genetics; Virginia Commonwealth University; Beijing Genomics Institute (BGI); Zhejiang Chinese Medical University; University of Oxford; Capital Medical University; Nanjing Medical University; Hebei Medical University; Harbin Medical University; Shantou University; Sichuan University; Jining Medical University; Sun Yat Sen University; Jinan University; Xi'an Jiaotong University; Shanxi Medical University; Zhengzhou University; Lanzhou University; Central South University; Jiangsu University; Wuhan University; Zhejiang Chinese Medical University; China Medical University; Kanazawa Medical University; Tongji University; Air Force Military Medical University; Max Planck Society; Shanghai Jiao Tong University; University of Oxford; Fudan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Copenhagen; Macau University of Science & Technology; King Abdulaziz University; East China Normal University	Cai, N (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.		Cai, Na/I-2977-2019; Li, Yingrui/K-1064-2015; liu, tieqiao/GSE-2327-2022; Yang, Fuzhong/ABE-7116-2021; Bigdeli, Tim B./AAX-7761-2020; wang, lina/HGC-1592-2022; Sun, Ning/AAO-9421-2021; Kendler, Kenneth/AAF-2876-2019; wang, lin/HHM-2225-2022; Marchini, Jonathan/ABE-9024-2020; Webb, Bradley T/B-1459-2009; Xu, Xun/AAI-6763-2020; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Cai, Na/0000-0001-7496-2075; Yang, Fuzhong/0000-0001-5093-087X; Bigdeli, Tim B./0000-0003-2215-5946; Sun, Ning/0000-0003-3844-2632; Marchini, Jonathan/0000-0003-0610-8322; Webb, Bradley T/0000-0002-0576-5366; Xu, Xun/0000-0002-5338-5173; Mott, Richard/0000-0002-1022-9330; Li, Yihan/0000-0002-3492-8873; Bacanu, Silviu-Alin/0000-0002-4364-1583; Flint, Jonathan/0000-0002-9427-4429; Wang, Jun/0000-0002-2113-5874; Gan, Xiangchao/0000-0001-6398-5191; Hu, Jingchu/0000-0001-6144-7226; Kretzschmar, Warren Winfried/0000-0002-2575-0807; Wang, Jun/0000-0002-8540-8931	Wellcome Trust [WT090532/Z/09/Z, WT083573/Z/07/Z, WT089269/Z/09/Z, WT097307]; NIH [MH-100549]; Brain and Behavior Research Foundation; Agency of Science, Technology and Research (A*STAR) Graduate Academy; ERC [617306]; 973 Program [2013CB531301]; NSFC [31430048, 31222031]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100549] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation; Agency of Science, Technology and Research (A*STAR) Graduate Academy(Agency for Science Technology & Research (A*STAR)); ERC(European Research Council (ERC)European Commission); 973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the Wellcome Trust (WT090532/Z/09/Z, WT083573/Z/07/Z, WT089269/Z/09/Z), NIH grant MH-100549 and the Brain and Behavior Research Foundation. All authors are part of the CONVERGE consortium (China, Oxford and VCU Experimental Research on Genetic Epidemiology) and gratefully acknowledge the support of all partners in hospitals across China. W. Kretzschmar is funded by the Wellcome Trust (WT097307). N. Cai is supported by the Agency of Science, Technology and Research (A*STAR) Graduate Academy. J. Marchini is funded by an ERC Consolidator Grant (617306). Q. Xu is funded by the 973 Program (2013CB531301) and NSFC (31430048, 31222031).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Angst J, 2007, ACTA PSYCHIAT SCAND, V115, P72, DOI 10.1111/j.1600-0447.2007.00965.x; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cai N, 2015, CURR BIOL, V25, P1146, DOI 10.1016/j.cub.2015.03.008; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; Foley DL, 2001, PSYCHOL MED, V31, P1413, DOI 10.1017/S0033291701004755; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Kendler KS, 2007, ACTA PSYCHIAT SCAND, V115, P214, DOI 10.1111/j.1600-0447.2006.00863.x; Kendler KS, 1997, ARCH GEN PSYCHIAT, V54, P299, DOI 10.1001/archpsyc.1997.01830160013002; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Lee S, 2009, PSYCHOL MED, V39, P735, DOI 10.1017/S0033291708004091; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Liao SC, 2012, PSYCHOL MED, V42, P1227, DOI 10.1017/S0033291711002364; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; *R DEV COR TEAM, 2004, LANG ENV STAT COMP; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Sun N, 2012, DEPRESS ANXIETY, V29, P4, DOI 10.1002/da.20875; Wang Y, 2013, GENOME RES, V23, P833, DOI 10.1101/gr.146084.112; Widmer C, 2014, SCI REP-UK, V4, DOI 10.1038/srep06874	29	544	577	19	379	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					588	+		10.1038/nature14659	http://dx.doi.org/10.1038/nature14659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26176920	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000358655200044
J	Hallinan, G; Littlefair, SP; Cotter, G; Bourke, S; Harding, LK; Pineda, JS; Butler, RP; Golden, A; Basri, G; Doyle, JG; Kao, MM; Berdyugina, SV; Kuznetsov, A; Rupen, MP; Antonova, A				Hallinan, G.; Littlefair, S. P.; Cotter, G.; Bourke, S.; Harding, L. K.; Pineda, J. S.; Butler, R. P.; Golden, A.; Basri, G.; Doyle, J. G.; Kao, M. M.; Berdyugina, S. V.; Kuznetsov, A.; Rupen, M. P.; Antonova, A.			Magnetospherically driven optical and radio aurorae at the end of the stellar main sequence	NATURE			English	Article							SIMULTANEOUS MULTIWAVELENGTH OBSERVATIONS; BROWN DWARF; ULTRACOOL DWARFS; MAGNETIC ACTIVITY; M8.5 DWARF; VARIABILITY; EMISSIONS; ROTATION; TEMPERATURE; TRANSITION	Aurorae are detected from all the magnetized planets in our Solar System, including Earth(1). They are powered by magnetospheric current systems that lead to the precipitation of energetic electrons into the high-latitude regions of the upper atmosphere. In the case of the gas-giant planets, these aurorae include highly polarized radio emission at kilohertz and megahertz frequencies produced by the precipitating electrons(2), as well as continuum and line emission in the infrared, optical, ultraviolet and X-ray parts of the spectrum, associated with the collisional excitation and heating of the hydrogen-dominated atmosphere(3). Here we report simultaneous radio and optical spectroscopic observations of an object at the end of the stellar main sequence, located right at the boundary between stars and brown dwarfs, from which we have detected radio and optical auroral emissions both powered by magnetospheric currents. Whereas the magnetic activity of stars like our Sun is powered by processes that occur in their lower atmospheres, these aurorae are powered by processes originating much further out in the magnetosphere of the dwarf star that couple energy into the lower atmosphere. The dissipated power is at least four orders of magnitude larger than what is produced in the Jovian magnetosphere, revealing aurorae to be a potentially ubiquitous signature of large-scale magnetospheres that can scale to luminosities far greater than those observed in our Solar System. These magnetospheric current systems may also play a part in powering some of the weather phenomena reported on brown dwarfs.	[Hallinan, G.; Bourke, S.; Pineda, J. S.; Kao, M. M.] CALTECH, Pasadena, CA 91125 USA; [Littlefair, S. P.] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Cotter, G.] Univ Oxford, Dept Astrophys, Oxford OX1 3RH, England; [Harding, L. K.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Butler, R. P.] Natl Univ Ireland, Ctr Astron, Galway, Ireland; [Golden, A.] Yeshiva Univ, Dept Math Sci, New York, NY 10033 USA; [Basri, G.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Doyle, J. G.] Armagh Observ, Armagh BT61 9DG, North Ireland; [Berdyugina, S. V.] Kiepenheuer Inst Sonnenphys, D-79104 Freiburg, Germany; [Kuznetsov, A.] Inst Solar Terr Phys, Irkutsk 664033, Russia; [Rupen, M. P.] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Antonova, A.] Sofia Univ St Kliment Ohridski, Dept Astron, Fac Phys, Sofia 1164, Bulgaria	California Institute of Technology; University of Sheffield; University of Oxford; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Ollscoil na Gaillimhe-University of Galway; Yeshiva University; University of California System; University of California Berkeley; Kiepenheuer Institut fur Sonnenphysik; Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Solar-Terrestrial Physics of the Siberian Branch of the Russian Academy of Sciences; National Radio Astronomy Observatory (NRAO); Bulgarian Academy of Sciences; University of Sofia	Hallinan, G (corresponding author), CALTECH, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	gh@astro.caltech.edu	Butler, Ray/A-6705-2012; Kuznetsov, Alexey/Q-9294-2016; Kuznetsov, Alexey/AAG-1696-2019; Basri, Gibor B/Y-4048-2018	Butler, Ray/0000-0002-8441-7596; Kuznetsov, Alexey/0000-0001-8644-8372; Kuznetsov, Alexey/0000-0001-8644-8372; Antonova, Antoaneta/0000-0003-0631-3254; Cotter, Gad/0000-0002-9613-3339; Pineda, J. Sebastian/0000-0002-4489-0135; Berdyugina, Svetlana/0000-0002-2238-7416; Littlefair, Stuart/0000-0001-7221-855X	W.M. Keck Foundation; Northern Ireland Department of Culture, Arts and Leisure; National Science Foundation [AST-1212226/DGE-1144469]; University of Oxford; STFC [ST/M006190/1]; Science and Technology Facilities Council [ST/M006190/1, ST/K005596/1, ST/H002456/1, ST/I003673/1, ST/M001350/1] Funding Source: researchfish; STFC [ST/M001350/1, ST/I003673/1, ST/K005596/1, ST/H001921/1, ST/H002456/1, ST/M002012/1] Funding Source: UKRI	W.M. Keck Foundation(W.M. Keck Foundation); Northern Ireland Department of Culture, Arts and Leisure; National Science Foundation(National Science Foundation (NSF)); University of Oxford; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We are grateful to T. Readhead, S. Kulkarni and J. McMullin for working to ensure that simultaneous Palomar and VLA observations could occur. We thank the staff of the Palomar Observatory, the W.M. Keck Observatory and the National Radio Astronomy Observatory for their support of this project. The W.M. Keck Observatory is operated as a scientific partnership among the California Institute of Technology, the University of California and the National Aeronautics and Space Administration. The Observatory was made possible by the generous financial support of the W.M. Keck Foundation. The VLA is operated by the National Radio Astronomy Observatory, a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. Armagh Observatory is grant-aided by the Northern Ireland Department of Culture, Arts and Leisure. G.H. acknowledges the generous support of D. Castleman and H. Rosen. This material is based upon work supported by the National Science Foundation under grant number AST-1212226/DGE-1144469. G.C. acknowledges support from the University of Oxford and from STFC grant ST/M006190/1. We thank J. Linsky and P. Goldreich for comments on this manuscript.	ABOUDARHAM J, 1987, ASTRON ASTROPHYS, V174, P270; Allard F, 2001, ASTROPHYS J, V556, P357, DOI 10.1086/321547; Artigau E, 2009, ASTROPHYS J, V701, P1534, DOI 10.1088/0004-637X/701/2/1534; Badman SV, 2015, SPACE SCI REV, V187, P99, DOI 10.1007/s11214-014-0042-x; Berger E, 2008, ASTROPHYS J, V676, P1307, DOI 10.1086/529131; Berger E, 2008, ASTROPHYS J, V673, P1080, DOI 10.1086/524769; Berger E, 2001, NATURE, V410, P338, DOI 10.1038/35066514; Bhardwaj A, 2000, REV GEOPHYS, V38, P295, DOI 10.1029/1998RG000046; Bochanski JJ, 2007, ASTRON J, V133, P531, DOI 10.1086/510240; Burgasser AJ, 2003, ASTROPHYS J, V594, P510, DOI 10.1086/376756; Cowley SWH, 2001, PLANET SPACE SCI, V49, P1067, DOI 10.1016/S0032-0633(00)00167-7; Crossfield IJM, 2014, NATURE, V505, P654, DOI 10.1038/nature12955; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; GOLDREICH P, 1969, ASTROPHYS J, V156, P59, DOI 10.1086/149947; Gray D. F., 2005, OBSERVATION ANAL STE; Hallinan G, 2008, ASTROPHYS J, V684, P644, DOI 10.1086/590360; Hallinan G, 2007, ASTROPHYS J, V663, pL25, DOI 10.1086/519790; Harding LK, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/101; Hill TW, 2001, J GEOPHYS RES-SPACE, V106, P8101, DOI 10.1029/2000JA000302; HORNE K, 1986, PUBL ASTRON SOC PAC, V98, P609, DOI 10.1086/131801; ISBELL J, 1984, J GEOPHYS RES-SPACE, V89, P716, DOI 10.1029/JA089iA12p10716; Littlefair SP, 2008, MON NOT R ASTRON SOC, V391, pL88, DOI 10.1111/j.1745-3933.2008.00562.x; Mohanty S, 2003, ASTROPHYS J, V583, P451, DOI 10.1086/345097; Nichols JD, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/59; Radigan J, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/105; Reid IN, 2003, ASTRON J, V125, P354, DOI 10.1086/344946; Reiners A, 2010, ASTROPHYS J, V710, P924, DOI 10.1088/0004-637X/710/2/924; Robinson TD, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/158; Route M, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L22; Schrijver CJ, 2009, ASTROPHYS J LETT, V699, pL148, DOI 10.1088/0004-637X/699/2/L148; Stelzer B, 2006, ASTRON ASTROPHYS, V448, P293, DOI 10.1051/0004-6361:20053677; Williams PKG, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/9; Zarka P, 1998, J GEOPHYS RES-PLANET, V103, P20159, DOI 10.1029/98JE01323; Zarka P, 2007, PLANET SPACE SCI, V55, P598, DOI 10.1016/j.pss.2006.05.045	34	83	83	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					568	+		10.1038/nature14619	http://dx.doi.org/10.1038/nature14619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26223623	Green Submitted, Green Accepted			2022-12-28	WOS:000358655200039
J	Riddell, A; Kennedy, I; Tong, CYW				Riddell, Anna; Kennedy, Ioana; Tong, C. Y. William			Management of sharps injuries in the healthcare setting	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEPATITIS-C VIRUS; POSTEXPOSURE PROPHYLAXIS; IMMUNODEFICIENCY-VIRUS; OCCUPATIONAL-EXPOSURE; NEEDLESTICK INJURY; TRANSMISSION; WORKERS; SEROCONVERSION; GUIDELINES; RISK		[Riddell, Anna; Tong, C. Y. William] Barts Hlth NHS Trust, Dept Infect, London E1 2ES, England; [Kennedy, Ioana] Guys & St Thomas NHS Fdn Trust, Occupat Hlth Serv, London, England; [Tong, C. Y. William] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England	Barts Health NHS Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; Queen Mary University London	Tong, CYW (corresponding author), Barts Hlth NHS Trust, Dept Infect, London E1 2ES, England.	william.tong@nhs.net	Tong, Cheuk Yan William/C-1312-2012	Tong, Cheuk Yan William/0000-0001-8401-6832				Anderson N, 2002, TRANSFUSION, V42, P1146; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Department of Health, 2010, ANN A EX UKAP ADV EX; Department of Health, 2008, HIV POST PROPH GUID; Diprose P, 2000, BRIT J ANAESTH, V84, P767, DOI 10.1093/oxfordjournals.bja.a013591; Expert Advisory Group on AIDS, 2013, UPD REC HIV POST PRO; Expert Advisory Group on AIDS, 2014, CHANG REC REG POST P; Expert Advisory Group on AIDS and the Advisory Group on Hepatitis, 1998, GUID CLIN HEALTHC WO; Ford N, 2015, CLIN INFECT DIS, V60, pS170, DOI 10.1093/cid/civ092; General Medical Council, 2008, CONS PAT DOCT MAK DE; Gunther S, 2011, J INFECT DIS, V204, pS785, DOI 10.1093/infdis/jir298; Hawkins DA, 2001, J INFECTION, V43, P12, DOI [10.1016/S0163-4453(01)90811-4, 10.1039/jinf.2001.0811]; Kuhar DT, 2013, INFECT CONT HOSP EP, V34, P875, DOI 10.1086/672271; Menna-Barreto M, 2006, AM J INFECT CONTROL, V34, P158, DOI 10.1016/j.ajic.2005.12.002; Naghavi SHR, 2013, OCCUP MED-OXFORD, V63, P260, DOI 10.1093/occmed/kqt027; Paintsil E, 2010, J INFECT DIS, V202, P984, DOI 10.1086/656212; Public Health England, 2013, IMM INF DIS GREEN BO, P161; Tarantola A, 2005, SCAND J INFECT DIS, V37, P131, DOI 10.1080/00365540410020839; Thomson EC, 2009, AIDS, V23, P89, DOI 10.1097/QAD.0b013e32831940a3; Tomkins SE, 2015, J HOSP INFECT, V89, P69, DOI 10.1016/j.jhin.2014.09.012; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; University of Liverpool, 2015, DRUG INT CHARTS; Webster DP, 2015, HIV MED, V16, P73, DOI 10.1111/hiv.12187; Woode Owusu M, 2014, EYE NEEDLE UK SURVEI; Yazdanpanah Y, 2005, CLIN INFECT DIS, V41, P1423, DOI 10.1086/497131; Young TN, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002835.pub3	26	10	11	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2015	351								h3733	10.1136/bmj.h3733	http://dx.doi.org/10.1136/bmj.h3733			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2UA	26223519				2022-12-28	WOS:000359010900003
J	Ghosh, T				Ghosh, Tushar			Stretch, wrap, and relax to smartness	SCIENCE			English	Editorial Material							CARBON NANOTUBES; ELECTRODES; CONDUCTORS; POLYMER		N Carolina State Univ, Fiber & Polymer Sci Program, Text Engn Chem & Sci Dept, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Ghosh, T (corresponding author), N Carolina State Univ, Fiber & Polymer Sci Program, Text Engn Chem & Sci Dept, Raleigh, NC 27695 USA.	tghosh@ncsu.edu		ghosh, tushar/0000-0002-8014-2513				Barber E.J.W., 1991, PREHISTORIC TEXTILES; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Cakmak E, 2015, CARBON, V89, P113, DOI 10.1016/j.carbon.2015.03.011; Hu LB, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3114463; Hyun DC, 2011, ADV MATER, V23, P2946, DOI 10.1002/adma.201100639; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Liu ZF, 2015, SCIENCE, V349, P400, DOI 10.1126/science.aaa7952; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Shankar R, 2007, ADV MATER, V19, P2218, DOI 10.1002/adma.200602644; Xu F, 2012, ADV FUNCT MATER, V22, P1279, DOI 10.1002/adfm.201102032; Zhu Y, 2012, ADV MATER, V24, P1073, DOI 10.1002/adma.201103382	12	21	24	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					382	383		10.1126/science.aac7417	http://dx.doi.org/10.1126/science.aac7417			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206920				2022-12-28	WOS:000358381400024
J	Huber, JA				Huber, Julie A.			Making methane down deep	SCIENCE			English	Editorial Material							MICROBIAL LIFE; SEA SEDIMENTS; FLOOR; SUBSEAFLOOR		Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA	Marine Biological Laboratory - Woods Hole	Huber, JA (corresponding author), Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA.	jhuber@mbl.edu		Huber, Julie/0000-0002-4790-7633				Ciobanu MC, 2014, ISME J, V8, P1370, DOI 10.1038/ismej.2013.250; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; D'Hondt S, 2015, NAT GEOSCI, V8, P299, DOI 10.1038/NGEO2387; Inagaki F, 2015, SCIENCE, V349, P420, DOI 10.1126/science.aaa6882; Inagaki F., 2013, INTEGR OCEAN DRILL P, V337; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Morono Y, 2009, ISME J, V3, P503, DOI 10.1038/ismej.2009.1; Orsi WD, 2013, NATURE, V499, P205, DOI 10.1038/nature12230; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Roy H, 2012, SCIENCE, V336, P922, DOI 10.1126/science.1219424; Stolper DA, 2014, SCIENCE, V344, P1500, DOI 10.1126/science.1254509	11	1	2	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					376	377		10.1126/science.aac6673	http://dx.doi.org/10.1126/science.aac6673			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206916				2022-12-28	WOS:000358381400020
J	Detollenaere, RJ; den Boon, J; Stekelenburg, J; IntHout, J; Vierhout, ME; Kluivers, KB; van Eijndhoven, HWF				Detollenaere, Renee J.; den Boon, Jan; Stekelenburg, Jelle; IntHout, Joanna; Vierhout, Mark E.; Kluivers, Kirsten B.; van Eijndhoven, Hugo W. F.			Sacrospinous hysteropexy versus vaginal hysterectomy with suspension of the uterosacral ligaments in women with uterine prolapse stage 2 or higher: multicentre randomised non-inferiority trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PELVIC ORGAN PROLAPSE; QUALITY-OF-LIFE; VAULT PROLAPSE; SURGERY; RISK; INCONTINENCE; PREVALENCE; ENTEROCELE; MANAGEMENT; DESCENT	OBJECTIVE To investigate whether uterus preserving vaginal sacrospinous hysteropexy is non-inferior to vaginal hysterectomy with suspension of the uterosacral ligaments in the surgical treatment of uterine prolapse. DESIGN Multicentre randomised controlled non-blinded non-inferiority trial. SETTING 4 non-university teaching hospitals, the Netherlands. PARTICIPANTS 208 healthy women with uterine prolapse stage 2 or higher requiring surgery and no history of pelvic floor surgery. INTERVENTIONS Treatment with sacrospinous hysteropexy or vaginal hysterectomy with suspension of the uterosacral ligaments. The predefined non-inferiority margin was an increase in surgical failure rate of 7%. MAIN OUTCOME MEASURES Primary outcome was recurrent prolapse stage 2 or higher of the uterus or vaginal vault (apical compartment) evaluated by the pelvic organ prolapse quantification system in combination with bothersome bulge symptoms or repeat surgery for recurrent apical prolapse at 12 months' follow-up. Secondary outcomes were overall anatomical recurrences, including recurrent anterior compartment (bladder) and/or posterior compartment (bowel) prolapse, functional outcome, complications, hospital stay, postoperative recovery, and sexual functioning. RESULTS Sacrospinous hysteropexy was non-inferior for anatomical recurrence of the apical compartment with bothersome bulge symptoms or repeat surgery (n=0, 0%) compared with vaginal hysterectomy with suspension of the uterosacral ligaments (n=4, 4.0%, difference -3.9%, 95% confidence interval for difference -8.6% to 0.7%). At 12 months, overall anatomical recurrences, functional outcome, quality of life, complications, hospital stay, measures on postoperative recovery, and sexual functioning did not differ between the two groups. Five serious adverse events were reported during hospital stay. None was considered to be related to the type of surgery. CONCLUSIONS Uterus preservation by sacrospinous hysteropexy was non-inferior to vaginal hysterectomy with suspension of the uterosacral ligaments for surgical failure of the apical compartment at 12 months' follow-up.	[Detollenaere, Renee J.; den Boon, Jan; van Eijndhoven, Hugo W. F.] Isala, Dept Obstet & Gynaecol, NL-8000 GK Zwolle, Netherlands; [Detollenaere, Renee J.; Vierhout, Mark E.; Kluivers, Kirsten B.] Radboud Univ Nijmegen, Dept Obstet & Gynaecol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Stekelenburg, Jelle] Med Ctr Leeuwarden, Dept Obstet & Gynaecol, Leeuwarden, Netherlands; [IntHout, Joanna] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Medical Center Leeuwarden; Radboud University Nijmegen	Detollenaere, RJ (corresponding author), Isala, Dept Obstet & Gynaecol, POB 10400, NL-8000 GK Zwolle, Netherlands.	r.j.detollenaere@isala.nl	Vierhout, M.E./H-8109-2014; IntHout, Joanna/A-1863-2016; Stekelenburg, Jelle/B-3129-2017; Kluivers, K.B./L-4439-2015	IntHout, Joanna/0000-0002-6127-0747; Stekelenburg, Jelle/0000-0002-2732-6620; Kluivers, K.B./0000-0002-4681-4304; Detollenaere, Renee/0000-0001-9707-5647	Isala research foundation	Isala research foundation	This study received an unrestricted grant from the Isala research foundation. The funding source had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	ACOG Committee on Practice Bulletins--Gynecology, 2007, Obstet Gynecol, V110, P717; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Altman D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.012; Barber MD, 2014, JAMA-J AM MED ASSOC, V311, P1023, DOI 10.1001/jama.2014.1719; Barber MD, 2009, OBSTET GYNECOL, V114, P600, DOI 10.1097/AOG.0b013e3181b2b1ae; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Brummen HJ, 2003, INT UROGYNECOL J, V14, P350; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; CRUIKSHANK SH, 1987, AM J OBSTET GYNECOL, V156, P1433, DOI 10.1016/0002-9378(87)90013-5; Dallenbach P, 2008, INT UROGYNECOL J, V19, P1623, DOI 10.1007/s00192-008-0718-4; de Boer TA, 2011, EUR J OBSTET GYN R B, V158, P343, DOI 10.1016/j.ejogrb.2011.04.029; Detollenaere RJ, 2013, INT UROGYNECOL J, V24, P781, DOI 10.1007/s00192-012-1934-5; Detollenaere RJ, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-4; Dietz V, 2008, INT UROGYNECOL J, V19, pS1; Dietz V, 2010, INT UROGYNECOL J, V21, P209, DOI 10.1007/s00192-009-1014-7; Dietz V, 2009, INT UROGYNECOL J, V20, P349, DOI 10.1007/s00192-008-0779-4; Frick AC, 2013, FEMALE PELVIC MED RE, V19, P103, DOI 10.1097/SPV.0b013e31827d8667; Gutman R, 2013, INT UROGYNECOL J, V24, P1803, DOI 10.1007/s00192-013-2171-2; Hefni M, 2003, AM J OBSTET GYNECOL, V188, P645, DOI 10.1067/mob.2003.75; Jeng CJ, 2005, J REPROD MED, V50, P669; Jha S, 2011, INT UROGYNECOL J, V22, P517, DOI 10.1007/s00192-011-1379-2; Kantartzis KL, 2015, INT UROGYNECOL J, V26, P207, DOI 10.1007/s00192-014-2474-y; Kluivers KB, 2008, SURGERY, V144, P12, DOI 10.1016/j.surg.2008.03.027; Korbly NB, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.003; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Lykke R, 2015, INT UROGYNECOL J, V26, P527, DOI 10.1007/s00192-014-2490-y; Maher CF, 2001, INT UROGYNECOL J PEL, V12, P381, DOI 10.1007/s001920170017; Maher C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub5; MCCALL ML, 1957, OBSTET GYNECOL, V10, P595, DOI 10.1097/00006250-195712000-00001; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Renganathan A, 2010, INT UROGYNECOL J, V21, P819, DOI 10.1007/s00192-010-1101-9; Roovers JPWR, 2005, BJOG-INT J OBSTET GY, V112, P1547, DOI 10.1111/j.1471-0528.2005.00734.x; Schweitzer KJ, 2008, NTOG, V121, P79; Slieker-ten Hove MCP, 2009, INT UROGYNECOL J, V20, P1037, DOI 10.1007/s00192-009-0902-1; Smilen SW, 1998, AM J OBSTET GYNECOL, V179, P1465, DOI 10.1016/S0002-9378(98)70041-9; van der Vaart CH, 2003, NEUROUROL URODYNAM, V22, P97, DOI 10.1002/nau.10038; Vanspauwen R, 2010, AUST NZ J OBSTET GYN, V50, P262, DOI 10.1111/j.1479-828X.2010.01145.x; Ware JE., 1994, SF 36 PHYS MENTAL CO; Wu MP, 2012, INT UROGYNECOL J, V23, P865, DOI 10.1007/s00192-011-1647-1	39	108	109	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2015	351								h3717	10.1136/bmj.h3717	http://dx.doi.org/10.1136/bmj.h3717			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WL	26206451	hybrid, Green Published			2022-12-28	WOS:000358645000002
J	Cacchiarelli, D; Trapnell, C; Ziller, MJ; Soumillon, M; Cesana, M; Karnik, R; Donaghey, J; Smith, ZD; Ratanasirintrawoot, S; Zhang, XL; Sui, SJH; Wu, ZT; Akopian, V; Gifford, CA; Doench, J; Rinn, JL; Daley, GQ; Meissner, A; Lander, ES; Mikkelsen, TS				Cacchiarelli, Davide; Trapnell, Cole; Ziller, Michael J.; Soumillon, Magali; Cesana, Marcella; Karnik, Rahul; Donaghey, Julie; Smith, Zachary D.; Ratanasirintrawoot, Sutheera; Zhang, Xiaolan; Sui, Shannan J. Ho; Wu, Zhaoting; Akopian, Veronika; Gifford, Casey A.; Doench, John; Rinn, John L.; Daley, George Q.; Meissner, Alexander; Lander, Eric S.; Mikkelsen, Tarjei S.			Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced Pluripotency	CELL			English	Article							EMBRYONIC STEM-CELLS; HUMAN SOMATIC-CELLS; GROUND-STATE PLURIPOTENCY; IPS CELLS; FIBROBLASTS; METHYLATION; CANCER; CONVERSION; SYSTEM; GENOME	Induced pluripotency is a promising avenue for disease modeling and therapy, but the molecular principles underlying this process, particularly in human cells, remain poorly understood due to donor-to-donor variability and intercellular heterogeneity. Here, we constructed and characterized a clonal, inducible human reprogramming system that provides a reliable source of cells at any stage of the process. This system enabled integrative transcriptional and epigenomic analysis across the human reprogramming timeline at high resolution. We observed distinct waves of gene network activation, including the ordered re-activation of broad developmental regulators followed by early embryonic patterning genes and culminating in the emergence of a signature reminiscent of pre-implantation stages. Moreover, complementary functional analyses allowed us to identify and validate novel regulators of the reprogramming process. Altogether, this study sheds light on the molecular underpinnings of induced pluripotency in human cells and provides a robust cell platform for further studies.	[Cacchiarelli, Davide; Ziller, Michael J.; Soumillon, Magali; Karnik, Rahul; Donaghey, Julie; Smith, Zachary D.; Akopian, Veronika; Gifford, Casey A.; Rinn, John L.; Meissner, Alexander; Mikkelsen, Tarjei S.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Cacchiarelli, Davide; Ziller, Michael J.; Soumillon, Magali; Karnik, Rahul; Donaghey, Julie; Smith, Zachary D.; Zhang, Xiaolan; Akopian, Veronika; Gifford, Casey A.; Doench, John; Rinn, John L.; Meissner, Alexander; Lander, Eric S.; Mikkelsen, Tarjei S.] Broad Inst, Cambridge, MA 02142 USA; [Cacchiarelli, Davide; Ziller, Michael J.; Soumillon, Magali; Cesana, Marcella; Karnik, Rahul; Donaghey, Julie; Smith, Zachary D.; Ratanasirintrawoot, Sutheera; Sui, Shannan J. Ho; Wu, Zhaoting; Akopian, Veronika; Gifford, Casey A.; Rinn, John L.; Daley, George Q.; Meissner, Alexander; Mikkelsen, Tarjei S.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Cesana, Marcella; Ratanasirintrawoot, Sutheera; Wu, Zhaoting; Daley, George Q.] Boston Childrens Hosp, Boston, MA 02115 USA; [Cesana, Marcella; Ratanasirintrawoot, Sutheera; Wu, Zhaoting; Daley, George Q.] Harvard Univ, Sch Med, Manton Ctr Orphan Dis Res, Dana Farber Canc Inst,Howard Hughes Med Inst,Dept, Boston, MA 02115 USA; [Sui, Shannan J. Ho] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Trapnell, Cole] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle	Mikkelsen, TS (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	tarjei@broadinstitute.org	Doench, John G/HCI-9570-2022; Cacchiarelli, Davide/AAC-2693-2022; Mikkelsen, Tarjei S/A-1306-2007; Cesana, Marcella/AAC-2697-2022; Doench, John/ABE-6251-2020	Doench, John G/0000-0002-3707-9889; Cacchiarelli, Davide/0000-0002-9621-6716; Mikkelsen, Tarjei S/0000-0002-8133-3135; Cesana, Marcella/0000-0002-9099-8681; Doench, John/0000-0002-3707-9889; Karnik, Rahul/0000-0002-0400-635X; Gifford, Casey/0000-0002-7757-573X; Rinn, John/0000-0002-7231-7539; Ratanasirintrawoot, Sutheera/0000-0002-0641-5106; /0000-0002-6191-4709	Swiss National Science Foundation postdoctoral fellowship; Harvard Stem Cell Institute; NIGMS [P01GM099117, R01GM107536]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107536, P01GM099117] Funding Source: NIH RePORTER	Swiss National Science Foundation postdoctoral fellowship(Swiss National Science Foundation (SNSF)); Harvard Stem Cell Institute; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Martin Sauvageau and Alexander Tsankov for technical assistance and for helpful discussion. D.C. is a Human Frontier Science Program Fellow. C.T. is a Damon Runyon Fellow. M.C. is an EMBO and Leukemia and Lymphoma Society Fellow. M.S. was supported by a Swiss National Science Foundation postdoctoral fellowship, and D.C., M.S., S.J.H.S., and T.S.M. were supported by the Harvard Stem Cell Institute. A.M. is a New York Stem Cell Foundation, Robertson Investigator. This work was supported by grants from NIGMS to T.S.M., A.M., and J.L.R. (P01GM099117) and G.Q.D. (R01GM107536).	Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Edgar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066629; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Fong AP, 2013, CURR OPIN GENET DEV, V23, P568, DOI 10.1016/j.gde.2013.05.002; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li WL, 2009, STEM CELLS, V27, P2992, DOI 10.1002/stem.240; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Neelamegam R, 2012, ACS CHEM NEUROSCI, V3, P120, DOI 10.1021/cn200104y; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nowakowski TJ, 2013, P NATL ACAD SCI USA, V110, P7056, DOI 10.1073/pnas.1219385110; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Parchem RJ, 2014, CELL STEM CELL, V14, P617, DOI 10.1016/j.stem.2014.01.021; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; SALVATORI G, 1995, J CELL SCI, V108, P2733; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4678; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020; Ziller MJ, 2015, NATURE, V518, P355, DOI 10.1038/nature13990	46	140	142	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					412	424		10.1016/j.cell.2015.06.016	http://dx.doi.org/10.1016/j.cell.2015.06.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186193	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000358087700020
J	Sivakumar, S; Rajamani, K				Sivakumar, Sanjeev; Rajamani, Kumar			Secondary Palatal Myoclonus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sivakumar, Sanjeev; Rajamani, Kumar] Wayne State Univ, Detroit, MI 48202 USA	Wayne State University	Sivakumar, S (corresponding author), Wayne State Univ, Detroit, MI 48202 USA.	ssivakum@med.wayne.edu		Sivakumar, Sanjeev/0000-0002-4846-4301					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3							e3	10.1056/NEJMicm1412079	http://dx.doi.org/10.1056/NEJMicm1412079			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MS	26176403				2022-12-28	WOS:000357956200010
J	Wei, JH; Zhang, ZC; Wynn, RM; Seemann, J				Wei, Jen-Hsuan; Zhang, Zi Chao; Wynn, R. Max; Seemann, Joachim			GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules	CELL			English	Article							MATRIX PROTEIN GM130; MITOTIC SPINDLE; IMPORTIN-ALPHA; HELA-CELLS; AURORA-A; RAN; NUCLEATION; APPARATUS; MITOSIS; COMPLEX	Spindle assembly requires the coordinated action of multiple cellular structures to nucleate and organize microtubules in a precise spatiotemporal manner. Amongthem, the contributions of centrosomes, chromosomes, and microtubules have been well studied, yet the involvement of membrane-bound organelles remains largely elusive. Here, we provide mechanistic evidence for a membrane-based, Golgi-derived microtubule assembly pathway in mitosis. Upon mitotic entry, the Golgi matrix protein GM130 interacts with importin alpha via a classical nuclear localization signal that recruits importin alpha to the Golgi membranes. Sequestration of importin alpha by GM130 liberates the spindle assembly factor TPX2, which activates Aurora-A kinase and stimulates local microtubule nucleation. Upon filament assembly, nascent microtubules are further captured by GM130, thus linking Golgi membranes to the spindle. Our results reveal an active role for the Golgi in regulating spindle formation to ensure faithful organelle inheritance.	[Wei, Jen-Hsuan; Seemann, Joachim] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Zhang, Zi Chao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Wynn, R. Max] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wei, JH (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	wei@msg.ucsf.edu; joachim.seemann@utsouthwestern.edu	Wei, Jen-Hsuan/AAG-2920-2021; ZHANG, ZICHAO/C-1764-2014	Wei, Jen-Hsuan/0000-0001-8958-6455; ZHANG, ZICHAO/0000-0003-3402-7757; Zhang, Zi Chao/0000-0001-5769-948X; Wynn, Richard/0000-0002-1879-2136	NIH [GM096070]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096070] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Rebecca Heald and Kara Helmke for insightful discussion and support during project development, Matthew Beard for GM130 constructs, Yuh Min Chook for importin constructs, Luke Rice for Mal3 protein, and Beatriz Fontoura for suggestions. This work is supported by the NIH grant GM096070 to J.S.	Baschieri F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5839; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chang P, 2009, MOL BIOL CELL, V20, P4575, DOI 10.1091/mbc.E09-06-0477; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hachet V, 2004, EMBO J, V23, P1526, DOI 10.1038/sj.emboj.7600154; Hehnly H, 2014, DEV CELL, V28, P497, DOI 10.1016/j.devcel.2014.01.014; Heidebrecht HJ, 1997, BLOOD, V90, P226; Ishida R, 2015, FEBS J, V282, P2232, DOI 10.1111/febs.13271; Jesch SA, 1998, MOL BIOL CELL, V9, P623, DOI 10.1091/mbc.9.3.623; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kodani A, 2008, MOL BIOL CELL, V19, P745, DOI 10.1091/mbc.E07-08-0847; Levine TP, 1996, J BIOL CHEM, V271, P17304, DOI 10.1074/jbc.271.29.17304; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Meunier S, 2012, J CELL SCI, V125, P2805, DOI 10.1242/jcs.092429; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Niclas J, 1996, J CELL BIOL, V133, P585, DOI 10.1083/jcb.133.3.585; Oddoux S, 2013, J CELL BIOL, V203, P205, DOI 10.1083/jcb.201304063; Ori-McKenney KM, 2012, NEURON, V76, P921, DOI 10.1016/j.neuron.2012.10.008; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Sardon T, 2008, EMBO J, V27, P2567, DOI 10.1038/emboj.2008.173; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Seemann J, 2002, SCIENCE, V295, P848, DOI 10.1126/science.1068064; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Shima DT, 1997, J CELL BIOL, V137, P1211, DOI 10.1083/jcb.137.6.1211; Tang DM, 2010, NAT PROTOC, V5, P758, DOI 10.1038/nprot.2010.38; Taylor RS, 1997, MOL BIOL CELL, V8, P1911, DOI 10.1091/mbc.8.10.1911; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Wei JH, 2009, SEMIN CELL DEV BIOL, V20, P810, DOI 10.1016/j.semcdb.2009.03.010; Wei JH, 2009, J CELL BIOL, V184, P391, DOI 10.1083/jcb.200809090; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilbur JD, 2013, ELIFE, V2, DOI 10.7554/eLife.00290; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Zhang CH, 2011, CELL CYCLE, V10, P1861, DOI 10.4161/cc.10.11.15797; Zheng YX, 2010, NAT REV MOL CELL BIO, V11, P529, DOI 10.1038/nrm2919	50	67	76	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					287	299		10.1016/j.cell.2015.06.014	http://dx.doi.org/10.1016/j.cell.2015.06.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26165940	Green Accepted, Bronze			2022-12-28	WOS:000358087700010
J	Ball, SL; Arullendran, P				Ball, Stephen L.; Arullendran, Puveendran			SPOT DIAGNOSIS Anatomy of a swallow	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ball, Stephen L.] Newcastle Univ, Newcastle Med Sch, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Arullendran, Puveendran] City Hosp Sunderland, Dept ENT Surg, Sunderland, Durham, England	Newcastle University - UK; Sunderland Royal Hospital	Ball, SL (corresponding author), Newcastle Univ, Newcastle Med Sch, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	s.l.ball@ncl.ac.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2015	351								h3494	10.1136/bmj.h3494	http://dx.doi.org/10.1136/bmj.h3494			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CD	26170254				2022-12-28	WOS:000358300400001
J	Desalegn, H; Solberg, E; Kim, JY				Desalegn, Hailemariam; Solberg, Erna; Kim, Jim Yong			The Global Financing Facility: country investments for every woman, adolescent, and child	LANCET			English	Editorial Material									[Desalegn, Hailemariam] Govt Ethiopia, Off Prime Minister, Addis Ababa, Ethiopia; [Solberg, Erna] Govt Norway, Off Prime Minister, Oslo, Norway; [Kim, Jim Yong] World Bank Grp, Washington, DC 20433 USA	The World Bank	Kim, JY (corresponding author), World Bank Grp, Washington, DC 20433 USA.	president@worldbank.org						Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; PMNCH WHO The World Bank Alliance for Health Policy and Systems Research, 2014, SUCC FACT WOM CHILDR; The World Bank, 2014, SMART APPR DEL MOR B; The World Bank, 2013, GLOB MON REP 2013; The World Bank, 2015, GLOB FIN FAC BUS PLA; UNICEF WHO The World Bank UN, 2014, LEV TRENDS CHILD MOR; United Nations, 2017, MILLENNIUM DEV GOALS; United Nations Department of Economic and Social Aff airs, 2015, SUST DEV GOALS KNOWL; United Nations Foundation, 2015, EV WOM EV CHILD GLOB; WHO UNICEF UNFPA The World Bank and the United Nations Population Division. World Health Organization, 2014, TRENDS MAT MORT 1990	10	13	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					105	106		10.1016/S0140-6736(15)61224-7	http://dx.doi.org/10.1016/S0140-6736(15)61224-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM5QC	26194379				2022-12-28	WOS:000357742200004
J	Dutton, A; Carlson, AE; Long, AJ; Milne, GA; Clark, PU; DeConto, R; Horton, BP; Rahmstorf, S; Raymo, ME				Dutton, A.; Carlson, A. E.; Long, A. J.; Milne, G. A.; Clark, P. U.; DeConto, R.; Horton, B. P.; Rahmstorf, S.; Raymo, M. E.			Sea-level rise due to polar ice-sheet mass loss during past warm periods	SCIENCE			English	Review							LAST GLACIAL MAXIMUM; DYNAMIC TOPOGRAPHY; UNITED-STATES; PROBABILISTIC ASSESSMENT; VOLUME CHANGES; UPPER-MANTLE; VM2 MODEL; PLIOCENE; CLIMATE; TEMPERATURE	Interdisciplinary studies of geologic archives have ushered in a new era of deciphering magnitudes, rates, and sources of sea-level rise from polar ice-sheet loss during past warm periods. Accounting for glacial isostatic processes helps to reconcile spatial variability in peak sea level during marine isotope stages 5e and 11, when the global mean reached 6 to 9 meters and 6 to 13 meters higher than present, respectively. Dynamic topography introduces large uncertainties on longer time scales, precluding robust sea-level estimates for intervals such as the Pliocene. Present climate is warming to a level associated with significant polar ice-sheet loss in the past. Here, we outline advances and challenges involved in constraining ice-sheet sensitivity to climate change with use of paleo-sea level records.	[Dutton, A.] Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA; [Carlson, A. E.; Clark, P. U.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Long, A. J.] Univ Durham, Dept Geog, Durham, England; [Milne, G. A.] Univ Ottawa, Dept Earth Sci, Ottawa, ON, Canada; [DeConto, R.] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Horton, B. P.] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Horton, B. P.] Nanyang Technol Univ, Earth Observ Singapore, Singapore 639798, Singapore; [Rahmstorf, S.] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Raymo, M. E.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	State University System of Florida; University of Florida; Oregon State University; Durham University; University of Ottawa; University of Massachusetts System; University of Massachusetts Amherst; Rutgers State University New Brunswick; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Potsdam Institut fur Klimafolgenforschung; Columbia University	Dutton, A (corresponding author), Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA.	adutton@ufl.edu	Rahmstorf, Stefan/A-8465-2010; Raymo, Maureen E/A-1270-2012; Dutton, Andrea/A-2506-2008	Rahmstorf, Stefan/0000-0001-6786-7723; Dutton, Andrea/0000-0002-3836-119X; Horton, Benjamin/0000-0001-9245-3768; Long, Antony/0000-0002-7605-1205	Past Global Changes (PAGES); International Union for Quaternary Science (INQUA); NSF [1155495, 1202632, 1343573, 0958417, 1043517, OCE1458904]; Natural Environment Research Council (UK) [NE/I008675/1]; Directorate For Geosciences [1417886] Funding Source: National Science Foundation; Div Atmospheric & Geospace Sciences [1203910] Funding Source: National Science Foundation; Division Of Earth Sciences [1440015] Funding Source: National Science Foundation; NERC [NE/I008675/1] Funding Source: UKRI; Natural Environment Research Council [NE/I008675/1] Funding Source: researchfish	Past Global Changes (PAGES); International Union for Quaternary Science (INQUA); NSF(National Science Foundation (NSF)); Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This manuscript was developed based on collaborations and discussions that have stemmed from the Paleo Constraints on Sea-Level Rise (PALSEA) and PALSEA2 working group, presently funded by Past Global Changes (PAGES) and International Union for Quaternary Science (INQUA). We thank four anonymous reviewers for comments that helped to improve the manuscript, A. Kemp for assistance with one of the figures, and A. Rovere and B. Honisch for helpful comments. Funding was provided by NSF awards 1155495 to A.D., 1202632 to M.E.R., 1343573 to A.E.C., 0958417 and 1043517 to P.U.C., OCE1458904 to B.P.H., and Natural Environment Research Council (UK) grant NE/I008675/1 to A.J.L.	Abe-Ouchi A, 2013, NATURE, V500, P190, DOI 10.1038/nature12374; Anderson P, 2006, QUATERNARY SCI REV, V25, P1383, DOI 10.1016/j.quascirev.2006.01.033; Austermann J, 2013, NAT GEOSCI, V6, P553, DOI 10.1038/NGEO1859; Bauch HA, 2013, QUATERNARY SCI REV, V63, P1, DOI 10.1016/j.quascirev.2012.11.023; Bentley MJ, 2010, J QUATERNARY SCI, V25, P5, DOI 10.1002/jqs.1287; Blanchon P, 2009, NATURE, V458, P881, DOI 10.1038/nature07933; Camoin GF, 2015, SEDIMENTOLOGY, V62, P401, DOI 10.1111/sed.12184; Carlson AE, 2014, GEOPHYS RES LETT, V41, P5514, DOI 10.1002/2014GL060800; Cazenave A, 2009, GLOBAL PLANET CHANGE, V65, P83, DOI 10.1016/j.gloplacha.2008.10.004; Chen F, 2014, J CLIMATE, V27, P8740, DOI 10.1175/JCLI-D-14-00282.1; CHEN JH, 1991, GEOL SOC AM BULL, V103, P82, DOI 10.1130/0016-7606(1991)103<0082:PCOTLI>2.3.CO;2; Church JA, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1137; CLARK JA, 1977, NATURE, V269, P206, DOI 10.1038/269206a0; CLARK JA, 1978, QUATERNARY RES, V9, P265, DOI 10.1016/0033-5894(78)90033-9; Clark PU, 2002, SCIENCE, V295, P2438; Coletti A. J., 2014, CLIMATE DISCUSSIONS, V10, P3127, DOI [10.5194/cpd-10-3127-2014, DOI 10.5194/CPD-10-3127-2014]; Colville EJ, 2011, SCIENCE, V333, P620, DOI 10.1126/science.1204673; Compton JS, 2001, HOLOCENE, V11, P395, DOI 10.1191/095968301678302832; Conrad CP, 2009, LITHOSPHERE-US, V1, P110, DOI 10.1130/L32.1; Conrad CP, 1997, GEOPHYS RES LETT, V24, P1503, DOI 10.1029/97GL01338; Cook CP, 2013, NAT GEOSCI, V6, P765, DOI [10.1038/ngeo1889, 10.1038/NGEO1889]; Cronin TM, 2013, QUATERNARY SCI REV, V79, P157, DOI 10.1016/j.quascirev.2012.12.010; Dahl-Jensen D, 2013, NATURE, V493, P489, DOI 10.1038/nature11789; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; DeConto RM, 2012, GLOBAL PLANET CHANGE, V88-89, P45, DOI 10.1016/j.gloplacha.2012.03.003; Deschamps P, 2012, NATURE, V483, P559, DOI 10.1038/nature10902; Dowsett HJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02013; DOWSETT HJ, 1990, GEOLOGY, V18, P435, DOI 10.1130/0091-7613(1990)018<0435:HESLDT>2.3.CO;2; Dutton A, 2012, SCIENCE, V337, P216, DOI 10.1126/science.1205749; Dutton A, 2015, QUATERNARY SCI REV, V107, P182, DOI 10.1016/j.quascirev.2014.10.025; Dwyer GS, 2009, PHILOS T R SOC A, V367, P157, DOI 10.1098/rsta.2008.0222; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; FARRELL WE, 1976, GEOPHYS J ROY ASTR S, V46, P647, DOI 10.1111/j.1365-246X.1976.tb01252.x; Fleming K, 1998, EARTH PLANET SC LETT, V163, P327, DOI 10.1016/S0012-821X(98)00198-8; Foster GL, 2013, P NATL ACAD SCI USA, V110, P1209, DOI 10.1073/pnas.1216073110; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; Grant KM, 2012, NATURE, V491, P744, DOI 10.1038/nature11593; Gregoire LJ, 2012, NATURE, V487, P219, DOI 10.1038/nature11257; GURNIS M, 1992, SCIENCE, V255, P1556, DOI 10.1126/science.255.5051.1556; Hansen James, 2013, Philos Trans A Math Phys Eng Sci, V371, P20120294, DOI 10.1098/rsta.2012.0294; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Hay C, 2014, QUATERNARY SCI REV, V87, P60, DOI 10.1016/j.quascirev.2013.12.022; Haywood AM, 2013, CLIM PAST, V9, P191, DOI 10.5194/cp-9-191-2013; Hearty PJ, 2007, QUATERNARY SCI REV, V26, P2090, DOI 10.1016/j.quascirev.2007.06.019; Hearty PJ, 1999, GEOLOGY, V27, P375, DOI 10.1130/0091-7613(1999)027<0375:AMMPSL>2.3.CO;2; Helm V., 2014, CRYOSPHERE DISCUSS, V8, P1673, DOI [10.5194/tcd-8-1673-2014, DOI 10.5194/TCD-8-1673-2014]; Johnson JS, 2014, SCIENCE, V343, P999, DOI 10.1126/science.1247385; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kemp AC, 2011, P NATL ACAD SCI USA, V108, P11017, DOI 10.1073/pnas.1015619108; Koenig SJ, 2014, GEOPHYS RES LETT, V41, P3933, DOI 10.1002/2014GL059770; Kopp RE, 2013, GEOPHYS J INT, V193, P711, DOI 10.1093/gji/ggt029; Kopp RE, 2010, CLIMATIC CHANGE, V103, P619, DOI 10.1007/s10584-010-9935-1; Kopp RE, 2009, NATURE, V462, P863, DOI 10.1038/nature08686; Kozdon R, 2013, PALEOCEANOGRAPHY, V28, P517, DOI 10.1002/palo.20048; KRANTZ DE, 1991, QUATERNARY SCI REV, V10, P163, DOI 10.1016/0277-3791(91)90016-N; Lambeck K, 1998, GEOPHYS J INT, V134, P102, DOI 10.1046/j.1365-246x.1998.00541.x; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Lambeck K, 2011, QUATERNARY SCI REV, V30, P3542, DOI 10.1016/j.quascirev.2011.08.008; Lang N, 2011, CLIM PAST, V7, P361, DOI 10.5194/cp-7-361-2011; Lecavalier BS, 2014, QUATERNARY SCI REV, V102, P54, DOI 10.1016/j.quascirev.2014.07.018; Levermann A, 2013, P NATL ACAD SCI USA, V110, P13745, DOI 10.1073/pnas.1219414110; Levitus S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037155; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Liu ZY, 2014, P NATL ACAD SCI USA, V111, pE3501, DOI 10.1073/pnas.1407229111; Long AJ, 2014, EARTH PLANET SC LETT, V388, P110, DOI 10.1016/j.epsl.2013.11.012; Long AJ, 2011, QUATERNARY SCI REV, V30, P3748, DOI 10.1016/j.quascirev.2011.10.013; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Marcott SA, 2011, P NATL ACAD SCI USA, V108, P13415, DOI 10.1073/pnas.1104772108; Masson-Delmotte V, 2010, QUATERNARY SCI REV, V29, P113, DOI 10.1016/j.quascirev.2009.09.030; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; McKay NP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048280; McKay R, 2012, QUATERNARY SCI REV, V34, P93, DOI 10.1016/j.quascirev.2011.12.012; MCKENZIE D, 1977, GEOPHYS J ROY ASTR S, V48, P211, DOI 10.1111/j.1365-246X.1977.tb01297.x; Melles M, 2012, SCIENCE, V337, P315, DOI 10.1126/science.1222135; Mengel M, 2014, NAT CLIM CHANGE, V4, P451, DOI [10.1038/NCLIMATE2226, 10.1038/nclimate2226]; Miller KG, 2012, GEOLOGY, V40, P407, DOI 10.1130/G32869.1; Mitrovica JX, 2009, SCIENCE, V323, P753, DOI 10.1126/science.1166510; MITROVICA JX, 1989, TECTONICS, V8, P1079, DOI 10.1029/TC008i005p01079; Mitrovica JX, 2002, QUATERNARY SCI REV, V21, P2179, DOI 10.1016/S0277-3791(02)00080-X; Mitrovica JX, 2001, NATURE, V409, P1026, DOI 10.1038/35059054; Moucha R, 2008, EARTH PLANET SC LETT, V271, P101, DOI 10.1016/j.epsl.2008.03.056; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; Murray-Wallace CV, 2002, J QUATERNARY SCI, V17, P469, DOI 10.1002/jqs.717; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Naish TR, 2009, PHILOS T R SOC A, V367, P169, DOI 10.1098/rsta.2008.0223; Neil EA, 1999, GEOPHYS J INT, V138, P89, DOI 10.1046/j.1365-246x.1999.00841.x; O'Brien CL, 2014, NAT GEOSCI, V7, P607, DOI 10.1038/NGEO2194; O'Leary MJ, 2013, NAT GEOSCI, V6, P796, DOI [10.1038/ngeo1890, 10.1038/NGEO1890]; Otto-Bliesner BL, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0097; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Patterson MO, 2014, NAT GEOSCI, V7, P841, DOI 10.1038/NGEO2273; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Plazait J.-C., 2008, CARNETS GEOL, V1; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Pysklywec RN, 2004, EARTH PLANET SC LETT, V221, P275, DOI 10.1016/S0012-821X(04)00098-6; Raymo ME, 2012, NATURE, V483, P453, DOI 10.1038/nature10891; Raymo ME, 2011, NAT GEOSCI, V4, P328, DOI [10.1038/ngeo1118, 10.1038/NGEO1118]; Reyes AV, 2014, NATURE, V510, P525, DOI 10.1038/nature13456; Ridley J, 2010, CLIM DYNAM, V35, P1065, DOI 10.1007/s00382-009-0646-0; Roberts DL, 2012, EARTH PLANET SC LETT, V357, P226, DOI 10.1016/j.epsl.2012.09.006; Rohling EJ, 2008, NAT GEOSCI, V1, P38, DOI 10.1038/ngeo.2007.28; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Rohling EJ, 2009, NAT GEOSCI, V2, P500, DOI 10.1038/ngeo557; Rostami K, 2000, QUATERNARY SCI REV, V19, P1495, DOI 10.1016/S0277-3791(00)00075-5; Rovere A, 2014, EARTH PLANET SC LETT, V387, P27, DOI 10.1016/j.epsl.2013.10.030; Rowley DB, 2013, SCIENCE, V340, P1560, DOI 10.1126/science.1229180; Scherer RP, 1998, SCIENCE, V281, P82, DOI 10.1126/science.281.5373.82; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Sosdian S, 2009, SCIENCE, V325, P306, DOI 10.1126/science.1169938; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; Stirling CH, 2009, EARTH PLANET SC LETT, V284, P269, DOI 10.1016/j.epsl.2009.04.045; Stone JO, 2003, SCIENCE, V299, P99, DOI 10.1126/science.1077998; Tarasov L, 2012, EARTH PLANET SC LETT, V315, P30, DOI 10.1016/j.epsl.2011.09.010; Thompson WG, 2011, NAT GEOSCI, V4, P684, DOI [10.1038/ngeo1253, 10.1038/NGEO1253]; TUSHINGHAM AM, 1991, J GEOPHYS RES-SOLID, V96, P4497, DOI 10.1029/90JB01583; Vaughan DG, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P317; WARDLAW BR, 1991, QUATERNARY SCI REV, V10, P247, DOI 10.1016/0277-3791(91)90023-N; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Wu P, 2003, EARTH PLANET SC LETT, V211, P57, DOI 10.1016/S0012-821X(03)00199-7; Yin QZ, 2010, NAT GEOSCI, V3, P243, DOI 10.1038/NGEO771; Yu JM, 2010, SCIENCE, V328, DOI 10.1126/science.1186544; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhong SJ, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002048	125	398	407	35	357	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244							aaa4019	10.1126/science.aaa4019	http://dx.doi.org/10.1126/science.aaa4019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26160951	Green Accepted			2022-12-28	WOS:000357664300032
J	Rodrigo, D; Limaj, O; Janner, D; Etezadi, D; de Abajo, FJG; Pruneri, V; Altug, H				Rodrigo, Daniel; Limaj, Odeta; Janner, Davide; Etezadi, Dordaneh; Javier Garcia de Abajo, F.; Pruneri, Valerio; Altug, Hatice			Mid-infrared plasmonic biosensing with graphene	SCIENCE			English	Article							METAMATERIALS; SPECTROSCOPY	Infrared spectroscopy is the technique of choice for chemical identification of biomolecules through their vibrational fingerprints. However, infrared light interacts poorly with nanometric-size molecules. We exploit the unique electro-optical properties of graphene to demonstrate a high-sensitivity tunable plasmonic biosensor for chemically specific label-free detection of proteinmonolayers. The plasmon resonance of nanostructured graphene is dynamically tuned to selectively probe the protein at different frequencies and extract its complex refractive index. Additionally, the extreme spatial light confinement in graphene-up to two orders of magnitude higher than in metals-produces an unprecedentedly high overlap with nanometric biomolecules, enabling superior sensitivity in the detection of their refractive index and vibrational fingerprints. The combination of tunable spectral selectivity and enhanced sensitivity of graphene opens exciting prospects for biosensing.	[Rodrigo, Daniel; Limaj, Odeta; Etezadi, Dordaneh; Altug, Hatice] Ecole Polytech Fed Lausanne, Inst BioEngn, CH-1015 Lausanne, Switzerland; [Janner, Davide; Javier Garcia de Abajo, F.; Pruneri, Valerio] Inst Ciencies Foton, Castelldefels 08860, Barcelona, Spain; [Javier Garcia de Abajo, F.; Pruneri, Valerio] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); ICREA	Altug, H (corresponding author), Ecole Polytech Fed Lausanne, Inst BioEngn, CH-1015 Lausanne, Switzerland.	hatice.altug@epfl.ch	Janner, Davide/E-3567-2019; janner, davide/N-7528-2014; Rodrigo, Daniel/G-1723-2013; García de Abajo, Javier/A-6095-2009	Janner, Davide/0000-0001-7954-979X; janner, davide/0000-0001-7954-979X; Rodrigo, Daniel/0000-0003-3759-2647; García de Abajo, Javier/0000-0002-4970-4565; Pruneri, Valerio/0000-0002-6425-9332	European Commission [FP7-IEF-2013-625673-GRYPHON, CNECT-ICT-604391, FP7-ICT-2013-613024-GRASP]; Spanish Ministry of Economy and Competitiveness (MINECO) [TEC2013-46168-R]; NATO's Public Diplomacy Division; European Union [644956]; Swiss National Science Foundation [133583]; Fundacio Privada Cellex; Severo Ochoa Program; Ramon y Cajal fellowship program; Ecole Polytechnique Federale de Lausanne; Center of MicroNano Technology; ICREA Funding Source: Custom	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); NATO's Public Diplomacy Division(NATO (North Atlantic Treaty Organisation)); European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fundacio Privada Cellex(Foundation CELLEX); Severo Ochoa Program(Spanish Government); Ramon y Cajal fellowship program(German Research Foundation (DFG)); Ecole Polytechnique Federale de Lausanne; Center of MicroNano Technology; ICREA(ICREA)	Supported by European Commission grants FP7-IEF-2013-625673-GRYPHON, Graphene Flagship CNECT-ICT-604391, and FP7-ICT-2013-613024-GRASP; the Spanish Ministry of Economy and Competitiveness (MINECO) "Fondo Europeo de Desarrollo Regional" (FEDER) through grant TEC2013-46168-R; NATO's Public Diplomacy Division in the framework of "Science for Peace"; European Union's Horizon 2020 research and innovation program under grant agreement No 644956; the Swiss National Science Foundation through project 133583; and Fundacio Privada Cellex, the Severo Ochoa Program, and the Ramon y Cajal fellowship program. We also acknowledge Ecole Polytechnique Federale de Lausanne and Center of MicroNano Technology for financial support and nanofabrication. This paper is dedicated to the memory of our friend and colleague, Julien Perruisseau-Carrier.	Adato R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3154; Adato R, 2013, NANO LETT, V13, P2584, DOI 10.1021/nl400689q; Brar VW, 2013, NANO LETT, V13, P2541, DOI 10.1021/nl400601c; de Abajo F. J. Garcia, 2014, ACS PHOTONICS, V1, P135; Fang ZY, 2013, ACS NANO, V7, P2388, DOI 10.1021/nn3055835; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Garcia de Abajo F Javier, 2013, Science, V339, P917, DOI 10.1126/science.1231119; Griffiths PR., 2007, FOURIER TRANSFORM IN, V2nd ed.; Grigorenko AN, 2012, NAT PHOTONICS, V6, P749, DOI [10.1038/nphoton.2012.262, 10.1038/NPHOTON.2012.262]; Jablan M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245435; Joannopoulos J. D., 2011, PHOTONIC CRYSTALS MO; Ju L, 2011, NAT NANOTECHNOL, V6, P630, DOI [10.1038/nnano.2011.146, 10.1038/NNANO.2011.146]; Koppens FHL, 2011, NANO LETT, V11, P3370, DOI 10.1021/nl201771h; Li PN, 2014, NANO LETT, V14, P4400, DOI 10.1021/nl501376a; Li YL, 2014, NANO LETT, V14, P1573, DOI 10.1021/nl404824w; Neubrech F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.157403; Palik E, 1998, HDB OPTICAL CONSTANT, V2; Vakil A, 2011, SCIENCE, V332, P1291, DOI 10.1126/science.1202691; Vasic B, 2013, J APPL PHYS, V113, DOI 10.1063/1.4773474; Woessner A, 2015, NAT MATER, V14, P421, DOI [10.1038/NMAT4169, 10.1038/nmat4169]; Wu CH, 2012, NAT MATER, V11, P69, DOI [10.1038/NMAT3161, 10.1038/nmat3161]; Yan HG, 2013, NAT PHOTONICS, V7, P394, DOI [10.1038/NPHOTON.2013.57, 10.1038/nphoton.2013.57]; Zhong YJ, 2015, J NANOPHOTONICS, V9, DOI 10.1117/1.JNP.9.093791	23	961	981	45	1000	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					165	168		10.1126/science.aab2051	http://dx.doi.org/10.1126/science.aab2051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26160941	Green Submitted			2022-12-28	WOS:000357664300037
J	Laux, P; Tralau, T; Tentschert, J; Blume, A; Al Dahouk, S; Baumler, W; Bernstein, E; Bocca, B; Alimonti, A; Colebrook, H; de Cuyper, C; Dahne, L; Hauri, U; Howard, PC; Janssen, P; Katz, L; Klitzman, B; Kluger, N; Krutak, L; Platzek, T; Scott-Lang, V; Serup, J; Teubner, W; Schreiver, I; Wilkniss, E; Luch, A				Laux, Peter; Tralau, Tewes; Tentschert, Jutta; Blume, Annegret; Al Dahouk, Sascha; Baeumler, Wolfgang; Bernstein, Eric; Bocca, Beatrice; Alimonti, Alessandro; Colebrook, Helen; de Cuyper, Christa; Daehne, Lars; Hauri, Urs; Howard, Paul C.; Janssen, Paul; Katz, Linda; Klitzman, Bruce; Kluger, Nicolas; Krutak, Lars; Platzek, Thomas; Scott-Lang, Victoria; Serup, Jorgen; Teubner, Wera; Schreiver, Ines; Wilkniss, Elena; Luch, Andreas			A medical-toxicological view of tattooing	LANCET			English	Review							RED TATTOO; 1064 NM; LASER; SKIN; INKS; PIGMENTS; REMOVAL; BLACK; INFECTION; MICE	Long perceived as a form of exotic self-expression in some social fringe groups, tattoos have left their maverick image behind and become mainstream, particularly for young people. Historically, tattoo-related health and safety regulations have focused on rules of hygiene and prevention of infections. Meanwhile, the increasing popularity of tattooing has led to the development of many new colours, allowing tattoos to be more spectacular than ever before. However, little is known about the toxicological risks of the ingredients used. For risk assessment, safe intradermal application of these pigments needs data for toxicity and biokinetics and increased knowledge about the removal of tattoos. Other concerns are the potential for phototoxicity, substance migration, and the possible metabolic conversion of tattoo ink ingredients into toxic substances. Similar considerations apply to cleavage products that are formed during laser-assisted tattoo removal. In this Review, we summarise the issues of concern, putting them into context, and provide perspectives for the assessment of the acute and chronic health effects associated with tattooing.	[Laux, Peter; Tralau, Tewes; Tentschert, Jutta; Blume, Annegret; Al Dahouk, Sascha; Platzek, Thomas; Schreiver, Ines; Wilkniss, Elena; Luch, Andreas] German Fed Inst Risk Assessment BfR, Dept Prod Safety, Berlin, Germany; [Baeumler, Wolfgang] Univ Regensburg, Klin & Poliklin Dermatol, D-93053 Regensburg, Germany; [Bernstein, Eric] Main Line Ctr Laser Surg, Ardmore, PA USA; [Bocca, Beatrice; Alimonti, Alessandro] Ist Super Sanita, I-00161 Rome, Italy; [Colebrook, Helen] Minist Hlth New Zealand, Wellington, New Zealand; [de Cuyper, Christa] Acad Hosp St Jan, Brugge, Belgium; [Daehne, Lars] Surflay Nanotec, Berlin, Germany; [Hauri, Urs] Kantonales Lab Basel Stadt, Basel, Switzerland; [Howard, Paul C.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Janssen, Paul] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Katz, Linda] US FDA, College Pk, MD USA; [Klitzman, Bruce] Duke Univ, Med Ctr, Durham, NC USA; [Kluger, Nicolas] Univ Helsinki, Helsinki, Finland; [Kluger, Nicolas] Helsinki Univ Hosp, Helsinki, Finland; [Krutak, Lars] Smithsonian Inst, Washington, DC 20560 USA; [Scott-Lang, Victoria] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland; [Serup, Jorgen] Bispebjerg Hosp, Dept Dermatol, Tattoo Clin, DK-2400 Copenhagen NV, Denmark; [Teubner, Wera] BASF Schweiz AG, Basel, Switzerland	Federal Institute for Risk Assessment; University of Regensburg; Istituto Superiore di Sanita (ISS); US Food & Drug Administration (FDA); Netherlands National Institute for Public Health & the Environment; US Food & Drug Administration (FDA); Duke University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Smithsonian Institution; Royal Infirmary of Edinburgh; University of Edinburgh; University of Copenhagen; Bispebjerg Hospital; BASF	Luch, A (corresponding author), German Fed Inst Risk Assessment BfR, Dept Prod Safety, Berlin, Germany.	andreas.luch@bfr.bund.de	Kluger, Nicolas/L-4220-2019; Bocca, Beatrice/AAB-7635-2019; Schreiver, Ines/Q-2196-2019	Kluger, Nicolas/0000-0002-5225-8316; Schreiver, Ines/0000-0001-9313-7193; Bocca, Beatrice/0000-0002-6503-6026; Tralau, Tewes/0000-0002-7857-4237; Al Dahouk, Sascha/0000-0003-3835-0818	BfR	BfR	The writing of this Review and the realisation of the 1st International Conference on Tattoo Safety at the German Federal Institute for Risk Assessment (BfR) in 2013 has been financially supported by intramural grants of the BfR. This document does not reflect the official policy of the USA Food and Drug Administration and the mention of specific products does not constitute an endorsement.	BAG-Bundesamt fur Gesundheit, 2009, BAG B, V29, P535; Baumgartner A, 2010, VERBRAUCH LEBENSM, V6, P319; Baumler W, 2000, LASER SURG MED, V26, P13, DOI 10.1002/(SICI)1096-9101(2000)26:1<13::AID-LSM4>3.0.CO;2-S; Bedard Brenden, 2012, Morbidity and Mortality Weekly Report, V61, P653; Bernstein Eric F, 2007, Semin Plast Surg, V21, P175, DOI 10.1055/s-2007-991186; Beute TC, 2008, DERMATOL SURG, V34, P508, DOI 10.1111/j.1524-4725.2007.34096.x; BfR, 2011, TATT REM US AQ LACT; Bhardwaj SS, 2003, CONTACT DERMATITIS, V48, P236, DOI 10.1034/j.1600-0536.2003.00090.x; BJORNBERG A, 1963, ARCH DERMATOL, V88, P267, DOI 10.1001/archderm.1963.01590210025003; Canadian Heritage, 2013, SPORT PARTICIPATION, P1; Carlsen KH, 2014, J EUR ACAD DERMATOL, V28, P231, DOI 10.1111/jdv.12093; CARSON S, 1984, J TOXICOL-CUTAN OCUL, V3, P357, DOI 10.3109/15569528409036288; Charnock C, 2006, AM J INFECT CONTROL, V34, P290, DOI 10.1016/j.ajic.2005.12.012; Conaglen PD, 2013, EUROSURVEILLANCE, V18, P10, DOI 10.2807/1560-7917.ES2013.18.32.20553; Cui Y, 2005, DRUG METAB DISPOS, V33, P1459, DOI 10.1124/dmd.104.003285; Cui YY, 2004, PHOTOCHEM PHOTOBIOL, V80, P175, DOI 10.1562/2004-04-06-RA-136.1; Das Eidgenossische Departement des Innern (EDI), 2005, VER GEG SCHLEIMH HAU, P1; De Cuper C, 2008, CLIN DERMATOL, V26, P30, DOI 10.1016/j.clindermatol.2007.10.009; Drage LA, 2010, J AM ACAD DERMATOL, V62, P501, DOI 10.1016/j.jaad.2009.03.034; Engel E, 2008, CONTACT DERMATITIS, V58, P228, DOI 10.1111/j.1600-0536.2007.01301.x; Engel E, 2006, ANAL CHEM, V78, P6440, DOI 10.1021/ac0607461; European Council, 1976, OFFICIAL J EUROPEA L, VL262, P1; [European Council Products CoEoC], 2008, PROD COEOC; Falconi M, 2009, ARCH DERMATOL RES, V301, P539, DOI 10.1007/s00403-009-0953-7; Fors R, 2012, ACTA DERM-VENEREOL, V92, P664, DOI 10.2340/00015555-1305; Forte G., 2009, OPEN CHEM BIOMED MET, V2, P42; Forte G, 2009, SCI TOTAL ENVIRON, V407, P5997, DOI 10.1016/j.scitotenv.2009.08.034; FUJITA H, 1988, ARCH HISTOL CYTOL, V51, P285, DOI 10.1679/aohc.51.285; Garcovich S, 2012, EUR J DERMATOL, V22, P93, DOI 10.1684/ejd.2011.1558; Gopee NV, 2005, TOXICOL APPL PHARM, V209, P145, DOI 10.1016/j.taap.2005.04.003; Hall AF, 1943, ARCH DERM SYPHILOL, V47, P610; Hanafiah M, 2013, BMJ CASE REP; Hauri U., 2011, INKS TATTOOS PMU PER; Hogsberg T, 2015, SKIN RES TECHNOL, V21, P449, DOI 10.1111/srt.12213; Hogsberg T, 2013, J EUR ACAD DERMATOL, V27, P846, DOI 10.1111/j.1468-3083.2012.04590.x; Hogsberg T, 2013, J EUR ACAD DERMATOL, V27, P73, DOI 10.1111/j.1468-3083.2011.04359.x; Hogsberg T, 2011, BRIT J DERMATOL, V165, P1210, DOI 10.1111/j.1365-2133.2011.10561.x; Hogsberg T, 2013, EXP DERMATOL, V22, P464, DOI 10.1111/exd.12178; Humphries A, 2013, LASER MED SCI, V28, P1107, DOI 10.1007/s10103-012-1198-9; Ibrahimi OA, 2013, JAMA DERMATOL, V149, P241, DOI 10.1001/jamadermatol.2013.2136; Izikson L, 2008, LASER SURG MED, V40, P231, DOI 10.1002/lsm.20618; Jacobsen E, 2012, CHEM SUBSTANCES TATT; Jafari S, 2012, CAN J PUBLIC HEALTH, V103, P207, DOI 10.1007/BF03403814; Kaatz M, 2008, CLIN DERMATOL, V26, P35, DOI 10.1016/j.clindermatol.2007.10.004; Kaur RR, 2009, J COSMET DERMATOL-US, V8, P295, DOI 10.1111/j.1473-2165.2009.00469.x; Kazandjieva J, 2007, CLIN DERMATOL, V25, P375, DOI 10.1016/j.clindermatol.2007.05.012; Kennedy BS, 2012, NEW ENGL J MED, V367, P1020, DOI 10.1056/NEJMoa1205114; Kent KM, 2012, DERMATOL SURG, V38, P1, DOI 10.1111/j.1524-4725.2011.02187.x; KILMER SL, 1993, J DERMATOL SURG ONC, V19, P330, DOI 10.1111/j.1524-4725.1993.tb00354.x; Kim JW, 2006, ACTA DERM-VENEREOL, V86, P110, DOI 10.2340/00015555-0014; Klitzman B., 2000, United States patent, Patent No. [US 6,013,122, 6013122]; Klitzman B, 2013, GERM FED I RISK ASS; Klugl I, 2010, DERMATOLOGY, V221, P43, DOI 10.1159/000292627; Kluger N, 2012, LANCET ONCOL, V13, pE161, DOI 10.1016/S1470-2045(11)70340-0; Kossida T, 2012, J AM ACAD DERMATOL, V66, P271, DOI 10.1016/j.jaad.2011.07.024; Laumann AE, 2006, J AM ACAD DERMATOL, V55, P413, DOI 10.1016/j.jaad.2006.03.026; Lehner K, 2011, J EUR ACAD DERMATOL, V25, P1340, DOI 10.1111/j.1468-3083.2011.03987.x; Lehner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092787; Lehner K, 2011, CONTACT DERMATITIS, V65, P231, DOI 10.1111/j.1600-0536.2011.01947.x; Long T., 2006, Morbidity and Mortality Weekly Report, V55, P677; MADDEN JF, 1949, ARCH DERMATOL SYPH, V60, P789, DOI 10.1001/archderm.1949.01530050151014; MANN R, 1981, ARCH DERMATOL RES, V271, P367, DOI 10.1007/BF00406680; McNichols RJ, 2005, LASER SURG MED, V36, P289, DOI 10.1002/lsm.20152; Mortimer NJ, 2003, CLIN EXP DERMATOL, V28, P508, DOI 10.1046/j.1365-2230.2003.01358.x; New Zealand Environmental Protection Agency, 2011, TATT PERM MAK SUBST; Ortiz AE, 2012, DERMATOL SURG, V38, P1730, DOI 10.1111/j.1524-4725.2012.02560.x; Ostheimer TA, 2014, AM J OPHTHALMOL, V158, P637, DOI 10.1016/j.ajo.2014.05.019; Patzelt Alexa, 2011, Pharmaceutics, V3, P307, DOI 10.3390/pharmaceutics3020307; Reddy KK, 2013, LASER SURG MED, V45, P76, DOI 10.1002/lsm.22106; Regensburger J, 2010, EXP DERMATOL, V19, pE275, DOI 10.1111/j.1600-0625.2010.01068.x; Rodriguez-Blanco I, 2011, ACTA DERM-VENEREOL, V91, P61, DOI 10.2340/00015555-1034; ROOK A J, 1952, Practitioner, V168, P60; Ross EV, 1998, ARCH DERMATOL, V134, P167, DOI 10.1001/archderm.134.2.167; Sepehri M, 2013, EUR C TATT PIGM RES; Serup J, 2014, CONTACT DERMATITIS, V71, P255, DOI 10.1111/cod.12271; SOWDEN JM, 1991, BRIT J DERMATOL, V124, P576, DOI 10.1111/j.1365-2133.1991.tb04954.x; TAAFFE A, 1978, BRIT MED J, V1, P616, DOI 10.1136/bmj.1.6113.616; Thum CK, 2015, AM J DERMATOPATH, V37, P54, DOI 10.1097/DAD.0b013e3182974558; Tohme RA, 2012, CLIN INFECT DIS, V54, P1167, DOI 10.1093/cid/cir991; Twain M, 1889, THE SUN, P4; Vasold R, 2004, PHOTOCHEM PHOTOBIOL, V80, P185, DOI 10.1562/2004-05-17-RA-170.1; Vasold R, 2008, ANAL BIOANAL CHEM, V391, P9, DOI 10.1007/s00216-008-1978-z; Wenzel SM, 2013, DERMATOLOGY, V226, P138, DOI 10.1159/000346943; Wenzel SM, 2010, CONTACT DERMATITIS, V63, P223, DOI 10.1111/j.1600-0536.2010.01799.x; Yazdian-Tehrani H, 2001, BRIT J PLAST SURG, V54, P555, DOI 10.1054/bjps.2001.3640; Zemtsov A, 1997, ACTA DERM-VENEREOL, V77, P497	86	127	127	2	69	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					395	402		10.1016/S0140-6736(15)60215-X	http://dx.doi.org/10.1016/S0140-6736(15)60215-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB4XI	26211826				2022-12-28	WOS:000368516500038
J	Bewtra, M; Newcomb, CW; Wu, QF; Chen, L; Xie, FL; Roy, JA; Aarons, CB; Osterman, MT; Forde, KA; Curtis, JR; Lewis, JD				Bewtra, Meenakshi; Newcomb, Craig W.; Wu, Qufei; Chen, Lang; Xie, Fenglong; Roy, Jason A.; Aarons, Cary B.; Osterman, Mark T.; Forde, Kimberly A.; Curtis, Jeffrey R.; Lewis, James D.			Mortality Associated With Medical Therapy Versus Elective Colectomy in Ulcerative Colitis	ANNALS OF INTERNAL MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; T-CELL LYMPHOMA; QUALITY-OF-LIFE; TERTIARY CARE CENTER; CROHNS-DISEASE; SERIOUS INFECTIONS; RISK; INFLIXIMAB; SURGERY; COMPLICATIONS	Background: Ulcerative colitis (UC) can be treated with surgery or medications. Patients often must choose between long-term immunosuppressant therapy or total colectomy. Whether one of these treatment approaches has a mortality benefit is uncertain. Objective: To determine whether patients with advanced UC treated with elective colectomy have improved survival compared with those treated with medical therapy. Design: Retrospective matched cohort study. Setting: Data from all 50 states for Medicaid beneficiaries (2000 to 2005), Medicare beneficiaries (2006 to 2011), and dualeligible persons (2000 to 2011). Patients: 830 patients with UC pursuing elective colectomy and 7541 matched patients with UC pursuing medical therapy. Measurements: The primary outcome was time to death. Cox proportional hazards models were used to compare the survival of patients with advanced UC treated with elective colectomy or medical therapy. The models controlled for significant comorbid conditions through matched and adjusted analysis. Results: The mortality rates associated with elective surgery and medical therapy were 34 and 54 deaths per 1000 person-years, respectively. Elective colectomy was associated with improved survival compared with long-term medical therapy (adjusted hazard ratio [HR], 0.67 [95% CI, 0.52 to 0.87]), although this result did not remain statistically significant in all sensitivity analyses. Post hoc analysis by age group showed improved survival with surgery in patients aged 50 years or older with advanced UC (HR, 0.60 [CI, 0.45 to 0.79]; P = 0.032 for age-by-treatment interaction). Limitations: Retrospective nonrandomized analysis is subject to residual confounding. The source cohort was derived from different databases throughout the study. Sensitivity and secondary analyses had reduced statistical power. Conclusion: Elective colectomy seemed to be associated with improved survival relative to medical therapy among patients aged 50 years or older with advanced UC.	[Bewtra, Meenakshi; Forde, Kimberly A.; Lewis, James D.] Univ Penn, Dept Gastroenterol, Philadelphia, PA 19104 USA; [Newcomb, Craig W.; Wu, Qufei; Roy, Jason A.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Chen, Lang; Xie, Fenglong; Curtis, Jeffrey R.] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Birmingham	Bewtra, M (corresponding author), Univ Penn, Dept Gastroenterol, 724 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	mbewtra@upenn.edu			National Institutes of Health; Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK078228, K08DK084347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health and Agency for Healthcare Research and Quality.	Alves A, 2003, J AM COLL SURGEONS, V197, P379, DOI 10.1016/S1072-7515(03)00434-4; Ananthakrishnan Ashwin N, 2013, Curr Gastroenterol Rep, V15, P302, DOI 10.1007/s11894-012-0302-4; Arora G, 2010, DIGEST DIS SCI, V55, P1689, DOI 10.1007/s10620-010-1236-z; Bach SP, 2007, WORLD J GASTROENTERO, V13, P3288, DOI 10.3748/wjg.v13.i24.3288; Beigel F, 2009, NAT REV GASTRO HEPAT, V6, P433, DOI 10.1038/nrgastro.2009.87; Bewtra M, 2007, CLIN GASTROENTEROL H, V5, P597, DOI 10.1016/j.cgh.2007.01.015; Bewtra M, 2014, INFLAMM BOWEL DIS, V20, P103, DOI 10.1097/01.MIB.0000437498.14804.50; Bewtra M, 2012, GASTROENTEROLOGY, V142, pS794; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2004, GASTROENTEROLOGY, V126, P19, DOI 10.1053/j.gastro.2003.10.047; Davies RJ, 2008, DIS COLON RECTUM, V51, P1032, DOI 10.1007/s10350-008-9248-x; FAZIO VW, 1995, ANN SURG, V222, P120, DOI 10.1097/00000658-199508000-00003; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Gross R, 2008, PHARMACOEPIDEM DR S, V17, P1029, DOI 10.1002/pds.1606; Harrell LE, 2004, GASTROENTEROL CLIN N, V33, P303, DOI 10.1016/j.gtc.2004.02.010; Hennessy S, 2007, MED CARE, V45, P1216, DOI 10.1097/MLR.0b013e318148435a; Kandiel A, 2005, GUT, V54, P1121, DOI 10.1136/gut.2004.049460; Kaplan GG, 2008, GASTROENTEROLOGY, V134, P680, DOI 10.1053/j.gastro.2008.01.004; Lewis JD, 2008, AM J GASTROENTEROL, V103, P1428, DOI 10.1111/j.1572-0241.2008.01836.x; Lichtenstein GR, 2006, CLIN GASTROENTEROL H, V4, P621, DOI 10.1016/j.cgh.2006.03.002; Lichtenstein GR, 2008, AM J GASTROENTEROL, V103, pP14; Mackey AC, 2009, J PEDIATR GASTR NUTR, V48, P386, DOI 10.1097/MPG.0b013e3181957a11; McLeod RS, 1998, WORLD J SURG, V22, P375, DOI 10.1007/s002689900400; Michelassi F, 2003, ANN SURG, V238, P433, DOI 10.1097/01.sla.0000086658.60555.ea; Nicholls RJ, 2010, ALIMENT PHARM THER, V31, P1310, DOI 10.1111/j.1365-2036.2010.04302.x; Ochenrider MG, 2010, CL LYMPH MYELOM LEUK, V10, P144, DOI 10.3816/CLML.2010.n.021; Osterman MT, 2014, CLIN GASTROENTEROL H, V12, P811, DOI 10.1016/j.cgh.2013.06.010; Pal S, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-39; Ravakhah K, 2006, SOUTH MED J, V99, P728, DOI 10.1097/01.smj.0000224337.77074.57; Roberts SE, 2007, BMJ-BRIT MED J, V335, P1033, DOI 10.1136/bmj.39345.714039.55; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sagar PM, 2012, BRIT J SURG, V99, P454, DOI 10.1002/bjs.8697; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Scott FI, 2015, CLIN GASTROENTEROL H, V13, P302, DOI 10.1016/j.cgh.2014.07.058; Siegel CA, 2009, CLIN GASTROENTEROL H, V7, P874, DOI 10.1016/j.cgh.2009.01.004; Su CY, 2007, GASTROENTEROLOGY, V132, P516, DOI 10.1053/j.gastro.2006.12.037; Timmer A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub3; Toruner M, 2008, GASTROENTEROLOGY, V134, P929, DOI 10.1053/j.gastro.2008.01.012; Waljee AK, 2011, AM J GASTROENTEROL, V106, P794, DOI 10.1038/ajg.2011.39; Wexelman BA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120288; Winthrop KL, 2013, JAMA-J AM MED ASSOC, V309, P887, DOI 10.1001/jama.2013.1099	42	28	29	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					262	+		10.7326/M14-0960	http://dx.doi.org/10.7326/M14-0960			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0LC	26168366	Green Accepted			2022-12-28	WOS:000360286400004
J	Lu, L; Wang, ZY; Ye, DX; Ran, LX; Fu, L; Joannopoulos, JD; Soljacic, M				Lu, Ling; Wang, Zhiyu; Ye, Dexin; Ran, Lixin; Fu, Liang; Joannopoulos, John D.; Soljacic, Marin			Experimental observation of Weyl points	SCIENCE			English	Article							3-DIMENSIONAL PHOTONIC CRYSTALS; SURFACE FERMI ARCS; BAND-STRUCTURE; TRANSITION; SEMIMETALS; STATES	The massless solutions to the Dirac equation are described by the so-called Weyl Hamiltonian. The Weyl equation requires a particle to have linear dispersion in all three dimensions while being doubly degenerate at a single momentum point. These Weyl points are topological monopoles of quantized Berry flux exhibiting numerous unusual properties. We performed angle-resolved microwave transmission measurements through a double-gyroid photonic crystal with inversion-breaking where Weyl points have been theoretically predicted to occur. The excited bulk states show two linear dispersion bands touching at four isolated points in the three-dimensional Brillouin zone, indicating the observation of Weyl points. This work paves the way to a variety of photonic topological phenomena in three dimensions.	[Lu, Ling; Fu, Liang; Joannopoulos, John D.; Soljacic, Marin] MIT, Dept Phys, Cambridge, MA 02139 USA; [Wang, Zhiyu; Ye, Dexin; Ran, Lixin] Zhejiang Univ, Lab Appl Res Electromagnet ARE, Hangzhou 310027, Zhejiang, Peoples R China	Massachusetts Institute of Technology (MIT); Zhejiang University	Lu, L (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	linglu@mit.edu	Joannopoulos, John D/E-6401-2013; Lu, Ling/E-1324-2017; Soljacic, Marin/AAA-4868-2019		U.S. Army Research Office through the Institute for Soldier Nanotechnologies [W911NF-13-D-0001]; U.S. Department of Energy (DOE) Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0010526]; Materials Research Science and Engineering Center Program of the NSF [DMR-1419807]; MIT Solid-State Solar-Thermal Energy Conversion Center; Energy Frontier Research Center of DOE [DE-SC0001299]; Chinese National Science Foundation (CNSF) [61401395, 61401393, 61131002]	U.S. Army Research Office through the Institute for Soldier Nanotechnologies; U.S. Department of Energy (DOE) Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Materials Research Science and Engineering Center Program of the NSF(National Science Foundation (NSF)); MIT Solid-State Solar-Thermal Energy Conversion Center; Energy Frontier Research Center of DOE; Chinese National Science Foundation (CNSF)(National Natural Science Foundation of China (NSFC))	We thank A. Gallant and E. Johnson at the MIT central machine shop for machining the gyroid layers; Y. Shen, B. Zhang, J. Liu, B. Zhen, B. Wang, A. Vishwanath, H. Chen, Q. Yan, and C. Fang for discussions; and P. Rebusco for critical reading and editing of the manuscript. J.D.J. was supported in part by the U.S. Army Research Office through the Institute for Soldier Nanotechnologies under contract W911NF-13-D-0001. L.F. was supported by the U.S. Department of Energy (DOE) Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, under award DE-SC0010526. L.L. was supported in part by the Materials Research Science and Engineering Center Program of the NSF under award DMR-1419807. M.S. and L.L. (analysis and reading of the manuscript) were supported in part by the MIT Solid-State Solar-Thermal Energy Conversion Center and Energy Frontier Research Center of DOE under grant DE-SC0001299. Z.W, D. Y., and L.R. were supported by the Chinese National Science Foundation (CNSF) under grants 61401395, 61401393, and 61131002, respectively.	ABRIKOSOV AA, 1971, SOV PHYS JETP-USSR, V32, P699; Bulmash D, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.081106; Chua SL, 2014, OPT LETT, V39, P2072, DOI 10.1364/OL.39.002072; Crossland EJW, 2009, NANO LETT, V9, P2807, DOI 10.1021/nl803174p; Fu LA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.106802; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Herring C, 1937, PHYS REV, V52, P0365, DOI 10.1103/PhysRev.52.365; Hosur P, 2013, CR PHYS, V14, P857, DOI 10.1016/j.crhy.2013.10.010; Hosur P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.046602; Huang SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8373; Liu JP, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155316; Liu ZK, 2014, SCIENCE, V343, P864, DOI 10.1126/science.1245085; Lu L., 2015, ARXIV150700337; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI [10.1038/nphoton.2014.248, 10.1038/NPHOTON.2014.248]; Lu L, 2013, NAT PHOTONICS, V7, P294, DOI [10.1038/nphoton.2013.42, 10.1038/NPHOTON.2013.42]; Lu L, 2012, OPT LETT, V37, P4726, DOI 10.1364/OL.37.004726; Murakami S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/9/356; NIELSEN HB, 1983, PHYS LETT B, V130, P389, DOI 10.1016/0370-2693(83)91529-0; OZBAY E, 1994, PHYS REV B, V50, P1945, DOI 10.1103/PhysRevB.50.1945; Potter AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6161; Pouya C, 2012, INTERFACE FOCUS, V2, P645, DOI 10.1098/rsfs.2011.0091; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; ROBERTSON WM, 1992, PHYS REV LETT, V68, P2023, DOI 10.1103/PhysRevLett.68.2023; Shen YC, 2014, SCIENCE, V343, P1499, DOI 10.1126/science.1249799; Takahashi S, 2009, NAT MATER, V8, P721, DOI [10.1038/nmat2507, 10.1038/NMAT2507]; Turner A. M., 2013, TOPOLOGICAL INSULATO, P293; Turner MD, 2013, NAT PHOTONICS, V7, P801, DOI [10.1038/NPHOTON.2013.233, 10.1038/nphoton.2013.233]; Turner MD, 2011, OPT EXPRESS, V19, P10001, DOI 10.1364/OE.19.010001; Volovik G. E., 2009, UNIVERSE HELIUM DROP; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; Weng HM, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.011029; Weyl H, 1929, Z PHYS, V56, P330, DOI 10.1007/BF01339504; Xu G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.186806; YABLONOVITCH E, 1991, PHYS REV LETT, V67, P2295, DOI 10.1103/PhysRevLett.67.2295; Yang KY, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075129; Young SM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140405	39	705	712	10	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2015	349	6248					622	624		10.1126/science.aaa9273	http://dx.doi.org/10.1126/science.aaa9273			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WW	26184914	Green Submitted			2022-12-28	WOS:000359092900036
J	Bosch, R; van de Pol, M; Philp, J				Bosch, Roeland; van de Pol, Mattheus; Philp, Jim			Policy: Define biomass sustainability	NATURE			English	Editorial Material							BIOENERGY		[Bosch, Roeland; van de Pol, Mattheus] Minist Econ Affairs, Unit Green Growth & Biobased Econ, The Hague, Netherlands; Org Econ Cooperat & Dev, Paris, France	Organisation for Economic Co-operation & Development (OECD)		james.philp@oecd.org						Biookonomierat, 2015, BIOECONOMY POLICY SY; European Commission, 2012, COM20120494 EUR COMM; Food and Agriculture Organization of the United Nations, 2009, STAT FOOD AGR LIV BA; Lu YL, 2015, NATURE, V520, P432, DOI 10.1038/520432a; Obidzinski K, 2012, ECOL SOC, V17, DOI 10.5751/ES-04775-170125; Organisation for Economic Co-operation and Development, 2010, OECDS PROD SUPP EST; Scarlat N, 2013, RENEW ENERG, V57, P448, DOI 10.1016/j.renene.2013.01.014; Singh R, 2013, NATURE, V500, P340, DOI 10.1038/nature12356; van Dam J, 2011, ENERG POLICY, V39, P4051, DOI 10.1016/j.enpol.2011.03.022; White House, 2012, NAT BIOEC BLUEPR	10	35	35	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					526	527		10.1038/523526a	http://dx.doi.org/10.1038/523526a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26223612	Bronze			2022-12-28	WOS:000358655200014
J	Bauchner, H				Bauchner, Howard			Medicare and Medicaid, the Affordable Care Act, and US Health Policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									JAMA, Chicago, IL 60611 USA		Bauchner, H (corresponding author), JAMA, 330 North Wabash Ave, Chicago, IL 60611 USA.	howard.bauchner@jamanetwork.org						Altman D, 2015, JAMA-J AM MED ASSOC, V314, P384, DOI 10.1001/jama.2015.7811; Bindman AB, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2015.8209, DOI 10.1001/JAMA.2015.8209]; Boozary AS, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2015.6507, DOI 10.1001/JAMA.2015.6507]; Butler SM, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2015.7153, DOI 10.1001/JAMA.2015.7153]; Clough JD, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2015.8047, DOI 10.1001/JAMA.2015.8047]; Cutler D, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2015.7683, DOI 10.1001/JAMA.2015.7683]; Gostin LO, 2015, JAMA-J AM MED ASSOC, V314, P333, DOI 10.1001/jama.2015.8673; Hwang A, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2015.8211, DOI 10.1001/JAMA.2015.8211]; Krumholz HM, 2015, JAMA-J AM MED ASSOC, V314, P355, DOI 10.1001/jama.2015.8035; Mann C, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2015.8433, DOI 10.1001/JAMA.2015.8433]; Rajaram R, 2015, JAMA-J AM MED ASSOC, V314, P375, DOI 10.1001/jama.2015.8609; Sommers BD, 2015, JAMA-J AM MED ASSOC, V314, P366, DOI 10.1001/jama.2015.8421; Wilensky GR, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2015.5468, DOI 10.1001/JAMA.2015.5468]	13	4	4	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					353	354		10.1001/jama.2015.8587	http://dx.doi.org/10.1001/jama.2015.8587			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219052				2022-12-28	WOS:000358581700016
J	Krumholz, HM; Nuti, SV; Downing, NS; Normand, SLT; Wang, Y				Krumholz, Harlan M.; Nuti, Sudhakar V.; Downing, Nicholas S.; Normand, Sharon-Lise T.; Wang, Yun			Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; HEART-FAILURE; AIR-POLLUTION; TRENDS; RATES; PERFORMANCE; BENEFICIARIES; STATES	IMPORTANCE In a period of dynamic change in health care technology, delivery, and behaviors, tracking trends in health and health care can provide a perspective on what is being achieved. OBJECTIVE To comprehensively describe national trends in mortality, hospitalizations, and expenditures in the Medicare fee-for-service population between 1999 and 2013. DESIGN, SETTING, AND PARTICIPANTS Serial cross-sectional analysis of Medicare beneficiaries aged 65 years or older between 1999 and 2013 using Medicare denominator and inpatient files. MAIN OUTCOMES AND MEASURES For all Medicare beneficiaries, trends in all-cause mortality; for fee-for-service beneficiaries, trends in all-cause hospitalization and hospitalization-associated outcomes and expenditures. Geographic variation, stratified by key demographic groups, and changes in the intensity of care for fee-for-service beneficiaries in the last 1, 3, and 6 months of life were also assessed. RESULTS The sample consisted of 68 374 904 unique Medicare beneficiaries (fee-for-service and Medicare Advantage). All-cause mortality for all Medicare beneficiaries declined from 5.30% in 1999 to 4.45% in 2013 (difference, 0.85 percentage points; 95% CI, 0.83-0.87). Among fee-for-service beneficiaries (n = 60 056 069), the total number of hospitalizations per 100 000 person-years decreased from 35 274 to 26 930 (difference, 8344; 95% CI, 8315-8374). Mean inflation-adjusted inpatient expenditures per Medicare fee-for-service beneficiary declined from $3290 to $2801 (difference, $489; 95% CI, $487-$490). Among fee-for-service beneficiaries in the last 6 months of life, the number of hospitalizations decreased from 131.1 to 102.9 per 100 deaths (difference, 28.2; 95% CI, 27.9-28.4). The percentage of beneficiaries with 1 or more hospitalizations decreased from 70.5 to 56.8 per 100 deaths (difference, 13.7; 95% CI, 13.5-13.8), while the inflation-adjusted inpatient expenditure per death increased from $15 312 in 1999 to $17 423 in 2009 and then decreased to $13 388 in 2013. Findings were consistent across geographic and demographic groups. CONCLUSIONS AND RELEVANCE Among Medicare fee-for-service beneficiaries aged 65 years or older, all-cause mortality rates, hospitalization rates, and expenditures per beneficiary decreased from 1999 to 2013. In the last 6 months of life, total hospitalizations and inpatient expenditures decreased in recent years.	[Krumholz, Harlan M.; Nuti, Sudhakar V.; Downing, Nicholas S.] Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Hlth Policy & Management, New Haven, CT 06510 USA; [Krumholz, Harlan M.; Nuti, Sudhakar V.; Downing, Nicholas S.; Wang, Yun] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Normand, Sharon-Lise T.; Wang, Yun] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Normand, Sharon-Lise/0000-0001-7027-4769	National Heart, Lung, and Blood Institute [UO1 HL105270-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Krumholz is supported by grant UO1 HL105270-05 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute.	Boccuti C, 2013, MED PATIENTS ACCESS; Chen J, 2013, J AM COLL CARDIOL, V61, P1078, DOI 10.1016/j.jacc.2012.11.057; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Correia AW, 2013, EPIDEMIOLOGY, V24, P23, DOI 10.1097/EDE.0b013e3182770237; Costante PA, 1999, NEW ENGL J MED, V96, P47; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Dowd B, 2011, HEALTH ECON, V20, P645, DOI 10.1002/hec.1623; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Field MJ, 1997, APPROACHING DEATH IM; Fisher ES, 2013, TRACKING IMPROVEMENT, P7; Institute of Medicine, 2014, DYING AM IMPR QUAL H; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; Kesselheim AS, 2013, NAT REV DRUG DISCOV, V12, P425, DOI 10.1038/nrd3977; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Krumholz HM, 2014, CIRCULATION, V130, P966, DOI 10.1161/CIRCULATIONAHA.113.007787; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Larson James S, 2002, J Health Hum Serv Adm, V25, P261; Lee KY, 2000, HLTH SERVICES OUTCOM, V1, P63; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Masoudi FA, 2006, CIRCULATION, V114, P2806, DOI 10.1161/CIRCULATIONAHA.106.611707; Newhouse JP, 2012, HEALTH AFFAIR, V31, P2618, DOI 10.1377/hlthaff.2012.0345; Nicholas Lauren Hersch, 2013, Forum Health Econ Policy, V16, P137; Normand SLT, 2007, HEALTH SERV OUTCOME, V7, P79, DOI 10.1007/s10742-006-0018-8; Nuti SV, 2015, MED CARE, V53, P485, DOI 10.1097/MLR.0000000000000358; Sawin CT, 2004, DIABETES CARE, V27, pB90, DOI 10.2337/diacare.27.suppl_2.B90; Wennberg JE, 2008, TRACKING CARE PATIEN	29	112	112	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					355	365		10.1001/jama.2015.8035	http://dx.doi.org/10.1001/jama.2015.8035			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219053	Bronze, Green Accepted			2022-12-28	WOS:000358581700017
J	Ginther, DK; Kahn, S				Ginther, Donna K.; Kahn, Shulamit			Comment on "Expectations of brilliance underlie gender distributions across academic disciplines"	SCIENCE			English	Editorial Material							SCIENCE; MATHEMATICS	Leslie et al. (Reports, 16 January 2015, p. 262) concluded that "expectations of brilliance" explained the gender makeup of academic disciplines. We reestimated their models after adding measures of disaggregated Graduate Record Examination scores by field. Our results indicated that female representation among Ph.D. recipients is associated with the field's mathematical content and that faculty beliefs about innate ability were irrelevant.	[Ginther, Donna K.] Univ Kansas, Inst Policy & Social Res, Dept Econ, Ctr Sci Technol & Econ Policy, Lawrence, KS 66045 USA; [Ginther, Donna K.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Kahn, Shulamit] Boston Univ, Questrom Sch Business, Boston, MA 02215 USA	University of Kansas; National Bureau of Economic Research; Boston University	Ginther, DK (corresponding author), Univ Kansas, Inst Policy & Social Res, Dept Econ, Ctr Sci Technol & Econ Policy, Lawrence, KS 66045 USA.	dginther@ku.edu	Ginther, Donna/W-9055-2019; Ginther, Donna K/F-7317-2016	Ginther, Donna/0000-0002-0881-7969; Ginther, Donna K/0000-0002-0881-7969	NIA NIH HHS [1R01AG36820-01, R01 AG036820] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG036820] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bages C, 2011, BRIT J SOC PSYCHOL, V50, P536, DOI 10.1111/j.2044-8309.2010.02017.x; Ceci SJ, 2014, PSYCHOL SCI PUBL INT, V15, P75, DOI 10.1177/1529100614541236; Educational Testing Service, 2013, GRE GUID US SCOR; Good C, 2003, J APPL DEV PSYCHOL, V24, P645, DOI 10.1016/j.appdev.2003.09.002; Lavy V, 2015, 20909 NAT BUR EC RES; Leslie SJ, 2015, SCIENCE, V347, P262, DOI 10.1126/science.1261375; Lubinski D, 2006, PERSPECT PSYCHOL SCI, V1, P316, DOI 10.1111/j.1745-6916.2006.00019.x; Wang MT, 2013, PSYCHOL SCI, V24, P770, DOI 10.1177/0956797612458937	8	9	9	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246								10.1126/science.aaa9632	http://dx.doi.org/10.1126/science.aaa9632			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN4DX	26206926				2022-12-28	WOS:000358381400032
J	Lo, B; Zhang, KJ; Lu, W; Zheng, LX; Zhang, Q; Kanellopoulou, C; Zhang, Y; Liu, ZD; Fritz, JM; Marsh, R; Husami, A; Kissell, D; Nortman, S; Chaturvedi, V; Haines, H; Young, LR; Mo, J; Filipovich, AH; Bleesing, JJ; Mustillo, P; Stephens, M; Rueda, CM; Chougnet, CA; Hoebe, K; McElwee, J; Hughes, JD; Karakoc-Aydiner, E; Matthews, HF; Price, S; Su, HC; Rao, VK; Lenardo, MJ; Jordan, MB				Lo, Bernice; Zhang, Kejian; Lu, Wei; Zheng, Lixin; Zhang, Qian; Kanellopoulou, Chrysi; Zhang, Yu; Liu, Zhiduo; Fritz, Jill M.; Marsh, Rebecca; Husami, Ammar; Kissell, Diane; Nortman, Shannon; Chaturvedi, Vijaya; Haines, Hilary; Young, Lisa R.; Mo, Jun; Filipovich, Alexandra H.; Bleesing, Jack J.; Mustillo, Peter; Stephens, Michael; Rueda, Cesar M.; Chougnet, Claire A.; Hoebe, Kasper; McElwee, Joshua; Hughes, Jason D.; Karakoc-Aydiner, Elif; Matthews, Helen F.; Price, Susan; Su, Helen C.; Rao, V. Koneti; Lenardo, Michael J.; Jordan, Michael B.			Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy	SCIENCE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; REGULATORY T-CELLS; LONG-TERM SAFETY; RHEUMATOID-ARTHRITIS; MUTATIONS; ACTIVATION; DISORDERS; DISEASE; GENE; LYMPHOPROLIFERATION	Mutations in the LRBA gene (encoding the lipopolysaccharide-responsive and beige-like anchor protein) cause a syndrome of autoimmunity, lymphoproliferation, and humoral immune deficiency. The biological role of LRBA in immunologic disease is unknown. We found that patients with LRBA deficiency manifested a dramatic and sustained improvement in response to abatacept, a CTLA4 (cytotoxic T lymphocyte antigen-4)-immunoglobulin fusion drug. Clinical responses and homology of LRBA to proteins controlling intracellular trafficking led us to hypothesize that it regulates CTLA4, a potent inhibitory immune receptor. We found that LRBA colocalized with CTLA4 in endosomal vesicles and that LRBA deficiency or knockdown increased CTLA4 turnover, which resulted in reduced levels of CTLA4 protein in FoxP3(+) regulatory and activated conventional Tcells. In LRBA-deficient cells, inhibition of lysosome degradation with chloroquine prevented CTLA4 loss. These findings elucidate a mechanism for CTLA4 trafficking and control of immune responses and suggest therapies for diseases involving the CTLA4 pathway.	[Lo, Bernice; Lu, Wei; Zheng, Lixin; Kanellopoulou, Chrysi; Fritz, Jill M.; Matthews, Helen F.; Price, Susan; Rao, V. Koneti; Lenardo, Michael J.] NIAID, Mol Dev Immune Syst Sect, NIH, Bethesda, MD 20892 USA; [Lo, Bernice; Lu, Wei; Zheng, Lixin; Kanellopoulou, Chrysi; Fritz, Jill M.; Matthews, Helen F.; Price, Susan; Rao, V. Koneti; Lenardo, Michael J.] NIAID, Clin & Mol Genom Unit, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Lo, Bernice; Lu, Wei; Zheng, Lixin; Zhang, Qian; Kanellopoulou, Chrysi; Zhang, Yu; Fritz, Jill M.; Matthews, Helen F.; Price, Susan; Su, Helen C.; Rao, V. Koneti; Lenardo, Michael J.] NIAID, NIAID Clin Genom Program, NIH, Bethesda, MD 20892 USA; [Zhang, Kejian; Husami, Ammar; Kissell, Diane; Nortman, Shannon] Univ Cincinnati, Dept Pediat, Div Human Genet, Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH USA; [Zhang, Qian; Zhang, Yu; Su, Helen C.] NIAID, Human Immunol Dis Unit, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Liu, Zhiduo] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Marsh, Rebecca; Chaturvedi, Vijaya; Filipovich, Alexandra H.; Bleesing, Jack J.; Jordan, Michael B.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Dept Pediat, Cincinnati, OH 45220 USA; [Haines, Hilary] Univ Alabama Birmingham, Div Pediat Hematol & Oncol, Dept Pediat, Birmingham, AL USA; [Young, Lisa R.] Vanderbilt Univ, Sch Med, Div Allergy Immunol & Pulm Med, Dept Pediat, Nashville, TN 37212 USA; [Young, Lisa R.] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care, Dept Med, Nashville, TN 37212 USA; [Mo, Jun] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Mo, Jun] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Mo, Jun] Rady Childrens Hosp, San Diego, CA USA; [Mustillo, Peter] Nationwide Childrens Hosp, Sect Allergy & Immunol, Columbus, OH USA; [Stephens, Michael] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA; [Rueda, Cesar M.; Chougnet, Claire A.; Hoebe, Kasper; Jordan, Michael B.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH USA; [McElwee, Joshua; Hughes, Jason D.] Merck & Co Inc, Merck Res Labs, Boston, MA USA; [Karakoc-Aydiner, Elif] Marmara Univ, Div Pediat Allergy & Immunol, Istanbul, Turkey	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham; Vanderbilt University; Vanderbilt University; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Mayo Clinic; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Merck & Company; Marmara University	Jordan, MB (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Dept Pediat, Cincinnati, OH 45220 USA.	michael.jordan@cchmc.org	zhang, ke/AAH-8217-2019; Rao, V. Koneti/AAR-2171-2020; Su, Helen C/H-9541-2015; Lo, Bernice/H-7538-2017; Husami, Ammar/K-7777-2012	Rao, V. Koneti/0000-0002-7881-6902; Su, Helen C/0000-0002-5582-9110; Lo, Bernice/0000-0002-1087-6845; Husami, Ammar/0000-0002-4287-2857; Zhang, Qian/0000-0002-9040-3289	American Society of Hematology Bridge award; Cincinnati Children's Hospital Medical Center Gap Award; Divisional Funds from Immunobiology and Bone Marrow Transplantation and Immune Deficiency; Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), NIH; Merck, Inc.; NIH [1RC2 HG005608]; Division of Intramural Research, NIAID, NIH [1ZIAAI000769-14]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000769, ZIAAI001059, ZIAAI000732] Funding Source: NIH RePORTER	American Society of Hematology Bridge award; Cincinnati Children's Hospital Medical Center Gap Award; Divisional Funds from Immunobiology and Bone Marrow Transplantation and Immune Deficiency; Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), NIH; Merck, Inc.(Merck & Company); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Sills for patient referrals and collaborative patient care; J. Davis, E. Smoot, and M. Similuk for clinical support; E. Jaffe and K. Dunleavy for help with diagnosis and management of lymphoma; J. Tabacof for patient care; I. Barlan and A. Ozen for patient referrals; S. Ganesan, A. Morawski, and K. Lampe for technical assistance; and C. Lucas for advice. Supported by an American Society of Hematology Bridge award, the Cincinnati Children's Hospital Medical Center Gap Award, and Divisional Funds from Immunobiology and Bone Marrow Transplantation and Immune Deficiency, as well as the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), NIH, and Merck, Inc. The Next Generation Mendelian Genetics project support was provided by NIH grant 1RC2 HG005608 to D. Nickerson, J. Shendure, M. Bamshad, and W. Raskind. The Autoimmune Lymphoproliferative Syndrome project is also supported through the Division of Intramural Research, NIAID, NIH, under project 1ZIAAI000769-14. The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	Alangari A, 2012, J ALLERGY CLIN IMMUN, V130, P481, DOI 10.1016/j.jaci.2012.05.043; Atzeni F, 2013, AUTOIMMUN REV, V12, P1115, DOI 10.1016/j.autrev.2013.06.011; Bates CA, 2004, J ALLERGY CLIN IMMUN, V114, P415, DOI 10.1016/j.jaci.2004.05.057; Burns SO, 2012, J ALLERGY CLIN IMMUN, V130, P1428, DOI 10.1016/j.jaci.2012.07.035; Chakrabarti LA, 2014, AIDS, V28, P1593, DOI 10.1097/QAD.0000000000000311; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Chapel H, 2009, BRIT J HAEMATOL, V145, P709, DOI 10.1111/j.1365-2141.2009.07669.x; Charbonnier LM, 2015, J ALLERGY CLIN IMMUN, V135, P217, DOI 10.1016/j.jaci.2014.10.019; Chase NM, 2013, J CLIN IMMUNOL, V33, P30, DOI 10.1007/s10875-012-9755-3; Costedoat-Chalumeau N, 2014, PRESSE MED, V43, pE167, DOI 10.1016/j.lpm.2014.03.007; Cunningham-Rundles C, 2012, HEMATOL-AM SOC HEMAT, P301, DOI 10.1182/asheducation-2012.1.301; de Souza N, 2007, DEVELOPMENT, V134, P691, DOI 10.1242/dev.02767; Gebauer D, 2004, BIOCHEMISTRY-US, V43, P14873, DOI 10.1021/bi049498y; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Kremer JM, 2011, ANN RHEUM DIS, V70, P1826, DOI 10.1136/ard.2010.139345; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Lopez-Herrera G, 2012, AM J HUM GENET, V90, P986, DOI 10.1016/j.ajhg.2012.04.015; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Qureshi OS, 2012, J BIOL CHEM, V287, P9429, DOI 10.1074/jbc.M111.304329; Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945; Schneider H, 1999, J IMMUNOL, V163, P1868; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wang JW, 2001, J IMMUNOL, V166, P4586, DOI 10.4049/jimmunol.166.7.4586; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Westhovens R, 2009, J RHEUMATOL, V36, P736, DOI 10.3899/jrheum.080813; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Wojciechowski D, 2012, CURR OPIN ORGAN TRAN, V17, P640, DOI 10.1097/MOT.0b013e32835a4c0d; Wolchok JD, 2013, ANN NY ACAD SCI, V1291, P1, DOI 10.1111/nyas.12180; Woodward JM, 2015, AM J GASTROENTEROL, V110, P320, DOI 10.1038/ajg.2014.432	33	398	416	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					436	440		10.1126/science.aaa1663	http://dx.doi.org/10.1126/science.aaa1663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206937				2022-12-28	WOS:000358381400045
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION How to read a forest plot in a meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Ford Alexander C, 2014, BMJ, V348, pg3174, DOI 10.1136/bmj.g3174; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2931; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1435; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f4040; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4960	5	25	25	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2015	351								h4028	10.1136/bmj.h4028	http://dx.doi.org/10.1136/bmj.h4028			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8HZ	26208517				2022-12-28	WOS:000358682400002
J	von Filseck, JM; Copic, A; Delfosse, V; Vanni, S; Jackson, CL; Bourguet, W; Drin, G				von Filseck, Joachim Moser; Copic, Alenka; Delfosse, Vanessa; Vanni, Stefano; Jackson, Catherine L.; Bourguet, William; Drin, Guillaume			Phosphatidylserine transport by ORP/Osh proteins is driven by phosphatidylinositol 4-phosphate	SCIENCE			English	Article							OXYSTEROL-BINDING PROTEINS; SAC1 LIPID PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; METABOLISM; PHOSPHOINOSITIDES; LOCALIZATION; TRAFFICKING; SPECIFICITY; MECHANISM	In eukaryotic cells, phosphatidylserine (PS) is synthesized in the endoplasmic reticulum (ER) but is highly enriched in the plasma membrane (PM), where it contributes negative charge and to specific recruitment of signaling proteins. This distribution relies on transport mechanisms whose nature remains elusive. Here, we found that the PS transporter Osh6p extracted phosphatidylinositol 4-phosphate (PI4P) and exchanged PS for PI4P between two membranes. We solved the crystal structure of Osh6p: PI4P complex and demonstrated that the transport of PS by Osh6p depends on PI4P recognition in vivo. Finally, we showed that the PI4P-phosphatase Sac1p, by maintaining a PI4P gradient at the ER/PM interface, drove PS transport. Thus, PS transport by oxysterol-binding protein-related protein (ORP)/oxysterol-binding homology (Osh) proteins is fueled by PI4P metabolism through PS/PI4P exchange cycles.	[von Filseck, Joachim Moser; Vanni, Stefano; Drin, Guillaume] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Copic, Alenka; Jackson, Catherine L.] Univ Paris Diderot, Inst Jacques Monod, CNRS, Sorbonne Paris Cite,UMR 7592, F-75013 Paris, France; [Delfosse, Vanessa; Bourguet, William] INSERM, U1054, F-34090 Montpellier, France; [Delfosse, Vanessa; Bourguet, William] Ctr Biochim Struct, CNRS, UMR5048, F-34090 Montpellier, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Drin, G (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	drin@ipmc.cnrs.fr	Vanni, Stefano/D-6414-2011; Bourguet, William/I-5569-2013; Vanni, Stefano/AAO-3144-2020; Jackson, Catherine/T-5688-2019; Bourguet, William/Y-6600-2019	Vanni, Stefano/0000-0003-2146-1140; Bourguet, William/0000-0002-0643-7719; Vanni, Stefano/0000-0003-2146-1140; Bourguet, William/0000-0002-0643-7719; Copic, Alenka/0000-0003-0166-7731; DRIN, Guillaume/0000-0002-3484-4581; Moser von Filseck, Joachim/0000-0001-9118-2986; Delfosse, Vanessa/0000-0002-7436-7935; Jackson, Catherine/0000-0002-0843-145X	CNRS; Agence Nationale de la Recherche [ANR-2010-1503-01]; European Research Council (ERC) [268888]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Marie Curie Grant [6319977]; ERC	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council (ERC)(European Research Council (ERC)European Commission); French Infrastructure for Integrated Structural Biology (FRISBI); Marie Curie Grant(European Commission); ERC(European Research Council (ERC)European Commission)	We thank B. Antonny, M. Dauvois, M. de Saint-Jean, L. d'Esposito, K. Eudes, C. La Torre, N. Leroudier, S. Leon, the staff of the European Synchrotron Radiation Facility (Grenoble, France), and the imaging facility of the Institut Jacques Monod (ImagoSeine) for help. This work was supported by the CNRS, the Agence Nationale de la Recherche (ANR-2010-1503-01), the European Research Council (ERC advanced grant 268888), the French Infrastructure for Integrated Structural Biology (FRISBI, ANR-10-INSB-05-01), and a Marie Curie Grant to A.C. (6319977). J.M.v.F. was supported by the ERC. Osh6p-PI4P structure is available under the Protein Data Bank code 4PH7.	Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drin G, 2014, ANNU REV BIOCHEM, V83, P51, DOI 10.1146/annurev-biochem-060713-035307; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Foti M, 2001, MOL BIOL CELL, V12, P2396, DOI 10.1091/mbc.12.8.2396; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Ridgway ND, 2010, SUBCELL BIOCHEM, V51, P159, DOI 10.1007/978-90-481-8622-8_6; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Tani M, 2014, YEAST, V31, P145, DOI 10.1002/yea.3004; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; von Filseck JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7671; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	27	217	223	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					432	436		10.1126/science.aab1346	http://dx.doi.org/10.1126/science.aab1346			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206936	Green Submitted			2022-12-28	WOS:000358381400044
J	Gerstein, NS; Deriy, LB				Gerstein, Neal S.; Deriy, Lev B.			Neck Impalement during Mountain Biking	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gerstein, Neal S.; Deriy, Lev B.] Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Gerstein, NS (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.	ngerstein@gmail.com							0	1	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					366	366		10.1056/NEJMicm1412571	http://dx.doi.org/10.1056/NEJMicm1412571			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3NL	26200982				2022-12-28	WOS:000358333500010
J	Kropff, E; Carmichael, JE; Moser, MB; Moser, EI				Kropff, Emilio; Carmichael, James E.; Moser, May-Britt; Moser, Edvard I.			Speed cells in the medial entorhinal cortex	NATURE			English	Article							GEOMETRIC BORDERS; PATH-INTEGRATION; PLACE CELLS; GRID CELLS; REPRESENTATION; INTERFERENCE; POSITION; THETA; MODEL; OSCILLATIONS	Grid cells in the medial entorhinal cortex have spatial firing fields that repeat periodically in a hexagonal pattern. When animals move, activity is translated between grid cells in accordance with the animal's displacement in the environment. For this translation to occur, grid cells must have continuous access to information about instantaneous running speed. However, a powerful entorhinal speed signal has not been identified. Here we show that running speed is represented in the firing rate of a ubiquitous but functionally dedicated population of entorhinal neurons distinct from other cell populations of the local circuit, such as grid, head-direction and border cells. These 'speed cells' are characterized by a context-invariant positive, linear response to running speed, and share with grid cells a prospective bias of 50-80ms. Our observations point to speed cells as a key component of the dynamic representation of self-location in the medial entorhinal cortex.	[Kropff, Emilio; Carmichael, James E.; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, N-7491 Trondheim, Norway; [Kropff, Emilio; Carmichael, James E.; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Neural Computat, MTFS, N-7491 Trondheim, Norway; [Kropff, Emilio] Consejo Nacl Invest Cient & Tecn, Leloir Inst, IIBBA, RA-1033 Buenos Aires, DF, Argentina	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Kropff, E (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, Olav Kyrres Gate 9, N-7491 Trondheim, Norway.	ekropff@leloir.org.ar; edvard.moser@ntnu.no		Carmichael, James/0000-0001-5218-804X; Kropff, Emilio/0000-0001-5996-8436	European Research Council [232608, 338865]; European Commission [600725]; FP7 collaborative project [200873]; Kavli Foundation; Louis-Jeantet Prize for Medicine; Centre of Excellence scheme of the Research Council of Norway (Centre for the Biology of Memory and Centre for Neural Computation); Ministry of Science of Argentina [PICT 2012-0548]	European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); FP7 collaborative project; Kavli Foundation; Louis-Jeantet Prize for Medicine; Centre of Excellence scheme of the Research Council of Norway (Centre for the Biology of Memory and Centre for Neural Computation); Ministry of Science of Argentina	We thank A. M. Amundsgard, K. Haugen, K. Jenssen, E. Krakvik, and H. Waade for technical assistance, R. Baldi for help with data collection in two initial experiments, J. Couey for inspiring the bottomless car, and A. Treves for discussions. The work was supported by two Advanced Investigator Grants from the European Research Council ('CIRCUIT', Grant Agreement No. 232608; 'GRIDCODE', Grant Agreement No. 338865), the European Commission's FP7 FET Proactive programme on Neuro-Bio-Inspired Systems (Grant Agreement 600725), an FP7 collaborative project ('SPACEBRAIN', Grant Agreement No. 200873), the Kavli Foundation, the Louis-Jeantet Prize for Medicine, the Centre of Excellence scheme of the Research Council of Norway (Centre for the Biology of Memory and Centre for Neural Computation), and a PICT 2012-0548 Grant to E.K. from the Ministry of Science of Argentina.	Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00030, 10.3389/fncir.2012.00005]; Bieri KW, 2014, NEURON, V82, P670, DOI 10.1016/j.neuron.2014.03.013; Bjerknes TL, 2014, NEURON, V82, P71, DOI 10.1016/j.neuron.2014.02.014; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; Buetfering C, 2014, NAT NEUROSCI, V17, P710, DOI 10.1038/nn.3696; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Bush D, 2014, J NEUROSCI, V34, P5065, DOI 10.1523/JNEUROSCI.4017-13.2014; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; De Almeida L, 2012, HIPPOCAMPUS, V22, P1647, DOI 10.1002/hipo.22030; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gupta AS, 2012, NAT NEUROSCI, V15, P1032, DOI 10.1038/nn.3138; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Lee AM, 2014, NEURON, V83, P455, DOI 10.1016/j.neuron.2014.06.031; Lever C., 2003, NEUROBIOLOGY SPATIAL; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2014, NAT REV NEUROSCI, V15, P466, DOI 10.1038/nrn3766; MULLER RU, 1989, J NEUROSCI, V9, P4101; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; O'Keefe J, 1998, PHILOS T ROY SOC B, V353, P1333, DOI 10.1098/rstb.1998.0287; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Wills TJ, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00021	33	328	344	7	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					419	U78		10.1038/nature14622	http://dx.doi.org/10.1038/nature14622			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26176924				2022-12-28	WOS:000358378900028
J	Kawaharada, Y; Kelly, S; Nielsen, MW; Hjuler, CT; Gysel, K; Muszynski, A; Carlson, RW; Thygesen, MB; Sandal, N; Asmussen, MH; Vinther, M; Andersen, SU; Krusell, L; Thirup, S; Jensen, KJ; Ronson, CW; Blaise, M; Radutoiu, S; Stougaard, J				Kawaharada, Y.; Kelly, S.; Nielsen, M. Wibroe; Hjuler, C. T.; Gysel, K.; Muszynski, A.; Carlson, R. W.; Thygesen, M. B.; Sandal, N.; Asmussen, M. H.; Vinther, M.; Andersen, S. U.; Krusell, L.; Thirup, S.; Jensen, K. J.; Ronson, C. W.; Blaise, M.; Radutoiu, S.; Stougaard, J.			Receptor-mediated exopolysaccharide perception controls bacterial infection	NATURE			English	Article							LEGUME LOTUS-JAPONICUS; HOST-SYMBIONT INTERACTIONS; GENETIC-LINKAGE MAP; RHIZOBIUM-MELILOTI; SINORHIZOBIUM-MELILOTI; STRUCTURAL-CHARACTERIZATION; NODULE ORGANOGENESIS; MEDICAGO-TRUNCATULA; ORGAN DEVELOPMENT; INNATE IMMUNITY	Surface polysaccharides are important for bacterial interactions with multicellular organisms, and some are virulence factors in pathogens. In the legume-rhizobium symbiosis, bacterial exopolysaccharides (EPS) are essential for the development of infected root nodules. We have identified a gene in Lotus japonicus, Epr3, encoding a receptor-like kinase that controls this infection. We show that epr3 mutants are defective in perception of purified EPS, and that EPR3 binds EPS directly and distinguishes compatible and incompatible EPS in bacterial competition studies. Expression of Epr3 in epidermal cells within the susceptible root zone shows that the protein is involved in bacterial entry, while rhizobial and plant mutant studies suggest that Epr3 regulates bacterial passage through the plant's epidermal cell layer. Finally, we show that Epr3 expression is inducible and dependent on host perception of bacterial nodulation ( Nod) factors. Plant-bacterial compatibility and bacterial access to legume roots is thus regulated by a two-stage mechanism involving sequential receptor-mediated recognition of Nod factor and EPS signals.	[Kawaharada, Y.; Kelly, S.; Nielsen, M. Wibroe; Hjuler, C. T.; Gysel, K.; Thygesen, M. B.; Sandal, N.; Asmussen, M. H.; Vinther, M.; Andersen, S. U.; Krusell, L.; Thirup, S.; Jensen, K. J.; Ronson, C. W.; Blaise, M.; Radutoiu, S.; Stougaard, J.] Aarhus Univ, Ctr Carbohydrate Recognit & Signalling, DK-8000 Aarhus C, Denmark; [Kawaharada, Y.; Kelly, S.; Nielsen, M. Wibroe; Gysel, K.; Sandal, N.; Asmussen, M. H.; Vinther, M.; Andersen, S. U.; Krusell, L.; Thirup, S.; Blaise, M.; Radutoiu, S.; Stougaard, J.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Kelly, S.; Ronson, C. W.] Univ Otago, Dept Microbiol & Immunol, Dunedin 9054, New Zealand; [Hjuler, C. T.; Thygesen, M. B.; Jensen, K. J.] Univ Copenhagen, Dept Chem, DK-1871 Frederiksberg C, Denmark; [Muszynski, A.; Carlson, R. W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Aarhus University; Aarhus University; University of Otago; University of Copenhagen; University System of Georgia; University of Georgia	Stougaard, J (corresponding author), Aarhus Univ, Ctr Carbohydrate Recognit & Signalling, DK-8000 Aarhus C, Denmark.	stougaard@mbg.au.dk	Blaise, Mickael/L-5585-2019; Gysel, Kira/GZM-5751-2022; Thygesen, Mikkel B/D-1098-2016; Jensen, Knud J/D-1145-2016; Kawaharada, Yasuyuki/AAO-3551-2021	Gysel, Kira/0000-0003-4245-9998; Thygesen, Mikkel B/0000-0002-0158-2802; Jensen, Knud J/0000-0003-3525-5452; Kawaharada, Yasuyuki/0000-0002-4756-4394; Blaise, Mickael/0000-0002-7860-3464; Stougaard, Jens/0000-0002-9312-2685; Kelly, Simon/0000-0003-4243-300X; Andersen, Stig U./0000-0002-1096-1468; Thirup, Soren/0000-0002-0061-7137; Toftegaard Hjuler, Christian/0000-0001-6055-6391	Danish National Research Foundation [DNRF79]; ERC Advanced Grant [268523]; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, US Department of Energy [DE-FG02-93ER20097]	Danish National Research Foundation(Danmarks Grundforskningsfond); ERC Advanced Grant; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, US Department of Energy(United States Department of Energy (DOE))	This work was supported by the Danish National Research Foundation grant no. DNRF79 and the ERC Advanced Grant 268523. We thank S. Bucholdt for technical help with Epr3 promoter-GUSfusions, T. Brock-Nannestad for technical assistance with FT-ICR mass spectrometry and J. Sullivan for comments on the manuscript. A.M. and R.W.C. were supported by the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, US Department of Energy grant (DE-FG02-93ER20097) to the DOE Center for Plant and Microbial Complex Carbohydrates at the Complex Carbohydrate Research Center.	AMAN P, 1981, CARBOHYD RES, V95, P263, DOI 10.1016/S0008-6215(00)85582-2; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; BATTISTI L, 1992, P NATL ACAD SCI USA, V89, P5625, DOI 10.1073/pnas.89.12.5625; Becker A, 2005, MOL PLANT MICROBE IN, V18, P899, DOI 10.1094/MPMI-18-0899; BREEDVELD MW, 1993, J BACTERIOL, V175, P750, DOI 10.1128/JB.175.3.750-757.1993; Broghammer A, 2012, P NATL ACAD SCI USA, V109, P13859, DOI 10.1073/pnas.1205171109; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Desbrosses GJ, 2011, CELL HOST MICROBE, V10, P348, DOI 10.1016/j.chom.2011.09.005; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fournier J, 2008, PLANT PHYSIOL, V148, P1985, DOI 10.1104/pp.108.125674; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Fukai E, 2012, PLANT J, V69, P720, DOI 10.1111/j.1365-313X.2011.04826.x; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; HANSEN J, 1989, PLANT CELL REP, V8, P12, DOI 10.1007/BF00735768; Hayashi M, 2001, DNA RES, V8, P301, DOI 10.1093/dnares/8.6.301; Heckmann AB, 2011, MOL PLANT MICROBE IN, V24, P1385, DOI 10.1094/MPMI-05-11-0142; HER GR, 1990, CARBOHYD RES, V198, P305, DOI 10.1016/0008-6215(90)84300-J; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Jones KM, 2008, P NATL ACAD SCI USA, V105, P704, DOI 10.1073/pnas.0709338105; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kawaharada Y, 2007, MICROBIOL-SGM, V153, P3983, DOI 10.1099/mic.0.2007/008631-0; Kelly S, 2014, STAND GENOMIC SCI, V9, DOI 10.1186/1944-3277-9-6; Kelly SJ, 2013, MOL PLANT MICROBE IN, V26, P319, DOI 10.1094/MPMI-09-12-0227-R; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Laroche RJF, 2013, GENE EXPR PATTERNS, V13, P212, DOI 10.1016/j.gep.2013.02.007; Laus MC, 2005, MOL PLANT MICROBE IN, V18, P533, DOI 10.1094/MPMI-18-0533; Lehman AP, 2013, J BACTERIOL, V195, P5362, DOI 10.1128/JB.00681-13; LEONG SA, 1985, NUCLEIC ACIDS RES, V13, P5965, DOI 10.1093/nar/13.16.5965; Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867; Lohmann GV, 2010, MOL PLANT MICROBE IN, V23, P510, DOI 10.1094/MPMI-23-4-0510; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Nishimura R, 2002, NATURE, V420, P426, DOI 10.1038/nature01231; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Perry JA, 2003, PLANT PHYSIOL, V131, P866, DOI 10.1104/pp.102.017384; PETIT A, 1987, MOL GEN GENET, V207, P245, DOI 10.1007/BF00331585; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; REINHOLD BB, 1994, J BACTERIOL, V176, P1997, DOI 10.1128/jb.176.7.1997-2002.1994; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Rodpothong P, 2009, MOL PLANT MICROBE IN, V22, P1546, DOI 10.1094/MPMI-22-12-1546; Sandal N, 2002, GENETICS, V161, P1673; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; STOUGAARD J, 1987, MOL GEN GENET, V207, P251, DOI 10.1007/BF00331586; Sullivan JT, 2002, J BACTERIOL, V184, P3086, DOI 10.1128/JB.184.11.3086-3095.2002; Tanaka K, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22598; Thygesen MB, 2010, J ORG CHEM, V75, P1752, DOI 10.1021/jo902425v; Thygesen MB, 2009, CHEM-EUR J, V15, P1649, DOI 10.1002/chem.200801521; Tirichine L, 2006, MOL PLANT MICROBE IN, V19, P373, DOI 10.1094/MPMI-19-0373; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862; Urbanski DF, 2012, PLANT J, V69, P731, DOI 10.1111/j.1365-313X.2011.04827.x; URZAINQUI A, 1992, J BACTERIOL, V174, P3403, DOI 10.1128/jb.174.10.3403-3406.1992; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang LX, 1999, J BACTERIOL, V181, P6788, DOI 10.1128/JB.181.21.6788-6796.1999; Wong JEMM, 2015, ACTA CRYSTALLOGR D, V71, P592, DOI 10.1107/S139900471402793X; Xie F, 2012, P NATL ACAD SCI USA, V109, P633, DOI 10.1073/pnas.1113992109; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372	62	243	252	14	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					308	+		10.1038/nature14611	http://dx.doi.org/10.1038/nature14611			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26153863	Green Accepted			2022-12-28	WOS:000357950900033
J	Bartlett, NW; Tolley, MT; Overvelde, JTB; Weaver, JC; Mosadegh, B; Bertoldi, K; Whitesides, GM; Wood, RJ				Bartlett, Nicholas W.; Tolley, Michael T.; Overvelde, Johannes T. B.; Weaver, James C.; Mosadegh, Bobak; Bertoldi, Katia; Whitesides, George M.; Wood, Robert J.			A 3D-printed, functionally graded soft robot powered by combustion	SCIENCE			English	Article							FABRICATION; CHALLENGES; DESIGN	Roboticists have begun to design biologically inspired robots with soft or partially soft bodies, which have the potential to be more robust and adaptable, and safer for human interaction, than traditional rigid robots. However, key challenges in the design and manufacture of soft robots include the complex fabrication processes and the interfacing of soft and rigid components. We used multimaterial three-dimensional (3D) printing to manufacture a combustion-powered robot whose body transitions from a rigid core to a soft exterior. This stiffness gradient, spanning three orders of magnitude in modulus, enables reliable interfacing between rigid driving components (controller, battery, etc.) and the primarily soft body, and also enhances performance. Powered by the combustion of butane and oxygen, this robot is able to perform untethered jumping.	[Bartlett, Nicholas W.; Overvelde, Johannes T. B.; Bertoldi, Katia; Wood, Robert J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Bartlett, Nicholas W.; Weaver, James C.; Whitesides, George M.; Wood, Robert J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Tolley, Michael T.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Mosadegh, Bobak] New York Presbyterian Hosp, Dept Radiol, Dalio Inst Cardiovasc Imaging, New York, NY 10021 USA; [Mosadegh, Bobak] Weill Cornell Med Coll, New York, NY 10021 USA; [Whitesides, George M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; University of California System; University of California San Diego; NewYork-Presbyterian Hospital; Cornell University; Harvard University	Bartlett, NW (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	nbartlett@seas.harvard.edu	Weaver, James C./AAE-7870-2019; Overvelde, Johannes T. B./G-5303-2012	Overvelde, Johannes T. B./0000-0003-0253-0147	NSF [DMR-1420570]; Wyss Institute for Biologically Inspired Research; Army Research Office, National Defense Science and Engineering Graduate (NDSEG) fellowship	NSF(National Science Foundation (NSF)); Wyss Institute for Biologically Inspired Research; Army Research Office, National Defense Science and Engineering Graduate (NDSEG) fellowship	This material is based on work supported by NSF under award number DMR-1420570; the Wyss Institute for Biologically Inspired Research; and an Army Research Office, National Defense Science and Engineering Graduate (NDSEG) fellowship. Any opinions, findings, conclusions, or recommendations expressed in this material are those of the authors and do not necessarily reflect those of the funding organizations.	Cho KJ, 2009, INT J PRECIS ENG MAN, V10, P171, DOI 10.1007/s12541-009-0064-6; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; Kim S, 2013, TRENDS BIOTECHNOL, V31, P23, DOI 10.1016/j.tibtech.2013.03.002; Laschi Cecilia, 2014, Front Bioeng Biotechnol, V2, P3; Laschi C, 2012, ADV ROBOTICS, V26, P709, DOI 10.1163/156855312X626343; Lin HT, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/2/026007; Lipson H, 2014, SOFT ROBOT, V1, P21, DOI 10.1089/soro.2013.0007; Loepfe M, 2015, SOFT ROBOT, V2, P33, DOI 10.1089/soro.2014.0021; Majidi C, 2014, SOFT ROBOT, V1, P5, DOI 10.1089/soro.2013.0001; Marchese AD, 2014, SOFT ROBOT, V1, P75, DOI 10.1089/soro.2013.0009; McMahan W, 2006, IEEE INT CONF ROBOT, P2336, DOI 10.1109/ROBOT.2006.1642051; Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117; Onal CD, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/026003; Park YL, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/1/016007; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Pfeifer R, 2012, COMMUN ACM, V55, P76, DOI 10.1145/2366316.2366335; Polygerinos P., ROBOT AUTON SYST; Roberts TJ, 2011, J EXP BIOL, V214, P353, DOI 10.1242/jeb.038588; Rus D, 2015, NATURE, V521, P467, DOI 10.1038/nature14543; Shepherd R.F., 2013, ANGEW CHEM, V125, P2964, DOI DOI 10.1002/ANGE.201209540; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Steltz E, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P5672, DOI 10.1109/IROS.2009.5354790; Suzumori K., 1992, IEEE Control Systems Magazine, V12, P21, DOI 10.1109/37.120448; Tolley MT, 2014, IEEE INT C INT ROBOT, P561, DOI 10.1109/IROS.2014.6942615; Tolley MT, 2014, SOFT ROBOT, V1, P213, DOI 10.1089/soro.2014.0008; Trivedi Deepak, 2008, Applied Bionics and Biomechanics, V5, P99, DOI 10.1080/11762320802557865	26	627	669	71	945	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					161	165		10.1126/science.aab0129	http://dx.doi.org/10.1126/science.aab0129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26160940	Green Submitted			2022-12-28	WOS:000357664300036
J	Duff, JF; Buckingham, WW				Duff, Jean F.; Buckingham, Warren W., III			Strengthening of partnerships between the public sector and faith-based groups	LANCET			English	Article								The sharpening focus on global health and the growing recognition of the capacities and scope of faith-based groups for improving community health outcomes suggest an intentional and systematic approach to forging strong, sustained partnerships between public sector agencies and faith-based organisations. Drawing from both development and faith perspectives, this Series paper examines trends that could ground powerful, more sustainable partnerships and identifies new opportunities for collaboration based on respective strengths and existing models. This paper concludes with five areas of recommendations for more effective collaboration to achieve health goals.	[Duff, Jean F.] Partnership Faith & Dev, Washington, DC 20016 USA; [Buckingham, Warren W., III] Buckingham Global Hlth LLC, Silver Spring, MD USA		Duff, JF (corresponding author), Partnership Faith & Dev, Washington, DC 20016 USA.	JeanDuff@pfaithdev.org			Capital for Good	Capital for Good	The writing of this Series paper, and the review process by the Lancet Working Group on Faith and Global Health was supported by Capital for Good. We would like to thank Sarla Chand, Frank Duff, Liz Grant, Leon Hooper SJ, Azza Karam, Samuel Luboga, Helena Manguerra, Katherine Marshall, Ed Mills, and Sally Smith, for their guidance and review during the writing process.	Africa Faith Leaders' Summit, POS PAP POST 2015 DE; Anglican Church of the Province of Congo, 2012, PIL STUD LONG LAST I; Berkley Center for Religion Peace & World Affairs, 2015, DISC VIN AR GEN SECR; Blevins J, ESSENTIAL PARTICIPAN; Center for Interfaith Action on Global Poverty, MAN FAITHS COMM ACT; Chand S, CHRISTIAN SERMON GUI; Clarke M., 2011, 201173 UN U; Department for International Development, FAITH PARTN PRINC WO; Duff J., 2007, DEV FAITH MIND HEART, P67; Duff J, SOURCES REVENUE US F; Fox E, 2014, J HEALTH COMMUN, V19, P3, DOI 10.1080/10810730.2014.934937; Haakenstad A, 2015, PLOS ONE IN PRESS; Hipple A, 2010, CROSS CURR, V60, P368, DOI 10.1111/j.1939-3881.2010.00137.x; Institute for Health Metrics and Evaluation, 2014, FIN GLOB HLTH 2013 T; InterAction, INTERACTION PVO STAN; International Interfaith Peace Corps, 2014, VACC REL ISS CHALL P; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Joint Learning Initiative on Faith and Local Communities, THEOR CHANG FAITH GR; Joint United Nations Programme on HIV/AIDS, 2009, PARTN FAITH BAS ORG; Karam A., RELIG DEV POST 2015; Krafess J., 2005, INT REV RED CROSS, V87, P327, DOI [10.1017/S1816383100181378, DOI 10.1017/S1816383100181378]; LaTondrese C., 2013, RELIG LEADERS NOISY; Micah Network, MIC DECL INT MISS; Nelson J., 2007, OPERATION NGOS WORLD; Obama B, EXECUTIVE ORDER FUND; Olivier J, 2015, LANCET; Olivier J, 2011, HIV AIDS CHARTING TE; Sector Programme Values Religion and Development, 2015, SECT PROGR VAL REL D; The African Christian Health Associations Platform Caritas Internationalis Churches Health Association of Zambia Ecumenical Advocacy Alliance UNAIDS, CONS REP SCAL ENG FA; The Global Fund, 2011, 2010 UPD REP INV FAI; Tomkins A, 2015, LANCET; UN Sustainable development Knowledge Platform, 12 SESS OP WORK GROU; UNAIDS-Caritas, JOINT CONS CATH CHUR; UNFPA UNAIDS, CALL ACT FAITH SEX R; UNICEF, BUILD TRUST IMM PART; United Nations Children's Fund, PARTN REL COMM CHILD; United Nations Children's Fund (UNICEF), COMM CHILD SURV PROM; United Nations Population Fund, BUILD BRIDG FAITHB O; US President's Emergency Plan for AIDS Relief, FIRM FDN PEPFAR CONS; USAID, US STRAT REL LEAD FA; WHO Programme on Partnerships and UN Reform, 2009, WHO CIFA CONS NGO MA; World Bank Group, WORLD BANK GROUP PRE; World Bank Group, MOR ACT EFF ENG FAIT; World Council of Churches, 2014, CHURCH AG FORM RESP; World Health Organization (WHO), SOCIAL DETERMINANTS; World Vision Inc, CHANN HOP IGN MOV TR	46	45	45	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1786	1794		10.1016/S0140-6736(15)60250-1	http://dx.doi.org/10.1016/S0140-6736(15)60250-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0WK	26159394				2022-12-28	WOS:000363974200038
J	Barer, D				Barer, David			In Chinese adults with hypertension, adding folic acid to enalapril reduced incident stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEART-DISEASE; METAANALYSIS; HOMOCYSTEINE; RISK		Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Barer, D (corresponding author), Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.							Clarke R, 2005, AM J CLIN NUTR, V82, P806, DOI 10.1093/ajcn/82.4.806; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Huo Y, 2012, INT J CLIN PRACT, V66, P544, DOI 10.1111/j.1742-1241.2012.02929.x; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023	4	1	1	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2							JC8	10.7326/ACPJC-2015-163-2-008	http://dx.doi.org/10.7326/ACPJC-2015-163-2-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26192588				2022-12-28	WOS:000358407500008
J	Smith, MD				Smith, Malcolm D.			Review: Methotrexate does not increase risk for lung disease in psoriasis, psoriatic arthritis, or IBD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TOXICITY		Repatriat Gen Hosp, Adelaide, SA, Australia	Flinders University South Australia	Smith, MD (corresponding author), Repatriat Gen Hosp, Adelaide, SA, Australia.							Margagnoni G, 2010, J CROHNS COLITIS, V4, P211, DOI 10.1016/j.crohns.2009.11.007; Rondon F, 2011, CLIN RHEUMATOL, V30, P1379, DOI 10.1007/s10067-011-1765-7; WEINBLATT ME, 1985, J RHEUMATOL, V12, P35	3	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2							JC7	10.7326/ACPJC-2015-163-2-007	http://dx.doi.org/10.7326/ACPJC-2015-163-2-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26192587				2022-12-28	WOS:000358407500007
J	Keesing, F; Ostfeld, RS				Keesing, Felicia; Ostfeld, Richard S.			ECOLOGY Is biodiversity good for your health?	SCIENCE			English	Editorial Material							INFECTIOUS-DISEASE; RISK; LIFE; PACE		[Keesing, Felicia] Bard Coll, Dept Biol, Annandale On Hudson, NY 12504 USA; Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA	Cary Institute of Ecosystem Studies	Keesing, F (corresponding author), Bard Coll, Dept Biol, Annandale On Hudson, NY 12504 USA.	keesing@bard.edu		Ostfeld, Richard/0000-0002-3707-9301				Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Civitello DJ, 2015, P NATL ACAD SCI USA, V112, P8667, DOI 10.1073/pnas.1506279112; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112; Huang ZYX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054341; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Lavergne S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0091; Martin II LB, 2006, OECOLOGIA, V147, P565, DOI 10.1007/s00442-005-0314-y; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; Rottstock T, 2014, ECOLOGY, V95, P1907, DOI 10.1890/13-2317.1; Salkeld DJ, 2013, ECOL LETT, V16, P679, DOI 10.1111/ele.12101; Wood CL, 2014, ECOLOGY, V95, P817, DOI 10.1890/13-1041.1; Young H, 2013, ECOL LETT, V16, P656, DOI 10.1111/ele.12094	13	43	43	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		235	236		10.1126/science.aac7892	http://dx.doi.org/10.1126/science.aac7892			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1ZB	26185230				2022-12-28	WOS:000358218600021
J	Sawleshwarkar, S; Dwyer, DE				Sawleshwarkar, Shailendra; Dwyer, Dominic E.			THERAPEUTICS Antivirals for herpes simplex viruses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GENITAL HERPES; DOUBLE-BLIND; ORAL ACYCLOVIR; VALACYCLOVIR; TRANSMISSION; MANAGEMENT; HIV-1; WOMEN; RISK		[Sawleshwarkar, Shailendra] Univ Sydney, Western Sydney Sexual Hlth Ctr, Parramatta, NSW 2150, Australia; [Dwyer, Dominic E.] Inst Clin Pathol & Med Res, Westmead, NSW 2145, Australia; [Dwyer, Dominic E.] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney	Sawleshwarkar, S (corresponding author), Univ Sydney, Western Sydney Sexual Hlth Ctr, Parramatta, NSW 2150, Australia.	shailendra.sawleshwarkar@sydney.edu.au	Sawleshwarkar, Shailendra/AAB-3628-2020	Sawleshwarkar, Shailendra/0000-0002-9399-0490				Abudalu M, 2008, CLIN INFECT DIS, V47, P651, DOI 10.1086/590561; Aurelius E, 2012, CLIN INFECT DIS, V54, P1304, DOI 10.1093/cid/cis031; Baeten JM, 2012, SEX TRANSM DIS, V39, P21, DOI 10.1097/OLQ.0b013e31823b50c6; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Fife KH, 1997, SEX TRANSM DIS, V24, P481, DOI 10.1097/00007435-199709000-00007; Glenny AM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006706.pub2; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; James SH, 2014, CURR OPIN VIROL, V8, P54, DOI 10.1016/j.coviro.2014.06.003; Kimberlin DW, 2013, PEDIATRICS, V131, pE635, DOI 10.1542/peds.2012-3216; Kimberlin DW, 2011, NEW ENGL J MED, V365, P1284, DOI 10.1056/NEJMoa1003509; Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013; Lam NN, 2013, AM J KIDNEY DIS, V61, P723, DOI 10.1053/j.ajkd.2012.12.008; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; Rahimi H, 2012, OR SURG OR MED OR PA, V113, P618, DOI 10.1016/j.oooo.2011.10.010; Trinquart L, 2014, COCHRANE DB SYST REV, V8; Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747; Worrall Graham, 2009, BMJ Clin Evid, V2009	19	3	5	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2015	351								h3350	10.1136/bmj.h3350	http://dx.doi.org/10.1136/bmj.h3350			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MU	26160487				2022-12-28	WOS:000357956500001
J	Levine, DA; Galecki, AT; Langa, KM; Unverzagt, FW; Kabeto, MU; Giordani, B; Wadley, VG				Levine, Deborah A.; Galecki, Andrzej T.; Langa, Kenneth M.; Unverzagt, Frederick W.; Kabeto, Mohammed U.; Giordani, Bruno; Wadley, Virginia G.			Trajectory of Cognitive Decline After Incident Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; ALZHEIMERS-DISEASE; NEUROPSYCHOLOGICAL ASSESSMENT; RACIAL-DIFFERENCES; ISCHEMIC-STROKE; 6-ITEM SCREENER; 1ST-EVER STROKE; VERBAL FLUENCY; OLDER-ADULTS; RISK-FACTORS	IMPORTANCE Cognitive decline is a major cause of disability in stroke survivors. The magnitude of survivors' cognitive changes after stroke is uncertain. OBJECTIVE To measure changes in cognitive function among survivors of incident stroke, controlling for their prestroke cognitive trajectories. DESIGN, SETTING, AND PARTICIPANTS Prospective study of 23 572 participants 45 years or older without baseline cognitive impairment from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort, residing in the continental United States, enrolled 2003-2007 and followed up through March 31, 2013. Over a median follow-up of 6.1 years (interquartile range, 5.0-7.1 years), 515 participants survived expert-adjudicated incident stroke and 23 057 remained stroke free. EXPOSURE Time-dependent incident stroke. MAIN OUTCOMES AND MEASURES The primary outcome was change in global cognition (Six-Item Screener [SIS], range, 0-6). Secondary outcomes were change in new learning (Consortium to Establish a Registry for Alzheimer Disease Word-List Learning; range, 0-30), verbal memory (Word-List Delayed Recall; range, 0-10), and executive function (Animal Fluency Test; range, >= 0), and cognitive impairment (SIS score < 5 [impaired] vs >= 5 [unimpaired]). For all tests, higher scores indicate better performance. RESULTS Stroke was associated with acute decline in global cognition (0.10 points [95% CI, 0.04 to 0.17]), new learning (1.80 points [95% CI, 0.73 to 2.86]), and verbal memory (0.60 points [95% CI, 0.13 to 1.07]). Participants with stroke, compared with those without stroke, demonstrated faster declines in global cognition (0.06 points per year faster [95% CI, 0.03 to 0.08]) and executive function (0.63 points per year faster [95% CI, 0.12 to 1.15]), but not in new learning and verbal memory, compared with prestroke slopes. Among survivors, the difference in risk of cognitive impairment acutely after stroke, compared with immediately before stroke, was not statistically significant (odds ratio, 1.32 [95% CI, 0.95 to 1.83]; P = .10); however, there was a significantly faster poststroke rate of incident cognitive impairment compared with the prestroke rate (odds ratio, 1.23 per year [95% CI, 1.10 to 1.38]; P < .001). For a 70-year-old black woman with average values for all covariates at baseline, stroke at year 3 was associated with greater incident cognitive impairment: absolute difference of 4.0% (95% CI, -1.2% to 9.2%) at year 3 and 12.4%(95% CI, 7.7% to 17.1%) at year 6. CONCLUSIONS AND RELEVANCE Incident stroke was associated with an acute decline in cognitive function and also accelerated and persistent cognitive decline over 6 years.	[Levine, Deborah A.; Galecki, Andrzej T.; Langa, Kenneth M.; Kabeto, Mohammed U.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Levine, Deborah A.; Langa, Kenneth M.; Kabeto, Mohammed U.] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Levine, Deborah A.; Langa, Kenneth M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Levine, Deborah A.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Levine, Deborah A.] Univ Michigan, Stroke Program, Ann Arbor, MI 48109 USA; [Galecki, Andrzej T.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI 48109 USA; [Unverzagt, Frederick W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Giordani, Bruno] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA; [Wadley, Virginia G.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Indiana University System; Indiana University Bloomington; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham	Levine, DA (corresponding author), Univ Michigan, Div Gen Med, NCRC, 2800 Plymouth Rd,Bldg 16,Room 430W, Ann Arbor, MI 48109 USA.	deblevin@umich.edu	Giordani, Bruno/AAR-1910-2021	Langa, Kenneth/0000-0002-2798-1836; Giordani, Bruno/0000-0001-5921-3455	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services [U01 NS041588]; National Institute on Aging [K23AG040278]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824, K23AG040278] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services. Additional funding was provided by a grant K23AG040278 from the National Institute on Aging (Dr Levine).	Ankolekar S, 2014, J STROKE CEREBROVASC, V23, P1821, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.022; [Anonymous], 1989, Stroke, V20, P1407; Atchison TB, 2007, ARCH CLIN NEUROPSYCH, V22, P99, DOI 10.1016/j.acn.2006.11.006; Bennett HP, 2002, J AM GERIATR SOC, V50, P1969, DOI 10.1046/j.1532-5415.2002.50608.x; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Carpenter CR, 2011, ANN EMERG MED, V57, P653, DOI 10.1016/j.annemergmed.2010.06.560; Clark LJ, 2009, AM J ALZHEIMERS DIS, V24, P461, DOI 10.1177/1533317509345154; Cosentino S, 2006, COGN BEHAV NEUROL, V19, P123, DOI 10.1097/01.wnn.0000213912.87642.3d; del Ser T, 2005, STROKE, V36, P2670, DOI 10.1161/01.STR.0000189626.71033.35; Desmond DW, 1998, ARCH NEUROL-CHICAGO, V55, P390, DOI 10.1001/archneur.55.3.390; Dhamoon MS, 2009, STROKE, V40, P2805, DOI 10.1161/STROKEAHA.109.549576; Douiri A, 2013, CIRCULATION, V128, P1341, DOI 10.1161/CIRCULATIONAHA.113.002236; Doyle KP, 2015, J NEUROSCI, V35, P2133, DOI 10.1523/JNEUROSCI.4098-14.2015; Edwards JD, 2010, STROKE, V41, P996, DOI 10.1161/STROKEAHA.109.576678; Erkinjuntti T, 2009, VASCULAR COGNITIVE IMPAIRMENT IN CLINICAL PRACTICE, P3, DOI 10.1017/CBO9780511575976.002; Ferraro FR, 2002, STUD NEUROPSYCHOL DE, P227; Garcia-Alloza M, 2011, BRAIN, V134, P3694, DOI 10.1093/brain/awr300; Hachinski V, 2007, STROKE, V38, P1118, DOI 10.1161/01.STR.0000259385.54832.e4; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Halanych JH, 2011, AM J EPIDEMIOL, V173, P1319, DOI 10.1093/aje/kwr033; He YL, 2010, CIRC-CARDIOVASC QUAL, V3, P98, DOI 10.1161/CIRCOUTCOMES.109.875658; Hertzog C, 1996, PERSPECTIVES COGNITI, P66; Howard VJ, 2011, ANN NEUROL, V69, P619, DOI 10.1002/ana.22385; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Iadecola C, 2003, STROKE, V34, P335, DOI 10.1161/01.STR.0000054050.51530.76; Knopman DS, 2009, ALZHEIMERS DEMENT, V5, P207, DOI 10.1016/j.jalz.2009.01.027; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levine DA, 2014, CIRC-CARDIOVASC QUAL, V7, P863, DOI 10.1161/HCQ.0000000000000008; Liman TG, 2011, DEMENT GERIATR COGN, V31, P291, DOI 10.1159/000327358; Lucas JA, 2005, CLIN NEUROPSYCHOL, V19, P243, DOI 10.1080/13854040590945337; MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; MORRIS JC, 1988, PSYCHOPHARMACOL BULL, V24, P641; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mozaffarian D, 2015, CIRCULATION, V131, P434, DOI 10.1161/CIR.0000000000000157; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Patel MD, 2002, J AM GERIATR SOC, V50, P700, DOI 10.1046/j.1532-5415.2002.50165.x; Rajan KB, 2014, STROKE, V45, P2563, DOI 10.1161/STROKEAHA.114.005143; Rapp SR, 2012, J AM GERIATR SOC, V60, P1616, DOI 10.1111/j.1532-5415.2012.04111.x; Reed BR, 2000, ANN NEUROL, V48, P275, DOI 10.1002/1531-8249(200009)48:3<275::AID-ANA1>3.0.CO;2-C; Rockwood K, 2002, STROKE, V33, P1605, DOI 10.1161/01.STR.0000017878.85274.44; Rossetti HC, 2010, ALZ DIS ASSOC DIS, V24, P138, DOI 10.1097/WAD.0b013e3181b76415; Sachdev PS, 2014, J NEUROL NEUROSUR PS, V85, P1324, DOI 10.1136/jnnp-2013-306776; Safford MM, 2012, JAMA-J AM MED ASSOC, V308, P1768, DOI 10.1001/jama.2012.14306; Salthouse TA, 2014, J GERONTOL B-PSYCHOL, V69, P567, DOI 10.1093/geronb/gbt046; Schaapsmeerders P, 2013, STROKE, V44, P1621, DOI 10.1161/STROKEAHA.111.000792; Schneider JA, 2007, ANN NEUROL, V62, P59, DOI 10.1002/ana.21142; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Srikanth VK, 2006, STROKE, V37, P2479, DOI 10.1161/01.STR.0000239666.46828.d7; Stein J, 2012, AM J GERIAT PSYCHIAT, V20, P84, DOI 10.1097/JGP.0b013e318209dd08; TATEMICHI TK, 1994, STROKE, V25, P1915, DOI 10.1161/01.STR.25.10.1915; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; TATEMICHI TK, 1992, NEUROLOGY, V42, P1185, DOI 10.1212/wnl.42.6.1185; Ukraintseva S, 2006, STROKE, V37, P1155, DOI 10.1161/01.STR.0000217971.88034.e9; Unger JM, 1999, J AM GERIATR SOC, V47, P559, DOI 10.1111/j.1532-5415.1999.tb02570.x; Unutzer J, 2003, J AM GERIATR SOC, V51, P505, DOI 10.1046/j.1532-5415.2003.51159.x; Unverzagt FW, 2007, J INT NEUROPSYCH SOC, V13, P799, DOI 10.1017/S1355617707071020; Wang QY, 2012, STROKE, V43, P2561, DOI 10.1161/STROKEAHA.112.661587; West BT., 2007, LINEAR MIXED MODELS; Whitehead SN, 2007, STROKE, V38, P3245, DOI 10.1161/STROKEAHA.107.492660; Wilson RS, 2010, ARCH NEUROL-CHICAGO, V67, P855, DOI 10.1001/archneurol.2010.129; Wolinsky FD, 2006, J GERONTOL A-BIOL, V61, P1324, DOI 10.1093/gerona/61.12.1324	64	241	249	4	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					41	51		10.1001/jama.2015.6968	http://dx.doi.org/10.1001/jama.2015.6968			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151265	Green Accepted			2022-12-28	WOS:000357455900013
J	Bremner, FD				Bremner, Fion D.			Putting raised intraocular pressure in context	LANCET			English	Editorial Material									Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Bremner, FD (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	fion.bremner@uclh.nhs.uk	Bremner, Fion/AAQ-8923-2020					Kiernan M, 2015, LANCET, V386, P101, DOI 10.1016/S0140-6736(15)61003-0; Teng C, 2003, BRIT J OPHTHALMOL, V87, P946, DOI 10.1136/bjo.87.8.946	2	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					102	102		10.1016/S0140-6736(15)61026-1	http://dx.doi.org/10.1016/S0140-6736(15)61026-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM2OA	26169869				2022-12-28	WOS:000357519400034
J	Daily, GC; Karp, DS				Daily, Gretchen C.; Karp, Daniel S.			Nature's bounties: reliance on pollinators for health	LANCET			English	Editorial Material							IMPACTS; BIODIVERSITY		[Daily, Gretchen C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Daily, Gretchen C.] Stanford Univ, Stanford Woods Inst, Stanford, CA 94305 USA; [Karp, Daniel S.] Dept Environm Sci Policy & Management, Berkeley, CA USA; [Karp, Daniel S.] Nature Conservancy, Seattle, WA USA	Stanford University; Stanford University; Nature Conservancy	Daily, GC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	gdaily@stanford.edu						Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chaplin-Kramer R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1799; Ellis AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114805; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Marks AR, 2010, ENVIRON HEALTH PERSP, V118, P1768, DOI 10.1289/ehp.1002056; Ponisio LC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1396; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Smith M. R., 2015, LANCET; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; Wood CL, 2014, ECOLOGY, V95, P817, DOI 10.1890/13-1041.1	14	1	1	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					1925	1927		10.1016/S0140-6736(15)61244-2	http://dx.doi.org/10.1016/S0140-6736(15)61244-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PI	26188743				2022-12-28	WOS:000364763200011
J	Li, JH; Guo, H; Gao, XH; Chen, HD				Li, Jiu-Hong; Guo, Hao; Gao, Xing-Hua; Chen, Hong-Duo			Multiple skin ulcers from malignant syphilis	LANCET			English	Editorial Material									[Li, Jiu-Hong; Guo, Hao; Gao, Xing-Hua; Chen, Hong-Duo] China Med Univ, Hosp 1, Dept Dermatol, Shenyang 110001, Peoples R China	China Medical University	Li, JH (corresponding author), China Med Univ, Hosp 1, Dept Dermatol, 155N Nanjing St, Shenyang 110001, Peoples R China.	Pfkl2011@126.com	Guo, Hao/K-1338-2019	Guo, Hao/0000-0003-3183-7607; Li, Jiu-Hong/0000-0001-7261-3664					0	6	11	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2015	386	10003					1564	1564		10.1016/S0140-6736(15)60157-X	http://dx.doi.org/10.1016/S0140-6736(15)60157-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5VC	26166319				2022-12-28	WOS:000362878200030
J	Dhillon, RS; Kelly, JD				Dhillon, Ranu S.; Kelly, J. Daniel			Community Trust and the Ebola Endgame	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dhillon, Ranu S.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Dhillon, Ranu S.] Columbia Univ, Earth Inst, New York, NY USA; [Kelly, J. Daniel] Univ Calif San Francisco, Div Infectious Dis, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Columbia University; University of California System; University of California San Francisco	Dhillon, RS (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], WORLD REP 2015 GUIN; [Anonymous], 2015, EB SIT REP 24 JUN 20; Davies Beauty Chiedza, 2015, Nurs Stand, V29, P37, DOI 10.7748/ns.29.26.37.e9837; Johnston A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7721; Plucinski MM, 2015, LANCET INFECT DIS	5	53	53	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					787	789		10.1056/NEJMp1508413	http://dx.doi.org/10.1056/NEJMp1508413			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP8VC	26222382				2022-12-28	WOS:000360171700003
J	Naggie, S; Cooper, C; Saag, M; Workowski, K; Ruane, P; Towner, WJ; Marks, K; Luetkemeyer, A; Baden, RP; Sax, PE; Gane, E; Santana-Bagur, J; Stamm, LM; Yang, JC; German, P; Dvory-Sobol, H; Ni, LY; Pang, PS; McHutchison, JG; Stedman, CAM; Morales-Ramirez, JO; Brau, N; Jayaweera, D; Colson, AE; Tebas, P; Wong, DK; Dieterich, D; Sulkowski, M				Naggie, Susanna; Cooper, Curtis; Saag, Michael; Workowski, Kimberly; Ruane, Peter; Towner, William J.; Marks, Kristen; Luetkemeyer, Anne; Baden, Rachel P.; Sax, Paul E.; Gane, Edward; Santana-Bagur, Jorge; Stamm, Luisa M.; Yang, Jenny C.; German, Polina; Dvory-Sobol, Hadas; Ni, Liyun; Pang, Phillip S.; McHutchison, John G.; Stedman, Catherine A. M.; Morales-Ramirez, Javier O.; Braeu, Norbert; Jayaweera, Dushyantha; Colson, Amy E.; Tebas, Pablo; Wong, David K.; Dieterich, Douglas; Sulkowski, Mark		ION-4 Investigators	Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-C VIRUS; GENOTYPE 1 INFECTION; ALPHA-2A PLUS RIBAVIRIN; HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; INTERFERON; CIRRHOSIS; THERAPY; COHORT; VETERANS	BACKGROUND Effective treatment for hepatitis C virus (HCV) in patients coinfected with human immunodeficiency virus type 1 (HIV-1) remains an unmet medical need. METHODS We conducted a multicenter, single-group, open-label study involving patients coinfected with HIV-1 and genotype 1 or 4 HCV receiving an antiretroviral regimen of tenofovir and emtricitabine with efavirenz, rilpivirine, or raltegravir. All patients received ledipasvir, an NS5A inhibitor, and sofosbuvir, a nucleotide polymerase inhibitor, as a single fixed-dose combination for 12 weeks. The primary end point was a sustained virologic response at 12 weeks after the end of therapy. RESULTS Of the 335 patients enrolled, 34% were black, 55% had been previously treated for HCV, and 20% had cirrhosis. Overall, 322 patients (96%) had a sustained virologic response at 12 weeks after the end of therapy (95% confidence interval [CI], 93 to 98), including rates of 96% (95% CI, 93 to 98) in patients with HCV genotype 1a, 96% (95% CI, 89 to 99) in those with HCV genotype 1b, and 100% (95% CI, 63 to 100) in those with HCV genotype 4. Rates of sustained virologic response were similar regardless of previous treatment or the presence of cirrhosis. Of the 13 patients who did not have a sustained virologic response, 10 had a relapse after the end of treatment. No patient had confirmed HIV-1 virologic rebound. The most common adverse events were headache (25%), fatigue (21%), and diarrhea (11%). No patient discontinued treatment because of adverse events. CONCLUSIONS Ledipasvir and sofosbuvir for 12 weeks provided high rates of sustained virologic response in patients coinfected with HIV-1 and HCV genotype 1 or 4. (Funded by Gilead Sciences;	[Naggie, Susanna] Duke Clin Res Inst, Durham, NC 27705 USA; [Cooper, Curtis] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada; [Wong, David K.] Univ Toronto, Toronto Gen Hosp, Dept Hepatol, Immunodeficiency Clin, Toronto, ON M5G 1L7, Canada; [Saag, Michael] Univ Alabama Birmingham, Birmingham, AL USA; [Workowski, Kimberly] Emory Univ, Emory Healthcare, Atlanta, GA 30322 USA; [Ruane, Peter] Ruane Med & Liver Hlth Inst, Los Angeles, CA USA; [Towner, William J.] Kaiser Permanente, Los Angeles Med Ctr, Los Angeles, CA USA; [Luetkemeyer, Anne] Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA USA; [Stamm, Luisa M.; Yang, Jenny C.; German, Polina; Dvory-Sobol, Hadas; Ni, Liyun; Pang, Phillip S.; McHutchison, John G.] Gilead Sci, Foster City, CA USA; [Marks, Kristen] Weill Cornell Med Coll, New York, NY USA; [Braeu, Norbert; Dieterich, Douglas] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Braeu, Norbert] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Baden, Rachel P.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Sax, Paul E.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Sax, Paul E.] Harvard Univ, Sch Med, Boston, MA USA; [Colson, Amy E.] Community Res Initiat New England, Boston, MA USA; [Gane, Edward] Univ Auckland, Auckland City Hosp, Auckland 1, New Zealand; [Stedman, Catherine A. M.] Christchurch Hosp, Christchurch, New Zealand; [Stedman, Catherine A. M.] Univ Otago, Christchurch, New Zealand; [Santana-Bagur, Jorge] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA; [Morales-Ramirez, Javier O.] Clin Res Puerto Rico, San Juan, PR USA; [Jayaweera, Dushyantha] Univ Miami, Miami, FL USA; [Tebas, Pablo] Univ Penn, Philadelphia, PA 19104 USA; [Sulkowski, Mark] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Duke University; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Alabama System; University of Alabama Birmingham; Emory University; Kaiser Permanente; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Gilead Sciences; Cornell University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Auckland City Hospital; University of Auckland; Christchurch Hospital New Zealand; University of Otago; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Miami; University of Pennsylvania; Johns Hopkins University	Naggie, S (corresponding author), Duke Clin Res Inst, Infect Dis Sect, 2400 Pratt St, Durham, NC 27705 USA.	susanna.naggie@duke.edu	Cooper, Curtis/M-9320-2019	Wong, David/0000-0002-3310-3538; Tebas, Pablo/0000-0001-5345-7942	Gilead Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, K23AI096913, P30AI064518, UM1AI069415] Funding Source: NIH RePORTER	Gilead Sciences(Gilead Sciences); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by Gilead Sciences; ION-4 ClinicalTrials.gov number, NCT02073656.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Alvarez D, 2006, J VIRAL HEPATITIS, V13, P683, DOI 10.1111/j.1365-2893.2006.00749.x; [Anonymous], 2015, HARVONI LEDIPASVIR S; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Brau N, 2007, J HEPATOL, V47, P527, DOI 10.1016/j.jhep.2007.06.010; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; German P, 2014, 65 ANN M AM ASS STUD; German P, 2015, ANN C RETR OPP INF S; Giordano TP, 2004, ARCH INTERN MED, V164, P2349, DOI 10.1001/archinte.164.21.2349; Haas DW, 2004, AIDS, V18, P2391; Kirk GD, 2013, ANN INTERN MED, V158, P658, DOI 10.7326/0003-4819-158-9-201305070-00604; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kramer JR, 2005, AM J GASTROENTEROL, V100, P56, DOI 10.1111/j.1572-0241.2005.40670.x; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; Osinusi A, 2015, JAMA-J AM MED ASSOC, V313, P1232, DOI 10.1001/jama.2015.1373; Rockstroh JK, 2014, 65 ANN M AM ASS STUD; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842	26	362	369	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2015	373	8					705	713		10.1056/NEJMoa1501315	http://dx.doi.org/10.1056/NEJMoa1501315			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LU	26196665	Green Accepted, Bronze			2022-12-28	WOS:000359709400007
J	Gaudet, D; Alexander, VJ; Baker, BF; Brisson, D; Tremblay, K; Singleton, W; Geary, RS; Hughes, SG; Viney, NJ; Graham, MJ; Crooke, RM; Witztum, JL; Brunzell, JD; Kastelein, JJP				Gaudet, Daniel; Alexander, Veronica J.; Baker, Brenda F.; Brisson, Diane; Tremblay, Karine; Singleton, Walter; Geary, Richard S.; Hughes, Steven G.; Viney, Nicholas J.; Graham, Mark J.; Crooke, Rosanne M.; Witztum, Joseph L.; Brunzell, John D.; Kastelein, John J. P.			Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; OF-FUNCTION MUTATIONS; CARDIOVASCULAR-DISEASE; REMNANT CHOLESTEROL; HIGH-RISK; APO-CIII; METABOLISM; PANCREATITIS	BACKGROUND Apolipoprotein C-III (APOC3) is a key regulator of plasma triglyceride levels. Elevated triglyceride levels are associated with a risk of adverse cardiovascular events and pancreatitis. ISIS 304801 is a second-generation antisense inhibitor of APOC3 synthesis. METHODS We conducted a randomized, double-blind, placebo-controlled, dose-ranging, phase 2 study to evaluate ISIS 304801 in untreated patients with fasting triglyceride levels between 350 mg per deciliter (4.0 mmol per liter) and 2000 mg per deciliter (22.6 mmol per liter) (ISIS 304801 monotherapy cohort), as well as in patients receiving stable fibrate therapy who had fasting triglyceride levels between 225 mg per deciliter (2.5 mmol per liter) and 2000 mg per deciliter (ISIS 304801-fibrate cohort). Eligible patients were randomly assigned to receive either ISIS 304801, at doses ranging from 100 to 300 mg, or placebo, once weekly for 13 weeks. The primary outcome was the percentage change in APOC3 level from baseline. RESULTS A total of 57 patients were treated in the ISIS 304801 monotherapy cohort (41 received active agent, and 16 received placebo), and 28 patients were treated in the ISIS 304801-fibrate cohort (20 received active agent, and 8 received placebo). The mean (+/- SD) baseline triglyceride levels in the two cohorts were 581 +/- 291 mg per deciliter (6.6 +/- 3.3 mmol per liter) and 376 +/- 188 mg per deciliter (4.2 +/- 2.1 mmol per liter), respectively. Treatment with ISIS 304801 resulted in dose-dependent and prolonged decreases in plasma APOC3 levels when the drug was administered as a single agent (decreases of 40.0 +/- 32.0% in the 100-mg group, 63.8 +/- 22.3% in the 200-mg group, and 79.6 +/- 9.3% in the 300-mg group, vs. an increase of 4.2 +/- 41.7% in the placebo group) and when it was administered as an add-on to fibrates (decreases of 60.2 +/- 12.5% in the 200-mg group and 70.9 +/- 13.0% in the 300-mg group, vs. a decrease of 2.2 +/- 25.2% in the placebo group). Concordant reductions of 31.3 to 70.9% were observed in triglyceride levels. No safety concerns were identified in this short-term study. CONCLUSIONS We found that treatment with ISIS 304801 was associated with significant lowering of triglyceride levels, among patients with a broad range of baseline levels, through selective antisense inhibition of APOC3 synthesis.	[Gaudet, Daniel; Brisson, Diane; Tremblay, Karine] Univ Montreal, Dept Med, Chicoutimi, PQ G7H 7P2, Canada; [Gaudet, Daniel; Brisson, Diane; Tremblay, Karine] Ecogene 21 Clin Res Ctr, Chicoutimi, PQ G7H 7P2, Canada; [Alexander, Veronica J.; Baker, Brenda F.; Singleton, Walter; Geary, Richard S.; Hughes, Steven G.; Viney, Nicholas J.; Graham, Mark J.; Crooke, Rosanne M.] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Witztum, Joseph L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Brunzell, John D.] Univ Washington, Dept Med, Seattle, WA USA; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	Universite de Montreal; Isis Pharmaceuticals Inc; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Amsterdam; Academic Medical Center Amsterdam	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Rm F4-159-2,Meibergdreef 9,POB 22660, NL-1100 DD Amsterdam, Netherlands.	daniel.gaudet@umontreal.ca; j.j.kastelein@amc.uva.nl	Kastelein, John/AAF-7950-2020; Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899; Baker, Brenda/0000-0001-8586-768X; Tremblay, Karine/0000-0002-2774-9738	Isis Pharmaceuticals	Isis Pharmaceuticals	Funded by Isis Pharmaceuticals; ClinicalTrials.gov number, NCT01529424.	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Akdim F, 2011, EUR HEART J, V32, P2650, DOI 10.1093/eurheartj/ehr148; Athyros VG, 2002, J CLIN GASTROENTEROL, V34, P472, DOI 10.1097/00004836-200204000-00020; Berglund L, 2012, J CLIN ENDOCR METAB, V97, P2969, DOI 10.1210/jc.2011-3213; Brown RJ, 2010, CIRC RES, V107, P357, DOI 10.1161/CIRCRESAHA.110.219188; Brunzell J D, 1973, Trans Assoc Am Physicians, V86, P245; Brunzell JD, 2012, J CLIN LIPIDOL, V6, P409, DOI 10.1016/j.jacl.2012.06.005; Chan DC, 2008, INT J CLIN PRACT, V62, P799, DOI 10.1111/j.1742-1241.2007.01678.x; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Christian JB, 2014, AM J MED, V127, P36, DOI 10.1016/j.amjmed.2013.09.018; CLAVEY V, 1995, ARTERIOSCL THROM VAS, V15, P963, DOI 10.1161/01.ATV.15.7.963; Cohen JC, 2014, CELL METAB, V20, P387, DOI 10.1016/j.cmet.2014.08.007; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Fredenrich A, 1997, J LIPID RES, V38, P1421; Gaudet D, 2014, NEW ENGL J MED, V371, P2200, DOI 10.1056/NEJMoa1400284; Ginsberg HN, 2011, ARTERIOSCL THROM VAS, V31, P471, DOI 10.1161/ATVBAHA.110.221846; GINSBERG HN, 1986, J CLIN INVEST, V78, P1287, DOI 10.1172/JCI112713; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hegele RA, 2014, LANCET DIABETES ENDO, V2, P655, DOI 10.1016/S2213-8587(13)70191-8; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Khetarpal SA, 2015, ARTERIOSCL THROM VAS, V35, pE3, DOI 10.1161/ATVBAHA.114.305172; KINNUNEN PKJ, 1976, FEBS LETT, V65, P354, DOI 10.1016/0014-5793(76)80145-7; Le N-A, 2011, ATLAS ATHEROSCLEROSI, P59; Mann CJ, 1997, J BIOL CHEM, V272, P31348, DOI 10.1074/jbc.272.50.31348; Mendivil CO, 2011, CIRCULATION, V124, P2065, DOI 10.1161/CIRCULATIONAHA.111.056986; Mendivil CO, 2010, ARTERIOSCL THROM VAS, V30, P239, DOI 10.1161/ATVBAHA.109.197830; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; Piolot A, 1996, PANCREAS, V13, P96, DOI 10.1097/00006676-199607000-00013; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Sacks FM, 2000, CIRCULATION, V102, P1886, DOI 10.1161/01.CIR.102.16.1886; Sacks FM, 2015, CURR OPIN LIPIDOL, V26, P56, DOI 10.1097/MOL.0000000000000146; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; SCHONFELD G, 1979, METABOLISM, V28, P1001, DOI 10.1016/0026-0495(79)90004-0; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; Shah A, 2010, ATHEROSCLEROSIS, V210, P35, DOI 10.1016/j.atherosclerosis.2009.11.010; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Thomsen M, 2014, CLIN CHEM, V60, P737, DOI 10.1373/clinchem.2013.219881; Tirosh A, 2007, ANN INTERN MED, V147, P377, DOI 10.7326/0003-4819-147-6-200709180-00007; Varbo A, 2014, PHARMACOL THERAPEUT, V141, P358, DOI 10.1016/j.pharmthera.2013.11.008; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Vega GL, 2003, AM J CARDIOL, V91, P956, DOI 10.1016/S0002-9149(03)00111-5; WINDLER E, 1985, J LIPID RES, V26, P556; Yu RZ, 2013, EXPERT OPIN DRUG MET, V9, P169, DOI 10.1517/17425255.2013.737320; Zheng CY, 2010, CIRCULATION, V121, P1722, DOI 10.1161/CIRCULATIONAHA.109.875807	48	364	376	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2015	373	5					438	447		10.1056/NEJMoa1400283	http://dx.doi.org/10.1056/NEJMoa1400283			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8BO	26222559				2022-12-28	WOS:000358662200007
J	Boozary, AS; Manchin, J; Wicker, RF				Boozary, Andrew S.; Manchin, Joseph, III; Wicker, Roger F.			The Medicare Hospital Readmissions Reduction Program Time for Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Boozary, Andrew S.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy &, Boston, MA 02115 USA; [Manchin, Joseph, III] US Senate D West Virginia, Washington, DC USA; [Wicker, Roger F.] US Senate R Mississippi, Washington, DC USA	Harvard University; Harvard T.H. Chan School of Public Health	Boozary, AS (corresponding author), Harvard Univ, Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	asb242@mail.harvard.edu						Conway PH, 2013, JAMA-J AM MED ASSOC, V309, P2215, DOI 10.1001/jama.2013.4929; Fiscella K, 2014, JAMA-J AM MED ASSOC, V312, P2615, DOI 10.1001/jama.2014.15372; Glass D, 2012, REFINING HOSP READMI; Hershberger PJ, 2014, JAMA-J AM MED ASSOC, V312, P2613, DOI 10.1001/jama.2014.13304; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, OUNCE EVIDENCE; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Rau J, MEDICARE FINES 2610; US Department of Health and Human Services, 2014, NEW HHS DAT SHOWS MA	9	65	65	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					347	348		10.1001/jama.2015.6507	http://dx.doi.org/10.1001/jama.2015.6507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219049				2022-12-28	WOS:000358581700013
J	Beverley, SM				Beverley, Stephen M.			PARASITOLOGY CRISPR for Cryptosporidium	NATURE			English	Editorial Material							GENOME		Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Beverley, SM (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	beverley@wusm.wustl.edu		Beverley, Stephen/0000-0001-5319-0811	NIAID NIH HHS [R01 AI029646] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029646] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Bouzid M, 2013, CLIN MICROBIOL REV, V26, P115, DOI 10.1128/CMR.00076-12; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; Striepen B, 2013, NATURE, V503, P189, DOI 10.1038/503189a; Vinayak S, 2015, NATURE, V523, P477, DOI 10.1038/nature14651; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977	8	6	6	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					413	414		10.1038/nature14636	http://dx.doi.org/10.1038/nature14636			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26176915	Green Accepted			2022-12-28	WOS:000358378900024
J	Li, PL; Lahvic, JL; Binder, V; Pugach, EK; Riley, EB; Tamplin, OJ; Panigrahy, D; Bowman, TV; Barrett, FG; Heffner, GC; McKinney-Freeman, S; Schlaeger, TM; Daley, GQ; Zeldin, DC; Zon, LI				Li, Pulin; Lahvic, Jamie L.; Binder, Vera; Pugach, Emily K.; Riley, Elizabeth B.; Tamplin, Owen J.; Panigrahy, Dipak; Bowman, Teresa V.; Barrett, Francesca G.; Heffner, Garrett C.; McKinney-Freeman, Shannon; Schlaeger, Thorsten M.; Daley, George Q.; Zeldin, Darryl C.; Zon, Leonard I.			Epoxyeicosatrienoic acids enhance embryonic haematopoiesis and adult marrow engraftment	NATURE			English	Article							STEM-CELLS; AORTIC ENDOTHELIUM; ZEBRAFISH; MIGRATION; RUNX1; TRANSPLANTATION; IDENTIFICATION; EXPRESSION; INVASION; INJURY	Haematopoietic stem and progenitor cell (HSPC) transplant is a widely used treatment for life-threatening conditions such as leukaemia; however, the molecular mechanisms regulating HSPC engraftment of the recipient niche remain incompletely understood. Here we develop a competitive HSPC transplant method in adult zebrafish, using in vivo imaging as a non-invasive readout. We use this system to conduct a chemical screen, and identify epoxyeicosatrienoic acids (EETs) as a family of lipids(1,2) that enhance HSPC engraftment. The pro-haematopoietic effects of EETs were conserved in the developing zebrafish embryo, where 11,12-EET promoted HSPC specification by activating a unique activator protein 1 (AP-1) and runx1 transcription program autonomous to the haemogenic endothelium. This effect required the activation of the phosphatidylinositol-3-OH kinase (PI(3) K) pathway, specifically PI(3) K gamma. In adult HSPCs, 11,12-EET induced transcriptional programs, including AP-1 activation, which modulate several cellular processes, such as migration, to promote engraftment. Furthermore, we demonstrate that the EET effects on enhancing HSPC homing and engraftment are conserved in mammals. Our study establishes a new method to explore the molecular mechanisms of HSPC engraftment, and discovers a previously unrecognized, evolutionarily conserved pathway regulating multiple haematopoietic generation and regeneration processes. EETs may have clinical application in marrow or cord blood transplantation.	[Li, Pulin; Lahvic, Jamie L.; Binder, Vera; Pugach, Emily K.; Riley, Elizabeth B.; Tamplin, Owen J.; Bowman, Teresa V.; Barrett, Francesca G.; Heffner, Garrett C.; Schlaeger, Thorsten M.; Daley, George Q.; Zon, Leonard I.] Harvard Univ, Sch Med, Stem Cell Program, Boston, MA 02115 USA; [Li, Pulin; Lahvic, Jamie L.; Binder, Vera; Pugach, Emily K.; Riley, Elizabeth B.; Tamplin, Owen J.; Bowman, Teresa V.; Barrett, Francesca G.; Heffner, Garrett C.; Schlaeger, Thorsten M.; Daley, George Q.; Zon, Leonard I.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Haematol Oncol, Boston, MA 02115 USA; [Li, Pulin; Lahvic, Jamie L.; Binder, Vera; Pugach, Emily K.; Riley, Elizabeth B.; Tamplin, Owen J.; Bowman, Teresa V.; Barrett, Francesca G.; Heffner, Garrett C.; Schlaeger, Thorsten M.; Daley, George Q.; Zon, Leonard I.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA; [Li, Pulin; Zon, Leonard I.] Harvard Univ, Chem Biol Program, Cambridge, MA 02138 USA; [Binder, Vera] Univ Munich, Dr von Hauner Childrens Hosp, Dept Hematol & Oncol, D-80337 Munich, Germany; [Panigrahy, Dipak] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Vasc Biol Res, Boston, MA 02115 USA; [McKinney-Freeman, Shannon] St Jude Childrens Res Hosp, Dept Haematol, Memphis, TN 38105 USA; [Zeldin, Darryl C.] Natl Inst Environm Hlth Sci, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; University of Munich; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zon, LI (corresponding author), Harvard Univ, Sch Med, Stem Cell Program, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	McKinney-Freeman, Shannon/N-8161-2018; Binder, Vera/N-2078-2015; Zeldin, Darryl C/Y-7091-2018; Tamplin, Owen/C-1617-2014	McKinney-Freeman, Shannon/0000-0001-8061-2557; Zeldin, Darryl C/0000-0002-2087-7307; Tamplin, Owen/0000-0001-9146-4860; Schlaeger, Thorsten/0000-0002-1599-9908; Li, Pulin/0000-0002-8525-4936; Lahvic, Jamie/0000-0003-4479-065X	NIH [P50-NS40828, P30-HD18655]; HHMI; National Institutes of Health (NIH) [R01 HL04880, P015PO1HL32262-32, 5P30 DK49216, 5R01 DK53298, 5U01 HL10001-05, R24 DK092760, 1R01HL097794-04]; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [Z01 ES025034]; National Cancer Institute [ROCA148633-01A5]; DFG; Care-for-Rare Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025034] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DFG(German Research Foundation (DFG)); Care-for-Rare Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. R. Lee, M. L. Edin and N. Gray for providing reagents; Y. Zhou, A. Dibiase, S. Yang, S. Datta, P. Manos, R. Mathieu and M. Ammerman for technical assistance; H. Huang for providing graphic illustration; R. M. White, T.E. North and C. Mosimann for discussion. Microarray studies were performed by the Molecular Genetics Core Facility at Boston Children's Hospital, supported by NIH-P50-NS40828 and NIH-P30-HD18655. S. Li in Y. Zhang's laboratory at the Longwood HHMI joint core facility helped with RNA-seq. L.I.Z. and G.Q.D. are Howard Hughes Medical Institute (HHMI) investigators. This work was supported by HHMI and National Institutes of Health (NIH) grants R01 HL04880, P015PO1HL32262-32, 5P30 DK49216, 5R01 DK53298, 5U01 HL10001-05, R24 DK092760, and 1R01HL097794-04 (to L.I.Z.). This work was also funded, in part, by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01 ES025034 to D.C.Z.), the National Cancer Institute grant ROCA148633-01A5 (D.P.), and DFG and Care-for-Rare Foundation (V.B.).	Bee T, 2009, BLOOD, V113, P5121, DOI 10.1182/blood-2008-12-193003; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Blake A., 2010, US patent, Patent No. [US7,700,825 B2, 7700825]; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Chen YM, 2011, BIOCHEMISTRY-US, V50, P3840, DOI 10.1021/bi102070w; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Fromel T, 2012, P NATL ACAD SCI USA, V109, P9995, DOI 10.1073/pnas.1206493109; Gilan O, 2015, ONCOGENE, V34, P1333, DOI 10.1038/onc.2014.26; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Ikebe D, 2007, GENES CELLS, V12, P197, DOI 10.1111/j.1365-2443.2007.01043.x; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lam BS, 2011, BLOOD, V117, P1167, DOI 10.1182/blood-2010-05-286294; Lam EYN, 2010, BLOOD, V116, P909, DOI 10.1182/blood-2010-01-264382; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Ma DD, 2011, BLOOD, V118, P289, DOI 10.1182/blood-2010-12-327403; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Panigrahy D, 2011, CANCER METAST REV, V30, P525, DOI 10.1007/s10555-011-9315-y; Pfister SL, 2010, ADV PHARMACOL, V60, P27, DOI [10.1016/B978-0-12-385061-4.00002-7, 10.1016/S1054-3589(10)60008-7]; Pugach Emily K, 2009, J Vis Exp, DOI 10.3791/1645; Renaud SJ, 2014, J BIOL CHEM, V289, P5025, DOI 10.1074/jbc.M113.523746; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Spector AA, 2015, BBA-MOL CELL BIOL L, V1851, P356, DOI 10.1016/j.bbalip.2014.07.020; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Yang WQ, 2008, J PHARMACOL EXP THER, V324, P1019, DOI 10.1124/jpet.107.129577	38	76	80	0	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					468	U203		10.1038/nature14569	http://dx.doi.org/10.1038/nature14569			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26201599	Green Accepted, Green Submitted			2022-12-28	WOS:000358378900038
J	Darzi, A				Darzi, Ara			PERSONAL VIEW We must convince the public that researchers need access to medical records	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Inst Global Hlth Innovat, London W2 1NY, England	Imperial College London	Darzi, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Inst Global Hlth Innovat, London W2 1NY, England.	a.darzi@imperial.ac.uk			National Institute for Health Research [NF-SI-0510-10186] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Caldicott F., 2013, INFORM SHARE NOT SHA	1	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2015	351								h3853	10.1136/bmj.h3853	http://dx.doi.org/10.1136/bmj.h3853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CW	26187611				2022-12-28	WOS:000358302500001
J	Mokyr, J				Mokyr, Joel			Intellectuals and the rise of the modern economy	SCIENCE			English	Editorial Material							EDUCATION		Northwestern Univ, Dept Econ, Evanston, IL 60208 USA	Northwestern University	Mokyr, J (corresponding author), Northwestern Univ, Dept Econ, Evanston, IL 60208 USA.	j-mokyr@northwestern.edu						[Anonymous], 1751, ENCY DICT RAISONNE S, P1751; Becker SO, 2011, AM ECON J-MACROECON, V3, P92, DOI 10.1257/mac.3.3.92; Easterly W., 2001, ELUSIVE QUEST GROWTH; Hooke R., 1666, ROYAL SOC CLASSIFIED, Vxx.50; Howitt P., 2009, EC GROWTH; McCloskey DN, 2006, BOURGEOIS VIRTUES ET; Meisenzahl R. R., 2012, RATE DIRECTION INVEN, P443; Mokyr J., 2002, THE GIFTS OF ATHENA; Mokyr J., 2010, ENLIGHTENED EC EC HI; North D.C., 1990, I I CHANGE EC PERFOR; Pritchett L, 2001, WORLD BANK ECON REV, V15, P367, DOI 10.1093/wber/15.3.367; Spolaore E, 2013, J ECON LIT, V51, P325, DOI 10.1257/jel.51.2.325; Squicciarini M. P., 2014, 20219 NAT BUR EC RES; Tabellini G, 2008, J EUR ECON ASSOC, V6, P255, DOI 10.1162/JEEA.2008.6.2-3.255; Tolstoy L., WAR PEACE	15	7	8	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					141	142		10.1126/science.aac6520	http://dx.doi.org/10.1126/science.aac6520			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4OM	26160932				2022-12-28	WOS:000357664300023
J	Haedler, AT; Kreger, K; Issac, A; Wittmann, B; Kivala, M; Hammer, N; Kohler, J; Schmidt, HW; Hildner, R				Haedler, Andreas T.; Kreger, Klaus; Issac, Abey; Wittmann, Bernd; Kivala, Milan; Hammer, Natalie; Koehler, Juergen; Schmidt, Hans-Werner; Hildner, Richard			Long-range energy transport in single supramolecular nanofibres at room temperature	NATURE			English	Article							EXCITON DIFFUSION; NANOTUBES; MIGRATION; POLYMERS; HETEROTRIANGULENES; FLUORESCENCE; COHERENCE; CRYSTALS; BLINKING; LENGTH	Efficient transport of excitation energy over long distances is a key process in light-harvesting systems, as well as in molecular electronics(1-3). However, in synthetic disordered organic materials, the exciton diffusion length is typically only around 10 nanometres (refs 4, 5), or about 50 nanometres in exceptional cases(6,7), a distance that is largely determined by the probability laws of incoherent exciton hopping. Only for highly ordered organic systems has the transport of excitation energy over macroscopic distances been reported-for example, for triplet excitons in anthracene single crystals at room temperature(8), as well as along single polydiacetylene chains embedded in their monomer crystalline matrix at cryogenic temperatures (at 10 kelvin, or -263 degrees Celsius)(9). For supramolecular nanostructures, uniaxial long-range transport has not been demonstrated at room temperature. Here we show that individual self-assembled nanofibres with molecular-scale diameter efficiently transport singlet excitons at ambient conditions over more than four micrometres, a distance that is limited only by the fibre length. Our data suggest that this remarkable long-range transport is predominantly coherent. Such coherent long-range transport is achieved by one-dimensional self-assembly of supramolecular building blocks, based on carbonyl-bridged triarylamines10, into well defined H-type aggregates (in which individual monomers are aligned cofacially) with substantial electronic interactions. These findings may facilitate the development of organic nanophotonic devices and quantum information technology.	[Haedler, Andreas T.; Kreger, Klaus; Schmidt, Hans-Werner] Univ Bayreuth, Macromol Chem 1, Bayreuth Inst Macromol Res, D-95440 Bayreuth, Germany; [Haedler, Andreas T.; Kreger, Klaus; Schmidt, Hans-Werner] Univ Bayreuth, Bayreuth Ctr Colloids & Interfaces, D-95440 Bayreuth, Germany; [Issac, Abey; Wittmann, Bernd; Koehler, Juergen; Hildner, Richard] Univ Bayreuth, Expt Phys 4, D-95440 Bayreuth, Germany; [Issac, Abey; Wittmann, Bernd; Koehler, Juergen; Hildner, Richard] Univ Bayreuth, Bayreuth Inst Macromol Res, D-95440 Bayreuth, Germany; [Kivala, Milan; Hammer, Natalie] Univ Erlangen Nurnberg, Dept Chem & Pharm, Chair Organ Chem 1, D-91054 Erlangen, Germany	University of Bayreuth; University of Bayreuth; University of Bayreuth; University of Bayreuth; University of Erlangen Nuremberg	Hildner, R (corresponding author), Univ Bayreuth, Expt Phys 4, D-95440 Bayreuth, Germany.	hans-werner.schmidt@uni-bayreuth.de; richard.hildner@uni-bayreuth.de	Kreger, Klaus/V-1151-2018; Hildner, Richard/O-6386-2014; Köhler, Jürgen/AAC-3030-2019; Kivala, Milan/D-2855-2012; Schmidt, Hans-Werner/J-1136-2014	Kreger, Klaus/0000-0003-3021-1311; Hildner, Richard/0000-0002-7282-3730; Köhler, Jürgen/0000-0002-4214-4008; Kivala, Milan/0000-0002-4960-4636; Schmidt, Hans-Werner/0000-0002-1761-1153	Bavarian State Ministry of Science, Research, and the Arts for the Collaborative Research Network 'Solar Technologies go Hybrid'; Deutsche Forschungsgemeinschaft (DFG) [GRK1640, SFB953]; Cluster of Excellence 'Engineering of Advanced Materials' (EAM) at the University of Erlangen-Nurnberg; 'Macromolecular Science' elite study program at the University of Bayreuth; 'Elite Netzwerk Bayern' fellowship	Bavarian State Ministry of Science, Research, and the Arts for the Collaborative Research Network 'Solar Technologies go Hybrid'; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cluster of Excellence 'Engineering of Advanced Materials' (EAM) at the University of Erlangen-Nurnberg; 'Macromolecular Science' elite study program at the University of Bayreuth; 'Elite Netzwerk Bayern' fellowship	We acknowledge financial support from the Bavarian State Ministry of Science, Research, and the Arts for the Collaborative Research Network 'Solar Technologies go Hybrid', the Deutsche Forschungsgemeinschaft (DFG) within projects GRK1640 (A.T.H., A.I., B.W., J.K., H.-W.S., R.H.) HI1508/2 (R.H.) and SFB953 'Synthetic Carbon Allotropes' (M.K., N.H.), and the Cluster of Excellence 'Engineering of Advanced Materials' (EAM) at the University of Erlangen-Nurnberg (M.K., N.H.). A.T.H. was funded by the 'Macromolecular Science' elite study program at the University of Bayreuth and an 'Elite Netzwerk Bayern' fellowship. We thank A. Schedl, M. Hund and M. Drechsler for their support with AFM and TEM.	Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; AVAKIAN P, 1964, PHYS REV LETT, V13, P541, DOI 10.1103/PhysRevLett.13.541; Bolinger JC, 2011, SCIENCE, V331, P565, DOI 10.1126/science.1199140; Cantekin S, 2012, CHEM SOC REV, V41, P6125, DOI 10.1039/c2cs35156k; Chaudhuri D, 2011, NANO LETT, V11, P488, DOI 10.1021/nl1033039; Clark KA, 2014, J PHYS CHEM LETT, V5, P2274, DOI 10.1021/jz500634f; Cogdell RJ, 2006, Q REV BIOPHYS, V39, P227, DOI 10.1017/S0033583506004434; Dou X, 2008, CHEM-EUR J, V14, P240, DOI 10.1002/chem.200700921; Dubin F, 2006, NAT PHYS, V2, P32, DOI 10.1038/nphys196; Eisele DM, 2014, P NATL ACAD SCI USA, V111, pE3367, DOI 10.1073/pnas.1408342111; Eisele DM, 2009, NAT NANOTECHNOL, V4, P658, DOI 10.1038/nnano.2009.227; Field JE, 2002, CHEM MATER, V14, P962, DOI 10.1021/cm010929y; Haedler AT, 2014, CHEM-EUR J, V20, P11708, DOI 10.1002/chem.201403667; Issac A, 2014, ACS NANO, V8, P1708, DOI 10.1021/nn4060946; Issac A, 2012, PHYS CHEM CHEM PHYS, V14, P10789, DOI 10.1039/c2cp41250k; Kivala M, 2013, CHEM-EUR J, V19, P8117, DOI 10.1002/chem.201300253; Laquai F, 2009, MACROMOL RAPID COMM, V30, P1203, DOI 10.1002/marc.200900309; Lin HZ, 2010, NANO LETT, V10, P620, DOI 10.1021/nl9036559; Lin JDA, 2014, MATER HORIZONS, V1, P280, DOI 10.1039/c3mh00089c; Menke SM, 2014, ENERG ENVIRON SCI, V7, P499, DOI 10.1039/c3ee42444h; Oostergetel GT, 2010, PHOTOSYNTH RES, V104, P245, DOI 10.1007/s11120-010-9533-0; Rawls H.R., 1965, PURE APPL CHEM, V11, P371; Scheblykin IG, 2000, J PHYS CHEM B, V104, P10949, DOI 10.1021/jp0030802; Scheibe G, 1939, NATURWISSENSCHAFTEN, V27, P499, DOI 10.1007/BF01488245; Scholes GD, 2012, ENERG ENVIRON SCI, V5, P9374, DOI 10.1039/c2ee23013e; Seki S, 2014, PHYS CHEM CHEM PHYS, V16, P11093, DOI 10.1039/c4cp00473f; Sengupta S, 2013, ACCOUNTS CHEM RES, V46, P2498, DOI 10.1021/ar400017u; Siebbeles L. D. A., 2011, CHARGE EXCITON TRANS; Spano FC, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1914768; Vogelsang J, 2011, NAT MATER, V10, P942, DOI [10.1038/NMAT3127, 10.1038/nmat3127]; Winiger CB, 2014, ANGEW CHEM INT EDIT, V53, P13609, DOI 10.1002/anie.201407968; Zhang W, 2011, SCIENCE, V334, P340, DOI 10.1126/science.1210369	32	222	225	14	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					196	U127		10.1038/nature14570	http://dx.doi.org/10.1038/nature14570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26156373				2022-12-28	WOS:000357695900031
J	Hoffmann, B; Tappe, D; Hoper, D; Herden, C; Boldt, A; Mawrin, C; Niederstrasser, O; Muller, T; Jenckel, M; van der Grinten, E; Lutter, C; Abendroth, B; Teifke, JP; Cadar, D; Schmidt-Chanasit, J; Ulrich, RG; Beer, M				Hoffmann, Bernd; Tappe, Dennis; Hoeper, Dirk; Herden, Christiane; Boldt, Annemarie; Mawrin, Christian; Niederstrasser, Olaf; Mueller, Tobias; Jenckel, Maria; van der Grinten, Elisabeth; Lutter, Christian; Abendroth, Bjoern; Teifke, Jens P.; Cadar, Daniel; Schmidt-Chanasit, Jonas; Ulrich, Rainer G.; Beer, Martin			A Variegated Squirrel Bornavirus Associated with Fatal Human Encephalitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE VIRUS; AVIAN BORNAVIRUS; RESERVOIR; PATHOGENESIS; INFECTION; FAILURE; SYSTEM; SHREWS; RATS; RNA	Between 2011 and 2013, three breeders of variegated squirrels (Sciurus variegatoides) had encephalitis with similar clinical signs and died 2 to 4 months after onset of the clinical symptoms. With the use of a metagenomic approach that incorporated next-generation sequencing and real-time reverse-transcriptase quantitative polymerase chain reaction (RT-qPCR), the presence of a previously unknown bornavirus was detected in a contact squirrel and in brain samples from the three patients. Phylogenetic analyses showed that this virus, tentatively named variegated squirrel 1 bornavirus (VSBV-1), forms a lineage separate from that of the known bornavirus species. (Funded by the Federal Ministry of Food and Agriculture [Germany] and others.)	[Hoffmann, Bernd; Hoeper, Dirk; Jenckel, Maria; Abendroth, Bjoern; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Teifke, Jens P.] Friedrich Loeffler Inst, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany; [Ulrich, Rainer G.] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany; [Tappe, Dennis; Cadar, Daniel; Schmidt-Chanasit, Jonas] World Hlth Org Collaborating Ctr Arbovirus & Hemo, Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Hoeper, Dirk; Cadar, Daniel; Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Hamburg, Germany; [Herden, Christiane] Univ Giessen, Inst Vet Pathol, Giessen, Germany; [Boldt, Annemarie; Niederstrasser, Olaf] Bergmannstrost Hosp, Dept Neurol, Halle, Saale, Germany; [Mueller, Tobias] Univ Hosp Halle Saale, Dept Neurol, Halle, Saale, Germany; [Mawrin, Christian] Otto Von Guericke Univ, Inst Neuropathol, Magdeburg, Germany; [van der Grinten, Elisabeth] State Inst Consumer Protect Saxony Anhalt, Dept Vet Med, Stendal, Germany; [Lutter, Christian] Special Serv Veterinarian Affairs & Consumer Prot, Bernburg, Saale, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Bernhard Nocht Institut fur Tropenmedizin; World Health Organization; German Center for Infection Research; Justus Liebig University Giessen; Martin Luther University Halle Wittenberg; Otto von Guericke University	Beer, M (corresponding author), OIE Collaborating Ctr Zoonoses Europe, Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Diagnost Virol, Sudufer 10, D-17493 Greifswald, Germany.	martin.beer@fli.bund.de	Daniel, Cadar/AAN-2658-2021; Jenckel, Maria/GOJ-7985-2022	Cadar, Daniel/0000-0002-8063-2766; Herden, Christiane/0000-0003-1858-2267; Teifke, Jens/0000-0001-7168-4970; Jenckel, Maria/0000-0001-9104-2369; Hoper, Dirk/0000-0001-8408-2274	Federal Ministry of Food and Agriculture (Germany); European Union ERA-NET project EpiSeq [2811ERA094]; Federal Ministry of Food and Agriculture [Germany];  [FV E/U2AD/CF512/DF557 META-InfRisk]	Federal Ministry of Food and Agriculture (Germany); European Union ERA-NET project EpiSeq; Federal Ministry of Food and Agriculture [Germany]; 	Funded by the Federal Ministry of Food and Agriculture [Germany] and others.	Bourg M, 2013, EMERG INFECT DIS, V19, P2064, DOI 10.3201/eid1912.131076; CARBONE KM, 1989, J NEUROPATH EXP NEUR, V48, P631, DOI 10.1097/00005072-198911000-00005; Durrwald R, 2007, REV MED VIROL, V17, P181, DOI 10.1002/rmv.530; Durrwald R, 2006, MICROBES INFECT, V8, P917, DOI 10.1016/j.micinf.2005.08.013; Durrwald R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093659; Durand B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070000; Fahnoe U, 2014, GENOME ANNOUNC, V2; Fujino K, 2014, P NATL ACAD SCI USA, V111, P13175, DOI 10.1073/pnas.1407046111; Herden C., 1999, Equine infectious diseases VIII: Proceedings of the Eighth International Conference, Dubai, 23rd-26th March 1998., P286; Herden C., 2013, FIELDS VIROLOGY, P1124; Hilbe M, 2006, EMERG INFECT DIS, V12, P675, DOI 10.3201/eid1204.051418; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Hornig M, 2012, MOL PSYCHIATR, V17, P486, DOI 10.1038/mp.2011.179; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Kramer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041476; Kuhn JH, 2015, ARCH VIROL, V160, P621, DOI 10.1007/s00705-014-2276-z; NARAYAN O, 1983, J INFECT DIS, V148, P305, DOI 10.1093/infdis/148.2.305; Piepenbring AK, 2012, EMERG INFECT DIS, V18, P234, DOI 10.3201/eid1802.111525; Richt JA, 1997, J NEUROVIROL, V3, P174, DOI 10.3109/13550289709015807; Rinder M, 2009, J VIROL, V83, P5401, DOI 10.1128/JVI.00133-09; Scheuch M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0503-6; Schwemmle M, 1999, LANCET, V354, P1973, DOI 10.1016/S0140-6736(99)04703-0; Werner-Keiss N, 2008, NEUROPATH APPL NEURO, V34, P590, DOI 10.1111/j.1365-2990.2008.00940.x; Wolff T, 2006, J CLIN VIROL, V36, P309, DOI 10.1016/j.jcv.2006.05.005	27	159	173	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					154	162		10.1056/NEJMoa1415627	http://dx.doi.org/10.1056/NEJMoa1415627			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3QP	26154788				2022-12-28	WOS:000357598600008
J	Siddiqui, NS; Altorok, N				Siddiqui, Nauman Saleem; Altorok, Nezam			Diffuse Soft-Tissue Calcinosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Siddiqui, Nauman Saleem; Altorok, Nezam] Univ Toledo, Med Ctr, Toledo, OH 43606 USA	University of Toledo	Siddiqui, NS (corresponding author), Univ Toledo, Med Ctr, 2801 W Bancroft St, Toledo, OH 43606 USA.	nezam.altorok@utoledo.edu							0	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					173	173		10.1056/NEJMicm1407238	http://dx.doi.org/10.1056/NEJMicm1407238			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3QP	26154790				2022-12-28	WOS:000357598600010
J	Summerskill, W; Horton, R				Summerskill, William; Horton, Richard			Faith-based delivery of science-based care	LANCET			English	Editorial Material									[Summerskill, William; Horton, Richard] The Lancet, London EC2Y 5AS, England		Summerskill, W (corresponding author), The Lancet, London EC2Y 5AS, England.							Duff JF, 2015, LANCET, V386, P1786, DOI 10.1016/S0140-6736(15)60250-1; General Medical Council, 2014, GOOD CLIN PRACT; Marshall K, 2015, LANCET, V386, pE24, DOI 10.1016/S0140-6736(15)61082-0; Olivier J, 2015, LANCET, V386, P1765, DOI 10.1016/S0140-6736(15)60251-3; Tomkins A, 2015, LANCET, V386, P1776, DOI 10.1016/S0140-6736(15)60252-5; World Health Organization, 2004, WORLD HLTH REP 2004	6	17	17	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					1709	1710		10.1016/S0140-6736(15)61104-7	http://dx.doi.org/10.1016/S0140-6736(15)61104-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV0WK	26159396				2022-12-28	WOS:000363974200007
J	Brufsky, A; Mathew, A				Brufsky, Adam; Mathew, Aju			Bisphosphonates, bone, and breast cancer recurrence	LANCET			English	Editorial Material							ZOLEDRONIC ACID; CONTROLLED TRIAL; WOMEN; CLODRONATE; THERAPY		[Brufsky, Adam; Mathew, Aju] Univ Pittsburgh, Magee Womens Hosp, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brufsky, A (corresponding author), Univ Pittsburgh, Magee Womens Hosp, Inst Canc, Pittsburgh, PA 15213 USA.	brufskyam@upmc.edu	Brufsky, Adam/AAE-7470-2020	Brufsky, Adam/0000-0001-8080-7960				Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Brufsky A, 2007, J CLIN ONCOL, V25, P829, DOI 10.1200/JCO.2005.05.3744; Coleman R, 2013, ANN ONCOL, V24, P398, DOI 10.1093/annonc/mds277; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Early Breast Cancer Trialists' Collaborative G, 2015, LANCET; Favus MJ, 2010, NEW ENGL J MED, V363, P2027, DOI 10.1056/NEJMct1004903; Gnant M, 2015, LANCET, V386, P433, DOI 10.1016/S0140-6736(15)60995-3; Gnant M, 2011, LANCET ONCOL, V12, P631, DOI 10.1016/S1470-2045(11)70122-X; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Powles T, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1384; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Saarto T, 2001, J CLIN ONCOL, V19, P10, DOI 10.1200/JCO.2001.19.1.10; Van Poznak CH, 2011, J CLIN ONCOL, V29, P1221, DOI 10.1200/JCO.2010.32.5209	14	11	11	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1319	1320		10.1016/S0140-6736(15)61163-1	http://dx.doi.org/10.1016/S0140-6736(15)61163-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8DP	26211825	hybrid			2022-12-28	WOS:000362316200009
J	Pritchard-Jones, K; Bergeron, C; de Camargo, B; van den Heuvel-Eibrink, MM; Acha, T; Godzinski, J; Oldenburger, F; Boccon-Gibod, L; Leuschner, I; Vujanic, G; Sandstedt, B; de Kraker, J; van Tinteren, H; Graf, N				Pritchard-Jones, Kathy; Bergeron, Christophe; de Camargo, Beatriz; van den Heuvel-Eibrink, Marry M.; Acha, Tomas; Godzinski, Jan; Oldenburger, Foppe; Boccon-Gibod, Liliane; Leuschner, Ivo; Vujanic, Gordan; Sandstedt, Bengt; de Kraker, Jan; van Tinteren, Harm; Graf, Norbert		SIOP Renal Tumours Study Grp	Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial	LANCET			English	Article							CHILDHOOD-CANCER; FAVORABLE-HISTOLOGY; PEDIATRIC-ONCOLOGY; INTERNATIONAL-SOCIETY; CARDIAC EVENTS; RENAL TUMORS; SURVIVORS; CHILDREN; CHEMOTHERAPY; EQUIVALENCE	Background Before this study started, the standard postoperative chemotherapy regimen for stage II-III Wilms' tumour pretreated with chemotherapy was to include doxorubicin. However, avoidance of doxorubicin-related cardiotoxicity effects is important to improve long-term outcomes for childhood cancers that have excellent prognosis. We aimed to assess whether doxorubicin can be omitted safely from chemotherapy for stage II-III, histological intermediate-risk Wilms' tumour when a newly defined high-risk blastemal subtype was excluded from randomisation. Methods For this international, multicentre, open-label, non-inferiority, phase 3, randomised SIOP WT 2001 trial, we recruited children aged 6 months to 18 years at the time of diagnosis of a primary renal tumour from 251 hospitals in 26 countries who had received 4 weeks of preoperative chemotherapy with vincristine and actinomycin D. Children with stage II-III intermediate-risk Wilms' tumours assessed after delayed nephrectomy were randomly assigned (1: 1) by a minimisation technique to receive vincristine 1.5 mg/m(2) at weeks 1-8, 11, 12, 14, 15, 17, 18, 20, 21, 23, 24, 26, and 27, plus actinomycin D 45 mu g/kg every 3 weeks from week 2, either with five doses of doxorubicin 50 mg/m(2) given every 6 weeks from week 2 (standard treatment) or without doxorubicin (experimental treatment). The primary endpoint was non-inferiority of event-free survival at 2 years, analysed by intention to treat and a margin of 10%. Assessment of safety and adverse events included systematic monitoring of hepatic toxicity and cardiotoxicity. This trial is registered with EudraCT, number 2007-004591-39, and is closed to new participants. Findings Between Nov 1, 2001, and Dec 16, 2009, we recruited 583 patients, 341 with stage II and 242 with stage III tumours, and randomly assigned 291 children to treatment including doxorubicin, and 292 children to treatment excluding doxorubicin. Median follow-up was 60.8 months (IQR 40.8-79.8). 2 year event-free survival was 92.6% (95% CI 89.6-95.7) for treatment including doxorubicin and 88.2% (84.5-92.1) for treatment excluding doxorubicin, a difference of 4.4% (95% CI 0.4-9.3) that did not exceed the predefined 10% margin. 5 year overall survival was 96.5% (94.3-98.8) for treatment including doxorubicin and 95.8% (93.3-98.4) for treatment excluding doxorubicin. Four children died from a treatment-related toxic effect; one (<1%) of 291 receiving treatment including doxorubicin died of sepsis, three (1%) of 292 receiving treatment excluding doxorubicin died of varicella, metabolic seizure, and sepsis during treatment for relapse. 17 patients (3%) had hepatic veno-occlusive disease. Cardiotoxic effects were reported in 15 (5%) of 291 children receiving treatment including doxorubicin. 12 children receiving treatment including doxorubicin, and ten children receiving treatment excluding doxorubicin, died, with the remaining deaths from tumour recurrence. Interpretation Doxorubicin does not need to be included in treatment of stage II-III intermediate risk Wilms' tumour when the histological response to preoperative chemotherapy is incorporated into the risk stratification. Copyright (C) Pritchard-Jones et al. Open Access article distributed under the terms of CC BY.	[Pritchard-Jones, Kathy] UCL, Inst Child Hlth, Canc Sect, London WC1H 1EH, England; [Bergeron, Christophe] Ctr Leon Berard, Dept Paediat Haematooncol, F-69373 Lyon, France; [de Camargo, Beatriz] Inst Nacl Canc, Res Ctr, Paediat Haematooncol Program, Rio De Janeiro, Brazil; [van den Heuvel-Eibrink, Marry M.] Princess Maxima Ctr Paediat Oncol, Utrecht, Netherlands; [Acha, Tomas] Hosp Maternoinfantil Carlos Haya, Unidad Oncol Pediat, Malaga, Spain; [Godzinski, Jan] Marciniak Hosp, Dept Paediat Surg, Wroclaw, Poland; [Oldenburger, Foppe] Univ Amsterdam, Acad Med Ctr, Dept Radiotherapy, NL-1105 AZ Amsterdam, Netherlands; [de Kraker, Jan] Univ Amsterdam, Acad Med Ctr, Dept Pediat Haematooncol, NL-1105 AZ Amsterdam, Netherlands; [Boccon-Gibod, Liliane] Univ Hop Armand Trousseau, Dept Paediat Pathol, Paris, France; [Leuschner, Ivo] Univ Hosp Schleswig Holstein, Dept Paediat Pathol, Kiel Paediat Tumour Registry, Kiel, Germany; [Vujanic, Gordan] Cardiff Univ, Inst Canc & Genet, Dept Paediat Pathol, Cardiff CF10 3AX, S Glam, Wales; [Sandstedt, Bengt] Karolinska Inst, Childhood Canc Res Unit, Stockholm, Sweden; [van Tinteren, Harm] Netherlands Canc Inst, Dept Biostat, Amsterdam, Netherlands; [Graf, Norbert] Univ Saarland, Dept Paediat Haematooncol, Homburg, Germany	University of London; University College London; UNICANCER; Centre Leon Berard; National Cancer Institute (Inca); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Kiel; Schleswig Holstein University Hospital; Cardiff University; Karolinska Institutet; Netherlands Cancer Institute; Saarland University	Pritchard-Jones, K (corresponding author), UCL, Inst Child Hlth, Canc Sect, London WC1H 1EH, England.	k.pritchard-jones@ucl.ac.uk	Øra, Ingrid/J-2596-2013; Graf, Norbert/H-1328-2011; Almaraz, Ricardo López/X-2931-2019; Vujanic, Gordan M./AAW-4712-2020; Gregianin, Lauro/W-5658-2019; de Camargo, Beatriz/I-8414-2014; Kuehne, Thomas/I-6143-2019; ANSARI, Marc/V-3334-2017; Vujanic, Gordan M./AFS-3176-2022; Llort, Anna/G-4066-2016; Pritchard-Jones, Kathryn/F-4286-2014	Øra, Ingrid/0000-0002-3931-4125; Graf, Norbert/0000-0002-2248-323X; Almaraz, Ricardo López/0000-0001-5521-9892; Vujanic, Gordan M./0000-0003-0726-6939; de Camargo, Beatriz/0000-0002-5794-1042; Kuehne, Thomas/0000-0002-7387-7028; Vujanic, Gordan M./0000-0003-0726-6939; Llort, Anna/0000-0001-9741-1655; Kager, Leo/0000-0003-4954-6488; Godzinski, Jan/0000-0001-9687-7146; van Tinteren, Harm/0000-0002-4626-8702; Zubizarreta, Pedro/0000-0001-8681-7502; DEFACHELLES, Anne-Sophie/0000-0002-4277-9871; Pritchard-Jones, Kathryn/0000-0002-2384-9475; Kearns, Pamela/0000-0003-2756-5813; ansari, marc/0000-0002-9649-6498; Vaidya, Sucheta/0000-0003-2980-9316; Ljungman, Gustaf/0000-0002-4949-2494	Cancer Research UK [C1188/A8687]; UK National Cancer Research Network; Children's Cancer and Leukaemia Group (CCLG); Societe Francaise des Cancers de l'Enfant; Association Leon Berard Enfant Cancereux and Enfant et Sante; Gesellschaft fur Padiatrische Onkologie und Hamatologie; Deutsche Krebschilfe [50-2709-Gr2]; Grupo Cooperativo Brasileiro para o Tratamento do Tumor de Wilms; Sociedade Brasileira de Oncologia Pediatrica; Spanish Society of Pediatric Haematology and Oncology; Spanish Association Against Cancer; SIOP-NL; National Institute for Health Research Biomedical Research Centre Funding Scheme; Cancer Research UK [15958] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); UK National Cancer Research Network; Children's Cancer and Leukaemia Group (CCLG); Societe Francaise des Cancers de l'Enfant; Association Leon Berard Enfant Cancereux and Enfant et Sante; Gesellschaft fur Padiatrische Onkologie und Hamatologie; Deutsche Krebschilfe; Grupo Cooperativo Brasileiro para o Tratamento do Tumor de Wilms; Sociedade Brasileira de Oncologia Pediatrica; Spanish Society of Pediatric Haematology and Oncology; Spanish Association Against Cancer; SIOP-NL; National Institute for Health Research Biomedical Research Centre Funding Scheme(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK)	The SIOP WT 2001 study was funded by Cancer Research UK (grant C1188/A8687), the UK National Cancer Research Network and Children's Cancer and Leukaemia Group (CCLG) (who supported the UK section), Societe Francaise des Cancers de l'Enfant and Association Leon Berard Enfant Cancereux and Enfant et Sante (who supported the French section), Gesellschaft fur Padiatrische Onkologie und Hamatologie and Deutsche Krebschilfe (grant 50-2709-Gr2, who supported the German section), Grupo Cooperativo Brasileiro para o Tratamento do Tumor de Wilms and Sociedade Brasileira de Oncologia Pediatrica (who supported the Brazilian section), the Spanish Society of Pediatric Haematology and Oncology and the Spanish Association Against Cancer (who supported the Spanish section) and SIOP-NL. K P-J is partly supported by the National Institute for Health Research Biomedical Research Centre Funding Scheme. We acknowledge the enormous efforts made by more than 1000 clinicians working at the 251 childhood cancer treatment centres in this study from 26 countries who enrolled and followed up patients in this study, and the patients and their families for their participation. The SIOP Renal Tumours Study Group and all authors thank the members of the independent data monitoring committee: Max Coppes (British Columbia Cancer Agency, Canada), Otilia Dalesio (Netherlands Cancer Institute, Amsterdam), and Dietmar Schmidt (Mannheim, Germany). We also acknowledge Lucy Wilkie and Aidan McManus for editorial assistance with journal style and formatting the final draft.	Armstrong GT, 2013, J CLIN ONCOL, V31, P3673, DOI 10.1200/JCO.2013.49.3205; Blanco JG, 2012, J CLIN ONCOL, V30, P1415, DOI 10.1200/JCO.2011.34.8987; Breslow NE, 2004, CANCER-AM CANCER SOC, V101, P1072, DOI 10.1002/cncr.20433; da Silva GT, 2009, BIOL BLOOD MARROW TR, V15, P120, DOI 10.1016/j.bbmt.2008.10.004; DANGIO GJ, 1989, CANCER-AM CANCER SOC, V64, P349, DOI 10.1002/1097-0142(19890715)64:2<349::AID-CNCR2820640202>3.0.CO;2-Q; de Kraker J, 2004, LANCET, V364, P1229, DOI 10.1016/S0140-6736(04)17139-0; Fernandez C, 2014, RENAL TUMORS CHILDHO, P77; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Graf N, 2012, EUR J CANCER, V48, P3240, DOI 10.1016/j.ejca.2012.06.007; Green DM, 2014, PEDIATR BLOOD CANCER, V61, P134, DOI 10.1002/pbc.24658; Green DM, 1998, J CLIN ONCOL, V16, P3744, DOI 10.1200/JCO.1998.16.12.3744; Green DM, 2004, J CLIN ONCOL, V22, P1366, DOI 10.1200/JCO.2004.08.008; Green DM, 2001, J CLIN ONCOL, V19, P1926, DOI 10.1200/JCO.2001.19.7.1926; Grundy PE, 2012, PEDIATR BLOOD CANCER, V59, P631, DOI 10.1002/pbc.24123; Grundy PE, 2005, J CLIN ONCOL, V23, P7312, DOI 10.1200/JCO.2005.01.2799; MACHIN D, 1988, BRIT MED J, V296, P1369, DOI 10.1136/bmj.296.6633.1369; Mertens AC, 2014, PSYCHO-ONCOLOGY, V23, P266, DOI 10.1002/pon.3414; Mitchell C, 2006, EUR J CANCER, V42, P2554, DOI 10.1016/j.ejca.2006.05.026; Pastore G, 2006, EUR J CANCER, V42, P2103, DOI 10.1016/j.ejca.2006.05.010; Pritchard-Jones K, 2012, ANN ONCOL, V23, P2457, DOI 10.1093/annonc/mds025; Reinhard H, 2004, KLIN PADIATR, V216, P132, DOI 10.1055/s-2004-822625; RODARY C, 1989, STAT MED, V8, P593, DOI 10.1002/sim.4780080508; TOURNADE MF, 1993, J CLIN ONCOL, V11, P1014, DOI 10.1200/JCO.1993.11.6.1014; Tournade MF, 2001, J CLIN ONCOL, V19, P488, DOI 10.1200/JCO.2001.19.2.488; UK Clinical Research Network Study Portfolio, SIOP NEPHR CLIN TRIA; Van Dalen E. C., 2006, COCHRANE DB SYST REV, V4; van Dalen EC, 2011, COCHRANE DB SYST REV, V19; van den Heuvel-Eibrink MM, 2015, EUR J CANCER, V51, P498, DOI 10.1016/j.ejca.2014.12.011; van der Pal HJ, 2012, J CLIN ONCOL, V30, P1429, DOI 10.1200/JCO.2010.33.4730; Verschuur AC, 2010, PEDIATR BLOOD CANCER, V55, P233, DOI 10.1002/pbc.22496; Vujanic GM, 2002, MED PEDIATR ONCOL, V38, P79, DOI 10.1002/mpo.1276; Wegert J, 2015, CANCER CELL, V27, P298, DOI 10.1016/j.ccell.2015.01.002; Weirich A, 2001, ANN ONCOL, V12, P311, DOI 10.1023/A:1011167924230	33	111	119	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					1156	1164		10.1016/S0140-6736(14)62395-3	http://dx.doi.org/10.1016/S0140-6736(14)62395-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5GE	26164096	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000361368000030
J	Sandhu, AT; Dudley, RA; Kazi, DS				Sandhu, Alexander T.; Dudley, R. Adams; Kazi, Dhruv S.			A Cost Analysis of the American Board of Internal Medicine's Maintenance-of-Certification Program	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH	Background: In 2014, the American Board of Internal Medicine (ABIM) substantially increased the requirements and fees for its maintenance-of-certification (MOC) program. Faced with mounting criticism, the ABIM suspended certain content requirements in February 2015 but retained the increased fees and number of modules. An objective appraisal of the cost of MOC would help inform upcoming consultations about MOC reform. Objective: To estimate the total cost of the 2015 version of the MOC program ("2015 MOC") and the incremental cost relative to the 2013 version ("2013 MOC"). Design: Decision analytic model. Data Sources: Published literature. Target Population: All ABIM-certified U.S. physicians. Time Horizon: 10 years (2015 to 2024). Perspective: Societal. Intervention: 2015 MOC. Outcome Measures: Testing costs (ABIM fees) and time costs (monetary value of physician time). Results of Base-Case Analysis: Internists will incur an average of $23 607 (95% CI, $5380 to $66 383) in MOC costs over 10 years, ranging from $16 725 for general internists to $40 495 for hematologists-oncologists. Time costs account for 90% of MOC costs. Cumulatively, 2015 MOC will cost $5.7 billion over 10 years, $1.2 billion more than 2013 MOC. This includes $5.1 billion in time costs (resulting from 32.7 million physician-hours spent on MOC) and $561 million in testing costs. Results of Sensitivity Analysis: Costs are sensitive to time spent on MOC and MOC credits obtainable from current continuing education activities. Limitation: Precise estimates of time required for MOC are not available. Conclusion: The ABIM MOC program will generate considerable costs, predominantly due to demands on physician time. A rigorous evaluation of its effect on clinical and economic outcomes is warranted to balance potential gains in health care quality and efficiency against the high costs identified in this study.	Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kazi, Dhruv S.] San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Sandhu, Alexander T.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Kazi, DS (corresponding author), San Francisco Gen Hosp, Div Cardiol, 1001 Potrero Ave,Room 5G1, San Francisco, CA 94110 USA.	kazi@ucsf.edu			University of California, San Francisco; U.S. Department of Veterans Affairs	University of California, San Francisco(University of California System); U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	University of California, San Francisco, and the U.S. Department of Veterans Affairs.	Accreditation Council for Continuing Medical Education, 2014, ANN REP EX SUMM TABL, P4; American Board of Internal Medicine, NUMB CAND CERT ANN A; American Board of Internal Medicine, CAND CERT ALL CAND; American Board of Internal Medicine, 2015, MAINT CERT GUID; American Board of Internal Medicine, 2014, MAINT CERT FREQ ASK; American Board of Internal Medicine, 2015, MAINT CERT PROGR COM; American Board of Internal Medicine, 1 TIM TAK PASS RAT M; American Medical Association, 2015, STAT MED LIC REQ STA, P65; Briggs AH, 2006, DECISION MODELLING H, P77; Bureau of Labor Statistics, 2015, OCC EMPL STAT OCC EM; Bureau of Labor Statistics, 2014, OCC EMPL STAT OCC EM; Centor RM, 2014, ANN INTERN MED, V161, P226, DOI 10.7326/M14-1014; Ehrenberg RG, 2011, MODERN EC THEORY PUB, V11th; Gray BM, 2014, JAMA-J AM MED ASSOC, V312, P2348, DOI 10.1001/jama.2014.12716; Irons MB, 2015, NEW ENGL J MED, V372, P104, DOI 10.1056/NEJMp1409923; Levinson W, 2011, AM J MED, V124, P180, DOI 10.1016/j.amjmed.2010.09.019; Levinson W, 2011, ARCH INTERN MED, V171, P174, DOI 10.1001/archinternmed.2010.477; Levinson W, 2010, NEW ENGL J MED, V362, P948, DOI 10.1056/NEJMclde0911205; O'Gara PT, 2014, J AM COLL CARDIOL, V64, P526, DOI 10.1016/j.jacc.2014.06.1160; Physicians for Certification Change, 2015, ABIM SHOULD RECALL R; Teirstein PS, 2015, NEW ENGL J MED, V372, P106, DOI 10.1056/NEJMp1407422; U.S. Department of Health and Human Services, 2008, PHYS WORKF PROJ RES, P29; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Woodruff TK, 2014, COMMUNICATION	24	37	37	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6					401	+		10.7326/M15-1011	http://dx.doi.org/10.7326/M15-1011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5FL	26216046				2022-12-28	WOS:000361365900014
J	Ohnmacht, C; Park, JH; Cording, S; Wing, JB; Atarashi, K; Obata, Y; Gaboriau-Routhiau, V; Marques, R; Dulauroy, S; Fedoseeva, M; Busslinger, M; Cerf-Bensussan, N; Boneca, IG; Voehringer, D; Hase, K; Honda, K; Sakaguchi, S; Eberl, G				Ohnmacht, Caspar; Park, Joo-Hong; Cording, Sascha; Wing, James B.; Atarashi, Koji; Obata, Yuuki; Gaboriau-Routhiau, Valerie; Marques, Rute; Dulauroy, Sophie; Fedoseeva, Maria; Busslinger, Meinrad; Cerf-Bensussan, Nadine; Boneca, Ivo G.; Voehringer, David; Hase, Koji; Honda, Kenya; Sakaguchi, Shimon; Eberl, Gerard			The microbiota regulates type 2 immunity through ROR gamma t(+) T cells	SCIENCE			English	Article							ROR-GAMMA-T; INNATE LYMPHOID-CELLS; EARLY-LIFE; PROINFLAMMATORY IL-17(+); OXAZOLONE COLITIS; DIFFERENTIATION; SUSCEPTIBILITY; ABSENCE; T(H)17; INFLAMMATION	Changes to the symbiotic microbiota early in life, or the absence of it, can lead to exacerbated type 2 immunity and allergic inflammations. Although it is unclear how the microbiota regulates type 2 immunity, it is a strong inducer of proinflammatory T helper 17 (T(H)17) cells and regulatory T cells (T-regs) in the intestine. Here, we report that microbiota-induced T-regs express the nuclear hormone receptor ROR gamma t and differentiate along a pathway that also leads to T(H)17 cells. In the absence of ROR gamma t+ T-regs, T(H)2-driven defense against helminths is more efficient, whereas T(H)2-associated pathology is exacerbated. Thus, the microbiota regulates type 2 responses through the induction of type 3 ROR gamma t+ T-regs and T(H)17 cells and acts as a key factor in balancing immune responses at mucosal surfaces.	[Ohnmacht, Caspar; Park, Joo-Hong; Cording, Sascha; Marques, Rute; Dulauroy, Sophie; Eberl, Gerard] Inst Pasteur, Microenvironm & Immun Unit, F-75724 Paris, France; [Wing, James B.; Sakaguchi, Shimon] Osaka Univ, Lab Expt Immunol, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Atarashi, Koji; Honda, Kenya] RIKEN Ctr Integrat Med Sci IMS RCAI, Yokohama, Kanagawa 2300045, Japan; [Atarashi, Koji] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan; [Obata, Yuuki; Hase, Koji] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; [Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine] INSERM, Lab Intestinal Immun, U1163, Paris, France; [Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine] Univ Paris 05, Inst Imagine, Paris, France; [Gaboriau-Routhiau, Valerie] INRA Micalis, UMR1319, Jouy En Josas, France; [Fedoseeva, Maria] Tech Univ Munich, Ctr Allergy & Environm ZAUM, Munich, Germany; [Fedoseeva, Maria] Helmholtz Zentrum Munchen, Munich, Germany; [Busslinger, Meinrad] Res Inst Mol Pathol, Vienna Bioctr, A-1030 Vienna, Austria; [Boneca, Ivo G.] Inst Pasteur, Biol & Genet Bacterial Cell Wall, F-75724 Paris, France; [Boneca, Ivo G.] INSERM, Grp Avenir, F-75015 Paris, France; [Voehringer, David] Univ Clin Erlangen, Inst Clin Microbiol Immunol & Hyg, Dept Infect Biol, D-91054 Erlangen, Germany; [Voehringer, David] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Honda, Kenya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Osaka University; RIKEN; Japan Science & Technology Agency (JST); University of Tokyo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Erlangen Nuremberg; University of Erlangen Nuremberg; Japan Science & Technology Agency (JST); Kyoto University	Eberl, G (corresponding author), Inst Pasteur, Microenvironm & Immun Unit, F-75724 Paris, France.	gerard.eberl@pasteur.fr	Honda, Kenya/N-5297-2015; Wing, James Badger/H-6256-2019; Eberl, Gerard/A-1160-2013; Boneca, Ivo G/H-1677-2014; GABORIAU-ROUTHIAU, Valérie/H-9493-2017; Cerf-Bensussan, nadine/H-9505-2017; Atarashi, Koji/I-5363-2014; Cording, Sascha/H-9470-2017; Busslinger, Meinrad J./J-1249-2016; Voehringer, David/K-2776-2019; Ohnmacht, Caspar/M-8033-2013; Sakaguchi, Shimon/C-9535-2009	Wing, James Badger/0000-0002-3462-1003; Boneca, Ivo G/0000-0001-8122-509X; GABORIAU-ROUTHIAU, Valérie/0000-0002-7662-4034; Cerf-Bensussan, nadine/0000-0003-0665-1245; Atarashi, Koji/0000-0001-5422-0736; Cording, Sascha/0000-0003-1926-2425; Busslinger, Meinrad J./0000-0002-9111-9351; Hase, Koji/0000-0001-9550-2334; Eberl, Gerard/0000-0002-1119-5638; Obata, Yuuki/0000-0001-5461-3521	Institut Pasteur; Agence Nationale de la Recherche (ANR) [11 BSV3 020 01]; Fondation de la Recherche Medicale [DEq. 2010318246]; Fondation Simone e Cino Del Duca from Institut de France; European Commission [MEXT-CT-2006-042374]; French government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; European Molecular Biology Organization; European Union; Japan Society for the Promotion of Science [15K19129]; Boehringer Ingelheim	Institut Pasteur(European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Simone e Cino Del Duca from Institut de France; European Commission(European CommissionEuropean Commission Joint Research Centre); French government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Union(European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Boehringer Ingelheim(Boehringer Ingelheim)	We thank B. Ryffel for providing the Il23a<SUP>-/-</SUP> mice, I. Forster for the Stat3<SUP>FL/FL</SUP> mice, and C. Leclerc for Il10<SUP>-/-</SUP> mice. We thank L. Polomack for technical assistance and the members of the Microenvironment and Immunity Unit for discussion and support. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by the Institut Pasteur, grants from the Agence Nationale de la Recherche (ANR 11 BSV3 020 01), the Fondation de la Recherche Medicale (DEq. 2010318246), the Fondation Simone e Cino Del Duca from the Institut de France, and an Excellence Grant from the European Commission (MEXT-CT-2006-042374). This study has received funding from the French government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant no. ANR-10-LABX-62-IBEID). C.O. was supported by a European Molecular Biology Organization fellowship, S.C. by a Marie Curie intra-European fellowship from the European Union, J.B.W. by Japan Society for the Promotion of Science Young Scientist B grant 15K19129, and M.B. by Boehringer Ingelheim.	Allen JE, 2014, SEMIN IMMUNOL, V26, P329, DOI 10.1016/j.smim.2014.06.003; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lochner M, 2011, J IMMUNOL, V186, P1531, DOI 10.4049/jimmunol.1001723; McCoy KD, 2006, IMMUNITY, V24, P329, DOI 10.1016/j.immuni.2006.01.013; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Prioult G, 2005, IMMUNOL REV, V206, P204, DOI 10.1111/j.0105-2896.2005.00277.x; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	42	487	505	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2015	349	6251					989	993		10.1126/science.aac4263	http://dx.doi.org/10.1126/science.aac4263			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5LW	26160380				2022-12-28	WOS:000360646800057
J	Li, NN; Zhai, YL; Zhang, YX; Li, WQ; Yang, MJ; Lei, JL; Tye, BK; Gao, N				Li, Ningning; Zhai, Yuanliang; Zhang, Yixiao; Li, Wanqiu; Yang, Maojun; Lei, Jianlin; Tye, Bik-Kwoon; Gao, Ning			Structure of the eukaryotic MCM complex at 3.8 angstrom	NATURE			English	Article							REPLICATIVE HELICASE MCM2-7; CRYO-EM STRUCTURE; ARCHAEAL MCM; CRYSTAL-STRUCTURE; MECHANISTIC INSIGHTS; DNA; BINDING; PROTEIN; DOMAIN; ORGANIZATION	DNA replication in eukaryotes is strictly regulated by several mechanisms. A central step in this replication is the assembly of the heterohexameric minichromosome maintenance (MCM2-7) helicase complex at replication origins during G1 phase as an inactive double hexamer. Here, using cryo-electron microscopy, we report a near-atomic structure of the MCM2-7 double hexamer purified from yeast G1 chromatin. Our structure shows that two single hexamers, arranged in a tilted and twisted fashion through interdigitated amino-terminal domain interactions, form a kinked central channel. Four constricted rings consisting of conserved interior beta-hairpins from the two single hexamers create a narrow passageway that tightly fits duplex DNA. This narrow passageway, reinforced by the offset of the two single hexamers at the double hexamer interface, is flanked by two pairs of gate-forming subunits, MCM2 and MCM5. These unusual features of the twisted and tilted single hexamers suggest a concerted mechanism for the melting of origin DNA that requires structural deformation of the intervening DNA.	[Li, Ningning; Zhang, Yixiao; Li, Wanqiu; Yang, Maojun; Lei, Jianlin; Gao, Ning] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Zhai, Yuanliang; Tye, Bik-Kwoon] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Zhai, Yuanliang] Hong Kong Univ Sci & Technol, Inst Adv Study, Kowloon, Hong Kong, Peoples R China; [Tye, Bik-Kwoon] Cornell Univ, Dept Mol Biol & Genet, Coll Agr & Life Sci, Ithaca, NY 14853 USA	Tsinghua University; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Cornell University	Gao, N (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China.	zhai@ust.hk; bt16@cornell.edu; ninggao@tsinghua.edu.cn	Gao, Ning/AAK-2214-2020; Gao, Ning/J-9623-2012	Gao, Ning/0000-0003-3067-9993; Gao, Ning/0000-0003-3067-9993; Li, Wanqiu/0000-0002-9227-3246; Zhai, Yuanliang/0000-0002-8897-6416; Li, Ningning/0000-0001-8601-5171; Yang, Maojun/0000-0002-6798-3094	Ministry of Science and Technology of China [2013CB910404]; National Natural Science Foundation of China [31422016]; Research Grants Council of Hong Kong [GRF664013, HKUST12/CRF/13G]; Hong Kong University of Science Technology	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong University of Science Technology	We thank X. Li for providing programs in data collection, motion correction and framed-based analysis, and J. Wang for advices on modelling and model refinement. We also thank the National Center for Protein Sciences (Beijing, China) for technical support with cryo-EMdata collection and for computation resource. This work was supported by the Ministry of Science and Technology of China (2013CB910404 to N.G.), the National Natural Science Foundation of China (31422016 to N.G.), the Research Grants Council of Hong Kong (GRF664013 and HKUST12/CRF/13G to Yu.Z.) and the Hong Kong University of Science & Technology (B.-K.T.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bae B, 2009, STRUCTURE, V17, P211, DOI 10.1016/j.str.2008.11.010; Bell SD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012807; Bleichert F, 2015, NATURE, V519, P321, DOI 10.1038/nature14239; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Brewster AS, 2008, P NATL ACAD SCI USA, V105, P20191, DOI 10.1073/pnas.0808037105; Bruck I, 2015, J BIOL CHEM, V290, P1210, DOI 10.1074/jbc.M114.608232; Bruck I, 2013, J BIOL CHEM, V288, P7550, DOI 10.1074/jbc.M112.440941; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Costa A, 2013, ANNU REV BIOCHEM, V82, P25, DOI 10.1146/annurev-biochem-052610-094414; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Cuesta I, 2010, J MOL BIOL, V397, P1276, DOI 10.1016/j.jmb.2010.02.042; Duderstadt KE, 2013, CURR OPIN STRUC BIOL, V23, P144, DOI 10.1016/j.sbi.2012.11.012; Eisenberg S, 2009, J BIOL CHEM, V284, P25412, DOI 10.1074/jbc.M109.033175; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Evrin C, 2014, NUCLEIC ACIDS RES, V42, P2257, DOI 10.1093/nar/gkt1148; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Froelich CA, 2014, ELIFE, V3, DOI 10.7554/eLife.01993; Fu Y, 2014, J MOL BIOL, V426, P1512, DOI 10.1016/j.jmb.2013.12.025; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Hesketh EL, 2015, J BIOL CHEM, V290, P7973, DOI 10.1074/jbc.M114.622738; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jenkinson ER, 2006, P NATL ACAD SCI USA, V103, P7613, DOI 10.1073/pnas.0509297103; Kang S, 2014, MOL CELL, V55, P655, DOI 10.1016/j.molcel.2014.06.033; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu W, 2008, NUCLEIC ACIDS RES, V36, P3235, DOI 10.1093/nar/gkn183; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Miller JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03433; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; On KF, 2014, EMBO J, V33, P605, DOI 10.1002/embj.201387369; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Samel SA, 2014, GENE DEV, V28, P1653, DOI 10.1101/gad.242404.114; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Siddiqui K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012930; Slaymaker IM, 2013, NUCLEIC ACIDS RES, V41, P3446, DOI 10.1093/nar/gkt022; Slaymaker Ian M, 2012, Subcell Biochem, V62, P89, DOI 10.1007/978-94-007-4572-8_6; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Tanaka S., 2013, COLD SPRING HARB PER, V5; Tognetti S, 2015, CHROMOSOMA, V124, P13, DOI 10.1007/s00412-014-0489-2; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Vijayraghavan Sriram, 2012, Subcell Biochem, V62, P113, DOI 10.1007/978-94-007-4572-8_7; Wang Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5808; Wei Z, 2010, J BIOL CHEM, V285, P12469, DOI 10.1074/jbc.C109.094599; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zhai YL, 2010, J CELL SCI, V123, P3933, DOI 10.1242/jcs.075366; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148	74	162	168	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2015	524	7564					186	+		10.1038/nature14685	http://dx.doi.org/10.1038/nature14685			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO8AM	26222030				2022-12-28	WOS:000359386900024
J	McMahon, GT				McMahon, Graham T.			Advancing Continuing Medical Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Accreditat Council Continuing Med Educ, Chicago, IL 60654 USA		McMahon, GT (corresponding author), Accreditat Council Continuing Med Educ, 515 N State St,Ste 1801, Chicago, IL 60654 USA.	gmcmahon@accme.org	McMahon, Graham/D-3740-2009	McMahon, Graham/0000-0003-4288-6535				Accreditation Council for Continuing Medical Education (ACCME), PROP NEW CRIT ACCR C; Accreditation Council for Continuing Medical Education (ACCME), 2015, 2014 ACCME ANN REP; Cervero RM, 2015, J CONTIN EDUC HEALTH, V35, P131, DOI 10.1002/chp.21290; Combes JR, 2014, CONTINUING MED ED ST; Institute of Medicine, 2015, MEASURING IMPACT INT; Steinman MA, 2010, ACAD MED, V85, P74, DOI 10.1097/ACM.0b013e3181c51d3f	6	22	22	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					561	562		10.1001/jama.2015.7094	http://dx.doi.org/10.1001/jama.2015.7094			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26192406				2022-12-28	WOS:000359388600012
J	Emmert, S; Schon, MP				Emmert, Steffen; Schoen, Michael P.			Squamous-Cell Carcinoma Resembling Pyoderma Gangrenosum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Emmert, Steffen] Univ Med Ctr Rostock, Rostock, Germany; [Schoen, Michael P.] Univ Med Ctr Gottingen, Gottingen, Germany	University of Rostock; University of Gottingen	Emmert, S (corresponding author), Univ Med Ctr Rostock, Rostock, Germany.	steffen.emmert@med.uni-rostock.de							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2015	373	5							e5	10.1056/NEJMicm1410236	http://dx.doi.org/10.1056/NEJMicm1410236			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8BO	26222581				2022-12-28	WOS:000358662200011
J	Butler, S				Butler, Stuart			Strengthening the Affordable Care Act The Need for Strategic Building Blocks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Butler, S (corresponding author), Brookings Inst, 1775 Massachusetts Ave NW, Washington, DC 20036 USA.	smbutler@brookings.edu						Butler SM, 2015, EVOLVING TRADITIONAL; Butler Stuart M, 2001, COVERING AM REAL REM, P23; Congressional Budget Office, 2015, PREM SUPP SYST AN IL; Furman J, 2008, HEALTH AFFAIR, V27, P622, DOI 10.1377/hlthaff.27.3.622; McDonough JE, 2014, J HEALTH POLIT POLIC, V39, P1099, DOI 10.1215/03616878-2744824	5	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					335	336		10.1001/jama.2015.7153	http://dx.doi.org/10.1001/jama.2015.7153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219043				2022-12-28	WOS:000358581700007
J	Moss, JD; Cifu, AS				Moss, Joshua D.; Cifu, Adam S.			Management of Anticoagulation in Patients With Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WARFARIN; STROKE; PREVENTION		[Moss, Joshua D.; Cifu, Adam S.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Camm AJ, 2012, EUR HEART J, V33; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Culebras A, 2014, NEUROLOGY, V82, P716, DOI 10.1212/WNL.0000000000000145; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	9	10	11	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					291	292		10.1001/jama.2015.3088	http://dx.doi.org/10.1001/jama.2015.3088			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197190				2022-12-28	WOS:000358228000024
J	[Anonymous]				[Anonymous]			New Opportunities in Health Broadcasting (Reprinted from JAMA, vol 115, pg 220, 1940)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Federal Security Agency U.S. Office of Education, 1940, FCC RUL STAT LESS F; 1940, JAMA, V115, P220	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					302	302		10.1001/jama.2014.11874	http://dx.doi.org/10.1001/jama.2014.11874			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197198				2022-12-28	WOS:000358228000031
J	Bohannon, J				Bohannon, John			SCIENTIFIC SOCIETIES Torture report prompts APA apology	SCIENCE			English	News Item																			0	3	3	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		221	222		10.1126/science.349.6245.221	http://dx.doi.org/10.1126/science.349.6245.221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185221				2022-12-28	WOS:000358218600012
J	Fraser, LH; Pither, J; Jentsch, A; Sternberg, M; Zobel, M; Askarizadeh, D; Bartha, S; Beierkuhnlein, C; Bennett, JA; Bittel, A; Boldgiv, B; Boldrini, II; Bork, E; Brown, L; Cabido, M; Cahill, J; Carlyle, CN; Campetella, G; Chelli, S; Cohen, O; Csergo, AM; Diaz, S; Enrico, L; Ensing, D; Fidelis, A; Fridley, JD; Foster, B; Garris, H; Goheen, JR; Henry, HAL; Hohn, M; Jouri, MH; Klironomos, J; Koorem, K; Lawrence-Lodge, R; Long, RJ; Manning, P; Mitchell, R; Moora, M; Muller, SC; Nabinger, C; Naseri, K; Overbeck, GE; Palmer, TM; Parsons, S; Pesek, M; Pillar, VD; Pringle, RM; Roccaforte, K; Schmidt, A; Shang, ZH; Stahlmann, R; Stotz, GC; Sugiyama, S; Szentes, S; Thompson, D; Tungalag, R; Undrakhbold, S; van Rooyen, M; Wellstein, C; Wilson, JB; Zupo, T				Fraser, Lauchlan H.; Pither, Jason; Jentsch, Anke; Sternberg, Marcelo; Zobel, Martin; Askarizadeh, Diana; Bartha, Sandor; Beierkuhnlein, Carl; Bennett, Jonathan A.; Bittel, Alex; Boldgiv, Bazartseren; Boldrini, Ilsi I.; Bork, Edward; Brown, Leslie; Cabido, Marcelo; Cahill, James; Carlyle, Cameron N.; Campetella, Giandiego; Chelli, Stefano; Cohen, Ofer; Csergo, Anna-Maria; Diaz, Sandra; Enrico, Lucas; Ensing, David; Fidelis, Alessandra; Fridley, Jason D.; Foster, Bryan; Garris, Heath; Goheen, Jacob R.; Henry, Hugh A. L.; Hohn, Maria; Jouri, Mohammad Hassan; Klironomos, John; Koorem, Kadri; Lawrence-Lodge, Rachael; Long, Ruijun; Manning, Pete; Mitchell, Randall; Moora, Mari; Mueller, Sandra C.; Nabinger, Carlos; Naseri, Kamal; Overbeck, Gerhard E.; Palmer, Todd M.; Parsons, Sheena; Pesek, Mari; Pillar, Valerio D.; Pringle, Robert M.; Roccaforte, Kathy; Schmidt, Amanda; Shang, Zhanhuan; Stahlmann, Reinhold; Stotz, Gisela C.; Sugiyama, Shu-ichi; Szentes, Szilard; Thompson, Don; Tungalag, Radnaakhand; Undrakhbold, Sainbileg; van Rooyen, Margaretha; Wellstein, Camilla; Wilson, J. Bastow; Zupo, Talita			Worldwide evidence of a unimodal relationship between productivity and plant species richness	SCIENCE			English	Article							DIVERSITY; BIOMASS; ENRICHMENT; MECHANISMS	The search for predictions of species diversity across environmental gradients has challenged ecologists for decades. The humped-back model (HBM) suggests that plant diversity peaks at intermediate productivity; at low productivity few species can tolerate the environmental stresses, and at high productivity a few highly competitive species dominate. Over time the HBM has become increasingly controversial, and recent studies claim to have refuted it. Here, by using data from coordinated surveys conducted throughout grasslands worldwide and comprising a wide range of site productivities, we provide evidence in support of the HBM pattern at both global and regional extents. The relationships described here provide a foundation for further research into the local, landscape, and historical factors that maintain biodiversity.	[Fraser, Lauchlan H.; Schmidt, Amanda] Thompson Rivers Univ, Dept Nat Resource Sci, Kamloops, BC, Canada; [Pither, Jason; Ensing, David; Klironomos, John] Univ British Columbia, Dept Biol, Kelowna, BC, Canada; [Jentsch, Anke] Univ Bayreuth, Dept Disturbance Ecol, BayCEER, Bayreuth, Germany; [Sternberg, Marcelo] Tel Aviv Univ, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel; [Zobel, Martin; Koorem, Kadri; Moora, Mari] Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Askarizadeh, Diana] Univ Tehran, Fac Nat Resources, Coll Agr & Nat Resources, Tehran 14174, Iran; [Bartha, Sandor] MTA Ctr Ecol Res, Inst Ecol & Bot, Vacratot, Hungary; [Bartha, Sandor] Univ Western Australia, Sch Plant Biol, Crawley, Australia; [Beierkuhnlein, Carl; Stahlmann, Reinhold] Univ Bayreuth, Dept Biogeog, BayCEER, Bayreuth, Germany; [Bennett, Jonathan A.; Cahill, James; Stotz, Gisela C.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Bittel, Alex; Foster, Bryan; Parsons, Sheena; Pesek, Mari; Roccaforte, Kathy] Univ Kansas, Dept Ecol & Evolutionary Biol, Manhattan, KS 66047 USA; [Boldgiv, Bazartseren; Tungalag, Radnaakhand; Undrakhbold, Sainbileg] Natl Univ Mongolia, Dept Biol, Ulaanbaatar, Mongolia; [Boldrini, Ilsi I.; Overbeck, Gerhard E.] Univ Fed Rio Grande do Sul, Dept Bot, Porto Alegre, RS, Brazil; [Bork, Edward; Carlyle, Cameron N.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Brown, Leslie] Univ S Africa, Appl Behav Ecol & Ecosyst Res Unit, Johannesburg, South Africa; [Cabido, Marcelo; Diaz, Sandra; Enrico, Lucas] Univ Nacl Cordoba, Inst Multidisciplinario Biol Vegetal IMBIV CONICE, Cordoba, Spain; [Cabido, Marcelo; Diaz, Sandra; Enrico, Lucas] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Cordoba, Spain; [Campetella, Giandiego; Chelli, Stefano] Univ Camerino, Sch Biosci & Vet Med, I-62032 Camerino, Italy; [Csergo, Anna-Maria] Trinity Coll Dublin, Sch Nat Sci, Dublin, Ireland; [Fidelis, Alessandra; Zupo, Talita] UNESP Univ Estadual Paulista, Dept Bot, Rio Claro, Brazil; [Fridley, Jason D.] Syracuse Univ, Dept Biol, Syracuse, NY 13210 USA; [Garris, Heath; Mitchell, Randall] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Goheen, Jacob R.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Henry, Hugh A. L.] Univ Western Ontario, Dept Biol, London, ON, Canada; [Hohn, Maria] Corvinus Univ Budapest, Dept Bot, Budapest, Hungary; [Jouri, Mohammad Hassan] Islamic Azad Univ, Hour Branch, Dept Nat Resources, Tehran, Iran; [Lawrence-Lodge, Rachael; Wilson, J. Bastow] Univ Otago, Dept Bot, Dunedin, New Zealand; [Long, Ruijun; Shang, Zhanhuan] Lanzhou Univ, Int Ctr Tibetan Plateau Ecosyst Management, Lanzhou 730000, Peoples R China; [Manning, Pete] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; [Mueller, Sandra C.; Pillar, Valerio D.] Univ Fed Rio Grande do Sul, Dept Ecol, Porto Alegre, RS, Brazil; [Nabinger, Carlos] Univ Fed Rio Grande do Sul, Fac Agron, Porto Alegre, RS, Brazil; [Naseri, Kamal] Ferdowsi Univ Mashhad, Dept Range & Watershed Management, Mashhad, Iran; [Palmer, Todd M.] Univ Florida, Dept Biol, Gainesville, FL 32311 USA; [Pringle, Robert M.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Sugiyama, Shu-ichi] Hirosaki Univ, Plant Ecol Lab, Hirosaki, Aomori, Japan; [Szentes, Szilard] Szent Istvan Univ, Inst Plant Prod, Godollo, Hungary; [Thompson, Don] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [van Rooyen, Margaretha] Univ Pretoria, Dept Plant Sci, ZA-0002 Pretoria, South Africa; [Wellstein, Camilla] Free Univ Bozen Bolzano, Fac Sci & Technol, Bolzano, Italy; [Wilson, J. Bastow] Landcare Res, Dunedin, New Zealand	University of British Columbia; University of Bayreuth; Tel Aviv University; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Tehran; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; University of Western Australia; University of Bayreuth; University of Alberta; University of Kansas; National University of Mongolia; Universidade Federal do Rio Grande do Sul; University of Alberta; University of South Africa; University of Camerino; Trinity College Dublin; Universidade Estadual Paulista; Syracuse University; University System of Ohio; University of Akron; University of Wyoming; Western University (University of Western Ontario); Corvinus University Budapest; Islamic Azad University; University of Otago; Lanzhou University; University of Bern; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Ferdowsi University Mashhad; State University System of Florida; University of Florida; Princeton University; Hirosaki University; Hungarian University of Agriculture & Life Sciences; Agriculture & Agri Food Canada; University of Pretoria; Free University of Bozen-Bolzano; Landcare Research - New Zealand	Fraser, LH (corresponding author), Thompson Rivers Univ, Dept Nat Resource Sci, Kamloops, BC, Canada.	lfraser@tru.ca	Sternberg, Marcelo/AFQ-1615-2022; Manning, Peter/I-6523-2012; Boldgiv, Bazartseren/I-4754-2013; Jouri, Mohammad Hasan/D-4212-2012; Bennett, Jonathan/AAH-3191-2021; Csergo, Anna Maria/AAB-3581-2021; van Rooyen, Margaretha W/AAC-9578-2022; Diaz, Sandra/Q-9804-2018; Zobel, Martin/H-1336-2015; Overbeck, Gerhard/D-8695-2013; Cahill, James F/B-6147-2015; Mitchell, Randall J/G-6380-2010; Pillar, Valerio/B-9872-2008; Stotz, Gisela/E-2197-2017; Beierkuhnlein, Carl/ABF-9693-2021; Bennett, Jonathan A/J-5839-2013; Brown, Leslie R/N-9762-2015; Müller, Sandra/G-3739-2012; Moora, Mari/D-1961-2009; van Rooyen, Margaretha W/K-3559-2019; Fidelis, Alessandra/B-9769-2012; Wellstein, Camilla/C-5042-2012; Palmer, Todd/GRS-0639-2022; Csergő, Anna Mária/J-3446-2013; Henry, Hugh A L/C-3955-2017; Beierkuhnlein, Carl/ABF-8797-2021	Sternberg, Marcelo/0000-0001-8710-4141; Manning, Peter/0000-0002-7940-2023; Boldgiv, Bazartseren/0000-0003-0015-8142; Bennett, Jonathan/0000-0001-5617-7524; Csergo, Anna Maria/0000-0003-3325-2995; Zobel, Martin/0000-0001-7957-6704; Overbeck, Gerhard/0000-0002-8716-5136; Cahill, James F/0000-0002-4110-1516; Mitchell, Randall J/0000-0001-7961-3560; Pillar, Valerio/0000-0001-6408-2891; Stotz, Gisela/0000-0001-8687-7361; Beierkuhnlein, Carl/0000-0002-6456-4628; Bennett, Jonathan A/0000-0001-5617-7524; Brown, Leslie R/0000-0002-1026-5438; Müller, Sandra/0000-0002-6316-2897; Moora, Mari/0000-0002-4819-7506; Fidelis, Alessandra/0000-0001-9545-2285; Csergő, Anna Mária/0000-0003-3325-2995; Carlyle, Cameron/0000-0003-4753-5945; Pither, Jason/0000-0002-7490-6839; Palmer, Todd/0000-0001-5710-9750; Campetella, Giandiego/0000-0001-6126-522X; Koorem, Kadri/0000-0002-3376-9372; Lawrence Lodge, Rachael/0000-0002-0059-3323; Wellstein, Camilla/0000-0001-6994-274X; CHELLI, Stefano/0000-0001-7184-8242; Stahlmann, Reinhold/0000-0001-5904-417X; Enrico, Lucas/0000-0002-8932-0144; Ensing, David/0000-0003-2903-1209; Garris, Heath/0000-0003-0416-4128	Canada Research Chair Program; Canadian Foundation for Innovation (CFI); Natural Sciences and Engineering Research Council Discovery Grant (NSERC-DG) of Canada; Thompson Rivers University; CFI; NSERC-DG; University of Tartu, Estonia; European Regional Development Fund: Centre of Excellence FIBIR; Hungarian National Science Foundation [OTKA K 105608]; Taylor Family-Asia Foundation Endowed Chair in Ecology and Conservation Biology; University of Mongolia's Support for High Impact Research program; Rangeland Research Institute, University of Alberta, Canada; CONICET; Universidad Nacional de Cordoba; FONCyT; Inter-American Institute for Global Change Research; NSF; State Nature Reserve "Montagna di Torricchio"; University of Camerino, Italy; Hungarian University of Transylvania, Romania; Fundacao Grupo Boticario, Brazil [0153_2011_PR]; NSF [DEB-1021158, DEB-0950100, DEB 1149980, DEB 1355122]; UHURU: NSERC; University of Wyoming; National Natural Science Foundation of China [41171417]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [307719/2012-0]; CNPq, Brazil [403750/2012-1, 307689/2014-0]; University of Florida; Princeton Environmental Institute; CONYCIT Becas-Chile Scholarship; Directorate For Geosciences [1138881] Funding Source: National Science Foundation; Division Of Environmental Biology [0950100] Funding Source: National Science Foundation	Canada Research Chair Program(Canada Research Chairs); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council Discovery Grant (NSERC-DG) of Canada; Thompson Rivers University; CFI(Canada Foundation for Innovation); NSERC-DG(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Tartu, Estonia; European Regional Development Fund: Centre of Excellence FIBIR(European Commission); Hungarian National Science Foundation; Taylor Family-Asia Foundation Endowed Chair in Ecology and Conservation Biology; University of Mongolia's Support for High Impact Research program; Rangeland Research Institute, University of Alberta, Canada; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Cordoba; FONCyT(FONCyT); Inter-American Institute for Global Change Research; NSF(National Science Foundation (NSF)); State Nature Reserve "Montagna di Torricchio"; University of Camerino, Italy; Hungarian University of Transylvania, Romania; Fundacao Grupo Boticario, Brazil; NSF(National Science Foundation (NSF)); UHURU: NSERC; University of Wyoming; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University of Florida(University of Florida); Princeton Environmental Institute; CONYCIT Becas-Chile Scholarship; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We are grateful to all of the people who helped in the collection and processing of the samples, including L. Alabiso-Cahill, D. Ariunzaya, M. R. Avila, J. C. R. Azambuja, L. Bachinger, I. Badamnyambuu, K. Baethke, J. Batbaatar, S. Ballelli, K. Bayarkhuu, G. Bertone, V. Besnyoi, C. L. Bonilha, G. Boorman, R. A. X. Borges, T. Broadbent, R. Canullo, J. Carding, B. Casper, K. Castillioni, M. Cervellini, G. Charles, G. Chiara, E. Cleland, R. Cornfoot, G. Crowder, A. I. Csatho, L. Demeter, M. Demski, M. Deutschlander, S. Donnelly, A. L. P. Dresseno, S. Enkhjin, O. Enkhmandal, T. Erdenebold, L. Erdenechimeg, B. Erdenetsetseg, J. K. Fedrigo, A. C. Ferreira, Z. Foldvari, L. Fourie, B. Fraser, J. Galdi-Rosa, E. Gorgone-Barbosa, R. Greuel, A. Guido, E. Gyorgy, D. Hall, A. Hassan, J. Hazi, R. Henkin, S. Hoffmann, T. Jairus, M. Jankju, U. Jogar, T. Jongbloets, M. Juhasz, C. F. Jurinitz, V. R. Kakroudi, A. Kelemen, T. Khandarmaa, E. Khash-Erdene, C. Koch, C. Komoly, S. Kurukura, P. Liancourt, S. Lima, A. Lkhagva, M. Lucrecia Lipoma, D. Lkhagvasuren, J. Lombardi, M. Eugenia Marcotti, J. McPhee, B. McWhirter, L. Menezes, J. McCulloch, M. Mesdaghi, I. Mathe, M. Messini, M. Mistral, C. Moffat, M. Mohamed, L. Mugwedi, J. Padgham, P. Padilha, S. Paetz, S. Pagmadulam, G. Pec, C. Peconi, G. Peter, S. Piros, V. C. Pistoia, L. Pyle, M. Randall, M. Ninno Rissi, R. G. Rolim, M. Ross, T. Salarian, S. Sandagdorj, S. Sangasuren, C. Santinelli, C. Scherer, G. H. M. Silva, M. G. Silva, T. Smith, S. Solongo, F. Spada, R. Stahlmann, J. Steel, M. Sulyok, A. Sywenky, G. Szabo, L. Szabules, V. Tomlinson, J. Tremblay-Gravel, G. Ungvari, O. Urangoo, M. Uuganbayar, M. S. Viera, C. E. Vogel, D. Wallach, R. Wellstein, J. I. Withworth Hulse, and Z. Zimmermann. This work was supported in part by the Canada Research Chair Program, Canadian Foundation for Innovation (CFI), and a Natural Sciences and Engineering Research Council Discovery Grant (NSERC-DG) of Canada awarded to L. H. F., and Thompson Rivers University; a CFI and NSERC-DG awarded to J. P.; the University of Tartu, Estonia, and a European Regional Development Fund: Centre of Excellence FIBIR awarded to M. Z. and M. M.; a Hungarian National Science Foundation (OTKA K 105608) awarded to S. B.; Taylor Family-Asia Foundation Endowed Chair in Ecology and Conservation Biology and University of Mongolia's Support for High Impact Research program awarded to B. B.; the Rangeland Research Institute, University of Alberta, Canada; CONICET, Universidad Nacional de Cordoba, FONCyT, and the Inter-American Institute for Global Change Research (with support of NSF) awarded to S. D., L. E., and M. C.; a NSERC-DG awarded to J. C.; State Nature Reserve "Montagna di Torricchio" and University of Camerino, Italy; Hungarian University of Transylvania, Romania; a Fundacao Grupo Boticario, Brazil (0153_2011_PR) awarded to A. F.; NSF DEB-1021158 and DEB-0950100 awarded to B. F.; UHURU: NSERC and CFI awarded to J. R. G. and the University of Wyoming; an NSERC-DG awarded to H. A. L. H.; an NSERC-DG awarded to J. K.; a National Natural Science Foundation of China grant (No. 41171417) awarded to R. L.; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil (n. 307719/2012-0) awarded to S. M.; CNPq, Brazil (grants 403750/2012-1 and 307689/2014-0) awarded to V. P.; University of Florida and a NSF DEB 1149980 awarded to T. P.; Princeton Environmental Institute and a NSF DEB 1355122 awarded to R. M. P.; a CONYCIT Becas-Chile Scholarship awarded to G. C. S.; Data and R scripts associated with this paper are deposited in the Dryad repository (http://datadryad.org/).	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; ALMUFTI MM, 1977, J ECOL, V65, P759, DOI 10.2307/2259378; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dickson TL, 2013, OECOLOGIA, V173, P1513, DOI 10.1007/s00442-013-2722-8; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Fraser LH, 2014, J VEG SCI, V25, P1160, DOI 10.1111/jvs.12167; Fraser LH, 2013, FRONT ECOL ENVIRON, V11, P147, DOI 10.1890/110279; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gillman LN, 2006, ECOLOGY, V87, P1234, DOI 10.1890/0012-9658(2006)87[1234:TIOPOT]2.0.CO;2; Grace JB, 2012, SCIENCE, V335, DOI 10.1126/science.1214939; Grace JB, 2014, FUNCT ECOL, V28, P787, DOI 10.1111/1365-2435.12269; GRIME JP, 1973, J ENVIRON MANAGE, V1, P151; Guo QF, 1998, ECOLOGY, V79, P2555, DOI 10.1890/0012-9658(1998)079[2555:SRABDO]2.0.CO;2; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; KNAPP AK, 1986, BIOSCIENCE, V36, P662, DOI 10.2307/1310387; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Oesterheld M, 2000, METHODS IN ECOSYSTEM SCIENCE, P151; Oksanen J, 1996, J ECOL, V84, P293, DOI 10.2307/2261364; Pan XB, 2012, SCIENCE, V335, DOI [10.1126/science.1214786, 10.1126/science.1215042]; Partel M, 2007, ECOLOGY, V88, P1091, DOI 10.1890/06-0997; Pierce S, 2014, FUNCT ECOL, V28, P253, DOI 10.1111/1365-2435.12147; Rajaniemi TK, 2002, J ECOL, V90, P316, DOI 10.1046/j.1365-2745.2001.00662.x; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; TAYLOR DR, 1990, OIKOS, V58, P239, DOI 10.2307/3545432; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Zobel M, 2008, GLOBAL ECOL BIOGEOGR, V17, P679, DOI 10.1111/j.1466-8238.2008.00400.x	28	249	270	32	564	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		302	305		10.1126/science.aab3916	http://dx.doi.org/10.1126/science.aab3916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185249	Green Accepted, Green Submitted			2022-12-28	WOS:000358218600050
J	Bianchi, DW; Chudova, D; Sehnert, AJ; Bhatt, S; Murray, K; Prosen, TL; Garber, JE; Wilkins-Haug, L; Vora, NL; Warsof, S; Goldberg, J; Ziainia, T; Halks-Miller, M				Bianchi, Diana W.; Chudova, Darya; Sehnert, Amy J.; Bhatt, Sucheta; Murray, Kathryn; Prosen, Tracy L.; Garber, Judy E.; Wilkins-Haug, Louise; Vora, Neeta L.; Warsof, Stephen; Goldberg, James; Ziainia, Tina; Halks-Miller, Meredith			Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-LABORATORY-EXPERIENCE; CELL-FREE DNA; FETAL ANEUPLOIDIES; DIAGNOSIS; SOCIETY; BLOOD	IMPORTANCE Understanding the relationship between aneuploidy detection on noninvasive prenatal testing (NIPT) and occult maternal malignanciesmay explain results that are discordant with the fetal karyotype and improve maternal clinical care. OBJECTIVE To evaluate massively parallel sequencing data for patterns of copy-number variations that might prospectively identify occult maternal malignancies. DESIGN, SETTING, AND PARTICIPANTS Case series identified from 125 426 samples submitted between February 15, 2012, and September 30, 2014, from asymptomatic pregnant women who underwent plasma cell-free DNA sequencing for clinical prenatal aneuploidy screening. Analyses were conducted in a clinical laboratory that performs DNA sequencing. Among the clinical samples, abnormal results were detected in 3757 (3%); these were reported to the ordering physician with recommendations for further evaluation. EXPOSURES NIPT for fetal aneuploidy screening (chromosomes 13, 18, 21, X, and Y). MAIN OUTCOMES AND MEASURES Detailed genome-wide bioinformatics analysiswas performed on available sequencing data from 8 of 10 women with known cancers. Genome-wide copy-number changes in the original NIPT samples and in subsequent serial samples from individual patients when available are reported. Copy-number changes detected in NIPT sequencing data in the known cancer cases were compared with the types of aneuploidies detected in the overall cohort. RESULTS From a cohort of 125 426 NIPT results, 3757 (3%) were positive for 1 or more aneuploidies involving chromosomes 13, 18, 21, X, or Y. From this set of 3757 samples, 10 cases of maternal cancer were identified. Detailed clinical and sequencing data were obtained in 8. Maternal cancers most frequently occurred with the rare NIPT finding of more than 1 aneuploidy detected (7 known cancers among 39 cases of multiple aneuploidies by NIPT, 18% [95% CI, 7.5%-33.5%]). All 8 cases that underwent further bioinformatics analysis showed unique patterns of nonspecific copy-number gains and losses across multiple chromosomes. In 1 case, blood was sampled after completion of treatment for colorectal cancer and the abnormal pattern was no longer evident. CONCLUSIONS AND RELEVANCE In this preliminary study, a small number of cases of occult malignancy were subsequently diagnosed among pregnant women whose noninvasive prenatal testing results showed discordance with the fetal karyotype. The clinical importance of these findings will require further research.	[Bianchi, Diana W.] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA 02111 USA; [Chudova, Darya; Sehnert, Amy J.; Bhatt, Sucheta; Halks-Miller, Meredith] Illumina, Redwood City, CA USA; [Murray, Kathryn] Ctr Genet & Maternal Fetal Med, Springfield, OR USA; [Prosen, Tracy L.] Univ Minnesota, Dept Obstet & Gynecol, Div Maternal Fetal Med, Minneapolis, MN 55455 USA; [Garber, Judy E.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Wilkins-Haug, Louise] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med & Reprod Genet, Boston, MA 02115 USA; [Vora, Neeta L.] Univ N Carolina, Chapel Hill, NC USA; [Warsof, Stephen] Eastern Virginia Med Sch, Div Maternal Fetal Med, Norfolk, VA 23501 USA; [Goldberg, James] San Francisco Perinatal Associates, San Francisco, CA USA; [Ziainia, Tina] Sharp Rees Stealy Med Grp, San Diego, CA USA	Tufts Medical Center; Illumina; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; Eastern Virginia Medical School	Bianchi, DW (corresponding author), Tufts Med Ctr, Mother Infant Res Inst, 800Washington St,Box 394, Boston, MA 02111 USA.	dbianchi@tuftsmedicalcenter.org	Miller, Meredith/K-5963-2019	Vora, Neeta/0000-0002-2504-9455	Illumina	Illumina	Funding for the study was provided by Illumina. Sponsored research funding from Illumina that is administered through Tufts Medical Center paid for the time that Dr Bianchi spent working with the full-time Illumina employees to design the study, analyze the data, and prepare the manuscript.	Amant F, 2015, JAMA ONCOL, V1, P814, DOI 10.1001/jamaoncol.2015.1883; Benn P, 2012, PRENATAL DIAG, V32, P1, DOI 10.1002/pd.2919; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bianchi DW, 2015, OBSTET GYNECOL, V125, P375, DOI 10.1097/AOG.0000000000000637; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Bianchi DW, 2014, CLIN CHEM, V60, P78, DOI 10.1373/clinchem.2013.202663; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Curnow KJ, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.012; Devers PL, 2013, J GENET COUNS, V22, P291, DOI 10.1007/s10897-012-9564-0; Futch T, 2013, PRENATAL DIAG, V33, P569, DOI 10.1002/pd.4123; Gil MM, 2015, ULTRASOUND OBST GYN, V45, P249, DOI 10.1002/uog.14791; Grody WW, 2013, GENET MED, V15, P482, DOI 10.1038/gim.2013.47; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau TK, 2013, PRENATAL DIAG, V33, P602, DOI 10.1002/pd.4076; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Osborne CM, 2013, PRENATAL DIAG, V33, P609, DOI 10.1002/pd.4100; Pavlidis NA, 2002, ONCOLOGIST, V7, P279; Rava RP, 2014, CLIN CHEM, V60, P243, DOI 10.1373/clinchem.2013.207951; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Snyder MW, 2015, NEW ENGL J MED, V372, P1639, DOI 10.1056/NEJMoa1408408; Vandenberghe P, 2015, LANCET HAEMATOL, V2, pE55, DOI 10.1016/S2352-3026(14)00039-8; Wang JC, 2015, GENET MED, V17, P234, DOI 10.1038/gim.2014.92; Warsof SL, 2015, PRENATAL DIAG, V35, P972, DOI 10.1002/pd.4601	23	250	259	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					162	169		10.1001/jama.2015.7120	http://dx.doi.org/10.1001/jama.2015.7120			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26168314	Bronze			2022-12-28	WOS:000357867500016
J	Schwartz, JL; Easterling, LA				Schwartz, Jason L.; Easterling, Laurel A.			Other Vaccines for Adolescents, 1990-2015 State Vaccination Requirements for HPV and	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Schwartz, Jason L.; Easterling, Laurel A.] Princeton Univ, Univ Ctr Human Values, Princeton, NJ 08544 USA	Princeton University	Schwartz, JL (corresponding author), Princeton Univ, Univ Ctr Human Values, 5 Ivy Ln, Princeton, NJ 08544 USA.	jlschwar@princeton.edu	Schwartz, Jason L./ABA-8718-2020					*ASS IMM MAN, POS STAT SCH CHILD C; Curtis C Robinette, 2014, MMWR Suppl, V63, P61; Elam-Evans LD, 2014, MMWR-MORBID MORTAL W, V63, P625; Savage L, 2007, J NATL CANCER I, V99, P665, DOI 10.1093/jnci/djk190; Schwartz JL, 2007, CLIN PHARMACOL THER, V82, P760, DOI 10.1038/sj.clpt.6100397; US Centers for Disease Control and Prevention, 2015, STAT VACC REQ	6	20	20	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					185	186		10.1001/jama.2015.6041	http://dx.doi.org/10.1001/jama.2015.6041			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26172898	Bronze			2022-12-28	WOS:000357867500019
J	Marban, E; Cingolani, E				Marban, Eduardo; Cingolani, Eugenio			Direct Reprogramming Bypassing Stem Cells for Therapeutics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FIBROBLASTS		[Marban, Eduardo; Cingolani, Eugenio] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Marban, E (corresponding author), Cedars Sinai Heart Inst, 127 S San Vicente Blvd, Los Angeles, CA 90048 USA.	eduardo.marban@csmc.edu	Marban, Eduardo/GWC-8514-2022					Atkinson PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102077; Clinicaltrials.gov, SAF TOL EFF CGF166 P; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Doudna JA, 2015, JAMA-J AM MED ASSOC, V313, P791, DOI 10.1001/jama.2015.287; Hu YF, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008681; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Yamanaka S., NOBEL LECT WINDING R; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	9	7	7	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					19	20		10.1001/jama.2015.4504	http://dx.doi.org/10.1001/jama.2015.4504			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151260				2022-12-28	WOS:000357455900006
J	Murray, C; Chambers, R				Murray, Christopher; Chambers, Ray			Keeping score: fostering accountability for children's lives	LANCET			English	Editorial Material									[Murray, Christopher] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Chambers, Ray] UN Secretary Gen Special Envoy Financing Hlth MDG, New York, NY 10019 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Chambers, R (corresponding author), UN Secretary Gen Special Envoy Financing Hlth MDG, New York, NY 10019 USA.	ray.chambers@mdghealthenvoy.org						Dieleman JL, JAMA IN PRESS; Dieleman JL, 2014, HEALTH AFFAIR, V33, P878, DOI 10.1377/hlthaff.2013.1432; Institute for Health Metrics and Evaluation, 2014, FIN GLOB HLTH 2013 T; UN Millennium Project, 2006, GOALS TARG IND; Wang H, 2014, LANCET	5	40	40	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					3	5		10.1016/S0140-6736(15)61171-0	http://dx.doi.org/10.1016/S0140-6736(15)61171-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM2OA	26169847				2022-12-28	WOS:000357519400004
J	Karam, A; Clague, J; Marshall, K; Olivier, J				Karam, Azza; Clague, Julie; Marshall, Katherine; Olivier, Jill		Faith & Hlth Series	The view from above: faith and health	LANCET			English	Editorial Material									[Karam, Azza] United Nations Populat Fund, New York, NY 10158 USA; [Clague, Julie] Univ Glasgow, Glasgow, Lanark, Scotland; [Marshall, Katherine] Georgetown Univ, Berkley Ctr Relig Peace & World Affairs, Washington, DC USA; [Olivier, Jill] Univ Cape Town, ZA-7925 Cape Town, South Africa	United Nations Population Fund; University of Glasgow; Georgetown University; University of Cape Town	Karam, A (corresponding author), United Nations Populat Fund, New York, NY 10158 USA.	karam@unfpa.org	Marshall, Katherine/AHC-5415-2022					[Anonymous], 2014, RELIG DEV POST2015 R; Lux S, 2007, SCALING EFFECTIVE PA; Marshall K, 2013, GLOB INST, P1; Pew Research Center, 2010, TOL TENS ISL CHRIST; The Pew Research Center, 2012, GLOB REL LANDSC REP; Tomkins A, 2015, LANCET, V386, P1776, DOI 10.1016/S0140-6736(15)60252-5	6	23	23	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					E22	E24		10.1016/S0140-6736(15)61036-4	http://dx.doi.org/10.1016/S0140-6736(15)61036-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV0WK	26159393				2022-12-28	WOS:000363974200001
J	Begemann, M; Zirn, B; Santen, G; Wirthgen, E; Soellner, L; Buttel, HM; Schweizer, R; van Workum, W; Binder, G; Eggermann, T				Begemann, Matthias; Zirn, Birgit; Santen, Gijs; Wirthgen, Elisa; Soellner, Lukas; Buettel, Hans-Martin; Schweizer, Roland; van Workum, Wilbert; Binder, Gerhard; Eggermann, Thomas			Paternally Inherited IGF2 Mutation and Growth Restriction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SILVER-RUSSELL-SYNDROME; FACTOR-II GENE; POSTNATAL-GROWTH; DEFICIENCY; FETAL	In humans, mutations in IGF1 or IGF1R cause intrauterine and postnatal growth restriction; however, data on mutations in IGF2, encoding insulin-like growth factor (IGF) II, are lacking. We report an IGF2 variant (c.191C -> A, p.Ser64Ter) with evidence of pathogenicity in a multigenerational family with four members who have growth restriction. The phenotype affects only family members who have inherited the variant through paternal transmission, a finding that is consistent with the maternal imprinting status of IGF2. The severe growth restriction in affected family members suggests that IGF-II affects postnatal growth in addition to prenatal growth. Furthermore, the dysmorphic features of affected family members are consistent with a role of deficient IGF-II levels in the cause of the Silver-Russell syndrome.	[Begemann, Matthias; Soellner, Lukas; Eggermann, Thomas] Rhein Westfal TH Aachen, Univ Hosp, Inst Human Genet, D-52074 Aachen, Germany; [Zirn, Birgit] Univ Med, Dept Pediat & Neuropediat, Gottingen, Germany; [Zirn, Birgit] Genetikum, Genet Counseling & Diagnost, Stuttgart, Germany; [Wirthgen, Elisa] Ligandis, Gulzow Pruzen, Germany; [Buettel, Hans-Martin] SLK Kliniken, Dept Pediat & Neuropediat, Heilbronn, Germany; [Schweizer, Roland; Binder, Gerhard] Univ Tubingen, Univ Childrens Hosp, Pediat Endocrinol Sect, Tubingen, Germany; [Santen, Gijs] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Santen, Gijs; van Workum, Wilbert] GenomeScan, Leiden, Netherlands; [van Workum, Wilbert] ServiceXS, Leiden, Netherlands	RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Eggermann, T (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Inst Human Genet, Pauwelsstr 30, D-52074 Aachen, Germany.	teggermann@ukaachen.de	Begemann, Matthias/AAL-6777-2021	Begemann, Matthias/0000-0002-4659-8437; Wirthgen, Elisa/0000-0002-8696-1675	Bundesministerium fur Bildung und Forschung; European Union	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	Funded by Bundesministerium fur Bildung und Forschung and the European Union.	Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; Binder G, 2006, J CLIN ENDOCR METAB, V91, P4709, DOI 10.1210/jc.2006-1127; BLUM WF, 1988, ACTA ENDOCRINOL-COP, V118, P374, DOI 10.1530/acta.0.1180374; Bonapace G, 2003, J MED GENET, V40, P913, DOI 10.1136/jmg.40.12.913; Brioude F, 2013, J MED GENET, V50, P823, DOI 10.1136/jmedgenet-2013-101691; Cohen P, 2006, HORM RES, V65, P3, DOI 10.1159/000090640; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Eggermann T, 2012, EXPERT REV MOL DIAGN, V12, P459, DOI [10.1586/ERM.12.43, 10.1586/erm.12.43]; EKSTROM TJ, 1995, DEVELOPMENT, V121, P309; Fowden AL, 2003, PLACENTA, V24, P803, DOI 10.1016/S0143-4004(03)00080-8; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; Gicquel C, 2006, HORM RES, V65, P28, DOI 10.1159/000091503; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Godfrey K M, 2001, Public Health Nutr, V4, P611; Klammt J, 2011, BEST PRACT RES CL EN, V25, P191, DOI 10.1016/j.beem.2010.09.012; Netchine I, 2011, BEST PRACT RES CL EN, V25, P181, DOI 10.1016/j.beem.2010.08.005; Netchine I, 2009, J CLIN ENDOCR METAB, V94, P3913, DOI 10.1210/jc.2009-0452; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; Wakeling EL, 2010, J MED GENET, V47, P760, DOI 10.1136/jmg.2010.079111; Wit JM, 2013, WORLD REV NUTR DIET, V106, P60, DOI 10.1159/000342546; Woods KA, 2000, J CLIN ENDOCR METAB, V85, P1407, DOI 10.1210/jc.85.4.1407	24	140	147	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					349	356		10.1056/NEJMoa1415227	http://dx.doi.org/10.1056/NEJMoa1415227			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3NL	26154720	Green Submitted, Green Published			2022-12-28	WOS:000358333500008
J	Vinayak, S; Pawlowic, MC; Sateriale, A; Brooks, CF; Studstill, CJ; Bar-Peled, Y; Cipriano, MJ; Striepen, B				Vinayak, Sumiti; Pawlowic, Mattie C.; Sateriale, Adam; Brooks, Carrie F.; Studstill, Caleb J.; Bar-Peled, Yael; Cipriano, Michael J.; Striepen, Boris			Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum	NATURE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PLASMODIUM-FALCIPARUM; ZAMBIAN CHILDREN; INFECTION; NITAZOXANIDE; ASSAY; TIME; MORTALITY; PARASITES; STRAINS	Recent studies into the global causes of severe diarrhoea in young children have identified the protozoan parasite Cryptosporidium as the second most important diarrhoeal pathogen after rotavirus(1-3). Diarrhoeal disease is estimated to be responsible for 10.5% of overall child mortality(4). Cryptosporidium is also an opportunistic pathogen in the contexts of human immunodeficiency virus (HIV)-caused AIDS and organ transplantation(5,6). There is no vaccine and only a single approved drug that provides no benefit for those in gravest danger: malnourished children and immunocompromised patients(7,8). Cryptosporidiosisdrug and vaccine development is limited by the poor tractability of the parasite, which includes a lack of systems for continuous culture, facile animal models, and molecular genetic tools(3,9). Here we describe an experimental framework to genetically modify this important human pathogen. We established and optimized transfection of C. parvum sporozoites in tissue culture. To isolate stable transgenics we developed a mouse model that delivers sporozoites directly into the intestine, aCryptosporidium clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system, and in vivo selection for aminoglycoside resistance. We derived reporter parasites suitable for in vitro and in vivo drug screening, and we evaluated the basis of drug susceptibility by gene knockout. We anticipate that the ability to genetically engineer this parasite will be transformative for Cryptosporidium research. Genetic reporters will provide quantitative correlates for disease, cure and protection, and the role of parasite genes in these processes is now open to rigorous investigation.	[Vinayak, Sumiti; Pawlowic, Mattie C.; Sateriale, Adam; Brooks, Carrie F.; Studstill, Caleb J.; Bar-Peled, Yael; Cipriano, Michael J.; Striepen, Boris] Univ Georgia, Ctr Trop & Emerging Global Dis, Paul D Coverdell Ctr, Athens, GA 30602 USA; [Striepen, Boris] Univ Georgia, Dept Cellular Biol, Paul D Coverdell Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Striepen, B (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Paul D Coverdell Ctr, 500 DW Brooks Dr, Athens, GA 30602 USA.	striepen@uga.edu	Pawlowic, Mattie Christine/AAC-3344-2019	Pawlowic, Mattie Christine/0000-0003-2002-6681; Cipriano, Michael/0000-0001-8163-8812; Striepen, Boris/0000-0002-7426-432X; Sateriale, Adam/0000-0001-8947-2714; /0000-0003-4549-6268; Studstill, Caleb J./0000-0003-3795-0774	National Institutes of Health (NIH) [R01AI112427]; Centers for Disease Control; University of Georgia Research Foundation;  [NIH T32AI060546]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112427, T32AI060546] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University of Georgia Research Foundation; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Sharling for initial contributions and L. Hedstrom, J. Mead, S. Vaishnava, L. Xiao and Y. Belkaid for discussion. This work was funded in part by the National Institutes of Health (NIH; R01AI112427) to B.S. and by a pilot grant from the Centers for Disease Control and the University of Georgia Research Foundation to B.S. and L. Xiao. M.J.C. was supported by training grant NIH T32AI060546 and B.S. is a Georgia Research Alliance Distinguished Investigator.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Amadi B, 2002, LANCET, V360, P1375, DOI 10.1016/S0140-6736(02)11401-2; Amadi B, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-195; Bessoff K, 2013, ANTIMICROB AGENTS CH, V57, P1804, DOI 10.1128/AAC.02460-12; Brooks CF, 2010, CELL HOST MICROBE, V7, P62, DOI 10.1016/j.chom.2009.12.002; Chakrabarti K, 2007, RNA, V13, P1923, DOI 10.1261/rna.751807; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; FAYER R, 1991, J PARASITOL, V77, P357, DOI 10.2307/3283119; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Griffiths JK, 1998, J CLIN MICROBIOL, V36, P2503, DOI 10.1128/JCM.36.9.2503-2508.1998; Gubbels MJ, 2003, ANTIMICROB AGENTS CH, V47, P309, DOI 10.1128/AAC.47.1.309-316.2003; GUEIROSFILHO FJ, 1994, EXP PARASITOL, V78, P425, DOI 10.1006/expr.1994.1048; Gut J, 1999, J EUKARYOT MICROBIOL, V46, p56S; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Harb OS, 2015, METHODS MOL BIOL, V1201, P1, DOI [10.1007/978-1-4939-1438-8_, 10.1007/978-1-4939-1438-8_1]; Hunter PR, 2002, CLIN MICROBIOL REV, V15, P145, DOI 10.1128/CMR.15.1.145-154.2002; Jiang L, 2000, ANTIMICROB AGENTS CH, V44, P1047, DOI 10.1128/AAC.44.4.1047-1050.2000; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lee AH, 2014, MICROBIOL MOL BIOL R, V78, P469, DOI 10.1128/MMBR.00059-13; Liu JY, 2009, EUKARYOT CELL, V8, P483, DOI 10.1128/EC.00298-08; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mary C, 2013, J CLIN MICROBIOL, V51, P2556, DOI 10.1128/JCM.03458-12; MCDONALD V, 1992, INFECT IMMUN, V60, P3325, DOI 10.1128/IAI.60.8.3325-3331.1992; Mochizuki K, 2008, GENE, V425, P79, DOI 10.1016/j.gene.2008.08.007; Mondal D, 2012, CLIN INFECT DIS, V54, P185, DOI 10.1093/cid/cir807; Raja Kapeel, 2014, J Nephropathol, V3, P127, DOI 10.12860/jnp.2014.25; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sharling L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000794; Sheoran A, 2012, J INFECT DIS, V205, P1019, DOI 10.1093/infdis/jir874; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Striepen B., 2007, P391, DOI 10.1016/B978-012369542-0/50017-9; Striepen B, 2004, P NATL ACAD SCI USA, V101, P3154, DOI 10.1073/pnas.0304686101; Striepen B, 2013, NATURE, V503, P189, DOI 10.1038/503189a; Striepen B, 2009, INFECT DIS-SER, P605, DOI 10.1007/978-1-59745-180-2_43; Theodos CM, 1998, ANTIMICROB AGENTS CH, V42, P1959, DOI 10.1128/AAC.42.8.1959; UPTON SJ, 1994, FEMS MICROBIOL LETT, V118, P233, DOI 10.1016/0378-1097(94)90509-6; UPTON SJ, 1997, CRYPTOSPORIDIUM CRYP, P181; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105	41	186	191	5	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					477	U232		10.1038/nature14651	http://dx.doi.org/10.1038/nature14651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26176919	Bronze, Green Accepted			2022-12-28	WOS:000358378900040
J	El-Khoury, F; Cassou, B; Latouche, A; Aegerter, P; Charles, MA; Dargent-Molina, P				El-Khoury, Fabienne; Cassou, Bernard; Latouche, Aurelien; Aegerter, Philippe; Charles, Marie-Aline; Dargent-Molina, Patricia			Effectiveness of two year balance training programme on prevention of fall induced injuries in at risk women aged 75-85 living in community: Ossebo randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OLDER-PEOPLE; GROUP EXERCISE; HIP FRACTURE; PARTICIPATION; INTERVENTION; ASSOCIATION; DISABILITY; BARRIERS; ADULTS	OBJECTIVE To assess the effectiveness of a two year exercise programme of progressive balance retraining in reducing injurious falls among women aged 75-85 at increased risk of falls and injuries and living in the community. DESIGN Pragmatic multicentre, two arm, parallel group, randomised controlled trial. SETTING 20 study sites in 16 medium to large cities throughout France. PARTICIPANTS 706 women aged 75-85, living in their own home, and with diminished balance and gait capacities, randomly allocated to the experimental intervention group (exercise programme, n=352) or the control group (no intervention, n=354). INTERVENTION Weekly supervised group sessions of progressive balance training offered in community based premises for two years, supplemented by individually prescribed home exercises. OUTCOME MEASURES A geriatrician blinded to group assignment classified falls into one of three categories (no consequence, moderate, severe) based on physical damage and medical care. The primary outcome was the rate of injurious falls (moderate and severe). The two groups were compared for rates of injurious falls with a "shared frailty" model. Other outcomes included the rates of all falls, physical functional capacities (balance and motor function test results), fear of falling (FES-I), physical activity level, and perceived health related quality of life (SF-36). Analysis was by intention to treat. RESULTS There were 305 injurious falls in the intervention group and 397 in the control group (hazard ratio 0.81, 95% confidence interval 0.67 to 0.99). The difference in severe injuries (68 in intervention group v 87 in control group) was of the same order of magnitude (0.83, 0.60 to 1.16). At two years, women in the intervention group performed significantly better on all physical tests and had significantly better perception of their overall physical function than women in the control group. Among women who started the intervention (n=294), the median number of group sessions attended was 53 (interquartile range 16-71). Five injurious falls related to the intervention were recorded. CONCLUSION A two year progressive balance retraining programme combining weekly group and individual sessions was effective in reducing injurious falls and in improving measured and perceived physical function in women aged 75-85 at risk of falling.	[El-Khoury, Fabienne] Univ Paris Sud, UMR S1018, F-94807 Villejuif, France; [El-Khoury, Fabienne; Charles, Marie-Aline; Dargent-Molina, Patricia] Univ Paris 05, UMR S 1153, F-75014 Paris, France; [El-Khoury, Fabienne; Charles, Marie-Aline; Dargent-Molina, Patricia] INSERM, Ctr Rech Epidemiol & Stat Sorbonne Paris Cite, U1153, F-94807 Villejuif, France; [Cassou, Bernard; Aegerter, Philippe] Univ Versailles, UMR S 1168, UVSQ, Yvelines, France; [Cassou, Bernard; Aegerter, Philippe] INSERM, VIMA Vieillissement Maladies Chron, U1168, F-94807 Villejuif, France; [Cassou, Bernard] Hop Sainte Perine, AP HP, Ctr Gerontol, F-75016 Paris, France; [Latouche, Aurelien] Ctr Res Comp Sci & Telecommunicat Cedric, Conservatoire Natl Arts & Metiers Cnam, Paris, France; [Aegerter, Philippe] Hop Ambroise Pare, Unite Rech Clin, Dept Sante Publ, A1 AP HP, Boulogne Billancourt, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Sainte-Perine - APHP; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Dargent-Molina, P (corresponding author), INSERM, CRESS Equipe ORCHARD, Hop Paul Brousse batiment 15-16,16 Ave Paul Vaill, F-94807 Villejuif, France.	patricia.dargent@inserm.fr	Khoury, Fabienne/AAB-2123-2020; Dargent-Molina, Patricia/N-3887-2017; AEGERTER, Philippe/AAY-6003-2021; Charles, Marie Aline/S-1866-2019; Charles, Marie Aline/F-8567-2017	Khoury, Fabienne/0000-0002-6915-6850; Dargent-Molina, Patricia/0000-0001-8596-6899; AEGERTER, Philippe/0000-0002-9156-5028; Charles, Marie Aline/0000-0003-4025-4390; Charles, Marie Aline/0000-0003-4025-4390; Latouche, Aurelien/0000-0001-9218-0333	"Assistance Publique-Hopitaux de Paris" (AP-HP); French Ministry of Health (Programme Hospitalier de Recherche Clinique PHRC National) [2006: AOM06076, 2010: AOM10144]; French National Research Agency (ANR) [BLAN06-3_135165]; National Institute of Health Prevention and Education (INPES) [047/06-DAS]; Council of the Ile-de-France region [09003420]; hospital group "Ste Perine, Chardon-Lalache, Rossini" (Assistance Publique-Hopitaux de Paris (AP-HP))	"Assistance Publique-Hopitaux de Paris" (AP-HP); French Ministry of Health (Programme Hospitalier de Recherche Clinique PHRC National); French National Research Agency (ANR)(French National Research Agency (ANR)); National Institute of Health Prevention and Education (INPES); Council of the Ile-de-France region(Region Ile-de-France); hospital group "Ste Perine, Chardon-Lalache, Rossini" (Assistance Publique-Hopitaux de Paris (AP-HP))	This study was sponsored by "Assistance Publique-Hopitaux de Paris" (AP-HP). The project funded by grants from the French Ministry of Health (Programme Hospitalier de Recherche Clinique PHRC National, 2006: AOM06076, 2010: AOM10144), the French National Research Agency (ANR) (BLAN06-3_135165), the National Institute of Health Prevention and Education (INPES) (project No 047/06-DAS), and the Council of the Ile-de-France region (Partnership of Citizens and Institutions for Research and Innovation, PICRI, No 09003420). The funders had no role in study design, data collection, and analysis, the decision to publish or preparation of the manuscript. PD-M received a "Contrat d'Interface vers l'hopital" (interface Inserm-Hospitals) from the hospital group "Ste Perine, Chardon-Lalache, Rossini" (Assistance Publique-Hopitaux de Paris (AP-HP)) in June 2008.	Auster J, 2009, AUSTRALAS J AGEING, V28, P149, DOI 10.1111/j.1741-6612.2009.00362.x; Box-Steffensmeier JM, 2006, STAT MED, V25, P3518, DOI 10.1002/sim.2434; BUCHNER DM, 1993, J AM GERIATR SOC, V41, P297, DOI 10.1111/j.1532-5415.1993.tb06708.x; Bunn F, 2008, AGEING SOC, V28, P449, DOI 10.1017/S0144686X07006861; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Close JCT, 2013, BEST PRACT RES CL RH, V27, P821, DOI 10.1016/j.berh.2013.12.001; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Dargent-Molina P, 2000, OSTEOPOROSIS INT, V11, P881, DOI 10.1007/s001980070048; Dargent- Molina P, 2008, GERONTOLOGIE SOC, V125, P65; Dargent-Molina P, 2013, GLOB HEALTH PROMOT, V20, P88, DOI 10.1177/1757975913483341; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Day L, 2002, BRIT MED J, V325, P128, DOI 10.1136/bmj.325.7356.128; de Groot GCL, 2011, SCAND J OCCUP THER, V18, P153, DOI 10.3109/11038128.2010.487113; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Delbaere K, 2010, BRIT J SPORT MED, V44, P1029, DOI 10.1136/bjsm.2009.060350; Dickinson Angela, 2011, Br J Community Nurs, V16, P174; Donaldson MG, 2007, J GERONTOL A-BIOL, V62, P415, DOI 10.1093/gerona/62.4.415; Duchateau L, 2007, THE FRAILTY MODEL; El-Khoury F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6234; Franco MR, 2015, J PHYSIOTHER, V61, P34, DOI 10.1016/j.jphys.2014.11.001; Freiberger E, 2013, CLIN INTERV AGING, V8, P1079, DOI 10.2147/CIA.S46218; Gill TM, 2013, AM J EPIDEMIOL, V178, P418, DOI 10.1093/aje/kws554; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Gutierrez RG, 2013, GOOD NEW BAD OLD ANA; Howe TE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004963.pub2; INSEE, 2005, INS REF PERS AG; Jones CJ, 2005, PHYS ACTIVITY INSTRU; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Lee SH, 2002, J BONE MINER RES, V17, P817, DOI 10.1359/jbmr.2002.17.5.817; Leon C, 2014, COMPORTEMENTS SANTE; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Lord SR, 2003, J AM GERIATR SOC, V51, P1685, DOI 10.1046/j.1532-5415.2003.51551.x; LORD SR, 1995, J AM GERIATR SOC, V43, P1198, DOI 10.1111/j.1532-5415.1995.tb07394.x; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; Nyman SR, 2012, AGE AGEING, V41, P16, DOI 10.1093/ageing/afr103; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Robertson MC, 2002, J AM GERIATR SOC, V50, P905, DOI 10.1046/j.1532-5415.2002.50218.x; Rose DJ, 2010, CLIN GERIATR MED, V26, P607, DOI 10.1016/j.cger.2010.07.003; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; SCHLESSELMAN JJ, 1974, AM J EPIDEMIOL, V99, P381, DOI 10.1093/oxfordjournals.aje.a121625; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Skelton D, 2005, AGE AGEING, V34, P636, DOI 10.1093/ageing/afi174; Stevens Z, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-192; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Treweek S, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-37; Yardley L, 2006, HEALTH EDUC RES, V21, P508, DOI 10.1093/her/cyh077; Yardley L, 2005, AGE AGEING, V34, P614, DOI 10.1093/ageing/afi196; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	51	74	77	0	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2015	351								h3830	10.1136/bmj.h3830	http://dx.doi.org/10.1136/bmj.h3830			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN7WI	26201510	Green Published, hybrid			2022-12-28	WOS:000358644600001
J	Itani, KMF				Itani, Kamal M. F.			Care Bundles and Prevention of Surgical Site Infection in Colorectal Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								IMPORTANCE Surgical site infections (SSIs) in colorectal surgery are associated with increased morbidity and health care costs. OBJECTIVE To determine the effect of a preventive SSI bundle (hereafter bundle) on SSI rates and costs in colorectal surgery. DESIGN Retrospective study of institutional clinical and cost data. The study period was January 1, 2008, to December 31, 2012, and outcomes were assessed and compared before and after implementation of the bundle on July 1, 2011. SETTING AND PARTICIPANTS Academic tertiary referral center among 559 patients who underwent major elective colorectal surgery. MAIN OUTCOMES AND MEASURES The primary outcome was the rate of superficial SSIs before and after implementation of the bundle. Secondary outcomes included deep SSIs, organ-space SSIs, wound disruption, postoperative sepsis, length of stay, 30-day readmission, and variable direct costs of the index admission. RESULTS Of 559 patients in the study, 346 (61.9%) and 213 (38.1%) underwent their operation before and after implementation of the bundle, respectively. Groups were matched on their propensity to be treated with the bundle to account for significant differences in the preimplementation and postimplementation characteristics. Comparison of the matched groups revealed that implementation of the bundle was associated with reduced superficial SSIs (19.3% vs 5.7%, P < .001) and postoperative sepsis (8.5% vs 2.4%, P = .009). No significant difference was observed in deep SSIs, organ-space SSIs, wound disruption, length of stay, 30-day readmission, or variable direct costs between the matched groups. However, in a subgroup analysis of the postbundle period, superficial SSI occurrence was associated with a 35.5% increase in variable direct costs ($13 253 vs $9779, P = .001) and a 71.7% increase in lengthof stay (7.9 vs 4.6days, P < .001). CONCLUSIONS AND RELEVANCE The preventive SSI bundle was associated with a substantial reduction in SSIs after colorectal surgery. The increased costs associated with SSIs support that the bundle represents an effective approach to reduce health care costs.	VA Boston Healthcare Syst, West Roxbury, MA USA; Boston Univ, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Harvard University; Harvard Medical School	Itani, KMF (corresponding author), VA Boston Healthcare Syst 112A, 1400 VFWPkwy, West Roxbury, MA 02132 USA.	kitani@va.gov						Anthony T, 2011, ARCH SURG-CHICAGO, V146, P263, DOI 10.1001/archsurg.2010.249; Artinyan A, 2015, ANN SURG, V261, P497, DOI 10.1097/SLA.0000000000000854; Deierhoi RJ, 2013, J AM COLL SURGEONS, V217, P763, DOI 10.1016/j.jamcollsurg.2013.07.003; Hawn MT, 2011, ANN SURG, V254, P494, DOI 10.1097/SLA.0b013e31822c6929; Itani KMF, 2013, COLORECTAL CANCER, V2, P467, DOI 10.2217/CRC.13.47; Keenan JE, 2014, JAMA SURG, V149, P1045, DOI 10.1001/jamasurg.2014.346; Merkow RP, 2015, JAMA-J AM MED ASSOC, V313, P483, DOI 10.1001/jama.2014.18614; Waits SA, 2014, SURGERY, V155, P602, DOI 10.1016/j.surg.2013.12.004	8	16	17	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					289	+		10.1001/jama.2015.4473	http://dx.doi.org/10.1001/jama.2015.4473			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197189				2022-12-28	WOS:000358228000023
J	Jacka, M; Nahirniak, S				Jacka, Michael; Nahirniak, Susan			In critically ill adults, transfusion of fresh vs standard-issue red blood cells did not differ for 90-day mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jacka, Michael; Nahirniak, Susan] Univ Alberta, Edmonton, AB, Canada	University of Alberta	Jacka, M (corresponding author), Univ Alberta, Edmonton, AB, Canada.			Nahirniak, Susan/0000-0002-2895-4805				Aubron C, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-2; Kor DJ, 2012, AM J RESP CRIT CARE, V185, P842, DOI 10.1164/rccm.201107-1332OC; Steiner ME, 2015, NEW ENGL J MED, V372, P1419, DOI 10.1056/NEJMoa1414219; Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x	4	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2							JC5	10.7326/ACPJC-2015-163-2-005	http://dx.doi.org/10.7326/ACPJC-2015-163-2-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26192585				2022-12-28	WOS:000358407500005
J	Horvitz, E; Mulligan, D				Horvitz, Eric; Mulligan, Deirdre			Data, privacy, and the greater good	SCIENCE			English	Editorial Material								Large-scale aggregate analyses of anonymized data can yield valuable results and insights that address public health challenges and provide new avenues for scientific discovery. These methods can extend our knowledge and provide new tools for enhancing health and wellbeing. However, they raise questions about how to best address potential threats to privacy while reaping benefits for individuals and to society as a whole. The use of machine learning to make leaps across informational and social contexts to infer health conditions and risks from nonmedical data provides representative scenarios for reflections on directions with balancing innovation and regulation.	[Horvitz, Eric] Microsoft Res, Redmond, WA 98052 USA; [Mulligan, Deirdre] Univ Calif Berkeley, Berkeley, CA 94720 USA	Microsoft; University of California System; University of California Berkeley	Horvitz, E (corresponding author), Microsoft Res, Redmond, WA 98052 USA.	horvitz@microsoft.com; dmulligan@berkeley.edu						[Anonymous], 2013, FTC STAFF REP MOB PR; [Anonymous], 2010, COMMUNICATION, P2; [Anonymous], 2014, BIG DAT PRIV TECHN P; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; De Choudhury M., 2013, P SIGCHI C HUM FACT, P3267, DOI [DOI 10.1145/2470654.2466447, 10.1145/2470654.2466447]; De Choudhury M., 2014, P INT C WEBL SOC MED; Executive Office of the President, 2015, BIG DAT DIFF PROC; Executive Office of the President, 2014, BIG DAT SEIZ OPP PRE; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Federal Trade Commission, 2012, BUSINESSES POLICYMAK; Federal Trade Commission [FTC], 2014, DAT BROK CALL TRANSP; FTC, 2014, WORKSH FTC WASH DC; Podesta J., BIG DATA PRIVACY 1 Y; Rothstein MA, 2008, J LAW MED ETHICS, V36, P837, DOI 10.1111/j.1748-720X.2008.00341.x; Sadilek A., 2012, P 26 AAAI C ART INT; Sweeney L., ONLINE ADS ROLL DICE; White House Council of Economic Advisers, 2015, BIG DAT DIFF PRIC; White RW, 2014, CLIN PHARMACOL THER, V96, P239, DOI 10.1038/clpt.2014.77	19	80	82	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		253	255		10.1126/science.aac4520	http://dx.doi.org/10.1126/science.aac4520			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1ZB	26185242				2022-12-28	WOS:000358218600039
J	von Bergmann, K				von Bergmann, Kirsten			PHYSICS Magnetic bubbles with a twist	SCIENCE			English	Editorial Material							SKYRMION LATTICE		Univ Hamburg, Dept Phys, D-20355 Hamburg, Germany	University of Hamburg	von Bergmann, K (corresponding author), Univ Hamburg, Dept Phys, D-20355 Hamburg, Germany.	kbergman@physnet.uni-hamburg.de	von Bergmann, Kirsten/S-5696-2016	von Bergmann, Kirsten/0000-0002-4514-3254				Bode M, 2007, NATURE, V447, P190, DOI 10.1038/nature05802; Fert A, 2013, NAT NANOTECHNOL, V8, P152, DOI 10.1038/nnano.2013.29; Heinze S, 2011, NAT PHYS, V7, P713, DOI [10.1038/NPHYS2045, 10.1038/nphys2045]; Jiang WJ, 2015, SCIENCE, V349, P283, DOI 10.1126/science.aaa1442; Jonietz F, 2010, SCIENCE, V330, P1648, DOI 10.1126/science.1195709; Kiselev NS, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/39/392001; Liu LQ, 2012, SCIENCE, V336, P555, DOI 10.1126/science.1218197; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Romming N, 2013, SCIENCE, V341, P636, DOI 10.1126/science.1240573; Sampaio J, 2013, NAT NANOTECHNOL, V8, P839, DOI [10.1038/nnano.2013.233, 10.1038/nnano.2013.210, 10.1038/NNANO.2013.210]; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124	12	10	10	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		234	235		10.1126/science.aab3689	http://dx.doi.org/10.1126/science.aab3689			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185229				2022-12-28	WOS:000358218600020
J	Keller, CB; Schoene, B; Barboni, M; Samperton, KM; Husson, JM				Keller, C. Brenhin; Schoene, Blair; Barboni, Melanie; Samperton, Kyle M.; Husson, Jon M.			Volcanic-plutonic parity and the differentiation of the continental crust	NATURE			English	Article							ARC MAGMAS; PHASE-RELATIONS; HIGH-PRESSURE; SUBDUCTION; WATER; H2O; EVOLUTION; GENESIS; MELTS; CRYSTALLIZATION	The continental crust is central to the biological and geological history of Earth. However, crustal heterogeneity has prevented a thorough geochemical comparison of its primary igneous building blocks-volcanic and plutonic rocks-and the processes by which they differentiate to felsic compositions. Our analysis of a comprehensive global data set of volcanic and plutonic whole-rock geochemistry shows that differentiation trends from primitive basaltic to felsic compositions for volcanic versus plutonic samples are generally indistinguishable in subduction-zone settings, but are divergent in continental rifts. Offsets in major- and trace-element differentiation patterns in rift settings suggest higher water content in plutonic magmas and reduced eruptibility of hydrous silicate magmas relative to dry rift volcanics. In both tectonic settings, our results indicate that fractional crystallization, rather than crustal melting, is predominantly responsible for the production of intermediate and felsic magmas, emphasizing the role of mafic cumulates as a residue of crustal differentiation.	[Keller, C. Brenhin; Schoene, Blair; Barboni, Melanie; Samperton, Kyle M.; Husson, Jon M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Barboni, Melanie] Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA; [Husson, Jon M.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA	Princeton University; University of California System; University of California Los Angeles; University of Wisconsin System; University of Wisconsin Madison	Keller, CB (corresponding author), Princeton Univ, Dept Geosci, Guyot Hall, Princeton, NJ 08544 USA.	cbkeller@princeton.edu	Samperton, Kyle/K-9286-2015; Barboni, Melanie/AAU-4262-2020; Schoene, Blair/C-3281-2014	Samperton, Kyle/0000-0003-0177-5978; Schoene, Blair/0000-0001-7092-8590; Keller, C Brenhin/0000-0001-7400-9428	US Department of Energy Office of Science [DE-FG02-97ER25308]; National Energy Research Scientific Computing Center under DOE Office of Science [DE-AC02-05CH11231]	US Department of Energy Office of Science(United States Department of Energy (DOE)); National Energy Research Scientific Computing Center under DOE Office of Science	C.B.K. was supported by a Computational Science Graduate Fellowship through US Department of Energy Office of Science grant DE-FG02-97ER25308. Computational resources were provided by the National Energy Research Scientific Computing Center under DOE Office of Science Contract No. DE-AC02-05CH11231, and by the Princeton Institute for Computational Science and Engineering. The authors are grateful to P. M. Antoshechkina for providing recompiled alphaMELTS executables and J. D. Gronewold for initial contributions.	Alonso-Perez R, 2009, CONTRIB MINERAL PETR, V157, P541, DOI 10.1007/s00410-008-0351-8; Annen C, 2009, EARTH PLANET SC LETT, V284, P409, DOI 10.1016/j.epsl.2009.05.006; Ashwal L.D., 1993, ANORTHOSITES SPRINGE; Bachmann O, 2007, J VOLCANOL GEOTH RES, V167, P1, DOI 10.1016/j.jvolgeores.2007.08.002; Bachmann O, 2004, J PETROL, V45, P1565, DOI 10.1093/petrology/egh019; BAILEY DK, 1983, TECTONOPHYSICS, V94, P585, DOI 10.1016/0040-1951(83)90035-5; Bebout GE, 2014, TREATISE GEOCHEMISTR, V4, P703, DOI DOI 10.1016/B978-0-08-095975-7.00322-3; Boehnke P, 2013, CHEM GEOL, V351, P324, DOI 10.1016/j.chemgeo.2013.05.028; Botcharnikov RE, 2008, J PETROL, V49, P1687, DOI 10.1093/petrology/egn043; Bowen N.L., 1928, EVOLUTION IGNEOUS RO; BURNHAM CW, 1974, AM J SCI, V274, P902, DOI 10.2475/ajs.274.8.902; CALDEIRA K, 1995, AM J SCI, V295, P1077, DOI 10.2475/ajs.295.9.1077; Carmichael ISE, 2002, CONTRIB MINERAL PETR, V143, P641, DOI 10.1007/s00410-002-0370-9; CHAYES F, 1963, J GEOPHYS RES, V68, P1519, DOI 10.1029/JZ068i005p01519; CHRISTENSEN NI, 1995, J GEOPHYS RES-SOL EA, V100, P9761, DOI 10.1029/95JB00259; CLAGUE DA, 1978, J GEOL, V86, P739, DOI 10.1086/649740; Daly RA, 1925, P AM ACAD ARTS SCI, V60, P3, DOI 10.2307/25130043; DRUMMOND MS, 1990, J GEOPHYS RES-SOLID, V95, P21503, DOI 10.1029/JB095iB13p21503; Dufek J, 2010, GEOLOGY, V38, P687, DOI 10.1130/G30831.1; Eichelberger JC, 2000, GEOLOGY, V28, P603, DOI 10.1130/0091-7613(2000)28<603:MICRCZ>2.0.CO;2; FROELICH PN, 1982, AM J SCI, V282, P474, DOI 10.2475/ajs.282.4.474; FYFE WS, 1975, AM J SCI, VA275, P285; Gelman SE, 2014, EARTH PLANET SC LETT, V403, P299, DOI 10.1016/j.epsl.2014.07.005; Geochemical, EARTH REF MOD PART C; Ghiorso MS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000217; Glazner A.F., 2004, GSA TODAY, V14, P4, DOI [10.1130/1052-5173(2004)0142.0.CO;2, DOI 10.1130/1052-5173(2004)014<0004:APA0M0>2.0.C0;2, DOI 10.1130/1052-5173(2004)0142.0.CO;2]; GREEN DH, 1973, EARTH PLANET SC LETT, V19, P37, DOI 10.1016/0012-821X(73)90176-3; Green T.H., 1968, CONTRIB MINERAL PETR, V18, P105, DOI [10.1007/BF00371806, DOI 10.1007/BF00371806]; Grove TL, 2012, ANNU REV EARTH PL SC, V40, P413, DOI 10.1146/annurev-earth-042711-105310; Grove TL, 1997, CONTRIB MINERAL PETR, V127, P205, DOI 10.1007/s004100050276; Gualda GAR, 2012, J PETROL, V53, P875, DOI 10.1093/petrology/egr080; HAMILTON DL, 1964, J PETROL, V5, P21, DOI 10.1093/petrology/5.1.21; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Holland TJB, 2011, J METAMORPH GEOL, V29, P333, DOI 10.1111/j.1525-1314.2010.00923.x; HUNTER RH, 1987, CONTRIB MINERAL PETR, V95, P451, DOI 10.1007/BF00402205; Jagoutz O, 2012, CHEM GEOL, V298, P79, DOI 10.1016/j.chemgeo.2011.10.022; KAY RW, 1991, GEOL RUNDSCH, V80, P259, DOI 10.1007/BF01829365; Kelemen P.B., 2014, TREATISE GEOCHEMISTR, V4, P749, DOI DOI 10.1016/B978-0-08-095975-7.00323-5; Keller CB, 2012, NATURE, V485, P490, DOI 10.1038/nature11024; Kent AJR, 2010, NAT GEOSCI, V3, P631, DOI 10.1038/NGEO924; LANGMUIR CH, 1978, EARTH PLANET SC LETT, V37, P380, DOI 10.1016/0012-821X(78)90053-5; Lee CTA, 2014, EARTH PLANET SC LETT, V393, P266, DOI 10.1016/j.epsl.2014.02.044; Miller CF, 2003, GEOLOGY, V31, P529, DOI 10.1130/0091-7613(2003)031<0529:HACGIO>2.0.CO;2; Morgan P., 1982, CONTINENTAL OCEANI G, V8, P107; Muntener O, 2001, CONTRIB MINERAL PETR, V141, P643; PEARCE JA, 1984, J PETROL, V25, P956, DOI 10.1093/petrology/25.4.956; PETFORD N, 1993, GEOLOGY, V21, P845, DOI 10.1130/0091-7613(1993)021<0845:DTOGM>2.3.CO;2; PHILPOTT.JA, 1968, CHEM GEOL, V3, P5, DOI 10.1016/0009-2541(68)90009-0; Plank T, 2013, EARTH PLANET SC LETT, V364, P168, DOI 10.1016/j.epsl.2012.11.044; Reubi O, 2009, NATURE, V461, P1269, DOI 10.1038/nature08510; ROSENBLATT P, 1994, GEOPHYS RES LETT, V21, P465, DOI 10.1029/94GL00419; RUDNICK RL, 1995, REV GEOPHYS, V33, P267, DOI 10.1029/95RG01302; SCHNETZLER CC, 1970, GEOCHIM COSMOCHIM AC, V34, P331, DOI 10.1016/0016-7037(70)90110-9; SISSON TW, 1993, CONTRIB MINERAL PETR, V113, P143, DOI 10.1007/BF00283225; Smith PM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000816; Sun S.-S., 1989, GEOLOGICAL SOC LONDO, V42, P323, DOI [10.1144/GSL.SP.1989.042.01.19, DOI 10.1144/GSL.SP.1989.042.01.19]; TATSUMI Y, 1986, J VOLCANOL GEOTH RES, V29, P293, DOI 10.1016/0377-0273(86)90049-1; TAYLOR SR, 1989, TECTONOPHYSICS, V161, P147, DOI 10.1016/0040-1951(89)90151-0; Thompson AB, 1996, T ROY SOC EDIN-EARTH, V87, P1; USGS, 1997, GLOB CRUST DAT; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WEILL DF, 1973, SCIENCE, V180, P1059, DOI 10.1126/science.180.4090.1059; WHITE AJR, 1983, GEOL SOC AM MEM, V159, P21; Yoder H., 1965, CARNEGIE I WASHINGTO, V64, P82; Zieg MJ, 2005, GEOL SOC AM BULL, V117, P1427, DOI 10.1130/B25579.1; Zimmer MM, 2010, J PETROL, V51, P2411, DOI 10.1093/petrology/egq062	66	142	154	3	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					301	+		10.1038/nature14584	http://dx.doi.org/10.1038/nature14584			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26178961	Green Submitted			2022-12-28	WOS:000357950900032
J	Benetos, A; Rossignol, P; Cherubini, A; Joly, L; Grodzicki, T; Rajkumar, C; Strandberg, TE; Petrovic, M				Benetos, Athanase; Rossignol, Patrick; Cherubini, Antonio; Joly, Laure; Grodzicki, Tomasz; Rajkumar, Chakravarthi; Strandberg, Timo E.; Petrovic, Mirko			Polypharmacy in the Aging Patient Management of Hypertension in Octogenarians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINES; ADVERSE DRUG-REACTIONS; HIGH BLOOD-PRESSURE; PULSE PRESSURE; OLDER PATIENTS; ELDERLY TRIAL; ARTERIAL STIFFNESS; AMERICAN SOCIETY; LIFE EXPECTANCY; MEDICATION USE	IMPORTANCE Hypertension treatment is beneficial for most hypertensive patients. The benefits for patients who are very old and frail, especially those taking numerous medications, are less certain. OBJECTIVE To provide recommendations for the evaluation and treatment of hypertension among patients aged 80 years and older. EVIDENCE ACQUISITION MEDLINE, PubMed Central, and the Cochrane Database of Systematic Reviews were searched from inception through April 2015, with an emphasis on 2010-2015. Manual cross-referencing of review articles and meta-analyses was also performed to identify randomized controlled trials (RCTs) examining antihypertensive use in octogenarians. The search strategy included the following Medical Subject Headings: hypertension or high blood pressure and trials and oldest old or very old or very elderly. FINDINGS Six post hoc analyses of the previously published Hypertension in the Very Elderly Trial (HYVET) met the inclusion criteria. In the only placebo-controlled RCT on hypertension management in patients older than 80 years (HYVET; N = 3845), the treatment was associated with lower total mortality and key cardiovascular end points but the effect on stroke (fatal and nonfatal), which was the primary outcome, failed to reach the significance level (P=.06). Post hoc analyses of HYVET suggested that active hypertension treatment in very elderly patients was beneficial by reducing blood pressure in individuals with white coat hypertension, showed moderate benefits of the active treatment for cognition, a possible effect for fractures prevention, and sustained differences in reductions of total mortality and cardiovascular mortality in those receiving active treatment. However, patients were community dwelling and less disabled than individuals of the same age in general. CONCLUSIONS AND RELEVANCE Hypertensive patients who are healthy, functionally independent, and aged 80 years and older should be treated according to current recommendations for people older than 65 years. There is insufficient evidence regarding the benefits of hypertension treatment for frail polymedicated octogenarians, for whom treatment should be individualized.	[Benetos, Athanase; Joly, Laure] Univ Lorraine, CHU Nancy, Dept Geriatr, Nancy, France; [Benetos, Athanase; Joly, Laure] Univ Lorraine, CHU Nancy, FHU CARTAGE, Nancy, France; [Rossignol, Patrick] Univ Lorraine, CHU Nancy, INSERM, Ctr Invest Clin Plurithemat 1433, Nancy, France; [Rossignol, Patrick] INI CRCT F CRIN Network, Nancy, France; [Cherubini, Antonio] IRCCS INRCA, Geriatria Accettaz Geriatr Urgenza, Ancona, Italy; [Grodzicki, Tomasz] Jagiellonian Univ, Dept Internal Med & Geriatr, Krakow, Poland; [Rajkumar, Chakravarthi] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Strandberg, Timo E.] Univ Helsinki, Cent Hosp, Dept Geriatr, Helsinki, Finland; [Strandberg, Timo E.] Univ Oulu, Inst Hlth Sci Geriatr, Oulu, Finland; [Petrovic, Mirko] Univ Ghent, Dept Geriatr, Ghent Univ Hosp, B-9000 Ghent, Belgium	CHU de Nancy; Universite de Lorraine; CHU de Nancy; Universite de Lorraine; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; IRCCS INRCA; Jagiellonian University; University of Brighton; University of Sussex; University of Helsinki; Helsinki University Central Hospital; University of Oulu; Ghent University; Ghent University Hospital	Benetos, A (corresponding author), Univ Lorraine, CHU Nancy, Dept Geriatr, Nancy, France.	a.benetos@chu-nancy.fr	Grodzicki, Tomasz/K-4451-2012; Cherubini, Antonio/AAL-4632-2020	Grodzicki, Tomasz/0000-0003-0159-4915; strandberg, timo/0000-0001-6299-925X; Joly, Laure/0000-0001-5389-6363; Cherubini, Antonio/0000-0003-0261-9897				Aguado A, 2009, BMC GERIATR, V8, P16; Alagiakrishnan K, 2003, J GERONTOL A-BIOL, V58, P362; Amati F, 2008, J APPL PHYSIOL, V105, P825, DOI 10.1152/japplphysiol.90384.2008; Aronow WS, 2011, J AM SOC HYPERTENS, V5, P259, DOI 10.1016/j.jash.2011.06.001; Askari M, 2004, AGING CLIN EXP RES, V16, P206, DOI 10.1007/BF03327385; Baitar A, 2013, J GERIATR ONCOL, V4, P32, DOI 10.1016/j.jgo.2012.08.001; Beckett N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7541; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; Bejan-Angoulvant T, 2010, J HYPERTENS, V28, P1366, DOI 10.1097/HJH.0b013e328339f9c5; Benetos A, 2005, J HYPERTENS, V23, P1803, DOI 10.1097/01.hjh.0000179512.71018.40; Benetos A, 2015, JAMA INTERN MED, V175, P989, DOI 10.1001/jamainternmed.2014.8012; Benetos A, 2013, J AM MED DIR ASSOC, V14, P791, DOI 10.1016/j.jamda.2013.08.003; Benetos A, 2012, J AM COLL CARDIOL, V60, P1503, DOI 10.1016/j.jacc.2012.04.055; Benetos A, 2010, J HYPERTENS, V28, P41, DOI 10.1097/HJH.0b013e328332b879; Berrut G, 2013, J NUTR HEALTH AGING, V17, P688, DOI 10.1007/s12603-013-0039-2; Blacher J, 2014, FUND CLIN PHARMACOL, V28, P1, DOI 10.1111/fcp.12044; Bromfield SG, 2014, J CLIN HYPERTENS, V16, P270, DOI 10.1111/jch.12281; Bulpitt CJ, 2013, HYPERTENSION, V61, P89, DOI 10.1161/HYPERTENSIONAHA.112.191791; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Cherubini A, 2011, ARCH INTERN MED, V171, P550, DOI 10.1001/archinternmed.2011.31; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Dalleur O, SCREENING TOOLS ASSE; Ellis G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub2; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Franco OH, 2005, HYPERTENSION, V46, P280, DOI 10.1161/01.HYP.0000173433.67426.9b; Franklin SS, 2001, CIRCULATION, V103, P1245; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried TR, 2014, J AM GERIATR SOC, V62, P2261, DOI 10.1111/jgs.13153; Fusco D, 2009, DRUG AGING, V26, P3, DOI 10.2165/11534620-000000000-00000; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; HANLON JT, 1992, J CLIN EPIDEMIOL, V45, P1045, DOI 10.1016/0895-4356(92)90144-C; Hiitola PK, 2007, J CLIN PHARM THER, V32, P253, DOI 10.1111/j.1365-2710.2007.00819.x; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; Hutchison LC., 2007, J PHARM PRACT, V20, P4, DOI [10.1177/0897190007304657, DOI 10.1177/0897190007304657]; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kalyanasundaram A, 2011, NAT REV CARDIOL, V8, P592, DOI 10.1038/nrcardio.2011.128; Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679; Kostis JB, 2008, NEW ENGL J MED, V358, P1958, DOI 10.1056/NEJMe0801709; Lampela P, 2010, DRUG AGING, V27, P507, DOI 10.2165/11536650-000000000-00000; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Lip GYH, 2015, JAMA-J AM MED ASSOC, V313, P1950, DOI 10.1001/jama.2015.4369; Lipsitz LA, 2013, JAMA-J AM MED ASSOC, V310, P1274, DOI 10.1001/jama.2013.277027; Lloyd-Jones DM, 2005, JAMA-J AM MED ASSOC, V294, P466, DOI 10.1001/jama.294.4.466; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; Mannucci PM, 2014, INTERN EMERG MED, V9, P723, DOI 10.1007/s11739-014-1124-1; MATTILA K, 1988, BRIT MED J, V296, P887, DOI 10.1136/bmj.296.6626.887; Molander L, 2008, J AM GERIATR SOC, V56, P1853, DOI 10.1111/j.1532-5415.2008.01948.x; Moorhouse P, 2012, J AM GERIATR SOC, V60, P2326, DOI 10.1111/j.1532-5415.2012.04210.x; Muller M, 2014, HYPERTENSION, V63, P433, DOI 10.1161/HYPERTENSIONAHA.113.00911; National Institute for Health and Care Excellence, 2011, HYP CLIN MAN PRIM HY; National Institute on Aging National Institutes of Health and World Health Organisation, 2011, NIH PUBL, V11-7737; Naugler C T, 2000, Can J Clin Pharmacol, V7, P103; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; Oates DJ, 2007, J AM GERIATR SOC, V55, P383, DOI 10.1111/j.1532-5415.2007.01069.x; Odden MC, 2012, ARCH INTERN MED, V172, P1162, DOI 10.1001/archinternmed.2012.2555; Onder G, 2014, J GERONTOL A-BIOL, V69, P430, DOI 10.1093/gerona/glt118; Onder G, 2011, CURR DRUG METAB, V12, P647, DOI 10.2174/138920011796504563; Organisation for Economic Co-operation and Development, HLTH GLANC 2009 OECD; Perry HM, 2000, JAMA-J AM MED ASSOC, V284, P465, DOI 10.1001/jama.284.4.465; Peters R, 2013, J HYPERTENS, V31, P1868, DOI 10.1097/HJH.0b013e3283622cc6; Peters R, 2010, AGE AGEING, V39, P609, DOI 10.1093/ageing/afq071; Peters R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011775; Petrovic M, 2012, DRUG AGING, V29, P453, DOI 10.2165/11631760-000000000-00000; Rastas S, 2006, J AM GERIATR SOC, V54, P912, DOI 10.1111/j.1532-5415.2006.00742.x; Romero-Ortuno R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006645; Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4; Sardar P, 2014, J AM GERIATR SOC, V62, P857, DOI 10.1111/jgs.12799; Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324; Sinclair A, 2015, LANCET DIABETES ENDO, V3, P275, DOI 10.1016/S2213-8587(14)70176-7; Sinclair AJ, 2011, DIABETES METAB, V37, pS27, DOI 10.1016/S1262-3636(11)70962-4; Sparling PB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h100; Strandberg TE, 2014, JAMA-J AM MED ASSOC, V312, P1136, DOI 10.1001/jama.2014.10924; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Thoenes M, 2013, J HUM HYPERTENS, V27, P131, DOI 10.1038/jhh.2011.114; Thomas DR, 2007, CLIN NUTR, V26, P389, DOI 10.1016/j.clnu.2007.03.008; Van Den Noortgate N, 2009, ACTA CLIN BELG, V64, P7, DOI 10.1179/acb.2009.003; van der Cammen TJM, 2014, AGE AGEING, V43, P20, DOI 10.1093/ageing/aft166; Van Kan GA, 2008, J NUTR HEALTH AGING, V12, P29, DOI 10.1007/BF02982161; van Kan GA, 2010, CLIN GERIATR MED, V26, P275, DOI 10.1016/j.cger.2010.02.002; Van Pottelbergh G, 2010, AGE AGEING, V39, P542, DOI 10.1093/ageing/afq091; Warwick J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0328-1; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]	87	88	94	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					170	180		10.1001/jama.2015.7517	http://dx.doi.org/10.1001/jama.2015.7517			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26172896				2022-12-28	WOS:000357867500017
J	Pursnani, A; Massaro, JM; D'Agostino, RB; O'Donnell, CJ; Hoffmann, U				Pursnani, Amit; Massaro, Joseph M.; D'Agostino, Ralph B., Sr.; O'Donnell, Christopher J.; Hoffmann, Udo			Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CALCIUM; CHOLESTEROL; RISK; ASSOCIATION; ACCURACY	IMPORTANCE The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines for cholesterol management defined new eligibility criteria for statin therapy. However, it is unclear whether this approach improves identification of adults at higher risk of cardiovascular events. OBJECTIVE To determine whether the ACC/AHA guidelines improve identification of individuals who develop incident cardiovascular disease (CVD) and/or have coronary artery calcification (CAC) compared with the National Cholesterol Education Program's 2004 Updated Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) guidelines. DESIGN, SETTING, AND PARTICIPANTS Longitudinal community-based cohort study, with participants for this investigation drawn from the offspring and third-generation cohorts of the Framingham Heart Study. Participants underwent multidetector computed tomography for CAC between 2002 and 2005 and were followed up for a median of 9.4 years for incident CVD. EXPOSURES Statin eligibility was determined based on Framingham risk factors and low-density lipoprotein thresholds for ATP III, whereas the pooled cohort calculator was used for ACC/AHA. MAIN OUTCOMES AND MEASURES The primary outcome was incident CVD (myocardial infarction, death due to coronary heart disease [CHD], or ischemic stroke). Secondary outcomes were CHD and CAC (as measured by the Agatston score). RESULTS Among 2435 statin-naive participants (mean age, 51.3 [SD, 8.6] years; 56% female), 39%(941/2435) were statin eligible by ACC/AHA compared with 14%(348/2435) by ATP III (P<.001). There were 74 incident CVD events (40 nonfatal myocardial infarctions, 31 nonfatal ischemic strokes, and 3 fatal CHD events). Participants who were statin eligible by ACC/AHA had increased hazard ratios for incident CVD compared with those eligible by ATP III: 6.8 (95% CI, 3.8-11.9) vs 3.1 (95% CI, 1.9-5.0), respectively (P<001). Similar results were seen for CVD in participants with intermediate Framingham Risk Scores and for CHD. Participants who were newly statin eligible (n = 593 [24%]) had an incident CVD rate of 5.7%, yielding a number needed to treat of 39 to 58. Participants with CAC were more likely to be statin eligible by ACC/AHA than by ATP III: CAC score >0 (n = 1015): 63% vs 23%; CAC score >100 (n = 376): 80% vs 32%; and CAC score >300 (n = 186): 85% vs 34%(all P<.001). A CAC score of 0 identified a low-risk group among ACC/AHA statin-eligible participants (306/941 [33%]) with a CVD rate of 1.6%. CONCLUSIONS AND RELEVANCE In this community-based primary prevention cohort, the ACC/AHA guidelines for determining statin eligibility, compared with the ATP III, were associated with greater accuracy and efficiency in identifying increased risk of incident CVD and subclinical coronary artery disease, particularly in intermediate-risk participants.	[Pursnani, Amit; Hoffmann, Udo] Harvard Univ, Cardiac MR PET CT Program, Massachusetts Gen Hosp, Dept Radiol,Med Sch, Boston, MA 02114 USA; [Pursnani, Amit] NorthShore Univ Hlth Syst, Div Cardiol, Evanston, IL USA; [Massaro, Joseph M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Massaro, Joseph M.; D'Agostino, Ralph B., Sr.; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Massaro, Joseph M.; D'Agostino, Ralph B., Sr.; O'Donnell, Christopher J.] Boston Univ, Framingham, MA USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Dept Math, Boston, MA 02215 USA; [O'Donnell, Christopher J.] NHLBI, Div Intramural Res, Bethesda, MD 20892 USA; [O'Donnell, Christopher J.; Hoffmann, Udo] Harvard Univ, Div Cardiol, Dept Med, Massachusetts Gen Hosp,Med Sch, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; NorthShore University Health System; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; Massachusetts General Hospital	Hoffmann, U (corresponding author), Massachusetts Gen Hosp, Cardiac MR PET CT Program, 100 Charles River Plaza,Ste 400, Boston, MA 02114 USA.	uhoffmann@mgh.harvard.edu			National Heart, Lung, and Blood Institute's Framingham Heart Study [N01-HC-25195, HL076784, AG028321, HL070100, HL060040, HL080124, HL071039, HL077447, HL107385]; National Institutes of Health [T32 HL076136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006173, ZIAHL006175, ZIAHL006002] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (contracts N01-HC-25195, HL076784, AG028321, HL070100, HL060040, HL080124, HL071039, HL077447, and HL107385). Dr Pursnani was supported by National Institutes of Health grant T32 HL076136.	Allison MA, 2003, INT J CARDIOL, V90, P281, DOI 10.1016/S0167-5273(02)00571-5; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guallar E, 2014, ANN INTERN MED, V160, P361, DOI 10.7326/M14-0112; Hoffmann U, 2006, EUR J RADIOL, V57, P396, DOI 10.1016/j.ejrad.2005.12.027; Hoffmann U, 2008, AM J CARDIOL, V102, P1136, DOI 10.1016/j.amjcard.2008.06.038; Hong C, 2003, RADIOLOGY, V227, P795, DOI 10.1148/radiol.2273020369; Johnson KM, 2014, J AM COLL CARDIOL, V64, P910, DOI 10.1016/j.jacc.2014.05.056; Lehman SJ, 2010, ATHEROSCLEROSIS, V210, P656, DOI 10.1016/j.atherosclerosis.2010.01.007; Martin SS, 2014, ANN INTERN MED, V160, P356, DOI 10.7326/M13-2805; Paixao ARM, 2014, CIRC-CARDIOVASC QUAL, V7, P778, DOI 10.1161/CIRCOUTCOMES.114.001139; Paramsothy P, 2010, AM J CARDIOL, V105, P352, DOI 10.1016/j.amjcard.2009.09.040; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Preis SR, 2009, AM J CARDIOL, V103, P1710, DOI 10.1016/j.amjcard.2009.02.020; Safford MM, 2012, JAMA-J AM MED ASSOC, V308, P1768, DOI 10.1001/jama.2012.14306; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Thanassoulis G, 2010, J AM COLL CARDIOL, V55, P2491, DOI 10.1016/j.jacc.2010.03.019; Wong ND, 2004, AM J CARDIOL, V94, P431, DOI 10.1016/j.amjcard.2004.05.003	23	112	115	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					134	141		10.1001/jama.2015.7515	http://dx.doi.org/10.1001/jama.2015.7515			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26172893	Bronze, Green Accepted			2022-12-28	WOS:000357867500013
J	Webb, RH; Grant, C; Harnden, A				Webb, Rachel Helena; Grant, Cameron; Harnden, Anthony			Acute rheumatic fever	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEART-DISEASE REGISTRY; NEW-ZEALAND CHILDREN; FOLLOW-UP; SYDENHAMS CHOREA; ECHOCARDIOGRAPHIC DIAGNOSIS; INTRAVENOUS IMMUNOGLOBULIN; DOPPLER-ECHOCARDIOGRAPHY; INFECTIVE ENDOCARDITIS; NORTHERN-TERRITORY; SODIUM VALPROATE		[Webb, Rachel Helena] Starship Childrens Hosp, Dept Paediat Infect Dis, Auckland 1023, New Zealand; [Grant, Cameron] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland 1, New Zealand; [Grant, Cameron] Starship Childrens Hosp, Dept Gen Paediat, Auckland 1023, New Zealand; [Harnden, Anthony] Univ Oxford, Dept Primary Hlth Care Sci, Primary Care, Oxford OX3 7LF, England	Starship Children's Hospital; University of Auckland; Starship Children's Hospital; University of Oxford	Webb, RH (corresponding author), Starship Childrens Hosp, Dept Paediat Infect Dis, Auckland 1023, New Zealand.	rwebb@adhb.govt.nz		Grant, Cameron/0000-0002-4032-7230				ABERNETHY M, 1994, AUST NZ J MED, V24, P530, DOI 10.1111/j.1445-5994.1994.tb01753.x; ALKASAB S, 1988, CHEST, V94, P830, DOI 10.1378/chest.94.4.830; [Anonymous], AUSTR GUID PREV DIAG; Beaton A, 2012, CIRCULATION, V125, P3127, DOI 10.1161/CIRCULATIONAHA.112.092312; Bessen DE, 2000, J INFECT DIS, V182, P1109, DOI 10.1086/315842; Bhaya M, 2010, ECHOCARDIOGR-J CARD, V27, P448, DOI 10.1111/j.1540-8175.2009.01055.x; Bitar FF, 2000, PEDIATR CARDIOL, V21, P119, DOI 10.1007/s002469910017; Bryant PA, 2009, CIRCULATION, V119, P742, DOI 10.1161/CIRCULATIONAHA.108.792135; Caldas AM, 2008, PEDIATR CARDIOL, V29, P1048, DOI 10.1007/s00246-008-9242-z; Carapetis JR, 2008, NAT CLIN PRACT CARD, V5, P411, DOI 10.1038/ncpcardio1185; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2001, ARCH DIS CHILD, V85, P223, DOI 10.1136/adc.85.3.223; Carapetis JR, 1999, AUST NZ J PUBL HEAL, V23, P159, DOI 10.1111/j.1467-842X.1999.tb01227.x; Carapetis JR, 1999, ARCH DIS CHILD, V80, P353, DOI 10.1136/adc.80.4.353; Cilliers AM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003176; Cunningham MW, 2014, INT REV IMMUNOL, V33, P314, DOI 10.3109/08830185.2014.917411; Cunningham MW, 2014, NAT REV CARDIOL, V11, P123, DOI 10.1038/nrcardio.2012.197-c1; DAJANI A, 1995, PEDIATRICS, V96, P758; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; Dale JB, 2013, VACCINE, V31, pB216, DOI 10.1016/j.vaccine.2012.09.045; DAOUD AS, 1990, NEUROLOGY, V40, P1140, DOI 10.1212/WNL.40.7.1140; EDWARDS WD, 1978, CIRCULATION, V57, P181, DOI 10.1161/01.CIR.57.1.181; Engel ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025326; FEINSTEIN AR, 1964, ANN INTERN MED, V60, P87, DOI 10.7326/0003-4819-60-2-87; Figueroa FE, 2001, HEART, V85, P407, DOI 10.1136/heart.85.4.407; FOLGER GM, 1992, BRIT HEART J, V67, P434; Garvey MA, 2005, J CHILD NEUROL, V20, P424, DOI 10.1177/08830738050200050601; Genel F, 2002, BRAIN DEV-JPN, V24, P73, DOI 10.1016/S0387-7604(01)00404-1; Gewitz MH, 2015, CIRCULATION, V131, P1806, DOI 10.1161/CIR.0000000000000205; Grassi A, 2009, CLIN EXP RHEUMATOL, V27, P366; Hashkes PJ, 2003, J PEDIATR-US, V143, P399, DOI 10.1067/S0022-3476(03)00388-3; Heart Foundation, 2014, NZ GUID RHEUM FEV DI; Infective Endocarditis Prophylaxis Experts Group, 2008, THER GUID ANT; Jaine R, 2008, J PAEDIATR CHILD H, V44, P564, DOI 10.1111/j.1440-1754.2008.01384.x; Jaine R, 2011, PEDIATR INFECT DIS J, V30, P315, DOI 10.1097/INF.0b013e3181fbd85b; Jones TD, 1944, J AMER MED ASSOC, V126, P481, DOI 10.1001/jama.1944.02850430015005; KAPLAN EL, 1988, NEW ZEAL MED J, V101, P402; Karthikeyan G, 2012, AM HEART J, V163, P535, DOI 10.1016/j.ahj.2012.01.003; Kerdemelidis M, 2009, NEW ZEAL MED J, V122, P10; Lawrence JG, 2013, CIRCULATION, V128, P492, DOI 10.1161/CIRCULATIONAHA.113.001477; Lennon D, 2009, PEDIATR INFECT DIS J, V28, P787, DOI 10.1097/INF.0b013e3181a282be; Lennon Diana, 2009, Pediatr Infect Dis J, V28, pe259, DOI 10.1097/INF.0b013e3181a8e12a; LUE HC, 1994, J PEDIATR-US, V125, P812, DOI 10.1016/S0022-3476(94)70082-6; MAJEED HA, 1992, J CLIN EPIDEMIOL, V45, P871, DOI 10.1016/0895-4356(92)90070-4; Manyemba J, 2003, SAMJ S AFR MED J, V93, P212; Manyemba J., 2002, COCHRANE DB SYST REV, V2002, pCD002227, DOI [10.1002/14651858.CD002227, DOI 10.1002/14651858.CD002227, 10.1002/14651858.CD00222712137650]; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Mayosi B, 2015, RHDGEN NETWORK GENET; Milne RJ, 2012, J PAEDIATR CHILD H, V48, P685, DOI 10.1111/j.1440-1754.2012.02447.x; Moreland NJ, 2014, VACCINE, V32, P3713, DOI 10.1016/j.vaccine.2014.05.017; National Heart Foundation of New Zealand Advisory Group, 2008, PREV INF END ASS DEN; Nkgudi B, 2006, S Afr Med J, V96, P206; Okello E, 2013, CARDIOVASC J AFR, V24, P80, DOI [10.5830/CVJA-2013-004, 10.5830/cvja-2013-004]; Ozkutlu S, 2003, CARDIOL YOUNG, V13, P495, DOI 10.1017/S1047951103001069; Paar JA, 2010, AM J CARDIOL, V105, P1809, DOI 10.1016/j.amjcard.2010.01.364; Panamonta M, 2004, INT J CARDIOL, V94, P241, DOI 10.1016/j.ijcard.2003.04.020; Pena J, 2002, ARQ NEURO-PSIQUIAT, V60, P374, DOI 10.1590/S0004-282X2002000300006; Ralph Anna, 2006, Heart Lung Circ, V15, P113, DOI 10.1016/j.hlc.2005.08.006; Remenyi B, 2013, WORLD J PEDIATR CONG, V4, P155, DOI 10.1177/2150135112474024; Remenyi B, 2012, NAT REV CARDIOL, V9, P297, DOI 10.1038/nrcardio.2012.7; Riaz BK, 2013, J HEALTH POPUL NUTR, V31, P70; Richey R, 2008, BMJ-BRIT MED J, V336, P770, DOI 10.1136/bmj.39510.423148.AD; Roberts K, 2014, CIRCULATION, V129, P1953, DOI 10.1161/CIRCULATIONAHA.113.003495; Roberts K, 2013, NAT REV CARDIOL, V10, P49, DOI 10.1038/nrcardio.2012.157; Russell K, 2014, J PAEDIATR CHILD H, V50, P112, DOI 10.1111/jpc.12400; Sadler L, 2000, BRIT J OBSTET GYNAEC, V107, P245, DOI 10.1111/j.1471-0528.2000.tb11696.x; SANYAL SK, 1982, CIRCULATION, V65, P375, DOI 10.1161/01.CIR.65.2.375; Seckeler Michael D, 2011, Clin Epidemiol, V3, P67, DOI 10.2147/CLEP.S12977; Sharma Satyavan, 2009, J Indian Med Assoc, V107, P611; Spinetto H, 2011, J PAEDIATR CHILD H, V47, P228, DOI 10.1111/j.1440-1754.2010.01942.x; Steer AC, 2009, J HEART VALVE DIS, V18, P327; TARAN LM, 1947, AM J MED, V2, P285, DOI 10.1016/0002-9343(47)90234-9; Tibazarwa KB, 2008, HEART, V94, P1534, DOI 10.1136/hrt.2007.141309; TOMPKINS DG, 1972, CIRCULATION, V45, P543, DOI 10.1161/01.CIR.45.3.543; Vasan RS, 1996, CIRCULATION, V94, P73, DOI 10.1161/01.CIR.94.1.73; Veasy LG, 2004, PEDIATRICS, V113, pE168, DOI 10.1542/peds.113.3.e168; VEASY LG, 1994, J PEDIATR-US, V124, P9, DOI 10.1016/S0022-3476(94)70247-0; Voss LM, 2001, CIRCULATION, V103, P401; Walker AR, 2007, J PEDIATR-US, V151, P679, DOI 10.1016/j.jpeds.2007.04.059; Walker Kathleen G, 2010, Ther Adv Neurol Disord, V3, P301, DOI 10.1177/1756285610382063; Webb R, 2014, PEDIATR INFECT DIS J, V33, P437, DOI 10.1097/INF.0000000000000133; Webb RH, 2011, CARDIOL YOUNG, V21, P436, DOI 10.1017/S1047951111000266; Wilson E, 2007, PEDIATR INFECT DIS J, V26, P369, DOI 10.1097/01.inf.0000259056.02569.0c; Wilson NJ, 2013, NEW ZEAL MED J, V126, P50; WILSON NJ, 1995, INT J CARDIOL, V50, P1, DOI 10.1016/0167-5273(95)02325-Q; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; World Health Organization, 2004, RHEUM FEV RHEUM HEAR, P923; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449; Zuhlke LJ, 2013, GLOB HEART, V8, P189, DOI 10.1016/j.gheart.2013.08.008	89	28	30	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2015	351								h3443	10.1136/bmj.h3443	http://dx.doi.org/10.1136/bmj.h3443			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CO	26175053				2022-12-28	WOS:000358301600004
J	Watts, G				Watts, Geoff			Michael Francis Oliver Obituary	LANCET			English	Biographical-Item																		OLIVER MF, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					130	130		10.1016/S0140-6736(15)61232-6	http://dx.doi.org/10.1016/S0140-6736(15)61232-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM5QC	26194386				2022-12-28	WOS:000357742200018
J	Horton, R; Lo, SL				Horton, Richard; Lo, Selina			Planetary health: a new science for exceptional action	LANCET			English	Editorial Material							ENVIRONMENT		[Horton, Richard] The Lancet, London EC2Y 5AS, England; [Lo, Selina] The Lancet, Beijing, Peoples R China		Horton, R (corresponding author), The Lancet, London EC2Y 5AS, England.							Boyden S., 2004, BIOL CIVILISATION; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3632, DOI 10.1073/pnas.1114845109; Dasgupta PS, 2013, SCIENCE, V340, P324, DOI 10.1126/science.1224664; Hauser OP, 2014, NATURE, V511, P220, DOI 10.1038/nature13530; Horton R, 2015, LANCET, V385, P314, DOI 10.1016/S0140-6736(15)60093-9; Horton R, 2014, LANCET, V383, P847, DOI 10.1016/S0140-6736(14)60409-8; Horton R, 2013, LANCET, V382, P1012, DOI 10.1016/S0140-6736(13)61936-4; Levin SA, 2014, P NATL ACAD SCI USA, V111, P10838, DOI 10.1073/pnas.1400830111; Lutz W, 2014, SCIENCE, V346, P1061, DOI 10.1126/science.1257975; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; Whitmee S., 2015, LANCET	11	60	63	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					1921	1922		10.1016/S0140-6736(15)61038-8	http://dx.doi.org/10.1016/S0140-6736(15)61038-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PI	26188746	Bronze			2022-12-28	WOS:000364763200008
J	Robinson, LN; Tharakaraman, K; Rowley, KJ; Costa, VV; Chan, KR; Wong, YH; Ong, LC; Tan, HC; Koch, T; Cain, D; Kirloskar, R; Viswanathan, K; Liew, CW; Tissire, H; Ramakrishnan, B; Myette, JR; Babcock, GJ; Sasisekharan, V; Alonso, S; Chen, J; Lescar, J; Shriver, Z; Ooi, EE; Sasisekharan, R				Robinson, Luke N.; Tharakaraman, Kannan; Rowley, Kirk J.; Costa, Vivian V.; Chan, Kuan Rong; Wong, Yee Hwa; Ong, Li Ching; Tan, Hwee Cheng; Koch, Tyree; Cain, David; Kirloskar, Rama; Viswanathan, Karthik; Liew, Chong Wai; Tissire, Hamid; Ramakrishnan, Boopathy; Myette, James R.; Babcock, Gregory J.; Sasisekharan, V.; Alonso, Sylvie; Chen, Jianzhu; Lescar, Julien; Shriver, Zachary; Ooi, Eng Eong; Sasisekharan, Ram			Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope	CELL			English	Article							NEUTRALIZING ANTIBODIES; VIRUS-INFECTION; MONOCLONAL-ANTIBODY; FUSION LOOP; DOMAIN III; IN-VIVO; INFLUENZA; PROTECTION; EFFICACY; PROTEIN	Dengue is the most common vector-borne viral disease, causing nearly 400 million infections yearly. Currently there are no approved therapies. Antibody epitopes that elicit weak humoral responses may not be accessible by conventional B cell panning methods. To demonstrate an alternative strategy to generating a therapeutic antibody, we employed a non-immunodominant, but functionally relevant, epitope in domain III of the E protein, and engineered by structure-guided methods an antibody directed to it. The resulting antibody, Ab513, exhibits high-affinity binding to, and broadly neutralizes, multiple genotypes within all four serotypes. To assess therapeutic relevance of Ab513, activity against important human clinical features of dengue was investigated. Ab513 mitigates thrombocytopenia in a humanized mouse model, resolves vascular leakage, reduces viremia to nearly undetectable levels, and protects mice in a maternal transfer model of lethal antibody-mediated enhancement. The results demonstrate that Ab513 may reduce the public health burden from dengue.	[Robinson, Luke N.; Rowley, Kirk J.; Koch, Tyree; Viswanathan, Karthik; Tissire, Hamid; Ramakrishnan, Boopathy; Myette, James R.; Babcock, Gregory J.; Shriver, Zachary] Visterra Inc, Cambridge, MA 02139 USA; [Robinson, Luke N.; Tharakaraman, Kannan; Cain, David; Kirloskar, Rama; Sasisekharan, V.; Sasisekharan, Ram] MIT, Koch Inst Integrat Canc Res, Dept Biol Engn, Cambridge, MA 02139 USA; [Costa, Vivian V.; Ong, Li Ching; Alonso, Sylvie; Chen, Jianzhu; Ooi, Eng Eong; Sasisekharan, Ram] Singapore MIT Alliance Res & Technol, Infectious Dis Interdisciplinary Res Grp, Singapore, Singapore; [Chan, Kuan Rong; Tan, Hwee Cheng; Ooi, Eng Eong] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore; [Wong, Yee Hwa; Liew, Chong Wai; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Alonso, Sylvie] Natl Univ Singapore, Dept Microbiol, Singapore 117545, Singapore; [Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Massachusetts Institute of Technology (MIT)	Sasisekharan, R (corresponding author), MIT, Koch Inst Integrat Canc Res, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu	Costa, Vivian VVC/I-2499-2018	Costa, Vivian VVC/0000-0002-0175-642X; Wong, Yee Hwa/0000-0002-2751-9721; Chan, Kuan Rong/0000-0002-2427-671X; Rowley, Kirk/0000-0002-8548-001X; Ooi, Eng Eong/0000-0002-0520-1544	NIH [1R01AI111395, R37 GM057073-13]; NIEHS [2T32ES007020]; National Research Foundation supported Interdisciplinary Research group in Infectious Diseases of SMART (Singapore MIT alliance for Research and Technology); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073, R01GM057073] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Research Foundation supported Interdisciplinary Research group in Infectious Diseases of SMART (Singapore MIT alliance for Research and Technology); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by NIH Award (1R01AI111395 to R.S.), NIEHS training grant (2T32ES007020 to L.N.R.), NIH Merit Award (R37 GM057073-13 to R.S.), and National Research Foundation supported Interdisciplinary Research group in Infectious Diseases of SMART (Singapore MIT alliance for Research and Technology). The authors would like to acknowledge the work of Wilton DePina and Andrew Wollacott in designing and testing of E proteins and dengue strains. L.N.R. is an employee and shareholder of Visterra, Inc.; K.J.R. is an employee and shareholder of Visterra, Inc.; T.K. is an employee and shareholder of Visterra, Inc.; K.V. is an employee and shareholder of Visterra, Inc.; H.T. is an employee and shareholder of Visterra, Inc.; B.R. is an employee and shareholder of Visterra, Inc.; J.R.M. is an employee and shareholder of Visterra, Inc.; G.J.B.; Z.S. is an employee and shareholder of Visterra, Inc.; and R.S. is a founder, shareholder, and member of the board of Visterra, Inc.	Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chan KR, 2014, P NATL ACAD SCI USA, V111, P2722, DOI 10.1073/pnas.1317454111; Chan KR, 2011, P NATL ACAD SCI USA, V108, P12479, DOI 10.1073/pnas.1106568108; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Lai CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002451; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Rainwater-Lovett K, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-233; Ramos EL, 2015, J INFECT DIS, V211, P1038, DOI 10.1093/infdis/jiu539; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; SIBER GR, 1993, J PEDIATR-US, V122, P204, DOI 10.1016/S0022-3476(06)80114-9; Siegrist CA, 1998, VACCINE, V16, P1409, DOI 10.1016/S0264-410X(98)00100-5; Simmons CP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001752; Smith S.A., 2013, MBIO, V4, pe13; Soundararajan V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00200; Sridharan A, 2013, J VIROL, V87, P11648, DOI 10.1128/JVI.01156-13; Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Tharakaraman K, 2013, P NATL ACAD SCI USA, V110, pE1555, DOI 10.1073/pnas.1303645110; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037; Wahala WMPB, 2012, J VIROL, V86, P4019, DOI 10.1128/JVI.06871-11; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Williams KL, 2012, VIROLOGY, V429, P12, DOI 10.1016/j.virol.2012.03.003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu RSL, 2012, ANTIVIR RES, V96, P340, DOI 10.1016/j.antiviral.2012.09.018; Zhang P, 2007, P NATL ACAD SCI USA, V104, P8449, DOI 10.1073/pnas.0703039104	46	78	82	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 30	2015	162	3					493	504		10.1016/j.cell.2015.06.057	http://dx.doi.org/10.1016/j.cell.2015.06.057			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN9WS	26189681	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000358801800010
J	Cutler, DM				Cutler, David M.			From the Affordable Care Act to Affordable Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE		Harvard Univ, Dept Econ, Cambridge, MA 02138 USA	Harvard University	Cutler, DM (corresponding author), Harvard Univ, Dept Econ, 1805 Cambridge St, Cambridge, MA 02138 USA.	dcutler@harvard.edu		Cutler, David/0000-0002-4949-8917				Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Bundorf MK., 2012, CONSUMER DIRECTED HL; Collins SR, 2014, TOO HIGH PRICE OUT O; Cutler D, 2012, NEW ENGL J MED, V367, P1875, DOI 10.1056/NEJMp1209711; Mello MM, 2014, JAMA-J AM MED ASSOC, V312, P2146, DOI 10.1001/jama.2014.10705; Nyweide DJ, 2015, JAMA-J AM MED ASSOC, V313, P2152, DOI 10.1001/jama.2015.4930; Song ZR, 2014, NEW ENGL J MED, V371, P1704, DOI 10.1056/NEJMsa1404026	7	14	14	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					337	338		10.1001/jama.2015.7683	http://dx.doi.org/10.1001/jama.2015.7683			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219044	Green Published			2022-12-28	WOS:000358581700008
J	Klimas, J				Klimas, J.			Training in addiction medicine should be standardised and scaled up	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EDUCATION		[Klimas, J.] Univ British Columbia, BC Ctr Excellence HIV AIDS, Urban Hlth Res Initiat, Vancouver, BC V6Z 1Y6, Canada; [Klimas, J.] Univ British Columbia, St Pauls Hosp, Dept Med, Vancouver, BC V6Z 1Y6, Canada; [Klimas, J.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University College Dublin	Klimas, J (corresponding author), Univ British Columbia, BC Ctr Excellence HIV AIDS, Urban Hlth Res Initiat, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jan.klimas@ucd.ie	Klimas, Jan/E-7191-2010	Klimas, Jan/0000-0002-5179-0052	NATIONAL INSTITUTE ON DRUG ABUSE [R25DA037756] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Atkinson C, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI DOI 10.1001/JAMA.2013.13805; Ayu AP, 2015, EUR ADDICT RES, V21, P223, DOI 10.1159/000381671; Carroll J, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-34; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; el-Guebaly N, 2011, SUBST ABUS, V32, P77, DOI 10.1080/08897077.2011.555697; Haber PS, 2011, SUBST ABUS, V32, P75, DOI 10.1080/08897077.2011.555695; International Society of Addiction Medicine, 2015, INT SOC ADD MED C; Lamb S, 1998, BRIDGING GAP PRACTIC; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; National Center on Addiction and Substance Abuse at Columbia University, 2000, MISS OPP CASA NAT SU; National Centre on Addiction and Substance Abuse at Columbia University, 2012, ADD MED CLOS GAP SCI; O'Brien S, 2011, IRISH J MED SCI, V180, P787, DOI 10.1007/s11845-011-0736-y; Uchtenhagen A, 2008, SUBST ABUS, V29, P95, DOI 10.1080/08897070802219263; Wood E, 2013, JAMA-J AM MED ASSOC, V310, P1673, DOI 10.1001/jama.2013.280377	14	14	14	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2015	351								h4027	10.1136/bmj.h4027	http://dx.doi.org/10.1136/bmj.h4027			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2TX	26220548	Green Submitted, Green Published			2022-12-28	WOS:000359010600007
J	Song, H; Ekheden, IG; Zheng, ZL; Ericsson, J; Nyren, O; Ye, WM				Song, Huan; Ekheden, Isabella Guncha; Zheng, Zongli; Ericsson, Jan; Nyren, Olof; Ye, Weimin			Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HELICOBACTER-PYLORI INFECTION; INTESTINAL METAPLASIA; FOLLOW-UP; ATYPIA; ADENOCARCINOMA; ERADICATION; DYSPLASIA; CARCINOMA; DIAGNOSIS; SOCIETY	OBJECTIVE To accurately measure the incidence of gastric cancer among patients with gastric precancerous lesions, and to quantify the excess incidence in comparison with people with normal mucosa on endoscopy and a general population. DESIGN Population based cohort study. SETTING Population of Sweden using data from its national disease registers. PARTICIPANTS 405 172 patients who had gastric biopsy samples taken for non-malignant indications between 1979 and 2011. MAIN OUTCOME MEASURES Incidence of gastric cancer, reported separately for patients with different mucosal changes in biopsy samples. Standardised incidence ratios provided estimation of the relative risk, using the general Swedish population as reference; and hazard ratios were derived from Cox regression modelling for internal comparisons with patients with normal gastric mucosa. RESULTS After excluding the first two years of follow-up, 1599 cases of gastric cancer were identified. The annual crude incidence of gastric cancer was 20x10(-5) for those in the normal mucosa group (standardised incidence ratio 1.0), 42x10(-5) for those with minor changes (1.5), 59x10(-5) for the gastritis group (1.8), 100x10(-5) for the atrophic gastritis group (2.8), 129x10(-5) for the intestinal metaplasia group (3.4), and 263x10(-5) for the dysplasia group (6.5). Cox regression modelling confirmed that excess risks increased monotonically with progressive severity of gastric lesions, with the highest hazard ratio of 10.9 (dysplasia versus normal mucosa, 95% confidence interval 7.7 to 15.4). The increased incidence was stable throughout the follow-up period, and the gaps between cumulative incidence curves grew continuously. CONCLUSIONS Among patients who undergo gastroscopy with biopsy for clinical indications, approximately 1 in 256 with normal mucosa, 1 in 85 with gastritis, 1 in 50 with atrophic gastritis, 1 in 39 with intestinal metaplasia, and 1 in 19 with dysplasia will develop gastric cancer within 20 years. These numbers, along with cost-benefit analyses, should guide future surveillance policies for these particular patient groups.	[Song, Huan; Ekheden, Isabella Guncha; Zheng, Zongli; Nyren, Olof; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Ericsson, Jan] Karolinska Hosp, Dept Pathol, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Ye, WM (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden.	weimin.ye@ki.se	zheng, zongli/C-7309-2008; Zheng, Zongli/B-2917-2011	Ekheden, Isabella/0000-0003-0445-6630; Zheng, Zongli/0000-0003-4849-4903; Song, Huan/0000-0003-3845-8079	Swedish Research Council [2011-3182]; Cancerfonden [2013-798]; China Scholarship Council; Karolinska Institutet MD/PhD programme	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); China Scholarship Council(China Scholarship Council); Karolinska Institutet MD/PhD programme	This study was supported by the Swedish Research Council (grant No 2011-3182) and Cancerfonden (grant No 2013-798). HS was partly supported by a scholarship from the China Scholarship Council, and IGE is partly supported by a scholarship from the Karolinska Institutet MD/PhD programme. The funders had no role in the conduct of this research.	Agoston AT, 2014, HUM PATHOL, V45, P446, DOI 10.1016/j.humpath.2013.10.032; Anderson WF, 2010, JAMA-J AM MED ASSOC, V303, P1723, DOI 10.1001/jama.2010.496; Annibale B, 2000, ALIMENT PHARM THERAP, V14, P625; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V59, P1; [Anonymous], 2015, CANC INC SWED 2013; ANTONIOLI DA, 1994, HUM PATHOL, V25, P994, DOI 10.1016/0046-8177(94)90058-2; Asfeldt AM, 2009, EUR J EPIDEMIOL, V24, P649, DOI 10.1007/s10654-009-9371-6; AXON ATR, 1995, BMJ-BRIT MED J, V310, P853, DOI 10.1136/bmj.310.6983.853; CORREA P, 1992, CANCER RES, V52, P6735; Cote RA, 1979, SYSTEMATIZED NOMENCL; de Vries AC, 2008, GASTROENTEROLOGY, V134, P945, DOI 10.1053/j.gastro.2008.01.071; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; Early DS, 2012, GASTROINTEST ENDOSC, V75, P1127, DOI 10.1016/j.gie.2012.01.011; Ekstrom AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; El-Omar EM, 2000, GASTROENTEROLOGY, V118, P22, DOI 10.1016/S0016-5085(00)70410-0; Genta RM, 2005, SEMIN DIAGN PATHOL, V22, P273, DOI 10.1053/j.semdp.2006.04.001; Ginsberg GG, 1996, AM J GASTROENTEROL, V91, P714; Goldstone AR, 1996, J PATHOL, V179, P129; Gonzalez CA, 2010, INT J CANCER, V127, P2654, DOI 10.1002/ijc.25273; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Kaise M, 2014, ENDOSCOPY, V46, P827, DOI 10.1055/s-0034-1377524; Kapadia CR, 2003, J CLIN GASTROENTEROL, V36, pS29, DOI 10.1097/00004836-200305001-00006; Kelly PJ, 2001, DIAGN HISTOPATHOL, V17, P50; Konturek PC, 2009, J PHYSIOL PHARMACOL, V60, P3; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Sanfrancesco J, 2013, UROL CLIN N AM, V40, P281, DOI 10.1016/j.ucl.2013.01.006; Satoh K, 1998, HELICOBACTER, V3, P236; Sipponen P, 2015, SCAND J GASTROENTERO, V50, P657, DOI 10.3109/00365521.2015.1019918; Song H, 2015, CLIN GASTROENTEROL H; Song H, 2014, INT J CANCER, V134, P2942, DOI 10.1002/ijc.28621; Wang J, 2011, DIGESTION, V83, P253, DOI 10.1159/000280318; Whiting JL, 2002, GUT, V50, P378, DOI 10.1136/gut.50.3.378; Ye WM, 1999, INT J CANCER, V83, P223, DOI 10.1002/(SICI)1097-0215(19991008)83:2<223::AID-IJC13>3.3.CO;2-D; Zheng ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026442; Zheng ZL, 2011, NAT PROTOC, V6, P1367, DOI 10.1038/nprot.2011.369; Zheng ZL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq332; Zwick A, 1997, GASTROENTEROLOGY, V113, P659, DOI 10.1053/gast.1997.v113.pm9247488	38	142	162	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2015	351								h3867	10.1136/bmj.h3867	http://dx.doi.org/10.1136/bmj.h3867			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2TV	26215280	hybrid, Green Published			2022-12-28	WOS:000359010400002
J	Stewart, CN				Stewart, C. Neal, Jr.			Songwriting and science	SCIENCE			English	Editorial Material								Each week, articles in Science and friends in science-related careers remind me how competitive the grant and paper scenes have gotten. One National Science Foundation (NSF) panelist, for example, recently told me that the panel's funding rate in the last competition was 3%. I don't need these reminders; my own steady diet of rejections from prospective funders and journal editors keeps the message vivid and personal.	Univ Tennessee, Plant Mol Genet, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Stewart, CN (corresponding author), Univ Tennessee, Plant Mol Genet, Knoxville, TN 37996 USA.								0	0	1	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					446	446		10.1126/science.349.6246.446	http://dx.doi.org/10.1126/science.349.6246.446			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206938				2022-12-28	WOS:000358381400046
J	Plotkin, SA; Mahmoud, AAF; Farrar, J				Plotkin, Stanley A.; Mahmoud, Adel A. F.; Farrar, Jeremy			Establishing a Global Vaccine-Development Fund	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Plotkin, Stanley A.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Plotkin, Stanley A.; Mahmoud, Adel A. F.] Fdn Vaccine Res, Washington, DC USA; [Mahmoud, Adel A. F.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Mahmoud, Adel A. F.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Farrar, Jeremy] Wellcome Trust Res Labs, London, England	University of Pennsylvania; Princeton University; Princeton University	Plotkin, SA (corresponding author), Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA.		Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X				Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Pronker ES, 2011, VACCINE, V29, P5846, DOI 10.1016/j.vaccine.2011.06.051; Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755	4	65	65	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					297	300		10.1056/NEJMp1506820	http://dx.doi.org/10.1056/NEJMp1506820			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN3NL	26200974	Bronze			2022-12-28	WOS:000358333500001
J	Romanov-Michailidis, F; Rovis, T				Romanov-Michailidis, Fedor; Rovis, Tomislav			ORGANIC CHEMISTRY Natural polarity inverted	NATURE			English	Editorial Material							BIOMIMETIC TRANSAMINATION; ASYMMETRIC-SYNTHESIS; ANION EQUIVALENTS; UMPOLUNG; REACTIVITY; DIAMINES; IMINES; AMINES		[Romanov-Michailidis, Fedor; Rovis, Tomislav] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA	Colorado State University	Romanov-Michailidis, F (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.	tomislav.rovis@colostate.edu						Brehme R, 2007, EUR J ORG CHEM, V2007, P5629, DOI 10.1002/ejoc.200700746; Denmark SE, 2010, NAT CHEM, V2, P937, DOI [10.1038/NCHEM.857, 10.1038/nchem.857]; Flanigan DM, 2015, CHEM REV, V115, P9307, DOI 10.1021/acs.chemrev.5b00060; Han JL, 2011, CURR ORG SYNTH, V8, P281, DOI 10.2174/157017911794697277; Kim H, 2008, J AM CHEM SOC, V130, P12184, DOI 10.1021/ja803951u; Liu XL, 2014, ORG LETT, V16, P2118, DOI 10.1021/ol500522d; Matsumoto M, 2014, CHEM COMMUN, V50, P13041, DOI 10.1039/c4cc06156j; Ogle JW, 2008, ORG LETT, V10, P3677, DOI 10.1021/ol8012765; SEEBACH D, 1979, ANGEW CHEM INT EDIT, V18, P239, DOI 10.1002/anie.197902393; Shirakawa S, 2013, ANGEW CHEM INT EDIT, V52, P4312, DOI 10.1002/anie.201206835; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Wu YW, 2015, NATURE, V523, P445, DOI 10.1038/nature14617; Wu YW, 2012, J AM CHEM SOC, V134, P14334, DOI 10.1021/ja306771n; Xiao X, 2011, J AM CHEM SOC, V133, P12914, DOI 10.1021/ja203138q; Zhu Y, 2014, J AM CHEM SOC, V136, P4500, DOI 10.1021/ja501560x	15	11	11	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					417	+		10.1038/523417a	http://dx.doi.org/10.1038/523417a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26201594				2022-12-28	WOS:000358378900027
J	Waller, L; Tian, L				Waller, Laura; Tian, Lei			COMPUTATIONAL IMAGING Machine learning for 3D microscopy	NATURE			English	Editorial Material									[Waller, Laura; Tian, Lei] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Waller, L (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.	waller@berkeley.edu	tian, lei/HGU-7245-2022; Tian, Lei/A-6463-2015; aubertin, rebeckah/O-9624-2015	Tian, Lei/0000-0002-1316-4456; aubertin, rebeckah/0000-0002-0558-7571				COWLEY JM, 1957, ACTA CRYSTALLOGR, V10, P609, DOI 10.1107/S0365110X57002194; Kamilov US, 2015, OPTICA, V2, P517, DOI 10.1364/OPTICA.2.000517; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Van den Broek W, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.245502	5	42	44	1	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					416	417		10.1038/523416a	http://dx.doi.org/10.1038/523416a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26201593				2022-12-28	WOS:000358378900026
J	Fekete, T				Fekete, Thomas			Clindamycin did not differ from trimethoprim-sulfamethoxazole for curing uncomplicated skin infections	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Temple Univ, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fekete, T (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.		Fekete, Thomas/AFI-5367-2022						0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2							JC9	10.7326/ACPJC-2015-163-2-009	http://dx.doi.org/10.7326/ACPJC-2015-163-2-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26192589				2022-12-28	WOS:000358407500009
J	Kleinman, A				Kleinman, Arthur			The art of medicine Care: in search of a health agenda	LANCET			English	Editorial Material									[Kleinman, Arthur] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Kleinman, Arthur] Harvard Univ, Dept Global Hlth & Social Med, Cambridge, MA 02138 USA	Harvard University; Harvard University	Kleinman, A (corresponding author), Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA.	kleinman@fas.harvard.edu							0	25	29	2	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					240	241		10.1016/S0140-6736(15)61271-5	http://dx.doi.org/10.1016/S0140-6736(15)61271-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN1XI	26194517				2022-12-28	WOS:000358213700018
J	Gershman, SJ; Horvitz, EJ; Tenenbaum, JB				Gershman, Samuel J.; Horvitz, Eric J.; Tenenbaum, Joshua B.			Computational rationality: A converging paradigm for intelligence in brains, minds, and machines	SCIENCE			English	Review							PREFRONTAL CORTEX; DECISION; UNCERTAINTY; PRINCIPLES; SYSTEMS; HABITS; SEARCH; PATHS	After growing up together, and mostly growing apart in the second half of the 20th century, the fields of artificial intelligence (AI), cognitive science, and neuroscience are reconverging on a shared view of the computational foundations of intelligence that promotes valuable cross-disciplinary exchanges on questions, methods, and results. We chart advances over the past several decades that address challenges of perception and action under uncertainty through the lens of computation. Advances include the development of representations and inferential procedures for large-scale probabilistic inference and machinery for enabling reflection and decisions about tradeoffs in effort, precision, and timeliness of computations. These tools are deployed toward the goal of computational rationality: identifying decisions with highest expected utility, while taking into consideration the costs of computation in complex real-world problems in which most relevant calculations can only be approximated. We highlight key concepts with examples that show the potential for interchange between computer science, cognitive science, and neuroscience.	[Gershman, Samuel J.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Gershman, Samuel J.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Horvitz, Eric J.] Microsoft Res, Redmond, WA 98052 USA; [Tenenbaum, Joshua B.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Harvard University; Harvard University; Microsoft; Massachusetts Institute of Technology (MIT)	Gershman, SJ (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	gershman@fas.harvard.edu; horvitz@microsoft.com; jbt@mit.edu			Center for Brains, Minds and Machines (CBMM) - National Science Foundation Science and Technology Center [CCF-1231216]	Center for Brains, Minds and Machines (CBMM) - National Science Foundation Science and Technology Center	We are grateful to A. Gershman and the three referees for helpful comments. This research was partly supported by the Center for Brains, Minds and Machines (CBMM), funded by National Science Foundation Science and Technology Center award CCF-1231216.	Anderson J. R., 1990, ADAPTIVE CHARACTER T; Buesing L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002211; Burns E, 2013, J ARTIF INTELL RES, V47, P697, DOI 10.1613/jair.4047; Chaslot G., 2008, AIIDE, P216; COOPER GF, 1990, ARTIF INTELL, V42, P393, DOI 10.1016/0004-3702(90)90060-D; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; DEAN T, 1995, ARTIF INTELL, V76, P35, DOI 10.1016/0004-3702(94)00086-G; Denison S, 2013, COGNITION, V126, P285, DOI 10.1016/j.cognition.2012.10.010; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Doya K., 2007, BAYESIAN BRAIN PROBA; Gershman SJ, 2012, NEURAL COMPUT, V24, P1, DOI 10.1162/NECO_a_00226; Gigerenzer G., 2008, RATIONALITY MORTALS; GOOD IJ, 1952, J ROY STAT SOC B, V14, P107; Griffiths TL, 2015, TOP COGN SCI, V7, P217, DOI 10.1111/tops.12142; Griffiths TL, 2005, COGNITIVE PSYCHOL, V51, P334, DOI 10.1016/j.cogpsych.2005.05.004; Guo X., 2014, ADV NEURAL INFORM PR, V27, P3338; Hay N., 2012, P 28 C UNC ART INT, P346; Heckerman D., 1989, P 1989 WORKSH UNC AR, P162; Horvitz E, 2001, ARTIF INTELL, V126, P159, DOI 10.1016/S0004-3702(00)00082-5; Horvitz E., 1987, P 3 WORKSH UNC ART I, P429; Horvitz E., 2001, P 17 C UNC ART INT U, P235; Horvitz E., 1991, P 7 C UNC ART INT, P151; HORVITZ EJ, 1989, P 11 INT JOINT C ART, P1121; Isard M, 1998, INT J COMPUT VISION, V29, P5, DOI 10.1023/A:1008078328650; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Keramati M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002055; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Koller D., 2009, PROBABILISTIC GRAPHI; Kool W, 2014, J EXP PSYCHOL GEN, V143, P131, DOI 10.1037/a0031048; Kool W, 2010, J EXP PSYCHOL GEN, V139, P665, DOI 10.1037/a0020198; Lee SW, 2014, NEURON, V81, P687, DOI 10.1016/j.neuron.2013.11.028; Levy R., 2009, ADV NEURAL INFORM PR, V2, P937; Lewis RL, 2014, TOP COGN SCI, V6, P279, DOI 10.1111/tops.12086; Lieder F., 2014, ADV NEURAL INFORM PR, V27, P2870; Lieder F., 2014, P ANN M COGNITIVE SC; Lin C. H., 2015, P IJCAI; McGuire JT, 2010, P NATL ACAD SCI USA, V107, P7922, DOI 10.1073/pnas.0910662107; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Oaksford M., 2007, BAYESIAN RATIONALITY; Otto AR, 2013, PSYCHOL SCI, V24, P751, DOI 10.1177/0956797612463080; PAYNE JW, 1988, J EXP PSYCHOL LEARN, V14, P534, DOI 10.1037/0278-7393.14.3.534; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; PETERSON CR, 1967, PSYCHOL BULL, V68, P29, DOI 10.1037/h0024722; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Rieskamp J, 2006, J EXP PSYCHOL GEN, V135, P207, DOI 10.1037/0096-3445.135.2.207; RUSSELL S, 1991, ARTIF INTELL, V49, P361, DOI 10.1016/0004-3702(91)90015-C; Russell S, 2009, ARTIFICIAL INTELLIGE; Sanborn AN, 2010, PSYCHOL REV, V117, P1144, DOI 10.1037/a0020511; Simon H. A., 1957, MODELS MAN; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Von Neumann J., 2012, COMPUTER BRAIN; Vul E., 2009, ADV NEURAL INF PROCE, V29, P1955; Vul E, 2014, COGNITIVE SCI, V38, P599, DOI 10.1111/cogs.12101; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	60	247	249	19	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		273	278		10.1126/science.aac6076	http://dx.doi.org/10.1126/science.aac6076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1ZB	26185246				2022-12-28	WOS:000358218600043
J	Long, SR				Long, Sharon R.			Receptive to infection	NATURE			English	Editorial Material							RHIZOBIUM; MORPHOGENESIS; NODULATION; LEGUMES; NODULE		Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Long, SR (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	srl@stanford.edu						BREWIN NJ, 1991, ANNU REV CELL BIOL, V7, P191, DOI 10.1146/annurev.cb.07.110191.001203; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; FISHER RF, 1992, NATURE, V357, P655, DOI 10.1038/357655a0; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kawaharada Y, 2015, NATURE, V523, P308, DOI 10.1038/nature14611; Kelly SJ, 2013, MOL PLANT MICROBE IN, V26, P319, DOI 10.1094/MPMI-09-12-0227-R; Niehaus K, 1998, Subcell Biochem, V29, P73; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839	10	5	5	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					298	299		10.1038/nature14632	http://dx.doi.org/10.1038/nature14632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM8KY	26153862				2022-12-28	WOS:000357950900031
J	Mohammed, H; Russell, IA; Stark, R; Rueda, OM; Hickey, TE; Tarulli, GA; Serandour, AAA; Birrell, SN; Bruna, A; Saadi, A; Menon, S; Hadfield, J; Pugh, M; Raj, GV; Brown, GD; D'Santos, C; Robinson, JLL; Silva, G; Launchbury, R; Perou, CM; Stingl, J; Caldas, C; Tilley, WD; Carroll, JS				Mohammed, Hisham; Russell, I. Alasdair; Stark, Rory; Rueda, Oscar M.; Hickey, Theresa E.; Tarulli, Gerard A.; Serandour, Aurelien A. A.; Birrell, Stephen N.; Bruna, Alejandra; Saadi, Amel; Menon, Suraj; Hadfield, James; Pugh, Michelle; Raj, Ganesh V.; Brown, Gordon D.; D'Santos, Clive; Robinson, Jessica L. L.; Silva, Grace; Launchbury, Rosalind; Perou, Charles M.; Stingl, John; Caldas, Carlos; Tilley, Wayne D.; Carroll, Jason S.			Progesterone receptor modulates ER alpha action in breast cancer	NATURE			English	Article							ESTROGEN-RECEPTOR; SYNTHETIC PROGESTIN; MECHANISM; THERAPY; REVEALS; ACETATE; CELLS; WOMEN; TRIAL; GENE	Progesterone receptor (PR) expression is used as a biomarker of oestrogen receptor-alpha (ER alpha) function and breast cancer prognosis. Here we show that PR is not merely an ER alpha-induced gene target, but is also an ER alpha-associated protein that modulates its behaviour. In the presence of agonist ligands, PR associates with ER alpha to direct ER alpha chromatin binding events within breast cancer cells, resulting in a unique gene expression programme that is associated with good clinical outcome. Progesterone inhibited oestrogen-mediated growth of ER alpha(+) cell line xenografts and primary ER alpha(+) breast tumour explants, and had increased anti-proliferative effects when coupled with an ER alpha antagonist. Copy number loss of PGR, the gene coding for PR, is a common feature in ER alpha(+) breast cancers, explaining lower PR levels in a subset of cases. Our findings indicate that PR functions as a molecular rheostat to control ER alpha chromatin binding and transcriptional activity, which has important implications for prognosis and therapeutic interventions.	[Mohammed, Hisham; Russell, I. Alasdair; Stark, Rory; Rueda, Oscar M.; Serandour, Aurelien A. A.; Bruna, Alejandra; Saadi, Amel; Menon, Suraj; Hadfield, James; Pugh, Michelle; Brown, Gordon D.; D'Santos, Clive; Robinson, Jessica L. L.; Launchbury, Rosalind; Stingl, John; Caldas, Carlos; Carroll, Jason S.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Hickey, Theresa E.; Tarulli, Gerard A.; Birrell, Stephen N.; Tilley, Wayne D.] Univ Adelaide, Dame Roma Mitchell Canc Res Labs, Adelaide, SA 5005, Australia; [Hickey, Theresa E.; Tarulli, Gerard A.; Birrell, Stephen N.; Tilley, Wayne D.] Univ Adelaide, Sch Med, Adelaide Prostate Canc Res Ctr, Adelaide, SA 5005, Australia; [Raj, Ganesh V.] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Silva, Grace; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Breast Unit, Cambridge CB2 2QQ, England; [Caldas, Carlos] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 2QQ, England; [Caldas, Carlos] Cambridge Expt Canc Med Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Adelaide; University of Adelaide; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Carroll, JS (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	wayne.tilley@adelaide.edu.au; jason.carroll@cruk.cam.ac.uk	Perou, Charles M/H-9934-2014; Serandour, Aurelien/AAG-7036-2019; Serandour, Aurelien/C-1390-2010; Tarulli, Gerard A/D-8863-2013; Rueda, Oscar/ABF-5479-2020; Caldas, Carlos/U-7250-2019	Perou, Charles M/0000-0001-9827-2247; Serandour, Aurelien/0000-0001-5253-9567; Serandour, Aurelien/0000-0001-5253-9567; Rueda, Oscar/0000-0003-0008-4884; Caldas, Carlos/0000-0003-3547-1489; Hickey, Theresa/0000-0002-2752-730X; Bruna, Alejandra/0000-0003-1214-9665; Stark, Rory/0000-0002-1790-5469; Carroll, Jason/0000-0003-3643-0080; Mohammed, Hisham/0000-0003-0275-9793; Saadi, Amel/0000-0001-6615-4254; Tarulli, Gerard/0000-0002-1327-4655; Tilley, Wayne/0000-0003-1893-2626	University of Cambridge; Cancer Research UK; Hutchison Whampoa Limited; National Cancer Institute of National Institutes of Health [5P30CA142543]; Department of Defense [W81XWH-12-1-0288-03]; National Health and Medical Research Council of Australia [1008349, 1084416]; Cancer Australia [627229]; US Department of Defense Breast Cancer Research Program (BCRP) [W81XWH-11-1-0592]; Royal Adelaide Hospital Research Foundation; ERC; EMBO Young investigator award; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; Cancer Research UK [20411, 22310, 16942] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited; National Cancer Institute of National Institutes of Health; Department of Defense(United States Department of Defense); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Australia; US Department of Defense Breast Cancer Research Program (BCRP)(United States Department of Defense); Royal Adelaide Hospital Research Foundation; ERC(European Research Council (ERC)European Commission); EMBO Young investigator award(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors would like to thank S. Leigh-Brown, the staff in the genomic core facility, S. Halim, the proteomic core facility and the bioinformatic core facility at Cancer Research UK. We acknowledge S. Jindal for pathology review, N. Ryan for technical assistance and S. Edwards for statistical analysis with ex vivo culture. The MCF7-LucYFP cells were a kind gift from N. Benaich. We thank H. Gronemeyer for the PR-A and PR-B expressing vectors. We would like to acknowledge the support of the University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited. Research reported in this manuscript was supported by the National Cancer Institute of the National Institutes of Health under award number 5P30CA142543 (to University of Texas Southwestern) and Department of Defense grants W81XWH-12-1-0288-03 (GVR). W.D.T. is supported by grants from the National Health and Medical Research Council of Australia (ID 1008349; ID 1084416) and Cancer Australia (ID 627229) T.E.H. held a Fellowship Award from the US Department of Defense Breast Cancer Research Program (BCRP; W81XWH-11-1-0592) and currently is supported by a Florey Fellowship from the Royal Adelaide Hospital Research Foundation. J.S.C. is supported by an ERC starting grant and an EMBO Young investigator award.	Badwe R, 2011, J CLIN ONCOL, V29, P2845, DOI 10.1200/JCO.2010.33.0738; Ballare C, 2003, MOL CELL BIOL, V23, P1994, DOI 10.1128/MCB.23.6.1994-2008.2003; Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Bentel JM, 1999, MOL CELL ENDOCRINOL, V154, P11, DOI 10.1016/S0303-7207(99)00109-4; Bines J, 2014, ANN ONCOL, V25, P831, DOI 10.1093/annonc/mdu015; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Centenera MM, 2012, CLIN CANCER RES, V18, P3562, DOI 10.1158/1078-0432.CCR-12-0782; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen CC, 2011, J BIOL CHEM, V286, P43091, DOI 10.1074/jbc.M111.295865; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Clarke CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035859; Cui XJ, 2005, J CLIN ONCOL, V23, P7721, DOI 10.1200/JCO.2005.09.004; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dean JL, 2012, CELL CYCLE, V11, P2756, DOI 10.4161/cc.21195; Dowsett M, 2005, J CLIN ONCOL, V23, P7512, DOI 10.1200/JCO.2005.01.4829; Fournier A, 2008, BREAST CANCER RES TR, V107, P103, DOI 10.1007/s10549-007-9523-x; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Kabos P, 2012, BREAST CANCER RES TR, V135, P415, DOI 10.1007/s10549-012-2164-8; Lee Y, 1996, P NATL ACAD SCI USA, V93, P15180, DOI 10.1073/pnas.93.26.15180; Liang Y, 2007, CANCER RES, V67, P9929, DOI 10.1158/0008-5472.CAN-07-1103; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Musgrove EA, 1998, MOL CELL BIOL, V18, P1812, DOI 10.1128/MCB.18.4.1812; PICHON MF, 1980, CANCER RES, V40, P3357; READ LD, 1988, MOL ENDOCRINOL, V2, P263, DOI 10.1210/mend-2-3-263; Stark R., 2011, R PACKAGE VERSION; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Tomlinson IPM, 1996, J PATHOL, V180, P38, DOI 10.1002/(SICI)1096-9896(199609)180:1<38::AID-PATH638>3.0.CO;2-C; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; VIGNON F, 1983, J CLIN ENDOCR METAB, V56, P1124, DOI 10.1210/jcem-56-6-1124; Zheng ZY, 2005, J BIOL CHEM, V280, P17480, DOI 10.1074/jbc.M501261200	31	388	408	6	115	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					313	+		10.1038/nature14583	http://dx.doi.org/10.1038/nature14583			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26153859	Green Accepted, Green Submitted			2022-12-28	WOS:000357950900034
J	Savage, N				Savage, Neil			Scientists in the Twitterverse	CELL			English	Editorial Material																			0	14	14	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					231	232		10.1016/j.cell.2015.06.062	http://dx.doi.org/10.1016/j.cell.2015.06.062			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186181	Bronze			2022-12-28	WOS:000358087700001
J	Newton, JN				Newton, John N.			Future inequalities in life expectancy in England and Wales	LANCET			English	Editorial Material							MORTALITY; PROJECTIONS; COUNTRIES; HEALTH		[Newton, John N.] Univ Manchester, Inst Populat Hlth, Manchester M13 9PL, Lancs, England; [Newton, John N.] Publ Hlth England, London, England	University of Manchester; Public Health England	Newton, JN (corresponding author), Univ Manchester, Inst Populat Hlth, Manchester M13 9PL, Lancs, England.	john.newton-3@man.ac.uk	Newton, John/HCH-8693-2022	Newton, John/0000-0002-5641-6457				[Anonymous], HIST PROJ MORT DAT P; [Anonymous], 2014, NAT LIF TABL UK 2011; Bennett JE, 2015, LANCET, V386, P163, DOI 10.1016/S0140-6736(15)60296-3; Bongaarts J, 2014, POPUL DEV REV, V40, P189, DOI 10.1111/j.1728-4457.2014.00670.x; Griffiths C., 2001, HLTH STAT Q, V09, P16; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Norman P, 2005, SOC SCI MED, V60, P2755, DOI 10.1016/j.socscimed.2004.11.008; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Office for National Statistics, 2014, LIF EXP BIRTH AG 65; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; World Health Organization, 2014, WORLD HLTH STAT 2014	14	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					115	117		10.1016/S0140-6736(15)60604-3	http://dx.doi.org/10.1016/S0140-6736(15)60604-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM5QC	26194380	hybrid			2022-12-28	WOS:000357742200010
J	Lovell, B; Connor, H				Lovell, Ben; Connor, Hilary			SPOT DIAGNOSIS Twelve lead electrocardiography after collapse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lovell, Ben] Royal Free Hosp, Dept Acute Med, London NW3 2CG, England; [Connor, Hilary] Royal Free Hosp, Emergency Dept, London NW3 2CG, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Lovell, B (corresponding author), Royal Free Hosp, Dept Acute Med, London NW3 2CG, England.	benlovell@doctors.org.uk		Lovell, Ben/0000-0001-8143-6380					0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2015	351								h3512	10.1136/bmj.h3512	http://dx.doi.org/10.1136/bmj.h3512			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MU	26160411				2022-12-28	WOS:000357956500003
J	Di Angelantonio, E; Kaptoge, S; Wormser, D; Willeit, P; Butterworth, AS; Bansal, N; O'Keeffe, LM; Gao, P; Wood, AM; Burgess, S; Freitag, DF; Pennells, L; Peters, SA; Hart, CL; Haheim, LL; Gillum, RF; Nordestgaard, BG; Psaty, BM; Yeap, BB; Knuiman, MW; Nietert, PJ; Kauhanen, J; Salonen, JT; Kuller, LH; Simons, LA; van der Schouw, YT; Barrett-Connor, E; Selmer, R; Crespo, CJ; Rodriguez, B; Verschuren, WMM; Salomaa, V; Svardsudd, K; van der Harst, P; Bjorkelund, C; Wilhelmsen, L; Wallace, RB; Brenner, H; Amouyel, P; Barr, ELM; Iso, H; Onat, A; Trevisan, M; D'Agostino, RB; Cooper, C; Kavousi, M; Welin, L; Roussel, R; Hu, FB; Sato, S; Davidson, KW; Howard, BV; Leening, M; Rosengren, A; Dorr, M; Deeg, DJH; Kiechl, S; Stehouwer, CDA; Nissinen, A; Giampaoli, S; Donfrancesco, C; Kromhout, D; Price, JF; Peters, A; Meade, TW; Casiglia, E; Lawlor, DA; Gallacher, J; Nagel, D; Franco, OH; Assmann, G; Dagenais, GR; Jukema, JW; Sundstrom, J; Woodward, M; Brunner, EJ; Khaw, KT; Wareham, NJ; Whitsel, EA; Njolstad, I; Hedblad, B; Wassertheil-Smoller, S; Engstrom, G; Rosamond, WD; Selvin, E; Sattar, N; Thompson, SG; Danesh, J				Di Angelantonio, Emanuele; Kaptoge, Stephen; Wormser, David; Willeit, Peter; Butterworth, Adam S.; Bansal, Narinder; O'Keeffe, Linda M.; Gao, Pei; Wood, Angela M.; Burgess, Stephen; Freitag, Daniel F.; Pennells, Lisa; Peters, Sanne A.; Hart, Carole L.; Haheim, Lise Lund; Gillum, Richard F.; Nordestgaard, Borge G.; Psaty, Bruce M.; Yeap, Bu B.; Knuiman, Matthew W.; Nietert, Paul J.; Kauhanen, Jussi; Salonen, Jukka T.; Kuller, Lewis H.; Simons, Leon A.; van der Schouw, Yvonne T.; Barrett-Connor, Elizabeth; Selmer, Randi; Crespo, Carlos J.; Rodriguez, Beatriz; Verschuren, W. M. Monique; Salomaa, Veikko; Svardsudd, Kurt; van der Harst, Pim; Bjorkelund, Cecilia; Wilhelmsen, Lars; Wallace, Robert B.; Brenner, Hermann; Amouyel, Philippe; Barr, Elizabeth L. M.; Iso, Hiroyasu; Onat, Altan; Trevisan, Maurizio; D'Agostino, Ralph B., Sr.; Cooper, Cyrus; Kavousi, Maryam; Welin, Lennart; Roussel, Ronan; Hu, Frank B.; Sato, Shinichi; Davidson, Karina W.; Howard, Barbara V.; Leening, Maarten; Rosengren, Annika; Dorr, Marcus; Deeg, Dorly J. H.; Kiechl, Stefan; Stehouwer, Coen D. A.; Nissinen, Aulikki; Giampaoli, Simona; Donfrancesco, Chiara; Kromhout, Daan; Price, Jackie F.; Peters, Annette; Meade, Tom W.; Casiglia, Edoardo; Lawlor, Debbie A.; Gallacher, John; Nagel, Dorothea; Franco, Oscar H.; Assmann, Gerd; Dagenais, Gilles R.; Jukema, J. Wouter; Sundstrom, Johan; Woodward, Mark; Brunner, Eric J.; Khaw, Kay-Tee; Wareham, Nicholas J.; Whitsel, Eric A.; Njolstad, Inger; Hedblad, Bo; Wassertheil-Smoller, Sylvia; Engstrom, Gunnar; Rosamond, Wayne D.; Selvin, Elizabeth; Sattar, Naveed; Thompson, Simon G.; Danesh, John		Emerging Risk Factors Collaboratio	Association of Cardiometabolic Multimorbidity With Mortality The Emerging Risk Factors Collaboration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; PRIOR MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; FASTING GLUCOSE; IMPACT; AGE; METAANALYSIS; INDIVIDUALS; DIAGNOSIS	IMPORTANCE The prevalence of cardiometabolic multimorbidity is increasing. OBJECTIVE To estimate reductions in life expectancy associated with cardiometabolic multimorbidity. DESIGN, SETTING, AND PARTICIPANTS Age-and sex-adjusted mortality rates and hazard ratios (HRs) were calculated using individual participant data from the Emerging Risk Factors Collaboration (689 300 participants; 91 cohorts; years of baseline surveys: 1960-2007; latest mortality follow-up: April 2013; 128 843 deaths). The HRs from the Emerging Risk Factors Collaboration were compared with those from the UK Biobank (499 808 participants; years of baseline surveys: 2006-2010; latest mortality follow-up: November 2013; 7995 deaths). Cumulative survival was estimated by applying calculated age-specific HRs for mortality to contemporary US age-specific death rates. EXPOSURES A history of 2 or more of the following: diabetes mellitus, stroke, myocardial infarction (MI). MAIN OUTCOMES AND MEASURES All-cause mortality and estimated reductions in life expectancy. RESULTS In participants in the Emerging Risk Factors Collaboration without a history of diabetes, stroke, or MI at baseline (reference group), the all-cause mortality rate adjusted to the age of 60 years was 6.8 per 1000 person-years. Mortality rates per 1000 person-years were 15.6 in participants with a history of diabetes, 16.1 in those with stroke, 16.8 in those with MI, 32.0 in those with both diabetes and MI, 32.5 in those with both diabetes and stroke, 32.8 in those with both stroke and MI, and 59.5 in those with diabetes, stroke, and MI. Compared with the reference group, the HRs for all-cause mortality were 1.9 (95% CI, 1.8-2.0) in participants with a history of diabetes, 2.1 (95% CI, 2.0-2.2) in those with stroke, 2.0 (95% CI, 1.9-2.2) in those with MI, 3.7 (95% CI, 3.3-4.1) in those with both diabetes and MI, 3.8 (95% CI, 3.5-4.2) in those with both diabetes and stroke, 3.5 (95% CI, 3.1-4.0) in those with both stroke and MI, and 6.9 (95% CI, 5.7-8.3) in those with diabetes, stroke, and MI. The HRs from the Emerging Risk Factors Collaboration were similar to those from the more recently recruited UK Biobank. The HRs were little changed after further adjustment for markers of established intermediate pathways (eg, levels of lipids and blood pressure) and lifestyle factors (eg, smoking, diet). At the age of 60 years, a history of any 2 of these conditions was associated with 12 years of reduced life expectancy and a history of all 3 of these conditions was associated with 15 years of reduced life expectancy. CONCLUSIONS AND RELEVANCE Mortality associated with a history of diabetes, stroke, or MI was similar for each condition. Because any combination of these conditions was associated with multiplicative mortality risk, life expectancy was substantially lower in people with multimorbidity.	[Di Angelantonio, Emanuele; Kaptoge, Stephen; Wormser, David; Willeit, Peter; Butterworth, Adam S.; Bansal, Narinder; O'Keeffe, Linda M.; Gao, Pei; Wood, Angela M.; Burgess, Stephen; Freitag, Daniel F.; Pennells, Lisa; Khaw, Kay-Tee; Thompson, Simon G.; Danesh, John] Univ Cambridge, Cambridge CB1 8RN, England; [Peters, Sanne A.; van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Hart, Carole L.; Sattar, Naveed] Univ Glasgow, Glasgow, Lanark, Scotland; [Haheim, Lise Lund] Univ Oslo, Oslo, Norway; [Gillum, Richard F.] Howard Univ, Coll Med, Washington, DC USA; [Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen, Denmark; [Psaty, Bruce M.] Univ Washington, Seattle, WA 98195 USA; [Yeap, Bu B.; Knuiman, Matthew W.] Univ Western Australia, Perth, WA 6009, Australia; [Nietert, Paul J.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Kauhanen, Jussi] Univ Eastern Finland, Kuopio, Finland; [Salonen, Jukka T.] Metab Analyt Serv Inc, Helsinki, Finland; [Kuller, Lewis H.] Univ Pittsburgh, Pittsburgh, PA USA; [Simons, Leon A.] Univ New S Wales, Sydney, NSW 2052, Australia; [Barrett-Connor, Elizabeth] Univ Calif San Diego, La Jolla, CA 92093 USA; [Selmer, Randi] Norwegian Inst Publ Hlth, Oslo, Norway; [Crespo, Carlos J.] Portland State Univ, Portland, OR 97207 USA; [Rodriguez, Beatriz] Univ Hawaii, Honolulu, HI 96822 USA; [Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Salomaa, Veikko; Nissinen, Aulikki] Natl Inst Hlth & Welf, Helsinki, Finland; [Svardsudd, Kurt; Sundstrom, Johan] Uppsala Univ, Uppsala, Sweden; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Bjorkelund, Cecilia; Wilhelmsen, Lars] Univ Gothenburg, Gothenburg, Sweden; [Wallace, Robert B.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Amouyel, Philippe] Inst Pasteur, Lille, France; [Barr, Elizabeth L. M.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Iso, Hiroyasu] Osaka Univ, Suita, Osaka, Japan; [Onat, Altan] Istanbul Univ, Istanbul, Turkey; [Trevisan, Maurizio] CUNY, New York, NY 10021 USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Boston, MA 02215 USA; [Cooper, Cyrus] Univ Southampton, Southampton, Hants, England; [Cooper, Cyrus] Univ Oxford, Oxford, England; [Kavousi, Maryam; Leening, Maarten; Franco, Oscar H.] Erasmus MC, Rotterdam, Netherlands; [Welin, Lennart] Lidkoping Hosp, Lidkoping, Sweden; [Roussel, Ronan] INSERM, Ctr Rech Cordeliers, Paris, France; [Roussel, Ronan] Univ Paris Diderot, Paris, France; [Roussel, Ronan] Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ FIRE, Diabetol, F-75877 Paris, France; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sato, Shinichi] Chiba Prefectural Inst Publ Hlth, Osaka Med Ctr Hlth Sci & Promot, Suita, Osaka, Japan; [Davidson, Karina W.] Columbia Univ, Med Ctr, New York, NY USA; [Howard, Barbara V.] MedStar Hlth Res Inst, Hyattsville, MD USA; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Dorr, Marcus] Univ Med Greifswald, Greifswald, Germany; [Dorr, Marcus] Partner Site Greifswald, DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Deeg, Dorly J. H.] Vrije Univ Med Ctr, Amsterdam, Netherlands; [Kiechl, Stefan] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Stehouwer, Coen D. A.] Maastricht Univ Med Ctr, Maastricht, Netherlands; [Giampaoli, Simona; Donfrancesco, Chiara] Ist Super Sanita, I-00161 Rome, Italy; [Kromhout, Daan] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Price, Jackie F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Peters, Annette] Helhmolhtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Peters, Annette] Partner Site Munich, German Res Ctr Cardiovasc Res DZHK eV, Munich, Germany; [Meade, Tom W.] London Sch Hyg & Trop Med, London WC1, England; [Casiglia, Edoardo] Univ Padua, Padua, Italy; [Lawlor, Debbie A.] Univ Bristol, Bristol, Avon, England; [Gallacher, John] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales; [Nagel, Dorothea] Klinikum Univ Munchen LMU, Munich, Germany; [Assmann, Gerd] Assmann Stiftung Pravent, Munster, Germany; [Dagenais, Gilles R.] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Leiden, Netherlands; [Woodward, Mark] Univ Sydney, Sydney, NSW 2006, Australia; [Brunner, Eric J.] UCL, London, England; [Wareham, Nicholas J.] MRC, Epidemiol Unit, Cambridge, England; [Whitsel, Eric A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Whitsel, Eric A.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Njolstad, Inger] Univ Tromso, Tromso, Norway; [Hedblad, Bo; Engstrom, Gunnar] Lund Univ, Lund, Sweden; [Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, New York, NY USA; [Rosamond, Wayne D.] Univ N Carolina, Chapel Hill, NC USA; [Selvin, Elizabeth] Johns Hopkins Univ, Baltimore, MD USA	University of Cambridge; Utrecht University; Utrecht University Medical Center; University of Glasgow; University of Oslo; Howard University; University of Copenhagen; University of Washington; University of Washington Seattle; University of Western Australia; Medical University of South Carolina; University of Eastern Finland; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of New South Wales Sydney; University of California System; University of California San Diego; Norwegian Institute of Public Health (NIPH); Portland State University; University of Hawaii System; Netherlands National Institute for Public Health & the Environment; Finland National Institute for Health & Welfare; Uppsala University; University of Groningen; University of Gothenburg; University of Iowa; Helmholtz Association; German Cancer Research Center (DKFZ); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Baker Heart and Diabetes Institute; Osaka University; Istanbul University; City University of New York (CUNY) System; Boston University; University of Southampton; University of Oxford; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; MedStar Health Research Institute; University of Gothenburg; Greifswald Medical School; German Centre for Cardiovascular Research; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Medical University of Innsbruck; Maastricht University; Maastricht University Medical Centre (MUMC); Istituto Superiore di Sanita (ISS); Wageningen University & Research; University of Edinburgh; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Centre for Cardiovascular Research; University of London; London School of Hygiene & Tropical Medicine; University of Padua; University of Bristol; Cardiff University; University of Munich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Sydney; University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; UiT The Arctic University of Tromso; Lund University; Yeshiva University; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University	Danesh, J (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England.	erfc@phpc.cam.ac.uk	Brenner, Hermann/ABE-6383-2020; Nordestgaard, Borge Gronne/ABF-1310-2020; Davidson, Karina/GWC-0996-2022; Woodward, Mark/L-6817-2017; DiAngelantonio, Emanuele/ABE-6852-2020; Njolstad, Inger/X-3784-2019; Jukema, J. Wouter/ABD-6503-2021; Dörr, Marcus/F-1919-2010; Franco, Óscar H/ABE-2305-2020; Kavousi, Maryam/F-1174-2018; Peters, Annette/A-6117-2011; Stehouwer, Coen/AAB-3435-2021; Brunner, Eric/H-2114-2011; Gao, Pei/R-4794-2018; van der Schouw, Yvonne T./F-8327-2014; Sundström, Johan/A-6286-2009; Brenner, Hermann/B-4627-2017; Wood, Angela/GZA-5762-2022; Willeit, Peter/HCI-7091-2022; Sundstrom, Johan/R-2139-2019; Woodward, Mark/D-8492-2015; Khaw, Kay-Tee/AAZ-3209-2021; Gao, Pei/AAF-3065-2019; Kauhanen, Jussi/ABC-4064-2021; Davidson, Karina/AAG-2388-2019; donfrancesco, chiara/K-1460-2016; Marmot, Michael/Y-3920-2019	Brenner, Hermann/0000-0002-6129-1572; Davidson, Karina/0000-0002-9162-477X; Jukema, J. Wouter/0000-0002-3246-8359; Dörr, Marcus/0000-0001-7471-475X; Franco, Óscar H/0000-0002-4606-4929; Kavousi, Maryam/0000-0001-5976-6519; Peters, Annette/0000-0001-6645-0985; Brunner, Eric/0000-0002-0595-4474; Gao, Pei/0000-0001-8649-1290; van der Schouw, Yvonne T./0000-0002-4605-435X; Sundström, Johan/0000-0003-2247-8454; Brenner, Hermann/0000-0002-6129-1572; Wood, Angela/0000-0002-7937-304X; Willeit, Peter/0000-0002-1866-7159; Sundstrom, Johan/0000-0003-2247-8454; Gao, Pei/0000-0001-8649-1290; Davidson, Karina/0000-0002-9162-477X; Peters, Sanne/0000-0003-0346-5412; Nietert, Paul/0000-0002-3933-4986; Stehouwer, Coen/0000-0001-8752-3223; donfrancesco, chiara/0000-0002-8040-5571; Sattar, Naveed/0000-0002-1604-2593; Butterworth, Adam/0000-0002-6915-9015; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Lawlor, Debbie A/0000-0002-6793-2262; Knuiman, Matthew/0000-0001-8874-2305; Pennells, Lisa Anne/0000-0002-8594-3061; Nordestgaard, Borge/0000-0002-1954-7220; O'Keeffe, Linda/0000-0002-0003-0774; Rosengren, Annika/0000-0002-5409-6605; Amouyel, Philippe/0000-0001-9088-234X; Burgess, Stephen/0000-0001-5365-8760; Woodward, Mark/0000-0001-9800-5296; Di Angelantonio, Emanuele/0000-0001-8776-6719; Whincup, Peter/0000-0002-5589-4107; Marmot, Michael/0000-0002-2431-6419; Melander, Olle/0000-0002-2581-484X; Price, Jackie/0000-0003-3251-3970	UK Medical Research Council [G0800270]; British Heart Foundation [SP/09/002]; British Heart Foundation Cambridge Cardiovascular Centre of Excellence; UK National Institute for Health Research Cambridge Biomedical Research Centre; European Research Council [268834]; European Commission [HEALTH-F2-2012-279233]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062, UL1TR001450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; MRC [G0800270, MC_UU_12015/1, MC_U147585827, MR/L003120/1, G0701619, G0400491, G0700463, MR/M014509/1, MC_U147585819, MC_PC_12028] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation Cambridge Cardiovascular Centre of Excellence; UK National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work of the coordinating center was funded by the UK Medical Research Council (grant G0800270), the British Heart Foundation (grant SP/09/002), the British Heart Foundation Cambridge Cardiovascular Centre of Excellence, UK National Institute for Health Research Cambridge Biomedical Research Centre, European Research Council (grant 268834), and the European Commission Framework Programme 7 (grant HEALTH-F2-2012-279233). This research has been conducted using the UK Biobank resource. The Emerging Risk Factor Collaboration's website http://www.phpc.cam.ac.uk/ceu/research/erfc/studies/ has a compiled list of some of the funders of the component studies in this analysis.	[Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; [Anonymous], 2015, DIABETES CARE, V38, pS49, DOI 10.2337/dc15-S011; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Carnethon MR, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.11.023; Cho E, 2002, J AM COLL CARDIOL, V40, P954, DOI 10.1016/S0735-1097(02)02044-2; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Glynn LG, 2009, LANCET, V374, P1421, DOI 10.1016/S0140-6736(09)61863-8; Hu FB, 2001, ARCH INTERN MED, V161, P1717, DOI 10.1001/archinte.161.14.1717; Hu G, 2005, DIABETOLOGIA, V48, P856, DOI 10.1007/s00125-005-1730-6; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Judd SE, 2013, STROKE, V44, P55, DOI 10.1161/STROKEAHA.112.675033; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Lotufo PA, 2001, ARCH INTERN MED, V161, P242, DOI 10.1001/archinte.161.2.242; May Margaret, 2011, BMJ, V343, pd6016, DOI 10.1136/bmj.d6016; Mozaffarian D, 2007, LANCET, V370, P667, DOI 10.1016/S0140-6736(07)61343-9; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Otiniano ME, 2003, ARCH PHYS MED REHAB, V84, P725, DOI 10.1016/S0003-9993(03)04941-9; Rocca WA, 2014, MAYO CLIN PROC, V89, P1336, DOI 10.1016/j.mayocp.2014.07.010; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sarwar N, 2010, LANCET, V376, P957, DOI 10.1016/S0140-6736(10)61450-X; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; UN Population Division, 2005, WORLD POP PROSP; Wannamethee SG, 2004, HEART, V90, P1398, DOI 10.1136/hrt.2003.026104; Weiss CO, 2007, JAMA-J AM MED ASSOC, V298, P1160, DOI 10.1001/jama.298.10.1160-a; Whiteley L, 2005, DIABETES CARE, V28, P1588, DOI 10.2337/diacare.28.7.1588; World Health Organization, 2007, WHO STAT INF SYST WH	34	427	447	3	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					52	60		10.1001/jama.2015.7008	http://dx.doi.org/10.1001/jama.2015.7008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151266	Bronze, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000357455900014
J	Clark, H				Clark, Helen			Governance for planetary health and sustainable development	LANCET			English	Editorial Material									United Nations Dev Programme, New York, NY 10017 USA		Clark, H (corresponding author), United Nations Dev Programme, New York, NY 10017 USA.	helen.clark@undp.org						Coady D., 2015, IMF WORKING PAPER LA; UNDP, 2013, CHANG WORLD UNDP STR; UNDP, 2015, PAYM PROGR EB RESP W; UNDP, 2013, GUID INT HIV GEND RE; UNDP, 2015, ENV FIN; UNDP Government of Sudan, 2013, REP MIDT EV SUD NAPA; Whitmee S., 2015, LANCET; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	8	11	12	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					E39	E41		10.1016/S0140-6736(15)61205-3	http://dx.doi.org/10.1016/S0140-6736(15)61205-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PI	26188750	Bronze			2022-12-28	WOS:000364763200003
J	Richards, DB; Cookson, LM; Berges, AC; Barton, SV; Lane, T; Ritter, JM; Fontana, M; Moon, JC; Pinzani, M; Gillmore, JD; Hawkins, PN; Pepys, MB				Richards, Duncan B.; Cookson, Louise M.; Berges, Alienor C.; Barton, Sharon V.; Lane, Thirusha; Ritter, James M.; Fontana, Marianna; Moon, James C.; Pinzani, Massimo; Gillmore, Julian D.; Hawkins, Philip N.; Pepys, Mark B.			Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; SYSTEMIC AMYLOIDOSIS; PHARMACOLOGICAL DEPLETION; AL AMYLOIDOSIS; VOLUME; QUANTIFICATION; SCINTIGRAPHY; TISSUE; LIVER	BACKGROUND The amyloid fibril deposits that cause systemic amyloidosis always contain the nonfibrillar normal plasma protein, serum amyloid P component (SAP). The drug (R)-1-[6-[(R)-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl] pyrrolidine-2-carboxylic acid (CPHPC) efficiently depletes SAP from the plasma but leaves some SAP in amyloid deposits that can be specifically targeted by therapeutic IgG anti-SAP antibodies. In murine amyloid A type amyloidosis, the binding of these antibodies to the residual SAP in amyloid deposits activates complement and triggers the rapid clearance of amyloid by macrophage-derived multinucleated giant cells. METHODS We conducted an open-label, single-dose-escalation, phase 1 trial involving 15 patients with systemic amyloidosis. After first using CPHPC to deplete circulating SAP, we infused a fully humanized monoclonal IgG1 anti-SAP antibody. Patients with clinical evidence of cardiac involvement were not included for safety reasons. Organ function, inflammatory markers, and amyloid load were monitored. RESULTS There were no serious adverse events. Infusion reactions occurred in some of the initial recipients of larger doses of antibody; reactions were reduced by slowing the infusion rate for later patients. At 6 weeks, patients who had received a sufficient dose of antibody in relation to their amyloid load had decreased liver stiffness, as measured with the use of transient elastography. These patients also had improvements in liver function in association with a substantial reduction in hepatic amyloid load, as shown by means of SAP scintigraphy and measurement of extracellular volume by magnetic resonance imaging. A reduction in kidney amyloid load and shrinkage of an amyloid-laden lymph node were also observed. CONCLUSIONS Treatment with CPHPC followed by an anti-SAP antibody safely triggered clearance of amyloid deposits from the liver and some other tissues.	[Richards, Duncan B.; Cookson, Louise M.; Berges, Alienor C.; Barton, Sharon V.] GlaxoSmithKline Res & Dev Ltd, Stevenage, Herts, England; [Lane, Thirusha; Fontana, Marianna; Gillmore, Julian D.; Hawkins, Philip N.; Pepys, Mark B.] UCL, Ctr Amyloidosis & Acute Phase Prot, Natl Hlth Serv, Natl Amyloidosis Ctr, London, England; [Lane, Thirusha; Fontana, Marianna; Gillmore, Julian D.; Hawkins, Philip N.; Pepys, Mark B.] Royal Free Hosp, London NW3 2QG, England; [Ritter, James M.] Guys Hosp, Quintiles Drug Res Unit, London SE1 9RT, England; [Fontana, Marianna] UCL, UCL Div Med, London, England; [Moon, James C.] UCL, UCL Inst Cardiovasc Sci, London, England; [Moon, James C.] UCL, Barts Heart Ctr, London, England; [Pinzani, Massimo] UCL, UCL Inst Liver & Digest Hlth, London, England; [Pepys, Mark B.] UCL, UCL Wolfson Drug Discovery Unit, London, England	GlaxoSmithKline; NHS Blood & Transplant (NHSBT); University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Guy's & St Thomas' NHS Foundation Trust; IQVIA; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Pepys, MB (corresponding author), Ctr Amyloidosis & Acute Phase Proteins, Wolfson Drug Discovery Unit, UCL Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	m.pepys@ucl.ac.uk	Moon, James C/F-1031-2014; Moon, James/AAA-9905-2020	Moon, James C/0000-0001-8071-1491; Moon, James/0000-0001-8071-1491; Richards, Duncan/0000-0002-8093-7084	GlaxoSmithKline; MRC [G0901596, G7900510] Funding Source: UKRI; British Heart Foundation [FS/10/40/28260, FS/12/56/29723] Funding Source: researchfish; Medical Research Council [G0901596, G7900510] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by GlaxoSmithKline; ClinicalTrials.gov number, NCT01777243.	Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Bandula S, 2013, RADIOLOGY, V268, P858, DOI 10.1148/radiol.13121889; Banypersad SM, 2013, CIRC-CARDIOVASC IMAG, V6, P34, DOI 10.1161/CIRCIMAGING.112.978627; Bodin K, 2010, NATURE, V468, P93, DOI 10.1038/nature09494; BREATHNACH SM, 1981, NATURE, V293, P652, DOI 10.1038/293652a0; DYCK RF, 1980, J EXP MED, V152, P1162, DOI 10.1084/jem.152.5.1162; Gillmore JD, 2010, BRIT J HAEMATOL, V148, P760, DOI 10.1111/j.1365-2141.2009.08036.x; HAWKINS PN, 1990, J CLIN INVEST, V86, P1862, DOI 10.1172/JCI114917; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; Hutt DF, 2010, AMYLOID, V17, P57; Kolstoe SE, 2009, P NATL ACAD SCI USA, V106, P7619, DOI 10.1073/pnas.0902640106; Lanzi A, 2010, EUR J GASTROEN HEPAT, V22, P895, DOI 10.1097/MEG.0b013e3283309d5b; Loustaud-Ratti V, 2011, AMYLOID, V18, P19, DOI 10.3109/13506129.2010.543443; Lovat LB, 1998, GUT, V42, P727, DOI 10.1136/gut.42.5.727; Moon JC, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-92; NELSON SR, 1991, CLIN CHIM ACTA, V200, P191, DOI 10.1016/0009-8981(91)90090-Y; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Pepys MB, 2010, OXFORD TXB MED, P1766; Pepys MB, 2011, US Patent, Patent No. [7,910,106, 7910106]; Sahota T, 2015, CPT-PHARMACOMET SYST, V4, P116, DOI 10.1002/psp4.15; Simons JP, 2013, P NATL ACAD SCI USA, V110, P16115, DOI 10.1073/pnas.1306621110; Venner CP, 2014, LEUKEMIA, V28, P2304, DOI 10.1038/leu.2014.218	25	239	251	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2015	373	12					1106	1114		10.1056/NEJMoa1504942	http://dx.doi.org/10.1056/NEJMoa1504942			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR7UG	26176329				2022-12-28	WOS:000361556400006
J	Lundgren, D; Babiker, AG; Gordin, F; Emery, S; Sharma, S; Avihingsanon, AC; Cooper, DA; Fatkenheuer, G; Llibre, JM; Moli-Na, JM; Munderi, P; Schechter, M; Wood, R; Klingman, KL; Collins, S; Lane, HC; Phillips, AN; Neaton, JD				Lundgren, Jens D.; Babiker, Abdel G.; Gordin, Fred; Emery, Sean; Sharma, Shweta; Avihingsanon, An-Chalee; Cooper, David A.; Faetkenheuer, Gerd; Llibre, Josep M.; Moli-Na, Jean-Michel; Munderi, Paula; Schechter, Mauro; Wood, Robin; Klingman, Karin L.; Collins, Simon; Lane, H. Clifford; Phillips, Andrew N.; Neaton, James D.			Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-OUTCOMES; CELL COUNTS; BASE-LINE; RISK; INTERRUPTION; PARTICIPANTS; DEATH; ART	BACKGROUND Data from randomized trials are lacking on the benefits and risks of initiating antiretroviral therapy in patients with asymptomatic human immunodeficiency virus (HIV) infection who have a CD4+ count of more than 350 cells per cubic millimeter. METHODS We randomly assigned HIV-positive adults who had a CD4+ count of more than 500 cells per cubic millimeter to start antiretroviral therapy immediately (immediate-initiation group) or to defer it until the CD4+ count decreased to 350 cells per cubic millimeter or until the development of the acquired immunodeficiency syndrome (AIDS) or another condition that dictated the use of antiretroviral therapy (deferred-initiation group). The primary composite end point was any serious AIDS-related event, serious non-AIDS-related event, or death from any cause. RESULTS A total of 4685 patients were followed for a mean of 3.0 years. At study entry, the median HIV viral load was 12,759 copies per milliliter, and the median CD4+ count was 651 cells per cubic millimeter. On May 15, 2015, on the basis of an interim analysis, the data and safety monitoring board determined that the study question had been answered and recommended that patients in the deferred-initiation group be offered antiretroviral therapy. The primary end point occurred in 42 patients in the immediate-initiation group (1.8%; 0.60 events per 100 person-years), as compared with 96 patients in the deferred-initiation group (4.1%; 1.38 events per 100 person-years), for a hazard ratio of 0.43 (95% confidence interval [CI], 0.30 to 0.62; P<0.001). Hazard ratios for serious AIDS-related and serious non-AIDS-related events were 0.28 (95% CI, 0.15 to 0.50; P<0.001) and 0.61 (95% CI, 0.38 to 0.97; P = 0.04), respectively. More than two thirds of the primary end points (68%) occurred in patients with a CD4+ count of more than 500 cells per cubic millimeter. The risks of a grade 4 event were similar in the two groups, as were the risks of unscheduled hospital admissions. CONCLUSIONS The initiation of antiretroviral therapy in HIV-positive adults with a CD4+ count of more than 500 cells per cubic millimeter provided net benefits over starting such therapy in patients after the CD4+ count had declined to 350 cells per cubic millimeter.	[Lundgren, Jens D.] Univ Copenhagen, Rigshosp, DK-2100 Copenhagen O, Denmark; [Babiker, Abdel G.] UCL, Med Res Council Clin Trials Unit, London WC1E 6BT, England; [Gordin, Fred] George Washington Univ, Washington Vet Affairs Med Ctr, Washington, DC USA; [Emery, Sean; Cooper, David A.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Sharma, Shweta] Univ Minnesota, Minneapolis, MN USA; [Avihingsanon, An-Chalee] Chulalongkorn Univ, Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Faetkenheuer, Gerd] German Ctr Infect Res, Univ Hosp Cologne, Cologne, Germany; [Llibre, Josep M.] Univ Barcelona, Univ Hosp Germans Trias, Badalona, Spain; [Moli-Na, Jean-Michel] Univ Paris Diderot, St Louis Hosp, Paris, France; [Munderi, Paula] Med Res Council Res Unit AIDS, Entebbe, Uganda; [Schechter, Mauro] Projeto Praca Onze, Rio De Janeiro, Brazil; [Wood, Robin] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Klingman, Karin L.; Lane, H. Clifford] NIAID, Bethesda, MD 20892 USA; [Collins, Simon] HIV I Base, London, England; [Phillips, Andrew N.] UCL, London, England; [Neaton, James D.] Univ Minnesota, Minneapolis, MN USA	Rigshospitalet; University of Copenhagen; Medical Research Council Clinical Trials Unit; University of London; University College London; George Washington University; University of New South Wales Sydney; Kirby Institute; University of Minnesota System; University of Minnesota Twin Cities; Chulalongkorn University; Thai Red Cross Society; German Center for Infection Research; University of Cologne; University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Cape Town; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; University College London; University of Minnesota System; University of Minnesota Twin Cities	Lundgren, D (corresponding author), Univ Copenhagen, Dept Infect Dis, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	jens.lundgren@regionh.dk	Cysique, Lucette A./U-1357-2017; Emery, Sean/O-9122-2019; Emery, Sean/J-3825-2017; Ostergaard, Lars/AAA-3020-2020; Brites, Carlos/D-1353-2013; Phillips, Andrew N/B-4427-2008; meger, sue/S-2351-2019; Stephan, Christoph/D-1305-2014; Schechter, Mauro/AAG-7445-2020; Azwa, Iskandar/N-9186-2017; Knobel, Hernando/B-5223-2016; Lundgren, Jens/AAE-6876-2019; Collins, Simon/AAB-5123-2022; Gisslen, Magnus/D-7454-2015; Borges, Alvaro Humberto/G-3231-2016	Cysique, Lucette A./0000-0002-7711-6373; Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Ostergaard, Lars/0000-0003-2459-0511; Brites, Carlos/0000-0002-4673-6991; Phillips, Andrew N/0000-0003-2384-4807; Stephan, Christoph/0000-0003-3777-9006; Azwa, Iskandar/0000-0003-1977-6709; Knobel, Hernando/0000-0003-3186-6416; Ostergaard, Lars/0000-0002-7619-605X; Kansau, Imad/0000-0002-1893-6822; Kelleher, Anthony/0000-0002-0009-3337; ERIOBU, NNAKELU/0000-0003-2528-8082; Estrada, Vicente/0000-0002-7795-5986; Arenas-Pinto, Alejandro/0000-0002-3368-5005; Harding, Jan/0000-0003-4624-9074; Mora Peris, Borja/0000-0002-4719-6827; Aagaard, Per/0000-0002-9773-7361; Lundgren, Jens/0000-0001-8901-7850; Gisslen, Magnus/0000-0002-2357-1020; BADIA, CRISTINA/0000-0002-7434-029X; Collins, Simon/0000-0002-3537-2432; Borges, Alvaro Humberto/0000-0003-2020-3828; Ristola, Matti/0000-0001-5115-2811	National Institute of Allergy and Infectious Diseases; MRC [MC_U122886352] Funding Source: UKRI; Medical Research Council [MC_UU_12023/23, MC_U122886352] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068641, ZIAAI000585, UM1AI069423, P30AI094189, UM1AI120197, UM1AI069476] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases and others; START ClinicalTrials.gov number, NCT00867048.	[Anonymous], 1992, MMWR RECOMM REP, V41; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; Babiker AG, 2013, CLIN TRIALS, V10, pS5, DOI 10.1177/1740774512440342; Baker JV, 2015, HIV MED, V16, P109, DOI 10.1111/hiv.12239; Baker JV, 2011, EUR HEART J, V32, P945, DOI 10.1093/eurheartj/ehq483; Baker JV, 2011, JAIDS-J ACQ IMM DEF, V56, P36, DOI 10.1097/QAI.0b013e3181f7f61a; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; De Cock KM, 2013, NEW ENGL J MED, V368, P886, DOI 10.1056/NEJMp1300458; Department for Health and Human Services, 2015, GUID US ANT AG HIV 1; Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases Division of AIDS, 2004, DIV AIDS TABL GRAD S; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; European AIDS Clinical Society, 2014, ANT THER GUID VERS 7; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Funk MJ, 2011, ARCH INTERN MED, V171, P1560, DOI 10.1001/archinternmed.2011.401; Grarup J, 2015, HIV MED, V16, P14, DOI 10.1111/hiv.12229; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Hernan MA, 2009, NEW ENGL J MED, V361, P822; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), 2010, CRIT EV REP START; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LANE HC, 1985, AM J MED, V78, P417, DOI 10.1016/0002-9343(85)90332-8; Lifson AR, 2006, HIV CLIN TRIALS, V7, P125, DOI 10.1310/7MER-XFA7-1762-E2WR; Lifson AR, 2010, HIV CLIN TRIALS, V11, P205, DOI 10.1310/hct1104-205; Lodi S, 2015, LANCET; Lundgren J, 2015, HIV MED, V16, P1, DOI 10.1111/hiv.12227; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Lundgren JD, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-148; Maduna PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121843; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Phillips AN, 2006, CURR OPIN HIV AIDS, V1, P43, DOI 10.1097/01.COH.0000194106.12816.b1; Phillips AN, 2007, AIDS, V21, P1717; Rodger A, 2014, ANN C RETR OPP INF B; Rodger AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097340; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sabin CA, 2013, AIDS, V27, P1839, DOI 10.1097/QAD.0b013e328360d546; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Soliman EZ, 2015, HIV MED, V16, P46, DOI 10.1111/hiv.12233; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; UNAIDS, 2015, IMPL START STUD DAT; UNAIDS, 2014, 90 90 90 AMB TREATM; WHO, 2014, HIV UN HLTH COV POST; Zeng M, 2012, BLOOD, V120, P1856, DOI 10.1182/blood-2012-03-418624	48	1796	1840	7	165	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2015	373	9					795	807		10.1056/NEJMoa1506816	http://dx.doi.org/10.1056/NEJMoa1506816			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP8VC	26192873	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000360171700006
J	Lebeis, SL; Paredes, SH; Lundberg, DS; Breakfield, N; Gehring, J; McDonald, M; Malfatti, S; del Rio, TG; Jones, CD; Tringe, SG; Dangl, JL				Lebeis, Sarah L.; Paredes, Sur Herrera; Lundberg, Derek S.; Breakfield, Natalie; Gehring, Jase; McDonald, Meredith; Malfatti, Stephanie; del Rio, Tijana Glavina; Jones, Corbin D.; Tringe, Susannah G.; Dangl, Jeffery L.			Salicylic acid modulates colonization of the root microbiome by specific bacterial taxa	SCIENCE			English	Article							PLANT IMMUNE-SYSTEM; ARABIDOPSIS-THALIANA; DEFENSE	Immune systems distinguish "self" from "nonself" to maintain homeostasis and must differentially gate access to allow colonization by potentially beneficial, nonpathogenic microbes. Plant roots grow within extremely diverse soil microbial communities but assemble a taxonomically limited root-associated microbiome. We grew isogenic Arabidopsis thaliana mutants with altered immune systems in a wild soil and also in recolonization experiments with a synthetic bacterial community. We established that biosynthesis of, and signaling dependent on, the foliar defense phytohormone salicylic acid is required to assemble a normal root microbiome. Salicylic acid modulates colonization of the root by specific bacterial families. Thus, plant immune signaling drives selection from the available microbial communities to sculpt the root microbiome.	[Lebeis, Sarah L.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Lebeis, Sarah L.; Paredes, Sur Herrera; Lundberg, Derek S.; Breakfield, Natalie; Gehring, Jase; McDonald, Meredith; Jones, Corbin D.; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Paredes, Sur Herrera; Dangl, Jeffery L.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Paredes, Sur Herrera; Jones, Corbin D.; Dangl, Jeffery L.] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Lundberg, Derek S.; Jones, Corbin D.; Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Malfatti, Stephanie; del Rio, Tijana Glavina; Tringe, Susannah G.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Jones, Corbin D.; Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lebeis, SL (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	slebeis@utk.edu; dangl@email.unc.edu	Paredes, Sur Herrera/I-8617-2019; Tringe, Susannah Green/T-9431-2019	Paredes, Sur Herrera/0000-0001-9246-8337; Tringe, Susannah Green/0000-0001-6479-8427; Breakfield, Natalie/0000-0001-8517-885X; McDonald, Meredith/0000-0002-4290-2366; Malfatti, Stephanie/0000-0003-4225-9857; Lundberg, Derek/0000-0001-7970-1595	NSF Microbial Systems Biology [IOS-0958245]; NSF INSPIRE [IOS-1343020]; NIH [T32 GM067553-06, T32 GM07092-34]; HHMI; Gordon and Betty Moore Foundation [GBMF3030]; NIH Minority Opportunities in Research division of the National Institute of General Medical Sciences (NIGMS) [K12GM000678]; NIH Dr. Ruth L. Kirschstein National Research Service Award Fellowship [F32-GM103156]; Office of Science of the DOE [DE-AC02-05CH11231]; DOE-JGI Director's Discretionary Grand Challenge Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092, K12GM000678, F32GM103156, T32GM067553] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1343020] Funding Source: National Science Foundation	NSF Microbial Systems Biology; NSF INSPIRE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NIH Minority Opportunities in Research division of the National Institute of General Medical Sciences (NIGMS); NIH Dr. Ruth L. Kirschstein National Research Service Award Fellowship; Office of Science of the DOE(United States Department of Energy (DOE)); DOE-JGI Director's Discretionary Grand Challenge Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF Microbial Systems Biology grant IOS-0958245 and NSF INSPIRE grant IOS-1343020 to J.L.D. S.H.P. was supported by NIH Training Grant T32 GM067553-06 and is a Howard Hughes Medical Institute (HHMI) International Student Research Fellow. D.S.L. was supported by NIH Training Grant T32 GM07092-34. J.L.D. is an Investigator of HHMI, supported by HHMI and the Gordon and Betty Moore Foundation (GBMF3030). S.L.L. was supported by the NIH Minority Opportunities in Research division of the National Institute of General Medical Sciences (NIGMS) grant K12GM000678. N.B. was supported by NIH Dr. Ruth L. Kirschstein National Research Service Award Fellowship F32-GM103156. The work conducted by the U.S. Department of Energy (DOE) Joint Genome Institute (JGI), a DOE Office of Science User Facility, is supported by the Office of Science of the DOE under contract DE-AC02-05CH11231. This work was also funded by the DOE-JGI Director's Discretionary Grand Challenge Program. We thank the Dangl laboratory microbiome group for useful discussions and S. Grant, S. Y. He, P. Hugenholtz, J. Kremer, and D. Weigel for critical comments on the manuscript. The supplementary materials contain additional data. J.L.D. is a cofounder, shareholder, and chair of the Scientific Advisory Board of AgBiome, a corporation whose goal is to use plant-associated microbes to improve plant productivity. Raw sequence data are available at the Short Read Archive accessions ERP010780 and ERP010863 and at the JGI portal http://genome.jgi.doe.gov/Immunesamples/Immunesamples.info.html, which requires registration to access.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Bakker PAHM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00165; Belkhadirl Y, 2014, TRENDS BIOCHEM SCI, V39, P447, DOI 10.1016/j.tibs.2014.06.006; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Carvalhais LC, 2014, APPL SOIL ECOL, V84, P1, DOI 10.1016/j.apsoil.2014.06.011; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Doornbos RF, 2011, MOL PLANT MICROBE IN, V24, P395, DOI 10.1094/MPMI-05-10-0115; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katagiri F, 2010, MOL PLANT MICROBE IN, V23, P1531, DOI 10.1094/MPMI-04-10-0099; Kim Y, 2014, CELL HOST MICROBE, V15, P84, DOI 10.1016/j.chom.2013.12.002; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055	16	570	591	57	649	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2015	349	6250					860	864		10.1126/science.aaa8764	http://dx.doi.org/10.1126/science.aaa8764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP4DR	26184915				2022-12-28	WOS:000359832700048
J	Makino, DL; Schuch, B; Stegmann, E; Baumgartner, M; Basquin, C; Conti, E				Makino, Debora Lika; Schuch, Benjamin; Stegmann, Elisabeth; Baumgaertner, Marc; Basquin, Claire; Conti, Elena			RNA degradation paths in a 12-subunit nuclear exosome complex	NATURE			English	Article							CRYSTAL-STRUCTURE; QUALITY-CONTROL; RIBOSOMAL-RNA; CORE; SUBUNIT; REVEALS; PHENIX; RRP6P; DIS3	The eukaryotic exosome is a conserved RNA-degrading complex that functions in RNA surveillance, turnover and processing. How the same machinery can either completely degrade or precisely trim RNA substrates has long remained unexplained. Here we report the crystal structures of a yeast nuclear exosome containing the 9-subunit core, the 3'-5' RNases Rrp44 and Rrp6, and the obligate Rrp6-binding partner Rrp47 in complex with different RNAs. The combined structural and biochemical data of this 12-subunit complex reveal how a single-stranded RNA can reach the Rrp44 or Rrp6 active sites directly or can bind Rrp6 and be threaded via the central channel towards the distal RNase Rrp44. When a bulky RNA is stalled at the entrance of the channel, Rrp6-Rrp47 swings open. The results suggest how the same molecular machine can coordinate processive degradation and partial trimming in an RNA-dependent manner by a concerted swinging mechanism of the two RNase subunits.	[Makino, Debora Lika; Schuch, Benjamin; Stegmann, Elisabeth; Baumgaertner, Marc; Basquin, Claire; Conti, Elena] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Conti, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.	conti@biochem.mpg.de		Conti, Elena/0000-0003-1254-5588	Max Planck Gesellschaft; European Commission (ERC Advanced Investigator Grant) [294371]; European Commission (Marie Curie ITN RNPnet); Deutsche Forschungsgemeinschaft [DFG SFB646, SFB1035, GRK1721, FOR1680]; Deutsche Forschungsgemeinschaft (CIPSM); Louis Jeantet Foundation	Max Planck Gesellschaft(Max Planck Society); European Commission (ERC Advanced Investigator Grant); European Commission (Marie Curie ITN RNPnet); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (CIPSM)(German Research Foundation (DFG)); Louis Jeantet Foundation	We would like to thank the MPIB Crystallization Facility and MPIB Core Facility; the beamline scientists at SLS beamlines PXII and PXIII and APS beamline 17-ID-B for assistance with data collection; M. Krause for the schematic drawing; F. Bonneau and J. Gagneur (Gene Center) for help with statistical analyses, members of our lab for comments and discussion. This study was supported by the Max Planck Gesellschaft, the European Commission (ERC Advanced Investigator Grant 294371 and Marie Curie ITN RNPnet), the Deutsche Forschungsgemeinschaft (DFG SFB646, SFB1035, GRK1721, FOR1680 and CIPSM) and the Louis Jeantet Foundation to E.C.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Arraiano CM, 2013, BBA-GENE REGUL MECH, V1829, P491, DOI 10.1016/j.bbagrm.2013.03.009; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Butler JS, 2010, ADV EXP MED BIOL, V702, P91, DOI 10.1007/978-1-4419-7841-7_8; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Drazkowska K, 2013, NUCLEIC ACIDS RES, V41, P3845, DOI 10.1093/nar/gkt060; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Januszyk K, 2014, CURR OPIN STRUC BIOL, V24, P132, DOI 10.1016/j.sbi.2014.01.011; Januszyk K, 2011, RNA, V17, P1566, DOI 10.1261/rna.2763111; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Liu JJ, 2014, NAT STRUCT MOL BIOL, V21, P95, DOI 10.1038/nsmb.2736; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Makino DL, 2013, NAT REV MOL CELL BIO, V14, P654, DOI 10.1038/nrm3657; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Malet H, 2010, EMBO REP, V11, P936, DOI 10.1038/embor.2010.164; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Porrua O, 2013, BBA-GENE REGUL MECH, V1829, P604, DOI 10.1016/j.bbagrm.2013.02.012; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Schaeffer D, 2010, ADV EXP MED BIOL, V702, P79, DOI 10.1007/978-1-4419-7841-7_7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Schuch B, 2014, EMBO J, V33, P2829, DOI 10.15252/embj.201488757; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wasmuth EV, 2014, NATURE, V511, P435, DOI 10.1038/nature13406; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	43	95	97	3	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					54	U89		10.1038/nature14865	http://dx.doi.org/10.1038/nature14865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26222026				2022-12-28	WOS:000359002300030
J	Zauri, M; Berridge, G; Thezenas, ML; Pugh, KM; Goldin, R; Kessler, BM; Kriaucionis, S				Zauri, Melania; Berridge, Georgina; Thezenas, Marie-Laetitia; Pugh, Kathryn M.; Goldin, Robert; Kessler, Benedikt M.; Kriaucionis, Skirmantas			CDA directs metabolism of epigenetic nucleosides revealing a therapeutic window in cancer	NATURE			English	Article							HUMAN-LEUKEMIC CELLS; MONOPHOSPHATE KINASE; DNA; EXPRESSION; 5-METHYL-2'-DEOXYCYTIDINE; 5-HYDROXYMETHYLCYTOSINE; 5-FORMYLCYTOSINE; 5-METHYLCYTOSINE; REPLICATION; GLYCOSYLASE	Cells require nucleotides to support DNA replication and repair damaged DNA. In addition to de novo synthesis, cells recycle nucleotides from the DNA of dying cells or from cellular material ingested through the diet. Salvaged nucleosides come with the complication that they can contain epigenetic modifications. Because epigenetic inheritance of DNA methylation mainly relies on copying of the modification pattern from parental strands(1-3), random incorporation of pre-modified bases during replication could have profound implications for epigenome fidelity and yield adverse cellular phenotypes. Although the salvage mechanism of 5-methyl-2'deoxycytidine (5mdC) has been investigated before(4-6), it remains unknown how cells deal with the recently identified oxidized forms of 5mdC: 5-hydroxymethyl-2'deoxycytidine (5hmdC), 5-formy-2'deoxycytidine (5fdC) and 5-carboxyl-2'deoxycytidine (5cadC)(7-10). Here we show that enzymes of the nucleotide salvage pathway display substrate selectivity, effectively protecting newly synthesized DNA from the incorporation of epigenetically modified forms of cytosine. Thus, cell lines and animals can tolerate high doses of these modified cytidines without any deleterious effects on physiology. Notably, by screening cancer cell lines for growth defects after exposure to 5hmdC, we unexpectedly identify a subset of cell lines in which 5hmdC or 5fdC administration leads to cell lethality. Using genomic approaches, we show that the susceptible cell lines overexpress cytidine deaminase (CDA). CDA converts 5hmdC and 5fdC into variants of uridine that are incorporated into DNA, resulting in accumulation of DNA damage, and ultimately, cell death. Our observations extend current knowledge of the nucleotide salvage pathway by revealing the metabolism of oxidized epigenetic bases, and suggest a new therapeutic option for cancers, such as pancreatic cancer, that have CDA overexpression and are resistant to treatment with other cytidine analogues(11).	[Zauri, Melania; Kriaucionis, Skirmantas] Univ Oxford, Nuffield Dept Med, Ludwig Canc Res, Oxford OX3 7DQ, England; [Berridge, Georgina; Thezenas, Marie-Laetitia; Pugh, Kathryn M.; Kessler, Benedikt M.] Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Oxford OX3 7FZ, England; [Pugh, Kathryn M.] Univ Oxford, Nuffield Dept Med, Struct Genom Consortium, Oxford OX3 7DQ, England; [Goldin, Robert] Univ London Imperial Coll Sci Technol & Med, Ctr Pathol, London W2 1NY, England	University of Oxford; University of Oxford; University of Oxford; Imperial College London	Kriaucionis, S (corresponding author), Univ Oxford, Nuffield Dept Med, Ludwig Canc Res, Oxford OX3 7DQ, England.	skirmantas.kriaucionis@ludwig.ox.ac.uk	Kriaucionis, Skirmantas/A-2986-2015; Zauri, Melania/Z-5870-2019; Kessler, Benedikt/AAY-8614-2021	Kriaucionis, Skirmantas/0000-0002-2273-5994; Zauri, Melania/0000-0003-2618-869X; Kessler, Benedikt/0000-0002-8160-2446; Goldin, Robert/0000-0001-5184-4519	Ludwig Cancer Research; BBSRC; John Fell Fund [133/075]; Wellcome Trust [097813/Z/11/Z]; BBSRC [BB/M001873/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M001873/1] Funding Source: researchfish	Ludwig Cancer Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Fell Fund; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We acknowledge Ludwig Cancer Research and BBSRC for funding; R. Klose, T. Milne, G. Bond, M. Muers and members of the Kriaucionis laboratory for the discussions and critical reading of the manuscript. M. Shipman for his technical assistance in image acquisition and analysis; I. Ratnayaka and R. Lisle for assistance with histology; S. Laird and J. Tanner for help with animal experiments; X. Lu, S. Lunardi and G. Bond for providing cell lines; P. Filippakopoulos for advice on molecular docking. B.M.K. was supported by the John Fell Fund 133/075 (BMK) and the Wellcome Trust 097813/Z/11/Z.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; BOORSTEIN RJ, 1992, MOL CELL BIOL, V12, P5536, DOI 10.1128/MCB.12.12.5536; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; Dietmair S, 2010, ANAL BIOCHEM, V404, P155, DOI 10.1016/j.ab.2010.04.031; Eliopoulos N, 1998, CANCER CHEMOTH PHARM, V42, P373, DOI 10.1007/s002800050832; Frese KK, 2012, CANCER DISCOV, V2, P260, DOI 10.1158/2159-8290.CD-11-0242; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; HERSHEY HV, 1973, EUR J BIOCHEM, V34, P383, DOI 10.1111/j.1432-1033.1973.tb02770.x; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; JEKUNEN A, 1984, MOL PHARMACOL, V25, P431; JEKUNEN A, 1983, BIOCHEM PHARMACOL, V32, P1165, DOI 10.1016/0006-2952(83)90265-4; Kemmerich K, 2012, NUCLEIC ACIDS RES, V40, P6016, DOI 10.1093/nar/gks259; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LIN KT, 1981, J PHARM SCI, V70, P1228, DOI 10.1002/jps.2600701112; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; MacKenzie C. J., 2011, CURR PROTOCOLS CELL; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Pfister TD, 2009, MOL CANCER THER, V8, P1878, DOI 10.1158/1535-7163.MCT-09-0016; PLANCK SR, 1977, BIOCHEMISTRY-US, V16, P2778, DOI 10.1021/bi00631a030; Qin TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023372; Ramsahoye Bernard H, 2002, Methods Mol Biol, V200, P9; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Shin G, 2011, CANCER INFORM, V10, P149, DOI 10.4137/CIN.S7226; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Van Rompay AR, 1999, MOL PHARMACOL, V56, P562, DOI 10.1124/mol.56.3.562; VILPO JA, 1993, MUTAT RES, V286, P217, DOI 10.1016/0027-5107(93)90186-J; Vincenzetti S, 1996, PROTEIN EXPRES PURIF, V8, P247, DOI 10.1006/prep.1996.0097; Weizman N, 2014, ONCOGENE, V33, P3812, DOI 10.1038/onc.2013.357; WIGLER M, 1981, CELL, V24, P33, DOI 10.1016/0092-8674(81)90498-0; Xu YJ, 2008, J BIOL CHEM, V283, P1563, DOI 10.1074/jbc.M707997200	40	61	63	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2015	524	7563					114	U269		10.1038/nature14948	http://dx.doi.org/10.1038/nature14948			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO2QS	26200337	Green Submitted, Green Accepted			2022-12-28	WOS:000359002300043
J	Niemann, CU; Feiner, J; Swain, S; Bunting, S; Friedman, M; Crutchfield, M; Broglio, K; Hirose, R; Roberts, JP; Malinoski, D				Niemann, Claus U.; Feiner, John; Swain, Sharon; Bunting, Scott; Friedman, Melissa; Crutchfield, Megan; Broglio, Kristine; Hirose, Ryutaro; Roberts, John P.; Malinoski, Darren			Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DELAYED GRAFT; CARDIAC-ARREST; RENAL-TRANSPLANTATION; PATIENT SURVIVAL; OUTCOMES; RISK; MANAGEMENT; IMPACT	BACKGROUND Delayed graft function, which is reported in up to 50% of kidney-transplant recipients, is associated with increased costs and diminished long-term graft function. The effect that targeted mild hypothermia in organ donors before organ recovery has on the rate of delayed graft function is unclear. METHODS We enrolled organ donors (after declaration of death according to neurologic criteria) from two large donation service areas and randomly assigned them to one of two targeted temperature ranges: 34 to 35 degrees C (hypothermia) or 36.5 to 37.5 degrees C (normothermia). Temperature protocols, which were initiated after authorization was obtained for the organ to be donated and for the donor's participation in the study, ended when organ donors left the intensive care unit for organ recovery in the operating room. The primary outcome was delayed graft function in the kidney recipients, which was defined as the requirement for dialysis during the first week after transplantation. Secondary outcomes were the rates of individual organs transplanted in each treatment group and the total number of organs transplanted from each donor. RESULTS The study was terminated early, on the recommendation of an independent data and safety monitoring board, after the interim analysis showed efficacy of hypothermia. At trial termination, 370 organ donors had been enrolled (180 in the hypothermia group and 190 in the normothermia group). A total of 572 patients received a kidney transplant (285 kidneys from donors in the hypothermia group and 287 kidneys from donors in the normothermia group). Delayed graft function developed in 79 recipients of kidneys from donors in the hypothermia group (28%) and in 112 recipients of kidneys from donors in the normothermia group (39%) (odds ratio, 0.62; 95% confidence interval, 0.43 to 0.92; P = 0.02). CONCLUSIONS Mild hypothermia, as compared with normothermia, in organ donors after declaration of death according to neurologic criteria significantly reduced the rate of delayed graft function among recipients.	[Niemann, Claus U.; Feiner, John] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Niemann, Claus U.; Hirose, Ryutaro; Roberts, John P.] Univ Calif San Francisco, Dept Surg, Div Transplant Surg, San Francisco, CA 94143 USA; [Swain, Sharon] Calif Transplant Donor Network, Oakland, CA USA; [Bunting, Scott; Friedman, Melissa] OneLegacy, Los Angeles, CA USA; [Crutchfield, Megan; Malinoski, Darren] Vet Affairs Portland Hlth Care Syst, Sect Surg Crit Care, Portland, OR USA; [Malinoski, Darren] Oregon Hlth & Sci Univ, Div Trauma Crit Care & Acute Care Surg, Portland, OR 97201 USA; [Broglio, Kristine] Berry Consultants, Austin, TX USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University	Niemann, CU (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, 521 Parnassus Ave, San Francisco, CA 94143 USA.	claus.niemann@ucsf.edu			Health Resources and Services Administration; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the Health Resources and Services Administration; ClinicalTrials.gov number, NCT01680744.	Abt PL, 2013, AM J TRANSPLANT, V13, P1400, DOI 10.1111/ajt.12243; [Anonymous], 2002, NAT SCI FDN FED POL; Azzopardi D, 2014, NEW ENGL J MED, V371, P140, DOI 10.1056/NEJMoa1315788; Butala NM, 2013, TRANSPLANTATION, V95, P1008, DOI 10.1097/TP.0b013e3182855544; Debaty G, 2014, INTENS CARE MED, V40, P1832, DOI 10.1007/s00134-014-3519-x; Fonseca I, 2015, TRANSPL INT, V28, P738, DOI 10.1111/tri.12543; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Israni AK, 2014, J AM SOC NEPHROL, V25, P1842, DOI 10.1681/ASN.2013070784; Mallon DH, 2013, TRANSPLANTATION, V96, P885, DOI 10.1097/TP.0b013e3182a19348; McLaren AJ, 1999, CLIN TRANSPLANT, V13, P266, DOI 10.1034/j.1399-0012.1999.130308.x; Mone T, 2013, LIVER TRANSPLANT, V19, P118, DOI 10.1002/lt.23579; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Patel MS, 2014, JAMA SURG, V149, P969, DOI 10.1001/jamasurg.2014.967; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; Schnuelle P, 2009, JAMA-J AM MED ASSOC, V302, P1067, DOI 10.1001/jama.2009.1310; Tapiawala SN, 2010, J AM SOC NEPHROL, V21, P153, DOI 10.1681/ASN.2009040412; Tissier R, 2014, ANESTHESIOLOGY, V120, P861, DOI 10.1097/ALN.0000000000000048; van der Worp HB, 2014, INT J STROKE, V9, P642, DOI 10.1111/ijs.12294; Wolfrum S, 2008, CRIT CARE MED, V36, P1780, DOI 10.1097/CCM.0b013e31817437ca; Yarlagadda G, 2008, NEPHROL DIAL TRANSPL, V23, P2995, DOI 10.1093/ndt/gfn158; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	22	156	164	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2015	373	5					405	414		10.1056/NEJMoa1501969	http://dx.doi.org/10.1056/NEJMoa1501969			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8BO	26222557				2022-12-28	WOS:000358662200004
J	Clough, JD; Richman, BD; Glickman, SW				Clough, Jeffrey D.; Richman, Barak D.; Glickman, Seth W.			Outlook for Alternative Payment Models in Fee-for-Service Medicare	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Clough, Jeffrey D.] Duke Clin Res Inst, Durham, NC 27715 USA; [Clough, Jeffrey D.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Richman, Barak D.] Duke Univ, Sch Law, Durham, NC 27706 USA; [Glickman, Seth W.] Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC USA	Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Clough, JD (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	jeffrey.clough@duke.edu						CAHPS, SURV TOOLS ADV PAT C; Centers for Medicare & Medicaid Services, 2015, 2015 VAL MOD RES; Centers for Medicare & Medicaid Services, 2014, 2014 ANN REP BOARDS; Centers for Medicare & Medicaid Services, 2020, MED SHAR SAV PROGR; Centers for Medicare & Medicaid Services, DAT AND REP; Morden NE, 2014, NEW ENGL J MED, V370, P589, DOI 10.1056/NEJMp1314965; Morsi E, 2012, J HOSP MED, V7, P370, DOI 10.1002/jhm.1931; Nyweide DJ, 2015, JAMA-J AM MED ASSOC, V313, P2152, DOI 10.1001/jama.2015.4930	8	3	3	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					341	342		10.1001/jama.2015.8047	http://dx.doi.org/10.1001/jama.2015.8047			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219046				2022-12-28	WOS:000358581700010
J	Smith, JM				Smith, Jeanette M.			Portrait of My Teacher, Fraulein Sophie von Prieser Florine Stettheimer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					322	323		10.1001/jama.2014.11881	http://dx.doi.org/10.1001/jama.2014.11881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219030				2022-12-28	WOS:000358581700032
J	[Anonymous]				[Anonymous]			Medicare: Theory and Practice (Reprint from JAMA vol 197, pg 362, 1966)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1966, JAMA-J AM MED ASSOC, V197, P362; ROTH RB, 1966, J AMER MED ASSOC, V197, P347; SCHOLTEN JR, 1966, J AMER MED ASSOC, V197, P333	3	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					411	411		10.1001/jama.2014.11888	http://dx.doi.org/10.1001/jama.2014.11888			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219068				2022-12-28	WOS:000358581700031
J	Cimpian, A; Leslie, SJ				Cimpian, Andrei; Leslie, Sarah-Jane			Response to Comment on "Expectations of brilliance underlie gender distributions across academic disciplines"	SCIENCE			English	Editorial Material								Ginther and Kahn claim that academics' beliefs about the importance of brilliance do not predict gender gaps in Ph.D. attainment beyond mathematics and verbal test scores. However, Ginther and Kahn's analyses are problematic, exhibiting more than 100 times the recommended collinearity thresholds. Multiple analyses that avoid this problem suggest that academics' beliefs are in fact uniquely predictive of gender gaps across academia.	[Cimpian, Andrei] Univ Illinois, Dept Psychol, Champaign, IL 61821 USA; [Leslie, Sarah-Jane] Princeton Univ, Dept Philosophy, Princeton, NJ 08544 USA	University of Illinois System; University of Illinois Urbana-Champaign; Princeton University	Cimpian, A (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL 61821 USA.	acimpian@illinois.edu; sjleslie@princeton.edu	Cimpian, Andrei/X-4605-2019	Cimpian, Andrei/0000-0002-3553-6097				Chatterjee S., 2015, REGRESSION ANAL EXAM; Fox J., 2015, APPL REGRESSION ANAL; Ginther DK, 2015, SCIENCE, V349, DOI 10.1126/science.aaa9632; Kutner M. H., 2004, APPL LINEAR REGRESSI; Leslie SJ, 2015, SCIENCE, V347, P262, DOI 10.1126/science.1261375; Meyer M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00235; National Science Foundation, 2011, SURV EARN DOCT; Riegle-Crumb C, 2012, AM EDUC RES J, V49, P1048, DOI 10.3102/0002831211435229; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wooldridge Jeffrey M., 2012, INTRO ECONOMETRICS M, VFifth	10	13	13	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246								10.1126/science.aaa9892	http://dx.doi.org/10.1126/science.aaa9892			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN4DX	26206927				2022-12-28	WOS:000358381400033
J	Anderson, C				Anderson, Claire			Changing the way pharmacy only drugs are supplied would be unwise	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Royal Pharmaceut Soc, London E1W 1AW, England		Anderson, C (corresponding author), Royal Pharmaceut Soc, London E1W 1AW, England.	claire.anderson@nottingham.ac.uk		Anderson, Claire/0000-0002-5406-2296				Rutter P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3415; Stevenson FA, 2008, SOCIOL HEALTH ILL, V30, P913, DOI 10.1111/j.1467-9566.2008.01108.x; Van Eikenhorst L, 2014, INT J PHARM PRAC S1, P27; Watson MC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006261; Watson MC, 2015, BMJ	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2015	351								h3951	10.1136/bmj.h3951	http://dx.doi.org/10.1136/bmj.h3951			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WL	26205650				2022-12-28	WOS:000358645000011
J	Chandra, A; Vanderpuye-Orgle, J				Chandra, Amitabh; Vanderpuye-Orgle, Jacqueline			Competition in the Age of Biosimilars	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chandra, Amitabh] Harvard Univ, Cambridge, MA 02138 USA; [Vanderpuye-Orgle, Jacqueline] Precis Hlth Econ, Los Angeles, CA USA	Harvard University	Chandra, A (corresponding author), Harvard Univ, 79 JFK St, Cambridge, MA 02138 USA.	amitabh_chandra@harvard.edu						[Anonymous], 2015, DAT ADV EV NOT MED S; [Anonymous], 2015, FDA APPR 1 BIOS PROD; Engelberg AB, 2009, NEW ENGL J MED, V361, P1917, DOI 10.1056/NEJMp0908496; Mulcahy A.W., 2014, COST SAVINGS POTENTI; Silver S, 2013, IND SURVEYS BIOTECHN; US Food and Drug Administration, 2014, INF CONS BIOS	6	10	10	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					225	226		10.1001/jama.2015.6170	http://dx.doi.org/10.1001/jama.2015.6170			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197179				2022-12-28	WOS:000358228000012
J	Chou, R				Chou, Roger			Review: Acetaminophen reduces pain in hip or knee osteoarthritis by a small amount, but not low back pain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.			Chou, Roger/0000-0001-9889-8610				Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; National Institute for Health and Care Excellence, 2014, OST THRIT CAR MAN AD; Verkleij SPJ, 2011, OSTEOARTHR CARTILAGE, V19, P921, DOI 10.1016/j.joca.2011.04.013; Wetzel L, 2014, EUR J ANAESTH, V31, P35, DOI 10.1097/EJA.0b013e328365ae28	5	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2							JC10	10.7326/ACPJC-2015-163-2-010	http://dx.doi.org/10.7326/ACPJC-2015-163-2-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26192578				2022-12-28	WOS:000358407500010
J	Li, YP; Ley, SH; Tobias, DK; Chiuve, SE; VanderWeele, TJ; Rich-Edwards, JW; Curhan, GC; Willett, WC; Manson, JE; Hu, FB; Qi, L				Li, Yanping; Ley, Sylvia H.; Tobias, Deirdre K.; Chiuve, Stephanie E.; VanderWeele, Tyler J.; Rich-Edwards, Janet W.; Curhan, Gary C.; Willett, Walter C.; Manson, JoAnn E.; Hu, Frank B.; Qi, Lu			Birth weight and later life adherence to unhealthy lifestyles in predicting type 2 diabetes: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPAIRED GLUCOSE-TOLERANCE; ADULT HYPERTENSION; PRENATAL EXPOSURE; PHYSICAL-ACTIVITY; CHINESE FAMINE; FOLLOW-UP; RISK; MELLITUS; GROWTH; FETAL	OBJECTIVES To prospectively assess the joint association of birth weight and established lifestyle risk factors in adulthood with incident type 2 diabetes and to quantitatively decompose the attributing effects to birth weight only, to adulthood lifestyle only, and to their interaction. DESIGN Prospective cohort study. SETTING Health Professionals Follow-up Study (1986-2010), Nurses' Health Study (1980-2010), and Nurses' Health Study II (1991-2011). PARTICIPANTS 149 794 men and women without diabetes, cardiovascular disease, or cancer at baseline. MAIN OUTCOME MEASURE Incident cases of type 2 diabetes, identified through self report and validated by a supplementary questionnaire. Unhealthy lifestyle was defined on the basis of body mass index, smoking, physical activity, alcohol consumption, and the alternate healthy eating index. RESULTS During 20-30 years of follow-up, 11 709 new cases of type 2 diabetes were documented. The multivariate adjusted relative risk of type 2 diabetes was 1.45 (95% confidence interval 1.32 to 1.59) per kg lower birth weight and 2.10 (1.71 to 2.58) per unhealthy lifestyle factor. The relative risk of type 2 diabetes associated with a combination of per kg lower birth weight and per unhealthy lifestyle factor was 2.86 (2.26 to 3.63), which was more than the addition of the risk associated with each individual factor, indicating a significant interaction on an additive scale (P for interaction<0.001). The attributable proportions of joint effect were 22% (95% confidence interval 18.3% to 26.4%) to lower birth weight alone, 59% (57.1% to 61.5%) to unhealthy lifestyle alone, and 18% (13.9% to 21.3%) to their interaction. CONCLUSION Most cases of type 2 diabetes could be prevented by the adoption of a healthier lifestyle, but simultaneous improvement of both prenatal and postnatal factors could further prevent additional cases.	[Li, Yanping; Ley, Sylvia H.; Tobias, Deirdre K.; Chiuve, Stephanie E.; Willett, Walter C.; Hu, Frank B.; Qi, Lu] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA; [Chiuve, Stephanie E.; Manson, JoAnn E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [VanderWeele, Tyler J.; Rich-Edwards, Janet W.; Curhan, Gary C.; Willett, Walter C.; Manson, JoAnn E.; Hu, Frank B.; Qi, Lu] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [VanderWeele, Tyler J.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Rich-Edwards, Janet W.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Connors Ctr Womens Hlth & Gender Biol, Boston, MA 02115 USA; [Curhan, Gary C.; Willett, Walter C.; Hu, Frank B.; Qi, Lu] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med,Dept Med, Boston, MA 02115 USA; [Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Qi, L (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	yanping@hsph.harvard.edu; nhlqi@channing.harvard.edu	; Li, Yanping/H-6437-2011	Chiuve, Stephanie/0000-0002-3524-8917; Li, Yanping/0000-0002-0412-2748; Ley, Sylvia/0000-0003-0084-2630	National Institutes of Health [P01 CA87969, UM1 CA176726, UM1 CA167552]; National Heart, Lung, and Blood Institute [HL071981, HL034594, HL126024]; National Institute of Diabetes and Digestive and Kidney Diseases [DK58845, DK091718, DK100383]; Boston Obesity Nutrition Research Center [DK46200]; United States-Israel Binational Science Foundation [2011036]; American Heart Association Scientist Development Award [0730094N]; NATIONAL CANCER INSTITUTE [UM1CA167552, P01CA087969, UM1CA176726] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071981, R21HL126024, R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100383, R01DK091718, R01DK058845, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Boston Obesity Nutrition Research Center; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); American Heart Association Scientist Development Award(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The cohorts were supported by grants P01 CA87969, UM1 CA176726, and UM1 CA167552 from the National Institutes of Health. This study was supported by the National Heart, Lung, and Blood Institute (HL071981, HL034594, HL126024), the National Institute of Diabetes and Digestive and Kidney Diseases (DK58845, DK091718, DK100383), the Boston Obesity Nutrition Research Center (DK46200), and United States-Israel Binational Science Foundation Grant 2011036. LQ was a recipient of the American Heart Association Scientist Development Award (0730094N). None of the sponsors participated in the design of study or in the collection, analysis, or interpretation of the data.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; BLOT WJ, 1979, AM J EPIDEMIOL, V110, P99, DOI 10.1093/oxfordjournals.aje.a112793; Chen HN, 2014, MATERN CHILD HLTH J, V18, P527, DOI 10.1007/s10995-013-1268-z; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Clark PM, 1998, EUR J PEDIATR, V157, pS7, DOI 10.1007/PL00014289; Cohen L, 2012, J AM SOC HYPERTENS, V6, P284, DOI 10.1016/j.jash.2012.06.002; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Eriksson JG, 2004, PREV MED, V39, P164, DOI 10.1016/j.ypmed.2004.01.035; Eriksson JG, 2003, DIABETES CARE, V26, P3006, DOI 10.2337/diacare.26.11.3006; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Fowden AL, 2001, BRIT MED BULL, V60, P123, DOI 10.1093/bmb/60.1.123; Franks PW, 2006, DIABETES, V55, P460, DOI 10.2337/diabetes.55.02.06.db05-0823; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HARRIS M, 1979, DIABETES, V28, P1039; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Horikoshi M, 2013, NAT GENET, V45, P76, DOI 10.1038/ng.2477; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; International Diabetes Federation, IDF DIAB ATL UPD 201; Koyanagi A, 2013, LANCET, V381, P476, DOI 10.1016/S0140-6736(12)61605-5; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; Li YP, 2010, DIABETES, V59, P2400, DOI 10.2337/db10-0385; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; MCCANCE DR, 1994, BRIT MED J, V308, P942, DOI 10.1136/bmj.308.6934.942; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; MONTERROSA AE, 1995, DIABETES CARE, V18, P448, DOI 10.2337/diacare.18.4.448; Mu R, 2008, GENDER DIFFERENCE LO; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Stefan N, 2004, METABOLISM, V53, P904, DOI 10.1016/j.metabol.2004.01.014; Troy LM, 1996, INT J EPIDEMIOL, V25, P122, DOI 10.1093/ije/25.1.122; US Department of Health and Human Services, 2013, CHILD HLTH US 2013; Vander Weele TJ, 2014, EPIDEMIOLOGY, V25, P711, DOI 10.1097/EDE.0000000000000096; VanderWeele TJ, 2014, EPIDEMIOL METHODS, V3, P33, DOI [DOI 10.1515/EM-2013-0005, 10.1515/em-2013-0005]; Vanderweele TJ, 2008, BIOMETRIKA, V95, P49, DOI 10.1093/biomet/asm090; VanderWeele TJ, 2012, AM J EPIDEMIOL, V175, P1013, DOI 10.1093/aje/kwr467; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; Wei JN, 2003, DIABETES CARE, V26, P343, DOI 10.2337/diacare.26.2.343; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219	50	79	82	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2015	351								h3672	10.1136/bmj.h3672	http://dx.doi.org/10.1136/bmj.h3672			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WG	26199273	Green Published, hybrid			2022-12-28	WOS:000358644400004
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Bias in experimental study designs: randomised controlled trials with parallel groups	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Sedgwick P., 2013, BMJ, V347, pf6304, DOI [DOI 10.1136/BMJ.F6304, 10.1136/bmj.f6304]; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2633; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6435; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2573; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1742; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5970; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5584	8	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2015	351								h3869	10.1136/bmj.h3869	http://dx.doi.org/10.1136/bmj.h3869			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CW	26187730				2022-12-28	WOS:000358302500002
J	Greinacher, A				Greinacher, Andreas			Heparin-Induced Thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR-WEIGHT HEPARIN; CONFORMATIONAL-CHANGES; PLATELET COUNT; IN-VITRO; ANTIBODIES; PLATELET-FACTOR-4; RISK; ACTIVATION; FONDAPARINUX; SCORE	A 64-year-old woman who is hospitalized with endocarditis and whose condition is clinically stable while she is receiving intravenous antibiotic agents has had a decrease in platelet count from 161,000 per cubic millimeter on day 7 of hospitalization to 60,000 per cubic millimeter on day 9. She has been receiving low-molecular-weight heparin at a dose of 40 mg per day since admission. How should her case be further evaluated and treated?	[Greinacher, Andreas] Univ Med Greifswald, Inst Immunol & Transfusionsmed, Greifswald, Germany	Greifswald Medical School	Greinacher, A (corresponding author), Greinacher Inst Immunol & Transfusionsmed, Sauerbruchstr, D-17475 Greifswald, Germany.	greinach@uni-greifswald.de			Instrumentation Laboratory; Bayer HealthCare; Macopharma; Merck Sharp Dohme; W.L. Gore and Associates; Bristol-Myers Squibb; Boehringer Ingelheim	Instrumentation Laboratory; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Macopharma; Merck Sharp Dohme(Merck & Company); W.L. Gore and Associates; Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim)	Dr. Greinacher reports receiving fees for serving on an advisory board from Instrumentation Laboratory; consulting fees from Bayer HealthCare, Macopharma, Merck Sharp & Dohme, and W.L. Gore and Associates; travel support from Boehringer Ingelheim; fees for the planning of and participation in a Continuing Medical Education program from Bristol-Myers Squibb; grant support from Macopharma; and institutional fees to his university from Boehringer Ingelheim. He also reports an agreement in development with BioMarin Nederland and Nanjing King-friend Biochemical Pharmaceutical, which will provide institutional but no personal fees. No other potential conflict of interest relevant to this article was reported.	Bartholomew JR, 2013, HEPARIN INDUCED THRO, P429; Brandt S, 2014, THROMB HAEMOSTASIS, V112, P53, DOI 10.1160/TH13-08-0634; Chong BH, 2001, THROMB HAEMOSTASIS, V86, P1170, DOI 10.1055/s-0037-1616046; Chong BH, 2013, HEPARIN INDUCED THRO, P466; CINES DB, 1987, NEW ENGL J MED, V316, P581, DOI 10.1056/NEJM198703053161004; Cuker A, 2010, J THROMB HAEMOST, V8, P2642, DOI 10.1111/j.1538-7836.2010.04059.x; Cuker A, 2012, BLOOD, V120, P4160, DOI 10.1182/blood-2012-07-443051; Farner B, 2001, THROMB HAEMOSTASIS, V85, P950, DOI 10.1055/s-0037-1615946; Goel R, 2015, BLOOD, V125, P1470, DOI 10.1182/blood-2014-10-605493; Greinacher A, 2005, THROMB HAEMOSTASIS, V94, P132, DOI 10.1160/TH04-12-0825; Greinacher A, 2010, J THROMB HAEMOST, V8, P2025, DOI 10.1111/j.1538-7836.2010.03974.x; Greinacher A, 2012, PLATELETS, P851; Greinacher A, 2014, BLOOD, V123, P3536, DOI 10.1182/blood-2014-04-566836; Greinacher A, 2008, EXPERT REV HEMATOL, V1, P75, DOI 10.1586/17474086.1.1.75; Gruel Y, 2004, BLOOD, V104, P2791, DOI 10.1182/blood-2004-01-0058; Jaax ME, 2013, BLOOD, V122, P272, DOI 10.1182/blood-2013-01-478966; Kang M, 2015, BLOOD, V125, P924, DOI 10.1182/blood-2014-09-599498; Kasthuri RS, 2012, BLOOD, V119, P5285, DOI 10.1182/blood-2011-06-359430; KELTON JG, 1988, BLOOD, V72, P925; Krauel K, 2008, J THROMB HAEMOST, V6, P2160, DOI 10.1111/j.1538-7836.2008.03171.x; Krauel K, 2012, BLOOD, V120, P3345, DOI 10.1182/blood-2012-06-434985; Krauel K, 2012, BLOOD, V119, P1248, DOI 10.1182/blood-2011-05-353391; Krauel K, 2011, BLOOD, V117, P1370, DOI 10.1182/blood-2010-08-301424; Kreimann M, 2014, BLOOD, V124, P2442, DOI 10.1182/blood-2014-03-559518; Lewis BE, 2006, CHEST, V129, P1407, DOI 10.1378/chest.129.6.1407; Li ZQ, 2002, BLOOD, V99, P1230, DOI 10.1182/blood.V99.4.1230; Linkins LA, 2012, CHEST S, V141, pe495S; Lo GK, 2006, J THROMB HAEMOST, V4, P759, DOI 10.1111/j.1538-7836.2006.01787.x; Lubenow N, 2010, BLOOD, V115, P1797, DOI 10.1182/blood-2009-07-231506; Martel N, 2005, BLOOD, V106, P2710, DOI 10.1182/blood-2005-04-1546; Potzsch B, 2000, NEW ENGL J MED, V343, P515, DOI 10.1056/NEJM200008173430718; Pouplard C, 2005, BRIT J HAEMATOL, V128, P837, DOI 10.1111/j.1365-2141.2005.05381.x; Prechel MM, 2005, J THROMB HAEMOST, V3, P2168, DOI 10.1111/j.1538-7836.2005.01560.x; Rauova L, 2010, BLOOD, V116, P5021, DOI 10.1182/blood-2010-03-276964; Selleng S, 2008, BLOOD, V112, P4024, DOI 10.1182/blood-2008-03-145243; Socher I, 2008, J THROMB HAEMOST, V6, P197; The Association of the Scientific Medical Societies of Germany, GERM GUID THROMB PRO; Tholl U, 1997, NEPHROL DIAL TRANSPL, V12, P2750, DOI 10.1093/ndt/12.12.2750; Tvito A, 2015, AM J HEMATOL, V90, P675, DOI 10.1002/ajh.23971; Warkentin TE, 2008, J THROMB HAEMOST, V6, P1304, DOI 10.1111/j.1538-7836.2008.03025.x; Warkentin TE, 2000, BLOOD, V96, P1703, DOI 10.1182/blood.V96.5.1703.h8001703_1703_1708; Warkentin TE, 2001, ANN INTERN MED, V135, P502, DOI 10.7326/0003-4819-135-7-200110020-00009; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; Warkentin TE, 2001, NEW ENGL J MED, V344, P1286, DOI 10.1056/NEJM200104263441704; Warkentin TE, 1996, AM J MED, V101, P502, DOI 10.1016/S0002-9343(96)00258-6; Warkentin TE, 2013, HEPARIN INDUCED THRO, P272; Warkentin TE, 2008, CHEST, V133, p340S, DOI 10.1378/chest.08-0677; Warkentin TE, 2015, BLOOD, V125, P195, DOI 10.1182/blood-2014-07-590844; Warkentin TE, 2014, BLOOD, V123, P3651, DOI 10.1182/blood-2014-01-549741; Warkentin TE, 2014, BLOOD, V123, P2485, DOI 10.1182/blood-2013-10-533083; Warkentin TE, 2009, EXPERT OPIN DRUG SAF, V8, P129, DOI [10.1517/14740330902778180, 10.1517/14740330902778180 ]; Warkentin TE, 2009, BLOOD, V113, P4963, DOI 10.1182/blood-2008-10-186064; Watson H, 2012, BRIT J HAEMATOL, V159, P528, DOI 10.1111/bjh.12059; Zheng YW, 2013, BLOOD, V121, P3484, DOI 10.1182/blood-2013-01-477091; Ziporen L, 1998, BLOOD, V92, P3250, DOI 10.1182/blood.V92.9.3250.421k23_3250_3259	55	306	319	3	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3					252	261		10.1056/NEJMcp1411910	http://dx.doi.org/10.1056/NEJMcp1411910			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MS	26176382				2022-12-28	WOS:000357956200008
J	Till, C				Till, Christy			Big geochemistry	NATURE			English	Editorial Material							CONTINENTAL-CRUST; EVOLUTION; DELAMINATION		Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe	Till, C (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85281 USA.	christy.till@asu.edu	Till, Christy/D-7771-2012; Till, Christy/Y-1173-2019	Till, Christy/0000-0001-8924-2206				Bowen NL, 1915, J GEOL, V23, P1; DALY RA, 1933, IGNEOUS ROCKS DEPTHS; Gao S, 2004, NATURE, V432, P892, DOI 10.1038/nature03162; Jull M, 2001, J GEOPHYS RES-SOL EA, V106, P6423, DOI 10.1029/2000JB900357; KAY RW, 1993, TECTONOPHYSICS, V219, P177, DOI 10.1016/0040-1951(93)90295-U; Keller CB, 2015, NATURE, V523, P301, DOI 10.1038/nature14584; Keller CB, 2012, NATURE, V485, P490, DOI 10.1038/nature11024; Levander A, 2011, NATURE, V472, P461, DOI 10.1038/nature10001; Plank T, 2005, J PETROL, V46, P921, DOI 10.1093/petrology/egi005; RUDNICK RL, 1995, NATURE, V378, P571, DOI 10.1038/378571a0; Valley JW, 2014, NAT GEOSCI, V7, P219, DOI [10.1038/ngeo2075, 10.1038/NGEO2075]	11	0	0	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					293	294		10.1038/523293a	http://dx.doi.org/10.1038/523293a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM8KY	26178958				2022-12-28	WOS:000357950900027
J	Dodonova, SO; Diestelkoetter-Bachert, P; von Appen, A; Hagen, WJH; Beck, R; Beck, M; Wieland, F; Briggs, JAG				Dodonova, S. O.; Diestelkoetter-Bachert, P.; von Appen, A.; Hagen, W. J. H.; Beck, R.; Beck, M.; Wieland, F.; Briggs, J. A. G.			A structure of the COPI coat and the role of coat proteins in membrane vesicle assembly	SCIENCE			English	Article							DILYSINE RETRIEVAL MOTIFS; CLATHRIN ADAPTER COMPLEX; CRYOELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE; CONFORMATIONAL-CHANGE; CRYSTAL-STRUCTURE; RECRUITMENT; TRANSPORT; BINDING; MODEL	Transport of material within cells is mediated by trafficking vesicles that bud from one cellular compartment and fuse with another. Formation of a trafficking vesicle is driven by membrane coats that localize cargo and polymerize into cages to bend the membrane. Although extensive structural information is available for components of these coats, the heterogeneity of trafficking vesicles has prevented an understanding of how complete membrane coats assemble on the membrane. We combined cryo-electron tomography, subtomogram averaging, and cross-linking mass spectrometry to derive a complete model of the assembled coat protein complex I (COPI) coat involved in traffic between the Golgi and the endoplasmic reticulum. The highly interconnected COPI coat structure contradicted the current "adaptor-and-cage" understanding of coated vesicle formation.	[Dodonova, S. O.; von Appen, A.; Hagen, W. J. H.; Beck, M.; Briggs, J. A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Diestelkoetter-Bachert, P.; Beck, R.; Wieland, F.] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Briggs, J. A. G.] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Briggs, JAG (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	john.briggs@embl.de	Beck, Martin/B-5589-2011; Dodonova, Svetlana/S-8919-2019	Beck, Martin/0000-0002-7397-1321; Dodonova, Svetlana/0000-0002-5002-8138; Hagen, Wim/0000-0001-6229-2692; Beck, Rainer/0000-0001-9304-2733; Briggs, John/0000-0003-3990-6910	Deutsche Forschungsgemeinschaft [SFB638 (A16)]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank K. Bacia for providing Arf1 protein; M. Schorb and J. Kosinski for technical assistance; and F. Schur, W. Wan, B. Brugger, D. Devos, M. Kozlov, and D. Owen for discussions. This work was technically supported by EMBL IT services and was funded by the Deutsche Forschungsgemeinschaft within SFB638 (A16) to J.A.G.B. and F. W. EM maps and structural models are deposited in the Electron Microscopy Data Bank (accession codes EMD-2985, EMD-2986, EMD-2987, EMD-2988, and EMD-2989) and the Protein Data Bank (PDB IDs 5A1U, 5A1V, 5A1W, 5A1X, and 5A1Y).	Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Chow VTK, 2001, BIOCHEM GENET, V39, P201, DOI 10.1023/A:1010245409552; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Faini M, 2013, TRENDS CELL BIOL, V23, P279, DOI 10.1016/j.tcb.2013.01.005; Faini M, 2012, SCIENCE, V336, P1451, DOI 10.1126/science.1221443; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hsia KC, 2010, P NATL ACAD SCI USA, V107, P11271, DOI 10.1073/pnas.1006297107; Jackson LP, 2012, DEV CELL, V23, P1255, DOI 10.1016/j.devcel.2012.10.017; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Langer JD, 2008, TRAFFIC, V9, P597, DOI 10.1111/j.1600-0854.2007.00697.x; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Noble AJ, 2013, NAT STRUCT MOL BIOL, V20, P167, DOI 10.1038/nsmb.2467; Reinhard C, 1999, P NATL ACAD SCI USA, V96, P1224, DOI 10.1073/pnas.96.4.1224; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; Schur FKM, 2013, J STRUCT BIOL, V184, P394, DOI 10.1016/j.jsb.2013.10.015; Spang A, 2013, EMBO J, V32, P915, DOI 10.1038/emboj.2013.57; Watson PJ, 2004, TRAFFIC, V5, P79, DOI 10.1111/j.1600-0854.2004.00158.x; Yu WY, 2009, J MOL BIOL, V386, P903, DOI 10.1016/j.jmb.2008.12.083; Yu XC, 2012, CELL, V148, P530, DOI 10.1016/j.cell.2012.01.015; Zanetti G, 2013, ELIFE, V2, DOI 10.7554/eLife.00951; Zhao LY, 1999, J BIOL CHEM, V274, P14198, DOI 10.1074/jbc.274.20.14198	32	112	115	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					195	198		10.1126/science.aab1121	http://dx.doi.org/10.1126/science.aab1121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26160949				2022-12-28	WOS:000357664300046
J	Resing, JA; Sedwick, PN; German, CR; Jenkins, WJ; Moffett, JW; Sohst, BM; Tagliabue, A				Resing, Joseph A.; Sedwick, Peter N.; German, Christopher R.; Jenkins, William J.; Moffett, James W.; Sohst, Bettina M.; Tagliabue, Alessandro			Basin-scale transport of hydrothermal dissolved metals across the South Pacific Ocean	NATURE			English	Article							FLOW-INJECTION-ANALYSIS; IRON; SEA; ATLANTIC; DEEP; CIRCULATION; MANGANESE; SEAWATER; PLUMES; AL	Hydrothermal venting along mid-ocean ridges exerts an important control on the chemical composition of sea water by serving as a major source or sink for a number of trace elements in the ocean(1-3). Of these, iron has received considerable attention because of its role as an essential and often limiting nutrient for primary production in regions of the ocean that are of critical importance for the global carbon cycle(4). It has been thought that most of the dissolved iron discharged by hydrothermal vents is lost from solution close to ridge-axis sources(2,5) and is thus of limited importance for ocean biogeochemistry(6). This long-standing view is challenged by recent studies which suggest that stabilization of hydrothermal dissolved iron may facilitate its longrange oceanic transport(7-10). Such transport has been subsequently inferred from spatially limited oceanographic observations(11-13). Here we report data from the US GEOTRACES Eastern Pacific Zonal Transect (EPZT) that demonstrate lateral transport of hydrothermal dissolved iron, manganese, and aluminium from the southern East Pacific Rise (SEPR) several thousand kilometres westward across the South Pacific Ocean. Dissolved iron exhibits nearly conservative (that is, no loss from solution during transport and mixing) behaviour in this hydrothermal plume, implying a greater longevity in the deep ocean than previously assumed(6,14). Based on our observations, we estimate a global hydrothermal dissolved iron input of three to four gigamoles per year to the ocean interior, which is more than fourfold higher than previous estimates(7,11,14). Complementary simulations with a global-scale ocean biogeochemical model suggest that the observed transport of hydrothermal dissolved iron requires some means of physicochemical stabilization and indicate that hydrothermally derived iron sustains a large fraction of Southern Ocean export production.	[Resing, Joseph A.] Univ Washington, Joint Inst Study Atmosphere & Ocean, Seattle, WA 98115 USA; [Resing, Joseph A.] NOAA, PMEL, Seattle, WA 98115 USA; [Sedwick, Peter N.; Sohst, Bettina M.] Old Dominion Univ, Dept Ocean Earth & Atmospher Sci, Norfolk, VA 23529 USA; [German, Christopher R.; Jenkins, William J.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Moffett, James W.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Tagliabue, Alessandro] Univ Liverpool, Sch Environm Sci, Dept Earth Ocean & Ecol Sci, Liverpool L69 3GP, Merseyside, England	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Old Dominion University; Woods Hole Oceanographic Institution; University of Southern California; University of Liverpool	Resing, JA (corresponding author), Univ Washington, Joint Inst Study Atmosphere & Ocean, 7600 Sand Point Way NE, Seattle, WA 98115 USA.	resing@uw.edu; a.tagliabue@liverpool.ac.uk	Resing, Joseph A/J-6110-2017	Resing, Joseph A/0000-0002-7334-4176; Tagliabue, Alessandro/0000-0002-3572-3634; Sedwick, Peter/0000-0003-0663-8323	US National Science Foundation [OCE-1237011, OCE-1237034, OCE-1232991, OCE-1130870, OCE-1131731, OCE-1260273]; N8 consortium; EPSRC [EP/K000225/1]; Humboldt Research Award; JISAO by the PMEL-Earth Oceans Interactions programme; EPSRC [EP/K000209/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K000209/1, EP/K000225/1] Funding Source: researchfish; Directorate For Geosciences [1237011, 1131731] Funding Source: National Science Foundation; Division Of Ocean Sciences [1232991, 1237034] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); N8 consortium; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Humboldt Research Award(Alexander von Humboldt Foundation); JISAO by the PMEL-Earth Oceans Interactions programme; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the captain and crew of the RV Thomas G. Thompson (TGT cruise 303) for their support during the 57-day mission. Samples were collected on board ship by C. Parker and C. Zurbrick, from the US GEOTRACES sampling system maintained and operated by G. Cutter. We thank the many people who have devoted time and effort to the international GEOTRACES programme. This work was funded by US National Science Foundation awards OCE-1237011 to J.A.R., OCE-1237034 to P.N.S., OCE-1232991 to W.J.J., OCE-1130870 to C.R.G., and OCE-1131731 and OCE-1260273 to J.W.M. Model simulations made use of the N8 HPC facilities, funded by the N8 consortium and EPSRC grant EP/K000225/1. C.R.G. also acknowledges support from a Humboldt Research Award. J.A.R. was funded in part through JISAO by the PMEL-Earth Oceans Interactions programme. This is JISAO publication number 2388 and PMEL publication number 4255.	Aumont O, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002591; Bennett SA, 2008, EARTH PLANET SC LETT, V270, P157, DOI 10.1016/j.epsl.2008.01.048; BENSON BB, 1980, J SOLUTION CHEM, V9, P895, DOI 10.1007/BF00646402; Bowie AR, 2004, LIMNOL OCEANOGR-METH, V2, P42, DOI 10.4319/lom.2004.2.42; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Bruland K.W., 2004, TREATISE GEOM, V6, P23; Conway TM, 2014, NATURE, V511, P212, DOI 10.1038/nature13482; Cutter GA, 2012, LIMNOL OCEANOGR-METH, V10, P425, DOI 10.4319/lom.2012.10.425; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; FARLEY KA, 1995, J GEOPHYS RES-SOL EA, V100, P3829, DOI 10.1029/94JB02913; Feely RA, 1996, GEOCHIM COSMOCHIM AC, V60, P2297, DOI 10.1016/0016-7037(96)00099-3; Fitzsimmons JN, 2014, P NATL ACAD SCI USA, V111, P16654, DOI 10.1073/pnas.1418778111; Flynn KJ, 1999, J PHYCOL, V35, P1171, DOI 10.1046/j.1529-8817.1999.3561171.x; GAMO T, 1993, DEEP-SEA RES PT I, V40, P2335, DOI 10.1016/0967-0637(93)90108-F; German C.R., 2014, OCEANS MARINE GEOCHE, Vsecond, P191, DOI [DOI 10.1016/B978-0-08-095975-7.00607-0, 10.1016/B978-0-08-095975-7.00607-0]; HAUTALA SL, 1993, J PHYS OCEANOGR, V23, P1975, DOI 10.1175/1520-0485(1993)023<1975:ANSDOT>2.0.CO;2; Ishibashi J, 1997, GEOCHIM COSMOCHIM AC, V61, P485, DOI 10.1016/S0016-7037(96)00304-3; KLINKHAMMER G, 1986, EARTH PLANET SC LETT, V79, P241, DOI 10.1016/0012-821X(86)90182-2; Klunder MB, 2011, DEEP-SEA RES PT II, V58, P2678, DOI 10.1016/j.dsr2.2010.10.042; Kondo Y, 2013, DEEP-SEA RES PT I, V73, P73, DOI 10.1016/j.dsr.2012.11.014; Liu XW, 2002, MAR CHEM, V77, P43, DOI 10.1016/S0304-4203(01)00074-3; Liu XW, 1999, GEOCHIM COSMOCHIM AC, V63, P3487, DOI 10.1016/S0016-7037(99)00270-7; Lott DE, 2001, GEOCHEM GEOPHY GEOSY, V2; LOTT DE, 1984, REV SCI INSTRUM, V55, P1982, DOI 10.1063/1.1137692; LUNEL T, 1990, NATURE, V344, P137, DOI 10.1038/344137a0; LUPTON JE, 1981, SCIENCE, V214, P13, DOI 10.1126/science.214.4516.13; LUPTON JE, 1993, GEOPHYS RES LETT, V20, P2913, DOI 10.1029/93GL00906; Measures C, 2015, DEEP-SEA RES PT II, V116, P176, DOI 10.1016/j.dsr2.2014.07.006; MEASURES CI, 1995, MAR CHEM, V50, P3, DOI 10.1016/0304-4203(95)00022-J; Middag R, 2011, DEEP-SEA RES PT II, V58, P2647, DOI 10.1016/j.dsr2.2011.03.001; Middag R, 2009, MAR CHEM, V115, P176, DOI 10.1016/j.marchem.2009.08.002; Moffett JW, 2007, DEEP-SEA RES PT I, V54, P1341, DOI 10.1016/j.dsr.2007.04.004; Nishioka J, 2013, EARTH PLANET SC LETT, V361, P26, DOI 10.1016/j.epsl.2012.11.040; RESING JA, 1992, ANAL CHEM, V64, P2682, DOI 10.1021/ac00046a006; RESING JA, 1994, ANAL CHEM, V66, P4105, DOI 10.1021/ac00094a039; Saito MA, 2013, NAT GEOSCI, V6, P775, DOI [10.1038/ngeo1893, 10.1038/NGEO1893]; Sander SG, 2011, NAT GEOSCI, V4, P145, DOI [10.1038/ngeo1088, 10.1038/NGEO1088]; Sands CM, 2012, EARTH PLANET SC LETT, V319, P15, DOI 10.1016/j.epsl.2011.12.031; Sedwick PN, 2008, DEEP-SEA RES PT I, V55, P911, DOI 10.1016/j.dsr.2008.03.011; Sedwick PN, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002445; Stanley RHR, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002429; Tagliabue A, 2014, GEOPHYS RES LETT, V41, P920, DOI 10.1002/2013GL059059; Tagliabue A, 2010, NAT GEOSCI, V3, P252, DOI 10.1038/NGEO818; TALLEY LD, 1994, SCIENCE, V263, P1125, DOI 10.1126/science.263.5150.1125; Thurnherr AM, 2011, DEEP-SEA RES PT I, V58, P365, DOI 10.1016/j.dsr.2011.01.009; URABE T, 1995, SCIENCE, V269, P1092, DOI 10.1126/science.269.5227.1092; Volker C, 2015, MAR CHEM, V173, P67, DOI 10.1016/j.marchem.2014.11.008; VONDAMM KL, 1990, ANNU REV EARTH PL SC, V18, P173, DOI 10.1146/annurev.ea.18.050190.001133; Wu JF, 2011, GEOCHIM COSMOCHIM AC, V75, P460, DOI 10.1016/j.gca.2010.10.024; Young C., 1983, EOS T AM GEOPHYS UN, V64, P735; Yucel M, 2011, NAT GEOSCI, V4, P367, DOI [10.1038/ngeo1148, 10.1038/NGEO1148]	51	308	319	9	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					200	U140		10.1038/nature14577	http://dx.doi.org/10.1038/nature14577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26156374				2022-12-28	WOS:000357695900032
J	Smith, MR; Singh, GM; Arian, DM; Myers, SS				Smith, Matthew R.; Singh, Gitanjali M.; Arian, Dariush Mozaff; Myers, Samuel S.			Effects of decreases of animal pollinators on human nutrition and global health: a modelling analysis	LANCET			English	Article							COLONY LOSSES; RISK-FACTORS; DENSITY; DISEASE; BURDEN	Background Anthropogenic declines of animal pollinators and the associated effects on human nutrition are of growing concern. We quantified the nutritional and health outcomes associated with decreased intake of pollinator-dependent foods for populations around the world. Methods We assembled a database of supplies of 224 types of food in 156 countries. We quantified nutrient composition and pollinator dependence of foods to estimate the size of possible reductions in micronutrient and food intakes for different national populations, while keeping calorie intake constant with replacement by staple foods. We estimated pollinator-decline-dependent changes in micronutrient-deficient populations using population-weighted estimated average requirements and the cutpoint method. We estimated disease burdens of non-communicable, communicable, and malnutrition-related diseases with the Global Burden of Disease 2010 comparative risk assessment framework. Findings Assuming complete removal of pollinators, 71 million (95% uncertainty interval 41-262) people in low-income countries could become newly deficient in vitamin A, and an additional 2.2 billion (1.2-2.5) already consuming below the average requirement would have further declines in vitamin A supplies. Corresponding estimates for folate were 173 million (134-225) and 1.23 billion (1.12-1.33). A 100% decline in pollinator services could reduce global fruit supplies by 22.9% (19.5-26.1), vegetables by 16.3% (15.1-17.7), and nuts and seeds by 22.1% (17.7-26.4), with significant heterogeneity by country. In sum, these dietary changes could increase global deaths yearly from non-communicable and malnutrition-related diseases by 1.42 million (1.38-1.48) and disability-adjusted life-years (DALYs) by 27.0 million (25.8-29.1), an increase of 2.7% for deaths and 1.1% for DALYs. A 50% loss of pollination services would be associated with 700 000 additional annual deaths and 13.2 million DALYs. Interpretation Declines in animal pollinators could cause significant global health burdens from both non-communicable diseases and micronutrient deficiencies.	[Smith, Matthew R.; Myers, Samuel S.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA; [Singh, Gitanjali M.; Arian, Dariush Mozaff] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Myers, Samuel S.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Tufts University; Harvard University	Myers, SS (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Landmark Ctr West, Room 405,401 Pk Dr, Boston, MA 02215 USA.	sam_myers@hms.harvard.edu		Smith, Matthew/0000-0001-5207-2370	Bill & Melinda Gates Foundation; Winslow Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Winslow Foundation	This research was funded by grants from the Bill & Melinda Gates Foundation and the Winslow Foundation. We gratefully acknowledge Liana Del Gobbo for her input on appropriate use of food balance sheet data, Ryan Wessells for her guidance on how to assess nutrient deficiency for entire populations, Danielle Medek for her help with resources related to micronutrient deficiency, and Joel Schwartz for his assistance in statistical analysis.	[Anonymous], 2009, TABL COMP AL AM LAT; Caulfi eld L. E., 2004, COMP QUANTIFICATION; Chaplin-Kramer R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1799; Clement SL, 2007, J ECON ENTOMOL, V100, P131, DOI 10.1603/0022-0493(2007)100[131:FDMCAE]2.0.CO;2; Dedej S, 2003, J ECON ENTOMOL, V96, P1215, DOI 10.1603/0022-0493-96.4.1215; DOWLER EA, 1985, FOOD POLICY, V10, P278, DOI 10.1016/0306-9192(85)90066-1; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Ellis AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114805; Food and Agriculture Organization, 2014, FOOD BAL SHEET DAT; Fox G., 1983, European Review of Agricultural Economics, V10, P325, DOI 10.1093/erae/10.4.325; Gopalan C, 1989, NUTR VALUE INDIAN FO; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Institute for Health Metrics and Evaluation, 2010, GLOB BURD DIS STUD 2; Institute of Nutrition-Mahidol University, 2014, ASEAN FOOD COMP DAT; Joy EJM, 2014, PHYSIOL PLANTARUM, V151, P208, DOI 10.1111/ppl.12144; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; Leung W.-T. W., 1968, FOOD COMPOSITION TAB; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McLellan R, 2014, LIVING PLANET REPORT; Micha R, 2012, EUR J CLIN NUTR, V66, P119, DOI 10.1038/ejcn.2011.147; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Myers SS, 2015, LANCET GLOB HLTH; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pollinator Research Action Plan, 2015, REP POLL HLTH TASK F; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Regan EC, 2015, CONSERV LETT, P1; Smil V., 1987, ENERGY FOOD ENV REAL; Steffan-Dewenter I, 2003, APIDOLOGIE, V34, P227, DOI [10.1051/apdio:2003015, 10.1051/apido:2003015]; van der Zee R, 2014, J APICULT RES, V53, P19, DOI 10.3896/IBRA.1.53.1.02; Whitmee S., 2015, LANCET; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; World Bank, 2012, NUTR MDGS FOOD PRIC, P63	34	105	111	0	105	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					1964	1972		10.1016/S0140-6736(15)61085-6	http://dx.doi.org/10.1016/S0140-6736(15)61085-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW1PI	26188748				2022-12-28	WOS:000364763200031
J	Pinnock, H; Taylor, SJC				Pinnock, Hilary; Taylor, Stephanie J. C.			CASE REVIEW Self management for a man with asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY-OF-LIFE; INTRANASAL CORTICOSTEROIDS; ALLERGIC RHINITIS; INTERVENTIONS; COMMUNITY; OUTCOMES; IMPACT		[Pinnock, Hilary] Univ Edinburgh, Asthma UK Ctr Appl Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh EH8 9AG, Midlothian, Scotland; [Taylor, Stephanie J. C.] Queen Mary Univ, Asthma UK Ctr Appl Res, Ctr Primary Care & Publ Hlth, Barts & London Sch Med & Dent, London, England	University of Edinburgh; University of London; Queen Mary University London	Pinnock, H (corresponding author), Univ Edinburgh, Asthma UK Ctr Appl Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh EH8 9AG, Midlothian, Scotland.	hilary.pinnock@ed.ac.uk	TAYLOR, STEPHANIE/GYV-4768-2022	Taylor, Stephanie/0000-0001-7454-6354	National Institute for Health Research [11/1014/04] Funding Source: researchfish; Asthma UK [AUK-AC-2012-01, 07/047] Funding Source: researchfish; Chief Scientist Office [PCRCA/08/01] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; Chief Scientist Office		Adams N P, 2005, COCHRANE DB SYST REV, V1; Adams NP, 1999, COCHRANE DB SYST REV, V4; Adams NP, 2008, COCHRANE DB SYST REV, V4; [Anonymous], 2014, THORAX, V69, P1; Asthma UK, ACT PLANS; Barbanel D, 2003, THORAX, V58, P851, DOI 10.1136/thorax.58.10.851; Bousquet J, 2008, ARIA ALLERGIC RHINIT; Gibson PG, 2004, THORAX, V59, P94, DOI 10.1136/thorax.2003.011858; GIBSON PG, 2003, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001117; Global Initiative for Asthma, 2014, GLOB STRAT ASTH MAN; Honkoop PJ, 2013, EUR RESPIR J, V41, P53, DOI 10.1183/09031936.00205911; Huckvale K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-144; Kielmann T, 2010, PATIENT EDUC COUNS, V79, P55, DOI 10.1016/j.pec.2009.07.015; Lohia S, 2013, ALLERGY, V68, P569, DOI 10.1111/all.12124; Marcano Belisario Jose S, 2013, Cochrane Database Syst Rev, pCD010013, DOI 10.1002/14651858.CD010013.pub2; Morrison D, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2814; Moudgil H, 2000, THORAX, V55, P177, DOI 10.1136/thorax.55.3.177; National Heart Lung and Blood Institute, 2007, 3 NAEPP; Nokela M, 2010, RESPIRATION, V79, P388, DOI 10.1159/000235548; Nunes V., 2009, MED ADHERENCE INVOLV; Partridge M, IMPERIAL COLL ELECT; Pinnock H, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0361-0; Pinnock H, 2015, CURR OPIN PULM MED, V21, P95, DOI 10.1097/MCP.0000000000000127; Powell H, 2002, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004107; Press VG, 2012, J GEN INTERN MED, V27, P1001, DOI 10.1007/s11606-012-2058-9; Royal College of Physicians, 2014, CONF ENQ REP; Ryan D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1756; Tapp S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003000.pub2; Taylor SJC, 2014, HLTH SERV DELIV RES, V2, P54, DOI DOI 10.3310/HSDR02530; Thoonen BPA, 2003, THORAX, V58, P30, DOI 10.1136/thorax.58.1.30; Weiner JM, 1998, BMJ-BRIT MED J, V317, P1624, DOI 10.1136/bmj.317.7173.1624; Wiener-Ogilvie S, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-32; Wiener-Ogilvie Sharon, 2007, Prim Care Respir J, V16, P369; Wolf FM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000326	34	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2015	351								h3970	10.1136/bmj.h3970	http://dx.doi.org/10.1136/bmj.h3970			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8HZ	26208652				2022-12-28	WOS:000358682400001
J	Kiser, B				Kiser, Barbara			Early child development: Body of knowledge	NATURE			English	Editorial Material																			0	7	9	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					286	287		10.1038/523286a	http://dx.doi.org/10.1038/523286a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM8KY	26178952	Bronze			2022-12-28	WOS:000357950900018
J	Vu, V; Verster, AJ; Schertzberg, M; Chuluunbaatar, T; Spensley, M; Pajkic, D; Hart, GT; Moffat, J; Fraser, AG				Vu, Victoria; Verster, Adrian J.; Schertzberg, Michael; Chuluunbaatar, Tungalag; Spensley, Mark; Pajkic, Djina; Hart, G. Traver; Moffat, Jason; Fraser, Andrew G.			Natural Variation in Gene Expression Modulates the Severity of Mutant Phenotypes	CELL			English	Article							MARFAN-SYNDROME; CYSTIC-FIBROSIS; MODIFIER; RNA; GENOTYPE; IDENTIFY; LINKAGE; ISOLATE	Many mutations cause genetic disorders. However, two people inheriting the same mutation often have different severity of symptoms, and this is partly genetic. The effects of genetic background on mutant phenotypes are poorly understood, but predicting them is critical for personalized medicine. To study this phenomenon comprehensively and systematically, we used RNAi to compare loss-of-function phenotypes for similar to 1,400 genes in two isolates of C. elegans and find that similar to 20% of genes differ in the severity of phenotypes in these two genetic backgrounds. Crucially, this effect of genetic background on the severity of both RNAi and mutant phenotypes can be predicted from variation in the expression levels of the affected gene. This is also true in mammalian cells, suggesting it is a general property of genetic networks. We suggest that differences in the manifestation of mutant phenotypes between individuals are largely the result of natural variation in gene expression.	[Vu, Victoria; Verster, Adrian J.; Schertzberg, Michael; Chuluunbaatar, Tungalag; Spensley, Mark; Hart, G. Traver; Moffat, Jason; Fraser, Andrew G.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Vu, Victoria; Verster, Adrian J.; Schertzberg, Michael; Chuluunbaatar, Tungalag; Spensley, Mark; Pajkic, Djina; Hart, G. Traver; Moffat, Jason; Fraser, Andrew G.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Fraser, AG (corresponding author), Univ Toronto, Donnelly Ctr, 160 Coll St, Toronto, ON M5S 3E1, Canada.	andyfraser.utoronto@gmail.com	Moffat, Jason/AAC-1110-2020	Moffat, Jason/0000-0002-5663-8586; Fraser, Andrew/0000-0001-9939-6014; Hart, Traver/0000-0002-1880-3341; Spensley, Mark/0000-0001-6167-4461	CIHR grant [488367]; NSERC [487143]; OGS; NSERC PGS-D; NSERC CGS-M; NIH Office of Research Infrastructure Programs [P40 OD010440]; NSERC CGS-D; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	CIHR grant(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); OGS(Ontario Graduate Scholarship); NSERC PGS-D(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS-M(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC CGS-D(Natural Sciences and Engineering Research Council of Canada (NSERC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Brent Derry for the generous gift of a worm sorter and Ben Lehner, Jovana Drinjakovic, and Leonid Kruglyak for helpful discussions. This research was primarily supported by a CIHR grant (488367) and also by an NSERC (487143) grant to A.G.F. V.V. was supported by OGS and NSERC PGS-D; A.J.V. was supported by NSERC CGS-M and CGS-D. All strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Antonarakis SE, 2006, NAT REV GENET, V7, P277, DOI 10.1038/nrg1826; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; BRENNER S, 1974, GENETICS, V77, P71; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Dorfman R, 2012, CURR PHARM DESIGN, V18, P674, DOI 10.2174/138161212799315920; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Hamilton BA, 2012, PLOS GENET, V8, P326, DOI 10.1371/journal.pgen.1002644; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hutchinson S, 2003, HUM MOL GENET, V12, P2269, DOI 10.1093/hmg/ddg241; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Maydan JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-62; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Pollard DA, 2013, G3-GENES GENOM GENET, V3, P941, DOI 10.1534/g3.113.005785; Stiernagle Theresa, 2006, WormBook, P1; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7; Vithana EN, 2003, INVEST OPHTH VIS SCI, V44, P4204, DOI 10.1167/iovs.03-0253; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838	25	80	82	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					391	402		10.1016/j.cell.2015.06.037	http://dx.doi.org/10.1016/j.cell.2015.06.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186192	Bronze			2022-12-28	WOS:000358087700018
J	Gordon, KB; Duffin, KC; Bissonnette, R; Prinz, JC; Wasfi, Y; Li, S; Shen, YK; Szapary, P; Randazzo, B; Reich, K				Gordon, Kenneth B.; Duffin, Kristina Callis; Bissonnette, Robert; Prinz, Joerg C.; Wasfi, Yasmine; Li, Shu; Shen, Yaung-Kaung; Szapary, Philippe; Randazzo, Bruce; Reich, Kristian			A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TO-SEVERE PSORIASIS; INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; LONG-TERM EFFICACY; DOUBLE-BLIND; FOLLOW-UP; USTEKINUMAB; MODERATE; SAFETY; THERAPY; CELLS	BACKGROUND Little is known about the effect of specific anti-interleukin-23 therapy, as compared with established anti-tumor necrosis factor therapies, for the treatment of moderate-to-severe plaque psoriasis. METHODS In a 52-week, phase 2, dose-ranging, randomized, double-blind, placebo-controlled, active-comparator trial, we compared guselkumab (CNTO 1959), an anti-interleukin- 23 monoclonal antibody, with adalimumab in patients with moderate-to-severe plaque psoriasis. A total of 293 patients were randomly assigned to receive guselkumab (5 mg at weeks 0 and 4 and every 12 weeks thereafter, 15 mg every 8 weeks, 50 mg at weeks 0 and 4 and every 12 weeks thereafter, 100 mg every 8 weeks, or 200 mg at weeks 0 and 4 and every 12 weeks thereafter) through week 40, placebo, or adalimumab (standard dosage for psoriasis). At week 16, patients in the placebo group crossed over to receive guselkumab at a dose of 100 mg every 8 weeks. The primary end point was the proportion of patients with a Physician's Global Assessment (PGA) score of 0 (indicating cleared psoriasis) or 1 (indicating minimal psoriasis) at week 16. RESULTS At week 16, the proportion of patients with a PGA score of 0 or 1 was significantly higher in each guselkumab group than in the placebo group: 34% in the 5-mg group, 61% in the 15-mg group, 79% in the 50-mg group, 86% in the 100-mg group, and 83% in the 200-mg group, as compared with 7% in the placebo group (P <= 0.002 for all comparisons). Moreover, the proportion was significantly higher in the 50-mg, 100-mg, and 200-mg guselkumab groups than in the adalimumab group (58%) (P<0.05 for all comparisons). At week 16, the proportion of patients with at least a 75% improvement in Psoriasis Area and Severity Index scores was significantly higher in each guselkumab group than in the placebo group (P<0.001 for all comparisons). At week 40, the proportion of patients with a PGA score of 0 or 1 remained significantly higher in the 50-mg, 100-mg, and 200-mg guselkumab groups than in the adalimumab group (71%, 77%, and 81%, respectively, vs. 49%) (P<0.05 for all comparisons). Between week 0 and week 16, infections were observed in 20% of the patients in the guselkumab groups, 12% in the adalimumab group, and 14% in the placebo group. CONCLUSIONS The results of this phase 2 trial suggest that guselkumab may be an effective therapy for plaque psoriasis and that control of psoriasis can be achieved with specific anti-interleukin-23 therapy.	[Gordon, Kenneth B.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA; [Duffin, Kristina Callis] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [Bissonnette, Robert] Innovaderm Res, Montreal, PQ, Canada; [Prinz, Joerg C.] Univ Munich, Dept Dermatol, D-80539 Munich, Germany; [Reich, Kristian] Dermatologikum Hamburg, D-20354 Hamburg, Germany; [Wasfi, Yasmine; Li, Shu; Shen, Yaung-Kaung; Szapary, Philippe; Randazzo, Bruce] Janssen Res & Dev, Spring House, PA USA; [Randazzo, Bruce] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	Northwestern University; Feinberg School of Medicine; Utah System of Higher Education; University of Utah; Innovaderm Research Inc.; University of Munich; Dermatologikum Hamburg; Johnson & Johnson; Janssen Pharmaceuticals; University of Pennsylvania	Reich, K (corresponding author), Dermatologikum Hamburg, Stephanspl 5, D-20354 Hamburg, Germany.	kreich@dermatologikum.de	Prinz, Jörg/AAP-9472-2021		Janssen Research and Development	Janssen Research and Development	Funded by Janssen Research and Development; X-PLORE ClinicalTrials.gov number, NCT01483599.	Benson JM, 2011, MABS-AUSTIN, V3, P535, DOI 10.4161/mabs.3.6.17815; Elloso MM, 2012, J LEUKOCYTE BIOL, V92, P1187, DOI 10.1189/jlb.0212101; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Kimball AB, 2013, J EUR ACAD DERMATOL, V27, P1535, DOI 10.1111/jdv.12046; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Langley RG, 2015, BRIT J DERMATOL, V172, P1371, DOI 10.1111/bjd.13469; Lara-Corrales I, 2011, REV RECENT CLIN TRIA, V6, P36, DOI 10.2174/157488711793980174; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; MAURER W, 1995, BIOMETRIE CHEM PHARM, P3; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McInnes IB, 2013, LANCET, V382, P780, DOI 10.1016/S0140-6736(13)60594-2; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Papp KA, 2013, BRIT J DERMATOL, V168, P844, DOI 10.1111/bjd.12214; Papp KA, 2013, BRIT J DERMATOL, V168, P412, DOI 10.1111/bjd.12110; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Rich P, 2013, BRIT J DERMATOL, V168, P402, DOI 10.1111/bjd.12112; Ritchlin C, 2014, ANN RHEUM DIS, V73, P990, DOI 10.1136/annrheumdis-2013-204655; Sofen H, 2014, J ALLERGY CLIN IMMUN, V133, P1032, DOI 10.1016/j.jaci.2014.01.025; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Viswanathan HN, 2014, J DERMATOL TREAT, P1; Yawalkar N, 2009, J DERMATOL SCI, V54, P99, DOI 10.1016/j.jdermsci.2009.01.003; Zhao YM, 2008, J INVEST DERMATOL, V128, P2190, DOI 10.1038/jid.2008.81	30	222	239	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					136	144		10.1056/NEJMoa1501646	http://dx.doi.org/10.1056/NEJMoa1501646			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3QP	26154787				2022-12-28	WOS:000357598600006
J	Greiner, J; Mazzali, PA; Kann, DA; Kruhler, T; Pian, E; Prentice, S; Olivares, EF; Rossi, A; Klose, S; Taubenberger, S; Knust, F; Afonso, PMJ; Ashall, C; Bolmer, J; Delvaux, C; Diehl, R; Elliott, J; Filgas, R; Fynbo, JPU; Graham, JF; Guelbenzu, AN; Kobayashi, S; Leloudas, G; Savaglio, S; Schady, P; Schmidl, S; Schweyer, T; Sudilovsky, V; Tanga, M; Updike, AC; van Eerten, H; Varela, K				Greiner, Jochen; Mazzali, Paolo A.; Kann, D. Alexander; Kruehler, Thomas; Pian, Elena; Prentice, Simon; Felipe Olivares, E.; Rossi, Andrea; Klose, Sylvio; Taubenberger, Stefan; Knust, Fabian; Afonso, Paulo M. J.; Ashall, Chris; Bolmer, Jan; Delvaux, Corentin; Diehl, Roland; Elliott, Jonathan; Filgas, Robert; Fynbo, Johan P. U.; Graham, John F.; Guelbenzu, Ana Nicuesa; Kobayashi, Shiho; Leloudas, Giorgos; Savaglio, Sandra; Schady, Patricia; Schmidl, Sebastian; Schweyer, Tassilo; Sudilovsky, Vladimir; Tanga, Mohit; Updike, Adria C.; van Eerten, Hendrik; Varela, Karla			A very luminous magnetar-powered supernova associated with an ultra-long gamma-ray burst	NATURE			English	Article							AFTERGLOW; EMISSION	A new class of ultra-long-duration (more than 10,000 seconds) gamma-ray bursts has recently been suggested(1-3). They may originate in the explosion of stars with much larger radii than those producing normal long-duration gamma-ray bursts(3,4) or in the tidal disruption of a star(3). No clear supernova has yet been associated with an ultra-long-duration gamma-ray burst. Here we report that a supernova (SN 2011kl) was associated with the ultra-long-duration gamma-ray burst GRB 111209A, at a redshift z of 0.677. This supernova is more than three times more luminous than type Ic supernovae associated with long-duration gamma-ray bursts(5-7), and its spectrum is distinctly different. The slope of the continuum resembles those of super-luminous supernovae(8,9), but extends further down into the rest-frame ultraviolet implying a low metal content. The light curve evolves much more rapidly than those of super-luminous supernovae. This combination of high luminosity and low metalline opacity cannot be reconciled with typical type Ic supernovae, but can be reproduced by a model where extra energy is injected by a strongly magnetized neutron star (a magnetar), which has also been proposed as the explanation for super-luminous supernovae(10).	[Greiner, Jochen; Kann, D. Alexander; Knust, Fabian; Bolmer, Jan; Delvaux, Corentin; Diehl, Roland; Elliott, Jonathan; Graham, John F.; Savaglio, Sandra; Schady, Patricia; Schweyer, Tassilo; Sudilovsky, Vladimir; Tanga, Mohit; van Eerten, Hendrik; Varela, Karla] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Greiner, Jochen; Kann, D. Alexander] Tech Univ Munich, Excellence Cluster Univ, D-85748 Garching, Germany; [Mazzali, Paolo A.; Prentice, Simon; Ashall, Chris; Kobayashi, Shiho] Liverpool John Moores Univ, Astrophys Res Inst, IC2, Liverpool L3 5RF, Merseyside, England; [Mazzali, Paolo A.; Taubenberger, Stefan] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Kann, D. Alexander; Rossi, Andrea; Klose, Sylvio; Schmidl, Sebastian] Thuringer Landessternwarte Tautenburg, D-07778 Tautenburg, Germany; [Kruehler, Thomas] European So Observ, Santiago 19, Chile; [Pian, Elena; Rossi, Andrea] Inst Space Astrophys & Cosm Phys, INAF, I-40129 Bologna, Italy; [Pian, Elena] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Felipe Olivares, E.] Univ Andres Bello, Dept Ciencias Fis, Santiago, Chile; [Taubenberger, Stefan] European So Observ, D-85748 Garching, Germany; [Afonso, Paulo M. J.] Amer River Coll, Dept Phys & Astron, Sacramento, CA 95841 USA; [Bolmer, Jan; Schweyer, Tassilo] Tech Univ Munich, Phys Dept, D-85748 Garching, Germany; [Elliott, Jonathan; Sudilovsky, Vladimir] Harvard Smithonian Ctr Astrophys, Astrophys Data Syst, Cambridge, MA 02138 USA; [Filgas, Robert] Czech Tech Univ, Inst Expt & Appl Phys, Prague 12800 2, Czech Republic; [Fynbo, Johan P. U.; Leloudas, Giorgos] Univ Copenhagen, DARK Cosmol Ctr, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Leloudas, Giorgos] Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel; [Savaglio, Sandra] Univ Calabria, I-87036 Arcavacata Di Rende, Italy; [Updike, Adria C.] Roger Williams Univ, Bristol, RI 02809 USA	Max Planck Society; Technical University of Munich; Liverpool John Moores University; Max Planck Society; European Southern Observatory; Istituto Nazionale Astrofisica (INAF); Scuola Normale Superiore di Pisa; Universidad Andres Bello; European Southern Observatory; Technical University of Munich; Czech Technical University Prague; University of Copenhagen; Niels Bohr Institute; Weizmann Institute of Science; University of Calabria	Greiner, J (corresponding author), Max Planck Inst Extraterr Phys, Giessenbachstr 1, D-85748 Garching, Germany.	jcg@mpe.mpg.de	Ashall, Chris/AAA-9307-2020; Rossi, Andrea/N-4674-2015; Diehl, Roland/K-4496-2016; Leloudas, Giorgos/E-4470-2015; Fynbo, Johan/L-8496-2014	Ashall, Chris/0000-0002-5221-7557; Rossi, Andrea/0000-0002-8860-6538; Diehl, Roland/0000-0002-8337-9022; Schady, Patricia/0000-0002-1214-770X; Afonso, Paulo Manuel Joao/0000-0003-4508-6664; Bolmer, Jan/0000-0002-3373-0646; Greiner, Jochen/0000-0002-9875-426X; van Eerten, Hendrik/0000-0002-8680-8718; Prentice, Simon/0000-0003-0486-6242; Pian, Elena/0000-0001-8646-4858; Leloudas, Giorgos/0000-0002-8597-0756; Mazzali, Paolo/0000-0001-6876-8284; Kann, David Alexander/0000-0003-2902-3583; Savaglio, Sandra/0000-0003-2354-3238; Olivares E., Felipe/0000-0002-5115-6377; Updike, Adria/0000-0002-3787-1227; Elliott, Jonathan/0000-0001-8043-4965; Kruehler, Thomas/0000-0002-8682-2384; Fynbo, Johan/0000-0002-8149-8298	DFG cluster of excellence "Origin and Structure of the Universe"; Alexander von Humboldt Foundation, Germany; EXTraS from the European Union; DFG; Thuringer Ministerium fur Bildung, Wissenschaft und Kultur; FONDECYT; Czech MEYS; Leibniz-Prize; DNRF; STFC [ST/L00061X/1] Funding Source: UKRI; Science and Technology Facilities Council [1507817, ST/L00061X/1] Funding Source: researchfish	DFG cluster of excellence "Origin and Structure of the Universe"(German Research Foundation (DFG)); Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation); EXTraS from the European Union; DFG(German Research Foundation (DFG)); Thuringer Ministerium fur Bildung, Wissenschaft und Kultur; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Czech MEYS; Leibniz-Prize(German Research Foundation (DFG)); DNRF; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank R. Lunnan and E. Berger for providing the spectrum of PS1-10bzj in digital form, and A. Levan for the HST grism spectra of GRB 111209A. J.G., R.D. and D.A.K. acknowledge support by the DFG cluster of excellence "Origin and Structure of the Universe" (http://www.universe-cluster.de). P.S., J.F.G. and M.T. acknowledge support through the Sofja Kovalevskaja award to P.S. from the Alexander von Humboldt Foundation, Germany. C.D. acknowledges support through EXTraS, funded from the European Union's Seventh Framework Programme for research, technological development and demonstration. S.K., D.A.K. and A.N.G. acknowledge support by DFG. S. Schmidl acknowledges support by the Thuringer Ministerium fur Bildung, Wissenschaft und Kultur. F.O.E. acknowledges support from FONDECYT. S.T. is supported by DFG. R.F. acknowledges support by Czech MEYS. Part of the funding for GROND (both hardware as well as personnel) was generously granted from the Leibniz-Prize to G. Hasinger. DARK is funded by the DNRF.	ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; Arnouts S., 2014, PHARE PHOTOMETRIC AN; Cano Z, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201423920; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Dessart L, 2012, MON NOT R ASTRON SOC, V426, pL76, DOI 10.1111/j.1745-3933.2012.01329.x; Gal-Yam A, 2012, SCIENCE, V337, P927, DOI 10.1126/science.1203601; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Gendre B, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/30; Golenetskii S, 2011, GCN CIRC; Greiner J, 2008, PUBL ASTRON SOC PAC, V120, P405, DOI 10.1086/587032; Hjorth J, 2003, NATURE, V423, P847, DOI 10.1038/nature01750; Hoversten E. A., 2011, GCN CIRC, V12632; Inserra C, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/128; Kasen D, 2010, ASTROPHYS J, V717, P245, DOI 10.1088/0004-637X/717/1/245; Kleiser IKW, 2011, MON NOT R ASTRON SOC, V415, P372, DOI 10.1111/j.1365-2966.2011.18708.x; Kruhler T, 2008, ASTROPHYS J, V685, P376, DOI 10.1086/590240; Kruhler T., 2015, ASTRON ASTR IN PRESS; Leloudas G, 2015, MON NOT R ASTRON SOC, V449, P917, DOI 10.1093/mnras/stv320; Levan AJ, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/13; Lunnan R, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/97; Mazzali PA, 2014, MON NOT R ASTRON SOC, V443, P67, DOI 10.1093/mnras/stu1124; MAZZALI PA, 1993, ASTRON ASTROPHYS, V279, P447; Mazzali PA, 2000, ASTRON ASTROPHYS, V363, P705; Mazzali PA, 2006, NATURE, V442, P1018, DOI 10.1038/nature05081; Mazzali PA, 2013, MON NOT R ASTRON SOC, V432, P2463, DOI 10.1093/mnras/stt605; Nakauchi D, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/67; Perna R, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/119; Poole TS, 2008, MON NOT R ASTRON SOC, V383, P627, DOI 10.1111/j.1365-2966.2007.12563.x; Quataert E, 2012, MON NOT R ASTRON SOC, V419, pL1, DOI 10.1111/j.1745-3933.2011.01151.x; Quimby RM, 2011, NATURE, V474, P487, DOI 10.1038/nature10095; Ryan G, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/3; Sauer DN, 2006, MON NOT R ASTRON SOC, V369, P1939, DOI 10.1111/j.1365-2966.2006.10438.x; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Stanek KZ, 2003, ASTROPHYS J, V591, pL17, DOI 10.1086/376976; Stratta G, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/66; TODY D, 1993, ASTR SOC P, V52, P173; Valenti S, 2008, MON NOT R ASTRON SOC, V383, P1485, DOI 10.1111/j.1365-2966.2007.12647.x; Vernet J, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117752; Virgili FJ, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/54; Vreeswijk PM, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/24; Yaron O, 2012, PUBL ASTRON SOC PAC, V124, P668, DOI 10.1086/666656; Yoldas AK, 2008, AIP CONF PROC, V1000, P227, DOI 10.1063/1.2943450; Zhang BB, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/66	44	182	184	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					189	U316		10.1038/nature14579	http://dx.doi.org/10.1038/nature14579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26156372	Green Accepted, Green Submitted			2022-12-28	WOS:000357695900029
J	Goldberg, TL; Patz, JA				Goldberg, Tony L.; Patz, Jonathan A.			The need for a global health ethic	LANCET			English	Editorial Material									[Goldberg, Tony L.; Patz, Jonathan A.] Univ Wisconsin, Global Hlth Inst, Madison, WI 53706 USA; [Goldberg, Tony L.; Patz, Jonathan A.] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Goldberg, Tony L.] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA; [Patz, Jonathan A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Goldberg, TL (corresponding author), Univ Wisconsin, Global Hlth Inst, Madison, WI 53706 USA.	tgoldberg@vetmed.wisc.edu						Atlas RM, 2013, CURR TOP MICROBIOL, V365, P1, DOI 10.1007/82_2012_223; Fleurbaey M, 2009, J ECON LIT, V47, P1029, DOI 10.1257/jel.47.4.1029; Horton R, 2014, LANCET, V383, P847, DOI 10.1016/S0140-6736(14)60409-8; Leopold A., 1949, SAND COUNTY ALMANAC; Whitmee S., 2015, LANCET	5	11	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2015	386	10007					E37	E39		10.1016/S0140-6736(15)60757-7	http://dx.doi.org/10.1016/S0140-6736(15)60757-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW1PI	26188749				2022-12-28	WOS:000364763200002
J	Muntner, P; Whittle, J; Lynch, AI; Colantonio, LD; Simpson, LM; Einhorn, PT; Levitan, EB; Whelton, PK; Cushman, WC; Louis, GT; Davis, BR; Oparil, S				Muntner, Paul; Whittle, Jeff; Lynch, Amy I.; Colantonio, Lisandro D.; Simpson, Lara M.; Einhorn, Paula T.; Levitan, Emily B.; Whelton, Paul K.; Cushman, William C.; Louis, Gail T.; Davis, Barry R.; Oparil, Suzanne			Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LIPID-LOWERING TREATMENT; LONG-TERM; FOLLOW-UP; CARDIOVASCULAR EVENTS; EUROPEAN LACIDIPINE; REGRESSION DILUTION; RISK-FACTOR; ATHEROSCLEROSIS; ASSOCIATION; FLUCTUATION	Background: Variability of blood pressure (BP) across outpatient visits is frequently dismissed as random fluctuation around a patient's underlying BP. Objective: To examine the association of visit-to-visit variability (VVV) of systolic BP (SBP) and diastolic BP with cardiovascular disease (CVD) and mortality outcomes. Design: Prospective cohort study. Setting: Post hoc analysis of ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). Participants: 25 814 ALLHAT participants. Measurements: The VVV of SBP was defined as the SD across SBP measurements obtained at 7 visits conducted from 6 to 28 months after ALLHAT enrollment. Participants without CVD events during the first 28 months of follow-up were followed from the 28-month visit through the end of active ALLHAT follow-up. Outcomes included fatal coronary heart disease (CHD) or nonfatal myocardial infarction, all-cause mortality, stroke, and heart failure. Results: During follow-up, 1194 fatal CHD or nonfatal MI events, 1948 deaths, 606 strokes, and 921 heart failure events occurred. After multivariable adjustment, including for mean SBP, the hazard ratio comparing participants in the highest versus lowest quintile of SD of SBP (>= 14.4 mm Hg vs. <6.5 mm Hg) was 1.30 (95% CI, 1.06 to 1.59) for fatal CHD or nonfatal MI, 1.58 (CI, 1.32 to 1.90) for all-cause mortality, 1.46 (CI, 1.06 to 2.01) for stroke, and 1.25 (CI, 0.97 to 1.61) for heart failure. Higher VVV of diastolic BP was also associated with CVD events and mortality. Limitation: Long-term outcomes were not available. Conclusion: Higher VVV of SBP is associated with an increased risk for CVD and mortality. Future studies should examine whether reducing VVV of BP lowers this risk.	[Muntner, Paul; Lynch, Amy I.; Levitan, Emily B.; Oparil, Suzanne] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Whittle, Jeff] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53295 USA; [Colantonio, Lisandro D.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Simpson, Lara M.; Davis, Barry R.] Univ Texas Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Einhorn, Paula T.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Whelton, Paul K.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; [Cushman, William C.] Memphis Vet Affairs Med Ctr, Memphis, TN 38104 USA; [Louis, Gail T.] Tulane Univ, Res Off, New Orleans, LA 70118 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tulane University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Tulane University	Muntner, P (corresponding author), Univ Alabama Birmingham, 1700 Univ Blvd,Suite 450, Birmingham, AL 35294 USA.	pmuntner@uab.edu		Colantonio, Lisandro/0000-0001-8742-1788; Levitan, Emily/0000-0002-5429-3852; Whittle, Jeff/0000-0002-9544-838X	National Institutes of Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health.	Andersson OK, 1998, BMJ-BRIT MED J, V317, P167, DOI 10.1136/bmj.317.7152.167; Brickman AM, 2010, ARCH NEUROL-CHICAGO, V67, P564, DOI 10.1001/archneurol.2010.70; Carr MJ, 2012, J HYPERTENS, V30, P1725, DOI 10.1097/HJH.0b013e3283568a73; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Cushman WC, 2008, J CLIN HYPERTENS, V10, P751, DOI 10.1111/j.1751-7176.2008.00015.x; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Di Iorio B, 2012, NEPHROL DIAL TRANSPL, V27, P4404, DOI 10.1093/ndt/gfs328; Diaz KM, 2012, HYPERTENS RES, V35, P55, DOI 10.1038/hr.2011.135; Eguchi K, 2012, AM J HYPERTENS, V25, P962, DOI 10.1038/ajh.2012.75; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Hastie CE, 2013, HYPERTENSION, V62, P698, DOI 10.1161/HYPERTENSIONAHA.113.01343; Hata J, 2013, CIRCULATION, V128, P1325, DOI 10.1161/CIRCULATIONAHA.113.002717; Krakoff LR, 2012, CIRCULATION, V126, P525, DOI 10.1161/CIRCULATIONAHA.112.124750; Lawlor DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017792; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levitan EB, 2013, J HUM HYPERTENS, V27, P589, DOI 10.1038/jhh.2013.19; Levitan EB, 2012, J CLIN HYPERTENS, V14, P744, DOI 10.1111/jch.12005; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mancia G, 2012, CIRCULATION, V126, P569, DOI 10.1161/CIRCULATIONAHA.112.107565; Mancia G, 2012, J HYPERTENS, V30, P1241, DOI 10.1097/HJH.0b013e32835339ac; McMullan CJ, 2013, CLIN J AM SOC NEPHRO, V8, P731, DOI 10.2215/CJN.10131012; Muntner P, 2013, J CLIN HYPERTENS, V15, P112, DOI 10.1111/jch.12037; Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255; Nagai M, 2011, J AM SOC HYPERTENS, V5, P184, DOI 10.1016/j.jash.2011.03.001; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Poortvliet RKE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052438; Pringle E, 2003, J HYPERTENS, V21, P2251, DOI 10.1097/00004872-200312000-00012; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Shimbo D, 2013, AM J HYPERTENS, V26, P896, DOI 10.1093/ajh/hpt040; Shimbo D, 2012, HYPERTENSION, V60, P625, DOI 10.1161/HYPERTENSIONAHA.112.193094; Tozawa M, 1999, NEPHROL DIAL TRANSPL, V14, P1976, DOI 10.1093/ndt/14.8.1976; Yinon L, 2013, PREV MED, V57, P807, DOI 10.1016/j.ypmed.2013.09.006	33	199	203	3	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2015	163	5					329	U42		10.7326/M14-2803	http://dx.doi.org/10.7326/M14-2803			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0OM	26215765	Green Accepted			2022-12-28	WOS:000360296000004
J	Macle, L; Khairy, P; Weerasooriya, R; Novak, P; Verma, A; Willems, S; Arentz, T; Deisenhofer, I; Veenhuyzen, G; Scavee, C; Jais, P; Puererfellner, H; Levesque, S; Andrade, JG; Rivard, L; Guerra, PG; Dubuc, M; Thibault, B; Talajic, M; Roy, D; Nattel, S				Macle, Laurent; Khairy, Paul; Weerasooriya, Rukshen; Novak, Paul; Verma, Atul; Willems, Stephan; Arentz, Thomas; Deisenhofer, Isabel; Veenhuyzen, George; Scavee, Christophe; Jais, Pierre; Puererfellner, Helmut; Levesque, Sylvie; Andrade, Jason G.; Rivard, Lena; Guerra, Peter G.; Dubuc, Marc; Thibault, Bernard; Talajic, Mario; Roy, Denis; Nattel, Stanley		ADVICE Trial Investigators	Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial	LANCET			English	Article							CATHETER ABLATION; RADIOFREQUENCY ABLATION; CONDUCTION; FORCE; RECURRENCE; CONTACT; RECONNECTION; SOCIETY	Background Catheter ablation is increasingly used to manage atrial fibrillation, but arrhythmia recurrences are common. Adenosine might identify pulmonary veins at risk of reconnection by unmasking dormant conduction, and thereby guide additional ablation to improve arrhythmia-free survival. We assessed whether adenosine-guided pulmonary vein isolation could prevent arrhythmia recurrence in patients undergoing radiofrequency catheter ablation for paroxysmal atrial fibrillation. Methods We did this randomised trial at 18 hospitals in Australia, Europe, and North America. We enrolled patients aged older than 18 years who had had at least three symptomatic atrial fibrillation episodes in the past 6 months, and for whom treatment with an antiarrhythmic drug failed. After pulmonary vein isolation, intravenous adenosine was administered. If dormant conduction was present, patients were randomly assigned (1: 1) to additional adenosine-guided ablation to abolish dormant conduction or to no further ablation. If no dormant conduction was revealed, randomly selected patients were included in a registry. Patients were masked to treatment allocation and outcomes were assessed by a masked adjudicating committee. Patients were followed up for 1 year. The primary outcome was time to symptomatic atrial tachyarrhythmia after a single procedure in the intention-to-treat population. The trial is registered with ClinicalTrials.gov, number NCT01058980. Findings Adenosine unmasked dormant pulmonary vein conduction in 284 (53%) of 534 patients. 102 (69.4%) of 147 patients with additional adenosine-guided ablation were free from symptomatic atrial tachyarrhythmia compared with 58 (42.3%) of 137 patients with no further ablation, corresponding to an absolute risk reduction of 27.1% (95% CI 15.9-38.2; p<0.0001) and a hazard ratio of 0.44 (95% CI 0.31-0.64; p<0.0001). Of 115 patients without dormant pulmonary vein conduction, 64 (55.7%) remained free from symptomatic atrial tachyarrhythmia (p=0.0191 vs dormant conduction with no further ablation). Occurrences of serious adverse events were similar in each group. One death (massive stroke) was deemed probably related to ablation in a patient included in the registry. Interpretation Adenosine testing to identify and target dormant pulmonary vein conduction during catheter ablation of atrial fibrillation is a safe and highly effective strategy to improve arrhythmia-free survival in patients with paroxysmal atrial fibrillation. This approach should be considered for incorporation into routine clinical practice.	[Macle, Laurent; Khairy, Paul; Levesque, Sylvie; Andrade, Jason G.; Rivard, Lena; Guerra, Peter G.; Dubuc, Marc; Thibault, Bernard; Talajic, Mario; Roy, Denis; Nattel, Stanley] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Macle, Laurent; Khairy, Paul; Levesque, Sylvie; Andrade, Jason G.; Rivard, Lena; Guerra, Peter G.; Dubuc, Marc; Thibault, Bernard; Talajic, Mario; Roy, Denis; Nattel, Stanley] Univ Montreal, Dept Med, Montreal Hlth Innovat Coordinating Ctr, Montreal, PQ H3C 3J7, Canada; [Weerasooriya, Rukshen] Univ Western Australia, Perth, WA 6009, Australia; [Weerasooriya, Rukshen] Hollywood Private Hosp, Perth, WA, Australia; [Novak, Paul] Royal Jubilee Hosp, Victoria, BC, Canada; [Verma, Atul] Southlake Reg Hlth Ctr, Newmarket, ON, Canada; [Willems, Stephan] Univ Hosp Eppendorf, Hamburg, Germany; [Arentz, Thomas] Herz Zentrum, Bad Krozingen, Germany; [Deisenhofer, Isabel] Deutsch Herz Zentrum Munchen, Munich, Germany; [Veenhuyzen, George] Libin Cardiovasc Inst, Calgary, AB, Canada; [Scavee, Christophe] Clin Univ St Luc, B-1200 Brussels, Belgium; [Jais, Pierre] Hop Haut Leveque, Bordeaux, France; [Puererfellner, Helmut] KH Elisabethinen, Linz, Austria	Universite de Montreal; Universite de Montreal; University of Western Australia; University of Western Australia; Southlake Regional Health Centre; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Heart Centre Munich; Libin Cardiovascular Institute Of Alberta; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; CHU Bordeaux; Ordensklinikum Linz Elisabethinen	Macle, L (corresponding author), Montreal Heart Inst, 5000 Belanger, Montreal, PQ H1T 1C8, Canada.	lmacle@mac.com	Jadidi, Amir/AAY-1683-2021; Macle, laurent/AAA-4675-2021; Andrade, Jason/AAK-5889-2020	Macle, laurent/0000-0002-3328-5239; Andrade, Jason/0000-0002-8493-5123; Nattel, Stanley/0000-0002-5565-3311; rivard, lena/0000-0002-1340-0850; Morillo, Carlos/0000-0002-8739-2099; Essebag, Vidal/0000-0003-0107-5197; Talajic, Mario/0000-0001-8469-4748; Deisenhofer, Isabel/0000-0001-5826-6846	Canadian Institutes of Health Research; St Jude Medical; Biosense-Webster	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); St Jude Medical(St. Jude Medical); Biosense-Webster	We thank Isabelle Robert and Diane David for coordinating the trial, and France Theriault and Antoinette Paolitto for secretarial help. This study was funded by the Canadian Institutes of Health Research with support from St Jude Medical and Biosense-Webster, and a personal contribution from M Lachapelle, Montreal Heart Institute Foundation.	Arentz T, 2004, J CARDIOVASC ELECTR, V15, P1041, DOI 10.1046/j.1540-8167.2004.04031.x; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Datino T, 2011, HEART RHYTHM, V8, P1426, DOI 10.1016/j.hrthm.2011.04.011; Datino T, 2010, CIRCULATION, V121, P963, DOI 10.1161/CIRCULATIONAHA.109.893107; Gula LJ, 2011, J CARDIOVASC ELECTR, V22, P982, DOI 10.1111/j.1540-8167.2011.02037.x; Hachiya H, 2007, J CARDIOVASC ELECTR, V18, P392, DOI 10.1111/j.1540-8167.2006.00753.x; Haldar S, 2013, INT J CARDIOL, V168, P1160, DOI 10.1016/j.ijcard.2012.11.072; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Kuck KH, 2012, HEART RHYTHM, V9, P18, DOI 10.1016/j.hrthm.2011.08.021; Macle L, 2012, CAN J CARDIOL, V28, P184, DOI 10.1016/j.cjca.2011.10.008; Matsuo S, 2007, J CARDIOVASC ELECTR, V18, P704, DOI 10.1111/j.1540-8167.2007.00842.x; Matsuo S, 2010, AM HEART J, V160, P337, DOI 10.1016/j.ahj.2010.05.025; Mclellan AJA, 2013, J CARDIOVASC ELECTR, V24, P742, DOI 10.1111/jce.12121; Miyazaki S, 2012, J CARDIOVASC ELECTR, V23, P256, DOI 10.1111/j.1540-8167.2011.02195.x; Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467; Natale A, 2014, J AM COLL CARDIOL, V64, P647, DOI 10.1016/j.jacc.2014.04.072; Nielsen JC, 2013, NEW ENGL J MED, V368, P478; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Ouyang FF, 2005, CIRCULATION, V111, P127, DOI 10.1161/01.CIR.0000151289.73085.36; Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064; Steven D, 2013, J AM COLL CARDIOL, V62, P44, DOI 10.1016/j.jacc.2013.03.059; Verma A, 2005, CIRCULATION, V112, P627, DOI 10.1161/CIRCULATIONAHA.104.533190; Verma A, 2011, CAN J CARDIOL, V27, P60, DOI 10.1016/j.cjca.2010.11.011; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Willems S, 2010, J CARDIOVASC ELECTR, V21, P1079, DOI 10.1111/j.1540-8167.2010.01773.x; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	27	131	133	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					672	679		10.1016/S0140-6736(15)60026-5	http://dx.doi.org/10.1016/S0140-6736(15)60026-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26211828				2022-12-28	WOS:000359849200034
J	Kang, YY; Zhou, XE; Gao, X; He, YZ; Liu, W; Ishchenko, A; Barty, A; Sathish, D; Yefanov, O; Han, GW; Xu, QP; de Waal, PW; Ke, JY; Tan, MHE; Zhang, CH; Moeller, A; West, GM; Pascal, BD; Van Eps, N; Caro, LN; Vishnivetskiy, SA; Lee, RJ; Suino-Powell, KM; Gu, X; Pal, K; Ma, JM; Zhi, XY; Boutet, S; Williams, GJ; Messerschmidt, M; Gati, C; Zatsepin, NA; Wang, DJ; James, D; Basu, S; Roy-Chowdhury, S; Conrad, CE; Coe, J; Liu, HG; Lisova, S; Kupitz, C; Grotjohann, I; Fromme, R; Jiang, Y; Tan, MJ; Yang, HY; Li, J; Wang, MT; Zheng, Z; Li, DF; Howe, N; Zhao, YM; Standfuss, J; Diederichs, K; Dong, YH; Potter, CS; Carragher, B; Caffrey, M; Jiang, HL; Chapman, HN; Spence, JCH; Fromme, P; Weierstall, U; Ernst, OP; Katritch, V; Gurevich, VV; Griffin, PR; Hubbell, WL; Stevens, RC; Cherezov, V; Melcher, K; Xu, HE				Kang, Yanyong; Zhou, X. Edward; Gao, Xiang; He, Yuanzheng; Liu, Wei; Ishchenko, Andrii; Barty, Anton; Sathish, D.; Yefanov, Oleksandr; Han, Gye Won; Xu, Qingping; de Waal, Parker W.; Ke, Jiyuan; Tan, M. H. Eileen; Zhang, Chenghai; Moeller, Arne; West, Graham M.; Pascal, Bruce D.; Van Eps, Ned; Caro, Lydia N.; Vishnivetskiy, Sergey A.; Lee, Regina J.; Suino-Powell, Kelly M.; Gu, Xin; Pal, Kuntal; Ma, Jinming; Zhi, Xiaoyong; Boutet, Sebastien; Williams, Garth J.; Messerschmidt, Marc; Gati, Cornelius; Zatsepin, Nadia A.; Wang, Dingjie; James, Daniel; Basu, Shibom; Roy-Chowdhury, Shatabdi; Conrad, Chelsie E.; Coe, Jesse; Liu, Haiguang; Lisova, Stella; Kupitz, Christopher; Grotjohann, Ingo; Fromme, Raimund; Jiang, Yi; Tan, Minjia; Yang, Huaiyu; Li, Jun; Wang, Meitian; Zheng, Zhong; Li, Dianfan; Howe, Nicole; Zhao, Yingming; Standfuss, Joerg; Diederichs, Kay; Dong, Yuhui; Potter, Clinton S.; Carragher, Bridget; Caffrey, Martin; Jiang, Hualiang; Chapman, Henry N.; Spence, John C. H.; Fromme, Petra; Weierstall, Uwe; Ernst, Oliver P.; Katritch, Vsevolod; Gurevich, Vsevolod V.; Griffin, Patrick R.; Hubbell, Wayne L.; Stevens, Raymond C.; Cherezov, Vadim; Melcher, Karsten; Xu, H. Eric			Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser	NATURE			English	Article							LIPIDIC CUBIC PHASE; VISUAL ARRESTIN; SPACE-GROUP; PROTEIN; ACTIVATION; BINDING; EXPRESSION; MICROSCOPY; PIGGYBAC; SYSTEM	G-protein-coupled receptors (GPCRs) signal primarily through G proteins or arrestins. Arrestin binding to GPCRs blocks G protein interaction and redirects signalling to numerous G-protein-independent pathways. Here we report the crystal structure of a constitutively active form of human rhodopsin bound to a pre-activated form of the mouse visual arrestin, determined by serial femtosecond X-ray laser crystallography. Together with extensive biochemical and mutagenesis data, the structure reveals an overall architecture of the rhodopsin-arrestin assembly in which rhodopsin uses distinct structural elements, including transmembrane helix 7 and helix 8, to recruit arrestin. Correspondingly, arrestin adopts the pre-activated conformation, with a similar to 20 degrees rotation between the amino and carboxy domains, which opens up a cleft in arrestin to accommodate a short helix formed by the second intracellular loop of rhodopsin. This structure provides a basis for understanding GPCR-mediated arrestin-biased signalling and demonstrates the power of X-ray lasers for advancing the frontiers of structural biology.	[Kang, Yanyong; Zhou, X. Edward; Gao, Xiang; He, Yuanzheng; de Waal, Parker W.; Ke, Jiyuan; Tan, M. H. Eileen; Zhang, Chenghai; Gu, Xin; Pal, Kuntal; Ma, Jinming; Zhi, Xiaoyong; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Ctr Struct Biol & Drug Discovery, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Liu, Wei; Zatsepin, Nadia A.; Wang, Dingjie; James, Daniel; Basu, Shibom; Roy-Chowdhury, Shatabdi; Conrad, Chelsie E.; Coe, Jesse; Liu, Haiguang; Lisova, Stella; Kupitz, Christopher; Grotjohann, Ingo; Fromme, Raimund; Spence, John C. H.; Fromme, Petra; Weierstall, Uwe] Arizona State Univ, Dept Chem & Biochem, Biodesign Inst, Tempe, AZ 85287 USA; [Liu, Wei; Zatsepin, Nadia A.; Wang, Dingjie; James, Daniel; Basu, Shibom; Roy-Chowdhury, Shatabdi; Conrad, Chelsie E.; Coe, Jesse; Liu, Haiguang; Lisova, Stella; Kupitz, Christopher; Grotjohann, Ingo; Fromme, Raimund; Spence, John C. H.; Fromme, Petra; Weierstall, Uwe] Arizona State Univ, Ctr Appl Struct Discovery, Biodesign Inst, Tempe, AZ 85287 USA; [Ishchenko, Andrii; Han, Gye Won; Stevens, Raymond C.; Cherezov, Vadim] Univ So Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA; [Barty, Anton; Sathish, D.; Yefanov, Oleksandr; Gati, Cornelius; Chapman, Henry N.] Deutsch Elektronen Synchrotron DESY, Ctr Free Elect Laser Sci, D-22607 Hamburg, Germany; [Xu, Qingping] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Tan, M. H. Eileen; Li, Jun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Singapore 117595, Singapore; [Moeller, Arne; Potter, Clinton S.; Carragher, Bridget] New York Struct Biol Ctr, Natl Resource Automated Mol Microscopy, New York, NY 10027 USA; [West, Graham M.; Pascal, Bruce D.; Griffin, Patrick R.] Scripps Florida, Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Van Eps, Ned; Hubbell, Wayne L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Van Eps, Ned; Hubbell, Wayne L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Caro, Lydia N.; Ernst, Oliver P.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Vishnivetskiy, Sergey A.; Lee, Regina J.; Suino-Powell, Kelly M.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Boutet, Sebastien; Williams, Garth J.; Messerschmidt, Marc] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Messerschmidt, Marc; Zhao, Yingming] NSF Sci & Technol Ctr, BioXFEL, Buffalo, NY 14203 USA; [Zatsepin, Nadia A.; Wang, Dingjie; James, Daniel; Basu, Shibom; Roy-Chowdhury, Shatabdi; Spence, John C. H.; Weierstall, Uwe] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Liu, Haiguang] Beijing Computat Sci Res Ctr, Beijing 10084, Peoples R China; [Kupitz, Christopher] Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA; [Jiang, Yi; Tan, Minjia; Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Wang, Meitian] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Zheng, Zhong; Katritch, Vsevolod; Stevens, Raymond C.] Univ So Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA; [Li, Dianfan; Howe, Nicole; Caffrey, Martin] Univ Dublin Trinity Coll, Sch Med & Sch Biochem & Immunol, Dublin 2, Ireland; [Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Standfuss, Joerg] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Diederichs, Kay] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Dong, Yuhui] Chinese Acad Sci, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China; [Chapman, Henry N.] Ctr Ultrafast Imaging, D-22761 Hamburg, Germany; [Ernst, Oliver P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China; [Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China	Van Andel Institute; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Southern California; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; National University of Singapore; Scripps Research Institute; State University System of Florida; University of Florida; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Toronto; Vanderbilt University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; National Science Foundation (NSF); NSF - Science and Technology Centers (STCs); Arizona State University; Arizona State University-Tempe; Chinese Academy of Engineering Physics; Beijing Computational Science Research Center (CSRC); University of Wisconsin System; University of Wisconsin Milwaukee; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Southern California; Trinity College Dublin; University of Chicago; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Konstanz; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; University of Toronto; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Xu, HE (corresponding author), Van Andel Res Inst, Ctr Struct Biol & Drug Discovery, Lab Struct Sci, Grand Rapids, MI 49503 USA.	Eric.Xu@vai.org	Zatsepin, Nadia/AAF-2451-2019; Messerschmidt, Marc/F-3796-2010; Stevens, Raymond/K-7272-2015; Barty, Anton/K-5137-2014; Fromme, Raimund/W-5838-2019; Liu, Wei/F-1820-2011; Vishnivetskiy, Sergey/AAJ-8661-2020; Li, Dianfan/AHC-2751-2022; FRS, Henry N Chapman/G-2153-2010; Basu, Shibom/GLU-3308-2022; Messerschmidt, Marc/Y-8929-2019; Melcher, Karsten/AAZ-3861-2020; Cote, Rick H/G-3363-2013; Cherezov, Vadim/L-9812-2013; Fromme, Raimund/C-8885-2012; Han, Gye Won/GLQ-8673-2022; Tan, Minjia/C-4491-2014; Pal, Kuntal/W-6348-2019; Han, Gye Won/GLQ-8724-2022; Han, Gye Won/GLT-1531-2022; Katritch, Vsevolod/Q-8357-2016; Katritch, Vsevolod/Y-2721-2019; Standfuss, Joerg/G-5126-2011; Ma, Jinming/N-3704-2014; Fromme, Raimund/AAG-6578-2019; Xu, H. Eric/ABD-7487-2021; sarkar, sabyasachi/A-9896-2010; Gurevich, Vsevolod/A-3236-2008; de Waal, Parker/M-1138-2017	Messerschmidt, Marc/0000-0002-8641-3302; Stevens, Raymond/0000-0002-4522-8725; Barty, Anton/0000-0003-4751-2727; Fromme, Raimund/0000-0003-4835-1080; Li, Dianfan/0000-0003-4729-4678; FRS, Henry N Chapman/0000-0002-4655-1743; Basu, Shibom/0000-0001-6484-8236; Messerschmidt, Marc/0000-0002-8641-3302; Melcher, Karsten/0000-0002-9125-4027; Cote, Rick H/0000-0002-1573-6526; Cherezov, Vadim/0000-0002-5265-3914; Fromme, Raimund/0000-0003-4835-1080; Tan, Minjia/0000-0002-6784-9653; Han, Gye Won/0000-0003-4107-835X; Katritch, Vsevolod/0000-0003-3883-4505; Ma, Jinming/0000-0002-7171-1059; sarkar, sabyasachi/0000-0002-8954-4375; Gurevich, Vsevolod/0000-0002-3950-5351; He, Yuanzheng/0000-0001-9131-140X; de Waal, Parker/0000-0001-6922-9768; Wang, Meitian/0000-0002-5340-3036; Zatsepin, Nadia/0000-0003-1757-0205; PAL, KUNTAL/0000-0001-7094-2456; Moeller, Arne/0000-0003-1101-5366; liu, haiguang/0000-0001-7324-6632; Dong, Yuhui/0000-0002-4422-4685; Lee, Regina/0000-0001-6091-8057; James, Daniel/0000-0002-8348-6661; Van Eps, Ned/0000-0001-9178-1436; Xu, H. Eric/0000-0002-6829-8144; Caffrey, Martin/0000-0002-2931-4551; Yefanov, Oleksandr/0000-0001-8676-0091	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; National Institutes of Health [P41GM103393]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Federal funds from the National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; Office of Science of the US Department of Energy [DE-AC02-06CH11357]; Jay and Betty Van Andel Foundation, Ministry of Science and Technology (China) [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; Amway (China); National Institute of Health [DK071662, GM073197, GM103310, GM102545, GM104212, EY011500, GM077561, EY005216, P30EY000331]; National Institutes of Health Common Fund in Structural Biology grants [P50 GM073197, P50 GM073210, GM095583]; NSF Science and Technology Center [1231306]; Swiss National Science Foundation [31003A_141235]; Canada Excellence Research Chair program; Anne & Max Tanenbaum Chair in Neuroscience at the University of Toronto; Science Foundation Ireland [12/IA/1255]; Helmholtz Gemeinschaft; DFG Cluster of Excellence Center for Ultrafast Imaging; BMBF [FKZ 05K12CH1]; Irene and Eric Simon Brain Research Foundation; PIER Helmholtz-Graduate School; Helmholtz Association; National Institute of General Medical Sciences PSI: Biology grants [U54 GM094618, GM108635, U54 GM094599, GM097463, U54 GM094586]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209, S10RR027270] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY000331, R01EY005216, R37EY005216, R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066202, R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108635, R01GM104212, U54GM094618, R01GM077561, U54GM094586, R01GM095583, R01GM109955, U54GM094599, P41GM103393, P50GM073197, P50GM073210, R01GM102545, P41GM103310, R01GM097463, R01GM087413] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Federal funds from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Jay and Betty Van Andel Foundation, Ministry of Science and Technology (China); Amway (China); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Common Fund in Structural Biology grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Science and Technology Center(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canada Excellence Research Chair program; Anne & Max Tanenbaum Chair in Neuroscience at the University of Toronto; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Helmholtz Gemeinschaft(Helmholtz Association); DFG Cluster of Excellence Center for Ultrafast Imaging(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Irene and Eric Simon Brain Research Foundation; PIER Helmholtz-Graduate School; Helmholtz Association(Helmholtz Association); National Institute of General Medical Sciences PSI: Biology grants; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this research were carried out at the Linac Coherent Light Source (LCLS) at the SLAC National Accelerator Laboratory. Use of the LCLS at the SLAC National Accelerator Laboratory is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. Parts of the sample injector used at LCLS for this research was funded by the National Institutes of Health, P41GM103393, formerly P41RR001209. We thank staff members of the Life Science Collaborative Access Team (ID-21) of the Advanced Photon Source (APS) for assistance in data collection at the beam lines of sector 21, which is in part funded by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817), and the General Medicine Collaborative Access Team for assistance in data collection at the beam lines of sector 23 (ID-23), funded in part with Federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). Use of APS was supported by the Office of Science of the US Department of Energy, under contract no. DE-AC02-06CH11357. This work was supported in part by the Jay and Betty Van Andel Foundation, Ministry of Science and Technology (China) grants 2012ZX09301001 and 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001, Amway (China), National Institute of Health grants, DK071662 (H.E.X.); GM073197 and GM103310 (C.S.P. and B.C.); GM102545 and GM104212 (K.M.); EY011500 and GM077561 (V.V.G.), EY005216 and P30EY000331 (W.L.H.), the National Institutes of Health Common Fund in Structural Biology grants P50 GM073197 (V.C. and R.C.S.), P50 GM073210 (M.C.), and GM095583 (P.F.); National Institute of General Medical Sciences PSI: Biology grants U54 GM094618 (V.C., V.K., and R.C.S.), GM108635 (V.C.), U54 GM094599 (P.F.), GM097463 (J.S.), and U54 GM094586 (JCSG); NSF Science and Technology Center award 1231306 (J.C.H.S., P.F. and U.W.); Swiss National Science Foundation grant 31003A_141235 (J.S.); the Canada Excellence Research Chair program and the Anne & Max Tanenbaum Chair in Neuroscience at the University of Toronto (O.P.E.); and Science Foundation Ireland, grant 12/IA/1255 (M.C.). Parts of this work were also supported by the Helmholtz Gemeinschaft, the DFG Cluster of Excellence Center for Ultrafast Imaging, and the BMBF project FKZ 05K12CH1 (H.N.C., A.B., C.G., O.Y., T.W.); the Irene and Eric Simon Brain Research Foundation (R.L.). We thank A. Brunger and O. Zeldin for analysing the XFEL data and for advising on refinement; B. Weis for advice on twin refinement and structure validation; J. Rini for advice on the piggyBac expression system; A. Lebedev for his advice regarding the Zanuda program and the choice of the space group; and A. Walker for final editing of the manuscript. C.G. kindly thanks the PIER Helmholtz-Graduate School and the Helmholtz Association for financial support. We also thank the TianHe research and development team of National University of Defense Technology (NUDT) for computational resources.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Arnautova YA, 2011, PROTEINS, V79, P477, DOI 10.1002/prot.22896; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caro LN, 2015, METHOD ENZYMOL, V556, P307, DOI 10.1016/bs.mie.2015.01.005; Chen AH, 1998, CHEM PHYS LIPIDS, V95, P11, DOI 10.1016/S0009-3084(98)00060-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Coin I, 2013, CELL, V155, P1258, DOI 10.1016/j.cell.2013.11.008; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; DUISENBERG AJM, 1992, J APPL CRYSTALLOGR, V25, P92, DOI 10.1107/S0021889891010634; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleissner MR, 2009, PROTEIN SCI, V18, P893, DOI 10.1002/pro.96; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; ICM, 2014, MAN V 3 8; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Kirian RA, 2011, ACTA CRYSTALLOGR A, V67, P131, DOI 10.1107/S0108767310050981; Klein-Seetharaman J, 1999, BIOCHEMISTRY-US, V38, P7938, DOI 10.1021/bi990013t; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Li ZJ, 2013, P NATL ACAD SCI USA, V110, P5004, DOI 10.1073/pnas.1218620110; Lietzow MA, 2004, BIOCHEMISTRY-US, V43, P3137, DOI 10.1021/bi0360962; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Liu W, 2014, NAT PROTOC, V9, P2123, DOI 10.1038/nprot.2014.141; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misquitta LV, 2004, STRUCTURE, V12, P2113, DOI 10.1016/j.str.2004.09.020; Misquitta Y, 2004, J STRUCT BIOL, V148, P169, DOI 10.1016/j.jsb.2004.06.008; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; Ostermaier MK, 2014, P NATL ACAD SCI USA, V111, P1825, DOI 10.1073/pnas.1319402111; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Qiu H, 2000, BIOMATERIALS, V21, P223, DOI 10.1016/S0142-9612(99)00126-X; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Siewert F, 2012, OPT EXPRESS, V20, P4525, DOI 10.1364/OE.20.004525; Smith SO, 2012, BIOCHEM SOC T, V40, P389, DOI 10.1042/BST20110751; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Standfuss J, 2008, J MOL BIOL, V380, P145, DOI 10.1016/j.jmb.2008.04.055; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tickle IJ, 2012, ACTA CRYSTALLOGR D, V68, P454, DOI 10.1107/S0907444911035918; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; West GM, 2013, STRUCTURE, V21, P229, DOI 10.1016/j.str.2012.12.001; White TA, 2013, ACTA CRYSTALLOGR D, V69, P1231, DOI 10.1107/S0907444913013620; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Xu F, 2011, CRYST GROWTH DES, V11, P1193, DOI 10.1021/cg101385e; Zhang HT, 2015, CELL, V161, P833, DOI 10.1016/j.cell.2015.04.011; Zhou XE, 2012, ACTA PHARMACOL SIN, V33, P291, DOI 10.1038/aps.2011.171; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	97	532	539	10	340	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					561	+		10.1038/nature14656	http://dx.doi.org/10.1038/nature14656			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26200343	Green Submitted, Green Accepted			2022-12-28	WOS:000358655200038
J	Tap, WD; Wainberg, ZA; Anthony, SP; Ibrahim, PN; Zhang, C; Healey, JH; Chmielowski, B; Staddon, AP; Cohn, AL; Shapiro, GI; Keedy, VL; Singh, AS; Puzanov, I; Kwak, EL; Wagner, AJ; Von Hoff, DD; Weiss, GJ; Ramanathan, RK; Zhang, J; Habets, G; Zhang, Y; Burton, EA; Visor, G; Sanftner, L; Severson, P; Nguyen, H; Kim, MJ; Marimuthu, A; Tsang, G; Shellooe, R; Gee, C; West, BL; Hirth, P; Nolop, K; van de Rijn, M; Hsu, HH; Peterfy, C; Lin, PS; Tong-Starksen, S; Bollag, G				Tap, W. D.; Wainberg, Z. A.; Anthony, S. P.; Ibrahim, P. N.; Zhang, C.; Healey, J. H.; Chmielowski, B.; Staddon, A. P.; Cohn, A. L.; Shapiro, G. I.; Keedy, V. L.; Singh, A. S.; Puzanov, I.; Kwak, E. L.; Wagner, A. J.; Von Hoff, D. D.; Weiss, G. J.; Ramanathan, R. K.; Zhang, J.; Habets, G.; Zhang, Y.; Burton, E. A.; Visor, G.; Sanftner, L.; Severson, P.; Nguyen, H.; Kim, M. J.; Marimuthu, A.; Tsang, G.; Shellooe, R.; Gee, C.; West, B. L.; Hirth, P.; Nolop, K.; van de Rijn, M.; Hsu, H. H.; Peterfy, C.; Lin, P. S.; Tong-Starksen, S.; Bollag, G.			Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PIGMENTED VILLONODULAR SYNOVITIS; RHEUMATOID-ARTHRITIS; MACROPHAGES; EXPRESSION; TRANSLOCATION; INHIBITION; EFFICACY; IMPROVES; THERAPY; GROWTH	BACKGROUND Expression of the colony-stimulating factor 1 (CSF1) gene is elevated in most tenosynovial giant-cell tumors. This observation has led to the discovery and clinical development of therapy targeting the CSF1 receptor (CSF1R). METHODS Using x-ray co-crystallography to guide our drug-discovery research, we generated a potent, selective CSF1R inhibitor, PLX3397, that traps the kinase in the auto-inhibited conformation. We then conducted a multicenter, phase 1 trial in two parts to analyze this compound. In the first part, we evaluated escalations in the dose of PLX3397 that was administered orally in patients with solid tumors (dose-escalation study). In the second part, we evaluated PLX3397 at the chosen phase 2 dose in an extension cohort of patients with tenosynovial giant-cell tumors (extension study). Pharmacokinetic and tumor responses in the enrolled patients were assessed, and CSF1 in situ hybridization was performed to confirm the mechanism of action of PLX3397 and that the pattern of CSF1 expression was consistent with the pathological features of tenosynovial giant-cell tumor. RESULTS A total of 41 patients were enrolled in the dose-escalation study, and an additional 23 patients were enrolled in the extension study. The chosen phase 2 dose of PLX3397 was 1000 mg per day. In the extension study, 12 patients with tenosynovial giant-cell tumors had a partial response and 7 patients had stable disease. Responses usually occurred within the first 4 months of treatment, and the median duration of response exceeded 8 months. The most common adverse events included fatigue, change in hair color, nausea, dysgeusia, and periorbital edema; adverse events rarely led to discontinuation of treatment. CONCLUSIONS Treatment of tenosynovial giant-cell tumors with PLX3397 resulted in a prolonged regression in tumor volume in most patients.	[Tap, W. D.; Healey, J. H.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Tap, W. D.] Weill Cornell Med Coll, New York, NY USA; [Wainberg, Z. A.; Chmielowski, B.; Singh, A. S.] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA; [Ibrahim, P. N.; Zhang, C.; Zhang, J.; Habets, G.; Zhang, Y.; Burton, E. A.; Visor, G.; Sanftner, L.; Severson, P.; Nguyen, H.; Kim, M. J.; Marimuthu, A.; Tsang, G.; Shellooe, R.; Gee, C.; West, B. L.; Hirth, P.; Nolop, K.; Hsu, H. H.; Lin, P. S.; Tong-Starksen, S.; Bollag, G.] Plexxikon, Berkeley, CA USA; [van de Rijn, M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Anthony, S. P.] Evergreen Hematol & Oncol, Spokane, WA USA; [Staddon, A. P.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Cohn, A. L.] Rocky Mt Canc Ctr, Denver, CO USA; [Shapiro, G. I.; Wagner, A. J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kwak, E. L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Keedy, V. L.; Puzanov, I.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Von Hoff, D. D.; Weiss, G. J.; Ramanathan, R. K.] Scottsdale Healthcare, Virginia G Piper Canc Ctr, Translat Genom Res Inst TGen, Scottsdale, AZ USA; [Peterfy, C.] Spire Sci, Boca Raton, FL USA	Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Plexxikon; Stanford University; University of Pennsylvania; Rocky Mountain Cancer Centers; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Vanderbilt University; Scottsdale Healthcare Osborn; Translational Genomics Research Institute	Tap, WD (corresponding author), Mem Sloan Kettering Canc Ctr, 300 E 66th St,Suite 1001, New York, NY 10065 USA.	tapw@mskcc.org	PUZANOV, IGOR/AAP-2966-2020	PUZANOV, IGOR/0000-0002-9803-3497; Chmielowski, Bartosz/0000-0002-2374-3320; West, Brian/0000-0002-5320-3691; Healey, John/0000-0002-0802-1186; van de Rijn, Matt/0000-0002-1909-9739	Plexxikon; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Plexxikon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Plexxikon; ClinicalTrials.gov number, NCT01004861.	Amber IB, 2013, BMJ CASE REP, V2013; Cassier PA, 2012, CANCER-AM CANCER SOC, V118, P1649, DOI 10.1002/cncr.26409; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Cupp JS, 2007, AM J SURG PATHOL, V31, P970, DOI 10.1097/PAS.0b013e31802b86f8; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Martin RCG, 2000, ONCOL REP, V7, P413; McTigue M, 2012, P NATL ACAD SCI USA, V109, P18281, DOI 10.1073/pnas.1207759109; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Molena B, 2011, CLIN EXP RHEUMATOL, V29, P547; Ostergaard M, 2003, J RHEUMATOL, V30, P1385; Patwardhan PP, 2014, CLIN CANCER RES, V20, P3146, DOI 10.1158/1078-0432.CCR-13-2576; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Prada CE, 2013, ACTA NEUROPATHOL, V125, P159, DOI 10.1007/s00401-012-1056-7; Radi ZA, 2011, AM J PATHOL, V179, P240, DOI 10.1016/j.ajpath.2011.03.029; Ravi V, 2011, CURR OPIN ONCOL, V23, P361, DOI 10.1097/CCO.0b013e328347e1e3; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Rubin BP, 2007, SKELETAL RADIOL, V36, P267, DOI 10.1007/s00256-006-0249-3; Verspoor FGM, 2013, FUTURE ONCOL, V9, P1515, DOI 10.2217/fon.13.124; Walter M, 2007, J MOL BIOL, V367, P839, DOI 10.1016/j.jmb.2007.01.036; Wang XL, 2012, J MED CHEM, V55, P7332, DOI 10.1021/jm300613w; West RB, 2006, P NATL ACAD SCI USA, V103, P690, DOI 10.1073/pnas.0507321103; Xu JY, 2013, CANCER RES, V73, P2782, DOI 10.1158/0008-5472.CAN-12-3981; Zhang C, 2013, P NATL ACAD SCI USA, V110, P5689, DOI 10.1073/pnas.1219457110	23	308	317	6	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2015	373	5					428	437		10.1056/NEJMoa1411366	http://dx.doi.org/10.1056/NEJMoa1411366			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8BO	26222558				2022-12-28	WOS:000358662200006
J	Chen, Y; Peng, R; You, Z				Chen, Yan; Peng, Rui; You, Zhong			Origami of thick panels	SCIENCE			English	Article								Origami patterns, including the rigid origami patterns in which flat inflexible sheets are joined by creases, are primarily created for zero-thickness sheets. In order to apply them to fold structures such as roofs, solar panels, and space mirrors, for which thickness cannot be disregarded, various methods have been suggested. However, they generally involve adding materials to or offsetting panels away from the idealized sheet without altering the kinematic model used to simulate folding. We develop a comprehensive kinematic synthesis for rigid origami of thick panels that differs from the existing kinematic model but is capable of reproducing motions identical to that of zero-thickness origami. The approach, proven to be effective for typical origami, can be readily applied to fold real engineering structures.	[Chen, Yan; Peng, Rui] Tianjin Univ, Sch Mech Engn, Tianjin 300072, Peoples R China; [You, Zhong] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England	Tianjin University; University of Oxford	You, Z (corresponding author), Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England.	zhong.you@eng.ox.ac.uk	Chen, Yan/A-3822-2011	Chen, Yan/0000-0002-4742-6944	Royal Academy of Engineering [1314RECI061]; National Natural Science Foundation of China [51290293, 51422506]; Air Force Office of Scientific Research (RD Project) [134028]; Div Of Civil, Mechanical, & Manufact Inn [1031829] Funding Source: National Science Foundation	Royal Academy of Engineering(Royal Academy of Engineering - UK); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Air Force Office of Scientific Research (RD Project)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was funded by the Royal Academy of Engineering (1314RECI061). Y.C. acknowledges the support of the National Natural Science Foundation of China (Projects 51290293 and 51422506), and Z.Y. acknowledges the support of the Air Force Office of Scientific Research (R&D Project 134028). The authors also thank H. Feng for verifying one of the diagrams.	[Anonymous], 2000, KINEMATICS SPHERICAL; Beggs J. S., 1966, ADV MECH; Bennett G T, 1903, ENGINEERING, V76, P777; Bricard R., 1927, CINEMATIQUE APPL, P7; De Temmerman I. A. N., 2007, INT J SPACE STRUCTUR, V22, P161, DOI DOI 10.1260/026635107782218868; Edmondson Bryce J., 2014, ASME 2014 INT DES EN; Felton S, 2014, SCIENCE, V345, P644, DOI 10.1126/science.1252610; Hagiwara I, 2012, COMM COM INF SC, V326, P259; Hoberman C.S., 1988, Google Patents, Patent No. [US4780344A, 4780344, 4,780,344]; Hull T, 1994, C NUMERANTIUM, V100, P215; Miura K., 1980, P 31 C INT ASTRONAUT, P1; Myard F.E, 1931, B SOC MATH FRANCE, V59, P183, DOI DOI 10.24033/BSMF.1179; Phillips J, 1990, FREEDOM OF MACHINERY, VII; Randlett S., 1963, ART ORIGAMI PAPER FO; Tachi T, 2011, ORIGAMI(5): FIFTH INTERNATIONAL MEETING OF ORIGAMI SCIENCE, MATHEMATICS, AND EDUCATION, P253, DOI 10.1201/b10971-24; You Z., 2012, MOTION STRUCTURES; You Z, 2014, SCIENCE, V345, P623, DOI 10.1126/science.1257841	17	260	286	49	386	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					396	400		10.1126/science.aab2870	http://dx.doi.org/10.1126/science.aab2870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206928				2022-12-28	WOS:000358381400035
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: The "breakthrough" drug that's not been shown to help in Alzheimer's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2015, CHANNEL 4 NEWS  0722; [Anonymous], 2015, BBC NEWS; Hodgekiss A, 2015, DAILY MAIL; Knapton S., 2015, DAILY TELEGRAPH; Liu-Seifert H, 2015, ALZHEIMERS DEMEN JUL	5	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2015	351								h4064	10.1136/bmj.h4064	http://dx.doi.org/10.1136/bmj.h4064			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8HZ	26208710	Bronze			2022-12-28	WOS:000358682400006
J	Wahl, MC; Luhrmann, R				Wahl, Markus C.; Luehrmann, Reinhard			SnapShot: Spliceosome Dynamics II	CELL			English	Editorial Material									[Wahl, Markus C.] Free Univ Berlin, Lab Struct Biochem, D-14195 Berlin, Germany; [Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	Free University of Berlin; Max Planck Society	Wahl, MC (corresponding author), Free Univ Berlin, Lab Struct Biochem, Takustr 6, D-14195 Berlin, Germany.		Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307				Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Turunen JJ, 2013, WIRES RNA, V4, P61, DOI 10.1002/wrna.1141; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	4	24	24	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					456	U254		10.1016/j.cell.2015.06.061	http://dx.doi.org/10.1016/j.cell.2015.06.061			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186196	Green Published, Bronze			2022-12-28	WOS:000358087700025
J	Fisher, P; Ernst, E				Fisher, Peter; Ernst, Edzard			Should doctors recommend homeopathy?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLACEBO-CONTROLLED TRIALS; METAANALYSIS		[Fisher, Peter] Royal London Hosp Integrated Med, Res, London WC1N 3HR, England; [Ernst, Edzard] Univ Exeter, Exeter EX4 4QJ, Devon, England	University of Exeter	Fisher, P (corresponding author), Royal London Hosp Integrated Med, Res, London WC1N 3HR, England.	peter.fisher@uclh.nhs.uk; E.Ernst@exeter.ac.uk						Australian National Health and Medical Research Council, 2015, STAT HOM; Bergemann SM, 2011, HOMEOPATHY HEALTHCAR, P127; Campbell A., 2008, HOMEOPATHY PERSPECTI; Chikramane PS, 2012, LANGMUIR, V28, P15864, DOI 10.1021/la303477s; Ernst E, 2005, TRENDS PHARMACOL SCI, V26, P547, DOI 10.1016/j.tips.2005.09.003; Ernst E, 2002, BRIT J CLIN PHARMACO, V54, P577, DOI 10.1046/j.1365-2125.2002.01699.x; Ernst E., 2014, HOMEOPATHY PROOF CON; Grimaldi-Bensouda L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089990; Haidvogl Max, 2007, BMC Complement Altern Med, V7, P7, DOI 10.1186/1472-6882-7-7; Jacobs J, 2003, PEDIATR INFECT DIS J, V22, P229, DOI 10.1097/00006454-200303000-00005; Kelley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094207; KLEIJNEN J, 1991, BRIT MED J, V302, P316, DOI 10.1136/bmj.302.6772.316; Linde K, 2005, LANCET, V366, P2081, DOI 10.1016/S0140-6736(05)67878-6; Mathie RT, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-142; Riley D, 2001, J ALTERN COMPLEM MED, V7, P149, DOI 10.1089/107555301750164226; Rossignol M, 2012, PHARMACOEPIDEM DR S, V21, P1093, DOI 10.1002/pds.3316; Schmidt K, 2003, VACCINE, V21, P1044, DOI 10.1016/S0264-410X(02)00628-X; Schneider B, 2005, ARZNEIMITTELFORSCH, V55, P23; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; Spence DS, 2005, J ALTERN COMPLEM MED, V11, P793, DOI 10.1089/acm.2005.11.793; Swayne J., 2000, INT DICT HOMEOPATHY; Taylor MA, 2000, BMJ-BRIT MED J, V321, P471, DOI 10.1136/bmj.321.7259.471; Trichard M, 2004, DIS MANAG HEALTH OUT, V12, P419, DOI 10.2165/00115677-200412060-00009; Walach H, 2000, CEPHALALGIA, V20, P835, DOI 10.1046/j.1468-2982.2000.00129.x; Wiesenauer M, 1996, FORSCH KOMPLEMENTMED, V3, P230; Witt C, 2005, COMPLEMENT THER MED, V13, P79, DOI 10.1016/j.ctim.2005.03.005; Witt CM, 2007, COMPLEMENT THER MED, V15, P128, DOI 10.1016/j.ctim.2007.01.011	27	6	6	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2015	351								h3735	10.1136/bmj.h3735	http://dx.doi.org/10.1136/bmj.h3735			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3CU	26173948				2022-12-28	WOS:000358302300002
J	Bakris, GL; Pitt, B; Weir, MR; Freeman, MW; Mayo, MR; Garza, D; Stasiv, Y; Zawadzki, R; Berman, L; Bushinsky, DA				Bakris, George L.; Pitt, Bertram; Weir, Matthew R.; Freeman, Mason W.; Mayo, Martha R.; Garza, Dahlia; Stasiv, Yuri; Zawadzki, Rezi; Berman, Lance; Bushinsky, David A.		AMETHYST-DN Investigators	Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease The AMETHYST-DN Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC HEART-FAILURE; MANAGEMENT; SAFETY; GUIDELINES; INHIBITOR; EFFICACY; SOCIETY; PLACEBO	IMPORTANCE Hyperkalemia is a potentially life-threatening condition predominantly seen in patients treated with renin-angiotensin-aldosterone system (RAAS) inhibitors with stage 3 or greater chronic kidney disease (CKD) who may also have diabetes, heart failure, or both. OBJECTIVES To select starting doses for a phase 3 study and to evaluate the long-term safety and efficacy of a potassium-binding polymer, patiromer, in outpatients with hyperkalemia. DESIGN, SETTING, AND PARTICIPANTS Phase 2, multicenter, open-label, dose-ranging, randomized clinical trial (AMETHYST-DN), conducted at 48 sites in Europe from June 2011 to June 2013 evaluating patiromer in 306 outpatients with type 2 diabetes (estimated glomerular filtration rate, 15 to <60 mL/min/1.73 m(2) and serum potassium level >5.0 mEq/L). All patients received RAAS inhibitors prior to and during study treatment. INTERVENTIONS Patients were stratified by baseline serum potassium level into mild or moderate hyperkalemia groups and received 1 of 3 randomized starting doses of patiromer (4.2 g [n = 74], 8.4 g [n = 74], or 12.6 g [n = 74] twice daily [mild hyperkalemia] or 8.4 g [n = 26], 12.6 g [n = 28], or 16.8 g [n = 30] twice daily [moderate hyperkalemia]). Patiromer was titrated to achieve and maintain serum potassium level 5.0 mEq/L or lower. MAIN OUTCOMES AND MEASURES The primary efficacy end point was mean change in serum potassium level from baseline to week 4 or prior to initiation of dose titration. The primary safety end point was adverse events through 52 weeks. Secondary efficacy end points included mean change in serum potassium level through 52 weeks. RESULTS A total of 306 patients were randomized. The least squares mean reduction from baseline in serum potassium level at week 4 or time of first dose titration in patients with mild hyperkalemia was 0.35 (95% CI, 0.22-0.48) mEq/L for the 4.2 g twice daily starting-dose group, 0.51 (95% CI, 0.38-0.64) mEq/L for the 8.4 g twice daily starting-dose group, and 0.55 (95% CI, 0.42-0.68) mEq/L for the 12.6 g twice daily starting-dose group. In those with moderate hyperkalemia, the reduction was 0.87 (95% CI, 0.60-1.14) mEq/L for the 8.4 g twice daily starting-dose group, 0.97 (95% CI, 0.70-1.23) mEq/L for the 12.6 g twice daily starting-dose group, and 0.92 (95% CI, 0.67-1.17) mEq/L for the 16.8 g twice daily starting-dose group (P<.001 for all changes vs baseline by hyperkalemia starting-dose groups within strata). From week 4 through week 52, statistically significant mean decreases in serum potassium levels were observed at each monthly point in patients with mild and moderate hyperkalemia. Over the 52 weeks, hypomagnesemia (7.2%) was the most common treatment-related adverse event, mild to moderate constipation (6.3%) was the most common gastrointestinal adverse event, and hypokalemia (<3.5 mEq/L) occurred in 5.6% of patients. CONCLUSIONS AND RELEVANCE Among patients with hyperkalemia and diabetic kidney disease, patiromer starting doses of 4.2 to 16.8 g twice daily resulted in statistically significant decreases in serum potassium level after 4 weeks of treatment, lasting through 52 weeks.	[Bakris, George L.] Univ Chicago Med, ASH Comprehens Hypertens Ctr, Div Endocrinol Diabet & Metab, Dept Med, Chicago, IL 60637 USA; [Pitt, Bertram] Univ Michigan, Ann Arbor, MI 48109 USA; [Weir, Matthew R.] Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA; [Freeman, Mason W.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Mayo, Martha R.; Garza, Dahlia; Stasiv, Yuri; Zawadzki, Rezi; Berman, Lance] Relypsa, Redwood City, CA USA; [Bushinsky, David A.] Univ Rochester, Dept Med, Div Nephrol, Rochester, NY USA	University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore; Harvard University; Massachusetts General Hospital; University of Rochester	Bakris, GL (corresponding author), Univ Chicago Med, ASH Comprehens Hypertens Ctr, Div Endocrinol Diabet & Metab, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	gbakris@gmail.com	Rački, Sanjin/H-6237-2013; Weir, Matthew R/ABC-3654-2021	Rački, Sanjin/0000-0002-3736-0929; Weir, Matthew R/0000-0001-8820-5702	Relypsa	Relypsa	This study was sponsored and funded by Relypsa.	Akrimax PharmaceuticalsLLC, 2010, IND PROP HYDR TABL P; Albert NM, 2009, JAMA-J AM MED ASSOC, V302, P1658, DOI 10.1001/jama.2009.1493; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bakris GL, 2000, ARCH INTERN MED, V160, P685, DOI 10.1001/archinte.160.5.685; Bomback AS, 2009, AM J EMERG MED, V27, P753; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Bushinsky DA, 2014, J AM SOC NEPHROL, V25, p669A; Buysse JM, 2012, FUTUR CARDIOL, V8, P17, DOI [10.2217/fca.11.71, 10.2217/FCA.11.71]; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; Harel Z, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.08.016; Hicks KA, 2015, J AM COLL CARDIOL, V66, P403, DOI 10.1016/j.jacc.2014.12.018; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT, V3, pS1; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; Palmer BF, 2004, NEW ENGL J MED, V351, P585, DOI 10.1056/NEJMra035279; Pappoe LS, 2010, DRUG AGING, V27, P87, DOI 10.2165/11316430-000000000-00000; Perazella MA, 1997, J GEN INTERN MED, V12, P646, DOI 10.1046/j.1525-1497.1997.07128.x; Pitt B, 2011, EUR HEART J, V32, P820, DOI 10.1093/eurheartj/ehq502; Roscioni SS, 2012, NAT REV NEPHROL, V8, P691, DOI 10.1038/nrneph.2012.217; Rossignol P, 2014, CIRC-HEART FAIL, V7, P51, DOI 10.1161/CIRCHEARTFAILURE.113.000792; SCHRODER CH, 1993, EUR J PEDIATR, V152, P263, DOI 10.1007/BF01956159; Sterns RH, 2010, J AM SOC NEPHROL, V21, P733, DOI 10.1681/ASN.2010010079; Thomas A, 2009, AM J MED SCI, V337, P305, DOI 10.1097/MAJ.0b013e31818dd715; Trottier V, 2009, CAN J GASTROENTEROL, V23, P689, DOI 10.1155/2009/986524; US Food and Drug Administration (FDA), ASS COL NECR LED US; Vardeny O, 2013, CIRC-HEART FAIL, V6, P970, DOI 10.1161/CIRCHEARTFAILURE.113.000530; Watson M, 2010, CLIN J AM SOC NEPHRO, V5, P1723, DOI 10.2215/CJN.03700410; Weber MA, 2014, J CLIN HYPERTENS, V16, P14, DOI 10.1111/jch.12237; Weinberg JM, 2009, ARCH INTERN MED, V169, P1587, DOI 10.1001/archinternmed.2009.284; Weir MR, 2015, NEW ENGL J MED, V372, P211, DOI 10.1056/NEJMoa1410853; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Yildirim T, 2012, RENAL FAILURE, V34, P1095, DOI 10.3109/0886022X.2012.717478	35	275	280	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					151	161		10.1001/jama.2015.7446	http://dx.doi.org/10.1001/jama.2015.7446			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26172895	Bronze			2022-12-28	WOS:000357867500015
J	Sherman, DH; Tsukamoto, S; Williams, RM				Sherman, David H.; Tsukamoto, Sachiko; Williams, Robert M.			Comment on "Asymmetric syntheses of sceptrin andmassadine and evidence for biosynthetic enantiodivergence"	SCIENCE			English	Editorial Material							FUNCTIONAL-CHARACTERIZATION; SYNTHASES; PARAHERQUAMIDE; METABOLISM; EVOLUTION	Ma et al. (Reports, 10 October 2014, p. 219) report asymmetric syntheses of sceptrin and massadine and, through a stereochemical reassignment, claim to "uncover enantiodivergence as a new biosynthetic paradigm for natural products." We challenge and clarify this claim with relevant examples from the literature of this well-known phenomenon of enantiodivergent congener biosynthesis within the same producing organism.	[Sherman, David H.] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Tsukamoto, Sachiko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan; [Williams, Robert M.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; [Williams, Robert M.] Univ Colorado, Ctr Canc, Aurora, CO 80045 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Kumamoto University; Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus	Williams, RM (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.	robert.williams@colostate.edu	tsukamoto, sachiko/HGE-7770-2022	tsukamoto, sachiko/0000-0002-7993-381X	NATIONAL CANCER INSTITUTE [R01CA070375] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA070375, CA70375] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BADAWI MM, 1983, J PHARM SCI, V72, P1285, DOI 10.1002/jps.2600721112; BIRCH AJ, 1972, TETRAHEDRON, V28, P2999, DOI 10.1016/0040-4020(72)80014-0; BLANCHFLOWER SE, 1993, J ANTIBIOT, V46, P1355, DOI 10.7164/antibiotics.46.1355; Finefield JM, 2012, ANGEW CHEM INT EDIT, V51, P4802, DOI 10.1002/anie.201107204; Greshock TJ, 2008, ANGEW CHEM INT EDIT, V47, P3573, DOI 10.1002/anie.200800106; Keeling CI, 2010, PLANT PHYSIOL, V152, P1197, DOI 10.1104/pp.109.151456; Kwon HJ, 2002, SCIENCE, V297, P1327, DOI 10.1126/science.1073175; Li SY, 2012, MEDCHEMCOMM, V3, P987, DOI 10.1039/c2md20029e; Ma ZQ, 2014, SCIENCE, V346, P219, DOI 10.1126/science.1255677; Okunishi T, 2000, J WOOD SCI, V46, P234, DOI 10.1007/BF00776455; Smith WC, 2000, ANTIMICROB AGENTS CH, V44, P1809, DOI 10.1128/AAC.44.7.1809-1817.2000; Suzuki S, 2002, BIOSCI BIOTECH BIOCH, V66, P1262, DOI 10.1271/bbb.66.1262; Umezawa T., 1997, Wood Research, P62; Zerbe P, 2014, PLANT J, V79, P914, DOI 10.1111/tpj.12589; Zhou K, 2012, PHYTOCHEMISTRY, V84, P47, DOI 10.1016/j.phytochem.2012.08.021	15	7	7	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244								10.1126/science.aaa9349	http://dx.doi.org/10.1126/science.aaa9349			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4OM	26160938	Green Accepted			2022-12-28	WOS:000357664300030
J	Salik, J; Tang, R				Salik, Jonathan; Tang, Randy			Diffuse Soft-Tissue Calcinosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Salik, Jonathan; Tang, Randy] Columbia Univ, New York, NY 10027 USA	Columbia University	Salik, J (corresponding author), Columbia Univ, New York, NY 10027 USA.	jrs2175@columbia.edu		Salik, Jonathan/0000-0002-3796-866X					0	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					E2	E2		10.1056/NEJMicm1412907	http://dx.doi.org/10.1056/NEJMicm1412907			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3QP	26154810				2022-12-28	WOS:000357598600011
J	Crabtree, S; Lowry, D; Tiwari, A; Gittoes, N				Crabtree, Sarah; Lowry, Danielle; Tiwari, Alok; Gittoes, Neil			Difficult access in the anaesthetic room leads to a difficult diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GROWTH-HORMONE; GUIDELINES; MULTICENTER; PASIREOTIDE; MORTALITY; REGISTRY; GHRELIN; PEPTIDE		[Crabtree, Sarah; Lowry, Danielle; Tiwari, Alok; Gittoes, Neil] Queen Elizabeth Hosp, Birmingham B15 2WB, W Midlands, England	University of Birmingham	Crabtree, S (corresponding author), Queen Elizabeth Hosp, Birmingham B15 2WB, W Midlands, England.	sarahcrabtree@doctors.org.uk						Ayuk J, 2004, J CLIN ENDOCR METAB, V89, P1613, DOI 10.1210/jc.2003-031584; Badami KG, 2012, TRANSFUSION MED, V22, P448, DOI 10.1111/j.1365-3148.2012.01203.x; Bassareo PP, 2012, CLIN ENDOCRINOL, V77, P79, DOI 10.1111/j.1365-2265.2011.04325.x; Bates PR, 2008, CLIN ENDOCRINOL, V68, P136, DOI 10.1111/j.1365-2265.2007.03012.x; Ben-Shlomo A, 2006, CLIN DERMATOL, V24, P256, DOI 10.1016/j.clindermatol.2006.04.011; Berne RM, 2000, PRINCIPLES PHYSL; Borlu M, 2012, GROWTH HORM IGF RES, V22, P82, DOI 10.1016/j.ghir.2012.02.006; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Chanson P, 2009, BEST PRACT RES CL EN, V23, P555, DOI 10.1016/j.beem.2009.05.010; Cheng S, 2012, CLIN ENDOCRINOL, V76, P264, DOI 10.1111/j.1365-2265.2011.04180.x; Colao A, 2014, J CLIN ENDOCR METAB, V99, P791, DOI 10.1210/jc.2013-2480; Dekkers OM, 2008, J CLIN ENDOCR METAB, V93, P61, DOI 10.1210/jc.2007-1191; Drange MR, 2000, J CLIN ENDOCR METAB, V85, P168, DOI 10.1210/jc.85.1.168; Gadelha MR, 2014, LANCET DIABETES ENDO, V2, P875, DOI 10.1016/S2213-8587(14)70169-X; Giustina A, 2014, J ENDOCRINOL INVEST, V37, P1017, DOI 10.1007/s40618-014-0146-x; Handelsman Y, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S2.1; Katznelson L, 2001, CLIN ENDOCRINOL, V54, P183, DOI 10.1046/j.1365-2265.2001.01214.x; Khatib N, 2014, J CLIN DIAGN RES, V8, pMC13, DOI 10.7860/JCDR/2014/9863.4767; Melmed S, 2009, J CLIN ENDOCR METAB, V94, P1509, DOI 10.1210/jc.2008-2421; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Petersen OH, 2007, LECT NOTES HUMAN PHY; Petersenn S, 2010, J CLIN ENDOCR METAB, V95, P2781, DOI 10.1210/jc.2009-2272; Raff H., 2011, MED PHYSL SYSTEMS AP, P1; Reid TJ, 2010, CLIN ENDOCRINOL, V72, P203, DOI 10.1111/j.1365-2265.2009.03626.x; Rivoal O, 2000, OPHTHALMOLOGY, V107, P991, DOI 10.1016/S0161-6420(00)00060-9; Rowland N, 2010, NEUROSURG FOCUS, P29; Tannenbaum GS, 2003, ENDOCRINOLOGY, V144, P967, DOI 10.1210/en.2002-220852; Weitz M, 2012, GANONGS REV MED PHYS	28	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2015	351								h3430	10.1136/bmj.h3430	http://dx.doi.org/10.1136/bmj.h3430			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MP	26156143				2022-12-28	WOS:000357955800006
J	Couturaud, F; Sanchez, O; Pernod, G; Mismetti, P; Jego, P; Duhamel, E; Provost, K; Sollier, CBD; Presles, E; Castellant, P; Parent, F; Salaun, PY; Bressollette, L; Nonent, M; Lorillon, P; Girard, P; Lacut, K; Guegan, M; Bosson, JL; Laporte, S; Leroyer, C; Decousus, H; Meyer, G; Mottier, D				Couturaud, Francis; Sanchez, Olivier; Pernod, Gilles; Mismetti, Patrick; Jego, Patrick; Duhamel, Elisabeth; Provost, Karine; Sollier, Claire Bal Dit; Presles, Emilie; Castellant, Philippe; Parent, Florence; Salaun, Pierre-Yves; Bressollette, Luc; Nonent, Michel; Lorillon, Philippe; Girard, Philippe; Lacut, Karine; Guegan, Marie; Bosson, Jean-Luc; Laporte, Silvy; Leroyer, Christophe; Decousus, Herve; Meyer, Guy; Mottier, Dominique		PADIS-PE Investigators	Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism The PADIS-PE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECURRENT VENOUS THROMBOEMBOLISM; INTENSITY WARFARIN THERAPY; DEEP-VEIN THROMBOSIS; LONG-TERM; PREVENTION; GUIDELINES; METAANALYSIS; DABIGATRAN; DIAGNOSIS; DURATION	IMPORTANCE The optimal duration of anticoagulation after a first episode of unprovoked pulmonary embolism is uncertain. OBJECTIVES To determine the benefits and harms of an additional 18-month treatment with warfarin vs placebo, after an initial 6-month nonrandomized treatment period on a vitamin K antagonist. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind trial (treatment period, 18 months; median follow-up, 24 months); 371 adult patients who had experienced a first episode of symptomatic unprovoked pulmonary embolism (ie, with no major risk factor for thrombosis) and had been treated initially for 6 uninterrupted months with a vitamin K antagonist were randomized and followed up between July 2007 and September 2014 in 14 French centers. INTERVENTIONS Warfarin or placebo for 18 months. MAIN OUTCOMES AND MEASURES The primary outcome was the composite of recurrent venous thromboembolism or major bleeding at 18 months after randomization. Secondary outcomes were the composite at 42 months (treatment period plus 24-month follow-up), as well as each component of the composite, and death unrelated to pulmonary embolism or major bleeding, at 18 and 42 months. RESULTS After randomization, 4 patients were lost to follow-up, all after month 18, and 1 withdrew due to an adverse event. During the 18-month treatment period, the primary outcome occurred in 6 of 184 patients (3.3%) in the warfarin group and in 25 of 187 (13.5%) in the placebo group (hazard ratio [HR], 0.22; 95% CI, 0.09-0.55; P = .001). Recurrent venous thromboembolism occurred in 3 patients in the warfarin group and 25 patients in the placebo group (HR, 0.15; 95% CI, 0.05-0.43); major bleeding occurred in 4 patients in the warfarin group and in 1 patient in the placebo group (HR, 3.96; 95% CI, 0.44 to 35.89). During the 42-month entire study period (including the study treatment and follow-up periods), the composite outcome occurred in 33 patients (20.8%) in the warfarin group and in 42 (24.0%) in the placebo group (HR, 0.75; 95% CI, 0.47-1.18). Rates of recurrent venous thromboembolism, major bleeding, and unrelated death did not differ between groups. CONCLUSIONS AND RELEVANCE Among patients with a first episode of unprovoked pulmonary embolism who received 6 months of anticoagulant treatment, an additional 18 months of treatment with warfarin reduced the composite outcome of recurrent venous thrombosis and major bleeding compared with placebo. However, benefit was not maintained after discontinuation of anticoagulation therapy.	[Couturaud, Francis; Lacut, Karine; Guegan, Marie; Laporte, Silvy; Mottier, Dominique] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, Dept Med Interne & Pneumol, Brest, France; [Couturaud, Francis; Lacut, Karine; Guegan, Marie; Leroyer, Christophe; Mottier, Dominique] CIC INSERM 1412, EA 3878, Brest, France; [Couturaud, Francis; Sanchez, Olivier; Pernod, Gilles; Mismetti, Patrick; Jego, Patrick; Duhamel, Elisabeth; Presles, Emilie; Parent, Florence; Salaun, Pierre-Yves; Bressollette, Luc; Nonent, Michel; Girard, Philippe; Lacut, Karine; Guegan, Marie; Bosson, Jean-Luc; Laporte, Silvy; Leroyer, Christophe; Decousus, Herve; Meyer, Guy; Mottier, Dominique] GIRC Thrombose, Paris, France; [Sanchez, Olivier; Meyer, Guy] Hop Europeen Georges Pompidou, AP HP, Serv Pneumol, Paris, France; [Sanchez, Olivier; Meyer, Guy] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Sanchez, Olivier; Meyer, Guy] INSERM, UMR S 970, Paris, France; [Pernod, Gilles] Univ Grenoble 1, CHU Grenoble, Dept Med Vasc, Grenoble, France; [Mismetti, Patrick; Decousus, Herve] Ctr Hosp Univ St Etienne, Unite Pharmacol Clin, Serv Med & Therapeut, St Etienne, France; [Mismetti, Patrick; Decousus, Herve] Univ St Etienne, EA3065, St Etienne, France; [Jego, Patrick] Univ Rennes 1, Ctr Hosp Univ Rennes, Serv Med Interne, Rennes, France; [Duhamel, Elisabeth] Ctr Hosp Gen St Brieuc, Serv Med Interne, St Brieuc, France; [Provost, Karine] Ctr Hosp Gen Lannion, Serv Cardiol, Lannion, France; [Sollier, Claire Bal Dit] Ctr Hosp Univ Lariboisiere, Clin Anticoagulants Ile France CREATIF, Paris, France; [Presles, Emilie; Laporte, Silvy] Ctr Hosp Univ St Etienne, Unite Rech Clin Innovat & Pharmacol, St Etienne, France; [Presles, Emilie; Laporte, Silvy] Univ St Etienne, EA3065, St Etienne, France; [Castellant, Philippe] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, Serv Cardiol, Brest, France; [Castellant, Philippe] Univ Bretagne Occidentale, EA 4324, Brest, France; [Parent, Florence] Ctr Hosp Univ Kremlin Bicetre, Serv Pneumol, Le Kremlin Bicetre, France; [Parent, Florence] Ctr Hosp Univ Kremlin Bicetre, INSERM 999, Le Kremlin Bicetre, France; [Salaun, Pierre-Yves] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, Serv Med Nucl, Brest, France; [Salaun, Pierre-Yves] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, EA 3878, Brest, France; [Bressollette, Luc] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, Serv Echo Doppler Vasc, Brest, France; [Bressollette, Luc] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, EA 3878, CIC INSERM 1412, Brest, France; [Nonent, Michel] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, Serv Radiol, Brest, France; [Nonent, Michel] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, EA 3878, CIC INSERM 1412, Brest, France; [Lorillon, Philippe] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, Pharm Cent, Brest, France; [Girard, Philippe] Inst Mutualiste Montsouris, Dept Thorac, Paris, France; [Bosson, Jean-Luc] Univ Grenoble 1, Ctr Invest Clin, Grenoble, France; [Bosson, Jean-Luc] Univ Grenoble 1, UMR CNRS 5525, Ctr Hosp Univ Grenoble, Grenoble, France	CHU Brest; Universite de Bretagne Occidentale; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU de St Etienne; Universite Jean Monnet; CHU Rennes; Universite de Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne; Universite Jean Monnet; CHU Brest; Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Couturaud, F (corresponding author), CHRU Brest, Hop Cavale Blanche, Dept Med Interne & Pneumol, F-29609 Brest, France.	francis.couturaud@chu-brest.fr	Couturaud, Francis/Q-1366-2019; bosson, jean-luc/AAP-5163-2020; SALAUN, Pierre-Yves/X-6701-2019	Couturaud, Francis/0000-0002-1855-8032; bosson, jean-luc/0000-0003-0967-6026; SALAUN, Pierre-Yves/0000-0002-3899-2135; tromeur, cecile/0000-0001-9161-7521; NONENT, Michel/0000-0002-1317-8997; de Saint-Martin, Luc/0000-0002-6761-0239; SANCHEZ, Olivier/0000-0003-1633-8391; leroyer, christophe/0000-0002-7601-1692; Lacut, Karine/0000-0002-4849-0454; Luc, Bressollette/0000-0002-8354-469X	Programme Hospitalier de Recherche Clinique (French Department of Health); University Hospital of Brest	Programme Hospitalier de Recherche Clinique (French Department of Health); University Hospital of Brest	The study was supported by grants from the Programme Hospitalier de Recherche Clinique (French Department of Health), and the sponsor was the University Hospital of Brest.	Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Baglin T, 2012, J THROMB HAEMOST, V10, P1702, DOI [10.1111/j.1538-7836.2012.04806.x, 10.1111/j.1538-7836.2012.04662.x]; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Boutitie F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3036; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Castellucci LA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5133; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; Kearon C, 2014, BLOOD, V123, P1794, DOI 10.1182/blood-2013-12-512681; Kearon C, 2012, CHEST, V142, P1075, DOI 10.1378/chest.12-1303; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Konstantinides S, 2008, NEW ENGL J MED, V359, P2804, DOI 10.1056/NEJMcp0804570; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI DOI 10.1093/EURHEARTJ/EHU283; Lecumberri R, 2013, THROMB HAEMOSTASIS, V110, P834, DOI 10.1160/TH13-02-0132; LEVINE MN, 1995, THROMB HAEMOSTASIS, V74, P606; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Mismetti P, 2010, J MAL VASCUL, V35, P127, DOI 10.1016/j.jmv.2009.12.002; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; SUDLOW MF, 1992, LANCET, V340, P873; Tapson VF, 2008, NEW ENGL J MED, V358, P1037, DOI 10.1056/NEJMra072753	34	159	169	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					31	40		10.1001/jama.2015.7046	http://dx.doi.org/10.1001/jama.2015.7046			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151264	Bronze			2022-12-28	WOS:000357455900012
J	Page, AE				Page, Alexandra E.			Stopping Time	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									San Diego Kaiser Permanente, La Jolla, CA USA		Page, AE (corresponding author), San Diego Kaiser Permanente, La Jolla, CA USA.	alexe.page@gmail.com							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					27	28		10.1001/jama.2015.1674	http://dx.doi.org/10.1001/jama.2015.1674			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151262				2022-12-28	WOS:000357455900010
J	Duan, CC; Tong, JH; Shang, M; Nikodemski, S; Sanders, M; Ricote, S; Almansoori, A; O'Hayre, R				Duan, Chuancheng; Tong, Jianhua; Shang, Meng; Nikodemski, Stefan; Sanders, Michael; Ricote, Sandrine; Almansoori, Ali; O'Hayre, Ryan			Readily processed protonic ceramic fuel cells with high performance at low temperatures	SCIENCE			English	Article							DOPED BARIUM ZIRCONATE; CONDUCTIVITY; STABILITY; CATHODE	Because of the generally lower activation energy associated with proton conduction in oxides compared to oxygen ion conduction, protonic ceramic fuel cells (PCFCs) should be able to operate at lower temperatures than solid oxide fuel cells (250 degrees to 550 degrees C versus >= 600 degrees C) on hydrogen and hydrocarbon fuels if fabrication challenges and suitable cathodes can be developed. We fabricated the complete sandwich structure of PCFCs directly from raw precursor oxides with only one moderate-temperature processing step through the use of sintering agents such as copper oxide. We also developed a proton-, oxygen-ion-, and electron-hole-conducting PCFC-compatible cathode material, BaCo0.4Fe0.4Zr0.1Y0.1O3-delta (BCFZY0.1), that greatly improved oxygen reduction reaction kinetics at intermediate to low temperatures. We demonstrated high performance from five different types of PCFC button cells without degradation after 1400 hours. Power densities as high as 455 milliwatts per square centimeter at 500 degrees C on H-2 and 142 milliwatts per square centimeter on CH4 were achieved, and operation was possible even at 350 degrees C.	[Duan, Chuancheng; Tong, Jianhua; Shang, Meng; Nikodemski, Stefan; Sanders, Michael; Ricote, Sandrine; O'Hayre, Ryan] Colorado Sch Mines, Golden, CO 80401 USA; [Almansoori, Ali] Petr Inst, Abu Dhabi, U Arab Emirates	Colorado School of Mines; Khalifa University of Science & Technology	Tong, JH (corresponding author), Colorado Sch Mines, 1500 Illinois St, Golden, CO 80401 USA.	jhtongm@gmail.com; rohayre@mines.edu	O'Hayre, Ryan/Q-7496-2019; Ricote, Sandrine/AAF-9543-2021; Tong, Jianhua/C-8324-2016; Sanders, Michael/Q-2477-2018	O'Hayre, Ryan/0000-0003-3762-3052; Ricote, Sandrine/0000-0001-7565-0284; Tong, Jianhua/0000-0002-0684-1658; Sanders, Michael/0000-0001-6366-5219; Almansoori, Ali/0000-0002-0789-5105	Advanced Research Projects Agency-Energy (ARPA-E) under the REBELS program [DE-AR0000493]; National Science Foundation Materials Research Science and Engineering Centers program [DMR-0820518]; Petroleum Institute in Abu Dhabi, United Arab Emirates	Advanced Research Projects Agency-Energy (ARPA-E) under the REBELS program(United States Department of Energy (DOE)); National Science Foundation Materials Research Science and Engineering Centers program(National Science Foundation (NSF)); Petroleum Institute in Abu Dhabi, United Arab Emirates	This work was supported by Advanced Research Projects Agency-Energy (ARPA-E) for funding under the REBELS program (award DE-AR0000493), the National Science Foundation Materials Research Science and Engineering Centers program under grant DMR-0820518, and the Petroleum Institute in Abu Dhabi, United Arab Emirates. This work is related to U.S. Patent application 62/101,285 (2015) and U.S. Patent application 14/621,091 (2015) filed by J. Tong et al. J.T. and R.O'H. developed the intellectual concept, designed all the experiments, and supervised this research. C.D. performed the fabrication and testing experiments of PCFC single cells. M.Sh. synthesized and tested the cathode materials. S.N. identified the copper oxide as an effective sintering aid for solid-state reactive sintering. M.Sa. measured proton concentration in cathode material. S.R. contributed to the preparation of the pastes for the electrolytes and cathode bones. A. A. participated in discussion and analysis of the methane-fueled cell testing. J.T., R.O'H., and C.D. analyzed all experimental data and wrote the paper.	Adams TA, 2013, IND ENG CHEM RES, V52, P3089, DOI 10.1021/ie300996r; Babilo P, 2005, J AM CERAM SOC, V88, P2362, DOI 10.1111/j.1551-2916.2005.00449.x; Babilo P, 2007, J MATER RES, V22, P1322, DOI 10.1557/JMR.2007.0163; Choi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02426; Clark D, 2014, PHYS CHEM CHEM PHYS, V16, P5076, DOI 10.1039/c4cp00468j; Cowin PI, 2011, ADV ENERGY MATER, V1, P314, DOI 10.1002/aenm.201100108; Fabbri E, 2008, SOLID STATE IONICS, V179, P558, DOI 10.1016/j.ssi.2008.04.002; Fabbri E, 2010, CHEM SOC REV, V39, P4355, DOI 10.1039/b902343g; Hashimoto D, 2014, SOLID STATE IONICS, V262, P687, DOI 10.1016/j.ssi.2013.12.029; Hibino T, 2000, SCIENCE, V288, P2031, DOI 10.1126/science.288.5473.2031; Jacobson AJ, 2010, CHEM MATER, V22, P660, DOI 10.1021/cm902640j; Kreuer KD, 2003, ANNU REV MATER RES, V33, P333, DOI 10.1146/annurev.matsci.33.022802.091825; Kreuer KD, 1999, SOLID STATE IONICS, V125, P285, DOI 10.1016/S0167-2738(99)00188-5; Kreuer KD, 2001, SOLID STATE IONICS, V145, P295, DOI 10.1016/S0167-2738(01)00953-5; Lee JG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5045; Luisetto I, 2011, J ELECTROCHEM SOC, V158, pB1368, DOI 10.1149/2.042111jes; Murray EP, 1999, NATURE, V400, P649, DOI 10.1038/23220; Nikodemski S, 2013, SOLID STATE IONICS, V253, P201, DOI 10.1016/j.ssi.2013.09.025; Park SD, 2000, NATURE, V404, P265, DOI 10.1038/35005040; Pergolesi D, 2010, NAT MATER, V9, P846, DOI [10.1038/nmat2837, 10.1038/NMAT2837]; Poetzsch D, 2014, PHYS CHEM CHEM PHYS, V16, P16446, DOI 10.1039/c4cp00459k; Ricote S, 2009, SOLID STATE IONICS, V180, P990, DOI 10.1016/j.ssi.2009.03.016; Shang M, 2013, RSC ADV, V3, P15769, DOI 10.1039/c3ra41828f; Tong JH, 2002, J MEMBRANE SCI, V203, P175, DOI 10.1016/S0376-7388(02)00005-4; Tong JH, 2010, SOLID STATE IONICS, V181, P496, DOI 10.1016/j.ssi.2010.02.008; Yamazaki Y, 2009, CHEM MATER, V21, P2755, DOI 10.1021/cm900208w; Yang L, 2009, SCIENCE, V326, P126, DOI 10.1126/science.1174811	27	712	721	77	910	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2015	349	6254					1321	1326		10.1126/science.aab3987	http://dx.doi.org/10.1126/science.aab3987			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR5CR	26217064				2022-12-28	WOS:000361357700045
J	Munjal, A; Philippe, JM; Munro, E; Lecuit, T				Munjal, Akankshi; Philippe, Jean-Marc; Munro, Edwin; Lecuit, Thomas			A self-organized biomechanical network drives shape changes during tissue morphogenesis	NATURE			English	Article							LIGHT-CHAIN; MYOSIN PHOSPHORYLATION; APICAL CONSTRICTION; NONMUSCLE MYOSIN; DROSOPHILA; DYNAMICS; ACTIN; CONTRACTIONS; CYTOKINESIS; ELONGATION	Tissue morphogenesis is orchestrated by cell shape changes. Forces required to power these changes are generated by non-muscle myosin II (MyoII) motor proteins pulling filamentous actin (F-actin). Actomyosin networks undergo cycles of assembly and disassembly (pulses)(1,2) to cause cell deformations alternating with steps of stabilization to result in irreversible shape changes(3-6). Although this ratchet-like behaviour operates in a variety of contexts, the underlying mechanisms remain unclear. Here we investigate the role of MyoII regulation through the conserved Rho1-Rok pathway(7) during Drosophila melanogaster germband extension. This morphogenetic process is powered by cell intercalation, which involves the shrinkage of junctions in the dorsal-ventral axis (vertical junctions) followed by junction extension in the anterior-posterior axis(8). While polarized flows of medial-apical MyoII pulses deform vertical junctions, MyoII enrichment on these junctions (planar polarity) stabilizes them(6). We identify two critical properties of MyoII dynamics that underlie stability and pulsatility: exchange kinetics governed by phosphorylation-dephosphorylation cycles of the MyoII regulatory light chain; and advection due to contraction of the motors on F-actin networks. Spatial control over MyoII exchange kinetics establishes two stable regimes of high and low dissociation rates, resulting in MyoII planar polarity. Pulsatility emerges at intermediate dissociation rates, enabling convergent advection of MyoII and its upstream regulators Rho1 GTP, Rok and MyoII phosphatase. Notably, pulsatility is not an outcome of an upstream Rho1 pacemaker. Rather, it is a self-organized system that involves positive and negative biomechanical feedback between MyoII advection and dissociation rates.	[Munjal, Akankshi; Philippe, Jean-Marc; Lecuit, Thomas] Aix Marseille Univ, CNRS, IBDM UMR7288, F-13009 Marseille, France; [Munro, Edwin] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Chicago	Lecuit, T (corresponding author), Aix Marseille Univ, CNRS, IBDM UMR7288, F-13009 Marseille, France.	thomas.lecuit@univ-amu.fr			Labex INFORM [ANR-11-LABX-0054]; ANR Archiplast; ERC (Biomecamorph) [323027]; HFSP; Ministere de l'Education nationale; Association pour la Recherche contre le Cancer (ARC); France-BioImaging/PICsL infrastructure [ANR-10-INSB-04-01]	Labex INFORM; ANR Archiplast(French National Research Agency (ANR)); ERC (Biomecamorph); HFSP(Human Frontier Science Program); Ministere de l'Education nationale; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); France-BioImaging/PICsL infrastructure(French National Research Agency (ANR))	We thank M. Rao for useful discussions, and the Lecuit and Lenne groups and the Labex INFORM (ANR-11-LABX-0054) for support and discussions. We are grateful to M. Krahn, A. Martin, V. Mirouse, J. Treisman and J. Zallen for the gift of flies. This work was supported by the ANR Archiplast and the ERC (Biomecamorph #323027) and HFSP (T.L. and E.M.). A. M. was supported by Ministere de l'Education nationale and the Association pour la Recherche contre le Cancer (ARC). We acknowledge the France-BioImaging/PICsL infrastructure (ANR-10-INSB-04-01).	Bardet PL, 2013, DEV CELL, V25, P534, DOI 10.1016/j.devcel.2013.04.020; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Cavey Matthieu, 2008, V420, P219, DOI 10.1007/978-1-59745-583-1_13; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; KARESS RE, 1991, CELL, V65, P1177, DOI 10.1016/0092-8674(91)90013-O; Kasza KE, 2014, P NATL ACAD SCI USA, V111, P11732, DOI 10.1073/pnas.1400520111; Kim HY, 2011, J CELL SCI, V124, P635, DOI 10.1242/jcs.067579; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lee A, 2004, MOL BIOL CELL, V15, P3285, DOI 10.1091/mbc.E04-01-0057; Levayer R, 2013, DEV CELL, V26, P162, DOI 10.1016/j.devcel.2013.06.020; Levayer R, 2012, TRENDS CELL BIOL, V22, P61, DOI 10.1016/j.tcb.2011.10.001; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mason FM, 2013, NAT CELL BIOL, V15, P926, DOI 10.1038/ncb2796; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; NEMOTO Y, 1991, J BIOL CHEM, V266, P19312; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Sen A, 2012, J CELL BIOL, V199, P685, DOI 10.1083/jcb.201206064; Simoes Sde M., 2010, DEV CELL, V19, P377; Simoes Sde M., 2014, J CELL BIOL, V204, P575; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Vasquez CG, 2014, J CELL BIOL, V206, P435, DOI 10.1083/jcb.201402004; Vereshchagina N, 2004, MOL BIOL CELL, V15, P4395, DOI 10.1091/mbc.E04-02-0139; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590	31	210	210	4	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2015	524	7565					351	+		10.1038/nature14603	http://dx.doi.org/10.1038/nature14603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP2NN	26214737				2022-12-28	WOS:000359714000036
J	Kaiser, D				Kaiser, David			History: From blackboards to bombs	NATURE			English	Editorial Material							COLD-WAR; PHYSICISTS		[Kaiser, David] MIT, Phys, Cambridge, MA 02139 USA; [Kaiser, David] MIT, Hist Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kaiser, D (corresponding author), MIT, Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dikaiser@mit.edu	Kaiser, David/C-7149-2014	Kaiser, David/0000-0002-5054-6744				Barnett L., 1949, LIFE, P120; Conant J. B., 1941, CHEM ENG NEWS, V19, P1237; Cope T. D., 1942, AM J PHYS, V10, P266; Galison P., 1997, IMAGE LOGIC MAT CULT; Gordin MD, 2007, FIVE DAYS IN AUGUST: HOW WORLD WAR II BECAME A NUCLEAR WAR, P1; Havighurst R. J., 1943, AM J PHYS, V11, P103; Kaiser D, 2002, HIST STUD PHYS BIOL, V33, P131, DOI 10.1525/hsps.2002.33.1.131; Kaiser D, 2005, REPRESENTATIONS, P28; Kaiser D, 2014, NATURE, V505, P153, DOI 10.1038/505153a; Moore Kelly, 2008, DISRUPTING SCI SOCIA; Schwartz R. P., 2008, THESIS PRINCETON U	11	6	6	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					523	525		10.1038/523523a	http://dx.doi.org/10.1038/523523a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26223611	Bronze			2022-12-28	WOS:000358655200013
J	Evans, S				Evans, Susan			Four legs too many?	SCIENCE			English	Editorial Material							BODY FORM; SNAKE; EVOLUTION		UCL, Dept Cell & Dev Biol, London W1N 8AA, England	University of London; University College London	Evans, S (corresponding author), UCL, Dept Cell & Dev Biol, London W1N 8AA, England.	s.e.evans@ucl.ac.uk	Evans, Susan/C-1888-2008	Evans, Susan/0000-0002-0799-4154				Apesteguia S, 2006, NATURE, V440, P1037, DOI 10.1038/nature04413; Brandley MC, 2008, EVOLUTION, V62, P2042, DOI 10.1111/j.1558-5646.2008.00430.x; Caldwell MW, 1999, ZOOL J LINN SOC-LOND, V125, P115; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Di-Poi N, 2010, NATURE, V464, P99, DOI 10.1038/nature08789; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Head JJ, 2015, PALAEONTOL ELECTRON, V18; Head JJ, 2015, NATURE, V520, P86, DOI 10.1038/nature14042; Martill DM, 2015, SCIENCE, V349, P416, DOI 10.1126/science.aaa9208; Reeder TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118199; Tchernov E, 2000, SCIENCE, V287, P2010, DOI 10.1126/science.287.5460.2010; Woltering JM, 2009, DEV BIOL, V332, P82, DOI 10.1016/j.ydbio.2009.04.031	12	4	4	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					374	375		10.1126/science.aac5672	http://dx.doi.org/10.1126/science.aac5672			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206915				2022-12-28	WOS:000358381400019
J	Lin, DYW; Huang, S; Chen, J				Lin, David Yin-wei; Huang, Shuo; Chen, Jue			Crystal structures of a polypeptide processing and secretion transporter	NATURE			English	Article							NUCLEOTIDE-BINDING DOMAIN; MALTOSE TRANSPORTER; ABC TRANSPORTERS; ATP HYDROLYSIS; STREPTOCOCCUS COMA; PEPTIDASE DOMAIN; PROTEIN; TRANSLOCATION; COMPLEX; CRYSTALLIZATION	Bacteria secrete peptides and proteins to communicate, to poison competitors, and to manipulate host cells. Among the various protein-translocation machineries, the peptidase-containing ATP-binding cassette transporters (PCATs) are appealingly simple. Each PCAT contains two peptidase domains that cleave the secretion signal from the substrate, two transmembrane domains that form a translocation pathway, and two nucleotide-binding domains that hydrolyse ATP. In Gram-positive bacteria, PCATs function both as maturation proteases and exporters for quorum-sensing or antimicrobial polypeptides. In Gram-negative bacteria, PCATs interact with two other membrane proteins to form the type 1 secretion system. Here we present crystal structures of PCAT1 from Clostridium thermocellum in two different conformations. These structures, accompanied by biochemical data, show that the translocation pathway is a large a-helical barrel sufficient to accommodate small folded proteins. ATP binding alternates access to the transmembrane pathway and also regulates the protease activity, thereby coupling substrate processing to translocation.	[Lin, David Yin-wei; Chen, Jue] Rockefeller Univ, Lab Membrane Biol & Biophys, New York, NY 10065 USA; [Lin, David Yin-wei; Huang, Shuo; Chen, Jue] Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute	Chen, J (corresponding author), Rockefeller Univ, Lab Membrane Biol & Biophys, 1230 York Ave, New York, NY 10065 USA.	juechen@rockefeller.edu		Lin, David/0000-0001-6149-5236	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank the staff at the Advance Photon Source GM/CA-CAT and NE-CAT for assistance with data collection, S. McCarry for editing the manuscript, R. MacKinnon and D. Kearns for helpful discussions, M. L. Oldham for help with figure preparation, and H. Zhang and W. Mi for efforts in the early stage of this project. This work was supported by the Howard Hughes Medical Institute.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; DeLano WL, 2002, PYMOL USERS MANUAL; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gebhard S, 2012, MOL MICROBIOL, V86, P1295, DOI 10.1111/mmi.12078; GENTSCHEV I, 1992, MOL GEN GENET, V232, P40, DOI 10.1007/BF00299135; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Ishii S, 2006, J BIOL CHEM, V281, P4726, DOI 10.1074/jbc.M512516200; Ishii S, 2013, BIOCHEMISTRY-US, V52, P2545, DOI 10.1021/bi3017069; Ishii S, 2010, J BIOL CHEM, V285, P10777, DOI 10.1074/jbc.M109.093781; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Koronakis V, 1993, Semin Cell Biol, V4, P7, DOI 10.1006/scel.1993.1002; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Lecher J, 2012, STRUCTURE, V20, P1778, DOI 10.1016/j.str.2012.08.005; Lenders MHH, 2013, BIOL CHEM, V394, P1371, DOI 10.1515/hsz-2013-0171; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rice AJ, 2014, CRIT REV BIOCHEM MOL, V49, P426, DOI 10.3109/10409238.2014.953626; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; SISSONS CH, 1987, APPL ENVIRON MICROB, V53, P832, DOI 10.1128/AEM.53.4.832-838.1987; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tao X, 2008, J MOL BIOL, V382, P24, DOI 10.1016/j.jmb.2008.06.085; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Ujwal R, 2012, JOVE-J VIS EXP, DOI 10.3791/3383; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wu KH, 2004, J BIOL CHEM, V279, P901, DOI 10.1074/jbc.M308296200; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	54	77	77	4	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					425	U92		10.1038/nature14623	http://dx.doi.org/10.1038/nature14623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26201595				2022-12-28	WOS:000358378900029
J	Whelan, TJ; Olivotto, IA; Parulekar, WR; Ackerman, I; Chua, BH; Nabid, A; Vallis, KA; White, JR; Rousseau, P; Fortin, A; Pierce, LJ; Manchul, L; Chafe, S; Nolan, MC; Craighead, P; Bowen, J; McCready, DR; Pritchard, KI; Gelmon, K; Murray, Y; Chapman, JAW; Chen, BSE; Levine, MN				Whelan, Timothy J.; Olivotto, Ivo A.; Parulekar, Wendy R.; Ackerman, Ida; Chua, Boon H.; Nabid, Abdenour; Vallis, Katherine A.; White, Julia R.; Rousseau, Pierre; Fortin, Andre; Pierce, Lori J.; Manchul, Lee; Chafe, Susan; Nolan, Maureen C.; Craighead, Peter; Bowen, Julie; McCready, David R.; Pritchard, Kathleen I.; Gelmon, Karen; Murray, Yvonne; Chapman, Judy-Anne W.; Chen, Bingshu E.; Levine, Mark N.		MA 20 Study Investigators	Regional Nodal Irradiation in Early-Stage Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CLINICAL-TRIAL; INTERNAL MAMMARY; HIGH-RISK; POSTMASTECTOMY RADIOTHERAPY; POSTOPERATIVE RADIOTHERAPY; AXILLARY DISSECTION; PREMENOPAUSAL WOMEN; COOPERATIVE-GROUP; MASTECTOMY; CHEMOTHERAPY	BACKGROUND Most women with breast cancer who undergo breast-conserving surgery receive whole-breast irradiation. We examined whether the addition of regional nodal irradiation to whole-breast irradiation improved outcomes. METHODS We randomly assigned women with node-positive or high-risk node-negative breast cancer who were treated with breast-conserving surgery and adjuvant systemic therapy to undergo either whole-breast irradiation plus regional nodal irradiation (including internal mammary, supraclavicular, and axillary lymph nodes) (nodal-irradiation group) or whole-breast irradiation alone (control group). The primary outcome was overall survival. Secondary outcomes were disease-free survival, isolated locoregional disease-free survival, and distant disease-free survival. RESULTS Between March 2000 and February 2007, a total of 1832 women were assigned to the nodal-irradiation group or the control group (916 women in each group). The median follow-up was 9.5 years. At the 10-year follow-up, there was no significant between-group difference in survival, with a rate of 82.8% in the nodal-irradiation group and 81.8% in the control group (hazard ratio, 0.91; 95% confidence interval [CI], 0.72 to 1.13; P = 0.38). The rates of disease-free survival were 82.0% in the nodal-irradiation group and 77.0% in the control group (hazard ratio, 0.76; 95% CI, 0.61 to 0.94; P = 0.01). Patients in the nodal-irradiation group had higher rates of grade 2 or greater acute pneumonitis (1.2% vs. 0.2%, P = 0.01) and lymphedema (8.4% vs. 4.5%, P = 0.001). CONCLUSIONS Among women with node-positive or high-risk node-negative breast cancer, the addition of regional nodal irradiation to whole-breast irradiation did not improve overall survival but reduced the rate of breast-cancer recurrence.	[Whelan, Timothy J.; Levine, Mark N.] McMaster Univ, Dept Oncol, Hamilton, ON, Canada; [Whelan, Timothy J.; Levine, Mark N.] Juravinski Canc Ctr, Hamilton, ON, Canada; [Olivotto, Ivo A.; Craighead, Peter] Tom Baker Canc Clin, Calgary, AB, Canada; [Olivotto, Ivo A.] BC Canc Agcy, Vancouver Isl Ctr, Victoria, BC, Canada; [Parulekar, Wendy R.; Murray, Yvonne; Chapman, Judy-Anne W.; Chen, Bingshu E.] Queens Univ, Kingston, ON, Canada; [Parulekar, Wendy R.; Murray, Yvonne; Chapman, Judy-Anne W.; Chen, Bingshu E.] NCIC Clin Trials Grp, Kingston, ON, Canada; [Ackerman, Ida; Pritchard, Kathleen I.] Univ Toronto, Toronto, ON, Canada; [Ackerman, Ida; Pritchard, Kathleen I.] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada; [Nabid, Abdenour] Fleurimont Hosp, Ctr Univ Sherbrooke, Sherbrooke, PQ, Canada; [Rousseau, Pierre] Univ Montreal, Montreal, PQ, Canada; [Fortin, Andre] Univ Laval, Quebec City, PQ, Canada; [Fortin, Andre] Hotel Dieu Quebec, Quebec City, PQ, Canada; [Manchul, Lee; McCready, David R.] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Chafe, Susan] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Nolan, Maureen C.] Nova Scotia Canc Ctr, Halifax, NS, Canada; [Bowen, Julie] Northeastern Ontario Reg Canc Ctr, Sudbury, ON, Canada; [Gelmon, Karen] BC Canc Agcy, Vancouver Ctr, Vancouver, BC, Canada; [Chua, Boon H.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Vallis, Katherine A.] Canc Res UK, MRC, Oxford Inst Radiat Oncol, Oxford, England; [White, Julia R.] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Pierce, Lori J.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	McMaster University; McMaster University; Tom Baker Cancer Clinic; University of Calgary; British Columbia Cancer Agency; Queens University - Canada; Queens University - Canada; Canadian Cancer Trials Group; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Universite de Montreal; Laval University; Laval University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Alberta; British Columbia Cancer Agency; Peter Maccallum Cancer Center; Cancer Research UK; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan	Whelan, TJ (corresponding author), Hamilton Hlth Sci, Juravinski Canc Ctr, 699 Concess St,Rm 4-204, Hamilton, ON L8V 5C2, Canada.	twhelan@hhsc.ca	Whelan, Timothy/D-3185-2017; Falkson, Conrad/N-2681-2018; Evans, Diane/F-9258-2017; Lambert, Colin/A-7025-2009	Whelan, Timothy/0000-0001-9844-2023; Falkson, Conrad/0000-0001-8959-3807; Lambert, Colin/0000-0003-2332-9610; Lavertu, Sophie/0000-0001-6788-8292; Vallis, Katherine/0000-0003-4672-5683; Delaney, Geoff/0000-0002-1829-396X; Chen, Bingshu/0000-0001-6139-0696; Spry, Nigel/0000-0001-8659-5065	Canadian Cancer Society Research Institute; Cancer Research UK [11564] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U10CA032102, U10CA077202, U10CA027057] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the Canadian Cancer Society Research Institute and others; MA.20 ClinicalTrials.gov number, NCT00005957.	Ceilley E, 2005, INT J RADIAT ONCOL, V61, P365, DOI 10.1016/j.ijrobp.2004.05.069; Clark RM, 1996, J NATL CANCER I, V88, P1659, DOI 10.1093/jnci/88.22.1659; Cook RJ, 1996, J ROY STAT SOC A STA, V159, P93, DOI 10.2307/2983471; FISHER B, 1985, NEW ENGL J MED, V312, P665, DOI 10.1056/NEJM198503143121101; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Hojris I, 2000, ACTA ONCOL, V39, P355, DOI 10.1080/028418600750013131; Huang O, 2008, BREAST CANCER RES TR, V107, P379, DOI 10.1007/s10549-007-9561-4; Kyndi M, 2008, J CLIN ONCOL, V26, P1419, DOI 10.1200/JCO.2007.14.5565; Mamounas EP, 2010, J CLIN ONCOL, V28, P1677, DOI 10.1200/JCO.2009.23.7610; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Poortmans PM, 2015, NEW ENGL J MED, V373, P317, DOI 10.1056/NEJMoa1415369; Ragaz J, 1997, NEW ENGL J MED, V337, P956, DOI 10.1056/NEJM199710023371402; RECHT A, 1988, INT J RADIAT ONCOL, V14, P477, DOI 10.1016/0360-3016(88)90263-5; Veronesi U, 2008, ANN ONCOL, V19, P1553, DOI 10.1093/annonc/mdn183; VERONESI U, 1993, NEW ENGL J MED, V328, P1587, DOI 10.1056/NEJM199306033282202; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Whelan TJ, 2011, J CLIN ONCOL S	21	725	755	3	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					307	316		10.1056/NEJMoa1415340	http://dx.doi.org/10.1056/NEJMoa1415340			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3NL	26200977	Green Accepted			2022-12-28	WOS:000358333500004
J	Bargmann, CI				Bargmann, Cornelia I.			How the New Neuroscience Will Advance Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AXON REGENERATION; DISCOVERY; CELLS		[Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Bargmann, CI (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	cori@rockefeller.edu		Bargmann, Cornelia/0000-0002-8484-0618	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; DeLong MR, 2014, JAMA-J AM MED ASSOC, V312, P1093, DOI 10.1001/jama.2014.11132; Dunnett SB, 2014, NEUROBIOL DIS, V61, P79, DOI 10.1016/j.nbd.2013.05.004; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hormozdiari F, 2015, GENOME RES, V25, P142, DOI 10.1101/gr.178855.114; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601	10	7	7	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					221	222		10.1001/jama.2015.3298	http://dx.doi.org/10.1001/jama.2015.3298			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197178				2022-12-28	WOS:000358228000010
J	DeFries, R; Fanzo, J; Remans, R; Palm, C; Wood, S; Anderman, TL				DeFries, Ruth; Fanzo, Jessica; Remans, Roseline; Palm, Cheryl; Wood, Stephen; Anderman, Tal L.			GLOBAL NUTRITION Metrics for land-scarce agriculture	SCIENCE			English	Editorial Material							FOOD SECURITY; DIETS		[DeFries, Ruth; Wood, Stephen] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Fanzo, Jessica] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Remans, Roseline; Palm, Cheryl; Wood, Stephen] Columbia Univ, Agr & Food Secur Ctr, Earth Inst, New York, NY USA; [Remans, Roseline] Biovers Int, Addis Ababa, Ethiopia; [Anderman, Tal L.] Environm Def Fund, San Francisco, CA USA	Columbia University; Columbia University; Columbia University; Alliance; Bioversity International; Environmental Defense Fund	DeFries, R (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	rd2402@columbia.edu	Fanzo, Jessica/HCH-3533-2022; Wood, Stephen/A-1928-2017	Wood, Stephen/0000-0002-9551-8165; Fanzo, Jessica/0000-0002-6760-1359				Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Carrasco LR, 2014, SCIENCE, V346, P38, DOI 10.1126/science.1256685; Cassidy ES, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034015; de Pee S, 2009, FOOD NUTR BULL, V30, pS434, DOI 10.1177/15648265090303S305; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Godfray HCJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0273; International Food Policy Research Institute, 2014, GLOB NUTR REP 2014 A; Jobbagy EG, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084014; Myers SS, 2014, NATURE, V510, P139, DOI 10.1038/nature13179; Palm CA, 2010, P NATL ACAD SCI USA, V107, P19661, DOI 10.1073/pnas.0912248107; Remans R., 2014, FOOD SECUR, V3, P174; Smil V, 2002, AMBIO, V31, P126, DOI 10.1639/0044-7447(2002)031[0126:NAFPPF]2.0.CO;2; Stevenson JR, 2013, P NATL ACAD SCI USA, V110, P8363, DOI 10.1073/pnas.1208065110; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; United Nations, 2019, WORLD FERT TRENDS OU; West PC, 2014, SCIENCE, V345, P325, DOI 10.1126/science.1246067	16	125	125	3	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		238	240		10.1126/science.aaa5766	http://dx.doi.org/10.1126/science.aaa5766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185232				2022-12-28	WOS:000358218600023
J	Kupferschmidt, K				Kupferschmidt, Kai			GLOBAL HEALTH Report prescribes strong medicine for WHO	SCIENCE			English	News Item																			0	2	2	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		223	224		10.1126/science.349.6245.223	http://dx.doi.org/10.1126/science.349.6245.223			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185223				2022-12-28	WOS:000358218600014
J	Gunderson, JG				Gunderson, John G.			Reducing Suicide Risk in Borderline Personality Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIALECTICAL BEHAVIOR-THERAPY	IMPORTANCE Dialectical behavior therapy (DBT) is an empirically supported treatment for suicidal individuals. However, DBT consists of multiple components, including individual therapy, skills training, telephone coaching, and a therapist consultation team, and little is known about which components are needed to achieve positive outcomes. OBJECTIVE To evaluate the importance of the skills training component of DBT by comparing skills training plus case management (DBT-S), DBT individual therapy plus activities group (DBT-I), and standard DBT which includes skills training and individual therapy. DESIGN, SETTING, AND PARTICIPANTS We performed a single-blind randomized clinical trial from April 24, 2004, through January 26, 2010, involving 1 year of treatment and 1 year of follow-up. Participants included 99 women (mean age, 30.3 years; 69 [71%] white) with borderline personality disorder who had at least 2 suicide attempts and/or nonsuicidal self-injury (NSSI) acts in the last 5 years, an NSSI act or suicide attempt in the 8 weeks before screening, and a suicide attempt in the past year. We used an adaptive randomization procedure to assign participants to each condition. Treatment was delivered from June 3, 2004, through September 29, 2008, in a university-affiliated clinic and community settings by therapists or case managers. Outcomes were evaluated quarterly by blinded assesssors. We hypothesized that standard DBT would outperform DBT-S and DBT-I. INTERVENTIONS The study compared standard DBT, DBT-S, and DBT-I. Treatment dose was controlled across conditions, and all treatment providers used the DBT suicide risk assessment and management protocol. MAIN OUTCOMES AND MEASURES Frequency and severity of suicide attempts and NSSI episodes. RESULTS All treatment conditions resulted in similar improvements in the frequency and severity of suicide attempts, suicide ideation, use of crisis services due to suicidality, and reasons for living. Compared with the DBT-I group, interventions that included skills training resulted in greater improvements in the frequency of NSSI acts (F-1,F-85 = 59.1 [P<.001] for standard DBT and F-1,F-85 = 56.3[P<.001] for DBT-S) and depression (t(399) = 1.8 [P=.03] for standard DBT and t(399) = 2.9[P=.004] forDBT-S) during the treatment year. In addition, anxiety significantly improved during the treatment year in standard DBT (t(94) = -3.5 [P<.001]) and DBT-S (t(94) = -2.6[P=.01]), but not in DBT-I. Compared with the DBT-I group, the standard DBT group had lower dropout rates from treatment (8 patients [24%] vs 16 patients [48%] [P=.04]), and patientswere less likely to use crisis services in follow-up (ED visits, 1 [3%] vs 3 [13%] [P=.02]; psychiatric hospitalizations, 1 [3%] vs 3 [13%] [P=.03]). CONCLUSIONS AND RELEVANCE A variety of DBT interventions with therapists trained in the DBT suicide risk assessment and management protocol are effective for reducing suicide attempts and NSSI episodes. Interventions that include DBT skills training are more effective than DBT without skills training, and standard DBT may be superior in some areas.	[Gunderson, John G.] Harvard Univ, Sch Med, Boston, MA USA; [Gunderson, John G.] McLean Hosp, Psychosocial Res, 115 Mill St, Belmont, MA 02478 USA; [Gunderson, John G.] McLean Hosp, Borderline Personal Disorder Ctr, Belmont, MA 02478 USA	Harvard University; Harvard Medical School; Harvard University; McLean Hospital; Harvard University; McLean Hospital	Gunderson, JG (corresponding author), McLean Hosp, Psychosocial Res, 115 Mill St, Belmont, MA 02478 USA.	jgunderson@mclean.harvard.edu						Bateman A, 1999, AM J PSYCHIAT, V156, P1563, DOI 10.1176/ajp.156.10.1563; Carmel A, 2014, COMMUNITY MENT HLT J, V50, P25, DOI 10.1007/s10597-013-9679-2; Chanen AM, 2008, BRIT J PSYCHIAT, V193, P477, DOI 10.1192/bjp.bp.107.048934; Clarkin JF, 2007, AM J PSYCHIAT, V164, P922, DOI 10.1176/appi.ajp.164.6.922; COWDRY RW, 1988, ARCH GEN PSYCHIAT, V45, P111; Gunderson JG., 2014, HDB GOOD PSYCHIAT MA; Linehan MM, 2015, JAMA PSYCHIAT, V72, P475, DOI 10.1001/jamapsychiatry.2014.3039; McMain SF, 2009, AM J PSYCHIAT, V166, P1365, DOI 10.1176/appi.ajp.2009.09010039; Yeomans FE, 2015, TRANSFERENCE FOCUSED	9	8	8	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					181	+		10.1001/jama.2015.4557	http://dx.doi.org/10.1001/jama.2015.4557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26172897				2022-12-28	WOS:000357867500018
J	Kerr, JT; Pindar, A; Galpern, P; Packer, L; Potts, SG; Roberts, SM; Rasmont, P; Schweiger, O; Colla, SR; Richardson, LL; Wagner, DL; Gall, LF; Sikes, DS; Pantoja, A				Kerr, Jeremy T.; Pindar, Alana; Galpern, Paul; Packer, Laurence; Potts, Simon G.; Roberts, Stuart M.; Rasmont, Pierre; Schweiger, Oliver; Colla, Sheila R.; Richardson, Leif L.; Wagner, David L.; Gall, Lawrence F.; Sikes, Derek S.; Pantoja, Alberto			Climate change impacts on bumblebees converge across continents	SCIENCE			English	Article							PATTERNS; SHIFTS; HYMENOPTERA; DIVERSITY; APIDAE	For many species, geographical ranges are expanding toward the poles in response to climate change, while remaining stable along range edges nearest the equator. Using long-term observations across Europe and North America over 110 years, we tested for climate change-related range shifts in bumblebee species across the full extents of their latitudinal and thermal limits and movements along elevation gradients. We found cross-continentally consistent trends in failures to track warming through time at species' northern range limits, range losses from southern range limits, and shifts to higher elevations among southern species. These effects are independent of changing land uses or pesticide applications and underscore the need to test for climate impacts at both leading and trailing latitudinal and thermal limits for species.	[Kerr, Jeremy T.; Pindar, Alana] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; [Galpern, Paul] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Packer, Laurence] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Potts, Simon G.; Roberts, Stuart M.] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England; [Rasmont, Pierre] Univ Mons, Dept Zool, B-7000 Mons, Belgium; [Schweiger, Oliver] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Colla, Sheila R.] Wildlife Preservat Canada, Guelph, ON, Canada; [Richardson, Leif L.] Univ Vermont, Gund Inst, Burlington, VT USA; [Wagner, David L.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Gall, Lawrence F.] Yale Univ, Div Entomol, Peabody Museum Nat Hist, New Haven, CT USA; [Sikes, Derek S.] Univ Alaska Fairbanks, Univ Alaska Museum, Fairbanks, AK USA; [Pantoja, Alberto] ARS, USDA, Subarctic Agr Res Unit, Fairbanks, AK USA	University of Ottawa; University of Calgary; York University - Canada; University of Reading; University of Mons; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Vermont; University of Connecticut; Yale University; University of Alaska System; University of Alaska Fairbanks; United States Department of Agriculture (USDA)	Kerr, JT (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.	jkerr@uottawa.ca	Schweiger, Oliver/B-4909-2008; Potts, Simon/ABF-9221-2020; Pindar, Alana/AAC-6906-2020; Potts, Simon G/C-7250-2008	Schweiger, Oliver/0000-0001-8779-2335; Potts, Simon/0000-0002-2045-980X; Potts, Simon G/0000-0002-2045-980X; Richardson, Leif/0000-0003-4855-5737; , Sheila/0000-0002-9621-8607; Pindar, Alana/0000-0002-4273-3267; Kerr, Jeremy/0000-0002-3972-7560; packer, laurence/0000-0002-1711-8203; Sikes, Derek/0000-0002-4336-2365	Natural Sciences and Engineering Research Council of Canada strategic network (CANPOLIN: Canadian Pollination Initiative); University of Ottawa Research Chair in Macroecology and Conservation; Div Of Biological Infrastructure [0956340] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada strategic network (CANPOLIN: Canadian Pollination Initiative); University of Ottawa Research Chair in Macroecology and Conservation; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the Natural Sciences and Engineering Research Council of Canada strategic network (CANPOLIN: Canadian Pollination Initiative) and Discovery Grant support and University of Ottawa Research Chair in Macroecology and Conservation to J.T.K. We are grateful to anonymous reviewers whose comments improved this paper and to P. Williams for advice and perspectives during development of the research. All data and supporting scripts are available from Dryad Digital Repository: doi: 10.5061/dryad.gf774.	Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Gehrig-Fasel J, 2007, J VEG SCI, V18, P571, DOI 10.1111/j.1654-1103.2007.tb02571.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Herrera JM, 2014, J BIOGEOGR, V41, P700, DOI 10.1111/jbi.12236; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Kellermann V, 2012, P NATL ACAD SCI USA, V109, P16228, DOI 10.1073/pnas.1207553109; Leroux SJ, 2013, ECOL APPL, V23, P815, DOI 10.1890/12-1407.1; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Ploquin EF, 2013, OECOLOGIA, V173, P1649, DOI 10.1007/s00442-013-2731-7; Rasmont P, 2012, ANN SOC ENTOMOL FR, V48, P275, DOI 10.1080/00379271.2012.10697776; Romdal TS, 2013, GLOBAL ECOL BIOGEOGR, V22, P344, DOI 10.1111/j.1466-8238.2012.00786.x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tuama O E, 2013, GBIF MET PROF REF GU; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams PH, 2014, BUMBLE BEES N AM IDE; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838	26	419	431	17	509	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					177	180		10.1126/science.aaa7031	http://dx.doi.org/10.1126/science.aaa7031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26160945	Green Accepted			2022-12-28	WOS:000357664300041
J	Ma, ZQ; Wang, XL; Wang, X; Rodriguez, RA; Moore, CE; Gao, SH; Tan, XH; Ma, YY; Rheingold, AL; Baran, PS; Chen, C				Ma, Zhiqiang; Wang, Xiaolei; Wang, Xiao; Rodriguez, Rodrigo A.; Moore, Curtis E.; Gao, Shuanhu; Tan, Xianghui; Ma, Yuyong; Rheingold, Arnold L.; Baran, Phil S.; Chen, Chuo			Response to Comment on "Asymmetric syntheses of sceptrin and massadine and evidence for biosynthetic enantiodivergence"	SCIENCE			English	Editorial Material								Sherman et al. commented on the precedence of enantiodivergence, listing a number of congeneric natural products with opposite chirality. However, these "congeners" are not derived from enantiodivergent biosyntheses. Instead, they are antipodes arising from separate enantiomeric biosyntheses. A distinct feature of the biosynthesis of the cyclic pyrrole-imidazole dimers is the production of antipodal congeners without the corresponding enantiomers.	[Ma, Zhiqiang; Wang, Xiaolei; Wang, Xiao; Gao, Shuanhu; Tan, Xianghui; Ma, Yuyong; Chen, Chuo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Rodriguez, Rodrigo A.; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Moore, Curtis E.; Rheingold, Arnold L.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Scripps Research Institute; University of California System; University of California San Diego	Chen, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	chuo.chen@utsouthwestern.edu	Rheingold, Arnold/U-4735-2019; wang, xiaolei/K-6888-2014; Ma, Yuyong/I-2678-2016	Rheingold, Arnold/0000-0003-4472-8127; Ma, Yuyong/0000-0001-9591-6465; Chen, Chuo/0000-0002-3118-4901	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073949, R01GM079554] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM079554, R01-GM073949, R01-GM079554, R01 GM073949] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR VN, 1972, CURR SCI INDIA, V41, P839; BALDAS J, 1974, J CHEM SOC PERK T 1, P50, DOI 10.1039/p19740000050; Finefield JM, 2012, ANGEW CHEM INT EDIT, V51, P4802, DOI 10.1002/anie.201107204; Kenmoku H, 2004, BIOSCI BIOTECH BIOCH, V68, P1574, DOI 10.1271/bbb.68.1574; LU TS, 1995, PHYTOCHEMISTRY, V38, P451; Ma ZQ, 2014, SCIENCE, V346, P219, DOI 10.1126/science.1255677; Sanz-Cervera JF, 2002, J AM CHEM SOC, V124, P2556, DOI 10.1021/ja017425l; Sherman DH, 2015, SCIENCE, V349, DOI 10.1126/science.aaa9349; Stout EP, 2012, ANGEW CHEM INT EDIT, V51, P4877, DOI 10.1002/anie.201108119; Williams RM, 2003, ACCOUNTS CHEM RES, V36, P127, DOI 10.1021/ar020229e; Xia ZQ, 2001, J BIOL CHEM, V276, P12614, DOI 10.1074/jbc.M008622200	11	4	4	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244								10.1126/science.aaa9626	http://dx.doi.org/10.1126/science.aaa9626			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4OM	26160939	Green Accepted			2022-12-28	WOS:000357664300031
J	Sedgwick, P; Hooper, C				Sedgwick, Philip; Hooper, Carwyn			Placebos and sham treatments	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sedgwick, Philip; Hooper, Carwyn] Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Hooper, Carwyn/AAM-1819-2021; Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175; Hooper, Carwyn/0000-0001-5147-3842				Heal CF, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2812; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h267; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5420; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4176	4	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2015	351								h3755	10.1136/bmj.h3755	http://dx.doi.org/10.1136/bmj.h3755			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MY	26162858				2022-12-28	WOS:000357956900003
J	Misumi, K				Misumi, Kazuhiro			BIOGEOCHEMISTRY Iron's voyage from the abyss	NATURE			English	Editorial Material							DISSOLVED IRON; OCEAN; ATLANTIC; PACIFIC; LIGANDS	An iron-rich plume of water from a hydrothermal vent has been found to extend more than 4,000 kilometres through the ocean. The finding has implications for the productivity of marine algae, and therefore for climate. See Letter p.200	Cent Res Inst Elect Power Ind, Environm Sci Res Lab, Abiko, Chiba 2701194, Japan	Central Research Institute of Electric Power Industry - Japan	Misumi, K (corresponding author), Cent Res Inst Elect Power Ind, Environm Sci Res Lab, Abiko, Chiba 2701194, Japan.	misumi@criepi.denken.or.jp						Bennett SA, 2008, EARTH PLANET SC LETT, V270, P157, DOI 10.1016/j.epsl.2008.01.048; Conway TM, 2014, NATURE, V511, P212, DOI 10.1038/nature13482; de Lavergne C, 2014, NAT CLIM CHANGE, V4, P278, DOI [10.1038/nclimate2132, 10.1038/NCLIMATE2132]; Fitzsimmons JN, 2014, P NATL ACAD SCI USA, V111, P16654, DOI 10.1073/pnas.1418778111; Kohfeld KE, 2009, GEOPHYS MONOGR SER, V187, P251, DOI 10.1029/2008GM000845; Lenton A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038227; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Nishioka J, 2013, EARTH PLANET SC LETT, V361, P26, DOI 10.1016/j.epsl.2012.11.040; Resing JA, 2015, NATURE, V523, P200, DOI 10.1038/nature14577; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Saito MA, 2013, NAT GEOSCI, V6, P775, DOI [10.1038/ngeo1893, 10.1038/NGEO1893]; Toner BM, 2012, OCEANOGRAPHY, V25, P209, DOI 10.5670/oceanog.2012.19; Volker C, 2015, MAR CHEM, V173, P67, DOI 10.1016/j.marchem.2014.11.008; VONDAMM KL, 1990, ANNU REV EARTH PL SC, V18, P173, DOI 10.1146/annurev.ea.18.050190.001133; Wu JF, 2011, GEOCHIM COSMOCHIM AC, V75, P460, DOI 10.1016/j.gca.2010.10.024; Yucel M, 2011, NAT GEOSCI, V4, P367, DOI [10.1038/ngeo1148, 10.1038/NGEO1148]	16	0	0	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					160	161		10.1038/523160a	http://dx.doi.org/10.1038/523160a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4ZO	26156367				2022-12-28	WOS:000357695900020
J	Smartt, SJ				Smartt, Stephen J.			ASTROPHYSICS A twist in the tale of gamma-ray bursts	NATURE			English	Editorial Material							SUPERLUMINOUS SUPERNOVAE; MAGNETAR	An unusually long burst of gamma-rays zapped Earth in December 2011, lasting 4 hours. The cause of this burst is now proposed to be a peculiar supernova produced by a spinning magnetic neutron star. See Letter p.189	Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Smartt, SJ (corresponding author), Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland.	s.smartt@qub.ac.uk						Aasi J, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/7; Burrows DN, 2011, NATURE, V476, P421, DOI 10.1038/nature10374; Chen TW, 2013, ASTROPHYS J LETT, V763, DOI 10.1088/2041-8205/763/2/L28; Gendre B, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/30; Greiner J, 2015, NATURE, V523, P189, DOI 10.1038/nature14579; Inserra C, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/128; Kasen D, 2010, ASTROPHYS J, V717, P245, DOI 10.1088/0004-637X/717/1/245; KLEBESADEL RW, 1973, ASTROPHYS J, V182, pL85, DOI 10.1086/181225; Levan AJ, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/13; Lunnan R, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/138; Nicholl M, 2014, MON NOT R ASTRON SOC, V444, P2096, DOI 10.1093/mnras/stu1579; Quimby RM, 2011, NATURE, V474, P487, DOI 10.1038/nature10095; Stratta G, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/66; Woosley SE, 2010, ASTROPHYS J LETT, V719, pL204, DOI 10.1088/2041-8205/719/2/L204	14	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					164	166		10.1038/523164b	http://dx.doi.org/10.1038/523164b			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4ZO	26156370				2022-12-28	WOS:000357695900023
J	Weeks, AD; Neilson, JP				Weeks, Andrew D.; Neilson, James P.			Rethinking our approach to postpartum haemorrhage and uterotonics	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Weeks, Andrew D.] Univ Liverpool, Dept Womens & Childrens Hlth, Int Maternal Hlth, Liverpool L8 7SS, Merseyside, England; [Neilson, James P.] Univ Liverpool, Dept Womens & Childrens Hlth, Obstet & Gynaecol, Liverpool L8 7SS, Merseyside, England	University of Liverpool; University of Liverpool	Weeks, AD (corresponding author), Univ Liverpool, Dept Womens & Childrens Hlth, Int Maternal Hlth, Crown St, Liverpool L8 7SS, Merseyside, England.	aweeks@liv.ac.uk		Weeks, Andrew/0000-0002-1909-337X	National Institute for Health Research [II-LA-0712-20007] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Aflaifel N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4546; Amelink-Verburg MP, 2008, BJOG-INT J OBSTET GY, V115, P570, DOI 10.1111/j.1471-0528.2007.01580.x; Balki M, 2013, ANESTHESIOLOGY, V119, P552, DOI 10.1097/ALN.0b013e318297d347; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Begley CM, 2011, COCHRANE DB SYST REV, V9; Blum J, 2010, LANCET, V375, P217, DOI 10.1016/S0140-6736(09)61923-1; Brace V, 2007, BJOG-INT J OBSTET GY, V114, P1388, DOI 10.1111/j.1471-0528.2007.01533.x; Cheung WMC, 2011, J OBSTET GYNAECOL, V31, P37, DOI 10.3109/01443615.2010.531301; Hall MH, 2002, MATERNAL MORBIDITY M, P227; Hofmeyr GJ, 2013, COCHRANE DB SYST REV, V7; Kerr RS, 2015, ACTA OBSTET GYN SCAN, V94, P664, DOI 10.1111/aogs.12635; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; MBRRACE-UK, 2014, SAV LIV IMPR MOTH CA; Mousa HA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003249.pub3; National Committee on Confidential Enquiries into Maternal Deaths, 2012, SAV MOTH 2008 2010 5; Oberg AS, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.872; Royal College of Obstetricians and Gynaecologists, 2009, POSTP HAEM PREV MAN; Sandall J, 2014, EFFICIENT USE MATERN; Say Lale, 2014, Lancet Glob Health, V2, pe323, DOI 10.1016/S2214-109X(14)70227-X; Smith JM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-44; Stafford I, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.049; Westhoff G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001808.pub2; Winikoff B, 2010, LANCET, V375, P210, DOI 10.1016/S0140-6736(09)61924-3; World Health Organization WHO, 2012, RECOMMENDATIONS PREV	24	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2015	351								h3251	10.1136/bmj.h3251	http://dx.doi.org/10.1136/bmj.h3251			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MP	26156874				2022-12-28	WOS:000357955800003
J	Schaferhoff, M; Fewer, S; Kraus, J; Richter, E; Summers, LH; Sundewall, J; Yamey, G; Jamison, DT				Schaeferhoff, Marco; Fewer, Sara; Kraus, Jessica; Richter, Emil; Summers, Lawrence H.; Sundewall, Jesper; Yamey, Gavin; Jamison, Dean T.			How much donor financing for health is channelled to global versus country-specific aid functions?	LANCET			English	Article							EBOLA	The slow global response to the Ebola crisis in west Africa suggests that important gaps exist in donor financing for key global functions, such as support for health research and development for diseases of poverty and strengthening of outbreak preparedness. In this Health Policy, we use the International Development Statistics databases to quantify donor support for such functions. We classify donor funding for health into aid for global functions (provision of global public goods, management of cross-border externalities, and fostering of leadership and stewardship) versus country-specific aid. We use a new measure of donor funding that combines official development assistance (ODA) for health with additional donor spending on research and development (R&D) for diseases of poverty. Much R&D spending falls outside ODA-ie, the assistance that is conventionally reported through ODA databases of the Organisation for Economic Co-operation and Development. This expanded definition, which we term health ODA plus, provides a more comprehensive picture of donor support for health that could reshape how policy makers will approach their support for global health.	[Schaeferhoff, Marco; Kraus, Jessica; Richter, Emil] SEEK Dev, D-10405 Berlin, Germany; [Fewer, Sara; Yamey, Gavin; Jamison, Dean T.] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Summers, Lawrence H.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Sundewall, Jesper] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	University of California System; University of California San Francisco; Harvard University; Karolinska Institutet	Schaferhoff, M (corresponding author), SEEK Dev, D-10405 Berlin, Germany.	mschaeferhoff@seekdevelopment.org		Sundewall, Jesper/0000-0001-5357-5754	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank Elina Madeleine Suzuki and Ben Louis Anton Mayer (SEEK Development, Berlin, Germany) and Katherine McClendon (The University of California, San Francisco, San Francisco, CA, USA) for their assistance with the data analysis, and the CIH International Collective Action Working Group for its ideas on the role of aid for health in the post-2015 era. This study was funded by the Bill & Melinda Gates Foundation.	[Anonymous], SCARCE DONOR FUNDING; [Anonymous], 2014, SHARED RESPONSIBILIT; Arregoces L, 2015, LANCET GLOB HEALTH, V3, pE410, DOI 10.1016/S2214-109X(15)00057-1; Blanchet N, 2013, COMMISSION INVESTING; Consultative Expert Working Group on Research and Development, 2012, RES DEV MEET HLTH NE; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; G-FINDER, 2014, NEGL DIS RES DEV EM; Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918; Gilbert BJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001834; Glassman A, 2011, GLOBAL HLTH NEW BOTT; Glassman A, 2008, 1 GLOB HLTH FIN IN; Gostin LO, 2014, LANCET, V384, P1323, DOI 10.1016/S0140-6736(14)61791-8; Grepin KA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h376; Institute for Health Metrics and Evaluation, 2014, FIN GLOB HLTH 2013 T; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jamison DT, 1998, LANCET, V351, P514, DOI 10.1016/S0140-6736(97)11451-9; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Mccoy D, 2009, HEALTH POLICY PLANN, V24, P407, DOI 10.1093/heapol/czp026; Piva P, 2009, B WORLD HEALTH ORGAN, V87, P930, DOI 10.2471/BLT.08.058677; PMNCH, 2014, PMNCH 2014 ACC REP T; Sridhar D, 2014, OVERSEEING GLOBAL HL; Summers L, 2014, WE PLAY FIRE WE SKIM; Sumner A, 2012, AID CUTS MIDDLE INCO; Vassall A, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23510; WHO, 2013, PROP PROGR BUDG 2015; WHO, 2015, WORLD HLTH ASS GIV G; WHO, 2014, WHOS BUDG WHATS NUMB; World Bank Brief, 2013, PAND RISK ON HLTH; Yamey G, 2014, SWEDENS DEV ASSISTAN	29	30	30	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2015	386	10011					2436	2441		10.1016/S0140-6736(15)61161-8	http://dx.doi.org/10.1016/S0140-6736(15)61161-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY3EE	26178405				2022-12-28	WOS:000366290400037
J	Senyilmaz, D; Virtue, S; Xu, XJ; Tan, CY; Griffin, JL; Miller, AK; Vidal-Puig, A; Teleman, AA				Senyilmaz, Deniz; Virtue, Sam; Xu, Xiaojun; Tan, Chong Yew; Griffin, Julian L.; Miller, Aubry K.; Vidal-Puig, Antonio; Teleman, Aurelio A.			Regulation of mitochondrial morphology and function by stearoylation of TFR1	NATURE			English	Article							MITOFUSIN 2; PARKINSONS-DISEASE; DROSOPHILA; PHOSPHORYLATION; DYNAMICS; ACID; DYSFUNCTION; APOPTOSIS; MUTANTS; STRESS	Mitochondria are involved in a variety of cellular functions, including ATP production, amino acid and lipid biogenesis and breakdown, signalling and apoptosis(1-3). Mitochondrial dysfunction has been linked to neurodegenerative diseases, cancer and ageing(4). Although transcriptional mechanisms that regulate mitochondrial abundance are known(5), comparatively little is known about how mitochondrial function is regulated. Here we identify the metabolite stearic acid (C18:0) and human transferrin receptor 1 (TFR1; also known as TFRC) as mitochondrial regulators. We elucidate a signalling pathway whereby C18:0 stearoylates TFR1, thereby inhibiting its activation of JNK signalling. This leads to reduced ubiquitination of mitofusin via HUWE1, thereby promoting mitochondrial fusion and function. We find that animal cells are poised to respond to both increases and decreases in C18:0 levels, with increased C18:0 dietary intake boosting mitochondrial fusion in vivo. Intriguingly, dietary C18:0 supplementation can counteract the mitochondrial dysfunction caused by genetic defects such as loss of the Parkinson's disease genes Pink or Parkin in Drosophila. This work identifies the metabolite C18:0 as a signalling molecule regulating mitochondrial function in response to diet.	[Senyilmaz, Deniz; Xu, Xiaojun; Miller, Aubry K.; Teleman, Aurelio A.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Virtue, Sam; Tan, Chong Yew; Vidal-Puig, Antonio] Univ Cambridge, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Cambridge CB2 0QQ, England; [Griffin, Julian L.] Dept Biochem, Cambridge CB2 1GA, England; [Vidal-Puig, Antonio] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England	Helmholtz Association; German Cancer Research Center (DKFZ); University of Cambridge; Wellcome Trust Sanger Institute	Teleman, AA (corresponding author), German Canc Res Ctr, D-69120 Heidelberg, Germany.	a.teleman@dkfz.de	Teleman, Aurelio/V-8470-2019; Senyilmaz Tiebe, Deniz/U-2434-2017; Teleman, Aurelio A/E-6864-2013; Miller, Aubry/AAO-3863-2020; 高, 雨莉/HGU-8187-2022; Tiebe, Deniz Senyilmaz/Z-3403-2019	Teleman, Aurelio/0000-0002-4237-9368; Senyilmaz Tiebe, Deniz/0000-0002-2976-1204; Teleman, Aurelio A/0000-0002-4237-9368; Tiebe, Deniz Senyilmaz/0000-0002-2976-1204; Miller, Aubry/0000-0002-1761-4143; Vidal-Puig, Antonio/0000-0003-4220-9577	Deutsche Forschungsgemeinschaft (DFG) [SFB1118]; Helmholtz Portfolio Topic 'Metabolic Dysfunction'; European Research Council [260602]; Biotechnology and Biological Sciences Research Council; Medical Research Council; British Heart Foundation; Biotechnology and Biological Sciences Research Council [BB/J009865/1, BB/H013539/2, BB/H002731/1] Funding Source: researchfish; British Heart Foundation [PG/12/53/29714, RG/12/13/29853] Funding Source: researchfish; Medical Research Council [MC_UP_A090_1006, MC_UU_12012/2, MC_UU_12012/5/B, G0400192, MC_PC_13030, G0802051] Funding Source: researchfish; BBSRC [BB/J009865/1, BB/H013539/2, BB/H002731/1] Funding Source: UKRI; MRC [MC_PC_13030, MC_UP_A090_1006, MC_UU_12012/2, G0802051, G0400192] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Helmholtz Portfolio Topic 'Metabolic Dysfunction'; European Research Council(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Zorzano and J. Seco for photo-activatable mitoGFP, A. Zorzano and J. Pablot for Myc-tagged MFN2, H. Jacobs for UAS-AOX flies, C. Frei for UAS-Spargel flies, P. Verstreken for Parkinson's flies, A. Whitworth for anti-dMfn, J. Chung for anti-dPorin, R. Lill for anti-IBA57, J. Sagales for help with respirometry on the dMfn-knockout animals, F. Melchior for advice on detecting ubiquitination, K. Richter and the DKFZ EM Core Facility for help with electron microscopy, the DKFZ Light Microscopy Core Facility for help with live-cell imaging, M. Schnolzer and the DKFZ Proteomics Core Facility for mass spectrometry analysis of proteins, and M. del Sol for technical support. This work was supported in part by Deutsche Forschungsgemeinschaft (DFG), SFB1118, Helmholtz Portfolio Topic 'Metabolic Dysfunction', and European Research Council Starting Grants (#260602) to A.A.T., and Biotechnology and Biological Sciences Research Council, Medical Research Council programme and British Heart Foundation grants to A.V.-P.	Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Groot REA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004985; Escobar-Henriques M, 2014, EMBO REP, V15, P231, DOI 10.1002/embr.201338225; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Guo M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009944; Jian JL, 2011, J BIOL CHEM, V286, P35708, DOI 10.1074/jbc.M111.271585; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Jump DB, 2009, METHODS MOL BIOL, V579, P375, DOI 10.1007/978-1-60761-322-0_19; Jung A, 2007, J CELL SCI, V120, P2924, DOI 10.1242/jcs.006551; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Moon YA, 2014, J LIPID RES, V55, P2597, DOI 10.1194/jlr.M054353; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Park J, 2009, DIS MODEL MECH, V2, P336, DOI 10.1242/dmm.003178; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Twig G, 2006, AM J PHYSIOL-CELL PH, V291, pC176, DOI 10.1152/ajpcell.00348.2005; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Whitworth AJ, 2006, DRUG DISCOV TODAY, V11, P119, DOI 10.1016/S1359-6446(05)03693-7; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	30	128	131	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					124	+		10.1038/nature14601	http://dx.doi.org/10.1038/nature14601			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26214738	Green Accepted, Green Submitted			2022-12-28	WOS:000360594100038
J	Bewtra, M; Newcomb, CW; Wu, Q; Chen, L; Xie, F; Roy, JA; Aarons, CB; Osterman, MT; Forde, KA; Curtis, JR; Lewis, JD				Bewtra, M.; Newcomb, C. W.; Wu, Q.; Chen, L.; Xie, F.; Roy, J. A.; Aarons, C. B.; Osterman, M. T.; Forde, K. A.; Curtis, J. R.; Lewis, J. D.			Mortality Associated With Medical Therapy in Ulcerative Colitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2015	163	4					I28	I28		10.7326/P15-9026	http://dx.doi.org/10.7326/P15-9026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0IT	26168403				2022-12-28	WOS:000364673500001
J	Glancy, B; Hartnell, LM; Malide, D; Yu, ZX; Combs, CA; Connelly, PS; Subramaniam, S; Balaban, RS				Glancy, Brian; Hartnell, Lisa M.; Malide, Daniela; Yu, Zu-Xi; Combs, Christian A.; Connelly, Patricia S.; Subramaniam, Sriram; Balaban, Robert S.			Mitochondrial reticulum for cellular energy distribution in muscle	NATURE			English	Article							LIMB SKELETAL-MUSCLE; RAT DIAPHRAGM MUSCLE; IN-VIVO; 3-DIMENSIONAL RECONSTRUCTION; ELECTRON-MICROSCOPY; CREATINE-KINASE; DEFICIENT; MYOGLOBIN; MICE; FLUORESCENCE	Intracellular energy distribution has attracted much interest and has been proposed to occur in skeletal muscle via metabolite-facilitated diffusion(1,2;) however, genetic evidence suggests that facilitated diffusion is not critical for normal function(3-7). We hypothesized that mitochondrial structure minimizes metabolite diffusion distances in skeletal muscle. Here we demonstrate a mitochondrial reticulum providing a conductive pathway for energy distribution, in the form of the proton-motive force, throughout the mouse skeletal muscle cell. Within this reticulum, we find proteins associated with mitochondrial proton-motive force production preferentially in the cell periphery and proteins that use the proton-motive force for ATP production in the cell interior near contractile and transport ATPases. Furthermore, we show a rapid, coordinated depolarization of the membrane potential component of the proton-motive force throughout the cell in response to spatially controlled uncoupling of the cell interior. We propose that membrane potential conduction via the mitochondrial reticulum is the dominant pathway for skeletal muscle energy distribution.	[Glancy, Brian; Malide, Daniela; Yu, Zu-Xi; Combs, Christian A.; Connelly, Patricia S.; Balaban, Robert S.] NHLBI, NIH, Bethesda, MD 20892 USA; [Hartnell, Lisa M.; Subramaniam, Sriram] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Balaban, RS (corresponding author), NHLBI, NIH, Bethesda, MD 20892 USA.	Robert.Balaban@nih.gov	Glancy, Brian/P-3163-2016	Glancy, Brian/0000-0002-8571-244X; Subramaniam, Sriram/0000-0003-4231-4115	Division of Intramural Research, National Heart, Lung, and Blood Institute; Center for Cancer Research, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZICBC011574, ZIABC010278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZICHL005906, ZICHL006019, ZICHL005904, ZIAHL004610] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank E. Tyler for his assistance with image rendering, J. Taraska for providing experimental advice, T. Karpova and the NCI Core Fluorescence Imaging Facility for access to a microscope with a 355-nm laser, and P. Kellman for assistance with image analysis. We would also like to thank S. Caldwell and R. Hartley for providing us with MitoPhotoDNP. This study was supported by intramural funding of the Division of Intramural Research, National Heart, Lung, and Blood Institute and the Center for Cancer Research, National Cancer Institute.	AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Bakalar M, 2012, J MICROSC-OXFORD, V246, P237, DOI 10.1111/j.1365-2818.2012.03613.x; BAKEEVA LE, 1981, EUR J CELL BIOL, V25, P175; BAKEEVA LE, 1978, BIOCHIM BIOPHYS ACTA, V501, P349, DOI 10.1016/0005-2728(78)90104-4; Balaban RS, 1996, ANAL BIOCHEM, V237, P274, DOI 10.1006/abio.1996.0239; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; BUBENZER HJ, 1966, Z ZELLFORSCH MIK ANA, V69, P520, DOI 10.1007/BF00406300; Chalmers S, 2012, J AM CHEM SOC, V134, P758, DOI 10.1021/ja2077922; Dahl R, 2015, ACTA PHYSIOL, V213, P145, DOI 10.1111/apha.12289; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; Garry DJ, 1998, NATURE, V395, P905, DOI 10.1038/27681; Glancy B, 2014, MICROCIRCULATION, V21, P131, DOI 10.1111/micc.12098; Glancy B, 2011, AM J PHYSIOL-CELL PH, V300, pC1280, DOI 10.1152/ajpcell.00496.2010; Hein B, 2010, BIOPHYS J, V98, P158, DOI 10.1016/j.bpj.2009.09.053; KAYAR SR, 1988, ANAT REC, V222, P333, DOI 10.1002/ar.1092220405; Kernec F, 2001, PHYSIOL GENOMICS, V6, P117, DOI 10.1152/physiolgenomics.2001.6.2.117; KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395; KIRKWOOD SP, 1987, ARCH BIOCHEM BIOPHYS, V255, P80, DOI 10.1016/0003-9861(87)90296-7; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lygate CA, 2013, CIRC RES, V112, P945, DOI 10.1161/CIRCRESAHA.112.300725; Murphy GE, 2011, J STRUCT BIOL, V176, P268, DOI 10.1016/j.jsb.2011.08.013; Narayan K, 2014, J STRUCT BIOL, V185, P278, DOI 10.1016/j.jsb.2013.11.008; OGATA T, 1985, CELL TISSUE RES, V241, P251, DOI 10.1007/BF00217168; Picard M, 2013, J APPL PHYSIOL, V115, P1562, DOI 10.1152/japplphysiol.00819.2013; Rothstein EC, 2005, BIOPHYS J, V88, P2165, DOI 10.1529/biophysj.104.053165; SAITO A, 1974, J CELL BIOL, V60, P653, DOI 10.1083/jcb.60.3.653; Skulachev VP, 1971, CURR TOP BIOENERG, V4, P127; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; WITTENBERG JB, 1970, PHYSIOL REV, V50, P559, DOI 10.1152/physrev.1970.50.4.559; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200	33	243	245	4	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					617	+		10.1038/nature14614	http://dx.doi.org/10.1038/nature14614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26223627	Green Accepted			2022-12-28	WOS:000358655200050
J	Hohenleutner, M; Langer, F; Schubert, O; Knorr, M; Huttner, U; Koch, SW; Kira, M; Huber, R				Hohenleutner, M.; Langer, F.; Schubert, O.; Knorr, M.; Huttner, U.; Koch, S. W.; Kira, M.; Huber, R.			Real-time observation of interfering crystal electrons in high-harmonic generation	NATURE			English	Article							ULTRASHORT LASER-PULSES; ATTOSECOND PULSES; TERAHERTZ PULSES; NONLINEAR OPTICS; DYNAMICS; MOLECULES	Acceleration and collision of particles has been a key strategy for exploring the texture of matter. Strong light waves can control and recollide electronic wavepackets, generating high-harmonic radiation that encodes the structure and dynamics of atoms and molecules and lays the foundations of attosecond science(1-3). The recent discovery of high-harmonic generation in bulk solids(4-6) combines the idea of ultrafast acceleration with complex condensed matter systems, and provides hope for compact solid-state attosecond sources(6-8) and electronics at optical frequencies(3,5,9,10). Yet the underlying quantum motion has not so far been observable in real time. Here we study high-harmonic generation in a bulk solid directly in the time domain, and reveal a new kind of strong-field excitation in the crystal. Unlike established atomic sources(1-3,9,11), our solid emits high-harmonic radiation as a sequence of subcycle bursts that coincide temporally with the field crests of one polarity of the driving terahertz waveform. We show that these features are characteristic of a non-perturbative quantum interference process that involves electrons from multiple valence bands. These results identify key mechanisms for future solid-state attosecond sources and next-generation light-wave electronics. The new quantum interference process justifies the hope for all-optical band-structure reconstruction and lays the foundation for possible quantum logic operations at optical clock rates.	[Hohenleutner, M.; Langer, F.; Schubert, O.; Knorr, M.; Huber, R.] Univ Regensburg, Dept Phys, D-93040 Regensburg, Germany; [Huttner, U.; Koch, S. W.; Kira, M.] Univ Marburg, Dept Phys, D-35032 Marburg, Germany	University of Regensburg; Philipps University Marburg	Huber, R (corresponding author), Univ Regensburg, Dept Phys, D-93040 Regensburg, Germany.	mackillo.kira@physik.uni-marburg.de; rupert.huber@physik.uni-regensburg.de	Kira, Mackillo/G-5812-2015; Huber, Rupert/N-4126-2018; Schubert, Olaf/A-6550-2009	Huber, Rupert/0000-0001-6617-9283; Kira, Gervais M/0000-0001-6989-7336; Knorr, Matthias/0000-0003-2043-4319	European Research Council [305003]; Deutsche Forschungsgemeinschaft [HU 1598/2-1, SFB 1083, KI 917/2-2]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work in Regensburg was supported by the European Research Council through grant no. 305003 (QUANTUMsubCYCLE) as well as by the Deutsche Forschungsgemeinschaft (through grant number HU 1598/2-1) and the work in Marburg by the Deutsche Forschungsgemeinschaft (through SFB 1083 and grant number KI 917/2-2).	Calegari F, 2014, SCIENCE, V346, P336, DOI 10.1126/science.1254061; Chin AH, 2001, PHYS REV LETT, V86, P3292, DOI 10.1103/PhysRevLett86.3292; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Dudovich N, 2006, NAT PHYS, V2, P781, DOI 10.1038/nphys434; EIMERL D, 1987, J APPL PHYS, V62, P1968, DOI 10.1063/1.339536; Foldi P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063019; Gallot G, 1999, J OPT SOC AM B, V16, P1204, DOI 10.1364/JOSAB.16.001204; Ghimire S, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/20/204030; Ghimire S, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.043836; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Golde D, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075330; Golde D, 2006, J OPT SOC AM B, V23, P2559, DOI 10.1364/JOSAB.23.002559; Golde D, 2011, PHYS STATUS SOLIDI B, V248, P863, DOI 10.1002/pssb.201000840; Goulielmakis E, 2007, SCIENCE, V317, P769, DOI 10.1126/science.1142855; Hawkins PG, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.013405; Higuchi T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.213901; Kanai T, 2005, NATURE, V435, P470, DOI 10.1038/nature03577; Kane DJ, 1998, IEEE J SEL TOP QUANT, V4, P278, DOI 10.1109/2944.686733; Kane DJ, 1999, IEEE J QUANTUM ELECT, V35, P421, DOI 10.1109/3.753647; Kemper AF, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/023003; Kira M, 1999, PROG QUANT ELECTRON, V23, P189, DOI 10.1016/S0079-6727(99)00008-7; Krausz F, 2014, NAT PHOTONICS, V8, P205, DOI 10.1038/nphoton.2014.28; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Linden S, 1998, PHYS STATUS SOLIDI B, V206, P119, DOI 10.1002/(SICI)1521-3951(199803)206:1<119::AID-PSSB119>3.0.CO;2-X; Liu Y.-W., 2012, FOURIER TRANSFORM AP, P291; Moiseyev N, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.053811; Mucke OD, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.081202; Neppl S, 2015, NATURE, V517, P342, DOI 10.1038/nature14094; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Ruffin AB, 1999, PHYS REV LETT, V83, P3410, DOI 10.1103/PhysRevLett.83.3410; Salieres P, 2001, SCIENCE, V292, P902, DOI 10.1126/science.108836; SCHLUTER M, 1976, PHYS REV B, V13, P3534, DOI 10.1103/PhysRevB.13.3534; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/NPHOTON.2013.349, 10.1038/nphoton.2013.349]; Schuh K, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.033103; Schultze M, 2014, SCIENCE, V346, P1348, DOI 10.1126/science.1260311; Segura A, 1997, PHYS REV B, V56, P4075, DOI 10.1103/PhysRevB.56.4075; Sekikawa T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.193902; Sell A, 2008, OPT LETT, V33, P2767, DOI 10.1364/OL.33.002767; Shafir D, 2009, NAT PHYS, V5, P412, DOI 10.1038/NPHYS1251; Shafir D, 2012, NATURE, V485, P343, DOI 10.1038/nature11025; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Vampa G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.073901; Vu QT, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.217403; Wyatt A., 2008, FREQUENCY RESOLVED O; Zaks B, 2012, NATURE, V483, P580, DOI 10.1038/nature10864; ZENER C, 1934, P ROYAL SOC, V145, P523, DOI DOI 10.1098/RSPA.1934.0116; Zhao H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.246601	49	391	397	5	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					572	+		10.1038/nature14652	http://dx.doi.org/10.1038/nature14652			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26223624	Green Submitted			2022-12-28	WOS:000358655200040
J	Bouche, CH; Garnier, JP; Choukem, SP; Gautier, JF				Bouche, Clara H.; Garnier, Jean-Pierre; Choukem, Simeon-Pierre; Gautier, Jean-Francois			Falsely elevated capillary glucose and ketone levels and use of skin lightening creams	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-GLUCOSE; METER		[Bouche, Clara H.; Choukem, Simeon-Pierre; Gautier, Jean-Francois] Univ Paris 07, Lariboisiere Hosp, AP HP, DHU FIRE,Dep Diabet & Endocrinol, F-75010 Paris, France; [Bouche, Clara H.; Choukem, Simeon-Pierre; Gautier, Jean-Francois] INSERM, UMRS 1138, Cordeliers Res Ctr, F-75006 Paris, France; [Garnier, Jean-Pierre] Univ Paris 05, St Louis Univ Hosp, AP HP, Biochem Lab, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Garnier, JP (corresponding author), Univ Paris 05, St Louis Univ Hosp, AP HP, Biochem Lab, F-75010 Paris, France.	jean-francois.gautier@lrb.aphp.fr						Arora S, 2011, DIABETES CARE, V34, P852, DOI 10.2337/dc10-1844; Bihan H, 2011, ANN INTERN MED, V155, P649, DOI 10.7326/0003-4819-155-9-201111010-00023; Dadzie OE, 2009, J EUR ACAD DERMATOL, V23, P741, DOI 10.1111/j.1468-3083.2009.03150.x; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; Mauvais-Jarvis F, 2004, DIABETES, V53, P645, DOI 10.2337/diabetes.53.3.645; Meas T, 2005, DIABETES METAB, V31, P299, DOI 10.1016/S1262-3636(07)70198-2; Olumide YM, 2008, INT J DERMATOL, V47, P344, DOI 10.1111/j.1365-4632.2008.02719.x; Vashist SK, 2011, ANAL CHIM ACTA, V703, P124, DOI 10.1016/j.aca.2011.07.024; Voulgari C, 2010, DIABETES TECHNOL THE, V12, P529, DOI 10.1089/dia.2010.0011; Wallace TM, 2001, DIABETIC MED, V18, P640, DOI 10.1046/j.1464-5491.2001.00550.x	10	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2015	351								h3879	10.1136/bmj.h3879	http://dx.doi.org/10.1136/bmj.h3879			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2UA	26223684				2022-12-28	WOS:000359010900006
J	Bindman, AB				Bindman, Andrew B.			Managing the Future of Medicaid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; RISK		[Bindman, Andrew B.] Univ Calif San Francisco, Dept Med, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Bindman, Andrew B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bindman, AB (corresponding author), Univ Calif San Francisco, Dept Med, Philip R Lee Inst Hlth Policy Studies, 3333 Calif St,Ste 265, San Francisco, CA 94143 USA.	andrew.bindman@ucsf.edu						Altman D, 2015, JAMA-J AM MED ASSOC, V314, P384, DOI 10.1001/jama.2015.7811; [Anonymous], EARL OUTC SHOW LTD P; [Anonymous], C MED CHIP; Bates DW, 2014, HEALTH AFFAIR, V33, P1123, DOI 10.1377/hlthaff.2014.0041; Bindman AB, 2008, MED CARE, V46, P1049, DOI 10.1097/MLR.0b013e318185ce24; Brenner J, 2014, MED CARE S3, V52, pS67; Goodell S, MEDICAID MANAGED CAR; Polsky D, 2015, NEW ENGL J MED, V372, P537, DOI 10.1056/NEJMsa1413299; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099	9	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					345	346		10.1001/jama.2015.8209	http://dx.doi.org/10.1001/jama.2015.8209			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219048	Green Published			2022-12-28	WOS:000358581700012
J	Hwang, A; Sharfstein, JM; Koller, CF				Hwang, Ann; Sharfstein, Joshua M.; Koller, Christopher F.			State Leadership in Health Care Transformation Red and Blue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hwang, Ann] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Koller, Christopher F.] Milbank Mem Fund, New York, NY USA	Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hwang, A (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180A Longwood Ave,Second Floor, Boston, MA 02115 USA.	hwang2@hcp.med.harvard.edu						CMS, STAT INN MOD IN GEN; National Association of State Budget Officers (NASBO), 2014, STAT EXP REP EX FISC; Schoenberg M, 2015, STATE EXPERIENCES DE	3	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					349	350		10.1001/jama.2015.8211	http://dx.doi.org/10.1001/jama.2015.8211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219050				2022-12-28	WOS:000358581700014
J	Donia, MS; Fischbach, MA				Donia, Mohamed S.; Fischbach, Michael A.			Small molecules from the human microbiota	SCIENCE			English	Review							FRAGILIS CAPSULAR POLYSACCHARIDE; NONRIBOSOMAL PEPTIDE SYNTHETASE; LANTIBIOTIC SALIVARICIN-A; STAPHYLOCOCCUS-AUREUS; NATURAL-PRODUCTS; MYCOBACTERIUM-ULCERANS; GENE-CLUSTER; SIDEROPHORE BIOSYNTHESIS; STREPTOCOCCUS-MUTANS; SECONDARY METABOLISM	Developments in the use of genomics to guide natural product discovery and a recent emphasis on understanding the molecular mechanisms of microbiota-host interactions have converged on the discovery of small molecules from the human microbiome. Here, we review what is known about small molecules produced by the human microbiota. Numerous molecules representing each of the major metabolite classes have been found that have a variety of biological activities, including immune modulation and antibiosis. We discuss technologies that will affect how microbiota-derived molecules are discovered in the future and consider the challenges inherent in finding specific molecules that are critical for driving microbe-host and microbe-microbe interactions and understanding their biological relevance.				donia@princeton.edu; fischbach@fischbachgroup.org		Fischbach, Michael/0000-0003-3079-8247	Princeton University; W.M. Keck Foundation; David and Lucile Packard Foundation; Burroughs Wellcome Foundation; Defense Advanced Research Projects Agency [HR0011-12-C-0067]; Program for Breakthrough Biomedical Research; NIH [OD007290, AI101018, GM081879, DK101674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007290] Funding Source: NIH RePORTER	Princeton University(Princeton University); W.M. Keck Foundation(W.M. Keck Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Program for Breakthrough Biomedical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Fischbach and Donia groups for helpful discussions. Work in the authors' laboratories is supported by Princeton University (M.S.D.); a Medical Research Program Grant from the W.M. Keck Foundation (M.A.F.); a Fellowship for Science and Engineering from the David and Lucile Packard Foundation (M.A.F.); an Investigators in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Foundation (M.A.F.); Defense Advanced Research Projects Agency award HR0011-12-C-0067 (M.A.F.); the Program for Breakthrough Biomedical Research (M.A.F.); and NIH grants OD007290, AI101018, GM081879, and DK101674 (M.A.F.). M.A.F. is on the scientific advisory boards of NGM Biopharmaceuticals and Warp Drive Bio.	AGATA N, 1995, FEMS MICROBIOL LETT, V129, P17, DOI 10.1016/0378-1097(95)00119-P; AKIMOTO K, 1993, TETRAHEDRON LETT, V34, P5593, DOI 10.1016/S0040-4039(00)73890-1; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barbour A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077751; Barkan D, 2012, INFECT IMMUN, V80, P1958, DOI 10.1128/IAI.00021-12; BARKER HA, 1981, ANNU REV BIOCHEM, V50, P23, DOI 10.1146/annurev.bi.50.070181.000323; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bian XY, 2013, CHEMBIOCHEM, V14, P1194, DOI 10.1002/cbic.201300208; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Brachmann AO, 2013, ADV BIOCHEM ENG BIOT, V135, P123, DOI 10.1007/10_2013_192; Brotherton CA, 2013, J AM CHEM SOC, V135, P3359, DOI 10.1021/ja312154m; Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Burokas A, 2015, ADV APPL MICROBIOL, V91, P1, DOI 10.1016/bs.aambs.2015.02.001; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Chany AC, 2013, NAT PROD REP, V30, P1527, DOI 10.1039/c3np70068b; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Coburn PS, 2003, CELL MICROBIOL, V5, P661, DOI 10.1046/j.1462-5822.2003.00310.x; Cotter PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000144; Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257; Crawford JM, 2011, CHEM COMMUN, V47, P7559, DOI 10.1039/c1cc11574j; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Crost EH, 2011, BIOCHIMIE, V93, P1487, DOI 10.1016/j.biochi.2011.05.001; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Cursino L, 2006, J APPL MICROBIOL, V100, P821, DOI 10.1111/j.1365-2672.2006.02834.x; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Daly KM, 2010, J BACTERIOL, V192, P1131, DOI 10.1128/JB.01375-09; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Donia MS, 2011, P NATL ACAD SCI USA, V108, pE1423, DOI 10.1073/pnas.1111712108; Duquesne S, 2007, NAT PROD REP, V24, P708, DOI 10.1039/b516237h; Ehling-Schulz M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-20; Ekkelenkamp MB, 2005, FEBS LETT, V579, P1917, DOI 10.1016/j.febslet.2005.01.083; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Flatt PM, 2007, NAT PROD REP, V24, P358, DOI 10.1039/b603816f; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gerard P, 2014, PATHOGENS, V3, P14, DOI 10.3390/pathogens3010014; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gonzalez DJ, 2010, J BIOL CHEM, V285, P28220, DOI 10.1074/jbc.M110.118554; Heidrich C, 1998, APPL ENVIRON MICROB, V64, P3140; Hogenauer C, 2006, NEW ENGL J MED, V355, P2418, DOI 10.1056/NEJMoa054765; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Hong H, 2008, NAT PROD REP, V25, P447, DOI 10.1039/b803101k; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; JACK RW, 1994, EUR J BIOCHEM, V220, P455, DOI 10.1111/j.1432-1033.1994.tb18643.x; Joyner PM, 2010, ORG BIOMOL CHEM, V8, P5486, DOI 10.1039/c0ob00579g; Kishi Y, 2011, P NATL ACAD SCI USA, V108, P6703, DOI 10.1073/pnas.1015252108; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Lai YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096292; LaMarche MJ, 2012, J MED CHEM, V55, P2376, DOI 10.1021/jm201685h; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Layre E, 2009, CHEM BIOL, V16, P82, DOI 10.1016/j.chembiol.2008.11.008; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Long SR, 2001, PLANT PHYSIOL, V125, P69, DOI 10.1104/pp.125.1.69; Marcille F, 2002, APPL ENVIRON MICROB, V68, P3424, DOI 10.1128/AEM.68.7.3424-3431.2002; Marcobal A, 2013, ISME J, V7, P1933, DOI 10.1038/ismej.2013.89; Margulis L., 1991, SYMBIOSISOURCE EVO; Marion E, 2014, CELL, V157, P1565, DOI 10.1016/j.cell.2014.04.040; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; MARSHALL JH, 1981, J BACTERIOL, V147, P900, DOI 10.1128/JB.147.3.900-913.1981; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McCranie EK, 2014, NAT PROD REP, V31, P1026, DOI 10.1039/c3np70128j; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; McWilliams V, 2012, DRUGS, V72, P2167, DOI 10.2165/11470590-000000000-00000; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Melby JO, 2011, CURR OPIN CHEM BIOL, V15, P369, DOI 10.1016/j.cbpa.2011.02.027; Micenkova L, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-109; Mitchell DA, 2009, J BIOL CHEM, V284, P13004, DOI 10.1074/jbc.M900802200; Molloy EM, 2011, NAT REV MICROBIOL, V9, P670, DOI 10.1038/nrmicro2624; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Mostafavi AZ, 2013, BIOCHEMISTRY-US, V52, P1939, DOI 10.1021/bi400126w; Mve-Obiang A, 2003, INFECT IMMUN, V71, P774, DOI 10.1128/IAI.71.2.774-783.2003; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nascimento JS, 2006, LETT APPL MICROBIOL, V42, P215, DOI 10.1111/j.1472-765X.2005.01832.x; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nolan EM, 2007, J AM CHEM SOC, V129, P14336, DOI 10.1021/ja074650f; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Olivier AC, 2009, J INFECT DIS, V200, P1367, DOI 10.1086/606012; OZAKI H, 1991, J BIOL CHEM, V266, P5934; Patel KP, 2012, CLIN J AM SOC NEPHRO, V7, P982, DOI 10.2215/CJN.12491211; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Pujol A, 2011, FEMS MICROBIOL ECOL, V78, P405, DOI 10.1111/j.1574-6941.2011.01176.x; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; RAMARE F, 1993, APPL ENVIRON MICROB, V59, P2876, DOI 10.1128/AEM.59.9.2876-2883.1993; Ridlon JM, 2010, ANAEROBE, V16, P137, DOI 10.1016/j.anaerobe.2009.05.004; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; ROSS KF, 1993, APPL ENVIRON MICROB, V59, P2014, DOI 10.1128/AEM.59.7.2014-2021.1993; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Roush RF, 2008, J AM CHEM SOC, V130, P3603, DOI 10.1021/ja7101949; SAHL HG, 1981, J GEN MICROBIOL, V127, P377; Sarfo FS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-202; Schneditz G, 2014, P NATL ACAD SCI USA, V111, P13181, DOI 10.1073/pnas.1403274111; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; SCOTT JC, 1992, FEMS MICROBIOL LETT, V93, P97, DOI 10.1016/0378-1097(92)90496-B; Secher T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077157; Smajs D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-288; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sun F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015703; SUWAN S, 1995, J CHEM SOC PERK T 1, P765, DOI 10.1039/p19950000765; Sztajer H, 2014, ISME J, V8, P2256, DOI 10.1038/ismej.2014.73; TAGG JR, 1978, ANTIMICROB AGENTS CH, V14, P31, DOI 10.1128/AAC.14.1.31; TAKAKI M, 1985, NEUROSCIENCE, V16, P223, DOI 10.1016/0306-4522(85)90059-4; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Teplova VV, 2006, TOXICOL APPL PHARM, V210, P39, DOI 10.1016/j.taap.2005.06.012; Troutman JM, 2014, CARBOHYD RES, V395, P19, DOI 10.1016/j.carres.2014.06.003; van Heel AJ, 2011, EXPERT OPIN DRUG MET, V7, P675, DOI 10.1517/17425255.2011.573478; Van Rhijn I, 2013, NAT IMMUNOL, V14, P706, DOI 10.1038/ni.2630; Velasquez JE, 2011, CHEM BIOL, V18, P857, DOI 10.1016/j.chembiol.2011.05.007; Vizcaino MI, 2015, NAT CHEM, V7, P411, DOI [10.1038/NCHEM.2221, 10.1038/nchem.2221]; Vizcaino MI, 2014, J AM CHEM SOC, V136, P9244, DOI 10.1021/ja503450q; Wang XR, 2012, ORG BIOMOL CHEM, V10, P2044, DOI 10.1039/c2ob06856g; Wescombe PA, 2006, APPL ENVIRON MICROB, V72, P1459, DOI 10.1128/AEM.72.2.1459-1466.2006; Wescombe Philip A, 2012, Int J Microbiol, V2012, P738503, DOI 10.1155/2012/738503; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; WIELAND B, 1994, J BACTERIOL, V176, P7719, DOI 10.1128/JB.176.24.7719-7726.1994; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams BB, 2014, CELL HOST MICROBE, V16, P495, DOI 10.1016/j.chom.2014.09.001; Wooley RE, 1999, AVIAN DIS, V43, P245, DOI 10.2307/1592614; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Wu CG, 2010, APPL ENVIRON MICROB, V76, P5815, DOI 10.1128/AEM.03079-09; Wyatt MA, 2010, SCIENCE, V329, P294, DOI 10.1126/science.1188888; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhang YX, 2015, CURR OPIN BIOTECH, V32, P136, DOI 10.1016/j.copbio.2014.12.006; Ziemert N, 2014, P NATL ACAD SCI USA, V111, pE1130, DOI 10.1073/pnas.1324161111; Zimmermann M, 2010, CHEM BIOL, V17, P925, DOI 10.1016/j.chembiol.2010.08.006; Zschuttig A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033351	148	411	425	12	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246							1254766	10.1126/science.1254766	http://dx.doi.org/10.1126/science.1254766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206939	Green Accepted			2022-12-28	WOS:000358381400034
J	Dyer, O				Dyer, Owen			Dr Foster goes to America	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												owen_dyer@hotmail.com						Association of American Medical Colleges, GUID PRINC PUBL REP; Austin JM, 2015, HEALTH AFFAIR, V34, P423, DOI 10.1377/hlthaff.2014.0201; Healthcare Association of New York State, 2013, REP ON REP CARDS; US News and World Report, 2015, US NEWS WORLD REPORT	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2015	351								h3928	10.1136/bmj.h3928	http://dx.doi.org/10.1136/bmj.h3928			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WI	26202944				2022-12-28	WOS:000358644600006
J	Lewis, JD; Habel, LA; Quesenberry, CP; Strom, BL; Peng, T; Hedderson, MM; Ehrlich, SF; Mamtani, R; Bilker, W; Vaughn, DJ; Nessel, L; Van Den Eeden, SK; Ferrara, A				Lewis, James D.; Habel, Laurel A.; Quesenberry, Charles P.; Strom, Brian L.; Peng, Tiffany; Hedderson, Monique M.; Ehrlich, Samantha F.; Mamtani, Ronac; Bilker, Warren; Vaughn, David J.; Nessel, Lisa; Van Den Eeden, Stephen K.; Ferrara, Assiamira			Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DECREASED RISK; METAANALYSIS; THIAZOLIDINEDIONES; ROSIGLITAZONE; METFORMIN; PROSTATE; MELLITUS; TAIWAN; COHORT; LUNG	IMPORTANCE Studies suggest pioglitazone use may increase risk of cancers. OBJECTIVE To examine whether pioglitazone use for diabetes is associated with risk of bladder and 10 additional cancers. DESIGN, SETTING, AND PARTICIPANTS Cohort and nested case-control analyses among persons with diabetes. A bladder cancer cohort followed 193 099 persons aged 40 years or older in 1997-2002 until December 2012; 464 case patients and 464 matched controls were surveyed about additional confounders. A cohort analysis of 10 additional cancers included 236 507 persons aged 40 years or older in 1997-2005 and followed until June 2012. Cohorts were from Kaiser Permanente Northern California. EXPOSURES Ever use, duration, cumulative dose, and time since initiation of pioglitazone as time dependent. MAIN OUTCOMES AND MEASURES Incident cancer, including bladder, prostate, female breast, lung/bronchus, endometrial, colon, non-Hodgkin lymphoma, pancreas, kidney/renal pelvis, rectum, and melanoma. RESULTS Among 193 099 persons in the bladder cancer cohort, 34 181 (18%) received pioglitazone (median duration, 2.8 years; range, 0.2-13.2 years) and 1261 had incident bladder cancer. Crude incidences of bladder cancer in pioglitazone users and nonusers were 89.8 and 75.9 per 100 000 person-years, respectively. Ever use of pioglitazone was not associated with bladder cancer risk (adjusted hazard ratio [HR], 1.06; 95% CI, 0.89-1.26). Results were similar in case-control analyses (pioglitazone use: 19.6% among case patients and 17.5% among controls; adjusted odds ratio, 1.18; 95% CI, 0.78-1.80). In adjusted analyses, there was no association with 8 of the 10 additional cancers; ever use of pioglitazone was associated with increased risk of prostate cancer (HR, 1.13; 95% CI, 1.02-1.26) and pancreatic cancer (HR, 1.41; 95% CI, 1.16-1.71). Crude incidences of prostate and pancreatic cancer in pioglitazone users vs nonusers were 453.3 vs 449.3 and 81.1 vs 48.4 per 100 000 person-years, respectively. No clear patterns of risk for any cancer were observed for time since initiation, duration, or dose. CONCLUSIONS AND RELEVANCE Pioglitazone use was not associated with a statistically significant increased risk of bladder cancer, although an increased risk, as previously observed, could not be excluded. The increased prostate and pancreatic cancer risks associated with ever use of pioglitazone merit further investigation to assess whether they are causal or are due to chance, residual confounding, or reverse causality.	[Lewis, James D.; Strom, Brian L.; Mamtani, Ronac; Bilker, Warren; Nessel, Lisa] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Lewis, James D.; Strom, Brian L.; Mamtani, Ronac; Bilker, Warren] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Lewis, James D.; Mamtani, Ronac; Vaughn, David J.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Habel, Laurel A.; Quesenberry, Charles P.; Peng, Tiffany; Hedderson, Monique M.; Ehrlich, Samantha F.; Van Den Eeden, Stephen K.; Ferrara, Assiamira] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; [Strom, Brian L.] Rutgers Biomed & Hlth Sci, New Brunswick, NJ USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Kaiser Permanente; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ferrara, A (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	assiamira.ferrara@kp.org	Ehrlich, Samantha/AAZ-1382-2020; Bilker, Warren/AAS-3515-2021	Ehrlich, Samantha/0000-0002-0074-8399; Ferrara, Assiamira/0000-0002-7505-4826; Habel, Laurel/0000-0002-7230-587X	Takeda Development Center Americas Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092924] Funding Source: NIH RePORTER	Takeda Development Center Americas Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by a grant from Takeda Development Center Americas Inc.	[Anonymous], 2013, ACT PIOGL HCI; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Bosetti C, 2013, ONCOLOGIST, V18, P148, DOI 10.1634/theoncologist.2012-0302; Chang CH, 2012, HEPATOLOGY, V55, P1462, DOI 10.1002/hep.25509; Chen RL, 1998, CANCER DETECT PREV, V22, P533, DOI 10.1046/j.1525-1500.1998.00A47.x; Colmers IN, 2012, DIABETES METAB, V38, P475, DOI 10.1016/j.diabet.2012.06.003; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Erdmann E, 2014, DIABETES OBES METAB, V16, P63, DOI 10.1111/dom.12180; Ferrara A, 2011, DIABETES CARE, V34, P923, DOI 10.2337/dc10-1067; Friedman G., 2000, PHARMACOEPIDEMIOLOGY, V3rd ed, P263, DOI [10.1002/0470842555.ch16, DOI 10.1002/0470842555.CH16]; Gomella LG, 2013, CAN J UROL, V20, P6668; Govindarajan R, 2007, J CLIN ONCOL, V25, P1476, DOI 10.1200/JCO.2006.07.2777; Henney JE, 2000, JAMA-J AM MED ASSOC, V283, P2228, DOI 10.1001/jama.283.17.2228-b; Hillaire-Buys D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3500; Johnson JA, 2012, DIABETES RES CLIN PR, V98, P1, DOI 10.1016/j.diabres.2012.08.005; Koro C, 2007, PHARMACOEPIDEM DR S, V16, P485, DOI 10.1002/pds.1352; KUNZE E, 1992, CANCER-AM CANCER SOC, V69, P1776, DOI 10.1002/1097-0142(19920401)69:7<1776::AID-CNCR2820690721>3.0.CO;2-P; Lai SW, 2012, CLIN LUNG CANCER, V13, P143, DOI 10.1016/j.cllc.2011.10.002; Lewis JD, 2014, PHARMACOEPIDEM DR S, V23, P636, DOI 10.1002/pds.3619; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P246, DOI 10.1001/jama.2013.8141; Monami M, 2014, ACTA DIABETOL, V51, P91, DOI 10.1007/s00592-013-0504-8; Neumann A, 2012, DIABETOLOGIA, V55, P1953, DOI 10.1007/s00125-012-2538-9; Oleksiewicz MB, 2008, PPAR RES, V2008, DOI 10.1155/2008/103167; Oliveria SA, 2008, DIABETES METAB SYND, V2, P47, DOI 10.1016/j.dsx.2007.11.002; Sinha B, 2013, DIABETES METAB SYND, V7, P243, DOI 10.1016/j.dsx.2013.06.005; Stephenson J, 2011, JAMA-J AM MED ASSOC, V306, P143, DOI 10.1001/jama.2011.939; Suissa S, 2012, DIABETES CARE, V35, P2665, DOI 10.2337/dc12-0788; Takkouche B, 2009, INT J EPIDEMIOL, V38, P1512, DOI 10.1093/ije/dyp283; Tseng CH, 2014, METABOLISM, V63, P1049, DOI 10.1016/j.metabol.2014.04.014; Tseng CH, 2013, GYNECOL ONCOL, V131, P135, DOI 10.1016/j.ygyno.2013.07.087; Turner RM, 2014, BRIT J CLIN PHARMACO, V78, P258, DOI 10.1111/bcp.12306; Vallarino C, 2013, CLIN DRUG INVEST, V33, P621, DOI 10.1007/s40261-013-0106-9; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Wong HK, 2014, ANN EPIDEMIOL, V24, P516, DOI 10.1016/j.annepidem.2014.05.001; Woodcock J, 2010, NEW ENGL J MED, V363, P1489, DOI 10.1056/NEJMp1010788	37	208	214	4	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					265	277		10.1001/jama.2015.7996	http://dx.doi.org/10.1001/jama.2015.7996			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197187	Bronze			2022-12-28	WOS:000358228000021
J	Navar, AM; Pencina, M				Navar, Ann Marie; Pencina, Michael			In adults without CV disease, most prediction scores overestimated risk for atherosclerotic CV events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Navar, Ann Marie; Pencina, Michael] Duke Clin Res Inst, Durham, NC 27705 USA	Duke University	Navar, AM (corresponding author), Duke Clin Res Inst, Durham, NC 27705 USA.								0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2							JC13	10.7326/ACPJC-2015-163-2-013	http://dx.doi.org/10.7326/ACPJC-2015-163-2-013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26192581				2022-12-28	WOS:000358407500013
J	Pottegard, A; Henriksen, DP; Madsen, KG; Hellfritzsch, M; Damkier, P; Stage, TB				Pottegard, Anton; Henriksen, Daniel P.; Madsen, Kenneth G.; Hellfritzsch, Maja; Damkier, Per; Stage, Tore B.			Change in International Normalized Ratio Among Patients Treated With Dicloxacillin and Vitamin K Antagonists	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							WARFARIN		[Pottegard, Anton; Madsen, Kenneth G.; Hellfritzsch, Maja; Damkier, Per; Stage, Tore B.] Univ Southern Denmark, Clin Pharmacol, DK-5000 Odense C, Denmark; [Henriksen, Daniel P.] Odense Univ Hosp, Dept Clin Chem & Pharmacol, DK-5000 Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Pottegard, A (corresponding author), Univ Southern Denmark, Clin Pharmacol, JB Winslows Vej 19, DK-5000 Odense C, Denmark.	apottegaard@health.sdu.dk	Damkier, Per/P-8217-2019; Madsen, Kenneth/C-7778-2012	Damkier, Per/0000-0003-0591-7187; Madsen, Kenneth/0000-0001-9274-6691; Pottegard, Anton/0000-0001-9314-5679; Stage, Tore Bjerregaard/0000-0002-4698-4389; Henriksen, Daniel Pilsgaard/0000-0003-1303-6195				Chen YP, 2009, CURR DRUG METAB, V10, P567, DOI 10.2174/138920009789375397; Khalili H, 2013, EUR J CLIN PHARMACOL, V69, P721, DOI 10.1007/s00228-012-1384-5; Lacey CS, 2004, ANN PHARMACOTHER, V38, P898, DOI 10.1345/aph.1D484; Mailloux AT, 1996, ANN PHARMACOTHER, V30, P1402, DOI 10.1177/106002809603001208; Self TH, 2015, THROMB RES, V135, P5, DOI 10.1016/j.thromres.2014.10.015; Yasuda K, 2008, DRUG METAB DISPOS, V36, P1689, DOI 10.1124/dmd.108.020701	6	16	16	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					296	297		10.1001/jama.2015.6669	http://dx.doi.org/10.1001/jama.2015.6669			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26197191	Bronze			2022-12-28	WOS:000358228000025
J	Ren, RB; Zhou, XH; He, Y; Ke, M; Wu, JP; Liu, XH; Yan, CY; Wu, YX; Gong, X; Lei, XG; Yan, SF; Radhakrishnan, A; Yan, NE				Ren, Ruobing; Zhou, Xinhui; He, Yuan; Ke, Meng; Wu, Jianping; Liu, Xiaohui; Yan, Chuangye; Wu, Yixuan; Gong, Xin; Lei, Xiaoguang; Yan, S. Frank; Radhakrishnan, Arun; Yan, Nieng			Crystal structure of a mycobacterial Insig homolog provides insight into how these sensors monitor sterol levels	SCIENCE			English	Article							CLEAVAGE-ACTIVATING PROTEIN; BOUND TRANSCRIPTION FACTOR; ELEMENT-BINDING PROTEINS; LEUCINE ZIPPER PROTEIN; HMG-COA REDUCTASE; ENDOPLASMIC-RETICULUM; REGULATORY ELEMENT; SREBP PATHWAY; FISSION YEAST; CHOLESTEROL HOMEOSTASIS	Insulin-induced gene 1 (Insig-1) and Insig-2 are endoplasmic reticulum membrane-embedded sterol sensors that regulate the cellular accumulation of sterols. Despite their physiological importance, the structural information on Insigs remains limited. Here we report the high-resolution structures of MvINS, an Insig homolog from Mycobacterium vanbaalenii. MvINS exists as a homotrimer. Each protomer comprises six transmembrane segments (TMs), with TM3 and TM4 contributing to homotrimerization. The six TMs enclose a V-shaped cavity that can accommodate a diacylglycerol molecule. A homology-based structural model of human Insig-2, together with biochemical characterizations, suggest that the central cavity of Insig-2 accommodates 25-hydroxycholesterol, whereas TM3 and TM4 engage in Scap binding. These analyses provide an important framework for further functional and mechanistic understanding of Insig proteins and the sterol regulatory element-binding protein pathway.	[Ren, Ruobing; Zhou, Xinhui; He, Yuan; Ke, Meng; Wu, Jianping; Yan, Chuangye; Wu, Yixuan; Gong, Xin; Yan, Nieng] Tsinghua Univ, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Ren, Ruobing; Zhou, Xinhui; He, Yuan; Ke, Meng; Wu, Jianping; Yan, Chuangye; Wu, Yixuan; Gong, Xin; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Sch Med, Struct Biol Ctr, Beijing 100084, Peoples R China; [Ren, Ruobing; Zhou, Xinhui; He, Yuan; Ke, Meng; Wu, Jianping; Yan, Chuangye; Wu, Yixuan; Gong, Xin; Yan, Nieng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Liu, Xiaohui; Lei, Xiaoguang] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Yan, S. Frank] Roche Pharma Res & Early Dev, Roche Innovat Ctr Shanghai, Molecular Design & Chem Biol, Therapeut Modal, Shanghai 201203, Peoples R China; [Radhakrishnan, Arun] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Tsinghua University; Tsinghua University; Tsinghua University; National Institute of Biological Sciences, Beijing; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yan, NE (corresponding author), Tsinghua Univ, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Radhakrishnan, Arun/Q-7437-2019; Yan, Chuangye/AAJ-5832-2021; Gong, Xin/W-6531-2018	Radhakrishnan, Arun/0000-0002-7266-7336; Yan, Chuangye/0000-0001-9338-8048; Ke, Meng/0000-0002-9213-7439; Ren, Ruobing/0000-0003-4517-7216; Yan, Frank/0000-0002-9121-9694	Ministry of Science and Technology of China [2015CB910101, 2011CB910501, 2014ZX09507003006]; National Natural Science Foundation of China [31130002, 31125009, 91313303, 20122209]; National Institutes of Health [HL-20948]; American Heart Association [12SDG12040267]; Welch Foundation [I-1793]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Rye, M. Brown, and J. Goldstein (University of Texas Southwestern Medical Center) for their assistance with studies on human Insig-2. We thank J. He, L. Tang, F. Yu, B. Sun, and S. Huang at the Shanghai Synchrotron Radiation Facility (SSRF) and K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU for onsite assistance; and B. Javid for critical discussion. This work was supported by funds from the Ministry of Science and Technology of China (grants 2015CB910101, 2011CB910501, 2014ZX09507003006) and National Natural Science Foundation of China (projects 31130002, 31125009, 91313303, and 20122209). A.R. was supported by the National Institutes of Health (HL-20948), American Heart Association (12SDG12040267), and Welch Foundation (I-1793). The research of N.Y. was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute and an endowed professorship from Bayer Healthcare. The coordinates and structure factors of the MvINS proteins have been deposited in the Protein Data Bank with accession codes 4XU4, 4XU5, and 4XU6. The authors declare no competing financial interests.	Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Burg JS, 2008, CELL METAB, V8, P522, DOI 10.1016/j.cmet.2008.09.004; Chemical Computing Group ULC, 2013, MOL OP ENV MOE; DeLano W.L, PYMOL MOL GRAPHICS S; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Gong X, 2015, CELL RES, V25, P401, DOI 10.1038/cr.2015.32; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yang T, 2000, J BIOL CHEM, V275, P29881, DOI 10.1074/jbc.M005439200; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	37	31	32	4	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					187	191		10.1126/science.aab1091	http://dx.doi.org/10.1126/science.aab1091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26160948	Green Accepted			2022-12-28	WOS:000357664300044
J	Qadri, F; Ali, M; Chowdhury, F; Khan, AI; Saha, A; Khan, IA; Begum, YA; Bhuiyan, TQR; Chowdhury, MI; Uddin, MJ; Khan, JAM; Chowdhury, AI; Rahman, A; Siddique, SA; Asaduzzaman, M; Akter, A; Khan, A; You, YA; Siddik, AU; Saha, NC; Kabir, A; Riaz, BK; Biswas, SK; Begum, F; Unicomb, L; Luby, SP; Cravioto, A; Clemens, JD				Qadri, Firdausi; Ali, Mohammad; Chowdhury, Fahima; Khan, Ashraful Islam; Saha, Amit; Khan, Iqbal Ansary; Begum, Yasmin A.; Bhuiyan, Taufi Qur R.; Chowdhury, Mohiul Islam; Uddin, Md Jasim; Khan, Jahangir A. M.; Chowdhury, Atique Iqbal; Rahman, Anisur; Siddique, Shah Alam; Asaduzzaman, Muhammad; Akter, Afroza; Khan, Arifuzzaman; You, Young Ae; Siddik, Ashraf Uddin; Saha, Nirod Chandra; Kabir, Alamgir; Riaz, Baizid Khoorshid; Biswas, Shwapon Kumar; Begum, Farzana; Unicomb, Leanne; Luby, Stephen P.; Cravioto, Alejandro; Clemens, John D.			Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial	LANCET			English	Article							GM1-ENZYME-LINKED IMMUNOSORBENT-ASSAY; ENTEROTOXIGENIC ESCHERICHIA-COLI; VIBRIO-CHOLERAE; EFFICACY; MODEL; DHAKA; COST	Background Cholera is endemic in Bangladesh with epidemics occurring each year. The decision to use a cheap oral killed whole-cell cholera vaccine to control the disease depends on the feasibility and effectiveness of vaccination when delivered in a public health setting. We therefore assessed the feasibility and protective effect of delivering such a vaccine through routine government services in urban Bangladesh and evaluated the benefit of adding behavioural interventions to encourage safe drinking water and hand washing to vaccination in this setting. Methods We did this cluster-randomised open-label trial in Dhaka, Bangladesh. We randomly assigned 90 clusters (1: 1: 1) to vaccination only, vaccination and behavioural change, or no intervention. The primary outcome was overall protective effectiveness, assessed as the risk of severely dehydrating cholera during 2 years after vaccination for all individuals present at time of the second dose. This study is registered with ClinicalTrials.gov, number NCT01339845. Findings Of 268 896 people present at baseline, we analysed 267 270: 94 675 assigned to vaccination only, 92 539 assigned to vaccination and behavioural change, and 80 056 assigned to non-intervention. Vaccine coverage was 65% in the vaccination only group and 66% in the vaccination and behavioural change group. Overall protective eff ectiveness was 37% (95% CI lower bound 18%; p=0.002) in the vaccination group and 45% (95% CI lower bound 24%; p= 0.001) in the vaccination and behavioural change group. We recorded no vaccine-related serious adverse events. Interpretation Our findings provide the first indication of the effect of delivering an oral killed whole-cell cholera vaccine to poor urban populations with endemic cholera using routine government services and will help policy makers to formulate vaccination strategies to reduce the burden of severely dehydrating cholera in such populations.	[Qadri, Firdausi; Chowdhury, Fahima; Khan, Ashraful Islam; Saha, Amit; Khan, Iqbal Ansary; Begum, Yasmin A.; Bhuiyan, Taufi Qur R.; Chowdhury, Mohiul Islam; Uddin, Md Jasim; Chowdhury, Atique Iqbal; Rahman, Anisur; Siddique, Shah Alam; Asaduzzaman, Muhammad; Akter, Afroza; Khan, Arifuzzaman; Siddik, Ashraf Uddin; Saha, Nirod Chandra; Kabir, Alamgir; Biswas, Shwapon Kumar; Begum, Farzana; Unicomb, Leanne; Clemens, John D.] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Riaz, Baizid Khoorshid] Govt Bangladesh, Dhaka, Bangladesh; [You, Young Ae; Cravioto, Alejandro] Int Vaccine Inst, Seoul, South Korea; [Ali, Mohammad] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA; [Luby, Stephen P.] Stanford Univ, Stanford, CA 94305 USA; [Clemens, John D.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA	International Centre for Diarrhoeal Disease Research (ICDDR); International Vaccine Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Stanford University; University of California System; University of California Los Angeles	Qadri, F (corresponding author), Int Ctr Diarrhoeal Dis Res Icddr B, 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali Dhaka 1212, Bangladesh.	fqadri@icddrb.org	Al, Mamun M./AAF-5850-2019; Khan, Arifuzzaman/C-1117-2019; Khan, Jahangir/AAG-4014-2019; Ali, Mohammad/E-2365-2017; Unicomb, Leanne Elizabeth/AAW-4900-2021; Kabir, Alamgir/H-3430-2019; Qadri, Firdausi/AAF-4583-2019; Asaduzzaman, Muhammad/O-5081-2017	Khan, Arifuzzaman/0000-0003-4770-8308; Ali, Mohammad/0000-0003-1410-388X; Unicomb, Leanne Elizabeth/0000-0002-7757-5641; Asaduzzaman, Muhammad/0000-0001-9048-7980; Luby, Stephen/0000-0001-5385-899X; Kabir, Alamgir/0000-0002-3762-8307; KHAN, JAHANGIR/0000-0002-6151-764X	Bill & Melinda Gates Foundation; Bill & Melinda Gates Foundation [OPP50419]; Government of Australia; Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Government of Australia; Government of Bangladesh; Government of Canada(CGIAR); Government of Sweden; Government of UK	Bill & Melinda Gates Foundation.; This study was supported by grant OPP50419 from the Bill & Melinda Gates Foundation. The study was also supported by core grants to the icddr,b. The icddr, b is thankful to the Governments of Australia, Bangladesh, Canada, Sweden, and the UK for providing core or unrestricted support. Shantha-Sanofi provided vaccine for the study at a discretionary price. We thank the people of Mirpur where our study is being undertaken; the field, laboratory, and data management staff who made tremendous efforts to make the study successful; and the people who provided valuable support to our study.	Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; Ansaruzzaman M, 2004, EMERG INFECT DIS, V10, P2057, DOI 10.3201/eid1011.040682; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Chowdhury F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000999; Halloran ME, 1997, AM J EPIDEMIOL, V146, P789; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Hulland KRS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-877; JERTBORN M, 1986, J CLIN MICROBIOL, V24, P203, DOI 10.1128/JCM.24.2.203-209.1986; Kanungo S, 2009, VACCINE, V27, P6887, DOI 10.1016/j.vaccine.2009.09.008; Khan IA, 2013, VACCINE, V31, P6058, DOI 10.1016/j.vaccine.2013.10.021; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lee E. W., 1992, SURVIVAL ANAL STATE, P237, DOI [DOI 10.1007/978-94-015-7983-4_14, 10.1007/978-94-015-7983-4_14]; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Luquero FJ, 2014, NEW ENGL J MED, V370, P2111, DOI 10.1056/NEJMoa1312680; REID N, 1985, BIOMETRIKA, V72, P1; Rodas C, 2009, J CLIN MICROBIOL, V47, P1218, DOI 10.1128/JCM.00316-09; Sarker AR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-518; Shapiro ED, 2004, PEDIATR INFECT DIS J, V23, P127, DOI 10.1097/01.inf.0000109248.32907.1d; Sinclair D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008603.pub2; Sridhar S, 2013, LANCET INFECT DIS, V13, P1000, DOI 10.1016/S1473-3099(13)70296-2; Sur D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001289; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; SVENNERHOLM AM, 1986, J CLIN MICROBIOL, V24, P585, DOI 10.1128/JCM.24.4.585-590.1986; SVENNERHOLM AM, 1983, J CLIN MICROBIOL, V17, P596, DOI 10.1128/JCM.17.4.596-600.1983; Wahed T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-242; World Health Organization, 2005, TREATM DIARRH MAN PH	28	93	94	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2015	386	10001					1362	1371		10.1016/S0140-6736(15)61140-0	http://dx.doi.org/10.1016/S0140-6736(15)61140-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CS8DP	26164097				2022-12-28	WOS:000362316200029
J	Green, DM				Green, Daniel M.			Doxorubicin in stage II-III, intermediate-risk Wilms' tumour	LANCET			English	Editorial Material							CHILDHOOD-CANCER; RENAL TUMORS; SURVIVORS; COHORT		St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Green, DM (corresponding author), St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 332 N Lauderdale St, Memphis, TN 38105 USA.	daniel.green@stjude.org						BECKWITH JB, 1986, J UROLOGY, V136, P320, DOI 10.1016/S0022-5347(17)44854-3; BRISTOW MR, 1978, ANN INTERN MED, V88, P168, DOI 10.7326/0003-4819-88-2-168; DANGIO GJ, 1989, CANCER-AM CANCER SOC, V64, P349, DOI 10.1002/1097-0142(19890715)64:2<349::AID-CNCR2820640202>3.0.CO;2-Q; Green DM, 2014, LANCET ONCOL, V15, P1215, DOI 10.1016/S1470-2045(14)70408-5; Green DM, 2004, J CLIN ONCOL, V22, P1366, DOI 10.1200/JCO.2004.08.008; Hudson MM, 2007, J CLIN ONCOL, V25, P3635, DOI 10.1200/JCO.2006.09.7451; Lipshultz SE, 2013, NAT REV CLIN ONCOL, V10, P697, DOI 10.1038/nrclinonc.2013.195; Perlman EJ, 2005, PEDIATR DEVEL PATHOL, V8, P320, DOI 10.1007/s10024-005-1156-7; Pritchard-Jones K, 2015, LANCET; TOURNADE MF, 1993, J CLIN ONCOL, V11, P1014, DOI 10.1200/JCO.1993.11.6.1014; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; Vujanic GM, 2009, CANCER-AM CANCER SOC, V115, P1977, DOI 10.1002/cncr.24214	12	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					1118	1119		10.1016/S0140-6736(15)60686-9	http://dx.doi.org/10.1016/S0140-6736(15)60686-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5GE	26164099				2022-12-28	WOS:000361368000011
J	Rigotti, NA; Wallace, RB				Rigotti, Nancy A.; Wallace, Robert B.			Using Agent-Based Models to Address "Wicked Problems" Like Tobacco Use: A Report From the Institute of Medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Rigotti, Nancy A.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; [Wallace, Robert B.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Iowa	Rigotti, NA (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, 50 Staniford St,Room 914, Boston, MA 02114 USA.	nrigotti@partners.org						Chakrabarti A, 2012, ANN BIOMED ENG, V40, P2488, DOI 10.1007/s10439-012-0655-8; Hammond RA, 2009, PREV CHRONIC DIS, V6; Institute of Medicine, 2015, ASS US AG BAS MOD TO; Kolko J, 2012, STANFORD SOCIAL INNO; Lee KA, 2014, NURS OUTLOOK, V62, P313, DOI 10.1016/j.outlook.2014.07.002; Marshall BDL, 2015, AM J EPIDEMIOL, V181, P92, DOI 10.1093/aje/kwu274; Nianogo RA, 2015, AM J PUBLIC HEALTH, V105, pE20, DOI 10.2105/AJPH.2014.302426; Rubin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080671; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G	9	6	6	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2015	163	6					469	+		10.7326/M15-1567	http://dx.doi.org/10.7326/M15-1567			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR5FL	26216183				2022-12-28	WOS:000361365900022
J	Skoglund, P; Mallick, S; Bortolini, MC; Chennagiri, N; Hunemeier, T; Petzl-Erler, ML; Salzano, FM; Patterson, N; Reich, D				Skoglund, Pontus; Mallick, Swapan; Bortolini, Maria Catira; Chennagiri, Niru; Huenemeier, Tabita; Petzl-Erler, Maria Luiza; Salzano, Francisco Mauro; Patterson, Nick; Reich, David			Genetic evidence for two founding populations of the Americas	NATURE			English	Article							HUMAN SKELETAL REMAINS; LATE PLEISTOCENE HUMAN; GENOME SEQUENCE; 1ST AMERICANS; NEW-WORLD; HISTORY; MORPHOLOGY; NEANDERTHAL; ADMIXTURE; SURVIVAL	Genetic studies have consistently indicated a single common origin of Native American groups from Central and South America(1-4). However, some morphological studies have suggested a more complex picture, whereby the northeast Asian affinities of present-day Native Americans contrast with a distinctive morphology seen in some of the earliest American skeletons, which share traits with present-day Australasians (indigenous groups in Australia, Melanesia, and island Southeast Asia)(5-8). Here we analyse genome-wide data to show that some Amazonian Native Americans descend partly from a Native American founding population that carried ancestry more closely related to indigenous Australians, New Guineans and Andaman Islanders than to any present-day Eurasians or Native Americans. This signature is not present to the same extent, or at all, in present-day Northern and Central Americans or in a similar to 12,600-year-old Clovis-associated genome, suggesting a more diverse set of founding populations of the Americas than previously accepted.	[Skoglund, Pontus; Mallick, Swapan; Chennagiri, Niru; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Skoglund, Pontus; Mallick, Swapan; Chennagiri, Niru; Patterson, Nick; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Mallick, Swapan; Reich, David] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Bortolini, Maria Catira; Salzano, Francisco Mauro] Univ Fed Rio Grande do Sul, Inst Biociencias, BR-91501970 Porto Alegre, RS, Brazil; [Huenemeier, Tabita] Univ Sao Paulo, Dept Genet Biol Evolut, BR-05508090 Sao Paulo, SP, Brazil; [Petzl-Erler, Maria Luiza] Univ Fed Parana, Dept Genet, BR-81531980 Curitiba, PR, Brazil	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade Federal do Parana	Skoglund, P (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	skoglund@genetics.med.harvard.edu; reich@genetics.med.harvard.edu	Petzl-Erler, Maria Luiza/H-8221-2012; Salzano, Francisco M/L-7916-2015; Hünemeier, Tábita/F-4181-2011	Petzl-Erler, Maria Luiza/0000-0002-0345-5276; Skoglund, Pontus/0000-0002-3021-5913; Hunemeier, Tabita/0000-0002-3156-2079	Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil); Wenner-Gren foundation; Swedish Research Council (VR) [2014-453]; US National Science Foundation HOMINID [BCS-1032255]; US National Institutes of Health [GM100233]; Simons Foundation [280376]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Wenner-Gren foundation; Swedish Research Council (VR)(Swedish Research Council); US National Science Foundation HOMINID(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the Native American volunteers who contributed the DNA samples used to generate the new data reported in this study and to the Fundacao Nacional do Indio (FUNAI, Brazil) for logistical support in sample collection. We thank W. Klitz and C. Winkler for sharing samples for whole-genome sequencing. We thank L. Fehren-Schmitz, Q. Fu, G. Hellenthal, A. Kim, I. Lazaridis, M. Lipson, I. Mathieson, D. Meltzer, P. Moorjani and J. Pickrell for comments, and A. Tandon for technical assistance. We thank T. Ferraz and R. Bisso-Machado for assistance with DNA extraction for the genotyping of Brazilian samples. We performed whole-genome sequencing aspart of the Simons Genome Diversity Project. Genotyping of the Brazilian samples was performed at the Children's Hospital of Philadelphia and we particularly thank C. Hou for her support in this. M.C.B., T.H., M.L.P.-E. and F.M.S. were supported by Conselho Nacional do Desenvolvimento Cientifico e Tecnologico and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil). P.S. was supported by the Wenner-Gren foundation and the Swedish Research Council (VR grant 2014-453). D. R. was supported by US National Science Foundation HOMINID grant BCS-1032255, US National Institutes of Health grant GM100233, Simons Foundation Grant 280376 and the Howard Hughes Medical Institute.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Becker R.A., 1993, 932 AT T BELL LAB; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Chatters JC, 2014, SCIENCE, V344, P750, DOI 10.1126/science.1252619; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Gillespie JH, 2000, GENETICS, V155, P909; Gonzalez-Jose R, 2005, AM J PHYS ANTHROPOL, V128, P772, DOI 10.1002/ajpa.20165; Gonzalez-Jose RG, 2003, NATURE, V425, P62, DOI 10.1038/nature01816; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Jantz RL, 2001, AM J PHYS ANTHROPOL, V114, P146, DOI 10.1002/1096-8644(200102)114:2<146::AID-AJPA1014>3.0.CO;2-E; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Neves WA, 2004, WORLD ARCHAEOL, V36, P479, DOI 10.1080/0043824042000303665; Neves WA, 2003, J HUM EVOL, V45, P19, DOI 10.1016/S0047-2484(03)00081-2; NEVES WA, 1990, AM J PHYS ANTHROPOL, V81, P274; Neves WA, 2007, AM J PHYS ANTHROPOL, V133, P1080, DOI 10.1002/ajpa.20637; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Qin P., 2015, MOL BIOL EVOL; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; Robbins RB, 1918, GENETICS, V3, P375; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Sparks CS, 2002, P NATL ACAD SCI USA, V99, P14636, DOI 10.1073/pnas.222389599; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185	38	185	191	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2015	525	7567					104	+		10.1038/nature14895	http://dx.doi.org/10.1038/nature14895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4SE	26196601	Green Accepted, Green Submitted			2022-12-28	WOS:000360594100034
J	Datino, T				Datino, Tomas			ADVICE on adenosine to improve atrial fibrillation ablation	LANCET			English	Editorial Material							PULMONARY VEIN CONDUCTION; CATHETER ABLATION; PATIENT		Hosp Gen Univ Gregorio Maranon, Dept Cardiol, Madrid 28007, Spain	General University Gregorio Maranon Hospital	Datino, T (corresponding author), Hosp Gen Univ Gregorio Maranon, Dept Cardiol, Madrid 28007, Spain.	tomas.datino@gmail.com		Datino, Tomas/0000-0002-9509-5801				Arentz T, 2004, J CARDIOVASC ELECTR, V15, P1041, DOI 10.1046/j.1540-8167.2004.04031.x; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Datino T, 2011, HEART RHYTHM, V8, P1426, DOI 10.1016/j.hrthm.2011.04.011; Datino T, 2010, CIRCULATION, V121, P963, DOI 10.1161/CIRCULATIONAHA.109.893107; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Jiang CY, 2009, J CARDIOVASC ELECTR, V20, P1382, DOI 10.1111/j.1540-8167.2009.01564.x; Macle L, 2015, LANCET, P60026; Matsuo S, 2010, AM HEART J, V160, P337, DOI 10.1016/j.ahj.2010.05.025; Mclellan AJA, 2013, J CARDIOVASC ELECTR, V24, P742, DOI 10.1111/jce.12121; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Miyazaki S, 2012, J CARDIOVASC ELECTR, V23, P256, DOI 10.1111/j.1540-8167.2011.02195.x; Nanthakumar K, 2004, CIRCULATION, V109, P1226, DOI 10.1161/01.CIR.0000121423.78120.49; Nishida K, 2014, J AM COLL CARDIOL, V64, P823, DOI 10.1016/j.jacc.2014.06.1172	13	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					633	634		10.1016/S0140-6736(15)60241-0	http://dx.doi.org/10.1016/S0140-6736(15)60241-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	26211829				2022-12-28	WOS:000359849200010
J	Torjesen, I				Torjesen, Ingrid			4bn pound of extra NHS funding should be allocated to patient centred reforms, IPPR think tank urges	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Core Cities, 2015, MOD CHART LOC FREED; Muir R, 2015, POWERFUL PEOPLE REIN	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2015	351								h4018	10.1136/bmj.h4018	http://dx.doi.org/10.1136/bmj.h4018			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WL	26205893				2022-12-28	WOS:000358645000016
J	Ehrenfreund, P; Foing, B				Ehrenfreund, Pascale; Foing, Bernard			Fullerene solves an interstellar puzzle	NATURE			English	Editorial Material							POLYCYCLIC AROMATIC-HYDROCARBONS; BANDS; C-60(+); FEATURES; BUCKMINSTERFULLERENE; IDENTIFICATION; SPECTRA		[Ehrenfreund, Pascale] George Washington Univ, Inst Space Policy, Washington, DC 20052 USA; [Foing, Bernard] ESA ESTEC, European Space Agcy, European Space Res & Technol Ctr, NL-2200 Noordwijk, Netherlands	George Washington University; European Space Agency	Ehrenfreund, P (corresponding author), George Washington Univ, Inst Space Policy, Washington, DC 20052 USA.	pehren@gwu.edu; bernard.foing@esa.int						ALLAMANDOLA LJ, 1985, ASTROPHYS J, V290, pL25, DOI 10.1086/184435; Berne O, 2012, P NATL ACAD SCI USA, V109, P401, DOI 10.1073/pnas.1114207108; Cami J, 2010, SCIENCE, V329, P1180, DOI 10.1126/science.1192035; Campbell EK, 2015, NATURE, V523, P322, DOI 10.1038/nature14566; Cox N.L.J., 2014, P INT ASTRON UN, V9; Ehrenfreund P, 1996, ASTRON ASTROPHYS, V307, pL25; FOING BH, 1994, NATURE, V369, P296, DOI 10.1038/369296a0; Foing BH, 1997, ASTRON ASTROPHYS, V317, pL59; FULARA J, 1993, CHEM PHYS LETT, V211, P227, DOI 10.1016/0009-2614(93)85190-Y; Galazutdinov GA, 2000, MON NOT R ASTRON SOC, V317, P750, DOI 10.1046/j.1365-8711.2000.03566.x; HERBIG GH, 1995, ANNU REV ASTRON ASTR, V33, P19, DOI 10.1146/annurev.aa.33.090195.000315; Hobbs LM, 2009, ASTROPHYS J, V705, P32, DOI 10.1088/0004-637X/705/1/32; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; LEGER A, 1984, ASTRON ASTROPHYS, V137, pL5; Salama F, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/154; SARRE PJ, 1995, MON NOT R ASTRON SOC, V277, pL41; Vuong MH, 2000, ASTRON ASTROPHYS, V363, pL5; Zhen JF, 2014, ASTROPHYS J LETT, V797, DOI 10.1088/2041-8205/797/2/L30	18	14	14	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					296	297		10.1038/523296a	http://dx.doi.org/10.1038/523296a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26178960				2022-12-28	WOS:000357950900029
J	Brooks, JR				Brooks, J. Renee			Water, bound and mobile	SCIENCE			English	Editorial Material							SEPARATION; ISOTOPES; STREAMS		US EPA, Western Ecol Div, Natl Hlth & Environm Effects Lab, Off Res & Dev, Corvallis, OR 97333 USA	United States Environmental Protection Agency	Brooks, JR (corresponding author), US EPA, Western Ecol Div, Natl Hlth & Environm Effects Lab, Off Res & Dev, Corvallis, OR 97333 USA.	brooks.reneej@epa.gov	Brooks, J. Renée/AAC-9090-2019; Brooks, J. Renee/D-9860-2018	Brooks, J. Renée/0000-0002-5008-9774; Brooks, J. Renee/0000-0002-5008-9774				Brooks JR, 2010, NAT GEOSCI, V3, P100, DOI 10.1038/NGEO722; Goldsmith GR, 2012, ECOHYDROLOGY, V5, P779, DOI 10.1002/eco.268; Good SP, 2015, GEOPHYS RES LETT, V42, P5042, DOI 10.1002/2015GL064117; Good SP, 2015, SCIENCE, V349, P175, DOI 10.1126/science.aaa5931; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; McDonnell JJ, 2014, WIRES WATER, V1, P323, DOI 10.1002/wat2.1027; Phillips FM, 2010, NAT GEOSCI, V3, P77, DOI 10.1038/ngeo762; Schlesinger WH, 2014, AGR FOREST METEOROL, V189, P115, DOI 10.1016/j.agrformet.2014.01.011; Sobota DJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/025006; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Welp LR, 2011, NATURE, V477, P579, DOI 10.1038/nature10421	11	29	30	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					138	139		10.1126/science.aac4742	http://dx.doi.org/10.1126/science.aac4742			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4OM	26160930				2022-12-28	WOS:000357664300021
J	Chhabra, E				Chhabra, Esha			Downside of becoming a richer country	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ec2440@gmail.com						French Foreign Ministry, IN 5 SIDA TUB PAL; Institute for Health Metrics and Evaluation, 2010, GLOB BURD DIS PROF V; Ministry of Health Vietnam, 2014, OPT VIET NAMS HIV RE; PEPFAR, VIETN PLANN FUND FY; UNAIDS, VIETN AIDS RESP PROG; UNAIDS, 2013, VIETN HIV AIDS EST; World health organization, 2013, WORLD HLTH STAT 2013	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2015	351								h3759	10.1136/bmj.h3759	http://dx.doi.org/10.1136/bmj.h3759			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MY	26162376				2022-12-28	WOS:000357956900005
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Edoxaban (Savaysa)-The Fourth New Oral Anticoagulant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							WARFARIN						Pflomm, Jean-Marie/HDO-0765-2022					[Anonymous], 2014, MED LETT DRUGS THER, V56, P103; [Anonymous], 2014, MED LETT DRUGS THER, V56, P53; [Anonymous], 2014, MED LETT DRUGS THER, V56, P3; [Anonymous], 2013, Med Lett Drugs Ther, V55, pe44; Blank MJ, CLIN REV EDOXABAN ND; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Camm AJ, 2012, EUR HEART J, V33; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Gonsalves WI, 2014, J HEMATOL TRANSFUS, V2, P1015; January CT, 2014, J AM COLL CARDIOL, Ve1, DOI [10.1016/j.jtcvs.2014.05.014, DOI 10.1016/J.JACC.2014.03.022]; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301	11	2	2	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					76	77		10.1001/jama.2015.7098	http://dx.doi.org/10.1001/jama.2015.7098			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151270				2022-12-28	WOS:000357455900018
J	Hejtmancik, JF				Hejtmancik, J. Fielding			OPHTHALMOLOGY Cataracts dissolved	NATURE			English	Editorial Material							CONGENITAL CATARACT; LENS; TRANSPARENCY; AGGREGATION; EYE	Mutations underlying hereditary cataracts in two families impair the function of an enzyme that synthesizes the lens molecule lanosterol. The finding may lead to non-surgical prevention and treatment of cataracts. See Letter p.607	NEI, Ophthalm Mol Genet Sect, Ophthalm Genet & Visual Funct Branch, Rockville, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Hejtmancik, JF (corresponding author), NEI, Ophthalm Mol Genet Sect, Ophthalm Genet & Visual Funct Branch, Rockville, MD 20892 USA.	hejtmancikj@nei.nih.gov			NATIONAL EYE INSTITUTE [ZIAEY000281] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Brewster D., 1833, PHIL T R SOC LOND, V123, P323; Datiles MB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1687, DOI 10.1001/archophthalmol.2008.507; KUPFER C, 1987, INVEST OPHTH VIS SCI, V28, P1; Michael R, 2003, EXP EYE RES, V77, P93, DOI 10.1016/S0014-4835(03)00065-4; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; Shiels A, 2013, CLIN GENET, V84, P120, DOI 10.1111/cge.12182; Spemann H, 1901, VERH ANAT GESELLSCH, V15, P61; Sun N, 2015, MOL VIS, V21, P428; Taylor HR, 2000, BRIT J OPHTHALMOL, V84, P1, DOI 10.1136/bjo.84.1.1; ZELENKA P, 1974, P NATL ACAD SCI USA, V71, P1896, DOI 10.1073/pnas.71.5.1896; Zhang TX, 2009, HUM MUTAT, V30, pE603, DOI 10.1002/humu.20995; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650	16	13	14	4	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					540	541		10.1038/nature14629	http://dx.doi.org/10.1038/nature14629			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26200338				2022-12-28	WOS:000358655200032
J	Sullivan, PF				Sullivan, Patrick F.			GENETICS OF DISEASE: Associations with depression	NATURE			English	Editorial Material								Two genetic regions associated with major depressive disorder have been revealed for the first time, through whole-genome sequencing of a population of Han Chinese women. See Letter p.588	[Sullivan, Patrick F.] Univ N Carolina, Dept Genet & Psychiat, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet	Sullivan, PF (corresponding author), Univ N Carolina, Dept Genet & Psychiat, Chapel Hill, NC 27599 USA.	pfsulliv@med.unc.edu						Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Kendler KS, 1997, ARCH GEN PSYCHIAT, V54, P299, DOI 10.1001/archpsyc.1997.01830160013002; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Levinson DF, 2014, BIOL PSYCHIAT, V76, P510, DOI 10.1016/j.biopsych.2014.07.029; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	8	13	15	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					539	540		10.1038/nature14635	http://dx.doi.org/10.1038/nature14635			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26176922				2022-12-28	WOS:000358655200031
J	Bruehl, S				Bruehl, Stephen			Complex regional pain syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							REFLEX SYMPATHETIC DYSTROPHY; SYNDROME-TYPE-I; SPINAL-CORD STIMULATION; IASP DIAGNOSTIC-CRITERIA; PRIMARY SOMATOSENSORY CORTEX; SYNDROME TYPE-1 CRPS1; GRADED MOTOR IMAGERY; LOW-DOSE NALTREXONE; VITAMIN-C; CORTICAL REORGANIZATION	Complex regional pain syndrome is a chronic pain condition characterized by autonomic and inflammatory features. It occurs acutely in about 7% of patients who have limb fractures, limb surgery, or other injuries. Many cases resolve within the first year, with a smaller subset progressing to the chronic form. This transition is often paralleled by a change from "warm complex regional pain syndrome," with inflammatory characteristics dominant, to "cold complex regional pain syndrome" in which autonomic features dominate. Multiple peripheral and central mechanisms seem to be involved, the relative contributions of which may differ between individuals and over time. Possible contributors include peripheral and central sensitization, autonomic changes and sympatho-afferent coupling, inflammatory and immune alterations, brain changes, and genetic and psychological factors. The syndrome is diagnosed purely on the basis of clinical signs and symptoms. Effective management of the chronic form of the syndrome is often challenging. Few high quality randomized controlled trials are available to support the efficacy of the most commonly used interventions. Reviews of available randomized trials suggest that physical and occupational therapy (including graded motor imagery and mirror therapy), bisphosphonates, calcitonin, subanesthetic intravenous ketamine, free radical scavengers, oral corticosteroids, and spinal cord stimulation may be effective treatments. Multidisciplinary clinical care, which centers around functionally focused therapies is recommended. Other interventions are used to facilitate engagement in functional therapies and to improve quality of life.	Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA	Vanderbilt University	Bruehl, S (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA.	Stephen.Bruehl@vanderbilt.edu		Bruehl, Stephen/0000-0003-2264-4758	Eli Lilly; Grunenthal GmbH; Thar Pharmaceuticals	Eli Lilly(Eli Lilly); Grunenthal GmbH; Thar Pharmaceuticals	I have read and understood BMJ policy on declaration of interests and declare the following interests: I have received consulting fees from Eli Lilly, Grunenthal GmbH, and Thar Pharmaceuticals for assistance in the design of clinical trials of complex regional pain syndrome.	Albrecht PJ, 2006, PAIN, V120, P244, DOI 10.1016/j.pain.2005.10.035; Alexander GM, 2005, PAIN, V116, P213, DOI 10.1016/j.pain.2005.04.013; Ali Z, 2000, PAIN, V88, P161, DOI 10.1016/S0304-3959(00)00327-4; Atalay NS, 2014, PAIN PHYSICIAN, V17, P179; Barad MJ, 2014, J PAIN, V15, P197, DOI 10.1016/j.jpain.2013.10.011; Baron R, 2002, LANCET, V359, P1655, DOI 10.1016/S0140-6736(02)08589-6; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; Bean DJ, 2014, J PAIN, V15, P677, DOI 10.1016/j.jpain.2014.01.500; Bean DJ, 2014, CLIN J PAIN, V30, P647, DOI 10.1097/AJP.0000000000000007; Beerthuizen A, 2012, PAIN, V153, P1187, DOI 10.1016/j.pain.2012.01.026; Beerthuizen A, 2011, EUR J PAIN, V15, P971, DOI 10.1016/j.ejpain.2011.02.008; Beerthuizen A, 2009, PAIN, V145, P52, DOI 10.1016/j.pain.2009.05.003; Besse Jean-Luc, 2009, Foot Ankle Surg, V15, P179, DOI 10.1016/j.fas.2009.02.002; Birklein F, 2013, NERVENARZT, V84, P1436, DOI 10.1007/s00115-012-3622-6; Birklein F, 2000, ACTA NEUROL SCAND, V101, P262, DOI 10.1034/j.1600-0404.2000.101004262x./; Birklein F, 2001, NEUROLOGY, V57, P2179, DOI 10.1212/WNL.57.12.2179; Birklein F, 2008, NEUROSCI LETT, V437, P199, DOI 10.1016/j.neulet.2008.03.081; Birklein F, 2014, J PAIN, V15, P485, DOI 10.1016/j.jpain.2014.01.490; Blaes F, 2004, NEUROLOGY, V63, P1734, DOI 10.1212/01.WNL.0000143066.58498.BA; Blair S J, 1998, Acta Orthop Belg, V64, P448; BLUMBERG H, 1991, PAIN RES CL, V4, P399; Bonica J.J., 1990, MANAGEMENT PAIN, P220; Bruehl S, 2003, PAIN, V104, P647, DOI 10.1016/S0304-3959(03)00135-0; Bruehl S, 1996, PAIN, V67, P107, DOI 10.1016/0304-3959(96)81973-7; Bruehl S, 1999, PAIN, V81, P147, DOI 10.1016/S0304-3959(99)00011-1; Bruehl S, 2002, PAIN, V95, P119, DOI 10.1016/S0304-3959(01)00387-6; Bruehl S, 2006, CLIN J PAIN, V22, P430, DOI 10.1097/01.ajp.0000194282.82002.79; Bruehl S, 2010, ANESTHESIOLOGY, V113, P713, DOI 10.1097/ALN.0b013e3181e3db38; Cazeneuve J F, 2002, Acta Orthop Belg, V68, P481; Cheng JK, 2008, NEUROCHEM RES, V33, P1970, DOI 10.1007/s11064-008-9711-z; Chopra P, 2013, J NEUROIMMUNE PHARM, V8, P470, DOI 10.1007/s11481-013-9451-y; Coderre TJ, 2010, PAIN MED, V11, P1224, DOI 10.1111/j.1526-4637.2010.00911.x; Coderre TJ, 2004, PAIN, V112, P94, DOI 10.1016/j.pain.2004.08.001; Cohen H, 2013, EUR J PAIN, V17, P527, DOI 10.1002/j.1532-2149.2012.00213.x; Cossins L, 2013, EUR J PAIN, V17, P158, DOI 10.1002/j.1532-2149.2012.00217.x; Couture R, 2001, EUR J PHARMACOL, V429, P161, DOI 10.1016/S0014-2999(01)01318-8; da Costa VV, 2011, REV BRAS ANESTESIOL, V61, P425, DOI 10.1016/S0034-7094(11)70050-2; Daly AE, 2009, EUR J PAIN, V13, P339, DOI 10.1016/j.ejpain.2008.05.003; de Boer RDH, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2011.01.012; de Jong JR, 2012, PAIN, V153, P2109, DOI 10.1016/j.pain.2012.07.001; de Jong JR, 2011, J PAIN, V12, P1209, DOI 10.1016/j.jpain.2011.06.010; de Mos M, 2007, PAIN, V129, P12, DOI 10.1016/j.pain.2006.09.008; de Mos M, 2009, J PAIN, V10, P1161, DOI 10.1016/j.jpain.2009.04.012; de Mos M, 2009, CLIN J PAIN, V25, P590, DOI 10.1097/AJP.0b013e3181a11623; de Rooij AM, 2009, PAIN, V145, P82, DOI 10.1016/j.pain.2009.05.015; Di Pietro F, 2015, HUM BRAIN MAPP, V36, P508, DOI 10.1002/hbm.22643; Di Pietro F, 2013, J PAIN, V14, P1270, DOI 10.1016/j.jpain.2013.07.004; Di Pietro F, 2013, J PAIN, V14, P1001, DOI 10.1016/j.jpain.2013.04.001; Dilek B, 2012, RHEUMATOL INT, V32, P915, DOI 10.1007/s00296-010-1714-9; Drummond ES, 2014, J PAIN, V15, P188, DOI 10.1016/j.jpain.2013.10.010; Drummond PD, 2001, NEUROLOGY, V57, P1296, DOI 10.1212/WNL.57.7.1296; Drummond PD, 2014, PAIN, V155, P606, DOI 10.1016/j.pain.2013.12.021; Eisenberg E, 2005, PAIN, V113, P99, DOI 10.1016/j.pain.2004.09.030; Eisenberg E, 2008, PAIN, V138, P226, DOI 10.1016/j.pain.2008.04.019; Ekrol I, 2014, J BONE JOINT SURG AM, V96A, P1451, DOI 10.2106/JBJS.M.00268; European Medicines Agency, 2013, PUBL SUMM OP ORPH DE; Evans AR, 2000, J PHARMACOL EXP THER, V293, P912; Finch PM, 2009, PAIN, V146, P18, DOI 10.1016/j.pain.2009.05.017; Forderreuther S, 2004, PAIN, V110, P756, DOI 10.1016/j.pain.2004.05.019; Freund W, 2011, CLIN J PAIN, V27, P796, DOI 10.1097/AJP.0b013e31821d9063; Galer BS, 1998, CLIN J PAIN, V14, P48, DOI 10.1097/00002508-199803000-00007; Gatchel RJ, 2006, J PAIN, V7, P779, DOI 10.1016/j.jpain.2006.08.005; Geertzen JHB, 1998, CLIN REHABIL, V12, P402, DOI 10.1191/026921598676761735; GIBBONS JJ, 1992, CLIN J PAIN, V8, P260, DOI 10.1097/00002508-199209000-00012; Goebel A, 2013, AUTOIMMUN REV, V12, P682, DOI 10.1016/j.autrev.2012.10.015; Goebel A, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.10.005; Goebel A, 2010, ANN INTERN MED, V152, P152, DOI 10.7326/0003-4819-152-3-201002020-00006; Groeneweg G, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-143; Guo TZ, 2014, J PAIN, V15, P1033, DOI 10.1016/j.jpain.2014.07.004; Guo TZ, 2004, PAIN, V108, P95, DOI 10.1016/j.pain.2003.12.010; Harden RN, 2013, PAIN MED, V14, P180, DOI 10.1111/pme.12033; Harden RN, 2010, PAIN, V151, P870, DOI 10.1016/j.pain.2010.09.031; Harden RN, 2010, PAIN, V150, P268, DOI 10.1016/j.pain.2010.04.030; Harden RN, 1999, PAIN, V83, P211, DOI 10.1016/S0304-3959(99)00104-9; Harden RN, 2003, PAIN, V106, P393, DOI 10.1016/j.pain.2003.08.009; Harke H, 2001, ANESTH ANALG, V92, P488, DOI 10.1213/00000539-200102000-00039; Herlyn P, 2010, CLIN J PAIN, V26, P175, DOI 10.1097/AJP.0b013e3181bff8b9; Horlocker TT, 2006, ANESTH ANALG, V102, P950, DOI 10.1213/01.ane.0000194875.05587.7e; Huygen FJPM, 2004, IMMUNOL LETT, V91, P147, DOI 10.1016/j.imlet.2003.11.013; International Association for the Study of Pain, CLASSIFICATION CHRON; Janig W, 2003, LANCET NEUROL, V2, P687, DOI 10.1016/S1474-4422(03)00557-X; Janig W, 1996, PROG BRAIN RES, V113, P161, DOI 10.1016/S0079-6123(08)61087-0; Janig W, 2002, CLIN AUTON RES, V12, P150, DOI 10.1007/s10286-002-0022-1; Jellad A, 2014, ARCH PHYS MED REHAB, V95, P487, DOI 10.1016/j.apmr.2013.09.012; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Johnson S, 2012, EUR J PAIN, V16, P550, DOI 10.1002/j.1532-2149.2011.00064.x; Jorum E, 2007, PAIN, V127, P296, DOI 10.1016/j.pain.2006.08.022; Juottonen K, 2002, PAIN, V98, P315, DOI 10.1016/S0304-3959(02)00119-7; Kalita J, 2006, QJM-INT J MED, V99, P89, DOI 10.1093/qjmed/hcl004; Karacan I, 2004, J BONE MINER METAB, V22, P44, DOI 10.1007/s00774-003-0447-1; Kaufmann I, 2007, CLIN IMMUNOL, V125, P103, DOI 10.1016/j.clim.2007.07.004; Kemler MA, 2000, NEW ENGL J MED, V343, P618, DOI 10.1056/NEJM200008313430904; Kemler MA, 2004, ANN NEUROL, V55, P13, DOI 10.1002/ana.10996; Kemler MA, 2008, J NEUROSURG, V108, P292, DOI 10.3171/JNS/2008/108/2/0292; Kharkar S, 2012, PAIN PHYSICIAN, V15, P255; Kingery WS, 1997, PAIN, V73, P123, DOI 10.1016/S0304-3959(97)00049-3; Klega A, 2010, NEUROLOGY, V75, P129, DOI 10.1212/WNL.0b013e3181e7ca2e; Kohr D, 2011, PAIN, V152, P2690, DOI 10.1016/j.pain.2011.06.012; Kohr D, 2009, PAIN, V143, P246, DOI 10.1016/j.pain.2009.03.009; Konrad G, 2005, CLIN ORTHOP RELAT R, P189, DOI 10.1097/01.blo.0000151849.37260.0a; KOZIN F, 1981, AM J MED, V70, P23, DOI 10.1016/0002-9343(81)90407-1; Kramer HH, 2014, PAIN, V155, P889, DOI 10.1016/j.pain.2014.01.014; Lebel A, 2008, BRAIN, V131, P1854, DOI 10.1093/brain/awn123; Lee DH, 2014, PSYCHIAT INVEST, V11, P32, DOI 10.4306/pi.2014.11.1.32; Leis S, 2004, NEUROSCI LETT, V359, P163, DOI 10.1016/j.neulet.2004.02.025; Lenz M, 2011, NEUROLOGY, V77, P1096, DOI 10.1212/WNL.0b013e31822e1436; Lenz M, 2013, PAIN, V154, P2142, DOI 10.1016/j.pain.2013.06.039; Lewis JS, 2007, PAIN, V133, P111, DOI 10.1016/j.pain.2007.03.013; Lewis JS, 2010, PAIN, V149, P463, DOI 10.1016/j.pain.2010.02.007; Li WW, 2014, PAIN, V155, P2377, DOI 10.1016/j.pain.2014.09.007; Li WW, 2009, PAIN, V144, P303, DOI 10.1016/j.pain.2009.04.033; Li WW, 2013, PAIN, V154, P1224, DOI 10.1016/j.pain.2013.03.033; Logan DE, 2013, PAIN RES MANAG, V18, P87, DOI 10.1155/2013/964352; Maihofner C, 2005, NEUROLOGY, V65, P311, DOI 10.1212/01.wnl.0000168866.62086.8f; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; Maleki J, 2000, PAIN, V88, P259, DOI 10.1016/S0304-3959(00)00332-8; Manicourt DH, 2004, ARTHRITIS RHEUM-US, V50, P3690, DOI 10.1002/art.20591; Marinus J, 2013, CLIN J PAIN, V29, P563, DOI 10.1097/AJP.0b013e31826f9a8a; McCabe CS, 2003, RHEUMATOLOGY, V42, P1067, DOI 10.1093/rheumatology/keg298; Meier PM, 2006, CLIN J PAIN, V22, P399, DOI 10.1097/01.ajp.0000192514.50955.d6; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Mitchell SW., 1864, GUNSHOT WOUNDS OTHER; Monti DA, 1998, CLIN J PAIN, V14, P295, DOI 10.1097/00002508-199812000-00005; Moseley GL, 2014, J PAIN, V15, P16, DOI 10.1016/j.jpain.2013.08.009; Moseley GL, 2004, NEUROLOGY, V62, P2182, DOI 10.1212/01.WNL.0000130156.05828.43; Moseley GL, 2004, PAIN, V108, P192, DOI 10.1016/j.pain.2004.01.006; Noppers IM, 2011, PAIN, V152, P2173, DOI 10.1016/j.pain.2011.03.026; O'Connell NE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009416.pub2; Oaklander AL, 2006, PAIN, V120, P235, DOI 10.1016/j.pain.2005.09.036; Oaklander AL, 2012, PAIN, V153, P934, DOI 10.1016/j.pain.2012.01.012; Oaklander AL, 2009, ANN NEUROL, V65, P629, DOI 10.1002/ana.21692; Omeroglu H, 1998, INT ORTHOP, V22, P369, DOI 10.1007/s002640050280; Omeroglu H, 1997, FOOT ANKLE INT, V18, P798, DOI 10.1177/107110079701801208; Perez RS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-20; Perez RSGM, 2007, EUR J PAIN, V11, P895, DOI 10.1016/j.ejpain.2007.02.006; Perez RSGM, 2001, J PAIN SYMPTOM MANAG, V21, P511, DOI 10.1016/S0885-3924(01)00282-2; Pleger B, 2005, ANN NEUROL, V57, P425, DOI 10.1002/ana.20394; Pleger B, 2004, EXP BRAIN RES, V155, P115, DOI 10.1007/s00221-003-1738-4; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Price DD, 1998, CLIN J PAIN, V14, P216, DOI 10.1097/00002508-199809000-00008; Ritz BW, 2011, CLIN EXP IMMUNOL, V164, P108, DOI 10.1111/j.1365-2249.2010.04308.x; ROBERTS WJ, 1986, PAIN, V24, P297, DOI 10.1016/0304-3959(86)90116-8; Robinson JN, 2004, PAIN MED, V5, P276, DOI 10.1111/j.1526-4637.2004.04038.x; Rodriguez-Raecke R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054475; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Rommel O, 2001, PAIN, V93, P279, DOI 10.1016/S0304-3959(01)00332-3; Ross-Huot MC, 2013, ANESTHESIOLOGY, V119, P687, DOI 10.1097/ALN.0b013e318299980c; Sandroni P, 2003, PAIN, V103, P199, DOI 10.1016/S0304-3959(03)00065-4; SARANGI PP, 1993, J BONE JOINT SURG BR, V75, P450, DOI 10.1302/0301-620X.75B3.8496220; SATO J, 1991, SCIENCE, V251, P1608, DOI 10.1126/science.2011742; Schasfoort FC, 2003, PAIN, V101, P79, DOI 10.1016/S0304-3959(02)00298-1; Schattschneider J, 2006, CLIN J PAIN, V22, P240, DOI 10.1097/01.ajp.0000169672.49438.67; Schinkel C, 2006, CLIN J PAIN, V22, P235, DOI 10.1097/01.ajp.0000169669.70523.f0; Schinkel C, 2009, EUR J MED RES, V14, P130, DOI 10.1186/2047-783X-14-3-130; Schlereth T, 2006, J PHYSIOL-LONDON, V576, P823, DOI 10.1113/jphysiol.2006.116111; Schurmann M, 2000, AUTON NEUROSCI-BASIC, V86, P127, DOI 10.1016/S1566-0702(00)00250-2; Schwartzman RJ, 2009, PAIN, V147, P107, DOI 10.1016/j.pain.2009.08.015; Schwartzman RJ, 2009, CLIN J PAIN, V25, P273, DOI 10.1097/AJP.0b013e31818ecea5; Sharma A, 2009, REGION ANESTH PAIN M, V34, P110, DOI 10.1097/AAP.0b013e3181958f90; Shibuya N, 2013, J FOOT ANKLE SURG, V52, P62, DOI 10.1053/j.jfas.2012.08.003; Sieweke N, 1999, PAIN, V80, P171, DOI 10.1016/S0304-3959(98)00200-0; Sigtermans MJ, 2009, PAIN, V145, P304, DOI 10.1016/j.pain.2009.06.023; Stanton TR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004598.pub3; Stanton-Hicks M, 2010, PAIN MED, V11, P1216, DOI 10.1111/j.1526-4637.2010.00910.x; Stanton-Hicks Michael D, 2002, Pain Pract, V2, P1, DOI 10.1046/j.1533-2500.2002.02009.x; Straube S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002918.pub3; Tan ECTH, 2009, INJURY, V40, P901, DOI 10.1016/j.injury.2009.01.134; Tekus V, 2014, PAIN, V155, P299, DOI 10.1016/j.pain.2013.10.011; Terkelsen AJ, 2008, ANESTHESIOLOGY, V109, P297, DOI 10.1097/ALN.0b013e31817f4c9d; Turner-Stokes L, 2011, CLIN MED, V11, P596, DOI 10.7861/clinmedicine.11-6-596; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; US Food and Drug Administration, 2013, ORPH DRUG DES APPR; van de Meent H, 2011, PAIN, V152, P1431, DOI 10.1016/j.pain.2011.02.032; van de Vusse AC, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-13; van Eijs F, 2011, PAIN PRACT, V11, P70, DOI 10.1111/j.1533-2500.2010.00388.x; van Rijn MA, 2009, PAIN, V143, P41, DOI 10.1016/j.pain.2009.01.014; van Rijn MA, 2011, J NEURAL TRANSM, V118, P1301, DOI 10.1007/s00702-011-0601-1; van Rooijen DE, 2012, J PAIN, V13, P784, DOI 10.1016/j.jpain.2012.05.003; van Velzen GAJ, 2014, PAIN, V155, P629, DOI 10.1016/j.pain.2013.12.017; Vaneker M, 2005, PAIN, V115, P204, DOI 10.1016/j.pain.2005.02.031; Varenna M, 2000, J RHEUMATOL, V27, P1477; Varenna M, 2013, RHEUMATOLOGY, V52, P534, DOI 10.1093/rheumatology/kes312; Veldman PHJM, 1996, PAIN, V64, P463, DOI 10.1016/0304-3959(95)00160-3; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Wang HB, 2005, J NEUROSCI, V25, P7986, DOI 10.1523/JNEUROSCI.2393-05.2005; Wesseldijk F, 2008, EUR J PAIN, V12, P716, DOI 10.1016/j.ejpain.2007.10.010; Wesseldijk F, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/469439; Xanthos DN, 2008, PAIN, V137, P640, DOI 10.1016/j.pain.2007.10.031; Younger J, 2013, ARTHRITIS RHEUM-US, V65, P529, DOI 10.1002/art.37734; Yung Chung Ok, 2003, Curr Treat Options Neurol, V5, P499; Zollinger PE, 2007, J BONE JOINT SURG AM, V89A, P1424, DOI 10.2106/JBJS.F.01147; Zollinger PE, 1999, LANCET, V354, P2025, DOI 10.1016/S0140-6736(99)03059-7; Zyluk A, 1998, J HAND SURG-BRIT EUR, V23B, P20, DOI 10.1016/S0266-7681(98)80211-8	195	186	187	4	60	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2015	351								h2730	10.1136/bmj.h2730	http://dx.doi.org/10.1136/bmj.h2730			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2UA	26224572				2022-12-28	WOS:000359010900001
J	Chadwick, R				Chadwick, Raymond			Compassion: hard to define, impossible to mandate	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Teesside, Sch Hlth & Social Care, Middlesbrough TS1 3BA, Cleveland, England	University of Teesside	Chadwick, R (corresponding author), Univ Teesside, Sch Hlth & Social Care, Middlesbrough TS1 3BA, Cleveland, England.	R.Chadwick@tees.ac.uk						Cole-King A., 2011, J HOLIST HEALTHC, V8, P29; Department of Health NHS Commissioning Board, 2012, COMP PRACT NURS MIDW; Francis R, 2013, REPORT PUBLIC INQUIR; Goodrich J, 2012, J ROY SOC MED, V105, P117, DOI 10.1258/jrsm.2011.110183; NHS Health Education England, 2014, FRAM 15 STRAG FRAM 2; NHS Health Education England, E LEARN HEALTHC COMP; Schwartz KB, 1995, BOSTON GLOBE MA 0716	7	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2015	351								h3991	10.1136/bmj.h3991	http://dx.doi.org/10.1136/bmj.h3991			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2UA	26224485	Green Submitted			2022-12-28	WOS:000359010900009
J	Strasser, P				Strasser, Peter			Catalysts by Platonic design	SCIENCE			English	Editorial Material							OXYGEN REDUCTION ACTIVITY; PLATINUM		Tech Univ Berlin, Dept Chem, Div Chem Engn, D-10623 Berlin, Germany	Technical University of Berlin	Strasser, P (corresponding author), Tech Univ Berlin, Dept Chem, Div Chem Engn, D-10623 Berlin, Germany.	pstrasser@tu-berlin.de	Strasser, Peter/A-1868-2012; Strasser, Peter/ABE-6795-2020	Strasser, Peter/0000-0002-3884-436X; Strasser, Peter/0000-0002-3884-436X				Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Choi SI, 2013, NANO LETT, V13, P3420, DOI 10.1021/nl401881z; Cui CH, 2013, NAT MATER, V12, P765, DOI [10.1038/NMAT3668, 10.1038/nmat3668]; Cui CH, 2012, NANO LETT, V12, P5885, DOI 10.1021/nl3032795; Gan L, 2014, SCIENCE, V346, P1502, DOI 10.1126/science.1261212; Gan L, 2013, NANO LETT, V13, P1131, DOI 10.1021/nl304488q; Gasteiger HA, 2009, SCIENCE, V324, P48, DOI 10.1126/science.1172083; Han BH, 2015, ENERG ENVIRON SCI, V8, P258, DOI 10.1039/c4ee02144d; Huang XQ, 2015, SCIENCE, V348, P1230, DOI 10.1126/science.aaa8765; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Stephens IEL, 2012, ENERG ENVIRON SCI, V5, P6744, DOI 10.1039/c2ee03590a; Wang X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8594; Wu JB, 2011, NANO LETT, V11, P798, DOI 10.1021/nl104094p; Wu JB, 2010, J AM CHEM SOC, V132, P4984, DOI 10.1021/ja100571h; Zhang J, 2010, NANO LETT, V10, P638, DOI 10.1021/nl903717z; Zhang L, 2015, SCIENCE, V349, P412, DOI 10.1126/science.aab0801	16	88	91	0	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					379	380		10.1126/science.aac7861	http://dx.doi.org/10.1126/science.aac7861			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206918				2022-12-28	WOS:000358381400022
J	Tabuchi, Y; Ishino, S; Noguchi, A; Ishikawa, T; Yamazaki, R; Usami, K; Nakamura, Y				Tabuchi, Yutaka; Ishino, Seiichiro; Noguchi, Atsushi; Ishikawa, Toyofumi; Yamazaki, Rekishu; Usami, Koji; Nakamura, Yasunobu			Coherent coupling between a ferromagnetic magnon and a superconducting qubit	SCIENCE			English	Article							QUANTUM; MICROWAVE; CIRCUITS; PHOTON; STATES; LIGHT	Rigidity of an ordered phase in condensed matter results in collective excitation modes spatially extending to macroscopic dimensions. A magnon is a quantum of such collective excitation modes in ordered spin systems. Here, we demonstrate the coherent coupling between a single-magnon excitation in a millimeter-sized ferromagnetic sphere and a superconducting qubit, with the interaction mediated by the virtual photon excitation in a microwave cavity. We obtain the coupling strength far exceeding the damping rates, thus bringing the hybrid system into the strong coupling regime. Furthermore, we use a parametric drive to realize a tunable magnon-qubit coupling scheme. Our approach provides a versatile tool for quantum control and measurement of the magnon excitations and may lead to advances in quantum information processing.	[Tabuchi, Yutaka; Ishino, Seiichiro; Noguchi, Atsushi; Ishikawa, Toyofumi; Yamazaki, Rekishu; Usami, Koji; Nakamura, Yasunobu] Univ Tokyo, RCAST, Meguro Ku, Tokyo 1538904, Japan; [Nakamura, Yasunobu] RIKEN, CEMS, Wako, Saitama 3510198, Japan	University of Tokyo; RIKEN	Tabuchi, Y (corresponding author), Univ Tokyo, RCAST, Meguro Ku, Tokyo 1538904, Japan.	tabuchi@qc.rcast.u-tokyo.ac.jp	Ishikawa, Toyofumi/C-3789-2013; Noguchi, Atsushi/D-4599-2017; Tabuchi, Yutaka/AAM-9174-2020; Nakamura, Yasunobu/H-1300-2012; Koji, Usami/AAG-4803-2020; Yamazaki, Rekishu/C-3308-2013	Ishikawa, Toyofumi/0000-0001-9089-0024; Noguchi, Atsushi/0000-0001-9435-4608; Tabuchi, Yutaka/0000-0003-2512-1856; Nakamura, Yasunobu/0000-0003-0424-630X; Yamazaki, Rekishu/0000-0002-9357-2643; Ishino, Seiichiro/0000-0001-9884-2588	Project for Developing Innovation System of the Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science KAKENHI [26600071, 26220601]; Murata Science Foundation; Research Foundation for Opto-Science and Technology; National Institute of Information and Communications Technology (NICT); Grants-in-Aid for Scientific Research [26600071] Funding Source: KAKEN	Project for Developing Innovation System of the Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Murata Science Foundation; Research Foundation for Opto-Science and Technology; National Institute of Information and Communications Technology (NICT); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge P.-M. Billangeon for fabricating the transmon qubit. This work was partly supported by the Project for Developing Innovation System of the Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science KAKENHI (grant no. 26600071, 26220601), the Murata Science Foundation, Research Foundation for Opto-Science and Technology, and National Institute of Information and Communications Technology (NICT).	Andrews RW, 2014, NAT PHYS, V10, P321, DOI [10.1038/nphys2911, 10.1038/NPHYS2911]; Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Astafiev O, 2010, SCIENCE, V327, P840, DOI 10.1126/science.1181918; Bagci T, 2014, NATURE, V507, P81, DOI 10.1038/nature13029; Bochmann J, 2013, NAT PHYS, V9, P712, DOI [10.1038/NPHYS2748, 10.1038/nphys2748]; Demokritov SO, 2006, NATURE, V443, P430, DOI 10.1038/nature05117; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Dickson NG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2920; Flurin E, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.090503; Goryachev M, 2014, PHYS REV APPL, V2, DOI 10.1103/PhysRevApplied.2.054002; Gurevich A. G., 2010, MAGNETIZATION OSCILL; Hammerer K, 2010, REV MOD PHYS, V82, P1041, DOI 10.1103/RevModPhys.82.1041; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Huebl H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.127003; Imamoglu A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.083602; Kajiwara Y, 2010, NATURE, V464, P262, DOI 10.1038/nature08876; Kubo Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.220501; Leek PJ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.180511; Longdell JJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063601; Probst S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.157001; Sparks M., 1964, FERROMAGNETIC RELAXA; Tabuchi Y, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.083603; Uchida K, 2008, NATURE, V455, P778, DOI 10.1038/nature07321; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Zakka-Bajjani E, 2011, NAT PHYS, V7, P599, DOI [10.1038/NPHYS2035, 10.1038/nphys2035]; Zhang XF, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.156401; Zhu XB, 2011, NATURE, V478, P221, DOI 10.1038/nature10462	28	375	376	13	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					405	408		10.1126/science.aaa3693	http://dx.doi.org/10.1126/science.aaa3693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26160378	Green Submitted			2022-12-28	WOS:000358381400037
J	Holbrook, A				Holbrook, Anne			Use of long-acting, vs short-acting, opioids for chronic pain was linked to unintentional overdose	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Holbrook, A (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2							JC11	10.7326/ACPJC-2015-163-2-011	http://dx.doi.org/10.7326/ACPJC-2015-163-2-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26192579				2022-12-28	WOS:000358407500011
J	Labib, PLZ; Gallegos, N; Hegarty, D				Labib, Peter Lawrence Zaki; Gallegos, Nick; Hegarty, David			10 MINUTE CONSULTATION Nipple discharge	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Labib, Peter Lawrence Zaki] Torbay Hosp, Torquay TQ2 7AA, England; [Gallegos, Nick] Weston Gen Hosp, Uphill BS23 4TQ, Weston Super Ma, England; [Hegarty, David] Wychbury Med Grp, Stourbridge DY9 9DS, England		Labib, PLZ (corresponding author), Torbay Hosp, Torquay TQ2 7AA, England.	peter.labib@nhs.net	Labib, Peter LZ/C-2467-2015	Labib, Peter LZ/0000-0003-2362-9218				Barankin B, 2004, J CUTAN MED SURG, V8, P126, DOI 10.1177/120347540400800209; Department of Health, 2010, BEST PRACT DIAGN GUI; Golshan M, 2014, NIPPLE DISCHARGE; Hughes LE, 2000, BENIGN DISORDERS DIS; NICE, 2015, SUSP CANC REC REF NI	5	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2015	351								h3123	10.1136/bmj.h3123	http://dx.doi.org/10.1136/bmj.h3123			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WG	26198815				2022-12-28	WOS:000358644400001
J	Davis, A; Matthews, Z; Szabo, S; Fogstad, H				Davis, Austen; Matthews, Zoe; Szabo, Sylvia; Fogstad, Helga			Measuring the SDGs: a two-track solution	LANCET			English	Editorial Material									[Davis, Austen] Norwegian Agcy Dev Cooperat, Sect Global Hlth, Oslo, Norway; [Fogstad, Helga] Norwegian Agcy Dev Cooperat, Dept Global Hlth Educ & Res, Oslo, Norway; [Matthews, Zoe; Szabo, Sylvia] Univ Southampton, Dept Social Stat & Demog, Southampton SO17 1BJ, Hants, England	University of Southampton	Davis, A (corresponding author), Norwegian Agcy Dev Cooperat, Sect Global Hlth, Oslo, Norway.	z.matthews@soton.ac.uk	Matthews, Zoe/HGD-0506-2022	Matthews, Zoe/0000-0003-1533-6618	Natural Environment Research Council [NE/L008726/1] Funding Source: researchfish; NERC [NE/L008726/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; United Nations, OP WORK GROUP PROP S; United Nations Statistical Commission, 2015, PROJ COMPL REV; Waage J, 2015, LANCET GLOB HEALTH, V3, pE251, DOI 10.1016/S2214-109X(15)70112-9	4	13	13	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					221	222		10.1016/S0140-6736(15)61081-9	http://dx.doi.org/10.1016/S0140-6736(15)61081-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN1XI	26194508				2022-12-28	WOS:000358213700005
J	Cohen, J				Cohen, Jon			No end in sight	SCIENCE			English	Editorial Material																			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		230	231		10.1126/science.349.6245.230	http://dx.doi.org/10.1126/science.349.6245.230			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185227				2022-12-28	WOS:000358218600018
J	Colliex, C				Colliex, Christian			CHEMISTRY Tracking the merry dance of nanoparticles	SCIENCE			English	Editorial Material							GRAPHENE LIQUID CELLS; ELECTRON-MICROSCOPY; RESOLUTION; EM		Univ Paris 11, CNRS, UMR 8502, Phys Solides Lab, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Colliex, C (corresponding author), Univ Paris 11, CNRS, UMR 8502, Phys Solides Lab, F-91405 Orsay, France.	christian.colliex@u-psud.fr						Agard D, 2014, ADV IMAG ELECT PHYS, V185, P113, DOI 10.1016/B978-0-12-800144-8.00002-1; Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Azubel M, 2014, SCIENCE, V345, P909, DOI 10.1126/science.1251959; Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Chen Q, 2013, NANO LETT, V13, P4556, DOI 10.1021/nl402694n; Howes PD, 2014, SCIENCE, V346, P53, DOI 10.1126/science.1247390; Jinschek JR, 2014, CHEM COMMUN, V50, P2696, DOI [10.1039/C3CC49092K, 10.1039/c3cc49092k]; Li ZY, 2008, NATURE, V451, P46, DOI 10.1038/nature06470; Van Aert S, 2011, NATURE, V470, P374, DOI 10.1038/nature09741; Wang CH, 2014, ADV MATER, V26, P3410, DOI 10.1002/adma.201306069; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654	15	2	2	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		232	233		10.1126/science.aac7627	http://dx.doi.org/10.1126/science.aac7627			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185228				2022-12-28	WOS:000358218600019
J	Huttlin, EL; Ting, L; Bruckner, RJ; Gebreab, F; Gygi, MP; Szpyt, J; Tam, S; Zarraga, G; Colby, G; Baltier, K; Dong, R; Guarani, V; Vaites, LP; Ordureau, A; Rad, R; Erickson, BK; Wuhr, M; Chick, J; Zhai, B; Kolippakkam, D; Mintseris, J; Obar, RA; Harris, T; Artavanis-Tsakonas, S; Sowa, ME; De Camilli, P; Paulo, JA; Harper, JW; Gygi, SP				Huttlin, Edward L.; Ting, Lily; Bruckner, Raphael J.; Gebreab, Fana; Gygi, Melanie P.; Szpyt, John; Tam, Stanley; Zarraga, Gabriela; Colby, Greg; Baltier, Kurt; Dong, Rui; Guarani, Virginia; Vaites, Laura Pontano; Ordureau, Alban; Rad, Ramin; Erickson, Brian K.; Wuehr, Martin; Chick, Joel; Zhai, Bo; Kolippakkam, Deepak; Mintseris, Julian; Obar, Robert A.; Harris, Tim; Artavanis-Tsakonas, Spyros; Sowa, Mathew E.; De Camilli, Pietro; Paulo, Joao A.; Harper, J. Wade; Gygi, Steven P.			The BioPlex Network: A Systematic Exploration of the Human Interactome	CELL			English	Article							PROTEIN COMPLEXES; LANDSCAPE; IDENTIFICATION; REVEALS	Protein interactions form a network whose structure drives cellular function and whose organization informs biological inquiry. Using high-throughput affinity-purification mass spectrometry, we identify interacting partners for 2,594 human proteins in HEK293T cells. The resulting network (BioPlex) contains 23,744 interactions among 7,668 proteins with 86% previously undocumented. BioPlex accurately depicts known complexes, attaining 80%-100% coverage for most CORUM complexes. The network readily subdivides into communities that correspond to complexes or clusters of functionally related proteins. More generally, network architecture reflects cellular localization, biological process, and molecular function, enabling functional characterization of thousands of proteins. Network structure also reveals associations among thousands of protein domains, suggesting a basis for examining structurally related proteins. Finally, BioPlex, in combination with other approaches, can be used to reveal interactions of biological or clinical significance. For example, mutations in the membrane protein VAPB implicated in familial amyotrophic lateral sclerosis perturb a defined community of interactors.	[Huttlin, Edward L.; Ting, Lily; Bruckner, Raphael J.; Gebreab, Fana; Gygi, Melanie P.; Szpyt, John; Tam, Stanley; Zarraga, Gabriela; Colby, Greg; Baltier, Kurt; Guarani, Virginia; Vaites, Laura Pontano; Ordureau, Alban; Rad, Ramin; Erickson, Brian K.; Wuehr, Martin; Chick, Joel; Zhai, Bo; Kolippakkam, Deepak; Mintseris, Julian; Obar, Robert A.; Artavanis-Tsakonas, Spyros; Sowa, Mathew E.; Paulo, Joao A.; Harper, J. Wade; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Dong, Rui; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA; [Dong, Rui; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Obar, Robert A.; Harris, Tim; Artavanis-Tsakonas, Spyros] Biogen, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Yale University; Howard Hughes Medical Institute; Yale University; Biogen	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu; steven_gygi@hms.harvard.edu	Colby, Geoffrey/G-2526-2017; Paulo, Joao/AAO-3981-2020; Ordureau, Alban/C-7558-2012; Wühr, Martin/A-2447-2009	Colby, Geoffrey/0000-0002-3376-0933; Paulo, Joao/0000-0002-4291-413X; Ordureau, Alban/0000-0002-4924-8520; Wühr, Martin/0000-0002-0244-8947; Zarraga, Gabriela/0000-0003-4344-7008; Erickson, Brian/0000-0002-1150-5042; Huttlin, Edward/0000-0002-1822-1173; Harper, Jeffrey/0000-0002-6944-7236; Dong, Rui/0000-0002-9118-3636	NIH [U41 HG006673, R37NS036251]; Damon Runyon Cancer Research Foundation; Charles A. King Trust Fellowship; Biogen;  [K01DK098285]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Charles A. King Trust Fellowship; Biogen(Biogen); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Marc Vidal and David Hill for ORFEOME 8.1 and Yasunori Saheki for advice. This work was supported by the NIH (U41 HG006673 to S.P.G., J.W.H., and M.E.S.; R37NS036251 to P.D.C.) and Biogen (S.P.G., J.W.H., and P.D.C.). L.P.V. is supported by a fellowship from Damon Runyon Cancer Research Foundation. J.A.P. is supported by K01DK098285. P.D.C. is an Investigator of the Howard Hughes Medical Institute. M.W. was supported by the Charles A. King Trust Fellowship. S.P.G. and J.W.H. are consultants for Biogen.	Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baron Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-39; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fung S, 2013, MOL BIOL CELL, V24, P184, DOI 10.1091/mbc.E12-09-0651; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gosselin P, 2013, NUCLEIC ACIDS RES, V41, P7783, DOI 10.1093/nar/gkt569; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Joshi P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.26; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Mesmin B, 2013, CELL MOL LIFE SCI, V70, P3405, DOI 10.1007/s00018-012-1247-3; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mroczek S, 2012, GENE DEV, V26, P1911, DOI 10.1101/gad.193169.112; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wojcik C, 1998, EUR J CELL BIOL, V77, P151, DOI 10.1016/S0171-9335(98)80083-6; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]	41	841	847	10	132	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					425	440		10.1016/j.cell.2015.06.043	http://dx.doi.org/10.1016/j.cell.2015.06.043			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186194	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000358087700021
J	Woo, JH; Shimoni, Y; Yang, WS; Subramaniam, P; Iyer, A; Nicoletti, P; Martinez, MR; Lopez, G; Mattioli, M; Realubit, R; Karan, C; Stockwell, BR; Bansal, M; Califano, A				Woo, Jung Hoon; Shimoni, Yishai; Yang, Wan Seok; Subramaniam, Prem; Iyer, Archana; Nicoletti, Paola; Martinez, Maria Rodriguez; Lopez, Gonzalo; Mattioli, Michela; Realubit, Ronald; Karan, Charles; Stockwell, Brent R.; Bansal, Mukesh; Califano, Andrea			Elucidating Compound Mechanism of Action by Network Perturbation Analysis	CELL			English	Article							DNA-DAMAGE; TARGET; IDENTIFICATION; PROTEIN; PREDICTION; MODE; INHIBITOR; INDUCTION; DATABASE; BIOLOGY	Genome-wide identification of the mechanism of action (MoA) of small-molecule compounds characterizing their targets, effectors, and activity modulators represents a highly relevant yet elusive goal, with critical implications for assessment of compound efficacy and toxicity. Current approaches are labor intensive and mostly limited to elucidating high-affinity binding target proteins. We introduce a regulatory network-based approach that elucidates genome-wide MoA proteins based on the assessment of the global dysregulation of their molecular interactions following compound perturbation. Analysis of cellular perturbation profiles identified established MoA proteins for 70% of the tested compounds and elucidated novel proteins that were experimentally validated. Finally, unknown-MoA compound analysis revealed altretamine, an anticancer drug, as an inhibitor of glutathione peroxidase 4 lipid repair activity, which was experimentally confirmed, thus revealing unexpected similarity to the activity of sulfasalazine. This suggests that regulatory network analysis can provide valuable mechanistic insight into the elucidation of small-molecule MoA and compound similarity.	[Woo, Jung Hoon; Califano, Andrea] Columbia Univ, DBMI, New York, NY 10032 USA; [Shimoni, Yishai; Subramaniam, Prem; Iyer, Archana; Nicoletti, Paola; Martinez, Maria Rodriguez; Lopez, Gonzalo; Stockwell, Brent R.; Bansal, Mukesh; Califano, Andrea] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Shimoni, Yishai; Subramaniam, Prem; Iyer, Archana; Nicoletti, Paola; Martinez, Maria Rodriguez; Lopez, Gonzalo; Bansal, Mukesh; Califano, Andrea] Columbia Univ, Ctr Computat Biol & Bioinformat C2B2, New York, NY 10032 USA; [Yang, Wan Seok; Stockwell, Brent R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Mattioli, Michela] Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, I-20139 Milan, Italy; [Realubit, Ronald; Karan, Charles] Columbia Univ, Columbia Genome Ctr, High Throughput Screening Facil, New York, NY 10032 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Istituto Italiano di Tecnologia - IIT; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University	Bansal, M (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10032 USA.	mb3113@cumc.columbia.edu; califano@cumc.columbia.edu	Martinez, Maria Rodriguez/M-4624-2019; Stockwell, Brent R/AAE-7200-2019; Mattioli, Michela/K-3951-2013; Lopez, Gonzalo/AAG-1169-2019	Martinez, Maria Rodriguez/0000-0003-3766-4233; Stockwell, Brent R/0000-0002-3532-3868; Mattioli, Michela/0000-0002-1692-9178; Lopez, Gonzalo/0000-0002-5092-1284; Califano, Andrea/0000-0003-4742-3679	CTD2 [5U01CA168426]; LINCS [1U01CA164184-02, 3U01HL111566-02]; MAGNet [5U54CA121852-08]; NIH [5R01CA097061, R01CA161061]; New York Stem Cell Science [C026715]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA161061, U01CA168426, U01CA164184, R01CA097061, U54CA121852] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL111566] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012351] Funding Source: NIH RePORTER	CTD2; LINCS; MAGNet; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Science; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Katia Basso for providing the U-2932 cell line for experimental validation, Wei Keat Lim for GEP normalization, and Beatrice Salvatori for helpful feedback on the manuscript. This work is supported in part by the CTD2 (5U01CA168426), LINCS (1U01CA164184-02 and 3U01HL111566-02), and MAGNet (5U54CA121852-08) grants to A.C. B.R.S. is supported by the NIH (5R01CA097061, R01CA161061) and New York Stem Cell Science (C026715) and is an Early Career Scientist of the Howard Hughes Medical Institute.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; Bansal M, 2014, NAT BIOTECHNOL, V32, P1213, DOI 10.1038/nbt.3052; Basilico C, 2013, CLIN CANCER RES, V19, P2381, DOI 10.1158/1078-0432.CCR-12-3459; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Choi J, 2009, NUCLEIC ACIDS RES, V37, P5993, DOI 10.1093/nar/gkp660; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Floratos A, 2010, BIOINFORMATICS, V26, P1779, DOI 10.1093/bioinformatics/btq282; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Goldwasser F, 1996, ONCOL RES, V8, P317; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Gupta M, 2012, BLOOD, V119, P2844, DOI 10.1182/blood-2011-10-388538; Hansen NT, 2009, CLIN PHARMACOL THER, V86, P183, DOI 10.1038/clpt.2009.42; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jang CY, 2012, BIOCHEM BIOPH RES CO, V429, P57, DOI 10.1016/j.bbrc.2012.10.093; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Li J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000450; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Miller MA, 2002, NAT REV DRUG DISCOV, V1, P220, DOI 10.1038/nrd745; Pang BX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2921; Romito A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009029; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Shao SJ, 2006, J BIOL CHEM, V281, P28943, DOI 10.1074/jbc.M600235200; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Silverman B., 1986, DENSITY ESTIMATION S, V175; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; THOMAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1045, P252, DOI 10.1016/0005-2760(90)90128-K; Wehling M, 2009, NAT REV DRUG DISCOV, V8, P541, DOI 10.1038/nrd2898; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wolpaw AJ, 2011, P NATL ACAD SCI USA, V108, pE771, DOI 10.1073/pnas.1106149108; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	54	181	192	2	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					441	451		10.1016/j.cell.2015.05.056	http://dx.doi.org/10.1016/j.cell.2015.05.056			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	26186195	Bronze, Green Accepted			2022-12-28	WOS:000358087700022
J	Latimer, KW; Yates, JL; Meister, MLR; Huk, AC; Pillow, JW				Latimer, Kenneth W.; Yates, Jacob L.; Meister, Miriam L. R.; Huk, Alexander C.; Pillow, Jonathan W.			Single-trial spike trains in parietal cortex reveal discrete steps during decision-making	SCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; DYNAMICS; COMPUTATIONS; NEURONS	Neurons in the macaque lateral intraparietal (LIP) area exhibit firing rates that appear to ramp upward or downward during decision-making. These ramps are commonly assumed to reflect the gradual accumulation of evidence toward a decision threshold. However, the ramping in trial-averaged responses could instead arise from instantaneous jumps at different times on different trials. We examined single-trial responses in LIP using statistical methods for fitting and comparing latent dynamical spike-train models. We compared models with latent spike rates governed by either continuous diffusion-to-bound dynamics or discrete "stepping" dynamics. Roughly three-quarters of the choice-selective neurons we recorded were better described by the stepping model. Moreover, the inferred steps carried more information about the animal's choice than spike counts.	[Latimer, Kenneth W.; Yates, Jacob L.; Huk, Alexander C.; Pillow, Jonathan W.] Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA; [Latimer, Kenneth W.; Yates, Jacob L.; Meister, Miriam L. R.; Huk, Alexander C.; Pillow, Jonathan W.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Meister, Miriam L. R.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Huk, Alexander C.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Huk, Alexander C.; Pillow, Jonathan W.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Pillow, Jonathan W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Pillow, Jonathan W.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Princeton University; Princeton University	Pillow, JW (corresponding author), Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA.	pillow@princeton.edu	Huk, Alexander/A-8031-2016	Huk, Alexander/0000-0003-1430-6935; , Kenneth/0000-0002-9981-3903; Yates, Jacob/0000-0001-8322-5982	National Eye Institute [EY017366]; National Institute of Mental Health [MH099611]; Sloan Foundation; McKnight Foundation; National Science Foundation CAREER award [IIS-1150186]; National Institutes of Health under Ruth L. Kirschstein National Research Service from the National Institute on Drug Abuse [T32DA018926]; National Institutes of Health under Ruth L. Kirschstein National Research Service from National Eye Institute [T32EY021462]; Direct For Computer & Info Scie & Enginr [1150186] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [1601115] Funding Source: National Science Foundation; NATIONAL EYE INSTITUTE [T32EY021462, R01EY017366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA018926] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sloan Foundation(Alfred P. Sloan Foundation); McKnight Foundation; National Science Foundation CAREER award(National Science Foundation (NSF)); National Institutes of Health under Ruth L. Kirschstein National Research Service from the National Institute on Drug Abuse; National Institutes of Health under Ruth L. Kirschstein National Research Service from National Eye Institute; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank I. Memming Park and C. Carvalho for constructive discussions and J. Roitman and M. Shadlen for public sharing of data. This research was supported by grants from the National Eye Institute (EY017366 to A.C.H.) and the National Institute of Mental Health (MH099611 to J.W.P. and A.C.H.), by the Sloan Foundation (J.W.P.), McKnight Foundation (J.W.P.), a National Science Foundation CAREER award (IIS-1150186 to J.W.P.), and the National Institutes of Health under Ruth L. Kirschstein National Research Service Awards T32DA018926 from the National Institute on Drug Abuse and T32EY021462 from the National Eye Institute. All behavioral and electrophysiological data are presented in (14) and are archived at the Center for Perceptual Systems, The University of Texas at Austin.	Bollimunta A, 2012, J NEUROSCI, V32, P12684, DOI 10.1523/JNEUROSCI.5752-11.2012; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Durstewitz D, 2008, EUR J NEUROSCI, V27, P217, DOI 10.1111/j.1460-9568.2007.05976.x; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldman M. S., 2015, ENCY COMPUTATIONAL N, P1177; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; Kaufman MT, 2015, ELIFE, V4, DOI 10.7554/eLife.04677; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kiani R, 2014, CURR BIOL, V24, P1542, DOI 10.1016/j.cub.2014.05.049; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; Miller P, 2010, J NEUROSCI, V30, P2559, DOI 10.1523/JNEUROSCI.3047-09.2010; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2013, NEURON, V80, P791, DOI 10.1016/j.neuron.2013.10.047; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731	22	157	157	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					184	187		10.1126/science.aaa4056	http://dx.doi.org/10.1126/science.aaa4056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26160947	Green Accepted			2022-12-28	WOS:000357664300043
J	Nie, YG; Speakman, JR; Wu, Q; Zhang, CL; Hu, YB; Xia, MH; Yan, L; Hambly, C; Wang, L; Wei, W; Zhang, JG; Wei, FW				Nie, Yonggang; Speakman, John R.; Wu, Qi; Zhang, Chenglin; Hu, Yibo; Xia, Maohua; Yan, Li; Hambly, Catherine; Wang, Lu; Wei, Wei; Zhang, Jinguo; Wei, Fuwen			Exceptionally low daily energy expenditure in the bamboo-eating giant panda	SCIENCE			English	Article							CONGENITAL HYPOTHYROIDISM; METABOLIC-RATE; GENE; HIBERNATION; ENERGETICS; MUTATIONS; MAMMALS; THOX2; FIELD	The carnivoran giant panda has a specialized bamboo diet, to which its alimentary tract is poorly adapted. Measurements of daily energy expenditure across five captive and three wild pandas averaged 5.2 megajoules (MJ)/day, only 37.7% of the predicted value (13.8 MJ/day). For the wild pandas, themean was 6.2 MJ/day, or 45% of themammalian expectation. Pandas achieve this exceptionally low expenditure in part by reduced sizes of several vital organs and low physical activity. In addition, circulating levels of thyroid hormones thyroxine (T-4) and triiodothyronine (T-3) averaged 46.9 and 64%, respectively, of the levels expected for a eutherianmammal of comparable size. A giant panda-uniquemutation in the DUOX2 gene, critical for thyroid hormone synthesis, might explain these low thyroid hormone levels. A combination of morphological, behavioral, physiological, and genetic adaptations, leading to low energy expenditure, likely enables giant pandas to survive on a bamboo diet.	[Nie, Yonggang; Wu, Qi; Hu, Yibo; Yan, Li; Wei, Wei; Wei, Fuwen] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Speakman, John R.; Wang, Lu] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China; [Speakman, John R.; Hambly, Catherine] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Zhang, Chenglin; Xia, Maohua; Zhang, Jinguo] Beijing Zoo, Beijing Key Lab Capt Wildlife Technol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of Aberdeen	Wei, FW (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	weifw@ioz.ac.cn	Zhang, Cheng/GRS-8698-2022; Speakman, John R./A-9494-2008	Speakman, John R./0000-0002-2457-1823; Wang, Lu/0000-0002-1654-3259	National Natural Science Foundation of China [31230011]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB13030000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank X. Wang, Y. Jin, W. Zhou, T. Pu, X. Wang, L. Shan, S. Ma, W. Du, Z. Tan, M. Wang, X. Zheng, H. Han, D. Wang, and T. Ma for help with the data collection and P. Thompson for technical assistance with the isotope analysis. We also thank the Foping Nature Reserve and Beijing Zoo for their assistance on this study. This work was supported jointly and equally by the Key Project of National Natural Science Foundation of China (grant 31230011) and the Strategic Priority Research Program of the Chinese Academy of Sciences (grant XDB13030000). The thermal image camera used for the dairy cow images was on loan from the UK Engineering and Physical Sciences Research Council equipment loan pool. The physiological and other data are presented in the supplementary materials. The genetic data have been deposited in the National Center for Biotechnology Information database with accession number KT000656.	BRADSHAW SD, 1994, AUST J ZOOL, V42, P29, DOI 10.1071/ZO9940029; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Chen Y., 1983, CHIN J WILDLIFE, V4, P46; DIERENFELD ES, 1982, J NUTR, V112, P636, DOI 10.1093/jn/112.4.636; Elia M., 1992, 1 CLINT INT HOR C EN, P19; Finley TG, 2011, ZOO BIOL, V30, P121, DOI 10.1002/zoo.20340; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Hulbert AJ, 2000, BIOL REV, V75, P519, DOI 10.1017/S146479310000556X; Johnson KR, 2007, MOL ENDOCRINOL, V21, P1593, DOI 10.1210/me.2007-0085; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; MacHutchon AG, 2001, URSUS-SERIES, V12, P189; MAINKA SA, 1989, J ZOO WILDLIFE MED, V20, P39; McNab B.K., 2012, EXTREME MEASURES ECO; McNab Brian K., 2005, Acta Zoologica Sinica, V51, P535; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; Nie YG, 2012, ANIM BEHAV, V84, P39, DOI 10.1016/j.anbehav.2012.03.026; Owen MA, 2005, URSUS, V16, P208, DOI 10.2192/1537-6176(2005)016[0208:SADDOG]2.0.CO;2; Pan W., 2014, CHANCE LASTING SURVI; Pfarr N, 2006, CLIN ENDOCRINOL, V65, P810, DOI 10.1111/j.1365-2265.2006.02672.x; Pontzer H, 2014, P NATL ACAD SCI USA, V111, P1433, DOI 10.1073/pnas.1316940111; Scantlebury M, 2005, PHYSIOL BEHAV, V84, P739, DOI 10.1016/j.physbeh.2005.02.022; Schaller GB, 1985, GIANT PANDA WOLONG; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Tomasi TE, 1998, GEN COMP ENDOCR, V109, P192, DOI 10.1006/gcen.1997.7018; Wang ZM, 2001, J NUTR, V131, P2967, DOI 10.1093/jn/131.11.2967; Wei FW, 2015, MOL BIOL EVOL, V32, P4, DOI 10.1093/molbev/msu278; Zhang ZH, 2006, GIANT PANDA EXSITU C	29	93	111	24	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					171	174		10.1126/science.aab2413	http://dx.doi.org/10.1126/science.aab2413			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26160943				2022-12-28	WOS:000357664300039
J	Radhakrishnan, P				Radhakrishnan, Priti			Commentary: Making middle income countries pay full price for drugs is a big mistake	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												priti@i-mak.org						Amin T, 2014, AL JAZEERA AM   1121; [Anonymous], 2015, AIDSINFO DATABASE; [Anonymous], 2009, IND REJ ARV PAT APPL; Glassman A., 2013, NEW DATA SAME STORY; Global Fund To Fight AIDS, 2014, EL LIST 2014; Ludwig M, 2014, TRUTHOUT         OCT; Medecins Sans Frontieres Access Campaign, 2013, PROP SHAK UP DRUG PR; Medecins Sans Frontieres Access Campaign, 2013, UNT WEB ANT PRIC RED; MSF Access Campaign, 2014, UNT WEB ANT PRIC RED; Pierson B, 2015, REUTERS; Provost C, 2014, GUARDIAN; Schwartlander B., 2012, WHAT WILL IT TAKE TU; Walker J, 2015, WALL STREET J; WHO, WTO TRIPS AGR; WHO, 2014, INCR ACC HIV TREATM; World Bank, MIDDL INC COUNTR; World Intellectual Property Organization, ADV FLEX TRIPS AGR	17	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2015	351								h3757	10.1136/bmj.h3757	http://dx.doi.org/10.1136/bmj.h3757			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MY	26163479				2022-12-28	WOS:000357956900004
J	Gharib, SD; Berger, DL; Choy, G; Huck, AE				Gharib, Soheyla D.; Berger, David L.; Choy, Garry; Huck, Amelia E.			Case 21-2015: A 37-Year-Old American Man Living in Vietnam, with Fever and Bacteremia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PYOGENIC LIVER-ABSCESS		[Gharib, Soheyla D.] Harvard Univ Hlth Serv, Dept Med, Cambridge, MA 02138 USA; [Berger, David L.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Choy, Garry] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Huck, Amelia E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Gharib, Soheyla D.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Berger, David L.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Choy, Garry] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Huck, Amelia E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gharib, SD (corresponding author), Harvard Univ Hlth Serv, Dept Med, Cambridge, MA 02138 USA.							ALTEMEIER WA, 1973, AM J SURG, V125, P70, DOI 10.1016/0002-9610(73)90010-X; Han JK, 2001, ARCH OTOLARYNGOL, V127, P650, DOI 10.1001/archotol.127.6.650; Horii K, 1999, SURG TODAY, V29, P922, DOI 10.1007/BF02482788; Kaplan GG, 2004, CLIN GASTROENTEROL H, V2, P1032, DOI 10.1016/S1542-3565(04)00459-8; NGAN JHK, 1990, ANN SURG, V211, P459, DOI 10.1097/00000658-199004000-00012; Rahimian J, 2004, CLIN INFECT DIS, V39, P1654, DOI 10.1086/425616; Rolleston HD, 1905, DIS LIVER GALL BLADD; Warshauer DM, 2001, AM J ROENTGENOL, V177, P837, DOI 10.2214/ajr.177.4.1770837	8	9	10	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					174	183		10.1056/NEJMcpc1411439	http://dx.doi.org/10.1056/NEJMcpc1411439			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3QP	26154791				2022-12-28	WOS:000357598600012
J	Le Gal, G; Righini, M; Wells, PS				Le Gal, Gregoire; Righini, Marc; Wells, Philip S.			Computed Tomographic Pulmonary Angiography for Pulmonary Embolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							METAANALYSIS		[Le Gal, Gregoire; Wells, Philip S.] Univ Ottawa, Dept Med, Div Hematol, Thrombosis Program, Ottawa, ON, Canada; [Le Gal, Gregoire; Wells, Philip S.] Ottawa Hlth Res Inst, Clin Epidemiol Unit, Ottawa, ON, Canada; [Le Gal, Gregoire; Wells, Philip S.] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada; [Le Gal, Gregoire] Univ Brest, Brest, France; [Righini, Marc] Univ Hosp Geneva, Div Angiol & Hemostasis, Geneva, Switzerland	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Universite de Bretagne Occidentale; University of Geneva	Wells, PS (corresponding author), Ottawa Gen Hosp, Gen Campus,501 Smyth Rd,POB 206, Ottawa, ON K1H 8L6, Canada.	pwells@toh.on.ca	Righini, Marc/AAX-8731-2020					Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; Gilman MD, 2014, STANDARDIZED REPORTI; Le Gal G, 2015, JAMA-J AM MED ASSOC, V313, P1668, DOI 10.1001/jama.2015.3703; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Mos ICM, 2009, J THROMB HAEMOST, V7, P1491, DOI 10.1111/j.1538-7836.2009.03518.x; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178; Winer-Muram HT, 2004, RADIOLOGY, V233, P806, DOI 10.1148/radiol.2333031744	10	3	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					74	75		10.1001/jama.2015.4970	http://dx.doi.org/10.1001/jama.2015.4970			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151269				2022-12-28	WOS:000357455900017
J	Nayak, RK; Wendler, D; Miller, FG; Kim, SYH				Nayak, Rahul K.; Wendler, David; Miller, Franklin G.; Kim, Scott Y. H.			Pragmatic Randomized Trials Without Standard Informed Consent? A National Survey	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH INFORMATION; MECHANICAL TURK; CLINICAL-TRIALS; ETHICS; INTERNET; QUALITY	Background: Significant debate surrounds the issue of whether written consent is necessary for pragmatic randomized, controlled trials (RCTs) with low risk. Objective: To assess the U.S. public's views on alternatives to written consent for low-risk pragmatic RCTs. Design: National experimental survey (2 x 2 factorial design) examining support for written consent versus general notification or verbal consent in 2 research scenarios. Setting: Web-based survey conducted in December 2014. Participants: 2130 U.S. adults sampled from a nationally representative, probability-based online panel (response rate, 64.0%). Measurements: Respondent's recommendation to an ethics review board and personal preference as a potential participant on how to obtain consent or notification in the 2 research scenarios. Results: Most respondents in each of the 4 groups (range, 60.3% to 71.5%) recommended written informed consent, and personal preferences were generally in accord with that advice. Most (78.9%) believed that the pragmatic RCTs did not pose additional risks, but 62.5% of these respondents would still recommend written consent. In contrast, a substantial minority in all groups (28.5% to 39.7%) recommended the alternative option (general notification or verbal consent) over written consent. Limitation: Framing effects could have affected respondents' attitudes, and nonrespondents may have differed in levels of trust toward research or health care institutions. Conclusion: Most of the public favored written informed consent over the most widely advocated alternatives for low-risk pragmatic RCTs; however, a substantial minority favored general notification or verbal consent.	[Nayak, Rahul K.; Wendler, David; Miller, Franklin G.; Kim, Scott Y. H.] NIH, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kim, SYH (corresponding author), NIH, Dept Bioeth, Ctr Clin, 10 Ctr Dr,Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	scott.kim@nih.gov		Nayak, Rahul/0000-0001-6725-7634	National Institutes of Health Clinical Center; CLINICAL CENTER [ZIACL010538] Funding Source: NIH RePORTER	National Institutes of Health Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	Time-sharing Experiments for the Social Sciences and Intramural Research Program of the National Institutes of Health Clinical Center.	[Anonymous], [No title captured]; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; Chiong W, 2014, JAMA-J AM MED ASSOC, V311, P1689, DOI 10.1001/jama.2014.3302; Cho MK, 2015, ANN INTERN MED, V162, P690, DOI 10.7326/M15-0166; Faden R, 2013, MED CARE, V51, pS53, DOI 10.1097/MLR.0b013e31829b1e4b; Faden RR, 2014, NEW ENGL J MED, V370, P766, DOI 10.1056/NEJMhle1313674; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Grande D, 2014, ANN INTERN MED, V161, P855, DOI 10.7326/M14-1118; Grande D, 2013, JAMA INTERN MED, V173, P1798, DOI 10.1001/jamainternmed.2013.9166; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Kim SYH, 2014, NEW ENGL J MED, V370, P769, DOI 10.1056/NEJMhle1312508; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; Platt R, 2014, JAMA-J AM MED ASSOC, V311, P1497, DOI 10.1001/jama.2014.2144; Pletcher MJ, 2014, JAMA INTERN MED, V174, P668, DOI 10.1001/jamainternmed.2013.13297; Smith MD, 2013, BEST CARE LOWER COST; Sugarman J, 2014, JAMA-J AM MED ASSOC, V311, P2381, DOI 10.1001/jama.2014.4164; Tomlinson T, 2015, JAMA-J AM MED ASSOC, V313, P417, DOI 10.1001/jama.2014.16363; Truog RD, 1999, NEW ENGL J MED, V340, P804, DOI 10.1056/NEJM199903113401013; U.S. Department of Health and Human Services. Office for Human Research Protections, DRAFT GUID DISCL REA; Wendler D, 2015, J GEN INTERN MED, V30, P679, DOI 10.1007/s11606-014-3169-2; Yeager DS, 2011, PUBLIC OPIN QUART, V75, P709, DOI 10.1093/poq/nfr020	23	36	36	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2015	163	5					356	U81		10.7326/M15-0817	http://dx.doi.org/10.7326/M15-0817			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0OM	26215125	Green Accepted			2022-12-28	WOS:000360296000007
J	Sigl, M; Winstrup, M; McConnell, JR; Welten, KC; Plunkett, G; Ludlow, F; Buntgen, U; Caffee, M; Chellman, N; Dahl-Jensen, D; Fischer, H; Kipfstuhl, S; Kostick, C; Maselli, OJ; Mekhaldi, F; Mulvaney, R; Muscheler, R; Pasteris, DR; Pilcher, JR; Salzer, M; Schupbach, S; Steffensen, JP; Vinther, BM; Woodruff, TE				Sigl, M.; Winstrup, M.; McConnell, J. R.; Welten, K. C.; Plunkett, G.; Ludlow, F.; Buentgen, U.; Caffee, M.; Chellman, N.; Dahl-Jensen, D.; Fischer, H.; Kipfstuhl, S.; Kostick, C.; Maselli, O. J.; Mekhaldi, F.; Mulvaney, R.; Muscheler, R.; Pasteris, D. R.; Pilcher, J. R.; Salzer, M.; Schuepbach, S.; Steffensen, J. P.; Vinther, B. M.; Woodruff, T. E.			Timing and climate forcing of volcanic eruptions for the past 2,500 years	NATURE			English	Article							CONTINUOUS-FLOW ANALYSIS; TREE-RING WIDTH; ICE CORES; MILLENNIUM ERUPTION; BRISTLECONE-PINE; COMMON ERA; AD 774-775; GREENLAND; TEMPERATURE; VARIABILITY	Volcanic eruptions contribute to climate variability, but quantifying these contributions has been limited by inconsistencies in the timing of atmospheric volcanic aerosol loading determined from ice cores and subsequent cooling from climate proxies such as tree rings. Here we resolve these inconsistencies and show that large eruptions in the tropics and high latitudes were primary drivers of interannual-to-decadal temperature variability in the Northern Hemisphere during the past 2,500 years. Our results are based on new records of atmospheric aerosol loading developed from high-resolution, multi-parameter measurements from an array of Greenland and Antarctic ice cores as well as distinctive age markers to constrain chronologies. Overall, cooling was proportional to the magnitude of volcanic forcing and persisted for up to ten years after some of the largest eruptive episodes. Our revised timescale more firmly implicates volcanic eruptions as catalysts in the major sixth-century pandemics, famines, and socioeconomic disruptions in Eurasia and Mesoamerica while allowing multi-millennium quantification of climate response to volcanic forcing.	[Sigl, M.; McConnell, J. R.; Chellman, N.; Maselli, O. J.; Pasteris, D. R.] Nevada Syst Higher Educ, Desert Res Inst, Reno, NV 89512 USA; [Winstrup, M.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Welten, K. C.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Plunkett, G.; Pilcher, J. R.] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast BT7 1NN, Antrim, North Ireland; [Ludlow, F.] Yale Univ, Yale Climate & Energy Inst, New Haven, CT 06511 USA; [Ludlow, F.] Yale Univ, Dept Hist, New Haven, CT 06511 USA; [Buentgen, U.] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Buentgen, U.; Fischer, H.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Buentgen, U.] Global Change Res Ctr AS CR, Brno 60300, Czech Republic; [Caffee, M.; Woodruff, T. E.] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Caffee, M.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Dahl-Jensen, D.; Steffensen, J. P.; Vinther, B. M.] Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, DK-2100 Copenhagen, Denmark; [Fischer, H.; Schuepbach, S.] Univ Bern, Climate & Environm Phys, CH-3012 Bern, Switzerland; [Kipfstuhl, S.] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, D-27570 Bremerhaven, Germany; [Kostick, C.] Univ Nottingham, Dept Hist, Nottingham NG7 2RD, England; [Mekhaldi, F.; Muscheler, R.] Lund Univ, Quaternary Sci, Dept Geol, S-22362 Lund, Sweden; [Mulvaney, R.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Salzer, M.] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; Queens University Belfast; Yale University; Yale University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Copenhagen; Niels Bohr Institute; University of Bern; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Nottingham; Lund University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Arizona	McConnell, JR (corresponding author), Nevada Syst Higher Educ, Desert Res Inst, Reno, NV 89512 USA.	joe.mcconnell@dri.edu	Salzer, Matthew/AAG-1405-2019; Plunkett, Gill/M-9934-2019; Dahl-Jensen, Dorthe/AAO-6951-2020; Fischer, Hubertus/A-1211-2014; buentgen, ulf/J-6952-2013; Caffee, Marc W/K-7025-2015; Dahl-Jensen, Dorthe/N-4401-2016; Plunkett, Gill/F-3311-2010; Winstrup, Mai/M-5844-2014	Salzer, Matthew/0000-0001-5353-7459; Plunkett, Gill/0000-0003-1014-3454; Dahl-Jensen, Dorthe/0000-0002-1474-1948; Fischer, Hubertus/0000-0002-2787-4221; Caffee, Marc W/0000-0002-6846-8967; Dahl-Jensen, Dorthe/0000-0002-1474-1948; Winstrup, Mai/0000-0002-4794-4004; Kostick, Conor/0000-0002-4767-7380; Steffensen, Jorgen Peder/0000-0002-5516-1093; Vinther, Bo/0000-0002-6078-771X; Muscheler, Raimund/0000-0003-2772-3631; Ludlow, Francis/0000-0003-0008-0314; Sigl, Michael/0000-0002-9028-9703; Welten, Kees/0000-0001-8577-6753	US National Science Foundation (NSF); FNRS-CFB in Belgium; FWO in Belgium; NRCan/GSC in Canada; CAS in China; FIST in Denmark; IPEV in France; CNRS/INSU in France; CEA in France; ANR in France; AWI in Germany; RannIs in Iceland; NIPR in Japan; KOPRI in Korea; NWO/ALW in The Netherlands; VR in Sweden; SNF in Switzerland; NERC in UK; US NSF, Office of Polar Programs in USA; NSF/OPP [0839093, 0968391, 1142166, 0909541, 1023672, 1204176, 0636964, 0839137, 0839042, 0636815]; Villum Foundation; Yale Climate and Energy Institute; Initiative for the Science of the Human Past at Harvard; Rachel Carson Center for Environment and Society of the Ludwig-Maximilians-Universitat (LMU Munich); Marie Curie FP7 Integration Grant within the 7th European Union Framework Programme; NSF [ATM1203749]; Swedish Research Council [DNR2013-8421]; SNF; Oeschger Centre; NERC [bas0100034] Funding Source: UKRI; Natural Environment Research Council [bas0100034] Funding Source: researchfish; Directorate For Geosciences [1203749] Funding Source: National Science Foundation; Div Atmospheric & Geospace Sciences [1203301] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [0944348, 1142166, 1204176] Funding Source: National Science Foundation; Office Of The Director [0968391] Funding Source: National Science Foundation	US National Science Foundation (NSF)(National Science Foundation (NSF)); FNRS-CFB in Belgium(Fonds de la Recherche Scientifique - FNRS); FWO in Belgium(FWO); NRCan/GSC in Canada; CAS in China; FIST in Denmark; IPEV in France; CNRS/INSU in France; CEA in France; ANR in France(French National Research Agency (ANR)); AWI in Germany; RannIs in Iceland; NIPR in Japan; KOPRI in Korea(Korea Polar Research Institute of Marine Research Placement (KOPRI)); NWO/ALW in The Netherlands; VR in Sweden; SNF in Switzerland; NERC in UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); US NSF, Office of Polar Programs in USA(National Science Foundation (NSF)); NSF/OPP(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Villum Foundation(Villum Fonden); Yale Climate and Energy Institute; Initiative for the Science of the Human Past at Harvard; Rachel Carson Center for Environment and Society of the Ludwig-Maximilians-Universitat (LMU Munich); Marie Curie FP7 Integration Grant within the 7th European Union Framework Programme; NSF(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); SNF; Oeschger Centre; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank the many people involved in logistics, drill development and drilling, and ice-core processing and analysis in the field and our laboratories. This work was supported by the US National Science Foundation (NSF). We appreciate the support of the WAIS Divide Science Coordination Office (M. Twickler and J. Souney) for collection and distribution of the WAIS Divide ice core; Ice Drilling and Design and Operations (K. Dahnert) for drilling; the National Ice Core Laboratory (B. Bencivengo) for curating the core; Raytheon Polar Services (M. Kippenhan) for logistics support in Antarctica; and the 109th New York Air National Guard for airlift in Antarctica. NEEM is directed and organized by the Center of Ice and Climate at the Niels Bohr Institute and the US NSF, Office of Polar Programs. It is supported by funding agencies and institutions in Belgium (FNRS-CFB and FWO), Canada (NRCan/GSC), China (CAS), Denmark (FIST), France (IPEV, CNRS/INSU, CEA and ANR), Germany (AWI), Iceland (RannIs), Japan (NIPR), Korea (KOPRI), The Netherlands (NWO/ALW), Sweden (VR), Switzerland (SNF), the UK (NERC), and the USA (the US NSF, Office of Polar Programs). We thank B. Nolan, O. Amir, K. D. Pang, M. McCormick, A. Matthews, and B. Rossignol for assistance in surveying and/or interpreting the historical evidence. We thank S. Kuehn for commenting on possible correlations for the tephra. We thank A. Aldahan and G. Possnert for their support in the NGRIP <SUP>10</SUP>Be preparations and measurements at the Department of Earth Sciences and the Tandem laboratory at Uppsala University. We gratefully acknowledge R. Kreidberg for his editorial advice. The following individual grants supported this work: NSF/OPP grants 0839093, 0968391, and 1142166 to J. R. M. for development of the Antarctic ice core records and NSF/OPP grants 0909541, 1023672, and 1204176 to J.R.M. for development of the Arctic ice core records. M.W. was funded by the Villum Foundation. K.C.W. was funded by NSF/OPP grants 0636964 and 0839137. M.C. and T.E.W. were funded by NSF/OPP grants 0839042 and 0636815. F.L. was funded by the Yale Climate and Energy Institute, Initiative for the Science of the Human Past at Harvard, and the Rachel Carson Center for Environment and Society of the Ludwig-Maximilians-Universitat (LMU Munich). C.K. was funded by a Marie Curie FP7 Integration Grant within the 7th European Union Framework Programme. M. Salzer was funded by NSF grantATM1203749. R.M. was funded by the Swedish Research Council (DNR2013-8421). The division of Climate and Environmental Physics, Physics Institute, University of Bern, acknowledges financial support by the SNF and the Oeschger Centre.	Abram NJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016147; Ahmed M, 2013, NAT GEOSCI, V6, P339, DOI [10.1038/NGEO1797, 10.1038/ngeo1797]; Anchukaitis KJ, 2012, NAT GEOSCI, V5, P836, DOI 10.1038/ngeo1645; Baillie MGL, 2015, CLIM PAST, V11, P105, DOI 10.5194/cp-11-105-2015; Baillie MGL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034755; Barbante C, 2013, CLIM PAST, V9, P1221, DOI 10.5194/cp-9-1221-2013; Berggren AM, 2013, NUCL INSTRUM METH B, V294, P568, DOI 10.1016/j.nimb.2012.05.041; Bigler M, 2011, ENVIRON SCI TECHNOL, V45, P4483, DOI 10.1021/es200118j; Bisiaux MM, 2012, ATMOS CHEM PHYS, V12, P4107, DOI 10.5194/acp-12-4107-2012; Briffa KR, 2013, QUATERNARY SCI REV, V72, P83, DOI 10.1016/j.quascirev.2013.04.008; Briffa KR, 1998, NATURE, V391, P678, DOI 10.1038/35596; Buntgen U, 2014, NAT CLIM CHANGE, V4, P404, DOI 10.1038/nclimate2240; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Bursik M, 2014, J VOLCANOL GEOTH RES, V275, P114, DOI 10.1016/j.jvolgeores.2014.02.015; Clausen HB, 1997, J GEOPHYS RES-OCEANS, V102, P26707, DOI 10.1029/97JC00587; Coulter SE, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017698; Crowley TJ, 2013, EARTH SYST SCI DATA, V5, P187, DOI 10.5194/essd-5-187-2013; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; D'Arrigo R, 2001, GEOPHYS RES LETT, V28, P543, DOI 10.1029/2000GL011845; D'Arrigo R, 2013, J GEOPHYS RES-ATMOS, V118, P9000, DOI 10.1002/jgrd.50692; Dahl-Jensen D, 2013, NATURE, V493, P489, DOI 10.1038/nature11789; Deirmendjian D., 1973, ADV GEOPHYS, V16, P267; Douglass DH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022119; Driscoll S, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017607; Dull RA, 2007, ANN ASSOC AM GEOGR, V97, P127, DOI 10.1111/j.1467-8306.2007.00527.x; Esper J, 2014, J QUATERNARY SCI, V29, P487, DOI 10.1002/jqs.2726; Esper J, 2013, DENDROCHRONOLOGIA, V31, P216, DOI 10.1016/j.dendro.2012.11.002; Esper J, 2013, B VOLCANOL, V75, DOI 10.1007/s00445-013-0736-z; Esper J, 2012, NAT CLIM CHANGE, V2, P862, DOI [10.1038/NCLIMATE1589, 10.1038/nclimate1589]; FRITTS HC, 1979, QUATERNARY RES, V12, P18, DOI 10.1016/0033-5894(79)90090-5; Gao CC, 2008, J GEOPHYS RES-ATMOS, V113, DOI [10.1029/2008JD010239, 10.1029/2009JD012133]; Gao CH, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007461; Grudd H, 2008, CLIM DYNAM, V31, P843, DOI 10.1007/s00382-007-0358-2; Guttler D, 2015, EARTH PLANET SC LETT, V411, P290, DOI 10.1016/j.epsl.2014.11.048; Hanhijarvi S, 2013, CLIM DYNAM, V41, P2039, DOI 10.1007/s00382-013-1701-4; HERRON MM, 1981, NATURE, V293, P389, DOI 10.1038/293389a0; Jensen BJL, 2014, GEOLOGY, V42, P875, DOI 10.1130/G35945.1; Jull AJT, 2014, GEOPHYS RES LETT, V41, P3004, DOI 10.1002/2014GL059874; Kaufman DS, 2012, J QUATERNARY SCI, V27, P344, DOI 10.1002/jqs.1552; Kaufmann PR, 2008, ENVIRON SCI TECHNOL, V42, P8044, DOI 10.1021/es8007722; Kuehn SC, 2011, QUATERN INT, V246, P19, DOI 10.1016/j.quaint.2011.08.022; Lakeman TR, 2008, CAN J EARTH SCI, V45, P935, DOI 10.1139/E08-035; Larsen LB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032450; Lavigne F, 2013, P NATL ACAD SCI USA, V110, P16742, DOI 10.1073/pnas.1307520110; Mann ME, 2013, J GEOPHYS RES-ATMOS, V118, P7617, DOI 10.1002/jgrd.50609; Mann ME, 2012, NAT GEOSCI, V5, P202, DOI [10.1038/ngeo1394, 10.1038/NGEO1394]; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Masarik J, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010557; Mass CF, 1989, J CLIMATE, V2, P566, DOI 10.1175/1520-0442(1989)002<0566:MVEACA>2.0.CO;2; McConnell JR, 2008, P NATL ACAD SCI USA, V105, P12140, DOI 10.1073/pnas.0803564105; McConnell JR, 2002, ENVIRON SCI TECHNOL, V36, P7, DOI 10.1021/es011088z; McCormick M, 2012, J INTERDISCIPL HIST, V43, P169, DOI 10.1162/JINH_a_00379; McMahon SM, 2010, P NATL ACAD SCI USA, V107, P3611, DOI 10.1073/pnas.0912376107; Miyake F, 2015, GEOPHYS RES LETT, V42, P84, DOI 10.1002/2014GL062218; Miyake F, 2012, NATURE, V486, P240, DOI 10.1038/nature11123; OSKARSSON N, 1982, J PETROL, V23, P28, DOI 10.1093/petrology/23.1.28; Pasteris D, 2014, J GEOPHYS RES-ATMOS, V119, P5640, DOI 10.1002/2013JD020377; Pasteris DR, 2014, J GEOPHYS RES-ATMOS, V119, P9168, DOI 10.1002/2013JD020720; Plummer CT, 2012, CLIM PAST, V8, P1929, DOI 10.5194/cp-8-1929-2012; Rasmussen SO, 2013, CLIM PAST, V9, P2713, DOI 10.5194/cp-9-2713-2013; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; Rohde R., 2013, GEOINFORM GEOSTAT OV, V1; Rolandi G, 2008, J VOLCANOL GEOTH RES, V169, P87, DOI 10.1016/j.jvolgeores.2007.08.020; Ruth U, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002376; Sachs A., 1996, ASTRONOMICAL DIARIES, V3; Salzer MW, 2007, QUATERNARY RES, V67, P57, DOI 10.1016/j.yqres.2006.07.004; Salzer MW, 2014, CLIM DYNAM, V42, P1517, DOI 10.1007/s00382-013-1911-9; Salzer MW, 2009, P NATL ACAD SCI USA, V106, P20348, DOI 10.1073/pnas.0903029106; SAMPSON DE, 1987, J GEOPHYS RES-SOLID, V92, P10403, DOI 10.1029/JB092iB10p10403; Schneider DP, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011222; Schurer AP, 2013, J CLIMATE, V26, P6954, DOI 10.1175/JCLI-D-12-00826.1; Siebert L., 2010, VOLCANOES WORLD, V3; Sigl M, 2014, NAT CLIM CHANGE, V4, P693, DOI 10.1038/nclimate2293; Sigl M, 2013, J GEOPHYS RES-ATMOS, V118, P1151, DOI 10.1029/2012JD018603; Stenseth NC, 2006, P NATL ACAD SCI USA, V103, P13110, DOI 10.1073/pnas.0602447103; STOTHERS RB, 1984, NATURE, V307, P344, DOI 10.1038/307344a0; Stothers RB, 1999, CLIMATIC CHANGE, V42, P713, DOI 10.1023/A:1005480105370; Sun CQ, 2014, GEOPHYS RES LETT, V41, P694, DOI 10.1002/2013GL058642; Taylor RE, 2013, NUCL INSTRUM METH B, V294, P440, DOI 10.1016/j.nimb.2012.08.057; Usoskin IG, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201321080; Usoskin IG, 2013, LIVING REV SOL PHYS, V10, DOI 10.12942/lrsp-2013-1; Veres D, 2013, CLIM PAST, V9, P1733, DOI 10.5194/cp-9-1733-2013; Vinther BM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006921; Vollmer M, 2005, APPL OPTICS, V44, P5658, DOI 10.1364/AO.44.005658; Webber WR, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012499; Winstrup M, 2012, CLIM PAST, V8, P1881, DOI 10.5194/cp-8-1881-2012; WITTMANN AD, 1987, ASTRON ASTROPHYS SUP, V70, P83; Woodruff TE, 2013, NUCL INSTRUM METH B, V294, P77, DOI 10.1016/j.nimb.2012.08.033; Xu JD, 2013, GEOPHYS RES LETT, V40, P54, DOI 10.1029/2012GL054246; Zanchettin D, 2014, EARTH SYST DYNAM, V5, P223, DOI 10.5194/esd-5-223-2014; Zhang ZB, 2010, P ROY SOC B-BIOL SCI, V277, P3745, DOI 10.1098/rspb.2010.0890	93	614	643	21	387	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2015	523	7562					543	+		10.1038/nature14565	http://dx.doi.org/10.1038/nature14565			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ZL	26153860	Green Accepted			2022-12-28	WOS:000358655200035
J	Elliott, L; Cifu, AS				Elliott, Lorrie; Cifu, Adam S.			Healthy Lifestyle Counseling in Persons With Cardiovascular Risk Factors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADULTS; INTERVENTION; MORTALITY	TARGET POPULATION Adults in primary care settings who are overweight or obese and have known cardiovascular (CVD) risk factors (hypertension, dyslipidemia, impaired fasting glucose, or metabolic syndrome) MAJOR RECOMMENDATION For adults who are overweight or obese and have known CVD risk factors, offer or refer for intensive behavioral counseling interventions to promote a healthful diet and physical activity (B recommendation: high certainty that the net benefit is moderate or moderate certainty that the net benefit is moderate to substantial).	[Elliott, Lorrie] Northwestern Univ, Dept Clin Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Cifu, Adam S.] Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; University of Chicago	Cifu, AS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Fagerberg B, 1998, AM J HYPERTENS, V11, P14, DOI 10.1016/S0895-7061(97)00363-4; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford ES, 2012, PREV MED, V55, P23, DOI 10.1016/j.ypmed.2012.04.016; Fryar CD, 2012, PREVALENCE UNCONTROL; Huffman MD, 2012, CIRCULATION, V125, P2595, DOI 10.1161/CIRCULATIONAHA.111.070722; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796	7	6	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2015	314	4					398	+		10.1001/jama.2015.4594	http://dx.doi.org/10.1001/jama.2015.4594			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN6YY	26219058				2022-12-28	WOS:000358581700022
J	Chung, J; Torta, F; Masai, K; Lucast, L; Czapla, H; Tanner, LB; Narayanaswamy, P; Wenk, MR; Nakatsu, F; De Camilli, P				Chung, Jeeyun; Torta, Federico; Masai, Kaori; Lucast, Louise; Czapla, Heather; Tanner, Lukas B.; Narayanaswamy, Pradeep; Wenk, Markus R.; Nakatsu, Fubito; De Camilli, Pietro			PI4P/phosphatidylserine countertransport at ORP5-and ORP8-mediated ER-plasma membrane contacts	SCIENCE			English	Article							OXYSTEROL-BINDING-PROTEINS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE LEVELS; PHOSPHATIDYLSERINE; SITES; 4-PHOSPHATE; METABOLISM; TRANSPORT; REVEALS; STEROL; PIPELINES	Lipid transfer between cell membrane bilayers at contacts between the endoplasmic reticulum (ER) and other membranes help to maintain membrane lipid homeostasis. We found that two similar ER integral membrane proteins, oxysterol-binding protein (OSBP)-related protein 5 (ORP5) and ORP8, tethered the ER to the plasma membrane (PM) via the interaction of their pleckstrin homology domains with phosphatidylinositol 4-phosphate (PI4P) in this membrane. Their OSBP-related domains (ORDs) harbored either PI4P or phosphatidylserine (PS) and exchanged these lipids between bilayers. Gain-and loss-of-function experiments showed that ORP5 and ORP8 could mediate PI4P/PS countertransport between the ER and the PM, thus delivering PI4P to the ER-localized PI4P phosphatase Sac1 for degradation and PS from the ER to the PM. This exchange helps to control plasma membrane PI4P levels and selectively enrich PS in the PM.	[Chung, Jeeyun; Masai, Kaori; Lucast, Louise; Czapla, Heather; Nakatsu, Fubito; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, Howard Hughes Med Inst,Kavli Inst Neurosci, New Haven, CT 06520 USA; [Chung, Jeeyun; Masai, Kaori; Lucast, Louise; Czapla, Heather; Nakatsu, Fubito; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA; [Torta, Federico; Tanner, Lukas B.; Narayanaswamy, Pradeep; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117456, Singapore	Howard Hughes Medical Institute; Yale University; Yale University; National University of Singapore	Nakatsu, F (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Neurochem & Mol Cell Biol, Niigata 9518510, Japan.	nakatsu@med.niigata-u.ac.jp; pietro.decamilli@yale.edu		Chung, Jeeyun/0000-0002-4617-7181; Torta, Federico/0000-0001-7545-7484	NIH [DK082700, R37NS036251, DK45735, DA018343]; National University of Singapore via the Life Sciences Institute; Biomedical Research Council (BMRC)-Science and Engineering Research (SERC) from the Agency for Science, Technology and Research [BMRC-SERC 112 148 0006]; Medical Research Internship program of Okayama University; Japan Student Service Organization; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082700, P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National University of Singapore via the Life Sciences Institute(National University of Singapore); Biomedical Research Council (BMRC)-Science and Engineering Research (SERC) from the Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); Medical Research Internship program of Okayama University; Japan Student Service Organization; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Y. Cai, X. Wu, C. Schauder, Y. Saheki, J. Park, and X. Bin for discussion and critical technical suggestions; T. Melia for discussion and advice for lipid experiments; and F. Wilson for outstanding technical support. We thank T. Balla for the kind gift of A1 compound. Generous gifts of plasmids are acknowledged in the materials and methods section of the supplementary materials. This work was supported in part from grants from the NIH (DK082700, R37NS036251, DK45735, and DA018343) to P.D.C., grants from the National University of Singapore via the Life Sciences Institute and a Biomedical Research Council (BMRC)-Science and Engineering Research (SERC) joint grant (BMRC-SERC 112 148 0006) from the Agency for Science, Technology and Research to M.R.W, and grants from the Medical Research Internship program of Okayama University and Japan Student Service Organization to K.M.	Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Beh CT, 2012, J BIOL CHEM, V287, P11481, DOI 10.1074/jbc.R111.338400; Bojjireddy N, 2014, J BIOL CHEM, V289, P6120, DOI 10.1074/jbc.M113.531426; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; von Filseck JM, 2014, BIOCHEM SOC T, V42, P1465, DOI 10.1042/BST20140143; Wu XD, 2014, DEV CELL, V28, P19, DOI 10.1016/j.devcel.2013.11.012; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	33	351	364	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					428	432		10.1126/science.aab1370	http://dx.doi.org/10.1126/science.aab1370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206935	Green Accepted			2022-12-28	WOS:000358381400043
J	Martill, DM; Tischlinger, H; Longrich, NR				Martill, David M.; Tischlinger, Helmut; Longrich, Nicholas R.			A four-legged snake from the Early Cretaceous of Gondwana	SCIENCE			English	Article							PHYLOGENETIC ANALYSIS; BODY-FORM; EVOLUTION; LIZARDS; SQUAMATA; ANATOMY; PERIOD	Snakes are a remarkably diverse and successful group today, but their evolutionary origins are obscure. The discovery of snakes with two legs has shed light on the transition from lizards to snakes, but no snake has been described with four limbs, and the ecology of early snakes is poorly known. We describe a four-limbed snake from the Early Cretaceous (Aptian) Crato Formation of Brazil. The snake has a serpentiform body plan with an elongate trunk, short tail, and large ventral scales suggesting characteristic serpentine locomotion, yet retains small prehensile limbs. Skull and body proportions as well as reduced neural spines indicate fossorial adaptation, suggesting that snakes evolved from burrowing rather than marine ancestors. Hooked teeth, an intramandibular joint, a flexible spine capable of constricting prey, and the presence of vertebrate remains in the guts indicate that this species preyed on vertebrates and that snakes made the transition to carnivory early in their history. The structure of the limbs suggests that they were adapted for grasping, either to seize prey or as claspers during mating. Together with a diverse fauna of basal snakes from the Cretaceous of South America, Africa, and India, this snake suggests that crown Serpentes originated in Gondwana.	[Martill, David M.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth PO1 3QL, Hants, England; [Longrich, Nicholas R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Longrich, Nicholas R.] Univ Bath, Milner Ctr Evolut, Bath BA2 7AY, Avon, England	University of Portsmouth; University of Bath; University of Bath	Martill, DM (corresponding author), Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth PO1 3QL, Hants, England.			Martill, David/0000-0002-3208-5702; Longrich, Nicholas/0000-0002-9586-8907				Apesteguia S, 2006, NATURE, V440, P1037, DOI 10.1038/nature04413; Caldwell MW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6996; Caldwell MW, 1997, NATURE, V386, P705, DOI 10.1038/386705a0; Gardner JD, 1999, SP PALAEONT, P87; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Greene H. W., 1997, SNAKES EVOLUTION MYS; Heimhofer U., 2007, CRATO FOSSIL BEDS BR, P44; Hildebrand M., 2001, ANAL VERTEBRATE STRU; Lee MSY, 1998, PHILOS T ROY SOC B, V353, P1521, DOI 10.1098/rstb.1998.0308; Longrich NR, 2012, P NATL ACAD SCI USA, V109, P21396, DOI 10.1073/pnas.1211526110; Longrich NR, 2012, NATURE, V488, P205, DOI 10.1038/nature11227; O'Connor PM, 2010, NATURE, V466, P748, DOI 10.1038/nature09061; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rage J.-C., 1989, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1989, P433; Rage J.C., 1999, Palaeontologia Africana, V35, P85; Rage JC, 1996, CR ACAD SCI II A, V322, P603; Rage JC, 2008, PALAEONTOGR ABT A, V285, P1; Reeder TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118199; Scanlon JD, 2000, NATURE, V403, P416, DOI 10.1038/35000188; Tchernov E, 2000, SCIENCE, V287, P2010, DOI 10.1126/science.287.5460.2010; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Wiens JJ, 2001, EVOLUTION, V55, P2303; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703; Zaher H, 2012, ZOOL J LINN SOC-LOND, V164, P194, DOI 10.1111/j.1096-3642.2011.00755.x; Zaher H, 2009, ZOOL J LINN SOC-LOND, V156, P801, DOI 10.1111/j.1096-3642.2009.00511.x	26	61	64	1	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2015	349	6246					416	419		10.1126/science.aaa9208	http://dx.doi.org/10.1126/science.aaa9208			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DX	26206932	Green Submitted			2022-12-28	WOS:000358381400040
J	Batchelor, TT; Chen, YB; Rapalino, O; Cobos, I				Batchelor, Tracy T.; Chen, Yi-Bin; Rapalino, Otto; Cobos, Inma			Case 23-2015: A 51-Year-Old Woman with Headache, Cognitive Impairment, and Weakness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY CNS LYMPHOMA; NERVOUS-SYSTEM LYMPHOMA; RECURRENT PRIMARY CNS; WHOLE-BRAIN RADIOTHERAPY; B-CELL LYMPHOMAS; CEREBRAL SCHISTOSOMIASIS; IMMUNOCOMPETENT PATIENTS; GLIOBLASTOMA-MULTIFORME; INTENSIVE CHEMOTHERAPY; CORPUS-CALLOSUM		[Batchelor, Tracy T.] Massachusetts Gen Hosp, Dept Neurol & Radiat Oncol, Boston, MA 02114 USA; [Chen, Yi-Bin] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Rapalino, Otto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Cobos, Inma] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Batchelor, Tracy T.] Harvard Univ, Sch Med, Dept Neurol & Radiat Oncol, Boston, MA USA; [Chen, Yi-Bin] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Rapalino, Otto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Cobos, Inma] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Batchelor, TT (corresponding author), Massachusetts Gen Hosp, Dept Neurol & Radiat Oncol, Boston, MA 02114 USA.			Rapalino, Otto/0000-0002-5038-4183; Cobos, Inma/0000-0002-2043-1890	Merck; Roche; Kyowa Hakko Kirin; Novartis; Proximagen; Agenus; Spectrum; Amgen; Champions Biotechnology; Advance Medical; Foundation Medicine; Robert Michael Educational Institute; Educational Concepts Group; Research to Practice; Oakstone Publishing; Imedex; Pfizer; AstraZeneca; Millennium; Otsuka Pharmaceuticals; Seattle Genetics; Bayer; Onyx Pharmaceuticals	Merck(Merck & Company); Roche(Roche Holding); Kyowa Hakko Kirin(Kyowa Kirin Ltd); Novartis(Novartis); Proximagen; Agenus; Spectrum; Amgen(Amgen); Champions Biotechnology; Advance Medical; Foundation Medicine; Robert Michael Educational Institute; Educational Concepts Group; Research to Practice; Oakstone Publishing; Imedex; Pfizer(Pfizer); AstraZeneca(AstraZeneca); Millennium(Takeda Pharmaceutical Company Ltd); Otsuka Pharmaceuticals(Otsuka Pharmaceutical); Seattle Genetics; Bayer(Bayer AG); Onyx Pharmaceuticals	Dr. Batchelor reports receiving consulting fees from Merck, Roche, Kyowa Hakko Kirin, Novartis, Proximagen, Agenus, Spectrum, Amgen, Champions Biotechnology, Advance Medical, and Foundation Medicine; lecture fees from Robert Michael Educational Institute, Educational Concepts Group, Research to Practice, Oakstone Publishing, and Imedex; and grant support from Pfizer, AstraZeneca, and Millennium. Dr. Chen reports receiving consulting fees from Otsuka Pharmaceuticals and grant support from Otsuka Pharmaceuticals, Seattle Genetics, Bayer and Onyx Pharmaceuticals, and Novartis. No other potential conflict of interest relevant to this article was reported.	Abrey LE, 2006, J CLIN ONCOL, V24, P5711, DOI 10.1200/JCO.2006.08.2941; Abrey LE, 2005, J CLIN ONCOL, V23, P5034, DOI 10.1200/JCO.2005.13.524; Abul-Kasim K, 2008, NEURORADIOL J, V21, P637, DOI 10.1177/197140090802100505; Al-Okaili RN, 2006, RADIOGRAPHICS, V26, pS173, DOI 10.1148/rg.26si065513; Bagley LJ, 1997, RADIOLOGY, V202, P511, DOI 10.1148/radiology.202.2.9015082; Batchelor T, 2003, J CLIN ONCOL, V21, P1044, DOI 10.1200/JCO.2003.03.036; Batchelor TT, 2011, NEUROLOGY, V76, P929, DOI 10.1212/WNL.0b013e31820f2d94; Bernarding J, 2002, J MAGN RESON IMAGING, V15, P96, DOI 10.1002/jmri.10045; Birnbaum T, 2012, J NEURO-ONCOL, V109, P285, DOI 10.1007/s11060-012-0891-7; Bolcaen J, 2013, J NEUROIMAGING, V23, P431, DOI 10.1111/j.1552-6569.2012.00760.x; Booman M, 2008, J PATHOL, V216, P209, DOI 10.1002/path.2399; Calvo-Vidal MN, 2013, CURR OPIN HEMATOL, V20, P345, DOI 10.1097/MOH.0b013e3283623d16; Camilleri-Broet S, 2006, BLOOD, V107, P190, DOI 10.1182/blood-2005-03-1024; Correa DD, 2007, ANN ONCOL, V18, P1145, DOI 10.1093/annonc/mdl464; Cote GM, 2012, BIOL BLOOD MARROW TR, V18, P76, DOI 10.1016/j.bbmt.2011.07.006; Coulon A, 2002, EUR RADIOL, V12, P329, DOI 10.1007/s003300101037; Deangelis L M, 1987, Oncology (Williston Park), V1, P52; Deckert M, 2011, LEUKEMIA, V25, P1797, DOI 10.1038/leu.2011.169; Deckert M, 2014, ACTA NEUROPATHOL, V127, P175, DOI 10.1007/s00401-013-1202-x; del Rio MS, 2012, J NEURO-ONCOL, V106, P143, DOI 10.1007/s11060-011-0649-7; Doolittle ND, 2013, NEUROLOGY, V81, P84, DOI 10.1212/WNL.0b013e318297eeba; FathOrdoubadi F, 1997, J NEUROL NEUROSUR PS, V63, P98, DOI 10.1136/jnnp.63.1.98; Ferreri AJM, 2003, J CLIN ONCOL, V21, P266, DOI 10.1200/JCO.2003.09.139; Fischer L, 2011, NEURO-ONCOLOGY, V13, P1090, DOI 10.1093/neuonc/nor107; George J, 2009, CAN J NEUROL SCI, V36, P244, DOI 10.1017/S0317167100006624; Gerstner ER, 2008, NEUROLOGY, V70, P401, DOI 10.1212/01.wnl.0000300671.37279.0e; Gupta RK, 2007, J COMPUT ASSIST TOMO, V31, P335, DOI 10.1097/01.rct.0000243443.10739.16; Hakyemez B, 2005, BRIT J RADIOL, V78, P989, DOI 10.1259/bjr/12830378; Hartmann M, 2003, NEUROSCI LETT, V338, P119, DOI 10.1016/S0304-3940(02)01367-8; Ho ML, 2013, AM J ROENTGENOL, V200, pW1, DOI 10.2214/AJR.11.8080; Hottinger AF, 2007, NEUROLOGY, V69, P1178, DOI 10.1212/01.wnl.0000276986.19602.c1; JACK CR, 1986, AM J ROENTGENOL, V146, P271, DOI 10.2214/ajr.146.2.271; Juergens A, 2010, ANN NEUROL, V67, P182, DOI 10.1002/ana.21824; Kasow DL, 2000, AM J NEURORADIOL, V21, P1876; Khan RB, 2002, J NEURO-ONCOL, V58, P175, DOI 10.1023/A:1016077907952; Kim EY, 2005, ACTA RADIOL, V46, P187, DOI 10.1080/02841850510022714; Lai R, 2004, NEUROLOGY, V62, P451, DOI 10.1212/01.WNL.0000106941.51340.A2; Liao WH, 2009, ACTA RADIOL, V50, P217, DOI 10.1080/02841850802616752; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Montesinos-Rongen M, 2008, LEUKEMIA, V22, P400, DOI 10.1038/sj.leu.2405019; Morris PG, 2013, J CLIN ONCOL, V31, P3971, DOI 10.1200/JCO.2013.50.4910; Nabors LB, 2015, NCCN CLIN PRACTICE G; Naphade PS, 2011, NEUROL INDIA, V59, P913, DOI 10.4103/0028-3886.91382; Nguyen PL, 2005, J CLIN ONCOL, V23, P1507, DOI 10.1200/JCO.2005.01.161; Ozawa Y, 1998, Radiat Med, V16, P69; Preusser M, 2010, PATHOLOGY, V42, P547, DOI 10.3109/00313025.2010.508786; Radbruch A, 2013, EUR J RADIOL, V82, P552, DOI 10.1016/j.ejrad.2012.11.002; Raoux D, 2010, NEUROPATHOLOGY, V30, P232, DOI 10.1111/j.1440-1789.2009.01074.x; Renard D, 2014, J NEUROL NEUROSUR PS, V85, P1041, DOI 10.1136/jnnp-2013-307072; Rubenstein JL, 2013, J CLIN ONCOL, V31, P3061, DOI 10.1200/JCO.2012.46.9957; Rubenstein JL, 2006, BLOOD, V107, P3716, DOI 10.1182/blood-2005-03-0897; Soussain C, 2001, J CLIN ONCOL, V19, P742, DOI 10.1200/JCO.2001.19.3.742; Soussain C, 2008, J CLIN ONCOL, V26, P2512, DOI 10.1200/JCO.2007.13.5533; Tang YZ, 2011, CLIN RADIOL, V66, P768, DOI 10.1016/j.crad.2011.03.006; Toh CH, 2006, J NEUROSURG, V105, P132, DOI 10.3171/jns.2006.105.1.132; Tun HW, 2008, BLOOD, V111, P3200, DOI 10.1182/blood-2007-10-119099; Braga MHV, 2011, WORLD NEUROSURG, V76, P200, DOI 10.1016/j.wneu.2010.12.002; Wan H, 2009, KOREAN J PARASITOL, V47, P53, DOI 10.3347/kjp.2009.47.1.53; Wang S, 2011, AM J NEURORADIOL, V32, P507, DOI 10.3174/ajnr.A2333; Wu LQ, 2012, CELL BIOCHEM BIOPHYS, V62, P289, DOI 10.1007/s12013-011-9294-1; Yamashita K, 2013, NEURORADIOLOGY, V55, P135, DOI 10.1007/s00234-012-1089-6; Zacharia TT, 2008, J NEUROIMAGING, V18, P411, DOI 10.1111/j.1552-6569.2007.00231.x	62	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					367	377		10.1056/NEJMcpc1406415	http://dx.doi.org/10.1056/NEJMcpc1406415			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3NL	26200983				2022-12-28	WOS:000358333500012
J	Chang, JE; Brundage, SC; Chokshi, DA				Chang, Ji Eun; Brundage, Suzanne C.; Chokshi, Dave A.			Convenient Ambulatory Care - Promise, Pitfalls, and Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							QUALITY-OF-CARE; RETAIL CLINICS; VISITS; COSTS; CONTINUITY; CENTERS		[Chang, Ji Eun] NYU, Wagner Sch Publ Serv, New York, NY 10003 USA; [Chang, Ji Eun; Chokshi, Dave A.] New York City Hlth & Hosp Corp, New York, NY USA; [Brundage, Suzanne C.] United Hosp Fund, New York, NY USA; [Chokshi, Dave A.] NYU, Langone Med Ctr, New York, NY USA	New York University; New York University; NYU Langone Medical Center	Chang, JE (corresponding author), NYU, Wagner Sch Publ Serv, New York, NY 10003 USA.			Chokshi, Dave/0000-0001-7467-4591				American Academy of Family Physicians, 2014, RET CLIN; [Anonymous], 2014, DEC COND APPL MINUTE; Bacharach D, 2015, BUILDING CULTURE HLT; Bohmer R, 2007, NEW ENGL J MED, V356, P765, DOI 10.1056/NEJMp068289; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P2151, DOI 10.1001/jama.2012.3966; Centers for Disease Control and Prevention, 2014, AMB CAR US PHYS OFF; Chang JE., 2015, CONVENIENT CARE RETA; Conners GP, 2014, PEDIATRICS, V133, P950, DOI 10.1542/peds.2014-0569; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hamilton M., 2014, WASHINGTON POST 0404; Hunter LP, 2009, J AM ACAD NURSE PRAC, V21, P565, DOI 10.1111/j.1745-7599.2009.00447.x; Hussey PS, 2014, JAMA INTERN MED, V174, P742, DOI 10.1001/jamainternmed.2014.245; Industry FAQs, 2012, IND FAQS; Jacoby Richard, 2011, Am J Med Qual, V26, P53, DOI 10.1177/1062860610375106; Johnson Thomas K., 2015, NY TIMES; Kaissi A, 2014, FLIPPING HLTH CARE R; Kirkner RM, 2014, URGENT CARE FINDS IT; Mehrotra A, 2008, HEALTH AFFAIR, V27, P1272, DOI 10.1377/hlthaff.27.5.1272; Mehrotra A, 2013, JAMA-J AM MED ASSOC, V310, P35, DOI 10.1001/jama.2013.6825; Mehrotra A, 2012, HEALTH AFFAIR, V31, P2123, DOI 10.1377/hlthaff.2011.1128; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; National Committee for Quality Assurance, 2015, PAT CTR CONN CAR REC; Patwardhan A, 2012, J PRIM CARE COMMUNIT, V3, P243, DOI 10.1177/2150131911436251; Pollack CE, 2010, HEALTH AFFAIR, V29, P998, DOI 10.1377/hlthaff.2010.0089; Pollack CE, 2009, ARCH INTERN MED, V169, P945, DOI 10.1001/archinternmed.2009.69; Reid RO, 2013, J GEN INTERN MED, V28, P504, DOI 10.1007/s11606-012-2243-x; Rohrer James E, 2012, Qual Manag Health Care, V21, P44, DOI 10.1097/QMH.0b013e3182418157; Rudavsky R, 2010, J AM BOARD FAM MED, V23, P42, DOI 10.3122/jabfm.2010.01.090033; Shrank WH, 2014, AM J MANAG CARE, V20, P794; Spetz J, 2013, HEALTH AFFAIR, V32, P1977, DOI 10.1377/hlthaff.2013.0544; Stempniak M., 2015, URGENT CARE 2 0 NEW; Sussman A, 2013, AM J MANAG CARE, V19, pE148; TAKACH M, 2009, ANAL STATE REGULATIO; Takach M, 2009, RETAIL CLIN 6 STATE; The Joint Commission, 2015, AMB HLTH CAR; Thygeson M, 2008, HEALTH AFFAIR, V27, P1283, DOI 10.1377/hlthaff.27.5.1283; Urgent Care Association of America, 2015, HLTH PROF STAFF URG; Urgent Care Association of America, 2014, BENCHM SURV HEADL SU; Urgent Care Association of America, 2014, URG CAR ASS AM UNV N; Viera AJ, 2006, ANN FAM MED, V4, P359, DOI 10.1370/afm.557; Weinick RM, 2007, NO APPOINTMENT NEEDE; Weinick RM, 2010, HEALTH AFFAIR, V29, P1630, DOI 10.1377/hlthaff.2009.0748; Weinick RM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-79; Wilson AR, 2010, AM J MANAG CARE, V16, P751	44	23	23	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					382	388		10.1056/NEJMhpr1503336	http://dx.doi.org/10.1056/NEJMhpr1503336			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN3NL	26200985				2022-12-28	WOS:000358333500014
J	Heald, AE; Charleston, JS; Iversen, PL; Warren, TK; Saoud, JB; Al-Ibrahim, M; Wells, J; Warfield, KL; Swenson, DL; Welch, LS; Sazani, P; Wong, M; Berry, D; Kaye, EM; Bavari, S				Heald, Alison E.; Charleston, Jay S.; Iversen, Patrick L.; Warren, Travis K.; Saoud, Jay B.; Al-Ibrahim, Mohamed; Wells, Jay; Warfield, Kelly L.; Swenson, Dana L.; Welch, Lisa S.; Sazani, Peter; Wong, Michael; Berry, Diane; Kaye, Edward M.; Bavari, Sina			AVI-7288 for Marburg Virus in Nonhuman Primates and Humans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EBOLA-VIRUS; MORPHOLINO OLIGOMERS; FILOVIRUS INFECTIONS; HEMORRHAGIC-FEVER; EPIDEMIC; DISEASE	BACKGROUND AVI-7288 is a phosphorodiamidate morpholino oligomer with positive charges that targets the viral messenger RNA that encodes Marburg virus (MARV) nucleoprotein. Its safety in humans is undetermined. METHODS We assessed the efficacy of AVI-7288 in a series of studies involving a lethal challenge with MARV in nonhuman primates. The safety of AVI-7288 was evaluated in a randomized, multiple-ascending-dose study in which 40 healthy humans (8 humans per dose group) received 14 once-daily infusions of AVI-7288 (1 mg, 4 mg, 8 mg, 12 mg, or 16 mg per kilogram of body weight) or placebo, in a 3: 1 ratio. We estimated the protective dose in humans by comparing pharmacokinetic variables in infected nonhuman primates, uninfected nonhuman primates, and uninfected humans. RESULTS Survival in infected nonhuman primates was dose-dependent, with survival rates of 0%, 30%, 59%, 87%, 100%, and 100% among monkeys treated with 0 mg, 3.75 mg, 7.5 mg, 15 mg, 20 mg, and 30 mg of AVI-7288 per kilogram, respectively (P < 0.001 with the use of the log-rank test for the comparison of survival across groups). No safety concern was identified at doses up to 16 mg per kilogram per day in humans. No serious adverse events were reported. Drug exposure (the area under the curve) was dose-dependent in both nonhuman primates and humans; drug clearance was independent of dose but was higher in nonhuman primates than in humans. The protective dose in humans was initially estimated, on the basis of exposure, to be 9.6 mg per kilogram per day (95% confidence interval, 6.6 to 12.5) for 14 days. Monte Carlo simulations supported a dose of 11 mg per kilogram per day to match the geometric mean protective exposure in nonhuman primates. CONCLUSIONS This study shows that, on the basis of efficacy in nonhuman primates and pharmacokinetic data in humans, AVI-7288 has potential as postexposure prophylaxis for MARV infection in humans.	[Heald, Alison E.; Charleston, Jay S.; Iversen, Patrick L.; Saoud, Jay B.; Sazani, Peter; Wong, Michael; Berry, Diane; Kaye, Edward M.] Sarepta Therapeut, Cambridge, MA USA; [Heald, Alison E.] Univ Washington, Div Infect Dis, Seattle, WA 98195 USA; [Iversen, Patrick L.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Warren, Travis K.; Wells, Jay; Warfield, Kelly L.; Swenson, Dana L.; Welch, Lisa S.; Bavari, Sina] US Army Med Res Inst Infect Dis, Therapeut Discovery Ctr, Mol & Translat Sci, Frederick, MD USA; [Al-Ibrahim, Mohamed] SNBL Clin Pharmacol Ctr, Baltimore, MD USA	University of Washington; University of Washington Seattle; Oregon State University; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army	Heald, AE (corresponding author), Harborview Med Ctr, 2 West Clin,Box 359930,325 Ninth Ave, Seattle, WA 98104 USA.	healda@uw.edu	Bavari, Sina/L-3642-2019; Iversen, Patrick L/D-8854-2019; Iversen, Patrick L./L-5454-2019	Bavari, Sina/0000-0001-8424-5635; Iversen, Patrick L/0000-0003-0106-9790; Iversen, Patrick L./0000-0003-0106-9790	Department of Defense	Department of Defense(United States Department of Defense)	Funded by the Department of Defense; ClinicalTrials.gov number, NCT01566877.	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bente D, 2009, DIS MODEL MECH, V2, P12, DOI 10.1242/dmm.000471; Brauburger K, 2012, VIRUSES-BASEL, V4, P1878, DOI 10.3390/v4101878; Centers for Disease Control and Prevention, 2014, EM PREP RESP BIOT AG; Feldmann H., 2013, FIELDS VIROLOGY, V1, P923; Friedrich BM, 2012, VIRUSES-BASEL, V4, P1619, DOI 10.3390/v4091619; Gene Olinger G., 2009, Infectious Disorders - Drug Targets, V9, P191; Gibaldi M, 1982, PHARMACOKINETICS; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; Heald AE, 2014, ANTIMICROB AGENTS CH, V58, P6639, DOI 10.1128/AAC.03442-14; Iversen PL, 2012, VIRUSES-BASEL, V4, P2806, DOI 10.3390/v4112806; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Kuhn Jens H, 2008, Arch Virol Suppl, V20, P13; MacNeil A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001546; MAST ST, 1993, J INFECT DIS, V168, P1589, DOI 10.1093/infdis/168.6.1589; Mehedi M, 2011, FUTURE VIROL, V6, P1091, DOI 10.2217/FVL.11.79; Nakayama E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00267; Shurtleff AC, 2012, EXPERT OPIN DRUG DIS, V7, P935, DOI 10.1517/17460441.2012.714364; US Food and Drug Administration, GUID IND PR IN PRESS; Warren TK, 2012, ANTIVIR RES, V94, P80, DOI 10.1016/j.antiviral.2012.02.004; Warren TK, 2010, NAT MED, V16, P991, DOI 10.1038/nm.2202; WHO (World Health Organization), 2012, MARB HAEM FEV FACT S	23	33	34	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2015	373	4					339	348		10.1056/NEJMoa1410345	http://dx.doi.org/10.1056/NEJMoa1410345			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN3NL	26200980	Bronze			2022-12-28	WOS:000358333500007
J	Lynch, M				Lynch, Michael			GENETICS Feedforward loop for diversity	NATURE			English	Editorial Material							MUTATION-RATE; DROSOPHILA-MELANOGASTER; MOLECULAR-SPECTRUM; GENOME; CONSEQUENCES; RATES		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Lynch, M (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	milynch@indiana.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036827] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM036827] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amos W, 2010, BIOESSAYS, V32, P82, DOI 10.1002/bies.200900108; Arbeithuber B, 2015, P NATL ACAD SCI USA, V112, P2109, DOI 10.1073/pnas.1416622112; Chen XZ, 2013, MOL BIOL EVOL, V30, P1559, DOI 10.1093/molbev/mst060; Dey A, 2013, P NATL ACAD SCI USA, V110, P11056, DOI 10.1073/pnas.1303057110; Foster PL, 2013, G3-GENES GENOM GENET, V3, P399, DOI 10.1534/g3.112.005355; Harris K, 2014, GENOME RES, V24, P1445, DOI 10.1101/gr.170696.113; Keightley PD, 2014, GENETICS, V196, P313, DOI 10.1534/genetics.113.158758; Lynch M., 1998, GENETICS ANAL QUANTI; Lynch M, 2014, GENETICS, V198, P269, DOI 10.1534/genetics.114.166843; Lynch M, 2011, GENOME BIOL EVOL, V3, P1107, DOI 10.1093/gbe/evr066; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Schrider DR, 2013, GENETICS, V194, P937, DOI 10.1534/genetics.113.151670; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Sung W, 2015, MOL BIOL EVOL, V32, P1672, DOI 10.1093/molbev/msv055; Sung W, 2012, P NATL ACAD SCI USA, V109, P19339, DOI 10.1073/pnas.1210663109; Venn O, 2014, SCIENCE, V344, P1272, DOI 10.1126/science.344.6189.1272; Yang SH, 2015, NATURE, V523, P463, DOI 10.1038/nature14649	18	8	8	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					414	416		10.1038/nature14634	http://dx.doi.org/10.1038/nature14634			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN4DD	26176917	Green Accepted			2022-12-28	WOS:000358378900025
J	Skidmore, AK; Pettorelli, N; Coops, NC; Geller, GN; Hansen, M; Lucas, R; Mucher, CA; O'Connor, B; Paganini, M; Pereira, HM; Schaepman, ME; Turner, W; Wang, TJ; Wegmann, M				Skidmore, Andrew K.; Pettorelli, Nathalie; Coops, Nicholas C.; Geller, Gary N.; Hansen, Matthew; Lucas, Richard; Muecher, Caspar A.; O'Connor, Brian; Paganini, Marc; Pereira, Henrique Miguel; Schaepman, Michael E.; Turner, Woody; Wang, Tiejun; Wegmann, Martin			Agree on biodiversity metrics to track from space	NATURE			English	Editorial Material									[Skidmore, Andrew K.] Univ Twente, Spatial Environm Resource Dynam, POB 217, NL-7500 AE Enschede, Netherlands; [Pettorelli, Nathalie] Zool Soc London, Inst Zool, Conservat Biol, London, England; [Coops, Nicholas C.] Univ British Columbia, Vancouver, BC, Canada; [Geller, Gary N.] Grp Earth Observat, Geneva, Switzerland; [Hansen, Matthew] Univ Maryland, College Pk, MD 20742 USA; [Lucas, Richard] Univ New South Wales, Sydney, NSW, Australia; [Muecher, Caspar A.] Wageningen Univ, Alterra, Wageningen, Netherlands; [O'Connor, Brian] UN, Environm Programme World Conservat Monitoring Ctr, Cambridge, England; [Paganini, Marc] European Space Agcy, Frascati, Italy; [Pereira, Henrique Miguel] German Ctr Integrat Biodivers Res iDiv, Halle Jena Leipzig, Germany; [Schaepman, Michael E.] Univ Zurich, Zurich, Switzerland; [Turner, Woody] NASA, Washington, DC 20546 USA; [Wang, Tiejun] Univ Twente, ITC, Enschede, Netherlands; [Wegmann, Martin] Univ Wurzburg, Wurzburg, Germany	University of Twente; Zoological Society of London; University of British Columbia; University System of Maryland; University of Maryland College Park; University of New South Wales Sydney; Wageningen University & Research; United Nations Environment Programme; European Space Agency; University of Zurich; National Aeronautics & Space Administration (NASA); University of Twente; University of Wurzburg	Skidmore, AK (corresponding author), Univ Twente, Spatial Environm Resource Dynam, POB 217, NL-7500 AE Enschede, Netherlands.	a.k.skidmore@utwente.nl	Coops, Nicholas C/J-1543-2012; Pereira, Henrique/B-3975-2009; Hansen, Matthew C/ABE-7226-2020; Pettorelli, Nathalie/AAW-8438-2021; Schaepman, Michael/B-9213-2009; Coops, Nicholas/L-3652-2019; Wang, Tiejun/A-4671-2010; Skidmore, Andrew K/C-7441-2011	Coops, Nicholas C/0000-0002-0151-9037; Pereira, Henrique/0000-0003-1043-1675; Schaepman, Michael/0000-0002-9627-9565; Coops, Nicholas/0000-0002-0151-9037; Wang, Tiejun/0000-0002-1138-8464; Skidmore, Andrew K/0000-0002-7446-8429; Lucas, Richard/0000-0003-3010-3302; Geller, Gary/0000-0002-4490-6002; Wegmann, Martin/0000-0003-0335-9601; Mucher, Sander/0000-0002-7997-8356				Food and Agriculture Organization of the United Nations, 2005, GLOB FOR RES ASS 200; Food and Agriculture Organization of the United Nations, 1993, FOR RES ASS 1990; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Secades C., 2014, EARTH OBSERVATION BI; Turner W, 2014, SCIENCE, V346, P301, DOI 10.1126/science.1256014; Wulder MA, 2014, NATURE, V513, P30, DOI 10.1038/513030a	7	263	273	5	135	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 23	2015	523	7561					403	405		10.1038/523403a	http://dx.doi.org/10.1038/523403a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN4DD	26201582	Green Accepted, Bronze			2022-12-28	WOS:000358378900014
J	Kamerow, D				Kamerow, Douglas			US Medicare, Medicaid, and nurse practitioners all turn 50	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA; [Kamerow, Douglas] Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University; Georgetown University	Kamerow, D (corresponding author), Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Blumenthal D, 2015, NEW ENGL J MED, V372, P671, DOI 10.1056/NEJMhpr1414856; Blumenthal D, 2015, NEW ENGL J MED, V372, P479, DOI 10.1056/NEJMhpr1411701; Cunningham R, 2015, HEALTH AFFAIR, V34, P1080, DOI 10.1377/hlthaff.2015.0552; Lesser LI, 2011, ANN FAM MED, V9, P44, DOI 10.1370/afm.1194; University of Colorado, GROUNDBR NP PROGR TU, P50	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2015	351								h3863	10.1136/bmj.h3863	http://dx.doi.org/10.1136/bmj.h3863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN7WE	26195442				2022-12-28	WOS:000358644200001
J	Cohen, J				Cohen, Jon			MEANS TO AN END	SCIENCE			English	Editorial Material																			0	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		226	+		10.1126/science.349.6245.226	http://dx.doi.org/10.1126/science.349.6245.226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26185226				2022-12-28	WOS:000358218600017
J	Good, SP; Noone, D; Bowen, G				Good, Stephen P.; Noone, David; Bowen, Gabriel			Hydrologic connectivity constrains partitioning of global terrestrial water fluxes	SCIENCE			English	Article							STABLE-ISOTOPES; TRANSPIRATION; EVAPOTRANSPIRATION; INTERCEPTION; PULSE; CYCLE; DRY	Continental precipitation not routed to the oceans as runoff returns to the atmosphere as evapotranspiration. Partitioning this evapotranspiration flux into interception, transpiration, soil evaporation, and surface water evaporation is difficult using traditional hydrological methods, yet critical for understanding the water cycle and linked ecological processes. We combined two large-scale flux-partitioning approaches to quantify evapotranspiration subcomponents and the hydrologic connectivity of bound, plant-available soil waters with more mobile surface waters. Globally, transpiration is 64 +/- 13% (mean +/- 1 standard deviation) of evapotranspiration, and 65 +/- 26% of evaporation originates from soils and not surface waters. We estimate that 38 +/- 28% of surface water is derived from the plant-accessed soil water pool. This limited connectivity between soil and surface waters fundamentally structures the physical and biogeochemical interactions of water transiting through catchments.	[Good, Stephen P.; Bowen, Gabriel] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Good, Stephen P.] Oregon State Univ, Dept Biol & Ecol Engn, Corvallis, OR 97331 USA; [Noone, David] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Bowen, Gabriel] Univ Utah, Global Change & Sustainabil Ctr, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Oregon State University; Oregon State University; Utah System of Higher Education; University of Utah	Good, SP (corresponding author), Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA.	stephen.good@oregonstate.edu	Good, Stephen/H-4432-2013	Good, Stephen/0000-0003-4363-1577; NOONE, DAVID/0000-0002-8642-7843	NSF Macrosystems Biology program [EF-01241286]; U.S. Department of Defense; NSF Climate and Large Scale Dynamic program as part of a Faculty Early Career Development award [AGS-0955841]; Center for High Performance Computing at the University of Utah; Div Atmospheric & Geospace Sciences [1539234] Funding Source: National Science Foundation	NSF Macrosystems Biology program(National Science Foundation (NSF)); U.S. Department of Defense(United States Department of Defense); NSF Climate and Large Scale Dynamic program as part of a Faculty Early Career Development award; Center for High Performance Computing at the University of Utah; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was funded by the NSF Macrosystems Biology program, grant EF-01241286, and the U.S. Department of Defense. D.N. acknowledges the support of the NSF Climate and Large Scale Dynamic program as part of a Faculty Early Career Development award (AGS-0955841). Support and resources from the Center for High Performance Computing at the University of Utah are also gratefully acknowledged. Bulk flux data used in this study are available online from NASA (http://precip.gsfc.nasa.gov/, http://gmao.gsfc.nasa.gov/merra/) and the Woods Hole Oceanographic Institute (http://oaflux.whoi.edu/). Global surface vapor isotope data are available as supplementary information in (23). The model code and input data files used in this study are available at http://waterisotopes.org.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Brooks JR, 2014, LIMNOL OCEANOGR, V59, P2150, DOI 10.4319/lo.2014.59.6.2150; Brooks JR, 2010, NAT GEOSCI, V3, P100, DOI 10.1038/NGEO722; Coenders-Gerrits AMJ, 2014, NATURE, V506, pE1, DOI 10.1038/nature12925; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; DONGMANN G, 1974, RADIAT ENVIRON BIOPH, V11, P41, DOI 10.1007/BF01323099; Gibson JJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001839; Goldsmith GR, 2012, ECOHYDROLOGY, V5, P779, DOI 10.1002/eco.268; Good SP, 2015, GEOPHYS RES LETT, V42, P5042, DOI 10.1002/2015GL064117; Good SP, 2014, WATER RESOUR RES, V50, P1410, DOI 10.1002/2013WR014333; Good SP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017168; Heidbuchel I, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011293; Jasechko S, 2013, NATURE, V496, P347, DOI 10.1038/nature11983; McDonnell JJ, 2014, WIRES WATER, V1, P323, DOI 10.1002/wat2.1027; Newman BD, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004141; Phillips FM, 2010, NAT GEOSCI, V3, P77, DOI 10.1038/ngeo762; Schlaepfer DR, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00391.1; Schlesinger WH, 2014, AGR FOREST METEOROL, V189, P115, DOI 10.1016/j.agrformet.2014.01.011; Stieglitz M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002041; Sutanto S. J., 2014, HYDROL EARTH SYST SC, V11, P2583, DOI DOI 10.5194/HESSD-11-2583-2014; Syed TH, 2010, P NATL ACAD SCI USA, V107, P17916, DOI 10.1073/pnas.1003292107; Wang DG, 2007, J HYDROL, V347, P308, DOI 10.1016/j.jhydrol.2007.09.041; Wang LX, 2014, GEOPHYS RES LETT, V41, P6753, DOI 10.1002/2014GL061439; Wang XF, 2000, HYDROL PROCESS, V14, P1407, DOI [10.1002/1099-1085(20000615)14:8<1407::AID-HYP992>3.0.CO;2-K, 10.1002/1099-1085(20000615)14:8&lt;1407::AID-HYP992&gt;3.0.CO;2-K]; Wang-Erlandsson L, 2014, EARTH SYST DYNAM, V5, P441, DOI 10.5194/esd-5-441-2014; Weiler M, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR004867; Worden J, 2012, ATMOS MEAS TECH, V5, P397, DOI 10.5194/amt-5-397-2012; Yepez EA, 2005, AGR FOREST METEOROL, V132, P359, DOI 10.1016/j.agrformet.2005.09.006	29	343	361	28	367	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					175	177		10.1126/science.aaa5931	http://dx.doi.org/10.1126/science.aaa5931			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4OM	26160944				2022-12-28	WOS:000357664300040
J	Noble, AJ; Stagg, SM				Noble, Alex J.; Stagg, Scott M.			COPI gets a fancy new coat	SCIENCE			English	Editorial Material							VESICLES; PROTEINS; SUBUNITS; COMPLEX		[Noble, Alex J.] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Stagg, Scott M.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Stagg, Scott M.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Noble, AJ (corresponding author), Florida State Univ, Dept Phys, 77 Chieftan Way, Tallahassee, FL 32306 USA.	sstagg@fsu.edu	Stagg, Scott/AAW-9294-2020	Noble, Alex/0000-0001-8634-2279				Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Dodonova SO, 2015, SCIENCE, V349, P195, DOI 10.1126/science.aab1121; Faini M, 2013, TRENDS CELL BIOL, V23, P279, DOI 10.1016/j.tcb.2013.01.005; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Lowe M, 1995, J BIOL CHEM, V270, P31364, DOI 10.1074/jbc.270.52.31364; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0	12	0	1	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2015	349	6244					142	143		10.1126/science.aac6537	http://dx.doi.org/10.1126/science.aac6537			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CM4OM	26160933				2022-12-28	WOS:000357664300024
J	Trecki, J; Gerona, RR; Schwartz, MD				Trecki, Jordan; Gerona, Roy R.; Schwartz, Michael D.			Synthetic Cannabinoid-Related Illnesses and Deaths	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STATES		[Trecki, Jordan] Drug Enforcement Adm, Off Div Control, Drug & Chem Evaluat Sect, Springfield, VA 22152 USA; [Gerona, Roy R.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Schwartz, Michael D.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA	Trecki, J (corresponding author), Drug Enforcement Adm, Off Div Control, Drug & Chem Evaluat Sect, Springfield, VA 22152 USA.							[Anonymous], 2015, MMWR MORB MORTAL WKL, V64, P618; Bonar EE, 2014, DRUG ALCOHOL DEPEN, V143, P268, DOI 10.1016/j.drugalcdep.2014.07.009; Centers for Disease Control (CDC), 2013, MMWR MORB MORTAL WKL, V62, P93; Schwartz MD, 2015, J EMERG MED, V48, P573, DOI 10.1016/j.jemermed.2014.12.038; van Amsterdam J, 2015, J PSYCHOPHARMACOL, V29, P254, DOI 10.1177/0269881114565142	5	198	200	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					103	107		10.1056/NEJMp1505328	http://dx.doi.org/10.1056/NEJMp1505328			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3QP	26154784				2022-12-28	WOS:000357598600002
J	Cole, TB				Cole, Thomas B.			Garden of the Generalife in Granada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					10	11		10.1001/jama.2014.11839	http://dx.doi.org/10.1001/jama.2014.11839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26151249				2022-12-28	WOS:000357455900001
J	Bestetti, RB; Garcia, ME; Restini, CBA				Bestetti, Reinaldo B.; Garcia, Marcelo E.; Restini, Carolina B. A.			Chagas' Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Bestetti, Reinaldo B.; Garcia, Marcelo E.; Restini, Carolina B. A.] Univ Ribeirao Preto, Ribeirao Preto, Brazil	Universidade de Ribeirao Preto	Bestetti, RB (corresponding author), Univ Ribeirao Preto, Ribeirao Preto, Brazil.	rbestetti44@gmail.com	Bestetti, Reinaldo B./AAH-4658-2019	Bern, Caryn/0000-0001-8195-7303				Ayub-Ferreira SM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002176; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Bestetti RB, 2014, INT J CARDIOL, V176, P309, DOI 10.1016/j.ijcard.2014.07.112; Garcia-Bournissen F, 2011, NEW ENGL J MED, V365, P1258, DOI 10.1056/NEJMc1108653; Theodoropoulos TAD, 2010, INT J CARDIOL, V145, P55, DOI 10.1016/j.ijcard.2009.04.011	5	493	503	1	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1881	1881		10.1056/NEJMc1510996	http://dx.doi.org/10.1056/NEJMc1510996			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FK	26222561				2022-12-28	WOS:000364144000021
J	Bern, C				Bern, Caryn			Chagas' Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRYPANOSOMA-CRUZI INFECTION; UNITED-STATES; AMERICAN TRYPANOSOMIASIS; HEART-TRANSPLANTATION; RANDOMIZED-TRIAL; BENZNIDAZOLE; CARDIOMYOPATHY; TRANSMISSION; NIFURTIMOX; EFFICACY		[Bern, Caryn] Univ Calif San Francisco, Dept Epidemiol & Biostat, Sch Med, Global Hlth Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Bern, C (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16th St, San Francisco, CA 94158 USA.	caryn.bern2@ucsf.edu	Bestetti, Reinaldo B./AAH-4658-2019	Bern, Caryn/0000-0001-8195-7303	Chemogroup	Chemogroup	Dr. Bern reports receiving consulting fees from Chemogroup. No other potential conflict of interest relevant to this article was reported.	Acquatella H, 2007, CIRCULATION, V115, P1124, DOI 10.1161/CIRCULATIONAHA.106.627323; Altcheh J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002907; Andrade ALSS, 2004, AM J TROP MED HYG, V71, P594, DOI 10.4269/ajtmh.2004.71.594; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; [Anonymous], 2014, GLOB BURD DIS EST 20; [Anonymous], [No title captured]; Bacal F, 2010, CLIN TRANSPLANT, V24, pE29, DOI 10.1111/j.1399-0012.2009.01202.x; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11; Bern C, 2011, ADV PARASIT, V75, P19, DOI 10.1016/B978-0-12-385863-4.00002-2; Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; Bocchi EA, 2001, ANN THORAC SURG, V71, P1833, DOI 10.1016/S0003-4975(01)02587-5; Bustamante JM, 2002, INT J PARASITOL, V32, P889, DOI 10.1016/S0020-7519(02)00023-1; Cantey PT, 2012, TRANSFUSION, V52, P1922, DOI 10.1111/j.1537-2995.2012.03581.x; Chatelain E, 2015, J BIOMOL SCREEN, V20, P22, DOI 10.1177/1087057114550585; Chin-Hong PV, 2011, AM J TRANSPLANT, V11, P672, DOI 10.1111/j.1600-6143.2011.03444.x; Coura J R, 1997, Rev Soc Bras Med Trop, V30, P139, DOI 10.1590/S0037-86821997000200009; de Oliveira RB, 1998, AM J GASTROENTEROL, V93, P884, DOI 10.1111/j.1572-0241.1998.270_r.x; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; del Puerto R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000687; Diez M, 2007, AM J TRANSPLANT, V7, P1633, DOI 10.1111/j.1600-6143.2007.01820.x; Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419; Dutra WO, 2014, PARASITE IMMUNOL, V36, P377, DOI 10.1111/pim.12107; Edwards MS, 2015, J PEDIAT INF DIS SOC, V4, P67, DOI 10.1093/jpids/pit056; Estani SS, 1998, AM J TROP MED HYG, V59, P526, DOI 10.4269/ajtmh.1998.59.526; Fabbro DL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003312; Feliciangeli MD, 2003, TRENDS PARASITOL, V19, P44, DOI 10.1016/S1471-4922(02)00013-2; Fiorelli AI, 2005, TRANSPLANT P, V37, P2793, DOI 10.1016/j.transproceed.2005.05.038; Gali WL, 2014, EUROPACE, V16, P674, DOI 10.1093/europace/eut422; Garcia MN, 2015, AM J TROP MED HYG, V92, P325, DOI 10.4269/ajtmh.14-0238; Gascon J, 2007, REV ESP CARDIOL, V60, P285, DOI 10.1157/13100280; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Gurtler RE, 2007, P NATL ACAD SCI USA, V104, P16194, DOI 10.1073/pnas.0700863104; Hashimoto K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-45; Huprikar S, 2013, AM J TRANSPLANT, V13, P2418, DOI 10.1111/ajt.12340; Jackson Y, 2010, CLIN INFECT DIS, V51, pE69, DOI 10.1086/656917; Pinazo MJ, 2010, GASTROENT HEPAT-BARC, V33, P191, DOI 10.1016/j.gastrohep.2009.07.009; Kapelusznik L, 2013, CLIN INFECT DIS, V57, pE7, DOI 10.1093/cid/cit199; Kransdorf EP, 2013, AM J TRANSPLANT, V13, P3262, DOI 10.1111/ajt.12507; Machado FS, 2012, SEMIN IMMUNOPATHOL, V34, P753, DOI 10.1007/s00281-012-0351-7; MAGUIRE JH, 1983, AM HEART J, V105, P287, DOI 10.1016/0002-8703(83)90529-X; Marin-Neto JA, 2009, MEM I OSWALDO CRUZ, V104, P319, DOI 10.1590/S0074-02762009000900042; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; MILES MA, 1981, LANCET, V1, P1338; Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122; Nouvellet P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002505; Perez-Molina JA, 2009, J ANTIMICROB CHEMOTH, V64, P1139, DOI 10.1093/jac/dkp357; Pinazo MJ, 2014, EXPERT REV ANTI-INFE, V12, P479, DOI 10.1586/14787210.2014.899150; Pinazo MJ, 2010, ANTIMICROB AGENTS CH, V54, P4896, DOI 10.1128/AAC.00537-10; Pinto Dias J C, 1995, Arq Bras Cardiol, V65, P359; Dias JCP, 2009, MEM I OSWALDO CRUZ, V104, P41, DOI 10.1590/S0074-02762009000900007; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Rassi A, 2009, HEART, V95, P524, DOI 10.1136/hrt.2008.159624; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Requena-Mendez A, 2013, EXPERT REV ANTI-INFE, V11, P957, DOI 10.1586/14787210.2013.824718; Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109; Sabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612; Samuels AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002358; Sartori AMC, 2007, ANN TROP MED PARASIT, V101, P31, DOI 10.1179/136485907X154629; Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931; Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011; Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956; Sholler GLS, 2011, J PEDIAT HEMATOL ONC, V33, P25, DOI 10.1097/MPH.0b013e3181f47061; Sosa-Estani S, 2006, CURR OPIN INFECT DIS, V19, P583, DOI 10.1097/01.qco.0000247592.21295.a5; Stimpert KK, 2010, EMERG INFECT DIS, V16, P871, DOI 10.3201/eid1605.091440; Streiger Mirtha L., 2004, Rev. Soc. Bras. Med. Trop., V37, P365; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; Tarleton RL, 2003, TRENDS PARASITOL, V19, P447, DOI 10.1016/j.pt.2003.08.008; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; Tornheim JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002407; Verani JR, 2010, AM J TROP MED HYG, V83, P891, DOI 10.4269/ajtmh.2010.09-0543; Villar Juan Carlos, 2014, Cochrane Database Syst Rev, pCD003463, DOI 10.1002/14651858.CD003463.pub2; Viotti R, 2014, ANTIMICROB AGENTS CH, V58, P635, DOI 10.1128/AAC.01662-13; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; WEGNER DHG, 1972, ARZNEI-FORSCHUNG, V22, P1635	77	493	503	1	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2015	373	5					456	466		10.1056/NEJMra1410150	http://dx.doi.org/10.1056/NEJMra1410150			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8BO	26222561				2022-12-28	WOS:000358662200009
J	Jain, S; Self, WH; Wunderink, RG; Fakhran, S; Balk, R; Bramley, AM; Reed, C; Grijalva, CG; Anderson, EJ; Courtney, DM; Chappell, JD; Qi, C; Hart, EM; Carroll, F; Trabue, C; Donnelly, HK; Williams, DJ; Zhu, Y; Arnold, SR; Ampofo, K; Waterer, GW; Levine, M; Lindstrom, S; Winchell, JM; Katz, JM; Erdman, D; Schneider, E; Hicks, LA; McCullers, JA; Pavia, AT; Edwards, KM; Finelli, L				Jain, S.; Self, W. H.; Wunderink, R. G.; Fakhran, S.; Balk, R.; Bramley, A. M.; Reed, C.; Grijalva, C. G.; Anderson, E. J.; Courtney, D. M.; Chappell, J. D.; Qi, C.; Hart, E. M.; Carroll, F.; Trabue, C.; Donnelly, H. K.; Williams, D. J.; Zhu, Y.; Arnold, S. R.; Ampofo, K.; Waterer, G. W.; Levine, M.; Lindstrom, S.; Winchell, J. M.; Katz, J. M.; Erdman, D.; Schneider, E.; Hicks, L. A.; McCullers, J. A.; Pavia, A. T.; Edwards, K. M.; Finelli, L.		CDC EPIC Study Team	Community-Acquired Pneumonia Requiring Hospitalization among US Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; PNEUMOCOCCAL CONJUGATE VACCINE; IMMUNIZATION PRACTICES ACIP; ACUTE RESPIRATORY-INFECTION; MYCOPLASMA-PNEUMONIAE; CHLAMYDIA-PNEUMONIAE; ADVISORY-COMMITTEE; REACTION ASSAYS; DIAGNOSIS; VIRUSES	BACKGROUND Community-acquired pneumonia is a leading infectious cause of hospitalization and death among U.S. adults. Incidence estimates of pneumonia confirmed radio-graphically and with the use of current laboratory diagnostic tests are needed. METHODS We conducted active population-based surveillance for community-acquired pneumonia requiring hospitalization among adults 18 years of age or older in five hospitals in Chicago and Nashville. Patients with recent hospitalization or severe immunosuppression were excluded. Blood, urine, and respiratory specimens were systematically collected for culture, serologic testing, antigen detection, and molecular diagnostic testing. Study radiologists independently reviewed chest radiographs. We calculated population-based incidence rates of community-acquired pneumonia requiring hospitalization according to age and pathogen. RESULTS From January 2010 through June 2012, we enrolled 2488 of 3634 eligible adults (68%). Among 2320 adults with radiographic evidence of pneumonia (93%), the median age of the patients was 57 years (interquartile range, 46 to 71); 498 patients (21%) required intensive care, and 52 (2%) died. Among 2259 patients who had radiographic evidence of pneumonia and specimens available for both bacterial and viral testing, a pathogen was detected in 853 (38%): one or more viruses in 530 (23%), bacteria in 247 (11%), bacterial and viral pathogens in 59 (3%), and a fungal or mycobacterial pathogen in 17 (1%). The most common pathogens were human rhinovirus (in 9% of patients), influenza virus (in 6%), and Streptococcus pneumoniae (in 5%). The annual incidence of pneumonia was 24.8 cases (95% confidence interval, 23.5 to 26.1) per 10,000 adults, with the highest rates among adults 65 to 79 years of age (63.0 cases per 10,000 adults) and those 80 years of age or older (164.3 cases per 10,000 adults). For each pathogen, the incidence increased with age. CONCLUSIONS The incidence of community-acquired pneumonia requiring hospitalization was highest among the oldest adults. Despite current diagnostic tests, no pathogen was detected in the majority of patients. Respiratory viruses were detected more frequently than bacteria.	[Jain, S.; Bramley, A. M.; Reed, C.; Levine, M.; Lindstrom, S.; Winchell, J. M.; Katz, J. M.; Erdman, D.; Schneider, E.; Hicks, L. A.; Finelli, L.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Self, W. H.; Grijalva, C. G.; Chappell, J. D.; Carroll, F.; Williams, D. J.; Zhu, Y.; Edwards, K. M.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Trabue, C.] Univ Tennessee, Hlth Sci Ctr, St Thomas Hlth, Nashville, TN USA; [Arnold, S. R.; McCullers, J. A.] Le Bonheur Childrens Hosp, Memphis, TN USA; [Arnold, S. R.; McCullers, J. A.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [McCullers, J. A.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Wunderink, R. G.; Anderson, E. J.; Courtney, D. M.; Qi, C.; Hart, E. M.; Donnelly, H. K.; Waterer, G. W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Fakhran, S.] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA; [Balk, R.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Ampofo, K.; Pavia, A. T.] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; [Waterer, G. W.] Univ Western Australia, Perth, WA 6009, Australia	Centers for Disease Control & Prevention - USA; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Northwestern University; Feinberg School of Medicine; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; Utah System of Higher Education; University of Utah; University of Western Australia	Jain, S (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS A-32, Atlanta, GA 30333 USA.	bwc8@cdc.gov	Arnold, Sandra R/O-4712-2014; Waterer, Grant/AAG-2385-2021; Levine, Min/ABB-4350-2021; Finelli, Lyn/AAK-2360-2020	Arnold, Sandra R/0000-0001-6130-8154; Self, Wesley/0000-0002-9300-3045; Grijalva, Carlos/0000-0002-2329-7797; Wunderink, Richard/0000-0002-8527-4195; Mizgerd, Joseph/0000-0002-4042-3169	Influenza Division of the National Center for Immunizations and Respiratory Diseases; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [U18IP000302, U18IP000299, U18IP000301, U18IP000303] Funding Source: NIH RePORTER; National Center for Immunization and Respiratory Diseases (NCIRD) [U18IP000489, U18IP000491, U18IP000490, U18IP000488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI104779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM110469] Funding Source: NIH RePORTER	Influenza Division of the National Center for Immunizations and Respiratory Diseases; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the Influenza Division of the National Center for Immunizations and Respiratory Diseases.	[Anonymous], 2014, MMWR MORB MORTAL WKL, V63, P822; [Anonymous], 2012, VINT 2012 POSTC EST; [Anonymous], 2012, VACCINES; Bartlett JG, 2011, CLIN INFECT DIS, V52, pS296, DOI 10.1093/cid/cir045; Bartlett RC, 1974, MED MICROBIOLOGY QUA, P24; Blaschke AJ, 2012, DIAGN MICR INFEC DIS, V74, P349, DOI 10.1016/j.diagmicrobio.2012.08.013; Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578; Caliendo AM, 2011, CLIN INFECT DIS, V52, pS326, DOI 10.1093/cid/cir047; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Centers for Disease Control and Prevention, FLUVIEW WEEKL INFL S; Charles PGP, 2008, CLIN INFECT DIS, V46, P1513, DOI 10.1086/586749; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Dare RK, 2007, J INFECT DIS, V196, P1321, DOI 10.1086/521308; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Feikin DR, 2013, CLIN VACCINE IMMUNOL, V20, P113, DOI 10.1128/CVI.00325-12; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017780; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Health United States, 2012, HLTH US 2012 SPEC FE, P297; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Johnstone J, 2008, CHEST, V134, P1141, DOI 10.1378/chest.08-0888; Karhu J, 2014, CLIN INFECT DIS, V59, P62, DOI 10.1093/cid/ciu237; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KENDAL AP, 1983, J CLIN MICROBIOL, V18, P930, DOI 10.1128/JCM.18.4.930-934.1983; Kumar S, 2007, CLIN INFECT DIS, V44, P568, DOI 10.1086/511076; Lanspa MJ, 2015, J HOSP MED, V10, P90, DOI 10.1002/jhm.2280; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Lieberman D, 2010, CHEST, V138, P811, DOI 10.1378/chest.09-2717; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; MONTO AS, 1981, J CLIN MICROBIOL, V13, P54, DOI 10.1128/JCM.13.1.54-57.1981; Murdoch DR, 2003, CLIN INFECT DIS, V36, P64, DOI 10.1086/345529; Murdoch DR, 2001, J CLIN MICROBIOL, V39, P3495, DOI 10.1128/JCM.39.10.3495-3498.2001; Musher DM, 2014, NEW ENGL J MED, V371, P1619, DOI 10.1056/NEJMra1312885; Nelson JC, 2008, VACCINE, V26, P4947, DOI 10.1016/j.vaccine.2008.07.016; Nilsson AC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-93; Nir-Paz R, 2006, CLIN MICROBIOL INFEC, V12, P685, DOI 10.1111/j.1469-0691.2006.01469.x; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; Pfuntner A., 2006, COSTS HOSP STAYS US; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; POLLOCK HM, 1983, J CLIN MICROBIOL, V17, P255, DOI 10.1128/JCM.17.2.255-259.1983; Ruuskanen O, 2014, CLIN INFECT DIS, V59, P71, DOI 10.1093/cid/ciu242; Sawatwong P, 2012, CLIN INFECT DIS, V54, P445, DOI 10.1093/cid/cir710; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; Thurman KA, 2011, DIAGN MICR INFEC DIS, V70, P1, DOI 10.1016/j.diagmicrobio.2010.11.014; Walsh EE, 2008, ARCH INTERN MED, V168, P2489, DOI 10.1001/archinte.168.22.2489; Watt JP, 2010, EPIDEMIOL INFECT, V138, P1146, DOI 10.1017/S0950268809991464; Weinberg GA, 2013, J CLIN VIROL, V57, P254, DOI 10.1016/j.jcv.2013.03.016; Werno AM, 2008, CLIN INFECT DIS, V46, P926, DOI 10.1086/528798; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU, P43; [No title captured]	54	1068	1123	6	122	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2015	373	5					415	427		10.1056/NEJMoa1500245	http://dx.doi.org/10.1056/NEJMoa1500245			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN8BO	26650159	Green Accepted			2022-12-28	WOS:000358662200005
J	Bern, C				Bern, Caryn			Chagas' Disease REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bern, C (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.	caryn.bern2@ucsf.edu	Bestetti, Reinaldo B./AAH-4658-2019	Bern, Caryn/0000-0001-8195-7303				Andrade J.P., 2011, Arq. Bras. Cardiol., V97, P01, DOI 10.1590/S0066-782X2011001600001; Bocchi EA, 1996, ANN THORAC SURG, V61, P1727, DOI 10.1016/0003-4975(96)00141-5; Campos SV, 2008, J HEART LUNG TRANSPL, V27, P597, DOI 10.1016/j.healun.2008.02.017; Clark EH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002801; Martinelli M, 2013, AM HEART J, V166, P976, DOI 10.1016/j.ahj.2013.08.027	5	493	503	1	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2015	373	19					1882	1882						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV3FK	26222561				2022-12-28	WOS:000364144000023
J	Wright, T				Wright, Tony			Ear wax	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, Ear Inst, London, England	University of London; University College London	Wright, T (corresponding author), UCL, Ear Inst, London, England.	anthony.wright@ucl.ac.uk						National Institute for Health and Care Excellence, 2012, CLIN KNOWL SUMM EARW; Wright T., 2015, CLIN EVID, V03, P504	2	3	3	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2015	351								h3601	10.1136/bmj.h3601	http://dx.doi.org/10.1136/bmj.h3601			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2TX	25738938				2022-12-28	WOS:000359010600001
